Citrus Sinensis ID: 008216
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 573 | 2.2.26 [Sep-21-2011] | |||||||
| Q9C823 | 552 | C-type lectin receptor-li | yes | no | 0.944 | 0.980 | 0.663 | 0.0 | |
| Q9LSC2 | 361 | PTI1-like tyrosine-protei | no | no | 0.532 | 0.844 | 0.391 | 3e-55 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.595 | 0.481 | 0.338 | 5e-54 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.586 | 0.493 | 0.333 | 9e-54 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.596 | 0.666 | 0.351 | 1e-53 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.528 | 0.464 | 0.384 | 2e-53 | |
| C0LGG9 | 1035 | Probable LRR receptor-lik | no | no | 0.596 | 0.330 | 0.36 | 3e-53 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.507 | 0.381 | 0.372 | 4e-53 | |
| Q9LS95 | 700 | Putative proline-rich rec | no | no | 0.493 | 0.404 | 0.405 | 2e-52 | |
| C0LGG8 | 1038 | Probable LRR receptor-lik | no | no | 0.513 | 0.283 | 0.387 | 4e-52 |
| >sp|Q9C823|Y1523_ARATH C-type lectin receptor-like tyrosine-protein kinase At1g52310 OS=Arabidopsis thaliana GN=At1g52310 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 709 bits (1829), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/556 (66%), Positives = 437/556 (78%), Gaps = 15/556 (2%)
Query: 5 MEKKLVPL--QCFLLLVAYYVLQLVASDTISNQSSNGQLAASMNK-DWKAPCPPDWIINE 61
ME K V Q L+ +L L + DTIS +S+ Q A K CPPDWII
Sbjct: 1 MELKWVSCRKQSLFLISCLALLCLASLDTISCEST--QNATDFKKRSQTVSCPPDWIIGP 58
Query: 62 EKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSIN 121
++KC+ Y N SW++SE +C+ GGHLA+L S +E QKLC NV+ CW+GGRS+N
Sbjct: 59 NQTKCYAYFKNSTSWEKSEMFCRTYGGHLASLASSKELSFVQKLCNGNVSSCWIGGRSMN 118
Query: 122 T-TVGLSWKWSD-NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTER 179
+ T G W WSD +WN+S+ + C + ++C V+NGS S+ ER
Sbjct: 119 SSTSGFRWSWSDPKTPQWNQSMFPKVPIRTRCGNGNGSSSCRANICIAVTNGSSSIFGER 178
Query: 180 CNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKS 239
CN SH F+C V+ + KC +CH+ YL+ L VVSGLIL TTFAI++WLL Y+RSK+RRKS
Sbjct: 179 CNASHAFVCAVDSDIKCR--NCHK-YLVILAVVSGLILFTTFAIILWLLVYKRSKKRRKS 235
Query: 240 RKLSNPAASALVPPS-WKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAV 298
RK+SNPA+S+ V P WK+FT+EELRS+TKNFSE NRL GD+KTGGTYSG L DG++VAV
Sbjct: 236 RKVSNPASSSSVVPPSWKIFTSEELRSMTKNFSEANRLAGDAKTGGTYSGGLSDGTKVAV 295
Query: 299 KRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHH 358
KRLKRSSFQRKKEFYSEI R A+L+HPN+VA+KGCCYDHG+R+IVYEF+ +GPLDRWLHH
Sbjct: 296 KRLKRSSFQRKKEFYSEIRRAAKLYHPNVVAIKGCCYDHGERFIVYEFIASGPLDRWLHH 355
Query: 359 IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418
+PRGGRSLDW MR+ +ATTLAQGIAFLHDKVKP VVHRDIRASNVLLDEEFGAHLMGVGL
Sbjct: 356 VPRGGRSLDWNMRLNIATTLAQGIAFLHDKVKPQVVHRDIRASNVLLDEEFGAHLMGVGL 415
Query: 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVD 478
SKFVPWEVMQERTVMAGGTYGYLAPE+VYRNELTTKSDVYSFGVLLLEIVSGRRP QAV+
Sbjct: 416 SKFVPWEVMQERTVMAGGTYGYLAPEYVYRNELTTKSDVYSFGVLLLEIVSGRRPTQAVN 475
Query: 479 -SVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMR 537
SV WQSIFEWATPLVQ++R+LE+LDP+I + +PEA VVQKVVDLVY+CTQ+VPSMR
Sbjct: 476 SSVGWQSIFEWATPLVQANRWLEILDPVI---TCGLPEACVVQKVVDLVYSCTQNVPSMR 532
Query: 538 PRMSHVVHQLQQLAQP 553
PRMSHVVHQLQQL QP
Sbjct: 533 PRMSHVVHQLQQLVQP 548
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 1 |
| >sp|Q9LSC2|Y3589_ARATH PTI1-like tyrosine-protein kinase At3g15890 OS=Arabidopsis thaliana GN=At3g15890 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 216 bits (551), Expect = 3e-55, Method: Compositional matrix adjust.
Identities = 123/314 (39%), Positives = 180/314 (57%), Gaps = 9/314 (2%)
Query: 253 PSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEF 312
PSW+VF+ +EL + T +F+ N+L G+ + G Y G L DGS++AVKRLK S + + +F
Sbjct: 22 PSWRVFSLKELHAATNSFNYDNKL-GEGRFGSVYWGQLWDGSQIAVKRLKEWSNREEIDF 80
Query: 313 YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 372
E+ AR+ H NL++V+G C + +R +VYE++ N L LH LDW RM
Sbjct: 81 AVEVEILARIRHKNLLSVRGYCAEGQERLLVYEYMQNLSLVSHLHGQHSAECLLDWTKRM 140
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
K+A + AQ IA+LHD PH+VH D+RASNVLLD EF A + G K +P + +
Sbjct: 141 KIAISSAQAIAYLHDHATPHIVHGDVRASNVLLDSEFEARVTDFGYGKLMPDDDTGDGAT 200
Query: 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL 492
A GY++PE + + SDVYSFG+LL+ +VSG+RP + ++ + I EW PL
Sbjct: 201 KAKSNNGYISPECDASGKESETSDVYSFGILLMVLVSGKRPLERLNPTTTRCITEWVLPL 260
Query: 493 VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
V + E++D +S A ++KVV + C Q P RP MS VV L ++
Sbjct: 261 VYERNFGEIVDKRLSEEHV----AEKLKKVVLVGLMCAQTDPDKRPTMSEVVEMLVNESK 316
Query: 553 PPVTKL----LFKG 562
+++L LFK
Sbjct: 317 EKISELEANPLFKN 330
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (541), Expect = 5e-54, Method: Compositional matrix adjust.
Identities = 132/390 (33%), Positives = 207/390 (53%), Gaps = 49/390 (12%)
Query: 206 LITLGVVSGLILLTTFAIVIWLLAYRRSKR-------------------------RRKS- 239
++ + V L++ T F I +W L +R KR R +S
Sbjct: 281 VVGISVAVALVVFTLFGIFVWCL-RKREKRLSAVSGGDVTPSPMSSTARSDSAFFRMQSS 339
Query: 240 -------RKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD 292
R S + S + S +F+ EEL T FS+ N LLG+ G Y GILPD
Sbjct: 340 APVGASKRSGSYQSQSGGLGNSKALFSYEELVKATNGFSQEN-LLGEGGFGCVYKGILPD 398
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
G VAVK+LK Q +EF +E+ +R+HH +LV++ G C R ++Y++V N L
Sbjct: 399 GRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDL 458
Query: 353 DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
LH G +S LDWA R+K+A A+G+A+LH+ P ++HRDI++SN+LL++ F A
Sbjct: 459 YFHLH----GEKSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDA 514
Query: 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 471
+ GL++ + T GT+GY+APE+ +LT KSDV+SFGV+LLE+++GR
Sbjct: 515 RVSDFGLARLA-LDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 573
Query: 472 RPAQAVDSVCWQSIFEWATPL----VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVY 527
+P + +S+ EWA PL +++ + L DP L + E+ + ++++
Sbjct: 574 KPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADP---KLGGNYVESEMF-RMIEAAG 629
Query: 528 ACTQHVPSMRPRMSHVVHQLQQLAQPPVTK 557
AC +H+ + RPRM +V + LA +T
Sbjct: 630 ACVRHLATKRPRMGQIVRAFESLAAEDLTN 659
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (538), Expect = 9e-54, Method: Compositional matrix adjust.
Identities = 131/393 (33%), Positives = 206/393 (52%), Gaps = 57/393 (14%)
Query: 206 LITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKS-----------RKLSNPAASALV--- 251
++ +GV+ GL+ L+ F + +W KR+RK S+P S +V
Sbjct: 238 IVAIGVIVGLVFLSLFVMGVWFT----RKRKRKDPGTFVGYTMPPSAYSSPQGSDVVLFN 293
Query: 252 -----PPSWKV----------------------FTTEELRSITKNFSEGNRLLGDSKTGG 284
PP + F+ +EL +T FSE N LLG+ G
Sbjct: 294 SRSSAPPKMRSHSGSDYMYASSDSGMVSNQRSWFSYDELSQVTSGFSEKN-LLGEGGFGC 352
Query: 285 TYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344
Y G+L DG VAVK+LK Q ++EF +E+ +R+HH +LV + G C R +VY
Sbjct: 353 VYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISRVHHRHLVTLVGYCISEQHRLLVY 412
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
++V N L LH G + W R++VA A+GIA+LH+ P ++HRDI++SN+L
Sbjct: 413 DYVPNNTLHYHLHA--PGRPVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNIL 470
Query: 405 LDEEFGAHLMGVGLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 463
LD F A + GL+K ++ + GT+GY+APE+ +L+ K+DVYS+GV+
Sbjct: 471 LDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVI 530
Query: 464 LLEIVSGRRPAQAVDSVCWQSIFEWATPL----VQSHRYLELLDPLISSLSSDIPEAGVV 519
LLE+++GR+P + +S+ EWA PL +++ + EL+DP + + IP G +
Sbjct: 531 LLELITGRKPVDTSQPLGDESLVEWARPLLGQAIENEEFDELVDPRLG--KNFIP--GEM 586
Query: 520 QKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
++V+ AC +H + RP+MS VV L L +
Sbjct: 587 FRMVEAAAACVRHSAAKRPKMSQVVRALDTLEE 619
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 211 bits (536), Expect = 1e-53, Method: Compositional matrix adjust.
Identities = 122/347 (35%), Positives = 193/347 (55%), Gaps = 5/347 (1%)
Query: 207 ITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSI 266
++ G V G+ + ++ + + KR R + L P L FT EL
Sbjct: 121 LSTGAVVGISIGGGVFVLTLIFFLCKKKRPRDDKALPAPIGLVL-GIHQSTFTYGELARA 179
Query: 267 TKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN 326
T FSE N LLG+ G Y GIL +G+ VAVK+LK S Q +KEF +E+ +++HH N
Sbjct: 180 TNKFSEAN-LLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNIISQIHHRN 238
Query: 327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 386
LV++ G C R +VYEFV N L+ LH +G +++W++R+K+A + ++G+++LH
Sbjct: 239 LVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHG--KGRPTMEWSLRLKIAVSSSKGLSYLH 296
Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV 446
+ P ++HRDI+A+N+L+D +F A + GL+K + + + GT+GYLAPE+
Sbjct: 297 ENCNPKIIHRDIKAANILIDFKFEAKVADFGLAK-IALDTNTHVSTRVMGTFGYLAPEYA 355
Query: 447 YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506
+LT KSDVYSFGV+LLE+++GRRP A + S+ +WA PL+ + L
Sbjct: 356 ASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLLVQALEESNFEGLA 415
Query: 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
++ + + ++V AC ++ RPRM VV L+ P
Sbjct: 416 DIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVRVLEGNISP 462
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 210 bits (535), Expect = 2e-53, Method: Compositional matrix adjust.
Identities = 118/307 (38%), Positives = 178/307 (57%), Gaps = 4/307 (1%)
Query: 242 LSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRL 301
L P+ ++ S FT EEL T FSE N LLG G + GILP G VAVK+L
Sbjct: 252 LPPPSPGLVLGFSKSTFTYEELSRATNGFSEAN-LLGQGGFGYVHKGILPSGKEVAVKQL 310
Query: 302 KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPR 361
K S Q ++EF +E+ +R+HH +LV++ G C R +VYEFV N L+ LH +
Sbjct: 311 KAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG--K 368
Query: 362 GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421
G +++W+ R+K+A A+G+++LH+ P ++HRDI+ASN+L+D +F A + GL+K
Sbjct: 369 GRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK- 427
Query: 422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC 481
+ + + GT+GYLAPE+ +LT KSDV+SFGV+LLE+++GRRP A +
Sbjct: 428 IASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYV 487
Query: 482 WQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS 541
S+ +WA PL+ + L S + + + ++V AC +H RPRMS
Sbjct: 488 DDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMS 547
Query: 542 HVVHQLQ 548
+V L+
Sbjct: 548 QIVRALE 554
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 210 bits (534), Expect = 3e-53, Method: Compositional matrix adjust.
Identities = 126/350 (36%), Positives = 190/350 (54%), Gaps = 8/350 (2%)
Query: 210 GVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKN 269
GVV+G+++ A + +L R +++ + FT ++++ T N
Sbjct: 607 GVVAGIVIAACVAFGLLVLVILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNN 666
Query: 270 FSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVA 329
F N++ G+ G Y G+L DG +AVK+L S Q +EF +EIG + L HPNLV
Sbjct: 667 FDPENKI-GEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVK 725
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
+ GCC + + +VYE++ N L R L + LDW+ R KV +A+G+A+LH++
Sbjct: 726 LYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEES 785
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
+ +VHRDI+A+NVLLD A + GL+K E T +A GT GY+APE+ R
Sbjct: 786 RLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIA-GTIGYMAPEYAMRG 844
Query: 450 ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509
LT K+DVYSFGV+ LEIVSG+ + + +WA L + LEL+DP + +
Sbjct: 845 YLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQGSLLELVDPDLGT- 903
Query: 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ--LAQPPVTK 557
S EA +++++ CT P++RP MS VV LQ QPP+ K
Sbjct: 904 SFSKKEA---MRMLNIALLCTNPSPTLRPPMSSVVSMLQGKIKVQPPLVK 950
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 209 bits (533), Expect = 4e-53, Method: Compositional matrix adjust.
Identities = 113/303 (37%), Positives = 176/303 (58%), Gaps = 12/303 (3%)
Query: 254 SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFY 313
S ++F+ EEL T FS+ N LLG+ G Y G+LPD VAVK+LK Q +EF
Sbjct: 414 SRELFSYEELVIATNGFSDEN-LLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDREFK 472
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
+E+ +R+HH NL+++ G C R ++Y++V N L + H G LDWA R+K
Sbjct: 473 AEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNL--YFHLHAAGTPGLDWATRVK 530
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
+A A+G+A+LH+ P ++HRDI++SN+LL+ F A + GL+K + T
Sbjct: 531 IAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLA-LDCNTHITTR 589
Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV 493
GT+GY+APE+ +LT KSDV+SFGV+LLE+++GR+P A + +S+ EWA PL+
Sbjct: 590 VMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLL 649
Query: 494 ----QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549
++ + L DP + + + ++++ AC +H + RPRMS +V
Sbjct: 650 SNATETEEFTALADPKLGRNYVGV----EMFRMIEAAAACIRHSATKRPRMSQIVRAFDS 705
Query: 550 LAQ 552
LA+
Sbjct: 706 LAE 708
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LS95|PERK6_ARATH Putative proline-rich receptor-like protein kinase PERK6 OS=Arabidopsis thaliana GN=PERK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 207 bits (527), Expect = 2e-52, Method: Compositional matrix adjust.
Identities = 120/296 (40%), Positives = 176/296 (59%), Gaps = 13/296 (4%)
Query: 257 VFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEI 316
FT +EL + T+ FS+ +RLLG G + GILP+G +AVK LK S Q ++EF +E+
Sbjct: 324 TFTYDELAAATQGFSQ-SRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEV 382
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 376
+R+HH LV++ G C G R +VYEF+ N L+ LH + G+ LDW R+K+A
Sbjct: 383 DIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHG--KSGKVLDWPTRLKIAL 440
Query: 377 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG 436
A+G+A+LH+ P ++HRDI+ASN+LLDE F A + GL+K V T + G
Sbjct: 441 GSAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRIM-G 499
Query: 437 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL---- 492
T+GYLAPE+ +LT +SDV+SFGV+LLE+V+GRRP + S+ +WA P+
Sbjct: 500 TFGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGEM-EDSLVDWARPICLNA 558
Query: 493 VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
Q Y EL+DP + + E + ++V A +H RP+MS +V L+
Sbjct: 559 AQDGDYSELVDPRLENQY----EPHEMAQMVACAAAAVRHSARRRPKMSQIVRALE 610
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 206 bits (524), Expect = 4e-52, Method: Compositional matrix adjust.
Identities = 117/302 (38%), Positives = 173/302 (57%), Gaps = 8/302 (2%)
Query: 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIG 317
FT ++++ T NF N++ G+ G Y G+L DG +AVK+L S Q +EF +EIG
Sbjct: 657 FTLKQIKRATNNFDPENKI-GEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIG 715
Query: 318 RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 377
+ L HPNLV + GCC + + +VYE++ N L R L + LDW+ R K+
Sbjct: 716 MISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKICIG 775
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
+A+G+A+LH++ + +VHRDI+A+NVLLD A + GL+K E T +A GT
Sbjct: 776 IAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLNDDENTHISTRIA-GT 834
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 497
GY+APE+ R LT K+DVYSFGV+ LEIVSG+ + + +WA L +
Sbjct: 835 IGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGS 894
Query: 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ--LAQPPV 555
LEL+DP + + S EA +++++ CT P++RP MS VV L+ QPP+
Sbjct: 895 LLELVDPDLGT-SFSKKEA---MRMLNIALLCTNPSPTLRPPMSSVVSMLEGKIKVQPPL 950
Query: 556 TK 557
K
Sbjct: 951 VK 952
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 573 | ||||||
| 225455058 | 542 | PREDICTED: C-type lectin receptor-like t | 0.945 | 1.0 | 0.793 | 0.0 | |
| 255556651 | 552 | kinase, putative [Ricinus communis] gi|2 | 0.954 | 0.990 | 0.779 | 0.0 | |
| 224137796 | 516 | predicted protein [Populus trichocarpa] | 0.870 | 0.967 | 0.810 | 0.0 | |
| 449503381 | 557 | PREDICTED: C-type lectin receptor-like t | 0.958 | 0.985 | 0.703 | 0.0 | |
| 449454927 | 557 | PREDICTED: C-type lectin receptor-like t | 0.956 | 0.983 | 0.702 | 0.0 | |
| 297745082 | 517 | unnamed protein product [Vitis vinifera] | 0.881 | 0.976 | 0.727 | 0.0 | |
| 356532800 | 545 | PREDICTED: C-type lectin receptor-like t | 0.910 | 0.957 | 0.709 | 0.0 | |
| 356558437 | 547 | PREDICTED: C-type lectin receptor-like t | 0.910 | 0.954 | 0.711 | 0.0 | |
| 357134621 | 557 | PREDICTED: C-type lectin receptor-like t | 0.860 | 0.885 | 0.709 | 0.0 | |
| 115434006 | 555 | Os01g0104000 [Oryza sativa Japonica Grou | 0.860 | 0.888 | 0.713 | 0.0 |
| >gi|225455058|ref|XP_002263812.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 885 bits (2287), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 439/553 (79%), Positives = 479/553 (86%), Gaps = 11/553 (1%)
Query: 5 MEKKLVPLQCFLLLVAYYVLQLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKS 64
ME KLV LQ LL+++ V QL ASD I ++S S+ +A CPPDWI +K+
Sbjct: 1 MEGKLVRLQFPLLVISCLVFQLRASDAILHESRR-----SLESRKEALCPPDWITGPDKN 55
Query: 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTV 124
KCF YIGN +SWD SE YCK +GGHLAALTS++E S Q LCG++ NGCWVGGR +N+T
Sbjct: 56 KCFRYIGNPQSWDVSEAYCKSLGGHLAALTSFQELSSVQNLCGESNNGCWVGGRGVNSTF 115
Query: 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSH 184
G WKWSDN S WNESI +CT+ CH+ +VD CTLV+NGS L+ ERCN SH
Sbjct: 116 GAGWKWSDNTSHWNESIFP------NCTNSSCHIKNSVDSCTLVTNGSTFLIGERCNMSH 169
Query: 185 PFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSN 244
ICM++ ENKCY++HCH+EYLI L VVSGLIL TT A+VIWLLAYRRSKRRR+SRKLSN
Sbjct: 170 ASICMIDIENKCYHMHCHKEYLIILAVVSGLILSTTLAVVIWLLAYRRSKRRRRSRKLSN 229
Query: 245 PAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS 304
PAASALVPPSWKVFT EELRSITKNFSEGNRLLGD+KTGGTYSG+LPDGSRVAVKRLKRS
Sbjct: 230 PAASALVPPSWKVFTNEELRSITKNFSEGNRLLGDAKTGGTYSGLLPDGSRVAVKRLKRS 289
Query: 305 SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR 364
+FQRKKEFYSEIGR ARLHHPNLVAVKGCCYDHGDRYIVYEF++NGPLDRWLHHIPRGGR
Sbjct: 290 TFQRKKEFYSEIGRVARLHHPNLVAVKGCCYDHGDRYIVYEFIINGPLDRWLHHIPRGGR 349
Query: 365 SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424
SLDWAMRMK+ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV W
Sbjct: 350 SLDWAMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVSW 409
Query: 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS 484
EVM + TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV WQS
Sbjct: 410 EVMHQGTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVGWQS 469
Query: 485 IFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
IFEWATPLVQSHRY ELLDPLISS S+DIPEAGV+QKVVDLVYACTQHVPSMRPRMSHVV
Sbjct: 470 IFEWATPLVQSHRYPELLDPLISSSSADIPEAGVIQKVVDLVYACTQHVPSMRPRMSHVV 529
Query: 545 HQLQQLAQPPVTK 557
HQLQQLAQPP+ K
Sbjct: 530 HQLQQLAQPPIAK 542
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255556651|ref|XP_002519359.1| kinase, putative [Ricinus communis] gi|223541426|gb|EEF42976.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 853 bits (2203), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/548 (77%), Positives = 466/548 (85%), Gaps = 1/548 (0%)
Query: 5 MEKKLVPLQCFLLLVAYYVLQLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKS 64
M+ KL LQ +LL+A VL VA + ISN + + L AS N+ K C W I+ K
Sbjct: 1 MDLKLTHLQFSVLLIAV-VLSFVAPENISNDTIHSPLIASRNESNKGWCHSGWDISPNKK 59
Query: 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTV 124
KC Y +SWD+SE C GGHLAALTS +E A++LCG+ V+GCWVG R IN+TV
Sbjct: 60 KCLKYFEKSKSWDDSEALCASYGGHLAALTSSQELTFAKQLCGQIVDGCWVGERVINSTV 119
Query: 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSH 184
G +WKW DN S WNESI + SF+S CT+L CH +AT + CTLV+N + LV ERCN SH
Sbjct: 120 GSNWKWFDNTSYWNESILSGASFDSKCTNLSCHNNATAEFCTLVNNRTTHLVDERCNKSH 179
Query: 185 PFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSN 244
FICM++ ENKCY++HCHREYLI L VVSGLIL T A+VIWLLAYRRS++RRKSRKLSN
Sbjct: 180 VFICMLDAENKCYHMHCHREYLIILAVVSGLILCTALAVVIWLLAYRRSRKRRKSRKLSN 239
Query: 245 PAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS 304
PAASALVPPSWKVFT EELRSITKNFSEGNRL GD+KTGGTYSG+LPDGSRVAVKRLKRS
Sbjct: 240 PAASALVPPSWKVFTNEELRSITKNFSEGNRLPGDAKTGGTYSGLLPDGSRVAVKRLKRS 299
Query: 305 SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR 364
SFQRKKEFYSEIGR ARLHHPNLVA+KGCCYDHGDRYIVYEFVVNGPLDRWLHHI RGGR
Sbjct: 300 SFQRKKEFYSEIGRVARLHHPNLVAIKGCCYDHGDRYIVYEFVVNGPLDRWLHHISRGGR 359
Query: 365 SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424
SLDW MRMK+ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW
Sbjct: 360 SLDWTMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 419
Query: 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS 484
EVM E TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV+GRRPAQAVDSV WQS
Sbjct: 420 EVMHEGTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVTGRRPAQAVDSVGWQS 479
Query: 485 IFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
IFEWATPLVQ+HRY ELLDPLI S SS+IPE GV+QKVVDLVYACTQHVPSMRPRMSHVV
Sbjct: 480 IFEWATPLVQAHRYPELLDPLIYSSSSEIPEPGVIQKVVDLVYACTQHVPSMRPRMSHVV 539
Query: 545 HQLQQLAQ 552
HQLQQLAQ
Sbjct: 540 HQLQQLAQ 547
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224137796|ref|XP_002326442.1| predicted protein [Populus trichocarpa] gi|222833764|gb|EEE72241.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 826 bits (2133), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 406/501 (81%), Positives = 439/501 (87%), Gaps = 2/501 (0%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP W I+ KSKCF I F+SW+ESE C GGH+A LTS EE AQKLCG+ NG
Sbjct: 18 CPSGWAISPNKSKCFKLIRRFKSWNESENRCMHYGGHVAGLTSSEELSFAQKLCGQTANG 77
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
CW GGR +N+T+G WKWSD+ S N+SI F +CTSL C DLCT+V NG+
Sbjct: 78 CWAGGRVMNSTIGFIWKWSDSTSHMNQSI-VPEPFPLNCTSLSCRNSIAADLCTVV-NGT 135
Query: 173 RSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRR 232
LV ERCN+SH FICM++ E KCY++HCHREYLI L VVSGLIL TT A+VIWLLAYRR
Sbjct: 136 ADLVAERCNSSHAFICMLDVEKKCYHMHCHREYLIILAVVSGLILCTTLAVVIWLLAYRR 195
Query: 233 SKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPD 292
SK+RRKSRKLSNPAASALVPPSWKVFT EELRSITKNFSEGNRLLGD+KTGGTYSG LPD
Sbjct: 196 SKKRRKSRKLSNPAASALVPPSWKVFTNEELRSITKNFSEGNRLLGDAKTGGTYSGFLPD 255
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
GSRVAVKRLKRSSFQRKKEFYSEIGR ARLHHPNLVA+KGCCYDHGDRYIVYEF++NGPL
Sbjct: 256 GSRVAVKRLKRSSFQRKKEFYSEIGRVARLHHPNLVAIKGCCYDHGDRYIVYEFILNGPL 315
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
DRWLHH+PRGGRSLDWAMRMK+ATTLAQGIAFLHDKVKPHVVHRDIRAS+VLLDEEFGAH
Sbjct: 316 DRWLHHVPRGGRSLDWAMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASSVLLDEEFGAH 375
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 472
LMGVGLSKF+PWEVM ERT+MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR
Sbjct: 376 LMGVGLSKFMPWEVMHERTMMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 435
Query: 473 PAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQH 532
P QAVDSV WQSIFEWATPLVQ+HRY ELLDPLI+ SSD+PEAGV+QKVVDLVYACTQH
Sbjct: 436 PMQAVDSVGWQSIFEWATPLVQAHRYPELLDPLITPPSSDVPEAGVIQKVVDLVYACTQH 495
Query: 533 VPSMRPRMSHVVHQLQQLAQP 553
VPSMRPRMSHVVHQLQQLAQP
Sbjct: 496 VPSMRPRMSHVVHQLQQLAQP 516
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449503381|ref|XP_004161974.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 802 bits (2072), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/556 (70%), Positives = 461/556 (82%), Gaps = 7/556 (1%)
Query: 9 LVPLQCFLLLVAYYVL----QLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKS 64
+ P + L ++ +VL ++ SDT+ N+S G S + K CP WII+ K+
Sbjct: 1 MAPTEVKTLFLSLFVLIWLSRMGVSDTMFNESGIGYSVVSRKEISKGRCPHGWIISPSKT 60
Query: 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTV 124
KCFG++ + +SW++SET C GG+LAAL +Y+E AQ LC + GCWVGGR+ N+
Sbjct: 61 KCFGFMSSPKSWNDSETQCNSFGGNLAALVTYQEFSYAQNLCNGTLGGCWVGGRAFNSLN 120
Query: 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRS--LVTERCNT 182
WKWSDN+SKWN+SI + S+C + CH + +V+ CTL+ G + L E+CN+
Sbjct: 121 DFVWKWSDNVSKWNDSIFPSATLQSNCKNASCHRNDSVETCTLIFGGPATPFLRDEKCNS 180
Query: 183 SHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKL 242
SHPFICM+ +++C+ +HCH+EYL+ L VVSGLI TT A+VIWLLA++RSK+RR+SRK
Sbjct: 181 SHPFICMINLDDRCHRMHCHKEYLVILAVVSGLIFCTTLAVVIWLLAHKRSKKRRRSRKP 240
Query: 243 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK 302
SNPAASALVPP W+VFT EELRS+TKNFSEGNRLLGD+KTGGTYSG+LPDGSRVA+KRLK
Sbjct: 241 SNPAASALVPPLWRVFTKEELRSMTKNFSEGNRLLGDAKTGGTYSGLLPDGSRVAIKRLK 300
Query: 303 RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG 362
+SSFQRKKEF+SEI R ARL HPNLVA+KGCCYDHGDRYIVYEF+VNGPLDRWLHH+PRG
Sbjct: 301 KSSFQRKKEFHSEIARVARLRHPNLVALKGCCYDHGDRYIVYEFIVNGPLDRWLHHVPRG 360
Query: 363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422
GRSLDW MRMK+ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK V
Sbjct: 361 GRSLDWTMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKLV 420
Query: 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW 482
+EVM ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV+GRRPAQAVDSV W
Sbjct: 421 AYEVMHERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVTGRRPAQAVDSVGW 480
Query: 483 QSIFEWATPLVQSHRYLELLDPLISSLS-SDIPEAGVVQKVVDLVYACTQHVPSMRPRMS 541
QSIFEWATPLVQ+HRYL+LLDP I++ S S+IPEAG+VQKVVDLVYACTQHVPSMRPRMS
Sbjct: 481 QSIFEWATPLVQAHRYLDLLDPHITATSTSEIPEAGIVQKVVDLVYACTQHVPSMRPRMS 540
Query: 542 HVVHQLQQLAQPPVTK 557
HVVHQLQQLA P+T+
Sbjct: 541 HVVHQLQQLAPSPLTR 556
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454927|ref|XP_004145205.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Cucumis sativus] gi|449473071|ref|XP_004153775.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 798 bits (2061), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/555 (70%), Positives = 459/555 (82%), Gaps = 7/555 (1%)
Query: 9 LVPLQCFLLLVAYYVL----QLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKS 64
+ P + L ++ +VL ++ SDT+ N+S G S + K CP WII+ K+
Sbjct: 1 MAPTEVKTLFLSLFVLIWLSRMGVSDTMFNESGIGYSVVSRKEISKGRCPHGWIISPSKT 60
Query: 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTV 124
KCFG++ + +SW++SET C GG+LAAL +Y+E AQ LC + GCWVGGR+ N+
Sbjct: 61 KCFGFMSSPKSWNDSETQCNSFGGNLAALVTYQEFSYAQNLCNGTLGGCWVGGRAFNSLN 120
Query: 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRS--LVTERCNT 182
WKWSDN+SKWN+SI + S+C + C + +V+ CTL+ G + L E+CN+
Sbjct: 121 DFVWKWSDNVSKWNDSIFPSATLQSNCKNASCLRNDSVETCTLIFGGPATPFLRDEKCNS 180
Query: 183 SHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKL 242
SHPFICM+ +++C+ +HCH+EYL+ L VVSGLI TT A+VIWLLA++RSK+RR+SRK
Sbjct: 181 SHPFICMINLDDRCHRMHCHKEYLVILAVVSGLIFCTTLAVVIWLLAHKRSKKRRRSRKP 240
Query: 243 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK 302
SNPAASALVPP W+VFT EELRS+TKNFSEGNRLLGD+KTGGTYSG+LPDGSRVA+KRLK
Sbjct: 241 SNPAASALVPPLWRVFTKEELRSMTKNFSEGNRLLGDAKTGGTYSGLLPDGSRVAIKRLK 300
Query: 303 RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG 362
+SSFQRKKEF+SEI R ARL HPNLVA+KGCCYDHGDRYIVYEF+VNGPLDRWLHH+PRG
Sbjct: 301 KSSFQRKKEFHSEIARVARLRHPNLVALKGCCYDHGDRYIVYEFIVNGPLDRWLHHVPRG 360
Query: 363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422
GRSLDW MRMK+ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK V
Sbjct: 361 GRSLDWTMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKLV 420
Query: 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW 482
+EVM ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV+GRRPAQAVDSV W
Sbjct: 421 AYEVMHERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVTGRRPAQAVDSVGW 480
Query: 483 QSIFEWATPLVQSHRYLELLDPLISSLS-SDIPEAGVVQKVVDLVYACTQHVPSMRPRMS 541
QSIFEWATPLVQ+HRYL+LLDP I++ S S+IPEAG+VQKVVDLVYACTQHVPSMRPRMS
Sbjct: 481 QSIFEWATPLVQAHRYLDLLDPHITATSTSEIPEAGIVQKVVDLVYACTQHVPSMRPRMS 540
Query: 542 HVVHQLQQLAQPPVT 556
HVVHQLQQLA P+T
Sbjct: 541 HVVHQLQQLAPSPLT 555
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745082|emb|CBI38674.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 796 bits (2056), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/555 (72%), Positives = 443/555 (79%), Gaps = 50/555 (9%)
Query: 3 LLMEKKLVPLQCFLLLVAYYVLQLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEE 62
+ ME KLV LQ LL+++ V QL ASD I ++S S+ +A CPPDWI +
Sbjct: 13 VFMEGKLVRLQFPLLVISCLVFQLRASDAILHESRR-----SLESRKEALCPPDWITGPD 67
Query: 63 KSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINT 122
K+KCF YIGN +SWD SE YCK +GGHLAALTS++E S Q LCG++ NGCWVGGR +N+
Sbjct: 68 KNKCFRYIGNPQSWDVSEAYCKSLGGHLAALTSFQELSSVQNLCGESNNGCWVGGRGVNS 127
Query: 123 TVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNT 182
T G WKWSDN S WNESI +CT+ CH+ +VD CTLV+NGS L+ ERCN
Sbjct: 128 TFGAGWKWSDNTSHWNESIFP------NCTNSSCHIKNSVDSCTLVTNGSTFLIGERCNM 181
Query: 183 SHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKL 242
SH ICM++ ENKCY++HCH+EYLI L VVSGLIL TT A+VIWLLAYRRSKRRR+SRKL
Sbjct: 182 SHASICMIDIENKCYHMHCHKEYLIILAVVSGLILSTTLAVVIWLLAYRRSKRRRRSRKL 241
Query: 243 SNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK 302
SNPAASALVPPSWKVFT EELRSITKNFSEGNRLLGD+KTGGTYSG+LPDGSRVAVKRLK
Sbjct: 242 SNPAASALVPPSWKVFTNEELRSITKNFSEGNRLLGDAKTGGTYSGLLPDGSRVAVKRLK 301
Query: 303 RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRG 362
RS+FQRKKEFYSEIGR ARLHHPNLVAVKGCCYDHGDRYIVYEF++NGPLDRWLHHIPRG
Sbjct: 302 RSTFQRKKEFYSEIGRVARLHHPNLVAVKGCCYDHGDRYIVYEFIINGPLDRWLHHIPRG 361
Query: 363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422
GRSLDWAMRMK+ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV
Sbjct: 362 GRSLDWAMRMKIATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 421
Query: 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW 482
WEVM + TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV W
Sbjct: 422 SWEVMHQGTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVGW 481
Query: 483 QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSH 542
QSIFEWATPL HVPSMRPRMSH
Sbjct: 482 QSIFEWATPL---------------------------------------HVPSMRPRMSH 502
Query: 543 VVHQLQQLAQPPVTK 557
VVHQLQQLAQPP+ K
Sbjct: 503 VVHQLQQLAQPPIAK 517
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356532800|ref|XP_003534958.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1943), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/530 (70%), Positives = 437/530 (82%), Gaps = 8/530 (1%)
Query: 27 VASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI 86
+AS+ N++ G S+N+D K PCP W+++ K+KCF ++G +SW++SET C +
Sbjct: 20 LASNATLNETC-GYFDGSLNRDPKVPCPIGWVMDPNKTKCFLHVGRPQSWNDSETCCSKY 78
Query: 87 GGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGS 146
GGHL +LTS +E AQ LCG+++N CW+GG+ +N+T G W WS+N S WN SI ++ +
Sbjct: 79 GGHLVSLTSLQELQFAQSLCGESINSCWIGGQRLNSTAGYQWMWSNN-SPWNNSIFSMVN 137
Query: 147 FNSSC--TSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHRE 204
C T CH ++T +LCT+V+N S SL+TERC+ H +C+++ + K +H RE
Sbjct: 138 VPPHCNGTGPSCHRNSTDNLCTVVTNNSNSLITERCDNPHASLCILDIDTKRNQMHRRRE 197
Query: 205 YLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELR 264
YLI L VVS LIL TT ++V+WLL Y+R K+RR+SRKLS P AS PSWKVFT EELR
Sbjct: 198 YLIILTVVSTLILSTTLSVVVWLLVYKRGKKRRRSRKLSIPGASL---PSWKVFTKEELR 254
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH 324
SITKNFSEGNRL+GD+KTGGTYSG+L DGS+VAVKRLKRSSFQRKKEFYSEI R ARL H
Sbjct: 255 SITKNFSEGNRLVGDAKTGGTYSGVLSDGSKVAVKRLKRSSFQRKKEFYSEISRVARLRH 314
Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
PNLVAV GCCYDHGDRYIVYEFV NGPLD+WLHHIPRGGR+LDWAMRMK+ATTLAQGIAF
Sbjct: 315 PNLVAVMGCCYDHGDRYIVYEFVANGPLDKWLHHIPRGGRNLDWAMRMKIATTLAQGIAF 374
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
LHDKVKP VVHRDIRASNVLLDEEFGA LMGVGLSKFVP+EVM ERTVMAGGTYGYLAPE
Sbjct: 375 LHDKVKPQVVHRDIRASNVLLDEEFGAQLMGVGLSKFVPYEVMHERTVMAGGTYGYLAPE 434
Query: 445 FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504
FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV WQSIFEWATPLVQ+HRY ELLD
Sbjct: 435 FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVGWQSIFEWATPLVQAHRYHELLDL 494
Query: 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
I+S SS IPEA +QKVVDLVY+CTQHVPSMRPRMSHVVHQLQQ+AQPP
Sbjct: 495 HITS-SSIIPEASTIQKVVDLVYSCTQHVPSMRPRMSHVVHQLQQIAQPP 543
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558437|ref|XP_003547513.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 743 bits (1917), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/530 (71%), Positives = 430/530 (81%), Gaps = 8/530 (1%)
Query: 27 VASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI 86
+AS+ N++ G S+N+D K PCP WI++ K+KCF ++G +SW++SET C +
Sbjct: 20 LASNATLNETC-GYFDGSLNRDPKVPCPIGWIMDPNKTKCFLHVGRPQSWNDSETCCSKY 78
Query: 87 GGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGS 146
GGHL +LTS E AQ LCG+++N CWVGG+ +N T G W WSDN S WN SI ++
Sbjct: 79 GGHLVSLTSLPELQFAQGLCGESINSCWVGGQRVNATAGNQWMWSDN-SPWNNSIFSMVE 137
Query: 147 FNSSC--TSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHRE 204
C T CH ++T +LCT+V+N S SL TERCN H +C+++ + KC +H RE
Sbjct: 138 VPPHCNGTGPSCHRNSTDNLCTVVTNNSNSLTTERCNNPHASLCILDIDTKCNQMHRRRE 197
Query: 205 YLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELR 264
Y I L VVS LIL TT A+V+WLL Y+R K+RR+SRKLS P AS PSWKVFT EELR
Sbjct: 198 YFIILTVVSALILSTTLAVVVWLLVYKRGKKRRRSRKLSIPGASL---PSWKVFTKEELR 254
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH 324
SITKNFSEGNRL+GD+KTGGTYSG++ DGS+VAVKRLKRS+FQRKKEFYSEIGR ARL H
Sbjct: 255 SITKNFSEGNRLVGDTKTGGTYSGVVSDGSKVAVKRLKRSNFQRKKEFYSEIGRVARLRH 314
Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
PNLVAV GCCYDHGDRYIVYEFV NGPLD+WLHHIPRGGRSLDWAMRMK+ATTLAQGIAF
Sbjct: 315 PNLVAVMGCCYDHGDRYIVYEFVANGPLDKWLHHIPRGGRSLDWAMRMKIATTLAQGIAF 374
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
LHDKVKP VVHRDIR SNVLLDEEFGA LMGVGLSKFVP+EVM ERTVMAGGTYGYLAPE
Sbjct: 375 LHDKVKPQVVHRDIRTSNVLLDEEFGARLMGVGLSKFVPYEVMHERTVMAGGTYGYLAPE 434
Query: 445 FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504
FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV WQSIFEWATPLVQ+HRY ELLD
Sbjct: 435 FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVGWQSIFEWATPLVQAHRYHELLDL 494
Query: 505 LIS-SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
I+ S SS IPEA +QKVVDLVY+CTQHVPSMRPRMSHV HQLQQ+ QP
Sbjct: 495 HITSSSSSIIPEASTIQKVVDLVYSCTQHVPSMRPRMSHVFHQLQQITQP 544
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357134621|ref|XP_003568915.1| PREDICTED: C-type lectin receptor-like tyrosine-protein kinase At1g52310-like [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 729 bits (1883), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/502 (70%), Positives = 416/502 (82%), Gaps = 9/502 (1%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP W I+ ++ KCF +I + SWD SE C+ GHLAAL+S ++ + A+ LCG + +G
Sbjct: 30 CPQGWQISPDRVKCFMHISSSLSWDGSEALCRNFSGHLAALSSVQDLNFAKSLCGASSSG 89
Query: 113 CWVGGR----SINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 168
CWVGGR S NTT + WKWSD+ S WN+++ +++C S C + + D+CTLV
Sbjct: 90 CWVGGRRYNTSSNTTSVVGWKWSDDSSFWNQTVFPGEPSHANCNSTHCGLATSYDICTLV 149
Query: 169 SNGSRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLL 228
+N +L +C SH ICM+ HE++CY+ HCH+EY I L VVSGLIL TT A+V+WLL
Sbjct: 150 TNKHAALTGRKCGESHGLICMINHEDRCYHDHCHKEYFIVLIVVSGLILSTTLAVVVWLL 209
Query: 229 AYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSG 288
YRRSK+RR+SR+ S +A+ALVPP WKVFT EELRSITKNFSEGNRL G++KTGGTYSG
Sbjct: 210 VYRRSKKRRRSREASGTSATALVPPLWKVFTGEELRSITKNFSEGNRLPGNAKTGGTYSG 269
Query: 289 ILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
I+PDGS+VA+KRLKRSS QRKK+FYSEI R A+L+HPNLVAVKGCCYDHGDR+IVYEFV
Sbjct: 270 IMPDGSKVAIKRLKRSSLQRKKDFYSEISRVAKLYHPNLVAVKGCCYDHGDRFIVYEFVA 329
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
NGPLD WLHHIPRGGRSLDW RM+VATTLAQGIAFLHDKVKP VVHRDIRASNVLLDEE
Sbjct: 330 NGPLDVWLHHIPRGGRSLDWVTRMRVATTLAQGIAFLHDKVKPQVVHRDIRASNVLLDEE 389
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
FG+HLMGVGLSKFVPWEVM ERTV A TYGYLAPEF+YRNELTTKSDVYSFGVLLLEI+
Sbjct: 390 FGSHLMGVGLSKFVPWEVMHERTVKA-ATYGYLAPEFIYRNELTTKSDVYSFGVLLLEII 448
Query: 469 SGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYA 528
SGRRPAQ+V+SV WQ+IFEWATPLVQSHRYLELLDPLI +D+PE GV+QKVVDLVY+
Sbjct: 449 SGRRPAQSVESVGWQTIFEWATPLVQSHRYLELLDPLI----NDLPEVGVIQKVVDLVYS 504
Query: 529 CTQHVPSMRPRMSHVVHQLQQL 550
CTQHVPS+RPRMSHVVHQLQQL
Sbjct: 505 CTQHVPSVRPRMSHVVHQLQQL 526
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|115434006|ref|NP_001041761.1| Os01g0104000 [Oryza sativa Japonica Group] gi|52075662|dbj|BAD44832.1| putative protein kinase [Oryza sativa Japonica Group] gi|113531292|dbj|BAF03675.1| Os01g0104000 [Oryza sativa Japonica Group] gi|125568686|gb|EAZ10201.1| hypothetical protein OsJ_00032 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 726 bits (1873), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/499 (71%), Positives = 408/499 (81%), Gaps = 6/499 (1%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE-IGGHLAALTSYEEEHSAQKLCGKNVN 111
CP W I KCF YI SWD SE C+ HLAAL+S ++ + A+ LCG + +
Sbjct: 32 CPDGWQITPALDKCFIYIPTPLSWDRSEALCRNNFTAHLAALSSLQDLNLAKSLCGPSPS 91
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
GCWVGG NT +WKWSD+ S WN++ ++C++ C + T D CTLV+N
Sbjct: 92 GCWVGGHRNNTASAFAWKWSDDSSSWNDTAFPADPLRANCSTTGCALATTNDACTLVTNT 151
Query: 172 SRSLVTERCNTSHPFICMVEHENKCYYLHCHREYLITLGVVSGLILLTTFAIVIWLLAYR 231
+L +RC+ SH ICM+ HE++CY+ HCH+EY I L VVSG ILLTT A+V+WLL YR
Sbjct: 152 HAALTAKRCSDSHGLICMINHEDRCYHDHCHKEYFIVLVVVSGFILLTTLAVVVWLLVYR 211
Query: 232 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILP 291
RSKRRR+SR+ S+ +A+ALVPP WKVFT+EELRSITKNFSEGNRL G++KTGGTYSGILP
Sbjct: 212 RSKRRRRSREGSSTSATALVPPLWKVFTSEELRSITKNFSEGNRLPGNAKTGGTYSGILP 271
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
DGSRVA+KRLKRSS QRKK+FYSEIGR A+L+HPNLVAVKGCCYDHGDR+IVYEFV NGP
Sbjct: 272 DGSRVAIKRLKRSSLQRKKDFYSEIGRVAKLYHPNLVAVKGCCYDHGDRFIVYEFVANGP 331
Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
LD WLHH+PRGGR LDW MRM+VATTLAQGIAFLHDKVKP VVHRDIRASNVLLDEEFG+
Sbjct: 332 LDVWLHHVPRGGRCLDWPMRMRVATTLAQGIAFLHDKVKPQVVHRDIRASNVLLDEEFGS 391
Query: 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 471
HLMGVGLSKFVPWEVM ERTV A TYGYLAPEF+YRNELTTKSDVYSFGVLLLEI+SGR
Sbjct: 392 HLMGVGLSKFVPWEVMHERTVKA-ATYGYLAPEFIYRNELTTKSDVYSFGVLLLEIISGR 450
Query: 472 RPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQ 531
RP Q+V+SV WQ+IFEWATPLVQSHRYLELLDPLI L P+ GV+QKVVDLVYACTQ
Sbjct: 451 RPTQSVESVGWQTIFEWATPLVQSHRYLELLDPLIQEL----PDVGVIQKVVDLVYACTQ 506
Query: 532 HVPSMRPRMSHVVHQLQQL 550
HVPS+RPRMSHVVHQLQQL
Sbjct: 507 HVPSVRPRMSHVVHQLQQL 525
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9C823 | Y1523_ARATH | 2, ., 7, ., 1, 0, ., 1 | 0.6636 | 0.9441 | 0.9800 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pg.C_290027 | hypothetical protein (517 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 573 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-36 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-34 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-33 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-26 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-26 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-20 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-16 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-15 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-13 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-13 | |
| smart00034 | 124 | smart00034, CLECT, C-type lectin (CTL) or carbohyd | 3e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-13 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-12 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-12 | |
| cd00037 | 116 | cd00037, CLECT, C-type lectin (CTL)/C-type lectin- | 4e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-11 | |
| cd03594 | 129 | cd03594, CLECT_REG-1_like, C-type lectin-like doma | 7e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-10 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-09 | |
| cd03590 | 126 | cd03590, CLECT_DC-SIGN_like, C-type lectin-like do | 3e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-08 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-08 | |
| cd03593 | 116 | cd03593, CLECT_NK_receptors_like, C-type lectin-li | 5e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-07 | |
| pfam00059 | 108 | pfam00059, Lectin_C, Lectin C-type domain | 1e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-07 | |
| cd03603 | 118 | cd03603, CLECT_VCBS, A bacterial subgroup of the C | 3e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-06 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-05 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-05 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-04 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-04 | |
| cd03589 | 137 | cd03589, CLECT_CEL-1_like, C-type lectin-like doma | 1e-04 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-04 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-04 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-04 | |
| cd03588 | 124 | cd03588, CLECT_CSPGs, C-type lectin-like domain (C | 4e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-04 | |
| PHA02642 | 216 | PHA02642, PHA02642, C-type lectin-like protein; Pr | 6e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-04 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 0.001 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.001 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.002 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 0.002 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.002 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.003 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 0.004 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.004 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 7e-37
Identities = 76/275 (27%), Positives = 121/275 (44%), Gaps = 36/275 (13%)
Query: 284 GTYSGILPDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342
G G + VAVK LK S + +K+F E +L HPN+V + G C + Y+
Sbjct: 14 GKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYL 73
Query: 343 VYEFVVNGPLDRWL-----HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
V E++ G L +L +L + A +A+G+ +L K VHRD
Sbjct: 74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRD 130
Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY---GYLAPEFVYRNELTTK 454
+ A N L+ E+ + GLS+ V + + G ++APE + T+K
Sbjct: 131 LAARNCLVGEDLVVKISDFGLSRDVYDD---DYYRKKTGGKLPIRWMAPESLKDGIFTSK 187
Query: 455 SDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 513
SDV+SFGVLL EI + G P + + + E+ L + +R L P
Sbjct: 188 SDVWSFGVLLWEIFTLGATPYPGLS---NEEVLEY---LRKGYR---LPKPEYCP----- 233
Query: 514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
++ +L+ +C Q P RP S +V +L+
Sbjct: 234 ------DELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 1e-36
Identities = 78/277 (28%), Positives = 122/277 (44%), Gaps = 49/277 (17%)
Query: 284 GTYSGILPDGS-RVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
GT G +VAVK LK + + ++EF E +L HPN+V + G C Y
Sbjct: 18 GTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLY 77
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
IV E++ G L +L + G L +++A +A+G+ +L K + VHRD+ A
Sbjct: 78 IVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLESK---NFVHRDLAAR 131
Query: 402 NVLLDEE-------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYG---YLAPEFVYRNEL 451
N L+ E F GLS+ + + + GG ++APE + +
Sbjct: 132 NCLVTENLVVKISDF-------GLSRDIYED---DYYRKRGGGKLPIKWMAPESLKDGKF 181
Query: 452 TTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
T+KSDV+SFGVLL EI + G +P + + + E L +R L P
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEQPYPGMS---NEEVLEL---LEDGYR---LPRPENCP-- 230
Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547
++ +L+ C + P RP S +V L
Sbjct: 231 ---------DELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 7e-36
Identities = 72/270 (26%), Positives = 112/270 (41%), Gaps = 35/270 (12%)
Query: 284 GTYSGILPDGS-RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
GT G VAVK LK S Q+ +EF E +L HPN+V + G C +
Sbjct: 18 GTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
IV E++ G L +L + L + + A +A+G+ +L K + +HRD+ A
Sbjct: 78 IVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAAR 132
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDVY 458
N L+ E + GLS+ + + G ++APE + + T+KSDV+
Sbjct: 133 NCLVGENLVVKISDFGLSRDLY----DDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVW 188
Query: 459 SFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAG 517
SFGVLL EI + G P + + E+ ++ L
Sbjct: 189 SFGVLLWEIFTLGEEPYPGMS---NAEVLEY----LKKGYRLP-------------KPPN 228
Query: 518 VVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547
++ L+ C P RP S +V L
Sbjct: 229 CPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 1e-35
Identities = 73/270 (27%), Positives = 117/270 (43%), Gaps = 36/270 (13%)
Query: 284 GTYSGILPDGSR-VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
G G VAVK LK +S Q+ +EF E +L HPN+V + G C + Y
Sbjct: 18 GKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLY 77
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
IV E++ G L +L + L + + A +A+G+ +L K + +HRD+ A
Sbjct: 78 IVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLESK---NFIHRDLAAR 131
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDVY 458
N L+ E + GLS+ + + G ++APE + + T+KSDV+
Sbjct: 132 NCLVGENLVVKISDFGLSRDLY----DDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVW 187
Query: 459 SFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAG 517
SFGVLL EI + G +P + + + E+ +++ L
Sbjct: 188 SFGVLLWEIFTLGEQPYPGMS---NEEVLEY----LKNGYRLP-------------QPPN 227
Query: 518 VVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547
++ DL+ C P RP S +V L
Sbjct: 228 CPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 63/248 (25%), Positives = 102/248 (41%), Gaps = 28/248 (11%)
Query: 292 DGSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
G VA+K +K+ ++ +E EI +L HPN+V + D Y+V E+ G
Sbjct: 23 TGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGG 82
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L L RG S D A + + +LH K +VHRD++ N+LLDE+
Sbjct: 83 DLFDLLKK--RGRLSEDEA--RFYLRQILSALEYLHSK---GIVHRDLKPENILLDEDGH 135
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
L GL++ + V GT Y+APE + D++S GV+L E+++G
Sbjct: 136 VKLADFGLARQLDPGEKLTTFV---GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTG 192
Query: 471 RRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACT 530
+ P D + +F+ + + PE + + DL+
Sbjct: 193 KPPFPGDDQL--LELFK----KIGKPKP-----------PFPPPEWDISPEAKDLIRKLL 235
Query: 531 QHVPSMRP 538
P R
Sbjct: 236 VKDPEKRL 243
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 1e-33
Identities = 53/179 (29%), Positives = 89/179 (49%), Gaps = 11/179 (6%)
Query: 292 DGSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
G +VA+K +K+ E EI +L+HPN+V + G D Y+V E+ G
Sbjct: 17 TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L L L +++ + +G+ +LH ++HRD++ N+LLD + G
Sbjct: 77 SLKDLLKENEGK---LSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNG 130
Query: 411 -AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FVYRNELTTKSDVYSFGVLLLEI 467
L GLSK + + +T++ GT Y+APE + + + KSD++S GV+L E+
Sbjct: 131 KVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 79/279 (28%), Positives = 114/279 (40%), Gaps = 35/279 (12%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE--FYSEIGRFARLHHPNLVAVK 331
R LG G Y G VAVK LK+ S + KK+ EI RL HPN+V +
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
D Y+V E+ G L +L G L K+A + +G+ +LH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLHSN--- 117
Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV-YRNE 450
++HRD++ N+LLDE + GL+K GT Y+APE + N
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKK--LLKSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 451 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS-- 508
K DV+S GV+L E+++G+ P + + Q +L P +
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILD------------QLQLIRRILGPPLEFDE 223
Query: 509 --LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545
SS EA DL+ C PS RP ++
Sbjct: 224 PKWSSGSEEA------KDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 12/204 (5%)
Query: 275 RLLGDSKTGGTYSGILPD-GSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVK 331
LLG G Y + D G +AVK L S + + EI + L HPN+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 332 GCCYD--HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
G D I E+V G L + + G+ L + K + +G+A+LH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLS---SLLKKFGK-LPEPVIRKYTRQILEGLAYLHSN- 120
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
+VHRDI+ +N+L+D + L G +K + E T GT ++APE +
Sbjct: 121 --GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 450 ELTTKSDVYSFGVLLLEIVSGRRP 473
E +D++S G ++E+ +G+ P
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 10/198 (5%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
+G G Y G VA+K +K S ++K++ +EI + HPN+V G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
+ +IV EF G L L ++L + V L +G+ +LH ++H
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIH 121
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 455
RDI+A+N+LL + L+ GLS + + R M GT ++APE + K+
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMV-GTPYWMAPEVINGKPYDYKA 178
Query: 456 DVYSFGVLLLEIVSGRRP 473
D++S G+ +E+ G+ P
Sbjct: 179 DIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 67/201 (33%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
+G + G G G +VAVK LK S + F +E L HPNLV + G
Sbjct: 13 TIGKGEFGDVMLGDY-RGQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
YIV E++ G L +L RG + A ++ A + +G+ +L +K + VH
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVH 125
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
RD+ A NVL+ E+ A + GL+K + G + APE + + +T
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFST 178
Query: 454 KSDVYSFGVLLLEIVS-GRRP 473
KSDV+SFG+LL EI S GR P
Sbjct: 179 KSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 82/278 (29%), Positives = 126/278 (45%), Gaps = 33/278 (11%)
Query: 277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
LG + G Y G+ VAVK LK + +EF E + HPNLV + G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
YI+ EF+ G L +L R + ++ + + +AT ++ + +L K + +H
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIH 127
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
RD+ A N L+ E + GLS+ + + T AG + + APE + N+ +
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512
KSDV++FGVLL EI + G P +D S Y ELL+ +
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGID---------------LSQVY-ELLE---KGYRME 225
Query: 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
PE G KV +L+ AC Q PS RP + + + +
Sbjct: 226 RPE-GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 58/198 (29%), Positives = 103/198 (52%), Gaps = 13/198 (6%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
R LG G + G+ + RVA+K LK ++++F E+ RL H +L+++ C
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
YI+ E + G L +L P G+ L A + +A +A+G+A+L ++ + +
Sbjct: 72 SVGEPVYIITELMEKGSLLAFLRS-PE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSI 126
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNEL 451
HRD+ A N+L+ E+ + GL++ +++E ++ Y + APE
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLAR-----LIKEDVYLSSDKKIPYKWTAPEAASHGTF 181
Query: 452 TTKSDVYSFGVLLLEIVS 469
+TKSDV+SFG+LL E+ +
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 12/202 (5%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
R LG + G + G+ + + VAVK LK + K+F +E +L HP L+ + C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
YIV E + G L +L GR+L + +A +A G+A+L + + +
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQ---NYI 125
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELT 452
HRD+ A NVL+ E + GL++ + ++ + R G + + APE N +
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE---GAKFPIKWTAPEAALYNRFS 182
Query: 453 TKSDVYSFGVLLLEIVS-GRRP 473
KSDV+SFG+LL EIV+ GR P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 103 bits (256), Expect = 8e-24
Identities = 81/311 (26%), Positives = 131/311 (42%), Gaps = 32/311 (10%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFARL-HHPNLVAV 330
R LG+ G Y D VA+K L + + KE F EI A L H PN+V +
Sbjct: 6 RKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
D G Y+V E+V G L+ L I R G + + + + +LH K
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEAL-FILAQILSALEYLHSK-- 120
Query: 391 PHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPWEV----MQERTVMAGGTYGYLAPEF 445
++HRDI+ N+LLD + L+ GL+K +P + + GT GY+APE
Sbjct: 121 -GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 446 VYRNEL---TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL-EL 501
+ L ++ SD++S G+ L E+++G P + + S Q+ + + EL
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS---------QTLKIILEL 230
Query: 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP----RMSHVVHQLQQLAQPPVTK 557
P ++S S + + DL+ P R +SH + +L + ++
Sbjct: 231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSD 290
Query: 558 LLFKGLDRLRH 568
LL
Sbjct: 291 LLKPDDSAPLR 301
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 67/267 (25%), Positives = 123/267 (46%), Gaps = 23/267 (8%)
Query: 293 GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVN 349
G +VAVK L S Q + +F EI L H N+V KG C G R ++ E++ +
Sbjct: 33 GEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPS 92
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
G L ++ R ++ + ++ + +G+ +L + +HRD+ A N+L++ E
Sbjct: 93 GSLR---DYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESED 146
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLL 464
+ GL+K +P +++ G + APE + ++ ++ SDV+SFGV L
Sbjct: 147 LVKISDFGLAKVLP----EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTL 202
Query: 465 LEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVD 524
E+ + P+Q+ + + I ++ + R LELL L +V D
Sbjct: 203 YELFTYGDPSQSPPAEFLRMIGIAQGQMIVT-RLLELLKE-GERLP---RPPSCPDEVYD 257
Query: 525 LVYACTQHVPSMRPRMSHVVHQLQQLA 551
L+ C + P RP + ++ + +L
Sbjct: 258 LMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 96/365 (26%), Positives = 169/365 (46%), Gaps = 41/365 (11%)
Query: 211 VVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASALVPPSWKV--FTTEELRSITK 268
+ L A+V + + R + + +++ N + W++ F ++ +SIT
Sbjct: 632 ITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGT------WELQFFDSKVSKSITI 685
Query: 269 N-----FSEGNRLLGDSKTGGTYSG-ILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL 322
N E N ++ K G +Y G + +G + VK + + SEI +L
Sbjct: 686 NDILSSLKEEN-VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKL 740
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
HPN+V + G C Y+++E++ L L R+L W R K+A +A+ +
Sbjct: 741 QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKAL 793
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
FLH + P VV ++ +++D + HL + L P + + Y+A
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL----PGLLCTDTKCFISS--AYVA 846
Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL- 501
PE ++T KSD+Y FG++L+E+++G+ PA A V SI EWA S +L++
Sbjct: 847 PETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWAR-YCYSDCHLDMW 904
Query: 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP---VTKL 558
+DP I S + + +V+ V++L CT P+ RP + V+ L+ ++ VT L
Sbjct: 905 IDPSIRGDVS-VNQNEIVE-VMNLALHCTATDPTARPCANDVLKTLESASRSSSSCVTGL 962
Query: 559 LFKGL 563
F L
Sbjct: 963 KFSSL 967
|
Length = 968 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 2e-22
Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 19/263 (7%)
Query: 293 GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVN 349
G VAVK LKR Q + EI L+H N+V KGCC + G + ++ E+V
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV-- 90
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
PL ++P+ L+ A + A + +G+A+LH + H +HRD+ A NVLLD +
Sbjct: 91 -PLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDR 144
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
+ GL+K VP R G + + A E + N+ + SDV+SFGV L E++
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
Query: 469 SGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS-SLSSDIPEAGVVQKVVDLVY 527
+ Q+ ++ + + R +ELL+ + + P Q+V L+
Sbjct: 205 THCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCP-----QEVYILMK 258
Query: 528 ACTQHVPSMRPRMSHVVHQLQQL 550
C + RP ++ L+++
Sbjct: 259 NCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 4e-22
Identities = 74/283 (26%), Positives = 117/283 (41%), Gaps = 48/283 (16%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVK 331
+G G Y+ + L G +AVK R++ + + KE E+ L HPNLV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
G YI E+ G L+ L H GR LD + L +G+A+LH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 392 HVVHRDIRASNVLLDE-------EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
+VHRDI+ +N+ LD +FG + + + E +Q GT Y+APE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVK-LKNNTTTMGEEVQSLA----GTPAYMAPE 173
Query: 445 FVYRNELTTK---SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWA---TPLVQSHRY 498
+ + +D++S G ++LE+ +G+RP +D+ +Q +F P +
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVGAGHKPPI----- 227
Query: 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS 541
P LS + D + C + P RP S
Sbjct: 228 -----PDSLQLSPE---------GKDFLDRCLESDPKKRPTAS 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 19/211 (9%)
Query: 269 NFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHP 325
N+ G+ L+G G Y G+ L G VA+K++ + + K EI L HP
Sbjct: 1 NYQLGD-LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHP 59
Query: 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GI 382
N+V G YI+ E+ NG L + + SL VA + Q G+
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-------VAVYVYQVLQGL 112
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
A+LH++ V+HRDI+A+N+L ++ L G++ + + +V+ GT ++A
Sbjct: 113 AYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV--GTPYWMA 167
Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
PE + + +T SD++S G ++E+++G P
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 274 NRLLGDSKTG----GTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVA 329
R LG + G GT++G VAVK LK + + F E +L H LV
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTK----VAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQ 65
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
+ C + YIV E++ G L +L G+ L + +A +A+G+A+L +
Sbjct: 66 LYAVCSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESR- 122
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVY 447
+ +HRD+ A N+L+ E + GL++ + + E T G + + APE
Sbjct: 123 --NYIHRDLAARNILVGENLVCKIADFGLARLIEDD---EYTAREGAKFPIKWTAPEAAN 177
Query: 448 RNELTTKSDVYSFGVLLLEIVS-GRRP 473
T KSDV+SFG+LL EIV+ GR P
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 5e-20
Identities = 67/256 (26%), Positives = 121/256 (47%), Gaps = 33/256 (12%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
VA+K +K S + EF E +L H LV + G C YIV E++ NG L
Sbjct: 31 VAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL--- 86
Query: 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415
L+++ G+ + +++ + +G+A+L K +HRD+ A N L+D++ +
Sbjct: 87 LNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSD 143
Query: 416 VGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRR 472
GLS++V + E T G + + PE + ++ ++KSDV++FGVL+ E+ S G+
Sbjct: 144 FGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKM 200
Query: 473 PAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQH 532
P + ++ E + Q R L P ++S +KV ++Y+C
Sbjct: 201 PYERFNNS------ETVEKVSQGLR---LYRPHLAS-----------EKVYAIMYSCWHE 240
Query: 533 VPSMRPRMSHVVHQLQ 548
RP ++ ++
Sbjct: 241 KAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 5e-20
Identities = 47/191 (24%), Positives = 86/191 (45%), Gaps = 15/191 (7%)
Query: 292 DGSRVAVKR--LKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
DG +K L S + +++ +E+ +L+HPN++ + G IV E+
Sbjct: 24 DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
G L + + + G+ + L + +LH + ++HRDI+ N+ L
Sbjct: 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNG 140
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNE-LTTKSDVYSFGVLLL 465
L G+SK V+ +A GT YL+PE + +N+ KSD++S G +L
Sbjct: 141 LVKLGDFGISK-----VLSSTVDLAKTVVGTPYYLSPE-LCQNKPYNYKSDIWSLGCVLY 194
Query: 466 EIVSGRRPAQA 476
E+ + + P +
Sbjct: 195 ELCTLKHPFEG 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 61/262 (23%), Positives = 112/262 (42%), Gaps = 47/262 (17%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
VA+K ++ + + +F E +L HPNLV + G C +IV E++ NG L +
Sbjct: 31 VAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNY 89
Query: 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415
L + + + + + + + +L +HRD+ A N L+ E+ +
Sbjct: 90 LRERKGKLGT---EWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSD 143
Query: 416 VGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GR 471
GL+++ V+ ++ + GT + PE + ++KSDV+SFGVL+ E+ S G+
Sbjct: 144 FGLARY----VLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
Query: 472 RP------AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDL 525
P ++ V+SV L P ++ +V +
Sbjct: 200 MPYERFSNSEVVESV---------------SAGYRLYRPKLAP-----------TEVYTI 233
Query: 526 VYACTQHVPSMRPRMSHVVHQL 547
+Y+C P RP ++ QL
Sbjct: 234 MYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-19
Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
LG + G + G ++VA+K LK+ S + F +E +L HP LV +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
YI+ E++ NG L +L G L + +A +A+G+AF+ K + +HR
Sbjct: 73 E-PIYIITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHR 126
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
D+RA+N+L+ E + GL++ + E T G + + APE + T K
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
SDV+SFG+LL EIV+ GR P
Sbjct: 184 SDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 8e-19
Identities = 72/258 (27%), Positives = 119/258 (46%), Gaps = 34/258 (13%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
G +VAVK +K + F E +LHH NLV + G H YIV E + G L
Sbjct: 29 GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVIL-HNGLYIVMELMSKGNL 85
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
+L RG + ++ + +A+G+ +L K +VHRD+ A N+L+ E+ A
Sbjct: 86 VNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAK 140
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GR 471
+ GL++ V + + + APE + + ++KSDV+S+GVLL E+ S GR
Sbjct: 141 VSDFGLARVGSMGVDNSKLPVK-----WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195
Query: 472 RPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQ 531
P + S+ E + + +R ++P PE G V L+ +C +
Sbjct: 196 APYPKM------SLKEVKECVEKGYR----MEP---------PE-GCPADVYVLMTSCWE 235
Query: 532 HVPSMRPRMSHVVHQLQQ 549
P RP + +L++
Sbjct: 236 TEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 74/291 (25%), Positives = 130/291 (44%), Gaps = 38/291 (13%)
Query: 275 RLLGDSKTGGTYSGIL--PDGS--RVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLV 328
++LG+ + G G L DGS +VAVK +K +EF SE HPN++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 329 AVKGCCYDHGDR------YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM--KVATTLAQ 380
+ G C++ ++ F+ +G L +L + GG ++ K +A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 440
G+ +L ++ + +HRD+ A N +L E+ + GLSK + + +A +
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499
+A E + T+KSDV++FGV + EI + G+ P P V++H
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP----------------YPGVENH--- 222
Query: 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
E+ D L PE + ++ DL+Y+C + P RP + + L+ +
Sbjct: 223 EIYDYLRHGNRLKQPE-DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 74/275 (26%), Positives = 130/275 (47%), Gaps = 35/275 (12%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
+G + G + G + +VA+K + R +++F E +L HP LV + G C +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
+V+EF+ +G L +L RG S + + M + +G+A+L +V+HR
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRA-QRGKFSQETLLGM--CLDVCEGMAYLESS---NVIHR 124
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTT 453
D+ A N L+ E + G+++F V+ ++ + GT + +PE ++ ++
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRF----VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512
KSDV+SFGVL+ E+ S G+ P + +S E + R L P ++S
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYEN------RSNSEVVETINAGFR---LYKPRLAS---- 227
Query: 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547
Q V +L+ C + P RP S ++HQL
Sbjct: 228 -------QSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 274 NRLLGDSKTGGTYSGILPDGSR----VAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLV 328
+++G + G G L + VA+K LK SS +++ +F +E + HPN++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
++G I+ E++ NG LD++L G+ + + +A G+ +L +
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRE--NDGK-FTVGQLVGMLRGIASGMKYLSEM 125
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT-YGYLAPEFVY 447
VHRD+ A N+L++ + GLS+ + + T G + APE +
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE-DSEATYTTKGGKIPIRWTAPEAIA 181
Query: 448 RNELTTKSDVYSFGVLLLEIVS-GRRP 473
+ T+ SDV+SFG+++ E++S G RP
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 4e-18
Identities = 82/299 (27%), Positives = 127/299 (42%), Gaps = 56/299 (18%)
Query: 275 RLLGDSKTGGTYSG----ILPDGS---RVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPN 326
LG G Y G IL GS RVAVK L++ ++ Q KKEF E + +HPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS-------LDWAMRMKVATTLA 379
+V + G C + +YI+ E + G L L ++ R R L + + +A
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDL---LSYL-RDARVERFGPPLLTLKELLDICLDVA 116
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV-----GLSKFV----PWEVMQER 430
+G +L H +HRD+ A N L+ E+ V GL++ + + E
Sbjct: 117 KGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWA 489
+ ++APE + + TT+SDV+SFGVL+ EI++ G++P A
Sbjct: 174 LL----PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA------------- 216
Query: 490 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
E+L + + PE K+ L+ C PS RP + LQ
Sbjct: 217 ------LNNQEVLQHVTAGGRLQKPE-NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 19/219 (8%)
Query: 282 TGGTYSGIL--PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG 338
G S +L P G +AVK ++ +K+ E+ + + P +V G Y++G
Sbjct: 13 NSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG 72
Query: 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
D I E++ G LD+ L + + K+A + +G+ +LH+K ++HRD+
Sbjct: 73 DISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIHRDV 127
Query: 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNELTTKS 455
+ SN+L++ L G+S Q +A GT Y+APE + N+ + KS
Sbjct: 128 KPSNILVNSRGQIKLCDFGVSG-------QLVNSLAKTFVGTSSYMAPERIQGNDYSVKS 180
Query: 456 DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ 494
D++S G+ L+E+ +GR P + IFE +V
Sbjct: 181 DIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVN 218
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 88/305 (28%), Positives = 139/305 (45%), Gaps = 59/305 (19%)
Query: 289 ILPDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY 344
I DG R+ A+KR+K +S ++F E+ +L HHPN++ + G C G Y+
Sbjct: 28 IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87
Query: 345 EFVVNGPLDRWLHHIPRGGRSLD----WAMRMKVATTL------------AQGIAFLHDK 388
E+ +G L +L R R L+ +A+ A+TL A+G+ +L K
Sbjct: 88 EYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 143
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
+HRD+ A N+L+ E + A + GLS+ EV ++T M ++A E +
Sbjct: 144 ---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT-MGRLPVRWMAIESLNY 197
Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507
+ TT SDV+S+GVLL EIVS G P C + E L Q +R L
Sbjct: 198 SVYTTNSDVWSYGVLLWEIVSLGGTP------YCGMTCAELYEKLPQGYR-------LEK 244
Query: 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVT--------KLL 559
L+ D +V DL+ C + P RP + ++ L ++ + T K
Sbjct: 245 PLNCD-------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFT 297
Query: 560 FKGLD 564
+ G+D
Sbjct: 298 YAGID 302
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 63/220 (28%), Positives = 108/220 (49%), Gaps = 29/220 (13%)
Query: 277 LGDSKTGGTYSGIL--PDG----SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVA 329
LG+ G Y G L P+ + VA+K LK + + ++EF E + L HPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWL-HHIP-----------RGGRSLDWAMRMKVATT 377
+ G C +++E++ +G L +L + P SLD + + +A
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMA 434
+A G+ +L H VHRD+ A N L+ E + GLS+ + + +Q ++++
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
++ PE + + TT+SD++SFGV+L EI S G +P
Sbjct: 190 ---VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 71/282 (25%), Positives = 122/282 (43%), Gaps = 47/282 (16%)
Query: 284 GTYSGILPD--GSRVAVKRL-KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
G G++ +RVA+K + + +S + + EF +E + ++V + G
Sbjct: 25 GLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84
Query: 341 YIVYEFVVNGPLDRWL--------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
+V E + G L +L ++ G +L ++M A +A G+A+L K
Sbjct: 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM--AAEIADGMAYLAAK---K 139
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APEFVY 447
VHRD+ A N ++ E+ + G+++ + E G G L APE +
Sbjct: 140 FVHRDLAARNCMVAEDLTVKIGDFGMTRDI-----YETDYYRKGGKGLLPVRWMAPESLK 194
Query: 448 RNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506
TTKSDV+SFGV+L E+ + +P Q + + E V +L+L
Sbjct: 195 DGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-------EEVLKFVIDGGHLDL----- 242
Query: 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
PE K+++L+ C Q+ P MRP +V L+
Sbjct: 243 -------PE-NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 77/293 (26%), Positives = 122/293 (41%), Gaps = 47/293 (16%)
Query: 275 RLLGDSKTG----GTYSGILPDGSR--VAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNL 327
R LG G G Y G D VAVK L S ++ + F E ++ +H N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-PRGGRSLDWAMR--MKVATTLAQGIAF 384
V + G ++ R+I+ E + G L +L PR R M+ + A +A+G +
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFG----AHLMGVGLSKFVPWEVMQERTVMAGGT--- 437
L + H +HRDI A N LL + G A + G+++ ++ + GG
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMAR----DIYRASYYRKGGRAML 183
Query: 438 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS 495
++ PE T+K+DV+SFGVLL EI S G P
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP-------------------YPG 224
Query: 496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
E+++ + D P G V ++ C QH P RP + ++ ++Q
Sbjct: 225 RTNQEVMEFVTGGGRLDPP-KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 69/265 (26%), Positives = 115/265 (43%), Gaps = 37/265 (13%)
Query: 295 RVAVKRLKRSSFQRKKE-FYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
+VAVK LK ++ ++E SE+ + L +H N+V + G C G ++ E+ G L
Sbjct: 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 353 DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
+L R S L + + +A+G+AFL K + +HRD+ A NVLL
Sbjct: 127 LNFLR---RKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIV 180
Query: 412 HLMGVGLSKFVPWEVMQERT-VMAGGTY---GYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ GL++ ++M + V+ G ++APE ++ T +SDV+S+G+LL EI
Sbjct: 181 KICDFGLAR----DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
Query: 468 VS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLV 526
S G P + V S Y + PE ++ D++
Sbjct: 237 FSLGSNPYPGM--------------PVDSKFY----KLIKEGYRMAQPEHA-PAEIYDIM 277
Query: 527 YACTQHVPSMRPRMSHVVHQLQQLA 551
C P RP +V + +
Sbjct: 278 KTCWDADPLKRPTFKQIVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 19/158 (12%)
Query: 323 HHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHI-PRGGRSLDWAMRMKVATTLA 379
P +V G D I E+ G LD + RGGR + + K+A ++
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL-GKIAESVL 115
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTVMAG--- 435
+G+++LH + ++HRDI+ SN+LL + L G+S + V +AG
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--------NSLAGTFT 164
Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
GT Y+APE + + SDV+S G+ LLE+ R P
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+ LG + G + G + ++VAVK LK + + F E L H LV +
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
YI+ E++ G L +L G + + + +A+G+A++ K + +
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLK--SDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 125
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELT 452
HRD+RA+NVL+ E + GL++ + E T G + + APE + T
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 453 TKSDVYSFGVLLLEIVS-GRRP 473
KSDV+SFG+LL EIV+ G+ P
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 72/260 (27%), Positives = 116/260 (44%), Gaps = 34/260 (13%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY-DHGDRYIVYEFVVNGP 351
G++VAVK +K + + F +E +L H NLV + G + G YIV E++ G
Sbjct: 29 GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86
Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
L +L RG L +K + + + + +L + VHRD+ A NVL+ E+ A
Sbjct: 87 LVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVA 141
Query: 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-G 470
+ GL+K Q+ + + APE + + +TKSDV+SFG+LL EI S G
Sbjct: 142 KVSDFGLTKEA--SSTQDTGKLP---VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 196
Query: 471 RRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACT 530
R P + PL +++ + D P+ G V D++ C
Sbjct: 197 RVPYPRI-------------PLK------DVVPRVEKGYKMDAPD-GCPPVVYDVMKQCW 236
Query: 531 QHVPSMRPRMSHVVHQLQQL 550
+ RP + QL+ +
Sbjct: 237 HLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 82/295 (27%), Positives = 134/295 (45%), Gaps = 44/295 (14%)
Query: 276 LLGDSKTGGTYSGILP-DGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAV 330
++G+ G ++ DG ++ A+K LK +S ++F E+ +L HHPN++ +
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 331 KGCCYDHGDRYIVYEFVVNGPL------DRWLHHIPRGGR------SLDWAMRMKVATTL 378
G C + G YI E+ G L R L P + +L ++ A+ +
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
A G+ +L +K +HRD+ A NVL+ E + + GLS+ EV ++T M
Sbjct: 129 ATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKT-MGRLPV 182
Query: 439 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
++A E + + TTKSDV+SFGVLL EIVS G P C + E L Q +R
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP------YCGMTCAELYEKLPQGYR 236
Query: 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
+ P +V +L+ C + P RP + + QL ++ +
Sbjct: 237 M-------------EKPR-NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 2e-16
Identities = 76/295 (25%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 276 LLGDSKTGGTYSGILP-DGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAV 330
++G+ G + DG R+ A+KR+K +S ++F E+ +L HHPN++ +
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 331 KGCCYDHGDRYIVYEFVVNGPL------DRWLHHIPRGGR------SLDWAMRMKVATTL 378
G C G Y+ E+ +G L R L P +L + A +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
A+G+ +L K +HRD+ A N+L+ E + A + GLS+ + + + M
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPV 175
Query: 439 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
++A E + + TT SDV+S+GVLL EIVS G P C + E L Q +R
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP------YCGMTCAELYEKLPQGYR 229
Query: 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
+ +V DL+ C + P RP + ++ L ++ +
Sbjct: 230 LEK--------------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-16
Identities = 64/256 (25%), Positives = 121/256 (47%), Gaps = 33/256 (12%)
Query: 295 RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
+VA+K + + +++F E +L HP LV + G C YIV EF+ NG L
Sbjct: 30 KVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN 88
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414
+L +G S D M + + + +G+ +L + +HRD+ A N L+ +
Sbjct: 89 YLRQ-RQGKLSKD--MLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVS 142
Query: 415 GVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GR 471
G++++V + E T +G + + PE ++ ++KSDV+SFGVL+ E+ + G+
Sbjct: 143 DFGMTRYV---LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199
Query: 472 RPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQ 531
P + +S +E + + R L P ++S++ V +++Y+C
Sbjct: 200 MPFEK------KSNYEVVEMISRGFR---LYRPKLASMT-----------VYEVMYSCWH 239
Query: 532 HVPSMRPRMSHVVHQL 547
P RP + ++ +
Sbjct: 240 EKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 36/211 (17%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
+G+ +G Y G VA+K+++ Q K+ +EI HPN+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK------VATTLAQGIAFLHDKV 389
+ ++V E++ G L + +RM V + QG+ +LH +
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNF---------VRMNEPQIAYVCREVLQGLEYLHSQ- 135
Query: 390 KPHVVHRDIRASNVLLDEE-------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
+V+HRDI++ N+LL ++ FG L+K +R + G Y ++A
Sbjct: 136 --NVIHRDIKSDNILLSKDGSVKLADFG---FAAQLTKEK-----SKRNSVVGTPY-WMA 184
Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
PE + R + K D++S G++ +E+ G P
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 77/286 (26%), Positives = 128/286 (44%), Gaps = 39/286 (13%)
Query: 275 RLLGDSKTGGTYSGILPDGSR----VAVKRLKRSSFQRKK-EFYSEIGRFARLHHPNLVA 329
+++G + G + GIL R VA+K LK ++++ +F SE + H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
++G I+ E++ NG LD++L S ++ +A G+ +L D
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSDM- 126
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG---TYGYLAPEFV 446
+ VHRD+ A N+L++ + GLS+ + E E T G + APE +
Sbjct: 127 --NYVHRDLAARNILVNSNLECKVSDFGLSRVL--EDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 447 YRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQ-SIFEWATPLVQSHRYLELLDP 504
+ T+ SDV+SFG+++ E++S G RP W S E + R L P
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERPY-------WDMSNHEVMKAINDGFR---LPAP 232
Query: 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
+ D P A V L+ C Q + RPR +V+ L +L
Sbjct: 233 M------DCPSA-----VYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 5e-16
Identities = 68/263 (25%), Positives = 126/263 (47%), Gaps = 17/263 (6%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNG 350
G VAVK+L+ S+ + ++F EI L H N+V KG CY G R +V E++ G
Sbjct: 33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L +L + LD + A+ + +G+ +L K VHRD+ N+L++ E
Sbjct: 93 SLRDYLQ---KHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENR 146
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGT--YGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
+ GL+K +P + + G + + Y APE + ++ + SDV+SFGV+L E+
Sbjct: 147 VKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELF 205
Query: 469 SGRRPAQAVDSVCWQSI-FEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVY 527
+ + + + + + + ++ H L++ L ++ P G ++ ++
Sbjct: 206 TYSDKSCSPPAEFMRMMGNDKQGQMIVYH----LIELLKNNGRLPAPP-GCPAEIYAIMK 260
Query: 528 ACTQHVPSMRPRMSHVVHQLQQL 550
C + PS RP S + Q++ +
Sbjct: 261 ECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 6e-16
Identities = 69/215 (32%), Positives = 99/215 (46%), Gaps = 37/215 (17%)
Query: 277 LGDSKTGGTYSGI--LPDGSR--VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVK 331
LG G G+ + G VAVK LK+ KKEF E A+L HP +V +
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 332 GCCYDHGDRYI-VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
G C G+ + V E GPL ++L + R + + ++A +A G+A+L K
Sbjct: 63 GVC--KGEPLMLVMELAPLGPLLKYL----KKRREIPVSDLKELAHQVAMGMAYLESK-- 114
Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----------G 439
H VHRD+ A NVLL A + G+S R + AG Y
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMS----------RALGAGSDYYRATTAGRWPLK 163
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
+ APE + + ++KSDV+S+GV L E S G +P
Sbjct: 164 WYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 8e-16
Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRV-AVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGC 333
+G G + + RV A+K++ S R ++E E A+L ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL--DWAMRMKVATTLAQGIAFLHDKVKP 391
D G IV E+ NG L + L + GR L D R + L G+A LH K
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKM--QRGRPLPEDQVWRFFIQILL--GLAHLHSK--- 120
Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
++HRDI++ N+ LD + +G++K + T++ GT YL+PE
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV--GTPYYLSPELCEDKPY 178
Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQA 476
KSDV++ GV+L E +G+ P A
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGC 333
+G G Y G+L + VAVK + + K + + + + HPN+V + G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
C YIV E V G L L + + L ++++ A G+ +L K +
Sbjct: 61 CVQKQPIYIVMELVPGGSL---LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NC 114
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG-----------YLA 442
+HRD+ A N L+ E + G+S+ +E GG Y + A
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR-------EE----EGGIYTVSDGLKQIPIKWTA 163
Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIVSG 470
PE + T++SDV+S+G+LL E S
Sbjct: 164 PEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 65/239 (27%), Positives = 114/239 (47%), Gaps = 28/239 (11%)
Query: 276 LLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSF-----QRKKEFYS----EIGRFARLHHP 325
L+G G Y G+ G +AVK+++ S RK+ EI L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
N+V G D I E+V G + L++ +L +R V L +G+ +L
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL---VRNFVRQIL-KGLNYL 122
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM-----QERTVMAGGTYGY 440
H++ ++HRDI+ +N+L+D + G + G+SK + + R + G + +
Sbjct: 123 HNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF-W 178
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF---EWATPLVQSH 496
+APE V + T K+D++S G L++E+++G+ P + Q+IF E A+P + S+
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QAIFKIGENASPEIPSN 235
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 13/196 (6%)
Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
L+HP LV + D + Y+V + ++ G L R+ H+ + + + ++ + +
Sbjct: 56 ELNHPFLVNLWYSFQDEENMYLVVDLLLGGDL-RY--HLSQKVKFSEEQVKFWICE-IVL 111
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 440
+ +LH K ++HRDI+ N+LLDE+ H+ ++ V + + T GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGY 165
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC---WQSIFEWATPLVQSHR 497
+APE + R + D +S GV E + G+RP + ++ E A L +
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW 225
Query: 498 YLELLDPLISSLSSDI 513
E +D + L D
Sbjct: 226 STEAIDAINKLLERDP 241
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 78/295 (26%), Positives = 132/295 (44%), Gaps = 49/295 (16%)
Query: 277 LGDSKTGGTYSG--ILP---DGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAV 330
LG+ G Y G LP VA+K LK ++ Q+ EF E A LHHPN+V +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWL----HHIPRG---------GRSLDWAMRMKVATT 377
G +++E++ G L +L H G SLD + +A
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMA 434
+A G+ +L VH+D+ A N+L+ E+ + +GLS+ + + +Q ++++
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493
++ PE + + ++ SD++SFGV+L EI S G +P + Q + E +V
Sbjct: 190 ---IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIE----MV 239
Query: 494 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
+ + L S D P ++ L+ C Q PS RPR + +L+
Sbjct: 240 RKRQLL--------PCSEDCPP-----RMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 2e-15
Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 12/186 (6%)
Query: 297 AVKRL-KRSSFQRKKEFYSEIGRF--ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
A+K L K+ +RK+ ++ R +R++HP +V + Y+V E+ G L
Sbjct: 22 AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL- 80
Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
H+ + GR + R A + + +LH +++RD++ N+LLD + L
Sbjct: 81 --FSHLSKEGRFSEERARFYAAE-IVLALEYLHSL---GIIYRDLKPENILLDADGHIKL 134
Query: 414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
GL+K + E + T GT YLAPE + D +S GVLL E+++G+ P
Sbjct: 135 TDFGLAKELSSEGSRTNTFC--GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
Query: 474 AQAVDS 479
A D
Sbjct: 193 FYAEDR 198
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 63/205 (30%), Positives = 90/205 (43%), Gaps = 28/205 (13%)
Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKK-EFYSEIGRFARLHHPNLVAVKGCC 334
LLG G + G L D + VAVK K Q K +F SE + HPN+V + G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
YIV E V G +L + + L +K A A G+A+L K + +
Sbjct: 62 TQRQPIYIVMELVPGGD---FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCI 115
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG----------YLAPE 444
HRD+ A N L+ E + G+S+ QE G Y + APE
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-------QED----DGIYSSSGLKQIPIKWTAPE 164
Query: 445 FVYRNELTTKSDVYSFGVLLLEIVS 469
+ +++SDV+S+G+LL E S
Sbjct: 165 ALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 69/277 (24%), Positives = 119/277 (42%), Gaps = 43/277 (15%)
Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRL------KRSSFQRKKEFYSEIGRFARLHHPNLVA 329
+LG G Y G+ G +AVK++ ++ + ++ E+ L H N+V
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
G C D I EFV G + L+ R G + K + G+A+LH+
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILN---RFGPLPEPVFC-KYTKQILDGVAYLHNN- 121
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW--------EVMQERTVMAGGTYGYL 441
VVHRDI+ +NV+L L+ G ++ + W +++ M G Y ++
Sbjct: 122 --CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS---MHGTPY-WM 175
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL 501
APE + + KSD++S G + E+ +G+ P ++D + ++F + +HR L
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL--AAMF-----YIGAHR--GL 226
Query: 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
+ L S S+ +D V +C RP
Sbjct: 227 MPRLPDSFSAA---------AIDFVTSCLTRDQHERP 254
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 2e-15
Identities = 70/271 (25%), Positives = 119/271 (43%), Gaps = 41/271 (15%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
VAVK LK +S +K+F+ E L H ++V G C + +V+E++ +G L+++
Sbjct: 38 VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97
Query: 356 LH-HIPRG--------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
L H P L + + +A +A G+ +L + H VHRD+ N L+
Sbjct: 98 LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVG 154
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGG----TYGYLAPEFVYRNELTTKSDVYSFGV 462
E + G+S+ +V GG ++ PE + + TT+SDV+S GV
Sbjct: 155 ENLLVKIGDFGMSR----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV 210
Query: 463 LLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQK 521
+L EI + G++P W + E+++ + P ++
Sbjct: 211 VLWEIFTYGKQP--------WYQLSN-----------NEVIECITQGRVLQRPRT-CPKE 250
Query: 522 VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
V DL+ C Q P MR + + LQ LA+
Sbjct: 251 VYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 277 LGDSKTGGTY----SGILPDGSR--VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAV 330
LG+ G + +LP+ + VAVK LK +S +++F E L H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLH------HIPRGGR-----SLDWAMRMKVATTLA 379
G C + +V+E++ +G L+R+L I GG L + +A+ +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG--- 436
G+ +L H VHRD+ N L+ + + G+S+ ++ GG
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGRTM 185
Query: 437 -TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
++ PE + + TT+SD++SFGV+L EI + G++P
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
LG+ + G + G ++VAVK LK + + F E +L H LV + +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
YIV E++ G L L + G GR+L + +A +A G+A++ + + +H
Sbjct: 73 E-PIYIVTEYMSKGSL---LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
RD+R++N+L+ + + GL++ + E T G + + APE T
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 454 KSDVYSFGVLLLEIVS-GRRP 473
KSDV+SFG+LL E+V+ GR P
Sbjct: 183 KSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 55/190 (28%), Positives = 89/190 (46%), Gaps = 17/190 (8%)
Query: 294 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
S VAVK LK + ++ + SE+ + H N++ + G C G Y+V E+ +G
Sbjct: 43 STVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGN 102
Query: 352 LDRWLH-HIPRG-----------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
L +L P G +L + A +A+G+ FL K +HRD+
Sbjct: 103 LRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLA 159
Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
A NVL+ E+ + GL++ + +T ++APE ++ T +SDV+S
Sbjct: 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 219
Query: 460 FGVLLLEIVS 469
FGVLL EI +
Sbjct: 220 FGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 12/181 (6%)
Query: 296 VAVKRL-KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
V VK L K + EF E+ F +L H N+V + G C + Y++ E+ G L +
Sbjct: 38 VLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQ 97
Query: 355 WL-----HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
+L L ++ + T +A G+ L VHRD+ A N L+ +
Sbjct: 98 FLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQR 154
Query: 410 GAHLMGVGLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
+ + LSK V E + R + +LAPE V ++ +TKSDV+SFGVL+ E+
Sbjct: 155 EVKVSLLSLSKDVYNSEYYKLRNALI--PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212
Query: 469 S 469
+
Sbjct: 213 T 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 69/294 (23%), Positives = 130/294 (44%), Gaps = 48/294 (16%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSR----VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLV 328
++LG G Y G+ +P+G + VA+K L+ + + KE E A + HP++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 329 AVKGCCYDHGDRY-IVYEFVVNGPLDRWLH-HIPRGGRS--LDWAMRMKVATTLAQGIAF 384
+ G C + ++ + + G L ++ H G L+W +A+G+++
Sbjct: 73 RLLGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC------VQIAKGMSY 124
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG---TYGYL 441
L +K +VHRD+ A NVL+ + GL+K + + E+ A G ++
Sbjct: 125 LEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD---VDEKEYHAEGGKVPIKWM 178
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500
A E + T KSDV+S+GV + E+++ G +P + + +V + E L Q
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ------ 232
Query: 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
P I ++ V ++ C RP ++++ ++A+ P
Sbjct: 233 ---PPICTID-----------VYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 74/273 (27%), Positives = 122/273 (44%), Gaps = 40/273 (14%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLK-----RSSFQRKKEFYSEIGRFARLHHPNLV 328
LLG G Y G+ L DG AVK + ++ + K+ EI ++L HPN+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
G + + YI E V G L + L + G + +R+ L G+ +LHD+
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILL-GLEYLHDR 121
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV--MAGGTYGYLAPEFV 446
+ VHRDI+ +N+L+D L G++K +V++ G Y ++APE +
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAK----QVVEFSFAKSFKGSPY-WMAPEVI 173
Query: 447 YR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505
+ +D++S G +LE+ +G+ P ++ V ++F+ L P+
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAVFKIGRSKE--------LPPI 223
Query: 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
LS EA D + C Q PS+RP
Sbjct: 224 PDHLS---DEAK------DFILKCLQRDPSLRP 247
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
LG G + G ++VA+K LK + + F E +L H LV + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
YIV EF+ G L L + G G+ L + +A +A G+A++ + + +H
Sbjct: 73 E-PIYIVTEFMGKGSL---LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIH 125
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTT 453
RD+RA+N+L+ + + GL++ + E T G + + APE T
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 454 KSDVYSFGVLLLEIVS-GRRP 473
KSDV+SFG+LL E+V+ GR P
Sbjct: 183 KSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 7e-15
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 24/199 (12%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
D VAVK LK + +K+F E L H ++V G C D +V+E++ +G
Sbjct: 34 DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGD 93
Query: 352 LDRWLH-HIP-----------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
L+++L H P + L + + +A+ +A G+ +L + H VHRD+
Sbjct: 94 LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLA 150
Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG----TYGYLAPEFVYRNELTTKS 455
N L+ + G+S+ +V GG ++ PE + + TT+S
Sbjct: 151 TRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 206
Query: 456 DVYSFGVLLLEIVS-GRRP 473
DV+SFGV+L EI + G++P
Sbjct: 207 DVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 9e-15
Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 261 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 313
E+LR+I K ++ ++ G +G Y+ I + G VA+K++ +K+
Sbjct: 6 EKLRTIVSVGDPKKKYTRFEKI-GQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELII 64
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 372
+EI HPN+V Y GD ++V E++ G L + +D
Sbjct: 65 NEILVMRENKHPNIVNYLDS-YLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIA 118
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
V Q + FLH V+HRDI++ N+LL + L G + E +R+
Sbjct: 119 AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST 174
Query: 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
M G Y ++APE V R K D++S G++ +E+V G P
Sbjct: 175 MVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 65/274 (23%), Positives = 111/274 (40%), Gaps = 43/274 (15%)
Query: 291 PDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR-LH---HPNLVAVKGCCYDHGDRYIVYEF 346
P G A+K++ +EF ++ R + L P +V G Y G+ IV E+
Sbjct: 24 PTGKIYALKKIH---VDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80
Query: 347 VVNGPLDRWL---HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
+ G L L IP + +A + +G+ +LH K H++HRDI+ SN+
Sbjct: 81 MDGGSLADLLKKVGKIPE-------PVLAYIARQILKGLDYLHTKR--HIIHRDIKPSNL 131
Query: 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 463
L++ + + G+SK + E ++ GT Y++PE + + +D++S G+
Sbjct: 132 LINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLT 189
Query: 464 LLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVV 523
LLE G+ P + EL+ + +P +
Sbjct: 190 LLECALGKFPFLPPGQPSF----------------FELMQAICDGPPPSLPAEEFSPEFR 233
Query: 524 DLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTK 557
D + AC Q P RP +L Q P + K
Sbjct: 234 DFISACLQKDPKKRPS----AAELLQH--PFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 29/221 (13%)
Query: 275 RLLGDSKTGGTYSG----ILPDGSR--VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNL 327
R LG+ G + G + P+ + VAVK LK ++ +K+F E H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLH-HIPRGGRS---------LDWAMRMKVATT 377
V G C + +V+E++ +G L+++L H P L + +++A
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
+A G+ +L + H VHRD+ N L+ + + G+S+ +V GG
Sbjct: 131 IASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGH 183
Query: 438 ----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
++ PE + + TT+SDV+SFGV+L EI + G++P
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 72/280 (25%), Positives = 125/280 (44%), Gaps = 36/280 (12%)
Query: 291 PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVV 348
P G+ +AVKR++ + + Q +K ++ R + P V G + GD +I E V+
Sbjct: 24 PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME-VM 82
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
+ LD++ + G ++ + K+A ++ + + +LH K+ V+HRD++ SNVL++
Sbjct: 83 DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRN 140
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV----YRNELTTKSDVYSFGVLL 464
L G+S ++ V +T+ A G Y+APE + + KSDV+S G+ +
Sbjct: 141 GQVKLCDFGISGYLVDSVA--KTIDA-GCKPYMAPERINPELNQKGYDVKSDVWSLGITM 197
Query: 465 LEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVD 524
+E+ +GR P W TP Q + +E +P S +P + D
Sbjct: 198 IELATGRFPYD-----------SWKTPFQQLKQVVE--EP-----SPQLPAEKFSPEFQD 239
Query: 525 LVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKLLFKGLD 564
V C + RP + L P L K D
Sbjct: 240 FVNKCLKKNYKERPNY------PELLQHPFFELHLSKNTD 273
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 56/182 (30%), Positives = 91/182 (50%), Gaps = 12/182 (6%)
Query: 293 GSRVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI--VYEFVVN 349
G +VAVK LK S + EI L+H N+V KG C + G I + EF+ +
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
G L +L PR ++ ++K A + +G+ +L + VHRD+ A NVL++ E
Sbjct: 93 GSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEH 146
Query: 410 GAHLMGVGLSKFVPW--EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ GL+K + E + + + Y APE + +++ SDV+SFGV L E+
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYEL 205
Query: 468 VS 469
++
Sbjct: 206 LT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 60/258 (23%), Positives = 108/258 (41%), Gaps = 30/258 (11%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFAR---------LHH---PNLVAVKGCCYDHGDR 340
GS VK + + KK + R +H P +V+ G + +
Sbjct: 19 GSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI 78
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
+ EF+ G LDR I + G + + K+A + +G+ +L++ ++HRDI+
Sbjct: 79 CMCMEFMDCGSLDR----IYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKP 132
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460
SN+L++ L G+S E++ GT Y++PE + + T KSDV+S
Sbjct: 133 SNILVNSRGQIKLCDFGVSG----ELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSL 188
Query: 461 GVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQ 520
G+ ++E+ G+ P + L+LL ++ +P + +
Sbjct: 189 GISIIELALGKFP--------FAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE 240
Query: 521 KVVDLVYACTQHVPSMRP 538
+ D V AC P+ RP
Sbjct: 241 DLRDFVDACLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 66/261 (25%), Positives = 110/261 (42%), Gaps = 33/261 (12%)
Query: 290 LPDGSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
L DG VA+K+++ K + EI +L HPN++ ++ + IV E
Sbjct: 24 LLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83
Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
G L R + H + R + K L + +H K ++HRDI+ +NV +
Sbjct: 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFIT 140
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
L +GL +F + +++ GT Y++PE ++ N KSD++S G LL E
Sbjct: 141 ATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198
Query: 467 IVSGRRP----AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV 522
+ + + P + S+C + I + P + + Y E L
Sbjct: 199 MAALQSPFYGDKMNLYSLC-KKIEKCDYPPLPADHYSEELR------------------- 238
Query: 523 VDLVYACTQHVPSMRPRMSHV 543
DLV C P RP +S+V
Sbjct: 239 -DLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 44/213 (20%)
Query: 288 GILP--DGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344
G+LP + VAVK LK +S + +F E A HPN+V + G C +++
Sbjct: 28 GLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF 87
Query: 345 EFVVNGPLD--------RWLHHIPRGGRS----------LDWAMRMKVATTLAQGIAFLH 386
E++ G L+ R + S L ++ +A +A G+A+L
Sbjct: 88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS 147
Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG------- 439
++ VHRD+ N L+ E + GLS R + + Y
Sbjct: 148 ER---KFVHRDLATRNCLVGENMVVKIADFGLS----------RNIYSADYYKASENDAI 194
Query: 440 ---YLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
++ PE ++ N TT+SDV+++GV+L EI S
Sbjct: 195 PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 18/220 (8%)
Query: 261 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 313
E+LR+I K ++ ++ G +G ++ I + G VA+K++ +K+
Sbjct: 6 EKLRTIVSIGDPKKKYTRYEKI-GQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELII 64
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
+EI L +PN+V + ++V E++ G L + +D A
Sbjct: 65 NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET-----CMDEAQIAA 119
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
V Q + FLH V+HRDI++ NVLL + L G + E +R+ M
Sbjct: 120 VCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-QSKRSTM 175
Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
G Y ++APE V R K D++S G++ +E+V G P
Sbjct: 176 VGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 77/304 (25%), Positives = 127/304 (41%), Gaps = 45/304 (14%)
Query: 275 RLLGDSKTGGTYSGILPD------GSRVAVKRLKRSSFQRKK-EFYSEIGRFARLHHPNL 327
R LG G Y G D +RVAVK + S+ R++ EF +E ++
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI------PRGGRSLDWAMRMKVATTLAQG 381
V + G +V E + +G L +L + G +++A +A G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---- 437
+A+L+ K VHRD+ A N ++ +F + G+++ ++ + GG
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 184
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSH 496
++APE + TT SD++SFGV+L EI S +P Q + + E V
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-------EQVLKFVMDG 237
Query: 497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVT 556
YL D P+ ++V DL+ C Q P MRP +V+ L+ P
Sbjct: 238 GYL------------DQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284
Query: 557 KLLF 560
++ F
Sbjct: 285 EVSF 288
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 67/283 (23%), Positives = 123/283 (43%), Gaps = 45/283 (15%)
Query: 290 LPDGSRVAVKRLKRSSFQRK-KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
+ VAVK LK ++ + ++ SE +++HP+++ + G C G ++ E+
Sbjct: 27 RAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAK 86
Query: 349 NGPLDRWLH--------HIPRGG------------RSLDWAMRMKVATTLAQGIAFLHDK 388
G L +L ++ G R+L + A +++G+ +L +
Sbjct: 87 YGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM 146
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
+VHRD+ A NVL+ E + GLS+ V E + ++A E ++
Sbjct: 147 ---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD 203
Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507
+ TT+SDV+SFGVLL EIV+ G P P + R LL +
Sbjct: 204 HIYTTQSDVWSFGVLLWEIVTLGGNP----------------YPGIAPERLFNLLK---T 244
Query: 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
+ PE +++ +L+ C + P RP + + +L+++
Sbjct: 245 GYRMERPE-NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 54/188 (28%), Positives = 97/188 (51%), Gaps = 24/188 (12%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGP 351
G +VAVK++ QR++ ++E+ HPN+V + Y GD ++V EF+ G
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS-YLVGDELWVVMEFLEGGA 102
Query: 352 LDRWLHHIPRGGRSLDWAMRM---KVATT---LAQGIAFLHDKVKPHVVHRDIRASNVLL 405
L + H RM ++AT + + ++FLH + V+HRDI++ ++LL
Sbjct: 103 LTDIVTH-----------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILL 148
Query: 406 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465
+ L G V EV + ++++ GT ++APE + R T+ D++S G++++
Sbjct: 149 TSDGRVKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAPEVISRLPYGTEVDIWSLGIMVI 206
Query: 466 EIVSGRRP 473
E+V G P
Sbjct: 207 EMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 32/197 (16%)
Query: 296 VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
VAVK L+ S +++F E+ +RL PN+ + G C ++ E++ NG L++
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 355 WLH-HIPR------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
+L H+ +SL ++ + +AT +A G+ +L + VHRD+ N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGK 165
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG----------YLAPEFVYRNELTTKSDV 457
+ + G+S R + + Y ++A E V + TTKSDV
Sbjct: 166 NYTIKIADFGMS----------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215
Query: 458 YSFGVLLLEIVS-GRRP 473
++FGV L EI++ R
Sbjct: 216 WAFGVTLWEILTLCREQ 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 29/263 (11%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
G +VAVK++ QR++ ++E+ HH N+V + + ++V EF+ G L
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
+ H ++ V ++ + +++LH++ V+HRDI++ ++LL +
Sbjct: 107 TDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIK 158
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 472
L G V EV + ++++ GT ++APE + R T+ D++S G++++E++ G
Sbjct: 159 LSDFGFCAQVSKEVPKRKSLV--GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216
Query: 473 PAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQH 532
P + P +Q+ R + D L + + V++ +DL+
Sbjct: 217 PY-------------FNEPPLQAMRRIR--DNLPPRVKDSHKVSSVLRGFLDLMLV---R 258
Query: 533 VPSMRPRMSHVV-HQLQQLAQPP 554
PS R ++ H +LA PP
Sbjct: 259 EPSQRATAQELLQHPFLKLAGPP 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 64/276 (23%), Positives = 115/276 (41%), Gaps = 35/276 (12%)
Query: 276 LLGDSKTGGTYSGI-LPDGSRVAVKR--LKRSSFQRKKE--------FYSEIGRFARLHH 324
L+G G Y + + G +AVK+ L + R SEI L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
N+V G I E+V G + L GR + + + +G+A+
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR---TYGR-FEEQLVRFFTEQVLEGLAY 123
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
LH K ++HRD++A N+L+D + + G+SK ++ + G+ ++APE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 445 FV--YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502
+ Y + K D++S G ++LE+ +GRRP +++ ++F+ +
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMFKLGN---KRSA----- 230
Query: 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
P+ +S ++ +D + AC P RP
Sbjct: 231 PPIPPDVSMNLSPVA-----LDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
LG G + G +RVA+K LK + + F E +L H LV + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
YIV E++ G L +L G+ L + +A +A G+A++ + + VHR
Sbjct: 73 E-PIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNELTTK 454
D+RA+N+L+ E + GL++ + E T G + + APE T K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 455 SDVYSFGVLLLEIVS-GRRP 473
SDV+SFG+LL E+ + GR P
Sbjct: 184 SDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 61/249 (24%), Positives = 111/249 (44%), Gaps = 16/249 (6%)
Query: 292 DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
DG VA+K+++ + + + EI +L+HPN++ + + IV E
Sbjct: 26 DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 85
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
G L R + H + R + K L + +H + V+HRDI+ +NV +
Sbjct: 86 AGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITAT 142
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
L +GL +F + +++ GT Y++PE ++ N KSD++S G LL E+
Sbjct: 143 GVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200
Query: 469 SGRRP----AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVD 524
+ + P + S+C + I + P + S Y E L L++ + PE + +
Sbjct: 201 ALQSPFYGDKMNLYSLC-KKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEK---RPDIT 256
Query: 525 LVYACTQHV 533
VY + +
Sbjct: 257 YVYDVAKRM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 1e-13
Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 18/220 (8%)
Query: 261 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 313
E+LRSI K ++ ++ G +G Y+ I + G VA+K++ +K+
Sbjct: 6 EKLRSIVSVGDPKKKYTRFEKI-GQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII 64
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
+EI +PN+V + ++V E++ G L + +D
Sbjct: 65 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAA 119
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
V Q + FLH V+HRDI++ N+LL + L G + E +R+ M
Sbjct: 120 VCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTM 175
Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
G Y ++APE V R K D++S G++ +E+V G P
Sbjct: 176 VGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 1e-13
Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 19/183 (10%)
Query: 296 VAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
A+K L ++ + K+ +E + HP LV + G D + Y+V E+V G L
Sbjct: 29 YALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL 88
Query: 353 DRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
H+ + GR A LA + +LH +V+RD++ N+LLD +
Sbjct: 89 ---FSHLRKSGRFPEPVARFYAAQVVLA--LEYLHSL---DIVYRDLKPENLLLDSDGYI 140
Query: 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVSG 470
+ G +K V RT GT YLAPE + ++ K+ D ++ G+L+ E+++G
Sbjct: 141 KITDFGFAKRVK-----GRTYTLCGTPEYLAPE-IILSKGYGKAVDWWALGILIYEMLAG 194
Query: 471 RRP 473
P
Sbjct: 195 YPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 50/200 (25%), Positives = 87/200 (43%), Gaps = 29/200 (14%)
Query: 296 VAVKRLKRSSFQR-KKEFYSEIGR--FARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
A+K L + + KK Y +I + RL HP ++ + D + Y V E+ NG
Sbjct: 29 YAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGE 88
Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--- 408
L L +I + G SLD A + + +LH K ++HRD++ N+LLD++
Sbjct: 89 L---LQYIRKYG-SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHI 141
Query: 409 ----FGA-----------HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT 453
FG G + E + R GT Y++PE +
Sbjct: 142 KITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGK 201
Query: 454 KSDVYSFGVLLLEIVSGRRP 473
SD+++ G ++ ++++G+ P
Sbjct: 202 SSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 11/156 (7%)
Query: 324 HPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
HP L + C+ DR + V E+V G L + HI R GR D A + G+
Sbjct: 55 HPFLTQLH-SCFQTKDRLFFVMEYVNGGDL---MFHIQRSGR-FDEPRARFYAAEIVLGL 109
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
FLH++ +++RD++ NVLLD E + G+ K + T GT Y+A
Sbjct: 110 QFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC--GTPDYIA 164
Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVD 478
PE + D ++ GVLL E+++G+ P + D
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|214480 smart00034, CLECT, C-type lectin (CTL) or carbohydrate-recognition domain (CRD) | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-13
Identities = 32/138 (23%), Positives = 60/138 (43%), Gaps = 17/138 (12%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP WI K C+ + ++W++++ +C+ +GGHLA++ S E L + +
Sbjct: 1 CPSGWISYGGK--CYKFSTEKKTWEDAQAFCQSLGGHLASIHSEAENDFVASLLKNSGSS 58
Query: 113 --CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
W+G ++ SW+WSD S S+++ P + + C ++S
Sbjct: 59 DYYWIGLSDPDSNG--SWQWSDG-SGPV-------SYSNWAPGEP---NNSSGDCVVLST 105
Query: 171 GSRSLVTERCNTSHPFIC 188
C + PF+C
Sbjct: 106 SGGKWNDVSCTSKLPFVC 123
|
Many of these domains function as calcium-dependent carbohydrate binding modules. Length = 124 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 63/268 (23%), Positives = 114/268 (42%), Gaps = 33/268 (12%)
Query: 290 LPDGSRVAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
L D VA+K+++ + +++ EI +L+HPN++ + + IV E
Sbjct: 24 LLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83
Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
G L + + + + R + K L + +H + V+HRDI+ +NV +
Sbjct: 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFIT 140
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
L +GL +F + +++ GT Y++PE ++ N KSD++S G LL E
Sbjct: 141 ATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198
Query: 467 IVSGRRP----AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV 522
+ + + P + S+C Q I + P PL P +K+
Sbjct: 199 MAALQSPFYGDKMNLFSLC-QKIEQCDYP------------PL--------PTEHYSEKL 237
Query: 523 VDLVYACTQHVPSMRPRMSHVVHQLQQL 550
+LV C P RP + +V +Q+
Sbjct: 238 RELVSMCIYPDPDQRPDIGYVHQIAKQM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 13/203 (6%)
Query: 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
+ LG + G + ++VAVK +K S + F +E L H LV +
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
YI+ EF+ G L +L G + + +A+G+AF+ + +
Sbjct: 70 VTKE-PIYIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 123
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY--GYLAPEFVYRNEL 451
+HRD+RA+N+L+ + GL++ + E T G + + APE +
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSF 180
Query: 452 TTKSDVYSFGVLLLEIVS-GRRP 473
T KSDV+SFG+LL+EIV+ GR P
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 60/258 (23%), Positives = 110/258 (42%), Gaps = 29/258 (11%)
Query: 292 DGSRVAVKR--LKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
D S V K L R S + +++ +EI + L HPN++A D I E+
Sbjct: 24 DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANG 83
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
G L + + G+ + M + + ++++H K ++HRDI+ N+ L +
Sbjct: 84 GTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAG 138
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
L G+SK + E TV+ GT Y++PE + KSD+++ G +L E+++
Sbjct: 139 LIKLGDFGISKILGSEYSMAETVV--GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196
Query: 470 GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYAC 529
+R F+ P L L+ ++ + + +++ LV++
Sbjct: 197 LKR------------TFDATNP-------LNLVVKIVQGNYTPVVS-VYSSELISLVHSL 236
Query: 530 TQHVPSMRPRMSHVVHQL 547
Q P RP V+ Q
Sbjct: 237 LQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 51/199 (25%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 277 LGDSKTGGT-YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
+G+ TG + + G VAVK++ QR++ ++E+ H N+V + Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-Y 86
Query: 336 DHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
GD ++V EF+ G L + H ++ V + + ++ LH + V+
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVI 138
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRDI++ ++LL + L G V EV + ++++ GT ++APE + R +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAPELISRLPYGPE 196
Query: 455 SDVYSFGVLLLEIVSGRRP 473
D++S G++++E+V G P
Sbjct: 197 VDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 79/289 (27%), Positives = 129/289 (44%), Gaps = 43/289 (14%)
Query: 275 RLLGDSKTGGTYSGIL--PDGSRV--AVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVA 329
R++G G Y G L DG ++ AVK L R + + ++F E HPN+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 330 VKGCCY-DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
+ G C G +V ++ +G L + I + + +A+G+ +L K
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDL---RNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK 117
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYLAPEF 445
VHRD+ A N +LDE F + GL++ + + + T A ++A E
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT-GAKLPVKWMALES 173
Query: 446 VYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLE---L 501
+ + TTKSDV+SFGVLL E+++ G P VDS F+ L+Q R L+
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITVYLLQGRRLLQPEYC 227
Query: 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
DPL ++ +C P MRP S +V +++Q+
Sbjct: 228 PDPLYE-----------------VMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 7e-13
Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 14/211 (6%)
Query: 274 NRLLGDSKTGGTYSGI--LPDGSR--VAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLV 328
R +G+ + G Y G+ P+ + VAVK K + +E F E + HP++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
+ G ++ +IV E G L +L SLD A + + L+ +A+L K
Sbjct: 71 KLIGVITEN-PVWIVMELAPLGELRSYLQ---VNKYSLDLASLILYSYQLSTALAYLESK 126
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
VHRDI A NVL+ L GLS+++ E + + ++APE +
Sbjct: 127 ---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWMAPESINF 182
Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRPAQAVD 478
T+ SDV+ FGV + EI+ G +P Q V
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 8e-13
Identities = 50/200 (25%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 284 GTYSGI-----LPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYD 336
G+Y + L D A+K + S + +++ +EI A ++HPN+++ K D
Sbjct: 11 GSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD 70
Query: 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
IV E+ G L + + + + + ++ L +G+ LH++ ++HR
Sbjct: 71 GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHR 127
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 456
D++++N+LL + +G+SK + + +T + GT Y+APE + KSD
Sbjct: 128 DLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI--GTPHYMAPEVWKGRPYSYKSD 183
Query: 457 VYSFGVLLLEIVSGRRPAQA 476
++S G LL E+ + P +A
Sbjct: 184 IWSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 9e-13
Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 18/220 (8%)
Query: 261 EELRSIT------KNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFY 313
E+LRSI K ++ ++ G +G Y+ + + G VA++++ +K+
Sbjct: 7 EKLRSIVSVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
+EI +PN+V + ++V E++ G L + +D
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAA 120
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
V Q + FLH V+HRDI++ N+LL + L G + E +R+ M
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTM 176
Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
G Y ++APE V R K D++S G++ +E++ G P
Sbjct: 177 VGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 71/304 (23%), Positives = 132/304 (43%), Gaps = 44/304 (14%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
++LG G Y G+ +P+G + VA+K L+ +S + KE E A + +P++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKVATTLAQGIAFLH 386
+ G C + I LD H G L+W ++ +A+G+ +L
Sbjct: 73 RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLE 126
Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG---TYGYLAP 443
++ +VHRD+ A NVL+ + GL+K + + E+ A G ++A
Sbjct: 127 ER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD---EKEYHAEGGKVPIKWMAL 180
Query: 444 EFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502
E + T +SDV+S+GV + E+++ G +P + + SI E L Q
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-------- 232
Query: 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKLLFKG 562
P I ++ V ++ C RP+ ++ + ++A+ P L+ +G
Sbjct: 233 -PPICTI-----------DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 280
Query: 563 LDRL 566
+R+
Sbjct: 281 DERM 284
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK-KEFYSEIGRFARLHHPNLVAVKGCC 334
+G T Y+ I LP+ +VA+KR+ Q E E+ ++ +HPN+V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 335 YDHGDRYIVYEFVVNGP-LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
+ ++V ++ G LD PRGG LD A+ V + +G+ +LH +
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGG--LDEAIIATVLKEVLKGLEYLHSNGQ--- 123
Query: 394 VHRDIRASNVLLDEEFGAHL--MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNE 450
+HRDI+A N+LL E+ + GV S + ++ GT ++APE + +
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 451 LTTKSDVYSFGVLLLEIVSGRRP 473
K+D++SFG+ +E+ +G P
Sbjct: 184 YDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 51/186 (27%), Positives = 85/186 (45%), Gaps = 13/186 (6%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
G A K ++ S + ++F EI + HPN+V + + +I+ EF G L
Sbjct: 30 GLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGAL 89
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
D + + RG L V + + + FLH V+HRD++A N+LL +
Sbjct: 90 DSIMLELERG---LTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVK 143
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV----YR-NELTTKSDVYSFGVLLLEI 467
L G+S +Q+R G Y ++APE V ++ N K+D++S G+ L+E+
Sbjct: 144 LADFGVSAKNKST-LQKRDTFIGTPY-WMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201
Query: 468 VSGRRP 473
P
Sbjct: 202 AQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 13/178 (7%)
Query: 334 CYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
C+ DR Y V E+V G L ++ I + GR + A +A G+ FLH K
Sbjct: 69 CFQTMDRLYFVMEYVNGGDL---MYQIQQVGR-FKEPHAVFYAAEIAIGLFFLHSK---G 121
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 452
+++RD++ NV+LD E + G+ K W+ + +T GT Y+APE +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC--GTPDYIAPEIIAYQPYG 179
Query: 453 TKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSIFEW--ATPLVQSHRYLELLDPLIS 507
D ++FGVLL E+++G+ P + D +QSI E A P S + + L++
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 276 LLGDSKTGGTYSGIL-PDGSR---VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAV 330
++G + G G L G R VA+K LK + +++++F SE + HPN++ +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA----FLH 386
+G I+ EF+ NG LD +L R D + + +GIA +L
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFL-------RQNDGQFTVIQLVGMLRGIAAGMKYLS 123
Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER-TVMAGGTYG--YLAP 443
+ + VHRD+ A N+L++ + GLS+F+ + T GG + AP
Sbjct: 124 EM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 444 EFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
E + + T+ SDV+S+G+++ E++S G RP
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 51/199 (25%), Positives = 87/199 (43%), Gaps = 22/199 (11%)
Query: 291 PDGSRVAVKRLKRSSFQRKKEFY--SEIGRFARLHHPNLVAVKGCCYDHG-DR-----YI 342
DG + K + + K++ SE+ L HPN+V YD DR YI
Sbjct: 23 SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY----YDRIIDRSNQTLYI 78
Query: 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRA 400
V E+ G L + + + + ++ ++ T L + H++ P V+HRD++
Sbjct: 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKP 138
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNELTTKSDV 457
+N+ LD L GL+K ++ + A GT Y++PE + KSD+
Sbjct: 139 ANIFLDANNNVKLGDFGLAK-----ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDI 193
Query: 458 YSFGVLLLEIVSGRRPAQA 476
+S G L+ E+ + P A
Sbjct: 194 WSLGCLIYELCALSPPFTA 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 275 RLLGDSKTGGTYSGILP-DGSR---VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVA 329
+++G + G SG L G R VA+K LK ++ +++F SE + HPN++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
++G IV E++ NG LD +L + + + +A G+ +L D
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLR---KHDGQFTVIQLVGMLRGIASGMKYLSDM- 125
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG------YLAP 443
VHRD+ A N+L++ + GLS+ V+++ A T G + AP
Sbjct: 126 --GYVHRDLAARNILVNSNLVCKVSDFGLSR-----VLEDDPEAAYTTRGGKIPIRWTAP 178
Query: 444 EFVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
E + + T+ SDV+S+G+++ E++S G RP
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 276 LLGDSKTGGTYSGI-LPDGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
LG+ G Y I G VA+K ++ + KE I + P +V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKE----ISILKQCDSPYIVKYYG 65
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKV 389
+ + D +IV E+ G + + ++L ++A L Q G+ +LH
Sbjct: 66 SYFKNTDLWIVMEYCGAGSV---SDIMKITNKTLTEE---EIAAILYQTLKGLEYLHSN- 118
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
+HRDI+A N+LL+EE A L G+S + + + TV+ GT ++APE +
Sbjct: 119 --KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI--GTPFWMAPEVIQEI 174
Query: 450 ELTTKSDVYSFGVLLLEIVSGRRP 473
K+D++S G+ +E+ G+ P
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 17/219 (7%)
Query: 275 RLLGDSKTGGTYSGILPDGS---RVAVKRLKRSSFQRKK--EFYSEIGRFARLHHPNLVA 329
+ LG+ + G G L +VAVK +K + R + +F SE HPN++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 330 VKGCCYDHGDR------YIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKVATTLAQG 381
+ G C + ++ F+ +G L +L + G L M +K T +A G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
+ +L K +HRD+ A N +L+E + GLSK + + +A ++
Sbjct: 125 MEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 479
A E + TTKSDV+SFGV + EI + G+ P V++
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN 220
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 33/234 (14%)
Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
P +V G Y G+ I E + G LD+ L R + + K++ + +G+ +
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPENILGKISIAVLRGLTY 114
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG---GTYGYL 441
L +K K ++HRD++ SN+L++ L G+S Q MA GT Y+
Sbjct: 115 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG-------QLIDSMANSFVGTRSYM 165
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF-------EWATPLV- 493
+PE + T +SD++S G+ L+E+ GR P D+ +++F E
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRP 225
Query: 494 ---------QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
+ ELLD +++ +P + D V C + P R
Sbjct: 226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA 279
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 57/195 (29%), Positives = 86/195 (44%), Gaps = 8/195 (4%)
Query: 277 LGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+G G +SG L D + VAVK + + K +F E + HPN+V + G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
YIV E V G +L G L +++ A G+ +L K H +
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCI 116
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRD+ A N L+ E+ + G+S+ V M + APE + +++
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 455 SDVYSFGVLLLEIVS 469
SDV+SFG+LL E S
Sbjct: 177 SDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 51/186 (27%), Positives = 85/186 (45%), Gaps = 18/186 (9%)
Query: 292 DGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
G VA+K++K K EI L+HPN++ + GD Y+V+EF
Sbjct: 23 TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF--- 79
Query: 350 GPLDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
+D L+ + + R L ++ L QG+AF H ++HRD++ N+L++ E
Sbjct: 80 --MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTE 134
Query: 409 FGAHLMGVGLSKFV--PWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLL 465
L GL++ P V T Y APE + ++ +T D++S G +
Sbjct: 135 GVLKLADFGLARSFGSPVRPYTHYVV----TRWYRAPELLLGDKGYSTPVDIWSVGCIFA 190
Query: 466 EIVSGR 471
E++S R
Sbjct: 191 ELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 70/303 (23%), Positives = 136/303 (44%), Gaps = 40/303 (13%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRV----AVKRLKRSSFQRKK-EFYSEIGRFARLHHPNLV 328
++LG G Y GI +P+G V A+K L ++ + EF E A + HP+LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLH-HIPRGGRSL--DWAMRMKVATTLAQGIAFL 385
+ G C + +V + + +G L ++H H G L +W ++ +A+G+ +L
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYL 125
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 445
++ +VHRD+ A NVL+ + GL++ + + + ++A E
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 446 VYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504
++ + T +SDV+S+GV + E+++ G +P + + + E L Q P
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ---------P 233
Query: 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKLLFKGLD 564
I ++ V ++ C RP+ + + ++A+ P L+ +G D
Sbjct: 234 PICTID-----------VYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDD 282
Query: 565 RLR 567
R++
Sbjct: 283 RMK 285
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 68/274 (24%), Positives = 117/274 (42%), Gaps = 42/274 (15%)
Query: 294 SRVAVKRLKRSSFQRK-KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
++VAVK LK + ++ + SE+ + H N++ + G C G Y++ E+ G
Sbjct: 51 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110
Query: 352 LDRWLH--------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
L +L +P L + + A +A+G+ +L K +HRD
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPE--EQLSFKDLVSCAYQVARGMEYLASK---KCIHRD 165
Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 457
+ A NVL+ E+ + GL++ + ++T ++APE ++ T +SDV
Sbjct: 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 225
Query: 458 YSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEA 516
+SFGVLL EI + G P V + E L + HR D P +
Sbjct: 226 WSFGVLLWEIFTLGGSPYPGV------PVEELFKLLKEGHRM-------------DKP-S 265
Query: 517 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
++ ++ C VPS RP +V L ++
Sbjct: 266 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 74/291 (25%), Positives = 124/291 (42%), Gaps = 38/291 (13%)
Query: 275 RLLGDSKTGGTYSGILP--DGS--RVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLV 328
R+LG + G L DGS +VAVK LK F +EF E HPN++
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 329 AVKGCCYDHGDR------YIVYEFVVNGPLDRWL--HHIPRGGRSLDWAMRMKVATTLAQ 380
+ G + ++ F+ +G L +L I +L ++ +A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 440
G+ +L K + +HRD+ A N +L+E + GLSK + + + +
Sbjct: 125 GMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499
LA E + N TT SDV++FGV + EI++ G+ P V++ I+ + L++ +R
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNY---LIKGNRLK 235
Query: 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
+ D L + V +L+ C P RP H+ QL+ +
Sbjct: 236 QPPDCL--------------EDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|153057 cd00037, CLECT, C-type lectin (CTL)/C-type lectin-like (CTLD) domain | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-12
Identities = 32/130 (24%), Positives = 56/130 (43%), Gaps = 22/130 (16%)
Query: 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEE-EHSAQKLCGKNVNGCWVGGRSINTT 123
C+ + +W+E++ YC+ +GGHLA++ S EE + A L + + W+G +++
Sbjct: 1 SCYKFSTEKLTWEEAQEYCRSLGGHLASIHSEEENDFLASLLKKSSSSDVWIGLNDLSS- 59
Query: 124 VGLSWKWSD-----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTE 178
+WKWSD + + W G + C L S+
Sbjct: 60 -EGTWKWSDGSPLVDYTNWAPGEPNPGG-SEDCV-------------VLSSSSDGKWNDV 104
Query: 179 RCNTSHPFIC 188
C++ PFIC
Sbjct: 105 SCSSKLPFIC 114
|
CLECT: C-type lectin (CTL)/C-type lectin-like (CTLD) domain; protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. This group is chiefly comprised of eukaryotic CTLDs, but contains some, as yet functionally uncharacterized, bacterial CTLDs. Many CTLDs are calcium-dependent carbohydrate binding modules; other CTLDs bind protein ligands, lipids, and inorganic surfaces, including CaCO3 and ice. Animal C-type lectins are involved in such functions as extracellular matrix organization, endocytosis, complement activation, pathogen recognition, and cell-cell interactions. For example: mannose-binding lectin and lung surfactant proteins A and D bind carbohydrates on surfaces (e.g. pathogens, allergens, necrotic, and apoptotic cells) and mediate functions associated with killing and phagocytosis; P (platlet)-, E (endothelial)-, and L (leukocyte)- selectins (sels) mediate the initial attachment, tethering, and rolling of lymphocytes on inflamed vascular walls enabling subsequent lymphocyte adhesion and transmigration. CTLDs may bind a variety of carbohydrate ligands including mannose, N-acetylglucosamine, galactose, N-acetylgalactosamine, and fucose. Several CTLDs bind to protein ligands, and only some of these binding interactions are Ca2+-dependent; including the CTLDs of Coagulation Factors IX/X (IX/X) and Von Willebrand Factor (VWF) binding proteins, and natural killer cell receptors. C-type lectins, such as lithostathine, and some type II antifreeze glycoproteins function in a Ca2+-independent manner to bind inorganic surfaces. Many proteins in this group contain a single CTLD; these CTLDs associate with each other through several different surfaces to form dimers, trimers, or tetramers, from which ligand-binding sites project in different orientations. Various vertebrate type 1 transmembrane proteins including macrophage mannose receptor, endo180, phospholipase A2 receptor, and dendritic and epithelial cell receptor (DEC205) have extracellular domains containing 8 or more CTLDs; these CTLDs remain in the parent model. In some members (IX/X and VWF binding proteins), a loop extends to the adjoining domain to form a loop-swapped dimer. A similar conformation is seen in the macrophage mannose receptor CRD4's putative non-sugar bound form of the domain in the acid environment of the endosome. Lineage specific expansions of CTLDs have occurred in several animal lineages including Drosophila melanogaster and Caenorhabditis elegans; these CTLDs also remain in the parent model. Length = 116 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-12
Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 22/200 (11%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLH----HPNLVAVKGCCYDHGDR-YIVYEFV 347
G A+K LK+S K + + A + P VA + D Y+V E++
Sbjct: 21 GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPY-VAKLYYSFQSKDYLYLVMEYL 79
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
G + + GG DWA + + G+ LH + ++HRDI+ N+L+D+
Sbjct: 80 NGGDCASLIKTL--GGLPEDWAK--QYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQ 132
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
L GLS+ + ++ V GT YLAPE + SD +S G ++ E
Sbjct: 133 TGHLKLTDFGLSRNG---LENKKFV---GTPDYLAPETILGVGDDKMSDWWSLGCVIFEF 186
Query: 468 VSGRRP--AQAVDSVCWQSI 485
+ G P A+ D+V + +I
Sbjct: 187 LFGYPPFHAETPDAV-FDNI 205
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 51/193 (26%), Positives = 94/193 (48%), Gaps = 25/193 (12%)
Query: 296 VAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
VAVK L+ ++ + +F E+ +RL PN++ + G C D ++ E++ NG L++
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 355 WL--HHIPRG-------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
+L HH+ ++ ++ + VA +A G+ +L + VHRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLA 165
Query: 400 ASNVLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 456
N L+ E + G+S+ + + +Q R V+ ++A E + + TT SD
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLP---IRWMAWECILMGKFTTASD 222
Query: 457 VYSFGVLLLEIVS 469
V++FGV L EI+
Sbjct: 223 VWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 46/208 (22%)
Query: 291 PD-GSRVAVKRLKRSSFQRKKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
PD G A+K LK+++ + + +++ R A ++HP +V + G Y++ +F+
Sbjct: 21 PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--------------- 392
RGG + T L++ + F + VK +
Sbjct: 81 -------------RGG---------DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM--QERTVMAGGTYGYLAPEFVYRNE 450
+++RD++ N+LLDEE L GLSK E + +++ GT Y+APE V R
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVEYMAPEVVNRRG 174
Query: 451 LTTKSDVYSFGVLLLEIVSGRRPAQAVD 478
T +D +SFGVL+ E+++G P Q D
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKD 202
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 61/261 (23%), Positives = 118/261 (45%), Gaps = 44/261 (16%)
Query: 293 GSRVAVKRLK--RSSFQRKKEFYS----EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
G+ +AVK++ R++ ++E EI ARL+HP+++ + G + + E+
Sbjct: 25 GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84
Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
+ G + L + A+ + L +G+++LH+ ++HRD++ +N+L+D
Sbjct: 85 MAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLID 137
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAG-------GTYGYLAPEFVYRNELTTKS-DVY 458
G L ++ F + + AG GT ++APE V R E +S DV+
Sbjct: 138 ST-GQRLR---IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE-VLRGEQYGRSCDVW 192
Query: 459 SFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS-DIPEAG 517
S G +++E+ + + P W +H L L+ + S+ ++ IPE
Sbjct: 193 SVGCVIIEMATAKPP--------------WNAEKHSNH--LALIFKIASATTAPSIPEH- 235
Query: 518 VVQKVVDLVYACTQHVPSMRP 538
+ + D+ C + P RP
Sbjct: 236 LSPGLRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 44/181 (24%), Positives = 89/181 (49%), Gaps = 10/181 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
G +VAVK + QR++ ++E+ H N+V + + +++ EF+ G L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
+ L+ V ++ Q + +LH + V+HRDI++ ++LL +
Sbjct: 106 TDIVSQT-----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVK 157
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRR 472
L G + +V + ++++ GT ++APE + R T+ D++S G++++E+V G
Sbjct: 158 LSDFGFCAQISKDVPKRKSLV--GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215
Query: 473 P 473
P
Sbjct: 216 P 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 11/171 (6%)
Query: 319 FARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 377
A P + C+ DR Y V E+V G L ++HI + G+ + A
Sbjct: 54 LALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGK-FKEPQAVFYAAE 109
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
++ G+ FLH + +++RD++ NV+LD E + G+ K + + RT GT
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC--GT 164
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSIFE 487
Y+APE + D +++GVLL E+++G+ P D +QSI E
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 57/186 (30%), Positives = 84/186 (45%), Gaps = 19/186 (10%)
Query: 293 GSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVV 348
G A+K LK+ + K+ E L HP +V + C + +R Y + EFVV
Sbjct: 43 GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM-CSFQDENRVYFLLEFVV 101
Query: 349 NGPLDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
G L H+ + GR D A LA +LH K +++RD++ N+LLD
Sbjct: 102 GGEL---FTHLRKAGRFPNDVAKFYHAELVLA--FEYLHSK---DIIYRDLKPENLLLDN 153
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ + G +K VP +RT GT YLAPE + D ++ GVLL E
Sbjct: 154 KGHVKVTDFGFAKKVP-----DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEF 208
Query: 468 VSGRRP 473
++G P
Sbjct: 209 IAGYPP 214
|
Length = 329 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 72/269 (26%), Positives = 120/269 (44%), Gaps = 28/269 (10%)
Query: 293 GSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
G VA+K+ S + KK EI +L H NLV + Y+V+EFV +
Sbjct: 26 GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
LD L P G LD + K + +GI F H +++HRDI+ N+L+ +
Sbjct: 86 VLDD-LEKYPNG---LDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGV 138
Query: 411 AHLMGVGLSKFV--PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEI 467
L G ++ + P EV + T Y APE + + ++ D+++ G L+ E+
Sbjct: 139 VKLCDFGFARTLAAPGEVYTDYV----ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEM 194
Query: 468 VSGRRPAQAVDSVCWQ--SIFEWATPLVQSHRYLELLDPLISSLS-SDIPEAGVVQK--- 521
++G P DS Q I + L+ H+ + +PL + + ++ E ++K
Sbjct: 195 LTG-EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFP 253
Query: 522 -----VVDLVYACTQHVPSMRPRMSHVVH 545
V+DL C + P RP S ++H
Sbjct: 254 KLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
LGD G Y + G+ A K ++ S + +++ EI A +HP +V + G Y
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
G +I+ EF G +D + + RG L + + + + +LH ++H
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVICRQMLEALQYLHSM---KIIH 133
Query: 396 RDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT- 453
RD++A NVLL + L G+S K V + +Q R G Y ++APE V +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNV--KTLQRRDSFIGTPY-WMAPEVVMCETMKDT 190
Query: 454 ----KSDVYSFGVLLLEIVSGRRP 473
K+D++S G+ L+E+ P
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 72/275 (26%), Positives = 117/275 (42%), Gaps = 48/275 (17%)
Query: 296 VAVKRLKRSSFQR-------KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
VAVK LK + ++ + E IG+ H N++ + G C G Y++ E+
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGK-----HKNIINLLGACTQDGPLYVIVEYAS 104
Query: 349 NGPLDRWLH-HIPRG-------GRSLDWAMRMK--VATT--LAQGIAFLHDKVKPHVVHR 396
G L +L P G R D M K V+ T +A+G+ +L + +HR
Sbjct: 105 KGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHR 161
Query: 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSD 456
D+ A NVL+ E + GL++ V ++T ++APE ++ T +SD
Sbjct: 162 DLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 221
Query: 457 VYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE 515
V+SFGVL+ EI + G P + + E L + HR D P
Sbjct: 222 VWSFGVLMWEIFTLGGSPYPGI------PVEELFKLLKEGHRM-------------DKP- 261
Query: 516 AGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
A ++ ++ C +PS RP +V L ++
Sbjct: 262 ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 283 GGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH----PNLVAVKGCCYDHG 338
GG + + S + + R K + K ++I R ++ H P +V G Y G
Sbjct: 18 GGVVTKVQHKPSGLIMAR-KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76
Query: 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
+ I E + G LD+ L + + + + KV+ + +G+A+L +K ++HRD+
Sbjct: 77 EISICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDV 130
Query: 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVY 458
+ SN+L++ L G+S +++ GT Y++PE + + +SD++
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 186
Query: 459 SFGVLLLEIVSGRRPAQAVDSVCWQSIF 486
S G+ L+E+ GR P D+ ++IF
Sbjct: 187 SMGLSLVELAIGRYPIPPPDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 51/156 (32%), Positives = 73/156 (46%), Gaps = 15/156 (9%)
Query: 324 HPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
HP L + CC+ DR + V EFV G L + HI + R D A A + +
Sbjct: 55 HPFLTQLY-CCFQTPDRLFFVMEFVNGGDL---MFHIQKS-RRFDEARARFYAAEITSAL 109
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGY 440
FLHDK +++RD++ NVLLD E L G+ K E + + GT Y
Sbjct: 110 MFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGIFNGKTTSTFCGTPDY 162
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
+APE + D ++ GVLL E++ G P +A
Sbjct: 163 IAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 45/195 (23%), Positives = 79/195 (40%), Gaps = 26/195 (13%)
Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVV 348
G A+K +K++ RK + +E ++ P +V + + Y+V E++
Sbjct: 18 GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLP 76
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
G L L ++ SLD + + + +LH ++HRD++ N+L+D
Sbjct: 77 GGDLASLLENV----GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSN 129
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAG----------GTYGYLAPEFVYRNELTTKSDVY 458
L GLSK + R + GT Y+APE + + D +
Sbjct: 130 GHLKLTDFGLSKVG----LVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWW 185
Query: 459 SFGVLLLEIVSGRRP 473
S G +L E + G P
Sbjct: 186 SLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 11/157 (7%)
Query: 333 CCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
C+ DR Y V E+V G L ++HI + G+ + A +A G+ FLH K
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGK-FKEPHAVFYAAEIAIGLFFLHSK--- 120
Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
+++RD++ NV+LD E + G+ K + RT GT Y+APE +
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC--GTPDYIAPEIIAYQPY 178
Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDS-VCWQSIFE 487
D ++FGVLL E+++G+ P D +QSI E
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 48/211 (22%), Positives = 91/211 (43%), Gaps = 19/211 (9%)
Query: 276 LLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGC 333
++G+ G Y G VA+K + ++E E + +HPN+ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 334 CY------DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
+ ++V E G + + + + G+ L + +G+A+LH+
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE 131
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
V+HRDI+ N+LL + L+ G+S + + + T + GT ++APE +
Sbjct: 132 N---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI--GTPYWMAPEVIA 186
Query: 448 RNE-----LTTKSDVYSFGVLLLEIVSGRRP 473
+E +SDV+S G+ +E+ G+ P
Sbjct: 187 CDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 48/185 (25%), Positives = 92/185 (49%), Gaps = 19/185 (10%)
Query: 292 DGSRVAVKRLKRSSFQRKK--EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
DG + +K + S K+ E E+ + + HPN+V + ++G+ YIV ++
Sbjct: 24 DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83
Query: 350 GPLDRWLHHIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
G L + ++ RG + LDW +++ +A + +HD+ ++HRDI++ N+
Sbjct: 84 GDLYKKINA-QRGVLFPEDQILDWFVQICLA------LKHVHDR---KILHRDIKSQNIF 133
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
L ++ L G+++ + V RT + GT YL+PE KSD+++ G +L
Sbjct: 134 LTKDGTIKLGDFGIARVLNSTVELARTCI--GTPYYLSPEICENRPYNNKSDIWALGCVL 191
Query: 465 LEIVS 469
E+ +
Sbjct: 192 YEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 55/231 (23%), Positives = 101/231 (43%), Gaps = 28/231 (12%)
Query: 296 VAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
VA+K++ S Q + ++ E+ +L HPN + +GC ++V E+ +
Sbjct: 43 VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS 102
Query: 353 DRW-LHHIPRGGRSLDWAMRMKVATTL---AQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
D +H P +++A QG+A+LH +++HRD++A N+LL E
Sbjct: 103 DLLEVHKKP--------LQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEP 151
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLL 465
V L F +M G Y ++APE + + K DV+S G+ +
Sbjct: 152 -----GLVKLGDFGSASIMAPANXFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCI 205
Query: 466 EIVSGRRPAQAVDSV-CWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE 515
E+ + P ++++ I + +P +QS + E + S IP+
Sbjct: 206 ELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQ 256
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 50/190 (26%), Positives = 93/190 (48%), Gaps = 26/190 (13%)
Query: 296 VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
VAVK L+ + + +F EI +RL +PN++ + G C ++ E++ NG L++
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 355 WL------------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 402
+L ++IP S+ A + +A +A G+ +L + VHRD+ N
Sbjct: 107 FLSQREIESTFTHANNIP----SVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRN 159
Query: 403 VLLDEEFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
L+ + + G+S+ + + +Q R V+ ++A E + + TT SDV++
Sbjct: 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLP---IRWMAWESILLGKFTTASDVWA 216
Query: 460 FGVLLLEIVS 469
FGV L E+ +
Sbjct: 217 FGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 67/294 (22%), Positives = 127/294 (43%), Gaps = 47/294 (15%)
Query: 275 RLLGDSKTGGTYSGIL-------PDGSRVAVKRLKRSSFQRKK-EFYSEIGRFARLHHPN 326
R LG G Y GI P+ +RVA+K + ++ R++ EF +E + +
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHI-----PRGGRSLDWAMRM-KVATTLAQ 380
+V + G ++ E + G L +L + ++ +M ++A +A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT--- 437
G+A+L+ VHRD+ A N ++ E+F + G+++ ++ + GG
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLL 183
Query: 438 -YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS 495
+++PE + TT SDV+SFGV+L EI + +P Q + + E V
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-------EQVLRFVME 236
Query: 496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549
L+ D + P+ + +L+ C Q+ P MRP ++ +++
Sbjct: 237 GGLLDKPD--------NCPDM-----LFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 5e-11
Identities = 62/278 (22%), Positives = 115/278 (41%), Gaps = 54/278 (19%)
Query: 296 VAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
VA+K++ S S ++ ++ E+ R+ HPN + KGC ++V E+ +
Sbjct: 53 VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSAS 112
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE----- 407
D H + L + QG+A+LH +++HRDI+A N+LL E
Sbjct: 113 DLLEVH----KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVK 165
Query: 408 --EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGV 462
+FG+ + + FV GT ++APE + + K DV+S G+
Sbjct: 166 LADFGSASIASPANSFV-------------GTPYWMAPEVILAMDEGQYDGKVDVWSLGI 212
Query: 463 LLLEIVSGRRPAQAVDSV-CWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQK 521
+E+ + P ++++ I + +P +QS+ + + + S
Sbjct: 213 TCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS------------- 259
Query: 522 VVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKLL 559
C Q +P RP ++ + L + P T L+
Sbjct: 260 -------CLQKIPQDRPTSEELLKHMFVLRERPETVLI 290
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 38/262 (14%)
Query: 292 DGSRVAVKRL--KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY-DHGDRYIVYEFVV 348
DG + +K+L + +S + +K E ++L HPN+VA + + G YIV F
Sbjct: 24 DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
G L L + G+ L ++ +A + +LH+K H++HRD++ NV L
Sbjct: 84 GGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRT 138
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465
+ +G+++ V++ + MA GT Y++PE KSDV++ G +
Sbjct: 139 NIIKVGDLGIAR-----VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVY 193
Query: 466 EIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE-LLDPLISSLSSDIPEAGVVQKVVD 524
E+ + + A D LV +R +E L P+ S PE G +
Sbjct: 194 EMATLKHAFNAKD----------MNSLV--YRIIEGKLPPMPKDYS---PELG------E 232
Query: 525 LVYACTQHVPSMRPRMSHVVHQ 546
L+ P RP + ++ Q
Sbjct: 233 LIATMLSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 62/226 (27%), Positives = 91/226 (40%), Gaps = 39/226 (17%)
Query: 277 LGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRK---------KEFYSEIGRFARLHHPN 326
LG Y G+L V + S K F+ ++L H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 386
LV + G C + +V E+V GPLD +LH SL W ++ VA LA + +L
Sbjct: 63 LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREK-NNVSLHW--KLDVAKQLASALHYLE 118
Query: 387 DKVKPHVVHRDIRASNVLL---DEEFGAHLM------GVGLSKFVPWEVMQERTVMAGGT 437
DK +VH ++ N+L+ G G+ ++ + E ER
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT-VLSREERVERI------ 168
Query: 438 YGYLAPEFVYRN---ELTTKSDVYSFGVLLLEIVS-GRRPAQAVDS 479
++APE RN LT +D +SFG LLEI S G P + S
Sbjct: 169 -PWIAPEC-IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|153064 cd03594, CLECT_REG-1_like, C-type lectin-like domain (CTLD) of the type found in Human REG-1 (lithostathine), REG-4, and avian eggshell-specific proteins: ansocalcin, structhiocalcin-1(SCA-1), and -2(SCA-2) | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 7e-11
Identities = 35/146 (23%), Positives = 51/146 (34%), Gaps = 29/146 (19%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEE-----EH-SAQK 104
CP W+ K C+GY SW ++E +C++ G HLA++ S E S+ +
Sbjct: 1 CPKGWL--PYKGNCYGYFRQPLSWSDAELFCQKYGPGAHLASIHSPAEAAAIASLISSYQ 58
Query: 105 LCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNS--SCTSLPCHVHATV 162
+ V W+G W+WSD S + C L
Sbjct: 59 KAYQPV---WIGLHDPQQ--SRGWEWSDGSKLDYRSWDRNPPYARGGYCAELSR------ 107
Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
S G C +PFIC
Sbjct: 108 ------STGFLKWNDANCEERNPFIC 127
|
CLECT_REG-1_like: C-type lectin-like domain (CTLD) of the type found in Human REG-1 (lithostathine), REG-4, and avian eggshell-specific proteins: ansocalcin, structhiocalcin-1(SCA-1), and -2(SCA-2). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. REG-1 is a proliferating factor which participates in various kinds of tissue regeneration including pancreatic beta-cell regeneration, regeneration of intestinal mucosa, regeneration of motor neurons, and perhaps in tissue regeneration of damaged heart. REG-1 may play a role on the pathophysiology of Alzheimer's disease and in the development of gastric cancers. Its expression is correlated with reduced survival from early-stage colorectal cancer. REG-1 also binds and aggregates several bacterial strains from the intestinal flora and it has been suggested that it is involved in the control of the intestinal bacterial ecosystem. Rat lithostathine has calcium carbonate crystal inhibitor activity in vitro. REG-IV is unregulated in pancreatic, gastric, hepatocellular, and prostrate adenocarcinomas. REG-IV activates the EGF receptor/Akt/AP-1 signaling pathway in colorectal carcinoma. Ansocalcin, SCA-1 and -2 are found at high concentration in the calcified egg shell layer of goose and ostrich, respectively and tend to form aggregates. Ansocalcin nucleates calcite crystal aggregates in vitro. Length = 129 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 284 GTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCY-- 335
GTY + DGS AVK L S +E +E L +HPN+V G Y
Sbjct: 33 GTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91
Query: 336 DH---GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
D G ++V E G + + + G+ LD AM + G+ LH+
Sbjct: 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---R 148
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV-----Y 447
++HRD++ +N+LL E G L+ G+S + ++ T + GT ++APE + Y
Sbjct: 149 IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPFWMAPEVIACEQQY 206
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRP 473
+ DV+S G+ +E+ G P
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 70/277 (25%), Positives = 114/277 (41%), Gaps = 52/277 (18%)
Query: 296 VAVKRLKR-------SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
VAVK LK S + E IG+ H N++ + G C G Y++ E+
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGK-----HKNIINLLGACTQDGPLYVLVEYAS 101
Query: 349 NGPLDRWLHHIPRGGRSLDWAMR--------------MKVATTLAQGIAFLHDKVKPHVV 394
G L +L R +D++ + A +A+G+ +L + +
Sbjct: 102 KGNLREYLR--ARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCI 156
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRD+ A NVL+ E+ + GL++ V ++T ++APE ++ T +
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 216
Query: 455 SDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 513
SDV+SFGVLL EI + G P + + E L + HR D
Sbjct: 217 SDVWSFGVLLWEIFTLGGSPYPGI------PVEELFKLLKEGHRM-------------DK 257
Query: 514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
P A ++ ++ C VPS RP +V L ++
Sbjct: 258 P-ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 9e-11
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 269 NFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLK--RSSFQRKKEFYS---EIGRFARL 322
N+ G +LLG G Y D G +AVK++ S + KKE + EI L
Sbjct: 3 NWRRG-KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
H +V GC D I E++ G + + G +L + K + +G+
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVK---DQLKAYG-ALTETVTRKYTRQILEGV 117
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE---RTVMAGGTYG 439
+LH +VHRDI+ +N+L D L G SK + ++V GT
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT--GTPY 172
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
+++PE + K+DV+S G ++E+++ + P
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 26/236 (11%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRY--IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 372
EI L H +V GC D ++ I E++ G + L + +L ++
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTR 109
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
K + +G+++LH + +VHRDI+ +N+L D L G SK + M +
Sbjct: 110 KYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI 166
Query: 433 MA-GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP 491
+ GT +++PE + K+DV+S G ++E+++ + P +++ +IF+ AT
Sbjct: 167 RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA--AIFKIAT- 223
Query: 492 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547
P L S I E + + ++ +H PS + H QL
Sbjct: 224 -----------QPTNPQLPSHISEHA--RDFLGCIFVEARHRPSAEELLRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 66/262 (25%), Positives = 104/262 (39%), Gaps = 32/262 (12%)
Query: 296 VAVKRLK--RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
VA+K+ K KK E+ +L H N+V +K G Y+V+E+V L+
Sbjct: 29 VAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLE 88
Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
L P G L L Q IA+ H +++HRDI+ N+L+ E L
Sbjct: 89 L-LEASPGG---LPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKL 141
Query: 414 MGVGLSKFVPWEVMQERTVMAGGTY----GYLAPEFVYRNELTTKS-DVYSFGVLLLEIV 468
G ++ ++ R Y Y APE + + K DV++ G ++ E++
Sbjct: 142 CDFGFARA-----LRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELL 196
Query: 469 SGRRPAQAVDSVCWQ--SIFEWATPLVQSHRYLELLDPLISSLS----SDI------PEA 516
G P DS Q I + PL SH+ L +P + ++ S
Sbjct: 197 DG-EPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPG 255
Query: 517 GVVQKVVDLVYACTQHVPSMRP 538
V +D + AC + P R
Sbjct: 256 KVSSPALDFLKACLRMDPKERL 277
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 47/206 (22%)
Query: 295 RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
RV +K L S F+ +++ H +L V G C + +V EFV +GPLD
Sbjct: 46 RVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDV 105
Query: 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD----EEFG 410
L +G + W ++ VA LA +++L DK ++VH ++ A N+LL E
Sbjct: 106 CLRK-EKGRVPVAW--KITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGT 159
Query: 411 AHLM-----GVGLSKF--------VPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSD 456
+ + GV + +PW +APE V N L+T +D
Sbjct: 160 SPFIKLSDPGVSFTALSREERVERIPW----------------IAPECVPGGNSLSTAAD 203
Query: 457 VYSFGVLLLEI-------VSGRRPAQ 475
+SFG LLEI + R P++
Sbjct: 204 KWSFGTTLLEICFDGEVPLKERTPSE 229
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 29/228 (12%)
Query: 284 GTYSGILPDGSR-VAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC-YDHGDR 340
G P V VK +K +S + E L H N++ + C D
Sbjct: 25 GILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84
Query: 341 YIVYEFVVNGPLDRWLH---HIPR-GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHR 396
+++Y ++ G L +L ++L + +A +A G+++LH + V+H+
Sbjct: 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHK 141
Query: 397 DIRASNVLLDEEFGAHLMGVGLSK-FVPWEVM-----QERTVMAGGTYGYLAPEFVYRNE 450
DI A N ++DEE + LS+ P + + R V ++A E + E
Sbjct: 142 DIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK------WMALESLVNKE 195
Query: 451 LTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
++ SDV+SFGVLL E+++ G+ P +D FE A L +R
Sbjct: 196 YSSASDVWSFGVLLWELMTLGQTPYVEID------PFEMAAYLKDGYR 237
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 57/195 (29%), Positives = 90/195 (46%), Gaps = 24/195 (12%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355
V +K L +S + F+ ++L H +LV G C + +V E+V G LD +
Sbjct: 30 VLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTY 89
Query: 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH--- 412
L + ++ + +++VA LA + FL DK + H ++ A NVLL E
Sbjct: 90 LK---KNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGN 143
Query: 413 -----LMGVGLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLL 465
L G+S V P E++ ER ++ PE + L+ +D +SFG L
Sbjct: 144 PPFIKLSDPGISITVLPKEILLERI-------PWVPPECIENPQNLSLAADKWSFGTTLW 196
Query: 466 EIVSG-RRPAQAVDS 479
EI SG +P A+DS
Sbjct: 197 EIFSGGDKPLSALDS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 57/229 (24%), Positives = 106/229 (46%), Gaps = 28/229 (12%)
Query: 293 GSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAV--KGCCYDHGDRYIVYEFV 347
G VA+K L+ + + + + F E ARL+HPN+VA+ G G + V+E+V
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYV 61
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-- 405
R L + +L ++ + +A H++ +VHRD++ N+++
Sbjct: 62 PG----RTLREVLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQ 114
Query: 406 -DEEFGAHLMGVGLSKFVP--WEVMQERTVMAG---GTYGYLAPEFVYRNE-LTTKSDVY 458
A ++ G+ +P + GT Y APE + R E +T SD+Y
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL-RGEPVTPNSDLY 173
Query: 459 SFGVLLLEIVSGRRPAQ--AVDSVCWQ--SIFEWATP-LVQSHRYLELL 502
++G++ LE ++G+R Q +V + +Q S + + P + H ++L
Sbjct: 174 AWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVL 222
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 65/277 (23%), Positives = 115/277 (41%), Gaps = 48/277 (17%)
Query: 294 SRVAVKRLKRSSFQR-------KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
VAVK LK ++ + + E IG+ H N++ + G C G Y++ E+
Sbjct: 45 VTVAVKMLKDNATDKDLADLISEMELMKLIGK-----HKNIINLLGVCTQEGPLYVIVEY 99
Query: 347 VVNGPLDRWLH--------HIPRGGRSLDWAMRMK----VATTLAQGIAFLHDKVKPHVV 394
G L +L + + + + K A +A+G+ +L + +
Sbjct: 100 AAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCI 156
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRD+ A NVL+ E+ + GL++ V ++T ++APE ++ T +
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ 216
Query: 455 SDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 513
SDV+SFG+L+ EI + G P + + E L + HR D
Sbjct: 217 SDVWSFGILMWEIFTLGGSPYPGI------PVEELFKLLREGHRM-------------DK 257
Query: 514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
P + ++ L+ C VP+ RP +V L ++
Sbjct: 258 P-SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 59/264 (22%), Positives = 108/264 (40%), Gaps = 29/264 (10%)
Query: 277 LGDSKTGGTYSGILPDGSRV-AVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
LG G Y R+ AVK + + + +K+ SE+ + P ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
+ I EF+ G LD + R + + ++A + +G+ +L ++
Sbjct: 69 FVENRISICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSL---KIL 117
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRD++ SN+L++ L G+S +++ GT Y+APE + +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 455 SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 514
SDV+S G+ +E+ GR P + I + L+ L+LL ++ +P
Sbjct: 174 SDVWSLGISFMELALGRFP--------YPQIQKNQGSLMP----LQLLQCIVDEDPPVLP 221
Query: 515 EAGVVQKVVDLVYACTQHVPSMRP 538
+K V + C + P RP
Sbjct: 222 VGQFSEKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 61/275 (22%), Positives = 111/275 (40%), Gaps = 44/275 (16%)
Query: 286 YSGILPDGSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRY- 341
Y GI + V ++ K+ K +EI R+ N++ + G D D
Sbjct: 37 YKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 342 ---IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-KPHVVHRD 397
++ E+ G L L + L + ++ +A +G+ L+ KP+ ++
Sbjct: 96 RLSLILEYCTRGYLREVL----DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPY---KN 148
Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 457
+ + + L+ E + ++ GL K + + M +Y L F +E T K D+
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIF---SEYTIKDDI 205
Query: 458 YSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS---SLSSDIP 514
YS GV+L EI +G+ P FE T E+ D +I+ SL +
Sbjct: 206 YSLGVVLWEIFTGKIP------------FENLT-------TKEIYDLIINKNNSLKLPLD 246
Query: 515 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549
++ +V+ ACT H RP + +++ L
Sbjct: 247 CPLEIKCIVE---ACTSHDSIKRPNIKEILYNLSL 278
|
Length = 283 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 296 VAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
VA+KR ++S ++K+ +SE ++HP V + G D Y+V EFV+ G
Sbjct: 59 VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP-HVVHRDIRASNVLLDEEFGA 411
+L R V A I + + ++ ++V+RD++ N+LLD++
Sbjct: 119 FTFLRRNKR--------FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFI 170
Query: 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 471
+ G +K V+ RT GT Y+APE + +D ++ G+ + EI+ G
Sbjct: 171 KMTDFGFAK-----VVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGC 225
Query: 472 RPAQAVDS-VCWQSIFE 487
P A + + +Q I E
Sbjct: 226 PPFYANEPLLIYQKILE 242
|
Length = 340 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 63/302 (20%)
Query: 277 LGDSKTGGTYSGIL------PDGSRVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVA 329
LG+ + G Y G L VA+K LK ++ ++EF E +RL HPN+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWL----HHIPRGGRSLDWAMR--------MKVATT 377
+ G +++ + + L +L H G D ++ + + T
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
+A G+ FL HVVH+D+ NVL+ ++ + +GL R V A
Sbjct: 133 IAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLF----------REVYAADY 179
Query: 438 YG----------YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIF 486
Y +++PE + + + SD++S+GV+L E+ S G +P + Q +
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVI 236
Query: 487 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546
E ++++ + L D D P V L+ C PS RPR + +
Sbjct: 237 E----MIRNRQVLPCPD--------DCPAW-----VYTLMLECWNEFPSRRPRFKDIHSR 279
Query: 547 LQ 548
L+
Sbjct: 280 LR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 24/217 (11%)
Query: 269 NFSEGNR--LLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP 325
+ E +LG G Y+ L R+A+K + + + + EI + L H
Sbjct: 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT------TLA 379
N+V G ++G I E V G L L RS ++ T +
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALL-------RSKWGPLKDNEQTIIFYTKQIL 118
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKFVPWEVMQERTVMAGGTY 438
+G+ +LHD +VHRDI+ NVL++ G + G SK + + T GT
Sbjct: 119 EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTL 173
Query: 439 GYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRP 473
Y+APE + + +D++S G ++E+ +G+ P
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 13/186 (6%)
Query: 292 DGSRV-AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
D R+ A+K ++++ + E +E A+++ P +V +K Y+V F+
Sbjct: 16 DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI 75
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
G L HH+ R GR R A L + LH K +V++RD++ N+LLD
Sbjct: 76 NGGEL---FHHLQREGRFDLSRARFYTAELLC-ALENLH---KFNVIYRDLKPENILLDY 128
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ L GL K + ++T GT YLAPE + + T D ++ GVLL E+
Sbjct: 129 QGHIALCDFGLCKLNMKD--DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEM 186
Query: 468 VSGRRP 473
++G P
Sbjct: 187 LTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 66/293 (22%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
++LG G Y GI +PDG VA+K L+ +S + KE E A + P +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS--LDWAMRMKVATTLAQGIAFLH 386
+ G C + + LD + R G L+W ++ +A+G+++L
Sbjct: 73 RLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLE 126
Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG---TYGYLAP 443
+ +VHRD+ A NVL+ + GL++ + + E A G ++A
Sbjct: 127 EV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD---IDETEYHADGGKVPIKWMAL 180
Query: 444 EFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502
E + T +SDV+S+GV + E+++ G +P + + +LL
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG----------------IPAREIPDLL 224
Query: 503 DPLISSLSSDIPEAGVVQKVVDLVYA-CTQHVPSMRPRMSHVVHQLQQLAQPP 554
+ +P+ + V ++ C RPR +V + ++A+ P
Sbjct: 225 EK-----GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 9/159 (5%)
Query: 319 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIP-RGGRSLDWAMRMKVATT 377
A++ HPN+VA K G YIV E+ G L + I + G+ ++
Sbjct: 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDL---MQKIKLQRGKLFPEDTILQWFVQ 108
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
+ G+ +H+K V+HRDI++ N+ L + L G ++ + T + GT
Sbjct: 109 MCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV--GT 163
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
Y+ PE KSD++S G +L E+ + + P QA
Sbjct: 164 PYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 87/345 (25%), Positives = 140/345 (40%), Gaps = 75/345 (21%)
Query: 245 PAASALVPPSWKVFTTEELRSITKNFSEGNRL--LGDSKTGGTYSGIL--PDGSRVAVKR 300
P S+ S + S K+ SE R+ +G S GGT ++ P G A+K
Sbjct: 48 PPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIG-SGAGGTVYKVIHRPTGRLYALKV 106
Query: 301 L---KRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-GDRYIVYEFVVNGPLDRWL 356
+ + +R + EI ++HPN+V +DH G+ ++ EF+ G L+
Sbjct: 107 IYGNHEDTVRR--QICREIEILRDVNHPNVVKCHDM-FDHNGEIQVLLEFMDGGSLEG-- 161
Query: 357 HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416
HI D VA + GIA+LH + H+VHRDI+ SN+L++ +
Sbjct: 162 THIADEQFLAD------VARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADF 212
Query: 417 GLSKFVPWEVMQ--ERTVMAGGTYGYLAPEFVYRNELTT------KSDVYSFGVLLLEIV 468
G+S+ + + M +V GT Y++PE + +L D++S GV +LE
Sbjct: 213 GVSRILA-QTMDPCNSSV---GTIAYMSPERI-NTDLNHGAYDGYAGDIWSLGVSILEFY 267
Query: 469 SGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS-SDIPEA--GVVQKVVDL 525
GR P V Q +WA+ L+ ++ S PEA ++
Sbjct: 268 LGRFPF----GVGRQG--DWAS--------------LMCAICMSQPPEAPATASREFRHF 307
Query: 526 VYACTQHVPSMRPRMSHVVH----------------QLQQLAQPP 554
+ C Q P+ R ++ L QL PP
Sbjct: 308 ISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGGPNLHQLLPPP 352
|
Length = 353 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 44/162 (27%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
P +V G Y G+ I E + G LD+ L + GR + + KV+ + +G+ +
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGR-IPEQILGKVSIAVIKGLTY 118
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
L +K K ++HRD++ SN+L++ L G+S +++ GT Y++PE
Sbjct: 119 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPE 172
Query: 445 FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF 486
+ + +SD++S G+ L+E+ GR P D+ + +F
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMF 214
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 8e-10
Identities = 60/196 (30%), Positives = 87/196 (44%), Gaps = 17/196 (8%)
Query: 292 DGSRV-AVKRLKRSSFQRKKEFYSEIG------RFARLHHPNLVAVKGCCYDHGDRYIVY 344
D R+ A+K L + KKE IG R P +V +K D Y+V
Sbjct: 16 DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVT 75
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
+++ G L W H+ + GR + + +A L + LH K +V+RD++ N+L
Sbjct: 76 DYMSGGEL-FW--HLQKEGRFSEDRAKFYIAE-LVLALEHLH---KYDIVYRDLKPENIL 128
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVL 463
LD L GLSK + T GT YLAPE + + TK D +S GVL
Sbjct: 129 LDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVL 186
Query: 464 LLEIVSGRRPAQAVDS 479
+ E+ G P A D+
Sbjct: 187 VFEMCCGWSPFYAEDT 202
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 13/159 (8%)
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
+HP LV + C + V E+V G L + H+ R + + R A ++ +
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLAL 109
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGY 440
+LH++ +++RD++ NVLLD E L G+ K E ++ + T GT Y
Sbjct: 110 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTTSTFCGTPNY 162
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 479
+APE + + D ++ GVL+ E+++GR P V S
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 201
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 53/190 (27%), Positives = 78/190 (41%), Gaps = 27/190 (14%)
Query: 296 VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-- 352
VAVK LK +F E L H NL+ + G H +V E G L
Sbjct: 26 VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTH-PLMMVTELAPLGSLLD 84
Query: 353 ---DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
L H D+A++ +A G+ +L K +HRD+ A N+LL +
Sbjct: 85 RLRKDALGHFLIS-TLCDYAVQ------IANGMRYLESK---RFIHRDLAARNILLASDD 134
Query: 410 GAHLMGVGLSKFVPWE----VMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
+ GL + +P VM+E V + + APE + + SDV+ FGV L
Sbjct: 135 KVKIGDFGLMRALPQNEDHYVMEEHLKV----PFAWCAPESLRTRTFSHASDVWMFGVTL 190
Query: 465 LEIVS-GRRP 473
E+ + G P
Sbjct: 191 WEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 6/102 (5%)
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
A + G+ LH + +V+RD++ NVLLD+ + +GL+ + ++
Sbjct: 101 AAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELK---GGKKIKGR 154
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
GT GY+APE + D ++ G L E+++GR P +
Sbjct: 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 12/153 (7%)
Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
+ HP ++ + +D Y++ E+V G L +L R + + A+ +
Sbjct: 57 EVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL----RNSGRFSNSTGLFYASEIVC 112
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 440
+ +LH K +V+RD++ N+LLD+E L G +K + ++RT GT Y
Sbjct: 113 ALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL-----RDRTWTLCGTPEY 164
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
LAPE + D ++ G+L+ E++ G P
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 52/172 (30%), Positives = 77/172 (44%), Gaps = 27/172 (15%)
Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
H++HRDI+++N+LL L G SK V + GT Y+APE R
Sbjct: 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY 222
Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511
+ K+D++S GVLL E+++ +RP D + + + RY DPL S+S
Sbjct: 223 SKKADMFSLGVLLYELLTLKRP---FDGENMEEVMHKTL----AGRY----DPLPPSIS- 270
Query: 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKLLFKGL 563
PE + ++V A P RP S +L P+ KL GL
Sbjct: 271 --PE------MQEIVTALLSSDPKRRPSSS-------KLLNMPICKLFISGL 307
|
Length = 496 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 13/160 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
EI L+HPN+V + + Y+V+EF+ + L +++ P G L +
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPL--PLIKSY 105
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTV 432
L QG+AF H V+HRD++ N+L++ E L GL++ VP V
Sbjct: 106 LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 162
Query: 433 MAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGR 471
T Y APE + + +T D++S G + E+V+ R
Sbjct: 163 ----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|153060 cd03590, CLECT_DC-SIGN_like, C-type lectin-like domain (CTLD) of the type found in human dendritic cell (DC)-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) and the related receptor, DC-SIGN receptor (DC-SIGNR) | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 3e-09
Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 7/82 (8%)
Query: 53 CPPDWIINEEKSKCFGYIGNFR-SWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
CP +W +S C+ + + SW+ES +C+++G HL + S EE+ K+ N +
Sbjct: 1 CPTNWK--SFQSSCY-FFSTEKKSWEESRQFCEDMGAHLVIINSQEEQEFISKILSGNRS 57
Query: 112 GCWVGGRSINTTVGLSWKWSDN 133
W+G T G WKW D
Sbjct: 58 -YWIGLSDEETE-G-EWKWVDG 76
|
CLECT_DC-SIGN_like: C-type lectin-like domain (CTLD) of the type found in human dendritic cell (DC)-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) and the related receptor, DC-SIGN receptor (DC-SIGNR). This group also contains proteins similar to hepatic asialoglycoprotein receptor (ASGP-R) and langerin in human. These proteins are type II membrane proteins with a CTLD ectodomain. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. DC-SIGN is thought to mediate the initial contact between dendritic cells and resting T cells, and may also mediate the rolling of DCs on epithelium. DC-SIGN and DC-SIGNR bind to oligosaccharides present on human tissues, as well as, on pathogens including parasites, bacteria, and viruses. DC-SIGN and DC-SIGNR bind to HIV enhancing viral infection of T cells. DC-SIGN and DC-SIGNR are homotetrameric, and contain four CTLDs stabilized by a coiled coil of alpha helices. The hepatic ASGP-R is an endocytic recycling receptor which binds and internalizes desialylated glycoproteins having a terminal galactose or N-acetylgalactosamine residues on their N-linked carbohydrate chains, via the clathrin-coated pit mediated endocytic pathway, and delivers them to lysosomes for degradation. It has been proposed that glycoproteins bearing terminal Sia (sialic acid) alpha2, 6GalNAc and Sia alpha2, 6Gal are endogenous ligands for ASGP-R and that ASGP-R participates in regulating the relative concentration of serum glycoproteins bearing alpha 2,6-linked Sia. The human ASGP-R is a hetero-oligomer composed of two subunits, both of which are found within this group. Langerin is expressed in a subset of dendritic leukocytes, the Langerhans cells (LC). Langerin induces the formation of Birbeck Granules (BGs) and associates with these BGs following internalization. Langerin binds, in a calcium-dependent manner, to glyco-conjugates containing mannose and related sugars mediating their uptake and degradation. Langerin molecules oligomerize as trimers with three CTLDs held together by a coiled-coil of alpha helices. Length = 126 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 49/156 (31%), Positives = 74/156 (47%), Gaps = 15/156 (9%)
Query: 324 HPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
HP L A+ CC+ DR + V E+V G L + I R R D A + +
Sbjct: 55 HPFLTALH-CCFQTKDRLFFVMEYVNGGDL---MFQIQRS-RKFDEPRSRFYAAEVTLAL 109
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGY 440
FLH + V++RD++ N+LLD E L G+ K E + T GT Y
Sbjct: 110 MFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK----EGILNGVTTTTFCGTPDY 162
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
+APE + E D ++ GVL+ E+++G+ P +A
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 22/212 (10%)
Query: 276 LLGDSKTGGTYSGI-LPDGSRVAVKRLKR-------SSFQRKKEFYSEIGRFARLHHPNL 327
L+G G Y G +P G VA+K + S QR+ S++ + PN+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP---PNI 64
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
G +I+ E+ G + + P + + +R + + ++H
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIH- 118
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
K V+HRDI+A+N+L+ L G++ + + +R+ G Y ++APE +
Sbjct: 119 --KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN-QNSSKRSTFVGTPY-WMAPEVIT 174
Query: 448 R-NELTTKSDVYSFGVLLLEIVSGRRPAQAVD 478
TK+D++S G+ + E+ +G P VD
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 53/184 (28%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
EI L HPN+V ++ Y+++EF ++ L ++L +P G+ +D A +K
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEF-LSMDLKKYLDSLP-KGQYMD-AELVKS 105
Query: 375 AT-TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERT 431
+ QGI F H + V+HRD++ N+L+D + L GL++ +P V
Sbjct: 106 YLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEV 162
Query: 432 VMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ--SIFE- 487
V T Y APE + + +T D++S G + E+ + ++P DS Q IF
Sbjct: 163 V----TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDSEIDQLFRIFRI 217
Query: 488 WATP 491
TP
Sbjct: 218 LGTP 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 275 RLLGDSKTGGTYSGILPDGSR----VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVA 329
R+LG + G G L S+ VA+ L+ S ++++ F +E + H N+V
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
++G IV E++ NG LD +L + L M + LA G+ +L +
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGLASGMKYLSEM- 126
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG-YLAPEFVYR 448
VH+ + A VL++ + + G + E + T M+G + + APE +
Sbjct: 127 --GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY--TTMSGKSPVLWAAPEAIQY 182
Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRP 473
+ ++ SDV+SFG+++ E++S G RP
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 46/192 (23%), Positives = 87/192 (45%), Gaps = 24/192 (12%)
Query: 292 DGSRVAVKR--LKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
D +K L + + K+ E+ A++ HPN+V ++G +IV E+
Sbjct: 24 DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDG 83
Query: 350 GPLDRWLHHIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
G L + ++ RG + L W ++ ++ G+ +HD+ ++HRDI++ N+
Sbjct: 84 GDLMKRINR-QRGVLFSEDQILSWFVQ------ISLGLKHIHDR---KILHRDIKSQNIF 133
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMA---GGTYGYLAPEFVYRNELTTKSDVYSFG 461
L + + M L F + + +A GT YL+PE K+D++S G
Sbjct: 134 LSK----NGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLG 189
Query: 462 VLLLEIVSGRRP 473
+L E+ + + P
Sbjct: 190 CVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 13/140 (9%)
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
+ V E++ G L + HI + D A + G+ FLH K +V+RD++
Sbjct: 72 FFVMEYLNGGDL---MFHIQSCHK-FDLPRATFYAAEIICGLQFLHSK---GIVYRDLKL 124
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVM--QERTVMAGGTYGYLAPEFVYRNELTTKSDVY 458
N+LLD + + G+ K E M +T GT Y+APE + + T D +
Sbjct: 125 DNILLDTDGHIKIADFGMCK----ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWW 180
Query: 459 SFGVLLLEIVSGRRPAQAVD 478
SFGVLL E++ G+ P D
Sbjct: 181 SFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 47/185 (25%), Positives = 93/185 (50%), Gaps = 17/185 (9%)
Query: 296 VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
VAVK L+ + + + +F EI +RL PN++ + C ++ E++ NG L++
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 355 WL--HHIPRGG-----RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
+L H ++ ++ + +AT +A G+ +L + VHRD+ N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGK 165
Query: 408 EFGAHLMGVGLSKFV---PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
+ + G+S+ + + +Q R V+ +++ E + + TT SDV++FGV L
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLP---IRWMSWESILLGKFTTASDVWAFGVTL 222
Query: 465 LEIVS 469
EI++
Sbjct: 223 WEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 54/227 (23%), Positives = 95/227 (41%), Gaps = 20/227 (8%)
Query: 296 VAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
VAVK++ S Q + ++ E+ +L HPN + KGC ++V E+ +
Sbjct: 49 VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSAS 108
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
D H + L + QG+A+LH +HRDI+A N+LL E
Sbjct: 109 DLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHNM---IHRDIKAGNILLTEP---- 157
Query: 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVS 469
V L+ F G Y ++APE + + K DV+S G+ +E+
Sbjct: 158 -GQVKLADFGSASKSSPANSFVGTPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 215
Query: 470 GRRPAQAVDSV-CWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE 515
+ P ++++ I + +P +QS+ + + + IP+
Sbjct: 216 RKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQ 262
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 13/120 (10%)
Query: 362 GGRSLDWAM-----RMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
GG +LD ++AT L + G+ +LH + K +HRDI+A+NVLL E+ L
Sbjct: 86 GGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKL 142
Query: 414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
G++ + ++ T + GT ++APE + ++ +K+D++S G+ +E+ G P
Sbjct: 143 ADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 53/183 (28%), Positives = 81/183 (44%), Gaps = 41/183 (22%)
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT-VMAGG 436
+A+G+ FL K + VHRD+ A NVLL + + GL++ ++M + V G
Sbjct: 246 VARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLAR----DIMHDSNYVSKGS 298
Query: 437 TY---GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS---GRRPAQAVDSVCWQSI---FE 487
T+ ++APE ++ N TT SDV+S+G+LL EI S P VDS + I +
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR 358
Query: 488 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547
A P H Q+V D++ C P RP H+ +
Sbjct: 359 MAKP---DH---------------------ATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394
Query: 548 QQL 550
+ L
Sbjct: 395 ESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 8e-09
Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 14/203 (6%)
Query: 277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
LGD G Y + G A K + S + +++ EI A HPN+V + Y
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
+ +I+ EF G +D + + R L V + + +LH+ ++H
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-----RNE 450
RD++A N+L + L G+S +Q R G Y ++APE V
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPY-WMAPEVVMCETSKDRP 184
Query: 451 LTTKSDVYSFGVLLLEIVSGRRP 473
K+DV+S G+ L+E+ P
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 8e-09
Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 20/186 (10%)
Query: 296 VAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
VAVK LK + K E E +L +P +V + G C + +V E GPL+
Sbjct: 25 VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLN 83
Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
++L + + ++ ++ G+ +L + + VHRD+ A NVLL + A +
Sbjct: 84 KFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKI 136
Query: 414 MGVGLSKFVPWEVMQERTVMAGGTYG-----YLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
GLSK + + T+G + APE + + ++KSDV+SFGVL+ E
Sbjct: 137 SDFGLSK----ALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAF 192
Query: 469 S-GRRP 473
S G++P
Sbjct: 193 SYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 13/152 (8%)
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
+P LV + C ++V E+V G L + H+ R R L A + +
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQ-RKLPEEHARFYAAEICIALN 110
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGYL 441
FLH++ +++RD++ NVLLD + L G+ K E + + T GT Y+
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCK----EGLGPGDTTSTFCGTPNYI 163
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
APE + E D ++ GVL+ E+++GR P
Sbjct: 164 APEILRGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 13/152 (8%)
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
HP LV + C + V EFV G L + H+ R + + R + ++ +
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARF-YSAEISLALN 110
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGYL 441
FLH++ +++RD++ NVLLD E L G+ K E ++ + T GT Y+
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK----EGIRPGDTTSTFCGTPNYI 163
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
APE + + D ++ GVL+ E+++GR P
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 51/187 (27%), Positives = 81/187 (43%), Gaps = 50/187 (26%)
Query: 351 PLDRWLHHIPRGGR---------SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
P D++L P R +L + + + +A G+ FL K + VHRD+ A
Sbjct: 212 PYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDV 457
NVL+ E + GL++ ++M++ ++ G+ ++APE ++ N TT SDV
Sbjct: 269 NVLICEGKLVKICDFGLAR----DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDV 324
Query: 458 YSFGVLLLEIVS---------------------GRR---PAQAVDSV------CWQSIFE 487
+SFG+LL EI + G R PA A D + CW+ FE
Sbjct: 325 WSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFE 384
Query: 488 WATPLVQ 494
Q
Sbjct: 385 IRPDFSQ 391
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 35/213 (16%)
Query: 277 LGDSKTGGTYSGILPDGS-------------RVAVKRLKRSSFQRKKEFYSEIGRFARLH 323
LG Y+GIL +V +K L S F+ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
H ++V + G C + +V EFV GPLD ++H R L + KVA LA ++
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASALS 119
Query: 384 FLHDKVKPHVVHRDIRASNVLL-----DEEFGAHLMGVGLSK-FVPWEVM--QERTVMAG 435
+L DK +VH ++ N+LL D E G + LS +P V+ QE
Sbjct: 120 YLEDK---DLVHGNVCTKNILLAREGIDGECGPF---IKLSDPGIPITVLSRQECV---- 169
Query: 436 GTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEI 467
++APE V ++ L+ +D +SFG L EI
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 41/199 (20%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYS-----EIGRFARLHHPNLVAVKGCCYDH--GDRYIVY 344
G VA+K+++ + +KE + EI +L HPN+V +K G Y+V+
Sbjct: 23 TGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79
Query: 345 EFV---VNGPLDRWLHHIPRGG-RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
E++ + G LD + M+ L +G+ +LH ++HRDI+
Sbjct: 80 EYMDHDLTGLLDSPEVKFTESQIKCY---MKQ-----LLEGLQYLHSN---GILHRDIKG 128
Query: 401 SNVLLDEEFGAHLMGVGLSKF---VPWEVMQERTVMAGGTYGYLAPE-----FVYRNELT 452
SN+L++ + L GL++ R + T Y PE Y
Sbjct: 129 SNILINNDGVLKLADFGLARPYTKRNSADYTNRVI----TLWYRPPELLLGATRY----G 180
Query: 453 TKSDVYSFGVLLLEIVSGR 471
+ D++S G +L E+ G+
Sbjct: 181 PEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 39/136 (28%), Positives = 66/136 (48%), Gaps = 12/136 (8%)
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
+V + G L ++H+ G + + A + G+ LH + +V+RD++
Sbjct: 77 LVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPE 131
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYS 459
N+LLD+ + +GL+ VP E + G GT GY+APE V T D ++
Sbjct: 132 NILLDDHGHIRISDLGLAVHVP-----EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWA 186
Query: 460 FGVLLLEIVSGRRPAQ 475
G LL E+++G+ P Q
Sbjct: 187 LGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 56/261 (21%), Positives = 104/261 (39%), Gaps = 36/261 (13%)
Query: 310 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 369
++ EI ++ P + G +I+ E++ G L P LD
Sbjct: 47 EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDET 101
Query: 370 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS-KFVPWEVMQ 428
+ + +G+ +LH + K +HRDI+A+NVLL E L G++ + ++ +
Sbjct: 102 QIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158
Query: 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488
V GT ++APE + ++ +K+D++S G+ +E+ G P
Sbjct: 159 NTFV---GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP--------------- 200
Query: 489 ATPLVQSHRYLELLDPLISSLSSDIP--EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546
H L + L ++ P E + + + V AC PS RP ++
Sbjct: 201 -------HSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253
Query: 547 LQQLAQPPVTKLLFKGLDRLR 567
+ T L + +DR +
Sbjct: 254 KFIVRFAKKTSYLTELIDRYK 274
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 51/221 (23%), Positives = 93/221 (42%), Gaps = 35/221 (15%)
Query: 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVK 331
GN G G + G+ +RV VK L+ S+ + F E+ + L+HPN++
Sbjct: 4 GNGWFGKVLLGEAHRGM--SKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM--------KVATTLAQGIA 383
G C + +V EF G L +L RS + ++A +A G+
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYL-------RSNRGMVAQMAQKDVLQRMACEVASGLL 114
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHL--MGVGLSKFVP-WEVMQERTVMAGGTYGY 440
+LH + +H D+ N L + + G+ L ++ + + ++ + +
Sbjct: 115 WLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP---LRW 168
Query: 441 LAPEFV-------YRNELTTKSDVYSFGVLLLEIVS-GRRP 473
LAPE V + T KS+++S GV + E+ + +P
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 22/206 (10%)
Query: 284 GTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYSEIGR----FARLHHPNLVAVKGCC 334
G++ +L DGS AVK L++ + +KKE + L HP LV +
Sbjct: 6 GSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF 65
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
Y V ++V G L H+ R L+ R A +A I +LH +++
Sbjct: 66 QTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARF-YAAEVASAIGYLHSL---NII 118
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGYLAPEFVYRNELT 452
+RD++ N+LLD + L GL K E ++ E T GT YLAPE + +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 453 TKSDVYSFGVLLLEIVSGRRPAQAVD 478
D + G +L E++ G P + D
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 21/160 (13%)
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
A + K + ++HRD++ SN+LLD L G+S + + + R G Y+A
Sbjct: 119 ALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA---GCRPYMA 175
Query: 443 PEFV---YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499
PE + R+ +SDV+S G+ L E+ +G+ P W S+F+ T +V+
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK-----WNSVFDQLTQVVKG---- 226
Query: 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR 539
DP I LS+ E V+ + C S RP+
Sbjct: 227 ---DPPI--LSNS-EEREFSPSFVNFINLCLIKDESKRPK 260
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 56/228 (24%), Positives = 92/228 (40%), Gaps = 26/228 (11%)
Query: 263 LRSITKNFSEG-NRLLGDSKTGGTYSGILPDGSRVAVKR--LKRSSFQRKKEFYSEIGRF 319
L I K F + L K T VAVK+ L S + K EI
Sbjct: 3 LTLIGKCFEDLMIVHLAKHKPTNTL---------VAVKKINLDSCSKEDLKLLQQEIITS 53
Query: 320 ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWL-HHIPRGGRSLDWAMRMKVATTL 378
+L HPN++ + Y+V + G + L H P G L A +K +
Sbjct: 54 RQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK---DV 110
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
+ ++H K +HR ++AS++LL + L G+ S + ++R V
Sbjct: 111 LNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167
Query: 439 G-----YLAPEFVYRNEL--TTKSDVYSFGVLLLEIVSGRRPAQAVDS 479
+L+PE + +N KSD+YS G+ E+ +G P + + +
Sbjct: 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA 215
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 44/175 (25%), Positives = 80/175 (45%), Gaps = 10/175 (5%)
Query: 299 KRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHH 358
KRLK+ S ++ EI +++ P +V + +V + G L +++
Sbjct: 29 KRLKKKSGEKMALLEKEI--LEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYN 86
Query: 359 IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418
+ G R L+ + + + GI LH +V+RD++ NVLLD++ L +GL
Sbjct: 87 V--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGL 141
Query: 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
+ + + GT GY+APE + + D ++ G + E+V+GR P
Sbjct: 142 AVELK---DGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 32/227 (14%)
Query: 275 RLLGDSKTGGTYSGILPDGSR-VAVKRLKR--SSFQR-KKEFYSEIGRFARLHHPNLVAV 330
RL+G G Y P SR VA+K+++ S KK F E A L HP +V V
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL--DWAMRMKVAT------TLAQGI 382
C D Y ++ L L + SL + A + V + I
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSV-WQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDE-------EFGAHLMGVG-------LSKFVPWEVMQ 428
++H K V+HRD++ N+LL ++GA + +
Sbjct: 127 EYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 429 ERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
T+ GT Y+APE + + +D+Y+ GV+L ++++ P
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 39/123 (31%), Positives = 66/123 (53%), Gaps = 14/123 (11%)
Query: 364 RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423
LD ++ ++ +AQG+ FL K + +HRD+ A NVLL + A + GL++
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLAR--- 260
Query: 424 WEVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRR--PAQA 476
++M + + G ++APE ++ T +SDV+S+G+LL EI S G+ P
Sbjct: 261 -DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319
Query: 477 VDS 479
V+S
Sbjct: 320 VNS 322
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 41/134 (30%), Positives = 65/134 (48%), Gaps = 11/134 (8%)
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
+ V E++ G L + HI GR + R A + G+ FLH K +++RD++
Sbjct: 72 FFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIIC-GLQFLHKK---GIIYRDLKL 124
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA-GGTYGYLAPEFVYRNELTTKSDVYS 459
NVLLD++ + G+ K + E GT Y+APE + + D +S
Sbjct: 125 DNVLLDKDGHIKIADFGMCKE---NMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWS 181
Query: 460 FGVLLLEIVSGRRP 473
FGVLL E++ G+ P
Sbjct: 182 FGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
G+ LH + +++RD++ NVLLD + + +GL+ V + Q +T GT G
Sbjct: 108 SGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPG 162
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
++APE + E D ++ GV L E+++ R P +A
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 19/231 (8%)
Query: 269 NFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRL--KRSSFQRKKEFYS---EIGRFARL 322
N+ G +LLG G Y D G +AVK++ S + KE + EI L
Sbjct: 3 NWRLG-KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 323 HHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
H +V GC D ++ I E++ G + L + +L + + + Q
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQ 117
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA-GGTYG 439
G+++LH + +VHRDI+ +N+L D L G SK + M + + GT
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT 490
+++PE + K+DV+S ++E+++ + P +++ +IF+ AT
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFKIAT 223
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 43/138 (31%), Positives = 64/138 (46%), Gaps = 9/138 (6%)
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
+ V EF+ G L + HI GR D A + G+ FLH K +++RD++
Sbjct: 72 FFVMEFLNGGDL---MFHIQDKGR-FDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKL 124
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460
NV+LD + + G+ K R GT Y+APE + + T D +SF
Sbjct: 125 DNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSF 182
Query: 461 GVLLLEIVSGRRPAQAVD 478
GVLL E++ G+ P D
Sbjct: 183 GVLLYEMLIGQSPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVA---- 329
++G+ G Y G ++A ++ + ++E EI + HH N+
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 330 -VKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
+K H D+ ++V EF G + + + DW + + +G+A LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHA 139
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
V+HRDI+ NVLL E L+ G+S + V + T + GT ++APE +
Sbjct: 140 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAPEVIA 194
Query: 448 RNE-----LTTKSDVYSFGVLLLEIVSGRRP 473
+E +SD++S G+ +E+ G P
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 55/187 (29%), Positives = 90/187 (48%), Gaps = 22/187 (11%)
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARLHH----PNLVAVKGCCYDHGDRYIVYEFVVNGP 351
VA+K LK + +K E+ R A + H P +V + G C + +V E GP
Sbjct: 25 VAIKVLKN---ENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGP 80
Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEE 408
L+++L G+ D V + Q G+ +L K + VHRD+ A NVLL +
Sbjct: 81 LNKFL-----SGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQ 131
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGG-TYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
A + GLSK + + + AG + APE + + +++SDV+S+G+ + E
Sbjct: 132 HYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEA 191
Query: 468 VS-GRRP 473
S G++P
Sbjct: 192 FSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 57/236 (24%), Positives = 102/236 (43%), Gaps = 28/236 (11%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSR----VAVKRLK-RSSFQRK 309
++ ELR + +LLG G + GI +P+G VA+K ++ RS Q
Sbjct: 2 RILKETELRKL--------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53
Query: 310 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 369
+E + L H +V + G C +V + PL L H+ + SLD
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLS---PLGSLLDHVRQHRDSLDPQ 109
Query: 370 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429
+ +A+G+ +L + +VHR++ A N+LL + + G++ + + +
Sbjct: 110 RLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166
Query: 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-------GRRPAQAVD 478
++A E + T +SDV+S+GV + E++S G RP + D
Sbjct: 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|153063 cd03593, CLECT_NK_receptors_like, C-type lectin-like domain (CTLD) of the type found in natural killer cell receptors (NKRs) | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 5e-08
Identities = 34/137 (24%), Positives = 51/137 (37%), Gaps = 22/137 (16%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP DWI K C+ + ++W+ES+ C L + EE Q G +
Sbjct: 1 CPKDWICYGNK--CYYFSMEKKTWNESKEACSSKNSSLLKIDDEEELEFLQSQIGS--SS 56
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
W+G + WKW D S N + GS S C +S+
Sbjct: 57 YWIGLSREKS--EKPWKWIDG-SPLNNLFNIRGSTKS-------------GNCAYLSST- 99
Query: 173 RSLVTERCNTSHPFICM 189
+ +E C+T +IC
Sbjct: 100 -GIYSEDCSTKKRWICE 115
|
CLECT_NK_receptors_like: C-type lectin-like domain (CTLD) of the type found in natural killer cell receptors (NKRs), including proteins similar to oxidized low density lipoprotein (OxLDL) receptor (LOX-1), CD94, CD69, NKG2-A and -D, osteoclast inhibitory lectin (OCIL), dendritic cell-associated C-type lectin-1 (dectin-1), human myeloid inhibitory C-type lectin-like receptor (MICL), mast cell-associated functional antigen (MAFA), killer cell lectin-like receptors: subfamily F, member 1 (KLRF1) and subfamily B, member 1 (KLRB1), and lys49 receptors. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. NKRs are variously associated with activation or inhibition of natural killer (NK) cells. Activating NKRs stimulate cytolysis by NK cells of virally infected or transformed cells; inhibitory NKRs block cytolysis upon recognition of markers of healthy self cells. Most Lys49 receptors are inhibitory; some are stimulatory. OCIL inhibits NK cell function via binding to the receptor NKRP1D. Murine OCIL in addition to inhibiting NK cell function inhibits osteoclast differentiation. MAFA clusters with the type I Fc epsilon receptor (FcepsilonRI) and inhibits the mast cells secretory response to FcepsilonRI stimulus. CD72 is a negative regulator of B cell receptor signaling. NKG2D is an activating receptor for stress-induced antigens; human NKG2D ligands include the stress induced MHC-I homologs, MICA, MICB, and ULBP family of glycoproteins Several NKRs have a carbohydrate-binding capacity which is not mediated through calcium ions (e.g. OCIL binds a range of high molecular weight sulfated glycosaminoglycans including dextran sulfate, fucoidan, and gamma-carrageenan sugars). Dectin-1 binds fungal beta-glucans and in involved in the innate immune responses to fungal pathogens. MAFA binds saccharides having terminal alpha-D mannose residues in a calcium-dependent manner. LOX-1 is the major receptor for OxLDL in endothelial cells and thought to play a role in the pathology of atherosclerosis. Some NKRs exist as homodimers (e.g.Lys49, NKG2D, CD69, LOX-1) and some as heterodimers (e.g. CD94/NKG2A). Dectin-1 can function as a monomer in vitro. Length = 116 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 53/185 (28%), Positives = 76/185 (41%), Gaps = 20/185 (10%)
Query: 297 AVKRLKRSSFQRKKE---FYSEIGRF---ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
A+K LK+ + E E F HP LV + C V E+ G
Sbjct: 28 AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGG 87
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L + HI S A+ L G+ +LH+ +V+RD++ N+LLD E
Sbjct: 88 DL---MMHIHTDVFSEPRAVFYAACVVL--GLQYLHEN---KIVYRDLKLDNLLLDTEGF 139
Query: 411 AHLMGVGLSKFVPWEVM--QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
+ GL K E M +RT GT +LAPE + T D + GVL+ E++
Sbjct: 140 VKIADFGLCK----EGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195
Query: 469 SGRRP 473
G P
Sbjct: 196 VGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 32/103 (31%), Positives = 58/103 (56%), Gaps = 8/103 (7%)
Query: 374 VATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430
+AT L + G+ +LH + K +HRDI+A+NVLL E+ L G++ + ++
Sbjct: 103 IATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159
Query: 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
T + GT ++APE + ++ K+D++S G+ +E+ G P
Sbjct: 160 TFV--GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 9e-08
Identities = 50/205 (24%), Positives = 87/205 (42%), Gaps = 17/205 (8%)
Query: 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR-LHHPNLVAVK 331
GN G Y+ +RV VK LK ++ +++ + + G R L HPN++
Sbjct: 4 GNGWFGKVLLSEIYTD--TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
G C + +V+E+ G L +L R+ + ++A +A G+ +H K
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KH 118
Query: 392 HVVHRDIRASNVLLDEEFGAHL--MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV--- 446
+ +H D+ N L + + G+G S++ + E +LAPE V
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV--PLRWLAPELVGEF 176
Query: 447 ----YRNELTTKSDVYSFGVLLLEI 467
E T S+V++ GV L E+
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 66/295 (22%), Positives = 120/295 (40%), Gaps = 61/295 (20%)
Query: 296 VAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
VA+K++ + S ++ ++ E+ +L HPN + KGC ++V E+ +
Sbjct: 43 VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSAS 102
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE----- 407
D H + + ++ A + QG+A+LH + +HRDI+A N+LL E
Sbjct: 103 DILEVH-KKPLQEVEIA---AICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVK 155
Query: 408 --EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGV 462
+FG+ + + FV GT ++APE + + K DV+S G+
Sbjct: 156 LADFGSASLVSPANSFV-------------GTPYWMAPEVILAMDEGQYDGKVDVWSLGI 202
Query: 463 LLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV 522
+E+ R+P PL + + L + + S +
Sbjct: 203 TCIELAE-RKP-----------------PLF-NMNAMSALYHIAQNDSPTLSSNDWSDYF 243
Query: 523 VDLVYACTQHVPSMRPRMSHVV-HQLQQLAQPPV--------TKLLFKGLDRLRH 568
+ V +C Q +P RP ++ H+ +PP TK + LD L++
Sbjct: 244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRTKDAVRELDNLQY 298
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|215684 pfam00059, Lectin_C, Lectin C-type domain | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-07
Identities = 30/116 (25%), Positives = 53/116 (45%), Gaps = 11/116 (9%)
Query: 74 RSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN 133
++W E+E C+++GGHL ++ S EE+ L + W+G INT +W W+D
Sbjct: 3 KTWAEAEAACQKLGGHLVSIQSAEEQDFLTSLVKASNTYAWIGLTDINT--EGTWVWTDG 60
Query: 134 MSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICM 189
S N + A G N+ + C V + ++ + E C + ++C
Sbjct: 61 -SPVNYTNWAPGEPNNKGGNEDC-VE-------IYTDTNGKWNDEPCGSKRLYVCE 107
|
This family includes both long and short form C-type. Length = 108 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 52/178 (29%), Positives = 80/178 (44%), Gaps = 27/178 (15%)
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
+A+G+ FL + +HRD+ A N+LL E + GL++ + + R A
Sbjct: 188 VAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS---GRRPAQAVDSVCWQSIFEWATPLVQ 494
++APE ++ T +SDV+SFGVLL EI S P +D E+ L +
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EFCRRLKE 297
Query: 495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
R + P ++ PE + Q ++D C PS RP S +V L L Q
Sbjct: 298 GTR---MRAPDYTT-----PE--MYQTMLD----CWHGEPSQRPTFSELVEHLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 47/194 (24%), Positives = 86/194 (44%), Gaps = 19/194 (9%)
Query: 291 PDGSRVAVKRLKRSS-FQRKKE--FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
A+K +K+ + ++ +SE +HP +V + D Y++ E+
Sbjct: 16 SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYC 75
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
+ G L L G ++ R +A LA +LH++ +++RD++ N+LLD
Sbjct: 76 LGGELWTILRDR---GLFDEYTARFYIACVVLA--FEYLHNR---GIIYRDLKPENLLLD 127
Query: 407 EEFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
L+ G +K ++ ++T GT Y+APE + D +S G+LL
Sbjct: 128 SNGYVKLVDFGFAK-----KLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILL 182
Query: 465 LEIVSGRRPAQAVD 478
E+++GR P D
Sbjct: 183 YELLTGRPPFGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 39/136 (28%), Positives = 66/136 (48%), Gaps = 12/136 (8%)
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
+++ ++V G L H+ + + +R+ +A + + LH + +++RDI+
Sbjct: 81 HLILDYVNGGEL---FTHLYQREHFTESEVRVYIAE-IVLALDHLH---QLGIIYRDIKL 133
Query: 401 SNVLLDEEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS--DV 457
N+LLD E L GLSK F+ E +ER GT Y+APE + D
Sbjct: 134 ENILLDSEGHVVLTDFGLSKEFLAEE--EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDW 191
Query: 458 YSFGVLLLEIVSGRRP 473
+S GVL E+++G P
Sbjct: 192 WSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
+A+G+ FL + +HRD+ A N+LL E + GL++ + + R A
Sbjct: 183 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
++APE ++ TT+SDV+SFGVLL EI S
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 33/83 (39%), Positives = 48/83 (57%), Gaps = 4/83 (4%)
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
+V+RDI+ N+LLD E L GLSK F+ E +ERT GT Y+APE +
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE--KERTYSFCGTIEYMAPEIIRGKGG 183
Query: 452 TTKS-DVYSFGVLLLEIVSGRRP 473
K+ D +S G+L+ E+++G P
Sbjct: 184 HGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 32/118 (27%), Positives = 65/118 (55%), Gaps = 9/118 (7%)
Query: 357 HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416
+H+ + G + MR AT + G+ +H++ VV+RD++ +N+LLDE + +
Sbjct: 86 YHLSQHGVFSEKEMRF-YATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 141
Query: 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRP 473
GL+ + +++ + GT+GY+APE + + + +D +S G +L +++ G P
Sbjct: 142 GLA----CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 19/210 (9%)
Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCC 334
L+G+ G Y G ++A ++ + ++E EI + HH N+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 335 YDHG------DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
++V EF G + + + G +L + + +G++ LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLH-- 128
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
+ V+HRDI+ NVLL E L+ G+S + V + T + GT ++APE +
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAPEVIAC 185
Query: 449 NE-----LTTKSDVYSFGVLLLEIVSGRRP 473
+E KSD++S G+ +E+ G P
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|153073 cd03603, CLECT_VCBS, A bacterial subgroup of the C-type lectin-like (CTLD) domain; a subgroup of bacterial protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-07
Identities = 21/70 (30%), Positives = 31/70 (44%), Gaps = 7/70 (10%)
Query: 75 SWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN- 133
+W+ ++T + +GGHL + S EE G W+G S T G +WKWSD
Sbjct: 11 TWEAAQTLAESLGGHLVTINSAEENDWLLSNFGGYGAS-WIGA-SDAATEG-TWKWSDGE 67
Query: 134 ---MSKWNES 140
+ W
Sbjct: 68 ESTYTNWGSG 77
|
CLECT_VCBS: A bacterial subgroup of the C-type lectin-like (CTLD) domain; a subgroup of bacterial protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. Many CTLDs are calcium-dependent carbohydrate binding modules; other CTLDs bind protein ligands, lipids, and inorganic surfaces including CaCO3 and ice. Bacterial CTLDs within this group are functionally uncharacterized. Animal C-type lectins are involved in such functions as extracellular matrix organization, endocytosis, complement activation, pathogen recognition, and cell-cell interactions. CTLDs may bind a variety of carbohydrate ligands including mannose, N-acetylglucosamine, galactose, N-acetylgalactosamine, and fucose. CTLDs associate with each other through several different surfaces to form dimers, trimers, or tetramers from which ligand-binding sites project in different orientations. In some CTLDs a loop extends to the adjoining domain to form a loop-swapped dimer. Length = 118 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 28/90 (31%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP-WEVMQERTVMAGGTYGYLAP 443
L D + +V+RD++ N+LLD+ + +GL+ +P E ++ R GT GY+AP
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV----GTVGYMAP 170
Query: 444 EFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
E + + T D + G L+ E++ G+ P
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 18/225 (8%)
Query: 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLK--RSSFQRKKEFYS---EIGRFARLHHPNLV 328
+LLG G Y D G +AVK+++ S + KE + EI L H +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 329 AVKGCCYDHGDRY--IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 386
GC D +R I E + G + L + +L + K + +G+++LH
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGVSYLH 123
Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA-GGTYGYLAPEF 445
+ +VHRDI+ +N+L D L G SK + + + + GT +++PE
Sbjct: 124 SNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 446 VYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT 490
+ K+D++S G ++E+++ + P +++ +IF+ AT
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA--AIFKIAT 223
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 46/187 (24%), Positives = 81/187 (43%), Gaps = 11/187 (5%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN--LVAVKGCCYDHGDRYIVYEFVVNG 350
G A KRL++ +++K + L N V Y+ D + ++NG
Sbjct: 25 GKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
D H G + + A + G+ LH + + V+RD++ N+LLD+
Sbjct: 85 G-DLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGH 140
Query: 411 AHLMGVGLSKFVP-WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
+ +GL+ +P E ++ R GT GY+APE + T D + G L+ E++
Sbjct: 141 IRISDLGLAVKIPEGESIRGRV----GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE 196
Query: 470 GRRPAQA 476
G+ P +
Sbjct: 197 GQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 24/210 (11%)
Query: 277 LGDSKTGGTYSGI-LPDGSR-VAVKRLKRSSFQRKKEFYSEIGRFARL------HHPNLV 328
+G+ G + L +G R VA+KR++ + + S I A L HPN+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL-STIREVAVLRHLETFEHPNVV 67
Query: 329 AV-KGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
+ C DR +V+E V + L +L +P G + M L +G+
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMF--QLLRGLD 124
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP 443
FLH VVHRD++ N+L+ L GL++ +++ V+ T Y AP
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYRAP 178
Query: 444 EFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
E + ++ T D++S G + E+ R+P
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFR-RKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 20/235 (8%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIVYEFVVN 349
G A+K LK+ K E + L HP L A+K H V E+
Sbjct: 20 GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
G L H+ R R + + +LH + +VV+RD++ N++LD++
Sbjct: 80 GEL---FFHLSRE-RVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDG 133
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ GL K E +++ M GT YLAPE + N+ D + GV++ E+
Sbjct: 134 HIKITDFGLCK----EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 189
Query: 468 VSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV 522
+ GR P D + +FE L++ R+ L P SL S + + Q++
Sbjct: 190 MCGRLPFYNQDH---EKLFELI--LMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 50/228 (21%), Positives = 93/228 (40%), Gaps = 34/228 (14%)
Query: 321 RLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLD----WAMRMKVA 375
+L HPN+V + DR YIV + + PL + + + W + +++
Sbjct: 65 QLRHPNIVRYYKT-FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 376 TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG 435
L +LH + + +VHRD+ +N++L E+ + GL+K + + +
Sbjct: 124 LALR----YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVV 174
Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS 495
GT Y PE V K+DV++FG +L ++ + P S
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-------------------LQPPFYS 215
Query: 496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
L L ++ ++ +PE + V D++ +C RP + V
Sbjct: 216 TNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
+A+G+ FL + +HRD+ A N+LL E + GL++ + + R A
Sbjct: 182 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
++APE ++ TT+SDV+SFGVLL EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 53/168 (31%), Positives = 81/168 (48%), Gaps = 14/168 (8%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
EI L+HPN+V + + Y+V+EF ++ L +++ P G LD +
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEF-LDLDLKKYMDSSPLTG--LDPPLIKSY 104
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK-F-VPWEVMQERTV 432
L QGIA+ H V+HRD++ N+L+D E L GL++ F VP V
Sbjct: 105 LYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV 161
Query: 433 MAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDS 479
T Y APE + + +T D++S G + E+V+ RRP DS
Sbjct: 162 ----TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPLFPGDS 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 56/192 (29%), Positives = 90/192 (46%), Gaps = 25/192 (13%)
Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGCCYDHG-----DRYIVY 344
+VA+K++ ++F + K EI L H N++A+K D YIVY
Sbjct: 30 NEKVAIKKIA-NAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY 88
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
E +D LH I R ++L L +G+ ++H +V+HRD++ SN+L
Sbjct: 89 EL-----MDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLL 140
Query: 405 LDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFG 461
L+ + GL++ + M E V T Y APE + +E TT DV+S G
Sbjct: 141 LNANCDLKICDFGLARTTSEKGDFMTEYVV----TRWYRAPELLLNCSEYTTAIDVWSVG 196
Query: 462 VLLLEIVSGRRP 473
+ E++ GR+P
Sbjct: 197 CIFAELL-GRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 15/167 (8%)
Query: 314 SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373
+E L HPN++ + IV E+ G L ++ R LD +
Sbjct: 48 NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILH 105
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER--- 430
+ + +H K+ ++HRD++ N+LLD+ H M V + F +++ +
Sbjct: 106 FFVQILLALHHVHTKL---ILHRDLKTQNILLDK----HKMVVKIGDFGISKILSSKSKA 158
Query: 431 -TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
TV+ GT Y++PE KSD+++ G +L E+ S +R +A
Sbjct: 159 YTVV--GTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 50/183 (27%), Positives = 83/183 (45%), Gaps = 17/183 (9%)
Query: 297 AVKRLKRSSFQRKKE---FYSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
AVK L++ + +KKE SE + + HP LV + Y V +++ G L
Sbjct: 24 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 83
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
+H+ R L+ R A +A + +LH ++V+RD++ N+LLD +
Sbjct: 84 ---FYHLQRERCFLEPRARF-YAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIV 136
Query: 413 LMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
L GL K E ++ + GT YLAPE +++ D + G +L E++ G
Sbjct: 137 LTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
Query: 471 RRP 473
P
Sbjct: 193 LPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 51/188 (27%), Positives = 83/188 (44%), Gaps = 17/188 (9%)
Query: 292 DGSRVAVKRLKRSSFQRKKE---FYSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFV 347
DG AVK L++ + +KKE +E + + HP LV + Y V ++V
Sbjct: 19 DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
G L H+ R + R A +A + +LH ++++RD++ N+LLD
Sbjct: 79 NGGEL---FFHLQRERSFPEPRARF-YAAEIASALGYLHSL---NIIYRDLKPENILLDS 131
Query: 408 EFGAHLMGVGLSKFVPWEVMQ--ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465
+ L GL K E ++ + T GT YLAPE + + D + G +L
Sbjct: 132 QGHVVLTDFGLCK----EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLY 187
Query: 466 EIVSGRRP 473
E++ G P
Sbjct: 188 EMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 283 GGTYSGI-----LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337
GTY + + G VA+K +K + EI HPN+VA G Y
Sbjct: 13 SGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS-YLR 71
Query: 338 GDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVA----TTLAQGIAFLHDKVKPH 392
D+ +IV E+ G L ++ + RG S ++A TL +G+A+LH+
Sbjct: 72 RDKLWIVMEYCGGGSLQD-IYQVTRGPLSEL-----QIAYVCRETL-KGLAYLHET---G 121
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 452
+HRDI+ +N+LL E+ L G+S + + +R G Y ++APE V E
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLT-ATIAKRKSFIGTPY-WMAPE-VAAVERK 178
Query: 453 ----TKSDVYSFGVLLLEIVSGRRP 473
K D+++ G+ +E+ + P
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 68/262 (25%), Positives = 110/262 (41%), Gaps = 49/262 (18%)
Query: 293 GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI-VYEFVVN 349
G +VA+K++ + K E+ H N++A++ G + VY VV
Sbjct: 30 GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY--VVM 87
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-- 407
++ LHHI + L L +G+ ++H +V+HRD++ SN+L++E
Sbjct: 88 DLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDC 144
Query: 408 -----EFGAHLMGVGLSKFVPWEV---MQERTVMAGGTYGYLAPEFVYR-NELTTKSDVY 458
+FG M GLS P E M E T Y APE + E TT D++
Sbjct: 145 ELRIGDFG---MARGLSSS-PTEHKYFMTEYV----ATRWYRAPELLLSLPEYTTAIDMW 196
Query: 459 SFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGV 518
S G + E++ GRR +F + Q L ++S L S P V
Sbjct: 197 SVGCIFAEML-GRRQ-----------LFPGKNYVHQ-------LKLILSVLGS--PSEEV 235
Query: 519 VQKV-VDLVYACTQHVPSMRPR 539
+ ++ D V Q++P +P
Sbjct: 236 LNRIGSDRVRKYIQNLPRKQPV 257
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 37/163 (22%), Positives = 74/163 (45%), Gaps = 12/163 (7%)
Query: 357 HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416
+H+ + G + MR A + G+ +H++ VV+RD++ +N+LLDE + +
Sbjct: 86 YHLSQHGVFSEAEMRF-YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 141
Query: 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQ 475
GL+ + +++ + GT+GY+APE + + + +D +S G +L +++ G P +
Sbjct: 142 GLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197
Query: 476 ---AVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE 515
D + + EL L L D+
Sbjct: 198 QHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 34/222 (15%)
Query: 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384
P +V G + G Y+ E++ G LD+ + +R ++ + +G+ F
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-RITYAVVKGLKF 117
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
L ++ +++HRD++ +NVL++ L G+S + + + G Y+APE
Sbjct: 118 LKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPE 171
Query: 445 FVY------RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY 498
+ T +SDV+S G+ +LE+ GR P + +IF + +V
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP---YPPETYANIFAQLSAIVDG--- 225
Query: 499 LELLDP--LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
DP L S S D D V C +P+ RP
Sbjct: 226 ----DPPTLPSGYSDD---------AQDFVAKCLNKIPNRRP 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 44/169 (26%), Positives = 80/169 (47%), Gaps = 14/169 (8%)
Query: 365 SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424
+LD + + +A+G++FL K + +HRD+ A N+LL + GL++
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR---- 262
Query: 425 EVMQERTVMAGGT----YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS---GRRPAQAV 477
++ + + G ++APE ++ T +SDV+S+G+LL EI S P V
Sbjct: 263 DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV 322
Query: 478 DSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLV 526
DS ++ I E L E+ D + S +D + +++V L+
Sbjct: 323 DSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 53/188 (28%), Positives = 82/188 (43%), Gaps = 18/188 (9%)
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
HP L A+K H V E+ G L H+ R + R A + +
Sbjct: 54 HPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAE-IVSALE 109
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYL 441
+LH + VV+RDI+ N++LD++ + GL K E + + M GT YL
Sbjct: 110 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYL 162
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL 501
APE + N+ D + GV++ E++ GR P D + +FE L++ R+
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELI--LMEEIRFPRT 217
Query: 502 LDPLISSL 509
L P SL
Sbjct: 218 LSPEAKSL 225
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 26/167 (15%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH-HIPRGGRSLDWAMRMK 373
EI L H N+V + + +V+E++ + L +++ H RG LD
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGA--LDPNTVKS 104
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-------EFG-AHLMGVGLSKFVPWE 425
L +GIAF H+ V+HRD++ N+L+++ +FG A G+ ++ F E
Sbjct: 105 FTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN-E 160
Query: 426 VMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGR 471
V+ T Y AP+ + + +T D++S G ++ E+++GR
Sbjct: 161 VV---------TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (118), Expect = 3e-06
Identities = 38/168 (22%), Positives = 73/168 (43%), Gaps = 42/168 (25%)
Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA- 379
L HPN+V + + Y+V+E+ + L ++L P + + ++
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGP-------LSPNLIKSIMY 105
Query: 380 ---QGIAFLHDKVKPHVVHRDIRASNVLLDEE-------FG-AHLMGVGLSKFVPWEVMQ 428
+G+A+ H ++HRD++ N+L++ + FG A G+ L + EV+
Sbjct: 106 QLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH-EVV- 160
Query: 429 ERTVMAGGTYGYLAPE-----FVYRNELTTKSDVYSFGVLLLEIVSGR 471
T Y APE Y +T D++S G + E+++G+
Sbjct: 161 --------TLWYRAPEILLGSKHY----STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 31/103 (30%), Positives = 53/103 (51%), Gaps = 8/103 (7%)
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP-WEVMQERTVM 433
A + G+ LH + +V+RD++ N+LLD+ + +GL+ +P E ++ R
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-- 162
Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
GT GY+APE V T D + G L+ E++ G+ P +
Sbjct: 163 --GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 7/90 (7%)
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
K K V+HRD++ SN+LLD L G+S + + R+ G Y+APE +
Sbjct: 131 KEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS---AGCAAYMAPERID 187
Query: 448 RNELTTK----SDVYSFGVLLLEIVSGRRP 473
+ K +DV+S G+ L+E+ +G+ P
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 36/161 (22%)
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIR 399
Y+V E++ G L L I + + A R +A LA + +H K +HRDI+
Sbjct: 77 YLVMEYMPGGDLMNLL--IRKDVFPEETA-RFYIAELVLA--LDSVH---KLGFIHRDIK 128
Query: 400 ASNVLLDEE-------FG-----------------AHLMGVGLSKFVPWEVMQERTVMAG 435
N+L+D + FG +H + + V ++R V A
Sbjct: 129 PDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRAN 188
Query: 436 ---GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
GT Y+APE + + D +S GV+L E++ G P
Sbjct: 189 STVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 52/218 (23%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARL 322
RS K++ GN ++G+ G Y I D S +VA+K++ + + +E L
Sbjct: 62 RSPNKSYKLGN-IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNL 116
Query: 323 HHPNLVAVKGCCYDHGDRY--------IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
+H N++ +K Y + +V EF+ + +++ H R +L +
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLY 175
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLSKFVPWEVMQERTVM 433
+ L + +A++H K + HRD++ N+L+D L G +K + + +R+V
Sbjct: 176 SYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL---LAGQRSVS 229
Query: 434 AGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIVSG 470
+ Y APE + TT D++S G ++ E++ G
Sbjct: 230 YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 47/190 (24%), Positives = 88/190 (46%), Gaps = 27/190 (14%)
Query: 291 PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV------- 343
P R+ KR+K S + + +EI RL+H N++ ++ + Y++
Sbjct: 190 PKCERLIAKRVKAGS-RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFD 248
Query: 344 -YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 402
Y F+ + D W R L R + L + ++HDK ++HRDI+ N
Sbjct: 249 LYSFMYDEAFD-W------KDRPLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLEN 297
Query: 403 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA---PEFVYRNELTTKSDVYS 459
+ L+ + G ++G +P+E +ER G G +A PE + + +D++S
Sbjct: 298 IFLNCD-GKIVLG-DFGTAMPFE--KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWS 353
Query: 460 FGVLLLEIVS 469
G++LL+++S
Sbjct: 354 CGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 67/266 (25%), Positives = 111/266 (41%), Gaps = 66/266 (24%)
Query: 301 LKRSSFQRKKEFY-----SEIGRFARLHHPNLVAVKGCCYDHGDR----------YIVYE 345
LK+ +KE + EI +L+H N+V +K D D Y+V+E
Sbjct: 37 LKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFE 96
Query: 346 FV---VNGPLDRWLHHIPRGG-RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
++ + G L+ L H +S MK L +G+ + H K + +HRDI+ S
Sbjct: 97 YMDHDLMGLLESGLVHFSEDHIKSF-----MK---QLLEGLNYCHKK---NFLHRDIKCS 145
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQER----TVMAGGTYGYLAPEFVYRNELTTKS-D 456
N+LL+ + L GL++ + + R V+ T Y PE + E + D
Sbjct: 146 NILLNNKGQIKLADFGLARL--YNSEESRPYTNKVI---TLWYRPPELLLGEERYGPAID 200
Query: 457 VYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEA 516
V+S G +L E+ + + P+ Q+++ L L+ LIS L P
Sbjct: 201 VWSCGCILGELFTKK-------------------PIFQANQELAQLE-LISRLCGS-PCP 239
Query: 517 GVVQKVVDLVYACTQHVPSMRPRMSH 542
V V+ L Y T M+P+ +
Sbjct: 240 AVWPDVIKLPYFNT-----MKPKKQY 260
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 53/186 (28%), Positives = 78/186 (41%), Gaps = 13/186 (6%)
Query: 292 DGSRVAVKRL-KRSSFQRKKEFYSEIGR---FARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
DG AVK L K+ RK++ + R + HP LV + Y V +FV
Sbjct: 19 DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
G L H+ R RS A +A + +LH ++V+RD++ N+LLD
Sbjct: 79 NGGEL---FFHLQRE-RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDS 131
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
+ L GL K + T GT YLAPE + + D + G +L E+
Sbjct: 132 QGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEM 189
Query: 468 VSGRRP 473
+ G P
Sbjct: 190 LYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 31/84 (36%), Positives = 44/84 (52%), Gaps = 5/84 (5%)
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
+++RDI+ N+LLD L GLSK F EV ER GT Y+AP+ V +
Sbjct: 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV--ERAYSFCGTIEYMAPDIVRGGDG 183
Query: 452 --TTKSDVYSFGVLLLEIVSGRRP 473
D +S GVL+ E+++G P
Sbjct: 184 GHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 23/201 (11%)
Query: 284 GTYSGI-----LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG 338
GTY + + G A+K +K + EI H N+VA G
Sbjct: 20 GTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79
Query: 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
+I EF G L ++H+ A V+ QG+ +LH K K +HRDI
Sbjct: 80 KLWICMEFCGGGSLQD-IYHVTGPLSESQIAY---VSRETLQGLYYLHSKGK---MHRDI 132
Query: 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF--VYR----NELT 452
+ +N+LL + L G+S + + + ++ + GT ++APE V R N+L
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRKSFI--GTPYWMAPEVAAVERKGGYNQLC 190
Query: 453 TKSDVYSFGVLLLEIVSGRRP 473
D+++ G+ +E+ + P
Sbjct: 191 ---DIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 24/106 (22%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 364 RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423
R L + + + +G+ +LH + ++HRD++ N+ +++ + +G ++F
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF-- 206
Query: 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
V+ + GT APE + R++ +K+D++S G++L E+++
Sbjct: 207 -PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 30/94 (31%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439
G+ +LH++ K +HRDI+A+N+LL EE L G+S + M +R G +
Sbjct: 109 LGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLT-STMSKRNTFVGTPF- 163
Query: 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
++APE + ++ K+D++S G+ +E+ G P
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 46/197 (23%)
Query: 296 VAVKRLKRSSFQRKKEFYS-----EIGRFARLHHPNLVAVK----GCCYDHGDRYIVYEF 346
VA+K+LK +++KE + EI +L HPN+V VK G + Y+V E+
Sbjct: 33 VALKKLK---MEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS--NLDKIYMVMEY 87
Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNV 403
V + L + + + +V + Q G+A LHD ++HRD++ SN+
Sbjct: 88 VEH-DLKSLMETMKQPFLQ------SEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNL 137
Query: 404 LLDE-------EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNELTTK 454
LL+ +FG A G L + V T Y APE + E +T
Sbjct: 138 LLNNRGILKICDFGLAREYGSPLKPYTQLVV----------TLWYRAPELLLGAKEYSTA 187
Query: 455 SDVYSFGVLLLEIVSGR 471
D++S G + E+++ +
Sbjct: 188 IDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 41/163 (25%), Positives = 68/163 (41%), Gaps = 19/163 (11%)
Query: 318 RFARLHHPNLVAVKGCCYD-HGDRYIVYEFV---VNGPLDRWLHHIPRGGRSLDWAMRMK 373
R HPN+V + C DR V V+ L +L +P G +
Sbjct: 55 RLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAE-----T 109
Query: 374 VATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430
+ + Q G+ FLH +VHRD++ N+L+ L GL++ ++
Sbjct: 110 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP 166
Query: 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
V+ T Y APE + ++ T D++S G + E+ R+P
Sbjct: 167 VVV---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 27/210 (12%)
Query: 275 RLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPN 326
+LLG GT+ ++ G A+K LK+ K E +E HP
Sbjct: 1 KLLGK----GTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPF 56
Query: 327 LVAVKGCCYDHGDRY-IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
L ++K + DR V E+V G L H+ R R + + +L
Sbjct: 57 LTSLK-YSFQTKDRLCFVMEYVNGGEL---FFHLSRE-RVFSEDRTRFYGAEIVSALDYL 111
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAP 443
H +V+RD++ N++LD++ + GL K E + + M GT YLAP
Sbjct: 112 HSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK----EGITDAATMKTFCGTPEYLAP 164
Query: 444 EFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
E + N+ D + GV++ E++ GR P
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 23/96 (23%), Positives = 46/96 (47%), Gaps = 11/96 (11%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWL---HHIPRGGRSLDWA 369
EI L H N+V++ +H D+ Y+++++ + D W H S+ +
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH---DLWQIIKFHRQAKRVSIPPS 108
Query: 370 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405
M + + G+ +LH V+HRD++ +N+L+
Sbjct: 109 MVKSLLWQILNGVHYLHSN---WVLHRDLKPANILV 141
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 56/234 (23%), Positives = 102/234 (43%), Gaps = 28/234 (11%)
Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIV 343
G VAVK+L R FQ + K Y E+ ++H N++++ + + D Y+V
Sbjct: 46 GINVAVKKLSRP-FQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104
Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
E +++ L + +H LD + + GI LH ++HRD++ SN+
Sbjct: 105 ME-LMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNI 154
Query: 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 463
++ + ++ GL++ M V+ T Y APE + D++S G +
Sbjct: 155 VVKSDCTLKILDFGLARTACTNFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCI 211
Query: 464 LLEIVSGRRPAQAVDSV-CWQSIFE-WATPLVQSHRYLELLDPLISSLSSDIPE 515
+ E+V G Q D + W + E TP S ++ L P + + + P+
Sbjct: 212 MGELVKGSVIFQGTDHIDQWNKVIEQLGTP---SAEFMNRLQPTVRNYVENRPQ 262
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVK 331
GN G G SG P ++V VK L+ S S Q + +F E + L H NL+
Sbjct: 4 GNGWFGKVILGEVNSGYTP--AQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL--DWAMRMKVATTLAQGIAFLHDKV 389
G C + +V EF G L +L R + D ++A +A G+ LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSC-RKAELMTPDPTTLQRMACEIALGLLHLH--- 117
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY---GYLAPEF- 445
K + +H D+ N LL + + GLS + ++ V + ++APE
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHN---KYKEDYYVTPDQLWVPLRWIAPELV 174
Query: 446 --VYRNEL----TTKSDVYSFGVLLLEI 467
V+ N L T +S+V+S GV + E+
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 284 GTYSGILP-----DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYD- 336
GTY + +GS+ AVK L +E +E L HPN+V G Y
Sbjct: 29 GTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87
Query: 337 ---HGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
+GD+ ++V E G + + + G ++ + + G+ LH
Sbjct: 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---K 144
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNEL 451
+HRD++ +N+LL E G L+ G+S + ++ T + GT ++APE + +L
Sbjct: 145 TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPFWMAPEVIACEQQL 202
Query: 452 TT----KSDVYSFGVLLLEIVSGRRP 473
+ + DV+S G+ +E+ G P
Sbjct: 203 DSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 36/128 (28%), Positives = 60/128 (46%), Gaps = 8/128 (6%)
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 452
++HRD++++N+ L L G SK V + GT YLAPE R +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 453 TKSDVYSFGVLLLEIVSGRRPAQA------VDSVCWQSIFEWATPLVQSHRYLELLDPLI 506
K+D++S GV+L E+++ RP + + V + + P+ + LLDPL+
Sbjct: 250 KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMK--ALLDPLL 307
Query: 507 SSLSSDIP 514
S + P
Sbjct: 308 SKNPALRP 315
|
Length = 478 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 25/206 (12%)
Query: 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVA 329
G +L K G Y A+K LK+ K E +E HP L A
Sbjct: 9 GKVILVREKATGKY---------YAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
+K H V E+ G L H+ R + R A ++ + +LH
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVS-ALGYLHSC- 114
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVY 447
VV+RD++ N++LD++ + GL K E + + M GT YLAPE +
Sbjct: 115 --DVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLE 168
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRP 473
N+ D + GV++ E++ GR P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 46/178 (25%), Positives = 76/178 (42%), Gaps = 10/178 (5%)
Query: 296 VAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
VA+K+ K S + + K+ E+ L N+V +K G Y+V+E+V L+
Sbjct: 29 VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE 88
Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
L +P G KV + + Q I +H K +VHRDI+ N+L+ L
Sbjct: 89 -LLEEMPNG------VPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKL 141
Query: 414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 471
G ++ + E T Y +PE + D++S G +L E+ G+
Sbjct: 142 CDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 9e-05
Identities = 47/201 (23%), Positives = 83/201 (41%), Gaps = 42/201 (20%)
Query: 292 DGSRVAVKRLKRSSFQRKKE-----FYSEIGRFARLHHPN---LVAVKGCCYDHGDR-YI 342
G VA+K++K + K+ EI L HPN L+ V + H +
Sbjct: 24 TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDV----FGHKSNINL 79
Query: 343 VYEFVVNGPLDRWLHHIPRGGRSLDWA-------MRMKVATTLAQGIAFLHDKVKPHVVH 395
V+EF ++ L + + +S+ M M +G+ +LH ++H
Sbjct: 80 VFEF-----METDLEKVIKD-KSIVLTPADIKSYMLM-----TLRGLEYLHSN---WILH 125
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFV--PWEVMQERTVMAGGTYGYLAPEFVY-RNELT 452
RD++ +N+L+ + L GL++ P M + V T Y APE ++
Sbjct: 126 RDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV----TRWYRAPELLFGARHYG 181
Query: 453 TKSDVYSFGVLLLEIVSGRRP 473
D++S G + E++ R P
Sbjct: 182 VGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 52/231 (22%), Positives = 98/231 (42%), Gaps = 28/231 (12%)
Query: 296 VAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIVYEF 346
VA+K+L R FQ + K Y E+ ++H N++ + + + D YIV E
Sbjct: 52 VAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
+D L + + LD + + GI LH ++HRD++ SN+++
Sbjct: 111 -----MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK 160
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
+ ++ GL++ M V+ T Y APE + D++S G ++ E
Sbjct: 161 SDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 467 IVSGRRPAQAVDSV-CWQSIFE-WATPLVQSHRYLELLDPLISSLSSDIPE 515
++ G D + W + E TP + +++ L P + + + P+
Sbjct: 218 MIKGGVLFPGTDHIDQWNKVIEQLGTPCPE---FMKKLQPTVRTYVENRPK 265
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 20/164 (12%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
EI + H N+V ++ + Y+V+E++ + L + + P ++ R+ +
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNP----RL-I 104
Query: 375 ATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDEEFGA-HLMGVGLSKF--VPWEVMQ 428
T L Q GIA+ H V+HRD++ N+L+D A L GL++ +P
Sbjct: 105 KTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161
Query: 429 ERTVMAGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIVSGR 471
V T Y APE + +T D++S G + E+V+ +
Sbjct: 162 HEVV----TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 38/200 (19%)
Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK-----GCCYDHGDRYIVY 344
G +VA+K++ F K EI L H N++ + D D YIV
Sbjct: 25 GRKVAIKKISNV-FDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVT 83
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRAS 401
E ++ LH + + + L + L Q G+ +LH +V+HRD++ S
Sbjct: 84 EL-----METDLHKVIKSPQPLTDD---HIQYFLYQILRGLKYLH---SANVIHRDLKPS 132
Query: 402 NVLLDEE-------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
N+L++ FG L + E V T Y APE + + TK
Sbjct: 133 NILVNSNCDLKICDFG--LARGVDPDEDEKGFLTEYVV----TRWYRAPELLLSSSRYTK 186
Query: 455 S-DVYSFGVLLLEIVSGRRP 473
+ D++S G + E++ R+P
Sbjct: 187 AIDIWSVGCIFAELL-TRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|153059 cd03589, CLECT_CEL-1_like, C-type lectin-like domain (CTLD) of the type found in CEL-1 from Cucumaria echinata and Echinoidin from Anthocidaris crassispina | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 1e-04
Identities = 28/152 (18%), Positives = 48/152 (31%), Gaps = 33/152 (21%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG-----GHLAALTSYEEEHSAQKLCG 107
CP W C+ + G+ +W+E+E C+ HL ++ S EE L
Sbjct: 1 CPTFW--TAFGGYCYRFFGDRLTWEEAELRCRSFSIPGLIAHLVSIHSQEENDFVYDL-- 56
Query: 108 KNVNGCWVGGRSINTTVGL-------SWKWSD----NMSKWNESIHAVGSFNSSCTSLPC 156
+GL ++W+D + +KW N C +
Sbjct: 57 --FESSRGPDTPYGLWIGLHDRTSEGPFEWTDGSPVDFTKWAGGQPDNYGGNEDCVQMWR 114
Query: 157 HVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
+ +S C+ P+IC
Sbjct: 115 R-----------GDAGQSWNDMPCDAVFPYIC 135
|
CLECT_CEL-1_like: C-type lectin-like domain (CTLD) of the type found in CEL-1 from Cucumaria echinata and Echinoidin from Anthocidaris crassispina. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. The CEL-1 CTLD binds three calcium ions and has a high specificity for N-acteylgalactosamine (GalNAc). CEL-1 exhibits strong cytotoxicity which is inhibited by GalNAc. This protein may play a role as a toxin defending against predation. Echinoidin is found in the coelomic fluid of the sea urchin and is specific for GalBeta1-3GalNAc. Echinoidin has a cell adhesive activity towards human cancer cells which is not mediated through the CTLD. Both CEL-1 and Echinoidin are multimeric proteins comprised of multiple dimers linked by disulfide bonds. Length = 137 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 49/214 (22%)
Query: 284 GTYSGILP-----DGSRVAVKRLK--------RSSFQRKKEFYSEIGRFARLHHPNLVAV 330
GTY + VA+KR++ SS R EI L H N+V +
Sbjct: 11 GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR------EICLLKELKHKNIVRL 64
Query: 331 KGCCYD--HGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT----LAQGI 382
YD H D+ +V+E+ + L ++ S + + ++ + L +G+
Sbjct: 65 ----YDVLHSDKKLTLVFEYC-DQDLKKYFD-------SCNGDIDPEIVKSFMFQLLKGL 112
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEVMQERTVMAGGTYGY 440
AF H +V+HRD++ N+L+++ L GL++ +P V T Y
Sbjct: 113 AFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV----TLWY 165
Query: 441 LAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRP 473
P+ ++ +L +T D++S G + E+ + RP
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 17/198 (8%)
Query: 284 GTYSGI-----LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG 338
GTY + L G AVK +K EI H N+VA G
Sbjct: 20 GTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE 79
Query: 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
+I E+ G L ++H+ L A V QG+A+LH K K +HRDI
Sbjct: 80 KLWICMEYCGGGSLQD-IYHVTGPLSELQIAY---VCRETLQGLAYLHSKGK---MHRDI 132
Query: 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF--VYRN-ELTTKS 455
+ +N+LL + L G++ + + + ++ + GT ++APE V +N
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPEVAAVEKNGGYNQLC 190
Query: 456 DVYSFGVLLLEIVSGRRP 473
D+++ G+ +E+ + P
Sbjct: 191 DIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 35/149 (23%), Positives = 66/149 (44%), Gaps = 6/149 (4%)
Query: 319 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTL 378
++L HP +V + I+ E+ LD L + G++L + L
Sbjct: 56 LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
G+ ++H + ++HRD++A N+ L + G+S+ + T GT
Sbjct: 116 LLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFT--GTP 169
Query: 439 GYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
Y++PE + +KSD++S G +L E+
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 35/219 (15%)
Query: 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
R LG G +S + D RVAVK++ + Q K EI RL H N+V V
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 334 CYDHGDR--------------YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
G YIV E+ + L L G + R+ L
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEY-METDLANVLEQ----GPLSEEHARL-FMYQLL 124
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG-VGLSKFVPWEV-----MQERTVM 433
+G+ ++H +V+HRD++ +NV ++ E +G GL++ V + E V
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV- 180
Query: 434 AGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
T Y +P + N T D+++ G + E+++G+
Sbjct: 181 ---TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 24/100 (24%), Positives = 49/100 (49%), Gaps = 4/100 (4%)
Query: 372 MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431
+ + ++ + I +LH+ ++HRDI+A N+ ++ L G + F P ++ +
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKY 240
Query: 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 471
GT APE + R+ D++S G++L E+ +
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 23/162 (14%)
Query: 321 RLHHPNLVAVKGCCYD-HGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLD---WAMRM 372
HPN+V + C+ DR +V+E V + L +L P+ G + MR
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 373 KVATTLAQGIAFLHDKVKPH-VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431
L +G+ FLH H +VHRD++ N+L+ + + GL++ +E M +
Sbjct: 116 -----LLRGVDFLHS----HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE-MALTS 165
Query: 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
V+ T Y APE + ++ T D++S G + E+ RRP
Sbjct: 166 VVV--TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 46/196 (23%), Positives = 81/196 (41%), Gaps = 39/196 (19%)
Query: 293 GSRVAVKR--LKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVN 349
G VA+K+ L+R + EI HP +V + + HG +V E++ +
Sbjct: 25 GETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV-FPHGSGFVLVMEYMPS 83
Query: 350 GPLDRWLHHIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
L L R +S MRM L +G+A++H ++HRD++ +N+L
Sbjct: 84 D-LSEVLRDEERPLPEAQVKSY---MRM-----LLKGVAYMHAN---GIMHRDLKPANLL 131
Query: 405 LDE-------EFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNELTTKS 455
+ +FG A L + +V T Y APE +Y +
Sbjct: 132 ISADGVLKIADFGLARLFSEEEPRLYSHQV---------ATRWYRAPELLYGARKYDPGV 182
Query: 456 DVYSFGVLLLEIVSGR 471
D+++ G + E+++G
Sbjct: 183 DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 44/197 (22%), Positives = 88/197 (44%), Gaps = 41/197 (20%)
Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
G++VA+K+L R FQ + K Y E+ + H N++ ++ F +
Sbjct: 40 GAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMKHENVIG------------LLDVFTPD 86
Query: 350 GPLDRWLHH---IPRGGRSLDWAMRMK---------VATTLAQGIAFLHDKVKPHVVHRD 397
LDR+ +P G L M+ + + + +G+ ++H ++HRD
Sbjct: 87 LSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRD 143
Query: 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG--TYGYLAPEFVYR-NELTTK 454
++ N+ ++E+ ++ GL++ Q + M G T Y APE + T
Sbjct: 144 LKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYVVTRWYRAPEVILNWMHYTQT 196
Query: 455 SDVYSFGVLLLEIVSGR 471
D++S G ++ E+++G+
Sbjct: 197 VDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|153058 cd03588, CLECT_CSPGs, C-type lectin-like domain (CTLD) of the type found in chondroitin sulfate proteoglycan core proteins | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 4e-04
Identities = 20/81 (24%), Positives = 41/81 (50%), Gaps = 9/81 (11%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
C W ++ + C+ + + +W+++E C+E GHL+++ + EE Q+ N
Sbjct: 1 CEEGW--DKFQGHCYRHFPDRETWEDAERRCREQQGHLSSIVTPEE----QEFVNNNAQD 54
Query: 113 C-WVGGRSINTTVGLSWKWSD 132
W+G + T+ ++WSD
Sbjct: 55 YQWIGLN--DRTIEGDFRWSD 73
|
CLECT_CSPGs: C-type lectin-like domain (CTLD) of the type found in chondroitin sulfate proteoglycan core proteins (CSPGs) in human and chicken aggrecan, frog brevican, and zebra fish dermacan. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Xenopus brevican is expressed in the notochord and the brain during early embryogenesis. Zebra fish dermacan is expressed in dermal bones and may play a role in dermal bone development. CSPGs do contain LINK domain(s) which bind HA. These LINK domains are considered by one classification system to be a variety of CTLD, but are omitted from this hierarchical classification based on insignificant sequence similarity. Length = 124 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 5e-04
Identities = 46/195 (23%), Positives = 89/195 (45%), Gaps = 38/195 (19%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYS--------EIGRFARL-HHPNLVAVKGCCYDHGDRYIV 343
G VA+K++K K+FYS E+ +L HPN+V +K ++ + Y V
Sbjct: 24 GELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV 76
Query: 344 YEFVVNGPLDRWLHHI--PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
+E+ ++ L+ + R G+ ++ + + QG+A +H K HRD++
Sbjct: 77 FEY-----MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPE 128
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERT----VMAGGTYGYLAPEFVYRNEL-TTKSD 456
N+L+ + GL++ E+ V T Y APE + R+ ++ D
Sbjct: 129 NLLVSGPEVVKIADFGLAR----EIRSRPPYTDYV---STRWYRAPEILLRSTSYSSPVD 181
Query: 457 VYSFGVLLLEIVSGR 471
+++ G ++ E+ + R
Sbjct: 182 IWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 15/156 (9%)
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL-DWAMRMKVATTLAQGI 382
HP +V + G Y++ E++ G L H+ R G + D A +LA +
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMHLEREGIFMEDTACFYLSEISLA--L 113
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGY 440
LH + +++RD++ N+LLD + L GL K E + E TV GT Y
Sbjct: 114 EHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEY 166
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476
+APE + R+ D +S G L+ ++++G P A
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|165024 PHA02642, PHA02642, C-type lectin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (96), Expect = 6e-04
Identities = 26/94 (27%), Positives = 44/94 (46%), Gaps = 7/94 (7%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP WI KCF + + ++W T+C +G L + + EE + ++ K+ +
Sbjct: 88 CPKGWI--GFGYKCFYFSEDSKNWTFGNTFCTSLGATLVKVETEEELNFLKRY--KDSSD 143
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGS 146
W+G + WKW+DN S +N S G+
Sbjct: 144 HWIGLN--RESSNHPWKWADN-SNYNASFVITGT 174
|
Length = 216 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 51/202 (25%), Positives = 83/202 (41%), Gaps = 39/202 (19%)
Query: 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH-PNLVAVKGCC 334
L+ D++T T+ +K L++SS YS H PN+V +
Sbjct: 11 LVMDTRTQQTF----------ILKGLRKSSE------YSRERLTIIPHCVPNMVCLHKYI 54
Query: 335 YDHGDRYIVYEFVVNGPLDRWLH-----HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
++V + G L W H +IP WA M VA + LH +
Sbjct: 55 VSEDSVFLVLQHAEGGKL--WSHISKFLNIPEE-CVKRWAAEMVVA------LDALHRE- 104
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
+V RD+ +N+LLD+ H + L+ F W +++ Y APE +
Sbjct: 105 --GIVCRDLNPNNILLDDR--GH---IQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGIS 157
Query: 450 ELTTKSDVYSFGVLLLEIVSGR 471
E T D +S G +L E+++G+
Sbjct: 158 EETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 262 ELRSITKNFSEGNRLLGDSKTGGTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYS- 314
RS+T F + NR+ G+ GTY GI G VA+K+++ +++
Sbjct: 2 RCRSVT-EFEKLNRI-GE----GTY-GIVYRARDTTSGEIVALKKVR---MDNERDGIPI 51
Query: 315 ----EIGRFARLHHPNLVAVKGCCY-DHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDW 368
EI L HPN+V +K H D ++V E+ L L ++P
Sbjct: 52 SSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC-EQDLASLLDNMPT---PFSE 107
Query: 369 AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF--VPWEV 426
+ + L +G+ +LH+ ++HRD++ SN+LL ++ + GL++ +P +
Sbjct: 108 SQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164
Query: 427 MQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVSGR 471
M + V T Y APE + T + D+++ G +L E+++ +
Sbjct: 165 MTPKVV----TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIVY 344
G RVAVK+L R S K Y E+ + H N++ + + D Y+V
Sbjct: 42 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
+ L++I + + D ++ + L +G+ ++H ++HRD++ SN+
Sbjct: 102 HL-----MGADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPSNLA 152
Query: 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFG 461
++E+ ++ GL++ E M G T Y APE + D++S G
Sbjct: 153 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 205
Query: 462 VLLLEIVSGR 471
++ E+++GR
Sbjct: 206 CIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 44/191 (23%), Positives = 85/191 (44%), Gaps = 29/191 (15%)
Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGC------CYDHGDRYIV 343
G +VA+K+L R FQ K Y E+ + H N++ + D D Y+V
Sbjct: 40 GRKVAIKKLSRP-FQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98
Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
+ L++I + + D ++ V L +G+ ++H ++HRD++ SN+
Sbjct: 99 THLM-----GADLNNIVKCQKLSDDHIQFLVYQIL-RGLKYIH---SAGIIHRDLKPSNI 149
Query: 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVY-RNELTTKSDVYSF 460
++E+ ++ GL++ M G T Y APE + D++S
Sbjct: 150 AVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202
Query: 461 GVLLLEIVSGR 471
G ++ E+++G+
Sbjct: 203 GCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 39/161 (24%), Positives = 73/161 (45%), Gaps = 16/161 (9%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
E+ L H N+V + + +V+E+ LD+ L ++ +K+
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKI 108
Query: 375 -ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL--SKFVPWEVMQERT 431
+ +G+A+ H + V+HRD++ N+L++E L GL +K VP +
Sbjct: 109 FLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEV 165
Query: 432 VMAGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIVSGR 471
V T Y P+ + +E +T+ D++ G + E+ SGR
Sbjct: 166 V----TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 34/114 (29%), Positives = 54/114 (47%), Gaps = 26/114 (22%)
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLD-------EEFGAHLMGVGLSKFVPWEVMQER 430
+A+ + +H + H VHRDI+ NVLLD +FG+ L ++ Q+
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCL-----------KMNQDG 156
Query: 431 TV---MAGGTYGYLAPEFVYRNE-----LTTKSDVYSFGVLLLEIVSGRRPAQA 476
TV +A GT Y++PE + E + D +S GV + E++ G P A
Sbjct: 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (96), Expect = 0.001
Identities = 46/192 (23%), Positives = 80/192 (41%), Gaps = 28/192 (14%)
Query: 307 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGR 364
+ K + E+ L H N+V + ++ YI+ EF G L R + +
Sbjct: 54 REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFG 113
Query: 365 SLDWAMRMKVATTLAQGIAFLHD-KVKPH---VVHRDIRASNVLLD---EEFG------- 410
++ + + L +A+ H+ K P+ V+HRD++ N+ L G
Sbjct: 114 KIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173
Query: 411 -------AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT--TKSDVYSFG 461
A + GLSK + E M V GT Y +PE + + KSD+++ G
Sbjct: 174 NLNGRPIAKIGDFGLSKNIGIESMAHSCV---GTPYYWSPELLLHETKSYDDKSDMWALG 230
Query: 462 VLLLEIVSGRRP 473
++ E+ SG+ P
Sbjct: 231 CIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 40/171 (23%), Positives = 79/171 (46%), Gaps = 23/171 (13%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRW----LHHIPRGGRSLDW 368
EI L HPN++A++ H DR ++++++ + D W H + +
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQ 104
Query: 369 AMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLSKF 421
R V + L Q GI +LH V+HRD++ +N+L+ E + +G ++
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161
Query: 422 V--PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVS 469
P + + + + T+ Y APE + TK+ D+++ G + E+++
Sbjct: 162 FNSPLKPLADLDPVV-VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 39/203 (19%)
Query: 295 RVAVKRLKRSSF----QRKKEFYS-EIGRFARLHHPNLVAVKGCCYDHGDRYI--VYEFV 347
R A+K++ + + Q ++ F +I FA +P +V++ C ++ R++ V E+V
Sbjct: 28 RFAMKKINKQNLILRNQIQQVFVERDILTFA--ENPFVVSMF-CSFE-TKRHLCMVMEYV 83
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
G L +I G +D A RM A T LA + +LH+ +VHRD++ N+L+
Sbjct: 84 EGGDCATLLKNI--GALPVDMA-RMYFAETVLA--LEYLHNY---GIVHRDLKPDNLLIT 135
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAG----------------GTYGYLAPEFVYRNE 450
L GLSK +M T + GT Y+APE + R
Sbjct: 136 SMGHIKLTDFGLSKI---GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG 192
Query: 451 LTTKSDVYSFGVLLLEIVSGRRP 473
D ++ G++L E + G P
Sbjct: 193 YGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 37/161 (22%), Positives = 72/161 (44%), Gaps = 16/161 (9%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWL-HHIPRGGRSLDWAMRMK 373
E+ L H N+V + + +V+E+ LD+ L ++ G S++
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKL 108
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL--SKFVPWEVMQERT 431
L +G+ + H + V+HRD++ N+L++E L GL +K +P +
Sbjct: 109 FLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEV 165
Query: 432 VMAGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIVSGR 471
V T Y P+ + + +T+ D++ G + E+ +GR
Sbjct: 166 V----TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 51/196 (26%), Positives = 86/196 (43%), Gaps = 27/196 (13%)
Query: 292 DGSRVAVKRLKRSSFQRK---KEFYSEIG--RFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
+ VA+K++ F +K K E+ R R H N+ C YD IV+
Sbjct: 26 EEETVAIKKITNV-FSKKILAKRALRELKLLRHFR-GHKNIT----CLYDMD---IVFPG 76
Query: 347 VVNG------PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
N ++ LH I R G+ L A + G+ ++H +V+HRD++
Sbjct: 77 NFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKP 133
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKS-DV 457
N+L++ + + GL++ + M T Y APE + + TK+ DV
Sbjct: 134 GNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDV 193
Query: 458 YSFGVLLLEIVSGRRP 473
+S G +L E++ GR+P
Sbjct: 194 WSVGCILAELL-GRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 45/185 (24%), Positives = 81/185 (43%), Gaps = 22/185 (11%)
Query: 293 GSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYEFVVN 349
G VA+K++ + S+ K Y E+ L H N++++ D Y V E
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL--- 91
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
L LH + L+ + +G+ ++H VVHRD++ SN+L++E
Sbjct: 92 --LGTDLHRLLTSRP-LEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENC 145
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYR-NELTTKSDVYSFGVLLLE 466
+ GL++ +Q+ M G T Y APE + + + D++S G + E
Sbjct: 146 DLKICDFGLAR------IQDPQ-MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAE 198
Query: 467 IVSGR 471
++ G+
Sbjct: 199 MLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 45/182 (24%), Positives = 78/182 (42%), Gaps = 14/182 (7%)
Query: 293 GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
G VA+K+ S KK EI +L HPNLV + ++V+E+ +
Sbjct: 26 GQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT 85
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L+ + PRG + + K+ Q + F H K + +HRD++ N+L+ ++
Sbjct: 86 VLNELEKN-PRG---VPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQ 138
Query: 411 AHLMGVGLSKFV-PWEVMQERTVMAGGTYGYLAPEF-VYRNELTTKSDVYSFGVLLLEIV 468
L G ++ + V T Y APE V + DV++ G + E++
Sbjct: 139 IKLCDFGFARILTGPGDDYTDYV---ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELL 195
Query: 469 SG 470
+G
Sbjct: 196 TG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 39/171 (22%), Positives = 79/171 (46%), Gaps = 23/171 (13%)
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRW----LHHIPRGGRSLDW 368
EI L HPN+++++ H DR ++++++ + D W H + +
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQ 104
Query: 369 AMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLSKF 421
R V + L Q GI +LH V+HRD++ +N+L+ E + +G ++
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161
Query: 422 V--PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVS 469
P + + + + T+ Y APE + TK+ D+++ G + E+++
Sbjct: 162 FNSPLKPLADLDPVV-VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 573 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| cd03599 | 153 | CLECT_DGCR2_like C-type lectin-like domain (CTLD) | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| cd03597 | 129 | CLECT_attractin_like C-type lectin-like domain (CT | 99.94 | |
| cd03588 | 124 | CLECT_CSPGs C-type lectin-like domain (CTLD) of th | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| PHA02642 | 216 | C-type lectin-like protein; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| cd03589 | 137 | CLECT_CEL-1_like C-type lectin-like domain (CTLD) | 99.93 | |
| cd03590 | 126 | CLECT_DC-SIGN_like C-type lectin-like domain (CTLD | 99.93 | |
| PHA02953 | 170 | IEV and EEV membrane glycoprotein; Provisional | 99.92 | |
| cd03596 | 129 | CLECT_tetranectin_like C-type lectin-like domain ( | 99.92 | |
| cd03593 | 116 | CLECT_NK_receptors_like C-type lectin-like domain | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| cd03594 | 129 | CLECT_REG-1_like C-type lectin-like domain (CTLD) | 99.91 | |
| PHA03097 | 157 | C-type lectin-like protein; Provisional | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| cd03591 | 114 | CLECT_collectin_like C-type lectin-like domain (CT | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| cd03601 | 119 | CLECT_TC14_like C-type lectin-like domain (CTLD) o | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| cd03603 | 118 | CLECT_VCBS A bacterial subgroup of the C-type lect | 99.88 | |
| cd03598 | 117 | CLECT_EMBP_like C-type lectin-like domain (CTLD) o | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| TIGR00864 | 2740 | PCC polycystin cation channel protein. Note: this | 99.87 | |
| PHA02867 | 167 | C-type lectin protein; Provisional | 99.87 | |
| smart00034 | 126 | CLECT C-type lectin (CTL) or carbohydrate-recognit | 99.87 | |
| cd03592 | 115 | CLECT_selectins_like C-type lectin-like domain (CT | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| cd03602 | 108 | CLECT_1 C-type lectin (CTL)/C-type lectin-like (CT | 99.85 | |
| cd03600 | 141 | CLECT_thrombomodulin_like C-type lectin-like domai | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| cd03595 | 149 | CLECT_chondrolectin_like C-type lectin-like domain | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.66 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.63 | |
| PHA02911 | 213 | C-type lectin-like protein; Provisional | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| cd00037 | 116 | CLECT C-type lectin (CTL)/C-type lectin-like (CTLD | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| PF00059 | 105 | Lectin_C: Lectin C-type domain; InterPro: IPR00130 | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.44 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.35 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.31 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.17 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.16 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.04 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.03 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.02 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.0 | |
| PF05473 | 200 | Herpes_UL45: UL45 protein; InterPro: IPR008646 Thi | 98.95 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.9 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.75 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.74 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.71 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.69 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.61 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.44 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.37 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.35 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.29 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.22 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.2 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.18 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.12 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.01 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.0 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.99 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.97 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.82 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.82 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.66 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.66 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.59 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.57 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.57 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-53 Score=429.78 Aligned_cols=292 Identities=42% Similarity=0.738 Sum_probs=252.9
Q ss_pred CCcccCHHHHHHhhcCCCcCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeE
Q 008216 254 SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333 (573)
Q Consensus 254 ~~~~~~~~el~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 333 (573)
....|+++|+..+|++|+..+ +||+|+||.||+|.+++|+.||||++.........+|.+|+.++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~-~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESN-LIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhc-ceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 567899999999999999876 5599999999999999999999998877643314569999999999999999999999
Q ss_pred EeeCC-ceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCee
Q 008216 334 CYDHG-DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412 (573)
Q Consensus 334 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 412 (573)
|.+.+ +.+||+||+++|+|.++|+..... .++|.++++|+.++|+||+|||+.+.+.||||||||+|||||+++++|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99999 499999999999999999864322 799999999999999999999999888999999999999999999999
Q ss_pred EecccCCccCCc-cccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhh
Q 008216 413 LMGVGLSKFVPW-EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP 491 (573)
Q Consensus 413 l~Dfg~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~ 491 (573)
|+|||+|+.... ....... . .||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+...+.....+.+|..+
T Consensus 218 lsDFGLa~~~~~~~~~~~~~-~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTT-V-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred ccCccCcccCCccccceeee-c-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 999999976654 2211111 1 499999999999999999999999999999999999999887655555668999999
Q ss_pred hhhccccccccccccccCCCCCcc-hHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 492 LVQSHRYLELLDPLISSLSSDIPE-AGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
.....++.+++|+.+.. .... ......+..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 296 ~~~~~~~~eiiD~~l~~---~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKE---GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHCcchhheeCCCccC---CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 99988999999998743 2222 25677799999999999999999999999999666543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=373.90 Aligned_cols=246 Identities=25% Similarity=0.429 Sum_probs=207.9
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCc-eEEEEEecCCCC
Q 008216 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-RYIVYEFVVNGP 351 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~lv~e~~~~gs 351 (573)
..||+|..|+||++.++ +++.+|+|++... .....+++.+|++++++.+||+||.++|.|..++. ..|+||||++|+
T Consensus 85 ~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGS 164 (364)
T KOG0581|consen 85 GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGS 164 (364)
T ss_pred hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCC
Confidence 35799999999999964 6889999999544 44557899999999999999999999999999995 999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
|++++.. .+.+++...-+|+.+|++||.|||+ + +||||||||+|||++..|.+||+|||.+..+... .
T Consensus 165 Ld~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~ 233 (364)
T KOG0581|consen 165 LDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----I 233 (364)
T ss_pred HHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh----h
Confidence 9999864 3569999999999999999999996 6 9999999999999999999999999999987654 2
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
.....||..|||||.+.+..|+.++||||||++++|+.+|+.||....+. .. ...+++..+....+
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~-------------~~~~Ll~~Iv~~pp 299 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YL-------------DIFELLCAIVDEPP 299 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CC-------------CHHHHHHHHhcCCC
Confidence 22344999999999999999999999999999999999999999775211 11 11223333333333
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+..|...+++++.+++..||++||.+|||+.|+++
T Consensus 300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 44444468899999999999999999999999986
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=389.02 Aligned_cols=251 Identities=30% Similarity=0.513 Sum_probs=208.2
Q ss_pred eecccCceEEEEEEeCCCCE-EEEEEecccchhh--HHHHHHHHHHHhhcCCCcEeEEeeEEeeCC-ceEEEEEecCCCC
Q 008216 276 LLGDSKTGGTYSGILPDGSR-VAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHG-DRYIVYEFVVNGP 351 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~g~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lv~e~~~~gs 351 (573)
.||+|+||+||+|.+ .|+. ||||++....... .++|.+|+.+|.+++|||||+++|++.+.. ..++||||+++|+
T Consensus 48 ~iG~G~~g~V~~~~~-~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs 126 (362)
T KOG0192|consen 48 VLGSGSFGTVYKGKW-RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS 126 (362)
T ss_pred hcccCCceeEEEEEe-CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence 379999999999999 5555 9999998653322 568999999999999999999999999987 7999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEcCCCCCCeeeCCCC-CeeEecccCCccCCcccccc
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH-VVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-iiH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|.++++.. ....+++..++.++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++...... .
T Consensus 127 L~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~ 199 (362)
T KOG0192|consen 127 LSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T 199 (362)
T ss_pred HHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence 99999763 457799999999999999999999999 7 99999999999999997 99999999998765432 1
Q ss_pred ceeccCCccccccccccc--CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVY--RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
......||+.|||||++. ...|+.|+||||||+++|||+||+.||....... .+........
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~------~~~~v~~~~~---------- 263 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ------VASAVVVGGL---------- 263 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcCC----------
Confidence 122234999999999999 5689999999999999999999999998876421 1111111111
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
....+..+++.+..+|.+||+.||+.||++.+++..|+.+...
T Consensus 264 ---Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 264 ---RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred ---CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 1111223667899999999999999999999999999977653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=387.97 Aligned_cols=247 Identities=23% Similarity=0.369 Sum_probs=211.6
Q ss_pred CCCcCCeeecccCceEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEE
Q 008216 269 NFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (573)
Q Consensus 269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 344 (573)
..++..++||+|||+.+|.++. ..|+.||+|++.+. ....++.+.+|+++.++|+|||||+++++|++.+..|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4567788999999999999997 78999999999874 3345677899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCc
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 424 (573)
|+|+.++|.++++ ..+++++.+++.++.||+.||.|||++ +|+|||||..|+|++++.++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999985 346799999999999999999999999 999999999999999999999999999998764
Q ss_pred cccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
+. +.....+|||.|+|||++.....+..+||||+|||+|-|++|++||+..+-.+. ...+. . .
T Consensus 171 ~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket---y~~Ik---~----~----- 233 (592)
T KOG0575|consen 171 DG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET---YNKIK---L----N----- 233 (592)
T ss_pred cc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH---HHHHH---h----c-----
Confidence 42 333456799999999999999999999999999999999999999987542211 11110 0 0
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.-..+...+.+..+||.++|+.||.+|||+++|+.
T Consensus 234 ------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 234 ------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11122356678999999999999999999999996
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=383.63 Aligned_cols=251 Identities=28% Similarity=0.464 Sum_probs=214.4
Q ss_pred eecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHHHH
Q 008216 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 355 (573)
.||+|.||.||.|.++...+||+|.++... ...++|.+|+++|++|+|+|||+++|+|..++..+||||||+.|+|.+|
T Consensus 213 ~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~y 291 (468)
T KOG0197|consen 213 ELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDY 291 (468)
T ss_pred HhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHH
Confidence 479999999999999777799999998763 3457888999999999999999999999999999999999999999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceeccC
Q 008216 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG 435 (573)
Q Consensus 356 l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 435 (573)
|+. ..+..++..+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+....+....... ..
T Consensus 292 Lr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~-~k 365 (468)
T KOG0197|consen 292 LRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG-GK 365 (468)
T ss_pred hhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCC-CC
Confidence 986 4567799999999999999999999999 99999999999999999999999999999655444333222 22
Q ss_pred CcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCc
Q 008216 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 514 (573)
Q Consensus 436 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (573)
-...|.|||.+..+.++.|||||||||+||||+| |+.||..++..+....++ ... .-..
T Consensus 366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le------~Gy--------------Rlp~ 425 (468)
T KOG0197|consen 366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE------RGY--------------RLPR 425 (468)
T ss_pred CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh------ccC--------------cCCC
Confidence 5678999999999999999999999999999999 999998876532211111 111 2233
Q ss_pred chHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 515 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 515 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
+..+++.+.++|..||..+|++|||++.+...|+++...
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 456888999999999999999999999999999887654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=370.63 Aligned_cols=254 Identities=23% Similarity=0.332 Sum_probs=206.3
Q ss_pred hhcCCCcCCeeecccCceEEEEEE-eCCCCEEEEEEecccchh-------hHHHHHHHHHHHhhcCCCcEeEEeeEEeeC
Q 008216 266 ITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQ-------RKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337 (573)
Q Consensus 266 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 337 (573)
..++++...+.||+|+||.|-+|. .++|+.||||++++.... ......+|+++|++|+|||||++.+++...
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 356777888899999999999998 467999999999764211 223467999999999999999999999999
Q ss_pred CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC---CCeeEe
Q 008216 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLM 414 (573)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~ 414 (573)
+..|+||||++||+|.+.+-. ++.+.+..-..++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred CceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEec
Confidence 999999999999999999853 45678888889999999999999999 99999999999999766 679999
Q ss_pred cccCCccCCccccccceeccCCcccccccccccCCCC---CcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhh
Q 008216 415 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL---TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP 491 (573)
Q Consensus 415 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~ 491 (573)
|||+|+.... .......+||+.|.|||++.+..+ ..+.|+||+||+||-+++|.+||.+..... .+.+
T Consensus 322 DFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~e---- 392 (475)
T KOG0615|consen 322 DFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKE---- 392 (475)
T ss_pred ccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHH----
Confidence 9999998752 233445679999999999987543 348899999999999999999998754321 0111
Q ss_pred hhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 492 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....+++.. ........+++..+||.+||..||++|||++|+++
T Consensus 393 QI~~G~y~f----------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 393 QILKGRYAF----------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHhcCcccc----------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 011111110 11224567889999999999999999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=357.15 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=211.7
Q ss_pred eeecccCceEEEEEE-eCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEee-EEeeCCc-eEEEEEecCC
Q 008216 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKG-CCYDHGD-RYIVYEFVVN 349 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~-~~~~~~~-~~lv~e~~~~ 349 (573)
+.||+|.||+||++. ..+|..||.|.++.+ +...+++...|+.+|++|+|||||++++ .+.+++. .+||||++.+
T Consensus 25 ~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~ 104 (375)
T KOG0591|consen 25 KKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDA 104 (375)
T ss_pred HHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcc
Confidence 357999999999998 678999999999765 4456788999999999999999999998 4555555 7999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP-HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~-~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
|+|...+....+..+.+++..+++++.|++.||.++|++... -|+||||||.||+++.+|.+||+|||+++.+......
T Consensus 105 GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tf 184 (375)
T KOG0591|consen 105 GDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTF 184 (375)
T ss_pred cCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHH
Confidence 999999998888889999999999999999999999994211 3999999999999999999999999999998765443
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
... ..|||.||+||.+.+.+|+.||||||+||++|||..-.+||.+.+- .+......+ .
T Consensus 185 A~S--~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~L~~KI~q-g------------ 243 (375)
T KOG0591|consen 185 AHS--LVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LSLCKKIEQ-G------------ 243 (375)
T ss_pred HHh--hcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HHHHHHHHc-C------------
Confidence 332 3399999999999999999999999999999999999999988632 121111111 1
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
..+..|...++.++..||..|+..||+.||+.-.+++.+..
T Consensus 244 d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 244 DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11334556788999999999999999999996666665544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=364.51 Aligned_cols=201 Identities=26% Similarity=0.472 Sum_probs=177.7
Q ss_pred CCCcCCeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEE
Q 008216 269 NFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
+|....+ ||+|+||+||+|++ +++..||||.+.+. .....+.+..|+.+|+.++|||||++++++.+++..|||||
T Consensus 11 ~y~~~~~-iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 11 DYELSRE-IGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred cceehhh-ccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 4444444 79999999999995 45899999999776 45556778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC------CCeeEecccCC
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE------FGAHLMGVGLS 419 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~------~~~kl~Dfg~~ 419 (573)
||.||+|.+|++. .+.+++..++.++.|||.||++||++ +||||||||+||||+.. -.+||+|||+|
T Consensus 90 yC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 90 YCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999975 34799999999999999999999999 99999999999999764 45899999999
Q ss_pred ccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcc
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV 480 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~ 480 (573)
+.+....... ..+|++-|||||++....|+.|+|+||+|+|+|++++|+.||+..+..
T Consensus 163 R~L~~~~~a~---tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 163 RFLQPGSMAE---TLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred hhCCchhHHH---HhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 9987544332 345999999999999999999999999999999999999999876654
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=390.89 Aligned_cols=258 Identities=27% Similarity=0.410 Sum_probs=216.1
Q ss_pred CeeecccCceEEEEEEeC------CCCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 274 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
.+-||+|+||.||+|+.. +...||||.++..... .+++|++|++++..|+|||||+++|+|.+++..++|+||
T Consensus 491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEY 570 (774)
T KOG1026|consen 491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEY 570 (774)
T ss_pred hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEe
Confidence 345799999999999843 3467999999987555 788999999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCC------C----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecc
Q 008216 347 VVNGPLDRWLHHIPR------G----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 416 (573)
|..|||.+||..... . ..+++..+.+.|+.|||.||.||-++ .+|||||.++|+||.++..|||+||
T Consensus 571 m~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIsDf 647 (774)
T KOG1026|consen 571 MDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKISDF 647 (774)
T ss_pred cccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEeccc
Confidence 999999999975321 1 23388999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhc
Q 008216 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS 495 (573)
Q Consensus 417 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 495 (573)
|+++..-..+.+......--..+|||||.+..+.+|++||||||||+|||++| |+.||.+....+ +......
T Consensus 648 GLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------VIe~i~~ 720 (774)
T KOG1026|consen 648 GLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------VIECIRA 720 (774)
T ss_pred ccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------HHHHHHc
Confidence 99997655444332211124679999999999999999999999999999999 999998876532 1122222
Q ss_pred cccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
++. ..-+..++.++++||..||+.+|++||++.||-..|+...+..
T Consensus 721 g~l-------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 721 GQL-------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred CCc-------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 221 1224467889999999999999999999999999999887654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=382.48 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=219.5
Q ss_pred CcCCeeecccCceEEEEEEeCC----CCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
....++||.|.||+|++|+++- ...||||.++.. ....+.+|+.|+.||.+++||||++|.|+.......+||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 3446789999999999999643 357999999976 44557889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
||++|+|+.||+. ....++..++..++++||.||+||-+. ++|||||.++|||++.+..+|++|||+++.+..+
T Consensus 711 yMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 711 YMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 9999999999985 335699999999999999999999999 9999999999999999999999999999987655
Q ss_pred ccccc-eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccc
Q 008216 426 VMQER-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503 (573)
Q Consensus 426 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (573)
..... +....-..+|.|||.+..+.+|.++||||||+++||.++ |..||.++...+..+.++ +
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe------~--------- 849 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE------Q--------- 849 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH------h---------
Confidence 42111 111113578999999999999999999999999999998 999998876532111111 1
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCch
Q 008216 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVT 556 (573)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 556 (573)
.-..+++.+++..|.+||..||+.|-.+||++.+|+..|+++...|..
T Consensus 850 -----gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 850 -----GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred -----ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence 114556778999999999999999999999999999999999876643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=345.71 Aligned_cols=238 Identities=22% Similarity=0.305 Sum_probs=199.4
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
+.-++||+|+||.||.++. ++++.+|+|++++.. ..+.+....|..+|.+++||.||++...|++.+..|+|+||+
T Consensus 28 ~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~ 107 (357)
T KOG0598|consen 28 EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYL 107 (357)
T ss_pred eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEecc
Confidence 3456889999999999985 458999999998763 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
.||.|..+|++ .+.+++..+..++.+|+.||.|||++ +||||||||+|||+|.+|+++|+|||+++.......
T Consensus 108 ~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 108 NGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred CCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 99999999964 46699999999999999999999999 999999999999999999999999999986543322
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
.+...+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+.....+. .....
T Consensus 181 --~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~------I~~~k----------- 241 (357)
T KOG0598|consen 181 --ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDK------ILKGK----------- 241 (357)
T ss_pred --ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHH------HhcCc-----------
Confidence 23346799999999999999999999999999999999999999988664321111 11100
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCC
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 538 (573)
...++.-.+.+.++++.++|+.||++|.
T Consensus 242 ---~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 ---LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1112223556799999999999999996
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=391.05 Aligned_cols=263 Identities=31% Similarity=0.440 Sum_probs=217.2
Q ss_pred CcCCeeecccCceEEEEEEeCC--CC----EEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILPD--GS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~~--g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 343 (573)
-+....||+|.||.||.|...+ |. .||||.+++. +.+...+|.+|..+|++++|||||+++|++.+....+|+
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 3445689999999999999643 43 4999999875 556678999999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 344 YEFVVNGPLDRWLHHIPR---GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
+|||++|+|..||++.+. ....++..+.+.++.|||+|+.||+++ ++|||||.++|+||+....+||+|||+|+
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhH
Confidence 999999999999986421 145689999999999999999999999 99999999999999999999999999999
Q ss_pred cCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
.+.............-..+|||||.+..+.++.|+|||||||++||++| |..||...+..+... .....+
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~gg--- 921 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLEGG--- 921 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHhCC---
Confidence 5544433332222224578999999999999999999999999999999 999998876532111 111111
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCch
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVT 556 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 556 (573)
...++..+++.+.++|.+||+.+|++||++..|++++..+......
T Consensus 922 -----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 922 -----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred -----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 2234556888999999999999999999999999998887664433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=347.37 Aligned_cols=252 Identities=24% Similarity=0.423 Sum_probs=200.0
Q ss_pred cCCeeecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC--ceEEEEEecC
Q 008216 272 EGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRYIVYEFVV 348 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~e~~~ 348 (573)
...+.||+|+||.||++...+ |+..|||.+........+.+.+|+.+|.+++|||||+++|...... .+++.|||++
T Consensus 20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~ 99 (313)
T KOG0198|consen 20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAP 99 (313)
T ss_pred hhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccC
Confidence 345678999999999999654 9999999997764333677899999999999999999999855544 5899999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-CCCeeEecccCCccCCcc-c
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFVPWE-V 426 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~-~ 426 (573)
+|+|.+++.. .++ .+++..++.+..||++||+|||++ ||+||||||+|||++. ++.+||+|||++...... .
T Consensus 100 ~GsL~~~~~~--~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 100 GGSLSDLIKR--YGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred CCcHHHHHHH--cCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 9999999975 222 699999999999999999999999 9999999999999999 799999999999877641 1
Q ss_pred cccceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCC-CcccchhhHHhhhhhhhcccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAV-DSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
.........||+.|||||++..+ ....++|||||||++.||+||++||... ... +.........
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~------~~~~~ig~~~-------- 239 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA------EALLLIGRED-------- 239 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH------HHHHHHhccC--------
Confidence 11222234599999999999853 3345999999999999999999999863 111 1111111000
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 548 (573)
.. +. .+...+++..+++.+|+..||++||||+++++..-
T Consensus 240 ~~----P~-ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 240 SL----PE-IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CC----CC-CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 00 11 12236678999999999999999999999998643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=351.89 Aligned_cols=244 Identities=22% Similarity=0.325 Sum_probs=203.7
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS---SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
.++||+|+|++|++|+. ..++.+|||++.+. .....+.+..|-.+|.+| .||.|++|+..|.+...+|+|+||++
T Consensus 78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~ 157 (604)
T KOG0592|consen 78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP 157 (604)
T ss_pred hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence 45789999999999994 56999999999765 223345677899999999 89999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+|+|.++|.. -+.+++...+.++.+|+.||+|||++ |||||||||+|||||+|+++||+|||.|+.+......
T Consensus 158 nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 158 NGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred CCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 9999999975 35699999999999999999999999 9999999999999999999999999999987654222
Q ss_pred -----------cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccc
Q 008216 429 -----------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 497 (573)
Q Consensus 429 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 497 (573)
.......||..|.+||++..+..++.+|+|+||||||+|+.|++||...++-. .++.+
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl---iFqkI-------- 299 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL---IFQKI-------- 299 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH---HHHHH--------
Confidence 11133559999999999999999999999999999999999999998876421 11111
Q ss_pred cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
++- .-..+.+.++.+.+|+.+.|..||++|+|+++|.+
T Consensus 300 ----~~l------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 300 ----QAL------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred ----HHh------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 110 11122344577999999999999999999988876
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=355.74 Aligned_cols=259 Identities=27% Similarity=0.377 Sum_probs=201.9
Q ss_pred cCCeeecccCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCC-ceEE
Q 008216 272 EGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHG-DRYI 342 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~-~~~l 342 (573)
+..+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++...+ ..++
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~l 89 (338)
T cd05102 10 RLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMV 89 (338)
T ss_pred eeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEE
Confidence 4456789999999999973 235689999997543 23356789999999999 8999999999887654 5789
Q ss_pred EEEecCCCCHHHHhccCCCC----------------------------------------------------------CC
Q 008216 343 VYEFVVNGPLDRWLHHIPRG----------------------------------------------------------GR 364 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~----------------------------------------------------------~~ 364 (573)
+|||+++|+|.+++...... ..
T Consensus 90 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (338)
T cd05102 90 IVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKS 169 (338)
T ss_pred EEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccC
Confidence 99999999999998642110 13
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceeccCCcccccccc
Q 008216 365 SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444 (573)
Q Consensus 365 ~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 444 (573)
.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...............++..|+|||
T Consensus 170 ~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 246 (338)
T cd05102 170 PLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246 (338)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence 478889999999999999999999 99999999999999999999999999998654332222222223677899999
Q ss_pred cccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHH
Q 008216 445 FVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVV 523 (573)
Q Consensus 445 ~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 523 (573)
++.+..++.++||||||+++|||++ |..||....... .... . ..... ....+...++.+.
T Consensus 247 ~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~---~-~~~~~-------------~~~~~~~~~~~l~ 307 (338)
T cd05102 247 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQ---R-LKDGT-------------RMRAPENATPEIY 307 (338)
T ss_pred HhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHH---H-HhcCC-------------CCCCCCCCCHHHH
Confidence 9998899999999999999999997 999997644211 0000 0 00000 0001123456799
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 524 DLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 524 ~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
+++.+||+.||++|||+.||++.|+++.+
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=354.27 Aligned_cols=247 Identities=23% Similarity=0.398 Sum_probs=209.3
Q ss_pred CcCCeeecccCceEEEEEE-eCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 271 SEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
+...+.||+|+.|.||.+. ..+++.||||++.......++-+.+|+.+|+..+|+|||.+++.+...++.|+||||++|
T Consensus 275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~g 354 (550)
T KOG0578|consen 275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEG 354 (550)
T ss_pred hcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCC
Confidence 3344567999999999998 457889999999888777788899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|.+.+.. ..+++.++..|+.++++||+|||.+ +|+|||||.+|||++.++.+||+|||++..+.......
T Consensus 355 gsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 355 GSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred Cchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence 999999864 4599999999999999999999999 99999999999999999999999999999887655432
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
....||+.|||||++....|++|.||||||++++||+-|.+||-..++. +.+.- ...++ .+
T Consensus 427 --~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl--rAlyL----Ia~ng------~P----- 487 (550)
T KOG0578|consen 427 --STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYL----IATNG------TP----- 487 (550)
T ss_pred --ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH--HHHHH----HhhcC------CC-----
Confidence 2234999999999999999999999999999999999999999865432 11111 11111 11
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
........+..+.+++.+||+.||++||++.|+|+
T Consensus 488 -~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 488 -KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 11223456788999999999999999999999997
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=346.44 Aligned_cols=260 Identities=25% Similarity=0.360 Sum_probs=212.8
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
.+.||+|.||+|.+.....+..||||.++.... ..+.+|.+|+++|.+|+||||++++|+|..++.+++++||+++|+|
T Consensus 543 ~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDL 622 (807)
T KOG1094|consen 543 KEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDL 622 (807)
T ss_pred hhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcH
Confidence 456899999999999997789999999998744 4458999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+|+...... .+..+...+|+.||++||+||.+. ++|||||.++|+|++.++++||+|||+++.+-.........
T Consensus 623 nqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqg 697 (807)
T KOG1094|consen 623 NQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQG 697 (807)
T ss_pred HHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceeeec
Confidence 9999764322 245556677999999999999999 99999999999999999999999999999776555544443
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc--CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS--GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
...-..+|||||.+..+.+|+++|||+||+++||+++ ...||+...++ +.++....+.........
T Consensus 698 r~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~~--------- 765 (807)
T KOG1094|consen 698 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQVV--------- 765 (807)
T ss_pred ceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCccee---------
Confidence 3446789999999999999999999999999999887 88899876653 223333222222111111
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
...+.-++..+.++|.+||..|-++||+++++...|++..
T Consensus 766 -l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 766 -LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred -ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1123346778999999999999999999999999887654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=343.57 Aligned_cols=262 Identities=23% Similarity=0.308 Sum_probs=202.2
Q ss_pred eeecccCceEEEEEE-eCCCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--CceEEEEEecCC
Q 008216 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVVN 349 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~~~ 349 (573)
+.||+|.||.||+|+ ..+|+.||+|.++.+.. .......+|+.+|++|+||||+++.+...+. +..|||+|||++
T Consensus 123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh 202 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH 202 (560)
T ss_pred HHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence 357999999999999 46799999999987642 3345678999999999999999999998876 689999999965
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
||..++. ..+-.+++.++..++.|++.||+|+|++ ||+|||||.+|||||.+|.+||+|||+|+++.......
T Consensus 203 -DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~ 275 (560)
T KOG0600|consen 203 -DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP 275 (560)
T ss_pred -hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCCcc
Confidence 8888886 3456799999999999999999999999 99999999999999999999999999999876554333
Q ss_pred ceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchh-hHHhhhhhhhccccccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
.+...-|.-|+|||++.+ ..|+.+.|+||.||||.||++|++.|.+.++.+... ++..... .....+...--+...
T Consensus 276 -~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGS-P~e~~W~~~kLP~~~ 353 (560)
T KOG0600|consen 276 -YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGS-PTEDYWPVSKLPHAT 353 (560)
T ss_pred -cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCC-CChhccccccCCccc
Confidence 223337999999999987 479999999999999999999999999877643222 1111111 011111100000000
Q ss_pred cCCCCCc--------chHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 508 SLSSDIP--------EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 508 ~~~~~~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.+....+ -...+....+|+..+|..||.+|.|+.++++
T Consensus 354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0000000 1234567889999999999999999999985
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=335.10 Aligned_cols=259 Identities=21% Similarity=0.310 Sum_probs=207.8
Q ss_pred CcCCeeecccCceEEEEEE-eCCCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 271 SEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
++....||.|..++||+|. .+.++.||||++.-+.- .+.+.+.+|+..|+.++||||++++..|..+...|+||.||.
T Consensus 28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa 107 (516)
T KOG0582|consen 28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA 107 (516)
T ss_pred eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence 4556678999999999999 56789999999976532 335889999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+|++.+.+..... ..+++..+..|++++++||.|||.+ |.||||||+.||||+.+|.+||+|||.+..+......
T Consensus 108 ~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 108 GGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred CCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 9999999987443 3499999999999999999999999 9999999999999999999999999998766544322
Q ss_pred cce--eccCCcccccccccccC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 429 ERT--VMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 429 ~~~--~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
... ....||+.|||||++.. ..|+.|+||||||++..||.+|..||....+... +.... + +......
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll~tL----q-n~pp~~~-- 253 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LLLTL----Q-NDPPTLL-- 253 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HHHHh----c-CCCCCcc--
Confidence 111 23359999999999654 4799999999999999999999999998765311 11000 0 0000000
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.+.............+++++..||+.||.+|||++++++
T Consensus 254 --t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 --TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred --cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 011112223345568999999999999999999999986
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=324.98 Aligned_cols=261 Identities=19% Similarity=0.236 Sum_probs=198.0
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
.+|+|+||.||+.+.+ +|+.||||.+.... ..-.+-.++|+++|++|+|||+|.++.+|......+||+||++..-|
T Consensus 9 kvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL 88 (396)
T KOG0593|consen 9 KVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVL 88 (396)
T ss_pred ccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHH
Confidence 4599999999999964 59999999997653 33356678999999999999999999999999999999999977555
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+ |.. ....++...+.+++.|++.|+.|+|++ ++|||||||+|||++.++.+||+|||+|+.+..... ..+
T Consensus 89 ~e-Le~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd--~YT 159 (396)
T KOG0593|consen 89 HE-LER---YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD--NYT 159 (396)
T ss_pred HH-HHh---ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcc--hhh
Confidence 54 443 235589999999999999999999999 999999999999999999999999999998863221 122
Q ss_pred ccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHh--------hhhhh-hcccccccc
Q 008216 433 MAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW--------ATPLV-QSHRYLELL 502 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~--------~~~~~-~~~~~~~~~ 502 (573)
....|..|+|||.+.+ .+|++.+||||+||++.||++|.+.|.+.++.+..-.+.. ...+. .+..+.-+.
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 2237999999999988 6899999999999999999999999988765422111111 00111 111111111
Q ss_pred ccccccCCC-CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 503 DPLISSLSS-DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 503 ~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
-|......+ ...-...+.-+.+++..||+.||.+|++.++++.
T Consensus 240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111100000 0001234557899999999999999999999874
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=347.16 Aligned_cols=247 Identities=24% Similarity=0.319 Sum_probs=202.7
Q ss_pred cCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEeccc----ch-hhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeCCce
Q 008216 268 KNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS----SF-QRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDR 340 (573)
Q Consensus 268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~ 340 (573)
.+.++..+.||+|+||.|+.|.. .+|+.||+|++.+. .. ...+.+.+|+.++++++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 34456677889999999999974 46899999987664 12 23456678999999998 99999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-CCeeEecccCC
Q 008216 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLS 419 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~~ 419 (573)
++||||+.||+|.+++.. ..++.+..+..++.|+++|++|+|++ ||+||||||+|||++.+ +++||+|||++
T Consensus 96 ~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 999999999999999964 46789999999999999999999999 99999999999999999 99999999999
Q ss_pred ccCCccccccceeccCCcccccccccccCCC-CC-cchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccc
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNE-LT-TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 497 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 497 (573)
.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..+... +... ...+.
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---l~~k----i~~~~ 239 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---LYRK----IRKGE 239 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---HHHH----HhcCC
Confidence 9874 1222334456999999999999877 75 78999999999999999999998854321 1110 00000
Q ss_pred cccccccccccCCCCCcchHH-HHHHHHHHHHhcCCCCCCCCCHHHHH
Q 008216 498 YLELLDPLISSLSSDIPEAGV-VQKVVDLVYACTQHVPSMRPRMSHVV 544 (573)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl 544 (573)
-..+... +.++.+|+.+||..||.+|+|+.+|+
T Consensus 240 --------------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 240 --------------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred --------------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0111122 67899999999999999999999999
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=338.97 Aligned_cols=246 Identities=20% Similarity=0.346 Sum_probs=199.0
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEecccchhh---HHHHHHHHHHHhhcCCCcEeEEeeEEee----CCceEEEEEec
Q 008216 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYEFV 347 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~e~~ 347 (573)
..||+|++|.||+|.+ +|+.||||+++...... .+.+.+|+.+|.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 3679999999999998 79999999997653322 4677899999999999999999999877 34678999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++|+|.+++.. ...+++.....++.|++.||.|||+.. +++||||||+||+++.++.+||+|||+++.......
T Consensus 105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~ 178 (283)
T PHA02988 105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF 178 (283)
T ss_pred CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhccccc
Confidence 99999999964 346889999999999999999999732 788999999999999999999999999886543211
Q ss_pred ccceeccCCcccccccccccC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||...+... .... ......
T Consensus 179 -----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~~---i~~~~~-------- 239 (283)
T PHA02988 179 -----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYDL---IINKNN-------- 239 (283)
T ss_pred -----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHHH---HHhcCC--------
Confidence 2237889999999876 678999999999999999999999998654321 1111 000000
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
....+...++.+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 240 -----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 240 -----SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -----CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 00011234668999999999999999999999999998764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=342.33 Aligned_cols=258 Identities=21% Similarity=0.316 Sum_probs=200.6
Q ss_pred eecccCceEEEEEEe-CCCCEEEEEEecccchhhHHH--HHHHHHHHhhcC-CCcEeEEeeEEeeCC-ceEEEEEecCCC
Q 008216 276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKE--FYSEIGRFARLH-HPNLVAVKGCCYDHG-DRYIVYEFVVNG 350 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-h~nIv~l~~~~~~~~-~~~lv~e~~~~g 350 (573)
.||.|.||.||+|+. .+|+.||||++++.-.. .++ -++|++.|++|+ ||||+++.+++.+.+ .+++||||| ..
T Consensus 17 klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M-d~ 94 (538)
T KOG0661|consen 17 KLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM-DC 94 (538)
T ss_pred HhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh-hh
Confidence 469999999999994 56899999999876322 333 368999999998 999999999999888 899999999 56
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++..+ ++.+++..++.|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+|+..........
T Consensus 95 NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTe 168 (538)
T KOG0661|consen 95 NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTE 168 (538)
T ss_pred hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCCCcch
Confidence 999999863 67899999999999999999999999 999999999999999888999999999998865544433
Q ss_pred eeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhh--hc------cccccc
Q 008216 431 TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV--QS------HRYLEL 501 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~------~~~~~~ 501 (573)
. ..|..|+|||++.. +.|+.+.|+||+|||++|+.+-++.|.+.++.+ ++.....-+. .. ..+...
T Consensus 169 Y---VSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D--qi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 169 Y---VSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID--QIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred h---hhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH--HHHHHHHHhCCCccccchhHHHHHHH
Confidence 3 28999999998864 678999999999999999999999998876532 1111111000 00 001111
Q ss_pred cccccccCCC---CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 502 LDPLISSLSS---DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 502 ~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
+.-.+..... ..--...+.++.++|.+|+..||.+||||.|.++.
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111110000 00011266789999999999999999999999974
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=348.18 Aligned_cols=263 Identities=23% Similarity=0.385 Sum_probs=209.3
Q ss_pred HhhcCCCcCCeeecccCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEE
Q 008216 265 SITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342 (573)
Q Consensus 265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 342 (573)
+++-++......||+|.||+||+|++ -..||||+++-. .....+.|.+|+..+++-+|.||+-+.|++..++. .|
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~w--hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRW--HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred ccCHHHhhccceeccccccceeeccc--ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 34444445566789999999999998 346999999765 34456889999999999999999999999988877 99
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
|+.+|+|.+|..+|+.. ...+...+.+.|+.||++|+.|||.+ +|||||||..|||+.++++|||+|||++..-
T Consensus 465 iTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeee
Confidence 99999999999999853 35688999999999999999999999 9999999999999999999999999998754
Q ss_pred CccccccceeccCCcccccccccccC---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 423 PWEVMQERTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
..-..........|...|||||++.. .+|+..+||||||+++|||+||..||.....+. -++.. ..+
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq--IifmV-----GrG--- 608 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ--IIFMV-----GRG--- 608 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh--eEEEe-----ccc---
Confidence 43222222333348889999999874 578999999999999999999999998433221 11100 000
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
.+.+.+ ......++.++.+|+..||..++++||.+.+|+..|+.+..
T Consensus 609 -~l~pd~-----s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 609 -YLMPDL-----SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -ccCccc-----hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 000111 11223566789999999999999999999999998888776
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=310.84 Aligned_cols=263 Identities=20% Similarity=0.270 Sum_probs=203.5
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccchhh--HHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.+|+|.||.||+|.. .+|+.||||.++.....+ .....+|++.|+.++|+||+.+++++...+..-||+||+ ..
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm-~t 85 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM-PT 85 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec-cc
Confidence 34679999999999994 579999999998664332 356789999999999999999999999999999999999 45
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|+..+++ ....++..++..++.++++||+|||++ .|+||||||.|+|++++|.+||+|||+++..........
T Consensus 86 dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 86 DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 99999974 456799999999999999999999999 999999999999999999999999999998875543333
Q ss_pred eeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccc---cccccc
Q 008216 431 TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE---LLDPLI 506 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 506 (573)
.. .-|.-|+|||.+.| ..|+...|+||.|||+.||+.|.+-|.+.++.+....+-.+........+.+ +.|-..
T Consensus 160 ~~--V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 160 HQ--VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cc--eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 22 37889999999887 5799999999999999999999988887665332221111111111111111 111000
Q ss_pred -ccC----CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 507 -SSL----SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 507 -~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
+.. ..... ...+.++.+|+..|+..||.+|+|+.|++++
T Consensus 238 ~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 238 IQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 000 01111 1245667999999999999999999999975
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=342.85 Aligned_cols=250 Identities=26% Similarity=0.455 Sum_probs=208.5
Q ss_pred cCHHHHHHhhcCCCcCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC
Q 008216 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337 (573)
Q Consensus 258 ~~~~el~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 337 (573)
+.++++.++. -||+|+.|.||+|++ .++.||||.++.- -..+++-|++|+||||+.+.|+|...
T Consensus 121 iPFe~IsELe--------WlGSGaQGAVF~Grl-~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 121 IPFEEISELE--------WLGSGAQGAVFLGRL-HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred CCHHHhhhhh--------hhccCcccceeeeec-cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCC
Confidence 4566655432 579999999999999 7899999988543 23578889999999999999999999
Q ss_pred CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEeccc
Q 008216 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (573)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 417 (573)
.-++||||||..|-|.+.|+ .+..++......+..+||.||.|||.+ .|||||||.-||||+.+..+||+|||
T Consensus 185 PcyCIiMEfCa~GqL~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFG 257 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFG 257 (904)
T ss_pred ceeEEeeeccccccHHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEecccc
Confidence 99999999999999999995 457799999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccc
Q 008216 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 497 (573)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 497 (573)
-++..... .....++||..|||||++.+.+.+.|+||||||||||||+||..||.+.+...+ -|.
T Consensus 258 TS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----IwG-------- 322 (904)
T KOG4721|consen 258 TSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IWG-------- 322 (904)
T ss_pred chHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EEe--------
Confidence 99876543 223345699999999999999999999999999999999999999987664311 010
Q ss_pred cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
+-...+ ....+..+++.+.-|+++||+..|..||++.+|+..|+-..+
T Consensus 323 ---VGsNsL----~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 323 ---VGSNSL----HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred ---ccCCcc----cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 001111 222344577789999999999999999999999999975544
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=337.68 Aligned_cols=243 Identities=23% Similarity=0.382 Sum_probs=204.9
Q ss_pred eeecccCceEEEEEEe-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
..||+|.||.||+|.. ..++.||+|++.-+. ....+++++|+.+|.+++++||.++|+.+..+..++++|||+.||++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 4689999999999995 468899999998663 33457899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+.+.. +..+.+..+.-++++++.||.|||++ +.+|||||+.|||+..+|.+||+|||.+..+....... .
T Consensus 99 ~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~ 169 (467)
T KOG0201|consen 99 LDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--K 169 (467)
T ss_pred hhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc--c
Confidence 999853 44558888888999999999999999 99999999999999999999999999998776554433 3
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
...||+.|||||++....|+.|+||||||++.+||++|.+|+....+... .-++.. .. +.
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv----------------lflIpk---~~-PP 229 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV----------------LFLIPK---SA-PP 229 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE----------------EEeccC---CC-CC
Confidence 34599999999999988999999999999999999999999988765311 111111 11 11
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
......++.+++++..||+.||+.||+|.++++.
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 1122567789999999999999999999999963
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=314.66 Aligned_cols=231 Identities=24% Similarity=0.327 Sum_probs=197.3
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccchh---hHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||.|+||.|.+++.+ +|..+|+|++++...- ..+...+|-.+|+.+.||+++++++.+.+.+..|+||||++|
T Consensus 49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~G 128 (355)
T KOG0616|consen 49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPG 128 (355)
T ss_pred eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCC
Confidence 346899999999999954 5889999999876433 345678899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|.|..+++. .+++++..++.++.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||+|+....
T Consensus 129 GElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~----- 196 (355)
T KOG0616|consen 129 GELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG----- 196 (355)
T ss_pred ccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC-----
Confidence 999999964 35699999999999999999999999 999999999999999999999999999997643
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
.+...+|||.|+|||.+...+++.++|-|||||++|||+.|.+||...++.. +.+ .++..
T Consensus 197 rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~---iY~------------KI~~~----- 256 (355)
T KOG0616|consen 197 RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ---IYE------------KILEG----- 256 (355)
T ss_pred cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH---HHH------------HHHhC-----
Confidence 3455679999999999999999999999999999999999999998876521 111 11111
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCC
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMR 537 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~R 537 (573)
.-..+.-.+..+.+|+...|+.|-.+|
T Consensus 257 -~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 257 -KVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 112233456689999999999999999
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=347.03 Aligned_cols=255 Identities=29% Similarity=0.408 Sum_probs=208.4
Q ss_pred eeecccCceEEEEEEeCC--C---CEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 275 RLLGDSKTGGTYSGILPD--G---SRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~--g---~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
+.||+|+||.||+|.+.. + ..||||..+.. ......++.+|+++|++++|||||+++|+.......++|||+
T Consensus 163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl 242 (474)
T KOG0194|consen 163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL 242 (474)
T ss_pred ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence 578999999999999643 2 23899999853 355678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
|.||+|.++|... ...++..++..++.+.|.||+|||++ +++||||.++|+|++.++.+||+|||+++......
T Consensus 243 ~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~ 316 (474)
T KOG0194|consen 243 CNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV 316 (474)
T ss_pred cCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence 9999999999752 23699999999999999999999999 99999999999999999999999999998764222
Q ss_pred cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.... ...-..+|+|||.+....++.++|||||||++||+++ |..||.+......... + ...+
T Consensus 317 ~~~~--~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~k---I---~~~~--------- 379 (474)
T KOG0194|consen 317 MKKF--LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAK---I---VKNG--------- 379 (474)
T ss_pred eccc--cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHH---H---HhcC---------
Confidence 1111 1125678999999999999999999999999999999 8999988764311111 1 0000
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCch
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVT 556 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 556 (573)
..-..+...+..+..++.+||..||++||+|.++.+.|+.+......
T Consensus 380 ----~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 380 ----YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ----ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 01112224566788999999999999999999999999988776543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=333.46 Aligned_cols=262 Identities=23% Similarity=0.336 Sum_probs=200.6
Q ss_pred cCCeeecccCceEEEEEEeCC-----------------CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeE
Q 008216 272 EGNRLLGDSKTGGTYSGILPD-----------------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGC 333 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 333 (573)
...+.||+|+||.||++.+.+ +..||+|+++... .....++.+|+.++.+++||||++++++
T Consensus 8 ~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 87 (304)
T cd05096 8 LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGV 87 (304)
T ss_pred eeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEE
Confidence 345578999999999997532 3479999997653 3345679999999999999999999999
Q ss_pred EeeCCceEEEEEecCCCCHHHHhccCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC
Q 008216 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPR---------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398 (573)
Q Consensus 334 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dl 398 (573)
+.+.+..++||||+++++|.+++..... ....+++..+..++.||+.||+|||+. +|+||||
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~dl 164 (304)
T cd05096 88 CVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDL 164 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCc
Confidence 9999999999999999999999864321 113478889999999999999999999 9999999
Q ss_pred CCCCeeeCCCCCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc--CCCCCCC
Q 008216 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS--GRRPAQA 476 (573)
Q Consensus 399 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~Pf~~ 476 (573)
||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ +..||..
T Consensus 165 kp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 244 (304)
T cd05096 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE 244 (304)
T ss_pred chhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCc
Confidence 99999999999999999999986543322222222235788999999988899999999999999999987 5677766
Q ss_pred CCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 477 VDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
.+.. ............... ... . ..+..++..+.+++.+||+.||++|||+++|.+.|++
T Consensus 245 ~~~~---~~~~~~~~~~~~~~~-~~~--------~-~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 245 LTDE---QVIENAGEFFRDQGR-QVY--------L-FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCHH---HHHHHHHHHhhhccc-ccc--------c-cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 5432 111111111110000 000 0 0011245679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=378.76 Aligned_cols=264 Identities=27% Similarity=0.483 Sum_probs=206.7
Q ss_pred cCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 268 KNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
..+.+ ..+||+|+||.||+|.. .+|..||||+++..... ...|++.+++++||||+++++++.+.+..++||||
T Consensus 690 ~~~~~-~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 690 SSLKE-ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hhCCc-ccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34443 34779999999999996 57899999998754322 23468889999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++|+|.++++ .+++..+.+++.|+++||+|||+.+.++|+||||||+||+++.++.+++. ||.........
T Consensus 765 ~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~ 836 (968)
T PLN00113 765 IEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT 836 (968)
T ss_pred CCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCC
Confidence 99999999995 28899999999999999999996655699999999999999998888775 66554332111
Q ss_pred cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
...+|+.|+|||++.+..++.++|||||||++|||+||+.||+.... ......+|.............+++.+
T Consensus 837 ------~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 837 ------KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred ------CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccc
Confidence 11378999999999999999999999999999999999999954322 22334444444333333344455544
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
... .........++.+++.+||+.||++||||+||++.|+++.+.
T Consensus 910 ~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 910 RGD--VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred cCC--CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 221 122345566789999999999999999999999999988764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=338.86 Aligned_cols=241 Identities=23% Similarity=0.358 Sum_probs=203.7
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|+||.||+|+.+ +.+.||+|.+.+.. .++.+.+.+|++++++++||||+.+++.|+...+.++|+||+.|
T Consensus 7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g- 85 (808)
T KOG0597|consen 7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG- 85 (808)
T ss_pred HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-
Confidence 346799999999999954 58899999997653 34456789999999999999999999999999999999999966
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|..+|.. ...++++.+..++.++.+||.|||++ +|+|||+||+|||++.++.+|++|||+++.+..... .
T Consensus 86 ~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~--v 156 (808)
T KOG0597|consen 86 DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS--V 156 (808)
T ss_pred hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCce--e
Confidence 99999964 56799999999999999999999999 999999999999999999999999999998765322 2
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
.....||+-|||||+..+.+|+..+|.||+|||+||+++|++||.... +.+....... |
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~--------d------- 215 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILK--------D------- 215 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhc--------C-------
Confidence 233449999999999999999999999999999999999999997533 1222221111 0
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+..++...+..+.+++...|..||..|.|-.+++.
T Consensus 216 ~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 216 PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 12233467788999999999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=327.75 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=201.6
Q ss_pred cCCeeecccCceEEEEEEeC----CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 272 EGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
...++||+|+||.||+|.+. .+..||+|.++... ......+.+|+.++.+++||||+++++++..++..++||||
T Consensus 8 ~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 87 (266)
T cd05064 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEY 87 (266)
T ss_pred EEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEe
Confidence 34567899999999999853 36689999998653 33346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++|+|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.++++|||.+.......
T Consensus 88 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 88 MSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred CCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999998642 24689999999999999999999999 99999999999999999999999999876543222
Q ss_pred cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
... .....++..|+|||.+.+..++.++||||||+++||+++ |..||........ .... ....
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~~----~~~~-------- 225 (266)
T cd05064 162 IYT-TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKAV----EDGF-------- 225 (266)
T ss_pred hhc-ccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHH----HCCC--------
Confidence 111 111225678999999998999999999999999999875 9999976543211 1100 0000
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
....+..++..+.+++.+||+.+|++||++++|++.|+++
T Consensus 226 -----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 -----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0011223556799999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=327.97 Aligned_cols=268 Identities=25% Similarity=0.354 Sum_probs=200.9
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhh--cCCCcEeEEeeEEeeCC----ceEEEEEecC
Q 008216 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR--LHHPNLVAVKGCCYDHG----DRYIVYEFVV 348 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~----~~~lv~e~~~ 348 (573)
+++|+|+||.||+|.+ +++.||||++... ..+.|.+|-++.+. ++|+||++++++-.... +++||+||.+
T Consensus 216 eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 216 ELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred HHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 3689999999999999 6699999999754 56778888777665 58999999999876555 7899999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK------VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
.|+|.+||.. ..++|....+++..+++||+|||+. .+|+|+|||||.+||||.+|+++.|+|||+|..+
T Consensus 292 kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 292 KGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred CCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 9999999974 5699999999999999999999965 4678999999999999999999999999999988
Q ss_pred CccccccceeccCCcccccccccccCCC-C-----CcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHH-hhhhhh--
Q 008216 423 PWEVMQERTVMAGGTYGYLAPEFVYRNE-L-----TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE-WATPLV-- 493 (573)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~-~~~~~~-- 493 (573)
.............||.+|||||++.+.- + -.+.||||+|.|||||++.-.-++.....+++--++ .+....
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence 7655444444455999999999997631 2 247899999999999999655443211111111111 000000
Q ss_pred ---hccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 494 ---QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 494 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
+..-..+-..|.+. ...........+.+.+..||..||+.|.|+.=+-+++.++....
T Consensus 447 e~mq~~VV~kK~RP~~p---~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 447 EEMQELVVRKKQRPKIP---DAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HHHHHHHHhhccCCCCh---hhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 00000111111111 11112234567999999999999999999999999988887644
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=345.37 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=200.4
Q ss_pred CCeeecccCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEE
Q 008216 273 GNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY 344 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 344 (573)
..+.||+|+||.||+|.. .++..||||+++... ....+.+.+|+.++..+ +||||+++++++.+.+..++||
T Consensus 39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~ 118 (375)
T cd05104 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVIT 118 (375)
T ss_pred hhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeee
Confidence 356789999999999973 246689999997542 33456788999999999 8999999999999999999999
Q ss_pred EecCCCCHHHHhccCCC---------------------------------------------------------------
Q 008216 345 EFVVNGPLDRWLHHIPR--------------------------------------------------------------- 361 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~--------------------------------------------------------------- 361 (573)
||+++|+|.+++.....
T Consensus 119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (375)
T cd05104 119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD 198 (375)
T ss_pred hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence 99999999999864211
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceec
Q 008216 362 --------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (573)
Q Consensus 362 --------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 433 (573)
....+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++.............
T Consensus 199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 275 (375)
T cd05104 199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275 (375)
T ss_pred cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCC
Confidence 112478889999999999999999999 999999999999999999999999999986543322111112
Q ss_pred cCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
..++..|+|||.+.+..++.++||||||+++|||++ |..||....... ..... ..... . ..
T Consensus 276 ~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~----~~~~~-----~-------~~ 337 (375)
T cd05104 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKM----IKEGY-----R-------ML 337 (375)
T ss_pred CCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHH----HHhCc-----c-------CC
Confidence 225678999999999999999999999999999998 889987643211 11111 01000 0 00
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
.+...+.++.+++.+||+.||++|||+.||++.|++.
T Consensus 338 -~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 -SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0112245799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=330.83 Aligned_cols=247 Identities=19% Similarity=0.268 Sum_probs=197.6
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|+||.||++.. .+|+.||+|.+..... .....+.+|+.++.+++|+||+++++++.+.+..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence 45789999999999985 5799999999875422 2234678899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.++|+|||++.........
T Consensus 85 g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 158 (285)
T cd05631 85 GDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV- 158 (285)
T ss_pred CcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee-
Confidence 999988754 2234689999999999999999999999 9999999999999999999999999999865432211
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
....||..|+|||++.+..++.++|||||||++|||++|+.||............ ..... ..
T Consensus 159 --~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~~--------~~----- 220 (285)
T cd05631 159 --RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV---DRRVK--------ED----- 220 (285)
T ss_pred --cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH---HHHhh--------cc-----
Confidence 1234899999999999999999999999999999999999999865432111100 00000 00
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH 545 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 545 (573)
........+..+.+|+.+||+.||++||+ ++++++
T Consensus 221 -~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 -QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 01112234567999999999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=339.03 Aligned_cols=240 Identities=23% Similarity=0.259 Sum_probs=195.9
Q ss_pred eecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
+||+|+||.||++.. .+|+.||||+++... ......+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 589999999999985 468999999997642 2334567889999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 82 L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~ 152 (323)
T cd05571 82 LFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cc
Confidence 9998864 35689999999999999999999999 999999999999999999999999999875422211 11
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ..... ....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~~----~~~~-------------- 211 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELI----LMEE-------------- 211 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHHH----HcCC--------------
Confidence 22348999999999999899999999999999999999999997644321 11100 0000
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH 545 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 545 (573)
...+...++++.+++.+||+.||++|| ++.++++
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 001123456799999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=328.56 Aligned_cols=248 Identities=31% Similarity=0.513 Sum_probs=194.3
Q ss_pred eeecccCceEEEEEEeC-----CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 275 RLLGDSKTGGTYSGILP-----DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
+.||.|.||.||+|.+. .+..|+||.++.. .....+.+.+|++.+++++||||++++|++...+..++|+||++
T Consensus 5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~ 84 (259)
T PF07714_consen 5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCP 84 (259)
T ss_dssp EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--T
T ss_pred eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccc
Confidence 46899999999999975 2678999999664 33447889999999999999999999999998888999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+|+|.++|... ....+++.++..++.||+.||+|||++ +++|+||+++||+++.++.+||+|||++.........
T Consensus 85 ~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 85 GGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp TEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 99999999863 245699999999999999999999999 9999999999999999999999999999876322222
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
...........|+|||.+.+..++.++||||||+++|||++ |+.||...+... +.. ......
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~---~~~~~~----------- 222 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIE---KLKQGQ----------- 222 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHH---HHHTTE-----------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccc---cccccc-----------
Confidence 22222236788999999988889999999999999999999 789987664321 111 110100
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 547 (573)
....+..++..+.+++.+||+.||++|||+.+|++.|
T Consensus 223 ---~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 ---RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0011223456799999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=343.37 Aligned_cols=258 Identities=26% Similarity=0.392 Sum_probs=201.1
Q ss_pred cCCeeecccCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEE
Q 008216 272 EGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 343 (573)
+..+.||+|+||.||++.. .++..||||.++... ......+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus 41 ~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv 120 (374)
T cd05106 41 QFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVI 120 (374)
T ss_pred eehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEe
Confidence 3455789999999999873 234589999997643 33356788999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHhccCCC--------------------------------------------------------------
Q 008216 344 YEFVVNGPLDRWLHHIPR-------------------------------------------------------------- 361 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~-------------------------------------------------------------- 361 (573)
|||+++|+|.+++.....
T Consensus 121 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (374)
T cd05106 121 TEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDE 200 (374)
T ss_pred HhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccch
Confidence 999999999999854210
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceeccCCc
Q 008216 362 ----GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437 (573)
Q Consensus 362 ----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 437 (573)
...++++..+++++.||+.||+|||++ +++||||||+|||+++++.+||+|||+++...............++
T Consensus 201 ~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~ 277 (374)
T cd05106 201 EDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277 (374)
T ss_pred hccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence 113478889999999999999999999 9999999999999999999999999999765433221111122256
Q ss_pred ccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcch
Q 008216 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEA 516 (573)
Q Consensus 438 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (573)
..|+|||++.+..++.++||||||+++|||++ |+.||....... ..... .... ... ..+.
T Consensus 278 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~----~~~~-----~~~--------~~~~ 338 (374)
T cd05106 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKM----VKRG-----YQM--------SRPD 338 (374)
T ss_pred cceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHH----HHcc-----cCc--------cCCC
Confidence 78999999988899999999999999999997 999997654321 11000 0000 000 0011
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 517 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 517 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
..+.++.+++.+||+.||++|||+.+|++.|+++.
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 13467999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=336.15 Aligned_cols=265 Identities=23% Similarity=0.351 Sum_probs=202.2
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
+..+.||+|+||.||+++.. +|..+|+|.++... ....+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 87 (331)
T cd06649 8 ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 87 (331)
T ss_pred eEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCC
Confidence 33456799999999999964 58899999997652 23456799999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
++|.+++.. ...+++..+..++.|++.||.|||++. +|+||||||+|||++.++.+||+|||++........
T Consensus 88 ~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 159 (331)
T cd06649 88 GSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-- 159 (331)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccccc--
Confidence 999999864 345889999999999999999999851 699999999999999999999999999876543211
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccc------------
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR------------ 497 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~------------ 497 (573)
....|++.|+|||++.+..++.++||||||+++|||++|+.||...+...................
T Consensus 160 --~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 160 --NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred --ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence 122389999999999988999999999999999999999999976543222111110000000000
Q ss_pred ---------------cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 498 ---------------YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 498 ---------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
..+..+..........+....++++.+|+.+||+.||++|||+++|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000111111111222356789999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=331.18 Aligned_cols=246 Identities=21% Similarity=0.276 Sum_probs=201.0
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccchhh---HHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
-++||+|+||.||+++. .+|..+|+|++++..... .+.+..|-.+|...++|.||+++..|.+...+||||||++|
T Consensus 146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG 225 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG 225 (550)
T ss_pred heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence 45789999999999994 569999999999875443 45577899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc----
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE---- 425 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---- 425 (573)
|++..+|.. ...|++..+..++.+++.|++-||+. |+|||||||+|+|||..|++||+|||++.-+...
T Consensus 226 GD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 226 GDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred ccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 999999954 46799999999999999999999999 9999999999999999999999999998543210
Q ss_pred ------------------ccc-----cc------------------eeccCCcccccccccccCCCCCcchhhHHHHHHH
Q 008216 426 ------------------VMQ-----ER------------------TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464 (573)
Q Consensus 426 ------------------~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil 464 (573)
... .. .....|||.|||||++.+..|+..+|.||||||+
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM 378 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence 000 00 0012399999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCcc-cchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCC---H
Q 008216 465 LEIVSGRRPAQAVDSV-CWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR---M 540 (573)
Q Consensus 465 ~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~ 540 (573)
|||+.|.+||...++. .+..+..|...+. .+.....+++..+||.+|+. ||++|.. +
T Consensus 379 yEmLvGyPPF~s~tp~~T~rkI~nwr~~l~------------------fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~ 439 (550)
T KOG0605|consen 379 YEMLVGYPPFCSETPQETYRKIVNWRETLK------------------FPEEVDLSDEAKDLITRLLC-DPENRLGSKGA 439 (550)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhhhcc------------------CCCcCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence 9999999999887654 3444444443221 11223344789999999999 9999975 5
Q ss_pred HHHHH
Q 008216 541 SHVVH 545 (573)
Q Consensus 541 ~evl~ 545 (573)
+||.+
T Consensus 440 ~EIK~ 444 (550)
T KOG0605|consen 440 EEIKK 444 (550)
T ss_pred HHHhc
Confidence 55543
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=351.30 Aligned_cols=252 Identities=20% Similarity=0.234 Sum_probs=203.8
Q ss_pred CcCCeeecccCceEEEEEEeC-C-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 271 SEGNRLLGDSKTGGTYSGILP-D-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
+...++||+|++|.||+|... + ++.||+|.+..........+.+|+.+|+.++||||+++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 445667899999999999853 3 67899998866655556678889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+|+|.+++........++++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999998865434445689999999999999999999999 9999999999999999999999999999876543222
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ... .... ..
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~---~~~~-~~----------- 287 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQ---QVLY-GK----------- 287 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHh-CC-----------
Confidence 22233448999999999998899999999999999999999999997644311 110 0000 00
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....+...+..+.++|.+||+.||++||++++++.
T Consensus 288 --~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 288 --YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 00111234567999999999999999999999874
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=303.66 Aligned_cols=267 Identities=22% Similarity=0.310 Sum_probs=213.9
Q ss_pred hhcCCCcCCeeecccCceEEEEEE-eCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC-----Cc
Q 008216 266 ITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GD 339 (573)
Q Consensus 266 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~ 339 (573)
+.++.+...+.||+|||+-||+++ ..+++.+|+|++.....++.+..++|++..++++|||+++++++...+ ..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 344455566788999999999998 668999999999988878888999999999999999999999887543 34
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCC
Q 008216 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (573)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 419 (573)
.||+++|...|+|.+.+......+..+++.+++.|+.+|.+||++||+. .++++||||||.|||+++++.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 7999999999999999988777777899999999999999999999998 335999999999999999999999999999
Q ss_pred ccCCccccccc-------eeccCCccccccccccc---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhh
Q 008216 420 KFVPWEVMQER-------TVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWA 489 (573)
Q Consensus 420 ~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 489 (573)
........... ......|..|+|||.+. +...+.++|||||||+||+|+.|..||+..-..
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~--------- 247 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ--------- 247 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---------
Confidence 87653321111 11122688999999885 345789999999999999999999999753221
Q ss_pred hhhhhccccc-cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 490 TPLVQSHRYL-ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 490 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
.+.+. .+..+.++ -+.....++.+.++|+.|++.||.+||++.+++..++.+.
T Consensus 248 -----GgSlaLAv~n~q~s----~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 -----GGSLALAVQNAQIS----IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -----CCeEEEeeeccccc----cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11111 11111111 1111226788999999999999999999999999988653
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=339.43 Aligned_cols=245 Identities=21% Similarity=0.305 Sum_probs=206.1
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
++.++-||.|+.|.|-+|+. .+|+.+|||++.+.. ......+.+|+-+|+.+.|||++++++++++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 45567789999999999984 579999999997652 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++|-|.+++.. .+++++.+..+++.||+.|+.|+|.. +|+||||||+|+|||..+++||+|||+|..-..+.
T Consensus 94 v~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 94 VPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred cCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 999999999954 46799999999999999999999999 99999999999999999999999999998655443
Q ss_pred cccceeccCCcccccccccccCCCCC-cchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.. ...||++.|.|||++.+.+|. .++||||.|||||.|+||+.||++.+. ..+...+. .+.+
T Consensus 167 lL---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LLlKV~----~G~f------- 229 (786)
T KOG0588|consen 167 LL---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLLLKVQ----RGVF------- 229 (786)
T ss_pred cc---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHHHHHH----cCcc-------
Confidence 32 234599999999999999884 799999999999999999999986442 22222211 1111
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
..+..++.++.+|+.+|+..||++|.|++||++.
T Consensus 230 -------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 -------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1124566789999999999999999999999984
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=322.62 Aligned_cols=251 Identities=25% Similarity=0.391 Sum_probs=203.3
Q ss_pred CCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
..+.||+|++|.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+.+.+..+++|||+++++|
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 88 (261)
T cd05072 10 LVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSL 88 (261)
T ss_pred EeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcH
Confidence 345679999999999998888999999987643 3457889999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........... .
T Consensus 89 ~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~-~ 162 (261)
T cd05072 89 LDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR-E 162 (261)
T ss_pred HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceecc-C
Confidence 9998652 335688899999999999999999999 999999999999999999999999999987643322111 1
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
...++..|+|||.+.+..++.++||||||+++|+|+| |..||........ .... ... . .
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~----~~~-----~--------~ 222 (261)
T cd05072 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSAL----QRG-----Y--------R 222 (261)
T ss_pred CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHHH----HcC-----C--------C
Confidence 1225678999999988889999999999999999998 9999976443211 1100 000 0 0
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
.......+.++.+++.+||+.+|++||+++++.+.|+++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 001112446789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=332.87 Aligned_cols=258 Identities=21% Similarity=0.361 Sum_probs=203.7
Q ss_pred cCCeeecccCceEEEEEEeC-CCC----EEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
+..+.||+|+||.||+|.+. +|+ .||+|.++... ....+++.+|+.+++.++||||+++++++... ..++++|
T Consensus 10 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e 88 (316)
T cd05108 10 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQ 88 (316)
T ss_pred eeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeeee
Confidence 34457899999999999853 333 48999997543 34457789999999999999999999998764 5679999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|+++|+|.+++... ...+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 89 LMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred cCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999998742 34588899999999999999999999 9999999999999999999999999999876543
Q ss_pred ccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
..........++..|+|||.+.+..++.++||||||+++|||++ |+.||............ ....
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-------~~~~------- 228 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------EKGE------- 228 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------hCCC-------
Confidence 32222222224678999999998999999999999999999998 99999765432211111 0000
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCch
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVT 556 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 556 (573)
....+..++..+.+++.+||+.||++||++.+++..|..+..++..
T Consensus 229 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~ 274 (316)
T cd05108 229 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 274 (316)
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCch
Confidence 0000112345689999999999999999999999999988876644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=333.74 Aligned_cols=239 Identities=23% Similarity=0.278 Sum_probs=193.3
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 277 LGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 277 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
||+|+||.||++... +++.||+|+++.. .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999964 5889999999753 223446678899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccc
Confidence 999864 34589999999999999999999999 999999999999999999999999999985432221 112
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+... .. ..... . ..
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~---~~---~~~~~---------~------~~ 210 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE---MY---RKILQ---------E------PL 210 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH---HH---HHHHc---------C------CC
Confidence 2348999999999999999999999999999999999999997644321 11 01000 0 00
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCC---HHHHHH
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPR---MSHVVH 545 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 545 (573)
..+...++.+.+++.+||+.||++||+ +.++++
T Consensus 211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 111234567899999999999999986 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=339.21 Aligned_cols=236 Identities=24% Similarity=0.332 Sum_probs=200.3
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
-++||+|+||.|+++..+ +++.+|||+++++. ..+.+..+.|.+++... +||.++.++..+.+.++.|.||||+.
T Consensus 373 l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~ 452 (694)
T KOG0694|consen 373 LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVA 452 (694)
T ss_pred EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecC
Confidence 457899999999999964 58899999999873 34556778898888877 59999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
||++..+.+ ...+++..+..++..|+.||+|||++ +||+||||.+|||||.+|.+||+|||+++..-. ..
T Consensus 453 Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~--~g 522 (694)
T KOG0694|consen 453 GGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG--QG 522 (694)
T ss_pred CCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC--CC
Confidence 999544433 36699999999999999999999999 999999999999999999999999999986532 23
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
..+...+||+.|||||++.+..|+.++|-|||||+||||+.|..||.+.++++ ++|.++..
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-------------------~FdsI~~d 583 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-------------------VFDSIVND 583 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-------------------HHHHHhcC
Confidence 35566789999999999999999999999999999999999999999877642 22222211
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM 540 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 540 (573)
....+..++.+..++++++|..+|++|..+
T Consensus 584 --~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 --EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 223345577889999999999999999866
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=334.54 Aligned_cols=240 Identities=23% Similarity=0.253 Sum_probs=195.1
Q ss_pred eecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
+||+|+||.||++.. .+|+.||+|+++... ......+.+|+.++++++||||+++++.+...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 689999999999985 468999999997642 2334567789999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|..++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........ ..
T Consensus 82 L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~ 152 (323)
T cd05595 82 LFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cc
Confidence 9988854 34689999999999999999999999 999999999999999999999999999875322211 11
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..... ... . .. .
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~---~~~---~-~~--------------~ 211 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF---ELI---L-ME--------------E 211 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH---HHH---h-cC--------------C
Confidence 2234899999999999889999999999999999999999999765432110 000 0 00 0
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH 545 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 545 (573)
...+...++++.+++.+||+.||++|| ++.++++
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 001123456789999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=324.23 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=202.4
Q ss_pred eeecccCceEEEEEEeCC------CCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 275 RLLGDSKTGGTYSGILPD------GSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
+.||+|+||.||+|...+ ++.||||.++..... ..+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 11 ~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 90 (280)
T cd05049 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYM 90 (280)
T ss_pred hhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecC
Confidence 467999999999998533 478999999765443 4578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEeccc
Q 008216 348 VNGPLDRWLHHIP----------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (573)
Q Consensus 348 ~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 417 (573)
++++|.+++.... .....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||
T Consensus 91 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~d~g 167 (280)
T cd05049 91 EHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFG 167 (280)
T ss_pred CCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeEEECCcc
Confidence 9999999996531 1234578899999999999999999999 99999999999999999999999999
Q ss_pred CCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcc
Q 008216 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSH 496 (573)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 496 (573)
++................+++.|+|||++.+..++.++||||||+++|||++ |..||...+... ..... ...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~----~~~ 240 (280)
T cd05049 168 MSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECI----TQG 240 (280)
T ss_pred cceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----HcC
Confidence 9976533222111112225788999999999999999999999999999998 999987654321 11111 000
Q ss_pred ccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
. ...++...+..+.+++.+||+.||++||++.||++.|++
T Consensus 241 ~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 241 R-------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred C-------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 0 011122345679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=325.86 Aligned_cols=258 Identities=28% Similarity=0.406 Sum_probs=206.1
Q ss_pred CCeeecccCceEEEEEEeC------CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 273 GNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
..+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 9 ~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (288)
T cd05093 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 88 (288)
T ss_pred eccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 3456799999999999842 3456999999876656677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEeccc
Q 008216 347 VVNGPLDRWLHHIP---------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (573)
Q Consensus 347 ~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 417 (573)
+++++|.+++.... .....+++..++.++.|++.||+|||++ +++||||||+||++++++.++|+|||
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg 165 (288)
T cd05093 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFG 165 (288)
T ss_pred CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEeccCC
Confidence 99999999986432 1123589999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcc
Q 008216 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSH 496 (573)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 496 (573)
++................++..|+|||.+.+..++.++||||||+++|+|+| |..||....... ..... ...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~i----~~~ 238 (288)
T cd05093 166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECI----TQG 238 (288)
T ss_pred ccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcC
Confidence 9986543322211222225778999999988889999999999999999998 999987654321 11100 000
Q ss_pred ccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
... ......+..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 239 ~~~-------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 239 RVL-------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CcC-------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 000 00112345799999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.28 Aligned_cols=258 Identities=24% Similarity=0.362 Sum_probs=219.3
Q ss_pred CCeeecccCceEEEEEEe-CCCC----EEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 273 GNRLLGDSKTGGTYSGIL-PDGS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~-~~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
..++||+|+||+||+|.+ ++|+ +||||++... ..+...++++|+-+|.+++|||+++++|+|..+. ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 456889999999999984 4444 7999998765 4455688999999999999999999999998766 7899999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++|+|.+|++. .+..+..+..+.|..|||+||.|||.+ +++||||.++|||+.....+|+.|||+++.+..+.
T Consensus 779 mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 779 MPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred cccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 999999999985 345688999999999999999999999 99999999999999999999999999999988766
Q ss_pred cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.........-.+.|||-|.+....++.++|||||||++||++| |..|+++....++.++++....
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-------------- 918 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-------------- 918 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc--------------
Confidence 5544444445678999999999999999999999999999999 9999998876655544433221
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCchh
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTK 557 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 557 (573)
...+..++.++..++.+||..|+..||+++++.+.+.+++.+|..-
T Consensus 919 ------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqry 964 (1177)
T KOG1025|consen 919 ------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRY 964 (1177)
T ss_pred ------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceE
Confidence 1112346678999999999999999999999999999999877543
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=317.82 Aligned_cols=248 Identities=28% Similarity=0.392 Sum_probs=197.8
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHH
Q 008216 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 353 (573)
.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 4799999999999864 68999999886542 334567899999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceec
Q 008216 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (573)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 433 (573)
+++.. ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++..............
T Consensus 82 ~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 82 TFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 99863 234588999999999999999999999 999999999999999999999999999876543211111111
Q ss_pred cCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
...+..|+|||.+.+..++.++||||||+++|||++ |..||............ ... . ..
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~-------~~~---------~----~~ 215 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-------EQG---------V----RL 215 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH-------HcC---------C----CC
Confidence 123567999999988889999999999999999998 88888654432111100 000 0 00
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
..+...+..+.+++.+||+.||++|||+.+|++.|+.
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 1112345679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=326.85 Aligned_cols=263 Identities=17% Similarity=0.209 Sum_probs=194.8
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
.+.||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++||||+++++++.+.+..++||||++ ++
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~ 88 (288)
T cd07871 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SD 88 (288)
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cC
Confidence 457899999999999864 68899999997542 2234567899999999999999999999999999999999996 58
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++.. .+..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 89 l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~--~ 160 (288)
T cd07871 89 LKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT--Y 160 (288)
T ss_pred HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc--c
Confidence 9988863 234578999999999999999999999 9999999999999999999999999999765322211 1
Q ss_pred eccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhh---------ccccccc
Q 008216 432 VMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ---------SHRYLEL 501 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---------~~~~~~~ 501 (573)
....+++.|+|||.+.+ ..++.++||||+|+++|||+||++||...+................ ...+...
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 12237899999998865 5689999999999999999999999976543321111100000000 0000001
Q ss_pred cccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
..+..............+.++.+|+.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 10000000000001123567899999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=334.58 Aligned_cols=241 Identities=22% Similarity=0.257 Sum_probs=196.1
Q ss_pred eecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
+||+|+||.||++.. .+|+.||+|+++... ......+.+|+.+++.++||||+++++++.+.+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 589999999999985 468999999997642 2334677889999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 82 L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~ 152 (328)
T cd05593 82 LFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TM 152 (328)
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cc
Confidence 9988853 34689999999999999999999999 999999999999999999999999999875432211 11
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .... . .. .
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~---~~~~---~-~~--------------~ 211 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELI---L-ME--------------D 211 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH---HHHh---c-cC--------------C
Confidence 223489999999999988999999999999999999999999976543211 1000 0 00 0
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVHQ 546 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 546 (573)
...+...+.++.+++.+||+.||++|| ++.++++.
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 212 IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 011123456789999999999999997 88988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=324.14 Aligned_cols=253 Identities=28% Similarity=0.456 Sum_probs=202.1
Q ss_pred CeeecccCceEEEEEEeCC------CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 274 NRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
.+.||+|+||.||+|.... ...||+|.++... ......+.+|+.++.+++||||+++++++.+.+..+++|||
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 89 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEY 89 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEec
Confidence 3467999999999998533 2579999997543 33456789999999999999999999999998999999999
Q ss_pred cCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEe
Q 008216 347 VVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 414 (573)
+++++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.++|+
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~L~ 166 (283)
T cd05048 90 LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKIS 166 (283)
T ss_pred CCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEEEC
Confidence 999999999965321 114588899999999999999999999 99999999999999999999999
Q ss_pred cccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhh
Q 008216 415 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493 (573)
Q Consensus 415 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 493 (573)
|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||....... .... .
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~~----i 239 (283)
T cd05048 167 DFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIEM----I 239 (283)
T ss_pred CCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----H
Confidence 9999986543322222222236788999999988899999999999999999998 999997654321 1111 0
Q ss_pred hccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 494 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
.... ....+..++.++.+|+.+||+.||.+||++.+|++.|+.
T Consensus 240 ~~~~-------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 RSRQ-------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HcCC-------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 0000 001123456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=329.91 Aligned_cols=240 Identities=20% Similarity=0.235 Sum_probs=196.6
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 85 (291)
T cd05612 6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPG 85 (291)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCC
Confidence 457899999999999964 68999999996542 23346688999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~--- 155 (291)
T cd05612 86 GELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--- 155 (291)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc---
Confidence 999999864 34689999999999999999999999 99999999999999999999999999998654321
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...+..... . .... ..
T Consensus 156 --~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~---~---~i~~-~~------------ 214 (291)
T cd05612 156 --WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY---E---KILA-GK------------ 214 (291)
T ss_pred --ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H---HHHh-CC------------
Confidence 1234899999999999888999999999999999999999999765432111 1 0000 00
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVHQ 546 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 546 (573)
...+...+..+.+++.+||+.||.+||+ ++++++.
T Consensus 215 --~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 --LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0011123557899999999999999995 8887753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=317.97 Aligned_cols=247 Identities=25% Similarity=0.421 Sum_probs=199.0
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHH
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 353 (573)
.+.||+|+||.||++...++..+|+|.++... .....+.+|+.++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 87 (256)
T cd05114 9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLL 87 (256)
T ss_pred eeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHH
Confidence 34679999999999998888899999987543 33567889999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceec
Q 008216 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (573)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 433 (573)
+++... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||.++.......... ..
T Consensus 88 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~-~~ 160 (256)
T cd05114 88 NYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS-SG 160 (256)
T ss_pred HHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc-CC
Confidence 998642 23588999999999999999999999 999999999999999999999999999886543222111 11
Q ss_pred cCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||...+... ..... ..... ..
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i---~~~~~---~~---------- 221 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMI---SRGFR---LY---------- 221 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH---HCCCC---CC----------
Confidence 225668999999988889999999999999999999 899997654321 11111 10000 00
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 548 (573)
.+...+..+.+++.+||+.+|++||+++++++.|.
T Consensus 222 -~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 222 -RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01112457899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=323.96 Aligned_cols=250 Identities=21% Similarity=0.315 Sum_probs=193.3
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchh--------------hHHHHHHHHHHHhhcCCCcEeEEeeEEe
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ--------------RKKEFYSEIGRFARLHHPNLVAVKGCCY 335 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 335 (573)
++..+-||+|.||.|-+|.. .+++.||||++.+.... ..+...+|+.+|++++|||||+|+.+..
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD 178 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD 178 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence 34445579999999999995 46899999999653211 1357889999999999999999999987
Q ss_pred eC--CceEEEEEecCCCCHHHHhccCCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCee
Q 008216 336 DH--GDRYIVYEFVVNGPLDRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412 (573)
Q Consensus 336 ~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 412 (573)
+. +..|||+|||..|.+... ..... +++.++++++.++..||+|||.+ |||||||||+|+||+++|++|
T Consensus 179 DP~s~~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 179 DPESDKLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred CcccCceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEE
Confidence 65 578999999998877432 22334 99999999999999999999999 999999999999999999999
Q ss_pred EecccCCccCCcc---ccccceeccCCcccccccccccCCC----CCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhh
Q 008216 413 LMGVGLSKFVPWE---VMQERTVMAGGTYGYLAPEFVYRNE----LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI 485 (573)
Q Consensus 413 l~Dfg~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~ 485 (573)
|+|||.+...... ..........||+.|+|||...++. .+.+.||||+||+||.|+.|+.||.+....+ +
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~---l 327 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE---L 327 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH---H
Confidence 9999999866322 1111112244999999999988732 3568999999999999999999998754321 1
Q ss_pred HHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008216 486 FEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547 (573)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 547 (573)
+. .++...+ ......+..+.+.+||.++|.+||+.|.+..+|....
T Consensus 328 ~~------------KIvn~pL----~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 328 FD------------KIVNDPL----EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HH------------HHhcCcc----cCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 11 1111111 1111224567899999999999999999999987543
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=324.49 Aligned_cols=258 Identities=26% Similarity=0.412 Sum_probs=207.7
Q ss_pred CeeecccCceEEEEEEeC------CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 274 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
.+.||+|+||.||+++.. ++..+++|.++.......+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM 89 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecC
Confidence 457899999999999742 35579999998776666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEec
Q 008216 348 VNGPLDRWLHHIP------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415 (573)
Q Consensus 348 ~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 415 (573)
++++|.+++.... .....+++..++.++.||+.||+|||++ +++||||||+||+++.++.++|+|
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~d 166 (291)
T cd05094 90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGD 166 (291)
T ss_pred CCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEECC
Confidence 9999999996432 1224588999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhh
Q 008216 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQ 494 (573)
Q Consensus 416 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 494 (573)
||++................++..|+|||.+.+..++.++||||||+++|||+| |+.||...+.... .+. ..
T Consensus 167 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~----~~ 239 (291)
T cd05094 167 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---IEC----IT 239 (291)
T ss_pred CCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----Hh
Confidence 999976543322222222236788999999998899999999999999999999 9999876543211 110 01
Q ss_pred ccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
..... ......+..+.+++.+||+.||++||++.+|++.|+++..+.
T Consensus 240 ~~~~~-------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 240 QGRVL-------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred CCCCC-------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 11000 011123467999999999999999999999999999986653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=301.41 Aligned_cols=245 Identities=26% Similarity=0.338 Sum_probs=204.8
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
+..+.||+|.||.||.|+. +++-.||+|++.+.. .....++.+|+++-+.|+||||+++|+++.+....||++||.
T Consensus 25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya 104 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA 104 (281)
T ss_pred cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence 4466889999999999995 457789999997653 233578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
.+|+|...|.. .....+++.....++.|+|.||.|+|.+ +|+||||||+|+|++.++..||+|||.+...+
T Consensus 105 ~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---- 175 (281)
T KOG0580|consen 105 PRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 175 (281)
T ss_pred CCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC----
Confidence 99999999975 3456689999999999999999999999 99999999999999999999999999998654
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
.......+||..|.|||+..+...+...|+|++|++.||++.|.+||......+ ...... ..++.
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---tYkrI~-------k~~~~----- 240 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---TYKRIR-------KVDLK----- 240 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---HHHHHH-------Hcccc-----
Confidence 223334569999999999999999999999999999999999999998755221 111110 01111
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
.+...+..+.++|.+|+..+|.+|.+..|+++.
T Consensus 241 ------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 241 ------FPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ------CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 123456779999999999999999999998864
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=319.46 Aligned_cols=251 Identities=29% Similarity=0.476 Sum_probs=203.2
Q ss_pred CCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
..+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++||||+++++++...+..+++|||+++++|
T Consensus 10 ~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 88 (261)
T cd05068 10 LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSL 88 (261)
T ss_pred eEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcH
Confidence 345789999999999998788899999997653 3456789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++... .+..+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++.......... ..
T Consensus 89 ~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~ 162 (261)
T cd05068 89 LEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA-RE 162 (261)
T ss_pred HHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc-cC
Confidence 9999652 235689999999999999999999999 99999999999999999999999999998765322111 11
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
....+..|+|||.+.+..++.++||||||+++|||+| |+.||....... .... .... . .
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~----~~~~-~------------~ 222 (261)
T cd05068 163 GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQQ----VDQG-Y------------R 222 (261)
T ss_pred CCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----HHcC-C------------C
Confidence 1113457999999988899999999999999999999 999997654321 1110 0000 0 0
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
...+...+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 001123456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=338.57 Aligned_cols=260 Identities=28% Similarity=0.404 Sum_probs=202.7
Q ss_pred CcCCeeecccCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeCCceEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYI 342 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~l 342 (573)
....++||+|+||.||+|... .+..||||+++... ....+.+.+|+.+++++. ||||+++++++.+.+..++
T Consensus 39 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (400)
T cd05105 39 LVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYI 118 (400)
T ss_pred eehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEE
Confidence 344567899999999999842 23479999997543 333567899999999995 9999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCC-------------------------------------------------------------
Q 008216 343 VYEFVVNGPLDRWLHHIPR------------------------------------------------------------- 361 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~------------------------------------------------------------- 361 (573)
||||+++|+|.+++.....
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (400)
T cd05105 119 ITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEAS 198 (400)
T ss_pred EEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhh
Confidence 9999999999998864210
Q ss_pred -------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCC
Q 008216 362 -------------------------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410 (573)
Q Consensus 362 -------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 410 (573)
....+++..+..++.|++.||+|||++ +++||||||+|||++.++.
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~ 275 (400)
T cd05105 199 KYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKI 275 (400)
T ss_pred hhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCE
Confidence 113478888999999999999999999 9999999999999999999
Q ss_pred eeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhh
Q 008216 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWA 489 (573)
Q Consensus 411 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~ 489 (573)
+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....... ....
T Consensus 276 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~~~-- 351 (400)
T cd05105 276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TFYN-- 351 (400)
T ss_pred EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HHHH--
Confidence 99999999986543322222222236788999999988889999999999999999997 999987643211 0000
Q ss_pred hhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 490 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
..... . ....+...+..+.+++.+||+.||++||++.+|.+.|+++.+
T Consensus 352 --~~~~~-----~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 352 --KIKSG-----Y--------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred --HHhcC-----C--------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 00000 0 000112345679999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=326.07 Aligned_cols=265 Identities=19% Similarity=0.209 Sum_probs=197.3
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
..+.||+|+||.||+++.. +++.||||+++... ....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07848 5 VLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK 84 (287)
T ss_pred EEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCC
Confidence 3457899999999999975 58899999997542 22346788999999999999999999999999999999999998
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
+++..+.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..........
T Consensus 85 ~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 85 NMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 77765543 234689999999999999999999999 99999999999999999999999999998764322211
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHh-hhhh--------hhcccccc
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW-ATPL--------VQSHRYLE 500 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-~~~~--------~~~~~~~~ 500 (573)
.....|++.|+|||++.+..++.++|||||||++|||++|++||...+.......... ..+. ........
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 158 -YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred -ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 1122389999999999988899999999999999999999999987543211100000 0000 00000000
Q ss_pred ccccccccCC--CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 501 LLDPLISSLS--SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 501 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
...+...... ........+..+.+|+.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 00001124567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=318.27 Aligned_cols=250 Identities=29% Similarity=0.476 Sum_probs=202.3
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
.+.||+|++|.||+|... +++.||+|.++... ....++.+|++++++++||||+++++++...+..+++|||+++++|
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (263)
T cd05052 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 89 (263)
T ss_pred eeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcH
Confidence 346799999999999964 58899999987553 3456789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++.. .....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++............
T Consensus 90 ~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~- 163 (263)
T cd05052 90 LDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA- 163 (263)
T ss_pred HHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccC-
Confidence 999864 2234689999999999999999999999 9999999999999999999999999999876543221111
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
...++..|+|||.+.+..++.++||||||+++|||++ |..||...+... ..... ... .. .
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~----~~~-----~~-------~ 224 (263)
T cd05052 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELL----EKG-----YR-------M 224 (263)
T ss_pred CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----HCC-----CC-------C
Confidence 1124668999999988899999999999999999998 999987654321 11100 000 00 0
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
..+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 225 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 -ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11123456799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=319.14 Aligned_cols=257 Identities=23% Similarity=0.335 Sum_probs=206.2
Q ss_pred CCeeecccCceEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 273 GNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
..+.||+|+||.||+|.. .+++.||||.++.. .......+.+|+.+++.++||||+++++++.+.+..++++||++
T Consensus 6 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08228 6 IEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELAD 85 (267)
T ss_pred eeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecC
Confidence 345689999999999995 46899999988642 23344678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+++|.+++.........+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.........
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~ 162 (267)
T cd08228 86 AGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162 (267)
T ss_pred CCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchhHH
Confidence 9999998865444445689999999999999999999999 9999999999999999999999999998876433221
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
. ....++..|+|||.+.+..++.++|+||||+++|||++|+.||....... ..... .. ...
T Consensus 163 ~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~---~~-~~~------------ 223 (267)
T cd08228 163 A--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQ---KI-EQC------------ 223 (267)
T ss_pred H--hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHH---HH-hcC------------
Confidence 1 12238889999999988889999999999999999999999986543210 11111 00 000
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
.....+....+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 224 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0011222345577999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=334.66 Aligned_cols=265 Identities=28% Similarity=0.440 Sum_probs=219.3
Q ss_pred CeeecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
...||.|.||.||.|.|+. .-.||||.++.+. -..++|+.|+.+|+.++|||+|+++|+|..+..+|||+|||..|+|
T Consensus 272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNL 350 (1157)
T KOG4278|consen 272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNL 350 (1157)
T ss_pred eeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccH
Confidence 4467999999999999865 6689999998874 4568999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+||+... ...++....+.++.||++||+||..+ ++|||||.++|+|+.++..+|++|||+++++..+......
T Consensus 351 LdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA- 424 (1157)
T KOG4278|consen 351 LDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA- 424 (1157)
T ss_pred HHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc-
Confidence 99998643 34577788899999999999999999 9999999999999999999999999999998765433222
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
...-...|.|||.+..+.++.|+|||+|||+|||+.| |..||.+.+-.....+. +.+- .
T Consensus 425 GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL-------Ekgy-------------R 484 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL-------EKGY-------------R 484 (1157)
T ss_pred CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH-------hccc-------------c
Confidence 2224678999999999999999999999999999999 99999887643211111 1110 1
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC-chhhhhhhhhc
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP-VTKLLFKGLDR 565 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~-~~~~~~~~~~~ 565 (573)
-..+.++++.+.+||+.||+.+|.+||++.|+-+.++.+..+. ..+...+.+.|
T Consensus 485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSisdEV~keLgk 539 (1157)
T KOG4278|consen 485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSISDEVQKELGK 539 (1157)
T ss_pred ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccccHHHHHHHhh
Confidence 1123468889999999999999999999999999999987754 33444444433
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=318.23 Aligned_cols=277 Identities=20% Similarity=0.273 Sum_probs=208.0
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEec--ccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEee-----CCceEEEEE
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLK--RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-----HGDRYIVYE 345 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~~~~lv~e 345 (573)
.+.||+|+||.|..+.. .+|+.||||.+. .......++..+|+++|+.++|+||+.+.+.+.. -++.|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 34679999999999985 468999999997 3455567888999999999999999999998865 356799999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
+| +.+|...++. ++.++...+..++.|++.||+|+|+. +|+||||||.|++++.+..+||+|||+|+.....
T Consensus 107 lM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 107 LM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred HH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeecccc
Confidence 99 7799999854 45599999999999999999999999 9999999999999999999999999999987643
Q ss_pred ccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccc--
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL-- 502 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 502 (573)
......+....|..|.|||++.. ..|+.+.||||.|||+.||++|++.|.+.+......++...........+..+-
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 22222222337899999998764 679999999999999999999999998876543322222111111111110000
Q ss_pred --ccccccCCCCCc------chHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-----HHhcccCCCchhh
Q 008216 503 --DPLISSLSSDIP------EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH-----QLQQLAQPPVTKL 558 (573)
Q Consensus 503 --~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~-----~L~~~~~~~~~~~ 558 (573)
.+.+++.+...+ -....+...+|+.+||..||.+|+|++|.++ .+.....+|..+.
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~ 327 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQP 327 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCC
Confidence 011111111100 0134567899999999999999999999986 3444445554433
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=318.14 Aligned_cols=250 Identities=27% Similarity=0.476 Sum_probs=206.5
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHH
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 353 (573)
.+.||.|++|.||+|...+++.+|+|.++.........+.+|+.+++.++||||+++++++.+.+..++||||+++++|.
T Consensus 11 ~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (261)
T cd05148 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL 90 (261)
T ss_pred hhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHH
Confidence 44679999999999998889999999998776656778999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceec
Q 008216 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (573)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 433 (573)
+++... .+..+++..+..++.|++.||+|||++ +++|+||||+||++++++.+||+|||.+........... .
T Consensus 91 ~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~--~ 163 (261)
T cd05148 91 AFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS--D 163 (261)
T ss_pred HHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccccc--C
Confidence 999752 345689999999999999999999999 999999999999999999999999999987643322111 2
Q ss_pred cCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
..++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+... ...... ... ..
T Consensus 164 ~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~~---~~~--------------~~ 223 (261)
T cd05148 164 KKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQIT---AGY--------------RM 223 (261)
T ss_pred CCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHH---hCC--------------cC
Confidence 226778999999988889999999999999999998 899997654321 111110 000 00
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
..+...++.+.+++.+||+.||++|||+.++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11123456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=330.39 Aligned_cols=264 Identities=22% Similarity=0.345 Sum_probs=199.1
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
+..+.||+|+||.||++... +|..+|+|.++.. .......+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 8 ~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 87 (333)
T cd06650 8 EKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 87 (333)
T ss_pred heeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCC
Confidence 34556799999999999965 5889999998764 223456789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
++|.+++.. ...+++..+..++.|++.||.|||+.. +++||||||+|||++.++.+||+|||++........
T Consensus 88 ~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-- 159 (333)
T cd06650 88 GSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-- 159 (333)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc--
Confidence 999999864 345889999999999999999999741 799999999999999999999999999875532211
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhh-hc-------------
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV-QS------------- 495 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~-~~------------- 495 (573)
....|+..|+|||++.+..++.++|||||||++|||++|+.||................... ..
T Consensus 160 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (333)
T cd06650 160 --NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP 237 (333)
T ss_pred --ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence 12238899999999998889999999999999999999999997654322111110000000 00
Q ss_pred -----------cccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 496 -----------HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 496 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.......+..........+....+.++.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 00000000001111111111124567899999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=320.59 Aligned_cols=254 Identities=23% Similarity=0.398 Sum_probs=199.1
Q ss_pred CCeeecccCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEE
Q 008216 273 GNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
..+.||+|++|.||+|... .+..||||.++... .....++.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 10 ~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e 89 (277)
T cd05062 10 MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 89 (277)
T ss_pred eeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEe
Confidence 3456799999999998752 35679999986542 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCC
Q 008216 346 FVVNGPLDRWLHHIPRG------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 419 (573)
|+++++|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg~~ 166 (277)
T cd05062 90 LMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 166 (277)
T ss_pred cCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCCCCc
Confidence 99999999998653211 23467888999999999999999999 9999999999999999999999999998
Q ss_pred ccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccc
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRY 498 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 498 (573)
................++..|+|||.+.+..++.++||||||+++|||++ |..||....... .... ......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~----~~~~~~ 239 (277)
T cd05062 167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRF----VMEGGL 239 (277)
T ss_pred cccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHcCCc
Confidence 76543322221112235778999999988889999999999999999999 788987654321 1110 000000
Q ss_pred ccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
. ..+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 240 ~-------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 240 L-------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred C-------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 0 0112234579999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=318.55 Aligned_cols=260 Identities=23% Similarity=0.310 Sum_probs=198.7
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCc-----eEEEEEe
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-----RYIVYEF 346 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-----~~lv~e~ 346 (573)
..+++|.|+||.||.|+.. +++.||||..-.+.. .-.+|+.+|++++|||||++.-++..... ..+||||
T Consensus 28 ~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 28 AVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred eeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 3568899999999999954 579999999865532 22369999999999999999988875432 2589999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-CCeeEecccCCccCCcc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~ 425 (573)
++. +|.++++.....+..++...++-+..||.+||+|||+. +|+||||||+|+|+|.+ +.+||+|||.|+.+...
T Consensus 104 mP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 104 MPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred chH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 965 89999986555667889999999999999999999998 99999999999999976 78999999999988766
Q ss_pred ccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhh--h-------c
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV--Q-------S 495 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~-------~ 495 (573)
....... .|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.+... ++....+-+. . .
T Consensus 180 epniSYi---cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 180 EPNISYI---CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred CCceeEE---EeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHHHHHhCCCCHHHHhhcC
Confidence 5543332 6889999999987 579999999999999999999999999865532 2222111110 0 0
Q ss_pred cccccccccccccCC-CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 496 HRYLELLDPLISSLS-SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....+...+.+.... ........+++..+|+.++|+.+|.+|.++.|++.
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 011111112111111 01123345678999999999999999999999985
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=317.32 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=202.0
Q ss_pred CCeeecccCceEEEEEEeCC----CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 273 GNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
..+.||+|+||.||+|.+.. ...||||.++... ......+.+|+.++++++||||+++++.+.+.+..+++|||+
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 87 (266)
T cd05033 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYM 87 (266)
T ss_pred eeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcC
Confidence 34577999999999998642 4589999987643 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++++|.+++... ...+++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||++........
T Consensus 88 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 88 ENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred CCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 999999998642 23689999999999999999999999 999999999999999999999999999987752221
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..... ....
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~~~--------- 225 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAV----EDGY--------- 225 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHH----HcCC---------
Confidence 111112225678999999988899999999999999999998 999986544321 11100 0000
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
....+...++.+.+++.+||+.+|++||++.+|++.|+++
T Consensus 226 ----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ----RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011123456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=344.71 Aligned_cols=258 Identities=21% Similarity=0.304 Sum_probs=210.0
Q ss_pred cCCeeecccCceEEEEEEeCCC-CEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEeEEeeEE-ee---C---CceEE
Q 008216 272 EGNRLLGDSKTGGTYSGILPDG-SRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCC-YD---H---GDRYI 342 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~-~~---~---~~~~l 342 (573)
...++|.+|||+.||.|....+ .+||+|++-..+....+.+.+|+.+|++|+ |+|||.+++.. .. . -+.+|
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence 3456899999999999997665 999999998777888899999999999995 99999999932 21 1 25689
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
+||||.||.|-+++..+.. ..|++.++++|+.|+++|+++||.. +++|||||||-|||||+.++..||||||.+.-.
T Consensus 120 LmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred ehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 9999999999999986443 3499999999999999999999987 678999999999999999999999999998743
Q ss_pred Cccccc-------cceeccCCccccccccccc---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhh
Q 008216 423 PWEVMQ-------ERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL 492 (573)
Q Consensus 423 ~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ 492 (573)
-..... +......-|+.|+|||++. +.+.++|+|||+|||+||-|+....||+.....
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------------ 264 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------------ 264 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce------------
Confidence 222111 1111223689999999874 678899999999999999999999999875322
Q ss_pred hhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCc
Q 008216 493 VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPV 555 (573)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 555 (573)
.+++... ..++...++..+.+||..||+.||.+||++-+|++.+-+++..+.
T Consensus 265 -------aIlng~Y----~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 265 -------AILNGNY----SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred -------eEEeccc----cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 1122111 122224688899999999999999999999999999999887543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.42 Aligned_cols=241 Identities=25% Similarity=0.336 Sum_probs=196.4
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
+..+.||+|+||.||++... +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 100 (329)
T PTZ00263 21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100 (329)
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCC
Confidence 33457899999999999964 58999999997542 223466889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 101 VGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred CCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 99999999864 34588899999999999999999999 99999999999999999999999999998654322
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
....||+.|+|||++.+..++.++|||||||++|||++|..||...+... ... ... ... .
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~---~i~-~~~--------~- 232 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IYE---KIL-AGR--------L- 232 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---HHH---HHh-cCC--------c-
Confidence 12348999999999999889999999999999999999999997654321 100 000 000 0
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 545 (573)
. .+...+..+.+|+.+||+.||.+||+ ++++++
T Consensus 233 ----~-~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 ----K-FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ----C-CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 01123457899999999999999997 577764
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=332.20 Aligned_cols=260 Identities=26% Similarity=0.372 Sum_probs=201.7
Q ss_pred cCCeeecccCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeC-CceEE
Q 008216 272 EGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH-GDRYI 342 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-~~~~l 342 (573)
+..++||+|+||.||+|.. .+++.||+|+++... ....+.+.+|+.++.++ +||||+++++++... ...++
T Consensus 10 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~ 89 (337)
T cd05054 10 KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMV 89 (337)
T ss_pred hhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEE
Confidence 3456789999999999963 235789999997543 23345678899999999 899999999988654 56789
Q ss_pred EEEecCCCCHHHHhccCCCC---------------------------------------------------------CCC
Q 008216 343 VYEFVVNGPLDRWLHHIPRG---------------------------------------------------------GRS 365 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~---------------------------------------------------------~~~ 365 (573)
+|||+++++|.+++...... ...
T Consensus 90 v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (337)
T cd05054 90 IVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEP 169 (337)
T ss_pred EEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcC
Confidence 99999999999998542110 136
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceeccCCccccccccc
Q 008216 366 LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 445 (573)
Q Consensus 366 l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 445 (573)
+++..+..++.||+.||+|||++ +|+||||||+|||++.++.++|+|||++................++..|+|||+
T Consensus 170 l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 170 LTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 88999999999999999999999 999999999999999999999999999987643322222222336778999999
Q ss_pred ccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHH
Q 008216 446 VYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVD 524 (573)
Q Consensus 446 ~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 524 (573)
+.+..++.++|||||||++|||++ |..||......+ .+.. ...... ....+...++++.+
T Consensus 247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~----~~~~~~-------------~~~~~~~~~~~~~~ 307 (337)
T cd05054 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCR----RLKEGT-------------RMRAPEYATPEIYS 307 (337)
T ss_pred hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHH----HHhccC-------------CCCCCccCCHHHHH
Confidence 999999999999999999999998 999997643211 0000 000000 00011234467999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 525 LVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 525 li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
++.+||+.+|++||++.||++.|+++.++
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=321.80 Aligned_cols=247 Identities=20% Similarity=0.264 Sum_probs=196.5
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEecccchh---hHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 277 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
||+|+||+||++... +|+.||+|.+...... ..+.+..|+.++++++||||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999854 6889999999754322 235677899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++.........+++..+..++.||+.||+|||++ +|+||||||+||+++.++.++|+|||++......... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 988865444456799999999999999999999999 9999999999999999999999999999765433221 11
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .... ..... ..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~---------~~~~~------~~ 218 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQ---------RILND------SV 218 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHHH---------hhccc------CC
Confidence 2348999999999999999999999999999999999999997643211000 0000 00000 00
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH 545 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 545 (573)
..+...+..+.+++.+||+.||++|| +++++++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 11123556799999999999999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=332.60 Aligned_cols=248 Identities=21% Similarity=0.240 Sum_probs=200.0
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|+||.||+|+.. +|+.||||+++... ......+.+|+.++..++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g 85 (333)
T cd05600 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPG 85 (333)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCC
Confidence 456899999999999965 58999999997642 23346688999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 86 ~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----- 153 (333)
T cd05600 86 GDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----- 153 (333)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence 999999964 34688999999999999999999999 999999999999999999999999999986543
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
......||+.|+|||++.+..++.++|||||||++|||++|..||...+..... ..... ....+....
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~i~~------~~~~~~~~~--- 221 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW---ENLKY------WKETLQRPV--- 221 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH---HHHHh------ccccccCCC---
Confidence 112234899999999999889999999999999999999999999865432111 10000 000000000
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
...+....+.++.+++.+||..+|.+||+++++++.
T Consensus 222 -~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 -YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 011112356789999999999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=314.85 Aligned_cols=256 Identities=24% Similarity=0.377 Sum_probs=207.1
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|++|.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+||+++++.+.+.+..++||||+++
T Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (267)
T cd08224 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADA 86 (267)
T ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCC
Confidence 457899999999999975 7999999988642 223356789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
++|.+++.........+++.++..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++..........
T Consensus 87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 163 (267)
T cd08224 87 GDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163 (267)
T ss_pred CCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCCccc
Confidence 999999875444456689999999999999999999999 99999999999999999999999999987654332111
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..... .... ...
T Consensus 164 --~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~---~~~~-------------~~~ 224 (267)
T cd08224 164 --HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLC---KKIE-------------KCD 224 (267)
T ss_pred --ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHH---hhhh-------------cCC
Confidence 1223788999999998888999999999999999999999998654321 01110 0000 000
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
....+....+..+.++|.+||+.+|++|||+.+|++.|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111222345668999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=314.82 Aligned_cols=246 Identities=26% Similarity=0.437 Sum_probs=198.6
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHHH
Q 008216 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 354 (573)
+.||+|++|.||+|...++..+|||.++... ...+++.+|+.++++++||||+++++++.+.+..+++|||+.+++|.+
T Consensus 10 ~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 88 (256)
T cd05113 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLN 88 (256)
T ss_pred eEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHH
Confidence 4679999999999998777789999987543 334678999999999999999999999998888999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceecc
Q 008216 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (573)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 434 (573)
++... ...+++..++.++.||+.||+|||+. +++|+||||+||+++.++.+||+|||.++......... ....
T Consensus 89 ~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~-~~~~ 161 (256)
T cd05113 89 YLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS-SVGS 161 (256)
T ss_pred HHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceee-cCCC
Confidence 98642 23689999999999999999999999 99999999999999999999999999987654332211 1112
Q ss_pred CCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCC
Q 008216 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 513 (573)
Q Consensus 435 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (573)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .... ..... ...
T Consensus 162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~---~~~~~--------------~~~ 221 (256)
T cd05113 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEK---VSQGL--------------RLY 221 (256)
T ss_pred ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHH---HhcCC--------------CCC
Confidence 25678999999988889999999999999999999 999987654321 1110 00000 000
Q ss_pred cchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008216 514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548 (573)
Q Consensus 514 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 548 (573)
.+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01123467999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=316.90 Aligned_cols=254 Identities=26% Similarity=0.416 Sum_probs=198.0
Q ss_pred CeeecccCceEEEEEEeCCC-C--EEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC------CceEE
Q 008216 274 NRLLGDSKTGGTYSGILPDG-S--RVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------GDRYI 342 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g-~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~l 342 (573)
.+.||+|+||.||+|...++ . .||+|.++.. .....+.+.+|+.+++.++||||+++++++... ...++
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 83 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV 83 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence 35689999999999997543 2 6999998754 334457788999999999999999999987532 24689
Q ss_pred EEEecCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 343 VYEFVVNGPLDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
+|||+++|+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCccc
Confidence 999999999999874321 2234589999999999999999999999 99999999999999999999999999998
Q ss_pred cCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .... ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~----~~~~~~- 232 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYDY----LRQGNR- 232 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHcCCC-
Confidence 7643322211222236778999999998899999999999999999999 889987644321 1110 000000
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
.......+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 233 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 ------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001123456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=319.70 Aligned_cols=247 Identities=21% Similarity=0.292 Sum_probs=194.6
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 277 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
||+|+||.||++... +|+.||+|.+..... .....+..|++++++++||||+++++.+.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999854 589999999965321 2234566799999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++.. .....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~ 152 (277)
T cd05607 81 KYHIYN--VGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---IT 152 (277)
T ss_pred HHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---ee
Confidence 988864 2334588999999999999999999999 999999999999999999999999999876643221 12
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
...|+..|+|||++.+..++.++|||||||++|||++|+.||......... ....... ..... .
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~---------~~~~~-----~ 216 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRT---------LEDEV-----K 216 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHh---------hcccc-----c
Confidence 234899999999999888999999999999999999999999754321100 0000000 00000 0
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 547 (573)
......+.++.+++.+||+.||++||++.|+++.+
T Consensus 217 ~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 217 FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 01123456789999999999999999998776433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=344.83 Aligned_cols=252 Identities=23% Similarity=0.291 Sum_probs=201.2
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC--------ce
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--------DR 340 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--------~~ 340 (573)
...+.||+|+||.||++.. .+|+.||||++... .......+.+|+..+..++|+||+++.+.+.... ..
T Consensus 35 ~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i 114 (496)
T PTZ00283 35 WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMI 114 (496)
T ss_pred EEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEE
Confidence 4456789999999999984 46999999998754 2344567889999999999999999988765432 25
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
++||||+++|+|.+++.........+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 115 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGls~ 191 (496)
T PTZ00283 115 ALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSK 191 (496)
T ss_pred EEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence 799999999999999976555556799999999999999999999999 99999999999999999999999999998
Q ss_pred cCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccc
Q 008216 421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500 (573)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (573)
...............||+.|+|||++.+..++.++||||||+++|||++|+.||...+... ... ... ...
T Consensus 192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~---~~~---~~~-~~~--- 261 (496)
T PTZ00283 192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---VMH---KTL-AGR--- 261 (496)
T ss_pred eccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHH---HHh-cCC---
Confidence 7643322222233459999999999999999999999999999999999999997644211 110 000 000
Q ss_pred ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
. ...+...++++.+++.+||+.||.+||++.++++.
T Consensus 262 -~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 -Y---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -C---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0 01112345679999999999999999999999863
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=329.52 Aligned_cols=241 Identities=22% Similarity=0.298 Sum_probs=194.0
Q ss_pred eeecccCceEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 275 RLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
+.||+|+||.||++.. .+++.||||+++... ......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 3689999999999985 357899999997542 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++++|.+++.. ...+.+..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999854 34578889999999999999999999 99999999999999999999999999987543222
Q ss_pred cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+... .. .... ....
T Consensus 155 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---~~---~~~~---------~~~~ 217 (323)
T cd05584 155 TV--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---TI---DKIL---------KGKL 217 (323)
T ss_pred Cc--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH---HH---HHHH---------cCCC
Confidence 11 122348999999999998889999999999999999999999997654321 00 0000 0000
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH 545 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 545 (573)
. .+...++.+.+++.+||+.||++|| +++++++
T Consensus 218 -----~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 -----N-LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -----C-CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 0 0112346789999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=332.75 Aligned_cols=240 Identities=23% Similarity=0.251 Sum_probs=194.6
Q ss_pred eecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
+||+|+||.||++.. .+|+.||+|+++... ......+.+|+.+++.++||||+++++++.+.+..++||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 589999999999985 468999999997642 2334567889999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
|.+++.. ...+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++........
T Consensus 82 L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-- 152 (325)
T cd05594 82 LFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-- 152 (325)
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--
Confidence 9988853 3468999999999999999999997 7 9999999999999999999999999998754322111
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
.....||+.|+|||++.+..++.++||||||+++|||+||+.||...+........ ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i-------~~~~------------- 212 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------LMEE------------- 212 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH-------hcCC-------------
Confidence 11234899999999999889999999999999999999999999765432111100 0000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH 545 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 545 (573)
...+...++++.+++.+||+.||++|+ ++.++++
T Consensus 213 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 213 -IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 001122456789999999999999996 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=320.62 Aligned_cols=257 Identities=25% Similarity=0.412 Sum_probs=204.0
Q ss_pred CeeecccCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 274 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
.+.||+|+||.||+|... ....+|+|.+.... ......+.+|+.+++.++||||+++++.+...+..++++||
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEY 84 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEe
Confidence 356799999999999852 23579999887553 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC
Q 008216 347 VVNGPLDRWLHHIPR--------------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~ 406 (573)
+.+++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||+++
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill~ 161 (290)
T cd05045 85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVA 161 (290)
T ss_pred cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEEc
Confidence 999999999864221 123588999999999999999999999 999999999999999
Q ss_pred CCCCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhh
Q 008216 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSI 485 (573)
Q Consensus 407 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 485 (573)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||+| |..||....... +
T Consensus 162 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~ 238 (290)
T cd05045 162 EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER---L 238 (290)
T ss_pred CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH---H
Confidence 999999999999986543322222222336678999999988889999999999999999998 999997654321 1
Q ss_pred HHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 486 FEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
.+... .. . ....+...+.++.+++.+||+.+|++||++.++++.|+++..+
T Consensus 239 ~~~~~----~~---------~----~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 239 FNLLK----TG---------Y----RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHHh----CC---------C----CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 11110 00 0 0011123456799999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=319.40 Aligned_cols=270 Identities=28% Similarity=0.395 Sum_probs=203.1
Q ss_pred CCCcCCeeecccCceEEEEEEe-----CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--Cce
Q 008216 269 NFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDR 340 (573)
Q Consensus 269 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 340 (573)
.+....+.||+|+||.||++.. .+++.||+|.++... ......+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 3445556789999999988653 357899999997653 23456788999999999999999999987654 357
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
+++|||+++++|.+++.. ..+++.++..++.|++.||+|||++ +++||||||+||++++++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccc
Confidence 899999999999999864 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cCCccccccc-eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 421 FVPWEVMQER-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 421 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
.......... .....++..|+|||.+.+..++.++||||||+++|||+||..|+...... ..................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhh
Confidence 7653322111 11122566799999998888999999999999999999999998654321 111111100000000111
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
+..+... ....+...+..+.+++.+||+.||++|||+++|++.|+++.
T Consensus 235 ~~~~~~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGM----RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCC----CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111111 11112235578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=318.60 Aligned_cols=253 Identities=27% Similarity=0.409 Sum_probs=200.3
Q ss_pred CeeecccCceEEEEEEe-----CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 274 NRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
.+.||+|+||.||+|.. .++..||+|.++... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 89 (283)
T cd05090 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL 89 (283)
T ss_pred eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcC
Confidence 35689999999999984 246789999997543 334467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEe
Q 008216 348 VNGPLDRWLHHIPR-------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414 (573)
Q Consensus 348 ~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 414 (573)
++++|.+++..... ....+++.+++.++.|++.||+|||++ +++||||||+||++++++.+||+
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~kl~ 166 (283)
T cd05090 90 NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKIS 166 (283)
T ss_pred CCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEEec
Confidence 99999999853211 123578899999999999999999999 99999999999999999999999
Q ss_pred cccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhh
Q 008216 415 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493 (573)
Q Consensus 415 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 493 (573)
|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||........ .+..
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~---~~~~---- 239 (283)
T cd05090 167 DLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV---IEMV---- 239 (283)
T ss_pred cccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH----
Confidence 9999986543322222222235678999999988889999999999999999999 9999876543211 1110
Q ss_pred hccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 494 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
..... ...+...+..+.+++.+||+.||++||++.+|++.|..
T Consensus 240 ~~~~~-------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 RKRQL-------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HcCCc-------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 00000 00112345679999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=319.01 Aligned_cols=254 Identities=21% Similarity=0.305 Sum_probs=199.7
Q ss_pred CeeecccCceEEEEEEeC-CCC----EEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 274 NRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
.+.||+|+||.||+|.+. +|+ .+++|.+..... ....++..|+..+++++||||+++++++. ....++++||+
T Consensus 12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~ 90 (279)
T cd05111 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLS 90 (279)
T ss_pred ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeC
Confidence 346899999999999863 344 478888764422 23467788888999999999999999875 45578899999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++|+|.+++.. ....+++..+..++.||+.||+|||++ +++||||||+||++++++.+||+|||+++.......
T Consensus 91 ~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 91 PLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred CCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 99999999964 234689999999999999999999999 999999999999999999999999999986543322
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
........++..|+|||.+.+..++.++||||||+++||+++ |..||.+.......... .....
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-------~~~~~-------- 229 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-------EKGER-------- 229 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HCCCc--------
Confidence 222222336778999999988899999999999999999998 99999765432211111 11100
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
...+..++..+.+++.+||..||++|||+.|+++.|..+..+|
T Consensus 230 -----~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 230 -----LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 0001113356888999999999999999999999999988776
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=312.46 Aligned_cols=246 Identities=28% Similarity=0.394 Sum_probs=198.8
Q ss_pred eecccCceEEEEEEeCCCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHHH
Q 008216 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 354 (573)
+||+|+||.||+|...+++.+|+|.++.... .....+.+|+.++++++||||+++++++...+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 5799999999999988899999999876532 334578899999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceecc
Q 008216 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (573)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 434 (573)
++... ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.......... ....
T Consensus 82 ~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~ 154 (250)
T cd05085 82 FLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLK 154 (250)
T ss_pred HHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccccc-CCCC
Confidence 98642 24578999999999999999999999 99999999999999999999999999987543322111 1112
Q ss_pred CCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCC
Q 008216 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 513 (573)
Q Consensus 435 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (573)
.++..|+|||++.+..++.++||||||+++|++++ |..||........ .. . ..... . . .
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~~---~-~~~~~-----~-------~-~ 214 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---RE---Q-VEKGY-----R-------M-S 214 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---HH---H-HHcCC-----C-------C-C
Confidence 25678999999988889999999999999999999 9999976543211 00 0 00000 0 0 0
Q ss_pred cchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008216 514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548 (573)
Q Consensus 514 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 548 (573)
.+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 11124567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=320.59 Aligned_cols=262 Identities=21% Similarity=0.283 Sum_probs=190.7
Q ss_pred CeeecccCceEEEEEEeC--CCCEEEEEEecccch--hhHHHHHHHHHHHhhc---CCCcEeEEeeEEee-----CCceE
Q 008216 274 NRLLGDSKTGGTYSGILP--DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARL---HHPNLVAVKGCCYD-----HGDRY 341 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~-----~~~~~ 341 (573)
.+.||+|+||.||+|+.. +|+.||||+++.... .....+.+|+.+++.+ +||||+++++++.. ....+
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~ 85 (290)
T cd07862 6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 85 (290)
T ss_pred eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence 456899999999999862 468899999875422 2234566777777665 69999999998852 35679
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCcc
Q 008216 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 421 (573)
+||||++ ++|.+++... ....+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++.
T Consensus 86 lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 86 LVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred EEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 9999995 6899998652 234589999999999999999999999 999999999999999999999999999976
Q ss_pred CCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccc-hhhHHhhhhhhhcccccc
Q 008216 422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLVQSHRYLE 500 (573)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 500 (573)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|++||........ ..+...... .....+..
T Consensus 160 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~-~~~~~~~~ 235 (290)
T cd07862 160 YSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL-PGEEDWPR 235 (290)
T ss_pred ccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC-CChhhchh
Confidence 54331 11223389999999999888899999999999999999999999987654321 111111000 00000000
Q ss_pred ---ccccccccCCCCCc---chHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 501 ---LLDPLISSLSSDIP---EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 501 ---~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.............. ....++.+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000000000000 0124567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=313.78 Aligned_cols=241 Identities=22% Similarity=0.336 Sum_probs=202.6
Q ss_pred eeecccCceEEEEEEe-CCCCEEEEEEecccchhh---HHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+.||+|.||.|-+|.. ..|+.||||.++++...+ .-.+.+|+++|..|+||||+.++.+|++.+...|||||..+|
T Consensus 59 etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~G 138 (668)
T KOG0611|consen 59 ETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGG 138 (668)
T ss_pred HHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCc
Confidence 3579999999999984 679999999998874444 455789999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
.|.+|+.. .+.+++.+.+.+++||.+|+.|+|.+ +++|||||.+|||+|.++++||+|||++..+.....
T Consensus 139 eLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf--- 208 (668)
T KOG0611|consen 139 ELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF--- 208 (668)
T ss_pred cHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccccH---
Confidence 99999965 45699999999999999999999999 999999999999999999999999999987754433
Q ss_pred eeccCCcccccccccccCCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 431 TVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
...++|++-|.+||++.+.+| ++..|-|||||+||-|+.|..||++.+-. .++. ....+.+.+
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lvr----QIs~GaYrE--------- 272 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLVR----QISRGAYRE--------- 272 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHHH----HhhcccccC---------
Confidence 234569999999999999888 47899999999999999999999987632 1111 111111111
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 547 (573)
...+....-||+.||..+|++|.|+++|....
T Consensus 273 ------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 ------PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11233477899999999999999999998754
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=328.54 Aligned_cols=254 Identities=28% Similarity=0.417 Sum_probs=213.9
Q ss_pred cCCeeecccCceEEEEEEeCC---CC--EEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGILPD---GS--RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~---g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
..+++||.|.||.||.|.+.+ |+ .||||+.+.+ ...+.+.|+.|+.+|++++||||++++|+|.+ ...+||||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence 345679999999999999643 33 5999999874 55667889999999999999999999999876 46899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
.++-|.|..||+. ....++......++.||..||+|||+. .+|||||..+|||+....-+||+|||+++.+..+
T Consensus 471 L~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 471 LAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred cccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 9999999999974 345699999999999999999999999 9999999999999999999999999999998877
Q ss_pred ccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
........ .-...|||||.+....++.++|||-|||.+||++. |..||.+....+.- .
T Consensus 545 ~yYkaS~~-kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI--------------------~ 603 (974)
T KOG4257|consen 545 AYYKASRG-KLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI--------------------G 603 (974)
T ss_pred chhhcccc-ccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE--------------------E
Confidence 66555432 25778999999999999999999999999999998 99999886543110 0
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
.+......+.+..+++.+..|+.+||..||.+||.+.||...|+++.+.
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 0111112333456888899999999999999999999999999888763
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=316.30 Aligned_cols=256 Identities=23% Similarity=0.355 Sum_probs=206.3
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|++|.||++.. .+|+.+|||.+... ......++.+|+.+++.++||||+++++++.+++..+++|||+++
T Consensus 7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08229 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 86 (267)
T ss_pred hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCC
Confidence 34689999999999995 57899999988653 223446788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
++|.+++.........+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++..........
T Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd08229 87 GDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163 (267)
T ss_pred CCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCccc
Confidence 999999875444456789999999999999999999999 99999999999999999999999999987654332111
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ... ... .... .
T Consensus 164 --~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~---~~~------~~~~-------~ 224 (267)
T cd08229 164 --HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSL---CKK------IEQC-------D 224 (267)
T ss_pred --ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHH---hhh------hhcC-------C
Confidence 12238889999999988889999999999999999999999986543210 010 000 0000 0
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
....+....++.+.+++.+||+.||++|||+.+|++.++++.
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 011222346678999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=328.98 Aligned_cols=248 Identities=21% Similarity=0.294 Sum_probs=208.0
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCc-eEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-RYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~lv~e~~ 347 (573)
+..+++|+|+||.++..+.+ +++.+|+|.+.-.. ...++...+|+.++++++|||||.+.+.+.+++. .+|||+|+
T Consensus 7 e~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~ 86 (426)
T KOG0589|consen 7 EVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYC 86 (426)
T ss_pred hhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeec
Confidence 33457899999999998853 57899999987543 3344578899999999999999999999999988 89999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
+||+|.+.+... .+..++++.+..++.|++.|+.|||++ .|+|||||+.|||++.+..+||+|||+|+.+.....
T Consensus 87 eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 87 EGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred CCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 999999999863 357799999999999999999999999 999999999999999999999999999999876652
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
... ...||+.||.||.+.+.+|+.|+|||||||++|||++-+++|...+-.. ++... ..
T Consensus 162 ~a~--tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~ki----------------~~ 220 (426)
T KOG0589|consen 162 LAS--TVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILKI----------------NR 220 (426)
T ss_pred hhh--eecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHHH----------------hh
Confidence 222 2339999999999999999999999999999999999999998765421 11111 10
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
.. ....+..++.++..+|..|+..+|..||++.+++.+
T Consensus 221 ~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 GL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 00 122234577889999999999999999999999875
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=330.80 Aligned_cols=240 Identities=22% Similarity=0.311 Sum_probs=195.3
Q ss_pred CeeecccCceEEEEEEeCC--CCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 274 NRLLGDSKTGGTYSGILPD--GSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
.+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~ 114 (340)
T PTZ00426 35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI 114 (340)
T ss_pred EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCC
Confidence 4578999999999998543 3689999986542 2334568899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 115 ~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~-- 185 (340)
T PTZ00426 115 GGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT-- 185 (340)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc--
Confidence 9999999864 34689999999999999999999999 99999999999999999999999999998654221
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
....||+.|+|||++.+..++.++|||||||++|||++|..||...+...... ... ....
T Consensus 186 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~------~i~---------~~~~-- 245 (340)
T PTZ00426 186 ---YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ------KIL---------EGII-- 245 (340)
T ss_pred ---ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH------HHh---------cCCC--
Confidence 12348999999999998889999999999999999999999998654321100 000 0000
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVHQ 546 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 546 (573)
..+...+..+.+++.+||+.||++|+ +++++++.
T Consensus 246 ----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 ----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01122345689999999999999995 88888763
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=328.12 Aligned_cols=235 Identities=28% Similarity=0.355 Sum_probs=190.2
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+||+|+||.||+++.+ +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 5899999999999964 58899999997542 22345677888888876 7999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~ 152 (320)
T cd05590 82 DLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--T 152 (320)
T ss_pred hHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--c
Confidence 99998864 34689999999999999999999999 999999999999999999999999999875432211 1
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+.... ... .. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~~---i~-~~~------------- 212 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---FEA---IL-NDE------------- 212 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HHH---Hh-cCC-------------
Confidence 1223489999999999988999999999999999999999999986543211 110 00 000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRM 540 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 540 (573)
...+...+.++.+++.+||+.||++||++
T Consensus 213 -~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 213 -VVYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 00111245678999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=315.19 Aligned_cols=254 Identities=25% Similarity=0.451 Sum_probs=200.4
Q ss_pred CeeecccCceEEEEEEeCC----CCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCc------eE
Q 008216 274 NRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD------RY 341 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------~~ 341 (573)
.+.||+|+||.||+|.... +..||||+++... ......+.+|+..++.++||||+++++++...+. .+
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM 83 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence 4568999999999998632 3689999997542 3345678999999999999999999998876554 69
Q ss_pred EEEEecCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCC
Q 008216 342 IVYEFVVNGPLDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (573)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 419 (573)
++|||+++++|..++.... .....+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++
T Consensus 84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccce
Confidence 9999999999999985432 1234689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccc
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRY 498 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 498 (573)
+...............++..|+|||.+.+..++.++||||||+++|||++ |..||....... ..+.. .. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~---~~-~~- 232 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYL---RH-GN- 232 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---Hc-CC-
Confidence 86644332222222225678999999988889999999999999999999 889987644321 11111 00 00
Q ss_pred ccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
....+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 233 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 ------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0001123456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=312.23 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=196.2
Q ss_pred ecccCceEEEEEEeC---CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 277 LGDSKTGGTYSGILP---DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 277 lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 699999999999753 35679999997653 233467899999999999999999999875 4578999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc-e
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER-T 431 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-~ 431 (573)
.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++........... .
T Consensus 82 ~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 82 NKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999863 234689999999999999999999999 999999999999999999999999999986543322111 1
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
....++..|+|||.+.+..++.++||||||+++||+++ |..||........... .....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-------~~~~~------------- 215 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF-------IEQGK------------- 215 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH-------HHCCC-------------
Confidence 11124578999999988889999999999999999996 9999976543211111 01000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
....+...++++.+++.+||+.||++||++.+|.+.|+..
T Consensus 216 ~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 216 RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 0011123456899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=314.06 Aligned_cols=246 Identities=24% Similarity=0.402 Sum_probs=197.9
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHH
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 353 (573)
.+.||+|++|.||++..+++..+|+|.+.... .....+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 9 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 87 (256)
T cd05059 9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLL 87 (256)
T ss_pred hhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHH
Confidence 34679999999999998777899999987543 23457888999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceec
Q 008216 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (573)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 433 (573)
+++... ...+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++.......... ..
T Consensus 88 ~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~-~~ 160 (256)
T cd05059 88 NYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS-QG 160 (256)
T ss_pred HHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc-CC
Confidence 998642 23689999999999999999999999 999999999999999999999999999876543221111 11
Q ss_pred cCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||...+.... .. ..... .. .
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~---~~~~~------~~-------~- 220 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VE---SVSAG------YR-------L- 220 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---HH---HHHcC------Cc-------C-
Confidence 114457999999998899999999999999999999 8999876543211 11 00000 00 0
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 547 (573)
..+...+.++.+++.+||+.+|++|||+.++++.|
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 01122456799999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=330.13 Aligned_cols=242 Identities=24% Similarity=0.379 Sum_probs=190.3
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
+.||+|+||.||++... +|+.||||++.... ......+.+|++++++++|+||+++++++.+.+..++||||+++++|
T Consensus 80 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 159 (353)
T PLN00034 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL 159 (353)
T ss_pred hhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcc
Confidence 46799999999999964 68999999996542 23356789999999999999999999999999999999999999998
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+. ...++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 160 ~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~~ 226 (353)
T PLN00034 160 EGT--------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CN 226 (353)
T ss_pred ccc--------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccccc--cc
Confidence 643 2356778889999999999999999 9999999999999999999999999999865432211 11
Q ss_pred ccCCcccccccccccC-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 433 MAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
...||..|+|||++.. ...+.++|||||||++|||++|+.||.......+........ .. .
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~---~~----~------- 292 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC---MS----Q------- 292 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---cc----C-------
Confidence 2348999999998743 234568999999999999999999997443322211111100 00 0
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
........+.++.+||.+||+.||++|||+.|+++.
T Consensus 293 ---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 ---PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122345679999999999999999999999974
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=328.10 Aligned_cols=240 Identities=25% Similarity=0.323 Sum_probs=193.3
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+||+|+||.||+|+.. +++.||||+++... ....+.+..|.+++..+ +||||+++++++.+.+..++||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 5799999999999964 57899999997642 23345677888888876 8999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|..++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-- 152 (321)
T cd05591 82 DLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT-- 152 (321)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcc--
Confidence 99988854 34588999999999999999999999 9999999999999999999999999998754322211
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+.... ... ... . +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~---~~~---i~~-~---~---------- 212 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL---FES---ILH-D---D---------- 212 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH---HHH---HHc-C---C----------
Confidence 1223489999999999988999999999999999999999999986553211 110 000 0 0
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCC-------CHHHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRP-------RMSHVVH 545 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~ 545 (573)
...+...+.++.+++.+||+.||++|| +++++++
T Consensus 213 -~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 213 -VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred -CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 001112346789999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=312.90 Aligned_cols=247 Identities=26% Similarity=0.380 Sum_probs=196.7
Q ss_pred eecccCceEEEEEEe---CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 276 LLGDSKTGGTYSGIL---PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.||+|+||.||+|.+ .++..+|+|+++... ....+++.+|+.+++.++||||+++++++. ....++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 369999999999974 357899999987543 234567899999999999999999999875 45678999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999853 24589999999999999999999999 999999999999999999999999999987654322111
Q ss_pred -eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 431 -TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 431 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
.....++..|+|||.+....++.++||||||+++|||++ |..||........... ......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-------i~~~~~---------- 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM-------IESGER---------- 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHCCCC----------
Confidence 111224578999999988888999999999999999998 9999976543211111 111000
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
.. .+...++++.++|.+||+.||++||++++|.+.|++.
T Consensus 217 --~~-~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 --ME-CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred --CC-CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 01 1123456799999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=321.24 Aligned_cols=256 Identities=27% Similarity=0.420 Sum_probs=203.3
Q ss_pred CCeeecccCceEEEEEEeC------CCCEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEE
Q 008216 273 GNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY 344 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 344 (573)
..+.||+|++|.||++... ....+|+|.++.. ......++.+|+.++.++ +||||+++++++..++..+++|
T Consensus 16 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~ 95 (293)
T cd05053 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV 95 (293)
T ss_pred EeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEE
Confidence 3457899999999999853 2368999998764 233446788999999999 8999999999999999999999
Q ss_pred EecCCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCee
Q 008216 345 EFVVNGPLDRWLHHIP------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 412 (573)
||+++|+|.+++.... .....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+|
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~k 172 (293)
T cd05053 96 EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMK 172 (293)
T ss_pred EeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCeEE
Confidence 9999999999986421 2345689999999999999999999999 999999999999999999999
Q ss_pred EecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhh
Q 008216 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATP 491 (573)
Q Consensus 413 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 491 (573)
|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||........ ...
T Consensus 173 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~--- 246 (293)
T cd05053 173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL---FKL--- 246 (293)
T ss_pred eCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH---HHH---
Confidence 999999987654332222222225678999999988889999999999999999998 9999876543211 110
Q ss_pred hhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 492 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
..... ....+...+..+.+|+.+||+.||++|||+.++++.|+++.
T Consensus 247 -~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 247 -LKEGY-------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHcCC-------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 00000 00011233567999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=317.48 Aligned_cols=256 Identities=22% Similarity=0.377 Sum_probs=202.6
Q ss_pred CCeeecccCceEEEEEEe-CCCC----EEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 273 GNRLLGDSKTGGTYSGIL-PDGS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~-~~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
..+.||+|+||.||+|.+ .+|+ +||+|+++.. .......+.+|+.+++.++||||+++++++.. ...++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~ 89 (279)
T cd05109 11 KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQL 89 (279)
T ss_pred eeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEc
Confidence 345789999999999984 3444 5899999754 33445678899999999999999999999875 457899999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++|+|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++......
T Consensus 90 ~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 90 MPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred CCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 999999999864 234689999999999999999999999 99999999999999999999999999998765332
Q ss_pred cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.........++..|+|||...+..++.++||||||+++|||++ |..||........... .....
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-------~~~~~-------- 228 (279)
T cd05109 164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL-------LEKGE-------- 228 (279)
T ss_pred ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HHCCC--------
Confidence 2211111225678999999988889999999999999999998 9999876443211111 01000
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCc
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPV 555 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 555 (573)
....+...+..+.+++.+||+.||++||++.++++.|++++..+.
T Consensus 229 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05109 229 -----RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273 (279)
T ss_pred -----cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence 001112345678999999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=317.37 Aligned_cols=257 Identities=25% Similarity=0.373 Sum_probs=204.6
Q ss_pred CCeeecccCceEEEEEEeCC-----CCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEee-CCceEEEEE
Q 008216 273 GNRLLGDSKTGGTYSGILPD-----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYE 345 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e 345 (573)
..++||+|+||.||+|...+ +..|++|+++.. .....+.+.+|+.++++++||||+++++++.. +...++++|
T Consensus 10 ~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 89 (280)
T cd05043 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYP 89 (280)
T ss_pred EeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEE
Confidence 35678999999999999755 788999998754 33445678899999999999999999998776 467899999
Q ss_pred ecCCCCHHHHhccCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRG----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 421 (573)
|+++++|.+++...... ...+++.++..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++.
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~~~~ 166 (280)
T cd05043 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRD 166 (280)
T ss_pred cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCCccc
Confidence 99999999998653322 15689999999999999999999999 999999999999999999999999999986
Q ss_pred CCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccc
Q 008216 422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500 (573)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (573)
..............++..|+|||++.+..++.++||||||+++||+++ |+.||...+.... ... ......
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~---~~~~~~--- 237 (280)
T cd05043 167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM---AAY---LKDGYR--- 237 (280)
T ss_pred ccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH---HHH---HHcCCC---
Confidence 543322211112236778999999988889999999999999999999 9999976543211 111 000000
Q ss_pred ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
.. ....+++.+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 238 ----------~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 238 ----------LA-QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ----------CC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00 011234678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=325.70 Aligned_cols=239 Identities=23% Similarity=0.292 Sum_probs=190.2
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.||+|+||.||+|... +++.||||+++... ....+.+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5799999999999964 57899999997642 22334556677777654 8999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 82 DLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 99998864 34689999999999999999999999 99999999999999999999999999997543222 11
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... .... ... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~~---i~~-~-------------- 211 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFDS---ILN-D-------------- 211 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHHH---HHc-C--------------
Confidence 222348999999999998899999999999999999999999998654321 1110 000 0
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMS-HVV 544 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 544 (573)
....+...+.++.+++.+||+.||++||++. +++
T Consensus 212 ~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 212 RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0001122456789999999999999999875 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=327.10 Aligned_cols=247 Identities=22% Similarity=0.277 Sum_probs=193.4
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+||+|+||.||++... +++.||||+++... ....+.+..|..++.++ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 6899999999999864 58899999998642 22345678899999998 7999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++....... .
T Consensus 82 ~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (329)
T cd05588 82 DLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--T 152 (329)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC--c
Confidence 99988853 35699999999999999999999999 999999999999999999999999999875322111 1
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCccc--chhhHHhhhhhhhcccccccccccccc
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC--WQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ............. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--------~~~--- 221 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL--------EKQ--- 221 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH--------cCC---
Confidence 122348999999999999999999999999999999999999996432211 0001111111000 000
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCC------HHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPR------MSHVVH 545 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~ 545 (573)
.. .+...+..+.+++.+||+.||.+||+ ++++++
T Consensus 222 --~~-~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 222 --IR-IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred --CC-CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 00 11224567899999999999999997 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=309.93 Aligned_cols=261 Identities=22% Similarity=0.380 Sum_probs=201.5
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc--CCCcEeEEeeEEeeCC----ceEEEEEec
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL--HHPNLVAVKGCCYDHG----DRYIVYEFV 347 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~l~~~~~~~~----~~~lv~e~~ 347 (573)
.+.||+|.||+||+|.+ .|+.||||++... +++.+.+|.++.+.. +|+||+.+++.-..++ +++||++|.
T Consensus 216 ~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH 291 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH 291 (513)
T ss_pred EEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence 46789999999999999 8999999999654 456788899888774 9999999998765543 569999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-----KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-----~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
+.|||.|||.. ..++....++++..+|+||++||. +.+|.|.|||||..|||+..++.+.|+|+|+|...
T Consensus 292 e~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h 366 (513)
T KOG2052|consen 292 EHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 366 (513)
T ss_pred cCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence 99999999974 569999999999999999999995 45889999999999999999999999999999876
Q ss_pred Cccc--cccceeccCCcccccccccccCCC----C--CcchhhHHHHHHHHHHHcC----------CCCCCCCCcccchh
Q 008216 423 PWEV--MQERTVMAGGTYGYLAPEFVYRNE----L--TTKSDVYSFGVLLLEIVSG----------RRPAQAVDSVCWQS 484 (573)
Q Consensus 423 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwSlGvil~elltG----------~~Pf~~~~~~~~~~ 484 (573)
.... .........||.+|||||++...- + -..+||||||.|+||+.-. ++||.+..+.+ .+
T Consensus 367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D-Ps 445 (513)
T KOG2052|consen 367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD-PS 445 (513)
T ss_pred cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC-CC
Confidence 5442 222333455999999999986531 1 2468999999999999852 46776543321 00
Q ss_pred hHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 485 IFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
++...... -.++.....+...........+.++|+.||..+|..|-|+-.|.+.|.++.+
T Consensus 446 -~eeMrkVV-------Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 446 -FEEMRKVV-------CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred -HHHHhcce-------eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 01111111 1111111222233345677789999999999999999999999999998875
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=312.85 Aligned_cols=250 Identities=28% Similarity=0.440 Sum_probs=201.0
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
+..+.||+|+||.||+|..++++.||+|.+.... .....+.+|+.++++++||||+++++++ ..+..+++|||+++++
T Consensus 9 ~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~~~~ 86 (260)
T cd05067 9 KLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYMENGS 86 (260)
T ss_pred eeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCCCCC
Confidence 3345789999999999998889999999997653 3356789999999999999999999986 4567899999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++.. ..+..+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++...........
T Consensus 87 L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~- 160 (260)
T cd05067 87 LVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR- 160 (260)
T ss_pred HHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc-
Confidence 9999864 2345689999999999999999999999 999999999999999999999999999976653222111
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
....++..|+|||++.+..++.++||||||+++||+++ |+.||...+...... . . ... .
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~---~-~~~-----~-------- 220 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ---N---L-ERG-----Y-------- 220 (260)
T ss_pred cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH---H---H-HcC-----C--------
Confidence 11225678999999988889999999999999999999 999997654321111 0 0 000 0
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
........+.++.+++.+||+.+|++||+++++++.|+.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 000111234579999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=317.52 Aligned_cols=253 Identities=25% Similarity=0.363 Sum_probs=201.6
Q ss_pred CeeecccCceEEEEEEeC------CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 274 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
.+.||+|+||.||++... ++..+|+|.++.......+.+.+|+++++.++||||+++++++.+.+..+++|||+
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM 89 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecC
Confidence 446799999999999732 35689999998776666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecc
Q 008216 348 VNGPLDRWLHHIPR-----------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (573)
Q Consensus 348 ~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 416 (573)
++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+||
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~df 166 (280)
T cd05092 90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDF 166 (280)
T ss_pred CCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEECCC
Confidence 99999999865321 113588999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhc
Q 008216 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS 495 (573)
Q Consensus 417 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 495 (573)
|++................+++.|+|||.+.+..++.++||||||+++|||++ |.+||.......... ....
T Consensus 167 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~------~~~~- 239 (280)
T cd05092 167 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE------CITQ- 239 (280)
T ss_pred CceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH------HHHc-
Confidence 99875543222111112225678999999998899999999999999999998 999986544321100 0000
Q ss_pred cccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
.. ....+..++..+.+++.+||+.||++||++++|++.|++
T Consensus 240 ~~-------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 240 GR-------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred Cc-------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 00 000112345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=322.18 Aligned_cols=262 Identities=18% Similarity=0.256 Sum_probs=193.3
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
..+.||+|+||.||+|... +++.||||+++.... .....+.+|+.+++.++||||+++++++.+....++||||++ +
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~ 87 (303)
T cd07869 9 KLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-T 87 (303)
T ss_pred EeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-c
Confidence 3457799999999999965 689999999975432 223467889999999999999999999999999999999995 6
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++........ .
T Consensus 88 ~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~ 159 (303)
T cd07869 88 DLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--T 159 (303)
T ss_pred CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--c
Confidence 88887753 234588999999999999999999999 999999999999999999999999999875432211 1
Q ss_pred eeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcc---ccc-----cc
Q 008216 431 TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH---RYL-----EL 501 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~-----~~ 501 (573)
.....+|+.|+|||++.+ ..++.++|||||||++|||++|..||....+. .............. .+. ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhccc
Confidence 122337899999998865 45788999999999999999999999865432 11111110000000 000 00
Q ss_pred ccc-ccccCCCCC-----cchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 502 LDP-LISSLSSDI-----PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 502 ~~~-~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
..+ ......... .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000 000000000 00112356889999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=312.63 Aligned_cols=248 Identities=26% Similarity=0.429 Sum_probs=198.9
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHH
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 353 (573)
.+.||+|++|.||++...++..+|+|.++.... ..+.+.+|+.++++++|||++++++++. .+..+++|||+++++|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~ 88 (260)
T cd05070 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLL 88 (260)
T ss_pred hheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHH
Confidence 346799999999999988888999999976533 3567899999999999999999999875 45689999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceec
Q 008216 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (573)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 433 (573)
+++.. .....+++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||++............ .
T Consensus 89 ~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~-~ 162 (260)
T cd05070 89 DFLKD--GEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ-G 162 (260)
T ss_pred HHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccccc-C
Confidence 99864 2234589999999999999999999999 9999999999999999999999999999865433221111 1
Q ss_pred cCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||...+... ..... .... ..
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~---~~~~--------------~~ 222 (260)
T cd05070 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQV---ERGY--------------RM 222 (260)
T ss_pred CCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH---HcCC--------------CC
Confidence 125567999999988889999999999999999999 899997644321 11110 0000 00
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
..+...+..+.+++.+|++.||++|||++++.+.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0112345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=305.61 Aligned_cols=268 Identities=21% Similarity=0.305 Sum_probs=201.0
Q ss_pred eecccCceEEEEEEe-CCCCEEEEEEecccchh--hHHHHHHHHHHHhhcCCCc-EeEEeeEEeeCC------ceEEEEE
Q 008216 276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPN-LVAVKGCCYDHG------DRYIVYE 345 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~------~~~lv~e 345 (573)
.||+|+||+||+|+. .+|+.||+|.++-.... ......+|+.+|++|+|+| |+++++++.+.+ ..++|+|
T Consensus 18 klGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe 97 (323)
T KOG0594|consen 18 KLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFE 97 (323)
T ss_pred HhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEE
Confidence 369999999999994 56899999999765332 3355789999999999999 999999998877 7899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|+ .-+|..++.........++...++.++.||+.||+|||++ +|+||||||+|||++++|.+||+|||+|+.....
T Consensus 98 ~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip 173 (323)
T KOG0594|consen 98 FL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFSIP 173 (323)
T ss_pred ee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhcCC
Confidence 99 5699999987554335677889999999999999999999 9999999999999999999999999999966533
Q ss_pred ccccceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccch-hhHHhhhhhhhccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQSHRYLELLD 503 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 503 (573)
... .....+|.-|+|||++.+. .|++..||||+|||+.||+++++.|.+..+.... .+++... ......+.....
T Consensus 174 ~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lG-tP~e~~Wp~v~~ 250 (323)
T KOG0594|consen 174 MRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLG-TPNEKDWPGVSS 250 (323)
T ss_pred ccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcC-CCCccCCCCccc
Confidence 221 2222378899999999886 7999999999999999999999999887653211 1111111 001111111000
Q ss_pred -cccc-cCCCCCcch-------HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhcc
Q 008216 504 -PLIS-SLSSDIPEA-------GVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQL 550 (573)
Q Consensus 504 -~~~~-~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 550 (573)
+... .......+. .......+++.+||+.+|.+|.|++.+++. +..+
T Consensus 251 ~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 251 LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 0000 000000010 112478899999999999999999999975 5444
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=317.38 Aligned_cols=266 Identities=25% Similarity=0.382 Sum_probs=199.4
Q ss_pred CeeecccCceEEEEEEe-----CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--CceEEEEEe
Q 008216 274 NRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEF 346 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~ 346 (573)
.+.||+|+||.||++.. .++..||+|.++.......+.+.+|+.++++++||||+++++++... ...++||||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 88 (284)
T cd05081 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEY 88 (284)
T ss_pred eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEe
Confidence 45689999999999974 25789999999877666677899999999999999999999987543 467899999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++++|.+++... ...+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 89 LPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred cCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 9999999998642 24589999999999999999999999 99999999999999999999999999998764332
Q ss_pred cccc-eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhc-ccccccccc
Q 008216 427 MQER-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS-HRYLELLDP 504 (573)
Q Consensus 427 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 504 (573)
.... .....++..|+|||.+.+..++.++||||||+++|||++|..|+.......... ....... .....+. .
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~-~ 237 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRM----MGNDKQGQMIVYHLI-E 237 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhh----cccccccccchHHHH-H
Confidence 2111 111113456999999988889999999999999999999887764332110000 0000000 0000000 0
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
.+............+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000001111233556799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=320.98 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=201.4
Q ss_pred cCCeeecccCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEE
Q 008216 272 EGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 343 (573)
...+.||+|+||.||++.. ..+..||||.++... ....+.+.+|+.+++++ +||||+++++++...+..+++
T Consensus 38 ~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 117 (302)
T cd05055 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVI 117 (302)
T ss_pred EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEE
Confidence 3355779999999999974 134589999987653 33456789999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCC
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 423 (573)
|||+++++|.+++... ....+++.++..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++....
T Consensus 118 ~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 118 TEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 9999999999998642 223489999999999999999999999 99999999999999999999999999998654
Q ss_pred ccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccc
Q 008216 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502 (573)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (573)
............++..|+|||.+.+..++.++||||||+++|||++ |..||....... .... .....
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~~----~~~~~------ 260 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFYK----LIKEG------ 260 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHHH----HHHcC------
Confidence 3322111112236778999999988889999999999999999998 999987654321 0100 00000
Q ss_pred ccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
. ....+...++.+.+++.+||+.+|++|||+.++++.|+++
T Consensus 261 ---~----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 ---Y----RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---C----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 0001112346799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=324.09 Aligned_cols=240 Identities=23% Similarity=0.325 Sum_probs=191.2
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.||+|+||.||+|... +++.||||+++... ......+..|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 5799999999999964 57899999997642 12334566778888764 9999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. ...+++.++..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++........ .
T Consensus 82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (316)
T cd05619 82 DLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--K 152 (316)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--c
Confidence 99999864 24588999999999999999999999 999999999999999999999999999875322111 1
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ...... .. .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i~----~~------~~------ 213 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSIR----MD------NP------ 213 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hC------CC------
Confidence 122348999999999998899999999999999999999999997654321 111100 00 00
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMS-HVVH 545 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 545 (573)
..+...+.++.+++.+||+.||++||++. ++++
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 214 --CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 01112445789999999999999999997 5643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=328.48 Aligned_cols=265 Identities=18% Similarity=0.272 Sum_probs=192.9
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC-----ceEEEEE
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-----DRYIVYE 345 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv~e 345 (573)
.+.||+|+||.||+|... +|+.||||+++.. .......+.+|+.++++++||||+++++++...+ ..++|||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e 84 (338)
T cd07859 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 84 (338)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence 457899999999999954 6899999998743 2233456889999999999999999999876432 4799999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|+ +++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 85 LM-ESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred cC-CCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 99 5689888853 34589999999999999999999999 9999999999999999999999999999865322
Q ss_pred ccc-cceeccCCcccccccccccC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhh--------hhhh
Q 008216 426 VMQ-ERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT--------PLVQ 494 (573)
Q Consensus 426 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~--------~~~~ 494 (573)
... .......||+.|+|||++.+ ..++.++|||||||++|||+||++||...+............ ....
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 211 11122348999999999865 678999999999999999999999997654321111000000 0000
Q ss_pred ccccccccccccccCCCC--CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 495 SHRYLELLDPLISSLSSD--IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
.....+.+.......... ......++.+.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000000000 0001234568899999999999999999999963
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=316.29 Aligned_cols=253 Identities=24% Similarity=0.372 Sum_probs=201.2
Q ss_pred CeeecccCceEEEEEEeCC------CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 274 NRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 90 (277)
T cd05032 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMEL 90 (277)
T ss_pred EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEec
Confidence 4578999999999998642 4689999987553 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 347 VVNGPLDRWLHHIPRG------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
+++++|.+++...... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg~~~ 167 (277)
T cd05032 91 MAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR 167 (277)
T ss_pred CCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCcccch
Confidence 9999999998653221 23478889999999999999999999 99999999999999999999999999988
Q ss_pred cCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
...............++..|+|||.+.+..++.++||||||+++||++| |..||...+.... .... .....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~~----~~~~~- 239 (277)
T cd05032 168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LKFV----IDGGH- 239 (277)
T ss_pred hhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HHHH----hcCCC-
Confidence 6543322222222236788999999988889999999999999999998 9999876543211 1110 00000
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
. ..+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 240 -----------~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 240 -----------L-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred -----------C-CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 0 0111235679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=316.54 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=199.4
Q ss_pred eeecccCceEEEEEEeC------CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 275 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
+.||+|+||.||+|... ++..||||+++.... ...+.+.+|+.++.+++||||+++++++.+.+..++++||+
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~ 90 (283)
T cd05091 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYC 90 (283)
T ss_pred HHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcC
Confidence 35799999999999853 257899999976532 23466889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEec
Q 008216 348 VNGPLDRWLHHIP------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415 (573)
Q Consensus 348 ~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 415 (573)
++++|.+++.... .....+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|
T Consensus 91 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl~D 167 (283)
T cd05091 91 SHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISD 167 (283)
T ss_pred CCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCceEecc
Confidence 9999999985321 1123578889999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhh
Q 008216 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQ 494 (573)
Q Consensus 416 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 494 (573)
||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||....... ..+.. .
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~i----~ 240 (283)
T cd05091 168 LGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VIEMI----R 240 (283)
T ss_pred cccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----H
Confidence 999886543322222222236778999999988889999999999999999998 888887654321 11110 0
Q ss_pred ccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
... ....+.+++..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 241 ~~~-------------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 NRQ-------------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred cCC-------------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 000 001122355679999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=312.01 Aligned_cols=250 Identities=30% Similarity=0.459 Sum_probs=204.4
Q ss_pred eecccCceEEEEEEeCC----CCEEEEEEecccchhh-HHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 276 LLGDSKTGGTYSGILPD----GSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.||+|+||.||++.... +..||+|.++...... .+.+.+|++.+..++|+||+++++++.+....+++|||++++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 57999999999999654 7899999998764333 678899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 351 PLDRWLHHIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 351 sL~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
+|.+++...... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||.+......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999764221 36799999999999999999999999 9999999999999999999999999999877644
Q ss_pred ccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
..........++..|+|||.+.+..++.++||||||+++|||++ |..||....... ...... . ..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~---~-~~------- 224 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYLR---K-GY------- 224 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH---c-CC-------
Confidence 32222223337889999999988889999999999999999999 699998764321 111100 0 00
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 548 (573)
....+...+.++.+++.+||+.||++|||+.++++.|+
T Consensus 225 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00111233568999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=325.45 Aligned_cols=241 Identities=23% Similarity=0.292 Sum_probs=190.7
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHH---hhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRF---ARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
.+.||+|+||.||++... +|+.||||+++... ....+.+.+|..++ +.++||||+++++++.+.+..++||||
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~ 83 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence 457899999999999864 68999999997542 22334566676655 566899999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++++|..++.. ..+++..+..++.||+.||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 84 AAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred CCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 999999988753 4589999999999999999999999 99999999999999999999999999987543221
Q ss_pred cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...+..... . .... ..
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~---~---~i~~-~~--------- 217 (324)
T cd05589 156 D--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF---D---SIVN-DE--------- 217 (324)
T ss_pred C--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH---H---HHHh-CC---------
Confidence 1 112234899999999999989999999999999999999999999765432111 0 0000 00
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH 545 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 545 (573)
...+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 218 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 -----VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 001122456789999999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=329.96 Aligned_cols=238 Identities=25% Similarity=0.316 Sum_probs=192.6
Q ss_pred eeecccCceEEEEEEe----CCCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 275 RLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
+.||+|+||.||++.. .+|+.||+|+++.... .....+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 3579999999999874 3588999999976432 234567789999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 9999999853 34689999999999999999999999 999999999999999999999999999876543211
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+.... .. .... . ..
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~---~i~~-~--------~~-- 215 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---MT---MILK-A--------KL-- 215 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---HH---HHHc-C--------CC--
Confidence 12223489999999999888899999999999999999999999976543211 10 0000 0 00
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSH 542 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 542 (573)
. .+...++.+.+++.+||+.||++||++.+
T Consensus 216 ---~-~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 ---G-MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ---C-CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0 11224567899999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=324.95 Aligned_cols=240 Identities=23% Similarity=0.301 Sum_probs=193.9
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+||+|+||.||++... +++.||||+++... ......+.+|..++..+ +||||+++++++.+.+..++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5899999999999864 57899999997642 23345677888998888 7999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|..++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++........
T Consensus 82 ~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (318)
T cd05570 82 DLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT-- 152 (318)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc--
Confidence 99988864 24689999999999999999999999 9999999999999999999999999998753222111
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.... ... .. ...
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~---~~~---i~-~~~------------- 212 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL---FQS---IL-EDE------------- 212 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH---HHH---HH-cCC-------------
Confidence 1223489999999999999999999999999999999999999976543211 110 00 000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRM-----SHVVH 545 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 545 (573)
...+...+..+.++|.+||+.||++||++ .++++
T Consensus 213 -~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 213 -VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 00112245678999999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=325.04 Aligned_cols=239 Identities=24% Similarity=0.303 Sum_probs=191.2
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+||+|+||.||++... +|+.||+|.++... .........|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 5899999999999964 58899999997642 12345567788888765 8999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (316)
T cd05620 82 DLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--R 152 (316)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--c
Confidence 99998854 34588999999999999999999999 999999999999999999999999999874322111 1
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+... ..+... . . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~~~~---~-~------~------- 212 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFESIR---V-D------T------- 212 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHH---h-C------C-------
Confidence 222348999999999999999999999999999999999999997654321 111100 0 0 0
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMS-HVV 544 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 544 (573)
.. .+...+.++.+++.+||+.||++||++. +++
T Consensus 213 ~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 213 PH-YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CC-CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 00 1112456789999999999999999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=304.08 Aligned_cols=264 Identities=21% Similarity=0.262 Sum_probs=198.3
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhh--HHHHHHHHHHHhhcCCCcEeEEeeEEeeC--CceEEEEEe
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEF 346 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~ 346 (573)
..++ |++|.||.||+|+. .+++.||+|+++.+.... .-.-++|+.+|.+.+|||||.+-.+.... +..|+||||
T Consensus 80 ~lnr-I~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~ 158 (419)
T KOG0663|consen 80 KLNR-IEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEY 158 (419)
T ss_pred HHhh-cccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHH
Confidence 3343 59999999999996 468899999998653221 23457999999999999999998887643 568999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
++. +|..++.... +++...++..+..|+++|++|||.+ .|+||||||+|+|++..|.+||+|||+|+.+....
T Consensus 159 ~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 159 VEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 955 8999998543 6799999999999999999999999 99999999999999999999999999999887553
Q ss_pred cccceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccch-hhHHhhhhhhhccccccc---
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQSHRYLEL--- 501 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~--- 501 (573)
.... ...-|.-|+|||.+.+. .|+++.|+||+|||+.||+++++.|.+..+.+.. .++..... .....+..+
T Consensus 232 k~~T--~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGt-Pte~iwpg~~~l 308 (419)
T KOG0663|consen 232 KPYT--PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGT-PSEAIWPGYSEL 308 (419)
T ss_pred ccCc--ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCC-CccccCCCcccc
Confidence 3222 22268899999999874 6899999999999999999999999887653221 11111100 000000000
Q ss_pred --c------ccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 502 --L------DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 502 --~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
. ......+.........++.-.+|+..+|..||.+|.|++|.++.
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0 00000011111112245778899999999999999999999863
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=315.15 Aligned_cols=254 Identities=28% Similarity=0.394 Sum_probs=199.0
Q ss_pred CCeeecccCceEEEEEEeCC------CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEE
Q 008216 273 GNRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
..+.||+|++|.||+|...+ +..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 89 (277)
T cd05036 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLE 89 (277)
T ss_pred eeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEe
Confidence 34578999999999999643 5689999887543 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC---CeeEecccCC
Q 008216 346 FVVNGPLDRWLHHIPR---GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGVGLS 419 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg~~ 419 (573)
|+++++|.+++..... ....+++..++.++.||+.||+|||++ +++||||||+||+++.++ .+||+|||++
T Consensus 90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~ 166 (277)
T cd05036 90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMA 166 (277)
T ss_pred cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCccc
Confidence 9999999999865321 123589999999999999999999999 999999999999998654 5899999999
Q ss_pred ccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccc
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRY 498 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 498 (573)
+................+..|+|||++.+..++.++|||||||++|||++ |..||...+....... .....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~------~~~~~-- 238 (277)
T cd05036 167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF------VTGGG-- 238 (277)
T ss_pred cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH------HHcCC--
Confidence 87633222111111124568999999988899999999999999999997 9999976543211110 00000
Q ss_pred ccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
....+...+..+.+++.+|++.+|++|||+.+|++.|+.
T Consensus 239 ------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 239 ------------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred ------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 001112345679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=317.69 Aligned_cols=247 Identities=19% Similarity=0.257 Sum_probs=197.2
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.++||+|+||.||++.. .+++.||||.+..... .....+.+|+.++++++||||+++++.+.+++..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05605 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCC
Confidence 45789999999999996 4689999999975422 2234577899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|.+++.. .....+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++.........
T Consensus 85 ~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 158 (285)
T cd05605 85 GDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI- 158 (285)
T ss_pred CcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc-
Confidence 999988864 2234689999999999999999999999 9999999999999999999999999999865432211
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
....|+..|+|||++.+..++.++||||+|+++|||++|+.||........... .... +...
T Consensus 159 --~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~---~~~~---------~~~~---- 220 (285)
T cd05605 159 --RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE---VERR---------VKED---- 220 (285)
T ss_pred --ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH---HHHH---------hhhc----
Confidence 122489999999999888899999999999999999999999986543211000 0000 0000
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH 545 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 545 (573)
....+...+..+.+++.+||+.||++|| +++++++
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 221 -QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 0111223566789999999999999999 7888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=325.73 Aligned_cols=242 Identities=22% Similarity=0.284 Sum_probs=189.6
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+||+|+||.||++... +++.||+|+++... ......+.+|..++.++ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 6899999999999964 57899999997642 23345677898888877 8999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 82 ~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~ 152 (329)
T cd05618 82 DLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--T 152 (329)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--c
Confidence 99988853 34689999999999999999999999 999999999999999999999999999875422211 1
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccc--hhhHHhhhhhhhcccccccccccccc
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW--QSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........ ...............
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------- 221 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------- 221 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-----------
Confidence 1223489999999999999999999999999999999999999964321110 000111111000000
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM 540 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 540 (573)
.. .+...+..+.+++.+||+.||++||++
T Consensus 222 --~~-~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 222 --IR-IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred --CC-CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 00 112345678999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=309.47 Aligned_cols=248 Identities=26% Similarity=0.395 Sum_probs=200.6
Q ss_pred eecccCceEEEEEEeCCCCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHHH
Q 008216 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 354 (573)
+||+|++|.||++...+++.||+|.++..... ....+.+|++++++++||||+++++++.+.+..++||||+++++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 57999999999999877999999998765433 45788999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceecc
Q 008216 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (573)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 434 (573)
++... ...+++..+..++.+++.||+|||++ +++||||||+||+++.++.++|+|||++...............
T Consensus 82 ~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 82 FLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 98642 24578999999999999999999999 9999999999999999999999999999865432221111122
Q ss_pred CCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCC
Q 008216 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 513 (573)
Q Consensus 435 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (573)
..+..|+|||.+.+..++.++|+||||+++|||+| |..||............ ... . ...
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-------~~~-----~--------~~~ 215 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-------ESG-----Y--------RMP 215 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-------hcC-----C--------CCC
Confidence 24667999999988889999999999999999999 88888765432111110 000 0 001
Q ss_pred cchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 514 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
.+...+..+.+++.+|++.+|.+|||+.||++.|+.
T Consensus 216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 112345679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=311.74 Aligned_cols=251 Identities=26% Similarity=0.388 Sum_probs=199.6
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
...+.||+|++|.||+|...++..||+|.++... ...+.+.+|+.++++++||||+++++.+. .+..++||||+++++
T Consensus 9 ~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~ 86 (262)
T cd05071 9 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGS 86 (262)
T ss_pred eEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCc
Confidence 3445679999999999998777789999997643 23467899999999999999999999874 456799999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+...........
T Consensus 87 L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~- 160 (262)
T cd05071 87 LLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR- 160 (262)
T ss_pred HHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccccc-
Confidence 99999642 234578999999999999999999999 999999999999999999999999999976543322111
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
....++..|+|||...+..++.++||||||+++|||+| |..||........ .. ......
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~~---~~~~~~-------------- 220 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LD---QVERGY-------------- 220 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---HH---HHhcCC--------------
Confidence 11226678999999988889999999999999999999 8888876543211 00 000000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
........+..+.+++.+|++.||++||++.++++.|+..
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0011123456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=330.36 Aligned_cols=264 Identities=23% Similarity=0.374 Sum_probs=214.4
Q ss_pred ecccCceEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 277 LGDSKTGGTYSGIL-PDGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 277 lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
||.|+||.||-+.. .+.+.||||.+... +....+++++|+..|++++|||++.+-|++..+...||||||| -|+-
T Consensus 34 IGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGSA 112 (948)
T KOG0577|consen 34 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSA 112 (948)
T ss_pred hcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hccH
Confidence 69999999999994 46889999999754 3345678999999999999999999999999999999999999 5677
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++.- ..+++.+..+..|..+.+.||+|||+. +.||||||+.|||+++.|.|||+|||.+....+..
T Consensus 113 sDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn------ 180 (948)
T KOG0577|consen 113 SDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN------ 180 (948)
T ss_pred HHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh------
Confidence 777753 346799999999999999999999999 99999999999999999999999999998765432
Q ss_pred ccCCccccccccccc---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 433 MAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
.+.|||.|||||++. .+.|+.++||||||++..||.-.++|...++... ....+.++ -
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS------ALYHIAQN-------------e 241 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQN-------------E 241 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH------HHHHHHhc-------------C
Confidence 234999999999986 4789999999999999999999999988766431 11111111 1
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh--------------cccCCCchhhhhhhhhcccccccc
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ--------------QLAQPPVTKLLFKGLDRLRHIFFF 572 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~--------------~~~~~~~~~~~~~~~~~~~~~~~~ 572 (573)
++.....+.++.+.+++..||+.-|.+|||.++++..-= .-.++.+..+..-+++|+++|+|.
T Consensus 242 sPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~dLIqRTKdaVrELDNlqYrKMkKilf~ 318 (948)
T KOG0577|consen 242 SPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQ 318 (948)
T ss_pred CCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchHHHHHHHHHHHHHHHhhhhhHHHHHHHHhh
Confidence 123334567889999999999999999999999886322 222234445556678889999884
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=310.89 Aligned_cols=239 Identities=26% Similarity=0.391 Sum_probs=189.6
Q ss_pred eecccCceEEEEEEeCC-------------CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEE
Q 008216 276 LLGDSKTGGTYSGILPD-------------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 342 (573)
.||+|+||.||+|.... ...|++|.+..........+.+|+.++..++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 47999999999998532 23689999876655556678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCC-------eeEec
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-------AHLMG 415 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~-------~kl~D 415 (573)
||||+++++|..++.. ....+++..++.++.||+.||+|||++ +++||||||+|||++.++. ++++|
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 82 VEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999998863 234589999999999999999999999 9999999999999986654 89999
Q ss_pred ccCCccCCccccccceeccCCccccccccccc-CCCCCcchhhHHHHHHHHHHH-cCCCCCCCCCcccchhhHHhhhhhh
Q 008216 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIV-SGRRPAQAVDSVCWQSIFEWATPLV 493 (573)
Q Consensus 416 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell-tG~~Pf~~~~~~~~~~~~~~~~~~~ 493 (573)
||++....... ...++..|+|||.+. +..++.++||||||+++|||+ +|..|+......+... ..
T Consensus 156 ~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-------~~ 222 (262)
T cd05077 156 PGIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-------FY 222 (262)
T ss_pred CCCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-------HH
Confidence 99987553221 122788899999886 467899999999999999998 5888876543221100 00
Q ss_pred hccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008216 494 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548 (573)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 548 (573)
. .. . . ......+++.+||.+||+.||++||++.+|++.|+
T Consensus 223 ~-~~--------~----~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 E-GQ--------C----M--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred h-cC--------c----c--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 00 0 0 00112357899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=324.05 Aligned_cols=243 Identities=21% Similarity=0.258 Sum_probs=191.3
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+||+|+||.||++... +++.||+|+++.... ...+.+.+|..++.++ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 5899999999999964 578999999986422 2345678899999888 6999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|..++.. ...+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (327)
T cd05617 82 DLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--T 152 (327)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--c
Confidence 99988853 34699999999999999999999999 999999999999999999999999999875322111 1
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||............+.........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------- 218 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-------------- 218 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--------------
Confidence 222348999999999999999999999999999999999999997543221111111111110000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMS 541 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 541 (573)
....+...+..+.+++.+||+.||++||++.
T Consensus 219 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 219 PIRIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 0011122456789999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.23 Aligned_cols=261 Identities=16% Similarity=0.172 Sum_probs=193.3
Q ss_pred CCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 270 FSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 270 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
.+...+.||+|+||.||++.. .+++.||+|.... ..+.+|+.++++++||||+++++++......++|+|++
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~- 165 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY- 165 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-
Confidence 345556789999999999985 4688999997542 34678999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+++|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.........
T Consensus 166 ~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 166 KTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 5788888854 24588999999999999999999999 9999999999999999999999999999754322111
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccc----hhhHHhhhhhhh----c-----
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW----QSIFEWATPLVQ----S----- 495 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~----~~~~~~~~~~~~----~----- 495 (573)
......||+.|+|||++.+..++.++|||||||++|||+||+.||........ ............ .
T Consensus 239 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 239 -KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred -ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 11223499999999999988999999999999999999999988754322110 000000000000 0
Q ss_pred -cccccccccccc---cCCCCC----cchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 496 -HRYLELLDPLIS---SLSSDI----PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 496 -~~~~~~~~~~~~---~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....+....... ...... .....+.++.+|+.+||+.||++|||++|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000 000000 01234568999999999999999999999985
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=309.75 Aligned_cols=248 Identities=27% Similarity=0.420 Sum_probs=198.3
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHH
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 353 (573)
...||+|++|.||++....+..+|+|.+.... ...+.+.+|+.++++++|||++++++++. .+..+++|||+++++|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 88 (260)
T cd05069 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLL 88 (260)
T ss_pred eeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHH
Confidence 44689999999999998777789999987543 33467889999999999999999999875 45679999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceec
Q 008216 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (573)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 433 (573)
+++... ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++........... ..
T Consensus 89 ~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~-~~ 162 (260)
T cd05069 89 DFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR-QG 162 (260)
T ss_pred HHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccccc-CC
Confidence 999652 234588999999999999999999999 999999999999999999999999999976543221111 11
Q ss_pred cCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
..++..|+|||...+..++.++||||||+++|||+| |..||....... ..... ... .. .
T Consensus 163 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~---~~~------~~-------~- 222 (260)
T cd05069 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQV---ERG------YR-------M- 222 (260)
T ss_pred CccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---HcC------CC-------C-
Confidence 225678999999988889999999999999999999 999987654321 11100 000 00 0
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
......+..+.+++.+||..||++||++++|++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0112345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=320.28 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=203.2
Q ss_pred cCCeeecccCceEEEEEEeC--------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceE
Q 008216 272 EGNRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY 341 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 341 (573)
...+.||+|+||.||++... ++..+|+|.++... .....++.+|+.+++++ +||||+++++++...+..+
T Consensus 21 ~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 100 (307)
T cd05098 21 VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 100 (307)
T ss_pred EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 44557799999999999742 23579999998642 33456788899999999 7999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC
Q 008216 342 IVYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409 (573)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~ 409 (573)
+||||+++++|.+++..... ....+++.+++.++.|++.||+|||++ +++||||||+||+++.++
T Consensus 101 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~ 177 (307)
T cd05098 101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDN 177 (307)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEcCCC
Confidence 99999999999999975321 123588999999999999999999999 999999999999999999
Q ss_pred CeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHh
Q 008216 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEW 488 (573)
Q Consensus 410 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 488 (573)
.+||+|||.+................++..|+|||.+.+..++.++||||||+++|||++ |..||....... ....
T Consensus 178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~---~~~~ 254 (307)
T cd05098 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFKL 254 (307)
T ss_pred cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHH
Confidence 999999999876543221111111224568999999988889999999999999999998 888886543221 1110
Q ss_pred hhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 489 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
..... ....+...+.++.+++.+||+.+|++|||+.+|++.|+++.+.
T Consensus 255 ----~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 255 ----LKEGH-------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred ----HHcCC-------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 00000 0001123456789999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=311.43 Aligned_cols=251 Identities=25% Similarity=0.434 Sum_probs=200.4
Q ss_pred CeeecccCceEEEEEEeCC-C---CEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 274 NRLLGDSKTGGTYSGILPD-G---SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
.+.||+|++|.||+|.... + ..+|+|.++.. .....+.+.+|+.++++++||||+++.+++.+.+..++||||++
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (268)
T cd05063 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYME 89 (268)
T ss_pred eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCC
Confidence 4578999999999999642 3 37999998765 23445678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+++|.+++.. ....+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 90 ~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 90 NGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 9999999864 234689999999999999999999999 9999999999999999999999999999866433221
Q ss_pred cce-eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 429 ERT-VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 429 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
... .....+..|+|||++.+..++.++||||||+++|||++ |+.||...+... ..... ....
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~i---~~~~---------- 227 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKAI---NDGF---------- 227 (268)
T ss_pred ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHH---hcCC----------
Confidence 111 11113457999999988889999999999999999998 999997644321 11100 0000
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
........+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011123456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=310.18 Aligned_cols=250 Identities=28% Similarity=0.457 Sum_probs=202.4
Q ss_pred CCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
..+.||+|++|.||+|..++++.||||.+.... ...+++.+|+.++++++||||+++++++.+....++||||+++++|
T Consensus 10 i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 88 (261)
T cd05034 10 LERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSL 88 (261)
T ss_pred eeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCH
Confidence 345789999999999998888899999997653 3456789999999999999999999999988899999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++.. ..+..+++..+..++.|++.||+|||++ +++|+||||+||++++++.++|+|||.+............
T Consensus 89 ~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~- 162 (261)
T cd05034 89 LDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE- 162 (261)
T ss_pred HHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhh-
Confidence 999975 2235689999999999999999999999 9999999999999999999999999998866432211111
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
...++..|+|||.+.+..++.++||||||+++|++++ |+.||....... ..... ... . .
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~---~~~------~--------~ 222 (261)
T cd05034 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQV---ERG------Y--------R 222 (261)
T ss_pred ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---HcC------C--------C
Confidence 1124568999999998889999999999999999999 999997644321 11110 000 0 0
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
...+...+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00111235679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=308.81 Aligned_cols=246 Identities=30% Similarity=0.452 Sum_probs=201.9
Q ss_pred CCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
..+.||.|++|.||++.. .|+.||+|.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||+++++|
T Consensus 10 ~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 87 (256)
T cd05039 10 LGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSL 87 (256)
T ss_pred ceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcH
Confidence 345789999999999987 589999999987644 567899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++... ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||.++.......
T Consensus 88 ~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----- 157 (256)
T cd05039 88 VDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----- 157 (256)
T ss_pred HHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-----
Confidence 9999652 223689999999999999999999999 999999999999999999999999999987632221
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
....+..|+|||.+.+..++.++||||||+++||+++ |..||....... +.... .... . .
T Consensus 158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~----~~~~-----~-------~ 218 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHV----EKGY-----R-------M 218 (256)
T ss_pred cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----hcCC-----C-------C
Confidence 1225667999999988889999999999999999997 999987654321 11100 0000 0 0
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
. .+...++.+.+++.+||..+|++|||++++++.|+++
T Consensus 219 ~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 E-APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred C-CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0 0122456799999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=311.64 Aligned_cols=250 Identities=28% Similarity=0.476 Sum_probs=196.8
Q ss_pred eecccCceEEEEEEeCC-CC--EEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 276 LLGDSKTGGTYSGILPD-GS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+||+|+||.||+|...+ +. .+|+|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||++++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 57999999999999744 43 5789988753 234456788999999999 8999999999999999999999999999
Q ss_pred CHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccC
Q 008216 351 PLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (573)
Q Consensus 351 sL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 418 (573)
+|.+++..... ....+++.++..++.|++.||+|||++ +++||||||+||++++++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCC
Confidence 99999864321 123578999999999999999999999 999999999999999999999999999
Q ss_pred CccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccc
Q 008216 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497 (573)
Q Consensus 419 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 497 (573)
+....... .......+..|+|||++.+..++.++||||||+++|||++ |..||...+... ..... .....
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~---~~~~~ 229 (270)
T cd05047 159 SRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL---PQGYR 229 (270)
T ss_pred ccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHHH---hCCCC
Confidence 86432111 1111224567999999988889999999999999999997 999997644221 11100 00000
Q ss_pred cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
.. .+...+.++.+++.+||+.||.+|||+.++++.|+++.
T Consensus 230 -------------~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 230 -------------LE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------------CC-CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00 11123457899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=310.85 Aligned_cols=248 Identities=24% Similarity=0.327 Sum_probs=199.6
Q ss_pred eecccCceEEEEEEeCC--C--CEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 276 LLGDSKTGGTYSGILPD--G--SRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.||+|++|.||+|.+.+ + ..||||.++.... ...+.+.+|+.++++++||||+++++.+.+ ...++||||++++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 57999999999998643 3 3699999987755 556789999999999999999999999988 8899999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc-c
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-E 429 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~ 429 (573)
+|.+++..... ..+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++......... .
T Consensus 81 ~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 81 SLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred cHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 99999975322 4689999999999999999999999 9999999999999999999999999999876542211 1
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
......++..|+|||.+.+..++.++||||||+++|||++ |..||...+.... ..... ... .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~---~~~-------~---- 218 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKID---KEG-------E---- 218 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH---hcC-------C----
Confidence 1112336788999999988889999999999999999999 9999975543211 11000 000 0
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 548 (573)
....+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 219 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 --RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00001124567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=307.17 Aligned_cols=247 Identities=22% Similarity=0.275 Sum_probs=201.2
Q ss_pred eeecccCceEEEEEEeCC-CCEEEEEEecccchh---hHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+.||.|.-|+||++++.+ +..+|+|++.+.... ...+.+.|-+||+.++||.++.+|+.++.+...+++||||+||
T Consensus 83 k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGG 162 (459)
T KOG0610|consen 83 KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGG 162 (459)
T ss_pred HHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCc
Confidence 357999999999999754 589999999876433 3456778999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc-----
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE----- 425 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----- 425 (573)
+|..+++. +.++.+++..++.++.+++-||+|||-. |||.|||||+||||.++|++-|+||.++......
T Consensus 163 dL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~ 237 (459)
T KOG0610|consen 163 DLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVK 237 (459)
T ss_pred cHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeec
Confidence 99998876 5567899999999999999999999999 9999999999999999999999999998543110
Q ss_pred ---------------------------c-c---------------------ccceeccCCcccccccccccCCCCCcchh
Q 008216 426 ---------------------------V-M---------------------QERTVMAGGTYGYLAPEFVYRNELTTKSD 456 (573)
Q Consensus 426 ---------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 456 (573)
. . ........||-.|.|||++.+...+.++|
T Consensus 238 s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVD 317 (459)
T KOG0610|consen 238 SSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVD 317 (459)
T ss_pred cCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhh
Confidence 0 0 00111234899999999999999999999
Q ss_pred hHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCC
Q 008216 457 VYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSM 536 (573)
Q Consensus 457 vwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 536 (573)
-|+|||++|||+.|..||.+.+..+ .+..++...+ .-......+..+++||++.|.+||++
T Consensus 318 WWtfGIflYEmLyG~TPFKG~~~~~---------------Tl~NIv~~~l----~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 318 WWTFGIFLYEMLYGTTPFKGSNNKE---------------TLRNIVGQPL----KFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred HHHHHHHHHHHHhCCCCcCCCCchh---------------hHHHHhcCCC----cCCCCCcchhHHHHHHHHHhccChhh
Confidence 9999999999999999998876531 1111111111 11112256678999999999999999
Q ss_pred CCC----HHHHHH
Q 008216 537 RPR----MSHVVH 545 (573)
Q Consensus 537 RPs----~~evl~ 545 (573)
|.. +.||-+
T Consensus 379 Rlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 379 RLGSKRGAAEIKR 391 (459)
T ss_pred hhccccchHHhhc
Confidence 998 777764
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=317.67 Aligned_cols=258 Identities=24% Similarity=0.403 Sum_probs=203.6
Q ss_pred CCeeecccCceEEEEEEe--------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEE
Q 008216 273 GNRLLGDSKTGGTYSGIL--------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI 342 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~--------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 342 (573)
..+.||+|+||.||++.. .++..||+|.++... ......+.+|+.+++.+ +||||+++++++...+..++
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 98 (304)
T cd05101 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 98 (304)
T ss_pred ecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEE
Confidence 345789999999999973 124579999987542 34456789999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCC
Q 008216 343 VYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 410 (573)
+|||+++++|.+++..... ....+++.++..++.||+.||+|||++ +++||||||+||+++.++.
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~~~~~ 175 (304)
T cd05101 99 IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNV 175 (304)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEcCCCc
Confidence 9999999999999975321 123578889999999999999999999 9999999999999999999
Q ss_pred eeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhh
Q 008216 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWA 489 (573)
Q Consensus 411 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~ 489 (573)
+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||....... ...
T Consensus 176 ~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~-- 250 (304)
T cd05101 176 MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LFK-- 250 (304)
T ss_pred EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHH--
Confidence 99999999987644322222222235678999999988889999999999999999998 788886544321 111
Q ss_pred hhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 490 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
...... ....+...+..+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 251 -~~~~~~--------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 251 -LLKEGH--------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -HHHcCC--------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 110000 0001123456799999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=311.66 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=192.9
Q ss_pred eecccCceEEEEEEeCC---CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 276 LLGDSKTGGTYSGILPD---GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
.||+|+||.||+|...+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 47999999999998643 4579999987653 2334578899999999999999999999999899999999999999
Q ss_pred HHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 352 LDRWLHHIPR-GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 352 L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
|.+++..... .....++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999965322 123467778889999999999999999 999999999999999999999999999975443322222
Q ss_pred eeccCCcccccccccccCC-------CCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccc
Q 008216 431 TVMAGGTYGYLAPEFVYRN-------ELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (573)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||......... .. ... .......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~---~~~-~~~~~~~ 231 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TY---TVR-EQQLKLP 231 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HH---Hhh-cccCCCC
Confidence 2223367889999988642 35789999999999999996 99999765432110 00 000 0001111
Q ss_pred ccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008216 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548 (573)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 548 (573)
++.. ....++.+.+++.+|+ .+|++|||++||+..|+
T Consensus 232 ~~~~--------~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRL--------KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCcc--------CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111 1123456888999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=324.57 Aligned_cols=247 Identities=22% Similarity=0.259 Sum_probs=193.7
Q ss_pred CeeecccCceEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEE
Q 008216 274 NRLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY 344 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 344 (573)
.+.||+|+||.||+++. .+++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL 84 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence 45789999999999875 358899999997532 22345678899999999 5999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCc
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 424 (573)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 85 DYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 99999999999864 34589999999999999999999999 999999999999999999999999999986533
Q ss_pred cccccceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccc
Q 008216 425 EVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503 (573)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (573)
..... .....||+.|+|||++.+. .++.++|||||||++|||+||+.||............. ..... .+
T Consensus 158 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~~-------~~ 227 (332)
T cd05614 158 EEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--RRILK-------CD 227 (332)
T ss_pred cCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--HHHhc-------CC
Confidence 22211 1223489999999998765 47889999999999999999999997543321111110 00000 00
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008216 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH 545 (573)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 545 (573)
+ ..+...+..+.+++.+||+.||++|| +++++++
T Consensus 228 ~--------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 228 P--------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred C--------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0 11123456789999999999999999 6777775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=330.50 Aligned_cols=250 Identities=21% Similarity=0.261 Sum_probs=194.0
Q ss_pred CCeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 273 GNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
..+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 345689999999999985 468899999997642 2334678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 85 gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 85 GGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9999999864 34588999999999999999999999 9999999999999999999999999997643210000
Q ss_pred ---------------------------------------------cceeccCCcccccccccccCCCCCcchhhHHHHHH
Q 008216 429 ---------------------------------------------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 463 (573)
Q Consensus 429 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvi 463 (573)
.......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00012348999999999998889999999999999
Q ss_pred HHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHH--hcCCCCCCCCCHH
Q 008216 464 LLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYA--CTQHVPSMRPRMS 541 (573)
Q Consensus 464 l~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~ 541 (573)
+|||+||+.||...+...... ....... .. ........++++.+++.+ |+..+|..||+++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~------~i~~~~~-------~~----~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQL------KVINWEN-------TL----HIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHH------HHHcccc-------cc----CCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 999999999997654321100 0000000 00 001111245678899988 4455666799999
Q ss_pred HHHHH
Q 008216 542 HVVHQ 546 (573)
Q Consensus 542 evl~~ 546 (573)
++++.
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=314.76 Aligned_cols=258 Identities=26% Similarity=0.423 Sum_probs=201.2
Q ss_pred CeeecccCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 274 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
.+.||+|+||.||+|... .+..||+|.++... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (288)
T cd05061 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMEL 90 (288)
T ss_pred eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeC
Confidence 457899999999999743 24589999987543 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 347 VVNGPLDRWLHHIPR------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
+++|+|.+++..... ....++...+..++.|++.||.|||++ +++||||||+||++++++.++|+|||+++
T Consensus 91 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Dfg~~~ 167 (288)
T cd05061 91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167 (288)
T ss_pred CCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcCCccc
Confidence 999999999965321 123456778899999999999999999 99999999999999999999999999988
Q ss_pred cCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
...............++..|+|||.+.+..++.++||||||+++|||++ |..||....... ... ...... .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~---~~~~~~-~- 239 (288)
T cd05061 168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLK---FVMDGG-Y- 239 (288)
T ss_pred cccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHcCC-C-
Confidence 6543322211122225678999999988889999999999999999998 788987644321 111 000000 0
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
.. .+...++.+.+++.+||+.||++|||+.++++.|++...+.
T Consensus 240 -----------~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~ 282 (288)
T cd05061 240 -----------LD-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282 (288)
T ss_pred -----------CC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCC
Confidence 00 01123467999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=313.29 Aligned_cols=239 Identities=27% Similarity=0.399 Sum_probs=188.6
Q ss_pred eecccCceEEEEEEeCC-------------------------CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEE
Q 008216 276 LLGDSKTGGTYSGILPD-------------------------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAV 330 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 330 (573)
.||+|+||.||+|.... ...||+|++..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 47999999999997421 23589999976554455678899999999999999999
Q ss_pred eeEEeeCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-
Q 008216 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF- 409 (573)
Q Consensus 331 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~- 409 (573)
++++.+.+..++||||+++|+|..++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 9999999999999999999999998863 234688999999999999999999999 999999999999997643
Q ss_pred ------CeeEecccCCccCCccccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHH-cCCCCCCCCCccc
Q 008216 410 ------GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIV-SGRRPAQAVDSVC 481 (573)
Q Consensus 410 ------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell-tG~~Pf~~~~~~~ 481 (573)
.+|++|||++....... ...++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 37999999876432211 1126788999998865 56899999999999999995 6999987654321
Q ss_pred chhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008216 482 WQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548 (573)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 548 (573)
..... .. . ... +......+.++|.+||+.+|++|||+.+|++.|+
T Consensus 230 ~~~~~-------~~---------~-----~~~-~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERFY-------EK---------K-----HRL-PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHH-------Hh---------c-----cCC-CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11110 00 0 000 0112346899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=329.63 Aligned_cols=256 Identities=27% Similarity=0.398 Sum_probs=200.1
Q ss_pred CeeecccCceEEEEEEeC------CCCEEEEEEecccch-hhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeCCceEEEEE
Q 008216 274 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e 345 (573)
.+.||+|+||.||+|.+. .++.||||+++.... ...+.+.+|+.+|.++. ||||+++++++...+..++|||
T Consensus 42 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E 121 (401)
T cd05107 42 GRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITE 121 (401)
T ss_pred hhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEe
Confidence 457899999999999853 346899999976532 23457889999999997 9999999999999999999999
Q ss_pred ecCCCCHHHHhccCCC----------------------------------------------------------------
Q 008216 346 FVVNGPLDRWLHHIPR---------------------------------------------------------------- 361 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~---------------------------------------------------------------- 361 (573)
|+++|+|.++++....
T Consensus 122 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (401)
T cd05107 122 YCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKY 201 (401)
T ss_pred ccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhh
Confidence 9999999999964211
Q ss_pred ------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCe
Q 008216 362 ------------------------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411 (573)
Q Consensus 362 ------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 411 (573)
....+++..+..++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~~~ 278 (401)
T cd05107 202 ADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLV 278 (401)
T ss_pred hhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCCCEE
Confidence 112467788899999999999999999 99999999999999999999
Q ss_pred eEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhh
Q 008216 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWAT 490 (573)
Q Consensus 412 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~ 490 (573)
||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||........ ..
T Consensus 279 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~--~~---- 352 (401)
T cd05107 279 KICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ--FY---- 352 (401)
T ss_pred EEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH--HH----
Confidence 9999999986533221111112236788999999988889999999999999999998 8999865432210 00
Q ss_pred hhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 491 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
....... . .. .+...+.++.+++.+||..+|.+||++++|++.|+++.
T Consensus 353 ~~~~~~~-----~-------~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 353 NAIKRGY-----R-------MA-KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHcCC-----C-------CC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0000000 0 00 11224567999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=325.20 Aligned_cols=236 Identities=23% Similarity=0.318 Sum_probs=187.9
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHH-HHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIG-RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+||+|+||.||+|... +|+.||||++..... .....+..|.. +++.++||||+++++.+.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 5899999999999964 689999999975421 22344555554 567789999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........ .
T Consensus 82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (323)
T cd05575 82 ELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--T 152 (323)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--c
Confidence 99998864 34689999999999999999999999 999999999999999999999999999875322211 1
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ... ... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~---~i~---------~~~~---- 213 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MYD---NIL---------NKPL---- 213 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH---HHH---HHH---------cCCC----
Confidence 222348999999999999899999999999999999999999997654321 110 000 0000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMS 541 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 541 (573)
. .....+..+.+++.+||+.||.+||++.
T Consensus 214 -~-~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 -R-LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -C-CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 0 0112356789999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=308.24 Aligned_cols=248 Identities=29% Similarity=0.422 Sum_probs=197.6
Q ss_pred eecccCceEEEEEEeCC----CCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 276 LLGDSKTGGTYSGILPD----GSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.||+|+||.||+|.+.. +..+|+|.++.... ...+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~ 80 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLG 80 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence 57999999999998532 36899999986643 34567899999999999999999999875 45689999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 81 PLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999964 23689999999999999999999999 999999999999999999999999999986643322111
Q ss_pred -eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 431 -TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 431 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||...+... ...... ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~----~~~----------- 215 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLE----SGE----------- 215 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHH----cCC-----------
Confidence 111114567999999988889999999999999999998 999997654321 111110 000
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
....+...+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 216 --~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 --RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 00111224467999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=316.40 Aligned_cols=255 Identities=29% Similarity=0.466 Sum_probs=200.3
Q ss_pred CeeecccCceEEEEEEeCC-CC--EEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 274 NRLLGDSKTGGTYSGILPD-GS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
.++||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..+++|||++
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (297)
T cd05089 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP 86 (297)
T ss_pred eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence 4578999999999998643 33 5799988753 334456789999999999 79999999999999999999999999
Q ss_pred CCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecc
Q 008216 349 NGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (573)
Q Consensus 349 ~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 416 (573)
+++|.+++..... ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+||
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~df 163 (297)
T cd05089 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADF 163 (297)
T ss_pred CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEECCc
Confidence 9999999964221 123588999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhc
Q 008216 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS 495 (573)
Q Consensus 417 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 495 (573)
|++........ ......+..|+|||.+.+..++.++||||||+++|||++ |..||....... .... ...
T Consensus 164 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~~~---~~~- 233 (297)
T cd05089 164 GLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LYEK---LPQ- 233 (297)
T ss_pred CCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH---Hhc-
Confidence 99864322111 111123567999999988889999999999999999998 999997654321 1110 000
Q ss_pred cccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
. .. .. .+...+..+.+++.+||+.+|.+||+++++++.|+.+....
T Consensus 234 ~-----~~-------~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 234 G-----YR-------ME-KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred C-----CC-------CC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0 00 00 11234567999999999999999999999999998887643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=318.80 Aligned_cols=258 Identities=28% Similarity=0.458 Sum_probs=201.4
Q ss_pred CCeeecccCceEEEEEEeC-CCC--EEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEec
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
..+.||+|+||.||+|... ++. .+|+|.++.. .......+.+|+.++.++ +||||+++++++.+++..++||||+
T Consensus 11 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 90 (303)
T cd05088 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 90 (303)
T ss_pred eeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeC
Confidence 3457899999999999964 454 4688877653 233456788999999999 8999999999999999999999999
Q ss_pred CCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEec
Q 008216 348 VNGPLDRWLHHIP------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415 (573)
Q Consensus 348 ~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 415 (573)
++++|.+++.... .....+++.+++.++.|++.||+|||++ +++||||||+|||++.++.+||+|
T Consensus 91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~d 167 (303)
T cd05088 91 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 167 (303)
T ss_pred CCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeCc
Confidence 9999999996432 1123588999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhh
Q 008216 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQ 494 (573)
Q Consensus 416 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 494 (573)
||++...... .......++..|+|||.+.+..++.++||||||+++|||+| |..||...+... .... ...
T Consensus 168 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~---~~~ 238 (303)
T cd05088 168 FGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEK---LPQ 238 (303)
T ss_pred cccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HHHH---Hhc
Confidence 9998643211 11111224667999999988889999999999999999998 999997554321 1110 000
Q ss_pred ccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCch
Q 008216 495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVT 556 (573)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 556 (573)
. .. .. .+...+..+.+++.+||+.+|++||+++++++.|+++.+...+
T Consensus 239 -~-----~~-------~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~ 286 (303)
T cd05088 239 -G-----YR-------LE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286 (303)
T ss_pred -C-----Cc-------CC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence 0 00 00 1112345789999999999999999999999999988765544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=308.26 Aligned_cols=246 Identities=24% Similarity=0.346 Sum_probs=200.6
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|++|.||++... +|+.|++|.+... .......+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENG 84 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCC
Confidence 346899999999999964 6899999998643 3445677899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..........
T Consensus 85 ~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~- 158 (256)
T cd08529 85 DLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA- 158 (256)
T ss_pred cHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccchh-
Confidence 999999752 235689999999999999999999999 99999999999999999999999999988665432211
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
....+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+... .... .. ....
T Consensus 159 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~---~~---------~~~~---- 218 (256)
T cd08529 159 -NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILK---II---------RGVF---- 218 (256)
T ss_pred -hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HH---------cCCC----
Confidence 12237889999999998889999999999999999999999997654211 0000 00 0000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
.. .....+..+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 PP-VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CC-CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11 111345679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=314.86 Aligned_cols=262 Identities=22% Similarity=0.322 Sum_probs=198.8
Q ss_pred cCCeeecccCceEEEEEEeCC---------------CCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEe
Q 008216 272 EGNRLLGDSKTGGTYSGILPD---------------GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~---------------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 335 (573)
+..+.||+|+||.||++...+ ...||+|.++.. .......+.+|++++++++||||+++++++.
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~ 87 (295)
T cd05097 8 RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCV 87 (295)
T ss_pred eehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEc
Confidence 334568999999999987532 235899999765 2334567899999999999999999999999
Q ss_pred eCCceEEEEEecCCCCHHHHhccCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC
Q 008216 336 DHGDRYIVYEFVVNGPLDRWLHHIPR--------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407 (573)
Q Consensus 336 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~ 407 (573)
..+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+||++++
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill~~ 164 (295)
T cd05097 88 SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGN 164 (295)
T ss_pred CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEEcC
Confidence 99999999999999999999864211 112478889999999999999999999 9999999999999999
Q ss_pred CCCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc--CCCCCCCCCcccchhh
Q 008216 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS--GRRPAQAVDSVCWQSI 485 (573)
Q Consensus 408 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~Pf~~~~~~~~~~~ 485 (573)
++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .
T Consensus 165 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~---~ 241 (295)
T cd05097 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ---V 241 (295)
T ss_pred CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH---H
Confidence 99999999999976543322211222235778999999988889999999999999999998 667776644321 1
Q ss_pred HHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 486 FEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
............. ... . ..+...++.+.+++.+||+.||++|||+++|++.|++
T Consensus 242 ~~~~~~~~~~~~~-~~~--------~-~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 242 IENTGEFFRNQGR-QIY--------L-SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHhhhhccc-ccc--------C-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111100000 000 0 0011234679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=321.99 Aligned_cols=237 Identities=24% Similarity=0.298 Sum_probs=189.4
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCC-CcEeEEeeEEeeCCceEEEEEecC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
.+.||+|+||.||+|... +++.||||+++... ....+.+..|..++..++| ++|+++++++.+.+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (324)
T cd05587 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (324)
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCC
Confidence 456899999999999964 47899999997542 2334567889999999966 568889999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 85 ~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 156 (324)
T cd05587 85 GGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK- 156 (324)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC-
Confidence 9999998854 34588999999999999999999999 999999999999999999999999999875322111
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...+... ..... .. .
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i---~~-~------------ 216 (324)
T cd05587 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQSI---ME-H------------ 216 (324)
T ss_pred -ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHH---Hc-C------------
Confidence 1222348999999999999999999999999999999999999997654321 11100 00 0
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM 540 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 540 (573)
....+...+.++.+++.+||+.||.+||+.
T Consensus 217 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 --NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 000112245678999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=311.48 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=197.5
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+..+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus 12 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~ 91 (267)
T cd06646 12 ELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGG 91 (267)
T ss_pred chhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCC
Confidence 3445679999999999995 568899999997654455567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.........
T Consensus 92 ~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~-- 162 (267)
T cd06646 92 SLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK-- 162 (267)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccccc--
Confidence 99998853 24689999999999999999999999 9999999999999999999999999999865422111
Q ss_pred eeccCCccccccccccc---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 431 TVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
.....++..|+|||.+. ...++.++||||||+++|||++|+.||........ ... .... ....+..
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~~-----~~~~---~~~~~~~- 231 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFL-----MSKS---NFQPPKL- 231 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--hee-----eecC---CCCCCCC-
Confidence 11223788999999874 34578899999999999999999999865432110 000 0000 0000000
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 547 (573)
......+..+.+++.+||+.||++|||+++|++.|
T Consensus 232 -----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 -----KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -----ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 01123456799999999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=327.67 Aligned_cols=250 Identities=19% Similarity=0.221 Sum_probs=192.8
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
..+.||+|+||.||++... +++.||||+++... ......+.+|+.++.+++||||+++++.+.+....++||||++
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence 3457899999999999854 58999999997542 2234567889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 85 gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 85 GGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999999864 35689999999999999999999999 9999999999999999999999999998754321100
Q ss_pred ---------------------------------cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 008216 429 ---------------------------------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQ 475 (573)
Q Consensus 429 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~ 475 (573)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00112349999999999999999999999999999999999999997
Q ss_pred CCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcC--CCCCCCCCHHHHHHH
Q 008216 476 AVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQ--HVPSMRPRMSHVVHQ 546 (573)
Q Consensus 476 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~evl~~ 546 (573)
....... .. ...... ... ...+....++++.+++.+++. .++..||+++||++.
T Consensus 238 ~~~~~~~---~~---~i~~~~--~~~---------~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 238 SETPQET---YK---KVMNWK--ETL---------IFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCHHHH---HH---HHHcCc--Ccc---------cCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 6543211 10 000000 000 000111234568888888654 233356899999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=330.26 Aligned_cols=248 Identities=21% Similarity=0.267 Sum_probs=199.1
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|+||.||++... +|+.||||+++.... .....+.+|+.++..++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (350)
T cd05573 6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPG 85 (350)
T ss_pred EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCC
Confidence 457899999999999964 689999999976421 3346788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc---
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV--- 426 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--- 426 (573)
++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 86 GDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999964 25689999999999999999999999 99999999999999999999999999998664332
Q ss_pred ------------------------cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccc
Q 008216 427 ------------------------MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW 482 (573)
Q Consensus 427 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~ 482 (573)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 00111223489999999999999999999999999999999999999987553211
Q ss_pred hhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q 008216 483 QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-MSHVVHQ 546 (573)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 546 (573)
. ..... .... . ........++.+.++|.+|+. ||.+||+ ++++++.
T Consensus 239 ~------~~i~~---~~~~----~----~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 239 Y------NKIIN---WKES----L----RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H------HHHhc---cCCc----c----cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 0 00000 0000 0 000111145679999999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=313.39 Aligned_cols=261 Identities=23% Similarity=0.338 Sum_probs=201.3
Q ss_pred CCeeecccCceEEEEEEeCC-----------------CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEE
Q 008216 273 GNRLLGDSKTGGTYSGILPD-----------------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCC 334 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 334 (573)
..+.||+|+||.||++...+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++
T Consensus 9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 88 (296)
T cd05051 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVC 88 (296)
T ss_pred ccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 34567999999999988532 2468999987653 34467789999999999999999999999
Q ss_pred eeCCceEEEEEecCCCCHHHHhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC
Q 008216 335 YDHGDRYIVYEFVVNGPLDRWLHHIPR-------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407 (573)
Q Consensus 335 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~ 407 (573)
..++..+++|||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+||+++.
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili~~ 165 (296)
T cd05051 89 TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGK 165 (296)
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---CccccccchhceeecC
Confidence 999999999999999999999865321 123689999999999999999999999 9999999999999999
Q ss_pred CCCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc--CCCCCCCCCcccchhh
Q 008216 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS--GRRPAQAVDSVCWQSI 485 (573)
Q Consensus 408 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~Pf~~~~~~~~~~~ 485 (573)
++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...... ..
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~---~~ 242 (296)
T cd05051 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ---QV 242 (296)
T ss_pred CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH---HH
Confidence 99999999999986543322222223336778999999988889999999999999999998 77787654422 11
Q ss_pred HHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 486 FEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
............... ....+...+.++.+++.+||+.||++|||+.||++.|++
T Consensus 243 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 243 IENAGHFFRDDGRQI----------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHhccccccccc----------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111100000000 000112244679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=310.28 Aligned_cols=252 Identities=25% Similarity=0.435 Sum_probs=200.2
Q ss_pred CCeeecccCceEEEEEEeCC-C---CEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 273 GNRLLGDSKTGGTYSGILPD-G---SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
..+.||+|+||.||+|.... + ..||||.++.. ......++..|+.++++++||||+++++++.+++..++||||+
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 87 (269)
T cd05065 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFM 87 (269)
T ss_pred EEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecC
Confidence 35578999999999999643 3 36999999765 3444678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++++|.+++... ...+++.+++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 88 ENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred CCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999998642 34589999999999999999999999 999999999999999999999999999876543221
Q ss_pred cccee-ccC--CcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccc
Q 008216 428 QERTV-MAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503 (573)
Q Consensus 428 ~~~~~-~~~--gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (573)
..... ... .+..|+|||.+.+..++.++||||||+++||+++ |..||...+... ...... ...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~---~~~------- 228 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIE---QDY------- 228 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHH---cCC-------
Confidence 11111 111 2457999999998899999999999999999887 999997654321 111110 000
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
......+.+..+.+++.+||+.+|++||++++|+..|+++
T Consensus 229 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 -------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011123456789999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=314.60 Aligned_cols=253 Identities=26% Similarity=0.406 Sum_probs=199.1
Q ss_pred CeeecccCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 274 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
.+.||+|+||.||++... ++..||+|.++... .....++.+|+.++++++||||+++++++.++...+++|||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (288)
T cd05050 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEY 89 (288)
T ss_pred cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEec
Confidence 345699999999999853 46789999997653 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC
Q 008216 347 VVNGPLDRWLHHIP------------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408 (573)
Q Consensus 347 ~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~ 408 (573)
+++++|.+++.... .....+++..++.++.|++.||+|||++ +++||||||+||+++.+
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~~~ 166 (288)
T cd05050 90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGEN 166 (288)
T ss_pred CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEecCC
Confidence 99999999996421 1123478889999999999999999999 99999999999999999
Q ss_pred CCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHH
Q 008216 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFE 487 (573)
Q Consensus 409 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 487 (573)
+.++|+|||++.................+..|+|||.+.+..++.++||||||+++|||++ |..||......+. ..
T Consensus 167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~---~~ 243 (288)
T cd05050 167 MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV---IY 243 (288)
T ss_pred CceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH
Confidence 9999999999876533221111111224667999999988899999999999999999998 8888875543211 10
Q ss_pred hhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 488 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
. ...... . ..+...+.++.+++.+||+.||++|||+.|+++.|++
T Consensus 244 ---~-~~~~~~------------~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 244 ---Y-VRDGNV------------L-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---H-HhcCCC------------C-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 0 000100 0 0011245679999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=335.31 Aligned_cols=264 Identities=20% Similarity=0.293 Sum_probs=190.1
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--------CceE
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--------GDRY 341 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------~~~~ 341 (573)
+...+.||+|+||.||+|.. .+++.||||++.... ....+|+.+|+.++||||+++++++... ...+
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 34456789999999999996 468999999886542 2345799999999999999999886532 1356
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-CeeEecccCCc
Q 008216 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSK 420 (573)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~~~ 420 (573)
+||||++ ++|.+++.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++
T Consensus 144 lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 144 VVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 8999996 478777765444556799999999999999999999999 999999999999998665 69999999998
Q ss_pred cCCccccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccc-hhhHHhhh-hhhh---
Q 008216 421 FVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWAT-PLVQ--- 494 (573)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~~~-~~~~--- 494 (573)
........ ....||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+...... ........ +...
T Consensus 220 ~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 220 NLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 66432211 12238999999998865 4689999999999999999999999987543211 11110000 0000
Q ss_pred --cccccccccccccc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 495 --SHRYLELLDPLISS-LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 495 --~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
...+.++.-+.... ......+...++++.+||.+||+.||.+|||+.|+++
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00000000000000 0000011124567999999999999999999999985
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.36 Aligned_cols=247 Identities=19% Similarity=0.233 Sum_probs=195.3
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+++..++||||+++
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~g 127 (370)
T cd05596 48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPG 127 (370)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCC
Confidence 457899999999999864 58899999997532 22345578899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..........
T Consensus 128 g~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~ 199 (370)
T cd05596 128 GDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR 199 (370)
T ss_pred CcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence 999999864 3478889999999999999999999 99999999999999999999999999998654322111
Q ss_pred ceeccCCcccccccccccCC----CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVYRN----ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+... .. ........ .
T Consensus 200 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~---~~i~~~~~--~----- 265 (370)
T cd05596 200 -CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---TY---SKIMDHKN--S----- 265 (370)
T ss_pred -CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH---HH---HHHHcCCC--c-----
Confidence 1223499999999998653 47889999999999999999999998654321 11 00000000 0
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSM--RPRMSHVVHQ 546 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 546 (573)
+ ........+.++.+++.+||+.+|.+ ||+++++++.
T Consensus 266 ~----~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 L----TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred C----CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 00111234578999999999999988 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=307.74 Aligned_cols=244 Identities=28% Similarity=0.427 Sum_probs=196.4
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEe-eCCceEEEEEecCCCCH
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY-DHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lv~e~~~~gsL 352 (573)
.+.||+|++|.||++.. .|..||+|.++... ..+.+.+|+.++++++|+|++++++++. +.+..+++|||+++++|
T Consensus 11 ~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L 87 (256)
T cd05082 11 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 87 (256)
T ss_pred eeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcH
Confidence 45789999999999987 58899999987543 3467889999999999999999999765 45678999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++........
T Consensus 88 ~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~----- 157 (256)
T cd05082 88 VDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----- 157 (256)
T ss_pred HHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccCC-----
Confidence 9998752 234588999999999999999999999 999999999999999999999999999875432211
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
...++..|+|||++.+..++.++||||||+++|||++ |+.||...... ...... .... .
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~----~~~~-------------~ 217 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EKGY-------------K 217 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----hcCC-------------C
Confidence 1125668999999988889999999999999999998 99998754321 111110 0000 0
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
.......+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 001123456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=307.93 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=201.6
Q ss_pred CcCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 271 SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
....+.||+|+||.||++...++..+|+|.++... ...+.+.+|+.++++++|+||+++.+.+.+ ...+++|||++++
T Consensus 8 ~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~ 85 (260)
T cd05073 8 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKG 85 (260)
T ss_pred eeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCC
Confidence 34456789999999999998788899999987653 345678899999999999999999999877 7789999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.+...........
T Consensus 86 ~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (260)
T cd05073 86 SLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 160 (260)
T ss_pred cHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc
Confidence 999999652 245678889999999999999999999 999999999999999999999999999876543221111
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
....++..|+|||++....++.++|+||||+++|+++| |..||...+..... ... ....
T Consensus 161 -~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~----~~~~------------ 220 (260)
T cd05073 161 -EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RAL----ERGY------------ 220 (260)
T ss_pred -cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH---HHH----hCCC------------
Confidence 11225678999999988889999999999999999999 99999765432111 100 0000
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
........+.++.+++.+|++.+|++||++.++++.|+.+
T Consensus 221 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 221 -RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred -CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 0001123446799999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=314.00 Aligned_cols=262 Identities=21% Similarity=0.313 Sum_probs=199.8
Q ss_pred cCCeeecccCceEEEEEEeC-----------------CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeE
Q 008216 272 EGNRLLGDSKTGGTYSGILP-----------------DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGC 333 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 333 (573)
+..+.||+|+||.||++... ++..||+|+++.. ......++.+|+.++++++||||++++++
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~ 87 (296)
T cd05095 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAV 87 (296)
T ss_pred eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 33456899999999998532 2446999999765 33345789999999999999999999999
Q ss_pred EeeCCceEEEEEecCCCCHHHHhccCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC
Q 008216 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRG-------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406 (573)
Q Consensus 334 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~ 406 (573)
+...+..+++|||+++++|.+++...... ...+++.++..++.|++.||+|||+. +++||||||+||+++
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili~ 164 (296)
T cd05095 88 CITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVG 164 (296)
T ss_pred EecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEEc
Confidence 99999999999999999999998753211 13477889999999999999999999 999999999999999
Q ss_pred CCCCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc--CCCCCCCCCcccchh
Q 008216 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS--GRRPAQAVDSVCWQS 484 (573)
Q Consensus 407 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~Pf~~~~~~~~~~ 484 (573)
.++.++|+|||++................++..|+|||...++.++.++||||||+++|||++ |..||...+...
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~--- 241 (296)
T cd05095 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ--- 241 (296)
T ss_pred CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH---
Confidence 999999999999986543322111111224678999999888889999999999999999998 778886554321
Q ss_pred hHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 485 IFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 485 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
................ . ...+..++..+.+++.+||+.||++||++.+|++.|++
T Consensus 242 ~~~~~~~~~~~~~~~~-~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 VIENTGEFFRDQGRQV-Y---------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHhhccccc-c---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111000000000 0 00112244679999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=323.78 Aligned_cols=240 Identities=21% Similarity=0.271 Sum_probs=188.9
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHH-HHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIG-RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.||+|+||.||+++.. +++.||+|++..... .....+..|.. +++.++||||+++++++.+.+..++||||++++
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 5899999999999964 578899999975421 22234444444 567789999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. ...+.+..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~ 152 (325)
T cd05602 82 ELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--T 152 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--C
Confidence 99999864 34578888999999999999999999 999999999999999999999999999875432211 1
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ... ... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~---i~~---------~~~---- 213 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YDN---ILN---------KPL---- 213 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HHH---HHh---------CCc----
Confidence 2223489999999999999999999999999999999999999976543211 110 000 000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
......+..+.+++.+||+.||.+||++.+.+.
T Consensus 214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 214 --QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 011134567899999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=311.39 Aligned_cols=251 Identities=29% Similarity=0.454 Sum_probs=198.7
Q ss_pred eecccCceEEEEEEeCC-------CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 276 LLGDSKTGGTYSGILPD-------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
+||+|+||.||+|...+ +..+|||.+.... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 57999999999998642 2579999886543 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-----CeeEecccCC
Q 008216 348 VNGPLDRWLHHIPR---GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-----GAHLMGVGLS 419 (573)
Q Consensus 348 ~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-----~~kl~Dfg~~ 419 (573)
++++|.+++..... ....+++.+++.++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999965321 224578899999999999999999999 999999999999999877 8999999999
Q ss_pred ccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccc
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRY 498 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 498 (573)
................++..|+|||.+.+..++.++||||||+++|||+| |..||...+... ..... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~---~~~~-- 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV---TAGG-- 230 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH---hcCC--
Confidence 76543322221222225678999999998899999999999999999998 999987544321 11100 0000
Q ss_pred ccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
........+..+.+++.+||+.+|++||++++|++.|++
T Consensus 231 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 001112345679999999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=319.78 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=208.3
Q ss_pred CCCcCCeeecccCceEEEEEEeCC-CCEEEEEEecccchh---hHHHHHHHHHHHhhcC-CCcEeEEeeEEeeCCceEEE
Q 008216 269 NFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 269 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv 343 (573)
.+++..+.||+|.||.||+++.+. |+.+|+|.+++.... ....+.+|+.+|+++. ||||+.+.+.+++....++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 344555678999999999999655 999999999876433 3468999999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC----CCeeEecccCC
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE----FGAHLMGVGLS 419 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfg~~ 419 (573)
||++.||.|.+.+... .+++..+..++.|++.+++|||+. |++||||||+|+|+... +.+|++|||++
T Consensus 115 mEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 9999999999999753 399999999999999999999999 99999999999999543 47999999999
Q ss_pred ccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||........... .....+
T Consensus 187 ~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~-------i~~~~~- 255 (382)
T KOG0032|consen 187 KFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA-------ILRGDF- 255 (382)
T ss_pred eEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH-------HHcCCC-
Confidence 98765 2233345599999999999999999999999999999999999999988764321110 011111
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
+ ....+....+..+.+++..|+..||.+|+|+.++++.
T Consensus 256 ~---------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 D---------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred C---------CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 0 1223344567889999999999999999999999984
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.37 Aligned_cols=247 Identities=19% Similarity=0.235 Sum_probs=195.5
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|+||.||+++.. +|+.||||+++... ......+.+|+.++..++||||+++++.+.+++..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG 85 (364)
T ss_pred EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCC
Confidence 457899999999999964 58999999997542 22345678899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.++|+|||++..........
T Consensus 86 g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 86 GDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred cHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999864 34589999999999999999999999 99999999999999999999999999987543211000
Q ss_pred ------------------------------------ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCC
Q 008216 430 ------------------------------------RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473 (573)
Q Consensus 430 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~P 473 (573)
......||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 00112489999999999988999999999999999999999999
Q ss_pred CCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCC---HHHHHH
Q 008216 474 AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR---MSHVVH 545 (573)
Q Consensus 474 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 545 (573)
|...+.... . ....... . .. ........++.+.++|.+|+. +|.+|++ ++++++
T Consensus 239 f~~~~~~~~---~---~~i~~~~---~----~~----~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 239 FCSDNPQET---Y---RKIINWK---E----TL----QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCHHHH---H---HHHHcCC---C----cc----CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 986543211 0 0000000 0 00 000111245678999999996 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=324.73 Aligned_cols=239 Identities=23% Similarity=0.296 Sum_probs=189.0
Q ss_pred eecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHH-HHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIG-RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+||+|+||.||++.. .+|+.||+|++.... ......+..|.. +++.++||||+++++.+...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 579999999999985 468999999997542 223345556654 467789999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|..++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 152 (325)
T cd05604 82 ELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--T 152 (325)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--C
Confidence 99988853 35689999999999999999999999 999999999999999999999999999875322211 1
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...+... ... .... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~---~~~~---------~~~---- 213 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MYD---NILH---------KPL---- 213 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HHH---HHHc---------CCc----
Confidence 122348999999999999999999999999999999999999997654321 111 0000 000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 544 (573)
. .....+..+.+++.+|++.||.+||++.+.+
T Consensus 214 ~--~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 214 V--LRPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred c--CCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 0 0112345688999999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=321.21 Aligned_cols=237 Identities=24% Similarity=0.317 Sum_probs=189.9
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
.+.||+|+||.||+|... +++.||||+++... ....+.+..|..++..+ +|++|+++++++.+.+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence 456899999999999864 57899999997642 22334567788888777 68999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~- 156 (323)
T cd05616 85 GGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV- 156 (323)
T ss_pred CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-
Confidence 9999998854 24588999999999999999999999 999999999999999999999999999875432211
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...+.... .... .. .
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~---~~~i---~~-~------------ 216 (323)
T cd05616 157 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQSI---ME-H------------ 216 (323)
T ss_pred -ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH---HHHH---Hh-C------------
Confidence 11223489999999999999999999999999999999999999986543211 1100 00 0
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM 540 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 540 (573)
....+...+.++.+++.+||+.||++|++.
T Consensus 217 --~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 217 --NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 001112345678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=316.53 Aligned_cols=262 Identities=22% Similarity=0.361 Sum_probs=199.9
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
.+.||+|+||.||++... ++..+|+|.++... .....++.+|++++++++||||+++++.+.+++..++||||+++++
T Consensus 6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~ 85 (308)
T cd06615 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 85 (308)
T ss_pred EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCc
Confidence 446799999999999854 58889999987542 2334668899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
|.+++.. ...+++..+..++.|++.||.|||+ . +++||||||+||+++.++.+||+|||++........
T Consensus 86 L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--- 155 (308)
T cd06615 86 LDQVLKK----AGRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--- 155 (308)
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCccccccccc---
Confidence 9999964 2458899999999999999999997 5 899999999999999999999999999875532211
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcc--------------
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH-------------- 496 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------------- 496 (573)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..................
T Consensus 156 -~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 156 -NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred -ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 12238899999999988889999999999999999999999997544322211111100000000
Q ss_pred ---ccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 497 ---RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 497 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
...+..+..........+....+.++.+++.+||+.||++|||+.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000011111111122222356679999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=325.34 Aligned_cols=247 Identities=23% Similarity=0.274 Sum_probs=196.5
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|+||.||++... +|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (330)
T cd05601 6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG 85 (330)
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCC
Confidence 457799999999999854 689999999976422 2345688899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.........
T Consensus 86 ~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~- 158 (330)
T cd05601 86 GDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV- 158 (330)
T ss_pred CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-
Confidence 9999999642 24689999999999999999999999 9999999999999999999999999999876533222
Q ss_pred ceeccCCccccccccccc------CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVY------RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (573)
......||+.|+|||++. ...++.++||||||+++|||++|+.||........ .......... +
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~~~---~- 228 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNFQRF---L- 228 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcCCCc---c-
Confidence 112234899999999986 45678899999999999999999999976543211 0111100000 0
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
........+..+.+|+..|++ +|.+||+++++++
T Consensus 229 -------~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 -------KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -------CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 000111245678999999998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=307.39 Aligned_cols=250 Identities=27% Similarity=0.436 Sum_probs=193.0
Q ss_pred eecccCceEEEEEEeC----CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEee-CCceEEEEEecCC
Q 008216 276 LLGDSKTGGTYSGILP----DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYEFVVN 349 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~~~~ 349 (573)
+||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.. ++..+++|||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 5799999999999853 2457999998643 33445778899999999999999999997764 5567999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc-
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ- 428 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~- 428 (573)
++|.+++... ...+++..+..++.|+++||+|||+. +++||||||+|||+++++.+||+|||+++........
T Consensus 82 ~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 82 GDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999998642 23467788899999999999999999 9999999999999999999999999999765432111
Q ss_pred -cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcC-CCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 429 -ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG-RRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 429 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
.......++..|+|||.+.+..++.++||||||+++|||++| .+||...+... . ........
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~---~~~~~~~~---------- 219 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---I---TVYLLQGR---------- 219 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H---HHHHhcCC----------
Confidence 111122257789999999888899999999999999999995 55665433211 1 11110000
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
....+...+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 220 ----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 220 ----RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ----CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 00011123457999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=312.36 Aligned_cols=271 Identities=23% Similarity=0.344 Sum_probs=201.2
Q ss_pred CCCcCCeeecccCceEEEEEEe-----CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--Cce
Q 008216 269 NFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDR 340 (573)
Q Consensus 269 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 340 (573)
.++...+.||+|+||.||++.+ .++..||+|.++... ......+.+|+.++++++||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3445566789999999999974 357899999997553 33456789999999999999999999998875 567
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
++||||+++++|.+++... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 9999999999999998642 23589999999999999999999999 99999999999999999999999999998
Q ss_pred cCCccccc-cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 421 FVPWEVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 421 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
........ .......++..|+|||.+.+..++.++||||||+++|||+|+..|........ .....+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~----~~~~~~~~~~~~~~ 233 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF----LKMIGPTHGQMTVT 233 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh----hhhcccccccccHH
Confidence 76433221 11112336778999999988889999999999999999999877653321100 00000000000000
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
..... +........+...+..+.+|+.+||+.||++|||+.++++.|+++
T Consensus 234 ~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 234 RLVRV-LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHH-HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000 000000111223567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=315.93 Aligned_cols=256 Identities=25% Similarity=0.408 Sum_probs=201.5
Q ss_pred CeeecccCceEEEEEEeC--------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEE
Q 008216 274 NRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 343 (573)
.+.||+|+||.||++... .+..+|+|.++... ......+.+|+.+++++ +||||+++++++.+.+..+++
T Consensus 17 ~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 96 (314)
T cd05099 17 GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVI 96 (314)
T ss_pred eeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEE
Confidence 456899999999999742 24579999987542 33456788999999999 699999999999999999999
Q ss_pred EEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCe
Q 008216 344 YEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 411 (573)
|||+++|+|.+++..... ....+++.++..++.|++.||.|||++ +++||||||+||+++.++.+
T Consensus 97 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~ 173 (314)
T cd05099 97 VEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVM 173 (314)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCCCcE
Confidence 999999999999965321 124588999999999999999999999 99999999999999999999
Q ss_pred eEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhh
Q 008216 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWAT 490 (573)
Q Consensus 412 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~ 490 (573)
||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....... .....
T Consensus 174 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~- 249 (314)
T cd05099 174 KIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---LFKLL- 249 (314)
T ss_pred EEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH-
Confidence 9999999986643222111111224567999999988889999999999999999999 899987654321 11110
Q ss_pred hhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 491 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
..... .. .+..++.++.+++.+||+.||++|||+.++++.|+++..
T Consensus 250 ---~~~~~------------~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 250 ---REGHR------------MD-KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred ---HcCCC------------CC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 00000 00 112334578899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=317.03 Aligned_cols=265 Identities=16% Similarity=0.211 Sum_probs=195.0
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
...+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++++++||||+++++++..++..++||||+++
T Consensus 9 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 88 (309)
T cd07872 9 IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK 88 (309)
T ss_pred EEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC
Confidence 33456899999999999864 578999999875432 2334677899999999999999999999999999999999964
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
+|.+++.. .+..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.........
T Consensus 89 -~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 160 (309)
T cd07872 89 -DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT- 160 (309)
T ss_pred -CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCccc-
Confidence 88888753 234588999999999999999999999 9999999999999999999999999998764332211
Q ss_pred ceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccc------c
Q 008216 430 RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL------L 502 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 502 (573)
.....+++.|+|||.+.+ ..++.++||||||+++|||+||+.||...+..+................+..+ .
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 161 -YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred -cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 112237889999998865 46789999999999999999999999776543221111110000000000000 0
Q ss_pred ccccccCCCC---CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 503 DPLISSLSSD---IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 503 ~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+......... ......++++.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000 001124567899999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=308.66 Aligned_cols=245 Identities=22% Similarity=0.372 Sum_probs=194.8
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
.++||+|++|.||+|.. .+++.||+|.+... .......+.+|+.++++++||||+++++.+...+..++||||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 85 (279)
T cd06619 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS 85 (279)
T ss_pred eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCC
Confidence 45789999999999985 56889999998754 33345678999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|..+. .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 86 l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~---- 150 (279)
T cd06619 86 LDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA---- 150 (279)
T ss_pred hHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccc----
Confidence 97553 367888999999999999999999 999999999999999999999999999976543211
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchh-hHHhhhhhhhccccccccccccccCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......... ........ .+.. .
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------~~~~----~ 217 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI---------VDED----P 217 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH---------hccC----C
Confidence 12348899999999998889999999999999999999999997543221100 00000000 0000 0
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
...+....++++.+++.+||+.||++||+++|+++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 218 PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111122345678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=310.77 Aligned_cols=256 Identities=22% Similarity=0.384 Sum_probs=203.4
Q ss_pred CeeecccCceEEEEEEeC-CCC----EEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 274 NRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
.+.||+|+||.||+|..+ +|+ .+|+|.++... .....++.+|+.++++++||||+++++++.. ...++||||+
T Consensus 12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 90 (279)
T cd05057 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLM 90 (279)
T ss_pred cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecC
Confidence 457899999999999854 333 69999987654 3345678899999999999999999999887 7889999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++|+|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++.......
T Consensus 91 ~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 91 PLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164 (279)
T ss_pred CCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence 99999999864 234589999999999999999999999 999999999999999999999999999987653322
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
........++..|+|||.+....++.++|+||||+++||+++ |+.||............ ....
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~--------- 228 (279)
T cd05057 165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL-------EKGE--------- 228 (279)
T ss_pred ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-------hCCC---------
Confidence 211111224568999999988889999999999999999999 99999765432211111 0000
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCch
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVT 556 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 556 (573)
....+...+..+.+++.+||..||++||++.++++.|+++...+..
T Consensus 229 ----~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~ 274 (279)
T cd05057 229 ----RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQR 274 (279)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcc
Confidence 0001112345688999999999999999999999999998776543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=313.19 Aligned_cols=245 Identities=21% Similarity=0.357 Sum_probs=199.3
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
.+.||+|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++.+......++||||+++++|
T Consensus 25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L 104 (296)
T cd06654 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (296)
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCH
Confidence 34679999999999985 46899999999876555667889999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++.. ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......... ..
T Consensus 105 ~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~ 174 (296)
T cd06654 105 TDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RS 174 (296)
T ss_pred HHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc--cC
Confidence 999853 3478899999999999999999999 9999999999999999999999999998765432211 11
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
...+++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ...... ... .+ ..
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~~~----~~~------~~------~~ 236 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLIA----TNG------TP------EL 236 (296)
T ss_pred cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHHHh----cCC------CC------CC
Confidence 2238889999999988888999999999999999999999997654311 110000 000 00 00
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
..+...+..+.+++.+||..||++||++.+|++.
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1122345678999999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=321.77 Aligned_cols=236 Identities=24% Similarity=0.298 Sum_probs=187.0
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHH-HHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIG-RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+||+|+||.||+++.. +|+.||+|++..... .....+..|.. +++.++||||+++++.+.+.+..++||||++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5899999999999964 588999999975422 22344555554 578889999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|..++.. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (321)
T cd05603 82 ELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--T 152 (321)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--c
Confidence 99888853 34588899999999999999999999 999999999999999999999999999875322211 1
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+... .... .. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~---i~---------~~~----- 212 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYDN---IL---------HKP----- 212 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHHH---Hh---------cCC-----
Confidence 122348999999999998889999999999999999999999997654321 1110 00 000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMS 541 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 541 (573)
. ..+...+..+.+++.+||+.||.+||++.
T Consensus 213 ~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 L-QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred C-CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0 01112345789999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=317.57 Aligned_cols=199 Identities=18% Similarity=0.328 Sum_probs=160.4
Q ss_pred CeeecccCceEEEEEEeC---CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEee--CCceEEEEEecC
Q 008216 274 NRLLGDSKTGGTYSGILP---DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEFVV 348 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~ 348 (573)
.+.||+|+||.||+|... +++.||+|.++... ....+.+|+.++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 446799999999999854 46789999997543 23457789999999999999999998864 345789999984
Q ss_pred CCCHHHHhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee----CCCCCeeEecccCC
Q 008216 349 NGPLDRWLHHIP-----RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLS 419 (573)
Q Consensus 349 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfg~~ 419 (573)
++|.+++.... .....+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58888775321 1123588999999999999999999999 99999999999999 45678999999999
Q ss_pred ccCCccccc-cceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 008216 420 KFVPWEVMQ-ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVD 478 (573)
Q Consensus 420 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 478 (573)
+........ .......+|+.|+|||++.+ ..++.++||||+||++|||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876433211 11122348999999999876 458899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=309.29 Aligned_cols=254 Identities=22% Similarity=0.335 Sum_probs=190.5
Q ss_pred eecccCceEEEEEEeCC---CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 276 LLGDSKTGGTYSGILPD---GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
.||+|+||.||+|...+ ...+|+|.+.... ......+.+|+..++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 37999999999997543 4578899876543 2334678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 352 LDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 352 L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
|.+++...... ....++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999753321 23356778899999999999999999 999999999999999999999999999875433221111
Q ss_pred eeccCCcccccccccccC-------CCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccc
Q 008216 431 TVMAGGTYGYLAPEFVYR-------NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (573)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||....+.. .. ....... .....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~---~~~~~~~-~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VL---KQVVREQ-DIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HH---HHHhhcc-CccCC
Confidence 122225678999998743 356789999999999999999 788887554321 00 0000100 00111
Q ss_pred ccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008216 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548 (573)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 548 (573)
.+ ......+..+.+++..|+ .||++|||+++|++.|.
T Consensus 232 ~~--------~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KP--------QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CC--------cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11 112234566788999998 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=311.90 Aligned_cols=247 Identities=23% Similarity=0.357 Sum_probs=197.1
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
.+.||+|+||.||+|... ++..+++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+++++|
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l 89 (282)
T cd06643 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 89 (282)
T ss_pred HhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcH
Confidence 446899999999999965 4778999999776666677889999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
..++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ ...
T Consensus 90 ~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~ 161 (282)
T cd06643 90 DAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRD 161 (282)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc--ccc
Confidence 988753 234689999999999999999999999 999999999999999999999999999876532211 112
Q ss_pred ccCCccccccccccc-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 433 MAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
...++..|+|||++. +..++.++|||||||++|||++|++||...+... .... ..... .+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~----~~~~~------~~--- 226 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLK----IAKSE------PP--- 226 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHH----HhhcC------CC---
Confidence 233889999999884 3457789999999999999999999987654311 0000 00000 00
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
....+...+.++.++|.+||+.||++||++.++++.
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 227 ---TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000112245679999999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=309.14 Aligned_cols=253 Identities=28% Similarity=0.385 Sum_probs=201.1
Q ss_pred CCeeecccCceEEEEEEeCC----CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 273 GNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
..+.||+|++|.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~ 88 (270)
T cd05056 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELA 88 (270)
T ss_pred eeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcC
Confidence 34578999999999998643 2479999987654 4456789999999999999999999998875 5578999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++.......
T Consensus 89 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 89 PLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred CCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 999999999642 23589999999999999999999999 999999999999999999999999999986654322
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
.... ...++..|+|||.+....++.++||||||+++||+++ |..||........ .. .. ....
T Consensus 163 ~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~---~~-~~~~--------- 225 (270)
T cd05056 163 YKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IG---RI-ENGE--------- 225 (270)
T ss_pred eecC-CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HH---HH-HcCC---------
Confidence 2111 2224568999999988889999999999999999996 9999976543211 10 00 0000
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
....+...+..+.+++.+|+..+|++|||+.++++.|+++..+
T Consensus 226 ----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 ----RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0001123456799999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=322.16 Aligned_cols=261 Identities=26% Similarity=0.365 Sum_probs=199.7
Q ss_pred CcCCeeecccCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeC-CceE
Q 008216 271 SEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH-GDRY 341 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-~~~~ 341 (573)
++..+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++... ...+
T Consensus 9 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (343)
T cd05103 9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (343)
T ss_pred hcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceE
Confidence 34456789999999999973 347899999997643 23346788999999999 789999999988654 4578
Q ss_pred EEEEecCCCCHHHHhccCCC------------------------------------------------------------
Q 008216 342 IVYEFVVNGPLDRWLHHIPR------------------------------------------------------------ 361 (573)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~------------------------------------------------------------ 361 (573)
++|||+++|+|.+++.....
T Consensus 89 lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (343)
T cd05103 89 VIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQ 168 (343)
T ss_pred EEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhh
Confidence 99999999999999864211
Q ss_pred ---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceeccCCcc
Q 008216 362 ---GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438 (573)
Q Consensus 362 ---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 438 (573)
....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++................++.
T Consensus 169 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 169 EDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 012467888899999999999999999 99999999999999999999999999998653322211122223567
Q ss_pred cccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchH
Q 008216 439 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAG 517 (573)
Q Consensus 439 ~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (573)
.|+|||.+.+..++.++||||||+++|+|++ |..||....... .... . ...... ... +..
T Consensus 246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~---~-~~~~~~------------~~~-~~~ 306 (343)
T cd05103 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR---R-LKEGTR------------MRA-PDY 306 (343)
T ss_pred ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHH---H-HhccCC------------CCC-CCC
Confidence 8999999988889999999999999999997 999987543210 0100 0 000000 000 111
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 518 VVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 518 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
.++++.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 345689999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=306.89 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=199.8
Q ss_pred CeeecccCceEEEEEEeC-C---CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 274 NRLLGDSKTGGTYSGILP-D---GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
.+.||+|+||.||+|... + +..+|+|.++... ....+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME 88 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence 457899999999999853 2 3379999987542 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+++|.+++... ...+++.++..++.|++.||+|||++ +++||||||+||+++.++.++|+|||++.........
T Consensus 89 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 89 NGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 99999999642 24589999999999999999999999 9999999999999999999999999999876543221
Q ss_pred cce-eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 429 ERT-VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 429 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
... ....++..|+|||.+.+..++.++||||||+++||+++ |..||....... ..... ....
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~---~~~~---------- 226 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAI---EEGY---------- 226 (267)
T ss_pred eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHH---hCCC----------
Confidence 111 11113568999999988889999999999999999887 999997654321 11110 0000
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
........++.+.+++.+|++.+|++||++.++++.|+++
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ----RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0001123456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=310.52 Aligned_cols=239 Identities=27% Similarity=0.403 Sum_probs=189.8
Q ss_pred eecccCceEEEEEEeCC--------CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 276 LLGDSKTGGTYSGILPD--------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
.||+|+||.||+|.... ..+||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 47999999999998532 2358999887665555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCC--------eeEecccCC
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG--------AHLMGVGLS 419 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~--------~kl~Dfg~~ 419 (573)
++|+|.+++... +..+++..++.++.||+.||+|||++ +|+||||||+||+++.++. ++++|||++
T Consensus 82 ~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 82 KFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999642 23689999999999999999999999 9999999999999987765 599999988
Q ss_pred ccCCccccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCC-CCCCCCCcccchhhHHhhhhhhhccc
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGR-RPAQAVDSVCWQSIFEWATPLVQSHR 497 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~ 497 (573)
....... ...++..|+|||++.+ ..++.++||||||+++|||++|. .|+...+....... ...
T Consensus 156 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-------~~~-- 220 (258)
T cd05078 156 ITVLPKE------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-------YED-- 220 (258)
T ss_pred cccCCch------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-------HHc--
Confidence 7543221 1237888999999976 45789999999999999999985 56554332211000 000
Q ss_pred cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008216 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548 (573)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 548 (573)
. .. .+.....++.+++.+||+.||++|||+++|++.|+
T Consensus 221 -------~-----~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 -------R-----HQ-LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -------c-----cc-CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00 01122356899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=311.37 Aligned_cols=247 Identities=21% Similarity=0.284 Sum_probs=196.2
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.++||+|+||.||++... +++.||||.+..... .....+.+|+.++++++|+||+++++.+.+.+..++||||+++
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 84 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence 457899999999999864 688999999865422 2234577899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
++|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 158 (285)
T cd05630 85 GDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI- 158 (285)
T ss_pred CcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc-
Confidence 9999988642 234589999999999999999999999 9999999999999999999999999998765432211
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
....|+..|+|||++.+..++.++||||||+++|+|++|+.||............ ... .....
T Consensus 159 --~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~~---------~~~~~--- 221 (285)
T cd05630 159 --KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERL---------VKEVQ--- 221 (285)
T ss_pred --cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hhh---------hhhhh---
Confidence 1224899999999999889999999999999999999999999764322100000 000 00000
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH 545 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 545 (573)
.......++.+.+|+.+||+.||++||| ++|+++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 --EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0011223457899999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=306.46 Aligned_cols=248 Identities=21% Similarity=0.320 Sum_probs=197.5
Q ss_pred CCeeecccCceEEEEEEe-CCCCEEEEEEecccc-----hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 273 GNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
..+.||+|++|.||.+.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|+||
T Consensus 6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence 355789999999999985 468999999986542 12235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||+++......
T Consensus 86 ~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 86 MPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred CCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 999999998864 24588899999999999999999999 99999999999999999999999999987654321
Q ss_pred cccc-eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 427 MQER-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 427 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...+... .. ....... .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~----~~~~~~~-----~--- 224 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA--AI----FKIATQP-----T--- 224 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH--HH----HHHhccC-----C---
Confidence 1111 012237789999999998889999999999999999999999997643321 00 0000000 0
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
....+...+..+.+++.+||..+|++|||+.++++.
T Consensus 225 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 -----NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 011112345678999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=298.81 Aligned_cols=245 Identities=21% Similarity=0.286 Sum_probs=197.5
Q ss_pred CeeecccCceEEEEEE-eCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|.|+.|++.. .++|+.+|+|++... +..+.+.+.+|+++-+.|+||||+++.+...+.+..|+|+|++.|+
T Consensus 16 ~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~ 95 (355)
T KOG0033|consen 16 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 95 (355)
T ss_pred HHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccch
Confidence 4468999999999987 457999999988543 3346688999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---CCCeeEecccCCccCCcccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~~~~~~~~~~ 427 (573)
+|..-+-. ....++..+-..++||+++|.|+|.+ +|||||+||+|+++.+ ..-+||+|||++..+.....
T Consensus 96 dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~ 168 (355)
T KOG0033|consen 96 ELFEDIVA----REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA 168 (355)
T ss_pred HHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence 99665543 24578888899999999999999999 9999999999999954 33489999999998763222
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
.....|||.|||||++...+|+..+|||+.|||||-|+.|.+||.+.+.. .+++.... +.+ +.
T Consensus 169 ---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I~~----g~y-d~------ 231 (355)
T KOG0033|consen 169 ---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQIKA----GAY-DY------ 231 (355)
T ss_pred ---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHHhc----ccc-CC------
Confidence 22344999999999999999999999999999999999999999885532 11111110 000 00
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+.......+++.++|+++||..||.+|.|+.|.++
T Consensus 232 ---~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 232 ---PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ---CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11122345678999999999999999999999985
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=311.09 Aligned_cols=262 Identities=19% Similarity=0.264 Sum_probs=189.7
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhc---CCCcEeEEeeEEeeC-----CceEE
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARL---HHPNLVAVKGCCYDH-----GDRYI 342 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~-----~~~~l 342 (573)
.+.||+|+||.||+|... +|+.||+|.++.... .....+.+|+.+++.+ +||||+++++++... ...++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l 84 (288)
T cd07863 5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL 84 (288)
T ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence 456899999999999864 689999999875421 1223456677776665 799999999987643 34799
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
+|||++ ++|.+++... ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 85 v~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 85 VFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred EEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 999996 5898888652 234589999999999999999999999 9999999999999999999999999999866
Q ss_pred CccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccc-hhhHHhhhhhhhccccccc
Q 008216 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLVQSHRYLEL 501 (573)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 501 (573)
...... ....+|..|+|||++.+..++.++|||||||++|||++|++||........ ......... .....+...
T Consensus 159 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 234 (288)
T cd07863 159 SCQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL-PPEDDWPRD 234 (288)
T ss_pred cCcccC---CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCC-CChhhCccc
Confidence 432211 122378999999999888999999999999999999999999976543211 111110000 000000000
Q ss_pred c---ccccccCCCC---CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 502 L---DPLISSLSSD---IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 502 ~---~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
. .......... ......++.+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0000000000 001134567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=328.19 Aligned_cols=248 Identities=19% Similarity=0.211 Sum_probs=192.8
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|+||.||++.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..|+||||+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~g 85 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG 85 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCC
Confidence 45789999999999985 468999999986542 22345688899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc-
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ- 428 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~- 428 (573)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 86 g~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 86 GDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999864 34688999999999999999999999 9999999999999999999999999998633210000
Q ss_pred -----------c---------------------------------ceeccCCcccccccccccCCCCCcchhhHHHHHHH
Q 008216 429 -----------E---------------------------------RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464 (573)
Q Consensus 429 -----------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil 464 (573)
. ......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 0 00013489999999999988999999999999999
Q ss_pred HHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCC---CCHH
Q 008216 465 LEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMR---PRMS 541 (573)
Q Consensus 465 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ 541 (573)
|||++|..||...+.... .. ...... . .+ ........+.++.+++.+||. +|.+| +++.
T Consensus 239 ~elltG~~Pf~~~~~~~~---~~---~i~~~~---~----~~----~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 239 FECLIGWPPFCSENSHET---YR---KIINWR---E----TL----YFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred hhhhcCCCCCCCCCHHHH---HH---HHHccC---C----cc----CCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 999999999976543211 00 000000 0 00 000011245678999999997 77765 5999
Q ss_pred HHHHH
Q 008216 542 HVVHQ 546 (573)
Q Consensus 542 evl~~ 546 (573)
++++.
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=328.21 Aligned_cols=248 Identities=21% Similarity=0.251 Sum_probs=192.8
Q ss_pred CCeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 273 GNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
..+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++++++||||+++++.+.+.+..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 345789999999999985 468899999997542 2334578899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc-
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM- 427 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 427 (573)
+|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 85 gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 85 GGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 9999999864 24588999999999999999999999 999999999999999999999999999753211000
Q ss_pred --------------------------------------------ccceeccCCcccccccccccCCCCCcchhhHHHHHH
Q 008216 428 --------------------------------------------QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 463 (573)
Q Consensus 428 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvi 463 (573)
........||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000012248999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCC---H
Q 008216 464 LLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR---M 540 (573)
Q Consensus 464 l~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~ 540 (573)
+|||++|+.||...+..... ...... .... ........++++.+++.+|+ .+|.+|++ +
T Consensus 238 l~elltG~~Pf~~~~~~~~~------~~i~~~-------~~~~----~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQ------MKVINW-------QTSL----HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHH------HHHHcc-------CCCc----CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 99999999999865432110 000000 0000 01111234567888898876 59999997 7
Q ss_pred HHHHH
Q 008216 541 SHVVH 545 (573)
Q Consensus 541 ~evl~ 545 (573)
+++++
T Consensus 300 ~ei~~ 304 (382)
T cd05625 300 DEIKA 304 (382)
T ss_pred HHHhc
Confidence 77764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=315.68 Aligned_cols=263 Identities=22% Similarity=0.389 Sum_probs=203.7
Q ss_pred CCeeecccCceEEEEEEeC-CCC----EEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
..+.||+|+||.||+|... +|. .||+|.+..... ....++.+|+.++++++||||+++++++... ..++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 3457899999999999853 444 579998876532 3345788999999999999999999998654 56799999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++|+|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 90 MPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred cCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCcc
Confidence 999999999864 234588999999999999999999999 99999999999999999999999999998765332
Q ss_pred cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.........++..|+|||.+.+..++.++||||||+++|||++ |..||............ .....
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-------~~~~~------- 229 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-------EKGER------- 229 (303)
T ss_pred cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HCCCC-------
Confidence 2212222225678999999988889999999999999999997 99998765432111111 10000
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCchhhhhhh
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKLLFKG 562 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~ 562 (573)
...+...+..+.+++.+||..+|++||+++++++.|+.+..++.....+..
T Consensus 230 ------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~ 280 (303)
T cd05110 230 ------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQG 280 (303)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhhheeecc
Confidence 000112345789999999999999999999999999998776655444433
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=304.78 Aligned_cols=247 Identities=26% Similarity=0.449 Sum_probs=198.1
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHH
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 353 (573)
.+.||+|++|.||++.+.+++.+|+|.++... ....++.+|++++++++||||+++++++......++||||+++++|.
T Consensus 9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 87 (256)
T cd05112 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLS 87 (256)
T ss_pred EeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHH
Confidence 34689999999999998778899999987543 23467889999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceec
Q 008216 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (573)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 433 (573)
+++... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+........... ..
T Consensus 88 ~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~-~~ 160 (256)
T cd05112 88 DYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS-TG 160 (256)
T ss_pred HHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc-CC
Confidence 998642 24578999999999999999999999 999999999999999999999999999876543221111 11
Q ss_pred cCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
..++..|+|||.+.+..++.++||||||+++|||++ |..||....... ... ...... ....
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~---~~~~~~---~~~~--------- 222 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVE---TINAGF---RLYK--------- 222 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHH---HHhCCC---CCCC---------
Confidence 125678999999988889999999999999999998 999987644321 111 000000 0000
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 548 (573)
+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 223 --~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 --PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1113467999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=325.26 Aligned_cols=246 Identities=24% Similarity=0.345 Sum_probs=202.4
Q ss_pred CeeecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
.-+||+|.||+||.|++.+ ...+|||-+........+-+..|+.+.++|+|.|||+++|.+.+++..-|.||.++||+|
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 3478999999999999654 568999999888777778899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC-CCCCeeEecccCCccCCcccccc
Q 008216 353 DRWLHHIPRGGRSL--DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 353 ~~~l~~~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
.++|+.. -+++ ++.++-.+.+||++||.|||++ .|||||||-+|||++ -.|.+||+|||-++.+..-..-
T Consensus 660 SsLLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~- 732 (1226)
T KOG4279|consen 660 SSLLRSK---WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC- 732 (1226)
T ss_pred HHHHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcc-
Confidence 9999752 2445 7888999999999999999999 999999999999996 4678999999999877533222
Q ss_pred ceeccCCcccccccccccCC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVYRN--ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
+....||..|||||++..+ .|+.++|||||||++.||.||++||........ +. .+-+-+
T Consensus 733 -TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------AM--FkVGmy--------- 794 (1226)
T KOG4279|consen 733 -TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------AM--FKVGMY--------- 794 (1226)
T ss_pred -ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------hh--hhhcce---------
Confidence 2233499999999999865 588999999999999999999999976543210 00 000000
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.. -...+.+.+.+...+|.+|+.+||.+||++.++++
T Consensus 795 Kv-HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 795 KV-HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ec-CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 00 11224567889999999999999999999999986
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=307.22 Aligned_cols=264 Identities=20% Similarity=0.322 Sum_probs=208.3
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++.+.+++..++||||+++++
T Consensus 9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06640 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCc
Confidence 345799999999999964 58899999987543 3445778999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++.. ..+++.++..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......... .
T Consensus 89 L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~--~ 158 (277)
T cd06640 89 ALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--R 158 (277)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCccc--c
Confidence 9999863 3588899999999999999999999 9999999999999999999999999999765433211 1
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
....++..|+|||.+.+..++.++|+||||+++|||+||..||.......... . ... ...
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~----------~~~----~~~ 218 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF------L----------IPK----NNP 218 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh------h----------hhc----CCC
Confidence 12237888999999988889999999999999999999999997654321100 0 000 001
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCchhhhhhhhhccc
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKLLFKGLDRLR 567 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~ 567 (573)
.......+..+.+++.+||+.+|++||+++++++.---......+..+-..++|++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~~~~ 274 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTELIDRFK 274 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchhhhHHHHHHHHHH
Confidence 11223466789999999999999999999999876433333333455555555443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=326.73 Aligned_cols=261 Identities=18% Similarity=0.249 Sum_probs=194.3
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC-----ceEEEEE
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-----DRYIVYE 345 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv~e 345 (573)
.+.||+|+||.||++.. .+|+.||||.+... .....+.+.+|+.+++.++||||+++++++...+ ..++|||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 84 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE 84 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence 45679999999999996 46899999998653 2334567889999999999999999999998776 7899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|+. ++|.+++.. ...+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 85 LMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred ccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 995 678887743 35689999999999999999999999 9999999999999999999999999999865432
Q ss_pred ccccceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccc------
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY------ 498 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------ 498 (573)
.... .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+......... ........
T Consensus 157 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~---~~~g~~~~~~~~~~ 232 (372)
T cd07853 157 ESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT---DLLGTPSLEAMRSA 232 (372)
T ss_pred cccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH---HHcCCCCHHHHHHh
Confidence 2211 1122378899999998764 47899999999999999999999998765432111110 00000000
Q ss_pred ----ccccccccccCC----CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 499 ----LELLDPLISSLS----SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 499 ----~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
...+........ ........++++.+|+.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000 000011235678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=305.80 Aligned_cols=246 Identities=22% Similarity=0.322 Sum_probs=198.8
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
.+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.++++++||||+++++.+.+.+..+++|||+++++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 84 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD 84 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCc
Confidence 457899999999999854 6889999998643 33445678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++.. ..+..+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||.+..........
T Consensus 85 l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~-- 157 (255)
T cd08219 85 LMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA-- 157 (255)
T ss_pred HHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccccc--
Confidence 9998864 2345588999999999999999999999 99999999999999999999999999987654322111
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
....+++.|+|||++.+..++.++|+||||+++|+|++|..||...+... .. .... ....
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~---~~~~-~~~~------------- 217 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN---LI---LKVC-QGSY------------- 217 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH---HH---HHHh-cCCC-------------
Confidence 12238889999999988889999999999999999999999997643211 10 0000 0000
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
...+...+..+.+++.+||+.||++||++.+|+..
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00112345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=320.70 Aligned_cols=264 Identities=22% Similarity=0.303 Sum_probs=193.4
Q ss_pred cCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC------
Q 008216 268 KNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------ 338 (573)
Q Consensus 268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 338 (573)
++| ...+.||+|+||.||++.. .+|+.||||++... .......+.+|+.+++.++||||+++++++...+
T Consensus 21 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 21 KRY-QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hce-EEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 444 3456789999999999986 45899999999654 2334567889999999999999999999886543
Q ss_pred ceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccC
Q 008216 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (573)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 418 (573)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999965 6666653 2478889999999999999999999 999999999999999999999999999
Q ss_pred CccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccc-hhhHHh---------
Q 008216 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEW--------- 488 (573)
Q Consensus 419 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~--------- 488 (573)
++........ ....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.... ......
T Consensus 170 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 170 ARTACTNFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccccCccC---CCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 9764332211 122389999999999999999999999999999999999999986543210 000000
Q ss_pred ------hhhhhhcc-c-----cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 489 ------ATPLVQSH-R-----YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 489 ------~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
........ . ..+........ .........++.+.+|+.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFP-SESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccc-cccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 0 00000000000 0000111234678999999999999999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=307.79 Aligned_cols=254 Identities=22% Similarity=0.350 Sum_probs=190.4
Q ss_pred eecccCceEEEEEEeCCC---CEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 276 LLGDSKTGGTYSGILPDG---SRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
.||+|+||.||+|...++ ..+++|.++... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 479999999999985443 356677776543 3445789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++..........+...+..++.||+.||+|||+. +++||||||+|||++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999975433334567778889999999999999999 9999999999999999999999999998643222111111
Q ss_pred eccCCcccccccccccC-------CCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccc
Q 008216 432 VMAGGTYGYLAPEFVYR-------NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (573)
....++..|+|||++.. ..++.++||||||+++|||++ |..||....... ... .... .......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~---~~~~-~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VLN---HVIK-DQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHh-hcccccCC
Confidence 22337889999998753 245789999999999999997 577876544321 111 1111 11111122
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008216 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548 (573)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 548 (573)
+.+ ....++.+.+++..|| .+|++||++++|++.|.
T Consensus 232 ~~~--------~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQL--------ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred Ccc--------CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 211 1124467888999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=324.35 Aligned_cols=249 Identities=19% Similarity=0.222 Sum_probs=194.3
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
+..+.||+|+||.||++... +++.||+|++.+. .......+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 46 ~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05621 46 DVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYM 125 (370)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCC
Confidence 33457899999999999964 5889999999653 2223456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 126 ~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 126 PGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 99999999864 3478899999999999999999999 999999999999999999999999999987643222
Q ss_pred ccceeccCCcccccccccccCC----CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRN----ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (573)
. ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...+.... ..........
T Consensus 198 ~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~~~i~~~~~~----- 265 (370)
T cd05621 198 V-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------YSKIMDHKNS----- 265 (370)
T ss_pred e-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCcc-----
Confidence 1 11233499999999998754 378899999999999999999999976543210 0111100000
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 008216 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSM--RPRMSHVVHQ 546 (573)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 546 (573)
+ ........+..+.+++.+|+..+|.+ ||++.|+++.
T Consensus 266 --~----~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 --L----NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred --c----CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 00111234567889999999865543 8999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=328.53 Aligned_cols=249 Identities=20% Similarity=0.233 Sum_probs=193.9
Q ss_pred CCeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 273 GNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
..+.||+|+||.||+++. .+++.||||++.... ......+.+|+.+|++++||||+++++.+.+++..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (376)
T cd05598 5 KIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (376)
T ss_pred EEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCC
Confidence 345789999999999995 458999999996542 1234567899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc-
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM- 427 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 427 (573)
+|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 85 ~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 85 GGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999999864 34588899999999999999999999 999999999999999999999999999753210000
Q ss_pred ----------------------------------------ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHH
Q 008216 428 ----------------------------------------QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467 (573)
Q Consensus 428 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~el 467 (573)
........||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0000123489999999999999999999999999999999
Q ss_pred HcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCC---CHHHHH
Q 008216 468 VSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP---RMSHVV 544 (573)
Q Consensus 468 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl 544 (573)
++|+.||........... ... .. ... ........+..+.+++.+|+ .+|.+|+ ++.+++
T Consensus 238 l~G~~Pf~~~~~~~~~~~------i~~---~~----~~~----~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 238 LVGQPPFLADTPAETQLK------VIN---WE----TTL----HIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred hhCCCCCCCCCHHHHHHH------Hhc---cC----ccc----cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 999999987653211110 000 00 000 00111234567888999876 5999999 888888
Q ss_pred HH
Q 008216 545 HQ 546 (573)
Q Consensus 545 ~~ 546 (573)
+.
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 64
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=309.37 Aligned_cols=247 Identities=20% Similarity=0.271 Sum_probs=195.4
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.++||+|+||+||++.. .+++.||+|.+..... .....+.+|+.++++++|+||+++.+.+.+++..+++|||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 35789999999999986 4688999999975432 2234578899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
++|.+++.. .....+++..+..++.|++.||.|||++ +|+||||||+||++++++.++|+|||++.........
T Consensus 85 ~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 158 (285)
T cd05632 85 GDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI- 158 (285)
T ss_pred ccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc-
Confidence 999988864 2234699999999999999999999999 9999999999999999999999999998765422111
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
....|+..|+|||.+.+..++.++|+||||+++|||++|..||............ ..... ..
T Consensus 159 --~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~---~~~~~-----~~-------- 220 (285)
T cd05632 159 --RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV---DRRVL-----ET-------- 220 (285)
T ss_pred --cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhhh-----cc--------
Confidence 1224899999999998888999999999999999999999999765432111000 00000 00
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH 545 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 545 (573)
........+..+.+|+.+||+.||++||+ ++++++
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 221 -EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 00011224457899999999999999999 556665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=305.92 Aligned_cols=253 Identities=21% Similarity=0.295 Sum_probs=198.0
Q ss_pred hhcCCCcCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEE
Q 008216 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (573)
Q Consensus 266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 344 (573)
.++++... .+||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++++
T Consensus 6 ~~~~~~~~-~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 6 EYDENGER-VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred ccccCCce-EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34455443 46799999999999954 57889999998776666778999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-CCCeeEecccCCcc
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSL--DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKF 421 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~~~~ 421 (573)
||+++++|.+++... ...+ ++..+..++.|++.||+|||++ +++||||||+||+++. ++.++|+|||.+..
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 85 EQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred ecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999998742 1234 7888899999999999999999 9999999999999976 67899999999876
Q ss_pred CCccccccceeccCCcccccccccccCCC--CCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 422 VPWEVMQERTVMAGGTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
....... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||......... .+...
T Consensus 159 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~-------- 225 (268)
T cd06624 159 LAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVG-------- 225 (268)
T ss_pred cccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhh--------
Confidence 5432211 11223788999999986643 788999999999999999999998754321100 00000
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.... ....+...++++.+++.+||+.+|++|||+.++++
T Consensus 226 --~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 226 --MFKI-----HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --hhcc-----CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0000 00112234567999999999999999999999985
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=341.86 Aligned_cols=259 Identities=22% Similarity=0.299 Sum_probs=201.0
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
..+.||+|+||.||+|... +|+.||||+++... ....+++.+|++++++++||||+++++++.+++..+++|||++
T Consensus 6 Ii~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~e 85 (932)
T PRK13184 6 IIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIE 85 (932)
T ss_pred EEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCC
Confidence 3457899999999999964 58999999997542 2235678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCcc
Q 008216 349 NGPLDRWLHHIPR-------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 349 ~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 421 (573)
|++|.+++..... .....++..++.++.||+.||+|||++ +|+||||||+||+++.++.++|+|||+++.
T Consensus 86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk~ 162 (932)
T PRK13184 86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIF 162 (932)
T ss_pred CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCccee
Confidence 9999999864211 123456778899999999999999999 999999999999999999999999999986
Q ss_pred CCccccc----------------cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhh
Q 008216 422 VPWEVMQ----------------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI 485 (573)
Q Consensus 422 ~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~ 485 (573)
....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...+.....
T Consensus 163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~-- 240 (932)
T PRK13184 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS-- 240 (932)
T ss_pred cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh--
Confidence 5211100 0011134899999999999999999999999999999999999999764321100
Q ss_pred HHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhcccC
Q 008216 486 FEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-RMSHVVHQLQQLAQ 552 (573)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~ 552 (573)
... ....+. ...+....++.+.+++.+|++.||++|| +++++++.|+...+
T Consensus 241 --------~~~---~i~~P~-----~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 241 --------YRD---VILSPI-----EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred --------hhh---hccChh-----hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000 000000 0011123456789999999999999995 67778888876644
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=310.43 Aligned_cols=258 Identities=21% Similarity=0.301 Sum_probs=213.2
Q ss_pred CCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 270 FSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 270 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
.+...+-||+|.|+.|-+|+. =+|++||||++.+... .....+.+|++.|+.++|||||++|.+.......|||+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 344456789999999999873 3799999999987633 3356789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC-CCCCeeEecccCCccCCcc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~ 425 (573)
-++|+|.+|+-. ....+.+....+++.||+.|+.|+|+. .+|||||||+||.+- .-|-+||.|||++..+.+.
T Consensus 99 GD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 99 GDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred cCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999964 446799999999999999999999999 999999999998875 5577999999999877544
Q ss_pred ccccceeccCCcccccccccccCCCCC-cchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
. .....+|+..|.|||++.+..|+ ++.||||||||||.|+.|++||+..++.+-. ..++|-
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDC 234 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDC 234 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhcc
Confidence 3 33345699999999999999886 7899999999999999999999877654211 112221
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcccCCCchh
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLAQPPVTK 557 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~~~~~ 557 (573)
.-.-+...+.+.++||..||..||.+|.+.+||.. .|+...+++.+.
T Consensus 235 ------KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~ 283 (864)
T KOG4717|consen 235 ------KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTA 283 (864)
T ss_pred ------cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCcccc
Confidence 11223457889999999999999999999999985 566666666664
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=316.41 Aligned_cols=259 Identities=25% Similarity=0.384 Sum_probs=202.9
Q ss_pred cCCeeecccCceEEEEEEeC--------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceE
Q 008216 272 EGNRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY 341 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 341 (573)
...+.||+|+||.||++... .+..||+|.++... ....+++.+|+.+++++ +||||+++++++...+..+
T Consensus 15 ~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 94 (334)
T cd05100 15 TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 94 (334)
T ss_pred eecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceE
Confidence 44567899999999999742 12369999887542 33456889999999999 8999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC
Q 008216 342 IVYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409 (573)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~ 409 (573)
++|||+++|+|.+++..... ....+++.+++.++.|++.||+|||++ +++||||||+||+++.++
T Consensus 95 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~~~~ 171 (334)
T cd05100 95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDN 171 (334)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCC
Confidence 99999999999999875321 224578899999999999999999999 999999999999999999
Q ss_pred CeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHh
Q 008216 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEW 488 (573)
Q Consensus 410 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 488 (573)
.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...+......
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~---- 247 (334)
T cd05100 172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK---- 247 (334)
T ss_pred cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH----
Confidence 999999999986543222111222224568999999998899999999999999999998 888987654321111
Q ss_pred hhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 489 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
.. ..... .. .+...+.++.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 248 --~~-~~~~~------------~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 248 --LL-KEGHR------------MD-KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred --HH-HcCCC------------CC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 00 00000 00 1112345799999999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.20 Aligned_cols=237 Identities=23% Similarity=0.296 Sum_probs=189.6
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeCCceEEEEEecC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
.++||+|+||.||++... +|+.||+|+++... ....+.+..|..++..+. |++|+++.+++.+.+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~ 84 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence 357899999999999854 68999999997542 223456778888988885 5778889999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+|+|.+++.. ...+++.++..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~- 156 (323)
T cd05615 85 GGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV- 156 (323)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-
Confidence 9999998854 34589999999999999999999999 999999999999999999999999999875432221
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...+... ..... .. ..
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i---~~-~~----------- 217 (323)
T cd05615 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQSI---ME-HN----------- 217 (323)
T ss_pred -cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHH---Hh-CC-----------
Confidence 1122348999999999998899999999999999999999999998654321 11110 00 00
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM 540 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 540 (573)
...+...+.++.+++.+||+.||.+|++.
T Consensus 218 ---~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 ---VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 00112234678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=324.12 Aligned_cols=263 Identities=17% Similarity=0.185 Sum_probs=196.8
Q ss_pred CcCCeeecccCceEEEEEEeC---CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 271 SEGNRLLGDSKTGGTYSGILP---DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
++..+.||+|+||.||++... .+..||+|.+... ....+|+.+|++++||||+++++++...+..+++||++
T Consensus 94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 168 (392)
T PHA03207 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY 168 (392)
T ss_pred eEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc
Confidence 344567899999999999743 3678999988654 23568999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
. ++|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.++|+|||++........
T Consensus 169 ~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 169 K-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred C-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 4 688888842 35689999999999999999999999 999999999999999999999999999976654333
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccc---------
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY--------- 498 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------- 498 (573)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.................+....
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 22223344899999999999889999999999999999999999999765432211111111110000000
Q ss_pred -----cccccccccc--CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 499 -----LELLDPLISS--LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 499 -----~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
.......... ..........+.++.++|.+||..||++|||+.|++..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 00000111234578899999999999999999999865
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=293.01 Aligned_cols=245 Identities=20% Similarity=0.347 Sum_probs=198.8
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccc--------hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEE
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--------FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 343 (573)
.++||.|..+.|-+... ++|..+|+|++.... ..-.+.-.+|+.+|+++ .||+|+++.++++.+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 45779999999887764 568899999985321 11134567899999998 799999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCC
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 423 (573)
+|.|+.|.|.++|.. ...++++...+|+.|+..|+.|||.+ +|+||||||+|||++++.++||+|||++..+.
T Consensus 102 Fdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccC
Confidence 999999999999964 46799999999999999999999999 99999999999999999999999999999876
Q ss_pred ccccccceeccCCcccccccccccC------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccc
Q 008216 424 WEVMQERTVMAGGTYGYLAPEFVYR------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 497 (573)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 497 (573)
.... ....+|||+|.|||.+.- ..|+...|+||.|||+|-|+.|.+||......-. ..+..+++
T Consensus 175 ~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM-------LR~ImeGk 244 (411)
T KOG0599|consen 175 PGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM-------LRMIMEGK 244 (411)
T ss_pred Cchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH-------HHHHHhcc
Confidence 5433 334569999999998852 3678899999999999999999999975332110 11111221
Q ss_pred cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+. . ......+.+..+.+||.+||+.||.+|.|++|+++
T Consensus 245 yq-F---------~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 245 YQ-F---------RSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred cc-c---------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11 0 22234567788999999999999999999999986
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=304.32 Aligned_cols=237 Identities=27% Similarity=0.431 Sum_probs=189.7
Q ss_pred eecccCceEEEEEEeCCCC-----------EEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEE
Q 008216 276 LLGDSKTGGTYSGILPDGS-----------RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 344 (573)
.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 5799999999999975433 5888887665433 6788999999999999999999999888 7789999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-------CeeEeccc
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-------GAHLMGVG 417 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-------~~kl~Dfg 417 (573)
||+++++|.+++... ...+++..+..++.||+.||+|||++ +++||||||+||+++.++ .+||+|||
T Consensus 80 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 80 EYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999742 22689999999999999999999999 999999999999999887 79999999
Q ss_pred CCccCCccccccceeccCCcccccccccccCC--CCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhh
Q 008216 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN--ELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQ 494 (573)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 494 (573)
++...... ....++..|+|||++.+. .++.++||||||+++|||++ |..|+...+.........
T Consensus 154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~------- 220 (259)
T cd05037 154 IPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ------- 220 (259)
T ss_pred cccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-------
Confidence 99865431 112267789999998876 78999999999999999999 577776654221111100
Q ss_pred ccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008216 495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548 (573)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 548 (573)
.. .. ...+ ....+.+++.+||..+|.+|||+.+|++.|+
T Consensus 221 ~~-------~~-----~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQ-------HR-----LPMP---DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cC-------CC-----CCCC---CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 00 0000 1157899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=314.81 Aligned_cols=264 Identities=18% Similarity=0.251 Sum_probs=193.4
Q ss_pred eeeccc--CceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 275 RLLGDS--KTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 275 ~~lg~G--~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+||+| ++++||++.. .+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 83 (327)
T cd08227 4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83 (327)
T ss_pred hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence 467999 7899999985 568999999997642 23345677899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc-
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ- 428 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~- 428 (573)
|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.++++||+...........
T Consensus 84 ~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 84 GSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 99999986422 24589999999999999999999999 9999999999999999999999999865433211100
Q ss_pred ----cceeccCCcccccccccccC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhh----h----
Q 008216 429 ----ERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV----Q---- 494 (573)
Q Consensus 429 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~----~---- 494 (573)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ......... .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccccccccch
Confidence 01111236778999999876 4588999999999999999999999976433210 000000000 0
Q ss_pred -ccc-------------ccc--c---cccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 495 -SHR-------------YLE--L---LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 495 -~~~-------------~~~--~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
... ..+ . ..+..............++.+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 000 0 00000000001112235678999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=310.04 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=202.2
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
.+.||+|++|.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 103 (297)
T cd06656 24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 103 (297)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCH
Confidence 34679999999999995 57999999999876555567788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++.. ..+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......... .
T Consensus 104 ~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~--~ 173 (297)
T cd06656 104 TDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--S 173 (297)
T ss_pred HHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc--C
Confidence 999853 3578899999999999999999999 99999999999999999999999999987654332211 1
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
...+++.|+|||.+.+..++.++|+||||+++|++++|+.||...+.... .. .... ......
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~-------------~~~~---~~~~~~ 235 (297)
T cd06656 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LY-------------LIAT---NGTPEL 235 (297)
T ss_pred cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--ee-------------eecc---CCCCCC
Confidence 22378899999999888899999999999999999999999976443110 00 0000 000011
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcccC
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLAQ 552 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~ 552 (573)
..+...+..+.+++.+||+.||++||+++++++ .++...+
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 112234567899999999999999999999997 4444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=306.09 Aligned_cols=246 Identities=21% Similarity=0.300 Sum_probs=195.3
Q ss_pred eeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHH
Q 008216 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 353 (573)
+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+++++|.
T Consensus 15 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (267)
T cd06645 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQ 94 (267)
T ss_pred HHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHH
Confidence 4579999999999985 468899999998765555567889999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceec
Q 008216 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (573)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 433 (573)
+++.. ...+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++........ ....
T Consensus 95 ~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~ 165 (267)
T cd06645 95 DIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA--KRKS 165 (267)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc--cccc
Confidence 98853 34689999999999999999999999 999999999999999999999999999876542211 1122
Q ss_pred cCCccccccccccc---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 434 AGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 434 ~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
..|+..|+|||++. ...++.++|||||||++|+|++|..||........ ... . ... ....+..
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~----~-~~~---~~~~~~~---- 231 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFL----M-TKS---NFQPPKL---- 231 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHh----h-hcc---CCCCCcc----
Confidence 34889999999874 45688899999999999999999999865443110 000 0 000 0000000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
......+..+.+++.+||+.||++||++++|++
T Consensus 232 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 --KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 001123456899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=309.28 Aligned_cols=266 Identities=23% Similarity=0.358 Sum_probs=201.2
Q ss_pred eeecccCceEEEEEEeC-----CCCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCcEeEEeeEEee--CCceEEEEEe
Q 008216 275 RLLGDSKTGGTYSGILP-----DGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEF 346 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~ 346 (573)
+.||+|+||.||++.+. +++.||||.++..... ..+.+.+|++++++++||||+++++++.. ....+++|||
T Consensus 10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 89 (284)
T cd05038 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEY 89 (284)
T ss_pred eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEec
Confidence 56799999999999853 3689999999866443 46789999999999999999999999887 5578999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++++|.+++... ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||.+.......
T Consensus 90 ~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 90 LPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred CCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence 9999999999642 23589999999999999999999999 99999999999999999999999999998765322
Q ss_pred cc-cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 427 MQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 427 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.. .......++..|+|||.+.+..++.++||||||+++|||+||..|+......... ..... ........+...
T Consensus 164 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~----~~~~~-~~~~~~~~~~~~ 238 (284)
T cd05038 164 DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR----MIGIA-QGQMIVTRLLEL 238 (284)
T ss_pred cceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc----ccccc-cccccHHHHHHH
Confidence 11 1111122556799999998888999999999999999999999998654321100 00000 000000000000
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
+........+..++.++.+++.+||+.+|++|||+.||+++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 0000011112234567999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=306.05 Aligned_cols=249 Identities=29% Similarity=0.439 Sum_probs=196.3
Q ss_pred CeeecccCceEEEEEEeCC-CCEEEEEEecccchhhHH--HHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKK--EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|+||+||++.... ++.||+|++......... ...+|+.++++++||||+++++++.+....++|||+++++
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 83 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGG 83 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTE
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccc
Confidence 4678999999999999754 668999999877544332 3456999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. ...+++..+..++.|++.||++||++ +++|+||||+||+++.++.++|+|||.+...... ...
T Consensus 84 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~~ 154 (260)
T PF00069_consen 84 SLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NEN 154 (260)
T ss_dssp BHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST--TSE
T ss_pred cccccccc----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--ccc
Confidence 99999972 35689999999999999999999999 9999999999999999999999999999764111 112
Q ss_pred eeccCCccccccccccc-CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 431 TVMAGGTYGYLAPEFVY-RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
.....++..|+|||++. +...+.++||||+|+++|+|++|..||.................. .....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~-------~~~~~----- 222 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR-------PLPSS----- 222 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT-------HHHHH-----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc-------ccccc-----
Confidence 22233889999999998 788999999999999999999999999876221111111110000 00000
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
..........+.+++.+||+.||++||++.++++
T Consensus 223 --~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 223 --SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --ccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000011267999999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=307.02 Aligned_cols=244 Identities=23% Similarity=0.384 Sum_probs=192.1
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeC------CceEEEEEe
Q 008216 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH------GDRYIVYEF 346 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~------~~~~lv~e~ 346 (573)
+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +||||+++++++... ...+++|||
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 90 (272)
T cd06637 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 90 (272)
T ss_pred HheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence 45799999999999854 58899999987553 3456788999999998 799999999998753 357899999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++++|.+++... ....+++..+..++.|++.||+|||++ +++|+||||+||++++++.++|+|||++.......
T Consensus 91 ~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~ 165 (272)
T cd06637 91 CGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 165 (272)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceeccccc
Confidence 9999999998752 234689999999999999999999999 99999999999999999999999999998654322
Q ss_pred cccceeccCCccccccccccc-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL 501 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (573)
. ......|+..|+|||++. +..++.++|||||||++|||++|+.||.......... .. ...
T Consensus 166 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~------~~-~~~----- 231 (272)
T cd06637 166 G--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------LI-PRN----- 231 (272)
T ss_pred c--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------HH-hcC-----
Confidence 1 112233889999999986 3357889999999999999999999997544321000 00 000
Q ss_pred cccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.. ........+..+.+++.+||..||.+|||+.++++
T Consensus 232 ~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 232 PA-------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CC-------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 11112234567899999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=301.85 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=200.7
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
..+.||+|++|.||++... +++.+|+|.+........+.+.+|+.++++++||||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~ 86 (262)
T cd06613 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGS 86 (262)
T ss_pred EEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCc
Confidence 3457899999999999964 578999999987655567889999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++.. ....+++.++..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++......... .
T Consensus 87 l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~--~ 158 (262)
T cd06613 87 LQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK--R 158 (262)
T ss_pred HHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhhc--c
Confidence 9998864 224689999999999999999999999 9999999999999999999999999998765432211 1
Q ss_pred eccCCcccccccccccCC---CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 432 VMAGGTYGYLAPEFVYRN---ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
....++..|+|||.+.+. .++.++||||||+++|||+||+.||...+.... ... . ... ....+
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~----~-~~~---~~~~~---- 224 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFL----I-SKS---NFPPP---- 224 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----H-Hhc---cCCCc----
Confidence 122378889999998776 788999999999999999999999976543211 000 0 000 00000
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
........+.++.+++.+||+.||.+|||+.+|+.
T Consensus 225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 --KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00112345678999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=305.60 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=198.6
Q ss_pred CeeecccCceEEEEEEeC------CCCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 274 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
.+.||+|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 346799999999999853 3467999998765433 456799999999999999999999999998999999999
Q ss_pred cCCCCHHHHhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCcc
Q 008216 347 VVNGPLDRWLHHIPRG-----GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 421 (573)
+++++|.+++...... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.++++|||++..
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~~ 166 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKD 166 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccccccc
Confidence 9999999999753311 12589999999999999999999999 999999999999999999999999999875
Q ss_pred CCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccc
Q 008216 422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500 (573)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (573)
........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..... ......
T Consensus 167 ~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~----~~~~~~- 237 (275)
T cd05046 167 VYNSEYYK-LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRL----QAGKLE- 237 (275)
T ss_pred cCcccccc-cCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHH----HcCCcC-
Confidence 43222111 111225778999999988888999999999999999999 888986543321 11110 000000
Q ss_pred ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
.......+..+.+++.+||+.||++|||+.++++.|.+
T Consensus 238 -----------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 238 -----------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred -----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 00111244679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=309.59 Aligned_cols=244 Identities=23% Similarity=0.372 Sum_probs=199.4
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
.+.||.|++|.||+|.. .+|+.||+|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 103 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence 34679999999999985 56899999999766555567889999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++.. ..+++.++..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......... ..
T Consensus 104 ~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~ 173 (296)
T cd06655 104 TDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RS 173 (296)
T ss_pred HHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc--CC
Confidence 998853 3589999999999999999999999 9999999999999999999999999998765433221 11
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.... ... ... .. .+ ..
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~~~----~~~-~~-----~~------~~ 235 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL----IAT-NG-----TP------EL 235 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----HHh-cC-----Cc------cc
Confidence 22388899999999888899999999999999999999999976543211 000 000 00 00 00
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
..+...++.+.++|.+||..||++||++.+|++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 112234567899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=301.46 Aligned_cols=244 Identities=24% Similarity=0.381 Sum_probs=198.8
Q ss_pred CeeecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
.+.||+|++|.||+|...+ ++.+++|.++.... .+++.+|++++++++||||+++++.+.+....++++||+++++|
T Consensus 8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 85 (256)
T cd06612 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV 85 (256)
T ss_pred hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcH
Confidence 4467999999999999754 88999999976532 67899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++.. ....+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++......... ..
T Consensus 86 ~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~--~~ 157 (256)
T cd06612 86 SDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--RN 157 (256)
T ss_pred HHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCccc--cc
Confidence 999863 235689999999999999999999999 9999999999999999999999999999876543211 11
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
...++..|+|||++.+..++.++||||||+++|+|++|+.||........ ... .. ....+ ..
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~~~-----~~-----~~~~~------~~ 219 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IFM-----IP-----NKPPP------TL 219 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--hhh-----hc-----cCCCC------CC
Confidence 22378899999999888899999999999999999999999976443210 000 00 00000 00
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
..+...+..+.+++.+||+.||++|||+.+|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 112234567999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=306.97 Aligned_cols=247 Identities=23% Similarity=0.342 Sum_probs=196.8
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
..+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++.+..++..++||||+++++
T Consensus 16 i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 95 (292)
T cd06644 16 IIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGA 95 (292)
T ss_pred hhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCc
Confidence 3446799999999999964 489999999987766667889999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|..++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||++......... .
T Consensus 96 l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~--~ 167 (292)
T cd06644 96 VDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR--R 167 (292)
T ss_pred HHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccccc--c
Confidence 9888753 234589999999999999999999999 9999999999999999999999999998754322111 1
Q ss_pred eccCCccccccccccc-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 432 VMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
....++..|+|||++. ...++.++||||||+++|||++|..||...+... . ....... ..+
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~----~~~~~~~------~~~-- 233 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--V----LLKIAKS------EPP-- 233 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--H----HHHHhcC------CCc--
Confidence 1223788999999885 3456789999999999999999999987644211 0 0000000 000
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....+...+.++.+++.+||+.||++||+++++++
T Consensus 234 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 ----TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ----cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00112234567899999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=309.40 Aligned_cols=262 Identities=21% Similarity=0.356 Sum_probs=199.8
Q ss_pred HHHHHHhhcCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEe--
Q 008216 260 TEELRSITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCY-- 335 (573)
Q Consensus 260 ~~el~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~-- 335 (573)
++.+....++|... +.||+|+||.||++.. .+++.+|+|+++... ....++.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~-~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 10 FDSFPDPSDTWEII-ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred eecCCCcccceeee-eeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34455566666544 4679999999999986 458899999986532 2345688899999999 7999999999874
Q ss_pred ---eCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCee
Q 008216 336 ---DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412 (573)
Q Consensus 336 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 412 (573)
.++..++||||+++++|.+++.........+++..+..++.|++.||.|||++ +++||||||+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 34568999999999999998864333445688999999999999999999999 999999999999999999999
Q ss_pred EecccCCccCCccccccceeccCCcccccccccccC-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHH
Q 008216 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE 487 (573)
Q Consensus 413 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 487 (573)
|+|||++......... .....|++.|+|||++.. ..++.++||||||+++|||++|+.||....... ....
T Consensus 165 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~~ 240 (286)
T cd06638 165 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALFK 240 (286)
T ss_pred EccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHhh
Confidence 9999998765432211 112238899999998753 457889999999999999999999987654311 0000
Q ss_pred hhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 488 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
. . ....+. ...+...+..+.+++.+||+.||++|||+.||++.
T Consensus 241 ----~-~-----~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 241 ----I-P-----RNPPPT------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ----c-c-----ccCCCc------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 0 000000 00111234569999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=320.98 Aligned_cols=240 Identities=23% Similarity=0.283 Sum_probs=186.8
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhc---CCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARL---HHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 277 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
||+|+||.||+|+.. +|+.||||++..... ........|..++..+ +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999864 589999999965422 1223455666777665 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.........
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~- 152 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT- 152 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC-
Confidence 999988853 35689999999999999999999999 9999999999999999999999999998754322211
Q ss_pred ceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.... .. .. ....
T Consensus 153 -~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~---~~---~i-~~~~----------- 213 (330)
T cd05586 153 -TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM---YR---NI-AFGK----------- 213 (330)
T ss_pred -ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH---HH---HH-HcCC-----------
Confidence 1223489999999998754 478999999999999999999999976543211 00 00 0000
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCC----CHHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRP----RMSHVVH 545 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~ 545 (573)
...+....++.+.+++.+||+.||.+|| ++.++++
T Consensus 214 --~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 214 --VRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --CCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0111122456789999999999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=312.03 Aligned_cols=199 Identities=19% Similarity=0.332 Sum_probs=159.8
Q ss_pred CeeecccCceEEEEEEeC---CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEee--CCceEEEEEecC
Q 008216 274 NRLLGDSKTGGTYSGILP---DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEFVV 348 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~ 348 (573)
...||+|+||.||+|... ++..||+|.++... ....+.+|+.++++++||||+++++++.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 346799999999999964 35789999987543 23457889999999999999999998854 456799999985
Q ss_pred CCCHHHHhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee----CCCCCeeEecccCC
Q 008216 349 NGPLDRWLHHIP-----RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLS 419 (573)
Q Consensus 349 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfg~~ 419 (573)
++|.+++.... .....+++..+..++.||+.||+|||++ +++||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 57877764321 1223588999999999999999999999 99999999999999 45678999999999
Q ss_pred ccCCccccc-cceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 008216 420 KFVPWEVMQ-ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVD 478 (573)
Q Consensus 420 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 478 (573)
+........ .......+|+.|+|||++.+ ..++.++||||||+++|||+||++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 876433221 11122337899999999876 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=304.58 Aligned_cols=251 Identities=22% Similarity=0.367 Sum_probs=199.2
Q ss_pred CeeecccCceEEEEEEeCC--CCEEEEEEeccc----------chhhHHHHHHHHHHHhh-cCCCcEeEEeeEEeeCCce
Q 008216 274 NRLLGDSKTGGTYSGILPD--GSRVAVKRLKRS----------SFQRKKEFYSEIGRFAR-LHHPNLVAVKGCCYDHGDR 340 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~ 340 (573)
.+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+.+..
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 84 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL 84 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence 3467999999999999754 688999988532 12234557788888875 6999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCCeeEecccCC
Q 008216 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 419 (573)
+++|||+++++|.+++.........+++..++.++.|++.||.|||+ . +++|+||+|+||+++.++.++|+|||.+
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 85 YIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred EEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEecccce
Confidence 99999999999999886544445678999999999999999999996 5 8999999999999999999999999999
Q ss_pred ccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+... . ..... ...
T Consensus 162 ~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~---~~~~~-~~~-- 229 (269)
T cd08528 162 KQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---L---ATKIV-EAV-- 229 (269)
T ss_pred eeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---H---HHHHh-hcc--
Confidence 8755432 1122338889999999998889999999999999999999999986543211 0 00000 000
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
. ........+..+.+++.+||+.||++||++.|+.+++++
T Consensus 230 ------~----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 230 ------Y----EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ------C----CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 0 011111245679999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=310.48 Aligned_cols=265 Identities=17% Similarity=0.214 Sum_probs=195.1
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
...+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~- 87 (301)
T cd07873 9 IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD- 87 (301)
T ss_pred EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-
Confidence 33456899999999999864 58899999987542 2234567889999999999999999999999999999999996
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
++|.+++.. ....+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.........
T Consensus 88 ~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~- 160 (301)
T cd07873 88 KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT- 160 (301)
T ss_pred cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc-
Confidence 589888864 234588999999999999999999999 9999999999999999999999999999764322211
Q ss_pred ceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccc----
Q 008216 430 RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP---- 504 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 504 (573)
.....+++.|+|||.+.+ ..++.++||||||+++|||+||++||...+...................+...+..
T Consensus 161 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 161 -YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred -ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 111236889999998865 45788999999999999999999999865532111111000000000000000000
Q ss_pred --ccccCCC---CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 505 --LISSLSS---DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 505 --~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....... .......++.+.+||.+||+.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 0011234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=301.44 Aligned_cols=243 Identities=28% Similarity=0.454 Sum_probs=195.6
Q ss_pred CCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
..+.||+|+||.||++.. +++.||+|.++... ..+.+.+|+.++++++||||+++++++... ..+++|||+++++|
T Consensus 10 ~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L 85 (254)
T cd05083 10 LGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNL 85 (254)
T ss_pred eeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCH
Confidence 345789999999999986 78899999987643 346788999999999999999999998654 57999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++... ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~----- 155 (254)
T cd05083 86 VNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD----- 155 (254)
T ss_pred HHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccCC-----
Confidence 9999752 234588999999999999999999999 999999999999999999999999999875432111
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
....+..|+|||.+.+..++.++|+||||+++|||++ |+.||...+....... ..... .
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-------~~~~~-------------~ 215 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC-------VEKGY-------------R 215 (254)
T ss_pred CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-------HhCCC-------------C
Confidence 1124567999999988889999999999999999998 9999876543211110 00000 0
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
..+....+..+.+++.+||+.+|++||++++|++.|++
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 01112345678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=310.47 Aligned_cols=243 Identities=23% Similarity=0.364 Sum_probs=197.6
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHHH
Q 008216 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 354 (573)
.||+|+||.||++... ++..||||.+........+.+.+|+.++++++||||+++++.+...+..++||||+++++|.+
T Consensus 29 ~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~ 108 (292)
T cd06658 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD 108 (292)
T ss_pred cccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHH
Confidence 4799999999999864 588999999977655666778999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceecc
Q 008216 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (573)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 434 (573)
++.. ..+++..+..++.||+.||+|||++ +++||||||+||+++.++.++|+|||++.......... ...
T Consensus 109 ~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~--~~~ 178 (292)
T cd06658 109 IVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR--KSL 178 (292)
T ss_pred HHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC--cee
Confidence 8853 3588999999999999999999999 99999999999999999999999999987653322111 122
Q ss_pred CCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCc
Q 008216 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 514 (573)
Q Consensus 435 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (573)
.++..|+|||.+.+..++.++||||||+++|||++|+.||...+.... .... ...+.+.. ..
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~~---------~~~~~~~~------~~ 240 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---MRRI---------RDNLPPRV------KD 240 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH---------HhcCCCcc------cc
Confidence 388899999999888899999999999999999999999976443210 0000 00111111 01
Q ss_pred chHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 515 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 515 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
....+..+.+++.+||..||++|||++++++.
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11244578899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=302.30 Aligned_cols=248 Identities=25% Similarity=0.442 Sum_probs=197.2
Q ss_pred CCeeecccCceEEEEEEeCCCCEEEEEEecccc------hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS------FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
..+.||+|+||.||+|...+|+.+|||.++... ......+.+|+.++++++|+||+++++++.+.+..++++||
T Consensus 4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence 345789999999999998889999999986432 12235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 84 VPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 999999999964 24578999999999999999999999 99999999999999999999999999987653211
Q ss_pred c----ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccc
Q 008216 427 M----QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502 (573)
Q Consensus 427 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (573)
. ........++..|+|||.+.+..++.++||||||+++|+|++|..||...+... .... .... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~----~~~~---~~~~ 227 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFY----IGAH---RGLM 227 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHH----hhhc---cCCC
Confidence 1 111112338889999999988889999999999999999999999997644221 0000 0000 0000
Q ss_pred ccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+ ..+...+..+.+++.+||+.+|++||++.++++
T Consensus 228 -~--------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 -P--------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -C--------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 011234567899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=320.60 Aligned_cols=252 Identities=19% Similarity=0.235 Sum_probs=194.5
Q ss_pred cCCCcCCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEE
Q 008216 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 343 (573)
++|.. .+.||+|+||.||++... +++.||+|++.... ......+.+|..+++.++||||+++++.+.+++..++|
T Consensus 43 ~~y~i-~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 43 EDYEV-VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhcEE-EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 44443 467899999999999964 58899999986532 22345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCC
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 423 (573)
|||+++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 122 ~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 122 MEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 999999999999864 3488889999999999999999999 99999999999999999999999999998664
Q ss_pred ccccccceeccCCcccccccccccCC----CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 424 WEVMQERTVMAGGTYGYLAPEFVYRN----ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+... .. .........
T Consensus 194 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~---~~i~~~~~~- 265 (371)
T cd05622 194 KEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---TY---SKIMNHKNS- 265 (371)
T ss_pred cCCccc-ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH---HH---HHHHcCCCc-
Confidence 332211 1223499999999998754 37889999999999999999999998654321 00 111100000
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSM--RPRMSHVVHQ 546 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 546 (573)
. ........+..+.++|.+||..++.+ ||+++++++.
T Consensus 266 ------~----~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 266 ------L----TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred ------c----cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 0 00111235567899999999844433 7899988874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=304.55 Aligned_cols=242 Identities=21% Similarity=0.336 Sum_probs=197.9
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++.++...++|+||+++++|
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 86 (274)
T cd06609 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSC 86 (274)
T ss_pred hhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcH
Confidence 45799999999999964 58899999987653 34456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++.. ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||+++........ ..
T Consensus 87 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~--~~ 156 (274)
T cd06609 87 LDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK--RN 156 (274)
T ss_pred HHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccccc--cc
Confidence 999864 2689999999999999999999999 9999999999999999999999999999876543211 11
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
...++..|+|||.+.+..++.++||||||+++|+|+||+.||...+..... .. .... .. ..
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~------~~-~~~~-----~~-------~~ 217 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL------FL-IPKN-----NP-------PS 217 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH------HH-hhhc-----CC-------CC
Confidence 223788999999999888999999999999999999999999765421100 00 0000 00 11
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
......+..+.+++.+||..||++|||++++++
T Consensus 218 ~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111114567999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=303.05 Aligned_cols=254 Identities=26% Similarity=0.428 Sum_probs=197.3
Q ss_pred CeeecccCceEEEEEEeC----CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC------ceE
Q 008216 274 NRLLGDSKTGGTYSGILP----DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRY 341 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~ 341 (573)
.++||+|+||.||+|... +++.||||+++.. .....+++.+|+.++++++||||+++++++.... ..+
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence 446899999999999853 3689999999764 2334567889999999999999999999886542 237
Q ss_pred EEEEecCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCC
Q 008216 342 IVYEFVVNGPLDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (573)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 419 (573)
+++||+.+|+|.+++.... .....++...+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECccccc
Confidence 8999999999998875322 1223578899999999999999999999 9999999999999999999999999999
Q ss_pred ccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccc
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRY 498 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 498 (573)
+...............+++.|++||.+....++.++||||||+++|||++ |++||...+... ..... .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~---~~~~~- 233 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYL---IKGNR- 233 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHH---HcCCc-
Confidence 86643322222222235678999999988889999999999999999999 889987654321 11100 00000
Q ss_pred ccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
. ......+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 234 -------~------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 -------L------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -------C------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00112446799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=301.92 Aligned_cols=245 Identities=24% Similarity=0.427 Sum_probs=196.2
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccchh---------hHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEE
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---------RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 343 (573)
...||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..+++
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEE
Confidence 357899999999999863 5889999988654221 125678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCC
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 423 (573)
|||+++++|.+++.. ...+++..+..++.|++.||+|||++ +++||||+|+||++++++.++|+|||.++...
T Consensus 85 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 85 LEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 999999999999964 24588899999999999999999999 99999999999999999999999999998765
Q ss_pred cccccc----ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 424 WEVMQE----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 424 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
...... ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.. .... .. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~----~~------~ 225 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QAIF----KI------G 225 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HHHH----HH------h
Confidence 321111 111223788999999998888999999999999999999999999764321 1110 00 0
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.... ...+...+..+.+++.+||+.||++||++.+|++
T Consensus 226 ~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 ENAS--------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ccCC--------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0000 0111234567999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=306.08 Aligned_cols=264 Identities=22% Similarity=0.323 Sum_probs=194.5
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|++|.||+|... +++.||||.++... ......+.+|+.++++++||||+++++++.+++..++||||++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-M 83 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-C
Confidence 346799999999999964 68999999986542 2234678899999999999999999999999999999999996 6
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++..... +..+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||++.........
T Consensus 84 ~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-- 157 (285)
T cd07861 84 DLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV-- 157 (285)
T ss_pred CHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc--
Confidence 89888865332 35689999999999999999999999 9999999999999999999999999998765432111
Q ss_pred eeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccch-hhHHhhhh----hhhc----ccccc
Q 008216 431 TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATP----LVQS----HRYLE 500 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~~----~~~~----~~~~~ 500 (573)
.....+++.|+|||.+.+. .++.++||||||+++|+|+||++||......... ........ .... .....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 1112368899999988654 5788999999999999999999999765432100 00000000 0000 00000
Q ss_pred ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
......... ........++++.++|.+||+.||++|||+.+|++
T Consensus 238 ~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 238 TFPKWKKGS-LRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hccccCcch-hHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 00001124567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=314.44 Aligned_cols=250 Identities=20% Similarity=0.209 Sum_probs=192.3
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|+||.||++... +++.||+|++.+.. ....+.+.+|..++..++|+||+++++++.+++..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (331)
T cd05597 6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVG 85 (331)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCC
Confidence 457899999999999964 58999999997532 22345688899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..........
T Consensus 86 ~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 86 GDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred CcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 999999863 234689999999999999999999999 99999999999999999999999999987654332211
Q ss_pred ceeccCCcccccccccccC-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
. ....||+.|+|||++.. ..++.++|||||||++|||++|+.||...+.... ............
T Consensus 160 ~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~---- 228 (331)
T cd05597 160 S-NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKEHFQ---- 228 (331)
T ss_pred c-cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCCCccc----
Confidence 1 12238999999999863 4578899999999999999999999976442211 111111000000
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCC--CCCCHHHHHHH
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPS--MRPRMSHVVHQ 546 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~ 546 (573)
........++.+.+++.+|+..+++ .||+++++++.
T Consensus 229 ------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 ------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0001112456789999998865443 37899988875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.50 Aligned_cols=260 Identities=20% Similarity=0.179 Sum_probs=190.6
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
.+.||+|+||.||++... .++.||||.... ..+.+|+.+|++++||||+++++++...+..++|||++ .++|
T Consensus 174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L 246 (461)
T PHA03211 174 HRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDL 246 (461)
T ss_pred EEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCH
Confidence 456899999999999965 478999996432 23568999999999999999999999999999999999 5788
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++.. ....+++.+++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++............
T Consensus 247 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 247 YTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 888853 224699999999999999999999999 99999999999999999999999999998654332221222
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccc-----hhhHHhhhhhhh-ccccccccc---
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-----QSIFEWATPLVQ-SHRYLELLD--- 503 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-----~~~~~~~~~~~~-~~~~~~~~~--- 503 (573)
...||..|+|||++.+..++.++|||||||++|||++|..|+........ ..+......... ...+.....
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 23489999999999999999999999999999999998876543321110 111111110000 000000000
Q ss_pred -----c-----ccccCCCCCc--chHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 504 -----P-----LISSLSSDIP--EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 504 -----~-----~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
. .......... ....+..+.+||.+||+.||.+|||+.|+++.
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 0000000000 01233578899999999999999999999864
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=304.51 Aligned_cols=242 Identities=21% Similarity=0.346 Sum_probs=196.8
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
+.||+|++|.||+|... +++.||+|.++... ....+.+.+|+.++++++||||+++++.+..++..++||||+++++|
T Consensus 10 ~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (277)
T cd06642 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA 89 (277)
T ss_pred HHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcH
Confidence 35799999999999854 57899999987543 33456789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++.. ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++.......... .
T Consensus 90 ~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~--~ 159 (277)
T cd06642 90 LDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--N 159 (277)
T ss_pred HHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchhh--h
Confidence 998853 4588999999999999999999999 99999999999999999999999999997664332111 1
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
...++..|+|||++.+..++.++||||||+++|||++|+.|+.......... . .. ... ..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~-~~-----~~~--------~~ 219 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF------L-IP-----KNS--------PP 219 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh------h-hh-----cCC--------CC
Confidence 2237889999999998889999999999999999999999987543321000 0 00 000 00
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
......+..+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1112345679999999999999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=320.60 Aligned_cols=247 Identities=19% Similarity=0.227 Sum_probs=192.7
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|+||.||++... +++.||||+++... ......+.+|+.++.+++||||+++++.+.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG 85 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 457899999999999864 58999999997532 22345678899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc-
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ- 428 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~- 428 (573)
|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.........
T Consensus 86 g~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 86 GDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999864 34689999999999999999999999 9999999999999999999999999998754321100
Q ss_pred --------------------------------cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 008216 429 --------------------------------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476 (573)
Q Consensus 429 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 476 (573)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 001123489999999999999999999999999999999999999976
Q ss_pred CCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCC---HHHHHH
Q 008216 477 VDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR---MSHVVH 545 (573)
Q Consensus 477 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 545 (573)
.+...... ...... . .+ ...+....++++.++|.+++. ||.+|++ ++++++
T Consensus 239 ~~~~~~~~------~i~~~~---~----~~----~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 239 ETPQETYR------KVMNWK---E----TL----VFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCHHHHHH------HHHcCC---C----ce----ecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 55421100 000000 0 00 000111245678899998774 9999985 566654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=306.37 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=198.9
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
+.||+|++|+||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 11 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (284)
T cd06620 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL 90 (284)
T ss_pred HHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCH
Confidence 46799999999999954 58899999886542 33457889999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
.+++.. ...+++..+..++.+++.||.|||+ . +++||||||+||++++++.++|+|||++........
T Consensus 91 ~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~---- 159 (284)
T cd06620 91 DRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA---- 159 (284)
T ss_pred HHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc----
Confidence 998854 3468999999999999999999997 5 899999999999999999999999999875432211
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccc-----hhhHHhhhhhhhcccccccccccc
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-----QSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
....|+..|+|||++.+..++.++||||||+++|+++||..||........ ......... ..
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-------------~~ 226 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ-------------IV 226 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH-------------Hh
Confidence 123489999999999888899999999999999999999999986543210 011111111 11
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 547 (573)
.......+....+..+.+++.+||+.||++|||+.|+++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11011122223556799999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=304.00 Aligned_cols=246 Identities=24% Similarity=0.360 Sum_probs=197.8
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHH
Q 008216 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 353 (573)
+.||.|++|.||++... ++..+|+|+++.......+.+.+|+.++++++||||+++++.+.+.+..++||||+++++|.
T Consensus 11 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (280)
T cd06611 11 GELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALD 90 (280)
T ss_pred HHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHH
Confidence 35799999999999964 58999999998776666778999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceec
Q 008216 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (573)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 433 (573)
+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++......... ...
T Consensus 91 ~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~ 162 (280)
T cd06611 91 SIMLE---LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDT 162 (280)
T ss_pred HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccccc--cce
Confidence 99864 234689999999999999999999999 9999999999999999999999999998765432211 112
Q ss_pred cCCccccccccccc-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 434 AGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 434 ~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
..++..|+|||.+. ...++.++||||||+++|||++|+.||...+... ... .. ... ..+
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~----~~-~~~-----~~~---- 226 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLL----KI-LKS-----EPP---- 226 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHH----HH-hcC-----CCC----
Confidence 23888999999875 3456789999999999999999999997654321 000 00 000 000
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
....+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 --TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 001112345678999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=317.17 Aligned_cols=265 Identities=20% Similarity=0.271 Sum_probs=193.9
Q ss_pred hcCCCcCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC------
Q 008216 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------ 337 (573)
Q Consensus 267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------ 337 (573)
.++|.. .+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQN-LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeE-EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 344443 457799999999999854 5889999999754 233456788999999999999999999987543
Q ss_pred CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEeccc
Q 008216 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (573)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 417 (573)
...++||||++ ++|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 35699999995 47777764 2478889999999999999999999 99999999999999999999999999
Q ss_pred CCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchh-hHHhh-------
Q 008216 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWA------- 489 (573)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~------- 489 (573)
+++........ ....+|..|+|||++.+..++.++|||||||++|||++|+.||...+...... .....
T Consensus 172 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 172 LARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CccccCCCCcc---cCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99865432211 12238999999999999999999999999999999999999997655321110 00000
Q ss_pred ----h----hhhhc-ccc-----ccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 490 ----T----PLVQS-HRY-----LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 490 ----~----~~~~~-~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
. ..... ... .+......... ...........+.+++.+||+.||.+|||+.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPA-DSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccc-cccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 00000 000 00000000000 000011134578999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=294.50 Aligned_cols=264 Identities=21% Similarity=0.344 Sum_probs=209.5
Q ss_pred CHHHHHHhhcCCCcCCeeecccCceEEEEEE-eCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEee
Q 008216 259 TTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD 336 (573)
Q Consensus 259 ~~~el~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 336 (573)
+++|+-.+|.+ +||+|+|+.|-..+ +.+|..+|||++.+.....+.++.+|++++.+. .|+||++++++|++
T Consensus 74 ~F~d~YkLt~e------~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 74 KFEDMYKLTSE------LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred hHHHHHHhHHH------HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 36777777754 68999999999887 678999999999988778889999999999999 69999999999999
Q ss_pred CCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCC---eeE
Q 008216 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHL 413 (573)
Q Consensus 337 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl 413 (573)
+...|||||.|.||+|..++++ ...+++.++..+..+|+.||.|||.+ ||.||||||+|||...... +||
T Consensus 148 d~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred cceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceee
Confidence 9999999999999999999865 45699999999999999999999999 9999999999999976554 799
Q ss_pred ecccCCccCCcc-----ccccceeccCCccccccccccc-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCccc--
Q 008216 414 MGVGLSKFVPWE-----VMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC-- 481 (573)
Q Consensus 414 ~Dfg~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-- 481 (573)
+||.+..-.... ........++|+..|||||+.. ...|+.+.|.||||||+|-|++|.+||.+.-..+
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 999887543211 1222334556999999999764 2357899999999999999999999998764321
Q ss_pred chh------hHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 482 WQS------IFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 482 ~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
|.. -.+.....++++.+ +. ++.....++.+..+++...+..||.+|.++.++++
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkY-eF---------PdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKY-EF---------PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCC-cC---------ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 100 00000111111111 11 12223567889999999999999999999999987
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=298.03 Aligned_cols=247 Identities=22% Similarity=0.340 Sum_probs=196.5
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC-CceEEEEEecC
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-GDRYIVYEFVV 348 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lv~e~~~ 348 (573)
..+.||+|++|.||++... +++.||+|.+.... ....+.+.+|+.++++++|||++++++.+... +..+++|||++
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (257)
T cd08223 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83 (257)
T ss_pred EEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccC
Confidence 3457899999999999954 57899999986542 23456788999999999999999999887643 45789999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+++|.+++.. .....+++.++..++.|++.||++||++ +++||||||+||+++.++.++|+|||++........
T Consensus 84 ~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~- 157 (257)
T cd08223 84 GGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD- 157 (257)
T ss_pred CCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC-
Confidence 9999999875 2235689999999999999999999999 999999999999999999999999999976643221
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
......+++.|+|||.+.+..++.++||||||+++++|++|+.||...+... . ...... .. .
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~---~---~~~~~~-~~--------~-- 219 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS---L---VYRIIE-GK--------L-- 219 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---H---HHHHHh-cC--------C--
Confidence 1122337889999999998889999999999999999999999987543211 0 001000 00 0
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
. ..+...++.+.+++.+|++.||++||++.++++.
T Consensus 220 --~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 --P-PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --C-CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 1122355679999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=297.39 Aligned_cols=243 Identities=23% Similarity=0.353 Sum_probs=205.0
Q ss_pred eecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHHH
Q 008216 276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 354 (573)
.||+|+||.||++.. ..|..+|||.+.-+ .+.+++.+|+.++++...|++|++||.+....++++|||||..|+..+
T Consensus 40 KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSD 117 (502)
T KOG0574|consen 40 KLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISD 117 (502)
T ss_pred HhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHH
Confidence 359999999999985 46999999999765 467899999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceecc
Q 008216 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (573)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 434 (573)
.++. .++++++.++..++...++||+|||.. .-+|||||+.|||++.+|.+||+|||.+..+........ ..
T Consensus 118 I~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN--TV 189 (502)
T KOG0574|consen 118 IMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN--TV 189 (502)
T ss_pred HHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC--cc
Confidence 9974 347899999999999999999999999 899999999999999999999999999987654332222 23
Q ss_pred CCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCc
Q 008216 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 514 (573)
Q Consensus 435 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (573)
.||+.|||||++..-.|..++||||||++..||..|++||.+..+... + ++-|.- ..+....
T Consensus 190 IGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA--I---------------FMIPT~-PPPTF~K 251 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA--I---------------FMIPTK-PPPTFKK 251 (502)
T ss_pred ccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce--e---------------EeccCC-CCCCCCC
Confidence 499999999999999999999999999999999999999988665310 0 000000 0001112
Q ss_pred chHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 515 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 515 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
+...+.++.+++++||...|++|-|+-++++.
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 45677899999999999999999999999874
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=337.51 Aligned_cols=257 Identities=20% Similarity=0.313 Sum_probs=196.5
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--CceEEEEEe
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEF 346 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~ 346 (573)
+..+.||+|+||.||++... ++..||+|.+... .......+..|+.++++|+||||+++++++.+. ...||||||
T Consensus 16 eIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY 95 (1021)
T PTZ00266 16 EVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEF 95 (1021)
T ss_pred EEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeC
Confidence 34457799999999999964 4778999998754 233456789999999999999999999988654 457999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEEcCCCCCCeeeCCC--------------
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK----PHVVHRDIRASNVLLDEE-------------- 408 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~----~~iiH~Dlkp~NIll~~~-------------- 408 (573)
+++++|.++|.........+++..++.|+.||+.||+|||+... .+|+||||||+||||+.+
T Consensus 96 ~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ 175 (1021)
T PTZ00266 96 CDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175 (1021)
T ss_pred CCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccccc
Confidence 99999999997543344579999999999999999999998511 259999999999999642
Q ss_pred ---CCeeEecccCCccCCccccccceeccCCcccccccccccC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccch
Q 008216 409 ---FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ 483 (573)
Q Consensus 409 ---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~ 483 (573)
..+||+|||++......... ....||+.|+|||++.+ ..++.++||||||||||||+||+.||...+.. .
T Consensus 176 ng~~iVKLsDFGlAr~l~~~s~~---~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~--~ 250 (1021)
T PTZ00266 176 NGRPIAKIGDFGLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF--S 250 (1021)
T ss_pred CCCCceEEccCCccccccccccc---cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH--H
Confidence 34899999999866433221 12248999999999864 45889999999999999999999999754431 1
Q ss_pred hhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhccc
Q 008216 484 SIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLA 551 (573)
Q Consensus 484 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~ 551 (573)
.+... .... ...+....+.++.+||..||+.+|.+||++.+++. .+..+.
T Consensus 251 qli~~----lk~~--------------p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 251 QLISE----LKRG--------------PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HHHHH----HhcC--------------CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 11110 0000 11111223567999999999999999999999984 454443
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=317.93 Aligned_cols=266 Identities=20% Similarity=0.273 Sum_probs=193.9
Q ss_pred hcCCCcCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC------
Q 008216 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------ 337 (573)
Q Consensus 267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------ 337 (573)
.++|.. .+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQN-LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeE-EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 344433 457899999999999853 5889999999754 233456788999999999999999999988643
Q ss_pred CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEeccc
Q 008216 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (573)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 417 (573)
...++||||+++ +|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 346999999965 6766664 2488899999999999999999999 99999999999999999999999999
Q ss_pred CCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccc-hhhHHh--------
Q 008216 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEW-------- 488 (573)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~-------- 488 (573)
+++........ ....||..|+|||++.+..++.++||||||+++|+|++|+.||...+.... ......
T Consensus 165 ~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 165 LARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred ccccCCCcccc---CCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99865432211 122389999999999988999999999999999999999999976543211 000000
Q ss_pred -------hhhhhhc-cccccccccc-cc-cCC--CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 489 -------ATPLVQS-HRYLELLDPL-IS-SLS--SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 489 -------~~~~~~~-~~~~~~~~~~-~~-~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
....... ........+. .. ... ........+..+.++|.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 0000000000 00 000 000111234678999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=298.20 Aligned_cols=246 Identities=24% Similarity=0.326 Sum_probs=199.6
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.++||.|+||.||.++. .+++.+++|.+... ......++.+|+.++++++|+||+++++++.+.+..+++|||++++
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (256)
T cd08221 5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGG 84 (256)
T ss_pred eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCC
Confidence 45789999999999884 46889999998654 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.... ...+++.++..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++........ .
T Consensus 85 ~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~ 157 (256)
T cd08221 85 TLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--M 157 (256)
T ss_pred cHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc--c
Confidence 9999997522 35689999999999999999999999 999999999999999999999999999886643332 1
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
.....+++.|+|||.+.+..++.++||||||+++|||++|..||........ ..... ....
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~-~~~~------------ 218 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VVKIV-QGNY------------ 218 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHH-cCCC------------
Confidence 1223388999999999888889999999999999999999999976433210 10000 0000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
.......+.++.+++.+||+.+|.+||++.++++.
T Consensus 219 -~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 219 -TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 00112345679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=311.29 Aligned_cols=259 Identities=20% Similarity=0.279 Sum_probs=204.7
Q ss_pred HHHHhhcCCCcCCeeecccCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCC
Q 008216 262 ELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHG 338 (573)
Q Consensus 262 el~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 338 (573)
++..+.+..++.-+.||+||.+.||++...+.+.+|+|.+... +.+...-|.+|+..|.+| .|.+|+++++|-..++
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 4445555566666789999999999999888888999877543 445567899999999999 6999999999999999
Q ss_pred ceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccC
Q 008216 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (573)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 418 (573)
..|+|||+- ..+|..+|... ...++.-.++.+..|++.++.++|.+ ||||.||||.|+|+-. |.+||+|||+
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGI 505 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGI 505 (677)
T ss_pred eEEEEeecc-cccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeech
Confidence 999999986 67999999752 22333337889999999999999999 9999999999999975 4799999999
Q ss_pred CccCCccccccceeccCCcccccccccccCC-----------CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHH
Q 008216 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-----------ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE 487 (573)
Q Consensus 419 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 487 (573)
|..+..+.+.......+||+.||+||.+... ..++++||||+|||||+|+.|+.||..... ..
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~~- 579 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----QI- 579 (677)
T ss_pred hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----HH-
Confidence 9998877766666666799999999988532 256899999999999999999999975431 11
Q ss_pred hhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 488 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.++..+.++.-.-..+..++. .++.++++.||..||.+|||+.|+|+
T Consensus 580 --------aKl~aI~~P~~~Iefp~~~~~---~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 --------AKLHAITDPNHEIEFPDIPEN---DELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --------HHHHhhcCCCccccccCCCCc---hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 112233333221111222222 23899999999999999999999986
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=298.28 Aligned_cols=247 Identities=29% Similarity=0.458 Sum_probs=198.9
Q ss_pred eeecccCceEEEEEEeCC-----CCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 275 RLLGDSKTGGTYSGILPD-----GSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
+.||.|+||.||++...+ +..||+|.++..... ..+.+.+|+..+.+++|+||+++++++.+.+..+++|||++
T Consensus 5 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~ 84 (258)
T smart00219 5 KKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYME 84 (258)
T ss_pred ceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccC
Confidence 467999999999999654 488999999766433 56789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+++|.+++.... ...+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.........
T Consensus 85 ~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 85 GGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred CCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999999986422 12289999999999999999999999 9999999999999999999999999999876544222
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
... ...+++.|+|||.+.+..++.++||||+|+++++|++ |.+||...+... ..... .....
T Consensus 160 ~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~----~~~~~--------- 222 (258)
T smart00219 160 KKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEYL----KKGYR--------- 222 (258)
T ss_pred ccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----hcCCC---------
Confidence 211 1226789999999988889999999999999999998 888887643321 11110 00000
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 547 (573)
. ......+.++.+++.+|++.||++|||+.++++.|
T Consensus 223 ---~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 ---L-PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---C-CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0 01112456799999999999999999999999764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=315.91 Aligned_cols=198 Identities=24% Similarity=0.309 Sum_probs=169.8
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-C-----CcEeEEeeEEeeCCceEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-H-----PNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~l~~~~~~~~~~~lv 343 (573)
++..++||+|.||.|-++.. ++++.||||+++... .-..+...|+.+|..|+ | -|+|++++++...++.|||
T Consensus 188 Y~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 188 YEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 34456899999999999985 569999999998763 33456678999999996 4 4899999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC--CCeeEecccCCcc
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--FGAHLMGVGLSKF 421 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~--~~~kl~Dfg~~~~ 421 (573)
+|.+ ..+|.++|... .-..++...++.++.||+.||.+||+. +|||+||||+||||.+. ..+||+|||.|..
T Consensus 267 fELL-~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 267 FELL-STNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ehhh-hhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999 67999999863 345699999999999999999999999 99999999999999654 3699999999987
Q ss_pred CCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcc
Q 008216 422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV 480 (573)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~ 480 (573)
...... ...-+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.++.
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 654332 112677899999999999999999999999999999999989887654
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=301.98 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=194.8
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccch----------hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEE
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF----------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 342 (573)
.+.||+|++|.||+|.. .+|+.||+|.++.... ...+.+.+|+.++++++||||+++++++...+..++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 45789999999999985 4689999998864211 112467889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
||||+++++|.+++... ..+++..+..++.|++.||.|||++ +++||||+|+||+++.++.++|+|||++...
T Consensus 86 v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 86 FLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred EEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 99999999999998642 4689999999999999999999999 9999999999999999999999999999765
Q ss_pred CccccccceeccCCcccccccccccCCC--CCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccc
Q 008216 423 PWEVMQERTVMAGGTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500 (573)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (573)
.............++..|+|||.+.... ++.++|+||||+++|++++|..||...+.. ..... .... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~----~~~~-~~~~ 231 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMFK----LGNK-RSAP 231 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHHHH----hhcc-ccCC
Confidence 4322222122233888999999987654 789999999999999999999998643321 11110 0000 0000
Q ss_pred ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.+ ........+..+.+++.+||+.||++||++++|++
T Consensus 232 ~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 232 PI--------PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cC--------CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00 01111234578999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=311.64 Aligned_cols=188 Identities=19% Similarity=0.326 Sum_probs=159.2
Q ss_pred CcCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 271 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
+...+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++...+..++|||++ .
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~ 140 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-S 140 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-C
Confidence 344567899999999999964 4778999986443 2346899999999999999999999999999999999 5
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
++|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 141 ~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-- 212 (357)
T PHA03209 141 SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA-- 212 (357)
T ss_pred CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCcc--
Confidence 688888853 235689999999999999999999999 999999999999999999999999999975432211
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPA 474 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf 474 (573)
.....||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 213 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 213 -FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 11233899999999999989999999999999999999865554
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=308.30 Aligned_cols=243 Identities=22% Similarity=0.339 Sum_probs=197.3
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHHH
Q 008216 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 354 (573)
.||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++.+..++..+++|||+++++|.+
T Consensus 28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~ 107 (297)
T cd06659 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD 107 (297)
T ss_pred hcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHH
Confidence 4799999999999864 689999999976555556778899999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceecc
Q 008216 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (573)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 434 (573)
++.. ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||++......... ....
T Consensus 108 ~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~ 177 (297)
T cd06659 108 IVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSL 177 (297)
T ss_pred HHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccce
Confidence 8753 4589999999999999999999999 9999999999999999999999999998755432211 1223
Q ss_pred CCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCc
Q 008216 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 514 (573)
Q Consensus 435 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (573)
.++..|+|||++.+..++.++||||||+++|||++|+.||...+..... ... ... .... ...
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~-~~~-----~~~~------~~~ 239 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------KRL-RDS-----PPPK------LKN 239 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHH-hcc-----CCCC------ccc
Confidence 3889999999998888999999999999999999999999754432110 000 000 0000 001
Q ss_pred chHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 515 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 515 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
....+..+.+++.+||+.+|++||+++++++.
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11234568999999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=305.88 Aligned_cols=263 Identities=25% Similarity=0.400 Sum_probs=201.3
Q ss_pred CHHHHHHhhcCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEee
Q 008216 259 TTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD 336 (573)
Q Consensus 259 ~~~el~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 336 (573)
..+++...+++|... ..||+|+||.||++.. .+++.+|+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus 13 ~~~~~~~~~~~y~~~-~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 13 GLESLGDPTDTWEII-ETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hcccCCCCCCCeEEE-EEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 334555566666554 4679999999999996 468899999987542 2345678899999999 89999999999875
Q ss_pred C-----CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCe
Q 008216 337 H-----GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411 (573)
Q Consensus 337 ~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 411 (573)
. +..++||||+++++|.+++.........+++..++.++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 4 357999999999999998865433456689999999999999999999999 99999999999999999999
Q ss_pred eEecccCCccCCccccccceeccCCcccccccccccCC-----CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhH
Q 008216 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-----ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF 486 (573)
Q Consensus 412 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 486 (573)
||+|||++.......... ....++..|+|||.+... .++.++||||||+++|||++|+.||...+.. ..+.
T Consensus 168 kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~ 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLF 243 (291)
T ss_pred EEeecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHH
Confidence 999999988654322111 122378899999987643 3688999999999999999999999765431 1111
Q ss_pred HhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 487 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 487 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
.. .. .. .+.. ..+......+.++|.+||+.||++||++.|+++.
T Consensus 244 ~~----~~-~~-----~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 KI----PR-NP-----PPTL------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HH----hc-CC-----CCCC------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 10 00 00 0000 0111234579999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=305.68 Aligned_cols=241 Identities=24% Similarity=0.392 Sum_probs=192.6
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|++|.||+|... +|+.||+|.+.... ....+++.+|+.+++.++||||+++.+++.+.+..++||||+.
T Consensus 20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~- 98 (307)
T cd06607 20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL- 98 (307)
T ss_pred heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-
Confidence 346799999999999864 68999999986432 2334678899999999999999999999999999999999996
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|.+++.. ....+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 99 g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~--- 169 (307)
T cd06607 99 GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN--- 169 (307)
T ss_pred CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCCC---
Confidence 577777653 224589999999999999999999999 99999999999999999999999999987654221
Q ss_pred ceeccCCccccccccccc---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
...++..|+|||++. ...++.++||||||+++|||+||+.||...+.... .......
T Consensus 170 ---~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~~~----------- 229 (307)
T cd06607 170 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQN----------- 229 (307)
T ss_pred ---CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHhcC-----------
Confidence 123788999999874 35688899999999999999999999876543210 0000000
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
..........+..+.+++.+||+.||++||++.+|+..
T Consensus 230 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 --DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00111223356789999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=320.57 Aligned_cols=248 Identities=20% Similarity=0.364 Sum_probs=196.6
Q ss_pred CCCcCCeeecccCceEEEEEEeC-CCCEEEEEEeccc----chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCc--eE
Q 008216 269 NFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS----SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD--RY 341 (573)
Q Consensus 269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--~~ 341 (573)
.|.....+||+|+|-+||+|.+. +|-.||--.++.. +....++|..|+.+|+.|+||||++++.++.+... .-
T Consensus 40 Ry~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 40 RYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred ceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence 34444567999999999999963 4777775544322 33445889999999999999999999999987765 67
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-CCeeEecccCCc
Q 008216 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSK 420 (573)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~~~ 420 (573)
+|+|.+..|+|..|+.+. +.++.+.++.|++||++||.|||++ .|+|||||||.+||||+.+ |.|||+|+|+|.
T Consensus 120 ~iTEL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT 194 (632)
T ss_pred eeeecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHH
Confidence 899999999999999753 4588899999999999999999998 7789999999999999865 779999999998
Q ss_pred cCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccc
Q 008216 421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500 (573)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (573)
........ ...|||.|||||++. ..|+...||||||+.++||+|+..||..-.... +
T Consensus 195 l~r~s~ak----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A------------------Q 251 (632)
T KOG0584|consen 195 LLRKSHAK----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA------------------Q 251 (632)
T ss_pred Hhhccccc----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH------------------H
Confidence 77543322 234999999999886 789999999999999999999999997654321 1
Q ss_pred ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+.....++..+.....--.++++++|.+||.. .++|||+.|+|+
T Consensus 252 IYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 252 IYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 11111111111111112246799999999999 999999999996
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=302.79 Aligned_cols=256 Identities=23% Similarity=0.391 Sum_probs=196.5
Q ss_pred HHHHhhcCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEee---
Q 008216 262 ELRSITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD--- 336 (573)
Q Consensus 262 el~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~--- 336 (573)
++....+.|.. .+.||.|+||.||+|.. .+++.+|+|++.... ....++..|+.+++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~~-~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 10 ALRDPAGIFEL-VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhcChhhhhhh-heeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 33344444433 45779999999999996 468899999986553 3345688899999998 79999999999853
Q ss_pred ---CCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeE
Q 008216 337 ---HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413 (573)
Q Consensus 337 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 413 (573)
....+++|||+++|+|.+++... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 35679999999999999998652 234588888999999999999999999 9999999999999999999999
Q ss_pred ecccCCccCCccccccceeccCCccccccccccc-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHh
Q 008216 414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488 (573)
Q Consensus 414 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 488 (573)
+|||++........ ......|+..|+|||.+. +..++.++||||||+++|||++|..||....... ....
T Consensus 163 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~--~~~~- 237 (282)
T cd06636 163 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR--ALFL- 237 (282)
T ss_pred eeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh--hhhh-
Confidence 99999876532211 112233889999999876 3457889999999999999999999997543211 0000
Q ss_pred hhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 489 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.... ..........+..+.++|.+||+.||.+||++.||++
T Consensus 238 ------------~~~~----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 ------------IPRN----PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ------------HhhC----CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000 0011112235568999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=297.54 Aligned_cols=243 Identities=27% Similarity=0.448 Sum_probs=196.7
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc-----hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
.+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.++++++||||+++++++.+....++++||+
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV 84 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence 457899999999999975 78999999986543 224467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 85 PGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 99999999864 24588999999999999999999999 99999999999999999999999999987654332
Q ss_pred ccceeccCCcccccccccccCCC-CCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
......++..|+|||.+.... ++.++|+||||+++|+|++|+.||....... .... ......
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~~~----~~~~~~--------- 219 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AVFK----IGRSKE--------- 219 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HHHH----HHhccc---------
Confidence 112233888999999987766 8999999999999999999999997654211 1100 000000
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....+...++.+.+++.+||+.+|++||++.+++.
T Consensus 220 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 ----LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 00011224567899999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=301.82 Aligned_cols=247 Identities=26% Similarity=0.444 Sum_probs=199.2
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
+.||+|++|.||++... +++.+|+|.+.... .....++.+|++++++++||||+++++.+...+..++++||+++++|
T Consensus 7 ~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (265)
T cd06605 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSL 86 (265)
T ss_pred HHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcH
Confidence 46799999999999975 58999999987653 34456789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
.+++.... ..+++..+..++.|++.||+|||+ . +++|+||||+||++++++.++|+|||.+..........
T Consensus 87 ~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~-- 158 (265)
T cd06605 87 DKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-- 158 (265)
T ss_pred HHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc--
Confidence 99987422 568999999999999999999999 8 99999999999999999999999999987654322111
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||...+... ....+....... ....
T Consensus 159 --~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~-------------~~~~ 222 (265)
T cd06605 159 --FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVN-------------EPPP 222 (265)
T ss_pred --ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhc-------------CCCC
Confidence 338889999999988899999999999999999999999997653210 111111111110 0011
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
..+....+.++.++|.+||..||++|||+.+++.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1122225677999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=301.47 Aligned_cols=263 Identities=19% Similarity=0.265 Sum_probs=195.4
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|++|.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++......++||||++++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (286)
T cd07847 6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT 85 (286)
T ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCcc
Confidence 456799999999999975 58999999986542 223456789999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|..++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.........
T Consensus 86 ~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-- 156 (286)
T cd07847 86 VLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-- 156 (286)
T ss_pred HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCccc--
Confidence 88887643 34589999999999999999999999 9999999999999999999999999999876543211
Q ss_pred eeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHh-hhhhhh-------ccccc-c
Q 008216 431 TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW-ATPLVQ-------SHRYL-E 500 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-~~~~~~-------~~~~~-~ 500 (573)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....... ...... ..... .
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 111237788999999876 4578899999999999999999999986554211110000 000000 00000 0
Q ss_pred ccccccccCCC-CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 501 LLDPLISSLSS-DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 501 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
...+....... .......+..+.+++.+||+.||++||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000000 0000123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=314.37 Aligned_cols=265 Identities=18% Similarity=0.287 Sum_probs=192.5
Q ss_pred hhcCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC-----
Q 008216 266 ITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH----- 337 (573)
Q Consensus 266 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----- 337 (573)
+.+.|.. .+.||+|+||.||++.. .+++.||||.+.... ......+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQN-LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhh-heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3344443 45679999999999985 468899999997542 22345678899999999999999999887543
Q ss_pred -CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecc
Q 008216 338 -GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (573)
Q Consensus 338 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 416 (573)
...++++|++ +++|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3468999988 7899888753 4589999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCccccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccch-hhHHhhhh---
Q 008216 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATP--- 491 (573)
Q Consensus 417 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~~--- 491 (573)
|++....... ....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..... ........
T Consensus 163 g~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 163 GLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred ccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9998654321 12238999999999876 56889999999999999999999999764432110 00000000
Q ss_pred -h---hhccccccccccccccCCCCC---cchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 492 -L---VQSHRYLELLDPLISSLSSDI---PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 492 -~---~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
. ........... .+....... ......+.+.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00000000000 000000000 001123457899999999999999999999963
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=298.33 Aligned_cols=245 Identities=22% Similarity=0.367 Sum_probs=190.3
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc-----hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--CceEEEEE
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYE 345 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e 345 (573)
.++||+|++|.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++.+. ...++++|
T Consensus 7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e 86 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86 (266)
T ss_pred cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence 457799999999999864 58999999986432 22345688899999999999999999988753 56789999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 87 YMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 9999999999864 23588899999999999999999999 9999999999999999999999999998765432
Q ss_pred ccc-cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 426 VMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 426 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...+... ... .... ....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~--~~~----~~~~-----~~~~- 227 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA--AIF----KIAT-----QPTN- 227 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH--HHH----HHhc-----CCCC-
Confidence 111 11112237889999999988889999999999999999999999997643211 100 0000 0000
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
...+...++.+.+++ +||..+|++||+++||++
T Consensus 228 -------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 228 -------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111223445677777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=296.74 Aligned_cols=245 Identities=20% Similarity=0.336 Sum_probs=197.8
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|+||.+|.+.. .+|+.||+|.+... .....+++.+|+.++++++||||+++++++.+.+..++|+||++++
T Consensus 5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08218 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGG 84 (256)
T ss_pred EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCC
Confidence 45689999999999985 46899999998653 2334567899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. .....+++.+++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++..........
T Consensus 85 ~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~- 158 (256)
T cd08218 85 DLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA- 158 (256)
T ss_pred cHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh-
Confidence 99998864 2234578999999999999999999999 99999999999999999999999999998654332211
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
....|++.|+|||++.+...+.++|+||||+++++|++|+.||...+... . ...... . ..
T Consensus 159 -~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~---~~~~~~-~--------~~---- 218 (256)
T cd08218 159 -RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN---L---VLKIIR-G--------SY---- 218 (256)
T ss_pred -hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH---H---HHHHhc-C--------CC----
Confidence 12237888999999988889999999999999999999999987543211 0 100000 0 00
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
. ..+...+.++.++|.+||+.+|++||++.+|++
T Consensus 219 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 219 P-PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred C-CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0 011234567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=298.11 Aligned_cols=247 Identities=21% Similarity=0.314 Sum_probs=198.6
Q ss_pred eeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEee--CCceEEEEEecCC
Q 008216 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEFVVN 349 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~~ 349 (573)
+.||.|++|.||++.. .+|+.||+|+++.. .....+.+.+|+.++++++||||+++++++.. ....+++|||+++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~ 85 (265)
T cd08217 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG 85 (265)
T ss_pred eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccC
Confidence 4679999999999985 46889999998754 23345678899999999999999999998764 3457999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH-----DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-----~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 424 (573)
++|.+++.........+++..++.++.|++.||+||| +. +++|+||||+||+++.++.+||+|||++.....
T Consensus 86 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~ 162 (265)
T cd08217 86 GDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162 (265)
T ss_pred CCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccccccC
Confidence 9999999765444567999999999999999999999 77 999999999999999999999999999987654
Q ss_pred cccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
..... ....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+... .... .....
T Consensus 163 ~~~~~--~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~----~~~~~------- 226 (265)
T cd08217 163 DSSFA--KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASK----IKEGK------- 226 (265)
T ss_pred Ccccc--cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHH----HhcCC-------
Confidence 33211 12238899999999988889999999999999999999999998654211 1110 00000
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
....+...+..+.+++.+|++.+|++||++.+|++.
T Consensus 227 ------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 ------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011122345679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.79 Aligned_cols=250 Identities=19% Similarity=0.216 Sum_probs=192.0
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|+||.||+++.+ +++.+|+|++.+.. ......+.+|..++..++|+||+++++.+.+.+..++||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~ 85 (332)
T cd05623 6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVG 85 (332)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCC
Confidence 457899999999999965 47889999996532 22234578899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.........
T Consensus 86 g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~- 158 (332)
T cd05623 86 GDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV- 158 (332)
T ss_pred CcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcc-
Confidence 999999964 234589999999999999999999999 9999999999999999999999999998755332221
Q ss_pred ceeccCCccccccccccc-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
......||+.|+|||++. ...++.++|||||||++|||++|+.||...+.... ............
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~~~---- 228 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKERFQ---- 228 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHHhCCCcccc----
Confidence 112234899999999986 34678899999999999999999999976543211 111110000000
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSM--RPRMSHVVHQ 546 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 546 (573)
........+..+.+++.+|+..+|.+ |++++++++.
T Consensus 229 ------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 ------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00011234567899999988665444 6889988765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=315.65 Aligned_cols=254 Identities=24% Similarity=0.350 Sum_probs=207.5
Q ss_pred CeeecccCceEEEEEEeCC--CC--EEEEEEecccchh-hHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 274 NRLLGDSKTGGTYSGILPD--GS--RVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~--g~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
.++||+|.||.|++|.|.. |+ .||||.++.+... ...+|++|+.+|.+|+|||++++||+..+ ....+|||+++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 3468999999999999753 43 6999999877544 67899999999999999999999999887 67889999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
.|+|.+.|+. .....+-......++.|||.||.||.++ ++|||||.++|+|+...-.+||+|||+.+.+......
T Consensus 194 lGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 194 LGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 9999999986 3445688888999999999999999999 9999999999999999889999999999988755433
Q ss_pred cce-eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 429 ERT-VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 429 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
... ....-...|.|||.+....++.++|||+|||+||||+| |..||-+.....+... +|.
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~----------------iD~-- 330 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN----------------IDA-- 330 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHh----------------ccc--
Confidence 221 11224568999999999999999999999999999999 8999987664321111 110
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HhcccCC
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ-LQQLAQP 553 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~-L~~~~~~ 553 (573)
......+..+++.++++++.||..+|++|||+..|.+. +...+++
T Consensus 331 --~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaqp 376 (1039)
T KOG0199|consen 331 --GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQP 376 (1039)
T ss_pred --cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCC
Confidence 00222345688999999999999999999999999843 3444443
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=301.88 Aligned_cols=249 Identities=22% Similarity=0.387 Sum_probs=195.9
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
.+.||+|+||.||++... +|+.||+|.++.. .......+.+|+.++++++||||+++++.+...+..++||||+++++
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (286)
T cd06622 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGS 85 (286)
T ss_pred hhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCC
Confidence 346799999999999975 6899999998754 23345678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|..++... .....+++..+..++.|++.||.|||+.. +++||||||+||+++.++.++|+|||++........
T Consensus 86 l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---- 158 (286)
T cd06622 86 LDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA---- 158 (286)
T ss_pred HHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc----
Confidence 99988642 12346899999999999999999999632 899999999999999999999999999876532221
Q ss_pred eccCCcccccccccccCC------CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 432 VMAGGTYGYLAPEFVYRN------ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........ ..... ......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~---------~~~~~~ 226 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQLS---------AIVDGD 226 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHHHH---------HHhhcC
Confidence 122378899999998554 347899999999999999999999975432211 11000 000000
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
. ... +...+.++.+++.+||+.+|++||+++++++.
T Consensus 227 ~----~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 P----PTL-PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred C----CCC-CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0 111 22356789999999999999999999999973
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=298.57 Aligned_cols=243 Identities=21% Similarity=0.360 Sum_probs=197.1
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
.+.||+|+||.||+|.. .+++.||||.+.... ......+.+|+.++.+++||||+++++++.+++..++||||+++++
T Consensus 9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06641 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 88 (277)
T ss_pred heeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCc
Confidence 44679999999999985 468899999986542 3344678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++.. ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++..........
T Consensus 89 l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~-- 158 (277)
T cd06641 89 ALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-- 158 (277)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhhh--
Confidence 9999853 3588999999999999999999999 99999999999999999999999999987654322111
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||........ .. . ..... .
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~---~-~~~~~-------------~ 218 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV---LF---L-IPKNN-------------P 218 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH---HH---H-HhcCC-------------C
Confidence 122378899999999888889999999999999999999999875443110 00 0 00000 0
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
.......+.++.+++.+||+.+|.+||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01112345678999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.93 Aligned_cols=249 Identities=20% Similarity=0.225 Sum_probs=191.8
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|+||.||+++.. +++.||+|++.... ......+.+|..++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~g 85 (331)
T cd05624 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVG 85 (331)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 457899999999999964 57899999997532 22345578899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..........
T Consensus 86 g~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 86 GDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred CcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 9999999642 34688999999999999999999999 99999999999999999999999999997654332211
Q ss_pred ceeccCCcccccccccccC-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
.....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+... . ............ +.
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~---~~~i~~~~~~~~-~p- 230 (331)
T cd05624 160 -SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE---T---YGKIMNHEERFQ-FP- 230 (331)
T ss_pred -eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH---H---HHHHHcCCCccc-CC-
Confidence 122348999999999875 467889999999999999999999997654321 0 001000000000 00
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSM--RPRMSHVVH 545 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 545 (573)
. .....++++.+++.+|+..++.+ |++++++++
T Consensus 231 ------~--~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 231 ------S--HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred ------C--ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 0 01124567999999999876554 467888865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=301.81 Aligned_cols=247 Identities=25% Similarity=0.439 Sum_probs=191.2
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHH-HhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGR-FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
+.||+|+||.||++... +|+.||+|+++... ......+..|+.. ++.++||||+++++++..++..+++|||++ ++
T Consensus 7 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~ 85 (283)
T cd06617 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TS 85 (283)
T ss_pred EEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-cc
Confidence 46799999999999964 69999999997652 2334456667665 556699999999999999999999999995 68
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++.........+++..+..++.|++.||+|||+++ +++||||||+||+++.++.+||+|||++.........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~--- 160 (283)
T cd06617 86 LDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK--- 160 (283)
T ss_pred HHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccccccc---
Confidence 98888654444467999999999999999999999853 8999999999999999999999999998865432111
Q ss_pred eccCCcccccccccccC----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 432 VMAGGTYGYLAPEFVYR----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... .... ..... .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~----~~~~~---------~--- 223 (283)
T cd06617 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQL----KQVVE---------E--- 223 (283)
T ss_pred ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHH----HHHHh---------c---
Confidence 11237889999998865 45688999999999999999999998653221 0111 00000 0
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.....+....+.++.+++.+||..+|.+||+++++++
T Consensus 224 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 -PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011122235567999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=300.30 Aligned_cols=244 Identities=23% Similarity=0.362 Sum_probs=198.2
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
.+.||+|++|.||++.. .+++.+++|+++.......+.+.+|+.+++.++||||+++++++...+..++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 34789999999999985 46889999998766555567789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++.. ..+++..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||.+......... ..
T Consensus 104 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~~ 173 (285)
T cd06648 104 TDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RK 173 (285)
T ss_pred HHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--cc
Confidence 999864 3588999999999999999999999 9999999999999999999999999988755432211 11
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
...|+..|+|||.+.+..++.++||||||+++|||++|+.||...+.... ...... ...+.. .
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~~~~~------~~~~~~----~- 236 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MKRIRD------NLPPKL----K- 236 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHHHh------cCCCCC----c-
Confidence 22388999999999888899999999999999999999999876443211 000000 000000 0
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.....+..+.+++.+||+.+|++||++.++++
T Consensus 237 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 -NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 01124567999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=296.17 Aligned_cols=253 Identities=22% Similarity=0.334 Sum_probs=200.2
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
.+.||.|++|.||+|... ++..+|+|++.... ....+.+.+|+..++.++|+||+++++.+...+..++|||++++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS 85 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCc
Confidence 456799999999999954 68899999997542 2355778999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc--
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE-- 429 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-- 429 (573)
|.+++..... ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++..........
T Consensus 86 l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 161 (267)
T cd06610 86 LLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK 161 (267)
T ss_pred HHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccc
Confidence 9999965221 24589999999999999999999999 99999999999999999999999999987665432221
Q ss_pred ceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
......++..|+|||.+... .++.++|+||||+++|+|++|+.||...+... ...... .. ..+..
T Consensus 162 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~----~~------~~~~~-- 227 (267)
T cd06610 162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTL----QN------DPPSL-- 227 (267)
T ss_pred ccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHh----cC------CCCCc--
Confidence 11222388899999998776 78899999999999999999999997654321 010000 00 00000
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.........++.+.+++.+||+.||++||++.+|++
T Consensus 228 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 -ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 011112245678999999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=297.05 Aligned_cols=249 Identities=19% Similarity=0.344 Sum_probs=197.2
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccc------hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS------FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
.++||+|++|.||++.. .+++.||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 45789999999999985 568999999997532 12346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-CeeEecccCCccCCcc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWE 425 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~ 425 (573)
+++++|.+++.. ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||.+......
T Consensus 85 ~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 85 MAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred cCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 999999999864 24688999999999999999999999 999999999999998776 5899999999876543
Q ss_pred ccccc--eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccc
Q 008216 426 VMQER--TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503 (573)
Q Consensus 426 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (573)
..... .....++..|+|||.+.+..++.++||||+|+++|+|++|..||............ .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~--------- 225 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FKIAS--------- 225 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH---HHHhc---------
Confidence 21111 11223788999999998888999999999999999999999999654322111100 00000
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.......+...+.++.+++.+|++.+|.+||++.++++
T Consensus 226 ----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 ----ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00011122345678999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=295.15 Aligned_cols=244 Identities=20% Similarity=0.294 Sum_probs=196.6
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|++|.||++.. .+++.+|||.+.... ......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08220 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGG 84 (256)
T ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCC
Confidence 45789999999999985 468899999987542 334567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-CeeEecccCCccCCcccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~ 429 (573)
+|.+++... ....+++..+..++.|++.||+|||++ +++|+||||+||+++.++ .+||+|||.+..........
T Consensus 85 ~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 85 TLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred CHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence 999999752 234589999999999999999999999 999999999999998654 57999999998764332211
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||...+... ... .... ..
T Consensus 160 ---~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~---~~~~---------~~---- 217 (256)
T cd08220 160 ---TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVL---KIMS---------GT---- 217 (256)
T ss_pred ---ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHH---HHHh---------cC----
Confidence 1237889999999988888999999999999999999999997654321 110 0000 00
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....+...+..+.+++.+||+.||++|||+.|+++
T Consensus 218 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 218 -FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00011224567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=298.49 Aligned_cols=243 Identities=21% Similarity=0.363 Sum_probs=195.3
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEeccc-chhhHHHHHHHHHHHhhcC---CCcEeEEeeEEeeCCceEEEEEecC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
.+.||+|+||.||+|.. .+++.||+|.++.. ......++.+|+.++++++ |||++++++++.+.+..++||||++
T Consensus 6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06917 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE 85 (277)
T ss_pred hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence 34679999999999995 56899999998754 2334567889999999996 9999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 86 ~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 86 GGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK 157 (277)
T ss_pred CCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence 9999999853 3689999999999999999999999 9999999999999999999999999999876543321
Q ss_pred cceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
.....|+..|+|||.+.++ .++.++|+||||+++|+|++|..||.......... . ......
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------~-----~~~~~~---- 219 (277)
T cd06917 158 --RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------L-----IPKSKP---- 219 (277)
T ss_pred --cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------c-----cccCCC----
Confidence 1222388899999988654 46889999999999999999999997644321000 0 000000
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
...+....+.++.+++.+||+.||++||++.++++
T Consensus 220 ---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 220 ---PRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ---CCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11111124567999999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=298.78 Aligned_cols=250 Identities=22% Similarity=0.380 Sum_probs=196.3
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCc------eEEE
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD------RYIV 343 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~------~~lv 343 (573)
+..+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++.+... .++|
T Consensus 9 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv 87 (275)
T cd06608 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLV 87 (275)
T ss_pred eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence 33567899999999999974 578999999876543 346789999999999 79999999999976553 7999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCC
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 423 (573)
|||+++++|.+++......+..+++..+..++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~ 164 (275)
T cd06608 88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164 (275)
T ss_pred EEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence 999999999999875443346789999999999999999999999 99999999999999999999999999987654
Q ss_pred ccccccceeccCCcccccccccccC-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccc
Q 008216 424 WEVMQERTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY 498 (573)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 498 (573)
..... .....++..|+|||.+.. ..++.++||||||+++|+|++|+.||...... ..... ..
T Consensus 165 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~----~~----- 231 (275)
T cd06608 165 STLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFK----IP----- 231 (275)
T ss_pred cchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHH----hh-----
Confidence 32211 122338889999998753 34678899999999999999999999754321 11110 00
Q ss_pred ccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....+ ........++.+.+++.+||..||++|||+.++++
T Consensus 232 -~~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 -RNPPP------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -ccCCC------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00000 01112235668999999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.15 Aligned_cols=255 Identities=23% Similarity=0.343 Sum_probs=197.4
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--CceEEEEEecCCC
Q 008216 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVVNG 350 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~~~g 350 (573)
+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+. +..++||||++++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 86 (287)
T cd06621 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGG 86 (287)
T ss_pred EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCC
Confidence 46799999999999974 588999999975432 3456789999999999999999999988654 4679999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 87 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-- 161 (287)
T cd06621 87 SLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG-- 161 (287)
T ss_pred CHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccccc--
Confidence 99998765434456689999999999999999999999 9999999999999999999999999998765432211
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ....+....... .. .+.+..
T Consensus 162 --~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~-~~-----~~~~~~-- 230 (287)
T cd06621 162 --TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIVN-MP-----NPELKD-- 230 (287)
T ss_pred --cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHHhc-CC-----chhhcc--
Confidence 2237888999999988899999999999999999999999997653210 000111110000 00 000100
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
........++.+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 00001234677999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=305.31 Aligned_cols=248 Identities=24% Similarity=0.296 Sum_probs=197.2
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccchh---hHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|++|.||++... +++.||+|.+...... ..+.+.+|+++++.++||||+++++.+.+.+..++||||+.+
T Consensus 6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG 85 (316)
T ss_pred eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCC
Confidence 356799999999999965 4899999999765322 446788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
++|.+++.. ..+..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++..........
T Consensus 86 ~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 86 GELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred CCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999864 2345689999999999999999999999 99999999999999999999999999987653221100
Q ss_pred ---------------------------ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccc
Q 008216 430 ---------------------------RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW 482 (573)
Q Consensus 430 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~ 482 (573)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~- 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE- 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH-
Confidence 0011237889999999998889999999999999999999999997654321
Q ss_pred hhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCC----HHHHHH
Q 008216 483 QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR----MSHVVH 545 (573)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 545 (573)
... ++..... ........+..+.+++.+||+.||++||| ++++++
T Consensus 240 -~~~-------------~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 240 -TFS-------------NILKKEV----TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred -HHH-------------HHhcCCc----cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 000 0000000 00111125678999999999999999999 777665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=294.40 Aligned_cols=248 Identities=23% Similarity=0.416 Sum_probs=202.3
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
.+.||+|++|.||++... +++.||||++..... .....+.+|+..+.+++||||+++++++...+..++||||+++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS 85 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCc
Confidence 457899999999999975 499999999977643 446789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
|.+++... ..+++..+..++.|++.||+|||+ . +++||||+|+||+++.++.++|+|||.+..........
T Consensus 86 L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~- 157 (264)
T cd06623 86 LADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC- 157 (264)
T ss_pred HHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-
Confidence 99999642 568999999999999999999999 8 99999999999999999999999999998765433221
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
....++..|+|||.+.+..++.++|+||||+++|+|+||+.||................ ....
T Consensus 158 -~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~------------~~~~---- 220 (264)
T cd06623 158 -NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC------------DGPP---- 220 (264)
T ss_pred -cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh------------cCCC----
Confidence 11237889999999988889999999999999999999999997764311111111111 0000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
...+....+..+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111111155689999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=295.62 Aligned_cols=245 Identities=22% Similarity=0.358 Sum_probs=191.6
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccc-----hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--CceEEEEE
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYE 345 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e 345 (573)
.++||+|+||.||+|.. .+|+.||||.+.... ....+.+.+|+.++++++||||+++++++.+. ...+++||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 56789999999999986 458999999886421 22345788899999999999999999988764 45789999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|+++++|.+++.. ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 87 HMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred ecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 9999999999864 23478888999999999999999999 9999999999999999999999999999865432
Q ss_pred ccc-cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 426 VMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 426 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...+... ... ..... +
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~----~~~~~--------~ 225 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA--AIF----KIATQ--------P 225 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH--HHH----HHhcC--------C
Confidence 111 11112238889999999988889999999999999999999999997543211 000 00000 0
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
. ....+...+..+.+++.+|+. +|++||++++|++
T Consensus 226 ~-----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 T-----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred C-----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0 111123455678899999995 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=300.22 Aligned_cols=245 Identities=22% Similarity=0.356 Sum_probs=198.6
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
.+.||+|+||.||++.. .++..||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L 103 (293)
T cd06647 24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103 (293)
T ss_pred eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcH
Confidence 45679999999999985 46889999998765555567789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++.. ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.......... .
T Consensus 104 ~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~--~ 173 (293)
T cd06647 104 TDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--S 173 (293)
T ss_pred HHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc--c
Confidence 999863 3478889999999999999999999 99999999999999999999999999887654332211 1
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
...+++.|+|||.+.+..++.++|+||||+++|++++|+.||...+.... .. .... .. ....
T Consensus 174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~----~~~~--------~~----~~~~ 235 (293)
T cd06647 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LY----LIAT--------NG----TPEL 235 (293)
T ss_pred cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--ee----ehhc--------CC----CCCC
Confidence 22388899999999888899999999999999999999999976543210 00 0000 00 0011
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
......+..+.+++.+||..+|++||++.+++..
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122345679999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=322.91 Aligned_cols=264 Identities=16% Similarity=0.207 Sum_probs=187.2
Q ss_pred hcCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC------CCcEeEEeeEEeeC-C
Q 008216 267 TKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH------HPNLVAVKGCCYDH-G 338 (573)
Q Consensus 267 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~l~~~~~~~-~ 338 (573)
+++| +..+.||+|+||.||+|.. .+++.||||+++... ........|+.+++.++ |++++++++++... +
T Consensus 128 ~~~y-~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 128 TQRF-KILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCcE-EEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 3344 3445789999999999986 457899999996532 22344566777777664 45689999988765 5
Q ss_pred ceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCC--------
Q 008216 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEF-------- 409 (573)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~~~-------- 409 (573)
..++|||++ +++|.+++.. ...+++..+..++.||+.||+|||+ . +|+||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred eEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccc
Confidence 678999988 7789888854 2468999999999999999999997 6 999999999999998765
Q ss_pred --------CeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCccc
Q 008216 410 --------GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC 481 (573)
Q Consensus 410 --------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~ 481 (573)
.+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred cccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 4899999987643211 122348999999999999999999999999999999999999998765432
Q ss_pred chhhHHhhhh-h---hhc----ccccccccccc-----------ccCCCC--CcchHHHHHHHHHHHHhcCCCCCCCCCH
Q 008216 482 WQSIFEWATP-L---VQS----HRYLELLDPLI-----------SSLSSD--IPEAGVVQKVVDLVYACTQHVPSMRPRM 540 (573)
Q Consensus 482 ~~~~~~~~~~-~---~~~----~~~~~~~~~~~-----------~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~ 540 (573)
.......... . +.. ....++.+... ...... .......+.+.+||.+||+.||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 2111111100 0 000 00000000000 000000 0001124568899999999999999999
Q ss_pred HHHHH
Q 008216 541 SHVVH 545 (573)
Q Consensus 541 ~evl~ 545 (573)
+|+++
T Consensus 433 ~e~L~ 437 (467)
T PTZ00284 433 RQMTT 437 (467)
T ss_pred HHHhc
Confidence 99996
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=301.60 Aligned_cols=261 Identities=19% Similarity=0.230 Sum_probs=191.9
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|++|.||+|... +|+.||+|+++.... .....+.+|+.++++++||||+++++++.+.+..++++||++ +
T Consensus 5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 83 (284)
T cd07839 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-Q 83 (284)
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-C
Confidence 356899999999999964 689999999975422 223567889999999999999999999999999999999996 5
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. ....+++..++.++.||+.||.|||++ +++||||||+||+++.++.++|+|||+++........
T Consensus 84 ~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-- 155 (284)
T cd07839 84 DLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-- 155 (284)
T ss_pred CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC--
Confidence 78887753 234589999999999999999999999 9999999999999999999999999999865432211
Q ss_pred eeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhc---c---ccccccc
Q 008216 431 TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS---H---RYLELLD 503 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~---~~~~~~~ 503 (573)
.....++..|+|||.+.+. .++.++||||||+++|||+||..|+....+.. ............ . ...+..+
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhccc
Confidence 1122378899999988764 46899999999999999999998865433211 111000000000 0 0000000
Q ss_pred c-ccccCCC----CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 504 P-LISSLSS----DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 504 ~-~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
. ....... .......++++.+++.+||+.||.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 0000000 0001124567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=300.24 Aligned_cols=265 Identities=18% Similarity=0.248 Sum_probs=197.0
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|++|.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++.+....++||||+ ++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~ 83 (286)
T cd07832 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PS 83 (286)
T ss_pred EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CC
Confidence 456799999999999964 68999999997653 233567899999999999999999999999999999999999 99
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++... ...+++.++..++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++......... .
T Consensus 84 ~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-~ 156 (286)
T cd07832 84 DLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR-L 156 (286)
T ss_pred CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC-c
Confidence 999998642 25689999999999999999999999 9999999999999999999999999999876543211 1
Q ss_pred eeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccch-hhHHhhh-------hhhh-cccccc
Q 008216 431 TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWAT-------PLVQ-SHRYLE 500 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~-------~~~~-~~~~~~ 500 (573)
.....++..|+|||.+.+. .++.++||||+|+++|||++|.+||....+.... ....... +... ......
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 1123388899999998654 4689999999999999999998888654432110 0000000 0000 000000
Q ss_pred ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
...+............+.+..+.+++.+||+.||++|||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000000001234789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=302.60 Aligned_cols=251 Identities=20% Similarity=0.273 Sum_probs=196.3
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|+||.||++... .++.||+|.+..... .....+.+|+.+++.++||||+++++.+..++..++||||+++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEG 85 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 456799999999999964 578999999876532 2345788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc-
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ- 428 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~- 428 (573)
++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||+++........
T Consensus 86 ~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 86 GDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999964 24589999999999999999999999 9999999999999999999999999998742111000
Q ss_pred ------------cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcc
Q 008216 429 ------------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH 496 (573)
Q Consensus 429 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 496 (573)
.......++..|+|||.+.+..++.++|+||||+++|||++|..||.+..... ... .... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~~~---~~~~-~ 231 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFG---QVIS-D 231 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHh-c
Confidence 00011237888999999988889999999999999999999999997543321 111 0000 0
Q ss_pred ccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
....+ ......+..+.+++.+||+.||++||++.++.+.|+.
T Consensus 232 ---~~~~~--------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 232 ---DIEWP--------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ---ccCCC--------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 00000 0011345678999999999999999997777666665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=300.55 Aligned_cols=262 Identities=19% Similarity=0.252 Sum_probs=191.9
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
..+.||+|++|.||+|... +++.||||.+..... .....+.+|+.++++++||||+++++++.+.+..++||||++ +
T Consensus 9 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 87 (291)
T cd07844 9 KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-T 87 (291)
T ss_pred EEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-C
Confidence 3457899999999999965 689999999875432 223457789999999999999999999999999999999997 4
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++... ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++........
T Consensus 88 ~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-- 159 (291)
T cd07844 88 DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT-- 159 (291)
T ss_pred CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCcc--
Confidence 999988642 24688999999999999999999999 9999999999999999999999999998754322111
Q ss_pred eeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhh---cccccc------
Q 008216 431 TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ---SHRYLE------ 500 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~------ 500 (573)
.....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||....... ........... ......
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhccc
Confidence 111226788999998865 457899999999999999999999997654210 00000000000 000000
Q ss_pred cccccccc-----CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 501 LLDPLISS-----LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 501 ~~~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
........ .............+.+++.+||+.+|++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000 0000001111257889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=301.03 Aligned_cols=264 Identities=18% Similarity=0.218 Sum_probs=195.7
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccchh-----hHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ-----RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
.+.||+|++|.||+|... +|+.||||.++..... ....+..|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (298)
T cd07841 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM 84 (298)
T ss_pred eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc
Confidence 346899999999999964 6899999999765332 2355778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
+++|.+++... ...+++..+..++.||++||+|||++ +++|+||||+||+++.++.++|+|||++........
T Consensus 85 -~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 85 -ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred -CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 99999999642 13689999999999999999999999 999999999999999999999999999986644321
Q ss_pred ccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccch-hhHHhhhhhh-----hcccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLV-----QSHRYLE 500 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~~~~-----~~~~~~~ 500 (573)
.. ....++..|+|||.+.+ ..++.++||||||+++|||++|.+||......... .......... .......
T Consensus 158 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 158 KM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred cc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 11 11226788999998854 45789999999999999999998888755432111 1110000000 0000000
Q ss_pred cccccc-ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 501 LLDPLI-SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 501 ~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
...... ............+..+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000 0000000112345789999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=297.78 Aligned_cols=242 Identities=20% Similarity=0.244 Sum_probs=186.8
Q ss_pred eecccCceEEEEEEe-CCCCEEEEEEecccch---hhHHHHHHHHHHHh---hcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFA---RLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
+||+|+||.||++.. .+++.+|+|.+..... .....+.+|..+++ ..+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 379999999999996 4589999999865421 12233444544333 3479999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 9999998863 34589999999999999999999999 999999999999999999999999999875532211
Q ss_pred cceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
....|+..|+|||.+.+ ..++.++||||||+++|||++|..||.............. .. ..
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~----~~------~~----- 214 (279)
T cd05633 153 ---HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----TL------TV----- 214 (279)
T ss_pred ---cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH----hh------cC-----
Confidence 12238999999998864 5678999999999999999999999976543211111000 00 00
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVHQ 546 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 546 (573)
....+...+.++.+++.+||+.||++|| |+.|+++.
T Consensus 215 ---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 ---NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0011223456899999999999999999 58888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=294.66 Aligned_cols=242 Identities=21% Similarity=0.274 Sum_probs=194.8
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 277 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
||.|++|.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 599999999999974 48999999997542 23346789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++.. ...+++..+..++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 999964 24589999999999999999999999 99999999999999999999999999998765432 112
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ..... ..+.. ...
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~---------~~~~~----~~~ 213 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM----EIYND---------ILKGN----GKL 213 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH----HHHHH---------HhccC----CCC
Confidence 22378899999999888899999999999999999999999976552110 00000 00000 001
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH 545 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 545 (573)
..+...+..+.+++.+||+.||++||+ ++|+++
T Consensus 214 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 214 EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 111122567999999999999999999 666664
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=313.13 Aligned_cols=245 Identities=23% Similarity=0.365 Sum_probs=202.0
Q ss_pred eecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHHH
Q 008216 276 LLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 354 (573)
-||.|+||.||+|+.++ +-..|-|++...+....++++-|+++|....||+||++++.++..+.++++.|||.||..+.
T Consensus 39 ELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDa 118 (1187)
T KOG0579|consen 39 ELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDA 118 (1187)
T ss_pred hhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhH
Confidence 36999999999999654 44567899887777788999999999999999999999999999999999999999999988
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceecc
Q 008216 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (573)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 434 (573)
.+-. -+..+++.++.-++.|++.||.|||++ +|||||||+.|||++-+|.++|+|||.+...... ......+
T Consensus 119 imlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qkRDsF 190 (1187)
T KOG0579|consen 119 IMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQKRDSF 190 (1187)
T ss_pred HHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH--Hhhhccc
Confidence 8764 346799999999999999999999999 9999999999999999999999999998754332 2223344
Q ss_pred CCccccccccccc-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 435 GGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 435 ~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
.|||.|||||+.. ..+|+.++||||||++|.||..+.+|....++.. -+...+ ..-.|
T Consensus 191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--VllKia----------KSePP----- 253 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIA----------KSEPP----- 253 (1187)
T ss_pred cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--HHHHHh----------hcCCC-----
Confidence 5999999999874 4689999999999999999999999977655421 111100 00011
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
....+...+..+.+++.+||..||..||++.++++.
T Consensus 254 -TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 254 -TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 122234567789999999999999999999999863
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=293.10 Aligned_cols=248 Identities=27% Similarity=0.429 Sum_probs=198.0
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|++|.||+|... +++.||+|.++.... ...+.+.+|+.++++++|+||+++++.+.+.+..++|+||++++
T Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06626 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGG 84 (264)
T ss_pred eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCC
Confidence 457899999999999864 689999999976643 35678899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. +..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++...........
T Consensus 85 ~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 85 TLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred cHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 99999864 34578899999999999999999999 999999999999999999999999999987654332211
Q ss_pred e--eccCCcccccccccccCCC---CCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 431 T--VMAGGTYGYLAPEFVYRNE---LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 431 ~--~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
. ....++..|+|||++.+.. .+.++||||||+++|++++|+.||...+... ..... . ... ..+.
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~----~-~~~-----~~~~ 226 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFH----V-GAG-----HKPP 226 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHH----H-hcC-----CCCC
Confidence 1 1233788999999998766 7899999999999999999999997653210 00000 0 000 0000
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.......+..+.+++.+||+.+|.+||++.+++.
T Consensus 227 ------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 227 ------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0111123567889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=300.86 Aligned_cols=249 Identities=24% Similarity=0.418 Sum_probs=196.5
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|+||.||+++. .+|..||+|.+.... ......+.+|+.++++++|||++++++++.+++..++||||+.
T Consensus 30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 108 (317)
T cd06635 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL- 108 (317)
T ss_pred hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-
Confidence 34579999999999995 468899999987532 2334578899999999999999999999999999999999996
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|.+.+.. ....+++.++..++.|++.||.|||++ +++||||+|+||+++.++.++|+|||++.......
T Consensus 109 g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~--- 179 (317)
T cd06635 109 GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN--- 179 (317)
T ss_pred CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCcc---
Confidence 577777653 234589999999999999999999999 99999999999999999999999999987543221
Q ss_pred ceeccCCccccccccccc---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
...++..|+|||.+. ++.++.++||||||+++|||++|+.||...+.... ... .....
T Consensus 180 ---~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~----~~~~~---------- 240 (317)
T cd06635 180 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYH----IAQNE---------- 240 (317)
T ss_pred ---cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHH----HHhcc----------
Confidence 123788999999874 45688999999999999999999999876432110 000 00000
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
.........++.+.+++.+||+.+|.+||++.++++.+-.....+
T Consensus 241 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 241 ---SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred ---CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 011112234567999999999999999999999998765555544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=296.68 Aligned_cols=245 Identities=22% Similarity=0.363 Sum_probs=199.1
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
...||+|++|.||+|... +++.|++|+++.... ..+.+.+|++.+++++|+||+++++.+...+..++++||+++++|
T Consensus 24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 102 (286)
T cd06614 24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL 102 (286)
T ss_pred hHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcH
Confidence 346799999999999975 689999999986644 567788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 103 ~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~ 174 (286)
T cd06614 103 TDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK--RN 174 (286)
T ss_pred HHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh--hc
Confidence 99997522 3699999999999999999999999 9999999999999999999999999998765432211 11
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..... . ... ... .. ..
T Consensus 175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~----~~~-~~~----~~-------~~ 236 (286)
T cd06614 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--F----LIT-TKG----IP-------PL 236 (286)
T ss_pred cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--H----HHH-hcC----CC-------CC
Confidence 223788999999998888999999999999999999999998765432100 0 000 000 00 11
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
......+..+.+++.+||+.+|.+||++.++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111224567999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=296.22 Aligned_cols=244 Identities=21% Similarity=0.280 Sum_probs=192.3
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 277 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
||+|+||+||++... +|+.||+|.+.... ......+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 599999999999854 68999999986542 12344567899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++... ....+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+......... .
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~---~ 152 (277)
T cd05577 81 KYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---K 152 (277)
T ss_pred HHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcc---c
Confidence 9998652 224689999999999999999999999 9999999999999999999999999998765432111 1
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||............. . . ... . ..
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~-~----~~~-~-----~~ 215 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK------R-R----TLE-M-----AV 215 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH------h-c----ccc-c-----cc
Confidence 2237889999999988889999999999999999999999997654311100000 0 0 000 0 00
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH 545 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 545 (573)
..+...++.+.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 11122456799999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=300.52 Aligned_cols=263 Identities=24% Similarity=0.301 Sum_probs=194.8
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|++|.||++... +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+++..++||||++++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (286)
T cd07846 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85 (286)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCcc
Confidence 457899999999999975 589999999865422 23467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.++... ...+++..++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.........
T Consensus 86 ~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-- 156 (286)
T cd07846 86 VLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-- 156 (286)
T ss_pred HHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc--
Confidence 99887643 23489999999999999999999999 9999999999999999999999999998865433211
Q ss_pred eeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccc-hhhHHhhhhhhhccc-c---cccccc
Q 008216 431 TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLVQSHR-Y---LELLDP 504 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~-~---~~~~~~ 504 (573)
.....++..|+|||++.+ ..++.++||||||+++|||++|++||........ ............... . ......
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 111237889999998875 3467899999999999999999999875443210 011100000000000 0 000000
Q ss_pred cc-ccCCC----CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 505 LI-SSLSS----DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 505 ~~-~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.. ..... .......+..+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 00000 0001234577999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=297.91 Aligned_cols=239 Identities=23% Similarity=0.316 Sum_probs=195.2
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|++|.||++... +++.||+|+++... ....+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (290)
T cd05580 6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG 85 (290)
T ss_pred EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCC
Confidence 457899999999999964 58999999987542 23346788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 86 ~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 86 GELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 999999864 25689999999999999999999999 9999999999999999999999999999876433
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...+... ..... . ...
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~---~-~~~------------ 214 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IYEKI---L-EGK------------ 214 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---h-cCC------------
Confidence 122238899999999988888999999999999999999999997654211 00000 0 000
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH 545 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 545 (573)
.. .+...+..+.+++.+||+.||.+|| +++|+++
T Consensus 215 -~~-~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 -VR-FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -cc-CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 00 0112356789999999999999999 6777763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=297.84 Aligned_cols=262 Identities=22% Similarity=0.280 Sum_probs=193.1
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEecccchh--hHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--CceEEEEEecCC
Q 008216 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVVN 349 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~~~ 349 (573)
+.||+|++|.||+|... +++.+|+|.++..... ....+.+|+.++.+++||||+++++++... +..++||||++
T Consensus 11 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~- 89 (293)
T cd07843 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE- 89 (293)
T ss_pred hhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-
Confidence 46799999999999975 5889999999754322 234567899999999999999999998877 88999999996
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
++|.+++... ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++..........
T Consensus 90 ~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 163 (293)
T cd07843 90 HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163 (293)
T ss_pred cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence 5999888642 23689999999999999999999999 99999999999999999999999999998765432111
Q ss_pred ceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchh-hHHhhh-------hhhhc---cc
Q 008216 430 RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWAT-------PLVQS---HR 497 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~~-------~~~~~---~~ 497 (573)
....+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||.......... +..... +.... ..
T Consensus 164 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 164 --TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred --ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 112378889999988754 46889999999999999999999997654321111 100000 00000 00
Q ss_pred cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
................+....++.+.++|.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000000011111114667899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.98 Aligned_cols=266 Identities=21% Similarity=0.316 Sum_probs=195.9
Q ss_pred hcCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC------
Q 008216 267 TKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------ 337 (573)
Q Consensus 267 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------ 337 (573)
.+.|.. .+.||+|+||.||++.. .+|+.||||.+... .......+.+|+.++++++||||+++++++...
T Consensus 15 ~~~y~~-~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQN-LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEE-EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 344444 45789999999999995 46899999998653 233446678899999999999999999987644
Q ss_pred CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEeccc
Q 008216 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (573)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 417 (573)
...++||||+. ++|.+.+.. .++...+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 34699999995 588887752 288899999999999999999999 99999999999999999999999999
Q ss_pred CCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCccc-chhhHHh--------
Q 008216 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC-WQSIFEW-------- 488 (573)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~-------- 488 (573)
+++....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+... +..+...
T Consensus 164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 164 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred cceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9986543222 112237889999999999999999999999999999999999997654321 0000000
Q ss_pred ---hh----hhhhc------cccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 489 ---AT----PLVQS------HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 489 ---~~----~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
.. ..... ..+.+..................+..+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 00000 000011111110000111122346678999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=280.62 Aligned_cols=245 Identities=23% Similarity=0.398 Sum_probs=195.4
Q ss_pred eecccCceEEEEEEe-CCCCEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
.||.|..|.|++.+. ..|...|||.+.+. +....++++..++++.+- ..|.||+.+|+|..+...++.||.| ..-+
T Consensus 99 dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ 177 (391)
T KOG0983|consen 99 DLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCA 177 (391)
T ss_pred hhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHH
Confidence 479999999999995 45899999999876 344557788888887766 4899999999999999999999998 4456
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
+.++.. ..+++++..+-++...+.+||.||-+++ +|+|||+||+|||+|+.|++||+|||++..+.....+...
T Consensus 178 ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrs- 251 (391)
T KOG0983|consen 178 EKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRS- 251 (391)
T ss_pred HHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccccccc-
Confidence 666653 3466999888999999999999999875 9999999999999999999999999999887655444333
Q ss_pred ccCCcccccccccccC---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 433 MAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
.|-+.|||||.+.- ..|+-++||||||++++||.||+.||...+.+ ++.......+ ..|.+
T Consensus 252 --AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-----Fe~ltkvln~------ePP~L--- 315 (391)
T KOG0983|consen 252 --AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-----FEVLTKVLNE------EPPLL--- 315 (391)
T ss_pred --cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-----HHHHHHHHhc------CCCCC---
Confidence 28899999999864 36788999999999999999999999875542 1111111110 01111
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
....+.++.+.+++..||+.|+.+||...++++.
T Consensus 316 ---~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 316 ---PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ---CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1223377889999999999999999999999863
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=287.39 Aligned_cols=245 Identities=24% Similarity=0.387 Sum_probs=200.5
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
.+.||+|++|.||++... +++.+++|++..........+.+|+.++++++||||+++++.+...+..++++||+++++|
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 84 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence 346799999999999975 6899999999877555667899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++... ...+++..+..++.|++.||++||+. +++||||+|+||+++.++.++|+|||.+........ ..
T Consensus 85 ~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~ 155 (253)
T cd05122 85 KDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RN 155 (253)
T ss_pred HHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc---cc
Confidence 9998642 25689999999999999999999999 999999999999999999999999999987654332 12
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||...+....... . ...... ..
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~------~-~~~~~~-----------~~ 217 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK------I-ATNGPP-----------GL 217 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH------H-HhcCCC-----------Cc
Confidence 23388899999999888889999999999999999999999976542211000 0 000000 00
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
......+..+.+++.+||+.||++|||+.++++
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111112567999999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=299.51 Aligned_cols=255 Identities=22% Similarity=0.291 Sum_probs=209.8
Q ss_pred HHHHhhcCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC
Q 008216 262 ELRSITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337 (573)
Q Consensus 262 el~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 337 (573)
|.+.++.+.....++||+|+||.||..+. .+|+.+|.|.+.+... ......++|-.+|.+++.+.||.+--.+++.
T Consensus 178 E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk 257 (591)
T KOG0986|consen 178 ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK 257 (591)
T ss_pred HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence 55667777777788999999999998874 5699999999866532 2345578899999999999999999999999
Q ss_pred CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEeccc
Q 008216 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (573)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 417 (573)
+.+++|+..|.||+|.-+|.+ -++..++++.++.++.+|+.||++||+. +||.|||||+|||+|+.|+++|+|+|
T Consensus 258 d~LClVLtlMNGGDLkfHiyn--~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLG 332 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYN--HGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLG 332 (591)
T ss_pred CceEEEEEeecCCceeEEeec--cCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccc
Confidence 999999999999999999876 3446799999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccc
Q 008216 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 497 (573)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 497 (573)
+|..+......... .||.+|||||++.+..|+...|-||+||+||||+.|+.||....+..-.
T Consensus 333 LAvei~~g~~~~~r---vGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~-------------- 395 (591)
T KOG0986|consen 333 LAVEIPEGKPIRGR---VGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR-------------- 395 (591)
T ss_pred eEEecCCCCccccc---cCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH--------------
Confidence 99988755443332 4999999999999999999999999999999999999999765432100
Q ss_pred cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHH
Q 008216 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS 541 (573)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 541 (573)
+-+|.+.... ....+...++++.++....|+.||++|....
T Consensus 396 --eEvdrr~~~~-~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 396 --EEVDRRTLED-PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred --HHHHHHHhcc-hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 1111111111 1222356778899999999999999996443
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=295.28 Aligned_cols=243 Identities=22% Similarity=0.308 Sum_probs=197.4
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||.|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++.+.++...++|+||+.+
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (258)
T cd05578 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLG 84 (258)
T ss_pred EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCC
Confidence 457899999999999975 58999999997542 23457889999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
++|.+++.. ...+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||.+........
T Consensus 85 ~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-- 155 (258)
T cd05578 85 GDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-- 155 (258)
T ss_pred CCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc--
Confidence 999999964 24689999999999999999999999 999999999999999999999999999887644321
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......... ... .
T Consensus 156 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~--------~----- 217 (258)
T cd05578 156 -TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK----QET--------A----- 217 (258)
T ss_pred -ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH----hcc--------c-----
Confidence 1223378899999999888899999999999999999999999987653211111100 000 0
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCH--HHHH
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRM--SHVV 544 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl 544 (573)
....+...+..+.++|.+||+.||.+||++ +|++
T Consensus 218 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 -DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111122345789999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=297.03 Aligned_cols=265 Identities=23% Similarity=0.285 Sum_probs=196.8
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
..+.||+|++|.||+|... +++.||||.++... ....+.+.+|++++++++|+||+++++++.+.+..+++|||+++
T Consensus 5 ~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 84 (288)
T cd07833 5 VLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER 84 (288)
T ss_pred EEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCC
Confidence 3456899999999999965 58899999987542 23346789999999999999999999999999999999999988
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
+.+..+... ...+++..+..++.|++.||+|||++ +++|+||+|+||++++++.+||+|||++..........
T Consensus 85 ~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 85 TLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 777665532 34589999999999999999999999 99999999999999999999999999998765443211
Q ss_pred ceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchh-hHHhhhhhhhccccccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
. ....++..|+|||++.+. .++.++||||||+++|+|++|++||.......... ..................++...
T Consensus 158 ~-~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 158 L-TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred c-cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 1 122378889999999887 78999999999999999999999997654321100 00000000000000000000000
Q ss_pred c--CC--------CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 508 S--LS--------SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 508 ~--~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
. .. ....+...+.++.++|.+||+.+|++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 00 00111223678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=295.58 Aligned_cols=262 Identities=18% Similarity=0.217 Sum_probs=190.4
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
.+.||+|+||.||+|.. .+|+.||+|+++.... .....+.+|+.+++.++|+||+++++++.+++..++||||+. ++
T Consensus 10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07870 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TD 88 (291)
T ss_pred EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CC
Confidence 45679999999999985 4689999999975432 223467889999999999999999999999999999999995 67
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++........ .
T Consensus 89 l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~ 160 (291)
T cd07870 89 LAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--Y 160 (291)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--C
Confidence 7776643 224578888999999999999999999 9999999999999999999999999998764332111 1
Q ss_pred eccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhh-----------hhhccccc
Q 008216 432 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP-----------LVQSHRYL 499 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-----------~~~~~~~~ 499 (573)
....++..|+|||.+.+. .++.++||||||+++|||++|..||...++.. ..+...... ........
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 122378899999998754 57889999999999999999999997654321 111100000 00000000
Q ss_pred ccccccc-c-cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 500 ELLDPLI-S-SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 500 ~~~~~~~-~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....... . ...........+..+.+++.+|+..||++|||+.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000 0 00000000112457889999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=298.48 Aligned_cols=250 Identities=23% Similarity=0.403 Sum_probs=190.6
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 276 LLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
.||+|+||.||++... +|+.||+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||+. ++|
T Consensus 11 ~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l 89 (288)
T cd06616 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISL 89 (288)
T ss_pred HhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCH
Confidence 5799999999999854 58999999987543 234567889999999996 9999999999999999999999985 466
Q ss_pred HHHhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 353 DRWLHHI-PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 353 ~~~l~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
.++.... ......+++..+..++.|++.||+|||+.. +++||||||+||+++.++.++|+|||++.........
T Consensus 90 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--- 164 (288)
T cd06616 90 DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK--- 164 (288)
T ss_pred HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc---
Confidence 5543211 122356899999999999999999999732 8999999999999999999999999998765432211
Q ss_pred eccCCcccccccccccCC---CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 432 VMAGGTYGYLAPEFVYRN---ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
....|+..|+|||.+.+. .++.++||||||+++|||++|+.||..... ..+....... ...+.+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~------~~~~~~-- 231 (288)
T cd06616 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK------GDPPIL-- 231 (288)
T ss_pred ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC------CCCCcC--
Confidence 112378899999998766 688999999999999999999999875431 1111100000 000111
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
........+.++.+|+.+||+.||++|||+++|++.
T Consensus 232 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 --SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011112356789999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=299.29 Aligned_cols=241 Identities=23% Similarity=0.383 Sum_probs=190.4
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|++|.||+|+. .+|+.||+|.+.... ......+.+|+.++++++|||++++++++.+....++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 34579999999999985 468899999987532 2334568899999999999999999999999999999999995
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
++|.+++.. ....+++.++..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||++......
T Consensus 105 ~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~---- 174 (313)
T cd06633 105 GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---- 174 (313)
T ss_pred CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC----
Confidence 577777753 234689999999999999999999999 9999999999999999999999999998643221
Q ss_pred ceeccCCccccccccccc---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
....|+..|+|||++. ...++.++||||||+++|+|++|..||...+..... ..... ...
T Consensus 175 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~-~~~-------- 237 (313)
T cd06633 175 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQ-NDS-------- 237 (313)
T ss_pred --CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHh-cCC--------
Confidence 1223788999999974 356888999999999999999999998765432110 00000 000
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
........+..+.+++.+||+.+|.+||++.+++..
T Consensus 238 ----~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 ----PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111112234568999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=297.07 Aligned_cols=243 Identities=22% Similarity=0.347 Sum_probs=197.0
Q ss_pred eeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHH
Q 008216 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 353 (573)
..||+|++|.||++.. .+|+.||||.+..........+.+|+.+++.++|+||+++++.+...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 3579999999999986 468999999987655556677999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceec
Q 008216 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433 (573)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 433 (573)
+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++......... ...
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~ 175 (292)
T cd06657 106 DIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKS 175 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccc--ccc
Confidence 98753 3478999999999999999999999 9999999999999999999999999998765432211 122
Q ss_pred cCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCC
Q 008216 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 513 (573)
Q Consensus 434 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (573)
..+++.|+|||.+.+..++.++|+||||+++|+|++|..||........... .. ....+...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~---~~---------~~~~~~~~------ 237 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM---IR---------DNLPPKLK------ 237 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH---------hhCCcccC------
Confidence 3388899999999888889999999999999999999999976443211100 00 00011110
Q ss_pred cchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 514 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.....+..+.+++.+||+.||.+||++.++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 238 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 01123456889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=297.92 Aligned_cols=268 Identities=18% Similarity=0.260 Sum_probs=193.5
Q ss_pred CeeecccCceEEEEEEeC---CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--CceEEEEE
Q 008216 274 NRLLGDSKTGGTYSGILP---DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYE 345 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e 345 (573)
.+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...++|||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 84 (316)
T cd07842 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFD 84 (316)
T ss_pred EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEe
Confidence 346799999999999964 47899999998732 23346678899999999999999999999988 77899999
Q ss_pred ecCCCCHHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC----CCCeeEecccCCc
Q 008216 346 FVVNGPLDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE----EFGAHLMGVGLSK 420 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~Dfg~~~ 420 (573)
|+++ +|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||+++. ++.+||+|||++.
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 85 YAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred CCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 9964 677766543322 23789999999999999999999999 9999999999999999 8899999999998
Q ss_pred cCCcccc-ccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccch------hhHHhhhhh
Q 008216 421 FVPWEVM-QERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ------SIFEWATPL 492 (573)
Q Consensus 421 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~------~~~~~~~~~ 492 (573)
....... ........++..|+|||.+.+ ..++.++||||||+++|+|++|++||......... .........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 7643322 111112237889999998766 45789999999999999999999999765443200 000000000
Q ss_pred hh------------cccccccccccc-ccCCCCCc----c--hHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 493 VQ------------SHRYLELLDPLI-SSLSSDIP----E--AGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 493 ~~------------~~~~~~~~~~~~-~~~~~~~~----~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.. ........+... ........ . ...+.++.+++.+||+.||++|||+.|+++
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 000000000000 00000000 0 023457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=296.39 Aligned_cols=265 Identities=19% Similarity=0.235 Sum_probs=191.6
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCc-----eEEEE
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD-----RYIVY 344 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~-----~~lv~ 344 (573)
.+.||+|+||.||+|... +|+.||||.++.... .....+.+|+.+++++ +||||+++++++...+. .++||
T Consensus 6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~ 85 (295)
T cd07837 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85 (295)
T ss_pred eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence 456799999999999964 689999999865422 2235788899999999 56999999999887665 79999
Q ss_pred EecCCCCHHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-CCCeeEecccCCccC
Q 008216 345 EFVVNGPLDRWLHHIPRG-GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFV 422 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~ 422 (573)
||+++ +|.+++...... ...+++..++.++.||+.||+|||++ +++||||||+||+++. ++.+||+|||++...
T Consensus 86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~ 161 (295)
T cd07837 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161 (295)
T ss_pred eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccceec
Confidence 99975 898888653322 35689999999999999999999999 9999999999999998 889999999998765
Q ss_pred CccccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccc-hhhHHhhhhhhhcccccc
Q 008216 423 PWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLVQSHRYLE 500 (573)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 500 (573)
...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.... ..+...... ........
T Consensus 162 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 238 (295)
T cd07837 162 SIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT-PTEQVWPG 238 (295)
T ss_pred CCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC-CChhhCcc
Confidence 332111 111226788999998865 4578999999999999999999999976543211 011100000 00000000
Q ss_pred c---cccc-cccCCC---CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 501 L---LDPL-ISSLSS---DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 501 ~---~~~~-~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
. .+.. ...... .......+.++.++|.+||+.||.+||+++|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0000 000000 0001134567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=295.32 Aligned_cols=257 Identities=21% Similarity=0.292 Sum_probs=193.2
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|++|.||+|+.. +|+.||||.++.... .....+.+|++++++++||||+++++++.+.+..++||||+. +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-Q 83 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-c
Confidence 346799999999999864 689999999875422 233578899999999999999999999999999999999995 6
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++... ....+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++.........
T Consensus 84 ~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~-- 156 (284)
T cd07860 84 DLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-- 156 (284)
T ss_pred CHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--
Confidence 898888652 235689999999999999999999999 9999999999999999999999999998765432211
Q ss_pred eeccCCcccccccccccCCC-CCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhc--------------
Q 008216 431 TVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS-------------- 495 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------------- 495 (573)
.....++..|+|||.+.+.. ++.++||||||+++|||+||+.||...+... ............
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 11122678899999887644 5889999999999999999999997654321 111110000000
Q ss_pred -cccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 496 -HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 496 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
..+.......... .....+..+.++|.+||+.||++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 235 KPSFPKWARQDFSK-----VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HhhcccccccCHHH-----HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000000 00123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=294.67 Aligned_cols=246 Identities=20% Similarity=0.313 Sum_probs=195.6
Q ss_pred ecccCceEEEEEEeCC-CCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 277 lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
||.|++|.||++...+ |+.+|+|++..... ...+.+.+|+.++++++||||+++++.+...+..+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 5899999999999764 99999999976533 3456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc----
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ---- 428 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~---- 428 (573)
.+++... ..+++..+..++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9998642 3689999999999999999999999 9999999999999999999999999998765432110
Q ss_pred --cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 429 --ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 429 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
.......++..|+|||...+...+.++||||||+++|++++|..||....... .... ... ...
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~---~~~-~~~-------- 218 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---IFQN---ILN-GKI-------- 218 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---Hhc-CCc--------
Confidence 11122337889999999988888999999999999999999999997654321 1100 000 000
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 548 (573)
........+..+.+++.+||+.+|.+|||+.++.+.|+
T Consensus 219 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 ----EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ----CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00000112567899999999999999999966555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=310.95 Aligned_cols=276 Identities=22% Similarity=0.316 Sum_probs=204.3
Q ss_pred CcCCeeecccCceEEEEEE-eCCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC------ceEE
Q 008216 271 SEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRYI 342 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~l 342 (573)
.+..+.||+|+||.||+|+ ..+|+.||||.++... ....+...+|+++|++|+|||||+++++-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4445678999999999999 5679999999998753 344677889999999999999999999865543 4589
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC--CCCC--eeEecccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD--EEFG--AHLMGVGL 418 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~--~~~~--~kl~Dfg~ 418 (573)
|||||.+|||...|+. +.....+++.+.+.++.++..||.|||++ +|+||||||.||++- .+|+ .||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999976 45567799999999999999999999999 999999999999983 3343 69999999
Q ss_pred CccCCccccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccc
Q 008216 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 497 (573)
Q Consensus 419 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 497 (573)
|+.++.+. ......||..|.+||++.. ..|+..+|.|||||++|+.+||..||.......-..-+.|.........
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99887655 2333449999999999984 7889999999999999999999999976543311000111111000000
Q ss_pred c-----ccccccccccCC---CCCcchHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHhcccCC
Q 008216 498 Y-----LELLDPLISSLS---SDIPEAGVVQKVVDLVYACTQHVPSMRP--RMSHVVHQLQQLAQP 553 (573)
Q Consensus 498 ~-----~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~~~~~ 553 (573)
. .+.-.+...+.. +..........+-..+..+|..+|.+|. ...+....+..+...
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 0 000001110000 1111233445677788889999999998 777776666665543
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=292.94 Aligned_cols=264 Identities=20% Similarity=0.270 Sum_probs=194.6
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
.+.||.|++|.||+|+.. +|+.||||.++.... .....+.+|+.++++++||||+++++++.+.+..++||||+++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 83 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-D 83 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-c
Confidence 346799999999999974 588999999976532 2345677899999999999999999999999999999999974 8
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++......... .
T Consensus 84 l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~ 157 (284)
T cd07836 84 LKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--F 157 (284)
T ss_pred HHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc--c
Confidence 888886432 234689999999999999999999999 9999999999999999999999999999765432111 1
Q ss_pred eccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchh-hHHhhhhhhhccccc-----ccccc
Q 008216 432 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPLVQSHRYL-----ELLDP 504 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~-----~~~~~ 504 (573)
....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+...... ....... .....+. .....
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGT-PTESTWPGISQLPEYKP 236 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC-CChhhHHHHhcCchhcc
Confidence 112368889999988654 56889999999999999999999997655321111 1100000 0000000 00000
Q ss_pred ccccCC---CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 505 LISSLS---SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 505 ~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
...... ........+..+.+++.+|++.||.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 00001123567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=290.59 Aligned_cols=242 Identities=21% Similarity=0.247 Sum_probs=187.9
Q ss_pred eecccCceEEEEEEe-CCCCEEEEEEecccchh---hHHHHHHHHHHH-hhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ---RKKEFYSEIGRF-ARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.||+|++|.||+|.. .+|+.||||+++..... ....+..|..++ ...+||||+++++++...+..++|+||++++
T Consensus 3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (260)
T cd05611 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGG 82 (260)
T ss_pred cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCC
Confidence 479999999999986 45899999999754321 223344555444 4458999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 83 ~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 150 (260)
T cd05611 83 DCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----- 150 (260)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc-----
Confidence 99999864 24589999999999999999999999 9999999999999999999999999998754321
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
....++..|+|||.+.+..++.++||||||+++|+|++|..||...+... .... . ...... .
T Consensus 151 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~---~-~~~~~~--~-------- 212 (260)
T cd05611 151 -KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VFDN---I-LSRRIN--W-------- 212 (260)
T ss_pred -ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHH---H-HhcccC--C--------
Confidence 12237889999999988888999999999999999999999997654321 1110 0 000000 0
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 547 (573)
.......++..+.+++.+||+.||++||++.++.+.|
T Consensus 213 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 0011113456799999999999999999886665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=304.60 Aligned_cols=246 Identities=21% Similarity=0.334 Sum_probs=202.9
Q ss_pred CCCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEE
Q 008216 269 NFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
+++...+.||+|.|+.|.+|.. .+|..||||.+.+.. ....+.+.+|+++|+.++|||||+++.+......+|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 3445566789999999999994 469999999998763 3334558999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|+.+|.+.+|+.. .....+..+..++.|+.+|++|||++ +|+|||||++||||+.+.++||+|||++..+...
T Consensus 136 ya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 136 YASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred eccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc
Confidence 9999999999965 34566688999999999999999999 9999999999999999999999999999988754
Q ss_pred ccccceeccCCcccccccccccCCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
... ...+|++.|.|||++.+..+ ++.+|+||+|+++|-|+.|..||++..-..... +
T Consensus 209 ~~l---qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~-------------------r 266 (596)
T KOG0586|consen 209 LML---QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP-------------------R 266 (596)
T ss_pred ccc---cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc-------------------h
Confidence 333 34569999999999998776 589999999999999999999998754321111 1
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.+... ..+ +.-.+.+..++|+++|..+|.+|++++++.+
T Consensus 267 vl~gk-~rI-p~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 267 VLRGK-YRI-PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred heeee-ecc-cceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 11000 000 1123456889999999999999999999976
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=286.78 Aligned_cols=247 Identities=25% Similarity=0.378 Sum_probs=200.7
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--CceEEEEEecC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVV 348 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~~ 348 (573)
.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++||||+++++.+.+. +..++++||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 457899999999999975 689999999976542 4467889999999999999999999999988 88999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 85 ~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 85 GGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999998642 2789999999999999999999999 9999999999999999999999999999877554321
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
.......++..|+|||.+.+...+.++||||||+++++|++|..||...+.. ............
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~----------- 221 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYKIGSSGE----------- 221 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHhccccCC-----------
Confidence 1122233888999999998888999999999999999999999999765521 000000000000
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....+...+..+.+++.+|++.||++||++.++++
T Consensus 222 --~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 --PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred --CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 01111233568999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=292.03 Aligned_cols=264 Identities=19% Similarity=0.240 Sum_probs=195.0
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--CceEEEEEecC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVV 348 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~~ 348 (573)
.+.||+|++|.||+|... +|+.+|+|+++... ......+.+|+.++++++|||++++++++.+. +..++||||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD 83 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence 456799999999999965 48899999998663 23345688999999999999999999999888 78999999996
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.........
T Consensus 84 -~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 84 -HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred -ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 4898888642 24689999999999999999999999 9999999999999999999999999999876543321
Q ss_pred cceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccc----
Q 008216 429 ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD---- 503 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 503 (573)
. .....++..|+|||.+.+ ..++.++||||||+++|||+||+.||...+...................+....+
T Consensus 157 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 157 D-YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred c-ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 1 112236788999998765 4578999999999999999999999976554211111000000000000000000
Q ss_pred ----ccc--ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 504 ----PLI--SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 504 ----~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+.. ...........++..+.+++.+||+.+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 000000001112567999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=288.15 Aligned_cols=247 Identities=21% Similarity=0.359 Sum_probs=201.8
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||.|++|.||++... +++.+|+|++..... .....+.+|++++++++|||++++.+.+...+..++|+|+++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 84 (258)
T cd08215 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGG 84 (258)
T ss_pred EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCC
Confidence 356899999999999964 589999999976533 45677899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++......+..+++..+..++.+++.||.|||++ +++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 159 (258)
T cd08215 85 DLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--L 159 (258)
T ss_pred cHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcc--e
Confidence 99999976443356799999999999999999999999 999999999999999999999999999987654331 1
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
.....+++.|+|||...+..++.++|+||+|+++++|++|+.||...+... ... .... ...
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~---~~~~---------~~~---- 220 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LAL---KILK---------GQY---- 220 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHH---HHhc---------CCC----
Confidence 112238889999999988889999999999999999999999987654211 110 0000 000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.. .+...+..+.+++.+||..+|++|||+.++++
T Consensus 221 ~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 PP-IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 11134567999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=289.98 Aligned_cols=246 Identities=20% Similarity=0.367 Sum_probs=196.0
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|++|.||++... +|..+|+|.+.... ....+.+.+|+.++++++|+||+++++.+.+.+..++++||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG 84 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCC
Confidence 456899999999999964 58899999986542 234467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCC-eeEecccCCccCCcccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-AHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~-~kl~Dfg~~~~~~~~~~~~ 429 (573)
+|.+++.. .....+++..+..++.|++.||+|||+. +++|+||||+||++++++. ++|+|||.+.........
T Consensus 85 ~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~- 158 (257)
T cd08225 85 DLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL- 158 (257)
T ss_pred cHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCccc-
Confidence 99999864 2234579999999999999999999999 9999999999999988754 699999998866433211
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
.....|++.|+|||.+.+..++.++|+||||+++|||++|..||...+... ....... ....+
T Consensus 159 -~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-----~~~~~----- 221 (257)
T cd08225 159 -AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQ-----GYFAP----- 221 (257)
T ss_pred -ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhc-----ccCCC-----
Confidence 112238889999999988889999999999999999999999987543211 1111000 00110
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
.....+..+.+++.+||+.+|++|||+.++++.
T Consensus 222 ----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 ----ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 011234579999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=288.05 Aligned_cols=249 Identities=21% Similarity=0.250 Sum_probs=189.5
Q ss_pred HHHHhhcCCCcCCee-ecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCC
Q 008216 262 ELRSITKNFSEGNRL-LGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHG 338 (573)
Q Consensus 262 el~~~~~~~~~~~~~-lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 338 (573)
+.....+++...+.+ ||+|+||.||++.. .++..+|+|.+........ |+.....+ +||||+++++.+...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 334444454443333 69999999999985 4688999999875422211 22222222 7999999999999999
Q ss_pred ceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-CeeEeccc
Q 008216 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVG 417 (573)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg 417 (573)
..++||||+++++|.+++.. ...+++.++..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 99999999999999999964 23789999999999999999999999 999999999999999988 89999999
Q ss_pred CCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccc
Q 008216 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 497 (573)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 497 (573)
++....... ...++..|+|||++.+..++.++||||||+++|||++|+.||........ ....+...
T Consensus 156 ~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~------ 222 (267)
T PHA03390 156 LCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKR------ 222 (267)
T ss_pred cceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHh------
Confidence 987654322 12388999999999988899999999999999999999999975433210 00000000
Q ss_pred cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 008216 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-MSHVVH 545 (573)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 545 (573)
... ........++.+.++|.+||+.||.+||+ ++++++
T Consensus 223 ----~~~------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 223 ----QQK------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----hcc------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 000 00111245678999999999999999996 588874
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=292.04 Aligned_cols=257 Identities=18% Similarity=0.184 Sum_probs=189.3
Q ss_pred eeecccCceEEEEEEe-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeC--CceEEEEEecCC
Q 008216 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDH--GDRYIVYEFVVN 349 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lv~e~~~~ 349 (573)
+.||+|++|.||+|.. .+++.||+|+++... ........+|+..+.++. ||||+++++++.+. +..++||||++
T Consensus 5 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~- 83 (282)
T cd07831 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD- 83 (282)
T ss_pred eeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-
Confidence 4679999999999995 468999999987642 222334567888999885 99999999999987 88999999996
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++. +.+||+|||++..........
T Consensus 84 ~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 84 MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence 5787777532 24689999999999999999999999 9999999999999999 999999999998664332211
Q ss_pred ceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhh-----------ccc
Q 008216 430 RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ-----------SHR 497 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-----------~~~ 497 (573)
...++..|+|||.+.. ..++.++|||||||++|||++|..||...+..+. ......... ...
T Consensus 157 ---~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 157 ---EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhcccc
Confidence 1237889999997654 5578899999999999999999999976543211 111100000 000
Q ss_pred cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
......+..............+..+.++|.+||+.||++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000000001234678999999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=290.73 Aligned_cols=241 Identities=19% Similarity=0.244 Sum_probs=186.7
Q ss_pred eecccCceEEEEEEe-CCCCEEEEEEecccchh---hHHHHHHHHH---HHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ---RKKEFYSEIG---RFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
+||+|+||.||++.. .+++.||+|.+...... ....+..|.. .++...||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 379999999999985 45889999998754221 1222334433 4444589999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 9999998853 34699999999999999999999999 999999999999999999999999999875533221
Q ss_pred cceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||.............. .. ...
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~------~~~---- 215 (278)
T cd05606 153 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----TL------TMA---- 215 (278)
T ss_pred ---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH----hh------ccC----
Confidence 122489999999998754 688999999999999999999999976533211111000 00 000
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 545 (573)
.. .+...+.++.+++.+|+..+|.+|| ++.++++
T Consensus 216 ---~~-~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 216 ---VE-LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ---CC-CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 01 1112356799999999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=296.84 Aligned_cols=263 Identities=17% Similarity=0.237 Sum_probs=191.4
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccchh--hHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--CceEEEEEecC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFVV 348 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~~ 348 (573)
.+.||+|++|.||+|... +|+.||+|.++..... ....+.+|+.++++++|+||+++++++.+. +..++||||+.
T Consensus 12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 91 (309)
T cd07845 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE 91 (309)
T ss_pred eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC
Confidence 446799999999999964 5899999998754322 233567899999999999999999998765 45799999995
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
++|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 92 -~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 164 (309)
T cd07845 92 -QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164 (309)
T ss_pred -CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence 5888888642 25689999999999999999999999 9999999999999999999999999999876533211
Q ss_pred cceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccc-----c
Q 008216 429 ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL-----L 502 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 502 (573)
.....++..|+|||.+.+ ..++.++||||||+++|||++|++||...+....................... .
T Consensus 165 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07845 165 --MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242 (309)
T ss_pred --CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence 111225778999999865 45789999999999999999999999865543211111100000000000000 0
Q ss_pred cc-ccccCCCC---CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 503 DP-LISSLSSD---IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 503 ~~-~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.. ........ ......++.+.++|.+||+.||++|||++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 00000000 000113567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=289.13 Aligned_cols=246 Identities=23% Similarity=0.330 Sum_probs=201.0
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|++|.||++.. .+++.+|+|.+.... ......+.+|+.++++++||||+++.+++.+....++||||++++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFG 84 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCC
Confidence 34679999999999985 468899999987542 334567789999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~--- 158 (256)
T cd08530 85 DLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA--- 158 (256)
T ss_pred CHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCCc---
Confidence 99999876444456789999999999999999999999 999999999999999999999999999987654411
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+....... ..... .
T Consensus 159 -~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~-------~~~~~--------~---- 218 (256)
T cd08530 159 -KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK-------VQRGK--------Y---- 218 (256)
T ss_pred -ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HhcCC--------C----
Confidence 112378899999999888899999999999999999999999976543211100 00000 0
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
.. .....+.++.+++.+|++.+|++||++.++++.
T Consensus 219 ~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 PP-IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CC-CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11 112456779999999999999999999999853
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=295.89 Aligned_cols=260 Identities=19% Similarity=0.227 Sum_probs=191.6
Q ss_pred cccCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHHHH
Q 008216 278 GDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355 (573)
Q Consensus 278 g~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 355 (573)
|.|+++.||++.. +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.++
T Consensus 11 ~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 11 EDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDL 89 (314)
T ss_pred cCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHH
Confidence 4455555555555 7999999999764 344557899999999999999999999999999999999999999999999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc-----ccc
Q 008216 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM-----QER 430 (573)
Q Consensus 356 l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-----~~~ 430 (573)
+... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+........ ...
T Consensus 90 l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 90 LKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 9753 234588999999999999999999999 999999999999999999999999998875432211 111
Q ss_pred eeccCCcccccccccccC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhh----hhcc-------c
Q 008216 431 TVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL----VQSH-------R 497 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~----~~~~-------~ 497 (573)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ...+..... .... .
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCC
Confidence 112236778999999875 357899999999999999999999998654321 111110000 0000 0
Q ss_pred ccc----ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 498 YLE----LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 498 ~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
... ..++..............+.++.+++.+||+.||++|||++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000 001111001111223345678999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=293.14 Aligned_cols=263 Identities=22% Similarity=0.291 Sum_probs=194.1
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||.|++|.||+|... +|+.||+|++..... .....+.+|+.++++++|||++++++++.+.+..+++|||+ ++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-~~ 82 (283)
T cd07835 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DL 82 (283)
T ss_pred heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-Cc
Confidence 456799999999999864 699999999875432 22356888999999999999999999999999999999999 46
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.... ...+++..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||++.........
T Consensus 83 ~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-- 155 (283)
T cd07835 83 DLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-- 155 (283)
T ss_pred CHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--
Confidence 8999886522 24689999999999999999999999 9999999999999999999999999999765432211
Q ss_pred eeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccc-hhhHHhhhhhh--------hcccccc
Q 008216 431 TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLV--------QSHRYLE 500 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~~~~~~--------~~~~~~~ 500 (573)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||...+.... ........... .......
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 1112368889999987654 568899999999999999999999976543210 01110000000 0000000
Q ss_pred ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.+.... ...........+..+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 236 TFPKWA-RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hccccc-ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000 00000011224467899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=297.73 Aligned_cols=262 Identities=19% Similarity=0.265 Sum_probs=191.3
Q ss_pred eccc--CceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 277 LGDS--KTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 277 lg~G--~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
||+| +||+||++.. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+++
T Consensus 6 ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~ 85 (328)
T cd08226 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGS 85 (328)
T ss_pred hCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCC
Confidence 4666 8999999996 479999999987542 2334678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc--
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE-- 429 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-- 429 (573)
|.+++.... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.++++||+.+..........
T Consensus 86 l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 86 ANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred HHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 999987532 24588999999999999999999999 99999999999999999999999998654322111110
Q ss_pred ---ceeccCCcccccccccccCC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhh------------
Q 008216 430 ---RTVMAGGTYGYLAPEFVYRN--ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL------------ 492 (573)
Q Consensus 430 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~------------ 492 (573)
......++..|+|||++.+. .++.++||||||+++|||++|+.||........ ........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccch
Confidence 01111256679999998763 478999999999999999999999976543210 00000000
Q ss_pred ----hhc--ccc----c-cccc-----cccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 493 ----VQS--HRY----L-ELLD-----PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 493 ----~~~--~~~----~-~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
... ... . .... ...............+..+.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 000 0 0000 000000011122346778999999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=335.18 Aligned_cols=246 Identities=28% Similarity=0.453 Sum_probs=197.7
Q ss_pred eeecccCceEEEEEE-eCCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
..||.|.||.||.+. .++|.-.|+|-++... ....+.+.+|..++..++|||+|+++|+-.+.+..+|.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 356999999999999 4579999999886543 2334667899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc--cc
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM--QE 429 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~ 429 (573)
|.+.+.. ++..++.....+..|++.|++|||++ |||||||||+||+++.+|.+|++|||.|........ ..
T Consensus 1321 La~ll~~----gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1321 LASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred HHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 9999864 44567777778899999999999999 999999999999999999999999999987765421 11
Q ss_pred ceeccCCcccccccccccCC---CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVYRN---ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
......||+.|||||++.+. ....++||||+|||+.||+||+.||...+.. +.-.+. +..+
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~aIMy~-----V~~g---------- 1457 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-WAIMYH-----VAAG---------- 1457 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-hHHHhH-----Hhcc----------
Confidence 11122399999999999763 3567899999999999999999999877642 111111 0111
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
-.+..|+ ..+.+-.+++.+||+.||++|.++.|+++.
T Consensus 1458 --h~Pq~P~-~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 --HKPQIPE-RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --CCCCCch-hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1123333 377889999999999999999999988763
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=293.81 Aligned_cols=262 Identities=14% Similarity=0.161 Sum_probs=184.3
Q ss_pred hhcCCCcCCeeecccCceEEEEEEeCC----CCEEEEEEecccchhh--H---------HHHHHHHHHHhhcCCCcEeEE
Q 008216 266 ITKNFSEGNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRSSFQR--K---------KEFYSEIGRFARLHHPNLVAV 330 (573)
Q Consensus 266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~--~---------~~~~~E~~~l~~l~h~nIv~l 330 (573)
+..+.+...++||+|+||.||+|...+ +..+|+|+........ . .....+...+..++|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 333445566788999999999999644 4566777643322111 0 112234455667789999999
Q ss_pred eeEEeeCC----ceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC
Q 008216 331 KGCCYDHG----DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406 (573)
Q Consensus 331 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~ 406 (573)
++++.... ..++++|++ ..++.+.+.. ....++..+..++.|++.||+|||++ +++||||||+|||++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~ 160 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD 160 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence 98766543 236788877 3467666643 12357888899999999999999999 999999999999999
Q ss_pred CCCCeeEecccCCccCCccccc-----cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCccc
Q 008216 407 EEFGAHLMGVGLSKFVPWEVMQ-----ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC 481 (573)
Q Consensus 407 ~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~ 481 (573)
.++.++|+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 9999999999999865422111 11122349999999999999999999999999999999999999998763221
Q ss_pred chhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008216 482 WQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548 (573)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 548 (573)
......... -...+.... ......+..+.+++..|++.+|++||+++++++.|+
T Consensus 241 --~~~~~~~~~----~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 241 --NLIHAAKCD----FIKRLHEGK-------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred --HHHHHhHHH----HHHHhhhhh-------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111000000 000000000 011123467999999999999999999999998763
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=296.09 Aligned_cols=265 Identities=18% Similarity=0.226 Sum_probs=189.5
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCc--------eEE
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD--------RYI 342 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--------~~l 342 (573)
.+.||+|++|.||++... +++.||||.+..... .....+.+|+.++++++||||+++++++...+. .++
T Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 96 (310)
T cd07865 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL 96 (310)
T ss_pred EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEE
Confidence 456799999999999964 689999999865422 223456789999999999999999999876543 499
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
||||+. ++|.+++.. ....+++.++..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++...
T Consensus 97 v~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 97 VFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred EEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 999995 588887753 234689999999999999999999999 9999999999999999999999999999866
Q ss_pred Ccccccc--ceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 423 PWEVMQE--RTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 423 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
....... ......++..|+|||.+.+. .++.++||||||+++|||++|..||...+.....................
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP 249 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 4332211 11122367889999988664 46889999999999999999999997655322111111110000000000
Q ss_pred -----cccc------cccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 500 -----ELLD------PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 500 -----~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+..+ ...............+..+.++|.+||+.||.+|||++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000 000000000001112356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=297.88 Aligned_cols=270 Identities=16% Similarity=0.227 Sum_probs=196.5
Q ss_pred hcCCCcCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhh--------------HHHHHHHHHHHhhcCCCcEeEEe
Q 008216 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQR--------------KKEFYSEIGRFARLHHPNLVAVK 331 (573)
Q Consensus 267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~nIv~l~ 331 (573)
.+.+....++||+|+||.||+|... +++.||||.++...... ...+.+|++++++++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 3445555667899999999999954 68999999986542221 12577899999999999999999
Q ss_pred eEEeeCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCe
Q 008216 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411 (573)
Q Consensus 332 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 411 (573)
+++...+..++||||+. ++|.+++.. ...+++.....++.|++.||+|||+. +++|+||+|+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCE
Confidence 99999999999999996 689998853 34589999999999999999999999 99999999999999999999
Q ss_pred eEecccCCccCCcccc------------ccceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 008216 412 HLMGVGLSKFVPWEVM------------QERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVD 478 (573)
Q Consensus 412 kl~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~ 478 (573)
+|+|||++........ ........++..|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999976541110 0111112267889999998764 46899999999999999999999998665
Q ss_pred cccch-hhHHhhhhhhhcccccccc-----ccccccCCCC--CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 479 SVCWQ-SIFEWATPLVQSHRYLELL-----DPLISSLSSD--IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 479 ~~~~~-~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
..... .+....... ....+.... .+........ ......+..+.+++.+||+.||++|||++|++.
T Consensus 239 ~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 239 EIDQLGRIFELLGTP-NEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHHHhCCC-chhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 42111 111100000 000000000 0000000000 000123567899999999999999999999996
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=291.79 Aligned_cols=263 Identities=22% Similarity=0.270 Sum_probs=196.7
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccchh--hHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|++|.||++... +|+.+++|.++..... ....+.+|+.++++++||||+++++++.+++..++|+||+++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~- 82 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT- 82 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-
Confidence 346799999999999864 6889999998765322 456788899999999999999999999999999999999965
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||.+........ .
T Consensus 83 ~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~ 154 (283)
T cd05118 83 DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--P 154 (283)
T ss_pred CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--c
Confidence 88888764 225689999999999999999999999 999999999999999999999999999977654331 1
Q ss_pred eeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccc------
Q 008216 431 TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD------ 503 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 503 (573)
.....++..|+|||.+.+. .++.++|+||||+++|+|+||+.||...+..+.....................+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 1112377889999998776 788999999999999999999999976553211100000000000000000000
Q ss_pred ---cccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 504 ---PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 504 ---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+..............+.++.++|.+||+.||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000000011235678999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=288.69 Aligned_cols=262 Identities=21% Similarity=0.302 Sum_probs=192.3
Q ss_pred CeeecccCceEEEEEEeCC-CCEEEEEEecccch--hhHHHHHHHHHHHhhc---CCCcEeEEeeEEeeCCc-----eEE
Q 008216 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSF--QRKKEFYSEIGRFARL---HHPNLVAVKGCCYDHGD-----RYI 342 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~-----~~l 342 (573)
.+.||+|++|.||+|+... ++.||+|+++.... .....+.+|+.+++++ +||||+++++++.+.+. .++
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 3467999999999999764 89999999975422 2234566787777666 69999999999988776 899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
+|||+. ++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 84 ~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 84 VFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred Eehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 999996 58988886422 23589999999999999999999999 9999999999999999999999999999876
Q ss_pred CccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccc-hhhHHhhhhhhhccccccc
Q 008216 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLVQSHRYLEL 501 (573)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 501 (573)
....... ...++..|+|||.+.+..++.++|+||||+++|||++|.+||......+. ....+..... ........
T Consensus 158 ~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 233 (287)
T cd07838 158 SFEMALT---SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLP-SEEEWPRN 233 (287)
T ss_pred cCCcccc---cccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCC-ChHhcCCC
Confidence 4332211 12278889999999988899999999999999999999999876543211 1111100000 00000000
Q ss_pred c---ccccccCCC---CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 502 L---DPLISSLSS---DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 502 ~---~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
. ......... .......+..+.+++.+||+.||++||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 000000000 0001234577899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=292.62 Aligned_cols=264 Identities=19% Similarity=0.237 Sum_probs=190.3
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|++|.||+|... +|+.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||++ +
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 85 (294)
T PLN00009 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-L 85 (294)
T ss_pred EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-c
Confidence 346799999999999964 689999999865422 234568899999999999999999999999999999999995 5
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-CCCeeEecccCCccCCcccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
+|.+++.. .....+++..+..++.||+.||+|||++ +++||||+|+||+++. ++.+||+|||++.........
T Consensus 86 ~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~- 159 (294)
T PLN00009 86 DLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT- 159 (294)
T ss_pred cHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc-
Confidence 78887754 2233468888899999999999999999 9999999999999985 456899999999765432111
Q ss_pred ceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccc-hhhHHhhhhhhhc-----ccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLVQS-----HRYLELL 502 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~ 502 (573)
.....+++.|+|||.+.+ ..++.++||||||+++|+|+||.+||...+.... ............. ....+..
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 160 -FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred -cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 111236889999998866 4578999999999999999999999976543211 0000000000000 0000000
Q ss_pred c--cccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 503 D--PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 503 ~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
. +..............++.+.+++.+|++.+|++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000000000001123567899999999999999999999986
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=284.53 Aligned_cols=255 Identities=24% Similarity=0.358 Sum_probs=208.5
Q ss_pred CeeecccCceEEEEEEeC------CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC-CceEEEEE
Q 008216 274 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-GDRYIVYE 345 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lv~e 345 (573)
.-++-+|.||.||+|.+. +.+.|-+|.++.. +.-....++.|.-.+..+.|||+.++.+++.++ ..+++++.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 346789999999999653 3456888888765 333456788999999999999999999998765 56789999
Q ss_pred ecCCCCHHHHhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCcc
Q 008216 346 FVVNGPLDRWLHHI----PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 346 ~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 421 (573)
++.-|+|..||... ....+.++..+...++.|++.|++|||++ ++||.||.++|++||+..++||+|=.+++.
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRD 445 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRD 445 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhccc
Confidence 99999999999732 23446688889999999999999999999 999999999999999999999999999998
Q ss_pred CCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccc
Q 008216 422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500 (573)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (573)
+-+...+.-.........||+||.+.+..|+.++|||||||++|||+| |+.|+...++.+..... .+..++
T Consensus 446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl------kdGyRl-- 517 (563)
T KOG1024|consen 446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL------KDGYRL-- 517 (563)
T ss_pred cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH------hcccee--
Confidence 766554443333336778999999999999999999999999999999 99999988775432222 122211
Q ss_pred ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
..+-++++++..+|..||..+|++||++++++.-|.+..
T Consensus 518 ------------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 518 ------------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred ------------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 223457889999999999999999999999999987653
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=301.41 Aligned_cols=270 Identities=21% Similarity=0.302 Sum_probs=194.7
Q ss_pred cCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC-----Cce
Q 008216 268 KNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDR 340 (573)
Q Consensus 268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 340 (573)
++|. ..+.||+|++|.||+|.. .+|+.||||.++... ......+.+|+.++++++||||+++++++... ...
T Consensus 5 ~~y~-i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQ-NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceE-EEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 3443 355789999999999985 468999999986432 23345678899999999999999999987654 347
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
++++||+. ++|.+++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 99999995 588877753 4589999999999999999999999 99999999999999999999999999987
Q ss_pred cCCcccccc-ceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhc---
Q 008216 421 FVPWEVMQE-RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS--- 495 (573)
Q Consensus 421 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--- 495 (573)
......... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+...... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~---~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN---LILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCCH
Confidence 654322111 1112237889999998754 468899999999999999999999997644221100 00000000
Q ss_pred cccccccccc----cccCC--CCCc----chHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhcc
Q 008216 496 HRYLELLDPL----ISSLS--SDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQL 550 (573)
Q Consensus 496 ~~~~~~~~~~----~~~~~--~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 550 (573)
.....+.+.. ..... ...+ ....+.++.+++.+||+.||++|||+.++++. ++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0000000000 00000 0000 01235679999999999999999999999985 5444
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=316.12 Aligned_cols=272 Identities=17% Similarity=0.189 Sum_probs=184.7
Q ss_pred hcCCCcCCeeecccCceEEEEEEeCC--CCEEEEE------------------EecccchhhHHHHHHHHHHHhhcCCCc
Q 008216 267 TKNFSEGNRLLGDSKTGGTYSGILPD--GSRVAVK------------------RLKRSSFQRKKEFYSEIGRFARLHHPN 326 (573)
Q Consensus 267 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n 326 (573)
..+|.. .+.||+|+||.||++.... +...++| .++. .......+.+|+.+|++++|||
T Consensus 147 ~~~Y~i-i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 147 LAHFRV-IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhccEE-EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence 344443 4567999999999987432 2222222 1111 1223456889999999999999
Q ss_pred EeEEeeEEeeCCceEEEEEecCCCCHHHHhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee
Q 008216 327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIP-RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405 (573)
Q Consensus 327 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll 405 (573)
|+++++++.+.+..++|+|++ +++|.+++.... ..........+..++.||+.||+|||++ +|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 999999999999999999998 457777764321 1122344567788999999999999999 99999999999999
Q ss_pred CCCCCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCC-CCCCCcccchh
Q 008216 406 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP-AQAVDSVCWQS 484 (573)
Q Consensus 406 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~P-f~~~~~~~~~~ 484 (573)
+.++.+||+|||+++.......... ....||..|+|||++.+..++.++|||||||++|||++|..+ +..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFD-YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccccccc-ccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999987643322111 123489999999999999999999999999999999998754 43322221122
Q ss_pred hHHhhhhhhh-cccc-------ccccccc-c----ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 485 IFEWATPLVQ-SHRY-------LELLDPL-I----SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 485 ~~~~~~~~~~-~~~~-------~~~~~~~-~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+......... ...+ .+.++.. . ............+..+.+++.+||+.||++|||+.|+++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 2111110000 0000 0000000 0 000000001123356788999999999999999999986
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=278.55 Aligned_cols=252 Identities=20% Similarity=0.270 Sum_probs=202.1
Q ss_pred HhhcCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeC----C
Q 008216 265 SITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH----G 338 (573)
Q Consensus 265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~----~ 338 (573)
.++.+|....++||-|-.|.|-.... .+|+++|+|++... ....+|+++.-.. .|||||++++++++. .
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 46777888888999999999988774 46899999998644 4456788776555 699999999998753 4
Q ss_pred ceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---CCCeeEec
Q 008216 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMG 415 (573)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~D 415 (573)
-+.+|||.|+||.|...+++ ++...+++.++-.|+.||..|+.|||+. +|.||||||+|+|.+. |..+||+|
T Consensus 133 cLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 46899999999999999986 5567799999999999999999999999 9999999999999964 45689999
Q ss_pred ccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhc
Q 008216 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS 495 (573)
Q Consensus 416 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 495 (573)
||+|+..... ......+-|+.|.|||++....|+...|+||+||++|-|+.|.+||..........
T Consensus 208 fGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp----------- 273 (400)
T KOG0604|consen 208 FGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----------- 273 (400)
T ss_pred cccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh-----------
Confidence 9999876532 23344568999999999998999999999999999999999999998765421100
Q ss_pred cccccccccccccCC---CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 496 HRYLELLDPLISSLS---SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
-+...+.... +.......++...++|+.+|..+|.+|.|+.++++
T Consensus 274 -----gMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 274 -----GMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred -----hHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 0011111111 22233467889999999999999999999999986
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=285.44 Aligned_cols=246 Identities=23% Similarity=0.339 Sum_probs=192.8
Q ss_pred CCeeecccCceEEEEEEe-CCCCEEEEEEeccc-----chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--CceEEEE
Q 008216 273 GNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS-----SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVY 344 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~ 344 (573)
..++||+|++|.||+|.. .+++.||+|.+... .......+.+|+.++++++||||+++++++.+. +..++++
T Consensus 6 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (264)
T cd06653 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFV 85 (264)
T ss_pred eeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEE
Confidence 355789999999999985 45899999987532 123346788999999999999999999998764 4578999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCc
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 424 (573)
||+++++|.+++.. ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+++....
T Consensus 86 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 86 EYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 99999999999863 23588899999999999999999999 999999999999999999999999999986543
Q ss_pred cccc-cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccc
Q 008216 425 EVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503 (573)
Q Consensus 425 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (573)
.... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ...... ...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~----~~~-------- 224 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AAIFKI----ATQ-------- 224 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HHHHHH----HcC--------
Confidence 2111 1111223788999999998888899999999999999999999999764321 111100 000
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
......+...++.+.+++.+|++ +|..||++.+++.
T Consensus 225 -----~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 225 -----PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -----CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00111123456789999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=293.14 Aligned_cols=248 Identities=24% Similarity=0.394 Sum_probs=194.9
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+.||+|++|.||+|+.. +++.+|+|.+... ......++.+|+.+++.++|+|++++++++......++||||+. |
T Consensus 21 ~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 99 (308)
T cd06634 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-G 99 (308)
T ss_pred HheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-C
Confidence 35799999999999964 5789999998643 22334568899999999999999999999999999999999996 6
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++.......
T Consensus 100 ~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~---- 169 (308)
T cd06634 100 SASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---- 169 (308)
T ss_pred CHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCcc----
Confidence 88777653 234589999999999999999999999 99999999999999999999999999987654221
Q ss_pred eeccCCccccccccccc---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 431 TVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
...++..|+|||.+. ...++.++||||||+++|+|++|..||...+...... .... ..
T Consensus 170 --~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~-~~---------- 230 (308)
T cd06634 170 --XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQ-NE---------- 230 (308)
T ss_pred --cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH------HHhh-cC----------
Confidence 123788999999874 3567889999999999999999999987643221100 0000 00
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
.........+..+.++|.+||+.+|++||+++++++.--.....+
T Consensus 231 --~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 231 --SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred --CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence 011112235567899999999999999999999998755554444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=282.87 Aligned_cols=243 Identities=26% Similarity=0.448 Sum_probs=198.9
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|++|.||++... +++.|++|.+..... ...+.+.+|++++++++|||++++++++.+.+..+++|||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG 84 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCC
Confidence 457899999999999864 578999999977643 45578999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||.+.........
T Consensus 85 ~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 155 (254)
T cd06627 85 SLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-- 155 (254)
T ss_pred cHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--
Confidence 99999864 25689999999999999999999999 9999999999999999999999999999876543321
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
.....++..|+|||...+..++.++||||+|+++|+|++|..||...+... .... ... ..
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~--~~~~----~~~-~~------------- 215 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA--ALFR----IVQ-DD------------- 215 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH--HHHH----Hhc-cC-------------
Confidence 112237889999999988788999999999999999999999987644211 0000 000 00
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....+...+..+.+++.+||+.+|++|||+.+++.
T Consensus 216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 216 HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 01111234567899999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=289.51 Aligned_cols=263 Identities=20% Similarity=0.316 Sum_probs=193.1
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|++|.||+|+.. +++.||||++..... .......+|+..+.+++ ||||+++++++.+++..++||||+ ++
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 82 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG 82 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence 346799999999999975 478999999876422 23334567999999998 999999999999999999999999 88
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++... ....+++..+..++.|++.+|.|||++ +++|+||+|+||++++++.++|+|||++..........
T Consensus 83 ~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~- 156 (283)
T cd07830 83 NLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT- 156 (283)
T ss_pred CHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcC-
Confidence 999888642 234689999999999999999999999 99999999999999999999999999998664332211
Q ss_pred eeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccch-hhHHhhhhh-----hhccccccccc
Q 008216 431 TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPL-----VQSHRYLELLD 503 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~ 503 (573)
...++..|+|||.+.+ ..++.++|+||||++++||++|++||......... ......... ..........+
T Consensus 157 --~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 157 --DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred --CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 1237889999998754 45789999999999999999999999765432110 000000000 00000000001
Q ss_pred cccccCCCCC---cchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 504 PLISSLSSDI---PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 504 ~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.......... .....+..+.+++.+||+.||++|||++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000000 00012467999999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=292.53 Aligned_cols=247 Identities=23% Similarity=0.417 Sum_probs=189.5
Q ss_pred CCeeecccCceEEEEEEeCC-CCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 273 GNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
..+.||+|++|.||+|...+ ++.||||.++... ......+..|+.++.+. .||||+++++++.+....+++|||+ +
T Consensus 19 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~ 97 (296)
T cd06618 19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM-S 97 (296)
T ss_pred eeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc-C
Confidence 34577999999999999764 8999999997643 23345667788777776 5999999999999999999999998 4
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
++|.+++... ...+++..+..++.|++.||+|||+ . +++||||+|+||++++++.+||+|||++.........
T Consensus 98 ~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~ 171 (296)
T cd06618 98 TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK 171 (296)
T ss_pred cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc
Confidence 5777776542 2468999999999999999999997 5 8999999999999999999999999998765432221
Q ss_pred cceeccCCcccccccccccCCC----CCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNE----LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
. ...++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .+......... .+
T Consensus 172 ~---~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~------~~ 237 (296)
T cd06618 172 T---RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE------PP 237 (296)
T ss_pred c---CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC------CC
Confidence 1 123778899999987553 788999999999999999999999653221 01111100000 00
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
.. ......+.++.+++.+||+.||++||+++++++.
T Consensus 238 ~~------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 SL------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0011245679999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=299.13 Aligned_cols=267 Identities=22% Similarity=0.274 Sum_probs=194.4
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC-----CceEEEEE
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIVYE 345 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~e 345 (573)
.+.||+|+||.||++.. .+|+.||||.++.. .......+.+|+.+++.++||||+++++++... ...++|+|
T Consensus 10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE 89 (337)
T ss_pred EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence 45789999999999985 46899999998753 223345677899999999999999999987654 34799999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|+. ++|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 90 LMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred CCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 995 689888853 35699999999999999999999999 9999999999999999999999999999866433
Q ss_pred ccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHH-hhhh-------hhhcc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE-WATP-------LVQSH 496 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~-~~~~-------~~~~~ 496 (573)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+......... .... .....
T Consensus 162 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 162 GD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred cc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 21 1112237889999998765 468899999999999999999999997654221111000 0000 00000
Q ss_pred ccccccccccccCCC--CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhcc
Q 008216 497 RYLELLDPLISSLSS--DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQL 550 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 550 (573)
............... .......++.+.+++.+||+.||++|||++++++. +..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000000000000 00012345778999999999999999999999975 5443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=290.17 Aligned_cols=264 Identities=21% Similarity=0.241 Sum_probs=190.6
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC----------ce
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG----------DR 340 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----------~~ 340 (573)
.+.||+|++|.||+|... +|+.||+|+++.... .....+.+|+.++++++||||+++++++.+.. ..
T Consensus 12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 91 (302)
T cd07864 12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF 91 (302)
T ss_pred eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcE
Confidence 346799999999999975 588999999975432 23356778999999999999999999987654 68
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
++|+||+++ +|..++.. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.
T Consensus 92 ~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 92 YLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred EEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 999999975 77777653 234689999999999999999999999 99999999999999999999999999998
Q ss_pred cCCccccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 421 FVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
.......... ....++..|+|||.+.+ ..++.++||||||+++|||++|++||...+.......+...........+.
T Consensus 165 ~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T cd07864 165 LYNSEESRPY-TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP 243 (302)
T ss_pred cccCCccccc-ccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 7643322111 11125778999998865 357889999999999999999999997644321111111000000000000
Q ss_pred ccc--------ccccccC-CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 500 ELL--------DPLISSL-SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 500 ~~~--------~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
++. +...... .........+..+.+++.+||+.||++||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 0000000 000001123567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=297.56 Aligned_cols=264 Identities=21% Similarity=0.256 Sum_probs=191.7
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeC--CceEEEEEec
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH--GDRYIVYEFV 347 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~--~~~~lv~e~~ 347 (573)
.+.||+|+||.||+|... +|+.+|+|++... .......+.+|+.+++++ +||||+++++++... ...++||||+
T Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~ 91 (337)
T cd07852 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM 91 (337)
T ss_pred hHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccc
Confidence 346799999999999965 5889999988543 223345677899999999 999999999988654 3579999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
+ ++|.+++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 92 ~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 92 E-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred c-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 6 599988853 2678889999999999999999999 999999999999999999999999999986643322
Q ss_pred c---cceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhh--------hc
Q 008216 428 Q---ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV--------QS 495 (573)
Q Consensus 428 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~--------~~ 495 (573)
. .......|+..|+|||.+.+ ..++.++||||||+++|+|+||+.||................... ..
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence 1 11112237889999998765 457889999999999999999999997654321111000000000 00
Q ss_pred cccccccccccccC--CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 496 HRYLELLDPLISSL--SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 496 ~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
....+.++...... .........+.++.++|.+||+.||++|||+.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000110000000 0000011245689999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=298.02 Aligned_cols=262 Identities=20% Similarity=0.302 Sum_probs=192.4
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEee----CCceEEEEEe
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYEF 346 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~e~ 346 (573)
.+.||+|++|.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 89 (334)
T cd07855 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL 89 (334)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence 456899999999999954 69999999987542 2334667889999999999999999988763 3467999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+. ++|.+++.. ...+++..+..++.||+.||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 90 ME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred hh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 95 689888853 34589999999999999999999999 99999999999999999999999999997654322
Q ss_pred cccc--eeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhh--------hc
Q 008216 427 MQER--TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV--------QS 495 (573)
Q Consensus 427 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~--------~~ 495 (573)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+............... ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 1111 112237889999998865 458899999999999999999999997654321111000000000 00
Q ss_pred cccccccccccccCCCCCc----chHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 496 HRYLELLDPLISSLSSDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....+..+. ... ....+ ....+.++.+++.+||+.||++||+++++++
T Consensus 242 ~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 242 DRVRKYIQN-LPR-KQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhHHHHHhh-ccc-CCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000000000 000 00000 1224678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=287.10 Aligned_cols=247 Identities=20% Similarity=0.255 Sum_probs=191.6
Q ss_pred CeeecccCceEEEEEEe----CCCCEEEEEEecccch----hhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEE
Q 008216 274 NRLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSSF----QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY 344 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 344 (573)
.+.||+|+||.||++.. .+|+.||+|+++.... ...+.+.+|+.++.++ +|+||+++++.+..++..++||
T Consensus 5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (290)
T cd05613 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL 84 (290)
T ss_pred eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence 45689999999999985 3689999999975422 2346678899999999 6999999999999988999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCc
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 424 (573)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 85 DYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 99999999999864 34588999999999999999999999 999999999999999999999999999986543
Q ss_pred cccccceeccCCcccccccccccCC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccc
Q 008216 425 EVMQERTVMAGGTYGYLAPEFVYRN--ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502 (573)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (573)
..... .....|+..|+|||.+.+. .++.++||||||+++|+|++|..||....... ............
T Consensus 158 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~------- 227 (290)
T cd05613 158 DEVER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS------- 227 (290)
T ss_pred ccccc-cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhcc-------
Confidence 32211 1123388899999998753 46789999999999999999999986432210 001111100000
Q ss_pred ccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008216 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH 545 (573)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 545 (573)
....+...+..+.+++.+||+.||++|| +++++++
T Consensus 228 --------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 --------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0011122456789999999999999997 6676654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.99 Aligned_cols=257 Identities=28% Similarity=0.424 Sum_probs=206.1
Q ss_pred CeeecccCceEEEEEEeC----C----CCEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEE
Q 008216 274 NRLLGDSKTGGTYSGILP----D----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~----~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 343 (573)
.+.||+|.||.|++|... . ...||||.++.. ...+.+.+..|+++|+.+ +||||+.++|+|...+..++|
T Consensus 301 ~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v 380 (609)
T KOG0200|consen 301 GKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVI 380 (609)
T ss_pred cceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEE
Confidence 347899999999999842 1 457999999865 335568899999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHhccCC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCe
Q 008216 344 YEFVVNGPLDRWLHHIP---RG-------G--RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 411 (573)
+||+..|+|.++|+..+ .. . ..++..+.+.++.|||.|++||++. +++||||.++|||++.+..+
T Consensus 381 ~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~~ 457 (609)
T KOG0200|consen 381 VEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNKVI 457 (609)
T ss_pred EEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCCEE
Confidence 99999999999998754 00 1 2388999999999999999999999 99999999999999999999
Q ss_pred eEecccCCccCCccccccceecc-CCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhh
Q 008216 412 HLMGVGLSKFVPWEVMQERTVMA-GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWA 489 (573)
Q Consensus 412 kl~Dfg~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~ 489 (573)
||+|||+++.............. .-...|||||.+....++.++|||||||+|||++| |..||.+.... ..+.+
T Consensus 458 kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~--~~l~~-- 533 (609)
T KOG0200|consen 458 KIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT--EELLE-- 533 (609)
T ss_pred EEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--HHHHH--
Confidence 99999999976544433322111 02456999999999999999999999999999999 99999774311 11111
Q ss_pred hhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 490 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
....+. ....+..+++++.++|+.||+.+|++||++.++.+.++.+.+
T Consensus 534 --~l~~G~-------------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 534 --FLKEGN-------------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred --HHhcCC-------------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 111111 112233457889999999999999999999999999998543
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=287.69 Aligned_cols=252 Identities=21% Similarity=0.223 Sum_probs=195.7
Q ss_pred CeeecccCceEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEE
Q 008216 274 NRLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVY 344 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 344 (573)
.+.||+|++|.||++.. .+++.||||+++... ....+.+.+|+.++.++ +||||+++++.+..+...++||
T Consensus 5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 84 (288)
T cd05583 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL 84 (288)
T ss_pred EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence 45789999999999884 357899999997542 22345678999999999 6999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCc
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 424 (573)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 85 DYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred ecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 99999999998853 24588999999999999999999999 999999999999999999999999999876543
Q ss_pred cccccceeccCCcccccccccccCCC--CCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccc
Q 008216 425 EVMQERTVMAGGTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502 (573)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (573)
...... ....++..|+|||.+.+.. .+.++||||||+++|||++|..||......... .........
T Consensus 158 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~-------- 226 (288)
T cd05583 158 EEEERA-YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRILK-------- 226 (288)
T ss_pred cccccc-ccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHHHc--------
Confidence 322111 1223788999999987654 788999999999999999999998643221100 000000000
Q ss_pred ccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
. ....+...+..+.+++.+||+.||++|||+.++.+.|+..
T Consensus 227 -~------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 227 -S------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -c------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 0001122445789999999999999999998888776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=295.06 Aligned_cols=275 Identities=17% Similarity=0.270 Sum_probs=198.7
Q ss_pred ccCHHHHHHhhcCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeE
Q 008216 257 VFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGC 333 (573)
Q Consensus 257 ~~~~~el~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 333 (573)
.....++..++++|.. .+.||+|+||.||++.. .+|+.||+|+++... ....+.+.+|+.++++++||||++++++
T Consensus 6 ~~~~~~~~~~~~~y~~-~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 6 QELNKTIWEVPERYQN-LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhHHHHHhhccCceEE-EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 3445567777777665 45779999999999985 568999999997542 2334668889999999999999999998
Q ss_pred EeeC------CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC
Q 008216 334 CYDH------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407 (573)
Q Consensus 334 ~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~ 407 (573)
+... ...+++++++ +++|.+++.. ..+++..+..++.|++.||+|||++ +++||||||+||++++
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~ 155 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 155 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcC
Confidence 7643 3467888877 7899888753 3589999999999999999999999 9999999999999999
Q ss_pred CCCeeEecccCCccCCccccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhH
Q 008216 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF 486 (573)
Q Consensus 408 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 486 (573)
++.+||+|||++....... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+........
T Consensus 156 ~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 230 (345)
T cd07877 156 DCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230 (345)
T ss_pred CCCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999987653221 11237889999998866 56788999999999999999999999754432111000
Q ss_pred Hhhhhhhhccccccccc-------cccccCCCCC---cchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 487 EWATPLVQSHRYLELLD-------PLISSLSSDI---PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 487 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
..............+.+ ..+....... .....+..+.++|.+|++.||.+||++.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000000000000000 0000000000 001235578999999999999999999999863
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=295.69 Aligned_cols=267 Identities=17% Similarity=0.272 Sum_probs=191.7
Q ss_pred cCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC------
Q 008216 268 KNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------ 338 (573)
Q Consensus 268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 338 (573)
.+|. ....||+|++|.||+|.. .+|+.||||+++... ......+.+|+.++++++||||+++++++....
T Consensus 15 ~~y~-~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYT-SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceE-EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 4443 356789999999999995 468999999987532 222456789999999999999999999987543
Q ss_pred ceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccC
Q 008216 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (573)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 418 (573)
..++|+||+. .+|..++. ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4589999995 47776652 3588999999999999999999999 999999999999999999999999999
Q ss_pred CccCCccccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhh------
Q 008216 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP------ 491 (573)
Q Consensus 419 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~------ 491 (573)
++...... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.............
T Consensus 164 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 164 ARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 87653221 11236888999999876 4688999999999999999999999986543211000000000
Q ss_pred --hhhccccccccccccccCCCCCc---chHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhccc
Q 008216 492 --LVQSHRYLELLDPLISSLSSDIP---EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQLA 551 (573)
Q Consensus 492 --~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 551 (573)
............. ......... ....+..+.+++.+||+.||++||++++++.. ++...
T Consensus 239 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 239 VQKLEDKAAKSYIKS-LPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHhcccchHHHHhh-cCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000000000000 000000000 01234568899999999999999999999953 55443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=293.30 Aligned_cols=244 Identities=21% Similarity=0.349 Sum_probs=199.7
Q ss_pred CeeecccCceEEEEEE-eCCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.++||+|.||+||-|+ .++|+.||||++.+.. .+...++.+|+.+|++++||.||.+...|+..+..++|||.+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 3578999999999998 4679999999997653 3345789999999999999999999999999999999999995 5
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC---CCeeEecccCCccCCcccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~~~ 427 (573)
+..+.+.. .....+++..-..++.||+.||.|||.+ +|+|+||||+|||+.+. .++||+|||+++.+.....
T Consensus 648 DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 648 DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 55555543 3446799999999999999999999999 99999999999999654 4589999999999875544
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
.. ...||+.|+|||++.+..|...-|+||.|||+|--++|..||....+. .+.++ +..+
T Consensus 723 Rr---sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQ-------NAaF--------- 781 (888)
T KOG4236|consen 723 RR---SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQ-------NAAF--------- 781 (888)
T ss_pred hh---hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHhh-------cccc---------
Confidence 32 334999999999999999999999999999999999999999765431 11111 1111
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.-+..|..++++...+||...|+..-.+|-|.++-+.
T Consensus 782 -MyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 782 -MYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred -ccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1134455678889999999999999999999887653
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=295.31 Aligned_cols=272 Identities=21% Similarity=0.266 Sum_probs=201.4
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC-----ceEEEEE
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-----DRYIVYE 345 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv~e 345 (573)
.+.||.|++|.||++... +|+.||||.+.... ....+.+.+|+.+++.++||||+++++++...+ ..+++||
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 84 (330)
T cd07834 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE 84 (330)
T ss_pred eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEec
Confidence 457899999999999965 48999999997653 344567899999999999999999999988775 7899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|++ ++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 85 LME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred chh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 996 589888853 23799999999999999999999999 9999999999999999999999999999876543
Q ss_pred ccc-cceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhh--------hc
Q 008216 426 VMQ-ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV--------QS 495 (573)
Q Consensus 426 ~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~--------~~ 495 (573)
... .......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...+............... ..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 210 111122378889999999887 78999999999999999999999998765422111100000000 00
Q ss_pred ccccccccccccc--CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhcccCC
Q 008216 496 HRYLELLDPLISS--LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQLAQP 553 (573)
Q Consensus 496 ~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~ 553 (573)
....+.+...... ..........+..+.+++.+||+.+|++||+++++++. +++...+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0000000000000 00000011245678999999999999999999999973 5555544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=284.44 Aligned_cols=246 Identities=19% Similarity=0.292 Sum_probs=192.5
Q ss_pred CeeecccCceEEEEEEeCC-CCEEEEEEeccc-----chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRS-----SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
.+.||+|++|.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++||||+
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (260)
T cd08222 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYC 84 (260)
T ss_pred eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeC
Confidence 4568999999999998643 455666666532 1223445778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++++|.+++.........+++..++.++.|++.||.|||+. +++|+||||+||++++ +.++|+|||++........
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~ 160 (260)
T cd08222 85 EGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD 160 (260)
T ss_pred CCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCCCcc
Confidence 99999998875444456799999999999999999999999 9999999999999976 4699999999876543222
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
. .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ........ ..
T Consensus 161 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~~---------~~-- 221 (260)
T cd08222 161 L--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------SVVLRIVE---------GP-- 221 (260)
T ss_pred c--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHc---------CC--
Confidence 1 11223788999999998888899999999999999999999998653321 10100000 00
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....+...+.++.++|.+||+.||++||++.++++
T Consensus 222 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 ---TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 01112345678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=286.43 Aligned_cols=244 Identities=20% Similarity=0.317 Sum_probs=196.8
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeCCceEEEEEecC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
.+.||+|++|.||++... +|+.||+|++... .....+.+.+|+.++++++ ||||+++++++.+.+..++|||+++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd05581 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85 (280)
T ss_pred eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence 456899999999999964 6899999998753 2233467889999999998 9999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 86 ~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 86 NGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999999964 23699999999999999999999999 9999999999999999999999999998866433221
Q ss_pred ------------------cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhh
Q 008216 429 ------------------ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT 490 (573)
Q Consensus 429 ------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 490 (573)
.......++..|+|||...+..++.++||||||++++++++|..||....... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~ 235 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---TFQKIL 235 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHH
Confidence 11122237889999999988889999999999999999999999998654210 010000
Q ss_pred hhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCH----HHHHH
Q 008216 491 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM----SHVVH 545 (573)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~ 545 (573)
. . ....+...++.+.+++.+||+.||++||++ +++++
T Consensus 236 ---~---------~------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 ---K---------L------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---h---------c------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 0 001112235679999999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=290.85 Aligned_cols=265 Identities=22% Similarity=0.329 Sum_probs=194.3
Q ss_pred HhhcCCCcCCeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEee-CCce
Q 008216 265 SITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDR 340 (573)
Q Consensus 265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~ 340 (573)
.++++|.. .+.||.|+||.||++... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.. .+..
T Consensus 7 ~~~~~y~~-~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 7 EITNRYVD-LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred ccccceEE-EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 34555444 567899999999999854 78999999886432 2234678899999999999999999998875 4578
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
++++||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+.
T Consensus 86 ~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 9999998 6789888753 3578888899999999999999999 99999999999999999999999999987
Q ss_pred cCCccccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchh-hHHhhhh----hh-
Q 008216 421 FVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATP----LV- 493 (573)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~~~----~~- 493 (573)
...... ....++..|+|||.+.+ ..++.++||||||+++|+|+||+.||.......... +.+.... ..
T Consensus 157 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 157 IQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred ccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 543221 11236788999998765 568999999999999999999999997654321100 0000000 00
Q ss_pred --hccccccccccccccCCCCCcc----hHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 494 --QSHRYLELLDPLISSLSSDIPE----AGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 494 --~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
......+.+.... . ....+. ...++.+.++|.+||+.+|++||++++++..
T Consensus 232 ~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 232 TICSENTLRFVQSLP-K-REPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccchhhHHHHhhcc-c-cCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000 0 000010 1235689999999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=296.39 Aligned_cols=268 Identities=21% Similarity=0.294 Sum_probs=191.9
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--------------C
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--------------G 338 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------------~ 338 (573)
.+.||.|+||.||+|.. .+|+.||+|.+........+.+.+|+.++++++||||+++++++... .
T Consensus 10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (342)
T cd07854 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89 (342)
T ss_pred EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccc
Confidence 45779999999999986 45899999999776555667788999999999999999999876543 3
Q ss_pred ceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-CCCeeEeccc
Q 008216 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVG 417 (573)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg 417 (573)
..++||||++ ++|.+++.. ..+++..+..++.||+.||.|||+. +++||||||+||+++. ++.++|+|||
T Consensus 90 ~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 90 SVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred eEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcc
Confidence 4689999996 589888753 3588999999999999999999999 9999999999999974 5568999999
Q ss_pred CCccCCccccccc-eeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhc
Q 008216 418 LSKFVPWEVMQER-TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS 495 (573)
Q Consensus 418 ~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 495 (573)
.+........... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....+...........+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9976533211111 111237888999998654 56788999999999999999999999765432111110000000000
Q ss_pred ---cccccccccccc--cCCCCCc----chHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcc
Q 008216 496 ---HRYLELLDPLIS--SLSSDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQL 550 (573)
Q Consensus 496 ---~~~~~~~~~~~~--~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 550 (573)
............ ......+ ....+.++.+++.+||+.||.+|||++++++ .++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 000000000000 0000000 0124467889999999999999999999984 45433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=279.09 Aligned_cols=236 Identities=25% Similarity=0.316 Sum_probs=192.0
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 277 LGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 277 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
||.|++|.||++... +++.+|+|+++.... .....+.+|+.++++++||||+++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 599999999999965 589999999876532 2346788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~ 151 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTN 151 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC--ccc
Confidence 999964 23589999999999999999999999 999999999999999999999999999987643321 122
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
...++..|+|||...+...+.++|+||||+++|++++|..||...+... ..... .. . ..
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~---~~-~--------------~~ 210 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYEKI---LK-D--------------PL 210 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH---hc-C--------------CC
Confidence 2337889999999988888999999999999999999999997654311 11100 00 0 00
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSH 542 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 542 (573)
..+...+..+.+++.+||..||++||++.+
T Consensus 211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 211 RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 111122567899999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=285.13 Aligned_cols=261 Identities=21% Similarity=0.309 Sum_probs=195.1
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
+.||+|++|.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++||||++ ++
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~ 83 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MD 83 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cC
Confidence 46799999999999965 48999999998653 2334677889999999999999999999999999999999997 58
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++.... ..+++..+..++.|++.||+|||++ +++||||+|+||++++++.++|+|||.+......... .
T Consensus 84 l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~ 155 (282)
T cd07829 84 LKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--Y 155 (282)
T ss_pred HHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc--c
Confidence 999997521 4689999999999999999999999 9999999999999999999999999999876433221 1
Q ss_pred eccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccch-hhHHhhh-------hhhhccc-cccc
Q 008216 432 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWAT-------PLVQSHR-YLEL 501 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~-------~~~~~~~-~~~~ 501 (573)
....++..|+|||.+.+. .++.++||||||+++|||++|.+||......... ....... ....... ....
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 112256789999998776 7899999999999999999999999765432110 0000000 0000000 0000
Q ss_pred cccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+....... ........+..+.+++.+||+.||++||++++++.
T Consensus 236 ~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 236 FPKFPPKD-LEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccCccc-hHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000 00001123567999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=292.74 Aligned_cols=264 Identities=18% Similarity=0.288 Sum_probs=192.7
Q ss_pred hhcCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC----
Q 008216 266 ITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG---- 338 (573)
Q Consensus 266 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---- 338 (573)
+.++|.. .+.||+|++|.||++.. .+|+.||||++.... ......+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRD-LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEE-EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 4444443 45679999999999984 468999999986532 223456889999999999999999999887653
Q ss_pred --ceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecc
Q 008216 339 --DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (573)
Q Consensus 339 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 416 (573)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 358999998 7899888753 4589999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCccccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccc-hhhHHhhhh---
Q 008216 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATP--- 491 (573)
Q Consensus 417 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~~~~--- 491 (573)
|++....... ....+++.|+|||.+.+ ..++.++|+||||+++|++++|..||...+.... .........
T Consensus 163 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 163 GLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred ccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9998654321 11237889999998876 4578999999999999999999999976543210 000000000
Q ss_pred ----hhhccccccccccccccCCCC---CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 492 ----LVQSHRYLELLDPLISSLSSD---IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 492 ----~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
............. +...... ......+..+.+++.+|++.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 238 EFVQKLQSEDAKNYVKK-LPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhhcchhHHHHHHh-ccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000 0000000 001123456899999999999999999999993
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=290.00 Aligned_cols=263 Identities=18% Similarity=0.224 Sum_probs=188.2
Q ss_pred CeeecccCceEEEEEEeC-C--CCEEEEEEecccc--hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeC----CceEEE
Q 008216 274 NRLLGDSKTGGTYSGILP-D--GSRVAVKRLKRSS--FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH----GDRYIV 343 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~--g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~----~~~~lv 343 (573)
.+.||+|+||.||++... . +..||+|.+.... ....+.+.+|+.+++++ +||||+++++.+... ...+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 84 (332)
T cd07857 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY 84 (332)
T ss_pred EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence 457899999999999964 3 7799999987532 22345678899999999 599999999875432 456889
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCC
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 423 (573)
+|++. ++|.+++.. ...+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 85 EELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred Eeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 99885 689888853 35689999999999999999999999 99999999999999999999999999998654
Q ss_pred cccccc--ceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchh-hHHhhh-------hh
Q 008216 424 WEVMQE--RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWAT-------PL 492 (573)
Q Consensus 424 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~~-------~~ 492 (573)
...... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|++||...+...... ...... ..
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 322111 1112248899999998765 468899999999999999999999997654321100 000000 00
Q ss_pred hhccccccccccccccCCCC---CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 493 VQSHRYLELLDPLISSLSSD---IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
............ ....... ......+..+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 237 IGSPKAQNYIRS-LPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhHHHHHHh-ccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000 0000000 000112467999999999999999999999974
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=285.03 Aligned_cols=265 Identities=20% Similarity=0.223 Sum_probs=188.2
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccchh--hHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC--------ceEE
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--------DRYI 342 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--------~~~l 342 (573)
.+.||+|++|.||+|... +++.+|||++...... ....+.+|++++++++||||+++++++.+.. ..++
T Consensus 13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~l 92 (311)
T cd07866 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM 92 (311)
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEE
Confidence 446799999999999964 5899999998654322 2345778999999999999999999875543 3599
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
|+||+. ++|...+.. ....+++..+..++.|+++||+|||++ +++|+||||+||++++++.++|+|||++...
T Consensus 93 v~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 93 VTPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred EEecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 999995 467776653 235699999999999999999999999 9999999999999999999999999999865
Q ss_pred Cccccccc---------eeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhh
Q 008216 423 PWEVMQER---------TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL 492 (573)
Q Consensus 423 ~~~~~~~~---------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ 492 (573)
........ .....+++.|+|||.+.+. .++.++||||||+++|||++|++||...+..............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 43221111 1112267889999987654 5789999999999999999999999765543211111100000
Q ss_pred hhc------cccccccc-cccccCCCCC--cchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 493 VQS------HRYLELLD-PLISSLSSDI--PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 493 ~~~------~~~~~~~~-~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
... .......+ .......... ......+.+.+++.+||+.||.+|||+.|++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000 00000000 0000000000 00112357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=273.14 Aligned_cols=250 Identities=23% Similarity=0.413 Sum_probs=194.7
Q ss_pred eecccCceEEEEEEe-CCCCEEEEEEecccch-hhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
.||.|+||+|++-.. +.|+..|||+++.... .+.++++.|.+...+- +.||||+++|.+..++..|+.||.| ..+|
T Consensus 71 ~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~Sl 149 (361)
T KOG1006|consen 71 EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISL 149 (361)
T ss_pred HhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhH
Confidence 479999999999874 5699999999987644 5567889999876665 7899999999999999999999999 5577
Q ss_pred HHHhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 353 DRWLHHI-PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 353 ~~~l~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
+.+-... ......+++..+-+|......||.||-+.. .|||||+||+|||++..|.+||+|||++..+..+....
T Consensus 150 DklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT-- 225 (361)
T KOG1006|consen 150 DKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKT-- 225 (361)
T ss_pred HHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHHhh--
Confidence 6543211 122356888888899999999999999774 89999999999999999999999999997665432222
Q ss_pred eccCCcccccccccccC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 432 VMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
...|-..|||||.+.. ..|+-+|||||||++|||+.||+.||...+. +++.......... |.+
T Consensus 226 -~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~gdp------p~l--- 290 (361)
T KOG1006|consen 226 -VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIGDP------PIL--- 290 (361)
T ss_pred -hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcCCC------Cee---
Confidence 2238889999999864 3488999999999999999999999976443 3443333322211 111
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
..+......+..+..+|..||..|-++||+..++++
T Consensus 291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 011122346678999999999999999999999876
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=273.24 Aligned_cols=235 Identities=23% Similarity=0.270 Sum_probs=194.8
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccchhh---HHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
-++||+|.||.|-+.+- .+|+.+|+|+++++-.-. ...-+.|-++|+..+||.+..+--.+...+..++||||..|
T Consensus 173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanG 252 (516)
T KOG0690|consen 173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANG 252 (516)
T ss_pred HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccC
Confidence 45789999999999884 469999999998874333 34456789999999999999998889999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|.|.-+|.. .+.+++...+.+...|.+||.|||++ +||.||||.+|.|+|.+|++||+|||+++..-. ...
T Consensus 253 GeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~--~g~ 323 (516)
T KOG0690|consen 253 GELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK--YGD 323 (516)
T ss_pred ceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc--ccc
Confidence 999888854 46789999999999999999999999 999999999999999999999999999985422 233
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
.....+|||.|+|||++....|+.+.|-|.+||++|||++|+.||...+.. .+++.+.. .
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---kLFeLIl~--e--------------- 383 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---KLFELILM--E--------------- 383 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---HHHHHHHh--h---------------
Confidence 445677999999999999999999999999999999999999999876542 22221110 0
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCC
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRP 538 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP 538 (573)
....+...+++...|+...|..||.+|.
T Consensus 384 -d~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 384 -DLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 1112334566789999999999999994
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=271.70 Aligned_cols=203 Identities=19% Similarity=0.312 Sum_probs=165.8
Q ss_pred CcCCeeecccCceEEEEEEeCC-----CCEEEEEEecccchh--hHHHHHHHHHHHhhcCCCcEeEEeeEEee-CCceEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILPD-----GSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYI 342 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~l 342 (573)
++..+.||+|.||.||+|+..+ ...+|||.++..... -.....+|+.+++.++||||+.+..++.. +...++
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 3445567999999999997432 337999999765221 23567799999999999999999999887 678899
Q ss_pred EEEecCCCCHHHHhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC----CCeeEeccc
Q 008216 343 VYEFVVNGPLDRWLHHIP-RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE----FGAHLMGVG 417 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfg 417 (573)
++||.+. +|...++..+ ...+.++...+..|+.||+.|+.|||++ =|+||||||.|||+..+ |.+||+|+|
T Consensus 106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999965 8888876433 2336789999999999999999999999 89999999999999877 899999999
Q ss_pred CCccCCcccccc-ceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 008216 418 LSKFVPWEVMQE-RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAV 477 (573)
Q Consensus 418 ~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~ 477 (573)
+++.+....... ......-|.-|+|||.+.+ ..||++.||||.|||+.||+|-++.|.+.
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999876543322 1222236889999999987 46999999999999999999999888664
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=308.19 Aligned_cols=254 Identities=23% Similarity=0.321 Sum_probs=183.2
Q ss_pred HhhcCCCcCCeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC-----
Q 008216 265 SITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH----- 337 (573)
Q Consensus 265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----- 337 (573)
+...+|.+. ++||+||||.||+++.+ ||+.||||++.... ......+.+|+..|++|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL-~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 476 RYLNDFEEL-ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hHhhhhHHH-HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 344555443 47899999999999943 89999999997653 33345688999999999999999987654110
Q ss_pred --------------------------------------------------------------------------------
Q 008216 338 -------------------------------------------------------------------------------- 337 (573)
Q Consensus 338 -------------------------------------------------------------------------------- 337 (573)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CceEEEEEecCCCCHHHHhccCCCCCCCC-CHHHHHHHHHHHHHHH
Q 008216 338 ----------------------------------GDRYIVYEFVVNGPLDRWLHHIPRGGRSL-DWAMRMKVATTLAQGI 382 (573)
Q Consensus 338 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l-~~~~~~~i~~qi~~~L 382 (573)
...||-||||+..+|.++++.. ... .....++++++|+.||
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N----~~~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN----HFNSQRDEAWRLFREILEGL 710 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc----ccchhhHHHHHHHHHHHHHH
Confidence 0126788899888787777541 112 3567789999999999
Q ss_pred HHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCC----c------------cccccceeccCCcccccccccc
Q 008216 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP----W------------EVMQERTVMAGGTYGYLAPEFV 446 (573)
Q Consensus 383 ~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~ 446 (573)
+|+|++ |||||||||.||+++++..+||+|||++.... . .......+...||.-|+|||++
T Consensus 711 aYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 999999 99999999999999999999999999998721 0 0011122334499999999999
Q ss_pred cCC---CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHH
Q 008216 447 YRN---ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVV 523 (573)
Q Consensus 447 ~~~---~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 523 (573)
.+. .|+.|+|+||||||++||+. ||...-+ .+..+. .+-+..+... .+ ...+..+.-.
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--------Ra~iL~------~LR~g~iP~~-~~-f~~~~~~~e~ 848 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME--------RASILT------NLRKGSIPEP-AD-FFDPEHPEEA 848 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCchHH--------HHHHHH------hcccCCCCCC-cc-cccccchHHH
Confidence 764 49999999999999999986 5544211 111110 1111111110 11 1222334567
Q ss_pred HHHHHhcCCCCCCCCCHHHHHH
Q 008216 524 DLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 524 ~li~~cl~~dP~~RPs~~evl~ 545 (573)
.+|.+|++.||++||||.|+|+
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhh
Confidence 8999999999999999999985
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=292.77 Aligned_cols=265 Identities=20% Similarity=0.320 Sum_probs=193.4
Q ss_pred hhcCCCcCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCc---
Q 008216 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD--- 339 (573)
Q Consensus 266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--- 339 (573)
+.++|. ..+.||+|++|.||+|... +++.||||++... .....+.+.+|+.++++++||||+++.+++...+.
T Consensus 13 ~~~~y~-~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQ-NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceE-EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 344543 3457899999999999964 5889999998653 22334567889999999999999999988766554
Q ss_pred ---eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecc
Q 008216 340 ---RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (573)
Q Consensus 340 ---~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 416 (573)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence 89999998 6799998863 4589999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCccccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccch-hhHHhhhh---
Q 008216 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATP--- 491 (573)
Q Consensus 417 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~~--- 491 (573)
|++....... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... .+.+....
T Consensus 163 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 163 GLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred cccccccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 9998654321 11237888999998865 36788999999999999999999999765432110 00000000
Q ss_pred -hhh---ccccccccccccccCCCCC--cchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 492 -LVQ---SHRYLELLDPLISSLSSDI--PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 492 -~~~---~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
... .......+........... .....++.+.+++.+||+.||++|||+.+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000 0000000000000000000 00123568999999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=272.88 Aligned_cols=221 Identities=19% Similarity=0.170 Sum_probs=176.7
Q ss_pred cCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHHHHhcc
Q 008216 280 SKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHH 358 (573)
Q Consensus 280 G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 358 (573)
|.+|.||++.. .+|+.||+|+++... .+.+|...+....||||+++++++.+.+..+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999996 468999999997653 233455555566799999999999999999999999999999999864
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceeccCCcc
Q 008216 359 IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438 (573)
Q Consensus 359 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 438 (573)
...+++..+..++.|++.||+|||++ +++||||||+||+++.++.++++|||.+....... ....++.
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~ 146 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVEN 146 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCc
Confidence 23589999999999999999999999 99999999999999999999999999876554321 1122567
Q ss_pred cccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHH
Q 008216 439 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGV 518 (573)
Q Consensus 439 ~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (573)
.|+|||.+.+..++.++||||+|+++|||++|+.|+....... . .... ... +...
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~-----~~~~-------~~~-~~~~ 201 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------N-----THTT-------LNI-PEWV 201 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------c-----cccc-------cCC-cccC
Confidence 8999999988889999999999999999999998875422110 0 0000 001 1224
Q ss_pred HHHHHHHHHHhcCCCCCCCCCHHH
Q 008216 519 VQKVVDLVYACTQHVPSMRPRMSH 542 (573)
Q Consensus 519 ~~~l~~li~~cl~~dP~~RPs~~e 542 (573)
++.+.+++.+|++.||++||++.+
T Consensus 202 ~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 202 SEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CHHHHHHHHHHccCCHHHhcCCCc
Confidence 567899999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=243.31 Aligned_cols=261 Identities=19% Similarity=0.228 Sum_probs=193.0
Q ss_pred eecccCceEEEEEEe-CCCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
.||+|.||+||+|+. .+++.||+|+++.++. .-.....+|+-+|+.++|.|||+++++...++..-+|+||| ..+|
T Consensus 9 kigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqdl 87 (292)
T KOG0662|consen 9 KIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDL 87 (292)
T ss_pred hhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHHH
Confidence 469999999999994 5688999999876532 22466889999999999999999999999999999999999 5689
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
..|... -++.++.+..+.++.|+++||.|.|++ ++.|||+||+|.|++.+|..||+|||+++.+........
T Consensus 88 kkyfds---lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrcys-- 159 (292)
T KOG0662|consen 88 KKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS-- 159 (292)
T ss_pred HHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee--
Confidence 988864 346799999999999999999999999 999999999999999999999999999997754432111
Q ss_pred ccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccc---ccccccc
Q 008216 433 MAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLE---LLDPLIS 507 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 507 (573)
...-|..|.+|.++.+. -|++..|+||.|||+.|+.. |++.|.+.+-.+....+-+......+..+.. +.|-..-
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 11268899999999875 47899999999999999998 6666766553321111111111111111111 1111000
Q ss_pred cC-CCCCcch----HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 508 SL-SSDIPEA----GVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 508 ~~-~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.. ....... .....=++++++.+.-+|..|.++++.++
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 00 0000001 12234568999999999999999998875
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=272.07 Aligned_cols=263 Identities=20% Similarity=0.250 Sum_probs=196.8
Q ss_pred CcCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcC-C-Cc----EeEEeeEEeeCCceEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-H-PN----LVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~n----Iv~l~~~~~~~~~~~lv 343 (573)
++...++|+|.||.|-..... .+..||||+++... ..++..+-|+++|+++. + |+ ++++.+++.-.++.+||
T Consensus 91 y~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCiv 169 (415)
T KOG0671|consen 91 YEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIV 169 (415)
T ss_pred eehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEE
Confidence 344457799999999988753 47899999998763 34566778999999993 2 33 78888999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC----------------
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---------------- 407 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---------------- 407 (573)
+|.+ |.|+.++|.. ..-.+++...++.++.|++++++|||+. +++|-||||+|||+.+
T Consensus 170 fell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 170 FELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred Eecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcccee
Confidence 9998 7799999975 4456789999999999999999999999 9999999999999832
Q ss_pred ----CCCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccch
Q 008216 408 ----EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ 483 (573)
Q Consensus 408 ----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~ 483 (573)
+..++++|||.|....... .....|..|.|||++.+..++.++||||+||||+|+.||...|+..++.+..
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred ccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 3458999999998754332 2233789999999999999999999999999999999999999887754432
Q ss_pred hhHHhhhhhhh-----ccccc-----cccc------c-----ccccC----CCCCcchHHHHHHHHHHHHhcCCCCCCCC
Q 008216 484 SIFEWATPLVQ-----SHRYL-----ELLD------P-----LISSL----SSDIPEAGVVQKVVDLVYACTQHVPSMRP 538 (573)
Q Consensus 484 ~~~~~~~~~~~-----~~~~~-----~~~~------~-----~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RP 538 (573)
.+.+.+..... ..... .-+| . ..... ..-........++.+|+++||..||.+|+
T Consensus 319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence 22222111000 00000 0000 0 00000 00011234556899999999999999999
Q ss_pred CHHHHHH
Q 008216 539 RMSHVVH 545 (573)
Q Consensus 539 s~~evl~ 545 (573)
|+.|++.
T Consensus 399 Tl~EAL~ 405 (415)
T KOG0671|consen 399 TLREALS 405 (415)
T ss_pred cHHHHhc
Confidence 9999985
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=286.46 Aligned_cols=231 Identities=25% Similarity=0.295 Sum_probs=187.4
Q ss_pred eecccCceEEEEEE-eCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCCCCHH
Q 008216 276 LLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 353 (573)
-+|.|+|+.|-+.. ..+++..+||++.+.. .+..+|+.++... +||||+++.+.+.+..+.|+|||.+.|+-|.
T Consensus 329 ~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell 404 (612)
T KOG0603|consen 329 ELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELL 404 (612)
T ss_pred ccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHH
Confidence 36999999998887 4568899999997652 2344677666665 7999999999999999999999999998887
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee-CCCCCeeEecccCCccCCcccccccee
Q 008216 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll-~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
+.+.. .+.....+..|+.+|+.|+.|||++ |++||||||+|||+ ++.++++|+|||.++..... ..
T Consensus 405 ~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~ 471 (612)
T KOG0603|consen 405 RRIRS-----KPEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CD 471 (612)
T ss_pred HHHHh-----cchhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-----hc
Confidence 76653 2223367778999999999999999 99999999999999 58889999999999877654 22
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
..+-|..|.|||++....|++++|+||||++||+|++|+.||...... ..+.. ... ..
T Consensus 472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~----~i~----------------~~ 529 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHT----RIQ----------------MP 529 (612)
T ss_pred ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHH----hhc----------------CC
Confidence 334688999999999999999999999999999999999999875542 01110 000 11
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
......++..++|+.+||+.||.+||+++++..
T Consensus 530 ~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 530 KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 112456788999999999999999999999985
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=301.24 Aligned_cols=140 Identities=24% Similarity=0.361 Sum_probs=125.3
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|+||.||+|... +++.||||+++... ......+.+|+.++..++||||+++++.+...+..++||||+.+
T Consensus 9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g 88 (669)
T cd05610 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIG 88 (669)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence 457899999999999975 68999999997542 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
++|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 89 GDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999864 24588899999999999999999999 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=263.08 Aligned_cols=266 Identities=19% Similarity=0.257 Sum_probs=193.2
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--------CceEEE
Q 008216 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--------GDRYIV 343 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------~~~~lv 343 (573)
..+|+|.||+||+|+.+ +|+.||+|.+--+.. .-.....+|+++|..|.|+|++.++..|... ...|+|
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 35799999999999954 578899987643211 1234567999999999999999999887542 347999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCC
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 423 (573)
|.+|+. +|..+|.+ ....++..++.+++.++..||.|+|.. .|+|||+||+|+||+.++.+||+|||+++.+.
T Consensus 103 f~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred HHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 999954 88888864 335689999999999999999999999 99999999999999999999999999998765
Q ss_pred ccccc--cceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhh--------hhh
Q 008216 424 WEVMQ--ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWA--------TPL 492 (573)
Q Consensus 424 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~--------~~~ 492 (573)
..... .......-|..|.+||.+.+ ..|+++.|||..|||+.||+||.+-+++..+.....++... ++.
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 43222 22222335899999999887 57899999999999999999999998876543221111111 111
Q ss_pred hhcccccccc--cccc----ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008216 493 VQSHRYLELL--DPLI----SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547 (573)
Q Consensus 493 ~~~~~~~~~~--~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 547 (573)
.....+.+.+ .|.. ..+.....+..-.++..+|+.+++..||.+|+++++++..-
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 1111111111 1000 00001111112235788999999999999999999998753
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=270.75 Aligned_cols=234 Identities=24% Similarity=0.320 Sum_probs=191.9
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+||+|+||.|-+|..+ +.+.+|||+++++-. .+.+--+.|-++|... +-|.++++..++..-+.+|.||||+.|
T Consensus 355 ~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnG 434 (683)
T KOG0696|consen 355 MVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNG 434 (683)
T ss_pred EEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecC
Confidence 47899999999999864 467899999987622 2233345677777766 578899999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|--++++ -..+.+..+..++.+||-||-+||++ |||.||||.+|||+|.+|++||+|||+++..-.+ ..
T Consensus 435 GDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~--~~ 505 (683)
T KOG0696|consen 435 GDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD--GV 505 (683)
T ss_pred chhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccccC--Cc
Confidence 999888864 24588888999999999999999999 9999999999999999999999999999854332 23
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
.+...+||+.|+|||++...+|+.++|-|||||+||||+.|++||++.++.+. ++.+ .+.
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el---F~aI------------~eh----- 565 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---FQAI------------MEH----- 565 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHH------------HHc-----
Confidence 34556799999999999999999999999999999999999999999876432 1111 111
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCC
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRP 538 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP 538 (573)
.-..+...+.+..++....|...|.+|.
T Consensus 566 -nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 -NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1223455677888999999999999995
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=294.68 Aligned_cols=250 Identities=25% Similarity=0.339 Sum_probs=189.6
Q ss_pred cCCCcCCeeecccCceE-EEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEE
Q 008216 268 KNFSEGNRLLGDSKTGG-TYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 268 ~~~~~~~~~lg~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
+.+...++++|.|+.|+ ||+|.+ +|+.||||++-.+. .....+|+..|+.- +|||||++++.-.+....||..|
T Consensus 508 k~~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 508 KLFFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eeeeccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 34444566789998865 799999 89999999986542 34567899999988 79999999999889999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---C--CCeeEecccCCc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---E--FGAHLMGVGLSK 420 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~--~~~kl~Dfg~~~ 420 (573)
.| ..+|.+++...............+.++.|+++||++||+. +||||||||.||||+. + ..++|+|||+++
T Consensus 584 LC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 584 LC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred Hh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 99 6699999976311111111144577899999999999998 9999999999999975 3 458999999999
Q ss_pred cCCccccccc-eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcC-CCCCCCCCcccchhhHHhhhhhhhcccc
Q 008216 421 FVPWEVMQER-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG-RRPAQAVDSVCWQSIFEWATPLVQSHRY 498 (573)
Q Consensus 421 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 498 (573)
.+..+...-. .....||.+|+|||++....-+.++||||+||++|+.++| .+||.+.-..+ + .......-
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-------~-NIl~~~~~ 731 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-------A-NILTGNYT 731 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-------h-hhhcCccc
Confidence 8876543322 2334499999999999988888899999999999999995 99997643210 0 01100000
Q ss_pred ccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
...+ .+..++ +..+||.+|+++||..||++.+|+.
T Consensus 732 L~~L----------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 732 LVHL----------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eeee----------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0000 111112 7899999999999999999999974
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=263.13 Aligned_cols=238 Identities=25% Similarity=0.371 Sum_probs=192.2
Q ss_pred CceEEEEEEeC-CCCEEEEEEecccchhh-HHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHHHHhcc
Q 008216 281 KTGGTYSGILP-DGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHH 358 (573)
Q Consensus 281 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 358 (573)
+||.||+|+.. +|+.+|+|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999975 48999999998765444 67899999999999999999999999999999999999999999999864
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceeccCCcc
Q 008216 359 IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438 (573)
Q Consensus 359 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 438 (573)
. ..+++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+....... ......++.
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 2 2388999999999999999999999 99999999999999999999999999998765432 112223788
Q ss_pred cccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHH
Q 008216 439 GYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGV 518 (573)
Q Consensus 439 ~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (573)
.|+|||.+.+..++.++||||||++++++++|..||...... ....+.. ...... ........
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~----~~~~~~-----------~~~~~~~~ 213 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKI----GKPKPP-----------FPPPEWKI 213 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHH----hccCCC-----------CccccccC
Confidence 999999998888899999999999999999999998763221 1111110 000000 00000014
Q ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 519 VQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 519 ~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+.++.+++.+|+..+|++||++.++++
T Consensus 214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 214 SPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CHHHHHHHHHHccCCchhccCHHHHhh
Confidence 567999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-33 Score=299.02 Aligned_cols=255 Identities=21% Similarity=0.218 Sum_probs=202.7
Q ss_pred HHhhcCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCc
Q 008216 264 RSITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD 339 (573)
Q Consensus 264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 339 (573)
+--..+|. ..++||+|+||.|..++. .+++.||.|++.+.. .....-|..|-.+|..-+.+=|+++.-.|.++..
T Consensus 71 rl~~~Dfe-ilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 71 RLKAEDFE-ILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred hCCHHhhH-HHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 33334443 345889999999999996 458899999998742 2344668889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCC
Q 008216 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (573)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 419 (573)
+|+|||||+||+|-.++... . .+++..++.++..|.-||+-||+. |+|||||||+|||||..|++||+|||.+
T Consensus 150 LYlVMdY~pGGDlltLlSk~---~-~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKF---D-RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred eEEEEecccCchHHHHHhhc---C-CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhH
Confidence 99999999999999999742 2 699999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCccccccceeccCCcccccccccccC-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhh
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ 494 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 494 (573)
-.+..+..... ....|||.|++||++.. +.|++.+|-||+||++|||+.|..||...+- ++-...+..
T Consensus 223 lkm~~dG~V~s-~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------veTY~KIm~ 295 (1317)
T KOG0612|consen 223 LKMDADGTVRS-SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------VETYGKIMN 295 (1317)
T ss_pred HhcCCCCcEEe-ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------HHHHHHHhc
Confidence 88875554433 34459999999999862 5689999999999999999999999986432 222222111
Q ss_pred ccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCC---HHHHHH
Q 008216 495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR---MSHVVH 545 (573)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 545 (573)
... .+ ..+.....+++..+||.+.+. +|+.|.. ++++..
T Consensus 296 hk~-------~l----~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 296 HKE-------SL----SFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred hhh-------hc----CCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 110 11 111233477889999999875 7888887 777764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-33 Score=280.48 Aligned_cols=235 Identities=21% Similarity=0.273 Sum_probs=197.7
Q ss_pred eecccCceEEEEEEeCCCC-EEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 276 LLGDSKTGGTYSGILPDGS-RVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~g~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
-||-|+||.|=++..+... .+|+|.+++. .....+.+..|-.+|...+.|.||++|..+.++...|++||-|-||.
T Consensus 427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGE 506 (732)
T KOG0614|consen 427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGE 506 (732)
T ss_pred hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCch
Confidence 3799999999999874433 3899998765 33445668889999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|-..|+. .+.++..+...++..+++|++|||++ +||.|||||+|.+++.+|-+||.|||+|+.+... ..+
T Consensus 507 lWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g---~KT 576 (732)
T KOG0614|consen 507 LWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG---RKT 576 (732)
T ss_pred hhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC---Cce
Confidence 9999964 46799999999999999999999999 9999999999999999999999999999987643 345
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
...+||+.|.|||++.+...+.++|.||||+++|||++|.+||++.++....+++- +.+..
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL-------------------kGid~ 637 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL-------------------KGIDK 637 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH-------------------hhhhh
Confidence 56779999999999999999999999999999999999999999987653222211 11111
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCCC
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRPR 539 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs 539 (573)
-..+..+.....+||++....+|.+|..
T Consensus 638 i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 638 IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 1223445567889999999999999975
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=268.02 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=192.7
Q ss_pred eeecccCceEEEEEE-eCCCCEEEEEEeccc-ch------hhHHHHHHHHHHHhhcCCCcEeEEeeEEee-CCceEEEEE
Q 008216 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRS-SF------QRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYE 345 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~-~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e 345 (573)
.+||+|||+.||++. +...+.||||+-... +. ...+...+|.++.+.|+||.||++|+++.- .+.++-|+|
T Consensus 469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE 548 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE 548 (775)
T ss_pred HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence 468999999999998 456889999986432 11 112456789999999999999999999874 456789999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---CCCeeEecccCCccC
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVGLSKFV 422 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~~~~~ 422 (573)
||+|.+|+-||.. .+.+++++++.|+.||+.||.||.+. +++|||=||||.|||+.+ -|.+||.|||+++.+
T Consensus 549 YceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIM 623 (775)
T KOG1151|consen 549 YCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIM 623 (775)
T ss_pred ecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhc
Confidence 9999999999954 56799999999999999999999987 789999999999999954 467999999999998
Q ss_pred Ccccccc-----ceeccCCcccccccccccCC----CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhh
Q 008216 423 PWEVMQE-----RTVMAGGTYGYLAPEFVYRN----ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV 493 (573)
Q Consensus 423 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 493 (573)
+.+.... .+....||..|++||.+.-+ ..+.|+||||+|||+|..+.|+.||...... +.+.+
T Consensus 624 dddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdILq------ 695 (775)
T KOG1151|consen 624 DDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDILQ------ 695 (775)
T ss_pred cCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHHh------
Confidence 7654331 22334599999999988643 4688999999999999999999999765331 11111
Q ss_pred hccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 008216 494 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544 (573)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 544 (573)
...+.....- ..++....+.+..++|++||+..-++|....++.
T Consensus 696 -eNTIlkAtEV------qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 -ENTILKATEV------QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -hhchhcceec------cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1111111110 1122234567889999999999999998777664
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=281.99 Aligned_cols=248 Identities=24% Similarity=0.386 Sum_probs=201.8
Q ss_pred cCCeeecccCceEEEEEE-eCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEee-----CCceEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD-----HGDRYIVY 344 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~-----~~~~~lv~ 344 (573)
+..+.||.|.+|.||+++ .++|+..|+|+..... ...+++..|.++|+.+ .|||++.++|++.. ++.+||||
T Consensus 22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM 100 (953)
T KOG0587|consen 22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM 100 (953)
T ss_pred EEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence 445678999999999998 5679999999987653 3446778899999988 79999999999874 46789999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCc
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 424 (573)
|||.+||..+++.... +..+.|+.+..|+..++.||.+||.+ .++|||||-.|||++.++.+||.|||.+..++.
T Consensus 101 EfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 101 EFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred eccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 9999999999998754 67899999999999999999999999 999999999999999999999999999987654
Q ss_pred cccccceeccCCcccccccccccC-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 425 EVMQERTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
... ......||+.|||||++.- ..|+..+|+||||++..||.-|.+|+.++.+.. .++...
T Consensus 176 T~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr--aLF~Ip---------- 241 (953)
T KOG0587|consen 176 TVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR--ALFLIP---------- 241 (953)
T ss_pred ccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--hhccCC----------
Confidence 322 2333449999999999864 346789999999999999999999998776531 000000
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
-.|. +....+...+.++.++|..||..|-++||++.++++
T Consensus 242 --RNPP----PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 242 --RNPP----PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --CCCC----ccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 0000 011123457789999999999999999999999986
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=242.14 Aligned_cols=197 Identities=26% Similarity=0.462 Sum_probs=168.4
Q ss_pred eecccCceEEEEEE-eCCCCEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 276 LLGDSKTGGTYSGI-LPDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
-||+|++|.|-+-+ ..+|+..|+|+++.. ..+..++.++|+.+..+- ..|.+|.++|.....++.++.||.| ..||
T Consensus 53 elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSl 131 (282)
T KOG0984|consen 53 ELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSL 131 (282)
T ss_pred hhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhH
Confidence 36999999988776 457999999999765 345567788999887665 7999999999999999999999999 5688
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
+.+-.+.-+.+..+++..+-+|+..+.+||.|||++. .++|||+||+|||++.+|++|++|||++..+..+....
T Consensus 132 dkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt--- 206 (282)
T KOG0984|consen 132 DKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKT--- 206 (282)
T ss_pred HHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhHHH---
Confidence 8887666667788999999999999999999999985 89999999999999999999999999998776543322
Q ss_pred ccCCcccccccccccC----CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 008216 433 MAGGTYGYLAPEFVYR----NELTTKSDVYSFGVLLLEIVSGRRPAQAVD 478 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 478 (573)
...|-..|||||.+.. ..|+-++||||||+++.||.+++.||+...
T Consensus 207 ~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 207 MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 2238889999998853 368899999999999999999999997644
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=278.43 Aligned_cols=266 Identities=17% Similarity=0.192 Sum_probs=177.6
Q ss_pred hcCCCcCCeeecccCceEEEEEEe-----------------CCCCEEEEEEecccchhhHHHH--------------HHH
Q 008216 267 TKNFSEGNRLLGDSKTGGTYSGIL-----------------PDGSRVAVKRLKRSSFQRKKEF--------------YSE 315 (573)
Q Consensus 267 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~~--------------~~E 315 (573)
.++|.. .++||+|+||.||+|.. .+++.||||+++.......++| ..|
T Consensus 144 ~d~F~i-~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 144 SDDFQL-RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred ccCceE-eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 345544 45779999999999963 2356899999875433322333 346
Q ss_pred HHHHhhcCCCcE-----eEEeeEEee--------CCceEEEEEecCCCCHHHHhccCCC--------------------C
Q 008216 316 IGRFARLHHPNL-----VAVKGCCYD--------HGDRYIVYEFVVNGPLDRWLHHIPR--------------------G 362 (573)
Q Consensus 316 ~~~l~~l~h~nI-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~ 362 (573)
+.++.+++|.++ +++++++.. .+..++||||+++++|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 667777653 3567999999999999999864211 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceeccCCcccccc
Q 008216 363 GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442 (573)
Q Consensus 363 ~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 442 (573)
...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......... .....+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeC
Confidence 12346778889999999999999999 99999999999999999999999999997654322111 111225789999
Q ss_pred cccccCCCC----------------------CcchhhHHHHHHHHHHHcCCC-CCCCCCcccchhhHHhhhhhhhccccc
Q 008216 443 PEFVYRNEL----------------------TTKSDVYSFGVLLLEIVSGRR-PAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 443 PE~~~~~~~----------------------~~~~DvwSlGvil~elltG~~-Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
||.+..... ..+.||||+||++++|++|.. |+........ .. ........ .+.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~-~~~~~~~~--~~r 454 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-EL-RQYDNDLN--RWR 454 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HH-hhccchHH--HHH
Confidence 998754221 134799999999999999875 6654321100 00 00000000 000
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCC---CCCCCHHHHHH
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVP---SMRPRMSHVVH 545 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~ 545 (573)
....... ........++...+|+.++|..+| .+|+|++|+++
T Consensus 455 ~~~~~~~----~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 455 MYKGQKY----DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred hhcccCC----CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0000000 000112345678999999999866 68999999985
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=287.04 Aligned_cols=263 Identities=14% Similarity=0.125 Sum_probs=162.1
Q ss_pred cCCeeecccCceEEEEEEeC-C----CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeE------EeeCCce
Q 008216 272 EGNRLLGDSKTGGTYSGILP-D----GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC------CYDHGDR 340 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~------~~~~~~~ 340 (573)
+..+.||+|+||.||+|... + +..||||++...... +...+| .+....+.++..++.. .......
T Consensus 135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (566)
T PLN03225 135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEY 210 (566)
T ss_pred EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCce
Confidence 44567899999999999964 4 689999998654211 111111 1122222222222111 2455678
Q ss_pred EEEEEecCCCCHHHHhccCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCee
Q 008216 341 YIVYEFVVNGPLDRWLHHIPRG----------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIl 404 (573)
++|+||+.+++|.+++...... ........+..++.||+.||+|||++ +|+||||||+|||
T Consensus 211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NIL 287 (566)
T PLN03225 211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNII 287 (566)
T ss_pred EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEE
Confidence 9999999999999998642100 01112345668999999999999999 9999999999999
Q ss_pred eCC-CCCeeEecccCCccCCccccccceeccCCcccccccccccCC----------------------CCCcchhhHHHH
Q 008216 405 LDE-EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN----------------------ELTTKSDVYSFG 461 (573)
Q Consensus 405 l~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DvwSlG 461 (573)
++. ++.+||+|||+++.......... ....+++.|+|||.+... .++.++||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~~~-~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINYIP-KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccccCC-cccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 986 57899999999986543322211 123488999999966422 233466999999
Q ss_pred HHHHHHHcCCCCCCCCCcccchhhHHhhhhh-hhccccccccccccccC-CCCC-cchHHHHHHHHHHHHhcCCCCCCCC
Q 008216 462 VLLLEIVSGRRPAQAVDSVCWQSIFEWATPL-VQSHRYLELLDPLISSL-SSDI-PEAGVVQKVVDLVYACTQHVPSMRP 538 (573)
Q Consensus 462 vil~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~l~~li~~cl~~dP~~RP 538 (573)
|++|||+++..|+.... ..+....... .....+.....+..... .... ..........+|+.+||+.||++||
T Consensus 367 viL~el~~~~~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ 442 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNL----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI 442 (566)
T ss_pred HHHHHHHhCcCCCchHH----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence 99999999776644211 0000000000 00000000011100000 0000 0000122456899999999999999
Q ss_pred CHHHHHHH
Q 008216 539 RMSHVVHQ 546 (573)
Q Consensus 539 s~~evl~~ 546 (573)
|+.++++.
T Consensus 443 ta~e~L~H 450 (566)
T PLN03225 443 SAKAALAH 450 (566)
T ss_pred CHHHHhCC
Confidence 99999973
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=260.69 Aligned_cols=241 Identities=21% Similarity=0.265 Sum_probs=187.0
Q ss_pred cCCeeecccCceEEEEEE-eCCCCEEEEEEecccchhh---HHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
...+-||-|+||+|.++. .++...+|.|.+++.+.-. ......|-+||..-+++-||+||-.|.+.+.+|+||+|+
T Consensus 632 vkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYI 711 (1034)
T KOG0608|consen 632 VKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 711 (1034)
T ss_pred EEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEecc
Confidence 334568999999999998 4457789999998764322 345678999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc-
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV- 426 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 426 (573)
+||++-.+|-. ...+.+..++.++.++..|+++.|.. |+|||||||+|||||.+|++||.|||++.-+....
T Consensus 712 PGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 712 PGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred CCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccc
Confidence 99999998854 35688889999999999999999999 99999999999999999999999999986432100
Q ss_pred -------ccc--------------------------------ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHH
Q 008216 427 -------MQE--------------------------------RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467 (573)
Q Consensus 427 -------~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~el 467 (573)
.+. ......||+.|+|||++....++..+|-||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 000 00011389999999999999999999999999999999
Q ss_pred HcCCCCCCCCCcccch-hhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCC
Q 008216 468 VSGRRPAQAVDSVCWQ-SIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538 (573)
Q Consensus 468 ltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 538 (573)
+.|+.||-...+.+.+ .+..|.. .+ ...+..+.+.+..++|.+++ -+++.|.
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~----------~l--------~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRN----------FL--------HIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhh----------cc--------ccccccccCHHHHHHHHHHh-cChhhhh
Confidence 9999999776553221 1222211 11 22233455667778877644 3566664
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=232.15 Aligned_cols=254 Identities=20% Similarity=0.292 Sum_probs=192.9
Q ss_pred eeecccCceEEEEEE-eCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeC--CceEEEEEecCCC
Q 008216 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDH--GDRYIVYEFVVNG 350 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lv~e~~~~g 350 (573)
+.+|+|.+++||.|. ..+.++++||+++.. ..+.+.+|+++|+.|. ||||+++++...+. ..+.|++||+.+.
T Consensus 44 rk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~ 120 (338)
T KOG0668|consen 44 RKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNT 120 (338)
T ss_pred HHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccc
Confidence 346999999999998 567899999999865 4567889999999996 99999999998875 4568999999998
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-CCeeEecccCCccCCcccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
+...+. ..++...+..++.++++||.|+|+. ||.|||+||.|+++|.. -.++|+|+|+|.+........
T Consensus 121 Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn 190 (338)
T KOG0668|consen 121 DFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190 (338)
T ss_pred cHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCceee
Confidence 887765 3588889999999999999999999 99999999999999864 458999999998876543332
Q ss_pred ceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhc------ccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS------HRYLELL 502 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~------~~~~~~~ 502 (573)
....+..|.-||.+.. ..|+..-|+|||||++..|+..+.||....+. ..+++..++-+... .++.-.+
T Consensus 191 ---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 191 ---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 2236777899998875 45788999999999999999999998755432 22333222221100 1111112
Q ss_pred ccccc------------cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 503 DPLIS------------SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 503 ~~~~~------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
++... .+.......-.++++.+++.+.|..|-++|||+.|.+.
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 22221 11112222234578999999999999999999998764
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-30 Score=241.90 Aligned_cols=241 Identities=23% Similarity=0.299 Sum_probs=188.5
Q ss_pred eeecccCceEEEEEEe-CCCCEEEEEEecccch---hhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
++||+|+|+.|-.+++ ++.+.+|+|+++++.. .+.+-.+.|-.+..+. +||.+|-+..++..+...++|.||++|
T Consensus 256 ~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~g 335 (593)
T KOG0695|consen 256 RVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNG 335 (593)
T ss_pred eeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecC
Confidence 5789999999999985 4578899999987632 2334456677777666 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|--+++. .+.++++.++.+...|..||.|||++ |||.||||.+|||+|..|.+||.|+|+++..-.. ..
T Consensus 336 gdlmfhmqr----qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~--gd 406 (593)
T KOG0695|consen 336 GDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP--GD 406 (593)
T ss_pred cceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCC--Cc
Confidence 999666643 45699999999999999999999999 9999999999999999999999999999864322 33
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCccc-chhhHHhhhhhhhcccccccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC-WQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
.+...+||+.|+|||++.+..|....|-|++||+++||+.|+.||+-....+ .++..+.... -+++..+
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq--------vilekqi-- 476 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ--------VILEKQI-- 476 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH--------HHhhhcc--
Confidence 3455679999999999999999999999999999999999999997432111 0111111111 1111111
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCC
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 538 (573)
. .+...+.....+++.-|+.||.+|.
T Consensus 477 ---r-iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 ---R-IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---c-ccceeehhhHHHHHHhhcCCcHHhc
Confidence 0 1122344567788999999999985
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-31 Score=246.67 Aligned_cols=265 Identities=19% Similarity=0.265 Sum_probs=193.2
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC-----CceEEEEE
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIVYE 345 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~e 345 (573)
.+.||-|+||.||.+.++ +|+.||+|.+... +....+.+.+|+++|..++|.|++..++...-. .+.|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 446899999999999864 6999999998654 344567899999999999999999999886544 24578889
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
.| ..+|...+- ..+.++...+.-++.||++||+|||+. +|.||||||.|.|+++|...||+|||+++..+.+
T Consensus 138 Lm-QSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 138 LM-QSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HH-Hhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 88 557877764 346788888999999999999999999 9999999999999999999999999999976654
Q ss_pred ccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhh--h------hhhcc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT--P------LVQSH 496 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~--~------~~~~~ 496 (573)
....-+ ...-|..|.|||.+.+ ..|+.+.||||.|||+.||+..+..|+...+....+++.... + ..-++
T Consensus 210 ~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 210 DRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 332222 1226788999999987 468999999999999999999999988765543222211110 0 00011
Q ss_pred cccccccccc-----ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008216 497 RYLELLDPLI-----SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547 (573)
Q Consensus 497 ~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 547 (573)
....++.... ..+-....+..-..+...+...++..||.+|.+.++.+..+
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111111110 00000001112223566788999999999999999887644
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=232.25 Aligned_cols=210 Identities=29% Similarity=0.494 Sum_probs=182.2
Q ss_pred ecccCceEEEEEEeCC-CCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHHH
Q 008216 277 LGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (573)
Q Consensus 277 lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 354 (573)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++|+++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 5899999999999754 899999999876432 35678999999999999999999999999899999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-CCCeeEecccCCccCCccccccceec
Q 008216 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFVPWEVMQERTVM 433 (573)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 433 (573)
++.... ..++...+..++.+++++|++||+. +++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 986421 4589999999999999999999999 9999999999999999 88999999999986654321 1112
Q ss_pred cCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCC
Q 008216 434 AGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512 (573)
Q Consensus 434 ~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 512 (573)
..+...|++||..... ..+.++|+|++|++++++
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 2377889999998776 788999999999999998
Q ss_pred CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 513 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
..+.+++.+|++.||++||++.++++.
T Consensus 188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 247899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=243.32 Aligned_cols=129 Identities=19% Similarity=0.260 Sum_probs=108.6
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-----C---CcEeEEeeEEee----C
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-----H---PNLVAVKGCCYD----H 337 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nIv~l~~~~~~----~ 337 (573)
+...+.||-|.|++||++.+ .+.+.||+|+.+.. ..-.+..+.|+++|++++ | .+||++++.|.. +
T Consensus 80 Y~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG 158 (590)
T KOG1290|consen 80 YHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNG 158 (590)
T ss_pred EEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCC
Confidence 34456679999999999985 45778999999765 344567789999999983 3 369999999975 4
Q ss_pred CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee
Q 008216 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405 (573)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll 405 (573)
.+.++|+|++ |.+|..+|.. ..-+.++...+.+|+.||+.||.|||.+| ||||-||||+|||+
T Consensus 159 ~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 159 QHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred cEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 5789999999 7789888875 33466999999999999999999999998 99999999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=253.74 Aligned_cols=270 Identities=17% Similarity=0.163 Sum_probs=202.0
Q ss_pred hhcCCCcCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcC------CCcEeEEeeEEeeCC
Q 008216 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH------HPNLVAVKGCCYDHG 338 (573)
Q Consensus 266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~l~~~~~~~~ 338 (573)
+..+-++.....|+|-|++|.+|... .|..||||++.... .-.+.=+.|+++|++|+ --|+++++..|...+
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 34444555556799999999999964 48899999998753 22344568999999994 357999999999999
Q ss_pred ceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-CeeEeccc
Q 008216 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVG 417 (573)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg 417 (573)
++|||+|-+ ..+|.+.|.... .+..|....+..++.|+.-||..|-.. +|+|.||||+|||+++.- .+||+|||
T Consensus 508 HLClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred eeEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCc
Confidence 999999988 669999997643 345688899999999999999999988 999999999999998754 57999999
Q ss_pred CCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhh----
Q 008216 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV---- 493 (573)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~---- 493 (573)
.|............ -+..|.|||++.|.+|+...|+||.||+||||.||+..|.+........++...+...
T Consensus 583 SA~~~~eneitPYL----VSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 583 SASFASENEITPYL----VSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred cccccccccccHHH----HHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 99877654433222 3557999999999999999999999999999999999998876554333332221110
Q ss_pred -hcccc-ccccc--------------------------c------cccc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCC
Q 008216 494 -QSHRY-LELLD--------------------------P------LISS-LSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538 (573)
Q Consensus 494 -~~~~~-~~~~~--------------------------~------~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 538 (573)
..+.+ .+.+| | .+.. .............+.+|+..|+..||++|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 00000 00011 1 0000 001111234567899999999999999999
Q ss_pred CHHHHHH
Q 008216 539 RMSHVVH 545 (573)
Q Consensus 539 s~~evl~ 545 (573)
|..+.|+
T Consensus 739 t~nqAL~ 745 (752)
T KOG0670|consen 739 TVNQALK 745 (752)
T ss_pred CHHHHhc
Confidence 9998875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=232.48 Aligned_cols=255 Identities=20% Similarity=0.286 Sum_probs=185.7
Q ss_pred eecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC------CceEEEEEe
Q 008216 276 LLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------GDRYIVYEF 346 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lv~e~ 346 (573)
.+|.|.- .|..+.+ -.+++||+|.+... .....++..+|+..+..++|+||++++.++.-. .+.|+|||+
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 4577776 5555542 25899999987544 233456788999999999999999999998644 356999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
| ..+|...+. -.++-+.+..|+.|++.|++|||+. +|+||||||+||++..+..+||.|||+++.....-
T Consensus 103 m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~ 172 (369)
T KOG0665|consen 103 M-DANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDF 172 (369)
T ss_pred h-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCccc
Confidence 9 668988876 3477889999999999999999999 99999999999999999999999999998755431
Q ss_pred cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcc-cchhhHH---------------hhh
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV-CWQSIFE---------------WAT 490 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-~~~~~~~---------------~~~ 490 (573)
.......|..|.|||++.+..+.+.+||||+||++.||++|..-|.+.+.. .+....+ .+.
T Consensus 173 ---~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 173 ---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred ---ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 111223788999999999988999999999999999999999988765321 1111111 000
Q ss_pred hhhh------ccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 491 PLVQ------SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 491 ~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.... ...+.+.+...+-..... .+.-....+.+++.+||..||++|.|++++|.
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e-~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLE-GSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHhhcChHhhccchhhhCCccccccccc-CCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0000 011111111111000000 11123456889999999999999999999986
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-29 Score=249.14 Aligned_cols=191 Identities=24% Similarity=0.327 Sum_probs=162.0
Q ss_pred eeecccCceEEEEEEeCC-CCEEEEEEecccchh--------hHHHHHHHHHHHhhcC---CCcEeEEeeEEeeCCceEE
Q 008216 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQ--------RKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYI 342 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~l 342 (573)
+.+|+|+||.|+.+.++. ...|+||.+.++..- +.-.+-.|+.+|..|+ |+||++++++|++++.+||
T Consensus 567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl 646 (772)
T KOG1152|consen 567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYL 646 (772)
T ss_pred eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEE
Confidence 457999999999999754 668999998765211 1122456999999996 9999999999999999999
Q ss_pred EEEec-CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCcc
Q 008216 343 VYEFV-VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 343 v~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 421 (573)
+||-- ++.+|.+++.. ...+++.+...|++||+.|+++||++ +|||||||-+||.++.+|-+||+|||.+..
T Consensus 647 ~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 647 ETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred EecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhh
Confidence 99965 56789999964 45699999999999999999999999 999999999999999999999999999876
Q ss_pred CCccccccceeccCCcccccccccccCCCC-CcchhhHHHHHHHHHHHcCCCCCCC
Q 008216 422 VPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQA 476 (573)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~ 476 (573)
...... ....||..|.|||++.+.+| +..-|||++|++||-++....||..
T Consensus 720 ~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 TKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 654322 23349999999999998877 5678999999999999999999863
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-29 Score=255.63 Aligned_cols=248 Identities=22% Similarity=0.304 Sum_probs=199.3
Q ss_pred CCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 273 GNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
.-..+|+|.||.||+++. ..++..|||+++-....+..-+++|+-+++..+||||+.++|.+......++.||||.+|+
T Consensus 19 llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs 98 (829)
T KOG0576|consen 19 LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS 98 (829)
T ss_pred heeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence 344569999999999995 4689999999998766777788899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+.-+ ...++++.++....+..+.||+|||+. +-+|||||-.||++++.+.+|++|||.+..+...... .
T Consensus 99 lQdiy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K--r 169 (829)
T KOG0576|consen 99 LQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK--R 169 (829)
T ss_pred ccceee----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhhh--h
Confidence 988654 356799999999999999999999999 9999999999999999999999999998766533222 2
Q ss_pred eccCCccccccccccc---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 432 VMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
....||+.|||||+.. .+.|...+|||++|+...|+---++|-....+. +.++-..+... ++.
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--r~l~LmTkS~~---------qpp--- 235 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--RALFLMTKSGF---------QPP--- 235 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--HHHHHhhccCC---------CCC---
Confidence 2344999999999764 467899999999999999998888886544332 11111111111 110
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.........+.+.++++.++..+|++||+++.+++
T Consensus 236 --~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 --TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred --cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 01112234567999999999999999999998876
|
|
| >cd03599 CLECT_DGCR2_like C-type lectin-like domain (CTLD) of the type found in DGCR2, an integral membrane protein deleted in DiGeorge Syndrome (DGS) | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=212.51 Aligned_cols=128 Identities=18% Similarity=0.323 Sum_probs=102.2
Q ss_pred CCccCcccCCCC--eeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCC---------CCCeEEeee---
Q 008216 53 CPPDWIINEEKS--KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---------VNGCWVGGR--- 118 (573)
Q Consensus 53 Cp~~w~~~~~~~--~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---------~~~~WiGl~--- 118 (573)
||+||. .|++ +||+++.+.+||.||+.+|++.|||||+|+|.+|++||.+++.+. ...+||||+
T Consensus 1 CP~gw~--~~~~~~~CYk~~~~~~tw~dA~~~C~~~Gg~Lasi~s~~e~~fl~~l~~~~~~~~~~~~~~~~~WIGL~~~~ 78 (153)
T cd03599 1 CPSGWH--HYEGTASCYKVYLSGENYWDAVQTCQKVNGSLATFTTDQELQFILAQEWDFDERVFGRKDQCKFWVGYQYVI 78 (153)
T ss_pred CCCchh--ccCCCCeEEEEeCCcCCHHHHHHHHHHcCCEEcCCCCHHHHHHHHHHHHhhcccccccccCCCEEEeecccc
Confidence 999999 8998 899999999999999999999999999999999999999998432 145999995
Q ss_pred -ecCCCCCCceEEc-CCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEee---------cCCCceeccccCCCCCcc
Q 008216 119 -SINTTVGLSWKWS-DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS---------NGSRSLVTERCNTSHPFI 187 (573)
Q Consensus 119 -~~~~~~~~~w~W~-Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~---------~~~~~W~d~~C~~~~~~i 187 (573)
+.+...+|+|+|+ |||++.+. .|. .+|..++|++ ++++|+.+. .....|+|..|+...+||
T Consensus 79 ~~~~~~~eg~w~WsddGs~~~y~-~w~----~~w~~gePn~---~~e~C~~~~~~~~~~~~~~~~~~W~d~~C~~~~~fi 150 (153)
T cd03599 79 TNRNHSLEGRWEVAYKGSMEVFL-PPE----PIFATGMSTN---DNVFCAQLQCFQIPSLRERGLHSWHAENCYEKSSFL 150 (153)
T ss_pred cccCcccCCeEEEecCCccceec-Ccc----ccCCCCCCCC---CCCCCeEEEeeccccccccccCeeeCccCCCCCcce
Confidence 2255678999999 59887533 332 2344455542 345777775 234579999999999999
Q ss_pred ccc
Q 008216 188 CMV 190 (573)
Q Consensus 188 C~~ 190 (573)
|++
T Consensus 151 Cq~ 153 (153)
T cd03599 151 CKR 153 (153)
T ss_pred eCC
Confidence 985
|
CLECT_DGCR2_like: C-type lectin-like domain (CTLD) of the type found in DGCR2, an integral membrane protein deleted in DiGeorge Syndrome (DGS). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. DGS is also known velo-cardio-facial syndrome (VCFS). DGS is a genetic abnormality that results in malformations of the heart, face, and limbs and is associated with schizophrenia and depressive disorders. DGCR2 is a candidate for involvement in the pathogenesis of DGS since the DGCR2 gene lies within the minimal DGS critical region (MDGRC) of 22q11, which when deleted gives rise to DGS, and the DGCR2 gene is in close proximity to the balanced translocation breakpoint in a DGS patient having a balanced translocation. |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=225.15 Aligned_cols=196 Identities=29% Similarity=0.449 Sum_probs=168.8
Q ss_pred CeeecccCceEEEEEEeCC-CCEEEEEEecccchh-hHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 274 NRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++|++++++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 83 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD 83 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence 3467999999999999765 899999999876544 56789999999999999999999999999899999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++.... ..+++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 84 L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~ 156 (225)
T smart00221 84 LFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL 156 (225)
T ss_pred HHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence 999986422 1178999999999999999999999 9999999999999999999999999999876543211 11
Q ss_pred eccCCcccccccccc-cCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 008216 432 VMAGGTYGYLAPEFV-YRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 476 (573)
....++..|++||.+ ....++.++|+||||+++++|++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122377889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=221.13 Aligned_cols=246 Identities=21% Similarity=0.296 Sum_probs=179.5
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeE-EeeCCceEEEEEecCC
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGC-CYDHGDRYIVYEFVVN 349 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~-~~~~~~~~lv~e~~~~ 349 (573)
.++.||+|.||.+-+++.. ..+.+|+|.+... ....++|.+|...--.| .|.||+..|+. ++..+.+++++||++.
T Consensus 28 I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~ 106 (378)
T KOG1345|consen 28 INKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPR 106 (378)
T ss_pred HHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCcc
Confidence 3557899999999999964 5778999999776 34567899998776666 68999987764 5666778899999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC-C-CCCeeEecccCCccCCcccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-E-EFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~-~-~~~~kl~Dfg~~~~~~~~~~ 427 (573)
|+|.+-+.. ..+.+..-.+++.|+++|+.|+|++ ++||||||.+||||- . ..++||+|||.++..+....
T Consensus 107 gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 107 GDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred chhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 999887753 4588888999999999999999999 999999999999993 3 34699999999986543221
Q ss_pred ccceeccCCcccccccccccCC-----CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRN-----ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (573)
.. ..+..|.|||..... ...+.+|||.||+++|.++||.+||+..... .+...+|.. +....
T Consensus 179 ~~-----~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~~~--w~~rk----- 245 (378)
T KOG1345|consen 179 YL-----EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEWEQ--WLKRK----- 245 (378)
T ss_pred hh-----hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHHHH--Hhccc-----
Confidence 11 145679999976532 3467899999999999999999999843221 112222211 11111
Q ss_pred ccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.+.+ +... ...++.+..+.++-+.++|++|-...++.+
T Consensus 246 ~~~~----P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 246 NPAL----PKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred CccC----chhh-cccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 1111 0000 124467888999999999999954444443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=233.00 Aligned_cols=260 Identities=25% Similarity=0.339 Sum_probs=189.5
Q ss_pred CCeeecccCceEEEEEEeC----CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEec
Q 008216 273 GNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
....||+|.|++||++.+. .++.||+|.+...+ ....+.+|++.|..+ .+.||+++.+++..++...+|+||+
T Consensus 40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~ 117 (418)
T KOG1167|consen 40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF 117 (418)
T ss_pred hhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence 3446699999999999853 46789999997653 345688999999999 6899999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-CCeeEecccCCccCCccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~ 426 (573)
++.+..++... ++..++..++..++.||+++|.+ |||||||||.|+|.+.. +.-.|.|||++.......
T Consensus 118 ~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 118 EHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred CccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 99999998853 77899999999999999999999 99999999999999864 457899999997211000
Q ss_pred ------------------------------------------cccceeccCCcccccccccccCC-CCCcchhhHHHHHH
Q 008216 427 ------------------------------------------MQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVL 463 (573)
Q Consensus 427 ------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvi 463 (573)
.........||++|.|||++... .-+++.||||.|||
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 00001122399999999998764 56889999999999
Q ss_pred HHHHHcCCCCCCCCCcccchhhHHhhhh-----------------hhhcccc---cccc---ccc-cccCC--------C
Q 008216 464 LLEIVSGRRPAQAVDSVCWQSIFEWATP-----------------LVQSHRY---LELL---DPL-ISSLS--------S 511 (573)
Q Consensus 464 l~elltG~~Pf~~~~~~~~~~~~~~~~~-----------------~~~~~~~---~~~~---~~~-~~~~~--------~ 511 (573)
++-+++++.||....++. ..+.+.+.. +.+..++ .+.. +.. ..... .
T Consensus 268 ~Lslls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~ 346 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTER 346 (418)
T ss_pred eehhhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceee
Confidence 999999999996543321 111110000 0000000 0000 000 00000 1
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.......+..+.+++.+|++.||.+|.|+++.|+
T Consensus 347 ~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 347 EIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 1111223457899999999999999999999985
|
|
| >cd03597 CLECT_attractin_like C-type lectin-like domain (CTLD) of the type found in human and mouse attractin (AtrN) and attractin-like protein (ALP) | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=200.16 Aligned_cols=121 Identities=21% Similarity=0.383 Sum_probs=100.6
Q ss_pred CCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCC-----CCCeEEeeeecCCCCCCc
Q 008216 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN-----VNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~-----~~~~WiGl~~~~~~~~~~ 127 (573)
||+||. .|+++||+++.+.++|.+|+.+|+++||+||+|+|.+|++||.+++.+. ...+||||+ |.. +|.
T Consensus 1 Cp~gw~--~~~~~Cy~~~~~~~tw~~A~~~C~~~g~~La~i~~~~E~~fi~~~~~~~~~~~~~~~~WIGl~--d~~-~g~ 75 (129)
T cd03597 1 CGEGWH--LVGNSCLKINTARESYDNAKLYCRNLNAVLASLTTQKKVEFVLKELQKHQMTKQKLTPWVGLR--KIN-VSY 75 (129)
T ss_pred CCCcCE--EcCCEEEEEEcCCCCHHHHHHHHHHcCCEEcCCCCHHHHHHHHHHHHhhcccCCCCceEEeee--cCC-CCc
Confidence 999999 9999999999999999999999999999999999999999999877542 246999999 554 588
Q ss_pred eEEcCCCCCCC-CCccccCCCCCCccCCCCcCCcccceeEEeecC-CCceeccccCCC-CCccccc
Q 008216 128 WKWSDNMSKWN-ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTS-HPFICMV 190 (573)
Q Consensus 128 w~W~Dgt~~~~-~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~-~~~W~d~~C~~~-~~~iC~~ 190 (573)
|.|+|||++.+ ++.|.+++|+++ ++|+.+... ...|+|..|... .+|||++
T Consensus 76 w~W~Dgs~~~~~~~~W~~geP~~~------------~~C~~~~~~~~~~w~d~~C~~~~~~~iCe~ 129 (129)
T cd03597 76 WCWEDMSPFTNTTLQWLPGEPSDA------------GFCGYLEEPAVSGLKANPCTNPVNGSVCER 129 (129)
T ss_pred eEECCCCCCCCccccCCCCCCCCc------------ccEEEEcccccCccccCCcCCCCcceeecC
Confidence 99999988753 556777776642 357776433 456999999998 6999974
|
CLECT_attractin_like: C-type lectin-like domain (CTLD) of the type found in human and mouse attractin (AtrN) and attractin-like protein (ALP). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. Mouse AtrN (the product of the mahogany gene) has been shown to bind Agouti protein and to function in agouti-induced pigmentation and obesity. Mutations in AtrN have also been shown to cause spongiform encephalopathy and hypomyelination in rats and hamsters. The cytoplasmic region of mouse ALP has been shown to binds to melanocortin receptor (MCR4). Signaling through MCR4 plays a role in appetite suppression. Attractin may have therapeutic potential in the treatment of obesity. Human attractin (hAtrN) has been shown to be expressed on activated T cells and released extracellularly. The |
| >cd03588 CLECT_CSPGs C-type lectin-like domain (CTLD) of the type found in chondroitin sulfate proteoglycan core proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=198.62 Aligned_cols=122 Identities=21% Similarity=0.461 Sum_probs=102.4
Q ss_pred CCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcC
Q 008216 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD 132 (573)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~D 132 (573)
||+||+ .|+++||+|+.+.++|.+|++.|+..||+||+|+|++|++||.++.. ..+||||+ +...++.|+|+|
T Consensus 1 Cp~gw~--~~~~~Cy~~~~~~~sw~~A~~~C~~~gg~La~i~s~~e~~fl~~~~~---~~~WIGl~--~~~~~~~~~W~d 73 (124)
T cd03588 1 CEEGWD--KFQGHCYRHFPDRETWEDAERRCREQQGHLSSIVTPEEQEFVNNNAQ---DYQWIGLN--DRTIEGDFRWSD 73 (124)
T ss_pred CCccce--ecCCEEEEEECCccCHHHHHHHHHhcCCEEeccCCHHHHHHHHHhcc---CcEEecce--ecCCCCceEeCC
Confidence 999999 99999999999999999999999999999999999999999998764 46899999 666779999999
Q ss_pred CCCCCCCCccccCCCCCCccCCCCcCCcccceeEEee-cCCCceeccccCCCCCccccc
Q 008216 133 NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS-NGSRSLVTERCNTSHPFICMV 190 (573)
Q Consensus 133 gt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~-~~~~~W~d~~C~~~~~~iC~~ 190 (573)
|++.. +..|..++|++ ...+.++|+.+. ...+.|++..|....+|||++
T Consensus 74 g~~~~-~~~W~~~~p~~--------~~~~~~~Cv~~~~~~~~~W~d~~C~~~~~fICe~ 123 (124)
T cd03588 74 GHPLQ-FENWRPNQPDN--------FFATGEDCVVMIWHEEGEWNDVPCNYHLPFTCKK 123 (124)
T ss_pred CCccc-ccCcCCCCCCC--------CCCCCCCeEEEecCCCCeEcCCCCCCCCeeeeeC
Confidence 97754 55677666553 122345676664 345689999999999999986
|
CLECT_CSPGs: C-type lectin-like domain (CTLD) of the type found in chondroitin sulfate proteoglycan core proteins (CSPGs) in human and chicken aggrecan, frog brevican, and zebra fish dermacan. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Xenopus brevican is expressed in the notochord and the brain during early embryogenesis. Zebra fish dermacan is expressed in dermal bones and may play a role in dermal bone development. CSPGs do contain LINK domain(s) which bind HA. These LINK domains are considered by one classif |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=263.99 Aligned_cols=196 Identities=21% Similarity=0.263 Sum_probs=139.1
Q ss_pred hcCC-CcEeEEeeEE-------eeCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 008216 321 RLHH-PNLVAVKGCC-------YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392 (573)
Q Consensus 321 ~l~h-~nIv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ 392 (573)
.++| +||.++++++ ......+.++|++ +++|.++|.. ....+++.+++.++.||++||+|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4455 5777788876 2234567788887 6799999963 235699999999999999999999999 9
Q ss_pred eEEcCCCCCCeeeCC-------------------CCCeeEecccCCccCCcccc--------------ccceeccCCccc
Q 008216 393 VVHRDIRASNVLLDE-------------------EFGAHLMGVGLSKFVPWEVM--------------QERTVMAGGTYG 439 (573)
Q Consensus 393 iiH~Dlkp~NIll~~-------------------~~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~gt~~ 439 (573)
|+||||||+||||+. ++.+|++|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 44566777777654221000 000011237888
Q ss_pred ccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHH
Q 008216 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVV 519 (573)
Q Consensus 440 y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (573)
|||||++.+..++.++|||||||+||||++|.+|+...... .. .... ..+.+.. ....
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~-----~~---~~~~-----~~~~~~~---------~~~~ 238 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT-----MS---SLRH-----RVLPPQI---------LLNW 238 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH-----HH---HHHH-----hhcChhh---------hhcC
Confidence 99999999999999999999999999999998886532110 00 0000 0011100 0112
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 520 QKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 520 ~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....+++.+||+.||.+||++.||++
T Consensus 239 ~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 239 PKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHHHhCCCChhhCcChHHHhh
Confidence 34668899999999999999999986
|
|
| >PHA02642 C-type lectin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-26 Score=207.73 Aligned_cols=123 Identities=24% Similarity=0.532 Sum_probs=103.3
Q ss_pred CCCCCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCC
Q 008216 47 KDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGL 126 (573)
Q Consensus 47 ~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~ 126 (573)
..++.+||.||. .|+++||+|+.+.++|.+|+.+|+++||+||+|+|++|++||+.+.. ...+||||+ +...++
T Consensus 82 ~~k~~~CP~gW~--~~~~kCYyfs~~~ksW~eA~~~C~s~ga~La~I~seeE~~FL~~~~~--~~~yWIGLs--d~~~e~ 155 (216)
T PHA02642 82 TIKYVTCPKGWI--GFGYKCFYFSEDSKNWTFGNTFCTSLGATLVKVETEEELNFLKRYKD--SSDHWIGLN--RESSNH 155 (216)
T ss_pred CcccCCCCCcCE--EECCEEEEEeCcccCHHHHHHHHhhCCCeEeeECCHHHHHHHHHhhc--CCeEEEEeE--eCCCCC
Confidence 455789999999 99999999999999999999999999999999999999999998876 457999999 556679
Q ss_pred ceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccccCC
Q 008216 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHEN 194 (573)
Q Consensus 127 ~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~~~ 194 (573)
.|+|+|||++ +..+|..| .++|+.+.. .++.+..|.....|||++....
T Consensus 156 ~W~WvDGS~~-n~~~~i~G----------------~g~CAyLs~--~~i~s~~C~~~~~wIC~K~l~~ 204 (216)
T PHA02642 156 PWKWADNSNY-NASFVITG----------------TGECAYLND--IRISSSRVYANRKWICSKTYTN 204 (216)
T ss_pred ceEECCCCcc-CcceeccC----------------CCceEEEeC--CceEccCcCCCceEEeeeeccc
Confidence 9999999654 44556433 134666654 4799999999999999986543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-26 Score=209.75 Aligned_cols=168 Identities=23% Similarity=0.270 Sum_probs=126.6
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|.+++.. .+..+++.+++.++.|++.||+|||++ + ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 689999864 235699999999999999999999999 6 999999999999999 99987654321
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
..||+.|+|||++.+..++.++|||||||++|||+||+.||...... ............ . ..+.
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~-----~-~~~~---- 127 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMP-----A-DDPR---- 127 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhc-----c-CCcc----
Confidence 13889999999999999999999999999999999999999654321 111111000000 0 0000
Q ss_pred CCCCcchHHHH--HHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 510 SSDIPEAGVVQ--KVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 510 ~~~~~~~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
.......... .+.+++.+||+.||.+||++.|+++.+..+.
T Consensus 128 -~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 128 -DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred -ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 0011222333 6999999999999999999999999886554
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd03589 CLECT_CEL-1_like C-type lectin-like domain (CTLD) of the type found in CEL-1 from Cucumaria echinata and Echinoidin from Anthocidaris crassispina | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=198.83 Aligned_cols=124 Identities=23% Similarity=0.509 Sum_probs=103.2
Q ss_pred CCccCcccCCCCeeeEEecccCChHHHHHHHhhc-----CCeEeeeCCHHHHHHHHHHhCCC-----CCCeEEeeeecCC
Q 008216 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-----GGHLAALTSYEEEHSAQKLCGKN-----VNGCWVGGRSINT 122 (573)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-----~~~L~~i~~~~e~~f~~~~~~~~-----~~~~WiGl~~~~~ 122 (573)
||+||+ .|+++||+++.+.++|.+|+.+|++. +|+||+|+|++|++||..++... ...+||||+ +.
T Consensus 1 Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~~g~~~~La~i~s~~e~~~l~~~~~~~~~~~~~~~~WiGl~--~~ 76 (137)
T cd03589 1 CPTFWT--AFGGYCYRFFGDRLTWEEAELRCRSFSIPGLIAHLVSIHSQEENDFVYDLFESSRGPDTPYGLWIGLH--DR 76 (137)
T ss_pred CCcchh--hhCCEEEEEeCCCcCHHHHHHHHHhhcCCCCCceEcccCCHHHHHHHHHHHhhccccCCCCcEEEeee--cC
Confidence 999999 99999999999999999999999997 69999999999999999988642 457999999 66
Q ss_pred CCCCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecC---CCceeccccCCCCCccccc
Q 008216 123 TVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG---SRSLVTERCNTSHPFICMV 190 (573)
Q Consensus 123 ~~~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~---~~~W~d~~C~~~~~~iC~~ 190 (573)
..++.|.|+||++. .+..|..++|++. + +.++|+.+... .+.|++..|+...+|||+.
T Consensus 77 ~~~~~~~W~dG~~~-~~~~W~~~~P~~~--------~-~~~~C~~~~~~~~~~~~W~d~~C~~~~~fIC~~ 137 (137)
T cd03589 77 TSEGPFEWTDGSPV-DFTKWAGGQPDNY--------G-GNEDCVQMWRRGDAGQSWNDMPCDAVFPYICKM 137 (137)
T ss_pred CccCceEeCCcCcC-CcCCcCCCCCCCC--------C-CCCCceeeecCCCCCCeecCCCCCCCcceeeeC
Confidence 67799999999774 5666777776642 1 34566666543 3569999999999999973
|
CLECT_CEL-1_like: C-type lectin-like domain (CTLD) of the type found in CEL-1 from Cucumaria echinata and Echinoidin from Anthocidaris crassispina. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. The CEL-1 CTLD binds three calcium ions and has a high specificity for N-acteylgalactosamine (GalNAc). CEL-1 exhibits strong cytotoxicity which is inhibited by GalNAc. This protein may play a role as a toxin defending against predation. Echinoidin is found in the coelomic fluid of the sea urchin and is specific for GalBeta1-3GalNAc. Echinoidin has a cell adhesive activity towards human cancer cells which is not mediated through the CTLD. Both CEL-1 and Echinoidin are multimeric proteins comprised of multiple dimers linked by disulfide bonds. |
| >cd03590 CLECT_DC-SIGN_like C-type lectin-like domain (CTLD) of the type found in human dendritic cell (DC)-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) and the related receptor, DC-SIGN receptor (DC-SIGNR) | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=193.32 Aligned_cols=125 Identities=25% Similarity=0.538 Sum_probs=106.1
Q ss_pred CCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcC
Q 008216 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD 132 (573)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~D 132 (573)
||.||. .|+++||+++...++|.+|+.+|+..||+||+|+|.+|++||.+++. ....+||||+ +...++.|+|+|
T Consensus 1 Cp~~w~--~~~~~Cy~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~-~~~~~WiGl~--~~~~~~~~~W~d 75 (126)
T cd03590 1 CPTNWK--SFQSSCYFFSTEKKSWEESRQFCEDMGAHLVIINSQEEQEFISKILS-GNRSYWIGLS--DEETEGEWKWVD 75 (126)
T ss_pred CCCCce--EeCCEEEEEeCCCcCHHHHHHHHHhCCCEEEeeCCHHHHHHHHHHhC-CCCCEEEeee--cCCCcCCeEecC
Confidence 999999 99999999999999999999999999999999999999999999986 3568999999 665679999999
Q ss_pred CCCCC-CCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccc
Q 008216 133 NMSKW-NESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (573)
Q Consensus 133 gt~~~-~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~ 190 (573)
|+++. .+..|..++|++. +.+.+.|+.+....+.|.+..|....+|||++
T Consensus 76 g~~~~~~~~~W~~~~p~~~--------~~~~~~C~~~~~~~~~w~~~~C~~~~~fiCek 126 (126)
T cd03590 76 GTPLNSSKTFWHPGEPNNW--------GGGGEDCAELVYDSGGWNDVPCNLEYRWICEK 126 (126)
T ss_pred CCCCCCccCCcCCCcCCCC--------CCCCCCCEEEECCCCcEeCcCCCCCEeeeeeC
Confidence 97763 6677777766542 11345677776554689999999999999974
|
CLECT_DC-SIGN_like: C-type lectin-like domain (CTLD) of the type found in human dendritic cell (DC)-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) and the related receptor, DC-SIGN receptor (DC-SIGNR). This group also contains proteins similar to hepatic asialoglycoprotein receptor (ASGP-R) and langerin in human. These proteins are type II membrane proteins with a CTLD ectodomain. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. DC-SIGN is thought to mediate the initial contact between dendritic cells and resting T cells, and may also mediate the rolling of DCs on epithelium. DC-SIGN and DC-SIGNR bind to oligosaccharides present on human tissues, as well as, on path |
| >PHA02953 IEV and EEV membrane glycoprotein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-25 Score=197.87 Aligned_cols=123 Identities=15% Similarity=0.227 Sum_probs=95.2
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEE
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW 130 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W 130 (573)
..||+||. .|+++||+++.+.++|.||+.+|.++||+|++|+ +|+.|+..+.. ...+||||+ | .+|+|.|
T Consensus 45 ~~CP~GW~--~~~~~CYk~f~~~~tW~~A~~~C~~~Gg~L~~~~--~e~~fv~~~~~--~~~~WIGL~--d--~eg~W~w 114 (170)
T PHA02953 45 SACAKGWI--PYDNYCYLDTNIQLSTYGAVYLCNKYRARLPKPN--FRHLKVLSLTY--GKDFWVSLK--K--KNNRWLD 114 (170)
T ss_pred CcCcccCh--hhCCEEEEEECCcCCHHHHHHHHHhcCCCCCCCc--HHHHHHHHhcc--CCCEEEeEE--C--CCCceEe
Confidence 47999999 9999999999999999999999999999998877 67889887755 457999999 6 5689999
Q ss_pred cCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 131 ~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
.||++...++.|. ...+|. ++| ++++++|+.+.. +.|+|..|+...+|||+++
T Consensus 115 ~Dggs~~~y~~~~--~~~~w~-~~~---~~~~e~C~~~~~--~~W~d~~C~~~~~fICqk~ 167 (170)
T PHA02953 115 INTNKTVDMNKNT--ELKKIK-SKT---KNDNEACYIYKS--GELKETVCNSVNYIICVKR 167 (170)
T ss_pred CCCCeeecccccc--cccccc-CCC---CCCCCCceEEeC--CeEEeccCCCCcEEEEEEe
Confidence 9975544333221 112232 222 114566777653 4799999999999999875
|
|
| >cd03596 CLECT_tetranectin_like C-type lectin-like domain (CTLD) of the type found in the tetranectin (TN), cartilage derived C-type lectin (CLECSF1), and stem cell growth factor (SCGF) | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=190.94 Aligned_cols=121 Identities=16% Similarity=0.292 Sum_probs=100.3
Q ss_pred CCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCCceE
Q 008216 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGLSWK 129 (573)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~~w~ 129 (573)
||+||. .+++||+++.+.++|.+|+.+|++.||+||+|+|.+|++||.++++.. ...+||||+ |...++.|.
T Consensus 1 c~~g~~---~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WiGl~--~~~~~~~w~ 75 (129)
T cd03596 1 CLKGTK---IHKKCYLVSEETKHYHEASEDCIARGGTLATPRDSDENDALRDYVKASVPGNWEVWLGIN--DMVAEGKWV 75 (129)
T ss_pred CCCCcE---ECCEEEEEecccCCHHHHHHHHHhcCCeEecCCCHHHHHHHHHHHHhccCCCCcEEEecc--ccCccCeEE
Confidence 999987 678999999999999999999999999999999999999998877532 357999999 777789999
Q ss_pred EcCCCCCCCCCcccc---CCCCCCccCCCCcCCcccceeEEeecC-CCceeccccCCCCCcccc
Q 008216 130 WSDNMSKWNESIHAV---GSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICM 189 (573)
Q Consensus 130 W~Dgt~~~~~~~~~~---~~~~~~~~~~p~~~~~~~~~C~~~~~~-~~~W~d~~C~~~~~~iC~ 189 (573)
|+||+++. +..|.. ++|++ .+.++|+.+... .+.|++..|....+|||+
T Consensus 76 w~dG~~~~-~~~W~~~~~~~p~~----------~~~~~Cv~l~~~~~~~W~d~~C~~~~~fICe 128 (129)
T cd03596 76 DVNGSPIS-YFNWEREITAQPDG----------GKRENCVALSSSAQGKWFDEDCRREKPYVCE 128 (129)
T ss_pred eCCCCCcc-ccccCCCCCCCCCC----------CCCCCCEEEccCCCCcCcCccCCCCCceecc
Confidence 99997764 455654 44432 234567777654 567999999999999996
|
CLECT_tetranectin_like: C-type lectin-like domain (CTLD) of the type found in the tetranectin (TN), cartilage derived C-type lectin (CLECSF1), and stem cell growth factor (SCGF). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. TN binds to plasminogen and stimulates activation of plasminogen, playing a key role in the regulation of proteolytic processes. The TN CTLD binds two calcium ions. Its calcium free form binds to various kringle-like protein ligands. Two residues involved in the coordination of calcium are critical for the binding of TN to the fourth kringle (K4) domain of plasminogen (Plg K4). TN binds the kringle 1-4 form of angiostatin (AST K1-4). AST K1-4 is a fragment of Plg, commonly found in cancer tissues. TN inhibits the bin |
| >cd03593 CLECT_NK_receptors_like C-type lectin-like domain (CTLD) of the type found in natural killer cell receptors (NKRs) | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=186.27 Aligned_cols=116 Identities=25% Similarity=0.529 Sum_probs=97.9
Q ss_pred CCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcC
Q 008216 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD 132 (573)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~D 132 (573)
||+||. .|+++||+++.+.++|.+|+..|+++||+||+|+|.+|++||.+++. ...+||||+ +...++.|.|+|
T Consensus 1 Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WiGl~--~~~~~~~~~W~d 74 (116)
T cd03593 1 CPKDWI--CYGNKCYYFSMEKKTWNESKEACSSKNSSLLKIDDEEELEFLQSQIG--SSSYWIGLS--REKSEKPWKWID 74 (116)
T ss_pred CCCcCE--EeCCEEEEEEcCCCCHHHHHHHHHhCCCcEEEECCHHHHHHHHHhcC--CCceEEEEe--ecCCCCCeEccC
Confidence 999999 99999999999999999999999999999999999999999999884 568999999 666679999999
Q ss_pred CCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccc
Q 008216 133 NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (573)
Q Consensus 133 gt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~ 190 (573)
|+++. +|+. .+|++ ..++|+.+... .|++..|....+|||++
T Consensus 75 g~~~~--~~~~-~~~~~-----------~~~~C~~~~~~--~w~~~~C~~~~~~IC~k 116 (116)
T cd03593 75 GSPLN--NLFN-IRGST-----------KSGNCAYLSST--GIYSEDCSTKKRWICEK 116 (116)
T ss_pred CCccc--cccc-ccCCC-----------CCCCceEEcCC--cEEcccCCcCceeeeeC
Confidence 98765 3332 22221 34567776543 79999999999999974
|
CLECT_NK_receptors_like: C-type lectin-like domain (CTLD) of the type found in natural killer cell receptors (NKRs), including proteins similar to oxidized low density lipoprotein (OxLDL) receptor (LOX-1), CD94, CD69, NKG2-A and -D, osteoclast inhibitory lectin (OCIL), dendritic cell-associated C-type lectin-1 (dectin-1), human myeloid inhibitory C-type lectin-like receptor (MICL), mast cell-associated functional antigen (MAFA), killer cell lectin-like receptors: subfamily F, member 1 (KLRF1) and subfamily B, member 1 (KLRB1), and lys49 receptors. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. NKRs are variously associated with activation or inhibition of natural killer (NK) cells. Activating NKRs stimulate cytolysis by NK cells of virally infected or transformed cells; inhibitory NKRs block cytolysis up |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-25 Score=205.26 Aligned_cols=245 Identities=23% Similarity=0.415 Sum_probs=189.4
Q ss_pred ecccCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHHH
Q 008216 277 LGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (573)
Q Consensus 277 lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 354 (573)
|.+...|+.|+|++ .|..+++|++.-. .....++|..|.-.|+-+.||||+.++|.|....+..++..||+.|+|..
T Consensus 198 l~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslyn 276 (448)
T KOG0195|consen 198 LAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYN 276 (448)
T ss_pred hccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHH
Confidence 57888999999999 6778888888643 23334678999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceecc
Q 008216 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (573)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 434 (573)
.|+. ..+...+..++.+++.++|+|++|||+. .+-|.---|....|++|++.+++|.- +-+++. -+....
T Consensus 277 vlhe--~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfs------fqe~gr 346 (448)
T KOG0195|consen 277 VLHE--QTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFS------FQEVGR 346 (448)
T ss_pred HHhc--CccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceee------eecccc
Confidence 9986 4556688889999999999999999987 33344446889999999999887742 111111 111111
Q ss_pred CCcccccccccccCCCCC---cchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 435 GGTYGYLAPEFVYRNELT---TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 435 ~gt~~y~aPE~~~~~~~~---~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
.-.+.||+||.++..+-+ .++|+|||.+++|||.|...||.+..+.+-.-. -.+..+..
T Consensus 347 ~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk------------------ialeglrv 408 (448)
T KOG0195|consen 347 AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK------------------IALEGLRV 408 (448)
T ss_pred ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh------------------hhhccccc
Confidence 256889999999876543 579999999999999999999988765421110 01111112
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
.+ +.+.+..+.+|+.-|++.||.+||.++.|+-.|+++.
T Consensus 409 ~i-ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 409 HI-PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cC-CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 22 2356778999999999999999999999999988763
|
|
| >cd03594 CLECT_REG-1_like C-type lectin-like domain (CTLD) of the type found in Human REG-1 (lithostathine), REG-4, and avian eggshell-specific proteins: ansocalcin, structhiocalcin-1(SCA-1), and -2(SCA-2) | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=189.30 Aligned_cols=121 Identities=26% Similarity=0.618 Sum_probs=101.1
Q ss_pred CCccCcccCCCCeeeEEecccCChHHHHHHHhhc--CCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCCc
Q 008216 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~~ 127 (573)
||.||. .|+++||+++.+.++|.+|+.+|++. ||+||+|+|.+|++||.+++... ...+||||+ +...++.
T Consensus 1 Cp~gw~--~~~~~Cy~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WiGl~--~~~~~~~ 76 (129)
T cd03594 1 CPKGWL--PYKGNCYGYFRQPLSWSDAELFCQKYGPGAHLASIHSPAEAAAIASLISSYQKAYQPVWIGLH--DPQQSRG 76 (129)
T ss_pred CCCCCE--ecCCEeeeEeccCcCHHHHHHHHHhcCCCceEcccCCHHHHHHHHHHHHhhccCCccEEEeec--cCCCCCc
Confidence 999999 99999999999999999999999998 59999999999999999888642 346999999 6666689
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCC--CceeccccCCCCCcccc
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICM 189 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~--~~W~d~~C~~~~~~iC~ 189 (573)
|+|+||++. .+..|..++|. .+.++|+.+...+ ..|++..|....+|||+
T Consensus 77 ~~W~dg~~~-~~~~W~~~~p~-----------~~~~~Cv~~~~~~~~~~W~~~~C~~~~~fICe 128 (129)
T cd03594 77 WEWSDGSKL-DYRSWDRNPPY-----------ARGGYCAELSRSTGFLKWNDANCEERNPFICK 128 (129)
T ss_pred eEeCCCCcc-eecccCCCCCC-----------CCCCCceEEEecCCCCeEECCCCCCCceeeee
Confidence 999999776 66667776652 2245677765433 36999999999999996
|
CLECT_REG-1_like: C-type lectin-like domain (CTLD) of the type found in Human REG-1 (lithostathine), REG-4, and avian eggshell-specific proteins: ansocalcin, structhiocalcin-1(SCA-1), and -2(SCA-2). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. REG-1 is a proliferating factor which participates in various kinds of tissue regeneration including pancreatic beta-cell regeneration, regeneration of intestinal mucosa, regeneration of motor neurons, and perhaps in tissue regeneration of damaged heart. REG-1 may play a role on the pathophysiology of Alzheimer's disease and in the development of gastric cancers. Its expression is correlated with reduced survival from early-stage colorectal cancer. REG-1 also binds and aggregates |
| >PHA03097 C-type lectin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=187.55 Aligned_cols=114 Identities=16% Similarity=0.408 Sum_probs=93.6
Q ss_pred CCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceE
Q 008216 50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWK 129 (573)
Q Consensus 50 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~ 129 (573)
...||.||. .|+++||+|+.+.++|.+|+.+|+++||+||+|+|++|++||.++.. ...|||||+ |.. .
T Consensus 43 ~~~CP~gW~--~~~~~CY~~s~~~~sW~~A~~~C~~~g~~La~I~~~~E~~fi~~~~~--~~~~WIGL~--d~~--~--- 111 (157)
T PHA03097 43 GLNCRSGWV--GYNNKCYTFSENITNKHLAIERCADMDGILTLIDDQKEVLFVSRYKG--GQDLWIGIE--KKK--G--- 111 (157)
T ss_pred CCCCCCCce--eeCCEEEEEecCCCcHHHHHHHHHhCCCEEeeeCCHHHHHHHHHhcC--CCCEEEeee--cCC--C---
Confidence 458999999 99999999999999999999999999999999999999999999876 457999999 543 2
Q ss_pred EcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccccc
Q 008216 130 WSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 130 W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
|+||++.. .+++. ..+.++|+.+... .|+|..|+....|||+++.
T Consensus 112 W~dgs~~~-~~~~~---------------~~~~e~Cv~i~~~--~w~d~~C~~~~~~ICek~~ 156 (157)
T PHA03097 112 DDDDREVL-DKVVK---------------PPKSGKCAYLKDK--TIISSNCNATKGWICFDRL 156 (157)
T ss_pred ccCCCccc-ccccC---------------CCCCCCEEEEECC--cEEeCCCCCCeeEEEeecC
Confidence 99997543 22221 0123567777553 5999999999999999863
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=209.12 Aligned_cols=261 Identities=17% Similarity=0.171 Sum_probs=194.4
Q ss_pred CcCCeeecccCceEEEEEEeCCC--CEEEEEEecccchhhHHHHHHHHHHHhhcCC----CcEeEEeeEE-eeCCceEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILPDG--SRVAVKRLKRSSFQRKKEFYSEIGRFARLHH----PNLVAVKGCC-YDHGDRYIV 343 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~l~~~~-~~~~~~~lv 343 (573)
+...+.||+|+||.||.+..... ..+|+|............+..|..++..+.. +++..+++.. ..+...++|
T Consensus 20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iV 99 (322)
T KOG1164|consen 20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIV 99 (322)
T ss_pred eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEE
Confidence 34566789999999999996553 4799998876533333367888988888863 6888998888 467778999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-----CCeeEecccC
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-----FGAHLMGVGL 418 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-----~~~kl~Dfg~ 418 (573)
|+.+ |.+|.++..... .+.++..+...|+.|++.+|++||+. |++||||||+|+++... ..+.|.|||+
T Consensus 100 M~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 100 MSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred Eecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 9988 899999876533 56799999999999999999999999 99999999999999754 3589999999
Q ss_pred CccCC--cccc----cc-c-eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhh
Q 008216 419 SKFVP--WEVM----QE-R-TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT 490 (573)
Q Consensus 419 ~~~~~--~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 490 (573)
++... .... .. . .....||.+|.++....+...+.+.|+||++.++.|+..|..||...........+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98322 2211 11 1 123349999999999999999999999999999999999999997655321111111000
Q ss_pred hhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 491 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
....... .....+..+.++...+-+.+..++|....+...|+....+
T Consensus 254 -------~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 254 -------RKLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred -------hhhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 0000000 1111234566677777778999999999999998776554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=197.42 Aligned_cols=257 Identities=16% Similarity=0.197 Sum_probs=197.9
Q ss_pred cCCeeecccCceEEEEEE-eCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 272 EGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
...+.||+|.||.++.|+ +-++++||||.-... .+..++..|.+..+.| ..++|...+-+..++.+..||+|.+ |
T Consensus 31 rVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 31 RVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred eeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 445567999999999999 558999999987654 3456788899988888 5799999998888888889999998 8
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-----CeeEecccCCccCCc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-----GAHLMGVGLSKFVPW 424 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-----~~kl~Dfg~~~~~~~ 424 (573)
.+|++++. -.++.++.+++..+|.|++.-++|+|++ .+|.|||||+|+||...+ .+.++|||+++....
T Consensus 108 PSLEDLFD---~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 108 PSLEDLFD---LCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred cCHHHHHH---HhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 99999886 3457799999999999999999999999 999999999999996543 489999999998765
Q ss_pred cccccce-----eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 425 EVMQERT-----VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 425 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
..+.... ....||.+||+--...+..-+.+.|+=|+|-++++.+-|..||++..........+.+....+.-.+.
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~ 261 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE 261 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence 5433222 22349999999999999999999999999999999999999999887654433333222111111111
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
+ ...+.+.++..-+.-.-..+-.+-|..+-+...+..+
T Consensus 262 ~-------------Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dv 299 (449)
T KOG1165|consen 262 V-------------LCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDV 299 (449)
T ss_pred H-------------HHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 1 1123455666666666667777888877666555443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-23 Score=207.38 Aligned_cols=162 Identities=15% Similarity=0.121 Sum_probs=123.6
Q ss_pred cCCCcCCeeecccCceEEEEEEeC--CCCEEEEEEeccc-----chhhHHHHHHHHHHHhhcCCCcEeE-EeeEEeeCCc
Q 008216 268 KNFSEGNRLLGDSKTGGTYSGILP--DGSRVAVKRLKRS-----SFQRKKEFYSEIGRFARLHHPNLVA-VKGCCYDHGD 339 (573)
Q Consensus 268 ~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~~~~~ 339 (573)
.+| ...+.||+|+||.||+|... +++.||||++... .....+.+.+|+++|++++|+|+++ +++ .+.
T Consensus 18 ~~Y-~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~ 92 (365)
T PRK09188 18 ARF-VETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGK 92 (365)
T ss_pred CCc-eEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCC
Confidence 344 44557799999999999864 5778899987533 1223567899999999999999985 443 256
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC-CCCCeeeCCCCCeeEecccC
Q 008216 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI-RASNVLLDEEFGAHLMGVGL 418 (573)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dl-kp~NIll~~~~~~kl~Dfg~ 418 (573)
.++||||++|++|.. +. . .. ...++.|+++||+|||++ ||+|||| ||+|||++.++.+||+|||+
T Consensus 93 ~~LVmE~~~G~~L~~-~~---~----~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 93 DGLVRGWTEGVPLHL-AR---P----HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred cEEEEEccCCCCHHH-hC---c----cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 799999999999963 21 1 11 146788999999999999 9999999 99999999999999999999
Q ss_pred CccCCccccccc------eeccCCcccccccccccC
Q 008216 419 SKFVPWEVMQER------TVMAGGTYGYLAPEFVYR 448 (573)
Q Consensus 419 ~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 448 (573)
++.......... .....+++.|+|||.+..
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 997654321111 122337888999998864
|
|
| >cd03591 CLECT_collectin_like C-type lectin-like domain (CTLD) of the type found in human collectins including lung surfactant proteins A and D, mannose- or mannan binding lectin (MBL), and CL-L1 (collectin liver 1) | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-23 Score=176.45 Aligned_cols=112 Identities=20% Similarity=0.275 Sum_probs=95.9
Q ss_pred eeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCCCCCcccc
Q 008216 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAV 144 (573)
Q Consensus 65 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dgt~~~~~~~~~~ 144 (573)
+||+++.+.++|.+|+.+|++.||+||+|+|.+|++||.+++......+||||+ +...++.|+|+||+++ .++.|.+
T Consensus 2 k~y~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~~~~~~~~w~dg~~~-~y~~W~~ 78 (114)
T cd03591 2 KIFVTNGEEKNFDDAQKLCSEAGGTLAMPRNAAENAAIASYVKKGNTYAFIGIT--DLETEGQFVYLDGGPL-TYTNWKP 78 (114)
T ss_pred cEEEeCCceeCHHHHHHHHhhcCCEEecCCCHHHHHHHHHHHhcCCccEEEecc--cCCcCCcEEeCCCCCc-ccCCcCC
Confidence 699999999999999999999999999999999999999999754567999999 6667899999999776 6676777
Q ss_pred CCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccc
Q 008216 145 GSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICM 189 (573)
Q Consensus 145 ~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~ 189 (573)
++|++.. +.++|+.+. .++.|++.+|....+|||+
T Consensus 79 ~ep~~~~---------~~~~Cv~~~-~~~~W~~~~C~~~~~fICe 113 (114)
T cd03591 79 GEPNNAG---------GGEDCVEMY-TSGKWNDVACNLTRLFVCE 113 (114)
T ss_pred CCCCCCC---------CCCCeEEEC-CCCcCcCccCCCCeeEEee
Confidence 7766532 245677776 4568999999999999997
|
CLECT_collectin_like: C-type lectin-like domain (CTLD) of the type found in human collectins including lung surfactant proteins A and D, mannose- or mannan binding lectin (MBL), and CL-L1 (collectin liver 1). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. The CTLDs of these collectins bind carbohydrates on surfaces (e.g. pathogens, allergens, necrotic, or apoptotic cells) and mediate functions associated with killing and phagocytosis. MBPs recognize high mannose oligosaccharides in a calcium dependent manner, bind to a broad range of pathogens, and trigger cell killing by activating the complement pathway. MBP also acts directly as an opsonin. SP-A and SP-D in addition to functioning as host defense components, a |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.4e-23 Score=186.06 Aligned_cols=257 Identities=17% Similarity=0.232 Sum_probs=191.9
Q ss_pred CcCCeeecccCceEEEEEE-eCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCC-CcEeEEeeEEeeCCceEEEEEecC
Q 008216 271 SEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
+...+.||+|+||.+|.|. ..+|+.||||+-+... ...++..|.++...|++ ..|..+..+..+.....+||+.+
T Consensus 17 y~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL- 93 (341)
T KOG1163|consen 17 YKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL- 93 (341)
T ss_pred eEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-
Confidence 3445567999999999998 5679999999876542 34567889999999965 77888888888888889999998
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC---CCeeEecccCCccCCcc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~ 425 (573)
|.+|++++.- ..+.++..+++-++-|++.-++|+|.+ +++||||||+|.|..-+ ..+.|+|||+|+...+.
T Consensus 94 GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 94 GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 8999998864 346699999999999999999999999 99999999999999643 45899999999876543
Q ss_pred cccc-----ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccc
Q 008216 426 VMQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500 (573)
Q Consensus 426 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (573)
.+.. ......||.+|.+--...+...+.+.|+=|+|.+|.++--|..||++.......+..+.... .+..-
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E----kK~s~ 243 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE----KKMST 243 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH----hhcCC
Confidence 2221 11223399999988887777788899999999999999999999998765433332222211 11111
Q ss_pred ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
.+ .....+.+.++.-.+.-|-..--++-|...-+.+.+.-
T Consensus 244 ~i---------e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 244 PI---------EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred CH---------HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 11 11122344566777777777777777777666655543
|
|
| >cd03601 CLECT_TC14_like C-type lectin-like domain (CTLD) of the type found in lectins TC14, TC14-2, TC14-3, and TC14-4 from the budding tunicate Polyandrocarpa misakiensis and PfG6 from the Acorn worm | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.7e-23 Score=176.03 Aligned_cols=113 Identities=19% Similarity=0.333 Sum_probs=88.9
Q ss_pred eEEecccCChHHHHHHHhhcCCeEeeeCCHHH--HHHHHHHhCCCCCCeEEeeeecCC-CCCCceEEcCCCCCC-CCCcc
Q 008216 67 FGYIGNFRSWDESETYCKEIGGHLAALTSYEE--EHSAQKLCGKNVNGCWVGGRSINT-TVGLSWKWSDNMSKW-NESIH 142 (573)
Q Consensus 67 y~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e--~~f~~~~~~~~~~~~WiGl~~~~~-~~~~~w~W~Dgt~~~-~~~~~ 142 (573)
|+|+.+.++|.+|+.+|+..||+||+|+|++| .++|..........+||||+ |. ..+|.|+|+||+++. .|+.|
T Consensus 3 ~~~~~~~~~w~~A~~~C~~~G~~La~i~s~~e~~~~~i~~~~~~~~~~~WIGl~--d~~~~~g~~~W~dG~~~~~~y~~W 80 (119)
T cd03601 3 ILCSDETMNYAKAGAFCRSRGMRLASLAMRDSEMRDAILAFTLVKGHGYWVGAD--NLQDGEYDFLWNDGVSLPTDSDLW 80 (119)
T ss_pred EEEcCCcCCHHHHHHHHHhcCCEEeeecCHHHHHHHHHHhccccCCccEEEEec--cCCCCCCCeEeCCCCCcCCCCCcc
Confidence 88999999999999999999999999999988 33333322111346999999 76 678999999998874 56778
Q ss_pred ccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccc
Q 008216 143 AVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (573)
Q Consensus 143 ~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~ 190 (573)
.+++|++. .+.++|+.+....+.|+|..|....+|||++
T Consensus 81 ~~geP~~~---------~~~e~Cv~~~~~~~~W~d~~C~~~~~fICek 119 (119)
T cd03601 81 APNEPSNP---------QSRQLCVQLWSKYNLLDDEYCGRAKRVICEK 119 (119)
T ss_pred CCCcCcCc---------CCCcCCeEEeCCCCCEeCccCCCCceeeecC
Confidence 77777653 2345677776555789999999999999974
|
CLECT_TC14_like: C-type lectin-like domain (CTLD) of the type found in lectins TC14, TC14-2, TC14-3, and TC14-4 from the budding tunicate Polyandrocarpa misakiensis and PfG6 from the Acorn worm. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. TC14 is homodimeric. The CTLD of TC14 binds D-galactose and D-fucose. TC14 is expressed constitutively by multipotent epithelial and mesenchymal cells and plays in role during budding, in inducing the aggregation of undifferentiated mesenchymal cells to give rise to epithelial forming tissue. TC14-2 and TC14-3 shows calcium-dependent galactose binding activity. TC14-3 is a cytostatic factor which blocks cell growth and dedifferentiation of the atrial epithelium during asexual reproducti |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-21 Score=194.74 Aligned_cols=258 Identities=27% Similarity=0.387 Sum_probs=193.5
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccchh---hHHHHHHHHHHHhhcCCC-cEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ---RKKEFYSEIGRFARLHHP-NLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+++.+.+......+++++++.+
T Consensus 5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 346799999999999985 88999999765332 367899999999999888 799999999777778999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-CeeEecccCCccCCccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~ 428 (573)
+++.+++...... ..+.......+..|++.++.|+|+. +++|||+||+||+++... .++++|||.+.........
T Consensus 83 ~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 83 GSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999777542211 3688999999999999999999999 999999999999999988 6999999999855443322
Q ss_pred c----ceeccCCcccccccccccC---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcc-cchhhHHhhhhhhhcccccc
Q 008216 429 E----RTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV-CWQSIFEWATPLVQSHRYLE 500 (573)
Q Consensus 429 ~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 500 (573)
. ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||...... ........... ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~----~~~~- 233 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE----LPTP- 233 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh----cCCc-
Confidence 1 1233449999999999987 57889999999999999999999997655431 00011110000 0000
Q ss_pred ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
...... ..... ......+.+++..++..+|..|.+..+....
T Consensus 234 ~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPL---SPSNP-ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccc---Ccccc-chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000 00000 2233568899999999999999998887764
|
|
| >cd03603 CLECT_VCBS A bacterial subgroup of the C-type lectin-like (CTLD) domain; a subgroup of bacterial protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=173.10 Aligned_cols=112 Identities=18% Similarity=0.356 Sum_probs=93.3
Q ss_pred eeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCCCCCcccc
Q 008216 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAV 144 (573)
Q Consensus 65 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dgt~~~~~~~~~~ 144 (573)
+||+|+.++++|.+|+..|++.||+||+|+|++|++||.+++. ....+||||+ +...++.|.|+||++ ..++.|..
T Consensus 1 ~~Y~~~~~~~sw~~A~~~C~~~g~~La~I~s~~E~~fv~~~~~-~~~~~WiG~~--~~~~~~~w~W~dg~~-~~~~~W~~ 76 (118)
T cd03603 1 HFYKFVDGGMTWEAAQTLAESLGGHLVTINSAEENDWLLSNFG-GYGASWIGAS--DAATEGTWKWSDGEE-STYTNWGS 76 (118)
T ss_pred CeEEEeCCCcCHHHHHHHHHHcCCEEcccCCHHHHHHHHHHhc-cCCCEEEeee--cCCCCCceEeCCCCc-CCCCCcCC
Confidence 6999999999999999999999999999999999999999986 3457999999 666679999999976 45666777
Q ss_pred CCC-CCCccCCCCcCCcccceeEEeec---CCCceeccccC-CCCCcccc
Q 008216 145 GSF-NSSCTSLPCHVHATVDLCTLVSN---GSRSLVTERCN-TSHPFICM 189 (573)
Q Consensus 145 ~~~-~~~~~~~p~~~~~~~~~C~~~~~---~~~~W~d~~C~-~~~~~iC~ 189 (573)
++| ++ ..+.++|+.+.. ..+.|+|..|+ ....|||.
T Consensus 77 ~eP~~~---------~~~~~~Cv~~~~~~~~~~~W~d~~C~~~~~~~iCe 117 (118)
T cd03603 77 GEPHNN---------GGGNEDYAAINHFPGISGKWNDLANSYNTLGYVIE 117 (118)
T ss_pred CCCCCC---------CCCCcCeEEeecCCCCCCcCccCCCCccccceEEe
Confidence 776 33 223456776654 35689999999 99999995
|
CLECT_VCBS: A bacterial subgroup of the C-type lectin-like (CTLD) domain; a subgroup of bacterial protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. Many CTLDs are calcium-dependent carbohydrate binding modules; other CTLDs bind protein ligands, lipids, and inorganic surfaces including CaCO3 and ice. Bacterial CTLDs within this group are functionally uncharacterized. Animal C-type lectins are involved in such functions as extracellular matrix organization, endocytosis, complement activation, pathogen recognition, and cell-cell interactions. CTLDs may bind a variety of carbohydrate ligands including mannose, N-acetylglucosamine, galactose, N-acetylgalactosamine, and fucose. CTLDs associate with each other through several different surface |
| >cd03598 CLECT_EMBP_like C-type lectin-like domain (CTLD) of the type found in the human proteins, eosinophil major basic protein (EMBP) and prepro major basic protein homolog (MBPH) | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=172.84 Aligned_cols=114 Identities=20% Similarity=0.462 Sum_probs=93.6
Q ss_pred CeeeEEecccCChHHHHHHHhh-cCCeEeeeCCHHHHHHHHHHhCCC-CCCeEEeeeecCCCCCCceEEcCCCCCCCCCc
Q 008216 64 SKCFGYIGNFRSWDESETYCKE-IGGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLSWKWSDNMSKWNESI 141 (573)
Q Consensus 64 ~~Cy~~~~~~~~w~~a~~~C~~-~~~~L~~i~~~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~w~W~Dgt~~~~~~~ 141 (573)
++||+|+.+.++|.||+..|++ .||+||+|+|++|++||.+++... ...+||||++.+...++.|.|+||++. .|..
T Consensus 1 ~~Cy~~~~~~~t~~~A~~~C~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~WiGl~~~~~~~~~~~~W~dg~~~-~y~~ 79 (117)
T cd03598 1 GRCYRFVKSPRTFRDAQVICRRCYRGNLASIHSFAFNYRVQRLVSTLNQAQVWIGGIITGKGRCRRFSWVDGSVW-NYAY 79 (117)
T ss_pred CceEEEecCCCCHHHHHHHhhcCCCceEeeecChhHhHHHHHHHhCCCCCCEEEeeEcCCCCcCCeeEeCCCCcc-CcCC
Confidence 5799999999999999999999 499999999999999999998643 457999999442256799999999765 4556
Q ss_pred cccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccc
Q 008216 142 HAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICM 189 (573)
Q Consensus 142 ~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~ 189 (573)
|.+++|++ +.+.|+.+....+.|++..|....+|||+
T Consensus 80 W~~g~p~~-----------~~~~Cv~~~~~~g~W~~~~C~~~~~fiC~ 116 (117)
T cd03598 80 WAPGQPGN-----------RRGHCVELCTRGGHWRRAHCKLRRPFICS 116 (117)
T ss_pred CCCCCCCC-----------CCCCcEEEeCCCCeECCCcCCCCceeeec
Confidence 77776554 23457777655568999999999999996
|
CLECT_EMBP_like: C-type lectin-like domain (CTLD) of the type found in the human proteins, eosinophil major basic protein (EMBP) and prepro major basic protein homolog (MBPH). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. Eosinophils and basophils carry out various functions in allergic, parasitic, and inflammatory diseases. EMBP is stored in eosinophil crystalloid granules and is released upon degranulation. EMBP is also expressed in basophils. The proform of EMBP is expressed in placental X cells and breast tissue and increases significantly during human pregnancy. EMBP has cytotoxic properties and damages bacteria and mammalian cells, in vitro, as well as, helminth parasites. EMBP deposition has been observed in the inflamed tissue of all |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-23 Score=225.15 Aligned_cols=256 Identities=18% Similarity=0.217 Sum_probs=185.8
Q ss_pred CCcCCeeecccCceEEEEEEe-CCCCEEEEEEec----c-cchhh-HHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEE
Q 008216 270 FSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLK----R-SSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342 (573)
Q Consensus 270 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~----~-~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 342 (573)
+.....++|.|++|.|+.... ...+..+.|... . ..... ...+..|+-+-..++|||++..+....+.....-
T Consensus 319 y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~ 398 (601)
T KOG0590|consen 319 YGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ 398 (601)
T ss_pred cCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh
Confidence 334566889999998877763 233434444332 1 11111 1226678888888999999888887777666666
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
.|||+++ +|..++.. ...++..++-.++.|++.|++|||+. |+.|||+||+|++++.++.+||+|||.+...
T Consensus 399 ~mE~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred hhhcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceee
Confidence 6999999 99998854 24688889999999999999999999 9999999999999999999999999999866
Q ss_pred Cccccc--cceeccCCcccccccccccCCCCCc-chhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 423 PWEVMQ--ERTVMAGGTYGYLAPEFVYRNELTT-KSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 423 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
...... .......|+..|+|||.+.+..|.+ ..||||.|+++..|.+|+.||........+. ..........
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~ 545 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRN 545 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccccc
Confidence 544332 2333445999999999999988875 6899999999999999999997544321110 0000000000
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
... .........+...+.+|.+||+.||.+|.|+++|++
T Consensus 546 ~~~-------~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 IFE-------GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccc-------ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000 011112345667889999999999999999999986
|
|
| >TIGR00864 PCC polycystin cation channel protein | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-22 Score=234.65 Aligned_cols=131 Identities=17% Similarity=0.342 Sum_probs=107.2
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhhc-CCeEeeeCCHHHHHHHHHHhCCC-CCCeEEeeeecCCCCCCc-
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLS- 127 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~~~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~- 127 (573)
..||+||..+.++++||+++.+.++|.||+.+|+++ |||||+|+|++|++||.+++... ...+||||+ |...+|.
T Consensus 316 ~~CP~GW~~f~~~g~CYk~~~e~~TW~dAe~~C~s~GGAhLAsI~S~eEn~FL~~lv~~s~~~~vWIGLs--D~~~EG~g 393 (2740)
T TIGR00864 316 PHCPKDGEIFEENGHCFQIVPEEAAWLDAQEQCLARAGAALAIVDNDALQNFLARKVTHSLDRGVWIGFS--DVNGAEKG 393 (2740)
T ss_pred CCCCCCCeecCCCCEEEEEeCCccCHHHHHHHhhccCCeEEecCCCHHHHHHHHHHhhccCCccEEEeee--CCCCCCce
Confidence 589999974466999999999999999999999999 69999999999999999988643 346999999 6666665
Q ss_pred -eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccccCC
Q 008216 128 -WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHEN 194 (573)
Q Consensus 128 -w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~~~ 194 (573)
|+|+|||++..|..|.+++|+|. +.++|+.+.. .+.|||..|....+|||++++..
T Consensus 394 ~WvWsDGS~l~~YtnW~pGEPNn~----------~~EdCV~l~~-~g~WND~~Cs~~~~FICE~~~~~ 450 (2740)
T TIGR00864 394 PAHQGEAFEAEECEEGLAGEPHPA----------RAEHCVRLDP-RGQCNSDLCNAPHAYVCELNPGG 450 (2740)
T ss_pred eeEECCCCcccCccCcCCCCCCCC----------CCCCCEEEcC-CCCEEccCCCCCeeEEeEECCCC
Confidence 99999988756667777776642 2356766643 35699999999999999876544
|
Note: this model has been restricted to the amino half because for technical reasons. |
| >PHA02867 C-type lectin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.7e-22 Score=176.50 Aligned_cols=113 Identities=19% Similarity=0.412 Sum_probs=91.1
Q ss_pred CCCCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCc
Q 008216 48 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 48 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~ 127 (573)
..+++||+||. .|+++||+|+.+.++|.+|+.+|.++||+||+|+|++|++|+.++.+ ..+||||+ +.. .
T Consensus 44 ~~~~~CP~gWi--~~~~~CY~fs~~~~tW~~A~~~C~~~ga~La~I~s~eE~~Fl~~~~~---~~~WIGLs--~~~---~ 113 (167)
T PHA02867 44 YFSKVCPDEWI--GYNSKCYYFTINETNWNDSKKLCDVMDSSLIRFDNIETLNFVSRYGK---GSYWIDIN--QNR---K 113 (167)
T ss_pred CcCCCCCCCCE--EECCEEEEEeccccCHHHHHHHHhhCCCEECCcCCHHHHHHHHHcCC---CCEEEEEE--eCC---C
Confidence 34468999999 99999999999999999999999999999999999999999998754 47999999 433 3
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccccc
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
|.|.+++.. .. ..+++.|+.+..+ ...+..|.....+||+++.
T Consensus 114 ~~~~~~s~~------~~--------------~~~~~~Ca~i~~~--~i~s~~C~~~~~wIC~K~~ 156 (167)
T PHA02867 114 IPGINFSLY------YE--------------QGVNDICLLFDTS--NIIEMSCIFHERTICVKED 156 (167)
T ss_pred CCCccCcee------ee--------------cCCCCcEEEEeCC--eEEeecccCCcEEEEEccC
Confidence 556555321 11 1123467777654 7899999999999999874
|
|
| >smart00034 CLECT C-type lectin (CTL) or carbohydrate-recognition domain (CRD) | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=170.86 Aligned_cols=122 Identities=26% Similarity=0.613 Sum_probs=102.5
Q ss_pred CCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCCceE
Q 008216 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGLSWK 129 (573)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~~w~ 129 (573)
||+||. .++++||+++.+.++|.+|+.+|+++||+||+|+|.+|++||.+++... ...+||||+ +...++.|+
T Consensus 1 Cp~~w~--~~~~~Cy~~~~~~~~~~~A~~~C~~~~~~La~i~~~~e~~~i~~~~~~~~~~~~~~WiG~~--~~~~~~~~~ 76 (126)
T smart00034 1 CPSGWI--SYGGKCYKFSTEKKTWADAQAFCQSLGAHLASIHSEAENDFVASLLKNSGSNSDYYWIGLS--DPDSNGSWQ 76 (126)
T ss_pred CCcchh--hhCCEEEEEECCccCHHHHHHHHHhcCCEEcccCCHHHHHHHHHHHHhhcCCCCCEEEecC--ccCcCCCeE
Confidence 999999 8999999999999999999999999999999999999999999998753 567999999 555668999
Q ss_pred EcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCC-CceeccccCCCCCcccc
Q 008216 130 WSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS-RSLVTERCNTSHPFICM 189 (573)
Q Consensus 130 W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~-~~W~d~~C~~~~~~iC~ 189 (573)
|+||++...+..|.++ ++ ....+.|+.+.... ..|.+.+|....+|||+
T Consensus 77 W~dg~~~~~~~~w~~~-~~----------~~~~~~C~~~~~~~~~~w~~~~C~~~~~~ICe 126 (126)
T smart00034 77 WSDGSGPVNYSNWAPG-EP----------NGGSGDCVVLSTSGGGKWNDVSCTSKLPFVCE 126 (126)
T ss_pred ECCCCCCCCccccCCC-CC----------CCCCCCCEEEecCCCCcccCCCCCCCcccccC
Confidence 9999775667777766 11 12344566666544 57999999999999995
|
Many of these domains function as calcium-dependent carbohydrate binding modules. |
| >cd03592 CLECT_selectins_like C-type lectin-like domain (CTLD) of the type found in the type 1 transmembrane proteins: P(platlet)-, E(endothelial)-, and L(leukocyte)- selectins (sels) | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=167.54 Aligned_cols=111 Identities=21% Similarity=0.349 Sum_probs=91.4
Q ss_pred eEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCC-CCCeEEeeeecCCCCCCceEEcCCCCCCCCCccccC
Q 008216 67 FGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVG 145 (573)
Q Consensus 67 y~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~w~W~Dgt~~~~~~~~~~~ 145 (573)
|+|+.+.++|.+|+.+|++.||+||+|+|++|++||.+++... ...+||||+ +...++.|.|+||++ ..+..|.++
T Consensus 3 Y~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~i~~~~~~~~~~~~WiG~~--~~~~~~~W~~~dg~~-~~y~~W~~g 79 (115)
T cd03592 3 YHYSTEKMTFNEAVKYCKSRGTDLVAIQNAEENALLNGFALKYNLGYYWIDGN--DINNEGTWVDTDKKE-LEYKNWAPG 79 (115)
T ss_pred EEEcCCccCHHHHHHHHHHcCCeEeecCCHHHHHHHHHHHHhcCCCCEEEeCc--cCCccCeEEeCCCCc-ccccccCCC
Confidence 8999999999999999999999999999999999999976533 447999999 666678999999976 456667667
Q ss_pred CCCCCccCCCCcCCcccceeEEeecC-CCceeccccCCCCCccccc
Q 008216 146 SFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMV 190 (573)
Q Consensus 146 ~~~~~~~~~p~~~~~~~~~C~~~~~~-~~~W~d~~C~~~~~~iC~~ 190 (573)
+|++. . .++|+.+... .+.|+|.+|....+|||++
T Consensus 80 eP~~~--------~--~~~Cv~~~~~~~g~W~d~~C~~~~~fICe~ 115 (115)
T cd03592 80 EPNNG--------R--NENCLEIYIKDNGKWNDEPCSKKKSAICYT 115 (115)
T ss_pred CCCCC--------C--CCCceEEccCCCCCCcCcCCCCCccceeCC
Confidence 66642 1 3457766543 5789999999999999974
|
CLECT_selectins_like: C-type lectin-like domain (CTLD) of the type found in the type 1 transmembrane proteins: P(platlet)-, E(endothelial)-, and L(leukocyte)- selectins (sels). CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. P- E- and L-sels are cell adhesion receptors that mediate the initial attachment, tethering, and rolling of lymphocytes on inflamed vascular walls enabling subsequent lymphocyte adhesion and transmigration. L- sel is expressed constitutively on most leukocytes. P-sel is stored in the Weibel-Palade bodies of endothelial cells and in the alpha granules of platlets. E- sels are present on endothelial cells. Following platelet and/or endothelial cell activation P- sel is rapidly translocated to the cell surface and E-sel exp |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=181.60 Aligned_cols=138 Identities=17% Similarity=0.164 Sum_probs=107.5
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEecccchh--h------------------------HHHHHHHHHHHhhcCCCcEe
Q 008216 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ--R------------------------KKEFYSEIGRFARLHHPNLV 328 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~nIv 328 (573)
..||+|++|.||+|...+|+.||||+++..... . .....+|+..+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 468999999999999888999999999754211 1 11224599999999877764
Q ss_pred EEeeEEeeCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEcCCCCCCeeeCC
Q 008216 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL-HDKVKPHVVHRDIRASNVLLDE 407 (573)
Q Consensus 329 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~iiH~Dlkp~NIll~~ 407 (573)
....+.. ...++||||++++++...... ...++...+..++.|++.+|.++ |+. +|+||||||+|||+++
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~~ 153 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYHD 153 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEEC
Confidence 4333222 234899999988877554321 24688999999999999999999 688 9999999999999984
Q ss_pred CCCeeEecccCCccC
Q 008216 408 EFGAHLMGVGLSKFV 422 (573)
Q Consensus 408 ~~~~kl~Dfg~~~~~ 422 (573)
+.++|+|||++...
T Consensus 154 -~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 -GKLYIIDVSQSVEH 167 (190)
T ss_pred -CcEEEEEccccccC
Confidence 68999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=184.14 Aligned_cols=174 Identities=10% Similarity=0.106 Sum_probs=133.8
Q ss_pred HHhhcCCCcCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHH---------HHHHHHHHHhhcCCCcEeEEeeEE
Q 008216 264 RSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKK---------EFYSEIGRFARLHHPNLVAVKGCC 334 (573)
Q Consensus 264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~h~nIv~l~~~~ 334 (573)
..+..+-+...+++|+|+||.||+... ++..+|||+++........ .+.+|+..+.+++||+|..+.+++
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 445556667778999999999999766 6779999999765322222 267899999999999999998886
Q ss_pred eeC--------CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC
Q 008216 335 YDH--------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406 (573)
Q Consensus 335 ~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~ 406 (573)
... +..+++|||++|.+|.++.. ++. ....+++.+|..+|+. |++|||+||+||+++
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~ 169 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS 169 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence 643 35789999999999988742 232 2456999999999999 999999999999999
Q ss_pred CCCCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHH
Q 008216 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468 (573)
Q Consensus 407 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 468 (573)
.++ ++|+|||.......+.... .+.....+..++|+||||+++..+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence 888 9999999887553221111 1233445667899999999887654
|
|
| >cd03602 CLECT_1 C-type lectin (CTL)/C-type lectin-like (CTLD) domain subgroup 1; a subgroup of protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-21 Score=162.99 Aligned_cols=108 Identities=21% Similarity=0.406 Sum_probs=90.0
Q ss_pred eeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCCCCCcccc
Q 008216 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAV 144 (573)
Q Consensus 65 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dgt~~~~~~~~~~ 144 (573)
+||+++.++++|.+|+.+|+..||+||+|+|++|++||.+++......+||||+ +. ++.|.|+||++ ..+..|.+
T Consensus 1 ~~y~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~--~~~~~W~dg~~-~~~~~w~~ 75 (108)
T cd03602 1 RTFYLVNESKTWSEAQQYCRENYTDLATVQNQEDNALLSNLSRVSNSAAWIGLY--RD--VDSWRWSDGSE-SSFRNWNT 75 (108)
T ss_pred CceEEeccccCHHHHHHHHHHHCCccCeecCHHHHHHHHHHHhccCCcEEEEEE--CC--CCceEEcCCCC-CccCccCC
Confidence 489999999999999999999999999999999999999998633567999999 44 68999999976 45666766
Q ss_pred CCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccc
Q 008216 145 GSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (573)
Q Consensus 145 ~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~ 190 (573)
++|+ ++++|+.+... +.|++..|....+|||++
T Consensus 76 ~~~~------------~~~~C~~~~~~-~~w~~~~C~~~~~fIC~~ 108 (108)
T cd03602 76 FQPF------------GQGDCATMYSS-GRWYAALCSALKPFICYD 108 (108)
T ss_pred CCCC------------CCCCeeEECcC-CeECcccCCCCcCEeccC
Confidence 6522 23467777654 689999999999999974
|
CLECT_1: C-type lectin (CTL)/C-type lectin-like (CTLD) domain subgroup 1; a subgroup of protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. Many CTLDs are calcium-dependent carbohydrate binding modules; other CTLDs bind protein ligands, lipids, and inorganic surfaces including CaCO3 and ice. Animal C-type lectins are involved in such functions as extracellular matrix organization, endocytosis, complement activation, pathogen recognition, and cell-cell interactions. CTLDs may bind a variety of carbohydrate ligands including mannose, N-acetylglucosamine, galactose, N-acetylgalactosamine, and fucose. CTLDs associate with each other through several different surfaces to form dimers, trimers, or tetramers from which ligand-binding sites project in differe |
| >cd03600 CLECT_thrombomodulin_like C-type lectin-like domain (CTLD) of the type found in human thrombomodulin(TM), Endosialin, C14orf27, and C1qR | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-21 Score=169.43 Aligned_cols=119 Identities=18% Similarity=0.305 Sum_probs=93.9
Q ss_pred CCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCC-------CCCeEEeeeecCC------CCCCce
Q 008216 62 EKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN-------VNGCWVGGRSINT------TVGLSW 128 (573)
Q Consensus 62 ~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~-------~~~~WiGl~~~~~------~~~~~w 128 (573)
.+++||+++.+.++|.+|+.+|++.|||||+|+|.+|++||+.++... ...+||||++... ..++.|
T Consensus 2 ~~~~Cy~~~~~~~sw~~A~~~C~~~gg~La~i~s~~E~~~v~~~l~~~~~~~~~~~~~~WIGl~~~~~~~~~~~~~~~~f 81 (141)
T cd03600 2 VSDACYTLHPQKLTFLEAQRSCIELGGNLATVRSGEEADVVSLLLAAGPGRHGRGSLRLWIGLQREPRQCSDPSLPLRGF 81 (141)
T ss_pred CCCceEEEeCCccCHHHHHHHHHhhCCEeeecCCHHHHHHHHHHHhhccccccCCCccEEEeEecCcccCccccccCCcc
Confidence 467899999999999999999999999999999999999999988653 3469999994211 234789
Q ss_pred EEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecC-----CCceeccccCCC-CCccccc
Q 008216 129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-----SRSLVTERCNTS-HPFICMV 190 (573)
Q Consensus 129 ~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~-----~~~W~d~~C~~~-~~~iC~~ 190 (573)
.|+||+....|+.|.++ |++.+. .++|+.+... ...|+|..|+.. .+|||+.
T Consensus 82 ~W~d~~~~~~y~~W~~~-p~n~~~---------~~~Cv~l~~~~~~~~~~~W~d~~C~~~~~~fIC~~ 139 (141)
T cd03600 82 SWVTGDQDTDFSNWLQE-PAGTCT---------SPRCVALSAAGSTPDNLKWKDGPCSARADGYLCKF 139 (141)
T ss_pred EECCCCCCCCccccccC-CCCCCC---------CCccEEEEccCCCCCCCccccCCcCCCCCCeEEee
Confidence 99998666667788877 454332 3456666543 357999999998 4799985
|
CLECT_thrombomodulin_like: C-type lectin-like domain (CTLD) of the type found in human thrombomodulin(TM), Endosialin, C14orf27, and C1qR. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. In these thrombomodulin-like proteins the residues involved in coordinating Ca2+ in the classical MBP-A CTLD are not conserved. TM exerts anti-fibrinolytic and anti-inflammatory activity. TM also regulates blood coagulation in the anticoagulant protein C pathway. In this pathway, the procoagulant properties of thrombin (T) are lost when it binds TM. TM also plays a key role in tumor biology. It is expressed on endothelial cells and on several type of tumor cell including squamous cell carcinoma. Loss of TM expression correlates with advanced stage and poor prognosis. Loss of function of TM func |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.3e-22 Score=213.45 Aligned_cols=262 Identities=22% Similarity=0.250 Sum_probs=183.3
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccc-hhhHHHHH---HHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS-FQRKKEFY---SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||++.|=.|.+++.++|. |+||++-+.. .-....+. .|++ ...++|||.+++.-+.....-.|||=+|..
T Consensus 28 ~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvk- 104 (1431)
T KOG1240|consen 28 VENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVK- 104 (1431)
T ss_pred ecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHh-
Confidence 345799999999999997887 9999986543 23333343 4444 445599999999887777777788889884
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC--Ccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV--PWEVM 427 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~--~~~~~ 427 (573)
.+|.|.+.. +.-+...+.+.|+.|++.||..+|.. ||+|||||.+||||+.-..+.|+||..-+.. +.+..
T Consensus 105 hnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 105 HNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred hhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 488888853 34577888899999999999999999 9999999999999999999999999876532 22222
Q ss_pred ccceec---cCCcccccccccccC----------CC-CCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhh
Q 008216 428 QERTVM---AGGTYGYLAPEFVYR----------NE-LTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPL 492 (573)
Q Consensus 428 ~~~~~~---~~gt~~y~aPE~~~~----------~~-~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 492 (573)
...... ...-..|+|||.+.. .+ .+++.||||+||++.||++ |++||.-. ++......
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr~~- 250 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYRSG- 250 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHhcc-
Confidence 211111 112346999998753 12 6789999999999999999 78887532 11111110
Q ss_pred hhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC-Cchhhhhhhhhc
Q 008216 493 VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP-PVTKLLFKGLDR 565 (573)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~-~~~~~~~~~~~~ 565 (573)
. .......+. .+ ....+++++..|++.||++|.++++.|+.-....=| .....+++.++.
T Consensus 251 ----~-~~~~e~~Le----~I----ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yFy~FL~~Y~~~ 311 (1431)
T KOG1240|consen 251 ----N-ADDPEQLLE----KI----EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYFYSFLYDYLDR 311 (1431)
T ss_pred ----C-ccCHHHHHH----hC----cCccHHHHHHHHHccCchhccCHHHHHHhhhccccHHHHHHHHHHHHHh
Confidence 0 011111111 11 112588999999999999999999999886655433 333444444433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=195.39 Aligned_cols=231 Identities=23% Similarity=0.374 Sum_probs=172.1
Q ss_pred HhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EEcC
Q 008216 319 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV-VHRD 397 (573)
Q Consensus 319 l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i-iH~D 397 (573)
|+.+.|.|+.+++|.+.+++..++|.+|+..|+|.+.+.. ....+++.....++++|+.||+|||+. .| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 4578999999999999999999999999999999999975 346688999999999999999999987 44 9999
Q ss_pred CCCCCeeeCCCCCeeEecccCCccCCccccccceeccCCcccccccccccCC-------CCCcchhhHHHHHHHHHHHcC
Q 008216 398 IRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-------ELTTKSDVYSFGVLLLEIVSG 470 (573)
Q Consensus 398 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~elltG 470 (573)
+++.|+++|....+||+|||+....................-|.|||.+.+. ..+.++||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999999877431111111111134569999998763 146789999999999999999
Q ss_pred CCCCCCCCcccch-hhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q 008216 471 RRPAQAVDSVCWQ-SIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549 (573)
Q Consensus 471 ~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 549 (573)
+.||......... .++..... .....+.|.+.. ..+..+.+..++.+||..+|.+||++++|-..++.
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~------~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~ 223 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIEL------LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT 223 (484)
T ss_pred cCccccccccCChHHHHHHHHh-----cCCCCcCcchhh------hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence 9999874432211 11111111 111222222211 11344579999999999999999999999999988
Q ss_pred ccCC-----Cchhhhhhhhhcc
Q 008216 550 LAQP-----PVTKLLFKGLDRL 566 (573)
Q Consensus 550 ~~~~-----~~~~~~~~~~~~~ 566 (573)
+... ...+..+..++++
T Consensus 224 ~~~~~~~~~nl~D~m~~~le~Y 245 (484)
T KOG1023|consen 224 INKGGSSKGNLMDSLFRMLESY 245 (484)
T ss_pred hcccccccchhHHHHHHHHHHH
Confidence 8774 3345555555543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=174.25 Aligned_cols=139 Identities=17% Similarity=0.171 Sum_probs=110.2
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEecccchh---------------------h-----HHHHHHHHHHHhhcCCCcEe
Q 008216 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ---------------------R-----KKEFYSEIGRFARLHHPNLV 328 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~nIv 328 (573)
..||+|++|.||+|...+|+.||||+++..... . ...+..|...+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 468999999999999878999999998764211 0 12235789999999999875
Q ss_pred EEeeEEeeCCceEEEEEecCCCCHHHH-hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeC
Q 008216 329 AVKGCCYDHGDRYIVYEFVVNGPLDRW-LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLD 406 (573)
Q Consensus 329 ~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~ 406 (573)
....+... ..++||||++++++... +. ...++......++.|++.+|.++|+ . ||+||||||+||+++
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 44433332 34899999988755433 32 2357788899999999999999999 8 999999999999999
Q ss_pred CCCCeeEecccCCccCCc
Q 008216 407 EEFGAHLMGVGLSKFVPW 424 (573)
Q Consensus 407 ~~~~~kl~Dfg~~~~~~~ 424 (573)
++.++|+|||++.....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 78999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd03595 CLECT_chondrolectin_like C-type lectin-like domain (CTLD) of the type found in the human type-1A transmembrane proteins chondrolectin (CHODL) and layilin | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.2e-20 Score=166.16 Aligned_cols=115 Identities=18% Similarity=0.379 Sum_probs=89.8
Q ss_pred CCCCeeeEEe-----cccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCC--------
Q 008216 61 EEKSKCFGYI-----GNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTV-------- 124 (573)
Q Consensus 61 ~~~~~Cy~~~-----~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~-------- 124 (573)
.|+++||+++ .+.+||.+|+..|+..||+||+|+|++|++||..+++.. ...+||||+ +...
T Consensus 7 ~~~~~Cy~~~~~~~~~~~~tw~~A~~~C~~~g~~LasI~s~~E~~~i~~~i~~~~~~~~~~WIGl~--~~~~~~~~~~~~ 84 (149)
T cd03595 7 GTEKPCYKIAYFQDSRRRLNFEEARQACREDGGELLSIESENEQKLIERFIQTLRASDGDFWIGLR--RSSQYNVTSSAC 84 (149)
T ss_pred CCCCccEEEEEEeccccccCHHHHHHHHHHcCCEECccCCHHHHHHHHHHHHhhcCCCCcEEEEeE--CCCCcccccccc
Confidence 4668999964 779999999999999999999999999999999887532 457999999 4433
Q ss_pred CCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecC-----------CCceeccccCCCCCcccc
Q 008216 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-----------SRSLVTERCNTSHPFICM 189 (573)
Q Consensus 125 ~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~-----------~~~W~d~~C~~~~~~iC~ 189 (573)
++.|.|+||+++ .+..|.+++|++ +.++|+.+... ...|+|..|....+|||+
T Consensus 85 ~~~~~W~dG~~~-~y~~W~~~eP~~-----------~~~~Cv~l~~~~~~~~~~~~~~~~~W~d~~C~~~~~fICe 148 (149)
T cd03595 85 SSLYYWLDGSIS-TFRNWYVDEPSC-----------GSEVCVVMYHQPSAPAGQGGPYLFQWNDDNCNMKNNFICK 148 (149)
T ss_pred CCccEEcCCCcc-CccCCCCCCCCC-----------cccCCEEEEecCCCCcCcCcccCCCccCCCCCCCcccccC
Confidence 256999999765 455677676553 12456655431 237999999999999997
|
CLECT_chondrolectin_like: C-type lectin-like domain (CTLD) of the type found in the human type-1A transmembrane proteins chondrolectin (CHODL) and layilin. CTLD refers to a domain homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. CHODL is predominantly expressed in muscle cells and is associated with T-cell maturation. Various alternatively spliced isoforms have been of CHODL have been identified. The transmembrane form of CHODL is localized in the ER-Golgi apparatus. Layilin is widely expressed in different cell types. The extracellular CTLD of layilin binds hyaluronan (HA), a major constituent of the extracellular matrix (ECM). The cytoplasmic tail of layilin binds various members of the band 4.1/ERM superfamily (talin, radixin, and merlin). The ERM proteins are cytoskeleton-membrane l |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.9e-20 Score=180.01 Aligned_cols=231 Identities=18% Similarity=0.180 Sum_probs=147.5
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCC----------CcEeEEeeEEee--
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHH----------PNLVAVKGCCYD-- 336 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~nIv~l~~~~~~-- 336 (573)
...+||.|+++.||.+++. +|+++|||++.... ....+++.+|.-....+.+ -.++..++...-
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 3457899999999999975 48999999985432 2334566666655444322 122222222221
Q ss_pred -------C---C-----ceEEEEEecCCCCHHHHhcc---CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC
Q 008216 337 -------H---G-----DRYIVYEFVVNGPLDRWLHH---IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398 (573)
Q Consensus 337 -------~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dl 398 (573)
. + ..+++|+-+ .+||.+++.. .......+....++.+..|+++.+++||+. |++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence 1 1 236788877 6688887542 122223344555677789999999999999 9999999
Q ss_pred CCCCeeeCCCCCeeEecccCCccCCccccccceeccCCcccccccccccC--------CCCCcchhhHHHHHHHHHHHcC
Q 008216 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR--------NELTTKSDVYSFGVLLLEIVSG 470 (573)
Q Consensus 399 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~elltG 470 (573)
+|+|++++.+|.+.|+||+........... ...+..|.|||.... -.++.+.|.|++|+++|.|++|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999877655432221 115577999997643 2468899999999999999999
Q ss_pred CCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCC
Q 008216 471 RRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMR 537 (573)
Q Consensus 471 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 537 (573)
..||........... .. ... . +.++.+..||..+|+.||.+|
T Consensus 247 ~lPf~~~~~~~~~~~-------------------~f----~~C-~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW-------------------DF----SRC-R-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG-------------------GG----TTS-S----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc-------------------cc----hhc-C-CcCHHHHHHHHHHccCCcccC
Confidence 999987644211100 11 111 1 567889999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.7e-21 Score=198.42 Aligned_cols=224 Identities=25% Similarity=0.287 Sum_probs=180.0
Q ss_pred ecccCceEEEEEE----eCCCCEEEEEEecccchhh--HHHHHHHHHHHhhcC-CCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 277 LGDSKTGGTYSGI----LPDGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 277 lg~G~~g~Vy~~~----~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
+|+|.||.|+++. .+.|.-+|.|++++..... ......|-.++...+ ||.++++.-.+..++..++++++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6999999999765 3457889999987653211 124456778888886 99999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|...+.. ...+.+.....+...++-+++++|+. +++|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 82 g~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 82 GDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred chhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999877743 34577888888999999999999999 9999999999999999999999999999876443332
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
+||..|||||++. ....++|-||||++++||+||..||.... .. .++..
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~----------~~-------------~Il~~- 202 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT----------MK-------------RILKA- 202 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH----------HH-------------HHhhh-
Confidence 5999999999987 56778999999999999999999998610 00 00000
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCH
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRM 540 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 540 (573)
....+......+.+++..++..+|..|--.
T Consensus 203 -~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 203 -ELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -ccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 122345667788999999999999999755
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.4e-19 Score=164.72 Aligned_cols=186 Identities=12% Similarity=0.020 Sum_probs=139.0
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccchh----hHHHHHHHHHHHhhcC-CCcEeEEeeEEeeCCceEEEEEecC
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ----RKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
...|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|++|. |+++++++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 34689999999997776 7888998888765331 1235789999999994 5889999886 45699999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC-CCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI-RASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dl-kp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
|.+|...+.. ....++.|++.+|+++|++ ||+|||| ||+|||++.++.++|+|||++........
T Consensus 82 G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 82 GAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred CccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9998654311 1135778999999999999 9999999 79999999999999999999986543321
Q ss_pred c----cc-------eeccCCcccccccccccCC-CCC-cchhhHHHHHHHHHHHcCCCCCCCCC
Q 008216 428 Q----ER-------TVMAGGTYGYLAPEFVYRN-ELT-TKSDVYSFGVLLLEIVSGRRPAQAVD 478 (573)
Q Consensus 428 ~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlGvil~elltG~~Pf~~~~ 478 (573)
. .. ......++.|++|+...-. ..+ ...+-++-|.-+|.++|+..++....
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 00 0111256777777744321 233 46788899999999999998865543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.2e-19 Score=167.35 Aligned_cols=134 Identities=16% Similarity=0.213 Sum_probs=105.3
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-----CCCcEeEEeeEEeeCC---ceE-EEE
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-----HHPNLVAVKGCCYDHG---DRY-IVY 344 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~---~~~-lv~ 344 (573)
..+||+|++|.||. .-.++.. +||++........+.+.+|+.+++.+ .||||++++|+++++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 45789999999996 3234444 79998765445567899999999999 5799999999998873 333 789
Q ss_pred Ee--cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEEcCCCCCCeeeCC----CCCeeEeccc
Q 008216 345 EF--VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI-AFLHDKVKPHVVHRDIRASNVLLDE----EFGAHLMGVG 417 (573)
Q Consensus 345 e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~Dfg 417 (573)
|| +.+++|.+++.+ ..+++. ..++.|++.++ +|||++ +|+||||||+|||++. +..++|+||+
T Consensus 85 e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 85 DFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred cCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 99 557999999964 225554 35678888887 999999 9999999999999974 3479999955
Q ss_pred CC
Q 008216 418 LS 419 (573)
Q Consensus 418 ~~ 419 (573)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.5e-19 Score=194.15 Aligned_cols=248 Identities=16% Similarity=0.162 Sum_probs=176.4
Q ss_pred CCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC---CCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
..+.+|+|+||.||+|...+|+.||+|+-+....-+ |.-=.+++.+|+ -+-|..+...+.-.+..+||+||.+.
T Consensus 702 I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~ 778 (974)
T KOG1166|consen 702 ISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPY 778 (974)
T ss_pred EEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccc
Confidence 345689999999999998889999999987653211 111223333443 23444555555666778999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC-------CCCCeeEecccCCccC
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-------EEFGAHLMGVGLSKFV 422 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~-------~~~~~kl~Dfg~~~~~ 422 (573)
|+|.+++. ..+.+++..++.++.|++..++.||.. +|||+||||+|.||. +...++|+|||.+..+
T Consensus 779 Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 779 GTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred ccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 99999996 467799999999999999999999999 999999999999994 2345899999999766
Q ss_pred CccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccc
Q 008216 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502 (573)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (573)
..-.....-....+|-.+-.+|+..|.+++...|.|.|.-+++-|+.|+.-- . ..+......
T Consensus 852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-~-----------------~~g~~~~~~ 913 (974)
T KOG1166|consen 852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-V-----------------KNGSSWMVK 913 (974)
T ss_pred eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-h-----------------cCCcceecc
Confidence 4333222333344888999999999999999999999999999999997531 0 011111100
Q ss_pred ccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCch
Q 008216 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVT 556 (573)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 556 (573)
.. + +..... +-..+++..+|+.|-..=|...++...+++......+
T Consensus 914 ~~-~----~Ry~~~---~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~ 959 (974)
T KOG1166|consen 914 TN-F----PRYWKR---DMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFT 959 (974)
T ss_pred cc-c----hhhhhH---HHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHH
Confidence 00 0 011111 2244666677775555557888888887776655444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=169.31 Aligned_cols=197 Identities=22% Similarity=0.317 Sum_probs=140.5
Q ss_pred CCCcEeEEeeEEeeC---------------------------CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHH
Q 008216 323 HHPNLVAVKGCCYDH---------------------------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVA 375 (573)
Q Consensus 323 ~h~nIv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 375 (573)
+|||||++.++|.++ ...|+||..+ ..+|.+++-. ...+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc-----CCCchHHHHHHH
Confidence 599999999988642 2358999988 4589999864 346677778899
Q ss_pred HHHHHHHHHHHhCCCCCeEEcCCCCCCeee--CCCC--CeeEecccCCccCCcc----ccccceeccCCccccccccccc
Q 008216 376 TTLAQGIAFLHDKVKPHVVHRDIRASNVLL--DEEF--GAHLMGVGLSKFVPWE----VMQERTVMAGGTYGYLAPEFVY 447 (573)
Q Consensus 376 ~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll--~~~~--~~kl~Dfg~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~ 447 (573)
.|+++|+.|||.+ ||.|||+|.+|||+ |+|. ...++|||.+-..+.. ..........|...-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 99999999999999 3443 3689999987543321 1111222334788899999876
Q ss_pred CCC------CCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHH
Q 008216 448 RNE------LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQK 521 (573)
Q Consensus 448 ~~~------~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (573)
..+ --.|+|.|+.|.+.||+++...||....+... +...+.+ ..+.. .+..+++.
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-----------~~r~Yqe---~qLPa-----lp~~vpp~ 485 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-----------DTRTYQE---SQLPA-----LPSRVPPV 485 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-----------chhhhhh---hhCCC-----CcccCChH
Confidence 422 12589999999999999999999987332211 1111111 11111 12234567
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008216 522 VVDLVYACTQHVPSMRPRMSHVVHQL 547 (573)
Q Consensus 522 l~~li~~cl~~dP~~RPs~~evl~~L 547 (573)
+.+++...|+.||++|++..-....|
T Consensus 486 ~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 486 ARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHHHHhcCCccccCCccHHHhHH
Confidence 89999999999999999987665554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.4e-17 Score=160.82 Aligned_cols=140 Identities=16% Similarity=0.146 Sum_probs=109.4
Q ss_pred CcCCeeecccCceEEEEEE--eCCCCEEEEEEecccchh------------------------hHHHHHHHHHHHhhcCC
Q 008216 271 SEGNRLLGDSKTGGTYSGI--LPDGSRVAVKRLKRSSFQ------------------------RKKEFYSEIGRFARLHH 324 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~h 324 (573)
+...+.||+|++|.||+|. ..+|+.||||+++..... ....+..|+..+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4556678999999999998 568999999998754210 11235689999999975
Q ss_pred C--cEeEEeeEEeeCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEcCCCCC
Q 008216 325 P--NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH-VVHRDIRAS 401 (573)
Q Consensus 325 ~--nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-iiH~Dlkp~ 401 (573)
. .++++++. ...++||||+++.+|...... ...+.......++.|++.+|++||++ + ++||||||+
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 3 34455543 235899999999888665421 23456667789999999999999999 9 999999999
Q ss_pred CeeeCCCCCeeEecccCCccC
Q 008216 402 NVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 402 NIll~~~~~~kl~Dfg~~~~~ 422 (573)
||+++ ++.++|+|||.+...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 788999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=158.63 Aligned_cols=133 Identities=19% Similarity=0.300 Sum_probs=113.0
Q ss_pred eecccCceEEEEEEeCCCCEEEEEEecccch--------hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
.||+|++|.||+|.. +|..+++|+...... .....+.+|+.++..+.|++|.....++.+.+..+++|||+
T Consensus 3 ~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 3 LIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred ccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 579999999999988 788899998754321 11245788999999999999887777777778889999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCcc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 421 (573)
+|++|.+++... .. .+..++.+++.+|.++|+. +++|||++|+|||++ ++.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999988531 12 7788999999999999999 999999999999999 77899999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=157.46 Aligned_cols=131 Identities=20% Similarity=0.299 Sum_probs=107.2
Q ss_pred eecccCceEEEEEEeCCCCEEEEEEecccch--------hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
+||+|++|.||+|.+ +|..|++|+...... ....++.+|++++..++|+++.....+....+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999996 788999998654311 11356778999999998887655555556667789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
+|++|.+++... . . .++.+++.+|.+||+. +++|||++|+||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~----~-~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEG----N-D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhc----H-H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999887531 1 0 7899999999999999 999999999999999 789999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.3e-18 Score=174.60 Aligned_cols=174 Identities=19% Similarity=0.329 Sum_probs=128.4
Q ss_pred ceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccC
Q 008216 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (573)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 418 (573)
..|+.|++|...+|.++|... ......++...+.++.|++.|++| + +.+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 468999999999999999753 334557788899999999999999 6 999999999999999999999999999
Q ss_pred CccCCccc----cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhh
Q 008216 419 SKFVPWEV----MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493 (573)
Q Consensus 419 ~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 493 (573)
........ .........||..||+||.+.+..|+.|+||||||+||+|+++ -..++....
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~--------------- 467 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA--------------- 467 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH---------------
Confidence 88765544 1112223349999999999999999999999999999999998 222222111
Q ss_pred hccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 008216 494 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSH 542 (573)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 542 (573)
...++-+..+. .... ...+.-..|+.+++...|.+||++.+
T Consensus 468 ---t~~d~r~g~ip----~~~~-~d~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 468 ---TLTDIRDGIIP----PEFL-QDYPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred ---hhhhhhcCCCC----hHHh-hcCcHHHHHHHHhcCCCcccCchHHH
Confidence 01111111110 0000 11123457999999999999995443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.5e-17 Score=151.90 Aligned_cols=137 Identities=16% Similarity=0.144 Sum_probs=107.6
Q ss_pred CcCCeeecccCceEEEEEEeCCCCEEEEEEecccch----------------------hhHHHHHHHHHHHhhcCCCc--
Q 008216 271 SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF----------------------QRKKEFYSEIGRFARLHHPN-- 326 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~n-- 326 (573)
+...+.||+|++|.||++..++|+.||||+++.... ........|+.++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 444567899999999999988899999998764320 01123677899999997774
Q ss_pred EeEEeeEEeeCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC
Q 008216 327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406 (573)
Q Consensus 327 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~ 406 (573)
+++.++ ....++||||+++++|.+.... .....++.+++.++.++|+. +++||||||+||+++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~ 159 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVD 159 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEc
Confidence 444443 2456899999999998765420 23457889999999999999 999999999999999
Q ss_pred CCCCeeEecccCCccCCc
Q 008216 407 EEFGAHLMGVGLSKFVPW 424 (573)
Q Consensus 407 ~~~~~kl~Dfg~~~~~~~ 424 (573)
+++.++|+|||.+.....
T Consensus 160 ~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 160 DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcEEEEECCccccCCC
Confidence 999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=172.77 Aligned_cols=133 Identities=18% Similarity=0.240 Sum_probs=108.6
Q ss_pred CCeeecccCceEEEEEEeCCCCEEEEEEe-ccc-c------hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEE
Q 008216 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRL-KRS-S------FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~-~~~-~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 344 (573)
..++||+|+||.||+|.+.. ..+++|+. .+. . ....+.+.+|++++..++|++++....+..+....++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 35678999999999998744 44444433 211 1 112356889999999999999998887777777889999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
||+++++|.+++. ....++.+++.+|.+||+. +++||||||+|||+ .++.++|+|||+++..
T Consensus 416 E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 416 EYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999874 3467899999999999999 99999999999999 5678999999999753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.7e-17 Score=173.77 Aligned_cols=208 Identities=21% Similarity=0.274 Sum_probs=140.6
Q ss_pred cCCCcCCeeecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 268 KNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 268 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
.+|.. .+++..|+||.||..+++. .+.+|+|+=+... +.+- ++.....|.+|
T Consensus 83 ~df~~-IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 83 SDFNT-IKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred cccce-eEeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCccee------------------
Confidence 34444 5688999999999998653 6678884332221 1110 22222333333
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
|+-...+.. -+.++.. ++.+++|||+. +|+|||+||+|.+|+.-|.+|+.|||+++......
T Consensus 136 ---gDc~tllk~----~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLKN----IGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhccc----CCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 344444432 2234332 27889999999 99999999999999999999999999987542111
Q ss_pred c------------c-cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhh
Q 008216 427 M------------Q-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV 493 (573)
Q Consensus 427 ~------------~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 493 (573)
. . -.....+||+.|+|||++....|+..+|-|++|+|+||.+-|..||.+..+++.-..+-..
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd---- 273 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD---- 273 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh----
Confidence 0 0 0112335999999999999999999999999999999999999999988665322111100
Q ss_pred hccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCC
Q 008216 494 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538 (573)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 538 (573)
...+.+- ......++.+++.++|+.+|..|-
T Consensus 274 -~i~wpE~-------------dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 274 -DIEWPEE-------------DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred -hcccccc-------------CcCCCHHHHHHHHHHHHhChHhhc
Confidence 0000010 122346789999999999999995
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.6e-15 Score=146.92 Aligned_cols=136 Identities=21% Similarity=0.221 Sum_probs=106.8
Q ss_pred Ceeec-ccCceEEEEEEeCCCCEEEEEEecccc-------------hhhHHHHHHHHHHHhhcCCCcE--eEEeeEEeeC
Q 008216 274 NRLLG-DSKTGGTYSGILPDGSRVAVKRLKRSS-------------FQRKKEFYSEIGRFARLHHPNL--VAVKGCCYDH 337 (573)
Q Consensus 274 ~~~lg-~G~~g~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~ 337 (573)
..+|| .|+.|+||.+.. ++..++||.+.... ......+.+|+.++.+|+|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45678 899999999988 57889999885421 1223567889999999988775 6777765433
Q ss_pred Cc----eEEEEEecCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCee
Q 008216 338 GD----RYIVYEFVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412 (573)
Q Consensus 338 ~~----~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 412 (573)
.. .++|||+++| .+|.+++.. ..++.. .+.+++.+|.+||++ ||+||||||+|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 22 2599999997 699988753 234443 357899999999999 999999999999999888999
Q ss_pred EecccCCccC
Q 008216 413 LMGVGLSKFV 422 (573)
Q Consensus 413 l~Dfg~~~~~ 422 (573)
|+|||.+...
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999988753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.4e-15 Score=142.16 Aligned_cols=135 Identities=19% Similarity=0.205 Sum_probs=98.1
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEecccchh--hHHH----------------------HHHHHHHHhhcCCC--cEe
Q 008216 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ--RKKE----------------------FYSEIGRFARLHHP--NLV 328 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--nIv 328 (573)
+.||+|+||.||+|...+|+.||||+++..... .... ...|...+.++.+. .+.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 467999999999999878999999998754211 1111 13566666666443 344
Q ss_pred EEeeEEeeCCceEEEEEecCCCCHHHH-hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeC
Q 008216 329 AVKGCCYDHGDRYIVYEFVVNGPLDRW-LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLD 406 (573)
Q Consensus 329 ~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~ 406 (573)
+.++. ...++||||++++++... +.. .... .....++.+++.++.++|. . +++||||||+||+++
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~-----~~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKD-----VRLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhh-----hhhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 44443 346899999998543211 111 0011 5678899999999999999 8 999999999999999
Q ss_pred CCCCeeEecccCCccCC
Q 008216 407 EEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 407 ~~~~~kl~Dfg~~~~~~ 423 (573)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8899999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PHA02911 C-type lectin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.1e-15 Score=133.38 Aligned_cols=108 Identities=22% Similarity=0.559 Sum_probs=81.2
Q ss_pred CCCCCCCccCcccCCCCeeeEEecccCCh--HHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCC
Q 008216 48 DWKAPCPPDWIINEEKSKCFGYIGNFRSW--DESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVG 125 (573)
Q Consensus 48 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w--~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~ 125 (573)
+...+||.+|. .|+++||+|+...++| ..|+++|..+||+|+. ++.||++||+. +|.|+.
T Consensus 98 ~~~~pC~~nW~--~H~nkCYlFS~~s~sWsW~~Srr~C~~kGATLLk-~sdEELeFIqn--------~wkGks------- 159 (213)
T PHA02911 98 PSEPICSRDWI--NHMGICLLSLGEEVGFRMEIAKRFCEKKDADLIG-KIDEEKKALEN--------IWTGND------- 159 (213)
T ss_pred CCCCCCchhhH--hhCCEEEEEeccccccchhHHHHHHHhcCCEecc-CcHHHHHHHHH--------HHhccc-------
Confidence 44558999999 9999999999995555 8999999999999999 88899999984 577764
Q ss_pred CceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecC----CCceeccccCCCCCccccccc
Q 008216 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG----SRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 126 ~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~----~~~W~d~~C~~~~~~iC~~~~ 192 (573)
+.|.|.||.. + ..+. + ....|+.+... .++.....|+....|||++..
T Consensus 160 ~~~fWID~r~--n-----gSt~-----------n-~s~sCA~Is~~~~~~~~~V~sesCs~~~~wICqK~~ 211 (213)
T PHA02911 160 HSRFWIDNRA--A-----ASTF-----------D-PVNECAIGTQNHIPEVPEVLKSPCDERHSFICIKKD 211 (213)
T ss_pred cceEEecCcc--c-----ccee-----------c-CCCCeEEEEcccccCCCceEccccCCCceEEEEecc
Confidence 5788888721 0 0000 0 12246666542 246788999999999999864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.7e-15 Score=132.36 Aligned_cols=134 Identities=18% Similarity=0.152 Sum_probs=112.9
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCC--CcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH--PNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
+.||+|.++.||++... +..+++|....... ...+.+|+..+..++| +++++++++....+..+++|||++++++
T Consensus 4 ~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 45799999999999984 48899999876543 5678899999999976 5899999988888889999999988766
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
..+ +......++.+++++|++||.....+++|+|++|+||+++.++.++++|||.+...
T Consensus 81 ~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 432 45667788999999999999864347999999999999999889999999988753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd00037 CLECT C-type lectin (CTL)/C-type lectin-like (CTLD) domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.9e-15 Score=126.76 Aligned_cols=114 Identities=28% Similarity=0.599 Sum_probs=90.8
Q ss_pred eeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCC-CCCCeEEeeeecCCCCCCceEEcCCCCCCCCCccc
Q 008216 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGK-NVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHA 143 (573)
Q Consensus 65 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~-~~~~~WiGl~~~~~~~~~~w~W~Dgt~~~~~~~~~ 143 (573)
.||+++....+|.+|+..|+++||+|++|++.+|++||.+++.. ....+|||++ .....+.|.|+||+....+..|.
T Consensus 1 ~Cy~~~~~~~~~~~A~~~C~~~~~~L~~~~~~~e~~~i~~~~~~~~~~~~wvg~~--~~~~~~~~~~~~~~~~~~~~~w~ 78 (116)
T cd00037 1 SCYKFSTEKLTWEEAQEYCRSLGGHLASIHSEEENDFLASLLKKSSSSDVWIGLN--DLSSEGTWKWSDGSPLVDYTNWA 78 (116)
T ss_pred CCEEEcCCccCHHHHHHHHHHcCCEEcccCCHHHHHHHHHHHhCCCCCCEEEccc--ccCcCCCeEecCCCccccccCCC
Confidence 49999999999999999999999999999999999999999862 2567999999 44356899999997755555565
Q ss_pred cCCCCCCccCCCCcCCcccceeEEeecC-CCceeccccCCCCCccccc
Q 008216 144 VGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMV 190 (573)
Q Consensus 144 ~~~~~~~~~~~p~~~~~~~~~C~~~~~~-~~~W~d~~C~~~~~~iC~~ 190 (573)
.++|. ....+.|+.+... ...|++.+|....++||++
T Consensus 79 ~~~~~----------~~~~~~C~~~~~~~~~~~~~~~C~~~~~~iC~~ 116 (116)
T cd00037 79 PGEPN----------PGGSEDCVVLSSSSDGKWNDVSCSSKLPFICEK 116 (116)
T ss_pred CCCcC----------CCCCCCeeEEccCCCCCccCCCCCCCceeeecC
Confidence 55541 2234456666544 3679999999999999963
|
CLECT: C-type lectin (CTL)/C-type lectin-like (CTLD) domain; protein domains homologous to the carbohydrate-recognition domains (CRDs) of the C-type lectins. This group is chiefly comprised of eukaryotic CTLDs, but contains some, as yet functionally uncharacterized, bacterial CTLDs. Many CTLDs are calcium-dependent carbohydrate binding modules; other CTLDs bind protein ligands, lipids, and inorganic surfaces, including CaCO3 and ice. Animal C-type lectins are involved in such functions as extracellular matrix organization, endocytosis, complement activation, pathogen recognition, and cell-cell interactions. For example: mannose-binding lectin and lung surfactant proteins A and D bind carbohydrates on surfaces (e.g. pathogens, allergens, necrotic, and apoptotic cells) and mediate functions associated with killing and phagocytosis; P (platlet)-, E (endothelial)-, and L (leukocyte)- selectins (sels) mediate the initia |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.7e-16 Score=171.88 Aligned_cols=250 Identities=19% Similarity=0.208 Sum_probs=186.4
Q ss_pred eeecccCceEEEEEEeCC--CCEEEEEEecccc--hhhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 275 RLLGDSKTGGTYSGILPD--GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
+.||+|+++.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++...+....++.++|..+
T Consensus 26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g 105 (601)
T KOG0590|consen 26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG 105 (601)
T ss_pred ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence 347999999998877533 4456777665442 222344555777777776 99999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEcCCCCCCeeeCCCC-CeeEecccCCccCCc-cc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH-DKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPW-EV 426 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~-~~ 426 (573)
+++.+-+.. ......+....-.++.|+..++.|+| .. ++.|+||||+|.+++..+ ..+++|||+|..... ..
T Consensus 106 ~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g 180 (601)
T KOG0590|consen 106 GSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNG 180 (601)
T ss_pred ccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccccCC
Confidence 999877731 11124566677788999999999999 87 999999999999999999 999999999988776 44
Q ss_pred cccceeccCC-cccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 427 MQERTVMAGG-TYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 427 ~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........ ... .....
T Consensus 181 ~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~-------------~~~~~ 246 (601)
T KOG0590|consen 181 AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYS-------------SWKSN 246 (601)
T ss_pred cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cce-------------eeccc
Confidence 4444444558 9999999998874 557889999999999999999999876544320 000 11110
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
. ......+.........+++.+++..+|..|.+.+++..
T Consensus 247 ~--~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 247 K--GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred c--cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0 00012223345566888999999999999999887754
|
|
| >PF00059 Lectin_C: Lectin C-type domain; InterPro: IPR001304 Lectins occur in plants, animals, bacteria and viruses | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.7e-15 Score=123.42 Aligned_cols=104 Identities=25% Similarity=0.542 Sum_probs=78.9
Q ss_pred ccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCCCCCccccCCCCCCc
Q 008216 72 NFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSC 151 (573)
Q Consensus 72 ~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dgt~~~~~~~~~~~~~~~~~ 151 (573)
++++|.+|+.+|+++||+||+|+|.+|++||..++. ....+|||+. ....+.|.|.||+......+ +++|
T Consensus 1 e~~~~~~A~~~C~~~~~~L~~i~~~~e~~~i~~~~~-~~~~~Wig~~---~~~~~~~~w~~~~~~~~~~~-----~~~w- 70 (105)
T PF00059_consen 1 EPMTWEEAQQYCQSMGAHLASINSEEENDFIQSQLK-SNESYWIGLD---SDNNGTWKWIDGSPNSPENF-----YTNW- 70 (105)
T ss_dssp EEEEHHHHHHHHHHTTSEEB-GSSHHHHHHHHHHHH-SSSEEEEEEE---SSSTSEEEETTSSBSSSTTB-----SGCB-
T ss_pred CCCCHHHHHHHHhcCCCEEeEeCCHHHhhhhhhccc-ccceeeeeee---ccccceeccccCCCcccccc-----cccc-
Confidence 468999999999999999999999999999999985 3668999992 22348999999977654322 1112
Q ss_pred cCCCCcCCcccceeEEe-ecCCCceeccccCCCCCccccc
Q 008216 152 TSLPCHVHATVDLCTLV-SNGSRSLVTERCNTSHPFICMV 190 (573)
Q Consensus 152 ~~~p~~~~~~~~~C~~~-~~~~~~W~d~~C~~~~~~iC~~ 190 (573)
......+.|+.+ ....+.|.+.+|....+|||++
T Consensus 71 -----~~~~~~~~C~~~~~~~~~~w~~~~C~~~~~fiCek 105 (105)
T PF00059_consen 71 -----NPPNDSENCAYIYYSSSGKWNDVPCSEKYPFICEK 105 (105)
T ss_dssp -----SSGGSSEEEEEEGCSTTTEEEEEETTSEEEEEEEE
T ss_pred -----ccCCCCCCeEEEEEcCCCeEEeeCCCCCeeEEeeC
Confidence 012345677777 4455779999999999999974
|
Initially described for their carbohydrate-binding activity [], they are now recognised as a more diverse group of proteins, some of which are involved in protein-protein, protein-lipid or protein-nucleic acid interactions []. There are at least twelve structural families of lectins: C-type lectins, which are Ca+-dependent. S-type (galectins), a widespread family of glycan-binding proteins []. I-type, which have an immunoglobulin-like fold and can recognise sialic acids, other sugars and glycosaminoglycans []. P-type, which bind phosphomannosyl receptors []. Pentraxins []. (Trout) egg lectins. Calreticulin and calnexin, which act as molecular chaperones of the endoplasmic reticulum []. ERGIC-53 and VIP-36 []. Discoidins []. Eel aggutinins (fucolectins) []. Annexin lectins []. Fibrinogen-type lectins, which includes ficolins, tachylectins 5A and 5B, and Limax flavus (Spotted garden slug) agglutinin (these proteins have clear distinctions from one another, but they share a homologous fibrinogen-like domain used for carbohydrate binding). Also unclassified orphan lectins, including amphoterin, Cel-II, complement factor H, thrombospondin, sailic acid-binding lectins, adherence lectin, and cytokins (such as tumour necrosis factor and several interleukins). C-type lectins can be further divided into seven subgroups based on additional non-lectin domains and gene structure: (I) hyalectans, (II) asialoglycoprotein receptors, (III) collectins, (IV) selectins, (V) NK group transmembrane receptors, (VI) macrophage mannose receptors, and (VII) simple (single domain) lectins []. Therefore, lectins are a diverse group of proteins, both in terms of structure and activity. Carbohydrate binding ability may have evolved independently and sporadically in numerous unrelated families, where each evolved a structure that was conserved to fulfil some other activity and function. In general, animal lectins act as recognition molecules within the immune system, their functions involving defence against pathogens, cell trafficking, immune regulation and the prevention of autoimmunity [].; GO: 0005488 binding; PDB: 1T8D_A 2H2T_B 1T8C_A 2H2R_A 1TN3_A 1RJH_A 1HTN_A 3G8K_B 2E3X_B 1UMR_D .... |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.6e-13 Score=144.42 Aligned_cols=140 Identities=19% Similarity=0.203 Sum_probs=100.3
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEecccchhh----------------------------------------HHHHHH
Q 008216 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR----------------------------------------KKEFYS 314 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~----------------------------------------~~~~~~ 314 (573)
+.||.|++|.||+|++.+|+.||||+.+...... +-++.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 4689999999999999999999999986542110 012455
Q ss_pred HHHHHhhcC-----CCcEeEEeeEE-eeCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 008216 315 EIGRFARLH-----HPNLVAVKGCC-YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ-GIAFLHD 387 (573)
Q Consensus 315 E~~~l~~l~-----h~nIv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~-~L~~LH~ 387 (573)
|+..+.+++ ++++. +-.++ ...+..+|||||++|++|.++..... ... ....++.+++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~-vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVY-VPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEE-eCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHh
Confidence 666665552 34433 22222 23456799999999999988764311 112 23456666665 4788899
Q ss_pred CCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCc
Q 008216 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (573)
Q Consensus 388 ~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 424 (573)
. |++|+|++|.||+++.++.++++|||++..++.
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.1e-14 Score=136.08 Aligned_cols=206 Identities=19% Similarity=0.287 Sum_probs=144.5
Q ss_pred HHHHhhcCCCcEeEEeeEEeeC-----CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 008216 316 IGRFARLHHPNLVAVKGCCYDH-----GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390 (573)
Q Consensus 316 ~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ 390 (573)
+.-|-++.|.||+++..|..+. ....++.||+..|+|..+|++.......+......+++.||++||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 3445566799999998887654 346889999999999999998777778899999999999999999999985 7
Q ss_pred CCeEEcCCCCCCeeeCCCCCeeEecccCCccCCc--cccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHH
Q 008216 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW--EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468 (573)
Q Consensus 391 ~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 468 (573)
|.|+|+++..+-|++..++-+|+.--.-...... ...........+-++|.|||.-.....+.++|||+||+..+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 8899999999999999888777742211111100 00111111223678999999877677788999999999999998
Q ss_pred cCCCCCCCCCcc-cchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 469 SGRRPAQAVDSV-CWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 469 tG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
.+..--...... ..+ +-....+..+... .=++++..|++..|+.||+|.+++..
T Consensus 277 ilEiq~tnseS~~~~e----------------e~ia~~i~~len~--------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVE----------------ENIANVIIGLENG--------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceeehh----------------hhhhhheeeccCc--------cccCcCcccccCCCCCCcchhhhhcC
Confidence 876542221111 000 0000001000011 12357889999999999999988753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.1e-13 Score=143.41 Aligned_cols=242 Identities=17% Similarity=0.209 Sum_probs=179.2
Q ss_pred eecc--cCceEEEEEEe---CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEec
Q 008216 276 LLGD--SKTGGTYSGIL---PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 276 ~lg~--G~~g~Vy~~~~---~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
-+|. |.+|.||.+.. .++..+|+|.-+.. .......-.+|+....++ .|+|.++....++..+..++-+|++
T Consensus 121 ~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~ 200 (524)
T KOG0601|consen 121 RTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC 200 (524)
T ss_pred ccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeeccc
Confidence 4588 99999999885 45889999984432 223344445677777777 5999999888889999999999998
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEEcCCCCCCeeeCCC-CCeeEecccCCccC
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFV 422 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~ 422 (573)
+.+|..+.+. ....++...++....+... ||.++|+. +++|-|+||+||+...+ ...+++|||+...+
T Consensus 201 -~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i 273 (524)
T KOG0601|consen 201 -GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKI 273 (524)
T ss_pred -cchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcceeEEc
Confidence 5788888764 2344777888888888888 99999999 99999999999999999 78999999999877
Q ss_pred Cccccccce---eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 423 PWEVMQERT---VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 423 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
......... ....|...|++||.. .+-++.++|+||+|.++.+..++..+........|..+-.+.
T Consensus 274 ~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~---------- 342 (524)
T KOG0601|consen 274 SDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY---------- 342 (524)
T ss_pred cCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc----------
Confidence 655422211 111377789999976 456788999999999999999988776543222222111100
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+ ........+..+...+..|++.+|..|++.+.+..
T Consensus 343 -i---------p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 343 -I---------PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -C---------chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0 11111122345666899999999999998877654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=9.6e-13 Score=140.01 Aligned_cols=145 Identities=17% Similarity=0.202 Sum_probs=95.4
Q ss_pred cCCCcCCeeecccCceEEEEEEeCC-CCEEEEEEecccchhh----------------------------------H---
Q 008216 268 KNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQR----------------------------------K--- 309 (573)
Q Consensus 268 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~----------------------------------~--- 309 (573)
..|.. +.||+|++|.||+|++++ |+.||||+.++..... .
T Consensus 120 ~~fd~--~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 120 DDFDI--KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HhcCh--hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 34544 467999999999999877 9999999997541100 0
Q ss_pred ---HHHHHHHHHHhhc----CCCcEeEEeeEEee-CCceEEEEEecCCCCHHHHhccCCCCC---CCCCHHHHHHHHHHH
Q 008216 310 ---KEFYSEIGRFARL----HHPNLVAVKGCCYD-HGDRYIVYEFVVNGPLDRWLHHIPRGG---RSLDWAMRMKVATTL 378 (573)
Q Consensus 310 ---~~~~~E~~~l~~l----~h~nIv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~---~~l~~~~~~~i~~qi 378 (573)
-++.+|+..+.++ .+.+.+.+-.++.+ .+..+|||||++|+.+.++-.- ...+ ..+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHHHHH
Confidence 1234455555544 23333333333332 4567899999999999874221 1111 123333344444444
Q ss_pred HHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC----CeeEecccCCccCCcc
Q 008216 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVGLSKFVPWE 425 (573)
Q Consensus 379 ~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfg~~~~~~~~ 425 (573)
... |++|+|++|.||+++.++ .+++.|||++..++..
T Consensus 277 -------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 -------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred -------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 345 999999999999999887 8999999999877543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.5e-11 Score=128.88 Aligned_cols=167 Identities=23% Similarity=0.272 Sum_probs=129.4
Q ss_pred eCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHHHHhccCCCCCCCCCHH
Q 008216 290 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 369 (573)
Q Consensus 290 ~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~ 369 (573)
..++.+|.|...+...........+-++.|+.++||||+++++..+.++..|||+|.+. .|..++.. +...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence 44688899998877655334567788899999999999999999999999999999884 57777754 4466
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceeccCCcccccccccccCC
Q 008216 370 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449 (573)
Q Consensus 370 ~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 449 (573)
.+.-.+.||+.||.|||+.+ +++|++|.-+.|+++..|..||++|.++........... ....-..|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~--~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAK--SLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccc--cchhhhcccChhhcCcc
Confidence 67778999999999999765 999999999999999999999999988765432221000 01122346667654322
Q ss_pred CCCcchhhHHHHHHHHHHHcCC
Q 008216 450 ELTTKSDVYSFGVLLLEIVSGR 471 (573)
Q Consensus 450 ~~~~~~DvwSlGvil~elltG~ 471 (573)
. -..|.|-||++++|++.|.
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcc
Confidence 2 3469999999999999993
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=5.9e-12 Score=115.56 Aligned_cols=129 Identities=14% Similarity=0.043 Sum_probs=95.3
Q ss_pred eecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcE-eEEeeEEeeCCceEEEEEecCCCCHHH
Q 008216 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL-VAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~gsL~~ 354 (573)
.++.|.++.||++.. .+..|++|+...... ....+.+|+.++..+.+.++ .+++... ....++|||+++|.++.+
T Consensus 5 ~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 5 PLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred ecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 568999999999987 488899999865432 23356789999998865444 3455443 334589999999988754
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCCeeeCCCCCeeEecccCCcc
Q 008216 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV--KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 421 (573)
.. . ....++.+++.+|+.||+.. ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 20 1 11245678999999999982 12359999999999999 56899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.6e-11 Score=112.41 Aligned_cols=135 Identities=15% Similarity=0.119 Sum_probs=99.1
Q ss_pred eecccCceEEEEEEeCC-------CCEEEEEEecccc----------------------hhhHHHHH----HHHHHHhhc
Q 008216 276 LLGDSKTGGTYSGILPD-------GSRVAVKRLKRSS----------------------FQRKKEFY----SEIGRFARL 322 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~~l 322 (573)
.||.|.-+.||.|...+ +..+|||+.+... ....+.+. +|++.|+++
T Consensus 4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl 83 (197)
T cd05146 4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM 83 (197)
T ss_pred ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 57999999999998543 5799999875210 01122333 799999998
Q ss_pred C--CCcEeEEeeEEeeCCceEEEEEecCCCCHHH-HhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEcCC
Q 008216 323 H--HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR-WLHHIPRGGRSLDWAMRMKVATTLAQGIAFL-HDKVKPHVVHRDI 398 (573)
Q Consensus 323 ~--h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~iiH~Dl 398 (573)
. .-++++++++ ...++||||+.+..+.. .+.+ ..++..+...+..+++.+|..| |.. +++|+||
T Consensus 84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 4 3566677764 46789999997643321 2221 2345566778889999999999 888 9999999
Q ss_pred CCCCeeeCCCCCeeEecccCCccCC
Q 008216 399 RASNVLLDEEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 399 kp~NIll~~~~~~kl~Dfg~~~~~~ 423 (573)
++.||++++ +.+.|+|||.+....
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeCC
Confidence 999999974 579999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.3e-10 Score=100.75 Aligned_cols=142 Identities=19% Similarity=0.229 Sum_probs=106.1
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEe-ccc-------chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEE
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRL-KRS-------SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
-.++-+|+-+.|+++.+ .|+...||-- .+. ..-.+++..+|++.|.+++--.|.-..-++.+...-.|+||
T Consensus 12 l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 45789999999999998 7888777743 221 11224567889999999875565555555667777789999
Q ss_pred ecCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCC---eeEecccCCcc
Q 008216 346 FVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGVGLSKF 421 (573)
Q Consensus 346 ~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~~~~ 421 (573)
|++| .++.+++..... .....+....++..|-..+.-||.+ +++|+||..+||++..++. +.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9976 478888865322 2233333467889999999999999 9999999999999976543 58999999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.4e-10 Score=101.30 Aligned_cols=130 Identities=20% Similarity=0.229 Sum_probs=99.7
Q ss_pred eecccCceEEEEEEeCCCCEEEEEEecccc--------hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSS--------FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
++++|+-+.+|.+.+ -|.++++|.-.+.. .-....-.+|+.++.+++--.|...+=+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 568999999999977 45567777532221 112345678999999986555555555556777888999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCcc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 421 (573)
+|..|.+.+... ...++..+-.-+.-||.. ||+|+||.++||++..+. +.++|||++..
T Consensus 82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888641 245667777778889999 999999999999998774 99999999874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.3e-11 Score=125.27 Aligned_cols=247 Identities=17% Similarity=0.180 Sum_probs=172.6
Q ss_pred HhhcCCCcCCeeecccCceEEEEEEe--CCCCEEEEEEecccchhhHHH--HHHHHHHHhhc-CCCcEeEEeeEEeeCCc
Q 008216 265 SITKNFSEGNRLLGDSKTGGTYSGIL--PDGSRVAVKRLKRSSFQRKKE--FYSEIGRFARL-HHPNLVAVKGCCYDHGD 339 (573)
Q Consensus 265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 339 (573)
..+.+|.+.. .||.|.|+.|+.... .++..+++|.+.+.......+ -..|+-+...+ .|.+++.++..+.....
T Consensus 262 ~~~~df~~v~-~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVS-KISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeE-EccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 3444565544 459999999998774 357899999887653332222 24566666666 68888888877777777
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-CCeeEecccC
Q 008216 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGL 418 (573)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~ 418 (573)
.|+-.||++++++...+. ....+++..++.+..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.
T Consensus 341 ~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred ccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccc
Confidence 889999999998876552 234577788899999999999999999 99999999999999886 7789999999
Q ss_pred CccCCccccccceeccCCcccc-cccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccc
Q 008216 419 SKFVPWEVMQERTVMAGGTYGY-LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 497 (573)
Q Consensus 419 ~~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 497 (573)
...+....... ...+..| .+|+......+..+.|++|||..+.+.+++..--.....
T Consensus 414 ~t~~~~~~~~~----~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------------------ 471 (524)
T KOG0601|consen 414 WTRLAFSSGVF----HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------------------ 471 (524)
T ss_pred ccccceecccc----cccccccccchhhccccccccccccccccccccccccCcccCccccc------------------
Confidence 87532221111 1123334 355555566778899999999999999998754322111
Q ss_pred cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008216 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547 (573)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 547 (573)
...+..... ...+ .....+..+...+...++..||.+.++....
T Consensus 472 ~~~i~~~~~----p~~~--~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 472 SLTIRSGDT----PNLP--GLKLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred ceeeecccc----cCCC--chHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 001111111 1111 1225677888999999999999998876543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.3e-10 Score=108.65 Aligned_cols=142 Identities=25% Similarity=0.278 Sum_probs=109.5
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEecccch-hhHHHHHHHHHHHhhcCC--CcEeEEeeEEeeC---CceEEEEEecC
Q 008216 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHH--PNLVAVKGCCYDH---GDRYIVYEFVV 348 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~---~~~~lv~e~~~ 348 (573)
+.|+.|..+.||++...+|+.+++|....... .....+.+|+.+++.+++ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 35799999999999987778999999865432 134578899999999965 4456777776553 25689999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV--------------------------------------- 389 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--------------------------------------- 389 (573)
|.++.+.+.. ..++..+...++.+++.+|..||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888765421 34677778888888888888888531
Q ss_pred --------------CCCeEEcCCCCCCeeeCC--CCCeeEecccCCcc
Q 008216 390 --------------KPHVVHRDIRASNVLLDE--EFGAHLMGVGLSKF 421 (573)
Q Consensus 390 --------------~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~~~~ 421 (573)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 236799999999999998 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=7.4e-11 Score=128.82 Aligned_cols=242 Identities=19% Similarity=0.178 Sum_probs=162.5
Q ss_pred eeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+-+.+|.++.++.+.- ..|...++|+..... ..+.+....+-.++-..+||-+++..--+......+|+++|+.++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 3567888898887662 234344444443221 111222333333333345676766555555567789999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCc------
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW------ 424 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~------ 424 (573)
+|...|+... ..+.+-.......+..++++||+. .+.|+|++|.|.+...++..++.|||.......
T Consensus 890 ~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 890 DLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred CchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 9999887532 355555666777888999999998 799999999999999999999999983322110
Q ss_pred ---------------cc----cc----cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCccc
Q 008216 425 ---------------EV----MQ----ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC 481 (573)
Q Consensus 425 ---------------~~----~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~ 481 (573)
.. .. .......+|+.|.+||...+......+|.|++|++++|.++|.+||......
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq- 1041 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ- 1041 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh-
Confidence 00 00 0112233899999999999999999999999999999999999999876542
Q ss_pred chhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHH
Q 008216 482 WQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS 541 (573)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 541 (573)
+.+ ..++..... -..-+...+....+++...+..+|.+|-.+.
T Consensus 1042 --~~f------------~ni~~~~~~---~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1042 --QIF------------ENILNRDIP---WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred --hhh------------hccccCCCC---CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 111 111111110 1111233556788999999999999997765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=6e-09 Score=102.16 Aligned_cols=141 Identities=13% Similarity=0.128 Sum_probs=102.2
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEecccchh-----------hHHHHHHHHHHHhhcCCCc--EeEEeeEEee-----
Q 008216 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ-----------RKKEFYSEIGRFARLHHPN--LVAVKGCCYD----- 336 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~----- 336 (573)
+++-......|++..+ +|+.+.||+....... ....+.+|...+.++...+ .++++++.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3445555556778777 7889999987544311 1124778999888884333 3344555543
Q ss_pred CCceEEEEEecCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-------C
Q 008216 337 HGDRYIVYEFVVNG-PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-------E 408 (573)
Q Consensus 337 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-------~ 408 (573)
....++|+|++++. +|.+++.... ....+......++.+++..+.-||.. ||+|+|+++.|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23468999999876 8999885321 23456677788999999999999999 9999999999999975 4
Q ss_pred CCeeEecccCCcc
Q 008216 409 FGAHLMGVGLSKF 421 (573)
Q Consensus 409 ~~~kl~Dfg~~~~ 421 (573)
..+.++||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6789999998854
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.9e-09 Score=99.63 Aligned_cols=126 Identities=23% Similarity=0.274 Sum_probs=83.9
Q ss_pred EEEEEEeCCCCEEEEEEecccc--------------h------------hhHHHHHHHHHHHhhcCCC--cEeEEeeEEe
Q 008216 284 GTYSGILPDGSRVAVKRLKRSS--------------F------------QRKKEFYSEIGRFARLHHP--NLVAVKGCCY 335 (573)
Q Consensus 284 ~Vy~~~~~~g~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~ 335 (573)
.||.|...+|..+|||+.+... . .......+|++.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999899999999875310 0 0123467899999999655 566776552
Q ss_pred eCCceEEEEEecC--CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEEcCCCCCCeeeCCCCCee
Q 008216 336 DHGDRYIVYEFVV--NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF-LHDKVKPHVVHRDIRASNVLLDEEFGAH 412 (573)
Q Consensus 336 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~~~~~iiH~Dlkp~NIll~~~~~~k 412 (573)
...|||||++ |..+..+... .++......++.+++..+.. +|.. |++|+||.+.||+++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 4579999998 6555443321 12234456677788886555 5687 99999999999999988 999
Q ss_pred EecccCCccCC
Q 008216 413 LMGVGLSKFVP 423 (573)
Q Consensus 413 l~Dfg~~~~~~ 423 (573)
++|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.1e-08 Score=104.47 Aligned_cols=218 Identities=16% Similarity=0.205 Sum_probs=152.7
Q ss_pred CceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEee----CCceEEEEEecCC-CCHHH
Q 008216 281 KTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYEFVVN-GPLDR 354 (573)
Q Consensus 281 ~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~e~~~~-gsL~~ 354 (573)
...+.|++.. .||..|++|+++............-+++++++.|+|+|++.+++.. +...++|++|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 4567888873 4799999999954433332233455788999999999999998873 3567899999986 56766
Q ss_pred HhccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCC
Q 008216 355 WLHHIP-----------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 355 ~l~~~~-----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 423 (573)
+-.... ..+...++..++.++.|+..||.++|+. |+.-+-|.|.+|+++.+.+++|+..|+.....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 543211 2234578899999999999999999999 99999999999999999999999888876654
Q ss_pred ccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccc
Q 008216 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503 (573)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (573)
.+.. |-+.+ -.+-|.=.||.+++.|.||..--...+.. ++. . +
T Consensus 445 ~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~--~~s-----------~----~- 487 (655)
T KOG3741|consen 445 EDPT----------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDST--QSS-----------H----L- 487 (655)
T ss_pred CCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccch--HHH-----------H----H-
Confidence 3320 11111 23579999999999999996432111100 000 0 0
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 008216 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547 (573)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 547 (573)
..-....+.++++++.-....++++ -++.+++.++
T Consensus 488 --------~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 488 --------TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred --------HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 0011235567778888888888887 5777777654
|
|
| >PF05473 Herpes_UL45: UL45 protein; InterPro: IPR008646 This family consists several UL45 proteins and homologues found in the herpes simplex virus family | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.2e-09 Score=97.65 Aligned_cols=58 Identities=19% Similarity=0.507 Sum_probs=51.6
Q ss_pred CCCCCCCccCcccCCCCeeeEEecccC-ChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhC
Q 008216 48 DWKAPCPPDWIINEEKSKCFGYIGNFR-SWDESETYCKEIGGHLAALTSYEEEHSAQKLCG 107 (573)
Q Consensus 48 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~-~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~ 107 (573)
..++.||+||. .|+++||+|+.+.+ +|.+|+.+|.++++.|+.+++.+....+.....
T Consensus 80 ~~~~~CP~~Wi--~~~~~Cy~~~~~~~~t~~eA~~~C~~~~s~L~~~~~~~~L~~ll~~~~ 138 (200)
T PF05473_consen 80 LGCGPCPKGWI--GYNNSCYRFSNSPKKTWEEARNICAAYNSTLANVNNAKSLLELLDVLN 138 (200)
T ss_pred ccCCCCCccce--eeCCEEEEEeCCCCcCHHHHHHHHHhcCCcCCCchhHHHHHHHHHHhc
Confidence 34579999999 99999999999998 999999999999999999999888777766544
|
The herpes simplex virus UL45 gene encodes an 18 kDa virion envelope protein whose function remains unknown. It has been suggested that the 18 kDa UL45 gene product is required for efficient growth in the central nervous system at low doses and may play an important role under the conditions of a naturally acquired infection []. The Equine herpesvirus 1 UL45 protein represents a type II membrane glycoprotein which has found to be non-essential for EHV-1 growth in vitro but deletion reduces the viruses' replication efficiency []. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.7e-08 Score=100.47 Aligned_cols=267 Identities=18% Similarity=0.183 Sum_probs=161.7
Q ss_pred CCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEE------eeCCc-eEEEE
Q 008216 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCC------YDHGD-RYIVY 344 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~------~~~~~-~~lv~ 344 (573)
..+-||+|+-+.+|-.- +-..-+-|+..........+. +..|.+. .||-+..-+.+- -+.+. .-++|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 34467999999999642 122345577765433222222 2223333 455443311110 11222 46777
Q ss_pred EecCCCC-HHHHhcc--CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCcc
Q 008216 345 EFVVNGP-LDRWLHH--IPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 345 e~~~~gs-L~~~l~~--~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 421 (573)
..+.+.- ...+.+. +++.-...+|...++.++.++.+.+-||.. |.+-+|+.++|+|+++++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence 7776542 2222221 122234578999999999999999999999 999999999999999999999988543332
Q ss_pred CCccccccceeccCCccccccccccc-----CCCCCcchhhHHHHHHHHHHHcC-CCCCCCCCcccc-hhhHHhhhhhhh
Q 008216 422 VPWEVMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSG-RRPAQAVDSVCW-QSIFEWATPLVQ 494 (573)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG-~~Pf~~~~~~~~-~~~~~~~~~~~~ 494 (573)
... ........|...|.+||.-. +-.-+...|.|.||+++++++.| ++||.+...... ..-.+ ..+.
T Consensus 167 ~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia 240 (637)
T COG4248 167 NAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIA 240 (637)
T ss_pred ccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhh
Confidence 211 11222334889999999654 33456789999999999999986 999987532100 00000 0011
Q ss_pred cccccccccc--ccccCCCCCcchHHHHHHHHHHHHhcCC--CCCCCCCHHHHHHHHhcccCC
Q 008216 495 SHRYLELLDP--LISSLSSDIPEAGVVQKVVDLVYACTQH--VPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 495 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~L~~~~~~ 553 (573)
.+.+...-+. -....+...+-.-.++.+..+..+|+.. +|.-|||++..+..|..+.+.
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 1111111111 1111223344455667888999999865 367899999999888776553
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=6.9e-08 Score=91.79 Aligned_cols=132 Identities=19% Similarity=0.219 Sum_probs=96.8
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccc----------------------hhhHHHHHHHHHHHhhcCCC--cEeE
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS----------------------FQRKKEFYSEIGRFARLHHP--NLVA 329 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--nIv~ 329 (573)
...||-|.-+.||.|..++|.++|||.-+... ...+....+|.++|++|... .+.+
T Consensus 96 G~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~ 175 (304)
T COG0478 96 GTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPK 175 (304)
T ss_pred ccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCC
Confidence 35689999999999999999999999753210 01124467899999999654 6777
Q ss_pred EeeEEeeCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC
Q 008216 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409 (573)
Q Consensus 330 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~ 409 (573)
.+++ +...+|||+++|-.|... +++.+..-.++..|+.-+.-+-.. |+||+|+.+-||+++++|
T Consensus 176 P~~~----nRHaVvMe~ieG~eL~~~---------r~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 176 PIAW----NRHAVVMEYIEGVELYRL---------RLDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDG 239 (304)
T ss_pred cccc----ccceeeeehcccceeecc---------cCcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCC
Confidence 6654 556899999988665432 123334444555555555555566 999999999999999999
Q ss_pred CeeEecccCCcc
Q 008216 410 GAHLMGVGLSKF 421 (573)
Q Consensus 410 ~~kl~Dfg~~~~ 421 (573)
.+.++||--+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999976553
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.7e-09 Score=112.62 Aligned_cols=152 Identities=21% Similarity=0.291 Sum_probs=104.2
Q ss_pred HHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc-------eeccCCccccccccccc
Q 008216 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER-------TVMAGGTYGYLAPEFVY 447 (573)
Q Consensus 375 ~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~ 447 (573)
+.+++.||.|+|.. .++||++|.|++|.++.++..||+.|+.+........... .....-...|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34455999999987 4999999999999999999999999998875543211110 01111456799999999
Q ss_pred CCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHH
Q 008216 448 RNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLV 526 (573)
Q Consensus 448 ~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 526 (573)
+...+.++|+||+|+++|.+.. |+.-+............. ...+.. ........+.++.+-+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~------------~~~~~~-----~~~~s~~~p~el~~~l 245 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR------------NLLNAG-----AFGYSNNLPSELRESL 245 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh------------cccccc-----cccccccCcHHHHHHH
Confidence 8888999999999999999994 554444332211110000 001111 1111234567899999
Q ss_pred HHhcCCCCCCCCCHHHHHH
Q 008216 527 YACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 527 ~~cl~~dP~~RPs~~evl~ 545 (573)
.+++..++.-||++.++..
T Consensus 246 ~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 246 KKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHhcCCcccCcchhhhhc
Confidence 9999999999997777653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=3e-07 Score=85.53 Aligned_cols=138 Identities=13% Similarity=0.087 Sum_probs=103.9
Q ss_pred cccCceEEEEEEeCCCCEEEEEEeccc---c---hhhHHHHHHHHHHHhhcCC--CcEeEEeeEEeeC----CceEEEEE
Q 008216 278 GDSKTGGTYSGILPDGSRVAVKRLKRS---S---FQRKKEFYSEIGRFARLHH--PNLVAVKGCCYDH----GDRYIVYE 345 (573)
Q Consensus 278 g~G~~g~Vy~~~~~~g~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~----~~~~lv~e 345 (573)
|+||.+.|++..+ +|..+-+|+-... + ......|.+|+..|.+|.. -.+.++....... -..+||+|
T Consensus 27 ~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 8899999999887 5667999987522 1 2356789999999999943 3345554222111 12489999
Q ss_pred ecCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCC--eeEecccCCcc
Q 008216 346 FVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG--AHLMGVGLSKF 421 (573)
Q Consensus 346 ~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~Dfg~~~~ 421 (573)
-++| .+|.+++... .-.+.+......++.+++..++-||+. |+.|+|+-+.||+++.++. ++++||.-++.
T Consensus 106 ~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 7753 5898888542 223467777889999999999999999 9999999999999986667 89999987664
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.4e-07 Score=89.40 Aligned_cols=124 Identities=25% Similarity=0.247 Sum_probs=91.7
Q ss_pred CCCEEEEEEecccch-------hhHHHHHHHHHHHhhcC--CCcEeEEeeEEeeCC----ceEEEEEecCCC-CHHHHhc
Q 008216 292 DGSRVAVKRLKRSSF-------QRKKEFYSEIGRFARLH--HPNLVAVKGCCYDHG----DRYIVYEFVVNG-PLDRWLH 357 (573)
Q Consensus 292 ~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~ 357 (573)
.++.+.+|....... .......+|...+..|. .-.+++.+++.+... ..++|+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 456677775432211 23456778888888874 333456666665532 348999999874 7999886
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC---CeeEecccCCccC
Q 008216 358 HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGVGLSKFV 422 (573)
Q Consensus 358 ~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg~~~~~ 422 (573)
... ..+......++.+++..++-||+. ||+|+|++|.|||++.+. .+.++||+-++..
T Consensus 111 ~~~----~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWE----QLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhc----ccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 421 256677888999999999999999 999999999999998886 7999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2e-07 Score=98.96 Aligned_cols=143 Identities=15% Similarity=0.160 Sum_probs=94.0
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEecccchhh----------------------------------------HHHHHH
Q 008216 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR----------------------------------------KKEFYS 314 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~----------------------------------------~~~~~~ 314 (573)
..|+.++-|.||+|++++|+.||||+.+..-... +-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 4689999999999999999999999986431100 012345
Q ss_pred HHHHHhhc-----CCCcEeEEeeEEeeCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 008216 315 EIGRFARL-----HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389 (573)
Q Consensus 315 E~~~l~~l-----~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 389 (573)
|+..+.++ +.|++.-.-=+.+-.+...|+|||++|..+.+...... ...+.+.+.....++. +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f--~~q~~~d- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAF--LRQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHH--HHHHHhc-
Confidence 66555555 23443322222233567789999999988888743211 2344333322222221 2222234
Q ss_pred CCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 390 ~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|+.|.|..|.||+++.++.+.+.|||+....+..
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 9999999999999999999999999999877543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.5e-06 Score=80.88 Aligned_cols=139 Identities=14% Similarity=0.215 Sum_probs=85.9
Q ss_pred eecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCc--EeEEeeEEeeCCceEEEEEecCCCC-H
Q 008216 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN--LVAVKGCCYDHGDRYIVYEFVVNGP-L 352 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lv~e~~~~gs-L 352 (573)
.||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++..+.+...+|||+++|.+ +
T Consensus 8 ~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 8 QTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 5799999999983 35568899887543 3455788999999885433 4677777777777889999998863 2
Q ss_pred HHHh---------------------ccCCCCCCCCCHHHHHHHHH----------HHHH-HHHHHHhC-CCCCeEEcCCC
Q 008216 353 DRWL---------------------HHIPRGGRSLDWAMRMKVAT----------TLAQ-GIAFLHDK-VKPHVVHRDIR 399 (573)
Q Consensus 353 ~~~l---------------------~~~~~~~~~l~~~~~~~i~~----------qi~~-~L~~LH~~-~~~~iiH~Dlk 399 (573)
...+ +........++.. ...+.. .+.. ...+|... ..+.++|+|+.
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 2111 1111111111100 000000 0111 12222211 13367899999
Q ss_pred CCCeeeCCCCCeeEecccCCcc
Q 008216 400 ASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 400 p~NIll~~~~~~kl~Dfg~~~~ 421 (573)
|.||++++++ +.++||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999887 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.37 E-value=7e-06 Score=76.77 Aligned_cols=139 Identities=14% Similarity=0.193 Sum_probs=90.6
Q ss_pred hhcCCCcCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHH---------HHHHHHHHhhcCC---CcEeEEeeE
Q 008216 266 ITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKE---------FYSEIGRFARLHH---PNLVAVKGC 333 (573)
Q Consensus 266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h---~nIv~l~~~ 333 (573)
+.++-....+++-......|.+-.. +|+.+++|..+.......+. ..+++..+.+++. .....++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3334444455667777777777776 78999999987654332222 2334444444432 222222222
Q ss_pred Eee-----CCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC
Q 008216 334 CYD-----HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408 (573)
Q Consensus 334 ~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~ 408 (573)
.+. ....+++|||++|..|.++.. +++ .++..+.+++.-||+. |+.|+|..|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence 221 234578999999988866532 232 2456677889999999 99999999999999865
Q ss_pred CCeeEecccCCcc
Q 008216 409 FGAHLMGVGLSKF 421 (573)
Q Consensus 409 ~~~kl~Dfg~~~~ 421 (573)
.++++||+..+.
T Consensus 172 -~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 -GIRIIDTQGKRM 183 (229)
T ss_pred -cEEEEECccccc
Confidence 599999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.35 E-value=5.4e-06 Score=78.33 Aligned_cols=153 Identities=19% Similarity=0.181 Sum_probs=102.4
Q ss_pred CHHHHHHhhcCC--CcCCeeecccCceEEEEEEeCCCCEEEEEEecccchhh-------------------HH-----HH
Q 008216 259 TTEELRSITKNF--SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR-------------------KK-----EF 312 (573)
Q Consensus 259 ~~~el~~~~~~~--~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-------------------~~-----~~ 312 (573)
+.+.+..+.... .+....|++|.-+.||+|...++..+|||+++.....- .. -.
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 344444444332 23334578888899999998889999999986431110 11 12
Q ss_pred HHHHHHHhhcC--CCcEeEEeeEEeeCCceEEEEEecCCCCH-HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 008216 313 YSEIGRFARLH--HPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389 (573)
Q Consensus 313 ~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 389 (573)
.+|+.-|.++. +-.+.+.+++. +..|||||+....+ .-.| ...++...+...+..++++.+.-|-...
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L-----kDv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL-----KDVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc-----ccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 46888888873 45555655543 34799999954311 1111 1122344467778888999988888732
Q ss_pred CCCeEEcCCCCCCeeeCCCCCeeEecccCCccCC
Q 008216 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 390 ~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 423 (573)
++||+||+.=|||+. ++.+.++|+|-|....
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 999999999999999 7789999999887654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.29 E-value=2e-05 Score=73.51 Aligned_cols=134 Identities=18% Similarity=0.294 Sum_probs=96.0
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccc----------------hhhHHHHHHHHHHHhhcC------CCcEeEEe
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS----------------FQRKKEFYSEIGRFARLH------HPNLVAVK 331 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~nIv~l~ 331 (573)
..+||+|+.-.||. .++.....||+..... .....+..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 34789999999996 5667788999987664 122456667776666655 88999999
Q ss_pred eEEeeCCceEEEEEecCC------CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee
Q 008216 332 GCCYDHGDRYIVYEFVVN------GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405 (573)
Q Consensus 332 ~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll 405 (573)
|+.+++-..-+|+|.+.+ .||.+++.+ ..++. ..... +-.-.+||-++ +|+.+|++|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~~---L~~f~~~l~~~---~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQA---LDEFKRYLLDH---HIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHHH---HHHHHHHHHHc---CCeecCCCcccEEE
Confidence 999999889999998643 368888853 33555 33333 33445677777 89999999999999
Q ss_pred CCCC----CeeEec-ccCCcc
Q 008216 406 DEEF----GAHLMG-VGLSKF 421 (573)
Q Consensus 406 ~~~~----~~kl~D-fg~~~~ 421 (573)
..+. .+.|+| ||....
T Consensus 152 ~~~~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred EecCCCceEEEEEeCCCCccc
Confidence 5332 467777 554443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=6.2e-06 Score=87.46 Aligned_cols=141 Identities=16% Similarity=0.113 Sum_probs=90.5
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEecccchhh-------------------------------------HHHHHHHHH
Q 008216 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR-------------------------------------KKEFYSEIG 317 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-------------------------------------~~~~~~E~~ 317 (573)
+-||.-+.|.||+|++++|+.||||+-+..-... +-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 4589999999999999999999999976431110 012344544
Q ss_pred HHhhc----CCCc------EeEEeeEEeeCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 008216 318 RFARL----HHPN------LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387 (573)
Q Consensus 318 ~l~~l----~h~n------Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 387 (573)
-..++ .|-+ |.+++- .-.....|+|||++|..+.+.-.- ....++...+..-+.+...-+-+ .
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~qIf--~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLEQIF--K 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHHHHH--h
Confidence 33333 4544 333332 223567899999999876654321 11335555444444333222222 2
Q ss_pred CCCCCeEEcCCCCCCeeeCC----CCCeeEecccCCccCCcc
Q 008216 388 KVKPHVVHRDIRASNVLLDE----EFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 388 ~~~~~iiH~Dlkp~NIll~~----~~~~kl~Dfg~~~~~~~~ 425 (573)
. |++|+|=.|.||+++. ++.+.+-|||+.......
T Consensus 320 ~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 320 T---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred c---CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2 9999999999999983 667999999998876543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.9e-05 Score=76.98 Aligned_cols=140 Identities=17% Similarity=0.150 Sum_probs=85.9
Q ss_pred cccCc-eEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeCCceEEEEEecCCCCHHHH
Q 008216 278 GDSKT-GGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355 (573)
Q Consensus 278 g~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 355 (573)
..|.+ ..||+.... +..+.||+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.+|...
T Consensus 7 ~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 7 TEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred CCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 44444 889998764 5789999886543 345677888888883 44466778877766678999999999877643
Q ss_pred h-------------------ccCCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHhC----CC
Q 008216 356 L-------------------HHIPRGGRSLDWA--MRMKVAT--------------------TLAQGIAFLHDK----VK 390 (573)
Q Consensus 356 l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------qi~~~L~~LH~~----~~ 390 (573)
. +.......++... ....... .+...+..|-.. ..
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 1111111111100 0000000 011112222111 13
Q ss_pred CCeEEcCCCCCCeeeCCCCCeeEecccCCcc
Q 008216 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 391 ~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 421 (573)
+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 4699999999999999977788999987753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.4e-05 Score=75.34 Aligned_cols=142 Identities=17% Similarity=0.200 Sum_probs=83.1
Q ss_pred eecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCC--CcEeEEeeEEee---CCceEEEEEecCCC
Q 008216 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH--PNLVAVKGCCYD---HGDRYIVYEFVVNG 350 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~---~~~~~lv~e~~~~g 350 (573)
.++.|..+.||+....+ ..+++|..... .....+.+|..+++.+.. ..+.+++..... ....+++|++++|.
T Consensus 4 ~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 4 PLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred cCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 57899999999999866 69999998655 455677889988888842 235566664432 23468999999998
Q ss_pred CHHH----------------Hhc---cCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh--
Q 008216 351 PLDR----------------WLH---HIPRGGRSLDWAM---------RMKV------------ATTLAQ-GIAFLHD-- 387 (573)
Q Consensus 351 sL~~----------------~l~---~~~~~~~~l~~~~---------~~~i------------~~qi~~-~L~~LH~-- 387 (573)
++.. .+. ............. .... ...+.. .++.+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8877 111 1110111111100 0000 112222 3333332
Q ss_pred --CCCCCeEEcCCCCCCeeeC-CCCCeeEecccCCc
Q 008216 388 --KVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLSK 420 (573)
Q Consensus 388 --~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~~~ 420 (573)
.....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1234799999999999999 55556799998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.12 E-value=5.9e-07 Score=94.22 Aligned_cols=180 Identities=17% Similarity=0.127 Sum_probs=129.6
Q ss_pred ecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCc-EeEEeeEEeeCCceEEEEEecCCC-CHHH
Q 008216 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN-LVAVKGCCYDHGDRYIVYEFVVNG-PLDR 354 (573)
Q Consensus 277 lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e~~~~g-sL~~ 354 (573)
+++|+++.+++.+-...+....+.+... ....-++++|.+++||| .+..++-+..+...+++++++.++ +-..
T Consensus 250 fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~ 324 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSAL 324 (829)
T ss_pred HHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccc
Confidence 4888999999877534444446666443 34456888999999999 666666666667778999999776 2111
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceecc
Q 008216 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434 (573)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 434 (573)
.. ......+...+...+...-+++|++||+. .=+|+| ||+..+ +..+..||+....+.... .....
T Consensus 325 ~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~ 390 (829)
T KOG0576|consen 325 EM---TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTA 390 (829)
T ss_pred cC---ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc---ccccC
Confidence 11 11122344445566777788899999987 568888 777766 578999999987765443 22334
Q ss_pred CCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 008216 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQ 475 (573)
Q Consensus 435 ~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~ 475 (573)
.+++.++|||+...+.+..+.|+||+|+-..++.-|.+|-.
T Consensus 391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 48999999999999999999999999987777777777754
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.01 E-value=0.00012 Score=73.39 Aligned_cols=76 Identities=9% Similarity=0.040 Sum_probs=56.5
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCC---CcEeEEeeEEeeC---CceEEEEEec
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH---PNLVAVKGCCYDH---GDRYIVYEFV 347 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~---~~~~lv~e~~ 347 (573)
.+-||.|..+.||+....++ .+++|..+.. .....+..|...|+.|.- ..++++++++... +..++|||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 34579999999999876555 4777875431 133578899999998842 4678888877543 6689999999
Q ss_pred CCCCH
Q 008216 348 VNGPL 352 (573)
Q Consensus 348 ~~gsL 352 (573)
++.++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=5.3e-05 Score=67.84 Aligned_cols=126 Identities=17% Similarity=0.204 Sum_probs=88.0
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEe-EEeeEEeeCCceEEEEEecCCCCHH
Q 008216 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLV-AVKGCCYDHGDRYIVYEFVVNGPLD 353 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~lv~e~~~~gsL~ 353 (573)
+.|++|.+|.||++.+ .|..+|+|+-+.++ .+..+..|+++|..+.-.++. +++.+. ..++.|||+.|-.|.
T Consensus 28 ~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~ 100 (201)
T COG2112 28 KELAKGTTSVVYLGEW-RGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhcccccEEEEeec-cCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchh
Confidence 4679999999999998 66799999887663 457789999999999876664 444443 234669999888887
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC-CCCeeeCCCCCeeEecccCCcc
Q 008216 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR-ASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlk-p~NIll~~~~~~kl~Dfg~~~~ 421 (573)
+.-.. .+...+. .++..---|... ||-|+.|. |...++..+..+.|+||..|..
T Consensus 101 ~~~~~-------~~rk~l~----~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 101 KLEIG-------GDRKHLL----RVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhc-------ccHHHHH----HHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 65431 1333333 344443334444 89999986 4444444445899999998874
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.99 E-value=8.2e-05 Score=85.28 Aligned_cols=150 Identities=18% Similarity=0.260 Sum_probs=93.4
Q ss_pred CeeecccCceEEEEEEeCCC---CEEEEEEecccc-hhhHHHHHHHHHHHhhcC-CCcE--eEEeeEEeeC---CceEEE
Q 008216 274 NRLLGDSKTGGTYSGILPDG---SRVAVKRLKRSS-FQRKKEFYSEIGRFARLH-HPNL--VAVKGCCYDH---GDRYIV 343 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nI--v~l~~~~~~~---~~~~lv 343 (573)
-..++.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |+++ .+++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 34579999999999886554 468888765432 223457889999999995 6665 7888887664 467999
Q ss_pred EEecCCCCHHH--------------------H---hccCCCC-------CCCCC--HHHHHHHH---------------H
Q 008216 344 YEFVVNGPLDR--------------------W---LHHIPRG-------GRSLD--WAMRMKVA---------------T 376 (573)
Q Consensus 344 ~e~~~~gsL~~--------------------~---l~~~~~~-------~~~l~--~~~~~~i~---------------~ 376 (573)
|||++|..+.+ . |+..... +.+.. ..++..+. .
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998764321 1 1111100 00111 11221111 1
Q ss_pred HHHHHHHHHHhCCC--------CCeEEcCCCCCCeeeCCC-CC-eeEecccCCccCC
Q 008216 377 TLAQGIAFLHDKVK--------PHVVHRDIRASNVLLDEE-FG-AHLMGVGLSKFVP 423 (573)
Q Consensus 377 qi~~~L~~LH~~~~--------~~iiH~Dlkp~NIll~~~-~~-~kl~Dfg~~~~~~ 423 (573)
.+...+++|..+.. +.++|+|+++.||+++.+ .. .-|.|+.++..-+
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 23334566754322 359999999999999853 33 5789999887643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.97 E-value=3.1e-05 Score=71.94 Aligned_cols=105 Identities=18% Similarity=0.165 Sum_probs=81.3
Q ss_pred HHHHHHHhhcCC-CcEeEEeeEEeeCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 008216 313 YSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391 (573)
Q Consensus 313 ~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~ 391 (573)
.+|.-+++.+++ +++++++|+|- .++|.||...+++...-... ..-...+|..+.+|+.++++.+.+|++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358888888866 69999999983 36799999876553210000 0112368999999999999999999986444
Q ss_pred CeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 392 ~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
.+.-.|++|+|+-+++++++|++|.+.....
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 6888999999999999999999999877544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00016 Score=70.10 Aligned_cols=72 Identities=14% Similarity=0.097 Sum_probs=45.3
Q ss_pred eecccCce-EEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCC---cEeEEeeEEeeC---CceEEEEEecC
Q 008216 276 LLGDSKTG-GTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP---NLVAVKGCCYDH---GDRYIVYEFVV 348 (573)
Q Consensus 276 ~lg~G~~g-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~~~---~~~~lv~e~~~ 348 (573)
.++.|+.. .||+. +..+++|..+.. .....+.+|.+++..+... .+.++++..... +..+++|++++
T Consensus 4 ~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 4 PVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 35666665 58874 345778876543 2345788999999887431 344444443332 23488999999
Q ss_pred CCCHH
Q 008216 349 NGPLD 353 (573)
Q Consensus 349 ~gsL~ 353 (573)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 87764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.82 E-value=9.2e-05 Score=83.30 Aligned_cols=198 Identities=19% Similarity=0.156 Sum_probs=135.8
Q ss_pred HHHHHHHHHhhcCCCcEeEEeeEEeeCCce----EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 008216 311 EFYSEIGRFARLHHPNLVAVKGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 386 (573)
Q Consensus 311 ~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH 386 (573)
....|+..+.+..|+|++.++.+....... .+..|++..-++...+.. -..++..+.+.+..++..||+|+|
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHH
Confidence 344577788888999999999987655332 345577877788777754 356888899999999999999999
Q ss_pred hCCCCCeEEcCCCCC---CeeeCCCCCeeEe--cccCCccCCccccccceeccCCcccccccccccCCCCCc--chhhHH
Q 008216 387 DKVKPHVVHRDIRAS---NVLLDEEFGAHLM--GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT--KSDVYS 459 (573)
Q Consensus 387 ~~~~~~iiH~Dlkp~---NIll~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DvwS 459 (573)
+. ...|.-+..+ +.-.+..+.+..+ ||+.+............. -+..+.|||......+.. ..|+|.
T Consensus 304 ~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~---~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 304 SL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDL---LAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred Hh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhc---CccccccccccccccchhhhhhHHHH
Confidence 98 5555555544 4444555666666 888887765433222211 345677888877665544 479999
Q ss_pred HHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCC
Q 008216 460 FGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR 539 (573)
Q Consensus 460 lGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 539 (573)
+|.....+..|..+-..... ...+++. .......+...+|+..++++|++
T Consensus 378 lgll~~~~~~~~~i~~~~~~------------------~~~~l~~------------~~~~~~~d~~~~~~~~~~~~Rl~ 427 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSAV------------------PVSLLDV------------LSTSELLDALPKCLDEDSEERLS 427 (1351)
T ss_pred HHHHHhhhhhcCcccccccc------------------hhhhhcc------------ccchhhhhhhhhhcchhhhhccc
Confidence 99999999988765321110 0001110 01114677889999999999999
Q ss_pred HHHHHHHHh
Q 008216 540 MSHVVHQLQ 548 (573)
Q Consensus 540 ~~evl~~L~ 548 (573)
+.+++...-
T Consensus 428 ~~~ll~~~f 436 (1351)
T KOG1035|consen 428 ALELLTHPF 436 (1351)
T ss_pred hhhhhhchh
Confidence 999997654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00056 Score=66.15 Aligned_cols=72 Identities=13% Similarity=0.031 Sum_probs=47.8
Q ss_pred eecccCceEEEEEEeCC--CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCc-EeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 276 LLGDSKTGGTYSGILPD--GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN-LVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
.|..|-...+|+....+ ++.|++|+...... ......+|+.++..+...+ .+++++... ..++|||++|.++
T Consensus 5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 46788889999988754 67899998764321 1123347888888884333 344544332 2489999998766
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00079 Score=62.45 Aligned_cols=120 Identities=27% Similarity=0.373 Sum_probs=84.6
Q ss_pred CeeecccCc-eEEEEEEeCCCCEEEEEEeccc---c-------h-----------hhHHHHHHHHHHHhhc---CCCcE-
Q 008216 274 NRLLGDSKT-GGTYSGILPDGSRVAVKRLKRS---S-------F-----------QRKKEFYSEIGRFARL---HHPNL- 327 (573)
Q Consensus 274 ~~~lg~G~~-g~Vy~~~~~~g~~vavK~~~~~---~-------~-----------~~~~~~~~E~~~l~~l---~h~nI- 327 (573)
-+.||.|.- |.||+++. +|+.+|+|+++.- . . .....|..|.+...+| .+.++
T Consensus 42 lefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~ 120 (207)
T PF13095_consen 42 LEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLW 120 (207)
T ss_pred eeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCce
Confidence 346899999 99999999 7889999994320 0 0 1123477888887777 34566
Q ss_pred -eEEeeEEeeC------------------CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 008216 328 -VAVKGCCYDH------------------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388 (573)
Q Consensus 328 -v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 388 (573)
++.+|+..-. ....||.||.+... .++... +.+|.+-|..+|..
T Consensus 121 Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~----~~~~~~dl~~~~k~ 183 (207)
T PF13095_consen 121 AVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRD----IPQMLRDLKILHKL 183 (207)
T ss_pred EEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhH----HHHHHHHHHHHHHC
Confidence 8999987422 11257777765432 123333 45677778889999
Q ss_pred CCCCeEEcCCCCCCeeeCCCCCeeEecccCC
Q 008216 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (573)
Q Consensus 389 ~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 419 (573)
||+-+|+++.|.. .-||+|||.+
T Consensus 184 ---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 184 ---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ---CeeeccCcccccc-----CCEEEecccC
Confidence 9999999999986 4589999864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.0012 Score=66.99 Aligned_cols=161 Identities=16% Similarity=0.163 Sum_probs=86.0
Q ss_pred ccCHHHHHHhhcCCCc----CCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCC--CcEeEE
Q 008216 257 VFTTEELRSITKNFSE----GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH--PNLVAV 330 (573)
Q Consensus 257 ~~~~~el~~~~~~~~~----~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l 330 (573)
..+.+++..+...|.. ..+.++.|....+|+....+| .+++|+.... ..+.+..|+.++..|.. -.+.++
T Consensus 6 ~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~ 81 (319)
T PRK05231 6 DVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAP 81 (319)
T ss_pred cCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcc
Confidence 3455666665555533 123456777788999887555 6889987622 22344445555555521 113333
Q ss_pred ee------EEeeCCceEEEEEecCCCCHH-----------HHhc---cCCC-------CCCCCCH-HHHH----------
Q 008216 331 KG------CCYDHGDRYIVYEFVVNGPLD-----------RWLH---HIPR-------GGRSLDW-AMRM---------- 372 (573)
Q Consensus 331 ~~------~~~~~~~~~lv~e~~~~gsL~-----------~~l~---~~~~-------~~~~l~~-~~~~---------- 372 (573)
+. +....+..++++|+++|..+. +.+. .... ....+.+ ....
T Consensus 82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (319)
T PRK05231 82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE 161 (319)
T ss_pred eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence 32 112345678999999886431 1111 1000 0001111 1111
Q ss_pred --HHH-HHHHHHHHHHHh----CCCCCeEEcCCCCCCeeeCCCCCeeEecccCCcc
Q 008216 373 --KVA-TTLAQGIAFLHD----KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 373 --~i~-~qi~~~L~~LH~----~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 421 (573)
..+ ..+...++.+.+ ....+++|+|+.|.||+++.+...-++||+.+..
T Consensus 162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 011 111122233321 1345899999999999999765568999998754
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0014 Score=68.02 Aligned_cols=74 Identities=18% Similarity=0.027 Sum_probs=53.6
Q ss_pred eeecccCceEEEEEEeCCC-CEEEEEEeccc------c-hhhHHHHHHHHHHHhhcC---CCcEeEEeeEEeeCCceEEE
Q 008216 275 RLLGDSKTGGTYSGILPDG-SRVAVKRLKRS------S-FQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~g-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv 343 (573)
+.||.|....||++...+| +.|+||.-... . ....++...|.+.|..+. ..++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 3579999999999998777 48999985421 1 123456777888888762 3467777776 44567899
Q ss_pred EEecCCC
Q 008216 344 YEFVVNG 350 (573)
Q Consensus 344 ~e~~~~g 350 (573)
||++++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0016 Score=65.82 Aligned_cols=161 Identities=14% Similarity=0.185 Sum_probs=90.3
Q ss_pred cCHHHHHHhhcCCCcC----CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCC--CcEeEEe
Q 008216 258 FTTEELRSITKNFSEG----NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH--PNLVAVK 331 (573)
Q Consensus 258 ~~~~el~~~~~~~~~~----~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~ 331 (573)
.+.+++......|... .+.++.|....+|+....+| .+++|+..... ..+.+..|+.++..|.. -.+++++
T Consensus 7 ~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i 83 (307)
T TIGR00938 7 VSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPV 83 (307)
T ss_pred CCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 3456666665555332 34567777789999876444 67789875532 23345567777777632 2244444
Q ss_pred eEE------eeCCceEEEEEecCCCCHH-----------HH---hccCCC----CCC----CCCHHHHH-----------
Q 008216 332 GCC------YDHGDRYIVYEFVVNGPLD-----------RW---LHHIPR----GGR----SLDWAMRM----------- 372 (573)
Q Consensus 332 ~~~------~~~~~~~lv~e~~~~gsL~-----------~~---l~~~~~----~~~----~l~~~~~~----------- 372 (573)
... ...+..++++||++|..+. .. ++.... ... .-.|....
T Consensus 84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~ 163 (307)
T TIGR00938 84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE 163 (307)
T ss_pred cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence 321 1235678999999885432 11 111000 000 00111100
Q ss_pred -HHHHHHHHHHHHHHh----CCCCCeEEcCCCCCCeeeCCCCCeeEecccCCcc
Q 008216 373 -KVATTLAQGIAFLHD----KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 373 -~i~~qi~~~L~~LH~----~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 421 (573)
.....+...++++.. ....+++|+|+.+.||+++.++...|+||+.+..
T Consensus 164 ~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 164 AHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 011223344555542 2245899999999999999887678999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 573 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-41 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-39 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-31 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-31 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-31 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-29 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-29 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-28 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-06 | ||
| 1jwi_A | 131 | Crystal Structure Of Bitiscetin, A Von Willeband Fa | 5e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-05 | ||
| 2afp_A | 129 | The Solution Structure Of Type Ii Antifreeze Protei | 3e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-05 | ||
| 2zib_A | 133 | Crystal Structure Analysis Of Calcium-Independent T | 6e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-05 | ||
| 1fvu_B | 125 | Crystal Structure Of Botrocetin Length = 125 | 8e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-04 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-04 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-04 | ||
| 1sl6_A | 184 | Crystal Structure Of A Fragment Of Dc-signr (contai | 8e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1JWI|A Chain A, Crystal Structure Of Bitiscetin, A Von Willeband Factor- Dependent Platelet Aggregation Inducer. Length = 131 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2AFP|A Chain A, The Solution Structure Of Type Ii Antifreeze Protein Reveals A New Member Of The Lectin Family Length = 129 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2ZIB|A Chain A, Crystal Structure Analysis Of Calcium-Independent Type Ii Antifreeze Protein Length = 133 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1FVU|B Chain B, Crystal Structure Of Botrocetin Length = 125 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1SL6|A Chain A, Crystal Structure Of A Fragment Of Dc-signr (containg The Carbohydrate Recognition Domain And Two Repeats Of The Neck) Complexed With Lewis-x. Length = 184 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 323 bits (830), Expect = e-107
Identities = 101/299 (33%), Positives = 165/299 (55%), Gaps = 13/299 (4%)
Query: 254 SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQ-RKKEF 312
K F+ EL+ + NFS N +LG G Y G L DG+ VAVKRLK Q + +F
Sbjct: 16 QLKRFSLRELQVASDNFSNKN-ILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF 74
Query: 313 YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 372
+E+ + H NL+ ++G C +R +VY ++ NG + L P LDW R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT- 431
++A A+G+A+LHD P ++HRD++A+N+LLDEEF A + GL+K + ++ T
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194
Query: 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP---AQAVDSVCWQSIFEW 488
V GT G++APE++ + + K+DV+ +GV+LLE+++G+R A+ + + +W
Sbjct: 195 VR--GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD-VMLLDW 251
Query: 489 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547
L++ + L+D L + + V++++ + CTQ P RP+MS VV L
Sbjct: 252 VKGLLKEKKLEALVDV---DLQGNYKDEE-VEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 314 bits (807), Expect = e-103
Identities = 94/326 (28%), Positives = 160/326 (49%), Gaps = 19/326 (5%)
Query: 233 SKRRRKSRKLSNPAASALVPPSW-KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILP 291
SK + + +++ +S+ + P +L T NF L+G G Y G+L
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKF-LIGHGVFGKVYKGVLR 61
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
DG++VA+KR S Q +EF +EI + HP+LV++ G C + + ++Y+++ NG
Sbjct: 62 DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
L R L+ S+ W R+++ A+G+ +LH ++HRD+++ N+LLDE F
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVP 178
Query: 412 HLMGVGLSKFVPWEVMQERT-----VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
+ G+SK ++T V GT GY+ PE+ + LT KSDVYSFGV+L E
Sbjct: 179 KITDFGISKKGTEL---DQTHLSTVVK--GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233
Query: 467 IVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLV 526
++ R ++ EWA + + +++DP +L+ I ++K D
Sbjct: 234 VLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP---NLADKIRPES-LRKFGDTA 289
Query: 527 YACTQHVPSMRPRMSHVVHQLQQLAQ 552
C RP M V+ +L+ +
Sbjct: 290 VKCLALSSEDRPSMGDVLWKLEYALR 315
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 3e-96
Identities = 99/309 (32%), Positives = 153/309 (49%), Gaps = 29/309 (9%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTG----GT-YSGILPDGSRVAVKRLK----RSSF 306
F+ EL+++T NF E +G +K G G Y G + + + VAVK+L ++
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 307 QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL 366
+ K++F EI A+ H NLV + G D D +VY ++ NG L L G L
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPL 130
Query: 367 DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426
W MR K+A A GI FLH+ H +HRDI+++N+LLDE F A + GL++
Sbjct: 131 SWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 427 MQERT--VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVD-SVCWQ 483
T ++ GT Y+APE + R E+T KSD+YSFGV+LLEI++G VD Q
Sbjct: 188 QTVMTSRIV--GTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPA---VDEHREPQ 241
Query: 484 SIFEWATPLVQSHRYLE-LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSH 542
+ + + + +E +D ++ S V+ + + C + RP +
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKMNDADST-----SVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 543 VVHQLQQLA 551
V LQ++
Sbjct: 297 VQQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-57
Identities = 66/320 (20%), Positives = 113/320 (35%), Gaps = 40/320 (12%)
Query: 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK---RSSFQRKKEFYS 314
TE L + + G + VAVK + S+Q + E YS
Sbjct: 14 LGTENLYFQSMPLQLLEVK-ARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQNEYEVYS 71
Query: 315 EIGRFARLHHPNLVAVKGCC----YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAM 370
+ H N++ G D +++ F G L +L + W
Sbjct: 72 ----LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNE 122
Query: 371 RMKVATTLAQGIAFLH-------DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423
+A T+A+G+A+LH D KP + HRDI++ NVLL A + GL+
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 424 WEVMQERTVMAGGTYGYLAPE-----FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVD 478
T GT Y+APE ++ + + D+Y+ G++L E+ S A
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 479 SVCWQSIFEWATPL------VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQH 532
FE +Q + P++ + + + + + C H
Sbjct: 243 DEY-MLPFEEEIGQHPSLEDMQEVVVHKKKRPVL---RDYWQKHAGMAMLCETIEECWDH 298
Query: 533 VPSMRPRMSHVVHQLQQLAQ 552
R V ++ Q+ +
Sbjct: 299 DAEARLSAGCVGERITQMQR 318
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-50
Identities = 79/275 (28%), Positives = 130/275 (47%), Gaps = 41/275 (14%)
Query: 293 GSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
GS VAVK L F +R EF E+ RL HPN+V G + IV E++ G
Sbjct: 60 GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L R LH LD R+ +A +A+G+ +LH++ P +VHR++++ N+L+D+++
Sbjct: 120 SLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYT 177
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAG-GTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIV 468
+ GLS+ + + + GT ++APE V R+E KSDVYSFGV+L E+
Sbjct: 178 VKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPE-VLRDEPSNEKSDVYSFGVILWELA 233
Query: 469 SGRRP------AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV 522
+ ++P AQ V +V ++ +IP + +V
Sbjct: 234 TLQQPWGNLNPAQVVAAVGFK------------------------CKRLEIPR-NLNPQV 268
Query: 523 VDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTK 557
++ C + P RP + ++ L+ L + V
Sbjct: 269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 4e-50
Identities = 73/282 (25%), Positives = 125/282 (44%), Gaps = 45/282 (15%)
Query: 283 GGTYSGILPDGSRVAVKRLKRSSFQ----RKKEFYSEIGRFARLHHPNLVAVKGCCYDHG 338
G Y G VAVK + + + E FA L HPN++A++G C
Sbjct: 21 GKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP 79
Query: 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
+ +V EF GPL+R L G+ + + + A +A+G+ +LHD+ ++HRD+
Sbjct: 80 NLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDL 134
Query: 399 RASNVLLDEEFGAHLMGV--------GLSKFVPWEVMQERTVMAG-GTYGYLAPEFVYRN 449
++SN+L+ ++ + GL++ T M+ G Y ++APE V R
Sbjct: 135 KSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAWMAPE-VIRA 188
Query: 450 EL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508
+ + SDV+S+GVLL E+++G P + +D A + + L
Sbjct: 189 SMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAYGVAMNKLALP-------- 234
Query: 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
+ S PE L+ C P RP ++++ QL +
Sbjct: 235 IPSTCPEP-----FAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 3e-49
Identities = 62/290 (21%), Positives = 114/290 (39%), Gaps = 51/290 (17%)
Query: 277 LGDSKTGGTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCC 334
L ++ +G + G G+ + VK LK + ++ ++F E R HPN++ V G C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 335 YD--HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
++ ++ G L LH +D + +K A +A+G+AFLH +P
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL-EPL 133
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE-- 450
+ + + +V++DE+ A + + Q M ++APE + +
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFS-----FQSPGRM--YAPAWVAPE-ALQKKPE 185
Query: 451 --LTTKSDVYSFGVLLLEIVSGRRP------AQAVDSVCWQSIFEWATPLVQSHRYLELL 502
+D++SF VLL E+V+ P + V +
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE------------------- 226
Query: 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
L IP G+ V L+ C P+ RP+ +V L+++
Sbjct: 227 -----GLRPTIPP-GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-47
Identities = 65/281 (23%), Positives = 119/281 (42%), Gaps = 45/281 (16%)
Query: 286 YSGI-LPDGSRVAVKRLKRSSFQ-------RKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337
+ G + D S VA+K L + + +EF E+ + L+HPN+V + G ++
Sbjct: 36 HKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN- 94
Query: 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
+V EFV G L L + W++++++ +A GI ++ ++ P +VHRD
Sbjct: 95 -PPRMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRD 149
Query: 398 IRASNVLLDEEFGAHLMGV-----GLSKFVPWEVMQERTVMAG-GTYGYLAPE-FVYRNE 450
+R+ N+ L + GLS+ +V G + ++APE E
Sbjct: 150 LRSPNIFLQSLDENAPVCAKVADFGLSQ------QSVHSVSGLLGNFQWMAPETIGAEEE 203
Query: 451 L-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509
T K+D YSF ++L I++G P + F + + +
Sbjct: 204 SYTEKADTYSFAMILYTILTGEGPFDEYSYG--KIKFINM--IREEGLRPT--------I 251
Query: 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
D P ++ +++ C P RP S++V +L +L
Sbjct: 252 PEDCPP-----RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 6e-47
Identities = 64/276 (23%), Positives = 114/276 (41%), Gaps = 46/276 (16%)
Query: 286 YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345
VA+K+++ S +K F E+ + +R++HPN+V + G C + +V E
Sbjct: 25 CKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVME 79
Query: 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405
+ G L LH A M +QG+A+LH ++HRD++ N+LL
Sbjct: 80 YAEGGSLYNVLHG-AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL 138
Query: 406 DEE--------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSD 456
FG + +Q G+ ++APE V+ + K D
Sbjct: 139 VAGGTVLKICDFG-------TACD-----IQTHMTNNKGSAAWMAPE-VFEGSNYSEKCD 185
Query: 457 VYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEA 516
V+S+G++L E+++ R+P + ++ WA V + L ++P+
Sbjct: 186 VFSWGIILWEVITRRKPFDEIGGPAFR--IMWA---VHNGTRPP--------LIKNLPKP 232
Query: 517 GVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
+ L+ C PS RP M +V + L +
Sbjct: 233 -----IESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-44
Identities = 62/282 (21%), Positives = 120/282 (42%), Gaps = 49/282 (17%)
Query: 284 GTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
G + G VAVK L ++ Q+ + F +E+G + H N++ G
Sbjct: 43 GKWHG------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLA 95
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
IV ++ L LH + + +A A+G+ +LH K ++HRD++++
Sbjct: 96 IVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSN 149
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL----TTKSDV 457
N+ L E+ + GL+ + G+ ++APE V R + + +SDV
Sbjct: 150 NIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSNPYSFQSDV 208
Query: 458 YSFGVLLLEIVSGRRP-------AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
Y+FG++L E+++G+ P Q ++ V L P +S +
Sbjct: 209 YAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG-----------------SLSPDLSKVR 251
Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
S+ P+ + L+ C + RP ++ ++++LA+
Sbjct: 252 SNCPKR-----MKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-42
Identities = 51/292 (17%), Positives = 105/292 (35%), Gaps = 64/292 (21%)
Query: 284 GTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
G + G VA++ + + K F E+ + + H N+V G C
Sbjct: 52 GRWHG------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
I+ L + LD ++A + +G+ +LH K ++H+D+++
Sbjct: 106 IITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSK 159
Query: 402 NVLLDEE------FGAHLMGVGLSKFV-PWEVMQERTVMAG--GTYGYLAPEFVYRNEL- 451
NV D F GL + + + G +LAPE + R
Sbjct: 160 NVFYDNGKVVITDF-------GLFSISGVLQAGRREDKLRIQNGWLCHLAPE-IIRQLSP 211
Query: 452 ---------TTKSDVYSFGVLLLEIVSGRRP--AQAVDSVCWQSIFEWATPLVQSHRYLE 500
+ SDV++ G + E+ + P Q +++ WQ + +
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ--------MGTGMK--- 260
Query: 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
++ + G+ +++ D++ C RP + ++ L++L +
Sbjct: 261 ----------PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 8e-42
Identities = 63/301 (20%), Positives = 111/301 (36%), Gaps = 40/301 (13%)
Query: 284 GTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343
T+ G + +K L R + ++ F E+ L HPN++ G Y +
Sbjct: 29 VTHRE---TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85
Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
E++ G L + W+ R+ A +A G+A+LH +++HRD+ + N
Sbjct: 86 TEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNC 139
Query: 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG------------GTYGYLAPEFVYRNEL 451
L+ E + GL++ + E Q + + G ++APE +
Sbjct: 140 LVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY 199
Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511
K DV+SFG++L EI+ F + +L+ P
Sbjct: 200 DEKVDVFSFGIVLCEIIGRVNADPDYLPR--TMDF-----GLNVRGFLDRYCP------P 246
Query: 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKL-LFKGLDRLRHIF 570
+ P + + C P RP + H L+ L L L L++L F
Sbjct: 247 NCPPS-----FFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGF 301
Query: 571 F 571
+
Sbjct: 302 W 302
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 71/330 (21%), Positives = 117/330 (35%), Gaps = 49/330 (14%)
Query: 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK---RSSFQRKKEFYS 314
E N + G + G Y G L D VAVK R +F +K Y
Sbjct: 3 AAASEPSLDLDNLKLLELI-GRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIY- 59
Query: 315 EIGRFARLHHPNLVAVKGCCY-----DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 369
R + H N+ + +V E+ NG L ++L + DW
Sbjct: 60 ---RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWV 111
Query: 370 MRMKVATTLAQGIAFLH------DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423
++A ++ +G+A+LH D KP + HRD+ + NVL+ + + GLS +
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 424 WEVMQERTVMAG------GTYGYLAPE-------FVYRNELTTKSDVYSFGVLLLEIVSG 470
+ GT Y+APE + D+Y+ G++ EI
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
Query: 471 RRPAQAVDSVC-WQSIFEWATPLVQSHRYLELLDPLISS--LSSDIPEA-----GVVQKV 522
+SV +Q F+ V +H E + L+S PEA V+ +
Sbjct: 232 CTDLFPGESVPEYQMAFQT---EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288
Query: 523 VDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
+ + C R ++ +L
Sbjct: 289 KETIEDCWDQDAEARLTAQXAEERMAELMM 318
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-39
Identities = 59/295 (20%), Positives = 117/295 (39%), Gaps = 33/295 (11%)
Query: 286 YSGILPDGSRVAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-- 340
+ G G +VAVK +S+ R+ E Y + H N++
Sbjct: 54 WMGKW-RGEKVAVKVFFTTEEASWFRETEIYQ----TVLMRHENILGFIAADIKGTGSWT 108
Query: 341 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHV 393
Y++ ++ NG L +L +LD +K+A + G+ LH ++ KP +
Sbjct: 109 QLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAI 163
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPE------F 445
HRD+++ N+L+ + + +GL+ + + GT Y+ PE
Sbjct: 164 AHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLN 223
Query: 446 VYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS--VCWQSIFEWATPLVQSHRYLELLD 503
+ +D+YSFG++L E+ V+ + + + + P + R + +
Sbjct: 224 RNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV-PSDPSYEDMREIVCIK 282
Query: 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKL 558
L S + ++++ L+ C H P+ R V L ++++ KL
Sbjct: 283 KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDIKL 337
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 57/296 (19%), Positives = 108/296 (36%), Gaps = 47/296 (15%)
Query: 286 YSGILPDGSRVAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-- 340
+ G G VAVK S+ R+ E Y L H N++
Sbjct: 59 WRGKW-RGEEVAVKIFSSREERSWFREAEIYQT----VMLRHENILGFIAADNKDNGTWT 113
Query: 341 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHV 393
++V ++ +G L +L+ ++ +K+A + A G+A LH ++ KP +
Sbjct: 114 QLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 168
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNEL 451
HRD+++ N+L+ + + +GL+ GT Y+APE V + +
Sbjct: 169 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSI 227
Query: 452 -------TTKSDVYSFGVLLLEIVSGRRPAQAVDS--------VCWQSIFEWATPLVQSH 496
++D+Y+ G++ EI + V E +V
Sbjct: 228 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 287
Query: 497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
+ L P I + ++ + ++ C + R + L QL+Q
Sbjct: 288 K----LRPNIPNRWQSCE---ALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 63/318 (19%), Positives = 118/318 (37%), Gaps = 52/318 (16%)
Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLK---RSSFQRKKEFYSEIGRFA 320
R++ ++ + + G + G + G G VAVK S+ R+ E Y+
Sbjct: 4 RTVARDITLLECV-GKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNT----V 57
Query: 321 RLHHPNLV----AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 376
L H N++ + + +++ + G L +L +LD +++
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVL 112
Query: 377 TLAQGIAFLH-----DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431
++A G+A LH + KP + HRD+++ N+L+ + + +GL+ Q
Sbjct: 113 SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV 172
Query: 432 VMAG--GTYGYLAPEFVYRNEL-------TTKSDVYSFGVLLLEIVSGRRPAQAV----- 477
GT Y+APE V + + D+++FG++L E+ V
Sbjct: 173 GNNPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231
Query: 478 ---DSVCWQSIFEWATPLV--QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQH 532
D V FE +V R P I + + + L+ C
Sbjct: 232 PFYDVVPNDPSFEDMRKVVCVDQQR------PNI---PNRWFSDPTLTSLAKLMKECWYQ 282
Query: 533 VPSMRPRMSHVVHQLQQL 550
PS R + L ++
Sbjct: 283 NPSARLTALRIKKTLTKI 300
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-33
Identities = 73/294 (24%), Positives = 110/294 (37%), Gaps = 51/294 (17%)
Query: 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
+G G +SG L D + VAVK + K +F E + HPN+V + G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
C YIV E V G +L G L +++ A G+ +L K
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESK---C 233
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APEFVY 447
+HRD+ A N L+ E+ + G+S+ + A G + APE +
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR-----EEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 448 RNELTTKSDVYSFGVLLLEIVS-GRRP------AQAVDSVCWQSIFEWATPLVQSHRYLE 500
+++SDV+SFG+LL E S G P Q + V + R
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE------------KGGR--- 333
Query: 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
L PE V L+ C + P RP S + +LQ + +
Sbjct: 334 -LPC---------PE-LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 76/286 (26%), Positives = 118/286 (41%), Gaps = 43/286 (15%)
Query: 284 GTYSGILPDGS--RVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
G SG+ D S +VAVK L S Q + +F E ++ +H N+V G R
Sbjct: 49 GQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108
Query: 341 YIVYEFVVNGPLDRWL-HHIPRGGRSLDWAMR--MKVATTLAQGIAFLHDKVKPHVVHRD 397
+I+ E + G L +L PR + AM + VA +A G +L + H +HRD
Sbjct: 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRD 165
Query: 398 IRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRN 449
I A N LL + + G+++ + + G L PE
Sbjct: 166 IAARNCLLTCPGPGRVAKIGDFGMARDI-----YRASYYRKGGCAMLPVKWMPPEAFMEG 220
Query: 450 ELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508
T+K+D +SFGVLL EI S G P + Q + E+ + R +DP
Sbjct: 221 IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEF---VTSGGR----MDP---- 266
Query: 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
P+ V ++ C QH P RP + ++ +++ Q P
Sbjct: 267 -----PK-NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-31
Identities = 75/280 (26%), Positives = 122/280 (43%), Gaps = 29/280 (10%)
Query: 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
LG + G Y G+ VAVK LK + + + EF E + HPNLV + G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 284
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
C YI+ EF+ G L +L + + + + +AT ++ + +L K +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NF 339
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT 453
+HR++ A N L+ E + GLS+ + + A + APE + N+ +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYNKFSI 398
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512
KSDV++FGVLL EI + G P +D ++ + L +
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRME 439
Query: 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
PE G +KV +L+ AC Q PS RP + + + + Q
Sbjct: 440 RPE-GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 76/286 (26%), Positives = 117/286 (40%), Gaps = 43/286 (15%)
Query: 284 GTYSGILPDGS--RVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
G SG+ D S +VAVK L S Q + +F E ++ +H N+V G R
Sbjct: 90 GQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149
Query: 341 YIVYEFVVNGPLDRWL-HHIPRGGRSLDWAMR--MKVATTLAQGIAFLHDKVKPHVVHRD 397
+I+ E + G L +L PR + AM + VA +A G +L + H +HRD
Sbjct: 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRD 206
Query: 398 IRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRN 449
I A N LL + + G+++ + G L PE
Sbjct: 207 IAARNCLLTCPGPGRVAKIGDFGMARDI-----YRAGYYRKGGCAMLPVKWMPPEAFMEG 261
Query: 450 ELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508
T+K+D +SFGVLL EI S G P + Q + E+ + R +DP
Sbjct: 262 IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEF---VTSGGR----MDP---- 307
Query: 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
P+ V ++ C QH P RP + ++ +++ Q P
Sbjct: 308 -----PK-NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 68/296 (22%), Positives = 114/296 (38%), Gaps = 58/296 (19%)
Query: 284 GTYSGILPDGS--RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
+ P VAVK LK + +K+F E L H ++V G C D
Sbjct: 34 AECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 93
Query: 342 IVYEFVVNGPLDRWL------------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
+V+E++ +G L+++L + L + + +A+ +A G+ +L +
Sbjct: 94 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ- 152
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL--- 441
H VHRD+ N L+ + G+S R V + Y L
Sbjct: 153 --HFVHRDLATRNCLVGANLLVKIGDFGMS----------RDVYSTDYYRVGGHTMLPIR 200
Query: 442 --APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRY 498
PE + + TT+SDV+SFGV+L EI + G++P + + E + R
Sbjct: 201 WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS---NTEVIE----CITQGRV 253
Query: 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
LE P ++V D++ C Q P R + + L L +
Sbjct: 254 LE------------RPR-VCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKAT 296
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-31
Identities = 63/290 (21%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 284 GTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-- 340
Y + + G VAVK+L+ S+ + ++F EI L H N+V KG CY G R
Sbjct: 29 CRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
++ E++ G L +L + +D ++ + + +G+ +L K +HRD+
Sbjct: 89 KLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLAT 142
Query: 401 SNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT------YGYLAPEFVYRNEL 451
N+L++ E + + + GL+K +P + +E + Y APE + ++
Sbjct: 143 RNILVENE---NRVKIGDFGLTKVLPQD--KEFFKVKEPGESPIFWY---APESLTESKF 194
Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD-------P 504
+ SDV+SFGV+L E+ + +++ + + I + +ELL P
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 254
Query: 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
P+ + ++ C + + RP + ++ Q+
Sbjct: 255 ------DGCPDE-----IYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 72/295 (24%), Positives = 116/295 (39%), Gaps = 57/295 (19%)
Query: 284 GTYSGILPDGS--RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
+LP+ VAVK LK +S +++F E L H ++V G C +
Sbjct: 60 AECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119
Query: 342 IVYEFVVNGPLDRWL-----------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
+V+E++ +G L+R+L L + VA+ +A G+ +L
Sbjct: 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL-- 177
Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL---- 441
H VHRD+ N L+ + + G+S R + + Y L
Sbjct: 178 -HFVHRDLATRNCLVGQGLVVKIGDFGMS----------RDIYSTDYYRVGGRTMLPIRW 226
Query: 442 -APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499
PE + + TT+SDV+SFGV+L EI + G++P + + + R L
Sbjct: 227 MPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS---NTEAID----CITQGREL 279
Query: 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
E P +V ++ C Q P R + V +LQ LAQ P
Sbjct: 280 E------------RPR-ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 63/298 (21%), Positives = 104/298 (34%), Gaps = 68/298 (22%)
Query: 284 GTYSGILPDGS----RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD 339
G + G V +K L ++ + F+ ++L H +LV G C +
Sbjct: 27 GVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86
Query: 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
+V EFV G LD +L + ++ +++VA LA + FL + ++H ++
Sbjct: 87 NILVQEFVKFGSLDTYLK---KNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVC 140
Query: 400 ASNVLLDEEFGAHLMGV--------GLSKF----------VPWEVMQERTVMAGGTYGYL 441
A N+LL E G+S +PW +
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPW----------------V 184
Query: 442 APE-FVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499
PE L +D +SFG L EI S G +P A+DS Q + + L
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS---QRKLQ----FYEDRHQL 237
Query: 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTK 557
E + +L+ C + P RP ++ L L P +
Sbjct: 238 PAPKA---------AE------LANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 63/297 (21%), Positives = 118/297 (39%), Gaps = 53/297 (17%)
Query: 284 GTYSGILPDGS--RVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
G G++ D RVA+K + +S + + EF +E + ++V + G
Sbjct: 44 GVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103
Query: 341 YIVYEFVVNGPLDRWL------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
++ E + G L +L + +++A +A G+A+L+ V
Sbjct: 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFV 160
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL-----APE 444
HRD+ A N ++ E+F + G++ R + Y G L +PE
Sbjct: 161 HRDLAARNCMVAEDFTVKIGDFGMT----------RDIYETDYYRKGGKGLLPVRWMSPE 210
Query: 445 FVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503
+ TT SDV+SFGV+L EI + +P Q + + + V L+
Sbjct: 211 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NEQVLR----FVMEGGLLD--- 260
Query: 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKLLF 560
P+ + +L+ C Q+ P MRP ++ +++ +P ++ F
Sbjct: 261 ---------KPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 307
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 72/291 (24%), Positives = 125/291 (42%), Gaps = 47/291 (16%)
Query: 284 GTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-- 340
Y + + G+ VAVK+L+ S ++++F EI LH +V +G Y G +
Sbjct: 42 CRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
+V E++ +G L +L R LD + + ++ + +G+ +L + VHRD+ A
Sbjct: 102 RLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAA 155
Query: 401 SNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT------YGYLAPEFVYRNEL 451
N+L++ E + + GL+K +P + ++ V+ Y APE + N
Sbjct: 156 RNILVESE---AHVKIADFGLAKLLPLD--KDYYVVREPGQSPIFWY---APESLSDNIF 207
Query: 452 TTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD------- 503
+ +SDV+SFGV+L E+ + + S + + + R LELL+
Sbjct: 208 SRQSDVWSFGVVLYELFTYCDKSCS--PSAEFLRMMGCERDVPALSRLLELLEEGQRLPA 265
Query: 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
P P V +L+ C P RP S + QL L
Sbjct: 266 P------PACPAE-----VHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 63/286 (22%), Positives = 124/286 (43%), Gaps = 44/286 (15%)
Query: 284 GTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-- 340
Y + + G VAVK+L+ S+ + ++F EI L H N+V KG CY G R
Sbjct: 60 CRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
++ E++ G L +L + +D ++ + + +G+ +L K +HRD+
Sbjct: 120 KLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLAT 173
Query: 401 SNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT------YGYLAPEFVYRNEL 451
N+L++ E + + + GL+K +P + +E + Y APE + ++
Sbjct: 174 RNILVENE---NRVKIGDFGLTKVLPQD--KEYYKVKEPGESPIFWY---APESLTESKF 225
Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD-------P 504
+ SDV+SFGV+L E+ + +++ + + I + +ELL P
Sbjct: 226 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 285
Query: 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
P+ + ++ C + + RP + ++ Q+
Sbjct: 286 ------DGCPDE-----IYMIMTECWNNNVNQRPSFRDLALRVDQI 320
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 54/258 (20%), Positives = 106/258 (41%), Gaps = 47/258 (18%)
Query: 295 RVAVKRLKRSSFQRKKEFYSEIGRF-------ARLHHPNLVAVKGCCYDHGD----RYIV 343
+VA+K + + K+E + RF ++L H N+V++ D + Y+V
Sbjct: 38 KVAIKAI-FIPPREKEET---LKRFEREVHNSSQLSHQNIVSM----IDVDEEDDCYYLV 89
Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
E++ L ++ G L + + GI HD +VHRDI+ N+
Sbjct: 90 MEYIEGPTLSEYIE---SHGP-LSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNI 142
Query: 404 LLDEEFGAHLMGVGLSKFVPWEVM-QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
L+D + G++K + + Q V+ GT Y +PE +D+YS G+
Sbjct: 143 LIDSNKTLKIFDFGIAKALSETSLTQTNHVL--GTVQYFSPEQAKGEATDECTDIYSIGI 200
Query: 463 LLLEIVSGRRPAQAVDSVCWQSIFEWATPL-VQSHRYLELLDPLISSLSSDIPEAGVVQK 521
+L E++ G P F T + + + + + + + DIP++
Sbjct: 201 VLYEMLVGEPP------------FNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS----- 243
Query: 522 VVDLVYACTQHVPSMRPR 539
+ +++ T+ + R +
Sbjct: 244 LSNVILRATEKDKANRYK 261
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 67/288 (23%), Positives = 120/288 (41%), Gaps = 44/288 (15%)
Query: 284 GTYSGILPD-GSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR- 340
Y + G +VAVK LK S + EI L+H N+V KG C + G
Sbjct: 40 CRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99
Query: 341 -YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
++ EF+ +G L +L P+ ++ ++K A + +G+ +L + VHRD+
Sbjct: 100 IKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLA 153
Query: 400 ASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT------YGYLAPEFVYRNE 450
A NVL++ E H + + GL+K + + +E + Y APE + +++
Sbjct: 154 ARNVLVESE---HQVKIGDFGLTKAIETD--KEYYTVKDDRDSPVFWY---APECLMQSK 205
Query: 451 LTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFE-WATPLVQSHRYLE----LLDP 504
SDV+SFGV L E+++ + + + + L+ L P
Sbjct: 206 FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCP 265
Query: 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
+ P+ V L+ C + PS R +++ + L +
Sbjct: 266 ------PNCPDE-----VYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 66/288 (22%), Positives = 121/288 (42%), Gaps = 41/288 (14%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+ +G + G + G + +VA+K ++ + +++F E +L HP LV + G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
+ +V EF+ +G L +L + + + +G+A+L + V+
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVI 126
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVYR 448
HRD+ A N L+ E + G+++FV + + T G +PE
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDD---QYTSSTGTKFPVKWA----SPEVFSF 179
Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507
+ ++KSDV+SFGVL+ E+ S G+ P + S E + R L
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENR------SNSEVVEDISTGFR----LYK--- 226
Query: 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPV 555
P V ++ C + P RP S ++ QL ++A+ +
Sbjct: 227 ------PR-LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 42/357 (11%), Positives = 85/357 (23%), Gaps = 65/357 (18%)
Query: 227 LLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTY 286
L+ Y R + ++ + + + P + + L + L +
Sbjct: 21 LIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLV-EPLRVGDRSVVF 79
Query: 287 SGI-LPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCC-------- 334
+ A+K + + E + ARL + +
Sbjct: 80 LVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139
Query: 335 ------------------YDHGDRYIVYEFVV--NGPLDRWLHHIPRGGRSLDWAMRMKV 374
Y + ++ L L + +
Sbjct: 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHIL 199
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
L + A L K +VH N+ + + L V V R +
Sbjct: 200 TAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPAS 251
Query: 435 GGTYGYLAPEFVYRNEL--TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL 492
Y EF+ + T + + G+ + + P F TP
Sbjct: 252 SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP------------FGLVTPG 299
Query: 493 VQSHRYLELL-----DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
++ L D L + +P+ V L+ R +
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDF-----VKTLIGRFLNFDRRRRLLPLEAM 351
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 63/292 (21%), Positives = 113/292 (38%), Gaps = 54/292 (18%)
Query: 284 GTYSGILPDGSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR- 340
+VAVK LK + +EF E HP++ + G +
Sbjct: 42 AQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101
Query: 341 -----YIVYEFVVNGPLDRWL--HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
++ F+ +G L +L I +L ++ +A G+ +L + +
Sbjct: 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NF 158
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL-----AP 443
+HRD+ A N +L E+ + GLS R + +G Y L A
Sbjct: 159 IHRDLAARNCMLAEDMTVCVADFGLS----------RKIYSGDYYRQGCASKLPVKWLAL 208
Query: 444 EFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502
E + N T SDV++FGV + EI++ G+ P +++ I+ + L+ +R L
Sbjct: 209 ESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN---AEIYNY---LIGGNR----L 258
Query: 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
P +++V DL+Y C P RP + + +L+ +
Sbjct: 259 KQ---------PP-ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-29
Identities = 72/284 (25%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+ +G + G G G++VAVK +K + + F +E +L H NLV + G
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 335 YDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
+ YIV E++ G L +L RG L +K + + + + +L +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 310
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY--LAPEFVYRNEL 451
VHRD+ A NVL+ E+ A + GL+K + + G APE + +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKF 363
Query: 452 TTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
+TKSDV+SFG+LL EI S GR P + + + + + ++ + P
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPR---VEKGYK---MDAP------ 408
Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
P A V D++ C + RP + QL+ +
Sbjct: 409 DGCPPA-----VYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 67/290 (23%), Positives = 124/290 (42%), Gaps = 53/290 (18%)
Query: 284 GTYSGILPDGSRVAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR- 340
G +VAVK +K SS + +EF SE HPN++ + G C + +
Sbjct: 53 GNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112
Query: 341 ----YIVYEFVVNGPLDRWL--HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
++ F+ G L +L + G + + +K +A G+ +L ++ + +
Sbjct: 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFL 169
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL-----APE 444
HRD+ A N +L ++ + GLS + + +G Y + A E
Sbjct: 170 HRDLAARNCMLRDDMTVCVADFGLS----------KKIYSGDYYRQGRIAKMPVKWIAIE 219
Query: 445 FVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503
+ T+KSDV++FGV + EI + G P V + ++++ L+ HR L
Sbjct: 220 SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN---HEMYDY---LLHGHR----LK 269
Query: 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
PE + ++ +++Y+C + P RP S + QL++L +
Sbjct: 270 Q---------PE-DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 82/288 (28%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 275 RLLGDSKTGGTYSGILPDGS-RVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
LG + G Y G+ S VAVK LK + + + EF E + HPNLV + G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 77
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
C YI+ EF+ G L +L + + + + +AT ++ + +L K +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVY 447
+HRD+ A N L+ E + GLS+ + + T AG T APE +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWT----APESLA 185
Query: 448 RNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506
N+ + KSDV++FGVLL EI + G P +D ++E L + +R ++
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYEL---LEKDYR----MER-- 233
Query: 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
PE G +KV +L+ AC Q PS RP + + + + Q
Sbjct: 234 -------PE-GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 29/281 (10%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
LG G + G +RVA+K LK + + F E +L H LV +
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
+ YIV E++ G L +L G+ L + +A +A G+A++ + V
Sbjct: 249 SEEP-IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 302
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRD+RA+N+L+ E + GL++ + R + APE T K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 361
Query: 455 SDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 513
SDV+SFG+LL E+ + GR P + + + + + + +R + P +
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMV---NREVLDQ---VERGYR---MPCP------PEC 406
Query: 514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
PE+ + DL+ C + P RP ++ L+
Sbjct: 407 PES-----LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-28
Identities = 67/250 (26%), Positives = 110/250 (44%), Gaps = 17/250 (6%)
Query: 227 LLAYRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTY 286
L+ + + +KLS P S+ W+ E I + + + LG + G +
Sbjct: 150 LVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWE----IPRESLKLEKKLGAGQFGEVW 205
Query: 287 SGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
++VAVK +K S + F +E L H LV + YI+ EF
Sbjct: 206 MATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEF 263
Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
+ G L +L G + + +A+G+AF+ + + +HRD+RA+N+L+
Sbjct: 264 MAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVS 318
Query: 407 EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY--LAPEFVYRNELTTKSDVYSFGVLL 464
+ GL++ + E T G + APE + T KSDV+SFG+LL
Sbjct: 319 ASLVCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 375
Query: 465 LEIVS-GRRP 473
+EIV+ GR P
Sbjct: 376 MEIVTYGRIP 385
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 41/285 (14%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+ LG + G G VAVK +K S + EF+ E +L HP LV G C
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
YIV E++ NG L +L G+ L+ + +++ + +G+AFL +
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLR---SHGKGLEPSQLLEMCYDVCEGMAFLESH---QFI 126
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVYR 448
HRD+ A N L+D + + G++++V + + G + APE +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDD---QYVSSVGTKFPVKWS----APEVFHY 179
Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507
+ ++KSDV++FG+L+ E+ S G+ P + E + Q HR L
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMPYDLY------TNSEVVLKVSQGHR----LYR--- 226
Query: 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
P + ++Y+C +P RP ++ ++ L +
Sbjct: 227 ------PH-LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 63/263 (23%), Positives = 107/263 (40%), Gaps = 52/263 (19%)
Query: 295 RVAVKRLKRSSFQRKKEFYSEIGRF-------ARLHHPNLVAVKGCCYDHGD-------- 339
VAVK L R+ R F RF A L+HP +VAV YD G+
Sbjct: 39 DVAVKVL-RADLARDPSF---YLRFRREAQNAAALNHPAIVAV----YDTGEAETPAGPL 90
Query: 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
YIV E+V L +H G + ++V Q + F H ++HRD++
Sbjct: 91 PYIVMEYVDGVTLRDIVH---TEGP-MTPKRAIEVIADACQALNFSHQN---GIIHRDVK 143
Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWE---VMQERTVMAGGTYGYLAPEFVYRNELTTKSD 456
+N+++ +M G+++ + V Q V+ GT YL+PE + + +SD
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI--GTAQYLSPEQARGDSVDARSD 201
Query: 457 VYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEA 516
VYS G +L E+++G P F +P+ +++++ S+ +
Sbjct: 202 VYSLGCVLYEVLTGEPP------------FTGDSPVSVAYQHVREDPIPPSARHEGLSAD 249
Query: 517 GVVQKVVDLVYACTQHVPSMRPR 539
+ +V P R +
Sbjct: 250 -----LDAVVLKALAKNPENRYQ 267
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-28
Identities = 69/277 (24%), Positives = 117/277 (42%), Gaps = 29/277 (10%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
LG G + G +RVA+K LK + + F E +L H LV +
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
+ YIV E++ G L +L G+ L + +A +A G+A++ + V
Sbjct: 332 SEEP-IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 385
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRD+RA+N+L+ E + GL++ + R + APE T K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 444
Query: 455 SDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 513
SDV+SFG+LL E+ + GR P + + + + + + +R + P +
Sbjct: 445 SDVWSFGILLTELTTKGRVPYPGMV---NREVLDQ---VERGYR---MPCP------PEC 489
Query: 514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
PE+ + DL+ C + P RP ++ L+
Sbjct: 490 PES-----LHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 70/281 (24%), Positives = 117/281 (41%), Gaps = 43/281 (15%)
Query: 284 GTYSGILPDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRY 341
GT AVK L R + +F +E HPN++++ G C G
Sbjct: 44 GTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
+V ++ +G L ++ + + +A+G+ +L K VHRD+ A
Sbjct: 104 VVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAAR 157
Query: 402 NVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRNELTT 453
N +LDE+F + V GL++ + +E + T L A E + + TT
Sbjct: 158 NCMLDEKF---TVKVADFGLARDM---YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 211
Query: 454 KSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512
KSDV+SFGVLL E+++ G P V++ I + L+Q R LL P
Sbjct: 212 KSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVY---LLQGRR---LLQP------EY 256
Query: 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
P+ + +++ C MRP S +V ++ +
Sbjct: 257 CPDP-----LYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 83/376 (22%), Positives = 141/376 (37%), Gaps = 53/376 (14%)
Query: 200 HCHREYLITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASAL------VPP 253
H R + G++ I ++ S L A+ + + P
Sbjct: 14 HGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNP 73
Query: 254 SWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGS----RVAVKRLKR-SSFQR 308
+ + N ++G G Y G L D AVK L R +
Sbjct: 74 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 133
Query: 309 KKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-RYIVYEFVVNGPLDRWLHHIPRGGRSLD 367
+F +E HPN++++ G C +V ++ +G L ++ +
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPT 190
Query: 368 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPW 424
+ +A+G+ FL K VHRD+ A N +LDE+F + V GL++ +
Sbjct: 191 VKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKF---TVKVADFGLARDM-- 242
Query: 425 EVMQERTVMAGGTYGYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVD 478
+E + T L A E + + TTKSDV+SFGVLL E+++ G P V+
Sbjct: 243 -YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301
Query: 479 SVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
+ I + L+Q R LL P P+ + +++ C MRP
Sbjct: 302 T---FDITVY---LLQGRR---LLQP------EYCPDP-----LYEVMLKCWHPKAEMRP 341
Query: 539 RMSHVVHQLQQLAQPP 554
S +V ++ +
Sbjct: 342 SFSELVSRISAIFSTF 357
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 73/288 (25%), Positives = 123/288 (42%), Gaps = 47/288 (16%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+ +G + G G G++VAVK +K + + F +E +L H NLV + G
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 335 YDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
+ YIV E++ G L +L RG L +K + + + + +L +
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 138
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVY 447
VHRD+ A NVL+ E+ A + GL+K + + G T APE +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWT----APEALR 187
Query: 448 RNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506
+ +TKSDV+SFG+LL EI S GR P + + + + + ++ +D
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPR---VEKGYK----MDA-- 235
Query: 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
P+ G V +++ C +MRP + QL+ +
Sbjct: 236 -------PD-GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 73/282 (25%), Positives = 114/282 (40%), Gaps = 34/282 (12%)
Query: 284 GTYSGILPD-GSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR- 340
Y G VAVK LK + Q + + EI L+H +++ KGCC D G
Sbjct: 50 YCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109
Query: 341 -YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
+V E+V G L +L S+ A + A + +G+A+LH + H +HRD+
Sbjct: 110 LQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLA 161
Query: 400 ASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRNEL 451
A NVLLD + L+ + GL+K VP E + G APE + +
Sbjct: 162 ARNVLLDND---RLVKIGDFGLAKAVPEG--HEYYRVRED--GDSPVFWYAPECLKEYKF 214
Query: 452 TTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
SDV+SFGV L E+++ V L + L
Sbjct: 215 YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL-----RLTELLERGER 269
Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
P+ +V L+ C + S RP +++ L+ + +
Sbjct: 270 LPRPD-KCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 69/308 (22%), Positives = 121/308 (39%), Gaps = 73/308 (23%)
Query: 284 GTYSGILPDGS--RVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
G+LP VAVK LK +S + +F E A +PN+V + G C
Sbjct: 66 ARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125
Query: 341 YIVYEFVVNGPLDRWL--------------------HHIPRGGRSLDWAMRMKVATTLAQ 380
+++E++ G L+ +L G L A ++ +A +A
Sbjct: 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAA 185
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT 437
G+A+L ++ VHRD+ N L+ E ++ + GLS R + +
Sbjct: 186 GMAYLSER---KFVHRDLATRNCLVGEN---MVVKIADFGLS----------RNIYSADY 229
Query: 438 Y-----GYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIF 486
Y + PE ++ N TT+SDV+++GV+L EI S G +P + + +
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA---HEEVI 286
Query: 487 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546
V+ L PE ++ +L+ C +P+ RP +
Sbjct: 287 Y----YVRDGNILA------------CPE-NCPLELYNLMRLCWSKLPADRPSFCSIHRI 329
Query: 547 LQQLAQPP 554
LQ++ +
Sbjct: 330 LQRMCERA 337
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 71/295 (24%), Positives = 114/295 (38%), Gaps = 57/295 (19%)
Query: 284 GTYSGILPDGS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 339
T G+ + + +VAVK LK + K+ SE+ + L H N+V + G C G
Sbjct: 65 ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124
Query: 340 RYIVYEFVVNGPLDRWL----------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
++ E+ G L +L + + ++ +AQG+AFL K
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK- 183
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY-----GYL--- 441
+ +HRD+ A NVLL A + GL+ R +M Y L
Sbjct: 184 --NCIHRDVAARNVLLTNGHVAKIGDFGLA----------RDIMNDSNYIVKGNARLPVK 231
Query: 442 --APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRY 498
APE ++ T +SDV+S+G+LL EI S G P P + +
Sbjct: 232 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----------------YPGILVNS- 274
Query: 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
+ + P + + ++ AC P+ RP + LQ+ AQ
Sbjct: 275 -KFYKLVKDGYQMAQPA-FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 8e-28
Identities = 63/291 (21%), Positives = 113/291 (38%), Gaps = 53/291 (18%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+ LG + G G VA+K +K S EF E L H LV + G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
+I+ E++ NG L +L +++ + + + +L K +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 142
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVYR 448
HRD+ A N L++++ + GLS++V + E T G + PE +
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---EYTSSVGSKFPVRWS----PPEVLMY 195
Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRP------AQAVDSVCWQSIFEWATPLVQSHRYLEL 501
++ ++KSD+++FGVL+ EI S G+ P ++ + + Q R
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI------------AQGLR---- 239
Query: 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
L P +KV ++Y+C RP ++ + +
Sbjct: 240 LYR---------PH-LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
LG + G + G ++VAVK LK+ S F +E +L H LV +
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
YI+ E++ NG L +L G L + +A +A+G+AF+ ++ + +
Sbjct: 78 TQEP-IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG------TYGYLAPEFVYR 448
HRD+RA+N+L+ + + GL++ + E T G T APE +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWT----APEAINY 184
Query: 449 NELTTKSDVYSFGVLLLEIVS-GRRP 473
T KSDV+SFG+LL EIV+ GR P
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 66/278 (23%), Positives = 125/278 (44%), Gaps = 37/278 (13%)
Query: 284 GTYSGILPDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRY 341
G Y + + A+K L R + Q+ + F E L+HPN++A+ G G +
Sbjct: 40 GEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
++ ++ +G L +++ R+ + +A+G+ +L ++ VHRD+ A
Sbjct: 100 VLLPYMCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAAR 153
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRNELTTKSD 456
N +LDE F + GL++ + + +E + + L A E + TTKSD
Sbjct: 154 NCMLDESFTVKVADFGLARDI---LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSD 210
Query: 457 VYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE 515
V+SFGVLL E+++ G P + +D + + L Q R L P P+
Sbjct: 211 VWSFGVLLWELLTRGAPPYRHIDP---FDLTHF---LAQGRR---LPQP------EYCPD 255
Query: 516 AGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
+ + ++ C + P++RP +V +++Q+
Sbjct: 256 S-----LYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 67/294 (22%), Positives = 113/294 (38%), Gaps = 65/294 (22%)
Query: 284 GTYSGILPDGS--RVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
G G P VA+K LK + ++EF E ARL HPN+V + G
Sbjct: 28 GHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 87
Query: 341 YIVYEFVVNGPLDRWL------------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
+++ + +G L +L +L+ + + +A G+ +L
Sbjct: 88 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH 147
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTY-----GY 440
HVVH+D+ NVL+ ++ + + GL R V A Y
Sbjct: 148 ---HVVHKDLATRNVLVYDK---LNVKISDLGLF----------REVYAADYYKLLGNSL 191
Query: 441 L-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQ 494
L APE + + + SD++S+GV+L E+ S G +P Q + E +++
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDVVE----MIR 244
Query: 495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
+ + L P+ V L+ C PS RPR + +L+
Sbjct: 245 NRQVLP------------CPD-DCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 69/284 (24%), Positives = 112/284 (39%), Gaps = 49/284 (17%)
Query: 284 GTYSGILPDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342
G VA+K LK + +++++F SE + HPN++ ++G I
Sbjct: 68 GRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127
Query: 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 402
V E++ NG LD +L + + + G+ +L D VHRD+ A N
Sbjct: 128 VTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARN 181
Query: 403 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG-----TYGYLAPEFVYRNELTTKSDV 457
VL+D + GLS+ + + T G T APE + ++ SDV
Sbjct: 182 VLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APEAIAFRTFSSASDV 237
Query: 458 YSFGVLLLEIVS-GRRP------AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
+SFGV++ E+++ G RP + SV + +R L
Sbjct: 238 WSFGVVMWEVLAYGERPYWNMTNRDVISSV------------EEGYR----LPA------ 275
Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
P G + L+ C + RPR S +V L L + P
Sbjct: 276 ---PM-GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 53/282 (18%), Positives = 102/282 (36%), Gaps = 36/282 (12%)
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFAR 321
S F + + +G Y G+ VA L+ + + F E
Sbjct: 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG 81
Query: 322 LHHPNLVAVKGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 377
L HPN+V +V E + +G L + + + +
Sbjct: 82 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL----KTYLKRFKVMKIKVLRSWCRQ 137
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG-VGLSKFVPWEVMQERTVMAGG 436
+ +G+ FLH + P ++HRD++ N+ + G+ +G +GL+ + V+ G
Sbjct: 138 ILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVI--G 192
Query: 437 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH 496
T ++APE +Y + DVY+FG+ +LE+ + P + I+ T
Sbjct: 193 TPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTS----- 244
Query: 497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
+ ++ PE +++ C + R
Sbjct: 245 ---GVKPASFDKVAI--PEV------KEIIEGCIRQNKDERY 275
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 71/295 (24%), Positives = 126/295 (42%), Gaps = 49/295 (16%)
Query: 275 RLLGDSKTGGTYSGILPDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVA 329
+++G + G SG L S+ VA+K LK + +++++F E + HPN++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
++G IV E++ NG LD +L + + + +A G+ +L D
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFV 446
VHRD+ A N+L++ + GL + + E E G + +PE +
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLGRVL--EDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 447 YRNELTTKSDVYSFGVLLLEIVS-GRRP------AQAVDSVCWQSIFEWATPLVQSHRYL 499
+ T+ SDV+S+G++L E++S G RP + +V + +R
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV------------DEGYR-- 268
Query: 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
L P D P A + L+ C Q + RP+ +V L +L + P
Sbjct: 269 --LPP-----PMDCPAA-----LYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 273 GNRLLGDSKTGGTYSGILPDGSR---VAVKRLKR--SSFQRKKEFYSEIGRFARLHHPNL 327
++ LG G G VAVK LK + K E +E +L +P +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD 387
V + G C +V E GPL+++L + R + +++ ++ G+ +L +
Sbjct: 81 VRMIGICEAES-WMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 388 KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPE 444
+ VHRD+ A NVLL + A + GLSK + + + + APE
Sbjct: 136 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD--ENYYKAQTHGKWPVKWYAPE 190
Query: 445 FVYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
+ + ++KSDV+SFGVL+ E S G++P
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 56/250 (22%), Positives = 99/250 (39%), Gaps = 25/250 (10%)
Query: 292 DGSRVAVKRLK---RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
DG VA+K+++ + + + EI +L+HPN++ + + IV E
Sbjct: 56 DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 115
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
G L R + H + R + K L + +H + V+HRDI+ +NV +
Sbjct: 116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITAT 172
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
L +GL +F + +++ GT Y++PE ++ N KSD++S G LL E+
Sbjct: 173 GVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 230
Query: 469 SGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYA 528
+ + P L + +P +++ LV
Sbjct: 231 ALQSPFYG-----------------DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 273
Query: 529 CTQHVPSMRP 538
C P RP
Sbjct: 274 CINPDPEKRP 283
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 67/298 (22%), Positives = 108/298 (36%), Gaps = 56/298 (18%)
Query: 284 GTYSGILPDGS--RVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 339
GI + VAVK LK ++ + SE+ + HH N+V + G C G
Sbjct: 46 ADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105
Query: 340 -RYIVYEFVVNGPL------------DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 386
++ EF G L + L + + +A+G+ FL
Sbjct: 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 165
Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL-- 441
+ +HRD+ A N+LL E+ ++ + GL++ + + L
Sbjct: 166 SR---KCIHRDLAARNILLSEKN---VVKICDFGLAR-----DIYKDPDYVRKGDARLPL 214
Query: 442 ---APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497
APE ++ T +SDV+SFGVLL EI S G P V + ++
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DEEFCR----RLKEGT 268
Query: 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPV 555
+ P+ ++ + C PS RP S +V L L Q
Sbjct: 269 RMR------------APD-YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 64/301 (21%), Positives = 126/301 (41%), Gaps = 46/301 (15%)
Query: 275 RLLGDSKTGGTYSGIL-PDGSR----VAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLV 328
++LG G Y G+ P+G + VA+K L+ ++ + KE E A + +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
+ G C ++ + + G L ++ ++ + +A+G+ +L D+
Sbjct: 81 RLLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT---YGYLA 442
+VHRD+ A NVL+ + + GL+K + E E+ A G ++A
Sbjct: 137 ---RLVHRDLAARNVLVKTP---QHVKITDFGLAKLLGAE---EKEYHAEGGKVPIKWMA 187
Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL 501
E + T +SDV+S+GV + E+++ G +P + + I L + R L
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSI---LEKGER---L 238
Query: 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKLLFK 561
P V ++ C RP+ ++ + ++A+ P L+ +
Sbjct: 239 PQP------PICTID-----VYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 287
Query: 562 G 562
G
Sbjct: 288 G 288
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 68/299 (22%), Positives = 110/299 (36%), Gaps = 68/299 (22%)
Query: 284 GTYSGILPDGS----RVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH 337
GI D VAVK LK ++ + + SE+ + H N++ + G C
Sbjct: 100 AEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159
Query: 338 GDRYIVYEFVVNGPL------------DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
G Y++ E+ G L + + + + LA+G+ +L
Sbjct: 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 219
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTY---- 438
+ +HRD+ A NVL+ E ++M + GL+ R + Y
Sbjct: 220 ASQ---KCIHRDLAARNVLVTEN---NVMKIADFGLA----------RDINNIDYYKKTT 263
Query: 439 -GYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATP 491
G L APE ++ T +SDV+SFGVL+ EI + G P +
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----------- 312
Query: 492 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
EL L D P ++ ++ C VPS RP +V L ++
Sbjct: 313 --------ELFKLLKEGHRMDKPA-NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 67/297 (22%), Positives = 110/297 (37%), Gaps = 58/297 (19%)
Query: 284 GTYSGILPDGS----RVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH 337
GI D VAVK LK ++ + + SE+ + H N++ + G C
Sbjct: 54 AEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113
Query: 338 GDRYIVYEFVVNGPL------------DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
G Y++ E+ G L + + + + LA+G+ +L
Sbjct: 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 173
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL- 441
+ +HRD+ A NVL+ E ++M + GL++ + T G L
Sbjct: 174 ASQ---KCIHRDLAARNVLVTEN---NVMKIADFGLAR-----DINNIDYYKKTTNGRLP 222
Query: 442 ----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSH 496
APE ++ T +SDV+SFGVL+ EI + G P +
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---------------- 266
Query: 497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
EL L D P ++ ++ C VPS RP +V L ++
Sbjct: 267 ---ELFKLLKEGHRMDKPA-NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 64/287 (22%), Positives = 120/287 (41%), Gaps = 54/287 (18%)
Query: 286 YSGIL--PDGSR---VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD 339
Y G+L G + VA+K LK + +++ +F E G + H N++ ++G +
Sbjct: 61 YKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120
Query: 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
I+ E++ NG LD++L + + +A G+ +L + + VHRD+
Sbjct: 121 MMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLA 174
Query: 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGG-----TYGYLAPEFVYRNELTTK 454
A N+L++ + GLS+ + + T G T APE + + T+
Sbjct: 175 ARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APEAISYRKFTSA 230
Query: 455 SDVYSFGVLLLEIVS-GRRP------AQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507
SDV+SFG+++ E+++ G RP + + ++ R L
Sbjct: 231 SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI------------NDGFR----LPT--- 271
Query: 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
P + L+ C Q + RP+ + +V L +L + P
Sbjct: 272 ------PM-DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 55/270 (20%), Positives = 101/270 (37%), Gaps = 34/270 (12%)
Query: 292 DGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR--YIVYEFV 347
DG + K + K+ SE+ L HPN+V D + YIV E+
Sbjct: 30 DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK--VKPHVVHRDIRASNVLL 405
G L + + + LD ++V T L + H + V+HRD++ +NV L
Sbjct: 90 EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149
Query: 406 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465
D + L GL++ + + +T + GT Y++PE + R KSD++S G LL
Sbjct: 150 DGKQNVKLGDFGLARILNHDTSFAKTFV--GTPYYMSPEQMNRMSYNEKSDIWSLGCLLY 207
Query: 466 EIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDL 525
E+ + P A + + ++ ++ + S ++ ++
Sbjct: 208 ELCALMPPFTAFS---QKELAG----KIREGKF----RRIPYRYSDEL---------NEI 247
Query: 526 VYACTQHVPSMRP------RMSHVVHQLQQ 549
+ RP ++
Sbjct: 248 ITRMLNLKDYHRPSVEEILENPLILEHHHH 277
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 56/282 (19%), Positives = 103/282 (36%), Gaps = 52/282 (18%)
Query: 295 RVAVKRLKRSSFQRKKEFYSEIGRF-------ARLHHPNLVAVKGCCYDHGD----RYIV 343
VA+K + + F R RL P++V + +D G+ Y+
Sbjct: 61 IVALKLM-SETLSSDPVF---RTRMQREARTAGRLQEPHVVPI----HDFGEIDGQLYVD 112
Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
+ L L +G + A+ + + + H HRD++ N+
Sbjct: 113 MRLINGVDLAAMLRR--QGPLAPPRAVA--IVRQIGSALDAAHAA---GATHRDVKPENI 165
Query: 404 LLDEEFGAHLMGVGLSKFVPWEVM-QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
L+ + A+L+ G++ E + Q + GT Y+APE + T ++D+Y+
Sbjct: 166 LVSADDFAYLVDFGIASATTDEKLTQLGNTV--GTLYYMAPERFSESHATYRADIYALTC 223
Query: 463 LLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV 522
+L E ++G P Q D + ++ +H + P S++ IP A
Sbjct: 224 VLYECLTGSPPYQG-DQL----------SVMGAHINQAI--PRPSTVRPGIPVA-----F 265
Query: 523 VDLVYACTQHVPSMRPR----MSHVVHQ-LQQLAQPPVTKLL 559
++ P R +S H L Q T +L
Sbjct: 266 DAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRATDIL 307
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 54/274 (19%), Positives = 112/274 (40%), Gaps = 35/274 (12%)
Query: 292 DGSRVAVK--RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
DG + +K + R S + ++E E+ A + HPN+V + ++G YIV ++
Sbjct: 48 DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
G L + ++ + G + + + +HD+ ++HRDI++ N+ L ++
Sbjct: 108 GDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDG 162
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
L G+++ + V R + GT YL+PE KSD+++ G +L E+ +
Sbjct: 163 TVQLGDFGIARVLNSTVELARACI--GTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220
Query: 470 GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYAC 529
+ +A +++ + S + P+ S D+ LV
Sbjct: 221 LKHAFEAGS---MKNLVL----KIISGSF----PPVSLHYSYDL---------RSLVSQL 260
Query: 530 TQHVPSMRP------RMSHVVHQLQQLAQPPVTK 557
+ P RP + ++++ P +
Sbjct: 261 FKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIA 294
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 63/302 (20%), Positives = 110/302 (36%), Gaps = 67/302 (22%)
Query: 284 GTYSGILPDGS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 339
T G++ + VAVK LK S ++ SE+ + L +H N+V + G C G
Sbjct: 42 ATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101
Query: 340 RYIVYEFVVNGPLDRWL-HHIPRGGRSLDWAMR-------------MKVATTLAQGIAFL 385
++ E+ G L +L S + + +A+G+AFL
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTY---- 438
K + +HRD+ A N+LL + + GL+ R + Y
Sbjct: 162 ASK---NCIHRDLAARNILLTHG---RITKICDFGLA----------RDIKNDSNYVVKG 205
Query: 439 -GYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATP 491
L APE ++ T +SDV+S+G+ L E+ S G P + + +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP--------YPGMPVDS-- 255
Query: 492 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551
+ + PE ++ D++ C P RP +V +++
Sbjct: 256 --------KFYKMIKEGFRMLSPE-HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
Query: 552 QP 553
Sbjct: 307 SE 308
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 68/304 (22%), Positives = 118/304 (38%), Gaps = 73/304 (24%)
Query: 284 GTYSGILPDGS--RVAVKRLK-RSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
T + VAVK LK +S ++ SE +++HP+++ + G C G
Sbjct: 42 ATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101
Query: 341 YIVYEFVVNGPLDRWL--------------------HHIPRGGRSLDWAMRMKVATTLAQ 380
++ E+ G L +L R+L + A ++Q
Sbjct: 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQ 161
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT 437
G+ +L + +VHRD+ A N+L+ E M + GLS R V +
Sbjct: 162 GMQYLAEM---KLVHRDLAARNILVAEG---RKMKISDFGLS----------RDVYEEDS 205
Query: 438 Y-----GYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIF 486
Y G + A E ++ + TT+SDV+SFGVLL EIV+ G P +
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--------- 256
Query: 487 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546
L + L + + P+ +++ L+ C + P RP + +
Sbjct: 257 --------PPE--RLFNLLKTGHRMERPD-NCSEEMYRLMLQCWKQEPDKRPVFADISKD 305
Query: 547 LQQL 550
L+++
Sbjct: 306 LEKM 309
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 71/303 (23%), Positives = 113/303 (37%), Gaps = 68/303 (22%)
Query: 284 GTYSGILPDGS----RVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH 337
G+ D +VAVK LK ++ + + SE+ + H N++ + G C
Sbjct: 88 AEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147
Query: 338 GDRYIVYEFVVNGPL------------DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
G Y++ E+ G L + + L + A +A+G+ +L
Sbjct: 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 207
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTY---- 438
K +HRD+ A NVL+ E+ ++M + GL+ R + Y
Sbjct: 208 ASK---KCIHRDLAARNVLVTED---NVMKIADFGLA----------RDIHHIDYYKKTT 251
Query: 439 -GYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATP 491
G L APE ++ T +SDV+SFGVLL EI + G P V
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----------- 300
Query: 492 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551
EL L D P ++ ++ C VPS RP +V L ++
Sbjct: 301 --------ELFKLLKEGHRMDKPS-NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351
Query: 552 QPP 554
Sbjct: 352 ALT 354
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 49/197 (24%), Positives = 77/197 (39%), Gaps = 16/197 (8%)
Query: 284 GTYSGILPDGSRVAVKRLKR---SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
G + VAVK LK S + +F E+ L H NL+ + G
Sbjct: 37 GEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
+V E G L L + + A +A+G+ +L K +HRD+ A
Sbjct: 96 KMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAA 149
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDV 457
N+LL + GL + +P + VM + + APE + + SD
Sbjct: 150 RNLLLATRDLVKIGDFGLMRALPQN--DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDT 207
Query: 458 YSFGVLLLEIVS-GRRP 473
+ FGV L E+ + G+ P
Sbjct: 208 WMFGVTLWEMFTYGQEP 224
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 49/196 (25%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 286 YSGILPDGSR---VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
G+ + VA+K LK+ + +E E +L +P +V + G C
Sbjct: 27 RQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LM 85
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
+V E GPL ++L + + ++ ++ G+ +L +K + VHRD+ A
Sbjct: 86 LVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAAR 139
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDVY 458
NVLL A + GLSK + + + APE + + +++SDV+
Sbjct: 140 NVLLVNRHYAKISDFGLSKALGAD--DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 197
Query: 459 SFGVLLLEIVS-GRRP 473
S+GV + E +S G++P
Sbjct: 198 SYGVTMWEALSYGQKP 213
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 69/304 (22%), Positives = 115/304 (37%), Gaps = 72/304 (23%)
Query: 284 GTYSGILPDGS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 339
T GI G +VAVK LK ++ SE+ +L H N+V + G C G
Sbjct: 64 ATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123
Query: 340 RYIVYEFVVNGPLDRWL-------------------HHIPRGGRSLDWAMRMKVATTLAQ 380
Y+++E+ G L +L L + + A +A+
Sbjct: 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGT 437
G+ FL K VHRD+ A NVL+ ++ + GL+ R +M+
Sbjct: 184 GMEFLEFK---SCVHRDLAARNVLVTHG---KVVKICDFGLA----------RDIMSDSN 227
Query: 438 Y-----GYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIF 486
Y L APE ++ T KSDV+S+G+LL EI S G P + + +
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV--DANFY 285
Query: 487 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546
+ L+Q+ ++ P +++ ++ +C RP ++
Sbjct: 286 K----LIQNGFKMD------------QPF-YATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328
Query: 547 LQQL 550
L
Sbjct: 329 LGCQ 332
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 67/303 (22%), Positives = 130/303 (42%), Gaps = 40/303 (13%)
Query: 275 RLLGDSKTGGTYSGIL-PDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
++LG G Y G+ P+G + VA+K L+ +S + KE E A + +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
+ G C ++ + + G L ++ ++ + +A+G+ +L D+
Sbjct: 81 RLLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEF 445
+VHRD+ A NVL+ + GL+K + E E+ A G ++A E
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE---EKEYHAEGGKVPIKWMALES 190
Query: 446 VYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504
+ T +SDV+S+GV + E+++ G +P + + I L + R L P
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSI---LEKGER---LPQP 241
Query: 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKLLFKGLD 564
I + V ++ C RP+ ++ + ++A+ P L+ +G +
Sbjct: 242 PICT-----------IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDE 290
Query: 565 RLR 567
R+
Sbjct: 291 RMH 293
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 53/290 (18%), Positives = 118/290 (40%), Gaps = 40/290 (13%)
Query: 275 RLLGDSKTGGTYSGILPDGSR-----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLV 328
++LG G + G+ V +K ++ S Q + + L H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
+ G C +V +++ G L + + +L + + +A+G+ +L +
Sbjct: 79 RLLGLCPGSS-LQLVTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEF 445
+VHR++ A NVLL + G++ +P + ++ ++ ++A E
Sbjct: 135 ---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD---DKQLLYSEAKTPIKWMALES 188
Query: 446 VYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504
++ + T +SDV+S+GV + E+++ G P + + + L + R L P
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL---AEVPDL---LEKGER---LAQP 239
Query: 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
I + V ++ C ++RP + ++ ++A+ P
Sbjct: 240 QICT-----------IDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 44/204 (21%), Positives = 80/204 (39%), Gaps = 39/204 (19%)
Query: 292 DGSRVAVKRLKRS---SFQRKKEFYSEIGRF-ARLHHPNLVAVKGCCYDHGDR------- 340
+G V +K L S Q +E +F A + HP++V + ++ +
Sbjct: 105 NGRPVVLKGLVHSGDAEAQAM--AMAE-RQFLAEVVHPSIVQI----FNFVEHTDRHGDP 157
Query: 341 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
YIV E+V L R + A+ + +++LH +V+ D+
Sbjct: 158 VGYIVMEYVGGQSLKRSK----GQKLPVAEAIA--YLLEILPALSYLHSI---GLVYNDL 208
Query: 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVY 458
+ N++L EE L+ +G + + GT G+ APE + R T +D+Y
Sbjct: 209 KPENIMLTEE-QLKLIDLGAVS----RINSFGYLY--GTPGFQAPE-IVRTGPTVATDIY 260
Query: 459 SFGVLLLEIVSGRRP--AQAVDSV 480
+ G L + + VD +
Sbjct: 261 TVGRTLAALTLDLPTRNGRYVDGL 284
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 72/295 (24%), Positives = 120/295 (40%), Gaps = 60/295 (20%)
Query: 286 YSGILPDGS---RVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR 340
+ A+KR+K +S ++F E+ +L HHPN++ + G C G
Sbjct: 42 LKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101
Query: 341 YIVYEFVVNGPLDRWL------------HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
Y+ E+ +G L +L +L + A +A+G+ +L K
Sbjct: 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 161
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGV---GLSKFVPWEVMQERTVMAGGTYGYL---- 441
+HRD+ A N+L+ E ++ + GLS+ + V T G L
Sbjct: 162 ---QFIHRDLAARNILVGEN---YVAKIADFGLSR--------GQEVYVKKTMGRLPVRW 207
Query: 442 -APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499
A E + + TT SDV+S+GVLL EIVS G P + ++E L Q +R
Sbjct: 208 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEK---LPQGYR-- 259
Query: 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
L+ P +V DL+ C + P RP + ++ L ++ +
Sbjct: 260 --LEK---------PL-NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 74/291 (25%), Positives = 116/291 (39%), Gaps = 44/291 (15%)
Query: 275 RLLGDSKTGGTYSGILPDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVA 329
R +G+ + G + GI VA+K K +S +++F E + HP++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
+ G ++ +I+ E G L +L SLD A + A L+ +A+L K
Sbjct: 81 LIGVITEN-PVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK- 135
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APE 444
VHRDI A NVL+ L GLS+++ A G L APE
Sbjct: 136 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM----EDSTYYKASK--GKLPIKWMAPE 187
Query: 445 FVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503
+ T+ SDV+ FGV + EI+ G +P Q V + + + R L
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGR---IENGER----LP 237
Query: 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
P + L+ C + PS RPR + + QL + +
Sbjct: 238 M---------PP-NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 54/197 (27%), Positives = 86/197 (43%), Gaps = 20/197 (10%)
Query: 284 GTYSGILPDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342
G Y+ + VAVK K+ + K++F SE L HP++V + G + +I
Sbjct: 31 GVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89
Query: 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 402
+ E G L +L R SL + + + + +A+L + VHRDI N
Sbjct: 90 IMELYPYGELGHYLE---RNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRN 143
Query: 403 VLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APEFVYRNELTTKSDV 457
+L+ L GLS+++ E A L +PE + TT SDV
Sbjct: 144 ILVASPECVKLGDFGLSRYI----EDEDYYKASV--TRLPIKWMSPESINFRRFTTASDV 197
Query: 458 YSFGVLLLEIVS-GRRP 473
+ F V + EI+S G++P
Sbjct: 198 WMFAVCMWEILSFGKQP 214
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 6e-24
Identities = 67/309 (21%), Positives = 118/309 (38%), Gaps = 36/309 (11%)
Query: 192 HENKCYYLHCHREYL--ITLGVVSGLILLTTFAIVIWLLAYRRSKRRRKSRKLSNPAASA 249
++C +E + SG T A L +R S + A
Sbjct: 240 KLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARI 299
Query: 250 LVPPSWKVFTT------------EELRSITKNFSEGNRLLGDSKTG----GT-YSGILPD 292
P + EEL+ N L+ D + G G+ G+
Sbjct: 300 TSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRM 359
Query: 293 GSR---VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
+ VA+K LK+ + +E E +L +P +V + G C +V E
Sbjct: 360 RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAG 418
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
GPL ++L + + ++ ++ G+ +L +K + VHR++ A NVLL
Sbjct: 419 GGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNR 472
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGT---YGYLAPEFVYRNELTTKSDVYSFGVLLL 465
A + GLSK + + + APE + + +++SDV+S+GV +
Sbjct: 473 HYAKISDFGLSKALGAD--DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 530
Query: 466 EIVS-GRRP 473
E +S G++P
Sbjct: 531 EALSYGQKP 539
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-24
Identities = 75/291 (25%), Positives = 117/291 (40%), Gaps = 44/291 (15%)
Query: 275 RLLGDSKTGGTYSGILPDGSR----VAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVA 329
R +G+ + G + GI VA+K K +S +++F E + HP++V
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
+ G ++ +I+ E G L +L SLD A + A L+ +A+L K
Sbjct: 456 LIGVITEN-PVWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLESK- 510
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL-----APE 444
VHRDI A NVL+ L GLS+ M++ T G L APE
Sbjct: 511 --RFVHRDIAARNVLVSSNDCVKLGDFGLSR-----YMEDSTYYKASK-GKLPIKWMAPE 562
Query: 445 FVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503
+ T+ SDV+ FGV + EI+ G +P Q V + + + R L
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGR---IENGER----LP 612
Query: 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
P + L+ C + PS RPR + + QL + +
Sbjct: 613 M---------PP-NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 55/278 (19%), Positives = 100/278 (35%), Gaps = 37/278 (13%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----YIVYEFV 347
DG A+KR+ Q ++E E +HPN++ + C +++ F
Sbjct: 53 DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
G L + + G L + + + +G+ +H HRD++ +N+LL +
Sbjct: 113 KRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGD 169
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAG-------GTYGYLAPEFV--YRNE-LTTKSDV 457
E LM +G V R + T Y APE + + ++DV
Sbjct: 170 EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDV 229
Query: 458 YSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAG 517
+S G +L ++ G P ++ S L IP++
Sbjct: 230 WSLGCVLYAMMFGEGP------------YDMVFQKGDSVA-------LAVQNQLSIPQSP 270
Query: 518 VV-QKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
+ L+ + P RP + ++ QL+ L P
Sbjct: 271 RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 63/323 (19%), Positives = 108/323 (33%), Gaps = 58/323 (17%)
Query: 230 YRRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI 289
Y +S + + R++S ++ S + ++F LG G+Y +
Sbjct: 19 YFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRL-SRLGH----GSYGEV 73
Query: 290 L-----PDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY 341
DG AVKR K +E+G ++ HP V ++ + G Y
Sbjct: 74 FKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
+ E L H G SL A +A LH + +VH D++ +
Sbjct: 134 LQTELC-GPSL---QQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPA 186
Query: 402 NVLLDEEFGAHLMGV------GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 455
N+ L G GL V G Y+APE + + T +
Sbjct: 187 NIFLGPR------GRCKLGDFGLLVE--LGTAGAGEVQEGDPR-YMAPE-LLQGSYGTAA 236
Query: 456 DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPE 515
DV+S G+ +LE+ + WQ + + L + LSS++
Sbjct: 237 DVFSLGLTILEVACNMELPHGGEG--WQQLRQ-----------GYLPPEFTAGLSSEL-- 281
Query: 516 AGVVQKVVDLVYACTQHVPSMRP 538
++ + P +R
Sbjct: 282 -------RSVLVMMLEPDPKLRA 297
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 7e-23
Identities = 53/263 (20%), Positives = 96/263 (36%), Gaps = 38/263 (14%)
Query: 231 RRSKRRRKSRKLSNPAASALVPPSW---KVFTTEELRSITKNFSEGNR------LLGDSK 281
K+ + L P + V TE+L+ + + E +G
Sbjct: 11 HSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGS 70
Query: 282 TGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
G + G + AVK+++ F+ + E+ A L P +V + G +
Sbjct: 71 FGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVREGPWV 125
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
I E + G L + + L + +G+ +LH + ++H D++A
Sbjct: 126 NIFMELLEGGSL----GQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKA 178
Query: 401 SNVLLDEE--------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
NVLL + FG L GL K + + G ++APE V
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGK-----SLLTGDYIPGTET-HMAPEVVMGKP 232
Query: 451 LTTKSDVYSFGVLLLEIVSGRRP 473
K D++S ++L +++G P
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHP 255
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 43/266 (16%), Positives = 86/266 (32%), Gaps = 47/266 (17%)
Query: 292 DGSRVAVKRLKR--SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV 348
DG A+KR K+ + ++ E+ A L H ++V + I E+
Sbjct: 35 DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCN 94
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
G L + R A + + +G+ ++H +VH DI+ SN+ +
Sbjct: 95 GGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRT 151
Query: 409 --------------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL--T 452
+ ++ + + + V G + +LA E V +
Sbjct: 152 SIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSR-FLANE-VLQENYTHL 209
Query: 453 TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512
K+D+++ + ++ + D W I + P + LS +
Sbjct: 210 PKADIFALALTVVCAAGAEPLPRNGDQ--WHEIRQGRLP------------RIPQVLSQE 255
Query: 513 IPEAGVVQKVVDLVYACTQHVPSMRP 538
+L+ P RP
Sbjct: 256 F---------TELLKVMIHPDPERRP 272
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 51/306 (16%), Positives = 104/306 (33%), Gaps = 69/306 (22%)
Query: 292 DGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR---------- 340
D A+KR++ + + +++ E+ A+L HP +V +
Sbjct: 29 DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKV 88
Query: 341 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
YI + L W++ + ++ + + +A+ + FLH K ++HRD+
Sbjct: 89 YLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDL 144
Query: 399 RASNVLLDEEFGAHLMGV-----GLSKFVPWEVMQERTVMAG----------GTYGYLAP 443
+ SN+ + V GL + + ++ + GT Y++P
Sbjct: 145 KPSNIFFTMD-----DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP 199
Query: 444 EFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVD--SVCWQSIFEWATPLVQSHRYLEL 501
E ++ N + K D++S G++L E++ P + P + + +Y
Sbjct: 200 EQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTDVRNLKFPPLFTQKYPCE 256
Query: 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKLLFK 561
+V P RP ++ + L F
Sbjct: 257 ---------------------YVMVQDMLSPSPMERPEAINI------IENAVFEDLDFP 289
Query: 562 GLDRLR 567
G LR
Sbjct: 290 GKTVLR 295
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 56/273 (20%), Positives = 106/273 (38%), Gaps = 63/273 (23%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----------- 340
DG +KR+K + ++ E+ A+L H N+V GC
Sbjct: 35 DGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90
Query: 341 -----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
+I EF G L++W+ R G LD + +++ + +G+ ++H K +++
Sbjct: 91 KTKCLFIQMEFCDKGTLEQWIEK--RRGEKLDKVLALELFEQITKGVDYIHSK---KLIN 145
Query: 396 RDIRASNVLLDEEFGAHLMGV-----GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
RD++ SN+ L + V GL + + + R+ GT Y++PE + +
Sbjct: 146 RDLKPSNIFLVDT-----KQVKIGDFGLVTSLKNDGKRTRSK---GTLRYMSPEQISSQD 197
Query: 451 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
+ D+Y+ G++L E++ A + +L D +IS +
Sbjct: 198 YGKEVDLYALGLILAELLHVCDTAFETSKF-----------------FTDLRDGIISDIF 240
Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
+K L+ P RP S +
Sbjct: 241 D--------KKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 7e-22
Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 38/273 (13%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
+LG G Y+G L + R+A+K + + + + EI L H N+V G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT-LAQGIAFLHDKVKPH 392
++G I E V G L L + G D + T + +G+ +LHD
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRS--KWGPLKDNEQTIGFYTKQILEGLKYLHDN---Q 142
Query: 393 VVHRDIRASNVLLDEEFGAHLMGV-----GLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
+VHRDI+ NVL++ G + G SK + T GT Y+APE +
Sbjct: 143 IVHRDIKGDNVLINTYSGV----LKISDFGTSKRLAGINPCTETFT--GTLQYMAPEIID 196
Query: 448 RNEL--TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505
+ +D++S G ++E+ +G+ P + ++F+ ++ +
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE-PQAAMFKVGM--------FKVHPEI 247
Query: 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
S+S++ + C + P R
Sbjct: 248 PESMSAE---------AKAFILKCFEPDPDKRA 271
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 46/184 (25%), Positives = 78/184 (42%), Gaps = 14/184 (7%)
Query: 293 GSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
+A+K L +S +++ + EI + L HPN++ + +D Y++ EF
Sbjct: 39 KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
G L + + GR + + LA + + H++ V+HRDI+ N+L+ +
Sbjct: 99 GEL---YKELQKHGRFDEQRSATFMEE-LADALHYCHER---KVIHRDIKPENLLMGYKG 151
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
+ G S P R GT YL PE + K D++ GVL E +
Sbjct: 152 ELKIADFGWSVHAP----SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 207
Query: 470 GRRP 473
G P
Sbjct: 208 GMPP 211
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 53/249 (21%), Positives = 97/249 (38%), Gaps = 19/249 (7%)
Query: 233 SKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEG---NRLLGDSKTGGTYSGI 289
SK R K WK + + + + + LG G + +
Sbjct: 12 SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71
Query: 290 -LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
G K + K +EI +LHHP L+ + D + ++ EF+
Sbjct: 72 EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131
Query: 349 NGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
G L DR I + A + +G+ +H+ +VH DI+ N++ +
Sbjct: 132 GGELFDR----IAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCET 184
Query: 408 EFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
+ + + + GL+ + P E+++ T T + APE V R + +D+++ GVL
Sbjct: 185 KKASSVKIIDFGLATKLNPDEIVKVTT----ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
Query: 465 LEIVSGRRP 473
++SG P
Sbjct: 241 YVLLSGLSP 249
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 44/184 (23%), Positives = 78/184 (42%), Gaps = 14/184 (7%)
Query: 293 GSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
+A+K L ++ ++ + E+ + L HPN++ + G +D Y++ E+
Sbjct: 34 KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
G + + + + + + LA +++ H K V+HRDI+ N+LL
Sbjct: 94 GTV---YRELQKLSKFDEQRTATYITE-LANALSYCHSK---RVIHRDIKPENLLLGSAG 146
Query: 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
+ G S P R GT YL PE + K D++S GVL E +
Sbjct: 147 ELKIADFGWSVHAP----SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202
Query: 470 GRRP 473
G+ P
Sbjct: 203 GKPP 206
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 37/212 (17%), Positives = 91/212 (42%), Gaps = 43/212 (20%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYS-----------------EIGRFARLHHPNLVAVKGCC 334
D A+K+ ++S ++K++F E+ + + + +G
Sbjct: 53 DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII 112
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVK 390
++ + YI+YE++ N + ++ + ++ + ++V + + +++H++
Sbjct: 113 TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK- 171
Query: 391 PHVVHRDIRASNVLLDEE-------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP 443
++ HRD++ SN+L+D+ F G S+++ + + + GTY ++ P
Sbjct: 172 -NICHRDVKPSNILMDKNGRVKLSDF-------GESEYMVDKKI--KGSR--GTYEFMPP 219
Query: 444 EFVYRNELT--TKSDVYSFGVLLLEIVSGRRP 473
EF K D++S G+ L + P
Sbjct: 220 EFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 8e-21
Identities = 58/250 (23%), Positives = 98/250 (39%), Gaps = 22/250 (8%)
Query: 231 RRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI- 289
R+ P F T + +++ + + LG G
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGM--FITSKKGHLSEMYQRV-KKLGSGAYGEVLLCRD 58
Query: 290 LPDGSRVAVKRLKRSSFQRKKE--FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
A+K ++++S E+ L HPN++ + D + Y+V E
Sbjct: 59 KVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118
Query: 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-D 406
G L I + + + + G+ +LH ++VHRD++ N+LL
Sbjct: 119 KGGEL---FDEIIHRMK-FNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLES 171
Query: 407 EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 463
+E A + V GLS + M+ER GT Y+APE V R + K DV+S GV+
Sbjct: 172 KEKDALIKIVDFGLSAVFENQKKMKERL----GTAYYIAPE-VLRKKYDEKCDVWSIGVI 226
Query: 464 LLEIVSGRRP 473
L +++G P
Sbjct: 227 LFILLAGYPP 236
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 8e-21
Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 21/226 (9%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE--- 311
+F + + R+LG G G AVK + + ++K +
Sbjct: 14 GMFVQHSTAIFSDRYKGQ-RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES 72
Query: 312 FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR 371
E+ +L HPN++ + D G Y+V E G L I R
Sbjct: 73 LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKR-FSEVDA 128
Query: 372 MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVM 427
++ + GI ++H +VHRD++ N+LL + A++ + GLS + M
Sbjct: 129 ARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185
Query: 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
+++ GT Y+APE V K DV+S GV+L ++SG P
Sbjct: 186 KDKI----GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 94.0 bits (233), Expect = 1e-20
Identities = 47/354 (13%), Positives = 88/354 (24%), Gaps = 74/354 (20%)
Query: 232 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-L 290
R+ + +++L EL + G +LG
Sbjct: 42 RTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRG-TVLGQEDPYAYLEATDQ 100
Query: 291 PDGSRVAVKRL---KRSSFQRKKEFYSEIGRFARL----------------------HHP 325
G V +R K+ E+ R L P
Sbjct: 101 ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160
Query: 326 NLVAVKGCCYDHGDRYIVYEFVV-------NGPLDRWLHHIPRGGRSLDWAMRMKVATTL 378
+ D D +++ F + L +SL R+++ +
Sbjct: 161 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQV 220
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
+ +A LH +VH +R +++LD+ G L G G +
Sbjct: 221 IRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV----RDGASAVSPIGRGF 273
Query: 439 G---YLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT 490
A + +T D ++ G+ + I P
Sbjct: 274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP------------NTDDA 321
Query: 491 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
L I +IP+ V L+ ++ R +
Sbjct: 322 AL--------GGSEWIFRSCKNIPQP-----VRALLEGFLRYPKEDRLLPLQAM 362
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 63/258 (24%), Positives = 106/258 (41%), Gaps = 33/258 (12%)
Query: 234 KRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPD 292
S + + + P + ++ I +++ + R LG G
Sbjct: 4 HHHHSSGRENLYFQGIAINPGM--YVRKKEGKIGESYFKV-RKLGSGAYGEVLLCKEKNG 60
Query: 293 GSRVAVKRLKRSSF-------------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD 339
S A+K +K+S F + +E Y+EI L HPN++ + D
Sbjct: 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120
Query: 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
Y+V EF G L I + D + + GI +LH ++VHRDI+
Sbjct: 121 FYLVTEFYEGGEL---FEQIINRHK-FDECDAANIMKQILSGICYLHKH---NIVHRDIK 173
Query: 400 ASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS 455
N+LL ++ ++ V GLS F +++R GT Y+APE V + + K
Sbjct: 174 PENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL----GTAYYIAPE-VLKKKYNEKC 228
Query: 456 DVYSFGVLLLEIVSGRRP 473
DV+S GV++ ++ G P
Sbjct: 229 DVWSCGVIMYILLCGYPP 246
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 51/252 (20%), Positives = 92/252 (36%), Gaps = 27/252 (10%)
Query: 235 RRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGI- 289
K P +A P+ E + S R LG +
Sbjct: 3 APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISD 62
Query: 290 LPDGSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
A K + +S + + EI L H ++V G D+ ++V E
Sbjct: 63 ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 122
Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
L L R + R + G +LH V+HRD++ N+ L+
Sbjct: 123 CRRRSL---LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLN 175
Query: 407 EEFGAHLMGV-----GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
E+ + V GL+ V ++ +++ + GT Y+APE + + + + DV+S G
Sbjct: 176 ED-----LEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWSIG 228
Query: 462 VLLLEIVSGRRP 473
++ ++ G+ P
Sbjct: 229 CIMYTLLVGKPP 240
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 43/274 (15%), Positives = 93/274 (33%), Gaps = 54/274 (19%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----------- 340
D A+K+++ + ++ SE+ A L+H +V + +
Sbjct: 30 DSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKS 88
Query: 341 --YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
+I E+ NG L I + ++ + + ++++H + ++HRD+
Sbjct: 89 TLFIQMEYCENGTL---YDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDL 142
Query: 399 RASNVLLDEE-------FG---AHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFV 446
+ N+ +DE FG + + K + + GT Y+A E V
Sbjct: 143 KPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE-V 201
Query: 447 YRNELT--TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504
K D+YS G++ E++ ++ + + +E
Sbjct: 202 LDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNI-LKKLRS---------VSIEFPPD 251
Query: 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
+ +K ++ H P+ RP
Sbjct: 252 FDDNKMKV-------EK--KIIRLLIDHDPNKRP 276
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 4e-20
Identities = 51/259 (19%), Positives = 83/259 (32%), Gaps = 41/259 (15%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
D VAVKR+ F E+ HPN++ D +YI E
Sbjct: 47 DNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AA 102
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L + + + + + + G+A LH ++VHRD++ N+L+
Sbjct: 103 TLQEY---VEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNA 156
Query: 411 AHLMGV-----GLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYRNE---LTTKSDVYSFG 461
+ GL K R GT G++APE + + T D++S G
Sbjct: 157 HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG 216
Query: 462 VLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS--SLSSDIPEAGVV 519
+ ++S F + L+ SL PE
Sbjct: 217 CVFYYVISEGSH-----------PF--------GKSLQRQANILLGACSLDCLHPEKHED 257
Query: 520 QKVVDLVYACTQHVPSMRP 538
+L+ P RP
Sbjct: 258 VIARELIEKMIAMDPQKRP 276
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 46/351 (13%), Positives = 87/351 (24%), Gaps = 79/351 (22%)
Query: 232 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-L 290
R+ + +++L EL + G +LG
Sbjct: 37 RTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRG-TVLGQEDPYAYLEATDQ 95
Query: 291 PDGSRVAVKRLKRSSFQRKKE----------------------------FYSEIGRFARL 322
G V + F
Sbjct: 96 ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 155
Query: 323 HHPNLVAVKGCCYDHG--DRYIVYEFVV--NGPLDRWLHHIPRGGRSLDWAMRMKVATTL 378
++ V+ D R+ +Y + L +SL R+++ +
Sbjct: 156 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQV 215
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
+ +A LH +VH +R +++LD+ G L G V V++ +
Sbjct: 216 IRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL------VRDGARVVSSVSR 266
Query: 439 GYLAPEFVYRNEL-----------TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE 487
G+ PE R T D ++ G+++ I P
Sbjct: 267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP------------IT 314
Query: 488 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
I +IP+ V L+ ++ R
Sbjct: 315 --------KDAALGGSEWIFRSCKNIPQP-----VRALLEGFLRYPKEDRL 352
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 4e-20
Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 30/212 (14%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQR---KKEFYSEIGRFARLHHPNLVAV 330
LLG G Y + G VA+K + + + + + +E+ +L HP+++ +
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
D Y+V E NG ++R+L + R + R + + G+ +LH
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQ-IITGMLYLHSH-- 131
Query: 391 PHVVHRDIRASNVLLDEE-------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
++HRD+ SN+LL FG L T+ GT Y+
Sbjct: 132 -GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH---------YTLC--GTPNYI 179
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
+PE R+ +SDV+S G + ++ GR P
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 37/266 (13%), Positives = 68/266 (25%), Gaps = 64/266 (24%)
Query: 296 VAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----YIVYEFVV 348
VA+ + +E S R +R+ P + V D +V E++
Sbjct: 59 VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV----LDVVHTRAGGLVVAEWIR 114
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
G L S A+R +LA H V S V + +
Sbjct: 115 GGSLQEVA----DTSPSPVGAIR--AMQSLAAAADAAHRA---GVALSIDHPSRVRVSID 165
Query: 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIV 468
L + + D+ G L ++
Sbjct: 166 GDVVL----------------------AYPATMPDA-------NPQDDIRGIGASLYALL 196
Query: 469 SGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYA 528
R P + + ++P + + DIP + +
Sbjct: 197 VNRWPLPEAGV-------RSGLAPAERDTAGQPIEP--ADIDRDIPFQ-----ISAVAAR 242
Query: 529 CTQHVPSMRPRMSHVVHQLQQLAQPP 554
Q +R S +++ +QQ
Sbjct: 243 SVQGDGGIRSA-STLLNLMQQATAVA 267
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 90.8 bits (225), Expect = 5e-20
Identities = 25/206 (12%), Positives = 59/206 (28%), Gaps = 19/206 (9%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
+ + +K K ++ + R + +V E G
Sbjct: 94 NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153
Query: 352 L-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L + + + + + + A + I +HD ++H DI+ N +L F
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFL 210
Query: 411 AHLMGV-----------GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDV 457
G S + ++ + T+ T G+ E + + D
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDM--KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDY 268
Query: 458 YSFGVLLLEIVSGRRPAQAVDSVCWQ 483
+ + ++ G + +
Sbjct: 269 FGVAATVYCMLFGTYMKVKNEGGECK 294
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 6e-20
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE-FYSEIGRFARL 322
+I F R LG G + G +K + + Q E +EI L
Sbjct: 19 TIDDLFIFK-RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGR--SLDWAMRMKVATTLA 379
HPN++ + D+ + YIV E G L +R + RG A MK +
Sbjct: 78 DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK---QMM 134
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAG 435
+A+ H + HVVH+D++ N+L D + + + GL++ E
Sbjct: 135 NALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---- 187
Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
GT Y+APE V++ ++T K D++S GV++ +++G P
Sbjct: 188 GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 7e-20
Identities = 47/250 (18%), Positives = 97/250 (38%), Gaps = 19/250 (7%)
Query: 232 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEG---NRLLGDSKTGGTYSG 288
+ + + + V WK + + + + + + LG G +
Sbjct: 117 EQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV 176
Query: 289 I-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
G+ A K + K+ EI + L HP LV + D + ++YEF+
Sbjct: 177 TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236
Query: 348 VNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
G L ++ + + ++ + +G+ +H+ + VH D++ N++
Sbjct: 237 SGGELFEK----VADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFT 289
Query: 407 EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 463
+ L + GL+ + P + ++ T GT + APE + +D++S GVL
Sbjct: 290 TKRSNELKLIDFGLTAHLDPKQSVKVTT----GTAEFAAPEVAEGKPVGYYTDMWSVGVL 345
Query: 464 LLEIVSGRRP 473
++SG P
Sbjct: 346 SYILLSGLSP 355
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 51/243 (20%), Positives = 96/243 (39%), Gaps = 21/243 (8%)
Query: 232 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSE-----GNRLLGDSKTGGTY 286
R + A + +P F + + + +LG + G +
Sbjct: 47 DLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVH 106
Query: 287 SGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345
G ++A K +K + K+E +EI +L H NL+ + D +V E
Sbjct: 107 KCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166
Query: 346 FVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
+V G L DR I +L + + +GI +H +++H D++ N+L
Sbjct: 167 YVDGGELFDR----IIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENIL 219
Query: 405 LDEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFG 461
+ + GL++ P E ++ GT +LAPE V + ++ +D++S G
Sbjct: 220 CVNRDAKQIKIIDFGLARRYKPREKLKVNF----GTPEFLAPEVVNYDFVSFPTDMWSVG 275
Query: 462 VLL 464
V+
Sbjct: 276 VIA 278
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 33/188 (17%), Positives = 71/188 (37%), Gaps = 22/188 (11%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
K +K + EI H N++ + + +++EF+ +
Sbjct: 30 KKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88
Query: 353 -DRWLHHIPRGGRSL---DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
+R I L + + + + + FLH ++ H DIR N++
Sbjct: 89 FER----INTSAFELNEREIVSYVH---QVCEALQFLHSH---NIGHFDIRPENIIYQTR 138
Query: 409 FGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLL 465
+ + + G ++ + P + + Y APE + ++T +D++S G L+
Sbjct: 139 RSSTIKIIEFGQARQLKPGDNFRLLF----TAPEYYAPEVHQHDVVSTATDMWSLGTLVY 194
Query: 466 EIVSGRRP 473
++SG P
Sbjct: 195 VLLSGINP 202
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 4e-19
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 22/212 (10%)
Query: 260 TEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGR 318
+ + +I K F +LG + G A+K +K+S R +EI
Sbjct: 1 SMQTTNIRKTFIFM-EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAV 59
Query: 319 FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGR--SLDWAMRMKVA 375
++ H N+V ++ Y+V + V G L DR I G D ++ ++
Sbjct: 60 LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDR----ILERGVYTEKDASLVIQ-- 113
Query: 376 TTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWEVMQERTV 432
+ + +LH+ +VHRD++ N+L E + +M GLSK +M
Sbjct: 114 -QVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC- 168
Query: 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
GT GY+APE + + + D +S GV+
Sbjct: 169 ---GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 20/217 (9%)
Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFA 320
+ + ++ +LG G AVK + ++S + K E+
Sbjct: 18 GTFAERYNIV-CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
+L HPN++ + D YIV E G L I + R ++ +
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGEL---FDEIIKRKR-FSEHDAARIIKQVFS 132
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGG 436
GI ++H ++VHRD++ N+LL +E + + GLS M++R G
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI----G 185
Query: 437 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
T Y+APE V R K DV+S GV+L ++SG P
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 49/217 (22%), Positives = 88/217 (40%), Gaps = 24/217 (11%)
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH 323
I + ++ +G G + R A K++ + + F EI L
Sbjct: 6 DINQYYTLE-NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGR--SLDWAMRMKVATTLAQ 380
HPN++ + D+ D Y+V E G L +R + D A MK +
Sbjct: 65 HPNIIRLYETFEDNTDIYLVMELCTGGELFER----VVHKRVFRESDAARIMK---DVLS 117
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGG 436
+A+ H +V HRD++ N L + + L + GL+ P ++M+ + G
Sbjct: 118 AVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV----G 170
Query: 437 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
T Y++P+ V + D +S GV++ ++ G P
Sbjct: 171 TPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 42/189 (22%), Positives = 79/189 (41%), Gaps = 22/189 (11%)
Query: 293 GSRVAVKRLKRSSFQRKK---EFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
A K + +S + + EI L H ++V G D+ ++V E
Sbjct: 40 KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409
L L R + R + G +LH V+HRD++ N+ L+E+
Sbjct: 100 RSL---LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNED- 151
Query: 410 GAHLMGV-----GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
+ V GL+ V ++ +++ + GT Y+APE + + + + DV+S G ++
Sbjct: 152 ----LEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 205
Query: 465 LEIVSGRRP 473
++ G+ P
Sbjct: 206 YTLLVGKPP 214
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 60/264 (22%), Positives = 107/264 (40%), Gaps = 50/264 (18%)
Query: 291 PDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV 348
P G +AVKR++ + Q +K ++ R P V G + GD +I E +
Sbjct: 30 PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM- 88
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
+ LD++ + G+++ + K+A ++ + + LH K+ V+HRD++ SNVL++
Sbjct: 89 DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINAL 146
Query: 409 -------FG--AHLMG-VGLSKFVPWEVMQERTVMAGGTYGYLAPE----FVYRNELTTK 454
FG +L+ V G Y+APE + + + K
Sbjct: 147 GQVKMCDFGISGYLVDDVAKDIDA-------------GCKPYMAPERINPELNQKGYSVK 193
Query: 455 SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 514
SD++S G+ ++E+ R P W TP + L ++ S +P
Sbjct: 194 SDIWSLGITMIELAILRFP-----------YDSWGTP-------FQQLKQVVEEPSPQLP 235
Query: 515 EAGVVQKVVDLVYACTQHVPSMRP 538
+ VD C + RP
Sbjct: 236 ADKFSAEFVDFTSQCLKKNSKERP 259
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 58/289 (20%), Positives = 104/289 (35%), Gaps = 56/289 (19%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH-----------GD 339
G A+KRL + ++ + E+ +L HPN+V
Sbjct: 52 SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ----FCSAASIGKEESDTGQA 107
Query: 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399
+++ + G L +L + G L +K+ + + +H + KP ++HRD++
Sbjct: 108 EFLLLTELCKGQLVEFLKKMESRGP-LSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLK 165
Query: 400 ASNVLLDEE-------FG---AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV--Y 447
N+LL + FG S + E + T Y PE + Y
Sbjct: 166 VENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY 225
Query: 448 RNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL-VQSHRYLELLDPL 505
N + K D+++ G +L + + P FE L + + +Y P
Sbjct: 226 SNFPIGEKQDIWALGCILYLLCFRQHP------------FEDGAKLRIVNGKYSI---PP 270
Query: 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
+ + L+ A Q P R ++ VVHQLQ++A
Sbjct: 271 HDTQYTVF---------HSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 87.4 bits (216), Expect = 3e-18
Identities = 43/193 (22%), Positives = 86/193 (44%), Gaps = 21/193 (10%)
Query: 293 GSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAV------KGCCYDHGDRYIVYE 345
G +VA+K+ ++ + +E + EI +L+HPN+V+ + + E
Sbjct: 39 GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98
Query: 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405
+ G L ++L+ L + + ++ + +LH+ ++HRD++ N++L
Sbjct: 99 YCEGGDLRKYLNQFENCCG-LKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVL 154
Query: 406 DEEFGAHLMGV---GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSF 460
+ + G +K + + + GT YLAPE + + + T D +SF
Sbjct: 155 QPGPQRLIHKIIDLGYAKE-----LDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSF 209
Query: 461 GVLLLEIVSGRRP 473
G L E ++G RP
Sbjct: 210 GTLAFECITGFRP 222
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 3e-18
Identities = 48/209 (22%), Positives = 70/209 (33%), Gaps = 34/209 (16%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
G VAVKR+ EI HPN++ YI E N
Sbjct: 38 QGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL-CNL 93
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLLDE 407
L + +L + L Q G+A LH ++HRD++ N+L+
Sbjct: 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVST 150
Query: 408 EFGAHLMGV-------------GLSKFVPWEVMQERTVM--AGGTYGYLAPE-------F 445
GL K + RT + GT G+ APE
Sbjct: 151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL 210
Query: 446 VYRNELTTKSDVYSFGVLLLEIVS-GRRP 473
+ LT D++S G + I+S G+ P
Sbjct: 211 QTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 26/219 (11%)
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE--FYSEIGRFAR 321
+ + ++ +LG G AVK + ++S + K E+ +
Sbjct: 19 TFAERYNIV-CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGR--SLDWAMRMKVATTL 378
L HPN++ + D YIV E G L D I + R D A +K +
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDE----IIKRKRFSEHDAARIIK---QV 130
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMA 434
GI ++H ++VHRD++ N+LL +E + + GLS M++R
Sbjct: 131 FSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--- 184
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
GT Y+APE V R K DV+S GV+L ++SG P
Sbjct: 185 -GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 4e-18
Identities = 52/362 (14%), Positives = 127/362 (35%), Gaps = 56/362 (15%)
Query: 231 RRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL 290
+ + + + + +P E + + +S + +G + + +
Sbjct: 19 ETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL-KQIGSGGSSKVFQVLN 77
Query: 291 PDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK--GCCYDHGDRYIVYEF 346
A+K + + + +EI +L + ++ Y+V E
Sbjct: 78 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 137
Query: 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD 406
N L+ WL +S+D R + + + +H +VH D++ +N L+
Sbjct: 138 G-NIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV 189
Query: 407 EE------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-----------FVYRN 449
+ FG ++ + + G Y+ PE ++
Sbjct: 190 DGMLKLIDFG-------IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242
Query: 450 ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509
+++ KSDV+S G +L + G+ P + + Q + ++DP +
Sbjct: 243 KISPKSDVWSLGCILYYMTYGKTP--------------FQQIINQISKLHAIIDP---NH 285
Query: 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQLQQLAQPPVTKLLFKGLDRLRH 568
+ P+ + + D++ C + P R + ++ H Q+ PV ++ + +++
Sbjct: 286 EIEFPD-IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKY 344
Query: 569 IF 570
+
Sbjct: 345 VL 346
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 6e-18
Identities = 43/209 (20%), Positives = 81/209 (38%), Gaps = 21/209 (10%)
Query: 278 GDSKTGGTYSGI-LPDGSRVAVKR--LKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
G P G V V+R L+ S + E+ +HPN+V +
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA---QGIAFLHDKVKP 391
+ ++V F+ G + G + +A L + + ++H
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVLKALDYIHHM--- 147
Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG-----GTYGYLAPEFV 446
VHR ++AS++L+ + +L G+ + + ++R V +L+PE +
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207
Query: 447 YRNEL--TTKSDVYSFGVLLLEIVSGRRP 473
+N KSD+YS G+ E+ +G P
Sbjct: 208 QQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 49/298 (16%), Positives = 107/298 (35%), Gaps = 55/298 (18%)
Query: 286 YSGILPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK--GCCYDHGDRY 341
+ + A+K + + + +EI +L + ++ Y
Sbjct: 45 FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
+V E N L+ WL +S+D R + + + +H +VH D++ +
Sbjct: 105 MVMECG-NIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPA 156
Query: 402 NVLLDEEFGAHLMGV------GLSKFVPWEVMQERTVMAGGTYGYLAPE----------- 444
N L+ + G+ G++ + + GT Y+ PE
Sbjct: 157 NFLIVD-------GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 209
Query: 445 FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504
+++++ KSDV+S G +L + G+ P + + Q + ++DP
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGKTP--------------FQQIINQISKLHAIIDP 255
Query: 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV-VHQLQQLAQPPVTKLLFK 561
+ + P+ + + D++ C + P R + + H Q+ PV ++
Sbjct: 256 ---NHEIEFPD-IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 309
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 29/207 (14%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
+G +G Y+ + + G VA++++ +K+ +EI +PN+V
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
+ ++V E++ G L + +D V Q + FLH V+H
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 396 RDIRASNVLLDEE-------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV 446
RDI++ N+LL + FG A + +R+ M G Y ++APE V
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQIT----------PEQSKRSTMVGTPY-WMAPEVV 188
Query: 447 YRNELTTKSDVYSFGVLLLEIVSGRRP 473
R K D++S G++ +E++ G P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 50/247 (20%), Positives = 90/247 (36%), Gaps = 35/247 (14%)
Query: 245 PAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVK---- 299
P S + ++ + ++G I G + AVK
Sbjct: 3 PGISGGGGGILDM--ADDDVLFEDVYELC-EVIGKGPFSVVRRCINRETGQQFAVKIVDV 59
Query: 300 -RLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLH 357
+ S ++ E L HP++V + G Y+V+EF+ L
Sbjct: 60 AKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFE--- 116
Query: 358 HIPRGGRSLDW------AMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFG 410
I + + + M+ + + + + HD +++HRD++ VLL +E
Sbjct: 117 -IVKRADAGFVYSEAVASHYMR---QILEALRYCHDN---NIIHRDVKPHCVLLASKENS 169
Query: 411 AHLMGV--GLSKFV--PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
A + G++ + V R GT ++APE V R DV+ GV+L
Sbjct: 170 APVKLGGFGVAIQLGESGLVAGGRV----GTPHFMAPEVVKREPYGKPVDVWGCGVILFI 225
Query: 467 IVSGRRP 473
++SG P
Sbjct: 226 LLSGCLP 232
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 66/250 (26%), Positives = 106/250 (42%), Gaps = 25/250 (10%)
Query: 231 RRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI- 289
+ + P ++LVP W + + +++ F LG T Y
Sbjct: 18 LYFQSMSSVTASAAPGTASLVPDYWIDGSNRD--ALSDFFEVE-SELGRGATSIVYRCKQ 74
Query: 290 LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
A+K LK++ KK +EIG RL HPN++ +K + +V E V
Sbjct: 75 KGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132
Query: 350 GPL-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-D 406
G L DR + +G S D A +K + + +A+LH+ +VHRD++ N+L
Sbjct: 133 GELFDRI---VEKGYYSERDAADAVK---QILEAVAYLHEN---GIVHRDLKPENLLYAT 183
Query: 407 EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVL 463
A L GLSK V +M+ GT GY APE + + D++S G++
Sbjct: 184 PAPDAPLKIADFGLSKIVEHQVLMKTVC----GTPGYCAPEILRGCAYGPEVDMWSVGII 239
Query: 464 LLEIVSGRRP 473
++ G P
Sbjct: 240 TYILLCGFEP 249
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 49/207 (23%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
+G+ TG G +VAVK + QR++ ++E+ H N+V +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
+ +++ EF+ G L + + L+ V + Q +A+LH + V+H
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYLHAQ---GVIH 164
Query: 396 RDIRASNVLLDEE-------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV 446
RDI++ ++LL + FG A + + + +R + G Y ++APE +
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQIS----------KDVPKRKSLVGTPY-WMAPEVI 213
Query: 447 YRNELTTKSDVYSFGVLLLEIVSGRRP 473
R+ T+ D++S G++++E+V G P
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 56/281 (19%), Positives = 103/281 (36%), Gaps = 52/281 (18%)
Query: 291 PDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
P G +A K + + + E+ + P +V G Y G+ I E +
Sbjct: 56 PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE- 408
G LD+ L + + + KV+ + +G+ +L +K K ++HRD++ SN+L++
Sbjct: 116 GSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRG 169
Query: 409 ------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSF 460
FG L+ + FV GT Y++PE + + +SD++S
Sbjct: 170 EIKLCDFGVSGQLIDSMANSFV-------------GTRSYMSPERLQGTHYSVQSDIWSM 216
Query: 461 GVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAG--- 517
G+ L+E+ GR P D+ + +F + P +
Sbjct: 217 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMA 276
Query: 518 ---VVQKVV-----------------DLVYACTQHVPSMRP 538
++ +V D V C P+ R
Sbjct: 277 IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 317
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 50/308 (16%), Positives = 114/308 (37%), Gaps = 57/308 (18%)
Query: 286 YSGILPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK--GCCYDHGDRY 341
+ + A+K + + + +EI +L + ++ Y
Sbjct: 26 FQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
+V E N L+ WL +S+D R + + + +H +VH D++ +
Sbjct: 86 MVMECG-NIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPA 137
Query: 402 NVLLDEEFGAHLMGV------GLSKFV-PWEVMQERTVMAGGTYGYLAPE---------- 444
N L+ + G+ G++ + P + G T Y+ PE
Sbjct: 138 NFLIVD-------GMLKLIDFGIANQMQPDTTSVVKDSQVG-TVNYMPPEAIKDMSSSRE 189
Query: 445 -FVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503
+++++ KSDV+S G +L + G+ P + + Q + ++D
Sbjct: 190 NGKSKSKISPKSDVWSLGCILYYMTYGKTP--------------FQQIINQISKLHAIID 235
Query: 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQLQQLAQPPVTKLLFKG 562
P + + P+ + + D++ C + P R + ++ H Q+ PV ++
Sbjct: 236 P---NHEIEFPD-IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGT 291
Query: 563 LDRLRHIF 570
+ ++++
Sbjct: 292 TEEMKYVL 299
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 47/183 (25%), Positives = 82/183 (44%), Gaps = 16/183 (8%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
A+K L++ ++ + E +RL HP V + D Y + NG L
Sbjct: 59 AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL- 117
Query: 354 RWLHHIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
L +I + G + R A A + +LH K ++HRD++ N+LL+E+ H
Sbjct: 118 --LKYIRKIGSFDETCTRFYTAEIVSA--LEYLHGK---GIIHRDLKPENILLNED--MH 168
Query: 413 LMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
+ G +K + E Q R GT Y++PE + SD+++ G ++ ++V+G
Sbjct: 169 IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228
Query: 471 RRP 473
P
Sbjct: 229 LPP 231
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 47/228 (20%), Positives = 81/228 (35%), Gaps = 27/228 (11%)
Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE-FYSEIGRFAR 321
+S + + + +LG T + G G A+K SF R + E +
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 322 LHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLA 379
L+H N+V + + R ++ EF G L L P L + + V +
Sbjct: 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVV 122
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH----LMGVGLSKFVPWEVMQERTVMAG 435
G+ L + +VHR+I+ N++ L G ++ +++
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-----LEDDEQFVS 174
Query: 436 --GTYGYLAPEFVYRNELTT--------KSDVYSFGVLLLEIVSGRRP 473
GT YL P+ R L D++S GV +G P
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 6e-17
Identities = 49/218 (22%), Positives = 87/218 (39%), Gaps = 23/218 (10%)
Query: 267 TKNFSEG---NRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFA 320
+ FS+ LG + G A K + + ++ E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 321 RLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLA 379
+L HPN+V + + Y+V++ V G L + + R S A +
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADAS--HCIQQIL 115
Query: 380 QGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAG 435
+ IA+ H +VHR+++ N+LL + GA + GL+ V E
Sbjct: 116 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---- 168
Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
GT GYL+PE + ++ + D+++ GV+L ++ G P
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 42/221 (19%), Positives = 87/221 (39%), Gaps = 25/221 (11%)
Query: 256 KVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEF 312
+ + + + + ++ LG K I G A K LK+ + E
Sbjct: 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEI 75
Query: 313 YSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSL---D 367
EI P ++ + + + ++ E+ G + +P + D
Sbjct: 76 LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC---LPELAEMVSEND 132
Query: 368 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-P 423
+K + +G+ +LH ++VH D++ N+LL + V G+S+ +
Sbjct: 133 VIRLIK---QILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186
Query: 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
++E GT YLAPE + + +TT +D+++ G++
Sbjct: 187 ACELREIM----GTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >1fm5_A Early activation antigen CD69; C-type lectin-like domain, natural killer cell receptor, lectin, C-type lectin, immune system; 2.27A {Homo sapiens} SCOP: d.169.1.1 Length = 199 | Back alignment and structure |
|---|
Score = 78.1 bits (192), Expect = 7e-17
Identities = 37/182 (20%), Positives = 69/182 (37%), Gaps = 29/182 (15%)
Query: 10 VPLQCFLLLVAYY---VLQLVASDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKC 66
VP+ C ++ V + ++ L+A + + + C DW+ + KC
Sbjct: 39 VPVLCAVMNVVFITILIIALIALSVGQYNCPGQYTFSMPSDSHVSSCSEDWVGYQ--RKC 96
Query: 67 FGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGL 126
+ RSW ++ C E G LA + S ++ + ++ G+ WVG + G
Sbjct: 97 YFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAGR--EEHWVG---LKKEPGH 151
Query: 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPF 186
WKWS+ ++N + GS C + N + + C + +
Sbjct: 152 PWKWSNG-KEFNNWFNVTGSDK----------------CVFLKNT--EVSSMECEKNLYW 192
Query: 187 IC 188
IC
Sbjct: 193 IC 194
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 46/219 (21%), Positives = 85/219 (38%), Gaps = 25/219 (11%)
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL- 322
++T ++ ++LG G G + A+K L S R+ E+ +
Sbjct: 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-----EVDHHWQAS 79
Query: 323 HHPNLVAVKGCCYDHGDR----YIVYEFVVNGPLDRWLHHI-PRGGRSLDWAMRMKVATT 377
P++V + + I+ E + G L I RG ++ ++
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL---FSRIQERGDQAFTEREAAEIMRD 136
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWEVMQERTVMA 434
+ I FLH ++ HRD++ N+L +E A L G +K +Q
Sbjct: 137 IGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC--- 190
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
T Y+APE + + D++S GV++ ++ G P
Sbjct: 191 -YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 43/232 (18%), Positives = 79/232 (34%), Gaps = 35/232 (15%)
Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE-FYSEIGRFAR 321
+S + + + +LG T + G G A+K SF R + E +
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 322 LHHPNLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT-- 377
L+H N+V + + R ++ EF G L + + + +
Sbjct: 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL---YTVLEEPSNA--YGLPESEFLIVL 118
Query: 378 --LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH----LMGVGLSKFVPWEVMQERT 431
+ G+ L + +VHR+I+ N++ L G ++ +++
Sbjct: 119 RDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-----LEDDE 170
Query: 432 VMAG--GTYGYLAPEFVYRNELTT--------KSDVYSFGVLLLEIVSGRRP 473
GT YL P+ R L D++S GV +G P
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 43/183 (23%), Positives = 84/183 (45%), Gaps = 16/183 (8%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
A+K + + + E + E+ L HP LV + D D ++V + ++ G L
Sbjct: 44 AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL- 102
Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
+H+ + + +++ + L + +L ++ ++HRD++ N+LLDE H+
Sbjct: 103 --RYHLQQNVHFKEETVKLFICE-LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHI 156
Query: 414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT--TKS-DVYSFGVLLLEIVSG 470
++ +P E + GT Y+APE + + + D +S GV E++ G
Sbjct: 157 TDFNIAAMLPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213
Query: 471 RRP 473
RRP
Sbjct: 214 RRP 216
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 47/247 (19%), Positives = 80/247 (32%), Gaps = 51/247 (20%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVK-----RLKRSSFQRKKEFYSEIGRFARLHHPNLV 328
+G G I + A+K ++++ + + + +E+ +LHHPN+
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRM--------------- 372
+ D +V E G L D+ I +
Sbjct: 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 373 --------------------KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
+ + + +LH++ + HRDI+ N L
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFE 208
Query: 413 LMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNEL--TTKSDVYSFGVLLLE 466
+ V GLSK E M GT ++APE + K D +S GVLL
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 467 IVSGRRP 473
++ G P
Sbjct: 269 LLMGAVP 275
|
| >1mpu_A NKG2-D type II integral membrane protein; C-type lectin-like domain, immune system; 2.50A {Homo sapiens} SCOP: d.169.1.1 PDB: 1hyr_B Length = 138 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-16
Identities = 31/155 (20%), Positives = 58/155 (37%), Gaps = 23/155 (14%)
Query: 34 NQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAAL 93
N N ++ + + + PCP +WI + + C+ + ++W ES+ C L +
Sbjct: 2 NSLFNQEVQIPLTESYCGPCPKNWICYK--NNCYQFFDESKNWYESQASCMSQNASLLKV 59
Query: 94 TSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTS 153
S E+ Q L + W+G + SW+W D S + ++ +
Sbjct: 60 YSKED----QDLLKLVKSYHWMGLV--HIPTNGSWQWEDG-SILSPNLLTIIEMQKG--- 109
Query: 154 LPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
D S+ E C+T + +IC
Sbjct: 110 ---------DCALYASSF--KGYIENCSTPNTYIC 133
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 48/223 (21%), Positives = 87/223 (39%), Gaps = 20/223 (8%)
Query: 259 TTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE--FYSE 315
T T+ + LG + + G A + + E
Sbjct: 2 ATITCTRFTEEYQLF-EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 316 IGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRS-LDWAMRMK 373
L HPN+V + + G Y++++ V G L + + R S D + ++
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI---VAREYYSEADASHCIQ 117
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWEVMQER 430
+ + + H VVHR+++ N+LL + GA + GL+ V E Q+
Sbjct: 118 ---QILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQA 169
Query: 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
GT GYL+PE + ++ D+++ GV+L ++ G P
Sbjct: 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >3rs1_A C-type lectin domain family 2 member I; C-type lectin-like, ligand of NK receptor, natural killer CE receptors, surface of activated T lymphocytes; 1.94A {Mus musculus} Length = 122 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-16
Identities = 30/144 (20%), Positives = 56/144 (38%), Gaps = 26/144 (18%)
Query: 45 MNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQK 104
MNK + A C +W +KCF + G R+W ++ +C LA + EE ++
Sbjct: 1 MNKTY-AACSKNWTGVG--NKCFYFSGYPRNWTFAQAFCMAQEAQLARFDNEEELIFLKR 57
Query: 105 LCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
G W+G ++ WKW++N +++N +G
Sbjct: 58 FKGD--FDSWIGLHRESS--EHPWKWTNN-TEYNNMNPILGVGR---------------- 96
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
+S+ + + R + +IC
Sbjct: 97 YAYLSSD--RISSSRSYINRMWIC 118
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 49/225 (21%), Positives = 90/225 (40%), Gaps = 23/225 (10%)
Query: 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYS 314
F + N+ LG + G A K + + ++
Sbjct: 19 FMMNASTKFSDNYDVK-EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL-DRWLHHIPRGGRS-LDWAMRM 372
E +L HPN+V + + Y+V++ V G L + + R S D + +
Sbjct: 78 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCI 134
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFV-PWEVMQ 428
+ + + IA+ H +VHR+++ N+LL + GA + GL+ V E
Sbjct: 135 Q---QILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 188
Query: 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
GT GYL+PE + ++ + D+++ GV+L ++ G P
Sbjct: 189 GFA----GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >1ypq_A Oxidised low density lipoprotein (lectin-like) receptor 1; oxidized low density lipoprotein receptor, LOX-1, CTLD, C- type lectin like domain; 1.40A {Homo sapiens} SCOP: d.169.1.1 PDB: 1ypu_A 1yxk_A 3vlg_A 1ypo_A 1yxj_A Length = 135 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-16
Identities = 28/139 (20%), Positives = 48/139 (34%), Gaps = 17/139 (12%)
Query: 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
APCP DWI + C+ + +W++S+ C + L + S + Q+ +
Sbjct: 7 APCPQDWIWHG--ENCYLFSSGSFNWEKSQEKCLSLDAKLLKINSTADLDFIQQAISYSS 64
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESI-HAVGSFNSSCTSLPCHVHATVDLCTLVS 169
W+G N W W D S + G+ + + S C
Sbjct: 65 FPFWMGLSRRNP--SYPWLWEDG-SPLMPHLFRVRGAVSQTYPSGTC-----------AY 110
Query: 170 NGSRSLVTERCNTSHPFIC 188
++ E C + IC
Sbjct: 111 IQRGAVYAENCILAAFSIC 129
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 51/208 (24%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQ-RKKEFYSEIGRFARLHHPNLVAVKGCC 334
+G T + P +VA+KR+ Q E EI ++ HHPN+V+
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR-MKVATTLAQ---GIAFLHDKVK 390
+ ++V + + G + + HI G + +AT L + G+ +LH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-- 140
Query: 391 PHVVHRDIRASNVLLDEEFGAHLM--GVG--LSKFVPWEVMQERTVMAGGTYGYLAPEFV 446
+HRD++A N+LL E+ + GV L+ + R G ++APE +
Sbjct: 141 -GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC-WMAPEVM 198
Query: 447 YRNEL-TTKSDVYSFGVLLLEIVSGRRP 473
+ K+D++SFG+ +E+ +G P
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 38/185 (20%), Positives = 75/185 (40%), Gaps = 26/185 (14%)
Query: 293 GSRVAVKRLKRSSFQR------KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
G A K +K+ + ++E E+ ++ H N++ + + D ++ E
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96
Query: 347 VVNGPL-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
V G L D + S + +K + G+ +LH K + H D++ N++
Sbjct: 97 VSGGELFDFL---AQKESLSEEEATSFIK---QILDGVNYLHTK---KIAHFDLKPENIM 147
Query: 405 LD--EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
L H+ + GL+ + + GT ++APE V L ++D++S
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF----GTPEFVAPEIVNYEPLGLEADMWS 203
Query: 460 FGVLL 464
GV+
Sbjct: 204 IGVIT 208
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 62/255 (24%), Positives = 99/255 (38%), Gaps = 40/255 (15%)
Query: 236 RRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGN--------RLLGDSKTGGTYS 287
+ K R L+N + AL KVF +L ++ + LG G
Sbjct: 94 KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKL 153
Query: 288 GI-LPDGSRVAVKRLKRSSFQRKKE--------FYSEIGRFARLHHPNLVAVKGCCYDHG 338
+VA++ + + F +EI +L+HP ++ +K +D
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAE 212
Query: 339 DRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
D YIV E + G L D+ + R L A + + +LH+ ++HRD
Sbjct: 213 DYYIVLELMEGGELFDK----VVGNKR-LKEATCKLYFYQMLLAVQYLHEN---GIIHRD 264
Query: 398 IRASNVLLD-EEFGAHLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPE---FVYRN 449
++ NVLL +E + G SK + E ++M GT YLAPE V
Sbjct: 265 LKPENVLLSSQEEDCLIKITDFGHSKI-----LGETSLMRTLCGTPTYLAPEVLVSVGTA 319
Query: 450 ELTTKSDVYSFGVLL 464
D +S GV+L
Sbjct: 320 GYNRAVDCWSLGVIL 334
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 5e-16
Identities = 38/185 (20%), Positives = 72/185 (38%), Gaps = 26/185 (14%)
Query: 293 GSRVAVK-----RLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
G A K RL S +E E+ + HPN++ + + D ++ E
Sbjct: 30 GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL 89
Query: 347 VVNGPL-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
V G L D + + + +K + G+ +LH K + H D++ N++
Sbjct: 90 VSGGELFDFL---AEKESLTEDEATQFLK---QILDGVHYLHSK---RIAHFDLKPENIM 140
Query: 405 LD--EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
L + + G++ + + GT ++APE V L ++D++S
Sbjct: 141 LLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF----GTPEFVAPEIVNYEPLGLEADMWS 196
Query: 460 FGVLL 464
GV+
Sbjct: 197 IGVIT 201
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 39/185 (21%), Positives = 75/185 (40%), Gaps = 26/185 (14%)
Query: 293 GSRVAVKRLKRSS------FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
G A K +K+ ++E E+ ++ HPN++ + + D ++ E
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL 96
Query: 347 VVNGPL-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
V G L D + S + +K + G+ +LH K + H D++ N++
Sbjct: 97 VSGGELFDFL---AQKESLSEEEATSFIK---QILDGVNYLHTK---KIAHFDLKPENIM 147
Query: 405 LD--EEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
L H+ + GL+ + + GT ++APE V L ++D++S
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF----GTPEFVAPEIVNYEPLGLEADMWS 203
Query: 460 FGVLL 464
GV+
Sbjct: 204 IGVIT 208
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 50/210 (23%), Positives = 89/210 (42%), Gaps = 33/210 (15%)
Query: 291 PDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV 348
P G +AVKR++ + +K+ ++ R P +V G + GD +I E +
Sbjct: 45 PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM- 103
Query: 349 NGPLDRWLHHI-PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407
+ D++ ++ + + K+ + + L + +K ++HRDI+ SN+LLD
Sbjct: 104 STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDR 161
Query: 408 E-------FG--AHLMG-VGLSKFVPWEVMQERTVMAGGTYGYLAPE----FVYRNELTT 453
FG L+ + ++ G Y+APE R
Sbjct: 162 SGNIKLCDFGISGQLVDSIAKTRDA-------------GCRPYMAPERIDPSASRQGYDV 208
Query: 454 KSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ 483
+SDV+S G+ L E+ +GR P +SV Q
Sbjct: 209 RSDVWSLGITLYELATGRFPYPKWNSVFDQ 238
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 8e-16
Identities = 47/256 (18%), Positives = 90/256 (35%), Gaps = 32/256 (12%)
Query: 232 RSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-L 290
+ P K + +I ++ +++LG G
Sbjct: 25 TPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNK 84
Query: 291 PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR----YIVYE 345
+ A+K L+ R+ E+ R P++V + + IV E
Sbjct: 85 RTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139
Query: 346 FVVNGPLDRWLHHI-PRGGRSL---DWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
+ G L I RG ++ + + MK ++ + I +LH ++ HRD++
Sbjct: 140 CLDGGEL---FSRIQDRGDQAFTEREASEIMK---SIGEAIQYLHSI---NIAHRDVKPE 190
Query: 402 NVLL-DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDV 457
N+L + A L G +K + T Y+APE + + D+
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC----YTPYYVAPEVLGPEKYDKSCDM 246
Query: 458 YSFGVLLLEIVSGRRP 473
+S GV++ ++ G P
Sbjct: 247 WSLGVIMYILLCGYPP 262
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 38/194 (19%), Positives = 78/194 (40%), Gaps = 26/194 (13%)
Query: 293 GSRVAVKRLKRS------SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346
G + A K +K+ +++ E+ + HPN++ + + D ++ E
Sbjct: 36 GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 347 VVNGPL-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
V G L D + + + +K + G+ +LH + H D++ N++
Sbjct: 96 VAGGELFDFL---AEKESLTEEEATEFLK---QILNGVYYLHSL---QIAHFDLKPENIM 146
Query: 405 L--DEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
L + + GL+ + + GT ++APE V L ++D++S
Sbjct: 147 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF----GTPEFVAPEIVNYEPLGLEADMWS 202
Query: 460 FGVLLLEIVSGRRP 473
GV+ ++SG P
Sbjct: 203 IGVITYILLSGASP 216
|
| >1jwi_A Bitiscetin; domain swapping, C-type lectin, toxin; 2.00A {Bitis arietans} SCOP: d.169.1.1 PDB: 1uex_A Length = 131 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-15
Identities = 36/144 (25%), Positives = 55/144 (38%), Gaps = 30/144 (20%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
C PDW + C+ +W+++E +C E GHLA++ S EE KL + +
Sbjct: 4 CLPDWSSYK--GHCYKVFKKVGTWEDAEKFCVENSGHLASIDSKEEADFVTKLASQTLTK 61
Query: 113 ----CWVGGRSINTTVGLSWKWSDNMS----KWNESIHAVGSFNSSCTSLPCHVHATVDL 164
W+G R + T S +W+D S +E + C L H
Sbjct: 62 FVYDAWIGLRDESKTQQCSPQWTDGSSVVYENVDE--------PTKCFGLDVHT------ 107
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
R+ C +PFIC
Sbjct: 108 ------EYRTWTDLPCGEKNPFIC 125
|
| >1hq8_A NKG2-D; homodimer, CIS-proline, apoptosis; 1.95A {Mus musculus} SCOP: d.169.1.1 PDB: 1jsk_A 1kcg_A* Length = 123 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-15
Identities = 27/137 (19%), Positives = 47/137 (34%), Gaps = 23/137 (16%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
PCP +WI + + C+ + ++W++S+ C L + S EE Q +
Sbjct: 5 PCPNNWICHR--NNCYQFFNEEKTWNQSQASCLSQNSSLLKIYSKEE----QDFLKLVKS 58
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
W+G SW+W D S + + + S+
Sbjct: 59 YHWMGLV--QIPANGSWQWEDG-SSLSYNQLTLVEIPKG------------SCAVYGSSF 103
Query: 172 SRSLVTERCNTSHPFIC 188
TE C + +IC
Sbjct: 104 --KAYTEDCANLNTYIC 118
|
| >2yhf_A C-type lectin domain family 5 member A; immune system; 1.90A {Homo sapiens} Length = 118 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-15
Identities = 29/136 (21%), Positives = 55/136 (40%), Gaps = 23/136 (16%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP DW + ++CF + SW+ES +CK G LA + + E+ Q + +
Sbjct: 2 CPKDWEFYQ--ARCFFLSTSESSWNESRDFCKGKGSTLAIVNTPEKLKFLQDI--TDAEK 57
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
++G W+W +N S +N ++ N +C ++ +
Sbjct: 58 YFIGLIYHRE--EKRWRWINN-SVFNGNVTNQNQ-NFNCATI---------------GLT 98
Query: 173 RSLVTERCNTSHPFIC 188
++ C+ S+ IC
Sbjct: 99 KTFDAASCDISYRRIC 114
|
| >3hup_A Early activation antigen CD69; C-type lectin-like domain, disulfide bond, glycoprotein, LEC membrane, phosphoprotein, signal-anchor, transmembrane; 1.37A {Homo sapiens} PDB: 1e87_A 1e8i_A 3cck_A Length = 130 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-15
Identities = 31/138 (22%), Positives = 54/138 (39%), Gaps = 26/138 (18%)
Query: 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
+ C DW+ + KC+ RSW ++ C E G LA + S ++ + ++ G+
Sbjct: 14 SSCSEDWVGYQ--RKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAGR-- 69
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
WVG + G WKWS+ ++N + GS C + N
Sbjct: 70 EEHWVG---LKKEPGHPWKWSNG-KEFNNWFNVTGSDK----------------CVFLKN 109
Query: 171 GSRSLVTERCNTSHPFIC 188
+ + C + +IC
Sbjct: 110 T--EVSSMECEKNLYWIC 125
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 32/212 (15%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
LGD G Y G+ A K ++ S + +++ EI A HP +V + G Y
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
G +I+ EF G +D + + RG L V + + + FLH K ++H
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHSK---RIIH 140
Query: 396 RDIRASNVLLDEE-------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV 446
RD++A NVL+ E FG A + + +Q+R G Y ++APE V
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNL----------KTLQKRDSFIGTPY-WMAPEVV 189
Query: 447 YRNELT-----TKSDVYSFGVLLLEIVSGRRP 473
+ K+D++S G+ L+E+ P
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 40/184 (21%), Positives = 83/184 (45%), Gaps = 18/184 (9%)
Query: 297 AVKRLKRSSFQRKKEFYSEIG------RFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
A+K L + + K+ + + P +V + + + + + G
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L +H+ + G + MR A + G+ +H++ VV+RD++ +N+LLDE
Sbjct: 278 DL---HYHLSQHGVFSEADMRFYAAE-IILGLEHMHNR---FVVYRDLKPANILLDEHGH 330
Query: 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVS 469
+ +GL+ + +++ + GT+GY+APE + + S D +S G +L +++
Sbjct: 331 VRISDLGLAC----DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 386
Query: 470 GRRP 473
G P
Sbjct: 387 GHSP 390
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 6e-15
Identities = 42/252 (16%), Positives = 83/252 (32%), Gaps = 50/252 (19%)
Query: 304 SSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGG 363
SS +I R N V YI + L W++
Sbjct: 100 SSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-CSL 158
Query: 364 RSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-------FGAHLMGV 416
+ + + + +A+ + FLH K ++HRD++ SN+ + FG
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFG------ 209
Query: 417 GLSKFVPWEVMQERTVMAG----------GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
L + + ++ + GT Y++PE ++ N + K D++S G++L E
Sbjct: 210 -LVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268
Query: 467 IVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLV 526
++ + + PL+ + +Y + +V
Sbjct: 269 LLYSFSTQMERVRI-ITDVRNLKFPLLFTQKYPQE---------------------HMMV 306
Query: 527 YACTQHVPSMRP 538
P+ RP
Sbjct: 307 QDMLSPSPTERP 318
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 29/207 (14%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY 335
LG+ G Y I G VA+K++ +E EI + P++V G +
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
+ D +IV E+ G + + + +L + + +G+ +LH +H
Sbjct: 95 KNTDLWIVMEYCGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYLHFM---RKIH 148
Query: 396 RDIRASNVLLDEE-------FG--AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV 446
RDI+A N+LL+ E FG L + M +R + G + ++APE +
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQLT----------DTMAKRNTVIGTPF-WMAPEVI 197
Query: 447 YRNELTTKSDVYSFGVLLLEIVSGRRP 473
+D++S G+ +E+ G+ P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 8e-15
Identities = 49/264 (18%), Positives = 102/264 (38%), Gaps = 37/264 (14%)
Query: 231 RRSKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI- 289
K K + + P ++ + + + ++G + +
Sbjct: 57 EAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPK-DVIGRGVSSVVRRCVH 115
Query: 290 LPDGSRVAVKRLKRSSFQRKKE--------FYSEIGRFARLH-HPNLVAVKGCCYDHGDR 340
G AVK ++ ++ + E E ++ HP+++ +
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175
Query: 341 YIVYEFVVNGPL-DRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
++V++ + G L D + S + +L + ++FLH ++VHRD+
Sbjct: 176 FLVFDLMRKGELFDY----LTEKVALSEKET--RSIMRSLLEAVSFLHAN---NIVHRDL 226
Query: 399 RASNVLLDEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNELTT-- 453
+ N+LLD+ + G S + P E ++E GT GYLAPE + + T
Sbjct: 227 KPENILLDDN--MQIRLSDFGFSCHLEPGEKLRELC----GTPGYLAPEILKCSMDETHP 280
Query: 454 ----KSDVYSFGVLLLEIVSGRRP 473
+ D+++ GV+L +++G P
Sbjct: 281 GYGKEVDLWACGVILFTLLAGSPP 304
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 9e-15
Identities = 46/199 (23%), Positives = 86/199 (43%), Gaps = 12/199 (6%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYS-EIGRFARLHHPNLVAVKGCC 334
+G G + GI VA+K + + + E EI ++ P + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
+I+ E++ G L P LD + + +G+ +LH + +
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE---KKI 141
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRDI+A+NVLL E L G++ + + +R G + ++APE + ++ +K
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPF-WMAPEVIKQSAYDSK 199
Query: 455 SDVYSFGVLLLEIVSGRRP 473
+D++S G+ +E+ G P
Sbjct: 200 ADIWSLGITAIELARGEPP 218
|
| >3vpp_A C-type lectin domain family 9 member A; dendritic cell, C-type lectin-like domain, membrane, immune; 1.64A {Homo sapiens} Length = 132 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-14
Identities = 34/142 (23%), Positives = 44/142 (30%), Gaps = 24/142 (16%)
Query: 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
+PCP +WI N C+ + W S+ C + G L + S EE K
Sbjct: 2 SPCPNNWIQNR--ESCYYVSEIWSIWHTSQENCLKEGSTLLQIESKEEMDFITGSLRKIK 59
Query: 111 NG--CWVGGRSINTTVGLSWKWSDN--MSKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
WVG W W D S S N C
Sbjct: 60 GSYDYWVGLSQDGH--SGRWLWQDGSSPSPGLLPAERSQSANQVC--------------- 102
Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
S SL++ C+T FIC
Sbjct: 103 -GYVKSNSLLSSNCDTWKYFIC 123
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 48/230 (20%), Positives = 91/230 (39%), Gaps = 25/230 (10%)
Query: 269 NFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPN 326
+ ++ LG+ + AVK + + ++ EI HPN
Sbjct: 11 DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPN 67
Query: 327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR--SLDWAMRMKVATTLAQGIAF 384
+V + +D ++V E + G L I + + + M+ L ++
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGEL---FERIKKKKHFSETEASYIMR---KLVSAVSH 121
Query: 385 LHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWEVMQERTVMAGGTYGYL 441
+HD VVHRD++ N+L DE + + G ++ P + +T T Y
Sbjct: 122 MHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC--FTLHYA 176
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRP----AQAVDSVCWQSIFE 487
APE + +N D++S GV+L ++SG+ P +++ I +
Sbjct: 177 APELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK 226
|
| >3m9z_A Killer cell lectin-like receptor subfamily B MEMB; C-type lectin-like domain, domain swapping, disulfide bond, transmembrane protein; 1.70A {Mus musculus} PDB: 3t3a_A Length = 139 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 2e-14
Identities = 30/136 (22%), Positives = 49/136 (36%), Gaps = 19/136 (13%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP DW+ + KCF +W+E C G L + EE + N
Sbjct: 6 CPQDWLSHR--DKCFHVSQVSNTWEEGLVDCDGKGATLMLIQDQEELRFLLDSIKEKYNS 63
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
W+G R ++WKW + S N + + + + C +S
Sbjct: 64 FWIGLRYTLP--DMNWKWING-STLNSDVLKITGDTENDS------------CAAISGD- 107
Query: 173 RSLVTERCNTSHPFIC 188
+ E CN+ + +IC
Sbjct: 108 -KVTFESCNSDNRWIC 122
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 15/182 (8%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
A+K LK+ K E +E HP L A+K H V E+ G L
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL- 235
Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413
H+ R + R A + + +LH + +VV+RD++ N++LD++ +
Sbjct: 236 --FFHLSRERVFSEDRARFYGAE-IVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKI 290
Query: 414 MGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 471
GL K E +++ M GT YLAPE + N+ D + GV++ E++ GR
Sbjct: 291 TDFGLCK----EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
Query: 472 RP 473
P
Sbjct: 347 LP 348
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 46/183 (25%), Positives = 86/183 (46%), Gaps = 17/183 (9%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPL 352
A K+L++ +++K +E +++ +V++ Y+ D +V + G L
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDL 271
Query: 353 DRWLHHIPRGGRSLDWAMRMKV-ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
HI G++ R A + G+ LH + +V+RD++ N+LLD+
Sbjct: 272 ---KFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHI 325
Query: 412 HLMGVGLSKFVPWEVMQERTVMA-GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
+ +GL+ V + +T+ GT GY+APE V T D ++ G LL E+++G
Sbjct: 326 RISDLGLAV----HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381
Query: 471 RRP 473
+ P
Sbjct: 382 QSP 384
|
| >1egg_A Macrophage mannose receptor; C-type lectin, sugar binding protein; 2.30A {Homo sapiens} SCOP: d.169.1.1 PDB: 1egi_A Length = 147 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-14
Identities = 32/148 (21%), Positives = 56/148 (37%), Gaps = 26/148 (17%)
Query: 52 PCPPDWIINEEKSKCFGYIGNF----RSWDESETYCKEIGGHLAALTSYEEEHSAQKLCG 107
CP DW + S CF ++W ES +C+ +GG LA++ + EE+ + +L
Sbjct: 4 KCPEDWGASSRTSLCFKLYAKGKHEKKTWFESRDFCRALGGDLASINNKEEQQTIWRLIT 63
Query: 108 KNVNG---CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHA 160
+ + W+G + + + WSD + W G N+ C
Sbjct: 64 ASGSYHKLFWLGLTYGSPS-E-GFTWSDGSPVSYENWAY-----GEPNNYQNVEYC-GE- 114
Query: 161 TVDLCTLVSNGSRSLVTERCNTSHPFIC 188
L + + S C + +IC
Sbjct: 115 ------LKGDPTMSWNDINCEHLNNWIC 136
|
| >2bpd_A Dectin-1; receptor, beta-glucan, fungal recognition, C-type lectin-like domain, CTLD, carbohydrate; 1.5A {Mus musculus} PDB: 2bph_A 2bpe_A 2cl8_A* Length = 142 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-14
Identities = 28/139 (20%), Positives = 50/139 (35%), Gaps = 18/139 (12%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHS--AQKLCGKN 109
C P+WI++ C+ + + SW S+ +C ++G HL + + +E +
Sbjct: 16 SCLPNWIMHG--KSCYLFSFSGNSWYGSKRHCSQLGAHLLKIDN-SKEFEFIESQTSSHR 72
Query: 110 VNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS 169
+N W+G + W W D + + S + C V
Sbjct: 73 INAFWIGLSRNQS--EGPWFWEDGSAFFPNSFQVRNAVPQESLLHNC-----------VW 119
Query: 170 NGSRSLVTERCNTSHPFIC 188
+ + CNTS IC
Sbjct: 120 IHGSEVYNQICNTSSYSIC 138
|
| >3c8j_A Natural killer cell receptor LY49C; MHC, virus, immune system; 2.60A {Mus musculus} SCOP: d.169.1.1 PDB: 3c8k_D 1p4l_D 1ja3_A 1p1z_D Length = 203 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 3e-14
Identities = 25/152 (16%), Positives = 43/152 (28%), Gaps = 25/152 (16%)
Query: 47 KDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLC 106
W +KC+ +I N +W + C+ G + + +E Q+
Sbjct: 74 SRDTGRGVKYWFCYS--TKCYYFIMNKTTWSGCKANCQHYGVPILKIEDEDELKFLQRHV 131
Query: 107 GKNVNGCWVGGRSINTTVGLSWKWSDN-MSKWNESIHAVGSFNSSCTSLPCHVHATVDLC 165
W+G W W DN SK + I + + C
Sbjct: 132 IP--GNYWIGLSYDKK--KKEWAWIDNGPSKLDMKIKKMNFKSRGC-------------- 173
Query: 166 TLVSNGSRSLVTERCNTSHPFICMVEHENKCY 197
V + CN + IC + +
Sbjct: 174 --VFLSKARIEDIDCNIPYYCIC--GKKLDKF 201
|
| >1sb2_A Rhodocetin alpha subunit; C-type lectin, domain swapping, toxin; 1.90A {Calloselasma rhodostoma} SCOP: d.169.1.1 PDB: 3gpr_A Length = 133 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-14
Identities = 27/146 (18%), Positives = 48/146 (32%), Gaps = 30/146 (20%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP W + S C+ ++W+E+E +C E HL ++ + E + N
Sbjct: 2 CPDGWSSTK--SYCYRPFKEKKTWEEAERFCTEQEKEAHLVSMENRLEAVFVDMVMENNF 59
Query: 111 NG----CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 162
W+G + N + +WSD + E + C +
Sbjct: 60 ENKIYRSWIGLKIENKGQRSNLEWSDGSSISYENLYE------PYMEKCFLM-------- 105
Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
+G T C + F+C
Sbjct: 106 ----DHQSGLPKWHTADCEEKNVFMC 127
|
| >1oz7_A Echicetin A-chain; platelet aggregation, dimer, toxin; 2.40A {Echis carinatus} SCOP: d.169.1.1 Length = 131 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 4e-14
Identities = 34/145 (23%), Positives = 53/145 (36%), Gaps = 30/145 (20%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG--GHLAALTSYEEEHSAQKLCGKNV 110
CPP W N C+ ++WDE+E +C + G GHL ++ S +EE + +N+
Sbjct: 2 CPPGWSSNG--VYCYMLFKEPKTWDEAEKFCNKQGKDGHLLSIESKKEEILVDIVVSENI 59
Query: 111 NG---CWVGGRSINTTVGLSWKWSDNMS----KWNESIHAVGSFNSSCTSLPCHVHATVD 163
W G + S +WSD + S C L
Sbjct: 60 GKMYKIWTGLSERSKEQHCSSRWSDGSFFRSYEIAIR-------YSECFVL--------- 103
Query: 164 LCTLVSNGSRSLVTERCNTSHPFIC 188
+ R+ V C + PF+C
Sbjct: 104 ---EKQSVFRTWVATPCENTFPFMC 125
|
| >3ff9_A Killer cell lectin-like receptor subfamily G member 1; natural killer cell receptor KLTG1, glycoprotein, membrane, phosphoprotein, signal-anchor; 1.80A {Mus musculus} PDB: 3ff8_C Length = 115 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-14
Identities = 25/136 (18%), Positives = 44/136 (32%), Gaps = 27/136 (19%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP W N S C+ + + W+ S +C + G HL + + G+ +
Sbjct: 2 CPILWTRNG--SHCYYFSMEKKDWNSSLKFCADKGSHLLTFPDNQGVKLFGEYLGQ--DF 57
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
W+G R+I+ W+W + I C ++
Sbjct: 58 YWIGLRNID-----GWRWEGG-PALSLRILTNSL-IQRCGAI----------------HR 94
Query: 173 RSLVTERCNTSHPFIC 188
L C + +IC
Sbjct: 95 NGLQASSCEVALQWIC 110
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 45/230 (19%), Positives = 89/230 (38%), Gaps = 30/230 (13%)
Query: 265 SITKNFSE----GNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRF 319
S + F + +LG+ + I L AVK +++ + + E+
Sbjct: 5 SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEML 64
Query: 320 ARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR--SLDWAMRMKVAT 376
+ H N++ + + Y+V+E + G + L HI + L+ ++ ++
Sbjct: 65 YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASVVVQ--- 118
Query: 377 TLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWE---VMQER 430
+A + FLH+K + HRD++ N+L + + L +
Sbjct: 119 DVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 431 TVMAG--GTYGYLAPEFVYRNELTTKS-----DVYSFGVLLLEIVSGRRP 473
+ G+ Y+APE V D++S GV+L ++SG P
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3bdw_B NKG2-A/NKG2-B type II integral membrane protein; NK cells, receptor, glycoprotein, lectin, signal-A transmembrane, immune system receptor; 2.50A {Homo sapiens} PDB: 3cdg_K 3cii_H Length = 120 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-14
Identities = 24/137 (17%), Positives = 43/137 (31%), Gaps = 25/137 (18%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
CP +WI + C+ R+W+ES C L ++ + EE K
Sbjct: 6 HCPEEWITYS--NSCYYIGKERRTWEESLLACTSKNSSLLSIDNEEE----MKFLSIISP 59
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
W+G ++ W + + I + +C L
Sbjct: 60 SSWIGVFRNSS--HHPWVTMNG-LAFKHEIKDSDNAELNCAVL----------------Q 100
Query: 172 SRSLVTERCNTSHPFIC 188
L + +C +S + C
Sbjct: 101 VNRLKSAQCGSSIIYHC 117
|
| >3bdw_A Natural killer cells antigen CD94; NK cells, receptor, glycoprotein, lectin, signal-A transmembrane, immune system receptor; 2.50A {Homo sapiens} SCOP: d.169.1.1 PDB: 3cdg_J 1b6e_A 3cii_G Length = 123 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-14
Identities = 22/139 (15%), Positives = 42/139 (30%), Gaps = 26/139 (18%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
C W+ C+ ++W+ES C L L + +E +
Sbjct: 4 SCQEKWVGYR--CNCYFISSEQKTWNESRHLCASQKSSLLQLQNTDE----LDFMSSSQQ 57
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSS--CTSLPCHVHATVDLCTLVS 169
W+G +W W + S ++ + ++ C
Sbjct: 58 FYWIGLSYSEE--HTAWLWENG-SALSQYLFPSFETFNTKNC-------------IAYNP 101
Query: 170 NGSRSLVTERCNTSHPFIC 188
NG + + E C + +IC
Sbjct: 102 NG--NALDESCEDKNRYIC 118
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 50/211 (23%), Positives = 85/211 (40%), Gaps = 21/211 (9%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEF----YSEIGRFARLHHPNLVA 329
LLG+ G + R AVK LK+ +R EI RL H N++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 330 VKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAF 384
+ Y+ + Y+V E+ V G + L +P + A Q G+ +
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEM-LDSVPEKRFPVCQAHGY-----FCQLIDGLEY 124
Query: 385 LHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
LH + +VH+DI+ N+LL + +G+++ + + + G+ + PE
Sbjct: 125 LHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 445 FVYRNEL--TTKSDVYSFGVLLLEIVSGRRP 473
+ K D++S GV L I +G P
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 47/189 (24%), Positives = 82/189 (43%), Gaps = 23/189 (12%)
Query: 293 GSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
G VA+K + ++ ++ + E+ L+HPN+V + Y++ E+ G
Sbjct: 40 GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99
Query: 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLLD 406
+ ++ GR M+ K A + + + + H K +VHRD++A N+LLD
Sbjct: 100 EV---FDYLVAHGR-----MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLD 148
Query: 407 EEFGAHLMGVGLS-KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLL 464
+ + G S +F + G Y APE + + DV+S GV+L
Sbjct: 149 ADMNIKIADFGFSNEFTVGGKLDA----FCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 204
Query: 465 LEIVSGRRP 473
+VSG P
Sbjct: 205 YTLVSGSLP 213
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 8e-14
Identities = 44/201 (21%), Positives = 83/201 (41%), Gaps = 34/201 (16%)
Query: 293 GSRVAVKRLKRSSFQ---------RKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI 342
AVK + + ++ E+ ++ HPN++ +K + ++
Sbjct: 42 CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101
Query: 343 VYEFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
V++ + G L D + S K+ L + I LH ++VHRD++
Sbjct: 102 VFDLMKKGELFDYL---TEKVTLSEKET--RKIMRALLEVICALHKL---NIVHRDLKPE 153
Query: 402 NVLLDEEFGAHLMGV--GLSKFV-PWEVMQERTVMAGGTYGYLAPE------FVYRNELT 452
N+LLD++ ++ G S + P E ++E GT YLAPE
Sbjct: 154 NILLDDD--MNIKLTDFGFSCQLDPGEKLREVC----GTPSYLAPEIIECSMNDNHPGYG 207
Query: 453 TKSDVYSFGVLLLEIVSGRRP 473
+ D++S GV++ +++G P
Sbjct: 208 KEVDMWSTGVIMYTLLAGSPP 228
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 45/192 (23%), Positives = 74/192 (38%), Gaps = 27/192 (14%)
Query: 297 AVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
A+K + + ++ E F E + + D Y+V E+ V G L
Sbjct: 90 AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDL- 148
Query: 354 RWLHHIPRGGR--SLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L + + G + A R +A +A I +H VHRDI+ N+LLD
Sbjct: 149 --LTLLSKFGERIPAEMA-RFYLAEIVMA--IDSVHRL---GYVHRDIKPDNILLDRC-- 198
Query: 411 AHLMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVY-------SFG 461
H+ G + + R+++A GT YL+PE + + Y + G
Sbjct: 199 GHIRLADFGSCLKLRAD-GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG 257
Query: 462 VLLLEIVSGRRP 473
V E+ G+ P
Sbjct: 258 VFAYEMFYGQTP 269
|
| >2c6u_A CLEC1B protein; lectin, rhodocytin, aggretin, C-type lectin-like, platelets, thrombosis; 1.6A {Homo sapiens} Length = 122 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-14
Identities = 26/142 (18%), Positives = 45/142 (31%), Gaps = 29/142 (20%)
Query: 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
+PC +W C+G+ + +W+ES+ YC ++ L + + +
Sbjct: 1 SPCDTNWRYYG--DSCYGFFRHNLTWEESKQYCTDMNATLLKIDNRNIVEYIKARTHLIR 58
Query: 111 NGCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
WVG WKW D + + + G+ N C
Sbjct: 59 ---WVGLS--RQKSNEVWKWEDGSVISENMFEFLEDGKGNMN----------------CA 97
Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
NG + C H +C
Sbjct: 98 YFHNG--KMHPTFCENKHYLMC 117
|
| >1c3a_A Flavocetin-A: alpha subunit; C-type lectin-like domains, membrane protein; 2.50A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1v4l_A Length = 135 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 1e-13
Identities = 29/146 (19%), Positives = 52/146 (35%), Gaps = 30/146 (20%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
C P W + C+ ++W+++E++C+E HL ++ S E +L + +
Sbjct: 4 CIPGWSAYD--RYCYQAFSKPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEKI 61
Query: 111 NG----CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 162
W+G R N +WSD N + F+ C +L
Sbjct: 62 KTSFQYVWIGLRIQNKEQQCRSEWSDASSVNYENLVK------QFSKKCYAL-------- 107
Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
R+ C T +P +C
Sbjct: 108 ----KKGTELRTWFNVYCGTENPEVC 129
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 40/184 (21%), Positives = 84/184 (45%), Gaps = 16/184 (8%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFVVNGPL 352
A K+L + +++K + E A++H +V++ ++ +V + G +
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDI 272
Query: 353 DRWLHHIPRGGRSLDWAMRMKV-ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
++++ R + G+ LH + ++++RD++ NVLLD++
Sbjct: 273 RYHIYNVDEDNPGFQEP-RAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNV 328
Query: 412 HLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS 469
+ +GL+ E+ +T G GT G++APE + E D ++ GV L E+++
Sbjct: 329 RISDLGLAV----ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384
Query: 470 GRRP 473
R P
Sbjct: 385 ARGP 388
|
| >3ff7_C Killer cell lectin-like receptor subfamily G member 1; KLRG1-cadherin complex, calcium, cell adhesion, cell junction, cell membrane; 1.80A {Homo sapiens} Length = 112 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-13
Identities = 27/136 (19%), Positives = 47/136 (34%), Gaps = 26/136 (19%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP W+ + C+ + + W+ S +C HL +T +E Q +
Sbjct: 1 CPDRWMKYG--NHCYYFSVEEKDWNSSLEFCLARDSHLLVITDNQEMSLLQVFLSE--AF 56
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
W+G R+ + W+W D S N S + SF +C ++
Sbjct: 57 SWIGLRNNS-----GWRWEDG-SPLNFSRISSNSFVQTCGAI----------------NK 94
Query: 173 RSLVTERCNTSHPFIC 188
L C ++C
Sbjct: 95 NGLQASSCEVPLHWVC 110
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 50/189 (26%), Positives = 79/189 (41%), Gaps = 31/189 (16%)
Query: 293 GSRVAVKRLKRSSFQRKKE--------FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344
+VA+K + + F +EI +L+HP ++ +K +D D YIV
Sbjct: 35 CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVL 93
Query: 345 EFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403
E + G L D+ + R L A + + +LH+ ++HRD++ NV
Sbjct: 94 ELMEGGELFDK----VVGNKR-LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENV 145
Query: 404 LLD-EEFGAHLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPE---FVYRNELTTKS 455
LL +E + G SK + E ++M GT YLAPE V
Sbjct: 146 LLSSQEEDCLIKITDFGHSKI-----LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV 200
Query: 456 DVYSFGVLL 464
D +S GV+L
Sbjct: 201 DCWSLGVIL 209
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 51/183 (27%), Positives = 80/183 (43%), Gaps = 18/183 (9%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
A+K L++ K E +E HP L A+K H V E+ G L
Sbjct: 34 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL- 92
Query: 354 RWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
H+ R + + A R A + + +LH + VV+RDI+ N++LD++
Sbjct: 93 --FFHLSRERVFTEERA-RFYGAE-IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIK 145
Query: 413 LMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
+ GL K E + + M GT YLAPE + N+ D + GV++ E++ G
Sbjct: 146 ITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201
Query: 471 RRP 473
R P
Sbjct: 202 RLP 204
|
| >1umr_C Convulxin beta, CVX beta; lectin, C-type lectin, platelet, sugar-binding protein, activator, snake venom; 2.40A {Crotalus durissus terrificus} SCOP: d.169.1.1 PDB: 1uos_B Length = 125 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-13
Identities = 27/144 (18%), Positives = 51/144 (35%), Gaps = 34/144 (23%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP W + C+ +W ++E +C + G HL + S EE K+ +++
Sbjct: 4 CPSHWSSYD--RYCYKVFKQEMTWADAEKFCTQQHTGSHLVSFHSTEEVDFVVKMTHQSL 61
Query: 111 NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
W+G N +W+WSD +W+E
Sbjct: 62 KSTFFWIGAN--NIWNKCNWQWSDGTKPEYKEWHEEFE---------------------- 97
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
C + ++ C+ ++ F+C
Sbjct: 98 CLISRTFDNQWLSAPCSDTYSFVC 121
|
| >1ukm_B EMS16 B chain, EMS16 subunit B; domain swapping, C-type lectin, toxin; HET: NAG; 1.90A {Echis multisquamatus} SCOP: d.169.1.1 PDB: 1v7p_B* Length = 128 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-13
Identities = 34/144 (23%), Positives = 49/144 (34%), Gaps = 32/144 (22%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP W + C+ ++W E+E C + G LA++ S EEE KL K +
Sbjct: 1 CPLGWSSFD--QHCYKVFEPVKNWTEAEEICMQQHKGSRLASIHSSEEEAFVSKLASKAL 58
Query: 111 NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
W+G N W+WSD + W CT +
Sbjct: 59 KFTSMWIGLN--NPWKDCKWEWSDNARFDYKAWKR--------RPYCTVM---------- 98
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
+V T C S F+C
Sbjct: 99 --VVKPDRIFWFTRGCEKSVSFVC 120
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 53/188 (28%), Positives = 73/188 (38%), Gaps = 22/188 (11%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
VAVK ++R + + EI L HPN+V K I+ E+ G L
Sbjct: 45 KELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL 103
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLLDEE 408
I GR A Q G+++ H + HRD++ N LLD
Sbjct: 104 ---YERICNAGR-----FSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGS 152
Query: 409 FGAHLMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLL 465
L G SK + TV GT Y+APE + R E +DV+S GV L
Sbjct: 153 PAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEVLLRQEYDGKIADVWSCGVTLY 209
Query: 466 EIVSGRRP 473
++ G P
Sbjct: 210 VMLVGAYP 217
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 46/183 (25%), Positives = 81/183 (44%), Gaps = 21/183 (11%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
A+K L + + K+ +E ++ P LV ++ D+ + Y+V E+V G +
Sbjct: 70 AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM- 128
Query: 354 RWLHHIPRGGRSLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
H+ R GR + R A L +LH +++RD++ N+L+D++ +
Sbjct: 129 --FSHLRRIGRFSEPHARFYAAQIVLT--FEYLHSL---DLIYRDLKPENLLIDQQ--GY 179
Query: 413 LMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
+ G +K V RT GT LAPE + D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAKRVK-----GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 471 RRP 473
P
Sbjct: 235 YPP 237
|
| >1sb2_B Rhodocetin beta subunit; C-type lectin, domain swapping, toxin; 1.90A {Calloselasma rhodostoma} SCOP: d.169.1.1 PDB: 3gpr_B Length = 129 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-13
Identities = 25/146 (17%), Positives = 43/146 (29%), Gaps = 36/146 (24%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP W ++ C+ ++W E+E +C + GHL ++ S E + N
Sbjct: 4 CPTTWSASK--LYCYKPFKEKKTWIEAERFCAKQAENGHLVSIGSAAEADFLDLVIVVNF 61
Query: 111 NGC----WVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 162
+ W G N KW++ + E + C
Sbjct: 62 DKQRYRAWTGLTERN------LKWTNGASVSYENLYE------PYIRKC----------- 98
Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
G C + F+C
Sbjct: 99 -FVVQPWEGKSKWYKADCEEKNAFLC 123
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 43/199 (21%), Positives = 77/199 (38%), Gaps = 30/199 (15%)
Query: 290 LPDGSRVAVKRLKRS--------SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341
V VK +K+ + + EI +R+ H N++ V + G
Sbjct: 46 KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQ 105
Query: 342 IVYEFVVNGP--LDRWLHHIPRGGRSLDWAMRMKVATT----LAQGIAFLHDKVKPHVVH 395
+V E +G I R R + +A+ L + +L K ++H
Sbjct: 106 LVMEKHGSGLDLFA----FIDRHPR-----LDEPLASYIFRQLVSAVGYLRLK---DIIH 153
Query: 396 RDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TK 454
RDI+ N+++ E+F L+ G + ++ + GT Y APE + N +
Sbjct: 154 RDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPEVLMGNPYRGPE 210
Query: 455 SDVYSFGVLLLEIVSGRRP 473
+++S GV L +V P
Sbjct: 211 LEMWSLGVTLYTLVFEENP 229
|
| >2py2_A Antifreeze protein type II; type II antifreeze protein; 1.70A {Clupea harengus} Length = 136 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-13
Identities = 27/144 (18%), Positives = 49/144 (34%), Gaps = 30/144 (20%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP DW + +CF + W +++ C + G +LA++ S EE ++L ++
Sbjct: 4 CPTDWKMFN--GRCFLFNPLQLHWADAQESCMKEGANLASIHSLEESTFVKELTSADLIP 61
Query: 113 CWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVG----SFNSSCTSLPCHVHATVDL 164
W+GG + W W D+ + W + C +
Sbjct: 62 SWIGGTDCQVS-T-RWFWMDSTSMDYADWCA-----AQPDTTLTECC------IQ----- 103
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
+ + C H IC
Sbjct: 104 --MNVGIGKCWNDTPCTHLHSSIC 125
|
| >3ubu_A Agglucetin subunit alpha-1; platelet inhibiting, agkisacucetin, dimer, toxin, C-type LEC GPIB inhibitor, GPIB binding; 1.91A {Deinagkistrodon acutus} Length = 131 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-13
Identities = 30/145 (20%), Positives = 56/145 (38%), Gaps = 28/145 (19%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN 109
C P W + C+ ++WD++E +C E GGHL ++ S E +L +N
Sbjct: 3 DCLPGWSAYD--QSCYRVFKLLKTWDDAEKFCTERPKGGHLVSIESAGERDFVAQLVSEN 60
Query: 110 VNG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVD 163
W+G + + S +W+D + ++E + C L
Sbjct: 61 KQTDNVWLGLKIQSKGQQCSTEWTDGSSVSYENFSE------YQSKKCFVL--------- 105
Query: 164 LCTLVSNGSRSLVTERCNTSHPFIC 188
+ G R+ + C + + F+C
Sbjct: 106 ---EKNTGFRTWLNLNCGSEYSFVC 127
|
| >2e3x_C Coagulation factor X-activating enzyme light CHAI; disintegrin, metalloproteinase, C-type lectin, hydrolase, BL clotting, toxin; HET: NAG MAN GM6; 2.91A {Daboia russellii siamensis} Length = 122 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-13
Identities = 32/144 (22%), Positives = 49/144 (34%), Gaps = 34/144 (23%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP W+ E C+ + ++W ++E +C E G HL +L S EEE L +N+
Sbjct: 3 CPSGWLSYE--QHCYKGFNDLKNWTDAEKFCTEQKKGSHLVSLHSREEEKFVVNLISENL 60
Query: 111 N--GCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
W+G N +WSD E S C +
Sbjct: 61 EYPATWIGLG--NMWKDCRMEWSDRGNVKYKALAE--------ESYCLIM---------- 100
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
+ + CN P +C
Sbjct: 101 ----ITHEKVWKSMTCNFIAPVVC 120
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 49/204 (24%), Positives = 86/204 (42%), Gaps = 20/204 (9%)
Query: 277 LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYS---EIGRFARLHHPNLVAVKG 332
+G G Y + + VA+K++ S Q +++ E+ +L HPN + +G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
C ++V E+ + D H + L V QG+A+LH +
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---N 174
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RN 449
++HRD++A N+LL E L G + +M G Y ++APE +
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTPY-WMAPEVILAMDEG 228
Query: 450 ELTTKSDVYSFGVLLLEIVSGRRP 473
+ K DV+S G+ +E+ + P
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPP 252
|
| >3gpr_D Rhodocetin subunit delta; disulfide bond, lectin, secreted, toxin, cell adhesion; 3.20A {Calloselasma rhodostoma} Length = 124 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-13
Identities = 29/144 (20%), Positives = 49/144 (34%), Gaps = 32/144 (22%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP W C+ ++W+++E++C G LA++ S EEE KL + +
Sbjct: 1 CPLHWSSYN--GYCYRVFSELKTWEDAESFCYAQHKGSRLASIHSREEEAFVGKLASQTL 58
Query: 111 N--GCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
W+G N W+WSD + W + C +
Sbjct: 59 KYTSMWLGLN--NAWAACKWEWSDDAKLDYKVWLR--------RAYCAVM---------- 98
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
+V C + F+C
Sbjct: 99 --VVKTDRIFWYNRGCEKTVSFLC 120
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 45/179 (25%), Positives = 77/179 (43%), Gaps = 22/179 (12%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
AVK + + K++ EI R HPN++ +K D Y+V E + G
Sbjct: 47 NMEFAVKIIDK----SKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE 102
Query: 352 L-DRWLHHIPRGGRS-LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL--DE 407
L D+ + + S + + + T+ + + +LH + VVHRD++ SN+L +
Sbjct: 103 LLDKI---LRQKFFSEREASAVLF---TITKTVEYLHAQ---GVVHRDLKPSNILYVDES 153
Query: 408 EFGAHLMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
+ G +K + E T T ++APE + R D++S GVLL
Sbjct: 154 GNPESIRICDFGFAKQLRAENGLLMTPC--YTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >1umr_A Convulxin alpha, CVX alpha; lectin, C-type lectin, platelet, sugar-binding protein, activator, snake venom; 2.40A {Crotalus durissus terrificus} SCOP: d.169.1.1 PDB: 1uos_A Length = 135 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 4e-13
Identities = 30/146 (20%), Positives = 51/146 (34%), Gaps = 30/146 (20%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP DW + C+ +W+++E +C + G HL ++ S +E + +N+
Sbjct: 4 CPSDWYYYD--QHCYRIFNEEMNWEDAEWFCTKQAKGAHLVSIKSAKEADFVAWMVTQNI 61
Query: 111 NG----CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 162
+G R N S KWSD + + + + C+ L
Sbjct: 62 EESFSHVSIGLRVQNKEKQCSTKWSDGSSVSYDNLLD------LYITKCSLL-------- 107
Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
G R C PF+C
Sbjct: 108 ----KKETGFRKWFVASCIGKIPFVC 129
|
| >1tdq_B Aggrecan core protein; extracellular matrix, lecticans, tenascins, protein-protein interactions, C-type lectin domain; 2.60A {Rattus norvegicus} SCOP: d.169.1.1 Length = 130 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-13
Identities = 29/142 (20%), Positives = 50/142 (35%), Gaps = 25/142 (17%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
C W + C+ + + +W ++E C+E HL+++ + EE+ K
Sbjct: 6 QCEEGWTKFQ--GHCYRHFPDRETWVDAERRCREQQSHLSSIVTPEEQEFVNKNAQDYQ- 62
Query: 112 GCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTL 167
W+G ++WSD KW + P + AT + C +
Sbjct: 63 --WIGLNDRTIEG--DFRWSDGHSLQFEKWRP-------------NQPDNFFATGEDCVV 105
Query: 168 VSNGSRSL-VTERCNTSHPFIC 188
+ R CN PF C
Sbjct: 106 MIWHERGEWNDVPCNYQLPFTC 127
|
| >1jwi_B Platelet aggregation inducer; domain swapping, C-type lectin, toxin; 2.00A {Bitis arietans} SCOP: d.169.1.1 PDB: 1uex_B Length = 125 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 5e-13
Identities = 29/144 (20%), Positives = 52/144 (36%), Gaps = 34/144 (23%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
C PDW + C+ ++W ++E +CKE+ GGHL ++ S EE KL + +
Sbjct: 4 CLPDWSSYK--GHCYKVFKVEKTWADAEKFCKELVNGGHLMSVNSREEGEFISKLALEKM 61
Query: 111 NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
W+G + +W+D + ++ P
Sbjct: 62 RIVLVWIGLS--HFWRICPLRWTDGARLDYRALSDE--------------PI-------- 97
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
C + + + CN F+C
Sbjct: 98 CFVAESFHNKWIQWTCNRKKSFVC 121
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 44/214 (20%), Positives = 88/214 (41%), Gaps = 41/214 (19%)
Query: 291 PDGSRVAVKRLKR-SSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVV 348
G +AVK+++R + + K ++ + H P +V G + D +I E +
Sbjct: 48 KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM- 106
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
++ + + + K+ + + + +L +K V+HRD++ SN+LLDE
Sbjct: 107 GTCAEKLKKRMQGP---IPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDER 161
Query: 409 -------FG--AHLMG-VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-----TT 453
FG L+ + G Y+APE + +
Sbjct: 162 GQIKLCDFGISGRLVDDKAKDRSA-------------GCAAYMAPERIDPPDPTKPDYDI 208
Query: 454 KSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE 487
++DV+S G+ L+E+ +G+ P + ++ FE
Sbjct: 209 RADVWSLGISLVELATGQFPYKN-----CKTDFE 237
|
| >1oz7_B Echicetin B-chain; platelet aggregation, dimer, toxin; 2.40A {Echis carinatus} SCOP: d.169.1.1 Length = 123 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-13
Identities = 27/144 (18%), Positives = 47/144 (32%), Gaps = 34/144 (23%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
C PDW + E C+ +W ++E +C + GHL + + +E L +
Sbjct: 2 CLPDWSVYE--GYCYKVFKERMNWADAEKFCTKQHKDGHLVSFRNSKEVDFVISLAFPML 59
Query: 111 NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
W+G + +W+WSD + W+ H
Sbjct: 60 KNDLVWIGLT--DYWRDCNWEWSDGAQLDYKAWDNERH---------------------- 95
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
C + N C + F+C
Sbjct: 96 CFIYKNTDNQWTRRDCTWTFSFVC 119
|
| >3bx4_B Aggretin beta chain; toxin; 1.70A {Agkistrodon rhodostoma} PDB: 2vrp_B Length = 146 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 8e-13
Identities = 33/146 (22%), Positives = 50/146 (34%), Gaps = 34/146 (23%)
Query: 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGK 108
A CP W E C+ ++W ++E +CK HL + S EE KL
Sbjct: 23 ADCPSGWSSYE--GHCYKPFNEPKNWADAERFCKLQPKHSHLVSFQSAEEADFVVKLTRP 80
Query: 109 NVNG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 162
+ W+G N G +W+WSD N W E S C +
Sbjct: 81 RLKANLVWMGLS--NIWHGCNWQWSDGARLNYKDWQE--------QSECLAF-------- 122
Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
+ C+++ F+C
Sbjct: 123 ------RGVHTEWLNMDCSSTCSFVC 142
|
| >3g8l_A Lectin-related NK cell receptor LY49L1; natural killer cell receptor, immune system; 2.50A {Mus musculus} Length = 190 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 9e-13
Identities = 23/140 (16%), Positives = 43/140 (30%), Gaps = 27/140 (19%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
W KC+ ++ + ++W + C+ L + + +E + L +
Sbjct: 66 GFEKYWFCYG--IKCYYFVMDRKTWSGCKQTCQISSLSLLKIDNEDELKFLKLLVPS--D 121
Query: 112 GCWVGGRSINTTVGLSWKWSDN---MSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 168
W+G N W W +N N + + C L+
Sbjct: 122 SYWIGLSYDNK--KKDWAWINNGPSKLALNTMKYNIRDGG----------------CMLL 163
Query: 169 SNGSRSLVTERCNTSHPFIC 188
S L + C+ S IC
Sbjct: 164 SKT--RLDNDNCDKSFICIC 181
|
| >1fvu_A Botrocetin alpha chain; VON WILLBRAND factor modulator, C-type lectin, metal- binding, loop exchanged dimer, toxin; 1.80A {Bothrops jararaca} SCOP: d.169.1.1 PDB: 1ijk_B 1u0n_B 1u0o_A Length = 133 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 9e-13
Identities = 34/147 (23%), Positives = 50/147 (34%), Gaps = 31/147 (21%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHS-AQKLCGKN 109
CP W E C+ + +W ++E +C E GGHL ++ Y +E L KN
Sbjct: 2 CPSGWSSYE--GNCYKFFQQKMNWADAERFCSEQAKGGHLVSIKIYSKEKDFVGDLVTKN 59
Query: 110 VNG----CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHAT 161
+ W+G R N S +WSD + E C
Sbjct: 60 IQSSDLYAWIGLRVENKEKQCSSEWSDGSSVSYENVVE------RTVKKC------FALE 107
Query: 162 VDLCTLVSNGSRSLVTERCNTSHPFIC 188
D G + C +PF+C
Sbjct: 108 KD------LGFVLWINLYCAQKNPFVC 128
|
| >2kv3_A Regenerating islet-derived protein 4; GISP, C-type lectin, REG IV, disulfide bond, glycoPro lectin, secreted, sugar binding protein; NMR {Homo sapiens} Length = 131 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-12
Identities = 30/147 (20%), Positives = 52/147 (35%), Gaps = 31/147 (21%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN 109
C P W ++ S C+GY R+W ++E C+ G HLA++ S +E + +
Sbjct: 2 SCAPGWFYHK--SNCYGYFRKLRNWSDAELECQSYGNGAHLASILSLKEASTIAEYISGY 59
Query: 110 VNG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSS--CTSLPCHVHAT 161
W+G + W+W D W+ S + C +
Sbjct: 60 QRSQSIWIGLH--DPQKRQQWQWIDGAMYLYRSWSG-----KSMGGNKHCAEM------- 105
Query: 162 VDLCTLVSNGSRSLVTERCNTSHPFIC 188
+N + + CN F+C
Sbjct: 106 -----SSNNNFLTWSSNECNKRQHFLC 127
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 50/189 (26%), Positives = 89/189 (47%), Gaps = 31/189 (16%)
Query: 297 AVKRLKRSSFQRKKEFYSEIGR--FARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354
A+K LK+++ + + +++ R ++HP +V + G Y++ +F+ G L
Sbjct: 56 AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL-- 113
Query: 355 WLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE----- 408
+ + + + + +A LA + LH +++RD++ N+LLDEE
Sbjct: 114 -FTRLSKEVMFTEEDV-KFYLAE-LALALDHLHSL---GIIYRDLKPENILLDEEGHIKL 167
Query: 409 --FGAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLL 464
FG LSK E + + GT Y+APE V R T +D +SFGVL+
Sbjct: 168 TDFG-------LSK----ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLM 216
Query: 465 LEIVSGRRP 473
E+++G P
Sbjct: 217 FEMLTGTLP 225
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 21/183 (11%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
A+K LK+ R K+ E + + HP ++ + G D +++ +++ G L
Sbjct: 35 AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL- 93
Query: 354 RWLHHIPRGGRSLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
+ + R + + A LA + +LH K +++RD++ N+LLD+ G H
Sbjct: 94 --FSLLRKSQRFPNPVAKFYAAEVCLA--LEYLHSK---DIIYRDLKPENILLDKN-G-H 144
Query: 413 LMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
+ G +K+VP + T GT Y+APE V D +SFG+L+ E+++G
Sbjct: 145 IKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
Query: 471 RRP 473
P
Sbjct: 200 YTP 202
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 46/187 (24%), Positives = 77/187 (41%), Gaps = 22/187 (11%)
Query: 297 AVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
A+K L + ++ + F+ E A + P +V + D Y+V E++ G L
Sbjct: 98 AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL- 156
Query: 354 RWLHHIPRGGRSLDWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
++ + WA R A LA + +H +HRD++ N+LLD+ H
Sbjct: 157 --VNLMSNYDVPEKWA-RFYTAEVVLA--LDAIHSM---GFIHRDVKPDNMLLDKS--GH 206
Query: 413 LMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT---TKS-DVYSFGVLLLE 466
L G + + R A GT Y++PE + + D +S GV L E
Sbjct: 207 LKLADFGTCMKMN-KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265
Query: 467 IVSGRRP 473
++ G P
Sbjct: 266 MLVGDTP 272
|
| >1j34_A Coagulation factor IX-binding protein A chain; magnesium ION, calcium ION, GLA domain, protein binding/blood clotting complex; HET: CGU; 1.55A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1bj3_A* 1j35_A* 1x2t_A* 1x2w_A 1ixx_A 1y17_A 1wt9_A 1iod_A* Length = 129 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-12
Identities = 37/148 (25%), Positives = 55/148 (37%), Gaps = 34/148 (22%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP W E C+ +++WD++E +C E GGHL ++ S E +L +N+
Sbjct: 2 CPSGWSSYE--GHCYKPFKLYKTWDDAERFCTEQAKGGHLVSIESAGEADFVAQLVTENI 59
Query: 111 NGC----WVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHVHA 160
W+G R S +WSD + W ES +G T
Sbjct: 60 QNTKSYVWIGLRVQGKEKQCSSEWSDGSSVSYENWIEAESKTCLG--LEKET-------- 109
Query: 161 TVDLCTLVSNGSRSLVTERCNTSHPFIC 188
G R V C +PF+C
Sbjct: 110 ----------GFRKWVNIYCGQQNPFVC 127
|
| >1sl6_A C-type lectin DC-signr; sugar binding protein; HET: GAL NDG FUC; 2.25A {Homo sapiens} SCOP: d.169.1.1 PDB: 1xar_A Length = 184 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 2e-12
Identities = 33/166 (19%), Positives = 59/166 (35%), Gaps = 27/166 (16%)
Query: 29 SDTISNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGG 88
S L + + + CP DW + C+ + R+W +S T C+E+
Sbjct: 30 SKQQQIYQELTDLKTAFERLCR-HCPKDWTFFQGN--CYFMSNSQRNWHDSVTACQEVRA 86
Query: 89 HLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN--MSKWNESIHAVGS 146
L + + EE++ Q ++ W+G +N G +W+W D +S + G
Sbjct: 87 QLVVIKTAEEQNFLQLQTSRSNRFSWMGLSDLNQE-G-TWQWVDGSPLSPSFQRYWNSGE 144
Query: 147 FNSS----CTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
N+S C RC+ + +IC
Sbjct: 145 PNNSGNEDC----------------AEFSGSGWNDNRCDVDNYWIC 174
|
| >3gpr_C Rhodocetin subunit gamma; disulfide bond, lectin, secreted, toxin, cell adhesion; 3.20A {Calloselasma rhodostoma} Length = 134 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-12
Identities = 33/148 (22%), Positives = 48/148 (32%), Gaps = 34/148 (22%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
C P W + C+ ++WDE+E +C E GHL ++ S E +L N+
Sbjct: 3 CLPGWSAYD--QHCYQAFNEPKTWDEAERFCTEQAKRGHLVSIGSDGEADFVAQLVTNNI 60
Query: 111 NG----CWVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHVHA 160
W+G R S +WS W ES G +
Sbjct: 61 KRPELYVWIGLRDRRKEQQCSSEWSMSASIIYVNWNTGESQMCQGLARWT---------- 110
Query: 161 TVDLCTLVSNGSRSLVTERCNTSHPFIC 188
G R C +PF+C
Sbjct: 111 ----------GFRKWDYSDCQAKNPFVC 128
|
| >1fvu_B Botrocetin beta chain; VON WILLBRAND factor modulator, C-type lectin, metal- binding, loop exchanged dimer, toxin; 1.80A {Bothrops jararaca} SCOP: d.169.1.1 PDB: 1ijk_C 1u0n_C 1u0o_B Length = 125 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-12
Identities = 28/144 (19%), Positives = 48/144 (33%), Gaps = 32/144 (22%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CPPDW E C+ + + WD++E +C E G HL + S EE + L + +
Sbjct: 2 CPPDWSSYE--GHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEML 59
Query: 111 NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
G W+G + ++W+D + + +
Sbjct: 60 KGDVVWIGLS--DVWNKCRFEWTDGMEFDYDDYYLI----AEYE---------------- 97
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
C + C F+C
Sbjct: 98 CVASKPTNNKWWIIPCTRFKNFVC 121
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 47/193 (24%), Positives = 79/193 (40%), Gaps = 31/193 (16%)
Query: 297 AVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353
A+K L + ++ E F E + + D + Y+V ++ V G L
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDL- 161
Query: 354 RWLHHIPRGGRSL--DWAMRMKVA-TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L + + L + A R +A +A I +H H VHRDI+ N+L+D
Sbjct: 162 --LTLLSKFEDRLPEEMA-RFYLAEMVIA--IDSVHQL---HYVHRDIKPDNILMDMN-- 211
Query: 411 AHLMGV--GLSKFVPWEVMQERTVMAG---GTYGYLAPEFVYRNELTTKS-----DVYSF 460
H+ G ++M++ TV + GT Y++PE + E D +S
Sbjct: 212 GHIRLADFGSCL----KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267
Query: 461 GVLLLEIVSGRRP 473
GV + E++ G P
Sbjct: 268 GVCMYEMLYGETP 280
|
| >1c3a_B Flavocetin-A: beta subunit; C-type lectin-like domains, membrane protein; 2.50A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1v4l_B Length = 125 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-12
Identities = 23/144 (15%), Positives = 45/144 (31%), Gaps = 34/144 (23%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP W + C+ +W+++E +C + G HL + S EE +
Sbjct: 4 CPLGWSSYD--EHCYQVFQQKMNWEDAEKFCTQQHKGSHLVSFHSSEEVDFVTSKTFPIL 61
Query: 111 NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
W+G N + +WSD + W+
Sbjct: 62 KYDFVWIGLS--NVWNECTKEWSDGTKLDYKAWSGGSD---------------------- 97
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
C + ++ C++ + +C
Sbjct: 98 CIVSKTTDNQWLSMDCSSKYYVVC 121
|
| >1j34_B Coagulation factor IX-binding protein B chain; magnesium ION, calcium ION, GLA domain, protein binding/blood clotting complex; HET: CGU; 1.55A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1bj3_B 1ixx_B* 1j35_B* 1x2t_B* 1x2w_B 1wt9_B 1iod_B 1y17_B Length = 123 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-12
Identities = 30/144 (20%), Positives = 48/144 (33%), Gaps = 34/144 (23%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP DW E C+ ++W ++E +C + GGHL + S EE KL +
Sbjct: 2 CPSDWSSYE--GHCYKPFSEPKNWADAENFCTQQHAGGHLVSFQSSEEADFVVKLAFQTF 59
Query: 111 NGC--WVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
W+G N +W+WS+ W E +
Sbjct: 60 GHSIFWMGLS--NVWNQCNWQWSNAAMLRYKAWAEESY---------------------- 95
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
C + + + C F+C
Sbjct: 96 CVYFKSTNNKWRSRACRMMAQFVC 119
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 48/187 (25%), Positives = 72/187 (38%), Gaps = 17/187 (9%)
Query: 293 GSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
VAVK + E EI L+H N+V G + +Y+ E+ G
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLLDE 407
L I M A G+ +LH + HRDI+ N+LLDE
Sbjct: 92 L---FDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDE 140
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLLE 466
+ GL+ + + GT Y+APE + R E DV+S G++L
Sbjct: 141 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTA 200
Query: 467 IVSGRRP 473
+++G P
Sbjct: 201 MLAGELP 207
|
| >1pwb_A SP-D, PSP-D, pulmonary surfactant-associated protein D; collectin, C-type lectin, alpha-helical coiled coil, carbohydrate recognition domain; HET: GLC; 1.40A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1 PDB: 1pw9_A* 3ikn_A* 3ikp_A* 3ikq_A* 3ikr_A* 2rie_A* 2ggx_A* 2ggu_A* 2ork_A* 2orj_A* 2ria_A* 2rib_A* 2ric_A* 2rid_A* 2os9_A* 3dbz_A 3g81_A* 3g83_A* 1b08_A 3g84_A* ... Length = 177 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-12
Identities = 22/104 (21%), Positives = 38/104 (36%), Gaps = 8/104 (7%)
Query: 40 QLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEE 99
L A+ ++ K P+ EK F G + + E++ C + GG LA+ S E
Sbjct: 42 HLQAAFSQYKKVELFPNGQSVGEK--IFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAEN 99
Query: 100 HSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD----NMSKWNE 139
+ Q+L ++ T G + + S W
Sbjct: 100 AALQQLVVAKNEAAFLSMTDSKTE-G-KFTYPTGESLVYSNWAP 141
|
| >2afp_A Protein (SEA raven type II antifreeze protein); recombinant SEA raven protein, solution backbone fold, C- type lectin; NMR {Hemitripterus americanus} SCOP: d.169.1.1 Length = 129 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-12
Identities = 35/145 (24%), Positives = 51/145 (35%), Gaps = 33/145 (22%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
CP W +C Y +W +ET C ++GGHLA++ S EE Q L V
Sbjct: 6 NCPAGWQPLG--DRCIYYETTAMTWALAETNCMKLGGHLASIHSQEEHSFIQTLNAGVV- 62
Query: 112 GCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVG----SFNSSCTSLPCHVHATVD 163
W+GG + G +W WSD N W + C +
Sbjct: 63 --WIGGSACLQA-G-AWTWSDGTPMNFRSWCS-----TKPDDVLAACC------MQ---- 103
Query: 164 LCTLVSNGSRSLVTERCNTSHPFIC 188
+ + + C SH +C
Sbjct: 104 ---MTAAADQCWDDLPCPASHKSVC 125
|
| >3c22_A C-type lectin domain family 4 member K; coiled coil, glycoprotein, membrane, signal-anchor, transmembrane, immune system, sugar binding protein; 1.50A {Homo sapiens} PDB: 3p5g_A* 3p5d_A* 3p5f_A* 3p5e_A* 3p5h_A* 3p5i_A* 3p7g_A* 3p7f_A* 3p7h_A* 3bc7_A* 3bbs_A* 3bc6_A* Length = 156 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-12
Identities = 19/94 (20%), Positives = 33/94 (35%), Gaps = 6/94 (6%)
Query: 40 QLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEE 99
++ M D W + + + ++W +E +C HL ++TS E+
Sbjct: 10 KIEGRMQNDILQVVSQGWKYFK--GNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQ 67
Query: 100 HSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN 133
K G W+G G W W D+
Sbjct: 68 EFLYKTAGG--LIYWIGLTKAGME-G-DWSWVDD 97
|
| >2xr6_A CD209 antigen; sugar binding protein, carbohydrate binding, mannose; HET: MAN 07B; 1.35A {Homo sapiens} PDB: 1sl4_A* 2it6_A* 1k9i_A* 2xr5_A* 1sl5_A* 2it5_A* 1xph_A 1k9j_A* Length = 170 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 4e-12
Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 4/81 (4%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
PCP +W + C+ + R+W +S T CKE+G L + S EE++ Q ++
Sbjct: 21 PCPWEWTFFQ--GNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNR 78
Query: 112 GCWVGGRSINTTVGLSWKWSD 132
W+G +N +W+W D
Sbjct: 79 FTWMGLSDLNQE--GTWQWVD 97
|
| >3bx4_A Aggretin alpha chain; toxin; 1.70A {Agkistrodon rhodostoma} PDB: 2vrp_A Length = 136 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 4e-12
Identities = 33/150 (22%), Positives = 51/150 (34%), Gaps = 35/150 (23%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCK--EIGGHLAALTSYEE-----EHSAQK 104
C W + C+ ++WDE+E +C+ E G HLA++ S E +QK
Sbjct: 4 DCDFGWSPYD--QHCYQAFNEQKTWDEAEKFCRAQENGAHLASIESNGEADFVSWLISQK 61
Query: 105 LCGKNVNGCWVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHV 158
+ + W+G R+ N S +WSD + + T
Sbjct: 62 DELADEDYVWIGLRAQNKEQQCSSEWSDGSSVSYENLIDLHTKKCGA--LEKLT------ 113
Query: 159 HATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
G R V C H F+C
Sbjct: 114 ------------GFRKWVNYYCEQMHAFVC 131
|
| >2b6b_D CD209 antigen; cryo EM dengue CRD DC-SIGN, icosahedral virus, virus-recepto; 25.00A {Homo sapiens} SCOP: d.169.1.1 Length = 175 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 4e-12
Identities = 26/101 (25%), Positives = 46/101 (45%), Gaps = 4/101 (3%)
Query: 33 SNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAA 92
+ S+G + + PCP +W + C+ + R+W +S T CKE+G L
Sbjct: 7 HHHHSSGLVPRGSHMRLCHPCPWEWTFFQ--GNCYFMSNSQRNWHDSITACKEVGAQLVV 64
Query: 93 LTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN 133
+ S EE++ Q ++ W+G +N +W+W D
Sbjct: 65 IKSAEEQNFLQLQSSRSNRFTWMGLSDLNQE--GTWQWVDG 103
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 53/249 (21%), Positives = 85/249 (34%), Gaps = 47/249 (18%)
Query: 252 PPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSF 306
PP+ T + E LLG G ++G L D +VA+K + R+
Sbjct: 10 PPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRV 69
Query: 307 QRKKEF------YSEIGRFARLH----HPNLVAVKGCCYDHGDRYIVYEFVVNGP-LDRW 355
E+ ++ HP ++ + +V E + L
Sbjct: 70 LGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDL--- 126
Query: 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE------- 408
+I G L + I H + VVHRDI+ N+L+D
Sbjct: 127 FDYITEKGP-LGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLI 182
Query: 409 ---FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLL 464
GA L + F GT Y PE++ R++ + V+S G+LL
Sbjct: 183 DFGSGALLHDEPYTDFD-------------GTRVYSPPEWISRHQYHALPATVWSLGILL 229
Query: 465 LEIVSGRRP 473
++V G P
Sbjct: 230 YDMVCGDIP 238
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 49/190 (25%), Positives = 74/190 (38%), Gaps = 43/190 (22%)
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
+ +A+G+ FL + +HRD+ A N+LL E+ + GL+ R +
Sbjct: 199 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLA----------RDIYK 245
Query: 435 GGTY-----GYL-----APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQ 483
Y L APE ++ T +SDV+SFGVLL EI S G P V +
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DE 303
Query: 484 SIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
L + R + P ++ ++ + C PS RP S +
Sbjct: 304 EFCRR---LKEGTR---MRAPDYTT-----------PEMYQTMLDCWHGEPSQRPTFSEL 346
Query: 544 VHQLQQLAQP 553
V L L Q
Sbjct: 347 VEHLGNLLQA 356
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 30/155 (19%), Positives = 49/155 (31%), Gaps = 16/155 (10%)
Query: 284 GTYSGILPDGS--RVAVKRLKRSSFQR-KKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD 339
GI + VAVK LK + + SE+ + HH N+V + G C G
Sbjct: 41 ADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100
Query: 340 R-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
++ EF G L +L R + +G F K + D+
Sbjct: 101 PLMVIVEFCKFGNLSTYLRS-----------KRNEFVPYKTKGARFRQGKDYVGAIPVDL 149
Query: 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
+ + + G K + +E
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED 184
|
| >3ubu_B Agglucetin subunit beta-2; platelet inhibiting, agkisacucetin, dimer, toxin, C-type LEC GPIB inhibitor, GPIB binding; 1.91A {Deinagkistrodon acutus} Length = 126 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 6e-12
Identities = 32/144 (22%), Positives = 52/144 (36%), Gaps = 33/144 (22%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP W E C+ + ++WD++E +C E GGHL ++ S EE L +
Sbjct: 4 CPLRWSAYE--GHCYLVVKEKKTWDDAEKFCTEQRKGGHLVSVHSREEADFLVHLAYPIL 61
Query: 111 NG--CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
+ W+G N +WSD + W + S C
Sbjct: 62 DLSLIWMGLS--NMWNDCKREWSDGTKLDFKSWAK--------TSDC------------- 98
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
++G + C+ H F+C
Sbjct: 99 LIGKTDGDNQWLNMDCSKKHYFVC 122
|
| >1qdd_A Lithostathine; pancreatic stone inhibitor, metal binding protein; HET: SIA NDG GAL; 1.30A {Homo sapiens} SCOP: d.169.1.1 PDB: 1lit_A Length = 144 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 7e-12
Identities = 25/146 (17%), Positives = 46/146 (31%), Gaps = 29/146 (19%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKNVN 111
CP S C+ + + +W +++ YC+ + G+L ++ + E L ++
Sbjct: 14 CPEGTNAYR--SYCYYFNEDRETWVDADLYCQNMNSGNLVSVLTQAEGAFVASLIKESGT 71
Query: 112 G---CWVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHVHATV 162
W+G + +W WS + W C SL
Sbjct: 72 DDFNVWIGLH--DPKKNRAWHWSSGSLVSYKSWGIGAPSSV---NPGYCVSL-------- 118
Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
S G + C F+C
Sbjct: 119 ----TSSTGFQKWKDVPCEDKFSFVC 140
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 7e-12
Identities = 48/187 (25%), Positives = 72/187 (38%), Gaps = 17/187 (9%)
Query: 293 GSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351
VAVK + E EI L+H N+V G + +Y+ E+ G
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLLDE 407
L I M A G+ +LH + HRDI+ N+LLDE
Sbjct: 92 L---FDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDE 140
Query: 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLLE 466
+ GL+ + + GT Y+APE + R E DV+S G++L
Sbjct: 141 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTA 200
Query: 467 IVSGRRP 473
+++G P
Sbjct: 201 MLAGELP 207
|
| >1jzn_A Galactose-specific lectin; C-type lectin, protein-disaccharide complex, sugar binding P; HET: BGC GAL; 2.20A {Crotalus atrox} SCOP: d.169.1.1 PDB: 1muq_A* Length = 135 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 7e-12
Identities = 32/147 (21%), Positives = 54/147 (36%), Gaps = 29/147 (19%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
CP DW+ C+ ++W+++E +C++ G HLA+ Y E +
Sbjct: 3 CPLDWLPMN--GLCYKIFNQLKTWEDAEMFCRKYKPGCHLASFHRYGESLEIAEYISDYH 60
Query: 111 NG---CWVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHVHAT 161
G W+G R + SW+W+D + W N+ H C L
Sbjct: 61 KGQENVWIGLR--DKKKDFSWEWTDRSCTDYLTWDKNQPDHYQN--KEFCVEL------- 109
Query: 162 VDLCTLVSNGSRSLVTERCNTSHPFIC 188
+ G R + C + F+C
Sbjct: 110 -----VSLTGYRLWNDQVCESKDAFLC 131
|
| >2e3x_B Coagulation factor X-activating enzyme light CHAI; disintegrin, metalloproteinase, C-type lectin, hydrolase, BL clotting, toxin; HET: NAG MAN GM6; 2.91A {Daboia russellii siamensis} Length = 134 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 7e-12
Identities = 32/146 (21%), Positives = 49/146 (33%), Gaps = 30/146 (20%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CPPD + C+ ++W+ +E +C E GHL ++ S EE KL
Sbjct: 3 CPPDSSLYR--YFCYRVFKEHKTWEAAERFCMEHPNNGHLVSIESMEEAEFVAKLLSNTT 60
Query: 111 NGC----WVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATV 162
W+G + S +WSD + K + F C L
Sbjct: 61 GKFITHFWIGLMIKDKEQECSSEWSDGSSVSYDKLGK-----QEFR-KCFVL-------- 106
Query: 163 DLCTLVSNGSRSLVTERCNTSHPFIC 188
+G R C + F+C
Sbjct: 107 ----EKESGYRMWFNRNCEERYLFVC 128
|
| >3kqg_A Langerin, C-type lectin domain family 4 member K; trimer, NECK and CRD, coiled coil, immune system; 2.30A {Homo sapiens} Length = 182 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 9e-12
Identities = 26/156 (16%), Positives = 52/156 (33%), Gaps = 12/156 (7%)
Query: 33 SNQSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAA 92
+ + +L N + W + + + ++W +E +C HL +
Sbjct: 30 GSLENMSKLLKRQNDILQ-VVSQGWKYFK--GNFYYFSLIPKTWYSAEQFCVSRNSHLTS 86
Query: 93 LTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCT 152
+TS E+ K G W+G G W W D+ + +N+ S
Sbjct: 87 VTSESEQEFLYKTAGG--LIYWIGLTKAGME-G-DWSWVDD-TPFNKV----QSARFWIP 137
Query: 153 SLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
P + + + ++ C+ + FIC
Sbjct: 138 GEPNNAGNNEHCGNIKAPSLQAWNDAPCDKTFLFIC 173
|
| >2ox9_A Collectin placenta 1; C-type lectin, sugar binding protein; HET: GAL NAG FUC; 1.95A {Mus musculus} PDB: 2ox8_A Length = 140 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-11
Identities = 26/140 (18%), Positives = 49/140 (35%), Gaps = 20/140 (14%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CPP W KC+ + +++++ +C++ HL + S EE+ +K
Sbjct: 5 CPPHWKNFT--DKCYYFSLEKEIFEDAKLFCEDKSSHLVFINSREEQQWIKKHTVGR-ES 61
Query: 113 CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 168
W+G WKW D + W G ++ + C +
Sbjct: 62 HWIGLTDSEQE-S-EWKWLDGSPVDYKNWKA-----GQPDNWGSGHGPGED-----CAGL 109
Query: 169 SNGSRSLVTERCNTSHPFIC 188
+ +C+ + FIC
Sbjct: 110 IYAGQ-WNDFQCDEINNFIC 128
|
| >1ukm_A EMS16 A chain, EMS16 subunit A; domain swapping, C-type lectin, toxin; HET: NAG; 1.90A {Echis multisquamatus} SCOP: d.169.1.1 PDB: 1v7p_A* Length = 134 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-11
Identities = 33/148 (22%), Positives = 52/148 (35%), Gaps = 34/148 (22%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP DW + C+ IG ++W E+E +C E GHL ++ S EE + +L +
Sbjct: 4 CPSDWTAYD--QHCYLAIGEPQNWYEAERFCTEQAKDGHLVSIQSREEGNFVAQLVSGFM 61
Query: 111 NG----CWVGGRSINTTVGLSWKWSD----NMSKW--NESIHAVGSFNSSCTSLPCHVHA 160
+ W+G R + +W+D W ES G + T
Sbjct: 62 HRSEIYVWIGLRDRREEQQCNPEWNDGSKIIYVNWKEGESKMCQG--LTKWT-------- 111
Query: 161 TVDLCTLVSNGSRSLVTERCNTSHPFIC 188
C +PF+C
Sbjct: 112 ----------NFHDWNNINCEDLYPFVC 129
|
| >1dv8_A Asialoglycoprotein receptor 1; C-type lectin CRD, signaling protein; 2.30A {Homo sapiens} SCOP: d.169.1.1 Length = 128 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-11
Identities = 27/147 (18%), Positives = 49/147 (33%), Gaps = 34/147 (23%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP +W+ +E C+ + + ++W +++ YC+ HL +TS+EE+ Q G
Sbjct: 1 CPVNWVEHE--RSCYWFSRSGKAWADADNYCRLEDAHLVVVTSWEEQKFVQHHIGP--VN 56
Query: 113 CWVGGRSINTTVGLSWKWSD------NMSKW-----NESIHAVGSFNSSCTSLPCHVHAT 161
W+G N WKW D W ++ C
Sbjct: 57 TWMGLHDQNGP----WKWVDGTDYETGFKNWRPEQPDDWYGHGLGGGEDCAHF------- 105
Query: 162 VDLCTLVSNGSRSLVTERCNTSHPFIC 188
+ C + ++C
Sbjct: 106 --------TDDGRWNDDVCQRPYRWVC 124
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 50/266 (18%), Positives = 85/266 (31%), Gaps = 45/266 (16%)
Query: 233 SKRRRKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGN----RLLGDSKTGGTYSG 288
S + + P + T+ K E LLG G YSG
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62
Query: 289 I-LPDGSRVAVKRLKRSSFQRKKEF------YSEIGRFARLHH--PNLVAVKGCCYDHGD 339
I + D VA+K +++ E E+ ++ ++ +
Sbjct: 63 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122
Query: 340 RYIVYEFVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398
++ E L I G L + + + + H+ V+HRDI
Sbjct: 123 FVLILERPEPVQDL---FDFITERGA-LQEELARSFFWQVLEAVRHCHNC---GVLHRDI 175
Query: 399 RASNVLLDEE----------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
+ N+L+D GA L + F GT Y PE++
Sbjct: 176 KDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-------------GTRVYSPPEWIRY 222
Query: 449 NELT-TKSDVYSFGVLLLEIVSGRRP 473
+ + V+S G+LL ++V G P
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >2h2t_B Low affinity immunoglobulin epsilon FC receptor ( IGE receptor) (FC-epsilon-RII)...; C-type lectin, calcium-bound, lectin domain; 1.30A {Homo sapiens} PDB: 2h2r_A 1t8c_A 1t8d_A Length = 175 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-11
Identities = 22/92 (23%), Positives = 38/92 (41%), Gaps = 10/92 (10%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
CP WI + KC+ + + W + C ++ G L ++ S EE+ K
Sbjct: 16 TCPEKWINFQ--RKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKRASH--T 71
Query: 112 GCWVGGRSINTTVGLSWKWSD----NMSKWNE 139
G W+G R+++ + W D + S W
Sbjct: 72 GSWIGLRNLDLK--GEFIWVDGSHVDYSNWAP 101
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 37/203 (18%)
Query: 286 YSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----- 340
+ L + VA+K++ Q K+ E+ + HPN+V +K Y +GD+
Sbjct: 57 FQAKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112
Query: 341 -YIVYEFVVNGPLD--RWLHHIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDKVKPHVVHR 396
+V E+V P R H + +++ + +K+ L + +A++H + HR
Sbjct: 113 LNLVLEYV---PETVYRASRHYAKLKQTMP-MLLIKLYMYQLLRSLAYIHSI---GICHR 165
Query: 397 DIRASNVLLDEEFGAHLMGV------GLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYR- 448
DI+ N+LLD GV G +K + E + Y APE ++
Sbjct: 166 DIKPQNLLLDPP-----SGVLKLIDFGSAKILIAGEPNVSYIC----SRYYRAPELIFGA 216
Query: 449 NELTTKSDVYSFGVLLLEIVSGR 471
TT D++S G ++ E++ G+
Sbjct: 217 TNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1uv0_A Pancreatitis-associated protein 1; lectin, C-type, secreted, inflammatory response, acute phase; 1.78A {Homo sapiens} SCOP: d.169.1.1 PDB: 2go0_A Length = 149 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 2e-11
Identities = 29/149 (19%), Positives = 49/149 (32%), Gaps = 30/149 (20%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE-IGGHLAALTSYEEEHSAQKLCGKNVN 111
CP S C+ + +SW +++ C++ G+L ++ S E L N
Sbjct: 14 CPKGSKAYG--SHCYALFLSPKSWTDADLACQKRPSGNLVSVLSGAEGSFVSSLVKSIGN 71
Query: 112 G---CWVGGRSIN---TTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHAT 161
W+G G W+WS N W + P + +
Sbjct: 72 SYSYVWIGLHDPTQGTEPNGEGWEWSSSDVMNYFAWERN--------------PSTISSP 117
Query: 162 VDLCTLVSNGSRSL--VTERCNTSHPFIC 188
C +S + L CN P++C
Sbjct: 118 GH-CASLSRSTAFLRWKDYNCNVRLPYVC 145
|
| >2ls8_A C-type lectin domain family 4 member D; structural genomics, NEW YORK structural genomics research consortium, nysgrc, PSI-biology, immune system; NMR {Homo sapiens} Length = 156 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 2e-11
Identities = 22/81 (27%), Positives = 41/81 (50%), Gaps = 5/81 (6%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP DW + S C+ + + ++W ESE C +G HL +++ E++ + + ++
Sbjct: 3 CPIDWRAFQ--SNCYFPLTDNKTWAESERNCSGMGAHLMTISTEAEQNFIIQFLDRRLS- 59
Query: 113 CWVGGRSINTTVGLSWKWSDN 133
++G R N G W+W D
Sbjct: 60 YFLGLRDENAK-G-QWRWVDQ 78
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 49/187 (26%), Positives = 90/187 (48%), Gaps = 25/187 (13%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDR-YIVYEFVVNGP 351
A+K +K+ ++ +E F + +HP LV + C+ R + V E+V G
Sbjct: 38 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGD 96
Query: 352 LDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L + H+ R + + A R A ++ + +LH++ +++RD++ NVLLD E
Sbjct: 97 L---MFHMQRQRKLPEEHA-RFYSAE-ISLALNYLHER---GIIYRDLKLDNVLLDSE-- 146
Query: 411 AHLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
H+ G+ K E ++ + GT Y+APE + + D ++ GVL+ E
Sbjct: 147 GHIKLTDYGMCK----EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 202
Query: 467 IVSGRRP 473
+++GR P
Sbjct: 203 MMAGRSP 209
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 60/253 (23%), Positives = 97/253 (38%), Gaps = 41/253 (16%)
Query: 237 RKSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSR 295
+R L SAL P+ +F EL +G+ G Y G + G
Sbjct: 6 SPARSLDEIDLSALRDPA-GIFELVEL-------------VGNGTYGQVYKGRHVKTGQL 51
Query: 296 VAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY------IVYEFVV 348
A+K + + ++E EI + HH N+ G +V EF
Sbjct: 52 AAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCG 110
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRASNVLL 405
G + + + +W +A + G++ LH V+HRDI+ NVLL
Sbjct: 111 AGSVTDLIKNTKGNTLKEEW-----IAYICREILRGLSHLHQH---KVIHRDIKGQNVLL 162
Query: 406 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-----TKSDVYSF 460
E L+ G+S + + R G Y ++APE + +E KSD++S
Sbjct: 163 TENAEVKLVDFGVSAQLD-RTVGRRNTFIGTPY-WMAPEVIACDENPDATYDFKSDLWSL 220
Query: 461 GVLLLEIVSGRRP 473
G+ +E+ G P
Sbjct: 221 GITAIEMAEGAPP 233
|
| >2zib_A Type II antifreeze protein; thermal hysteresis, lectin; 1.34A {Brachyopsis rostratus} Length = 133 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-11
Identities = 32/144 (22%), Positives = 51/144 (35%), Gaps = 33/144 (22%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP W ++ +CF +WD +E C GGHLA++ S EE+ + + V
Sbjct: 10 CPAGWTLHG--QRCFYSEATAMTWDLAEANCVNKGGHLASIHSLEEQLYIKDIVAGIV-- 65
Query: 113 CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVG----SFNSSCTSLPCHVHATVDL 164
W+GG + G +W W+D + W + C
Sbjct: 66 -WIGGSACKVA-G-AWSWTDGTPVDYRTWCP-----TKPNDILSDCC------------- 104
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
+ + + C SH IC
Sbjct: 105 MQMTAAVDKCWDDLPCPASHASIC 128
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 48/187 (25%), Positives = 90/187 (48%), Gaps = 25/187 (13%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDR-YIVYEFVVNGP 351
A++ +K+ ++ +E F + +HP LV + C+ R + V E+V G
Sbjct: 81 AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGD 139
Query: 352 LDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L + H+ R + + A R A ++ + +LH++ +++RD++ NVLLD E
Sbjct: 140 L---MFHMQRQRKLPEEHA-RFYSAE-ISLALNYLHER---GIIYRDLKLDNVLLDSE-- 189
Query: 411 AHLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
H+ G+ K E ++ + GT Y+APE + + D ++ GVL+ E
Sbjct: 190 GHIKLTDYGMCK----EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 245
Query: 467 IVSGRRP 473
+++GR P
Sbjct: 246 MMAGRSP 252
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 51/191 (26%), Positives = 79/191 (41%), Gaps = 26/191 (13%)
Query: 293 GSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349
G +VAVK L R + EI HP+++ + D ++V E+V
Sbjct: 36 GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95
Query: 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRASNVLL 405
G L +I + GR + A L Q + + H VVHRD++ NVLL
Sbjct: 96 GEL---FDYICKHGR-----VEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLL 144
Query: 406 DEEFGAHLMGVGLSKFVPWEVMQERTVM--AGGTYGYLAPEFVYRNELT-TKSDVYSFGV 462
D A + GLS M + + + G+ Y APE + + D++S GV
Sbjct: 145 DAHMNAKIADFGLSNM-----MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGV 199
Query: 463 LLLEIVSGRRP 473
+L ++ G P
Sbjct: 200 ILYALLCGTLP 210
|
| >1gz2_A Ovocleidin-17, OC-17 ovocleidin; structural protein, CTLD, eggshell structural protein, phosphoprotein, sugar-binding protein, glycoprotein; HET: SEP; 1.5A {Gallus gallus} SCOP: d.169.1.1 Length = 142 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 5e-11
Identities = 32/153 (20%), Positives = 50/153 (32%), Gaps = 36/153 (23%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
C P W+ C G+ SW +E++C+ G HLAA+ S E +L +
Sbjct: 5 CGPGWVPTP--GGCLGFFSRELSWSRAESFCRRWGPGSHLAAVRSAAELRLLAELLNASR 62
Query: 111 NGCWVGGRSINTT-VGLS-------WKWSD----NMSKWNESIHAVGSFNSS---CTSLP 155
G G + +GL W+WSD + W+ + C +L
Sbjct: 63 GGDGSGEGADGRVWIGLHRPAGSRSWRWSDGTAPRFASWHR-----TAKARRGGRCAAL- 116
Query: 156 CHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
S C + F+C
Sbjct: 117 -----------RDEEAFTSWAARPCTERNAFVC 138
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 56/187 (29%), Positives = 85/187 (45%), Gaps = 25/187 (13%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDR-YIVYEFVVNGP 351
AVK LK+ + + E A P L + C+ DR Y V E+V G
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGD 107
Query: 352 LDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG 410
L ++HI + GR A A +A G+ FL K +++RD++ NV+LD E G
Sbjct: 108 L---MYHIQQVGRFKEPHA-VFYAAE-IAIGLFFLQSK---GIIYRDLKLDNVMLDSE-G 158
Query: 411 AHLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
H+ G+ K E + + GT Y+APE + D ++FGVLL E
Sbjct: 159 -HIKIADFGMCK----ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 213
Query: 467 IVSGRRP 473
+++G+ P
Sbjct: 214 MLAGQAP 220
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 7e-11
Identities = 54/186 (29%), Positives = 79/186 (42%), Gaps = 23/186 (12%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
AVK LK+ + + +E + +HP L + C + V EFV G L
Sbjct: 52 AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL 111
Query: 353 DRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411
+ HI + R A R A + + FLHDK +++RD++ NVLLD E
Sbjct: 112 ---MFHIQKSRRFDEARA-RFYAAE-IISALMFLHDK---GIIYRDLKLDNVLLDHE--G 161
Query: 412 HLMGV--GLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEI 467
H G+ K E + A GT Y+APE + D ++ GVLL E+
Sbjct: 162 HCKLADFGMCK----EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEM 217
Query: 468 VSGRRP 473
+ G P
Sbjct: 218 LCGHAP 223
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 24/160 (15%)
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR-SLDWAMRMKVA-TTLAQ 380
P LV + +++ +++ G L H+ + R + ++ V LA
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGEL---FTHLSQRERFTEHEV-QIYVGEIVLA- 171
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV--GLSKFVPWEVMQERTVMAG--- 435
+ LH +++RDI+ N+LLD G H++ GLSK E + + T A
Sbjct: 172 -LEHLHKL---GIIYRDIKLENILLDSN-G-HVVLTDFGLSK----EFVADETERAYDFC 221
Query: 436 GTYGYLAPEFVYRNEL-TTKS-DVYSFGVLLLEIVSGRRP 473
GT Y+AP+ V + K+ D +S GVL+ E+++G P
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 45/191 (23%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 297 AVKRLKRSS-FQRKKEFY---SEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
A+K LK++ + K+ +E + HP +V + G Y++ E++ G L
Sbjct: 49 AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL 108
Query: 353 DRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--- 408
+ R G D A +A ++ + LH K +++RD++ N++L+ +
Sbjct: 109 ---FMQLEREGIFMEDTA-CFYLAE-ISMALGHLHQK---GIIYRDLKPENIMLNHQGHV 160
Query: 409 ----FGAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGV 462
FG L K E + + T GT Y+APE + R+ D +S G
Sbjct: 161 KLTDFG-------LCK----ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGA 209
Query: 463 LLLEIVSGRRP 473
L+ ++++G P
Sbjct: 210 LMYDMLTGAPP 220
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 52/183 (28%), Positives = 81/183 (44%), Gaps = 17/183 (9%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
AVK LK+ + + E A P L + C Y V E+V G L
Sbjct: 370 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429
Query: 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412
++HI + GR + A +A G+ FL K +++RD++ NV+LD E
Sbjct: 430 ---MYHIQQVGRFKEPHAVFYAAE-IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIK 482
Query: 413 LMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG 470
+ G+ K E + + T GT Y+APE + D ++FGVLL E+++G
Sbjct: 483 IADFGMCK----ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538
Query: 471 RRP 473
+ P
Sbjct: 539 QAP 541
|
| >2vuv_A Codakine; sugar-binding protein, C-type, lectin, mannose, invertebrate; HET: CIT; 1.3A {Codakia orbicularis} PDB: 2vuz_A* Length = 129 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-10
Identities = 28/140 (20%), Positives = 52/140 (37%), Gaps = 21/140 (15%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP W C+ Y SW +++ C+ +GG LA + E +C +N +
Sbjct: 2 CPDGWTQFL--DLCYIYQSAKASWASAQSSCQALGGILAEPDTACENEVLIHMCKENGDA 59
Query: 113 ----CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 168
W+GG+ + +W+WS + + + + P + D C +
Sbjct: 60 GSFGPWLGGQKVGG----AWQWSSSGAA--------FDYLRWGPNEPNNSGGNED-C--L 104
Query: 169 SNGSRSLVTERCNTSHPFIC 188
S RC+ ++C
Sbjct: 105 HYNWLSWNDLRCHYQASYLC 124
|
| >1tn3_A Tetranectin; plasminogen binding, kringle 4, C-type lectin, carbohydrate recognition domain; 2.00A {Homo sapiens} SCOP: d.169.1.1 PDB: 1rjh_A 3l9j_C Length = 137 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-10
Identities = 15/85 (17%), Positives = 30/85 (35%), Gaps = 8/85 (9%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
C ++ KCF +++ E+ C GG L+ + E + + ++V
Sbjct: 5 VCLKGTKVHM---KCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSVG 61
Query: 112 G---CWVGGRSINTTVGLSWKWSDN 133
W+G + G +W
Sbjct: 62 NEAEIWLGLNDMAAE-G-TWVDMTG 84
|
| >3pbf_A Pulmonary surfactant-associated protein A; collectin, carbohydrate binding, lectin, mannose, sugar BIND protein; 1.80A {Rattus norvegicus} PDB: 1r14_A* 1r13_A* 3paq_A* 3par_A 3pak_A Length = 148 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-10
Identities = 17/91 (18%), Positives = 32/91 (35%), Gaps = 8/91 (8%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
+ +K F G ++D + C GG++A + EE + + K N
Sbjct: 27 LQGSMLSVGDK--VFSTNGQSVNFDTIKEMCTRAGGNIAVPRTPEENEAIASIAKKYNNY 84
Query: 113 CWVGGRSINTTVGLSWKWSDNM----SKWNE 139
++G T G + + D + W
Sbjct: 85 VYLGMIEDQTP-G-DFHYLDGASVSYTNWYP 113
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 50/191 (26%), Positives = 79/191 (41%), Gaps = 33/191 (17%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352
A+K LK+ + E + HP L + + + V E++ G L
Sbjct: 46 AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL 105
Query: 353 DRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--- 408
++HI + L A A + G+ FLH K +V+RD++ N+LLD++
Sbjct: 106 ---MYHIQSCHKFDLSRA-TFYAAE-IILGLQFLHSK---GIVYRDLKLDNILLDKDGHI 157
Query: 409 ----FGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFGV 462
FG + K E M GT Y+APE + + D +SFGV
Sbjct: 158 KIADFG-------MCK----ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGV 206
Query: 463 LLLEIVSGRRP 473
LL E++ G+ P
Sbjct: 207 LLYEMLIGQSP 217
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 44/211 (20%)
Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337
G++ G+ G VA+K++ Q K+ E+ +L H N+V ++ Y
Sbjct: 65 GSF-GVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSS 119
Query: 338 GDR------YIVYEFVVNGPLD--RWLHHIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDK 388
G++ +V ++V P R H R ++L + +K+ L + +A++H
Sbjct: 120 GEKKDEVYLNLVLDYV---PETVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLAYIHSF 175
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGV------GLSK-FVPWEVMQERTVMAGGTYGYL 441
+ HRDI+ N+LLD + V G +K V E + Y
Sbjct: 176 ---GICHRDIKPQNLLLDPD-----TAVLKLCDFGSAKQLVRGEPNVSYIC----SRYYR 223
Query: 442 APEFVYR-NELTTKSDVYSFGVLLLEIVSGR 471
APE ++ + T+ DV+S G +L E++ G+
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 35/192 (18%)
Query: 297 AVKRLKRSSFQRKKEF---YSEIGRFAR-LHHPNLVAVKGCCYDHGDR-YIVYEFVVNGP 351
AVK L++ + +KKE SE + + HP LV + + D+ Y V +++ G
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGE 125
Query: 352 LDRWLHHIPRGGR-SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-- 408
L +H+ R A R A +A + +LH ++V+RD++ N+LLD +
Sbjct: 126 L---FYHLQRERCFLEPRA-RFYAAE-IASALGYLHSL---NIVYRDLKPENILLDSQGH 177
Query: 409 -----FGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVYSFG 461
FG L K E ++ + + GT YLAPE +++ D + G
Sbjct: 178 IVLTDFG-------LCK----ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLG 226
Query: 462 VLLLEIVSGRRP 473
+L E++ G P
Sbjct: 227 AVLYEMLYGLPP 238
|
| >1rtm_1 Mannose-binding protein-A; lectin; 1.80A {Rattus norvegicus} SCOP: d.169.1.1 h.1.1.1 PDB: 1kwu_A* 1kwv_A* 1kwt_A* 1kwx_A* 1kwy_A* 1kx1_A* 1kww_A 1kwz_A* 1kx0_A* 3kmb_1* 1kmb_1* 2kmb_1* 4kmb_1* 1afb_1* 1afa_1* 1afd_1 1bch_1* 1bcj_1* 1fif_A 1fih_A* Length = 149 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-10
Identities = 16/104 (15%), Positives = 34/104 (32%), Gaps = 11/104 (10%)
Query: 40 QLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEE 99
L + + K + K F + + + C E+ G +A + EE
Sbjct: 15 TLKSKLELTNKLHAFSMG--KKSGKKFFVTNHERMPFSKVKALCSELRGTVAIPRNAEEN 72
Query: 100 HSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD----NMSKWNE 139
+ Q++ + ++G T G + + S W +
Sbjct: 73 KAIQEVAKTSA---FLGITDEVTE-G-QFMYVTGGRLTYSNWKK 111
|
| >1htn_A Tetranectin; plasminogen binding, kringle 4, alpha-helical coiled coil, C-type lectin, carbohydrate recognition domain; 2.80A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1 Length = 182 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 5e-10
Identities = 15/86 (17%), Positives = 30/86 (34%), Gaps = 8/86 (9%)
Query: 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
C ++ KCF +++ E+ C GG L+ + E + + ++V
Sbjct: 49 TVCLKGTKVHM---KCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSV 105
Query: 111 NG---CWVGGRSINTTVGLSWKWSDN 133
W+G + G +W
Sbjct: 106 GNEAEIWLGLNDMAAE-G-TWVDMTG 129
|
| >1buu_A Protein (mannose-binding protein A); lectin, HOST defense, metalloprotein, sugar binding protein; 1.90A {Rattus norvegicus} SCOP: d.169.1.1 h.1.1.1 Length = 168 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-10
Identities = 17/110 (15%), Positives = 37/110 (33%), Gaps = 13/110 (11%)
Query: 35 QSSNGQLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALT 94
++ L + + K + K F + + + C E+ G +A
Sbjct: 29 EAEINTLKSKLELTNKLHAFSMG--KKSGKKFFVTNHERMPFSKVKALCSELRGTVAIPR 86
Query: 95 SYEEEHSA-QKLCGKNVNGCWVGGRSINTTVGLSWKWSD----NMSKWNE 139
+ EE+ A Q++ + ++G T G + + S W +
Sbjct: 87 N-AEENKAIQEVAKTSA---FLGITDEVTE-G-QFMYVTGGRLTYSNWKK 130
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 54/225 (24%), Positives = 85/225 (37%), Gaps = 65/225 (28%)
Query: 292 DGSRVAVKRLKRSSFQRKKEFYS--------------------------EIGRFARLHHP 325
D + A+K L + R+ F EI +L HP
Sbjct: 37 DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHP 96
Query: 326 NLVAVKGCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ--- 380
N+V + D + Y+V+E V GP+ +P + A Q
Sbjct: 97 NVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKP-----LSEDQARFYFQDLI 147
Query: 381 -GIAFLHDKVKPHVVHRDIRASNVLLDEE-------FGAHLMGVGLS-KFVPWEVMQERT 431
GI +LH + ++HRDI+ SN+L+ E+ F G+S +F + + T
Sbjct: 148 KGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADF-------GVSNEFKGSDALLSNT 197
Query: 432 VMAGGTYGYLAPEFVYRNELT---TKSDVYSFGVLLLEIVSGRRP 473
V GT ++APE + DV++ GV L V G+ P
Sbjct: 198 V---GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >1hup_A Mannose-binding protein; alpha-helical coiled-coil, C-type lectin; 2.50A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1 Length = 141 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-10
Identities = 17/104 (16%), Positives = 34/104 (32%), Gaps = 11/104 (10%)
Query: 40 QLAASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEE 99
L M + K + +K F G ++++ + C + +A + E
Sbjct: 7 ALQTEMARIKKWLTFSLG--KQVGNKFFLTNGEIMTFEKVKALCVKFQASVATPRNAAEN 64
Query: 100 HSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNM----SKWNE 139
+ Q L + ++G T G + + WNE
Sbjct: 65 GAIQNLIKEEA---FLGITDEK-TEG-QFVDLTGNRLTYTNWNE 103
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 8e-10
Identities = 55/217 (25%), Positives = 82/217 (37%), Gaps = 50/217 (23%)
Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337
GT+ G G VA+K++ + + + A LHHPN+V ++ Y
Sbjct: 34 GTF-GTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTL 91
Query: 338 GDR-------YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT----LAQGIAFLH 386
G+R +V E+V P LH R A + L + I LH
Sbjct: 92 GERDRRDIYLNVVMEYV---PDT--LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH 146
Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGV------GLSK-FVPWEVMQERTVMAGGTYG 439
+V HRDI+ NVL++E G G +K P E +
Sbjct: 147 LPSV-NVCHRDIKPHNVLVNEA-----DGTLKLCDFGSAKKLSPSEPNVAYIC----SRY 196
Query: 440 YLAPEFV-----YRNELTTKSDVYSFGVLLLEIVSGR 471
Y APE + Y TT D++S G + E++ G
Sbjct: 197 YRAPELIFGNQHY----TTAVDIWSVGCIFAEMMLGE 229
|
| >3cfw_A L-selectin; EGF, cell adhesion, EGF-like domain, glycoprotein, membrane, sushi, transmembrane; HET: NAG MAN BMA; 2.20A {Homo sapiens} Length = 164 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-09
Identities = 18/123 (14%), Positives = 41/123 (33%), Gaps = 7/123 (5%)
Query: 66 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVG 125
+ Y +W + +C++ L A+ + E +K + + W+G R I
Sbjct: 2 TYHYSEKPMNWQRARRFCRDNYTDLVAIQNKAEIEYLEKTLPFSRSYYWIGIRKIGGI-- 59
Query: 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHP 185
+W ++ G N+ C V++ + + + C+
Sbjct: 60 WTWVGTNKSLTEEAENWGDGEPNNKKNKEDC-----VEIYIKRNKDAGKWNDDACHKLKA 114
Query: 186 FIC 188
+C
Sbjct: 115 ALC 117
|
| >1h8u_A MBP, eosinophil granule major basic protein 1; lectin, eosinophil granule protein, EMBP; 1.8A {Homo sapiens} SCOP: d.169.1.1 PDB: 2brs_A* Length = 117 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-09
Identities = 22/125 (17%), Positives = 43/125 (34%), Gaps = 14/125 (11%)
Query: 66 CFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGK-NVNGCWVGGRSINTT 123
+ + + +++ ++ C+ G+L ++ ++ + Q N W+GGR +
Sbjct: 3 RYLLVRSLQTFSQAWFTCRRCYRGNLVSIHNFNINYRIQCSVSALNQGQVWIGGRITGSG 62
Query: 124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS 183
++W D S+WN F P C + C
Sbjct: 63 RCRRFQWVDG-SRWN--------FAYWAAHQPWSRGGH---CVALCTRGGYWRRAHCLRR 110
Query: 184 HPFIC 188
PFIC
Sbjct: 111 LPFIC 115
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 48/206 (23%), Positives = 85/206 (41%), Gaps = 24/206 (11%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKG 332
R LG K + I + + +V VK LK +KK+ EI L PN++ +
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLAD 98
Query: 333 CCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
D R +V+E V N + + D+ +R + L + + + H
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLYQTLT------DYDIRFYMYEIL-KALDYCHSM-- 149
Query: 391 PHVVHRDIRASNVLLDEEFGA-HLMGVGLSKF-VPWEVMQERTVMAGGTYGYLAPE-FVY 447
++HRD++ NV++D E L+ GL++F P + R + + PE V
Sbjct: 150 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA----SRYFKGPELLVD 204
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRP 473
D++S G +L ++ + P
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 55/197 (27%), Positives = 83/197 (42%), Gaps = 38/197 (19%)
Query: 293 GSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYE 345
G +VAVK L R + EI HP+++ + Y D ++V E
Sbjct: 41 GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL----YQVISTPSDIFMVME 96
Query: 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRAS 401
+V G L +I + GR + K + L Q G+ + H VVHRD++
Sbjct: 97 YVSGGEL---FDYICKNGR-----LDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPE 145
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQE----RTVMAGGTYGYLAPEFVYRNELT-TKSD 456
NVLLD A + GLS M + RT + G+ Y APE + + D
Sbjct: 146 NVLLDAHMNAKIADFGLSNM-----MSDGEFLRT--SCGSPNYAAPEVISGRLYAGPEVD 198
Query: 457 VYSFGVLLLEIVSGRRP 473
++S GV+L ++ G P
Sbjct: 199 IWSSGVILYALLCGTLP 215
|
| >1byf_A TC14, protein (polyandrocarpa lectin); C-type lectin, galactose-specific, sugar binding protein; 2.00A {Polyandrocarpa misakiensis} SCOP: d.169.1.1 PDB: 1tlg_A* Length = 125 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-09
Identities = 10/71 (14%), Positives = 25/71 (35%), Gaps = 3/71 (4%)
Query: 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEE--HSAQKLCGKNVNGCWVGGRSINT 122
+ ++ ++ TYC+ G L + + + + WVG ++
Sbjct: 3 YEILFSDETMNYADAGTYCQSRGMALVSSAMRDSTMVKAILAFTEVKGHDYWVGADNLQD 62
Query: 123 TVGLSWKWSDN 133
++ W+D
Sbjct: 63 G-AYNFLWNDG 72
|
| >3alu_A Lectin CEL-IV, C-type; C-type lectin, raffinose, sugar binding protein; HET: RAF; 1.65A {Cucumaria echinata} PDB: 3als_A* 3alt_A* Length = 157 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 1e-09
Identities = 29/155 (18%), Positives = 52/155 (33%), Gaps = 29/155 (18%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG-----------GHLAALTSYEEEH 100
CPP W KCF N ++D +E C++ G GHLA++ S E +
Sbjct: 4 SCPPLWTGFN--GKCFRLFHNHLNFDNAENACRQFGLASCSGDELATGHLASIHSAESQA 61
Query: 101 SAQKLCGKNVNGCWVGGRSINTTVGLS-------WKWSDNMSKWNESIHAVGSFNSSCTS 153
+L ++ GG + +G+ W+D S + ++ +
Sbjct: 62 FLTELVKTSLPDLITGGWAPQVYIGMKVGSTNSDQTWTDG-SSVD--------YDGWVSG 112
Query: 154 LPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
P + + N + +IC
Sbjct: 113 EPNNGPNSRGAIAAGDYSRGFWADVYSNNNFKYIC 147
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 47/195 (24%), Positives = 77/195 (39%), Gaps = 35/195 (17%)
Query: 293 GSRVAVKRLKRSSFQRKKEF---YSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYE 345
+VA+K + R ++ EI L HP+++ + YD D +V E
Sbjct: 34 QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL----YDVITTPTDIVMVIE 89
Query: 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ----GIAFLHDKVKPHVVHRDIRAS 401
+ G L +I R M Q I + H +VHRD++
Sbjct: 90 YA-GGEL---FDYIVEKKR-----MTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPE 137
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM--AGGTYGYLAPEFVYRNELT-TKSDVY 458
N+LLD+ + GLS M + + + G+ Y APE + + DV+
Sbjct: 138 NLLLDDNLNVKIADFGLSNI-----MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVW 192
Query: 459 SFGVLLLEIVSGRRP 473
S G++L ++ GR P
Sbjct: 193 SCGIVLYVMLVGRLP 207
|
| >1g1t_A E-selectin; EGF, adhesion molecule, SLEX, immune system, membrane protein; HET: SIA GAL MAG FUC; 1.50A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1esl_A Length = 157 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-09
Identities = 24/130 (18%), Positives = 42/130 (32%), Gaps = 21/130 (16%)
Query: 66 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVG 125
+ ++DE+ YC++ HL A+ + EE + + + W+G R +N
Sbjct: 2 SYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRKVNNV-- 59
Query: 126 LSWKWSD-------NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTE 178
W W W G N+ C V++ E
Sbjct: 60 --WVWVGTQKPLTEEAKNWAP-----GEPNNRQKDEDC-----VEIYIKREKDVGMWNDE 107
Query: 179 RCNTSHPFIC 188
RC+ +C
Sbjct: 108 RCSKKKLALC 117
|
| >1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A Length = 162 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 3e-09
Identities = 16/67 (23%), Positives = 25/67 (37%), Gaps = 4/67 (5%)
Query: 66 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVG 125
+ Y SW+ S YC+ L A+ + E K+ + W+G R N
Sbjct: 2 TYHYSTKAYSWNISRKYCQNRYTDLVAIQNKNEIDYLNKVLPYYSSYYWIGIRKNNK--- 58
Query: 126 LSWKWSD 132
+W W
Sbjct: 59 -TWTWVG 64
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 43/222 (19%), Positives = 81/222 (36%), Gaps = 51/222 (22%)
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL- 322
+I ++ +++LG G + A+K L+ R+ E+ R
Sbjct: 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRAS 68
Query: 323 HHPNLVAVKGCCYDHGDR----YIVYEFVVNGPL-DRWLHHIPRGGRSL---DWAMRMKV 374
P++V + + IV E + G L R RG ++ + + MK
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMK- 124
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLL-DEEFGAHLMGV--GLSKFVPWEVMQERT 431
++ + I +LH ++ HRD++ N+L + A L G +K E E+
Sbjct: 125 --SIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTGEK- 174
Query: 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473
Y D++S GV++ ++ G P
Sbjct: 175 ------YD-------------KSCDMWSLGVIMYILLCGYPP 197
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 7e-09
Identities = 48/213 (22%), Positives = 84/213 (39%), Gaps = 47/213 (22%)
Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQ--------RKKEFYSEIGRFARLHHPNLVA 329
GTY G VA+KR++ R EI L H N+V
Sbjct: 13 GTY-GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR------EICLLKELKHKNIVR 65
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
+ + +V+EF + L ++ LD + L +G+ F H +
Sbjct: 66 LHDVLHSDKKLTLVFEF-CDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 390 KPHVVHRDIRASNVLLDEE-------FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
+V+HRD++ N+L++ FG A G+ + + EV+ T Y
Sbjct: 121 --NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA-EVV---------TLWYR 168
Query: 442 APEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRP 473
P+ ++ +L +T D++S G + E+ + RP
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 29/145 (20%), Positives = 60/145 (41%), Gaps = 32/145 (22%)
Query: 284 GTYSGI-------LPDGSRVAVKRLKRSSF----QRKKEFYSEIGRFARLHHPNLVAVKG 332
GTY + D A+K+++ + R EI L HPN+++++
Sbjct: 32 GTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNVISLQK 85
Query: 333 CCYDHGDR--YIVYEFVVNGPLD-RWLHHIPRGGRSLDWAMRMKVATT------LAQGIA 383
H DR ++++++ D + R ++ +++ + GI
Sbjct: 86 VFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEE 408
+LH V+HRD++ +N+L+ E
Sbjct: 143 YLHAN---WVLHRDLKPANILVMGE 164
|
| >1wmz_A Lectin CEL-I, N-acetyl-D-galactosamine-specific C-type; C-type lectin, N-acetylgalactosamine, invertebrate, sugar binding protein; HET: NGA A2G; 1.70A {Cucumaria echinata} SCOP: d.169.1.1 PDB: 1wmy_A* Length = 140 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 8e-09
Identities = 19/155 (12%), Positives = 40/155 (25%), Gaps = 31/155 (20%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG-------GHLAALTSYEEEHSAQKL 105
CP DW C+ + +W+ + C L ++ S E+
Sbjct: 3 CPTDWEAEG--DHCYRFFNTLTTWENAHHECVSYSCSTLNVRSDLVSVHSAAEQAYVFNY 60
Query: 106 CGKNVNG---CWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHV 158
+ W+G + + W+D +KW G ++ +
Sbjct: 61 WRGIDSQAGQLWIGLY--DKYNEGDFIWTDGSKVGYTKWAG-----GQPDNWNNAEDY-- 111
Query: 159 HATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHE 193
+ ++C + E
Sbjct: 112 ------GQFRHTEGGAWNDNSAAAQAKYMCKLTFE 140
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 35/120 (29%), Positives = 53/120 (44%), Gaps = 13/120 (10%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYS----EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
G VA+K+ S K EI +L H NLV + C Y+V+EF V
Sbjct: 50 GRIVAIKKFLESDD--DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF-V 106
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
+ + L P G LD+ + K + GI F H +++HRDI+ N+L+ +
Sbjct: 107 DHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQS 160
|
| >2msb_A Mannose-binding protein-A; lectin; HET: BMA MAN; 1.70A {Rattus rattus} SCOP: d.169.1.1 PDB: 1msb_A 1ytt_A* Length = 115 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-08
Identities = 14/80 (17%), Positives = 29/80 (36%), Gaps = 9/80 (11%)
Query: 64 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 123
K F + + + C E+ G +A + EE + Q++ + ++G T
Sbjct: 3 KKFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAKTSA---FLGITDEVTE 59
Query: 124 VGLSWKWSD----NMSKWNE 139
G + + S W +
Sbjct: 60 -G-QFMYVTGGRLTYSNWKK 77
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 42/193 (21%), Positives = 81/193 (41%), Gaps = 33/193 (17%)
Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK------GCCYDHGDRYIV 343
VA+K+L R FQ + K Y E+ ++H N++++ + D Y+V
Sbjct: 87 DRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145
Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRA 400
E +D L + + + +++ L Q GI LH ++HRD++
Sbjct: 146 MEL-----MDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHLHSA---GIIHRDLKP 192
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVY 458
SN+++ + ++ GL++ +M T Y APE + D++
Sbjct: 193 SNIVVKSDCTLKILDFGLAR-----TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 247
Query: 459 SFGVLLLEIVSGR 471
S G ++ E+V +
Sbjct: 248 SVGCIMGEMVRHK 260
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 31/146 (21%), Positives = 55/146 (37%), Gaps = 39/146 (26%)
Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRKKE-FYS----EIGRFARLHHPNLVAVKG 332
G + VA+K++K K+ EI L HPN++ +
Sbjct: 21 GQF-ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD 79
Query: 333 CCYDHGDRYIVYEFV----------VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
+ +V++F+ + L HI ++ M M QG+
Sbjct: 80 AFGHKSNISLVFDFMETDLEVIIKDNSLVLT--PSHI----KAY---MLM-----TLQGL 125
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEE 408
+LH ++HRD++ +N+LLDE
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDEN 148
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 27/119 (22%), Positives = 50/119 (42%), Gaps = 11/119 (9%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYS--EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350
G VA+K+ S + + EI +L HPNLV + ++V+E+
Sbjct: 28 GQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY---- 83
Query: 351 PLDRWL-HHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
D + H + R R + + + Q + F H + +HRD++ N+L+ +
Sbjct: 84 -CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKH 138
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 5e-08
Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 49/214 (22%)
Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYS----EIGRFARLHHPNLVAVKGC 333
GTY G VA+K +K ++ S EI L H N+V +
Sbjct: 16 GTY-ATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVK 390
+ +V+EF ++ L +++ G + + V Q G+AF H+
Sbjct: 72 IHTENKLTLVFEF-MDNDLKKYMDSRTVGNTPRGLELNL-VKYFQWQLLQGLAFCHEN-- 127
Query: 391 PHVVHRDIRASNVLLDEE-------FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLA 442
++HRD++ N+L+++ FG A G+ ++ F EV+ T Y A
Sbjct: 128 -KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS-EVV---------TLWYRA 176
Query: 443 PEF-----VYRNELTTKSDVYSFGVLLLEIVSGR 471
P+ Y +T D++S G +L E+++G+
Sbjct: 177 PDVLMGSRTY----STSIDIWSCGCILAEMITGK 206
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 43/193 (22%), Positives = 80/193 (41%), Gaps = 33/193 (17%)
Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK------GCCYDHGDRYIV 343
VA+K+L R FQ + K Y E+ ++H N++ + + D YIV
Sbjct: 50 ERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108
Query: 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRA 400
E +D L + + + +++ L Q GI LH ++HRD++
Sbjct: 109 MEL-----MDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHLHSA---GIIHRDLKP 155
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELTTKSDVY 458
SN+++ + ++ GL++ +M T Y APE + D++
Sbjct: 156 SNIVVKSDCTLKILDFGLAR-----TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 210
Query: 459 SFGVLLLEIVSGR 471
S G ++ E++ G
Sbjct: 211 SVGCIMGEMIKGG 223
|
| >1rdl_1 SUB-MBP-C, mannose-binding protein-C; C-type lectin, calcium-binding protein; HET: MMA; 1.70A {Rattus rattus} SCOP: d.169.1.1 PDB: 1rdj_1* 1rdk_1* 1rdi_1* 1rdm_1* 1rdn_1* 1rdo_1 1bv4_A 1kza_1* 1kzb_1* 1kzc_1* 1kzd_1* 1kze_1* Length = 113 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-08
Identities = 15/80 (18%), Positives = 28/80 (35%), Gaps = 11/80 (13%)
Query: 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSA-QKLCGKNVNGCWVGGRSINTT 123
K F + ++ C E+ G +A + EE+ A Q + ++G T
Sbjct: 2 KYFMSSVRRMPLNRAKALCSELQGTVATPRN-AEENRAIQNVAKDVA---FLGITDQRTE 57
Query: 124 VGLSWKWSD----NMSKWNE 139
++ + WNE
Sbjct: 58 -N-VFEDLTGNRVRYTNWNE 75
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 9e-08
Identities = 40/220 (18%), Positives = 79/220 (35%), Gaps = 61/220 (27%)
Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRKKE-FYS----EIGRFARLHHPNLVAVKG 332
GTY G VA+KR++ + ++E E+ L H N++ +K
Sbjct: 45 GTY-GEVYKAIDTVTNETVAIKRIR---LEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 333 CCYDHGDRYIVYEFV---------VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
+ + ++++E+ N + + I +S + L G+
Sbjct: 101 VIHHNHRLHLIFEYAENDLKKYMDKNPDVS--MRVI----KSF---LYQ-----LINGVN 146
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV-----GLSKF--VPWEVMQERTVMAGG 436
F H + +HRD++ N+LL + + GL++ +P +
Sbjct: 147 FCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII---- 199
Query: 437 TYGYLAPEF-----VYRNELTTKSDVYSFGVLLLEIVSGR 471
T Y PE Y +T D++S + E++
Sbjct: 200 TLWYRPPEILLGSRHY----STSVDIWSIACIWAEMLMKT 235
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 46/196 (23%), Positives = 85/196 (43%), Gaps = 40/196 (20%)
Query: 293 GSRVAVKRLKRSSFQ--------RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344
G VA+KR++ + R EI LHHPN+V++ + +V+
Sbjct: 45 GRIVALKRIRLDAEDEGIPSTAIR------EISLLKELHHPNIVSLIDVIHSERCLTLVF 98
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404
EF + L + L G L + L +G+A H ++HRD++ N+L
Sbjct: 99 EF-MEKDLKKVLDENKTG---LQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLL 151
Query: 405 LDEE-------FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKS 455
++ + FG A G+ + + EV+ T Y AP+ + ++ +T
Sbjct: 152 INSDGALKLADFGLARAFGIPVRSYTH-EVV---------TLWYRAPDVLMGSKKYSTSV 201
Query: 456 DVYSFGVLLLEIVSGR 471
D++S G + E+++G+
Sbjct: 202 DIWSIGCIFAEMITGK 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 1e-07
Identities = 46/203 (22%), Positives = 85/203 (41%), Gaps = 54/203 (26%)
Query: 293 GSRVAVKRLKRSSFQRKKE-FYS----EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347
G A+K+++ +++ E S EI L H N+V + + +V+E +
Sbjct: 26 GETFALKKIR---LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82
Query: 348 ----------VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRD 397
G L+ +S + L GIA+ HD+ V+HRD
Sbjct: 83 DQDLKKLLDVCEGGLE--SVTA----KSF---LLQ-----LLNGIAYCHDR---RVLHRD 125
Query: 398 IRASNVLLDEE-------FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
++ N+L++ E FG A G+ + K+ E++ T Y AP+ + +
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIV---------TLWYRAPDVLMGS 175
Query: 450 EL-TTKSDVYSFGVLLLEIVSGR 471
+ +T D++S G + E+V+G
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 3e-07
Identities = 37/192 (19%), Positives = 80/192 (41%), Gaps = 33/192 (17%)
Query: 293 GSRVAVKRLKRSSFQRKKEFYS----EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348
+ VA+K ++ + ++ E+ L H N+V + + +V+E++
Sbjct: 27 DNLVALKEIR---LEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL- 82
Query: 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
+ L ++L ++ L +G+A+ H + V+HRD++ N+L++E
Sbjct: 83 DKDLKQYLDDCGNI---INMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINER 136
Query: 409 -------FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY-RNELTTKSDVYS 459
FG A + + EV+ T Y P+ + + +T+ D++
Sbjct: 137 GELKLADFGLARAKSIPTKTYDN-EVV---------TLWYRPPDILLGSTDYSTQIDMWG 186
Query: 460 FGVLLLEIVSGR 471
G + E+ +GR
Sbjct: 187 VGCIFYEMATGR 198
|
| >1wk1_A Hypothetical protein YK1067A12; lectin C-type domain, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Caenorhabditis elegans} SCOP: d.169.1.1 Length = 150 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-07
Identities = 11/70 (15%), Positives = 23/70 (32%), Gaps = 5/70 (7%)
Query: 64 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 123
K + S ++ +C GG+LA ++ + + W+G +
Sbjct: 8 VKFLTVNDDILSMPQARNFCASAGGYLADDLGDDKNNFYSSIAAN--TQFWIGLF--KNS 63
Query: 124 VGLSWKWSDN 133
G + W
Sbjct: 64 DG-QFYWDRG 72
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 50/247 (20%), Positives = 101/247 (40%), Gaps = 49/247 (19%)
Query: 249 ALVPPSWKVFTTEELRSITKNFSEGNR-----LLGDSKTGGTYSGI-LPDGSRVAVKRLK 302
+ PP+ F +E+ + +G G S + G++VA+K+L
Sbjct: 2 SSPPPARSGFYRQEVTKTA--WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY 59
Query: 303 RSSFQRK---KEFYSEIGRFARLHHPNLVAVK------GCCYDHGDRYIVYEFVVNGPLD 353
R FQ + K Y E+ + H N++ + D D Y+V F +
Sbjct: 60 RP-FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-----MG 113
Query: 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE----- 408
L + + + + ++ V L +G+ ++H ++HRD++ N+ ++E+
Sbjct: 114 TDLGKLMKHEKLGEDRIQFLVYQML-KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKI 169
Query: 409 --FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSFGVLL 464
FG A ++ +V T Y APE + T++ D++S G ++
Sbjct: 170 LDFGLARQADSEMTGYV-------------VTRWYRAPEVILNWMRYTQTVDIWSVGCIM 216
Query: 465 LEIVSGR 471
E+++G+
Sbjct: 217 AEMITGK 223
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 34/153 (22%), Positives = 60/153 (39%), Gaps = 48/153 (31%)
Query: 284 GTYSGI-----LPDGSRVAVKRLKRSSFQRKKE-FYS----EIGRFARLHHPNLVAVKGC 333
GT+ + G +VA+K++ + +KE F EI L H N+V +
Sbjct: 28 GTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 334 CYDHGDR--------YIVYEFV----------VNGPLDRWLHHIPRGGRSLDWAMRMKVA 375
C Y+V++F V L I + + M+M
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFT--LSEI----KRV---MQM--- 132
Query: 376 TTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408
L G+ ++H ++HRD++A+NVL+ +
Sbjct: 133 --LLNGLYYIHRN---KILHRDMKAANVLITRD 160
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 39/165 (23%), Positives = 64/165 (38%), Gaps = 36/165 (21%)
Query: 323 HHPNLVAVKGCCYDHGDR-----YIVYEFVVNGPLDRWLHHIPRGGRSLDWA---MRMKV 374
HPN+V + C +V+E V + L +L +P G + M
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ-- 128
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-------FG-AHLMGVGLSKFVPWEV 426
L +G+ FLH VVHRD++ N+L+ FG A + + V
Sbjct: 129 ---LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTS-VV 180
Query: 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 471
+ T Y APE + ++ T D++S G + E+ +
Sbjct: 181 V---------TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3fd4_A Glycoprotein GP42; C type lectin, virus entry, membrane fusion, HOST-virus interaction, lectin, membrane, transmembrane, viral protein; 2.40A {Human herpesvirus 4} PDB: 1kg0_C Length = 191 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 5e-06
Identities = 21/146 (14%), Positives = 36/146 (24%), Gaps = 25/146 (17%)
Query: 50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN 109
+ CF + +W+ C E+ +
Sbjct: 69 YCNTREYTFSYK--GCCFYFTKKKHTWNGCFQACAELYPCTYFYGPTPDILPVVTRNLNA 126
Query: 110 VNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS 169
+ WVG + +W D + I CT VS
Sbjct: 127 IESLWVG---VYRVGEGNWTSLDGGTFKVYQIFGSH-------------------CTYVS 164
Query: 170 NGSRSLVTE-RCNTSHPFICMVEHEN 194
S V+ C+ P +C+ + N
Sbjct: 165 KFSTVPVSHHECSFLKPCLCVSQRSN 190
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 8e-06
Identities = 49/221 (22%), Positives = 78/221 (35%), Gaps = 57/221 (25%)
Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYS--------EIGRFARLH---HPN 326
G Y G G VA+K ++ E+ RL HPN
Sbjct: 20 GAY-GTVYKARDPHSGHFVALKSVR---VPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 327 LVAVKGCCYDHGDR-----YIVYEFVVNGPLDRWLHHIPRGGRSLDWA---MRMKVATTL 378
+V + C +V+E V + L +L P G + MR
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ-----F 129
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEE-------FG-AHLMGVGLSKFVPWEVMQER 430
+G+ FLH +VHRD++ N+L+ FG A + + P V+
Sbjct: 130 LRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTP-VVV--- 181
Query: 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR 471
T Y APE + ++ T D++S G + E+ +
Sbjct: 182 ------TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 49/219 (22%), Positives = 88/219 (40%), Gaps = 49/219 (22%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 330
+G G S I G +VA+K+L R FQ + K Y E+ + H N++ +
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-FQSEIFAKRAYRELLLLKHMQHENVIGL 88
Query: 331 K------GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---G 381
+ D Y+V F + L I S + K+ + Q G
Sbjct: 89 LDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLKFSEE-----KIQYLVYQMLKG 138
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEE-------FG-AHLMGVGLSKFVPWEVMQERTVM 433
+ ++H VVHRD++ N+ ++E+ FG A ++ +V
Sbjct: 139 LKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV----------- 184
Query: 434 AGGTYGYLAPEFVYRNELTTKS-DVYSFGVLLLEIVSGR 471
T Y APE + ++ D++S G ++ E+++G+
Sbjct: 185 --VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 44/191 (23%), Positives = 87/191 (45%), Gaps = 25/191 (13%)
Query: 291 PDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK------GCCYDHGDRY 341
G RVAVK+L R FQ K Y E+ + H N++ + + D Y
Sbjct: 52 KTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110
Query: 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401
+V + L++I + + D ++ + L +G+ ++H ++HRD++ S
Sbjct: 111 LVTHL-----MGADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHSA---DIIHRDLKPS 161
Query: 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKS-DVYSF 460
N+ ++E+ ++ GL++ + M T Y APE + ++ D++S
Sbjct: 162 NLAVNEDCELKILDFGLARHTA-DEMTGYVA----TRWYRAPEIMLNWMHYNQTVDIWSV 216
Query: 461 GVLLLEIVSGR 471
G ++ E+++GR
Sbjct: 217 GCIMAELLTGR 227
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 31/142 (21%), Positives = 57/142 (40%), Gaps = 30/142 (21%)
Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGCC 334
G+Y G + VA+K++ R F+ K EI RL+H ++V V
Sbjct: 64 GSY-GHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIV 121
Query: 335 YDHG-----DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLH 386
+ Y+V E D + R L + + T L G+ ++H
Sbjct: 122 IPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLT---ELHIKTLLYNLLVGVKYVH 173
Query: 387 DKVKPHVVHRDIRASNVLLDEE 408
++HRD++ +N L++++
Sbjct: 174 SA---GILHRDLKPANCLVNQD 192
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 45/205 (21%), Positives = 83/205 (40%), Gaps = 44/205 (21%)
Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK--------------GCCY 335
RVA+K++ K EI RL H N+V V G
Sbjct: 36 DKRVAIKKI---VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92
Query: 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVH 395
+ YIV E+ ++ L ++ G L+ R+ + L +G+ ++H +V+H
Sbjct: 93 ELNSVYIVQEY-----METDLANVLEQGPLLEEHARLFMYQLL-RGLKYIHSA---NVLH 143
Query: 396 RDIRASNVLLDEE--------FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE-FV 446
RD++ +N+ ++ E FG L + + + E V T Y +P +
Sbjct: 144 RDLKPANLFINTEDLVLKIGDFG--LARIMDPHYSHKGHLSEGLV----TKWYRSPRLLL 197
Query: 447 YRNELTTKSDVYSFGVLLLEIVSGR 471
N T D+++ G + E+++G+
Sbjct: 198 SPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 43/216 (19%), Positives = 77/216 (35%), Gaps = 44/216 (20%)
Query: 293 GSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVKGCCY-----DHGDRYIVY 344
VA+K++ R F+ K EI RL ++ + + YIV
Sbjct: 51 EKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109
Query: 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ---GIAFLHDKVKPHVVHRDIRAS 401
E D L + + L + T L G F+H+ ++HRD++ +
Sbjct: 110 EI-----ADSDLKKLFKTPIFLT---EEHIKTILYNLLLGENFIHES---GIIHRDLKPA 158
Query: 402 NVLLDEE-------FG-AHLMGVGLSKFVPWEVMQERTVMAGGTYG------------YL 441
N LL+++ FG A + + ++ + Y
Sbjct: 159 NCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYR 218
Query: 442 APEFVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQA 476
APE + E TKS D++S G + E+++ +
Sbjct: 219 APELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 48/245 (19%), Positives = 85/245 (34%), Gaps = 80/245 (32%)
Query: 284 GTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337
G++ GI + G R A+K++ Q + E+ L H N++ + Y
Sbjct: 18 GSF-GIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDHVNIIKLVDYFYTT 72
Query: 338 GDR--------------------------------------YIVYEFVVNGPLD--RWLH 357
GD ++ E+V P + L
Sbjct: 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV---PDTLHKVLK 129
Query: 358 HIPRGGRSLDWAMRMKVAT-TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-------- 408
R GRS+ + + L + + F+H + HRDI+ N+L++ +
Sbjct: 130 SFIRSGRSIP-MNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 409 FGAHLMGVGLSK-FVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLE 466
F G +K +P E + Y APE + E T D++S G + E
Sbjct: 186 F-------GSAKKLIPSEPSVAYIC----SRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 467 IVSGR 471
++ G+
Sbjct: 235 LILGK 239
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 34/214 (15%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 330
+G+ G S + RVA+K K S F+ + + EI R H N++ +
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIK--KISPFEHQTYCQRTLREIKILLRFRHENIIGI 90
Query: 331 K-----GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
D YIV + ++ L+ + + + + + L +G+ ++
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHICYFLYQIL-RGLKYI 144
Query: 386 HDKVKPHVVHRDIRASNVLLDEE-------FGAHLMGVGLSKFVPWEVMQERTVMAGGTY 438
H +V+HRD++ SN+LL+ FG L V + E T
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFG--LARVADPDHDHTGFLTEYVA----TR 195
Query: 439 GYLAPEFVYRNELTTKS-DVYSFGVLLLEIVSGR 471
Y APE + ++ TKS D++S G +L E++S R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 44/213 (20%), Positives = 79/213 (37%), Gaps = 39/213 (18%)
Query: 284 GTY----SGILPDGSRVAVKRLKRSS--------FQRK---KEFYSEIGRFARLHHPNLV 328
G+Y +G+ +G VA+KR+ + K EI HHPN++
Sbjct: 33 GSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92
Query: 329 AVK-----GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSL--DWAMRMKVATTLAQG 381
++ Y+V E + L + R + ++ + L G
Sbjct: 93 GLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQVIHDQRIVISPQHIQYFMYHIL-LG 146
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYG 439
+ LH+ VVHRD+ N+LL + + L++
Sbjct: 147 LHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAR-----EDTADANKTHYVTHRW 198
Query: 440 YLAPEFVYRNELTTKS-DVYSFGVLLLEIVSGR 471
Y APE V + + TK D++S G ++ E+ + +
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 45/200 (22%), Positives = 81/200 (40%), Gaps = 32/200 (16%)
Query: 291 PDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAVK-----GCCYDHGDRYI 342
P G VA+K++ F + EI H N++ + + + YI
Sbjct: 34 PTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91
Query: 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASN 402
+ E + LH + D ++ + TL + + LH +V+HRD++ SN
Sbjct: 92 IQEL-----MQTDLHRVISTQMLSDDHIQYFIYQTL-RAVKVLHGS---NVIHRDLKPSN 142
Query: 403 VLLDEE-------FG-AHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAPEFVYRNELT 452
+L++ FG A + S E +++ M T Y APE + +
Sbjct: 143 LLINSNCDLKVCDFGLAR--IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY 200
Query: 453 TKS-DVYSFGVLLLEIVSGR 471
+++ DV+S G +L E+ R
Sbjct: 201 SRAMDVWSCGCILAELFLRR 220
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 573 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 1ypq_A | 135 | Oxidised low density lipoprotein (lectin-like) rec | 99.95 | |
| 3vpp_A | 132 | C-type lectin domain family 9 member A; dendritic | 99.95 | |
| 2py2_A | 136 | Antifreeze protein type II; type II antifreeze pro | 99.95 | |
| 3rs1_A | 122 | C-type lectin domain family 2 member I; C-type lec | 99.94 | |
| 3kqg_A | 182 | Langerin, C-type lectin domain family 4 member K; | 99.94 | |
| 2b6b_D | 175 | CD209 antigen; cryo EM dengue CRD DC-SIGN, icosahe | 99.94 | |
| 1dv8_A | 128 | Asialoglycoprotein receptor 1; C-type lectin CRD, | 99.94 | |
| 1sl6_A | 184 | C-type lectin DC-signr; sugar binding protein; HET | 99.94 | |
| 3c22_A | 156 | C-type lectin domain family 4 member K; coiled coi | 99.94 | |
| 2c6u_A | 122 | CLEC1B protein; lectin, rhodocytin, aggretin, C-ty | 99.94 | |
| 2afp_A | 129 | Protein (SEA raven type II antifreeze protein); re | 99.94 | |
| 1wmz_A | 140 | Lectin CEL-I, N-acetyl-D-galactosamine-specific C- | 99.94 | |
| 2kv3_A | 131 | Regenerating islet-derived protein 4; GISP, C-type | 99.94 | |
| 3bx4_B | 146 | Aggretin beta chain; toxin; 1.70A {Agkistrodon rho | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1tdq_B | 130 | Aggrecan core protein; extracellular matrix, lecti | 99.93 | |
| 1gz2_A | 142 | Ovocleidin-17, OC-17 ovocleidin; structural protei | 99.93 | |
| 3bdw_B | 120 | NKG2-A/NKG2-B type II integral membrane protein; N | 99.93 | |
| 2bpd_A | 142 | Dectin-1; receptor, beta-glucan, fungal recognitio | 99.93 | |
| 3m9z_A | 139 | Killer cell lectin-like receptor subfamily B MEMB; | 99.93 | |
| 3bdw_A | 123 | Natural killer cells antigen CD94; NK cells, recep | 99.93 | |
| 1egg_A | 147 | Macrophage mannose receptor; C-type lectin, sugar | 99.93 | |
| 1jwi_B | 125 | Platelet aggregation inducer; domain swapping, C-t | 99.93 | |
| 3g8k_A | 130 | Lectin-related NK cell receptor LY49L1; natural ki | 99.93 | |
| 2yhf_A | 118 | C-type lectin domain family 5 member A; immune sys | 99.93 | |
| 2ox9_A | 140 | Collectin placenta 1; C-type lectin, sugar binding | 99.93 | |
| 1fvu_B | 125 | Botrocetin beta chain; VON WILLBRAND factor modula | 99.93 | |
| 2xr6_A | 170 | CD209 antigen; sugar binding protein, carbohydrate | 99.93 | |
| 1mpu_A | 138 | NKG2-D type II integral membrane protein; C-type l | 99.93 | |
| 1fm5_A | 199 | Early activation antigen CD69; C-type lectin-like | 99.93 | |
| 2zib_A | 133 | Type II antifreeze protein; thermal hysteresis, le | 99.93 | |
| 1jzn_A | 135 | Galactose-specific lectin; C-type lectin, protein- | 99.93 | |
| 1hq8_A | 123 | NKG2-D; homodimer, CIS-proline, apoptosis; 1.95A { | 99.93 | |
| 1qdd_A | 144 | Lithostathine; pancreatic stone inhibitor, metal b | 99.93 | |
| 2h2t_B | 175 | Low affinity immunoglobulin epsilon FC receptor ( | 99.93 | |
| 1oz7_B | 123 | Echicetin B-chain; platelet aggregation, dimer, to | 99.93 | |
| 1umr_C | 125 | Convulxin beta, CVX beta; lectin, C-type lectin, p | 99.93 | |
| 1j34_B | 123 | Coagulation factor IX-binding protein B chain; mag | 99.93 | |
| 3hup_A | 130 | Early activation antigen CD69; C-type lectin-like | 99.92 | |
| 2e3x_C | 122 | Coagulation factor X-activating enzyme light CHAI; | 99.92 | |
| 1hup_A | 141 | Mannose-binding protein; alpha-helical coiled-coil | 99.92 | |
| 1c3a_A | 135 | Flavocetin-A: alpha subunit; C-type lectin-like do | 99.92 | |
| 1uv0_A | 149 | Pancreatitis-associated protein 1; lectin, C-type, | 99.92 | |
| 3alu_A | 157 | Lectin CEL-IV, C-type; C-type lectin, raffinose, s | 99.92 | |
| 1c3a_B | 125 | Flavocetin-A: beta subunit; C-type lectin-like dom | 99.92 | |
| 3bx4_A | 136 | Aggretin alpha chain; toxin; 1.70A {Agkistrodon rh | 99.92 | |
| 1rtm_1 | 149 | Mannose-binding protein-A; lectin; 1.80A {Rattus n | 99.92 | |
| 3ff9_A | 115 | Killer cell lectin-like receptor subfamily G membe | 99.92 | |
| 3gpr_D | 124 | Rhodocetin subunit delta; disulfide bond, lectin, | 99.92 | |
| 3ubu_B | 126 | Agglucetin subunit beta-2; platelet inhibiting, ag | 99.92 | |
| 1ukm_A | 134 | EMS16 A chain, EMS16 subunit A; domain swapping, C | 99.92 | |
| 3gpr_C | 134 | Rhodocetin subunit gamma; disulfide bond, lectin, | 99.92 | |
| 3ubu_A | 131 | Agglucetin subunit alpha-1; platelet inhibiting, a | 99.92 | |
| 2vuv_A | 129 | Codakine; sugar-binding protein, C-type, lectin, m | 99.92 | |
| 1ukm_B | 128 | EMS16 B chain, EMS16 subunit B; domain swapping, C | 99.92 | |
| 3ff7_C | 112 | Killer cell lectin-like receptor subfamily G membe | 99.92 | |
| 1tn3_A | 137 | Tetranectin; plasminogen binding, kringle 4, C-typ | 99.92 | |
| 1buu_A | 168 | Protein (mannose-binding protein A); lectin, HOST | 99.92 | |
| 1jwi_A | 131 | Bitiscetin; domain swapping, C-type lectin, toxin; | 99.92 | |
| 2ls8_A | 156 | C-type lectin domain family 4 member D; structural | 99.86 | |
| 1umr_A | 135 | Convulxin alpha, CVX alpha; lectin, C-type lectin, | 99.92 | |
| 1sb2_A | 133 | Rhodocetin alpha subunit; C-type lectin, domain sw | 99.92 | |
| 1fvu_A | 133 | Botrocetin alpha chain; VON WILLBRAND factor modul | 99.92 | |
| 3c8j_A | 203 | Natural killer cell receptor LY49C; MHC, virus, im | 99.91 | |
| 2e3x_B | 134 | Coagulation factor X-activating enzyme light CHAI; | 99.91 | |
| 1j34_A | 129 | Coagulation factor IX-binding protein A chain; mag | 99.91 | |
| 1oz7_A | 131 | Echicetin A-chain; platelet aggregation, dimer, to | 99.91 | |
| 3g8l_A | 190 | Lectin-related NK cell receptor LY49L1; natural ki | 99.91 | |
| 1sb2_B | 129 | Rhodocetin beta subunit; C-type lectin, domain swa | 99.91 | |
| 2msb_A | 115 | Mannose-binding protein-A; lectin; HET: BMA MAN; 1 | 99.91 | |
| 1wk1_A | 150 | Hypothetical protein YK1067A12; lectin C-type doma | 99.91 | |
| 1htn_A | 182 | Tetranectin; plasminogen binding, kringle 4, alpha | 99.9 | |
| 1rdl_1 | 113 | SUB-MBP-C, mannose-binding protein-C; C-type lecti | 99.9 | |
| 1pwb_A | 177 | SP-D, PSP-D, pulmonary surfactant-associated prote | 99.9 | |
| 1h8u_A | 117 | MBP, eosinophil granule major basic protein 1; lec | 99.89 | |
| 3pbf_A | 148 | Pulmonary surfactant-associated protein A; collect | 99.89 | |
| 1byf_A | 125 | TC14, protein (polyandrocarpa lectin); C-type lect | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1g1s_A | 162 | P-selectin; selectin, lectin, EGF, sulphated, SLEX | 99.85 | |
| 3cfw_A | 164 | L-selectin; EGF, cell adhesion, EGF-like domain, g | 99.85 | |
| 1g1t_A | 157 | E-selectin; EGF, adhesion molecule, SLEX, immune s | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.08 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.94 | |
| 3k7b_A | 96 | Protein A33; C-type lectin-like domain, homodimer, | 98.75 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.65 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.57 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.46 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.43 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.31 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.26 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.01 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.99 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.95 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.88 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.66 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.59 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.45 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.43 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.22 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.19 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.05 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.9 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.89 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.71 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 96.48 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.48 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.42 | |
| 3fd4_A | 191 | Glycoprotein GP42; C type lectin, virus entry, mem | 96.07 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 95.82 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 95.52 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.08 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.99 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.64 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.4 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-56 Score=449.94 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=207.7
Q ss_pred CeeecccCceEEEEEEeC------CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 274 NRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
.+.||+|+||.||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++|++.+.+..+|||||+
T Consensus 46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 125 (329)
T 4aoj_A 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM 125 (329)
T ss_dssp EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 456899999999999864 47889999998877777889999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecc
Q 008216 348 VNGPLDRWLHHIPR-----------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (573)
Q Consensus 348 ~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 416 (573)
++|+|.++++.... ...++++.+++.|+.||++||+|||++ +|+||||||+||||++++.+||+||
T Consensus 126 ~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~DF 202 (329)
T 4aoj_A 126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDF 202 (329)
T ss_dssp TTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCC
T ss_pred CCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEccc
Confidence 99999999975322 134699999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhc
Q 008216 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS 495 (573)
Q Consensus 417 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 495 (573)
|+++...............||+.|||||++.+..++.++|||||||++|||+| |+.||...+.... ... ....
T Consensus 203 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~~---i~~g 276 (329)
T 4aoj_A 203 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---IDC---ITQG 276 (329)
T ss_dssp C----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---HHH---HHHT
T ss_pred ccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---HHH---HHcC
Confidence 99987654433333334459999999999999999999999999999999999 9999987654321 111 1111
Q ss_pred cccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
. ....+..+++++.+||.+||+.||++|||++||++.|+.+.+.|
T Consensus 277 ~--------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 277 R--------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp C--------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred C--------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 0 01112345678999999999999999999999999999997754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-56 Score=442.86 Aligned_cols=257 Identities=27% Similarity=0.392 Sum_probs=212.3
Q ss_pred CCeeecccCceEEEEEEeC------CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 273 GNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
..+.||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|++.+++..+|||||
T Consensus 17 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 96 (299)
T 4asz_A 17 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 96 (299)
T ss_dssp EEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEc
Confidence 3467899999999999863 4778999999887777778999999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEeccc
Q 008216 347 VVNGPLDRWLHHIP---------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (573)
Q Consensus 347 ~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 417 (573)
+++|+|.++|+... .....+++.+++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DFG 173 (299)
T 4asz_A 97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFG 173 (299)
T ss_dssp CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCS
T ss_pred CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCcc
Confidence 99999999997532 2345699999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcc
Q 008216 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSH 496 (573)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 496 (573)
+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||...+..+. ... .. .+
T Consensus 174 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~~---i~-~~ 246 (299)
T 4asz_A 174 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IEC---IT-QG 246 (299)
T ss_dssp CHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHH---HH-HT
T ss_pred cceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH---HH-cC
Confidence 9987654433322223348999999999999999999999999999999999 9999987654321 111 11 11
Q ss_pred ccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
. ....+..+++++.+||.+||+.||++|||++||++.|+++.+
T Consensus 247 ~-------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 247 R-------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp C-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1 011123456789999999999999999999999999998765
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-55 Score=436.58 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=208.7
Q ss_pred eeecccCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 275 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
+.||+|+||.||+|.+. +++.||||+++... ....++|.+|+.++++++|||||+++|++.+++..+|||||+
T Consensus 32 ~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~ 111 (308)
T 4gt4_A 32 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYC 111 (308)
T ss_dssp EEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcC
Confidence 46899999999999862 46789999997643 334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEec
Q 008216 348 VNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415 (573)
Q Consensus 348 ~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 415 (573)
++|+|.++|..... ....+++.+++.|+.|||.||+|||++ +||||||||+||||++++.+||+|
T Consensus 112 ~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki~D 188 (308)
T 4gt4_A 112 SHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISD 188 (308)
T ss_dssp SSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred CCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCEEECC
Confidence 99999999965321 124589999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhh
Q 008216 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQ 494 (573)
Q Consensus 416 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 494 (573)
||+++...............||+.|||||++.++.++.++|||||||++|||+| |+.||.+.+... +.... .
T Consensus 189 FGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~~i----~ 261 (308)
T 4gt4_A 189 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVEMI----R 261 (308)
T ss_dssp SCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHHHH----H
T ss_pred cccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----H
Confidence 999987654443333334459999999999999999999999999999999999 899998765432 11111 1
Q ss_pred ccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
.+. ....+..+++.+.+||.+||+.||++|||+.||++.|+..
T Consensus 262 ~~~-------------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 262 NRQ-------------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp TTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred cCC-------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111 0111234567899999999999999999999999999865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=431.70 Aligned_cols=257 Identities=24% Similarity=0.385 Sum_probs=201.2
Q ss_pred CCeeecccCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
..+.||+|+||+||+|++. ..||||+++.. +....+.|.+|+.+|++++|||||+++|++.+ +..+|||||+++|
T Consensus 40 l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gG 116 (307)
T 3omv_A 40 LSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGS 116 (307)
T ss_dssp EEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSC
T ss_pred EeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCC
Confidence 3456899999999999874 36999999754 33456789999999999999999999998754 5689999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.++|.. ....+++.+++.|+.|||.||+|||++ +||||||||+||||++++.+||+|||+|+..........
T Consensus 117 sL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 190 (307)
T 3omv_A 117 SLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190 (307)
T ss_dssp BHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred CHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence 99999974 235699999999999999999999999 999999999999999999999999999987654433333
Q ss_pred eeccCCcccccccccccC---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 431 TVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
.....||+.|||||++.+ +.++.++|||||||++|||+||+.||...+.... + ....... ...+.+.
T Consensus 191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~--~----~~~~~~~----~~~p~~~ 260 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ--I----IFMVGRG----YASPDLS 260 (307)
T ss_dssp ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--H----HHHHHTT----CCCCCST
T ss_pred ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH--H----HHHHhcC----CCCCCcc
Confidence 344569999999999864 4689999999999999999999999987554211 1 1111111 1111111
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
.....+++.+.+||.+||+.||++|||+.||++.|+.+..+
T Consensus 261 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 261 -----KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp -----TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred -----cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 11234567899999999999999999999999999877554
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=428.80 Aligned_cols=246 Identities=22% Similarity=0.334 Sum_probs=206.3
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+..+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+++..||||||++||
T Consensus 77 ~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 156 (346)
T 4fih_A 77 DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 156 (346)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTE
T ss_pred EEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 33456899999999999964 69999999998765556677899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. ..+++.++..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+........
T Consensus 157 ~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~-- 226 (346)
T 4fih_A 157 ALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-- 226 (346)
T ss_dssp EHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--
T ss_pred cHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc--
Confidence 99999974 4599999999999999999999999 9999999999999999999999999999876543222
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+.... .... ... ..+
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i---~~~------~~~------ 288 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMI---RDN------LPP------ 288 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHH---HHS------SCC------
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHH---HcC------CCC------
Confidence 2234599999999999999999999999999999999999999987553211 1111 000 000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
........++++.+||.+||+.||++|||++|+++
T Consensus 289 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 289 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11112345678999999999999999999999987
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=428.71 Aligned_cols=247 Identities=20% Similarity=0.332 Sum_probs=199.6
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
+..+.||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+.+|++|+|||||++++++.+++..||||||++
T Consensus 27 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~ 106 (350)
T 4b9d_A 27 VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCE 106 (350)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 3445789999999999995 46999999999765 33446789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
||+|.++|.. ..+..+++.+++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+........
T Consensus 107 gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 107 GGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp TCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred CCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 9999999975 3345689999999999999999999999 9999999999999999999999999999977543221
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
....+||+.|||||++.+..|+.++|||||||++|||+||+.||...+... +.. .... ...
T Consensus 182 --~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~---~i~~-~~~---------- 242 (350)
T 4b9d_A 182 --ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---LVL---KIIS-GSF---------- 242 (350)
T ss_dssp --HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH---HHHH-TCC----------
T ss_pred --ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHH---HHHc-CCC----------
Confidence 122349999999999999999999999999999999999999998765321 111 1111 100
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
...+...++++.+||.+||+.||++|||++|+++
T Consensus 243 ---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 ---PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112235678999999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=424.02 Aligned_cols=246 Identities=21% Similarity=0.290 Sum_probs=206.4
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
+..+.||+|+||.||+|+. .+|+.||||++++.. ....+.+.+|+++|++++|||||++++++.+++..|+||||+
T Consensus 35 ~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~ 114 (311)
T 4aw0_A 35 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA 114 (311)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence 4456889999999999995 469999999997542 234577999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
+||+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 115 ~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 115 KNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp TTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999964 35699999999999999999999999 999999999999999999999999999998765444
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
.......+||+.|||||++.+..|+.++||||+||++|||+||++||...+... +.... .. ..
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i---~~-~~---------- 250 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IFAKI---IK-LE---------- 250 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HH-TC----------
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---Hc-CC----------
Confidence 334445569999999999999999999999999999999999999998755321 11111 00 00
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
. ..+...++++.+||.+||+.||++|||++|++.
T Consensus 251 ---~-~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 251 ---Y-DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp ---C-CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred ---C-CCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 0 011234567999999999999999999998753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=416.05 Aligned_cols=246 Identities=19% Similarity=0.340 Sum_probs=196.4
Q ss_pred CCcCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEee----CCceEE
Q 008216 270 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYI 342 (573)
Q Consensus 270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~l 342 (573)
|.+..+.||+|+||.||+|... ++..||||++... .....+.|.+|+.+|++++|||||++++++.+ ++..||
T Consensus 27 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred eEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 3344456899999999999964 5899999999654 33445779999999999999999999999875 245799
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCeeeCC-CCCeeEecccCC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLDE-EFGAHLMGVGLS 419 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--iiH~Dlkp~NIll~~-~~~~kl~Dfg~~ 419 (573)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ + |+||||||+|||++. ++.+||+|||+|
T Consensus 107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla 179 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence 9999999999999964 35699999999999999999999998 7 999999999999984 789999999999
Q ss_pred ccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
+...... ....+||+.|||||++.+ .|+.++|||||||++|||+||+.||...... ..+.... ....
T Consensus 180 ~~~~~~~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~~~i----~~~~-- 246 (290)
T 3fpq_A 180 TLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRV----TSGV-- 246 (290)
T ss_dssp GGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHH----TTTC--
T ss_pred EeCCCCc----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHHHHHH----HcCC--
Confidence 8654322 223459999999998864 6999999999999999999999999764432 1111110 0000
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
. +...+...++++.+||.+||+.||++|||++|+++
T Consensus 247 ---~-------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 247 ---K-------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---C-------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---C-------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00111223457999999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=421.01 Aligned_cols=250 Identities=19% Similarity=0.220 Sum_probs=202.0
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+..+.||+|+||.||+|+. .+|+.||||+++.... ..+|+.+|++++|||||++++++.+++..||||||++||
T Consensus 61 ~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred EeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 3345689999999999996 4699999999976532 246999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-CeeEecccCCccCCcccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~ 429 (573)
+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+||||+.++ .+||+|||+|+.........
T Consensus 136 ~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 136 SLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp BHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999964 34699999999999999999999999 999999999999999987 59999999998775443221
Q ss_pred ---ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 430 ---RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 430 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
.....+||+.|||||++.+..++.++|||||||++|||+||++||...+.......+ .... +..
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~~-------~~~ 275 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI------ASEP-------PPI 275 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH------HHSC-------CGG
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------HcCC-------CCc
Confidence 122345999999999999999999999999999999999999999876543221111 0000 000
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
.. .+..+++.+.++|.+||+.||++|||+.||++.|....
T Consensus 276 ~~-----~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 276 RE-----IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp GG-----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hh-----cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 00 11234567999999999999999999999999887654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=430.04 Aligned_cols=247 Identities=22% Similarity=0.338 Sum_probs=206.8
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
++..+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..|||||||+|
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 44456789999999999996 46999999999876656667799999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|.+++.. ..+++.++..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+........
T Consensus 233 G~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~- 303 (423)
T 4fie_A 233 GALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR- 303 (423)
T ss_dssp EEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC-
T ss_pred CcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc-
Confidence 999999964 4599999999999999999999999 9999999999999999999999999999876543222
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+.... .... ... ..+.+
T Consensus 304 -~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i---~~~------~~~~~--- 367 (423)
T 4fie_A 304 -RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMI---RDN------LPPRL--- 367 (423)
T ss_dssp -BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHH---HHS------CCCCC---
T ss_pred -ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHH---HcC------CCCCC---
Confidence 2234499999999999999999999999999999999999999987554211 1111 000 01111
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
......++++.+||.+||+.||++|||++|+++
T Consensus 368 ---~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 ---KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp ---SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111234578999999999999999999999987
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=428.99 Aligned_cols=263 Identities=26% Similarity=0.342 Sum_probs=211.0
Q ss_pred CCCcCCeeecccCceEEEEEEeCC------CCEEEEEEecccc-hhhHHHHHHHHHHHhhcCC-CcEeEEeeEEeeC-Cc
Q 008216 269 NFSEGNRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDH-GD 339 (573)
Q Consensus 269 ~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~-~~ 339 (573)
+-.+..+.||+|+||.||+|.+.. ++.||||+++... ....++|.+|+.+|.+++| ||||+++|+|.+. +.
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~ 143 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 143 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence 334556678999999999998532 3689999997653 3445779999999999965 9999999998765 56
Q ss_pred eEEEEEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC
Q 008216 340 RYIVYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE 407 (573)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~ 407 (573)
.++|||||++|+|.++|+.... ....+++..++.++.|||+||+|||++ +||||||||+|||+++
T Consensus 144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 220 (353)
T ss_dssp CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCC
Confidence 8999999999999999975321 134589999999999999999999999 9999999999999999
Q ss_pred CCCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhH
Q 008216 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIF 486 (573)
Q Consensus 408 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~ 486 (573)
++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||.+..... .+.
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~--~~~ 298 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC 298 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH--HHH
Confidence 99999999999997755443333334458999999999999999999999999999999998 999998754321 111
Q ss_pred HhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 487 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 487 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
. ....+. ....+..+++++.++|.+||+.||++|||+.||++.|+++.+.
T Consensus 299 ~----~i~~g~-------------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 299 R----RLKEGT-------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp H----HHHHTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H----HHHcCC-------------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 1 111110 0111223456899999999999999999999999999887643
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=404.48 Aligned_cols=242 Identities=19% Similarity=0.285 Sum_probs=189.0
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
+..+.||+|+||.||+|.. .+|+.||||++++.. ....+.+.+|+.+|++++||||+++++++.+++..|+||||+
T Consensus 16 ~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 95 (275)
T 3hyh_A 16 QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA 95 (275)
T ss_dssp EEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 4456789999999999995 469999999997642 233567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
+|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 96 -~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 96 -GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp -CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred -CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 7899999865 34699999999999999999999999 999999999999999999999999999987643322
Q ss_pred ccceeccCCcccccccccccCCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
....+||+.|||||++.+..+ +.++||||+||++|||+||+.||...+... +..... ...
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~~~i~----~~~--------- 228 (275)
T 3hyh_A 168 ---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LFKNIS----NGV--------- 228 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HTC---------
T ss_pred ---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH----cCC---------
Confidence 223459999999999988876 579999999999999999999998654321 111110 000
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
...+...++++.+||.+||+.||++|||++|+++
T Consensus 229 -----~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 229 -----YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0011234567999999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=417.25 Aligned_cols=267 Identities=21% Similarity=0.289 Sum_probs=200.1
Q ss_pred CCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC----ceEEEEEecC
Q 008216 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG----DRYIVYEFVV 348 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~e~~~ 348 (573)
..+.||+|+||.||+|++ +|+.||||+++.... ....+..|+..+.+++|||||++++++.+++ ..+|||||++
T Consensus 7 L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~ 84 (303)
T 3hmm_A 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence 345789999999999998 789999999976532 2233445666777899999999999998764 4699999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEcCCCCCCeeeCCCCCeeEecccCCccCC
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 423 (573)
+|+|.++++. ..+++..+.+++.|++.||+|||+++ .++|+||||||+|||++.++.+||+|||+|+...
T Consensus 85 ~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 85 HGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp TCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 9999999975 45899999999999999999999762 4589999999999999999999999999998664
Q ss_pred ccccc--cceeccCCcccccccccccCC------CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccch--hh------HH
Q 008216 424 WEVMQ--ERTVMAGGTYGYLAPEFVYRN------ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ--SI------FE 487 (573)
Q Consensus 424 ~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~--~~------~~ 487 (573)
..... .......||+.|||||++.+. .++.++|||||||++|||+||.+||......... .. ..
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 33221 112233599999999998754 4678999999999999999998887654321100 00 00
Q ss_pred hhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 488 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
....... ...+++.+ +......+.+..+.+|+.+||+.||++||||.||++.|+++.+.
T Consensus 240 ~~~~~~~----~~~~rp~~---p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 240 EMRKVVC----EQKLRPNI---PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHT----TSCCCCCC---CGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHh----cccCCCCC---CccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 0000000 01111111 11112235677899999999999999999999999999988765
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=410.82 Aligned_cols=239 Identities=24% Similarity=0.277 Sum_probs=190.6
Q ss_pred cCCeeecccCceEEEEEEe----CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
+..+.||+|+||.||+|+. .+++.||||+++... ......+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 27 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 106 (304)
T 3ubd_A 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILD 106 (304)
T ss_dssp EEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEEC
T ss_pred EEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEE
Confidence 4456789999999999985 247899999997642 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|++||+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 107 y~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 107 FLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp CCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred cCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 9999999999964 34699999999999999999999999 9999999999999999999999999999865433
Q ss_pred ccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.. .....+||+.|||||++.+..++.++|||||||++|||+||+.||.+.+.... .... .. ..
T Consensus 180 ~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~~~i---~~-~~-------- 242 (304)
T 3ubd_A 180 EK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET---MTMI---LK-AK-------- 242 (304)
T ss_dssp -C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH---HH-CC--------
T ss_pred Cc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH---HHHH---Hc-CC--------
Confidence 22 22234599999999999999999999999999999999999999987654321 1111 00 00
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCH
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM 540 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 540 (573)
...+...++++.+||.+||+.||++|||+
T Consensus 243 ------~~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 243 ------LGMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ------CCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 01122356789999999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=394.77 Aligned_cols=246 Identities=20% Similarity=0.302 Sum_probs=184.3
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCc------------
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD------------ 339 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------------ 339 (573)
.+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~ 89 (299)
T 4g31_A 10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY 89 (299)
T ss_dssp EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEE
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcE
Confidence 45789999999999996 469999999997543 3345779999999999999999999999876543
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCC
Q 008216 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (573)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 419 (573)
.|+||||+++|+|.+++.... .....++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 90 l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFGla 165 (299)
T 4g31_A 90 LYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLV 165 (299)
T ss_dssp EEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred EEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCccc
Confidence 689999999999999997522 122356677889999999999999999 9999999999999999999999999999
Q ss_pred ccCCcccccc----------ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhh
Q 008216 420 KFVPWEVMQE----------RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWA 489 (573)
Q Consensus 420 ~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 489 (573)
+......... .....+||+.|||||++.+..|+.++|||||||++|||++ ||...... ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~-----~~~~ 237 (299)
T 4g31_A 166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER-----VRTL 237 (299)
T ss_dssp --------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-----HHHH
T ss_pred eecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH-----HHHH
Confidence 8765432211 1123359999999999999999999999999999999996 77542110 0000
Q ss_pred hhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 490 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.. ..... ........++.+.+||.+||+.||++|||+.|+++
T Consensus 238 ~~-~~~~~-------------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 238 TD-VRNLK-------------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-HHTTC-------------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-HhcCC-------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 00000 00011234456789999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=398.29 Aligned_cols=266 Identities=20% Similarity=0.271 Sum_probs=198.6
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEee------CCceEE
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD------HGDRYI 342 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~l 342 (573)
+..+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.. .+..||
T Consensus 57 ~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~i 136 (398)
T 4b99_A 57 EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYV 136 (398)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEE
Confidence 4456789999999999996 46999999999754 23345678899999999999999999998764 357899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
||||++ |+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 137 vmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 137 VLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 999995 689999853 45799999999999999999999999 9999999999999999999999999999876
Q ss_pred Ccccc--ccceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 423 PWEVM--QERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 423 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
..... .......+||+.|||||++.+. .++.++||||+||++|||++|++||.+.+.......+.............
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 43321 1222344599999999998775 56999999999999999999999998765432211111100000000000
Q ss_pred c----ccccccccCCCCCc------chHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 500 E----LLDPLISSLSSDIP------EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 500 ~----~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
. .............+ ....++++.+||.+||+.||++|||++|+++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 00000000001000 0123567899999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=384.38 Aligned_cols=287 Identities=30% Similarity=0.522 Sum_probs=236.0
Q ss_pred cCHHHHHHhhcCCCcCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC
Q 008216 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337 (573)
Q Consensus 258 ~~~~el~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 337 (573)
++..++...+++|.. .+.||+|+||.||+|...+|+.||||++........+.+.+|+.++++++||||+++++++.+.
T Consensus 29 ~~~~~~~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 29 VPLVDLEEATNNFDH-KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp -CCSCCCCCCCCCSC-CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred ecHHHHHHHHhccCc-cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 333445556677655 4467999999999999888999999999877666678899999999999999999999999999
Q ss_pred CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEeccc
Q 008216 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (573)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 417 (573)
+..++||||+++|+|.+++.........+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999976544445699999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccc
Q 008216 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 497 (573)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 497 (573)
++................||+.|+|||++.+..++.++||||||+++|||++|+.||....+........+.........
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 99865433222222223389999999999888999999999999999999999999987666555555555444444444
Q ss_pred cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
....+++.. ........+..+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 265 ~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 265 LEQIVDPNL----ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CCSSSSSSC----TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcChhh----ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 444444433 233456788899999999999999999999999999987753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=386.35 Aligned_cols=197 Identities=22% Similarity=0.324 Sum_probs=166.8
Q ss_pred CcCCeeecccCceEEEEEEeC----CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
++..+.||+|+||.||+|+.+ +++.||||.+.... ...++.+|+++|+.+ +||||+++++++.+.+..|+|||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 455667899999999999852 46789999987653 345688999999998 69999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-CCeeEecccCCccCCc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPW 424 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~ 424 (573)
|+++|+|.+++. .+++.++..++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 101 ~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 101 YLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp CCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred CCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 999999999984 389999999999999999999999 99999999999999876 7899999999976543
Q ss_pred cccc--------------------------cceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 008216 425 EVMQ--------------------------ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAV 477 (573)
Q Consensus 425 ~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~ 477 (573)
.... ......+||+.|+|||++.+. .++.++||||+||++|||+||+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 2110 111233599999999999875 5899999999999999999999999655
Q ss_pred Cc
Q 008216 478 DS 479 (573)
Q Consensus 478 ~~ 479 (573)
++
T Consensus 251 ~~ 252 (361)
T 4f9c_A 251 SD 252 (361)
T ss_dssp SS
T ss_pred CC
Confidence 43
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=376.38 Aligned_cols=295 Identities=33% Similarity=0.580 Sum_probs=237.9
Q ss_pred CCCcccCHHHHHHhhcCCCcCCeeecccCceEEEEEEeCCCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEeEEe
Q 008216 253 PSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVK 331 (573)
Q Consensus 253 ~~~~~~~~~el~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~ 331 (573)
.....++..++....++|... +.||+|+||.||+|...+|+.||||+++.... .....+.+|+.++++++||||++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNK-NILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCST-TEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred CccceecHHHHHHHhhccccc-eeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 345678889999888888665 46799999999999988899999999976532 2234689999999999999999999
Q ss_pred eEEeeCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCe
Q 008216 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411 (573)
Q Consensus 332 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 411 (573)
+++.+.+..++||||+++|+|.+++.........+++..+..++.|++.||+|||+++.++|+||||||+|||++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 99999999999999999999999998766566679999999999999999999999877799999999999999999999
Q ss_pred eEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCc--ccchhhHHhh
Q 008216 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS--VCWQSIFEWA 489 (573)
Q Consensus 412 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~~ 489 (573)
||+|||++.......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ........+.
T Consensus 174 kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp EECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred EeccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 999999998765433222 2223499999999999888899999999999999999999999963211 1112233333
Q ss_pred hhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 490 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
.............+... ........+..+.+++.+||+.||++|||+.||++.|++....
T Consensus 253 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDL----QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp TTTTSSCCSTTSSCTTC----TTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred HHHhhchhhhhhcChhh----ccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 33333333334433333 3334567788999999999999999999999999999876544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=404.99 Aligned_cols=248 Identities=19% Similarity=0.279 Sum_probs=206.3
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+..+.||+|+||.||++.. .+|+.||||++........+.+.+|+.+|+.++||||+++++++.+.+..||||||++||
T Consensus 160 ~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg 239 (573)
T 3uto_A 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239 (573)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCC
Confidence 3456789999999999996 469999999998876677788999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC--CCeeEecccCCccCCccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--FGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~--~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.......
T Consensus 240 ~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~- 312 (573)
T 3uto_A 240 ELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS- 312 (573)
T ss_dssp BHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE-
T ss_pred cHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc-
Confidence 99999863 235699999999999999999999999 99999999999999854 7899999999998754332
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+...... .. . .... ..
T Consensus 313 --~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~---~i---~-~~~~-~~------- 375 (573)
T 3uto_A 313 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR---NV---K-SCDW-NM------- 375 (573)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH---HH---H-TTCC-CC-------
T ss_pred --eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---HH---H-hCCC-CC-------
Confidence 223359999999999999999999999999999999999999998765432111 00 0 0000 00
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
........++++.+||.+||+.||++|||+.|+++
T Consensus 376 --~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 376 --DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp --CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111234567999999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=399.11 Aligned_cols=245 Identities=19% Similarity=0.238 Sum_probs=196.6
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHH---HHHHHHhhcCCCcEeEEeeEEeeCCceEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFY---SEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 344 (573)
+..++||+|+||.||+|+.. +|+.||||++++... .....+. .++.+++.++|||||++++++.+.+..|+||
T Consensus 192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVm 271 (689)
T 3v5w_A 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 271 (689)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEE
Confidence 44578899999999999964 699999999975421 1222333 3466777889999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCc
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 424 (573)
||++||+|.++|.. ...+++..+..++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+....
T Consensus 272 Ey~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 272 DLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp CCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999965 34699999999999999999999999 999999999999999999999999999987654
Q ss_pred cccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccc
Q 008216 425 EVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503 (573)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (573)
.. ....+||+.|||||++.+ ..|+.++|+|||||++|||++|++||...+......+..... . .
T Consensus 345 ~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~---~-~------- 409 (689)
T 3v5w_A 345 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---T-M------- 409 (689)
T ss_dssp CC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH---H-C-------
T ss_pred CC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc---C-C-------
Confidence 32 223459999999999964 579999999999999999999999997654332111111110 0 0
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008216 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH 545 (573)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 545 (573)
....+...++++.+||.+||+.||++|++ ++||++
T Consensus 410 -------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 410 -------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 01112235678999999999999999998 677764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=357.97 Aligned_cols=247 Identities=20% Similarity=0.322 Sum_probs=205.9
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
+...+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 22 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 101 (297)
T 3fxz_A 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (297)
T ss_dssp BCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCC
Confidence 34456789999999999995 56899999999876656677899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
++|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.........
T Consensus 102 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 172 (297)
T 3fxz_A 102 GSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (297)
T ss_dssp CBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-
Confidence 999999975 3589999999999999999999999 9999999999999999999999999999876543322
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+...... .......
T Consensus 173 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~~~~~~~------------ 233 (297)
T 3fxz_A 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGT------------ 233 (297)
T ss_dssp -BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHCS------------
T ss_pred -cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCC------------
Confidence 222349999999999999999999999999999999999999997654321110 0000000
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.....+...+..+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 011112345667999999999999999999999987
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=361.13 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=201.0
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
...+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 40 ~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 118 (309)
T 3p86_A 40 NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118 (309)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTT
T ss_pred eeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCC
Confidence 3456789999999999987 78999999997653 33456789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++|.+++.... ....+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||+|||+++.......
T Consensus 119 ~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 194 (309)
T 3p86_A 119 GSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL 194 (309)
T ss_dssp CBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred CcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc
Confidence 99999997421 112489999999999999999999999 8 99999999999999999999999999986543321
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+........ .....
T Consensus 195 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~------~~~~~---------- 256 (309)
T 3p86_A 195 S--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV------GFKCK---------- 256 (309)
T ss_dssp ---------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH------HHSCC----------
T ss_pred c--cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhcCC----------
Confidence 1 12234899999999999999999999999999999999999999876542111100 00000
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCch
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVT 556 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 556 (573)
....+...++.+.++|.+||+.||++|||+.++++.|+.+.+....
T Consensus 257 ---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 257 ---RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred ---CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 1111223456799999999999999999999999999988775433
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=368.91 Aligned_cols=258 Identities=24% Similarity=0.392 Sum_probs=209.7
Q ss_pred cCCeeecccCceEEEEEEe--------CCCCEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceE
Q 008216 272 EGNRLLGDSKTGGTYSGIL--------PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY 341 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~--------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 341 (573)
...+.||+|+||.||+|.. .++..||||+++.. .....+.+.+|+.+++++ +||||+++++++.+.+..+
T Consensus 84 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ 163 (370)
T 2psq_A 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 163 (370)
T ss_dssp EEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCE
T ss_pred EeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEE
Confidence 4456789999999999985 23567999999765 334457799999999999 8999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC
Q 008216 342 IVYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409 (573)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~ 409 (573)
+||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~ 240 (370)
T 2psq_A 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENN 240 (370)
T ss_dssp EEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTC
T ss_pred EEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCCC
Confidence 99999999999999976432 124589999999999999999999999 999999999999999999
Q ss_pred CeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHh
Q 008216 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEW 488 (573)
Q Consensus 410 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 488 (573)
.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||+| |..||........ ...
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~---~~~ 317 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL---FKL 317 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHH
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH
Confidence 999999999986654333222233347889999999999999999999999999999999 9999987543221 111
Q ss_pred hhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 489 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
. .... ....+..++..+.++|.+||+.||++|||+.|+++.|+++..
T Consensus 318 ~----~~~~-------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 318 L----KEGH-------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp H----HTTC-------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H----hcCC-------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 0000 011122345679999999999999999999999999998753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=353.27 Aligned_cols=286 Identities=32% Similarity=0.503 Sum_probs=227.5
Q ss_pred CCcccCHHHHHHhhcCCCcC-----CeeecccCceEEEEEEeCCCCEEEEEEeccc----chhhHHHHHHHHHHHhhcCC
Q 008216 254 SWKVFTTEELRSITKNFSEG-----NRLLGDSKTGGTYSGILPDGSRVAVKRLKRS----SFQRKKEFYSEIGRFARLHH 324 (573)
Q Consensus 254 ~~~~~~~~el~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h 324 (573)
....|+.+++..++++|... .+.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678999999999998875 25679999999999997 7899999998653 22345779999999999999
Q ss_pred CcEeEEeeEEeeCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCee
Q 008216 325 PNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404 (573)
Q Consensus 325 ~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIl 404 (573)
|||+++++++.+.+..++||||+++++|.+++.... ....+++..+..++.|++.||+|||++ +++||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence 999999999999999999999999999999986422 235689999999999999999999999 9999999999999
Q ss_pred eCCCCCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchh
Q 008216 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS 484 (573)
Q Consensus 405 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~ 484 (573)
++.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|..||..........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence 99999999999999987654332222223348999999998864 57899999999999999999999998755432111
Q ss_pred hHHhhhhhhh-ccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 485 IFEWATPLVQ-SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 485 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
. ....... ...+.+.+++.+ .......++.+.+++.+||+.||++|||+.+|++.|+++..
T Consensus 245 ~--~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 245 D--IKEEIEDEEKTIEDYIDKKM-----NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp H--HHHHHHTTSCCHHHHSCSSC-----SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred H--HHHHhhhhhhhhhhhccccc-----cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1 1111111 111122222221 22345678889999999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=359.71 Aligned_cols=263 Identities=22% Similarity=0.318 Sum_probs=214.9
Q ss_pred cccCHHHHHHhhcCCC---------cCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCC
Q 008216 256 KVFTTEELRSITKNFS---------EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP 325 (573)
Q Consensus 256 ~~~~~~el~~~~~~~~---------~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 325 (573)
..++.++++.+++... ...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 4578888888876532 23457899999999999975 6999999999876666678899999999999999
Q ss_pred cEeEEeeEEeeCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee
Q 008216 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405 (573)
Q Consensus 326 nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll 405 (573)
||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999999863 3589999999999999999999999 99999999999999
Q ss_pred CCCCCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhh
Q 008216 406 DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI 485 (573)
Q Consensus 406 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~ 485 (573)
+.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~--- 249 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--- 249 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---
T ss_pred CCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---
Confidence 99999999999999876543222 1223499999999999999999999999999999999999999976543211
Q ss_pred HHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 486 FEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
.. .... ...+. .......++.+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~---~~~~------~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 250 MK---RLRD------SPPPK------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HH---HHHH------SSCCC------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HH---HHhc------CCCCC------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10 0000 00000 01122345679999999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=364.96 Aligned_cols=258 Identities=26% Similarity=0.401 Sum_probs=208.3
Q ss_pred cCCeeecccCceEEEEEEeC----CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 272 EGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
...+.||+|+||.||+|... .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 52 ~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 131 (325)
T 3kul_A 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEY 131 (325)
T ss_dssp EEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEEC
T ss_pred EEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeC
Confidence 33567899999999999974 3456999999865 344567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++++|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 132 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 132 MENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp CTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred CCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 999999999964 235699999999999999999999999 99999999999999999999999999998765432
Q ss_pred ccc-ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 427 MQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 427 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||............ ....
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~------~~~~-------- 271 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV------EEGY-------- 271 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH------HTTC--------
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH------HcCC--------
Confidence 211 1122236788999999998899999999999999999999 99999776543211110 0000
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCc
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPV 555 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 555 (573)
....+..+++.+.+++.+||+.||++|||+.+|++.|+.+...+.
T Consensus 272 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 272 ------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred ------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 111122355679999999999999999999999999999876543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=359.76 Aligned_cols=257 Identities=23% Similarity=0.374 Sum_probs=208.8
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
...+.||+|+||.||++... +++.||+|++........+.+.+|+.++++++||||+++++++.+++..++||||++++
T Consensus 13 ~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 92 (310)
T 3s95_A 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGG 92 (310)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCC
Confidence 34567899999999999964 58999999998776777788999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++... ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...........
T Consensus 93 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 93 TLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp BHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred cHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 999999752 35699999999999999999999999 999999999999999999999999999987654322111
Q ss_pred ------------eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccc
Q 008216 431 ------------TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY 498 (573)
Q Consensus 431 ------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 498 (573)
.....||+.|+|||++.+..++.++||||||+++|||++|..|+............. .
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~----------~ 236 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN----------V 236 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC----------H
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh----------h
Confidence 113349999999999999999999999999999999999999987644321110000 0
Q ss_pred ccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
....+.. .+..+++.+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 237 ~~~~~~~--------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 237 RGFLDRY--------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp HHHHHHT--------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcccccc--------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0000000 011233468999999999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=352.33 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=209.6
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
+..+.||+|+||.||+|...+++.||+|++.... ...+++.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (269)
T 4hcu_A 13 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 91 (269)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred eeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCc
Confidence 3345789999999999999889999999998653 334679999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++............
T Consensus 92 L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 92 LSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp HHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred HHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 9999964 234689999999999999999999999 9999999999999999999999999999876543322222
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
...+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||........ ... .... .
T Consensus 166 -~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~---~~~---~~~~------~-------- 224 (269)
T 4hcu_A 166 -GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VED---ISTG------F-------- 224 (269)
T ss_dssp -STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH---HHTT------C--------
T ss_pred -CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH---HHH---HhcC------c--------
Confidence 2237788999999998999999999999999999999 9999987553211 110 0000 0
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
....+...++.+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 225 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 1111222356799999999999999999999999999988654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=351.19 Aligned_cols=254 Identities=26% Similarity=0.433 Sum_probs=209.5
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
...+.||+|+||.||++...++..||||+++... ...+++.+|+.++.+++||||+++++++.+.+..++||||+++++
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (268)
T 3sxs_A 11 TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGC 89 (268)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred eeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCc
Confidence 4456789999999999999888899999997653 345678999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++... +..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...........
T Consensus 90 L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~- 162 (268)
T 3sxs_A 90 LLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS- 162 (268)
T ss_dssp HHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC-
T ss_pred HHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc-
Confidence 99999642 34589999999999999999999999 999999999999999999999999999987654432222
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
....+|+.|+|||.+.+..++.++||||||+++|+|+| |+.||........... .....
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~------~~~~~-------------- 222 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK------VSQGH-------------- 222 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH------HHTTC--------------
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH------HHcCC--------------
Confidence 22236788999999998889999999999999999999 9999976554311110 00000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
....+...++.+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 223 RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 0111122346799999999999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=363.41 Aligned_cols=271 Identities=21% Similarity=0.288 Sum_probs=205.7
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCc----eEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD----RYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----~~lv~e~~ 347 (573)
+..+.||+|+||.||+|+. .++.||||+++... .......+|+.++++++||||+++++++.+... .++||||+
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~ 104 (322)
T 3soc_A 27 QLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104 (322)
T ss_dssp EEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred hhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecC
Confidence 3456789999999999998 48999999997653 334556679999999999999999999987543 69999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------CCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-------KPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
++|+|.+++.. ..+++..+..++.|++.||+|||+.. .++|+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~ 179 (322)
T 3soc_A 105 EKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179 (322)
T ss_dssp TTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence 99999999975 34999999999999999999999752 3389999999999999999999999999998
Q ss_pred cCCccccccceeccCCcccccccccccC-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhc
Q 008216 421 FVPWEVMQERTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS 495 (573)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 495 (573)
...............||+.|+|||++.+ ..++.++||||||+++|||+||+.||.....................
T Consensus 180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (322)
T 3soc_A 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL 259 (322)
T ss_dssp EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence 7654433323333459999999999876 35567899999999999999999999875443211111100000000
Q ss_pred cc-----cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 496 HR-----YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 496 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
.. ......+.+ .........++.+.+||.+||+.||++|||+.||++.|+++.+
T Consensus 260 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 260 EDMQEVVVHKKKRPVL---RDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHHHHHTTSCCCCCC---CGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhhhhcccCCCCc---cccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00 000001100 0111223566789999999999999999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=372.98 Aligned_cols=255 Identities=26% Similarity=0.368 Sum_probs=207.6
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
...+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 117 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 196 (377)
T 3cbl_A 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 196 (377)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCC
Confidence 34567899999999999975 68999999997652 23345788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|.+++.. .+..+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++.........
T Consensus 197 g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 197 GDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp CBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 999999964 234589999999999999999999999 99999999999999999999999999998654332222
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
......+++.|+|||.+.+..++.++||||||+++|||+| |..||............ ....
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~-------~~~~----------- 332 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV-------EKGG----------- 332 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH-------HTTC-----------
T ss_pred cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcCC-----------
Confidence 1112225778999999998899999999999999999999 99999876542211111 1100
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
....+..+++.+.++|.+||+.||++|||+++|++.|+++..
T Consensus 333 --~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 333 --RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 011122345679999999999999999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=359.23 Aligned_cols=244 Identities=19% Similarity=0.278 Sum_probs=201.8
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 18 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 97 (328)
T 3fe3_A 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYAS 97 (328)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCC
Confidence 4456789999999999996 57999999999764 33445678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 169 (328)
T 3fe3_A 98 GGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK- 169 (328)
T ss_dssp TCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG-
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc-
Confidence 9999999864 24589999999999999999999999 999999999999999999999999999986543322
Q ss_pred cceeccCCcccccccccccCCCCC-cchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
.....||+.|+|||++.+..++ .++||||||+++|||++|+.||...+....... ... ..
T Consensus 170 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------i~~-~~---------- 230 (328)
T 3fe3_A 170 --LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER------VLR-GK---------- 230 (328)
T ss_dssp --GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHH-CC----------
T ss_pred --cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHH------HHh-CC----------
Confidence 2233499999999999887765 799999999999999999999987653221111 000 00
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
...+...++.+.+|+.+||+.||.+|||++|+++.
T Consensus 231 ----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 231 ----YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00112245678999999999999999999999863
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=351.69 Aligned_cols=274 Identities=20% Similarity=0.311 Sum_probs=211.0
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
++..+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 92 (294)
T 4eqm_A 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY 92 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeC
Confidence 44456789999999999995 46899999998543 233456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 93 IEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp CCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 999999999964 24689999999999999999999999 99999999999999999999999999998765432
Q ss_pred cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
... .....||+.|+|||.+.+..++.++||||||+++|||+||+.||........ ...... .......
T Consensus 166 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~-----~~~~~~~ 233 (294)
T 4eqm_A 166 LTQ-TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQ-----DSVPNVT 233 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHS-----SCCCCHH
T ss_pred ccc-cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhh-----ccCCCcc
Confidence 222 2223489999999999999999999999999999999999999987553211 000000 0000000
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhcccCCCchhhhhhhhhcccc
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-RMSHVVHQLQQLAQPPVTKLLFKGLDRLRH 568 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~~~~~~~~~~~~~~~ 568 (573)
... ....++.+.+++.+||+.||++|| +++++.+.|+.+..+.........+++++.
T Consensus 234 ~~~-----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~ 291 (294)
T 4eqm_A 234 TDV-----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVYELDKMKT 291 (294)
T ss_dssp HHS-----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCCCCC------
T ss_pred hhc-----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcchhhhhcchh
Confidence 000 122456799999999999999998 999999999999877666555555555544
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=359.36 Aligned_cols=275 Identities=21% Similarity=0.342 Sum_probs=206.5
Q ss_pred CCCcCCeeecccCceEEEEEEe-----CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--CceE
Q 008216 269 NFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRY 341 (573)
Q Consensus 269 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~ 341 (573)
+.++..+.||+|+||.||++++ .+++.||||+++.......+.+.+|+.++++++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 3344556789999999999984 35889999999887766778899999999999999999999998654 5689
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCcc
Q 008216 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 421 (573)
+||||+++++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 90 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 999999999999999752 24589999999999999999999999 999999999999999999999999999987
Q ss_pred CCccccc-cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccc
Q 008216 422 VPWEVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500 (573)
Q Consensus 422 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (573)
....... .......++..|+|||.+.+..++.++||||||+++|||+||..|+..................... ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 240 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV---FH 240 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH---HH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH---HH
Confidence 6543221 1122233778899999999999999999999999999999999998653221000000000000000 00
Q ss_pred ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
.... +........+..+++++.+++.+||+.||++|||+.|+++.|+++...
T Consensus 241 ~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 241 LIEL-LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHH-HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHH-HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 0000 000011112334567899999999999999999999999999987654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=366.66 Aligned_cols=258 Identities=24% Similarity=0.403 Sum_probs=198.5
Q ss_pred CcCCeeecccCceEEEEEEeC----CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
+...+.||+|+||.||+|+.. ++..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 126 (373)
T 2qol_A 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE 126 (373)
T ss_dssp CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEe
Confidence 344678899999999999864 5778999999765 33456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|+++++|.+++.. .+..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 127 ~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 127 YMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp CCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred CCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 9999999999974 235699999999999999999999999 9999999999999999999999999999876543
Q ss_pred cccc-ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccc
Q 008216 426 VMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503 (573)
Q Consensus 426 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (573)
.... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||........ .... ...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~---~~~i----~~~------- 266 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IKAV----DEG------- 266 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH---HHHH----HTT-------
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HcC-------
Confidence 2211 1111225778999999999999999999999999999998 9999976553211 1110 000
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
. ....+..++..+.+++.+||+.||++||++.+|++.|+++...+
T Consensus 267 --~----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 267 --Y----RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp --E----ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred --C----CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 0 00112234567999999999999999999999999999886543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=356.70 Aligned_cols=260 Identities=25% Similarity=0.390 Sum_probs=211.0
Q ss_pred CcCCeeecccCceEEEEEEe------CCCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 343 (573)
+...+.||+|+||.||+|.. .+++.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 104 (314)
T 2ivs_A 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI 104 (314)
T ss_dssp EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence 34456789999999999985 34588999999765 334457889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCe
Q 008216 344 YEFVVNGPLDRWLHHIPR--------------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NI 403 (573)
|||+++++|.+++..... ....+++..++.++.||+.||+|||++ +++||||||+||
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NI 181 (314)
T 2ivs_A 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNI 181 (314)
T ss_dssp EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheE
Confidence 999999999999976432 123489999999999999999999999 999999999999
Q ss_pred eeCCCCCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccc
Q 008216 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCW 482 (573)
Q Consensus 404 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~ 482 (573)
+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 261 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987654433322333347889999999998889999999999999999999 9999987654321
Q ss_pred hhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 483 QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
.... .... ....+...++.+.+++.+||+.||++|||+.++++.|+++...
T Consensus 262 ~~~~-------~~~~-------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 262 FNLL-------KTGH-------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHHH-------HTTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHh-------hcCC-------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 1111 0000 0111223456799999999999999999999999999987543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=376.13 Aligned_cols=255 Identities=25% Similarity=0.400 Sum_probs=209.4
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
...+.||+|+||.||+|.+.++..||||+++... ...+.+.+|+.+|++++||||+++++++. .+..++||||+++|+
T Consensus 191 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~ 268 (454)
T 1qcf_A 191 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGS 268 (454)
T ss_dssp EEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred EEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCc
Confidence 4456789999999999999889999999998654 35678999999999999999999999986 667899999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 269 L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~- 342 (454)
T 1qcf_A 269 LLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR- 342 (454)
T ss_dssp HHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT-
T ss_pred HHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc-
Confidence 99999742 123588899999999999999999999 999999999999999999999999999987654322221
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
....+|..|+|||++.+..++.++||||||+++|||+| |+.||...+....... .....
T Consensus 343 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~------i~~~~-------------- 402 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA------LERGY-------------- 402 (454)
T ss_dssp CSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH------HHHTC--------------
T ss_pred CCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH------HHcCC--------------
Confidence 22236789999999998899999999999999999999 9999987654221111 10100
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
....+..+++.+.++|.+||+.||++|||+++|++.|+++....
T Consensus 403 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 01112235678999999999999999999999999999987643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=369.99 Aligned_cols=261 Identities=27% Similarity=0.354 Sum_probs=208.9
Q ss_pred CcCCeeecccCceEEEEEEeC------CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 343 (573)
+...+.||+|+||.||+|.+. +++.||||+++.. .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 152 (367)
T 3l9p_A 73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 152 (367)
T ss_dssp EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEE
Confidence 344567899999999999943 4678999999754 344556789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC---CeeEeccc
Q 008216 344 YEFVVNGPLDRWLHHIP---RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGVG 417 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg 417 (573)
|||+++|+|.+++.... .....+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||
T Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG 229 (367)
T 3l9p_A 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 229 (367)
T ss_dssp EECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCc
Confidence 99999999999997533 1224589999999999999999999999 999999999999999554 49999999
Q ss_pred CCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcc
Q 008216 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSH 496 (573)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 496 (573)
+++...............+|+.|+|||++.+..++.++||||||+++|||+| |..||........... . ...
T Consensus 230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~---i----~~~ 302 (367)
T 3l9p_A 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF---V----TSG 302 (367)
T ss_dssp HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH---H----HTT
T ss_pred cccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---H----HcC
Confidence 9975433322222223347899999999999999999999999999999998 9999987554211111 0 000
Q ss_pred ccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
. ....+..++..+.+|+.+||+.||++|||+.+|++.|+.+.+.+
T Consensus 303 ~-------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 303 G-------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp C-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred C-------------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 0 11112234567999999999999999999999999998886543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=359.37 Aligned_cols=261 Identities=25% Similarity=0.383 Sum_probs=209.9
Q ss_pred CcCCeeecccCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 343 (573)
++..+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 128 (343)
T 1luf_A 49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 128 (343)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEE
Confidence 344567899999999999964 34889999998653 34457799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCe
Q 008216 344 YEFVVNGPLDRWLHHIPRG--------------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NI 403 (573)
|||+++++|.+++...... ...+++.+++.++.||+.||+|||++ +|+||||||+||
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NI 205 (343)
T 1luf_A 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 205 (343)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceE
Confidence 9999999999999763221 25689999999999999999999999 999999999999
Q ss_pred eeCCCCCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccc
Q 008216 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCW 482 (573)
Q Consensus 404 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~ 482 (573)
|++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |..||........
T Consensus 206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 285 (343)
T 1luf_A 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285 (343)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHH
Confidence 999999999999999986544332222333448899999999998899999999999999999999 9999987553211
Q ss_pred hhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 483 QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
. . . ...... ...+..++..+.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 286 ~---~---~-~~~~~~-------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 286 I---Y---Y-VRDGNI-------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp H---H---H-HHTTCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred H---H---H-HhCCCc-------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 1 1 0 011100 0111234567999999999999999999999999999987754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=363.35 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=210.7
Q ss_pred CcCCeeecccCceEEEEEEeC--------CCCEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCce
Q 008216 271 SEGNRLLGDSKTGGTYSGILP--------DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR 340 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 340 (573)
+...+.||+|+||.||+|... ++..||||+++.. .......+.+|+++++++ +||||+++++++.+.+..
T Consensus 71 y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 150 (382)
T 3tt0_A 71 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 150 (382)
T ss_dssp EEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred eEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCce
Confidence 344567899999999999852 2457999999765 334457789999999999 999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC
Q 008216 341 YIVYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~ 408 (573)
++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 227 (382)
T 3tt0_A 151 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED 227 (382)
T ss_dssp EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT
T ss_pred EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCC
Confidence 999999999999999976432 124599999999999999999999999 99999999999999999
Q ss_pred CCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHH
Q 008216 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFE 487 (573)
Q Consensus 409 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 487 (573)
+.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||...+.... ..
T Consensus 228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~---~~ 304 (382)
T 3tt0_A 228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL---FK 304 (382)
T ss_dssp CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HH
T ss_pred CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH
Confidence 9999999999987654433233333447889999999999999999999999999999999 9999976553211 11
Q ss_pred hhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 488 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
.. .... ....+..+++++.+++.+||+.||++|||+.||++.|+++..
T Consensus 305 ~~----~~~~-------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 305 LL----KEGH-------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp HH----HTTC-------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH----HcCC-------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 1100 001112345679999999999999999999999999998854
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=347.50 Aligned_cols=253 Identities=23% Similarity=0.376 Sum_probs=205.9
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
+..+.||+|+||.||++...++..||||+++... ...+++.+|+.++.+++||||+++++++.+.+..++||||+++++
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 105 (283)
T 3gen_A 27 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 105 (283)
T ss_dssp EEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCB
T ss_pred HhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCc
Confidence 3346789999999999999888899999998653 234678999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++............
T Consensus 106 L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (283)
T 3gen_A 106 LLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179 (283)
T ss_dssp HHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT
T ss_pred HHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccccc
Confidence 99999642 34599999999999999999999999 9999999999999999999999999999876543322222
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
...+|+.|+|||.+.+..++.++||||||+++|+|+| |+.||.......... ..... .
T Consensus 180 -~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~------~~~~~------~-------- 238 (283)
T 3gen_A 180 -GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE------HIAQG------L-------- 238 (283)
T ss_dssp -STTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH------HHHTT------C--------
T ss_pred -CCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH------HHhcc------c--------
Confidence 2237788999999998899999999999999999998 999998765421111 00000 0
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
....+...++.+.+++.+||+.||++|||+.++++.|+++..
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 011112234679999999999999999999999999988754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=357.93 Aligned_cols=248 Identities=20% Similarity=0.261 Sum_probs=202.0
Q ss_pred CcCCeeecccCceEEEEEEeC-CCCEEEEEEecccchh------hHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ------RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 343 (573)
++..+.||+|+||.||++... +|+.||||+++..... ..+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 93 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI 93 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence 344567899999999999964 5899999999765322 357899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC----CeeEecccCC
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVGLS 419 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfg~~ 419 (573)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus 94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 94 LELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999953 35699999999999999999999999 999999999999998776 7999999999
Q ss_pred ccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+.... .... . ....
T Consensus 167 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~---~~~i---~-~~~~- 235 (361)
T 2yab_A 167 HEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LANI---T-AVSY- 235 (361)
T ss_dssp EECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHH---H-TTCC-
T ss_pred eEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH---H-hcCC-
Confidence 87654322 1223499999999999988999999999999999999999999987553211 1100 0 0000
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
. +++. .....++.+.+||.+||..||++|||+.|+++
T Consensus 236 ~-~~~~--------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 D-FDEE--------FFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp C-CCHH--------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C-CCch--------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0000 01124567999999999999999999999985
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=364.79 Aligned_cols=260 Identities=27% Similarity=0.366 Sum_probs=207.0
Q ss_pred CcCCeeecccCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCc-eE
Q 008216 271 SEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGD-RY 341 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~-~~ 341 (573)
++..+.||+|+||.||+|.+ .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++.+.+. .+
T Consensus 24 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~ 103 (359)
T 3vhe_A 24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 103 (359)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred eeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceE
Confidence 34466789999999999973 346799999997653 34456799999999999 89999999999987654 89
Q ss_pred EEEEecCCCCHHHHhccCCCC-----------------------------------------------------------
Q 008216 342 IVYEFVVNGPLDRWLHHIPRG----------------------------------------------------------- 362 (573)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------------- 362 (573)
+||||+++|+|.+++......
T Consensus 104 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (359)
T 3vhe_A 104 VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE 183 (359)
T ss_dssp EEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------
T ss_pred EEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccccc
Confidence 999999999999999764321
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceeccCCccc
Q 008216 363 ---GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYG 439 (573)
Q Consensus 363 ---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 439 (573)
...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++................||+.
T Consensus 184 ~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~ 260 (359)
T 3vhe_A 184 DLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260 (359)
T ss_dssp CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred chhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence 12289999999999999999999999 999999999999999999999999999987654433223333348899
Q ss_pred ccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHH
Q 008216 440 YLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGV 518 (573)
Q Consensus 440 y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (573)
|+|||++.+..++.++||||||+++|||+| |..||....... .... ...... ....+...
T Consensus 261 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~~~~-------------~~~~~~~~ 321 (359)
T 3vhe_A 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLKEGT-------------RMRAPDYT 321 (359)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHH----HHHHTC-------------CCCCCTTC
T ss_pred eEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHH----HHHcCC-------------CCCCCCCC
Confidence 999999999999999999999999999998 999997754321 1100 000000 01111224
Q ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 519 VQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 519 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
++++.+++.+||+.||++|||+.||++.|+++.+
T Consensus 322 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 322 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 5679999999999999999999999999998754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=361.89 Aligned_cols=264 Identities=25% Similarity=0.341 Sum_probs=205.9
Q ss_pred CcCCeeecccCceEEEEEEe------CCCCEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEE
Q 008216 271 SEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI 342 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 342 (573)
+...+.||+|+||.||+|.. .++..||||+++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 47 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 126 (344)
T 1rjb_A 47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 126 (344)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEE
Confidence 34456789999999999995 24568999999754 233457899999999999 99999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCe
Q 008216 343 VYEFVVNGPLDRWLHHIPRG-------------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NI 403 (573)
||||+++|+|.+++...... ...+++..++.++.||+.||+|||++ +|+||||||+||
T Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NI 203 (344)
T 1rjb_A 127 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNV 203 (344)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGE
T ss_pred EEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhE
Confidence 99999999999999753221 13479999999999999999999999 999999999999
Q ss_pred eeCCCCCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccc
Q 008216 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCW 482 (573)
Q Consensus 404 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~ 482 (573)
|++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |..||.......
T Consensus 204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~- 282 (344)
T 1rjb_A 204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA- 282 (344)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH-
Confidence 999999999999999986654332222223337889999999998899999999999999999998 999997764321
Q ss_pred hhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCch
Q 008216 483 QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVT 556 (573)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 556 (573)
.... ..... . ....+...++.+.+++.+||+.||.+|||+.+|++.|+.+......
T Consensus 283 -~~~~----~~~~~-----~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 283 -NFYK----LIQNG-----F--------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp -HHHH----HHHTT-----C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred -HHHH----HHhcC-----C--------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 1110 00100 0 0011123456799999999999999999999999999988775443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=352.37 Aligned_cols=244 Identities=23% Similarity=0.259 Sum_probs=200.9
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
+..+.||+|+||.||+++.. +|+.||||++++.. ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~ 87 (337)
T 1o6l_A 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 33467899999999999964 68999999997642 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 88 ~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 88 NGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp TTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 99999999864 34689999999999999999999999 999999999999999999999999999986432221
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...+.... .... .. ..
T Consensus 161 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~i---~~-~~---------- 221 (337)
T 1o6l_A 161 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELI---LM-EE---------- 221 (337)
T ss_dssp --CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH---HH-CC----------
T ss_pred --cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH---HHHH---Hc-CC----------
Confidence 12233499999999999999999999999999999999999999986543211 1110 00 00
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 545 (573)
...+...++++.++|.+||+.||++|| +++||++
T Consensus 222 ----~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 222 ----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 001123456799999999999999999 8999976
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=357.83 Aligned_cols=257 Identities=22% Similarity=0.365 Sum_probs=201.2
Q ss_pred cCCeeecccCceEEEEEEeC-CCC----EEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
...+.||+|+||.||+|... +|+ +||+|.++.. .....+.+.+|+.++++++||||+++++++.+. ..++|+|
T Consensus 18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e 96 (327)
T 3poz_A 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQ 96 (327)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEE
T ss_pred ccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEE
Confidence 44567899999999999953 444 4688888654 234457899999999999999999999999875 4789999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|+.+|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 97 LMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp CCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred ecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 99999999999752 35699999999999999999999999 9999999999999999999999999999876544
Q ss_pred ccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
..........+|+.|+|||++.+..++.++||||||+++|||+| |+.||.............. ..
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-------~~------- 236 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------GE------- 236 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-------TC-------
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc-------CC-------
Confidence 33333333347889999999999999999999999999999999 9999987654322111110 00
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCc
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPV 555 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 555 (573)
....+...+..+.+++.+||+.||++|||+.++++.|+.+...+.
T Consensus 237 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 281 (327)
T 3poz_A 237 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp ------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHH
T ss_pred ------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhh
Confidence 011122345679999999999999999999999999998876543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=345.34 Aligned_cols=247 Identities=27% Similarity=0.477 Sum_probs=192.5
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccch----hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF----QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
...+.||+|+||.||+|.. .|+.||||+++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (271)
T 3dtc_A 10 TLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFA 88 (271)
T ss_dssp EEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECC
T ss_pred eeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcC
Confidence 3456789999999999998 589999999876432 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEEcCCCCCCeeeCC--------CCCeeEecc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH---VVHRDIRASNVLLDE--------EFGAHLMGV 416 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~---iiH~Dlkp~NIll~~--------~~~~kl~Df 416 (573)
++++|.+++.. ..+++..+..++.|++.||+|||++ + ++||||||+||+++. ++.+||+||
T Consensus 89 ~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 89 RGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp TTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred CCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999853 4689999999999999999999999 7 999999999999986 677999999
Q ss_pred cCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcc
Q 008216 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH 496 (573)
Q Consensus 417 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 496 (573)
|++......... ...||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+...... .... .
T Consensus 161 g~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~-~ 229 (271)
T 3dtc_A 161 GLAREWHRTTKM----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY------GVAM-N 229 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------HHHT-S
T ss_pred Cccccccccccc----CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------hhhc-C
Confidence 999865433221 2248999999999998899999999999999999999999998755321100 0000 0
Q ss_pred ccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
.. ....+...++.+.+++.+||+.||++|||+.|+++.|+++
T Consensus 230 ~~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 KL------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CC------------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00 1111223456799999999999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=373.87 Aligned_cols=257 Identities=28% Similarity=0.442 Sum_probs=212.0
Q ss_pred cCCeeecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
...+.||+|+||.||+|.+.. +..||||+++... ...+++.+|+.+|++++||||+++++++.+.+..++||||+++|
T Consensus 223 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g 301 (495)
T 1opk_A 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 301 (495)
T ss_dssp EEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred eeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCC
Confidence 335678999999999999754 8899999998653 34678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 302 ~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~- 375 (495)
T 1opk_A 302 NLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA- 375 (495)
T ss_dssp BHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC-
T ss_pred CHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceee-
Confidence 999999753 235689999999999999999999999 99999999999999999999999999998765432221
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
.....++..|+|||++.+..++.++||||||+++|||+| |..||...+....... . ... .
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~---~----~~~---------~--- 436 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---L----EKD---------Y--- 436 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---H----HTT---------C---
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH---H----HcC---------C---
Confidence 122236789999999998899999999999999999999 9999987654321111 1 000 0
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCc
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPV 555 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 555 (573)
....+..+++.+.+||.+||+.||++|||+.+|++.|+.+.+...
T Consensus 437 -~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~~ 481 (495)
T 1opk_A 437 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 481 (495)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSSC
T ss_pred -CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhccc
Confidence 011122355679999999999999999999999999999877643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=354.20 Aligned_cols=250 Identities=22% Similarity=0.317 Sum_probs=200.1
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
+..+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 10 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 89 (323)
T 3tki_A 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 89 (323)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCC
Confidence 33557899999999999965 789999999975432 2346688999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..........
T Consensus 90 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 90 GELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 999999853 35699999999999999999999999 99999999999999999999999999998664333322
Q ss_pred ceeccCCcccccccccccCCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........ ....+. ... .
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~----~~~---~-------- 226 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKK---T-------- 226 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHH----TTC---T--------
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHh----ccc---c--------
Confidence 2333459999999999987765 7799999999999999999999976543211 111100 000 0
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
...+....+..+.+|+.+||+.||++|||++|+++.
T Consensus 227 --~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 227 --YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 111123455678999999999999999999999863
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=353.59 Aligned_cols=261 Identities=23% Similarity=0.366 Sum_probs=195.9
Q ss_pred CcCCeeecccCceEEEEEEeCCC----CEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCce----
Q 008216 271 SEGNRLLGDSKTGGTYSGILPDG----SRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR---- 340 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~~g----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~---- 340 (573)
+...+.||+|+||.||+|..... ..||||+++.. .....+.+.+|+.++++++||||+++++++......
T Consensus 25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (323)
T 3qup_A 25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP 104 (323)
T ss_dssp CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence 34456789999999999996443 28999999765 334567899999999999999999999999877655
Q ss_pred --EEEEEecCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecc
Q 008216 341 --YIVYEFVVNGPLDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (573)
Q Consensus 341 --~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 416 (573)
++||||+++++|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeec
Confidence 99999999999999986432 2223589999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhc
Q 008216 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQS 495 (573)
Q Consensus 417 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 495 (573)
|+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||............ ...
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~------~~~ 255 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL------IGG 255 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH------HTT
T ss_pred cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH------hcC
Confidence 99987654433333333337889999999999999999999999999999999 99999876543211110 000
Q ss_pred cccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
. ....+...++.+.+++.+||+.||++|||+.++++.|+++...+
T Consensus 256 ~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 256 N--------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp C--------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred C--------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 0 01112234567999999999999999999999999999887644
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=351.69 Aligned_cols=247 Identities=17% Similarity=0.193 Sum_probs=201.4
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
...+.||+|+||.||++... +|+.||+|.++... .....+.+|+.+++.++||||+++++++.+.+..++||||++++
T Consensus 8 ~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~ 86 (321)
T 1tki_A 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred EeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCC
Confidence 33457899999999999964 58899999997653 44567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC--CCCeeEecccCCccCCccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE--EFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||++.........
T Consensus 87 ~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 87 DIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp BHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 99999963 234699999999999999999999999 9999999999999987 789999999999876543322
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
....||+.|+|||++.+..++.++||||||+++|+|++|..||........ ... ... ... . .+.
T Consensus 161 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~---i~~-~~~-~-~~~---- 224 (321)
T 1tki_A 161 ---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI---IEN---IMN-AEY-T-FDE---- 224 (321)
T ss_dssp ---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHH---HHH-TCC-C-CCH----
T ss_pred ---ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH---HHH---HHc-CCC-C-CCh----
Confidence 223389999999999988899999999999999999999999987553211 110 000 000 0 000
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
......+.++.+++.+||+.||++|||+.|+++
T Consensus 225 ----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 225 ----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001134567999999999999999999999997
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=349.20 Aligned_cols=265 Identities=20% Similarity=0.259 Sum_probs=197.7
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
+..+.||+|+||.||+|...+|+.||||+++.... .....+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 24 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~- 102 (311)
T 3niz_A 24 QKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME- 102 (311)
T ss_dssp EEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-
T ss_pred HhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-
Confidence 33457799999999999998899999999975432 234678899999999999999999999999999999999997
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.........
T Consensus 103 ~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~- 175 (311)
T 3niz_A 103 KDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS- 175 (311)
T ss_dssp EEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred CCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCccc-
Confidence 488888764 235599999999999999999999999 9999999999999999999999999999876433221
Q ss_pred ceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccc------
Q 008216 430 RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL------ 502 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 502 (573)
.....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.......................+....
T Consensus 176 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 176 -YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred -ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 122348999999999876 568999999999999999999999998765432211110000000000000000
Q ss_pred ccccccCCCCC---cchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 503 DPLISSLSSDI---PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 503 ~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
........... .....++++.+||.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000000 01123467899999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=349.30 Aligned_cols=259 Identities=20% Similarity=0.329 Sum_probs=197.4
Q ss_pred CcCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhh--cCCCcEeEEeeEEeeC----CceEEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR--LHHPNLVAVKGCCYDH----GDRYIVY 344 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~----~~~~lv~ 344 (573)
+...+.||+|+||.||+|.. +|+.||||++... ....+.+|.+++.. ++||||+++++++.+. +..++||
T Consensus 10 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp CEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 34456789999999999998 7999999999754 34455667666666 7999999999987653 4579999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEcCCCCCCeeeCCCCCeeEecc
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH--------DKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 416 (573)
||+++|+|.+++.. ..+++..++.++.|++.||+||| ++ +|+||||||+|||++.++.+||+||
T Consensus 86 e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 86 HYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp CCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCC
T ss_pred hhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeC
Confidence 99999999999953 46999999999999999999999 77 9999999999999999999999999
Q ss_pred cCCccCCcccccc--ceeccCCcccccccccccCC------CCCcchhhHHHHHHHHHHHcC----------CCCCCCCC
Q 008216 417 GLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRN------ELTTKSDVYSFGVLLLEIVSG----------RRPAQAVD 478 (573)
Q Consensus 417 g~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG----------~~Pf~~~~ 478 (573)
|+++......... ......||+.|+|||++.+. .++.++||||||+++|||+|| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9997654332211 11223499999999999876 456799999999999999999 78876543
Q ss_pred cccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 479 SVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 479 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
..... ........... ...............++.+.+++.+||+.||++|||+.+|++.|+++
T Consensus 238 ~~~~~--~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDPS--FEDMRKVVCVD-------QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSCC--HHHHHHHHTTS-------CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcc--hhhhhHHHhcc-------CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 22110 00000100000 00000011112345778899999999999999999999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=359.35 Aligned_cols=252 Identities=22% Similarity=0.291 Sum_probs=201.7
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccc-----hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 344 (573)
++..+.||+|+||.||++.. .+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 26 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 105 (351)
T 3c0i_A 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVF 105 (351)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 45566789999999999986 468999999986432 123577999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCC---eeEecccCCcc
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGVGLSKF 421 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~~~~ 421 (573)
||+++++|.+++......+..+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++..
T Consensus 106 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp ECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 99999999988865433445689999999999999999999999 9999999999999986654 99999999987
Q ss_pred CCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccc
Q 008216 422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL 501 (573)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (573)
....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ..... .. ....
T Consensus 183 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~i---~~-~~~~-- 250 (351)
T 3c0i_A 183 LGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----LFEGI---IK-GKYK-- 250 (351)
T ss_dssp CCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----HHHHH---HH-TCCC--
T ss_pred ecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----HHHHH---Hc-CCCC--
Confidence 6543221 12234999999999999989999999999999999999999999764321 11100 00 0000
Q ss_pred cccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
..+. .....++.+.+||.+||+.||++|||+.|+++
T Consensus 251 ~~~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 MNPR--------QWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCHH--------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCcc--------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 00123567999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=342.98 Aligned_cols=249 Identities=23% Similarity=0.376 Sum_probs=202.5
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--CceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~ 347 (573)
...+.||+|+||.||+|+. +|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+. +..++||||+
T Consensus 13 ~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 91 (271)
T 3kmu_A 13 NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM 91 (271)
T ss_dssp EEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECC
T ss_pred HHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeeccc
Confidence 3456789999999999998 5899999999765 234456799999999999999999999999887 7789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
++|+|.+++.. .....+++..+..++.|++.||+|||++ + ++||||||+||+++.++.++|.|||++......
T Consensus 92 ~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~ 166 (271)
T 3kmu_A 92 PYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP 166 (271)
T ss_dssp TTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCT
T ss_pred CCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeeccc
Confidence 99999999975 2234689999999999999999999998 8 999999999999999999999999887653221
Q ss_pred ccccceeccCCcccccccccccCCCCCc---chhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTT---KSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (573)
...||+.|+|||.+.+..++. ++||||||+++|||++|+.||......... ....... .
T Consensus 167 -------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~-----~ 228 (271)
T 3kmu_A 167 -------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG------MKVALEG-----L 228 (271)
T ss_dssp -------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH------HHHHHSC-----C
T ss_pred -------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH------HHHHhcC-----C
Confidence 123899999999998765544 899999999999999999999865532110 0110000 0
Q ss_pred ccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
....+...++.+.+++.+||+.||++|||++++++.|+++.+
T Consensus 229 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 229 --------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 011122345679999999999999999999999999998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=352.11 Aligned_cols=261 Identities=23% Similarity=0.369 Sum_probs=210.5
Q ss_pred CcCCeeecccCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEE
Q 008216 271 SEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI 342 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 342 (573)
+...+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 104 (313)
T 1t46_A 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 104 (313)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred hhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEE
Confidence 34456789999999999984 346799999997653 34457899999999999 99999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC
Q 008216 343 VYEFVVNGPLDRWLHHIPR--------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~ 408 (573)
||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+||+++.+
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG 181 (313)
T ss_dssp EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETT
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCC
Confidence 9999999999999976332 123589999999999999999999999 99999999999999999
Q ss_pred CCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHH
Q 008216 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFE 487 (573)
Q Consensus 409 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 487 (573)
+.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |..||....... ....
T Consensus 182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~ 259 (313)
T 1t46_A 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--KFYK 259 (313)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--HHHH
T ss_pred CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--HHHH
Confidence 9999999999987765433222223337889999999998999999999999999999999 999997654321 1111
Q ss_pred hhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 488 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
. .... . ....+...+..+.+++.+||+.||.+|||+.|+++.|+++..+
T Consensus 260 ~----~~~~-----~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 260 M----IKEG-----F--------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp H----HHHT-----C--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H----hccC-----C--------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 0 0000 0 0111123456799999999999999999999999999987653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=366.06 Aligned_cols=249 Identities=27% Similarity=0.389 Sum_probs=204.6
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC-ceEEEEEecCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG-DRYIVYEFVVNG 350 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lv~e~~~~g 350 (573)
...+.||+|+||.||+|.+ .|+.||||+++... ..+.+.+|+.+|++++||||+++++++.+.+ ..++||||+++|
T Consensus 196 ~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g 272 (450)
T 1k9a_A 196 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 272 (450)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTC
T ss_pred EEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCC
Confidence 3456789999999999998 58899999998653 4578999999999999999999999987765 789999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++... ....+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++......
T Consensus 273 ~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 343 (450)
T 1k9a_A 273 SLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 343 (450)
T ss_dssp BHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred cHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc----
Confidence 999999752 234479999999999999999999999 99999999999999999999999999998543221
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
....++..|+|||.+.+..++.++||||||+++|||+| |+.||............ ..+.
T Consensus 344 -~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-------~~~~------------ 403 (450)
T 1k9a_A 344 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKGY------------ 403 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH-------HTTC------------
T ss_pred -cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcCC------------
Confidence 11237889999999999999999999999999999999 99999876543211110 0000
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
....+..+++.+.++|.+||+.||++|||+.+|++.|+.+...
T Consensus 404 -~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 404 -KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 0111234567899999999999999999999999999987543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=371.41 Aligned_cols=255 Identities=26% Similarity=0.378 Sum_probs=203.9
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
...+.||+|+||.||+|.+.++..||||+++... ...+.+.+|+.+|++++||||+++++++.+ +..++||||+++|+
T Consensus 187 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gs 264 (452)
T 1fmk_A 187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 264 (452)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred eeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCC
Confidence 3456789999999999999888899999998654 345789999999999999999999999876 67899999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++... .+..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 265 L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~- 338 (452)
T 1fmk_A 265 LLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR- 338 (452)
T ss_dssp HHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred HHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc-
Confidence 99999641 234589999999999999999999999 999999999999999999999999999987653322211
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
....++..|+|||.+.+..++.++||||||+++|||+| |+.||......... .. .....
T Consensus 339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~~---i~~~~-------------- 398 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---DQ---VERGY-------------- 398 (452)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HH---HHTTC--------------
T ss_pred cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HH---HHcCC--------------
Confidence 12237789999999998999999999999999999999 99999876532111 10 00000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
....+..+++.+.++|.+||+.||++|||+++|++.|+.+....
T Consensus 399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 01112245667999999999999999999999999999987643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=345.23 Aligned_cols=278 Identities=16% Similarity=0.174 Sum_probs=210.1
Q ss_pred CCcCCeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC--ceEEEEE
Q 008216 270 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRYIVYE 345 (573)
Q Consensus 270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~e 345 (573)
.+...++||+|+||.||+|... +|+.||||+++... ....+.+.+|+.++++++||||+++++++...+ ..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 3455668899999999999975 48999999997643 234577889999999999999999999988765 6799999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee----CCCCCeeEecccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLSKF 421 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfg~~~~ 421 (573)
|+++++|.+++.... ....+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 90 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 90 FCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp CCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred CCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 999999999997532 223499999999999999999999999 99999999999999 7777899999999987
Q ss_pred CCccccccceeccCCccccccccccc--------CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCccc-chhhHHhhhhh
Q 008216 422 VPWEVMQERTVMAGGTYGYLAPEFVY--------RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC-WQSIFEWATPL 492 (573)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~~~~~ 492 (573)
........ ...||+.|+|||++. +..++.++||||||+++|||+||+.||....... ...........
T Consensus 166 ~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 166 LEDDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CCTTCCBC---CCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred cCCCCcee---ecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 65433221 234899999999886 5678999999999999999999999997544321 11111111110
Q ss_pred hhcccccc---cccccc----ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 493 VQSHRYLE---LLDPLI----SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 493 ~~~~~~~~---~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
........ ...... ............+..+.+++.+||+.||++|||++|+++...+.+..-
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~ 311 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRG 311 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC--
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcC
Confidence 00000000 000000 000112234577889999999999999999999999999988776543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=347.26 Aligned_cols=255 Identities=27% Similarity=0.362 Sum_probs=195.6
Q ss_pred CcCCeeecccCceEEEEEEeCC----CCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
++..+.||+|+||.||+|.... +..||+|+++.. .....+.+.+|+.++++++||||+++++++ .++..++|||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 95 (281)
T 1mp8_A 17 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIME 95 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred eEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEEe
Confidence 3445678999999999998643 457999998764 334457789999999999999999999997 4567899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|+++++|.+++... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++.....
T Consensus 96 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 96 LCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp CCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 99999999999742 34689999999999999999999999 9999999999999999999999999999876543
Q ss_pred ccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
..... ....+|+.|+|||.+.+..++.++||||||+++|||++ |..||........... . ....
T Consensus 170 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~---i----~~~~------- 234 (281)
T 1mp8_A 170 TYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---I----ENGE------- 234 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---H----HTTC-------
T ss_pred ccccc-ccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH---H----HcCC-------
Confidence 22211 22237789999999988899999999999999999997 9999987654321110 0 0000
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
....+...++.+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 235 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 235 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0011223456799999999999999999999999999987643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=347.09 Aligned_cols=264 Identities=23% Similarity=0.407 Sum_probs=197.1
Q ss_pred hhcCCCcCCeeecccCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEE
Q 008216 266 ITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 343 (573)
+.++-+...+.||+|+||.||+|+.. ..||||+++.. .....+.+.+|+.++++++||||++++++. ..+..++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 33444555678899999999999863 36999999754 334457799999999999999999999965 55678999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCC
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 423 (573)
|||+++++|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence 999999999999963 335699999999999999999999999 99999999999999999999999999998655
Q ss_pred ccccccceeccCCccccccccccc---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccc
Q 008216 424 WEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500 (573)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (573)
............||+.|+|||.+. +..++.++||||||+++|+|++|+.||....... .... .......
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~----~~~~~~~-- 243 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIE----MVGRGSL-- 243 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHH----HHHHTSC--
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHH----Hhccccc--
Confidence 332222223334899999999986 5678889999999999999999999998754321 1111 1111111
Q ss_pred ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
.+... .....+++.+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 244 --~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~e 289 (289)
T 3og7_A 244 --SPDLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289 (289)
T ss_dssp --CCCTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTCC
T ss_pred --Ccchh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhhC
Confidence 11110 11123456799999999999999999999999999988753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=342.77 Aligned_cols=254 Identities=24% Similarity=0.391 Sum_probs=208.7
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
...+.||+|+||.||++...+++.||+|+++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (267)
T 3t9t_A 11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89 (267)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCB
T ss_pred eeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCc
Confidence 33457899999999999988889999999986532 34679999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...........
T Consensus 90 L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~- 162 (267)
T 3t9t_A 90 LSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS- 162 (267)
T ss_dssp HHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST-
T ss_pred HHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccc-
Confidence 99999752 34689999999999999999999999 999999999999999999999999999987654322211
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
....++..|+|||.+.+..++.++||||||+++|+|++ |+.||........ .. ......
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~---~i~~~~-------------- 222 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VE---DISTGF-------------- 222 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HH---HHHTTC--------------
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH---HH---HHhcCC--------------
Confidence 12237789999999988899999999999999999999 8999976543211 11 000000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
....+...+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 223 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0011122356799999999999999999999999999988653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=351.73 Aligned_cols=248 Identities=19% Similarity=0.271 Sum_probs=201.5
Q ss_pred CcCCeeecccCceEEEEEEeC-CCCEEEEEEecccchh------hHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ------RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 343 (573)
+...+.||+|+||.||++... +|+.||||+++..... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 92 (326)
T 2y0a_A 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 92 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 344567899999999999964 5899999999764321 357899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC----CeeEecccCC
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVGLS 419 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfg~~ 419 (573)
|||+++++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus 93 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 93 LELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999953 35699999999999999999999999 999999999999998877 7999999999
Q ss_pred ccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||......... ... .. ...
T Consensus 166 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~~---~~-~~~- 234 (326)
T 2y0a_A 166 HKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANV---SA-VNY- 234 (326)
T ss_dssp EECCTTSCC---CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHH---HH-TCC-
T ss_pred eECCCCCcc---ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---HHH---Hh-cCC-
Confidence 876533221 2234999999999999889999999999999999999999999765432111 100 00 000
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
..... .....+..+.++|.+||+.||++|||+.|+++
T Consensus 235 ~~~~~---------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 EFEDE---------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCCHH---------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CcCcc---------ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000 01123467899999999999999999999987
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=355.15 Aligned_cols=256 Identities=20% Similarity=0.318 Sum_probs=202.8
Q ss_pred cCCeeecccCceEEEEEEeC-CCCE----EEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSR----VAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
+..+.||+|+||.||+|... +++. ||+|.+.... ......+.+|+.++++++||||+++++++. .+..++|||
T Consensus 16 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 94 (325)
T 3kex_A 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQ 94 (325)
T ss_dssp EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEE
T ss_pred eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEE
Confidence 44567899999999999954 4443 8888875442 233456778999999999999999999886 567899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|+++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 95 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 95 YLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp CCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred eCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 9999999999964 234688999999999999999999999 9999999999999999999999999999987654
Q ss_pred ccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
..........+|..|+|||++.+..++.++||||||+++|||+| |..||............. ...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~------- 234 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-------KGE------- 234 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-------TTC-------
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-------cCC-------
Confidence 43333334448889999999998999999999999999999999 999998765432211111 000
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
....+...+..+.+++.+||+.||++|||+.++++.|+++...+
T Consensus 235 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 235 ------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp ------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred ------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 00011113345889999999999999999999999999887654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=350.57 Aligned_cols=259 Identities=24% Similarity=0.391 Sum_probs=208.2
Q ss_pred CcCCeeecccCceEEEEEEe--------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCce
Q 008216 271 SEGNRLLGDSKTGGTYSGIL--------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR 340 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~--------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 340 (573)
+...+.||+|+||.||+|.. .++..||||+++... ....+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus 37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 116 (334)
T 2pvf_A 37 LTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 116 (334)
T ss_dssp EEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCC
T ss_pred eEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCce
Confidence 44456789999999999986 346789999997653 34457789999999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC
Q 008216 341 YIVYEFVVNGPLDRWLHHIPRG------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~ 408 (573)
++||||+++++|.+++...... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 117 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 193 (334)
T 2pvf_A 117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193 (334)
T ss_dssp EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcCC
Confidence 9999999999999999753321 23489999999999999999999999 99999999999999999
Q ss_pred CCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHH
Q 008216 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFE 487 (573)
Q Consensus 409 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 487 (573)
+.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |..||........ ..
T Consensus 194 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~ 270 (334)
T 2pvf_A 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL---FK 270 (334)
T ss_dssp CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HH
T ss_pred CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH---HH
Confidence 9999999999987654433222333347889999999988889999999999999999999 9999976543211 11
Q ss_pred hhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 488 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
.. .... ....+..++..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 271 ~~----~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 271 LL----KEGH-------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HH----HHTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH----hcCC-------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 10 0000 001112345679999999999999999999999999998854
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=356.30 Aligned_cols=250 Identities=19% Similarity=0.283 Sum_probs=204.4
Q ss_pred CcCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 271 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
++..+.||+|+||.||+|... +|+.||+|++..........+.+|+.+|++++||||+++++++.+.+..++||||+++
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g 132 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence 344567899999999999964 6899999999877666677899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC--CCCeeEecccCCccCCcccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE--EFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~~~~~~~~~~ 427 (573)
|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||++........
T Consensus 133 g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 133 GELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 999999863 234699999999999999999999999 9999999999999974 46799999999987654322
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
. ....||+.|+|||++.+..++.++||||||+++|||++|..||...+.... .. .... ... . .
T Consensus 207 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~---~i~~-~~~-~-~----- 269 (387)
T 1kob_A 207 V---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQ---NVKR-CDW-E-F----- 269 (387)
T ss_dssp E---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HH---HHHH-CCC-C-C-----
T ss_pred e---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH---HH---HHHh-CCC-C-C-----
Confidence 2 223499999999999999999999999999999999999999987553211 11 0000 000 0 0
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
........++++.++|.+||+.||++|||+.|+++.
T Consensus 270 ---~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 ---DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ---CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 001112345679999999999999999999999973
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=357.09 Aligned_cols=260 Identities=27% Similarity=0.381 Sum_probs=206.7
Q ss_pred CcCCeeecccCceEEEEEEeCC------CCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI 342 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 342 (573)
+...+.||+|+||.||+|.... +..||+|.++... ....+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 127 (333)
T 2i1m_A 48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV 127 (333)
T ss_dssp EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEE
Confidence 3445678999999999999632 3489999997653 34457789999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCee
Q 008216 343 VYEFVVNGPLDRWLHHIPR----------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH 412 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 412 (573)
||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|
T Consensus 128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~k 204 (333)
T 2i1m_A 128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAK 204 (333)
T ss_dssp EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEE
T ss_pred EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEE
Confidence 9999999999999864211 134589999999999999999999999 999999999999999999999
Q ss_pred EecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhh
Q 008216 413 LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATP 491 (573)
Q Consensus 413 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 491 (573)
|+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |..||........ ...
T Consensus 205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~~---- 278 (333)
T 2i1m_A 205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--FYK---- 278 (333)
T ss_dssp BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--HHH----
T ss_pred ECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--HHH----
Confidence 999999986543322222222337889999999998899999999999999999999 9999976543211 100
Q ss_pred hhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 492 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
..... . ....+...++.+.+++.+||+.||.+|||+.+|++.|+++..
T Consensus 279 ~~~~~-----~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 279 LVKDG-----Y--------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHT-----C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcC-----C--------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 00000 0 001112234679999999999999999999999999988764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=353.19 Aligned_cols=248 Identities=20% Similarity=0.274 Sum_probs=201.1
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
+..+.||+|+||.||++... +|+.||+|+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 32 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 111 (362)
T 2bdw_A 32 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 111 (362)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 34557899999999999964 5899999999764 23445678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC---CeeEecccCCccCCcc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGVGLSKFVPWE 425 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg~~~~~~~~ 425 (573)
+|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++......
T Consensus 112 gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 112 GGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp SCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999998853 35689999999999999999999999 999999999999998654 5999999999876533
Q ss_pred ccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+.... .... ..... ..
T Consensus 185 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---~~~i----~~~~~-~~---- 249 (362)
T 2bdw_A 185 EA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---YAQI----KAGAY-DY---- 249 (362)
T ss_dssp CS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHTCC-CC----
T ss_pred cc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHH----HhCCC-CC----
Confidence 22 1223499999999999988999999999999999999999999987553211 1110 00000 00
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
........++++.+||.+||+.||++|||+.++++.
T Consensus 250 -----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 -----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011112345679999999999999999999999863
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=356.91 Aligned_cols=246 Identities=21% Similarity=0.290 Sum_probs=197.9
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
.++||+|+||.||+|.. .+|+.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 34689999999999986 46899999999887666778899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee--CCCCCeeEecccCCccCCccccccc
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL--DEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++........
T Consensus 174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~-- 245 (373)
T 2x4f_A 174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL-- 245 (373)
T ss_dssp HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC--
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc--
Confidence 998864 234689999999999999999999999 99999999999999 56778999999999876543222
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...+..... ...... .. ...
T Consensus 246 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------~~i~~~-~~-~~~-------- 308 (373)
T 2x4f_A 246 -KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL------NNILAC-RW-DLE-------- 308 (373)
T ss_dssp -CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHT-CC-CSC--------
T ss_pred -ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhc-cC-CCC--------
Confidence 2234999999999999889999999999999999999999999876542111 011000 00 000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.......++++.+||.+||+.||++|||+.|+++
T Consensus 309 -~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 309 -DEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0011234567999999999999999999999997
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=342.29 Aligned_cols=263 Identities=21% Similarity=0.291 Sum_probs=196.9
Q ss_pred CCeeecccCceEEEEEEeCCCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
..+.||+|+||.||+|...+|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 84 (288)
T 1ob3_A 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-
T ss_pred hhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-
Confidence 3457899999999999998899999999975532 2246788999999999999999999999999999999999965
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.........
T Consensus 85 ~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 156 (288)
T 1ob3_A 85 DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-- 156 (288)
T ss_dssp EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccccc--
Confidence 89998864 235689999999999999999999999 9999999999999999999999999999765422111
Q ss_pred eeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchh-hHHhhhhhhhccccc-----cccc
Q 008216 431 TVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPLVQSHRYL-----ELLD 503 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~-----~~~~ 503 (573)
.....||+.|+|||++.+. .++.++||||||+++|||++|+.||...+...... ....... .....+. ...+
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT-PNSKNWPNVTELPKYD 235 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTTTSTTGGGSTTCC
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCC-CChhhchhhhcccccc
Confidence 1222389999999998764 58999999999999999999999998765432111 1000000 0000000 0001
Q ss_pred cccccCCC---CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 504 PLISSLSS---DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 504 ~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+....... .......++.+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 10000000 0001234567899999999999999999999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=351.12 Aligned_cols=243 Identities=19% Similarity=0.268 Sum_probs=198.9
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
+...+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 90 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY 90 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence 34456789999999999996 5789999999975421 2245789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+ +|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 91 ~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 91 A-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp C-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred C-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 9 7899888864 24699999999999999999999999 99999999999999999999999999998765432
Q ss_pred cccceeccCCcccccccccccCCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.. ....||+.|+|||++.+..+ ++++||||||+++|+|++|+.||........ ....
T Consensus 163 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------------------~~~i 220 (336)
T 3h4j_B 163 FL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------------------FKKV 220 (336)
T ss_dssp TT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------------------BCCC
T ss_pred cc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------------------HHHH
Confidence 22 22349999999999988776 6899999999999999999999976443211 0000
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
... ....+...++.+.+||.+||+.||.+|||++|+++
T Consensus 221 ~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 221 NSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 000 01112234567999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=347.34 Aligned_cols=252 Identities=26% Similarity=0.424 Sum_probs=200.5
Q ss_pred CcCCeeecccCceEEEEEEeCC-C-------CEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILPD-G-------SRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 342 (573)
+...+.||+|+||.||+|.... + ..||+|++........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (289)
T 4fvq_A 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENIL 89 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEE
T ss_pred eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEE
Confidence 3445678999999999998543 3 5799999987766677889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCC--------eeEe
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG--------AHLM 414 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~--------~kl~ 414 (573)
||||+++++|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+
T Consensus 90 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 90 VQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp EEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred EEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999752 24489999999999999999999999 9999999999999998877 9999
Q ss_pred cccCCccCCccccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCC-CCCCCCcccchhhHHhhhhh
Q 008216 415 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRR-PAQAVDSVCWQSIFEWATPL 492 (573)
Q Consensus 415 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~-Pf~~~~~~~~~~~~~~~~~~ 492 (573)
|||++........ ..+|+.|+|||++.+ ..++.++||||||+++|||++|.. |+...+........
T Consensus 164 Dfg~~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~------ 231 (289)
T 4fvq_A 164 DPGISITVLPKDI------LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY------ 231 (289)
T ss_dssp CCCSCTTTSCHHH------HHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH------
T ss_pred cCcccccccCccc------cCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh------
Confidence 9999976543221 227889999999987 678999999999999999999554 44443321110000
Q ss_pred hhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCch
Q 008216 493 VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVT 556 (573)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 556 (573)
..... . +...++++.+++.+||+.||++|||+.++++.|+++..+..+
T Consensus 232 ~~~~~--------~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 232 EDRHQ--------L--------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp HTTCC--------C--------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred hccCC--------C--------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 00000 0 011134588999999999999999999999999999876544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=360.73 Aligned_cols=248 Identities=20% Similarity=0.261 Sum_probs=199.8
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
+..+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 14 ~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 93 (444)
T 3soa_A 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVT 93 (444)
T ss_dssp EEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCB
T ss_pred EEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCC
Confidence 3355789999999999985 468999999997653 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC---CCCCeeEecccCCccCCcc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~ 425 (573)
+|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++......
T Consensus 94 gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 94 GGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999999865 34699999999999999999999999 999999999999998 4578999999999876543
Q ss_pred ccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
... .....||+.|+|||++.+..++.++||||||+++|+|++|.+||...+...... .. ..... ..
T Consensus 167 ~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~---~i----~~~~~-~~---- 232 (444)
T 3soa_A 167 QQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQ---QI----KAGAY-DF---- 232 (444)
T ss_dssp CCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HH----HHTCC-CC----
T ss_pred Cce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHH---HH----HhCCC-CC----
Confidence 221 122349999999999999899999999999999999999999997755321111 10 00000 00
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
........++++.+||.+||+.||++|||+.|+++
T Consensus 233 -----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 233 -----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 01111234567999999999999999999999987
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=350.99 Aligned_cols=261 Identities=22% Similarity=0.360 Sum_probs=202.1
Q ss_pred CcCCeeecccCceEEEEEEeC-CCC----EEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 344 (573)
++..+.||+|+||.||+|... +++ +||+|.+... .....+.+.+|+.++++++||||+++++++.+.. .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence 344567899999999999953 454 4577777543 3345678999999999999999999999988754 78999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCc
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 424 (573)
|++.+|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 96 QLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp CCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999752 34689999999999999999999999 999999999999999999999999999987654
Q ss_pred cccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccc
Q 008216 425 EVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503 (573)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (573)
...........+|+.|+|||.+.+..++.++||||||+++|||++ |..||............. ...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-------~~~------ 236 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE------ 236 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTC------
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCC------
Confidence 433333333347889999999999999999999999999999999 999998765432211111 000
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCchhh
Q 008216 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKL 558 (573)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 558 (573)
....+...+..+.+++.+||+.||.+|||+.|+++.|+++...+....
T Consensus 237 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 284 (327)
T 3lzb_A 237 -------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYL 284 (327)
T ss_dssp -------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHHHB
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCceE
Confidence 111122345679999999999999999999999999999987764433
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=343.50 Aligned_cols=261 Identities=22% Similarity=0.318 Sum_probs=209.7
Q ss_pred CCCcCCeeecccCceEEEEEEeC---CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEE
Q 008216 269 NFSEGNRLLGDSKTGGTYSGILP---DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (573)
Q Consensus 269 ~~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 344 (573)
++....+.||+|+||.||+|... ++..||||+++.. .....+.+.+|+.++++++||||+++++++ ..+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 33344457899999999999853 5788999999875 334567899999999999999999999998 556789999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCc
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 424 (573)
||+++++|.+++.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 89 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 89 EMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp ECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 99999999999963 235699999999999999999999999 999999999999999999999999999987653
Q ss_pred cccc-cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccc
Q 008216 425 EVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502 (573)
Q Consensus 425 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (573)
.... .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||............ ....
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i-------~~~~----- 230 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-------EQGK----- 230 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH-------HTTC-----
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-------hcCC-----
Confidence 3221 11222336889999999988889999999999999999999 99999876543211110 0000
Q ss_pred ccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCch
Q 008216 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVT 556 (573)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 556 (573)
....+...++.+.++|.+||+.||++||++.++++.|+.+..+...
T Consensus 231 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 231 --------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp --------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred --------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 0111223456899999999999999999999999999988654433
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=345.42 Aligned_cols=246 Identities=23% Similarity=0.306 Sum_probs=191.7
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchh--------------------------hHHHHHHHHHHHhhcC
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ--------------------------RKKEFYSEIGRFARLH 323 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~ 323 (573)
+...+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|+.++++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 94 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD 94 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence 34456789999999999986 46889999999754211 1356889999999999
Q ss_pred CCcEeEEeeEEee--CCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 008216 324 HPNLVAVKGCCYD--HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401 (573)
Q Consensus 324 h~nIv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~ 401 (573)
||||+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.||+.||+|||++ +|+||||||+
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 166 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPS 166 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence 9999999999987 567899999999999987653 24699999999999999999999999 9999999999
Q ss_pred CeeeCCCCCeeEecccCCccCCccccccceeccCCcccccccccccCCC---CCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 008216 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE---LTTKSDVYSFGVLLLEIVSGRRPAQAVD 478 (573)
Q Consensus 402 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltG~~Pf~~~~ 478 (573)
|||++.++.+||+|||++......... .....||+.|+|||.+.+.. ++.++||||||+++|||++|+.||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999999876533221 12234999999999997655 3788999999999999999999997654
Q ss_pred cccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 479 SVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 479 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.... .. ... .... ........++.+.++|.+||+.||++|||+.|+++
T Consensus 245 ~~~~---~~---~~~-~~~~------------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 IMCL---HS---KIK-SQAL------------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHH---HH---HHH-HCCC------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHH---HH---HHh-cccC------------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 3211 10 000 0000 00011234567999999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=341.75 Aligned_cols=260 Identities=18% Similarity=0.227 Sum_probs=207.6
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
++..+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+.+++++ +|+|++++++++.+....++||||+
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 88 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 88 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence 44456789999999999995 578999999987543 334678899999999 8999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCC-----eeEecccCCccCC
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-----AHLMGVGLSKFVP 423 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~Dfg~~~~~~ 423 (573)
+++|.+++... +..+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +||+|||++....
T Consensus 89 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 89 GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999999752 34599999999999999999999999 9999999999999987765 9999999998765
Q ss_pred ccccc-----cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccc
Q 008216 424 WEVMQ-----ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY 498 (573)
Q Consensus 424 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 498 (573)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........................
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 43221 1122334999999999999999999999999999999999999999876543222222111111000000
Q ss_pred ccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
.+ . ....++.+.+++.+||+.||++|||+++|++.|+++.+
T Consensus 243 ~~-----~--------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 243 RE-----L--------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HH-----H--------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HH-----H--------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 00 0 01234679999999999999999999999999998764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=344.15 Aligned_cols=256 Identities=29% Similarity=0.457 Sum_probs=211.0
Q ss_pred cCCeeecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
...+.||+|+||.||+|.... +..||||+++... ...+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 16 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 94 (288)
T 3kfa_A 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 94 (288)
T ss_dssp EEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTE
T ss_pred eEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCC
Confidence 345578999999999999754 8899999997653 45678899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...........
T Consensus 95 ~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 169 (288)
T 3kfa_A 95 NLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169 (288)
T ss_dssp EHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEE
T ss_pred cHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccccc
Confidence 999999752 345699999999999999999999999 999999999999999999999999999987654432221
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+......... .. .
T Consensus 170 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-------~~-----~------- 229 (288)
T 3kfa_A 170 -AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KD-----Y------- 229 (288)
T ss_dssp -TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-------TT-----C-------
T ss_pred -cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-------cc-----C-------
Confidence 12227888999999998999999999999999999999 999998765432111110 00 0
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
....+...++.+.+++.+||+.||++|||+.++++.|+.+.+..
T Consensus 230 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 230 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11112234567999999999999999999999999999887653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=353.98 Aligned_cols=245 Identities=26% Similarity=0.317 Sum_probs=197.7
Q ss_pred CcCCeeecccCceEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
++..+.||+|+||.||+++.. +|+.||||++++. .....+.+.+|..++..+ +||||+++++++.+.+..++|||
T Consensus 25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E 104 (353)
T 3txo_A 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME 104 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEe
Confidence 344567899999999999964 5899999999764 223456688999999988 79999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 105 FVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 9999999999964 24699999999999999999999999 9999999999999999999999999999864332
Q ss_pred ccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .... .. .
T Consensus 178 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~~i---~~-~--------- 239 (353)
T 3txo_A 178 GV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL---FEAI---LN-D--------- 239 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH---HH-C---------
T ss_pred Cc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH---HHHH---Hc-C---------
Confidence 21 22234599999999999988899999999999999999999999987654211 1111 00 0
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCH------HHHHH
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM------SHVVH 545 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 545 (573)
....+...++.+.++|.+||+.||++||++ +|+++
T Consensus 240 -----~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 240 -----EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 001112245679999999999999999998 67764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=348.13 Aligned_cols=264 Identities=22% Similarity=0.352 Sum_probs=211.6
Q ss_pred cCCeeecccCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 344 (573)
...+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 107 (322)
T 1p4o_A 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 107 (322)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEE
Confidence 44567899999999999853 37889999997653 344567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccC
Q 008216 345 EFVVNGPLDRWLHHIP------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 418 (573)
||+++++|.+++.... .....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 108 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg~ 184 (322)
T 1p4o_A 108 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 184 (322)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCcc
Confidence 9999999999986421 1124578999999999999999999999 999999999999999999999999999
Q ss_pred CccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccc
Q 008216 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497 (573)
Q Consensus 419 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 497 (573)
+................+|+.|+|||.+.+..++.++||||||+++|||++ |..||.......... .. ....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~------~~-~~~~ 257 (322)
T 1p4o_A 185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR------FV-MEGG 257 (322)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH------HH-HTTC
T ss_pred ccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH------HH-HcCC
Confidence 986644332222222336889999999998899999999999999999999 899997754321111 00 0000
Q ss_pred cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCchhh
Q 008216 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKL 558 (573)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 558 (573)
. ...+...+..+.+++.+||+.||++|||+.|+++.|+++..+...+.
T Consensus 258 ~-------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~ 305 (322)
T 1p4o_A 258 L-------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305 (322)
T ss_dssp C-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred c-------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccc
Confidence 0 01112345679999999999999999999999999999887655543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=339.26 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=198.9
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhh-------HHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEE
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQR-------KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 342 (573)
++..+.||+|+||.||+|.. .+++.||||++....... .+.+.+|+.++++++||||+++++++.+.. ++
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~l 98 (287)
T 4f0f_A 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RM 98 (287)
T ss_dssp EEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EE
T ss_pred ceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eE
Confidence 44456789999999999996 478999999996543221 167899999999999999999999986554 79
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCeeeCCCCC-----eeEec
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLDEEFG-----AHLMG 415 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--iiH~Dlkp~NIll~~~~~-----~kl~D 415 (573)
||||+++++|.+++.. ....+++..++.++.|++.||+|||++ + ++||||||+||+++.++. +||+|
T Consensus 99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred EEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 9999999999988864 335699999999999999999999999 8 999999999999988776 99999
Q ss_pred ccCCccCCccccccceeccCCccccccccccc--CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhh
Q 008216 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY--RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV 493 (573)
Q Consensus 416 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 493 (573)
||+++..... .....||+.|+|||++. ...++.++||||||+++|||++|+.||............ ...
T Consensus 173 fg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~ 243 (287)
T 4f0f_A 173 FGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN----MIR 243 (287)
T ss_dssp CTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH----HHH
T ss_pred CCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH----HHh
Confidence 9999854332 22234899999999984 456789999999999999999999999765543211110 000
Q ss_pred hccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 494 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
. .. . ....+...++.+.+++.+||+.||++|||++++++.|+++
T Consensus 244 ~-~~----~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 E-EG----L--------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp H-SC----C--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred c-cC----C--------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0 00 0 1111223456799999999999999999999999999874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=353.30 Aligned_cols=246 Identities=22% Similarity=0.321 Sum_probs=200.0
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
+..+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+.+|++++||||+++++++.+.+..++||||+
T Consensus 18 ~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 97 (384)
T 4fr4_A 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLL 97 (384)
T ss_dssp EEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecC
Confidence 44567899999999999964 58899999997542 233567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
.+|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 98 ~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 170 (384)
T 4fr4_A 98 LGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170 (384)
T ss_dssp TTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence 99999999964 35699999999999999999999999 999999999999999999999999999987653322
Q ss_pred ccceeccCCcccccccccccC---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||................. .
T Consensus 171 ---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----~-------- 235 (384)
T 4fr4_A 171 ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----T-------- 235 (384)
T ss_dssp ---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----C--------
T ss_pred ---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----c--------
Confidence 223449999999999864 4589999999999999999999999976544322222111110 0
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-MSHVVH 545 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 545 (573)
....+...+..+.+||.+||+.||.+||+ +++|++
T Consensus 236 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 ------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 01112234567999999999999999998 666654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=348.59 Aligned_cols=257 Identities=14% Similarity=0.165 Sum_probs=205.0
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
...+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+.+++++ +||||+++++++.+.+..++||||+ +
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (330)
T 2izr_A 12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-G 88 (330)
T ss_dssp EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-C
Confidence 3456789999999999995 578999999997553 234688999999999 9999999999999999999999999 9
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCC-----eeEecccCCccCCc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-----AHLMGVGLSKFVPW 424 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~Dfg~~~~~~~ 424 (573)
++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++....
T Consensus 89 ~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 89 PSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 9999999753 35699999999999999999999999 9999999999999998877 99999999987543
Q ss_pred ccccc-----ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 425 EVMQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 425 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......................
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-- 240 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP-- 240 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC--
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC--
Confidence 32211 11234499999999999999999999999999999999999999987654332222221111000000
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
. ... ....+ ++.+++..||+.||.+||++++|++.|+++.
T Consensus 241 --~-~~~--------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 241 --I-EVL--------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp --H-HHH--------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred --H-HHH--------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 0 000 01123 7999999999999999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=341.66 Aligned_cols=253 Identities=27% Similarity=0.432 Sum_probs=205.3
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
...+.||+|+||.||+|...+++.||||+++... ...+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 93 (279)
T 1qpc_A 16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGS 93 (279)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCB
T ss_pred hheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCC
Confidence 3456789999999999998888899999997653 34578999999999999999999999876 456899999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++... .+..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...........
T Consensus 94 L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~- 167 (279)
T 1qpc_A 94 LVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR- 167 (279)
T ss_dssp HHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC-
T ss_pred HHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc-
Confidence 99998641 123589999999999999999999999 999999999999999999999999999987654322211
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||........ ... .... .
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~---~~~~------~-------- 227 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQN---LERG------Y-------- 227 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHH---HHTT------C--------
T ss_pred cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---HHH---Hhcc------c--------
Confidence 12236788999999988889999999999999999999 9999976543211 110 0000 0
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
....+...++.+.+++.+||+.||++|||++++++.|+++..
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 001112345679999999999999999999999999998754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=347.95 Aligned_cols=272 Identities=24% Similarity=0.346 Sum_probs=205.4
Q ss_pred CCCcCCeeecccCceEEEEEEe-----CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--Cce
Q 008216 269 NFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GDR 340 (573)
Q Consensus 269 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 340 (573)
++++..+.||+|+||.||++.+ .+++.||||+++... ....+.+.+|+.++++++||||+++++++.+. +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4455567889999999999983 468899999997543 33457789999999999999999999999876 668
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
++||||+++++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 9999999999999999542 24589999999999999999999999 99999999999999999999999999998
Q ss_pred cCCccccc-cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 421 FVPWEVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 421 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
........ .......+|..|+|||.+.+..++.++||||||+++|+|+||..|+...... ......+........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLKMIGPTHGQMTVT 250 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCGGGHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH----HhhccCCcccccCHH
Confidence 76544321 1222334888899999999889999999999999999999999986432110 000000000000000
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
...... ........+...++.+.+++.+||+.||++|||+.++++.|+++.
T Consensus 251 ~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 251 RLVNTL-KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHH-HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHH-hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 000000 000011122345678999999999999999999999999998764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=348.81 Aligned_cols=266 Identities=22% Similarity=0.262 Sum_probs=207.9
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEee----CCceEEEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYIVYE 345 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~e 345 (573)
++..+.||+|+||.||++.. .+|+.||||++........+.+.+|+.++++++||||+++++++.. ....++|||
T Consensus 31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 110 (317)
T 2buj_A 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110 (317)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEE
T ss_pred EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEE
Confidence 44456789999999999996 5799999999987766677889999999999999999999999873 346799999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|+++++|.+++......+..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp CCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred eCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence 9999999999976444556799999999999999999999999 9999999999999999999999999998765432
Q ss_pred cccc-------ceeccCCcccccccccccCCC---CCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhc
Q 008216 426 VMQE-------RTVMAGGTYGYLAPEFVYRNE---LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS 495 (573)
Q Consensus 426 ~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 495 (573)
.... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||........ .... ....
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~----~~~~ 262 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL----AVQN 262 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH----HHHC
T ss_pred cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH----Hhhc
Confidence 1110 011123799999999987554 68899999999999999999999864211100 0000 0000
Q ss_pred cccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCchh
Q 008216 496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTK 557 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 557 (573)
.. ........+..+.+++.+||+.||.+|||+.++++.|+.+..+...+
T Consensus 263 ---------~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 263 ---------QL----SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp ---------C------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred ---------cC----CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 00 00111234567999999999999999999999999999988765443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=348.12 Aligned_cols=272 Identities=28% Similarity=0.379 Sum_probs=208.8
Q ss_pred cCCCcCCeeecccCceEEEEEEeC-----CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--Cc
Q 008216 268 KNFSEGNRLLGDSKTGGTYSGILP-----DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--GD 339 (573)
Q Consensus 268 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~ 339 (573)
+.+....+.||+|+||.||++.+. +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 344455678899999999998742 58899999998653 34467799999999999999999999999874 56
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCC
Q 008216 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (573)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 419 (573)
.++||||+++++|.+++.. ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred EEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccc
Confidence 7999999999999999965 3489999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCccccc-cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccc
Q 008216 420 KFVPWEVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY 498 (573)
Q Consensus 420 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 498 (573)
......... .......+|..|+|||.+.+..++.++||||||+++|+|+||..||....... ................
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 260 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRL 260 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHH
Confidence 876543221 11223347888999999998889999999999999999999999986532210 0000000000000000
Q ss_pred ccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
.+.+... .....+..++..+.++|.+||+.||++|||+.|+++.|+.+.+
T Consensus 261 ~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 261 TELLERG----ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHHHHTT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcc----cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111110 1111223456789999999999999999999999999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=344.28 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=195.8
Q ss_pred cCCeeecccCceEEEEEEeC----CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCc-----e
Q 008216 272 EGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-----R 340 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-----~ 340 (573)
...+.||+|+||.||+|... ++..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+. .
T Consensus 37 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 116 (313)
T 3brb_A 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKP 116 (313)
T ss_dssp EEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CE
T ss_pred eeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCccc
Confidence 34567899999999999853 3458999999754 33445778999999999999999999999987653 4
Q ss_pred EEEEEecCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccC
Q 008216 341 YIVYEFVVNGPLDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 418 (573)
++||||+++++|.+++.... .....+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 117 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~ 193 (313)
T 3brb_A 117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGL 193 (313)
T ss_dssp EEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred EEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecCc
Confidence 99999999999999985422 2345699999999999999999999999 999999999999999999999999999
Q ss_pred CccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccc
Q 008216 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHR 497 (573)
Q Consensus 419 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 497 (573)
+................+++.|+|||.+.+..++.++||||||+++|+|++ |..||........... .....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~------~~~~~- 266 (313)
T 3brb_A 194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY------LLHGH- 266 (313)
T ss_dssp C----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH------HHTTC-
T ss_pred ceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH------HHcCC-
Confidence 987654433222333347889999999999999999999999999999999 8999976554321110 00000
Q ss_pred cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
....+...++.+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 267 -------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 267 -------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp -------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 011122345679999999999999999999999999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=342.65 Aligned_cols=240 Identities=23% Similarity=0.325 Sum_probs=199.8
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
..+.||+|+||.||+++.. +|+.||+|+++... ....+.+.+|..+++.++||||+++++++.+.+..++||||++
T Consensus 10 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~ 89 (318)
T 1fot_A 10 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 89 (318)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCC
Confidence 3457899999999999964 69999999997642 2345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 90 GGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp SCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 9999999965 34689999999999999999999999 9999999999999999999999999999865432
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+.... .. ..... . .
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~---~i~~~-~--------~-- 220 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---YE---KILNA-E--------L-- 220 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH---HHHHC-C--------C--
T ss_pred --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HH---HHHhC-C--------C--
Confidence 2233599999999999999999999999999999999999999976543211 11 11100 0 0
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH 545 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 545 (573)
..+...++++.+++.+||+.||++|| ++++|++
T Consensus 221 ----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 ----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 01123456799999999999999999 8899884
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=348.19 Aligned_cols=249 Identities=22% Similarity=0.319 Sum_probs=179.9
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
.+.||+|+||.||++... +|+.||||++... ....+.+|+.+++++. ||||+++++++.+.+..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 457899999999999964 5899999999654 3466788999999996 9999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC---CeeEecccCCccCCccccc
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg~~~~~~~~~~~ 428 (573)
|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++........
T Consensus 93 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 93 LFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp HHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 9999975 35699999999999999999999999 999999999999997665 7999999999865433221
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccch-hhHHhhhhhhhccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..... ...+.... ....... .
T Consensus 166 --~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-i~~~~~~-~------ 235 (325)
T 3kn6_A 166 --LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-IKKGDFS-F------ 235 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-HTTTCCC-C------
T ss_pred --ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-HHcCCCC-C------
Confidence 12234899999999999999999999999999999999999999865432110 00110100 0000000 0
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
........++++.+||.+||+.||++|||++|+++
T Consensus 236 ---~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 236 ---EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp ---CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ---CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 00011234678999999999999999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=351.00 Aligned_cols=243 Identities=22% Similarity=0.290 Sum_probs=199.1
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEe
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
+..+.||+|+||.||+|+.. +|+.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||
T Consensus 20 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~ 99 (345)
T 1xjd_A 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY 99 (345)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence 44567899999999999964 58899999997642 23456678899999887 999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 100 LNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 999999999964 24589999999999999999999999 99999999999999999999999999998643222
Q ss_pred cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
. .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+.... .... .. ..
T Consensus 173 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~i---~~-~~--------- 234 (345)
T 1xjd_A 173 A--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---FHSI---RM-DN--------- 234 (345)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH---HH-CC---------
T ss_pred C--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH---Hh-CC---------
Confidence 1 12234599999999999999999999999999999999999999987553211 1111 00 00
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS-HVV 544 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 544 (573)
...+...++++.++|.+||+.||++||++. +|+
T Consensus 235 -----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 -----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 001122456799999999999999999997 665
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=347.40 Aligned_cols=255 Identities=24% Similarity=0.424 Sum_probs=200.5
Q ss_pred CeeecccCceEEEEEEeCC-----CCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 274 NRLLGDSKTGGTYSGILPD-----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
.++||+|+||.||+|.... +..||||+++.. .......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 4678999999999998643 236999999765 3344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++++|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 129 ~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 129 ENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp TTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred CCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence 99999999974 235699999999999999999999999 999999999999999999999999999987654322
Q ss_pred cc-ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 428 QE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 428 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.. ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ... .....
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~~~---~~~~~--------- 267 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---MKA---INDGF--------- 267 (333)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH---HHTTC---------
T ss_pred cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH---HHH---HHCCC---------
Confidence 11 1112236788999999998999999999999999999999 9999976543211 110 00000
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
....+...+..+.+++.+||+.||++||++.++++.|+++...+
T Consensus 268 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 268 -----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp -----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 00111234567999999999999999999999999999886544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=350.82 Aligned_cols=241 Identities=23% Similarity=0.390 Sum_probs=196.3
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+.
T Consensus 59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~- 137 (348)
T 1u5q_A 59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 137 (348)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-
Confidence 45689999999999995 578999999997542 2334678999999999999999999999999999999999996
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 138 g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~--- 208 (348)
T 1u5q_A 138 GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN--- 208 (348)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC---
T ss_pred CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCCC---
Confidence 6888877532 35689999999999999999999999 99999999999999999999999999998664321
Q ss_pred ceeccCCccccccccccc---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
...||+.|+|||++. +..++.++||||||+++|||++|+.||...+.... ........ .
T Consensus 209 ---~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~~------~--- 270 (348)
T 1u5q_A 209 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNE------S--- 270 (348)
T ss_dssp ---CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSC------C---
T ss_pred ---cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcC------C---
Confidence 234999999999984 56789999999999999999999999976543211 11111100 0
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
........++.+.++|.+||+.||++|||++++++.
T Consensus 271 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 271 ----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111122345679999999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=373.50 Aligned_cols=255 Identities=26% Similarity=0.381 Sum_probs=208.8
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
...+.||+|+||.||+|.+.++..||||+++... ...+++.+|+.+|++++||||+++++++.+ +..++||||+++|+
T Consensus 270 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gs 347 (535)
T 2h8h_A 270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 347 (535)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEE
T ss_pred hhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCc
Confidence 4456789999999999999888899999998654 345789999999999999999999999876 67899999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++... .+..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 348 L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~- 421 (535)
T 2h8h_A 348 LLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR- 421 (535)
T ss_dssp HHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT-
T ss_pred HHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc-
Confidence 99999642 224589999999999999999999999 999999999999999999999999999987654322211
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
....++..|+|||++.+..++.++||||||+++|||+| |+.||......+. .... ....
T Consensus 422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~---~~~i---~~~~-------------- 481 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQV---ERGY-------------- 481 (535)
T ss_dssp CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH---HHHH---HTTC--------------
T ss_pred cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH---HcCC--------------
Confidence 12237789999999998899999999999999999999 9999987653211 1110 0000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
....+..+++.+.+||.+||+.||++|||+++|++.|+.+....
T Consensus 482 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 00112234567999999999999999999999999999987643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=352.99 Aligned_cols=274 Identities=17% Similarity=0.227 Sum_probs=203.1
Q ss_pred CcCCeeeccc--CceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEE
Q 008216 271 SEGNRLLGDS--KTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 271 ~~~~~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
++..+.||+| +||.||+++.. +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 106 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 106 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence 3445678999 99999999975 69999999997653 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|+++++|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+......
T Consensus 107 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 107 FMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp CCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred ccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 99999999999763 234599999999999999999999999 9999999999999999999999999998654322
Q ss_pred ccc-----cceeccCCcccccccccccC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhh----
Q 008216 426 VMQ-----ERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ---- 494 (573)
Q Consensus 426 ~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---- 494 (573)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..... .........
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~ 259 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLD 259 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC----------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCCcccc
Confidence 111 11122348999999999987 57899999999999999999999999775443211 000000000
Q ss_pred c------------------ccccccccc-----ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhc
Q 008216 495 S------------------HRYLELLDP-----LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQ 549 (573)
Q Consensus 495 ~------------------~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~ 549 (573)
. ....+.... ..............++.+.+||.+||+.||++|||++|+++. +++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 0 000000000 000000011123345679999999999999999999999864 444
Q ss_pred cc
Q 008216 550 LA 551 (573)
Q Consensus 550 ~~ 551 (573)
+.
T Consensus 340 ~~ 341 (389)
T 3gni_B 340 IK 341 (389)
T ss_dssp C-
T ss_pred Hh
Confidence 43
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=338.90 Aligned_cols=253 Identities=26% Similarity=0.387 Sum_probs=200.9
Q ss_pred cCCeeecccCceEEEEEEeCC----CCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 272 EGNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
...+.||+|+||.||+|...+ +..||||+++.. .....+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus 15 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 93 (281)
T 3cc6_A 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMEL 93 (281)
T ss_dssp EEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEec
Confidence 345678999999999998533 336999999765 34456789999999999999999999999765 467899999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++++|.+++... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 94 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 94 YPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp CTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred CCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 9999999999642 34589999999999999999999999 99999999999999999999999999998765433
Q ss_pred cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
... .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||............. ...
T Consensus 168 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~------~~~--------- 231 (281)
T 3cc6_A 168 YYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE------KGD--------- 231 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH------HTC---------
T ss_pred ccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh------cCC---------
Confidence 222 122337889999999988899999999999999999998 999997655432111110 000
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
....+...++.+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 232 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 232 -----RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 001112245679999999999999999999999999987743
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=346.33 Aligned_cols=260 Identities=27% Similarity=0.366 Sum_probs=206.9
Q ss_pred CcCCeeecccCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCC-ceE
Q 008216 271 SEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHG-DRY 341 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~-~~~ 341 (573)
+...+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++...+ ..+
T Consensus 29 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~ 108 (316)
T 2xir_A 29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 108 (316)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred eeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceE
Confidence 44566789999999999984 356899999997653 33456789999999999 7999999999988765 489
Q ss_pred EEEEecCCCCHHHHhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC
Q 008216 342 IVYEFVVNGPLDRWLHHIPRG------------GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409 (573)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~ 409 (573)
+||||+++++|.+++...... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~ 185 (316)
T 2xir_A 109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKN 185 (316)
T ss_dssp EEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCC
Confidence 999999999999999753321 12388999999999999999999999 999999999999999999
Q ss_pred CeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHh
Q 008216 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEW 488 (573)
Q Consensus 410 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 488 (573)
.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||+| |..||....... .....
T Consensus 186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~ 263 (316)
T 2xir_A 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRR 263 (316)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HHHHH
T ss_pred CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH--HHHHH
Confidence 999999999987654433222223337889999999999999999999999999999998 999997654321 11100
Q ss_pred hhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 489 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
..... ....+...++.+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus 264 ----~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 264 ----LKEGT-------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp ----HHHTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----hccCc-------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00000 001112235679999999999999999999999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=351.66 Aligned_cols=246 Identities=22% Similarity=0.287 Sum_probs=194.3
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEe
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
+..++||+|+||.||+++.. +++.||||++++... ...+.+.+|..++.++ +||||+++++++.+.+..++||||
T Consensus 55 ~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~ 134 (396)
T 4dc2_A 55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 134 (396)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEc
Confidence 44567899999999999965 578999999976532 2334578899999887 899999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 135 ~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 135 VNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 999999999864 24699999999999999999999999 99999999999999999999999999998633221
Q ss_pred cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccc--hhhHHhhhhhhhcccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW--QSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..............
T Consensus 208 --~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-------- 277 (396)
T 4dc2_A 208 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-------- 277 (396)
T ss_dssp --CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC--------
T ss_pred --CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc--------
Confidence 122334599999999999999999999999999999999999999975432110 00000000000000
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCH
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM 540 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 540 (573)
....+...+.++.+||.+||+.||++||++
T Consensus 278 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 278 ------QIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 011122345679999999999999999996
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=351.60 Aligned_cols=249 Identities=21% Similarity=0.258 Sum_probs=190.4
Q ss_pred CcCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 271 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
+...+.||+|+||.||+++.. +|+.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 100 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG 100 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCC
Confidence 344567899999999999965 68999999997653 3346788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCC--eeEecccCCccCCcccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG--AHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~ 427 (573)
|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++.......
T Consensus 101 ~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~ 173 (361)
T 3uc3_A 101 GELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173 (361)
T ss_dssp CBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence 999999864 24599999999999999999999999 9999999999999987765 99999999975432221
Q ss_pred ccceeccCCcccccccccccCCCCCcc-hhhHHHHHHHHHHHcCCCCCCCCCcccc-hhhHHhhhhhhhccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTK-SDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.....||+.|+|||++.+..++.+ +||||||+++|+|++|+.||........ ..... .... ..
T Consensus 174 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---~~~~---------~~ 238 (361)
T 3uc3_A 174 ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ---RILS---------VK 238 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH---HHHT---------TC
T ss_pred ---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH---HHhc---------CC
Confidence 122349999999999988877655 8999999999999999999986543211 11111 0000 00
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
. ........++.+.+||.+||+.||++|||+.|+++.
T Consensus 239 ~----~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 239 Y----SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp C----CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred C----CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0 001111245678999999999999999999999873
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=343.05 Aligned_cols=252 Identities=23% Similarity=0.403 Sum_probs=195.6
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
+..+.||+|+||.||++.. .++.||||++... ...+.+.+|+.++++++||||+++++++. +..++||||+++++
T Consensus 11 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~ 85 (307)
T 2eva_A 11 EVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGS 85 (307)
T ss_dssp EEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCB
T ss_pred eeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCC
Confidence 3456789999999999998 5889999999754 34578899999999999999999999876 45899999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCC-eeEecccCCccCCccccccc
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-AHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~-~kl~Dfg~~~~~~~~~~~~~ 430 (573)
|.+++.... ....++...++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++.......
T Consensus 86 L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~---- 160 (307)
T 2eva_A 86 LYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---- 160 (307)
T ss_dssp HHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred HHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc----
Confidence 999997522 1234788999999999999999999921129999999999999998887 7999999997654221
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
....||+.|+|||++.+..++.++||||||+++|||++|+.||........... ... ....
T Consensus 161 -~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~-~~~~------------- 221 (307)
T 2eva_A 161 -TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM----WAV-HNGT------------- 221 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH----HHH-HTTC-------------
T ss_pred -ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH----HHH-hcCC-------------
Confidence 122389999999999998999999999999999999999999976543211100 000 0000
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
........+..+.+++.+||+.||++|||++++++.|+.+.+
T Consensus 222 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 222 RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 001112345679999999999999999999999999988754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=344.27 Aligned_cols=260 Identities=20% Similarity=0.283 Sum_probs=195.3
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
.++||+|+||.||++.. .+++.||||+++.......+.+.+|+.++.++ +||||+++++++.+.+..++||||+++++
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 45789999999999995 46999999999876555677899999999995 79999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCC---eeEecccCCccCCcccc-
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGVGLSKFVPWEVM- 427 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~~~~~~~~~~- 427 (573)
|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++........
T Consensus 98 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 98 ILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp HHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred HHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 9999965 24689999999999999999999999 9999999999999998776 99999999986542211
Q ss_pred ----ccceeccCCcccccccccccC-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccc
Q 008216 428 ----QERTVMAGGTYGYLAPEFVYR-----NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY 498 (573)
Q Consensus 428 ----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 498 (573)
........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....................
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 247 (316)
T 2ac3_A 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN--- 247 (316)
T ss_dssp -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH---
T ss_pred ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH---
Confidence 111122348999999999875 45789999999999999999999999875432100000000000000
Q ss_pred ccccccccccCCCCCcc---hHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 499 LELLDPLISSLSSDIPE---AGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 499 ~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
......... ....+. ...+..+.+|+.+||+.||++|||++|+++
T Consensus 248 -~~~~~i~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 248 -MLFESIQEG-KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp -HHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHHHHHhcc-CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000000000 001111 124567999999999999999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=338.53 Aligned_cols=257 Identities=25% Similarity=0.403 Sum_probs=202.0
Q ss_pred cCCeeecccCceEEEEEEeCC----CCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEe-eCCceEEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCY-DHGDRYIVYE 345 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lv~e 345 (573)
+..+.||+|+||.||+|...+ +..||+|.++.. .....+.+.+|+.++++++||||+++++++. .++..++|||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 107 (298)
T 3f66_A 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 107 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEE
T ss_pred hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEe
Confidence 334678999999999998543 236899999764 3344577999999999999999999999865 4567899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|+++++|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 108 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 108 YMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred CCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999999964 335689999999999999999999999 9999999999999999999999999999876543
Q ss_pred ccc--cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccc
Q 008216 426 VMQ--ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502 (573)
Q Consensus 426 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (573)
... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||............ ....
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~------~~~~------ 249 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL------LQGR------ 249 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH------HTTC------
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH------hcCC------
Confidence 321 11222347889999999999999999999999999999999 56666554432111100 0000
Q ss_pred ccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
....+...++.+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 250 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 250 --------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred --------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11112224467999999999999999999999999999886543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=352.90 Aligned_cols=266 Identities=15% Similarity=0.141 Sum_probs=201.9
Q ss_pred CCcCCeeecccCceEEEEEEeCC------CCEEEEEEecccchhh-----------HHHHHHHHHHHhhcCCCcEeEEee
Q 008216 270 FSEGNRLLGDSKTGGTYSGILPD------GSRVAVKRLKRSSFQR-----------KKEFYSEIGRFARLHHPNLVAVKG 332 (573)
Q Consensus 270 ~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~nIv~l~~ 332 (573)
-+...+.||+|+||.||+|.+.+ ++.||||++....... ...+..|+..+..++||||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 34456678999999999998754 4789999987653211 123445666778889999999999
Q ss_pred EEeeC----CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC--
Q 008216 333 CCYDH----GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-- 406 (573)
Q Consensus 333 ~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~-- 406 (573)
++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence 98775 3479999999 9999999975 235699999999999999999999999 999999999999998
Q ss_pred CCCCeeEecccCCccCCccccccc-----eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCccc
Q 008216 407 EEFGAHLMGVGLSKFVPWEVMQER-----TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC 481 (573)
Q Consensus 407 ~~~~~kl~Dfg~~~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~ 481 (573)
.++.+||+|||+++.......... .....||+.|+|||++.+..++.++||||||+++|||+||+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 889999999999987654322211 122349999999999999999999999999999999999999998643221
Q ss_pred chhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 482 WQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
......... ......+.+++.+ +....++++.+++..||+.||++||++.+|++.|+++..
T Consensus 269 --~~~~~~~~~-~~~~~~~~~~~~~-------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 269 --KYVRDSKIR-YRENIASLMDKCF-------PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp --HHHHHHHHH-HHHCHHHHHHHHS-------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred --HHHHHHHHH-hhhhHHHHHHHhc-------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 111111100 0111122222211 012235679999999999999999999999999987754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=350.38 Aligned_cols=271 Identities=24% Similarity=0.315 Sum_probs=208.4
Q ss_pred CcCCeeecccCceEEEEEEe-----CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEee--CCceEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIV 343 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv 343 (573)
++..+.||+|+||.||++.+ .+++.||||++........+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 104 (327)
T 3lxl_A 25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLV 104 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEE
T ss_pred hhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEE
Confidence 34456789999999999984 4688999999988776777889999999999999999999998874 4568999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCC
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 423 (573)
|||+++++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 105 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 105 MEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999642 24589999999999999999999999 99999999999999999999999999998765
Q ss_pred ccccc-cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccc
Q 008216 424 WEVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502 (573)
Q Consensus 424 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (573)
..... .......+|..|+|||++.+..++.++||||||+++|+|++|..||........... .............
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM----GCERDVPALSRLL 254 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC----C----CCHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc----ccccccccHHHHH
Confidence 43221 112223488889999999988899999999999999999999999865432110000 0000000000000
Q ss_pred ccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
.... .......+..+++.+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 255 ~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 255 ELLE-EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHhh-cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0000 001111233456789999999999999999999999999998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=339.93 Aligned_cols=266 Identities=18% Similarity=0.216 Sum_probs=196.6
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccch-----hhHHHHHHHHHHHhhc---CCCcEeEEeeEEeeCC---
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF-----QRKKEFYSEIGRFARL---HHPNLVAVKGCCYDHG--- 338 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~--- 338 (573)
++..+.||+|+||.||+|.. .+|+.||||+++.... .....+.+|+.+++++ +||||+++++++....
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~ 90 (308)
T 3g33_A 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDR 90 (308)
T ss_dssp CEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSS
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCC
Confidence 44456789999999999995 5689999999874321 1234566777777766 5999999999998765
Q ss_pred --ceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecc
Q 008216 339 --DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (573)
Q Consensus 339 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 416 (573)
..++||||+. ++|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 91 EIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp EEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECSC
T ss_pred ceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEeeC
Confidence 4799999996 6999999752 234499999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcc
Q 008216 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH 496 (573)
Q Consensus 417 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 496 (573)
|++......... ....||+.|+|||++.+..++.++||||||+++|||++|++||...+..................
T Consensus 165 g~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 165 GLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 999876533222 22338999999999999999999999999999999999999998765432111111000000000
Q ss_pred ccccccccccccCCCCC------cchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 497 RYLELLDPLISSLSSDI------PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.+............... .....++.+.+||.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00000000000000000 01134567899999999999999999999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=344.69 Aligned_cols=245 Identities=20% Similarity=0.263 Sum_probs=191.1
Q ss_pred CcCCeeecccCceEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEE
Q 008216 271 SEGNRLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 342 (573)
++..+.||+|+||.||+++. .+|+.||+|+++... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 98 (327)
T 3a62_A 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL 98 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence 34456789999999999986 478999999997652 2334567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
||||+++++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 99 ILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 9999999999999964 24589999999999999999999999 9999999999999999999999999999754
Q ss_pred CccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccc
Q 008216 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502 (573)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (573)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+.... .. .... ..
T Consensus 172 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~---~i~~-~~----- 237 (327)
T 3a62_A 172 IHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT---ID---KILK-CK----- 237 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH---HHHH-TC-----
T ss_pred ccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH---HH---HHHh-CC-----
Confidence 32221 12233499999999999998999999999999999999999999987553211 11 1100 00
Q ss_pred ccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008216 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH 545 (573)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 545 (573)
. ..+...+..+.++|.+||+.||++|| +++|+++
T Consensus 238 --------~-~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 --------L-NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp --------C-CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred --------C-CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0 01122456799999999999999999 7778875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=349.45 Aligned_cols=251 Identities=18% Similarity=0.276 Sum_probs=194.1
Q ss_pred CCCcCCeeecccCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCC--CcEeEEeeEEeeCCceEEEE
Q 008216 269 NFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHH--PNLVAVKGCCYDHGDRYIVY 344 (573)
Q Consensus 269 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lv~ 344 (573)
+.++..+.||+|+||.||++...+++.||||++... .....+.+.+|+.+|.+++| |||+++++++.+.+..++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 334556688999999999999888999999999754 33445778999999999976 99999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCc
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 424 (573)
|+ .+++|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++ ++.+||+|||+++....
T Consensus 89 e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 89 EC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp CC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred eC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 95 58899999975 34689999999999999999999999 999999999999997 56799999999987754
Q ss_pred cccccceeccCCcccccccccccC-----------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhh
Q 008216 425 EVMQERTVMAGGTYGYLAPEFVYR-----------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV 493 (573)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 493 (573)
...........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ....
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~--- 231 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLH--- 231 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHH---
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----HHHH---
Confidence 433322333459999999999864 678899999999999999999999997643210 0000
Q ss_pred hccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 494 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
..+++.. ....+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 232 ------~~~~~~~----~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 232 ------AIIDPNH----EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ------HHHCTTS----CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------HHhcCCc----ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 0111111 001111223568999999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=336.04 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=202.2
Q ss_pred CeeecccCceEEEEEEeC-CC---CEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCce-EEEEEec
Q 008216 274 NRLLGDSKTGGTYSGILP-DG---SRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR-YIVYEFV 347 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~lv~e~~ 347 (573)
.++||+|+||.||+|... ++ ..||+|+++... ....+.+.+|+.++++++||||+++++++.+.+.. ++||||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 367899999999999853 22 379999997643 34457889999999999999999999999876665 9999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
.+++|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++........
T Consensus 106 ~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 106 CHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred cCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999974 345689999999999999999999999 999999999999999999999999999986654322
Q ss_pred c--cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCC-CCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 428 Q--ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP-AQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 428 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
. .......+|+.|+|||.+.+..++.++||||||+++|+|++|..| |...+......... ...
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-------~~~------- 245 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-------QGR------- 245 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-------TTC-------
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-------cCC-------
Confidence 1 122233478999999999999999999999999999999995555 44433221111100 000
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
....+...++.+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 246 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 246 ------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111223456799999999999999999999999999987654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=342.42 Aligned_cols=259 Identities=23% Similarity=0.368 Sum_probs=198.0
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
...+.||+|+||.||+|.. .+|+.||||+++.. .......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 35 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 114 (310)
T 2wqm_A 35 RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELA 114 (310)
T ss_dssp EEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecC
Confidence 4456789999999999995 57999999999753 3345677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++++|.+++.........+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++........
T Consensus 115 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 191 (310)
T 2wqm_A 115 DAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191 (310)
T ss_dssp CSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred CCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc
Confidence 99999999875433456689999999999999999999999 999999999999999999999999999986643322
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... .... ... .....
T Consensus 192 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~---~~~-~~~~~--------- 255 (310)
T 2wqm_A 192 A--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLC---KKI-EQCDY--------- 255 (310)
T ss_dssp ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHH---HHH-HTTCS---------
T ss_pred c--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHH---HHh-hcccC---------
Confidence 1 112238999999999999999999999999999999999999997643211 1111 110 00000
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
...+....++.+.+++.+||+.||++|||+.+|++.|+++..
T Consensus 256 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 256 ---PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp ---CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 111122345679999999999999999999999999998864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=338.51 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=195.7
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
...+.||+|+||.||++.. .++..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 25 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 104 (285)
T 3is5_A 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEG 104 (285)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSC
T ss_pred eecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCC
Confidence 3356789999999999996 468999999997653 33467899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee---CCCCCeeEecccCCccCCccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
++|.+++......+..+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++.......
T Consensus 105 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 105 GELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp CBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred CcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 999999865333346699999999999999999999999 99999999999999 456789999999998764432
Q ss_pred cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
.. ....||+.|+|||.+. ..++.++||||||+++|||++|+.||.............. . .+..
T Consensus 182 ~~---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~-------~------~~~~ 244 (285)
T 3is5_A 182 HS---TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY-------K------EPNY 244 (285)
T ss_dssp --------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------C------CCCC
T ss_pred cC---cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc-------C------Cccc
Confidence 21 2234899999999875 5689999999999999999999999987653221111000 0 0000
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.......++.+.+++.+||+.||++|||+.|+++
T Consensus 245 -----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 -----AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -----CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -----ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001113457899999999999999999999985
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=342.64 Aligned_cols=266 Identities=21% Similarity=0.289 Sum_probs=191.6
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
.+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+++..++||||++ ++
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~ 88 (317)
T 2pmi_A 10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-ND 88 (317)
T ss_dssp ---------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CB
T ss_pred eeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CC
Confidence 456799999999999964 589999999976532 234678899999999999999999999999999999999997 69
Q ss_pred HHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 352 LDRWLHHIP--RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 352 L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|.+++.... .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.........
T Consensus 89 L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~- 164 (317)
T 2pmi_A 89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT- 164 (317)
T ss_dssp HHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC-
T ss_pred HHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCccc-
Confidence 999886432 2224589999999999999999999999 9999999999999999999999999999876432211
Q ss_pred ceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc-----cccc
Q 008216 430 RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL-----ELLD 503 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 503 (573)
.....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+...................+. ....
T Consensus 165 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T 2pmi_A 165 -FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN 243 (317)
T ss_dssp -CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCC
T ss_pred -CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcc
Confidence 122348999999999876 468999999999999999999999998765432111110000000000000 0000
Q ss_pred cccccCCCC--------CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 504 PLISSLSSD--------IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 504 ~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+........ ......+.++.+|+.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 244 PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000000 001123567999999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=344.18 Aligned_cols=247 Identities=19% Similarity=0.299 Sum_probs=193.4
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCc-----------
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD----------- 339 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----------- 339 (573)
..+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~ 89 (332)
T 3qd2_B 10 PIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIW 89 (332)
T ss_dssp EEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--
T ss_pred eeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhh
Confidence 3457899999999999975 79999999997543 3356789999999999999999999999866542
Q ss_pred ----------------------------------------------eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHH
Q 008216 340 ----------------------------------------------RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMK 373 (573)
Q Consensus 340 ----------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ 373 (573)
.++||||+++++|.+++.... .....++..++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ 168 (332)
T 3qd2_B 90 LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHGVCLH 168 (332)
T ss_dssp ------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHHHHHH
T ss_pred hccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhHHHHH
Confidence 799999999999999997532 224466778899
Q ss_pred HHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc----------cceeccCCccccccc
Q 008216 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ----------ERTVMAGGTYGYLAP 443 (573)
Q Consensus 374 i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~gt~~y~aP 443 (573)
++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........ .......||+.|+||
T Consensus 169 i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 245 (332)
T 3qd2_B 169 IFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245 (332)
T ss_dssp HHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred HHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence 999999999999999 9999999999999999999999999999876544211 111223499999999
Q ss_pred ccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHH
Q 008216 444 EFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVV 523 (573)
Q Consensus 444 E~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 523 (573)
|++.+..++.++||||||+++|||++|..|+.... ..... .... .........++.+.
T Consensus 246 E~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--------~~~~~-~~~~-------------~~~~~~~~~~~~~~ 303 (332)
T 3qd2_B 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--------RIITD-VRNL-------------KFPLLFTQKYPQEH 303 (332)
T ss_dssp HHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--------HHHHH-HHTT-------------CCCHHHHHHCHHHH
T ss_pred HHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--------HHHHH-hhcc-------------CCCcccccCChhHH
Confidence 99999999999999999999999999877642210 00000 0000 01111234556789
Q ss_pred HHHHHhcCCCCCCCCCHHHHHH
Q 008216 524 DLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 524 ~li~~cl~~dP~~RPs~~evl~ 545 (573)
+++.+||+.||++|||++|+++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 9999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=352.99 Aligned_cols=252 Identities=18% Similarity=0.270 Sum_probs=192.1
Q ss_pred cCCCcCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhh-cCCCcEeEEeeEEee----CCceE
Q 008216 268 KNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFAR-LHHPNLVAVKGCCYD----HGDRY 341 (573)
Q Consensus 268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~----~~~~~ 341 (573)
++|....++||+|+||.||++... +|+.||||+++.. ..+.+|+.++.+ .+||||+++++++.. .+..+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 344444467899999999999964 6899999999643 456788888755 489999999999875 56689
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---CCCeeEecccC
Q 008216 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVGL 418 (573)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~ 418 (573)
+||||+++|+|.+++.. .....+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 136 lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999975 2235699999999999999999999999 9999999999999987 78899999999
Q ss_pred CccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchh-hHHhhhhhhhccc
Q 008216 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPLVQSHR 497 (573)
Q Consensus 419 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~ 497 (573)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..... ....
T Consensus 211 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~ 283 (400)
T 1nxk_A 211 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQ 283 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTC
T ss_pred ccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCc
Confidence 986543221 223348999999999999999999999999999999999999997654322110 00000 0000
Q ss_pred cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
. .. ........++++.+||.+||+.||++|||+.|+++.
T Consensus 284 ~-~~---------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 284 Y-EF---------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp C-CC---------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c-cC---------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 00 001112345679999999999999999999999973
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=348.57 Aligned_cols=248 Identities=24% Similarity=0.307 Sum_probs=186.5
Q ss_pred CcCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 271 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
++..+.||+|+||.||+|... +++.||||+++... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 132 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence 344567899999999999975 58899999997653 346788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---CCCeeEecccCCccCCccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~~~~~~~~~ 426 (573)
++|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++......
T Consensus 133 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 133 GELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp CBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 999999854 35689999999999999999999999 9999999999999975 8889999999998664332
Q ss_pred cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
. .....||+.|+|||++.+..++.++||||||+++|||++|..||....... ..... .. .... ..
T Consensus 206 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~---i~-~~~~-~~----- 270 (349)
T 2w4o_A 206 L---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFRR---IL-NCEY-YF----- 270 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHHH---HH-TTCC-CC-----
T ss_pred c---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHHH---HH-hCCC-cc-----
Confidence 1 122348999999999999899999999999999999999999997654321 01110 00 0000 00
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
........+..+.+||.+||+.||++|||+.|+++.
T Consensus 271 ----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 ----ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001112345679999999999999999999999973
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=336.78 Aligned_cols=262 Identities=19% Similarity=0.262 Sum_probs=195.7
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
..+.||+|+||.||+|... +|+.||||+++... ......+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 85 (292)
T 3o0g_A 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC
Confidence 3457899999999999964 58999999997543 23347788999999999999999999999999999999999975
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.........
T Consensus 86 -~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 157 (292)
T 3o0g_A 86 -DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC- 157 (292)
T ss_dssp -EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC-
T ss_pred -CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc-
Confidence 56565543 235699999999999999999999999 9999999999999999999999999999876433221
Q ss_pred ceeccCCcccccccccccCCC-CCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhc---cccc---ccc
Q 008216 430 RTVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS---HRYL---ELL 502 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~---~~~ 502 (573)
.....||+.|+|||++.+.. ++.++||||||+++|||++|..||....... ............ ..+. ...
T Consensus 158 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred -ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhcccc
Confidence 12234899999999997765 7999999999999999999888864433221 111111110000 0000 000
Q ss_pred cc----cc-ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 503 DP----LI-SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 503 ~~----~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+. .. ............++.+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 00 000000111235567899999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=349.99 Aligned_cols=267 Identities=27% Similarity=0.376 Sum_probs=206.6
Q ss_pred HhhcCCCcCCeeecccCceEEEEEEe------CCCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC
Q 008216 265 SITKNFSEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337 (573)
Q Consensus 265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 337 (573)
.+..+-+...+.||+|+||.||+|.. .+++.||||++... ......++.+|+.++++++||||+++++++.+.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 34444455567889999999999984 34778999999754 344567789999999999999999999999999
Q ss_pred CceEEEEEecCCCCHHHHhccCCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---CCCe
Q 008216 338 GDRYIVYEFVVNGPLDRWLHHIPRG---GRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGA 411 (573)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~ 411 (573)
+..++||||+++++|.+++...... ...+++..++.++.|++.||.|||++ +++||||||+|||++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence 9999999999999999999764321 24589999999999999999999999 9999999999999984 4469
Q ss_pred eEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhh
Q 008216 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWAT 490 (573)
Q Consensus 412 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~ 490 (573)
||+|||++................+|+.|+|||.+.+..++.++||||||+++|+|+| |..||........ ....
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~- 258 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LEFV- 258 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHHH-
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH---HHHH-
Confidence 9999999875433222222222337889999999988899999999999999999998 9999976543211 1110
Q ss_pred hhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 491 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
.... ....+...+..+.+++.+||+.||.+|||+.+|++.|+.+...+
T Consensus 259 ---~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 259 ---TSGG-------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp ---HTTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ---hcCC-------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 0000 01112234567999999999999999999999999999876543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=352.51 Aligned_cols=256 Identities=26% Similarity=0.432 Sum_probs=195.4
Q ss_pred CeeecccCceEEEEEEeC--CC--CEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEee-CCceEEEEEec
Q 008216 274 NRLLGDSKTGGTYSGILP--DG--SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYEFV 347 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~--~g--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~~ 347 (573)
.+.||+|+||.||+|... ++ ..||||.++.. .....+.+.+|+.++++++||||+++++++.+ ++..++||||+
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~ 173 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence 457899999999999853 22 36899998754 33456789999999999999999999998754 46789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 174 ~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 174 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 99999999964 335688999999999999999999999 999999999999999999999999999986643321
Q ss_pred cc--ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 428 QE--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 428 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
.. ......+|+.|+|||.+.+..++.++||||||+++|||+| |.+||...+........ ....
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~------~~~~-------- 313 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL------LQGR-------- 313 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH------HTTC--------
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH------HcCC--------
Confidence 11 1122237889999999999999999999999999999999 77788765443211110 0000
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCc
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPV 555 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 555 (573)
....+..++..+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 314 ------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 314 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 011122345679999999999999999999999999998875443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=359.01 Aligned_cols=260 Identities=19% Similarity=0.224 Sum_probs=203.8
Q ss_pred HHHHhhcCCCcCCeeecccCceEEEEEEeCC-CCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC
Q 008216 262 ELRSITKNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337 (573)
Q Consensus 262 el~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 337 (573)
++....++|.. .++||+|+||.||+|+..+ ++.||||++++... .....+.+|..++..++||||+++++++.+.
T Consensus 68 ~~~~~~~~y~~-~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 68 QMRLHREDFEI-LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHSCCGGGEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred cccCChhheEE-EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 33334455544 5678999999999999754 78999999975422 1223488999999999999999999999999
Q ss_pred CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEeccc
Q 008216 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (573)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 417 (573)
+..++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence 999999999999999999974 235699999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCccccccceeccCCccccccccccc-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhh
Q 008216 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL 492 (573)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ 492 (573)
+++......... .....||+.|+|||++. ...++.++|||||||++|||++|+.||...+..... ......
T Consensus 221 la~~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~---~~i~~~ 296 (437)
T 4aw2_A 221 SCLKLMEDGTVQ-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY---GKIMNH 296 (437)
T ss_dssp TCEECCTTSCEE-CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHHTH
T ss_pred hhhhcccCCCcc-cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH---Hhhhhc
Confidence 997665433222 22235999999999987 467899999999999999999999999876542211 111000
Q ss_pred hhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q 008216 493 VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSM--RPRMSHVVH 545 (573)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 545 (573)
.....+ + ......++++.+||.+||..+|++ ||+++|+++
T Consensus 297 ~~~~~~------------p-~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 297 KERFQF------------P-TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHCCC------------C-SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cccccC------------C-cccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 000000 0 001124567999999999988888 999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=345.95 Aligned_cols=241 Identities=20% Similarity=0.264 Sum_probs=200.1
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
+..+.||+|+||.||+++.. +|+.||||+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 44 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 123 (350)
T 1rdq_E 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123 (350)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence 33467899999999999964 68999999997542 233567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 124 ~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~- 195 (350)
T 1rdq_E 124 AGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp TTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCCc-
Confidence 99999999975 24589999999999999999999999 99999999999999999999999999998664321
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...+.... .. .... ..
T Consensus 196 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~---~i~~-~~---------- 254 (350)
T 1rdq_E 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---YE---KIVS-GK---------- 254 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HHHH-CC----------
T ss_pred ----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH---HH---HHHc-CC----------
Confidence 223489999999999999999999999999999999999999986543211 11 1110 00
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 545 (573)
...+...+..+.++|.+||+.||++||+ +++|++
T Consensus 255 ----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 255 ----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 0011234567999999999999999998 888875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=343.34 Aligned_cols=251 Identities=21% Similarity=0.271 Sum_probs=198.0
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEe
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
+..+.||+|+||.||+++.. +|+.||||+++... ....+.+.+|..++.++ +||||+++++++.+.+..++||||
T Consensus 12 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~ 91 (345)
T 3a8x_A 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 91 (345)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeC
Confidence 33567899999999999964 58899999997652 33456688999999988 899999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 92 ~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 92 VNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 999999999864 24699999999999999999999999 99999999999999999999999999998643222
Q ss_pred cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccch--hhHHhhhhhhhcccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ--SIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 504 (573)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..............
T Consensus 165 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------- 235 (345)
T 3a8x_A 165 D--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------- 235 (345)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-------
T ss_pred C--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-------
Confidence 1 122345999999999999999999999999999999999999999753221100 00000000000000
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCH------HHHHH
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM------SHVVH 545 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 545 (573)
. ..+...+..+.++|.+||+.||++||++ +|+++
T Consensus 236 ------~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 236 ------I-RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp ------C-CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred ------C-CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 0 1112345679999999999999999996 56654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=358.45 Aligned_cols=244 Identities=23% Similarity=0.341 Sum_probs=201.3
Q ss_pred CcCCeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 271 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
+...+.||+|+||.||+|... +|+.||||+++.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 97 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 344567899999999999964 699999999975422 2346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 98 VSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp CSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999999953 35699999999999999999999999 99999999999999999999999999998765432
Q ss_pred cccceeccCCcccccccccccCCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
. ....+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...+... ..... .. ..
T Consensus 171 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~~~i---~~-~~-------- 232 (476)
T 2y94_A 171 F---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---LFKKI---CD-GI-------- 232 (476)
T ss_dssp C---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---HHHHH---HT-TC--------
T ss_pred c---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---HHHHH---hc-CC--------
Confidence 2 223349999999999988765 689999999999999999999998654321 11110 00 00
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
. ..+...++.+.+||.+||+.||++|||++|+++
T Consensus 233 ~------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 233 F------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp C------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0 011223467999999999999999999999997
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=340.46 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=202.6
Q ss_pred cCCeeecccCceEEEEEEe---CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 272 EGNRLLGDSKTGGTYSGIL---PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
...+.||+|+||.||+|.+ .+++.||||+++... ....+.+.+|+.++++++||||+++++++ ..+..++||||
T Consensus 20 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~ 98 (291)
T 1xbb_A 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEM 98 (291)
T ss_dssp EEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEEC
T ss_pred hccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEe
Confidence 3334789999999999964 346889999997653 22357799999999999999999999998 66788999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 99 AELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp CTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 999999999975 34589999999999999999999999 99999999999999999999999999998765433
Q ss_pred ccc-ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 427 MQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 427 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||............ ....
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-------~~~~------- 237 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGE------- 237 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------HTTC-------
T ss_pred CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-------HcCC-------
Confidence 221 1222236789999999988889999999999999999999 99999876542211110 0000
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
....+...++.+.+++.+||+.||++|||+.++++.|+++...
T Consensus 238 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 238 ------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0111223456799999999999999999999999999987543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=372.46 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=200.5
Q ss_pred eecccCceEEEEEEeC---CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 276 LLGDSKTGGTYSGILP---DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
.||+|+||.||+|.+. ++..||||+++... ....+++.+|+.+|++++||||+++++++.+ +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 5899999999999863 46689999998653 3356789999999999999999999999876 56899999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc-cc
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-ER 430 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~ 430 (573)
|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 422 L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 9999964 245699999999999999999999999 9999999999999999999999999999876543221 11
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
.....+++.|+|||++.+..++.++||||||+++|||+| |+.||...+.......+ ....
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i-------~~~~------------ 556 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-------EQGK------------ 556 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH-------HTTC------------
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------HcCC------------
Confidence 122236689999999998999999999999999999998 99999876543211111 1110
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
....+..+++++.+||.+||+.||++||++.+|++.|+.+.
T Consensus 557 -~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 557 -RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp -CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01112235578999999999999999999999999998764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=342.47 Aligned_cols=260 Identities=18% Similarity=0.222 Sum_probs=197.2
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
...+.||+|+||.||++... +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 37 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 116 (309)
T 2h34_A 37 RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLI 116 (309)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEec
Confidence 44567899999999999964 688999999976532 23477899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 117 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 117 NGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp CCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999999964 24589999999999999999999999 999999999999999999999999999986654322
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ...... ... ..
T Consensus 190 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~----~~~--~~ 255 (309)
T 2h34_A 190 TQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG-------AHINQA----IPR--PS 255 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH-------HHHHSC----CCC--GG
T ss_pred cc-ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH-------HHhccC----CCC--cc
Confidence 21 12233899999999999889999999999999999999999999765432100 000000 000 00
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhcccCCCchh
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-RMSHVVHQLQQLAQPPVTK 557 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~~~~ 557 (573)
. .....+..+.+++.+||+.||++|| +++++++.|++........
T Consensus 256 ~-----~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 256 T-----VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp G-----TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred c-----cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 0 0122345699999999999999999 9999999999887765443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=346.22 Aligned_cols=244 Identities=23% Similarity=0.303 Sum_probs=199.1
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEe
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
+..++||+|+||.||+++.. +|+.||||+++... ....+.+.+|..++..+ +||||+++++++.+.+..++||||
T Consensus 23 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~ 102 (353)
T 2i0e_A 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 102 (353)
T ss_dssp EEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeC
Confidence 44567899999999999975 47899999997642 23456788999999988 899999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 103 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 103 VNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 999999999964 24599999999999999999999999 99999999999999999999999999998643222
Q ss_pred cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
. .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+.... ... ... ..
T Consensus 176 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~~---i~~-~~--------- 237 (353)
T 2i0e_A 176 V--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQS---IME-HN--------- 237 (353)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH---HHH-CC---------
T ss_pred c--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH---HHH---HHh-CC---------
Confidence 1 12234599999999999999999999999999999999999999987553211 111 100 00
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH 545 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 545 (573)
...+...+.++.+||.+||+.||++||+ +++|++
T Consensus 238 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 238 -----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0111234567999999999999999995 567764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=356.38 Aligned_cols=252 Identities=19% Similarity=0.228 Sum_probs=201.0
Q ss_pred hcCCCcCCeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEE
Q 008216 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342 (573)
Q Consensus 267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 342 (573)
.++| +..+.||+|+||.||+++.. +++.||+|++++... ...+.+.+|..+++.++||||+++++++.+.+..++
T Consensus 68 ~~~y-~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 68 AEDY-EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp GGGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccc-EEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 3444 34567899999999999965 588999999975321 223457899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 147 V~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp EECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 9999999999999964 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CccccccceeccCCcccccccccccCCC----CCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccc
Q 008216 423 PWEVMQERTVMAGGTYGYLAPEFVYRNE----LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY 498 (573)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 498 (573)
....... ....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+...... .. .....
T Consensus 219 ~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~---~i---~~~~~- 290 (410)
T 3v8s_A 219 NKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS---KI---MNHKN- 290 (410)
T ss_dssp CTTSEEE-CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HH---HTHHH-
T ss_pred ccCCccc-ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH---HH---Hhccc-
Confidence 5433221 22345999999999998655 7899999999999999999999998765421111 11 00000
Q ss_pred ccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q 008216 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSM--RPRMSHVVH 545 (573)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 545 (573)
. . ........+.++.+||.+||+.+|.+ ||+++||++
T Consensus 291 -~-----~----~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 291 -S-----L----TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp -H-----C----CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred -c-----c----cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 0 0 00001124567999999999999988 999999996
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=331.52 Aligned_cols=247 Identities=22% Similarity=0.325 Sum_probs=200.3
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
.+.||+|+||.||+|... +|+.||||+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (276)
T 2yex_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (276)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCc
Confidence 457899999999999965 68999999997543 3345778999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||.+............
T Consensus 92 L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 92 LFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp GGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred HHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 9998853 35689999999999999999999999 9999999999999999999999999999865433222222
Q ss_pred eccCCcccccccccccCCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 432 VMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....+. ... .
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~~---~---------- 226 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKK---T---------- 226 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHH----TTC---T----------
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhh----hcc---c----------
Confidence 33448999999999987665 7899999999999999999999976543211 111100 000 0
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
........++.+.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 01112234567899999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=340.76 Aligned_cols=241 Identities=22% Similarity=0.287 Sum_probs=189.8
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
+..+.||+|+||+||+|... +|+.||||++... ..........|+..+.++ +||||+++++++.+.+..++||||+
T Consensus 60 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~ 139 (311)
T 3p1a_A 60 QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC 139 (311)
T ss_dssp EEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc
Confidence 33456799999999999975 6999999998654 233344566666666665 9999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
+++|.+++... +..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 140 -~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 140 -GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp -CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred -CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence 77999988652 35699999999999999999999999 999999999999999999999999999987643322
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
.....||+.|+|||++.+ .++.++||||||+++|||++|..|+...... .. .... ...+.
T Consensus 213 ---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~--------~~~~----~~~~~-- 272 (311)
T 3p1a_A 213 ---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW--QQ--------LRQG----YLPPE-- 272 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH--HH--------HTTT----CCCHH--
T ss_pred ---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH--HH--------Hhcc----CCCcc--
Confidence 222348999999998875 7899999999999999999997776542210 00 0000 00110
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.....++.+.+++.+||+.||++|||++|+++
T Consensus 273 ------~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 ------FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ------cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11224567999999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=333.26 Aligned_cols=243 Identities=21% Similarity=0.278 Sum_probs=200.1
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
...+.||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (277)
T 3f3z_A 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGG 91 (277)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCC
Confidence 44557899999999999964 47799999998765566788999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee---CCCCCeeEecccCCccCCcccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||++ +.++.+||+|||++........
T Consensus 92 ~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 92 ELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp BHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 99998864 34589999999999999999999999 99999999999999 7888999999999987654322
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
. ....||+.|+|||.+.+ .++.++||||||+++|||++|+.||........... ... ..
T Consensus 165 ~---~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------~~~-~~---------- 223 (277)
T 3f3z_A 165 M---RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK------IRE-GT---------- 223 (277)
T ss_dssp B---CCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHH-CC----------
T ss_pred h---hccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH------HHh-CC----------
Confidence 2 22348999999998865 489999999999999999999999987554211110 000 00
Q ss_pred cCCCCCcc---hHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 508 SLSSDIPE---AGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
...+. ...++.+.+++.+||+.||++|||+.++++
T Consensus 224 ---~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 224 ---FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ---CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00011 124567999999999999999999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=349.09 Aligned_cols=273 Identities=22% Similarity=0.365 Sum_probs=207.8
Q ss_pred CCCcCCeeecccCceEEEEEEe-----CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC--ceE
Q 008216 269 NFSEGNRLLGDSKTGGTYSGIL-----PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRY 341 (573)
Q Consensus 269 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~ 341 (573)
+.++..+.||+|+||.||++.+ .+|+.||||++........+.+.+|+.++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 3344556789999999999984 368899999998776666788999999999999999999999987654 679
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCcc
Q 008216 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 421 (573)
+||||+++++|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 121 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 999999999999999752 24589999999999999999999999 999999999999999999999999999987
Q ss_pred CCcccccc-ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhh-hhhccccc
Q 008216 422 VPWEVMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP-LVQSHRYL 499 (573)
Q Consensus 422 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~ 499 (573)
........ ......++..|+|||.+.+..++.++||||||+++|||+||..|+...... .......... ........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-FMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH-HHHHHCTTCCTHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH-HHHhhccccchhhhHHHHH
Confidence 65432211 112233778899999998888999999999999999999999997643111 0000000000 00000000
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
+.+.. ......+..+++++.++|.+||+.||++|||+.+|++.|+++..
T Consensus 274 ~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 274 ELLKN----NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHT----TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhhc----CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00000 00111123456789999999999999999999999999998753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=333.23 Aligned_cols=244 Identities=22% Similarity=0.350 Sum_probs=180.2
Q ss_pred CCeeecccCceEEEEEEe-CCCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 273 GNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
..+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 15 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (278)
T 3cok_A 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCH 94 (278)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCC
Confidence 346789999999999996 5799999999975422 224678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+++|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.........
T Consensus 95 ~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 95 NGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp TEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred CCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 9999999974 235689999999999999999999999 9999999999999999999999999999876433221
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .....
T Consensus 169 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~~~---- 227 (278)
T 3cok_A 169 --HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN---------------KVVLA---- 227 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSS----
T ss_pred --ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH---------------HHhhc----
Confidence 112348999999999998889999999999999999999999997654321000 00000
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....+...+.++.+++.+||+.||++|||++++++
T Consensus 228 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 --DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00111234567899999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=351.64 Aligned_cols=249 Identities=18% Similarity=0.273 Sum_probs=193.7
Q ss_pred CcCCeeecccCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcC--CCcEeEEeeEEeeCCceEEEEEe
Q 008216 271 SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLH--HPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
+...+.||+|+||.||++...+++.||||++... .....+.+.+|+.+|.+++ ||||+++++++...+..++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 4445678999999999999888999999999754 3344578999999999996 5999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+.+++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++ ++.+||+|||+++......
T Consensus 137 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 137 CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 568899999975 24688999999999999999999999 999999999999996 5789999999998765443
Q ss_pred cccceeccCCcccccccccccC-----------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYR-----------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS 495 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 495 (573)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~~~----- 278 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLH----- 278 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHHH-----
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HHHH-----
Confidence 3222233459999999999865 368899999999999999999999997643210 0000
Q ss_pred cccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
.++++.. ....+...+..+.+||.+||+.||++|||+.|+++.
T Consensus 279 ----~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 279 ----AIIDPNH----EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ----HHHCTTS----CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----HHhCccc----cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111111 000011124578999999999999999999999863
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=345.15 Aligned_cols=257 Identities=28% Similarity=0.457 Sum_probs=203.7
Q ss_pred cCCeeecccCceEEEEEEeC-CCCE--EEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEe
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSR--VAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
...+.||+|+||.||+|... +|.. +|||.++.. .....+.+.+|+.+++++ +||||+++++++.+.+..++||||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 107 (327)
T 1fvr_A 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 107 (327)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEec
Confidence 44567899999999999964 4554 499998754 233456789999999999 999999999999999999999999
Q ss_pred cCCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEe
Q 008216 347 VVNGPLDRWLHHIP------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLM 414 (573)
Q Consensus 347 ~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 414 (573)
+++++|.+++.... .....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred CCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEEc
Confidence 99999999997532 2235699999999999999999999999 99999999999999999999999
Q ss_pred cccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhh
Q 008216 415 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLV 493 (573)
Q Consensus 415 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 493 (573)
|||++........ .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||........ ... ..
T Consensus 185 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~~~---~~ 255 (327)
T 1fvr_A 185 DFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YEK---LP 255 (327)
T ss_dssp CTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH---GG
T ss_pred ccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH---HHH---hh
Confidence 9999975432211 122237889999999988889999999999999999998 9999977553211 110 00
Q ss_pred hccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 494 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
.. . ....+...++.+.+++.+||+.||++|||++++++.|+++....
T Consensus 256 ~~------~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 256 QG------Y--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp GT------C--------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred cC------C--------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 00 0 01112234567999999999999999999999999999876543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=340.82 Aligned_cols=248 Identities=19% Similarity=0.236 Sum_probs=201.4
Q ss_pred CcCCeeecccCceEEEEEEeC-CCCEEEEEEecccchh------hHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQ------RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 343 (573)
+...+.||+|+||.||++... +|+.||||+++..... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (321)
T 2a2a_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLI 93 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 344567899999999999964 6899999999764321 357799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC----CeeEecccCC
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVGLS 419 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfg~~ 419 (573)
|||+++++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++ .+||+|||++
T Consensus 94 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 94 LELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp ECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 999999999999964 35689999999999999999999999 999999999999999887 7999999999
Q ss_pred ccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
......... ....||+.|+|||.+.+..++.++||||||+++|+|++|..||......... . .... ..
T Consensus 167 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~---~i~~-~~-- 234 (321)
T 2a2a_A 167 HEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---A---NITS-VS-- 234 (321)
T ss_dssp EECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---H---HHHT-TC--
T ss_pred eecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH---H---HHHh-cc--
Confidence 876543221 2234899999999999899999999999999999999999999765432111 0 0000 00
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
...++.. ....++.+.++|.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 YDFDEEF--------FSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCCCHHH--------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cccChhh--------hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000 1123467899999999999999999999987
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=360.78 Aligned_cols=245 Identities=22% Similarity=0.238 Sum_probs=191.9
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
++..+.||+|+||.||++.. .+|+.||||+++.. .......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 229 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 229 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence 34456789999999999995 46899999999754 223345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ + +|+||||||+|||++.++.+||+|||+++.....
T Consensus 230 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 230 ANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp CSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 999999999864 3468999999999999999999998 8 9999999999999999999999999999864332
Q ss_pred ccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+...... .. .. .
T Consensus 303 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~---~i---~~-~--------- 364 (446)
T 4ejn_A 303 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE---LI---LM-E--------- 364 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HH---HH-C---------
T ss_pred Cc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH---HH---Hh-C---------
Confidence 22 1223459999999999999999999999999999999999999997755421111 10 00 0
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH 545 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 545 (573)
....+...++++.+||.+||+.||++|| +++|+++
T Consensus 365 -----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 365 -----EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0001123456799999999999999999 9999985
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=338.61 Aligned_cols=261 Identities=19% Similarity=0.262 Sum_probs=196.2
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
..+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 7 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (311)
T 4agu_A 7 KIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH 86 (311)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred EeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCC
Confidence 3457899999999999974 589999999865532 3356788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++..........
T Consensus 87 ~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 87 TVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp EHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred chHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc
Confidence 999998753 35589999999999999999999999 99999999999999999999999999998765332211
Q ss_pred ceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhh--------hhhhcccccc
Q 008216 430 RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT--------PLVQSHRYLE 500 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 500 (573)
....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||................ ..........
T Consensus 160 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 160 --DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred --CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 12348999999999876 568999999999999999999999998765432211111000 0000000000
Q ss_pred ccccccccCCCCCc-----chHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 501 LLDPLISSLSSDIP-----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 501 ~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.. .... ..... ....+..+.+++.+||+.||++|||++|+++
T Consensus 238 ~~--~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 238 GV--KIPD-PEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TC--CCCC-CSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cC--cCCC-ccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0000 00000 0234567999999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=333.18 Aligned_cols=247 Identities=20% Similarity=0.272 Sum_probs=200.0
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
...+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 88 (284)
T 3kk8_A 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 88 (284)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCC
Confidence 34557899999999999964 5899999999754 33345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCC---eeEecccCCccCCcc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGVGLSKFVPWE 425 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~~~~~~~~ 425 (573)
+++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++. +||+|||++......
T Consensus 89 ~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 89 GGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp SCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999888864 24589999999999999999999999 9999999999999986655 999999999766543
Q ss_pred ccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
... ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||............ ..... ..
T Consensus 162 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-------~~~~~-~~---- 226 (284)
T 3kk8_A 162 EAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-------KAGAY-DY---- 226 (284)
T ss_dssp CBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTCC-CC----
T ss_pred ccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH-------Hhccc-cC----
Confidence 222 1234899999999999999999999999999999999999999775532111110 00000 00
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
........++.+.+++.+||+.||++|||++|+++
T Consensus 227 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 227 -----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00011234567999999999999999999999987
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=341.38 Aligned_cols=267 Identities=21% Similarity=0.371 Sum_probs=198.7
Q ss_pred CcCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc--CCCcEeEEeeEEeeC----CceEEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL--HHPNLVAVKGCCYDH----GDRYIVY 344 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~l~~~~~~~----~~~~lv~ 344 (573)
+...+.||+|+||.||+|+. .|+.||||++.... ...+..|.+++..+ +||||+++++++.+. ...++||
T Consensus 39 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 114 (337)
T 3mdy_A 39 IQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLIT 114 (337)
T ss_dssp CEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEE
T ss_pred eEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEE
Confidence 34456789999999999998 59999999996542 33445555555554 999999999999887 6789999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEcCCCCCCeeeCCCCCeeEecccCC
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 419 (573)
||+++|+|.+++.. ..+++..++.++.|++.||+|||++. +++|+||||||+|||++.++.+||+|||++
T Consensus 115 e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 189 (337)
T 3mdy_A 115 DYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189 (337)
T ss_dssp CCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred eccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence 99999999999965 35999999999999999999999752 338999999999999999999999999999
Q ss_pred ccCCccccccc--eeccCCcccccccccccCCCCCcc------hhhHHHHHHHHHHHcC----------CCCCCCCCccc
Q 008216 420 KFVPWEVMQER--TVMAGGTYGYLAPEFVYRNELTTK------SDVYSFGVLLLEIVSG----------RRPAQAVDSVC 481 (573)
Q Consensus 420 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGvil~elltG----------~~Pf~~~~~~~ 481 (573)
........... .....||+.|+|||++.+...+.+ +||||||+++|||+|| ..||.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 269 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269 (337)
T ss_dssp EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence 76644322211 122349999999999987766554 9999999999999999 55554432211
Q ss_pred chhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCc
Q 008216 482 WQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPV 555 (573)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 555 (573)
.. ............ ..+ ..........+++.+.+++.+||+.||++|||+.+|++.|+++.+...
T Consensus 270 ~~--~~~~~~~~~~~~----~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 270 PS--YEDMREIVCIKK----LRP---SFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp CC--HHHHHHHHTTSC----CCC---CCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred Cc--hhhhHHHHhhhc----cCc---cccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 00 000000000000 000 000111234678899999999999999999999999999999877643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=332.41 Aligned_cols=242 Identities=26% Similarity=0.333 Sum_probs=196.7
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
+..+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (279)
T 3fdn_A 12 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA 91 (279)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecC
Confidence 33557899999999999864 57799999996542 223567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 164 (279)
T 3fdn_A 92 PLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 164 (279)
T ss_dssp TTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcccc
Confidence 99999999864 24589999999999999999999999 999999999999999999999999999865543221
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
....||+.|+|||.+.+..++.++||||||+++|+|++|..||............ ...
T Consensus 165 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~----------- 222 (279)
T 3fdn_A 165 ----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------SRV----------- 222 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------HHT-----------
T ss_pred ----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH-------HhC-----------
Confidence 2234899999999999989999999999999999999999999865432111100 000
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....+...++.+.+++.+||+.||++|||++|+++
T Consensus 223 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 223 ---EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ---CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00111224467899999999999999999999996
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=345.82 Aligned_cols=261 Identities=19% Similarity=0.222 Sum_probs=199.6
Q ss_pred HHhhcCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEeccc-----chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC
Q 008216 264 RSITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS-----SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337 (573)
Q Consensus 264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 337 (573)
..+.++|.. .+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 22 LELQKKYHL-KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHEEE-EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhheee-cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 445555544 45779999999999996 46889999998654 234457899999999999999999999999999
Q ss_pred CceEEEEEecCCCCHHHHhccCCCC------------------------------------CCCCCHHHHHHHHHHHHHH
Q 008216 338 GDRYIVYEFVVNGPLDRWLHHIPRG------------------------------------GRSLDWAMRMKVATTLAQG 381 (573)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qi~~~ 381 (573)
+..++||||+++|+|.+++...... ...+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999998521110 1234677888999999999
Q ss_pred HHHHHhCCCCCeEEcCCCCCCeeeCCCC--CeeEecccCCccCCcccccc--ceeccCCcccccccccccC--CCCCcch
Q 008216 382 IAFLHDKVKPHVVHRDIRASNVLLDEEF--GAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYR--NELTTKS 455 (573)
Q Consensus 382 L~~LH~~~~~~iiH~Dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~ 455 (573)
|+|||++ +|+||||||+||+++.++ .+||+|||++.......... ......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998776 89999999998653321111 1223349999999999875 6789999
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCC
Q 008216 456 DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPS 535 (573)
Q Consensus 456 DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 535 (573)
||||||+++|||++|+.||......... ........ .. ........++.+.++|.+||+.||.
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~------~~~~~~~~--~~---------~~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTI------SQVLNKKL--CF---------ENPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCCC--CT---------TSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHH------HHHHhccc--cc---------CCcccccCCHHHHHHHHHHcCCChh
Confidence 9999999999999999999876543111 11111000 00 0111123456799999999999999
Q ss_pred CCCCHHHHHH
Q 008216 536 MRPRMSHVVH 545 (573)
Q Consensus 536 ~RPs~~evl~ 545 (573)
+|||+.++++
T Consensus 321 ~Rps~~~~l~ 330 (345)
T 3hko_A 321 ERFDAMRALQ 330 (345)
T ss_dssp TSCCHHHHHH
T ss_pred HCCCHHHHhc
Confidence 9999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=371.64 Aligned_cols=249 Identities=27% Similarity=0.386 Sum_probs=200.0
Q ss_pred eeecccCceEEEEEEe---CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 275 RLLGDSKTGGTYSGIL---PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
+.||+|+||.||+|.+ ..++.||||+++... ....+++.+|+.+|++++||||+++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4689999999999965 246789999998653 2335789999999999999999999999864 568999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc-
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ- 428 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~- 428 (573)
|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999964 35689999999999999999999999 9999999999999999999999999999876543221
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
.......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+........ ....
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i-------~~~~---------- 589 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGE---------- 589 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------HTTC----------
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcCC----------
Confidence 12222337789999999999999999999999999999998 99999876543211111 1110
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
....+..+++++.+||.+||+.||++|||+++|++.|+++.
T Consensus 590 ---~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 590 ---RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 01112235578999999999999999999999999998754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=337.18 Aligned_cols=256 Identities=23% Similarity=0.295 Sum_probs=202.5
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEee--CCceEEEEEe
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEF 346 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~ 346 (573)
+..+.||+|+||.||++... +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+ .+..++||||
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 88 (279)
T 2w5a_A 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88 (279)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEEC
T ss_pred eeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeC
Confidence 33457899999999999964 6899999999754 23445778999999999999999999998754 5678999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEEcCCCCCCeeeCCCCCeeEecccCCcc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH-----VVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-----iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 421 (573)
+++++|.+++.........+++..++.++.|++.||+|||++ + ++||||||+||+++.++.+||+|||++..
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 89 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp CTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred CCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 999999999976443445699999999999999999999998 7 99999999999999999999999999986
Q ss_pred CCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccc
Q 008216 422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL 501 (573)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (573)
........ ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+.... .. . .......
T Consensus 166 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~---~-i~~~~~~-- 234 (279)
T 2w5a_A 166 LNHDTSFA--KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AG---K-IREGKFR-- 234 (279)
T ss_dssp C---CHHH--HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---H-HHHTCCC--
T ss_pred eccccccc--cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH---HH---H-Hhhcccc--
Confidence 64332211 112389999999999988999999999999999999999999987643211 11 0 0111100
Q ss_pred cccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
..+...+.++.+++.+||+.||++|||++||++.+....+
T Consensus 235 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 235 -----------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred -----------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 1112345679999999999999999999999987655443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=361.95 Aligned_cols=249 Identities=21% Similarity=0.268 Sum_probs=203.0
Q ss_pred CcCCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 271 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
++..++||+|+||.||++... +|+.||||++.... ......+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 344567899999999999964 69999999997542 23346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
++||+|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 266 ~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 266 MNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp CCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred CCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 9999999999752 234599999999999999999999999 99999999999999999999999999998765332
Q ss_pred cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccch-hhHHhhhhhhhccccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-SIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .+..... ..
T Consensus 341 ~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~----~~--------- 404 (576)
T 2acx_A 341 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK----EV--------- 404 (576)
T ss_dssp C---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH----HC---------
T ss_pred c---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh----cc---------
Confidence 2 12235999999999999989999999999999999999999999875432111 1111100 00
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH 545 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 545 (573)
....+...++++.+||.+||+.||++|| +++||++
T Consensus 405 -----~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 -----PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -----cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0011123456899999999999999999 7888875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=350.09 Aligned_cols=278 Identities=17% Similarity=0.185 Sum_probs=210.0
Q ss_pred CCcCCeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC--ceEEEEE
Q 008216 270 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG--DRYIVYE 345 (573)
Q Consensus 270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~e 345 (573)
.+...++||+|+||.||+|... +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+ ..++|||
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 3455668899999999999975 48999999997643 234567889999999999999999999988765 6799999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee----CCCCCeeEecccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLMGVGLSKF 421 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfg~~~~ 421 (573)
|+++|+|.+++.... ....+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 90 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 90 FCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred cCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 999999999997532 123499999999999999999999999 99999999999999 7777899999999987
Q ss_pred CCccccccceeccCCcccccccccccC--------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCccc-chhhHHhhhhh
Q 008216 422 VPWEVMQERTVMAGGTYGYLAPEFVYR--------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVC-WQSIFEWATPL 492 (573)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~~~~~ 492 (573)
....... ....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ...........
T Consensus 166 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 166 LEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CCCGGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred ccCCCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 6543322 22349999999999865 567889999999999999999999997543321 11111111000
Q ss_pred hhccccc---ccccccc----ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 493 VQSHRYL---ELLDPLI----SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 493 ~~~~~~~---~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
....... ....... ............+..+.+++.+||+.||++||+++++++.++++....
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 0000000 0000000 000011223567889999999999999999999999999998887653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=349.12 Aligned_cols=263 Identities=22% Similarity=0.353 Sum_probs=203.5
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
+..+.||+|+||.||++... +|+.||+|+++.. .....+.+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus 36 ~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 115 (360)
T 3eqc_A 36 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115 (360)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCC
Confidence 44567899999999999965 6899999999765 334457789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
++|.+++.. ...+++..+..++.|++.||+|||+ + +|+||||||+|||++.++.+||+|||++.......
T Consensus 116 ~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 186 (360)
T 3eqc_A 116 GSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 186 (360)
T ss_dssp CBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCccccccc--
Confidence 999999965 2458999999999999999999998 5 79999999999999999999999999987543221
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhh-----------------
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP----------------- 491 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~----------------- 491 (573)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.............
T Consensus 187 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 187 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp ------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred --ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 1223489999999999999999999999999999999999999987554322111100000
Q ss_pred ------hhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 492 ------LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 492 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
........+.++..........+....+..+.+||.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000011111111111222233345678999999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=336.52 Aligned_cols=246 Identities=21% Similarity=0.353 Sum_probs=202.5
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
++..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 34456789999999999985 468999999997653 3446789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+++|.+++.. ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.........
T Consensus 104 ~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 104 GGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp TEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 9999999863 4689999999999999999999999 9999999999999999999999999999766433221
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
.....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........... .....
T Consensus 176 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~----------- 235 (303)
T 3a7i_A 176 --RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL-------IPKNN----------- 235 (303)
T ss_dssp --BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------HHHSC-----------
T ss_pred --cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH-------hhcCC-----------
Confidence 1223489999999999999999999999999999999999999976543211100 00000
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
........+..+.+++.+||+.||++|||+.++++.
T Consensus 236 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 236 --PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp --CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred --CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 001112234679999999999999999999999974
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=354.88 Aligned_cols=259 Identities=20% Similarity=0.224 Sum_probs=202.0
Q ss_pred HHHHhhcCCCcCCeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC
Q 008216 262 ELRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337 (573)
Q Consensus 262 el~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 337 (573)
+.....++|. ..+.||+|+||.||+++.. +|+.||||++++... ...+.+.+|..++.+++||||+++++++.+.
T Consensus 55 ~~~~~~~~f~-~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 55 EVRLQRDDFE-ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHSCCGGGEE-EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hccCChhhEE-EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 3333344554 4567899999999999974 699999999975422 2234578999999999999999999999999
Q ss_pred CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEeccc
Q 008216 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (573)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 417 (573)
+..|+||||+++|+|.+++... +..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999742 24699999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCccccccceeccCCccccccccccc-------CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhh
Q 008216 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVY-------RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT 490 (573)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 490 (573)
+++......... ....+||+.|+|||++. +..++.++|||||||++|||++|+.||...+...... ...
T Consensus 208 la~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~---~i~ 283 (412)
T 2vd5_A 208 SCLKLRADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG---KIV 283 (412)
T ss_dssp TCEECCTTSCEE-CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHH
T ss_pred hheeccCCCccc-cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH---HHH
Confidence 998765433211 22335999999999987 3568999999999999999999999998765432111 110
Q ss_pred hhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCC---CCHHHHHH
Q 008216 491 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMR---PRMSHVVH 545 (573)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~ 545 (573)
....... ........++++.+||.+||. +|.+| |+++||++
T Consensus 284 ~~~~~~~-------------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 284 HYKEHLS-------------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp THHHHCC-------------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred hcccCcC-------------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0000000 000012345679999999999 99998 58999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=344.27 Aligned_cols=275 Identities=17% Similarity=0.212 Sum_probs=203.5
Q ss_pred cCHHHHHHhhcCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-----CCcEeEEe
Q 008216 258 FTTEELRSITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-----HPNLVAVK 331 (573)
Q Consensus 258 ~~~~el~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv~l~ 331 (573)
++..+...+.++|. ..+.||+|+||.||+|.. .+++.||||+++.. ......+..|+.+++.++ ||||++++
T Consensus 25 ~~~~~g~~~~~~y~-~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 25 FSWKKGMLLNNAFL-VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp CCCCTTCEETTTEE-EEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeecceEecCEEE-EEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 33333334444443 456779999999999996 46899999999754 344566788999999986 99999999
Q ss_pred eEEeeCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC----
Q 008216 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---- 407 (573)
Q Consensus 332 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---- 407 (573)
+++...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCC
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccc
Confidence 9999999999999999 99999999763 234589999999999999999999999 9999999999999975
Q ss_pred ---------------------CCCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHH
Q 008216 408 ---------------------EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLE 466 (573)
Q Consensus 408 ---------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~e 466 (573)
++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 7889999999998654321 12348999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCcccchhhHHhhhhhhhc--------ccccccccc-c-cccCCCCCcc---------------hHHHHH
Q 008216 467 IVSGRRPAQAVDSVCWQSIFEWATPLVQS--------HRYLELLDP-L-ISSLSSDIPE---------------AGVVQK 521 (573)
Q Consensus 467 lltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~-~-~~~~~~~~~~---------------~~~~~~ 521 (573)
|++|+.||...+................. .......+. . .......... ....+.
T Consensus 252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 99999999876543221111110000000 000000000 0 0000000000 011256
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 522 VVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 522 l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+.+|+.+||+.||++|||++|+++
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHhcCChhhCCCHHHHhc
Confidence 889999999999999999999974
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=333.62 Aligned_cols=261 Identities=17% Similarity=0.229 Sum_probs=201.9
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEE-eeCCceEEEEEecC
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC-YDHGDRYIVYEFVV 348 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lv~e~~~ 348 (573)
+...+.||+|+||.||+|.. .+++.||||++.... ....+.+|+.+++.++|++++..++.+ .+.+..++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 4hgt_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence 34456789999999999995 578999999876543 224578899999999887766666555 5667789999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee---CCCCCeeEecccCCccCCcc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~ 425 (573)
+++|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++......
T Consensus 88 ~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 88 GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999998742 34699999999999999999999999 99999999999999 78889999999999876543
Q ss_pred cccc-----ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccc
Q 008216 426 VMQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500 (573)
Q Consensus 426 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (573)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch---
Confidence 2211 11233489999999999999999999999999999999999999987654322222211111000000
Q ss_pred ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
... .....++.+.+++.+||+.||++|||+++|++.|+++.+.
T Consensus 239 -~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 239 -IEV---------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp -HHH---------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -hhh---------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 000 0012346799999999999999999999999999988653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=344.03 Aligned_cols=271 Identities=17% Similarity=0.223 Sum_probs=195.2
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEecccchhh-HHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
..+.||+|+||.||+|... +++.||||+++...... ...+.+|+.++++++||||+++++++.+.+..++||||++ +
T Consensus 6 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (324)
T 3mtl_A 6 KLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-K 84 (324)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-E
T ss_pred EEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-c
Confidence 3457899999999999965 68999999997543221 2245679999999999999999999999999999999996 5
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++... +..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.........
T Consensus 85 ~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~-- 156 (324)
T 3mtl_A 85 DLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-- 156 (324)
T ss_dssp EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCccc--
Confidence 899988752 34689999999999999999999999 9999999999999999999999999999865433221
Q ss_pred eeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc----
Q 008216 431 TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL---- 505 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 505 (573)
.....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+...................+.......
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 112238999999999876 568999999999999999999999998765432111111000000000000000000
Q ss_pred --cccCCCC---CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcccC
Q 008216 506 --ISSLSSD---IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLAQ 552 (573)
Q Consensus 506 --~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~ 552 (573)
....... ......++.+.+|+.+||+.||++|||++|+++ .+.++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 0000000 001124567899999999999999999999987 4444443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=344.52 Aligned_cols=238 Identities=23% Similarity=0.344 Sum_probs=197.1
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccch--------hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEE
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 342 (573)
...+.||+|+||.||+|.. .+|+.||||+++.... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 27 ~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 106 (335)
T 3dls_A 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQL 106 (335)
T ss_dssp EEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred EEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEE
Confidence 3456789999999999985 4688999999976521 123457789999999999999999999999999999
Q ss_pred EEEecCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCcc
Q 008216 343 VYEFVVNG-PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 343 v~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 421 (573)
||||+.+| +|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 107 v~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 107 VMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 99999776 99999864 34699999999999999999999999 999999999999999999999999999987
Q ss_pred CCccccccceeccCCcccccccccccCCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccc
Q 008216 422 VPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500 (573)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (573)
........ ...||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 180 ~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------------- 236 (335)
T 3dls_A 180 LERGKLFY---TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------------- 236 (335)
T ss_dssp CCTTCCBC---EECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------------
T ss_pred CCCCCcee---ccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------------
Confidence 65433221 2348999999999988776 78999999999999999999999753211
Q ss_pred ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
.... ...+...++++.+|+.+||+.||++|||++++++.
T Consensus 237 -~~~~------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -VEAA------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -TTTC------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -Hhhc------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 01111245679999999999999999999999974
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=334.77 Aligned_cols=246 Identities=22% Similarity=0.308 Sum_probs=198.1
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
...+.||+|+||.||++... +|+.||||+++.......+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (304)
T 2jam_A 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGG 91 (304)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCc
Confidence 34567899999999999964 69999999998765555677899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee---CCCCCeeEecccCCccCCcccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||++ +.++.+||+|||++........
T Consensus 92 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 164 (304)
T 2jam_A 92 ELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM 164 (304)
T ss_dssp BHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc
Confidence 99999864 24589999999999999999999999 99999999999999 7788999999999976543221
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
....||+.|+|||.+.+..++.++||||||+++|+|++|..||........ ... .. .... ..
T Consensus 165 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~---i~-~~~~-~~------ 226 (304)
T 2jam_A 165 ----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL---FEK---IK-EGYY-EF------ 226 (304)
T ss_dssp ----HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHH---HH-HCCC-CC------
T ss_pred ----ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HHH---HH-cCCC-CC------
Confidence 112389999999999999999999999999999999999999976543211 110 00 0000 00
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
........++.+.+++.+||+.||++|||++++++
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 227 ---ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ---CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ---CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01111234567999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=345.83 Aligned_cols=266 Identities=17% Similarity=0.150 Sum_probs=198.1
Q ss_pred CCCcCCeeecccCceEEEEEEeC----CCCEEEEEEecccchh-----------hHHHHHHHHHHHhhcCCCcEeEEeeE
Q 008216 269 NFSEGNRLLGDSKTGGTYSGILP----DGSRVAVKRLKRSSFQ-----------RKKEFYSEIGRFARLHHPNLVAVKGC 333 (573)
Q Consensus 269 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nIv~l~~~ 333 (573)
+-+...+.||+|+||.||+|... ++..||||++...... ....+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 33455667899999999999975 5789999998765321 12346678899999999999999999
Q ss_pred Eee----CCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC
Q 008216 334 CYD----HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409 (573)
Q Consensus 334 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~ 409 (573)
+.+ ....++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 988 67789999999 9999999964 23799999999999999999999999 999999999999998877
Q ss_pred --CeeEecccCCccCCcccccc-----ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccc
Q 008216 410 --GAHLMGVGLSKFVPWEVMQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW 482 (573)
Q Consensus 410 --~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~ 482 (573)
.+||+|||+++......... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 99999999998765432111 11233499999999999998999999999999999999999999965322111
Q ss_pred hhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 483 QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
......... ...+...+.. ..+....++++.+++.+||+.||++|||+++|++.|+++..
T Consensus 269 -~~~~~~~~~------~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 -AVQTAKTNL------LDELPQSVLK---WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp -HHHHHHHHH------HHTTTHHHHH---HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred -HHHHHHHhh------cccccHHHHh---hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 000000000 0000010000 00011345679999999999999999999999999998765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=348.99 Aligned_cols=251 Identities=15% Similarity=0.171 Sum_probs=201.0
Q ss_pred CcCCeeecccCceEEEEEE------eCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC---CCcEeEEeeEEeeCCceE
Q 008216 271 SEGNRLLGDSKTGGTYSGI------LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRY 341 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~ 341 (573)
+...+.||+|+||.||+|. ..+++.||||+++... ..++.+|+.++..++ |+||+++++++...+..+
T Consensus 67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~ 143 (365)
T 3e7e_A 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV 143 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence 3445678999999999994 4568999999997653 456777888887776 999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-----------CC
Q 008216 342 IVYEFVVNGPLDRWLHHIPR-GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-----------EF 409 (573)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-----------~~ 409 (573)
+||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++. ++
T Consensus 144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CT
T ss_pred EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccC
Confidence 99999999999999964222 345699999999999999999999999 9999999999999998 89
Q ss_pred CeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhh
Q 008216 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWA 489 (573)
Q Consensus 410 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 489 (573)
.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------- 293 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------- 293 (365)
T ss_dssp TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-------
T ss_pred CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-------
Confidence 9999999999765432222233344599999999999999999999999999999999999999864332100
Q ss_pred hhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcccC
Q 008216 490 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMR-PRMSHVVHQLQQLAQ 552 (573)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~~~~ 552 (573)
...... ...+ ..+.+.+++..|++.+|.+| |+++++.+.|++..+
T Consensus 294 -----------~~~~~~----~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 294 -----------KPEGLF----RRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp -----------EECSCC----TTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred -----------eechhc----cccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 001111 1111 24568899999999999999 678888888887654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=335.43 Aligned_cols=248 Identities=28% Similarity=0.411 Sum_probs=196.0
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC-CceEEEEEecCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-GDRYIVYEFVVNG 350 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lv~e~~~~g 350 (573)
+..+.||+|+||.||++.. +|+.||||+++... ..+.+.+|+.++++++||||+++++++.+. +..++||||++++
T Consensus 24 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~ 100 (278)
T 1byg_A 24 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 100 (278)
T ss_dssp EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred eEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCC
Confidence 4456789999999999988 58999999997653 456789999999999999999999987654 4789999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++... ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 101 ~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 171 (278)
T 1byg_A 101 SLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 171 (278)
T ss_dssp EHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc----
Confidence 999999642 122378899999999999999999999 99999999999999999999999999987654321
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
....+++.|+|||.+.+..++.++||||||+++|||+| |..||........ .... ... .
T Consensus 172 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~----~~~-----~------- 231 (278)
T 1byg_A 172 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRV----EKG-----Y------- 231 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHH----TTT-----C-------
T ss_pred -cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----hcC-----C-------
Confidence 11237889999999988899999999999999999998 9999976543211 1100 000 0
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
....+...++.+.+++.+||+.||++|||+.++++.|+++..
T Consensus 232 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 232 -KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 011122345679999999999999999999999999998754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=341.07 Aligned_cols=257 Identities=18% Similarity=0.263 Sum_probs=202.2
Q ss_pred HhhcCCCcCCeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCce
Q 008216 265 SITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR 340 (573)
Q Consensus 265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 340 (573)
.+.+.+....+.||+|+||.||++... +|+.||||+++... ......+.+|+.++.++ +||||+++++++.+.+..
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 344444444478899999999999964 58999999997642 23357889999999999 569999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---CCCeeEeccc
Q 008216 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVG 417 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg 417 (573)
++||||+++|+|.+++.. .....+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 105 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred EEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 999999999999999864 3345699999999999999999999999 9999999999999987 7899999999
Q ss_pred CCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccc
Q 008216 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 497 (573)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 497 (573)
++......... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+........ .. ..
T Consensus 180 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------~~-~~ 249 (327)
T 3lm5_A 180 MSRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI------SQ-VN 249 (327)
T ss_dssp GCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HH-TC
T ss_pred cccccCCcccc---ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH------Hh-cc
Confidence 99876533221 2234999999999999999999999999999999999999999775542111000 00 00
Q ss_pred cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
. .. ........++.+.++|.+||+.||++|||++++++.
T Consensus 250 ~-~~---------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 250 V-DY---------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp C-CC---------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred c-cc---------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 00 011112345679999999999999999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=353.01 Aligned_cols=266 Identities=23% Similarity=0.287 Sum_probs=188.8
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeCC--ceEEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHG--DRYIVYE 345 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~--~~~lv~e 345 (573)
+..+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.++.++. ||||+++++++...+ ..++|||
T Consensus 12 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 91 (388)
T 3oz6_A 12 ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFD 91 (388)
T ss_dssp EEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEE
T ss_pred EEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEec
Confidence 3455789999999999985 46899999998653 3445677889999999997 999999999997654 6899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|++ ++|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 92 YME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp CCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred ccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 996 689999864 4589999999999999999999999 9999999999999999999999999999865321
Q ss_pred c-------------------cccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhh
Q 008216 426 V-------------------MQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI 485 (573)
Q Consensus 426 ~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~ 485 (573)
. .........||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0 0111122359999999999876 6789999999999999999999999987654321111
Q ss_pred HHhhhhhhhccccc--------ccccccc------ccCCCC------------CcchHHHHHHHHHHHHhcCCCCCCCCC
Q 008216 486 FEWATPLVQSHRYL--------ELLDPLI------SSLSSD------------IPEAGVVQKVVDLVYACTQHVPSMRPR 539 (573)
Q Consensus 486 ~~~~~~~~~~~~~~--------~~~~~~~------~~~~~~------------~~~~~~~~~l~~li~~cl~~dP~~RPs 539 (573)
.............. ..+.... ...... .+....++++.+|+.+||+.||++|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 10000000000000 0000000 000000 001133567999999999999999999
Q ss_pred HHHHHHH
Q 008216 540 MSHVVHQ 546 (573)
Q Consensus 540 ~~evl~~ 546 (573)
++|+++.
T Consensus 323 ~~e~l~H 329 (388)
T 3oz6_A 323 ANDALKH 329 (388)
T ss_dssp HHHHTTS
T ss_pred HHHHhCC
Confidence 9999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=333.12 Aligned_cols=246 Identities=19% Similarity=0.339 Sum_probs=195.4
Q ss_pred CCcCCeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEee----CCceEE
Q 008216 270 FSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYI 342 (573)
Q Consensus 270 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~l 342 (573)
++...+.||+|+||.||+|.. .++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 344456789999999999986 45889999999754 33456778999999999999999999999875 345799
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCeeeC-CCCCeeEecccCC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLD-EEFGAHLMGVGLS 419 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--iiH~Dlkp~NIll~-~~~~~kl~Dfg~~ 419 (573)
||||+++++|.+++.. ...+++..+..++.|++.||+|||++ + ++||||||+||+++ .++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 9999999999999964 24589999999999999999999999 8 99999999999997 7889999999999
Q ss_pred ccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
........ ....||+.|+|||.+. +.++.++||||||+++|+|++|+.||....... .... .. .....
T Consensus 180 ~~~~~~~~----~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~---~~-~~~~~- 247 (290)
T 1t4h_A 180 TLKRASFA----KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYR---RV-TSGVK- 247 (290)
T ss_dssp GGCCTTSB----EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHH---HH-TTTCC-
T ss_pred cccccccc----ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH--HHHH---HH-hccCC-
Confidence 76543321 2234899999999876 458999999999999999999999997654321 1110 00 00000
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
........++.+.++|.+||+.||++|||++++++
T Consensus 248 -----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 -----------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00111123357999999999999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=341.69 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=193.8
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCce----EE
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR----YI 342 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~----~l 342 (573)
++..+.||+|+||.||++.. .+++.||||+++... ......+.+|+.++++++||||+++++++...... ++
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~l 93 (311)
T 3ork_A 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 93 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEE
Confidence 34456789999999999995 578999999997653 23346788999999999999999999998876543 99
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
||||+++++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 94 v~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 94 VMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 9999999999999964 24689999999999999999999999 9999999999999999999999999999876
Q ss_pred Cccccc-cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccc
Q 008216 423 PWEVMQ-ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL 501 (573)
Q Consensus 423 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (573)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ....... .
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~----~ 236 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVRED----P 236 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCC----C
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcCC----C
Confidence 543221 1222234899999999999999999999999999999999999999876542110 0000000 0
Q ss_pred cccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHhcc
Q 008216 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQLQQL 550 (573)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl-~~L~~~ 550 (573)
..+. ......+..+.+++.+||+.||++||++.+++ ..|.+.
T Consensus 237 ~~~~-------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 237 IPPS-------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CCHH-------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCcc-------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0000 00112456799999999999999999666554 555544
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=339.55 Aligned_cols=268 Identities=21% Similarity=0.321 Sum_probs=205.3
Q ss_pred HhhcCCCcCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhh--cCCCcEeEEeeEEeeCC----
Q 008216 265 SITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFAR--LHHPNLVAVKGCCYDHG---- 338 (573)
Q Consensus 265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~---- 338 (573)
.+.++| ...+.||+|+||.||+|+. +|+.||||++... ....+.+|.+++.. ++||||+++++++...+
T Consensus 39 ~~~~~y-~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 39 TIARTI-VLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHC-EEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred cccccE-EEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 334444 4456789999999999998 6999999999654 34567788888887 79999999999998876
Q ss_pred ceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEcCCCCCCeeeCCCCC
Q 008216 339 DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH--------DKVKPHVVHRDIRASNVLLDEEFG 410 (573)
Q Consensus 339 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~iiH~Dlkp~NIll~~~~~ 410 (573)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +. +|+||||||+|||++.++.
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSC
T ss_pred eeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCC
Confidence 78999999999999999975 35899999999999999999999 77 9999999999999999999
Q ss_pred eeEecccCCccCCcccccc--ceeccCCcccccccccccCC------CCCcchhhHHHHHHHHHHHcC----------CC
Q 008216 411 AHLMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYRN------ELTTKSDVYSFGVLLLEIVSG----------RR 472 (573)
Q Consensus 411 ~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG----------~~ 472 (573)
+||+|||++.......... ......||+.|+|||++.+. .++.++||||||+++|||+|| ..
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 9999999997654332211 12233489999999998765 234789999999999999999 67
Q ss_pred CCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 473 PAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 473 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
||........ ........ .... ...+.. .........++.+.+|+.+||+.||++|||+.+|++.|+++.+
T Consensus 266 p~~~~~~~~~-~~~~~~~~-~~~~----~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 266 PYYDLVPSDP-SVEEMRKV-VCEQ----KLRPNI---PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp TTTTTSCSSC-CHHHHHHH-HTTS----CCCCCC---CGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccccCcCcc-cHHHHHHH-HHHH----HhCCCC---cccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 7765432110 00000000 0000 011100 0111224677889999999999999999999999999999876
Q ss_pred CC
Q 008216 553 PP 554 (573)
Q Consensus 553 ~~ 554 (573)
..
T Consensus 337 ~~ 338 (342)
T 1b6c_B 337 QE 338 (342)
T ss_dssp TT
T ss_pred Hh
Confidence 54
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=335.05 Aligned_cols=247 Identities=23% Similarity=0.432 Sum_probs=199.6
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEee---------------
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--------------- 336 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------------- 336 (573)
..+.||+|+||.||+|... +|+.||||+++... +.+.+|+.++++++||||+++++++..
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 15 EIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp EEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred eeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence 3457899999999999975 79999999997653 346789999999999999999998864
Q ss_pred -CCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEec
Q 008216 337 -HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415 (573)
Q Consensus 337 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 415 (573)
....++||||+++++|.+++... ....+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred CcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECc
Confidence 34579999999999999999752 235689999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhc
Q 008216 416 VGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS 495 (573)
Q Consensus 416 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 495 (573)
||++......... ....||+.|+|||.+.+..++.++||||||+++|||++|..|+..... ... . ..
T Consensus 166 fg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~~~---~-~~- 232 (284)
T 2a19_B 166 FGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-----FFT---D-LR- 232 (284)
T ss_dssp CTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-----HHH---H-HH-
T ss_pred chhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-----HHH---H-hh-
Confidence 9999876543221 223389999999999999999999999999999999999988642110 000 0 00
Q ss_pred cccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCch
Q 008216 496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVT 556 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 556 (573)
.... +...+..+.+++.+||+.||++|||+.|+++.|..+...+..
T Consensus 233 -------~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 233 -------DGII--------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp -------TTCC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred -------cccc--------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 0000 112345689999999999999999999999999988876543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=357.91 Aligned_cols=250 Identities=19% Similarity=0.291 Sum_probs=203.1
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
..++||+|+||.||+++.. +|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 189 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~ 268 (543)
T 3c4z_A 189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMN 268 (543)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEecc
Confidence 3467899999999999974 699999999976432 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
||+|.+++.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 269 gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~ 345 (543)
T 3c4z_A 269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345 (543)
T ss_dssp TCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred CCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence 9999999976544456799999999999999999999999 9999999999999999999999999999876543221
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccc-hhhHHhhhhhhhccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW-QSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+... ... .
T Consensus 346 --~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~---i~~---------~--- 408 (543)
T 3c4z_A 346 --TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR---VLE---------Q--- 408 (543)
T ss_dssp --BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHH---HHH---------C---
T ss_pred --cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHH---Hhh---------c---
Confidence 2223599999999999999999999999999999999999999987543211 111110 000 0
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM-----SHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 545 (573)
....+...+..+.+||.+||+.||++||++ ++|++
T Consensus 409 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 409 ---AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ---ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 001122345679999999999999999975 66664
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=332.14 Aligned_cols=247 Identities=22% Similarity=0.314 Sum_probs=196.5
Q ss_pred eeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCHH
Q 008216 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 353 (573)
.+||+|+||.||+|.. .+++.||||.++.......+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4789999999999995 468899999998776566788999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-CCCeeEecccCCccCCcccccccee
Q 008216 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-EFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
+++.... ....+++..+..++.|++.||+|||++ +++||||||+||+++. ++.+||+|||++......... ..
T Consensus 108 ~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~--~~ 181 (295)
T 2clq_A 108 ALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TE 181 (295)
T ss_dssp HHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------C
T ss_pred HHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc--cc
Confidence 9997532 234577899999999999999999999 9999999999999987 889999999999876432211 12
Q ss_pred ccCCcccccccccccCCC--CCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 433 MAGGTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
...||+.|+|||++.+.. ++.++||||||+++|+|++|+.||......... ... .. .. ..
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~--~~--~~-----~~-------- 243 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MFK--VG--MF-----KV-------- 243 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HHH--HH--HH-----CC--------
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HHh--hc--cc-----cc--------
Confidence 234899999999987643 789999999999999999999999754332110 000 00 00 00
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....+...++.+.+++.+||+.||++|||++++++
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00112234567999999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=331.30 Aligned_cols=260 Identities=17% Similarity=0.240 Sum_probs=202.0
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEE-eeCCceEEEEEecCC
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC-YDHGDRYIVYEFVVN 349 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lv~e~~~~ 349 (573)
...+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+.+++.++|++++..+..+ .+.+..++||||+ +
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (296)
T 3uzp_A 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 88 (296)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-C
Confidence 4456789999999999995 579999999987653 234688999999999888766655554 5667779999999 9
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee---CCCCCeeEecccCCccCCccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++.......
T Consensus 89 ~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 89 PSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred CCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 9999999742 34699999999999999999999999 99999999999999 478899999999998765432
Q ss_pred ccc-----ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccc
Q 008216 427 MQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL 501 (573)
Q Consensus 427 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (573)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---- 238 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP---- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC----
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc----
Confidence 211 11233499999999999999999999999999999999999999987544322222111111000000
Q ss_pred cccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
. +.+ ....++.+.+++.+||+.||++|||+++|++.|+++...
T Consensus 239 ~-~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 239 I-EVL--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp H-HHH--------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred h-HHH--------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 0 000 112346799999999999999999999999999987643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=332.09 Aligned_cols=241 Identities=18% Similarity=0.251 Sum_probs=194.3
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
..+.||+|+||.||+|... +++.||||+++.. .......+.+|+..+.++ +||||+++++++.+.+..++||||++
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 94 (289)
T 1x8b_A 15 ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCN 94 (289)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecC
Confidence 3457899999999999975 7999999999764 234457788999999999 99999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-------------------C
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-------------------F 409 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-------------------~ 409 (573)
+++|.+++.........+++..+..++.||+.||+|||++ +|+||||||+||+++.+ .
T Consensus 95 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 171 (289)
T 1x8b_A 95 GGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171 (289)
T ss_dssp TCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------------CC
T ss_pred CCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence 9999999975333335689999999999999999999999 99999999999999844 4
Q ss_pred CeeEecccCCccCCccccccceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHh
Q 008216 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488 (573)
Q Consensus 410 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 488 (573)
.+||+|||.+........ ..||+.|+|||.+.+. .++.++||||||+++|+|++|.+|+...... ..
T Consensus 172 ~~kl~Dfg~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--~~---- 239 (289)
T 1x8b_A 172 MFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW--HE---- 239 (289)
T ss_dssp CEEECCCTTCEETTCSCC------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH--HH----
T ss_pred EEEEcccccccccCCccc------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH--HH----
Confidence 799999999987653321 2389999999999765 5678999999999999999999876543210 00
Q ss_pred hhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 489 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
..... . . ..+...++.+.+++.+||+.||++|||+.++++
T Consensus 240 ----~~~~~--------~----~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 240 ----IRQGR--------L----P-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ----HHTTC--------C----C-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHcCC--------C----C-CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 00010 0 0 011224567999999999999999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=355.88 Aligned_cols=260 Identities=19% Similarity=0.255 Sum_probs=191.8
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC------CceEE
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------GDRYI 342 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~l 342 (573)
+..+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+|+.++||||+++++++... ...++
T Consensus 65 ~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l 144 (464)
T 3ttj_A 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144 (464)
T ss_dssp EEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred EEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEE
Confidence 4456789999999999985 45899999999764 334467788999999999999999999998755 35699
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
||||+++ +|.+.+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 145 v~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 145 VMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred EEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 9999965 5666664 2489999999999999999999999 9999999999999999999999999999876
Q ss_pred CccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchh-hHHhhh-----------
Q 008216 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWAT----------- 490 (573)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~~----------- 490 (573)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...... +.....
T Consensus 215 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 215 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp --CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred CCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 43321 122348999999999999999999999999999999999999998765421111 110000
Q ss_pred ----hhhhcc-c-----cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 491 ----PLVQSH-R-----YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 491 ----~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
...... . +...+...... .........++++.+|+.+||+.||++|||++|+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFP-ADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSC-CSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhHhhcccccCCCChHHhCcccccc-cccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 0 00000000000 000011223678999999999999999999999987
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=346.27 Aligned_cols=241 Identities=21% Similarity=0.278 Sum_probs=187.7
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHH-HhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGR-FARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
+..++||+|+||.||+++.. +++.||||++++... .....+.+|..+ ++.++||||+++++++.+.+..|+||||
T Consensus 41 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~ 120 (373)
T 2r5t_A 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY 120 (373)
T ss_dssp EEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeC
Confidence 44567899999999999965 588999999976532 233456677776 5678999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 121 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 121 INGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 999999999864 24689999999999999999999999 99999999999999999999999999998532221
Q ss_pred cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
......+||+.|+|||++.+..++.++||||||+++|||++|..||...+.... .. .... . ..
T Consensus 194 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~---~i~~-~--------~~ 256 (373)
T 2r5t_A 194 --STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YD---NILN-K--------PL 256 (373)
T ss_dssp --CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH---HH---HHHH-S--------CC
T ss_pred --CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---HH---HHHh-c--------cc
Confidence 122234599999999999999999999999999999999999999986543211 11 1110 0 00
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSH 542 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 542 (573)
..+...+..+.+||.+||+.||.+||++.+
T Consensus 257 ------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 257 ------QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 011224567999999999999999999853
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=340.86 Aligned_cols=267 Identities=23% Similarity=0.361 Sum_probs=194.4
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHH--HHHhhcCCCcEeEEeeEEee-----CCceEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEI--GRFARLHHPNLVAVKGCCYD-----HGDRYIVY 344 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~--~~l~~l~h~nIv~l~~~~~~-----~~~~~lv~ 344 (573)
+..+.||+|+||.||+|+. +++.||||+++... ...+..|. ..+..++||||+++++.+.. ....++||
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 91 (336)
T 3g2f_A 16 KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91 (336)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred heeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence 4456789999999999987 78999999997543 23344444 44556899999999986543 23568999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEEcCCCCCCeeeCCCCCeeEecccC
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV------KPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 418 (573)
||+++|+|.+++.. ...++..+..++.||+.||+|||++. .++|+||||||+|||++.++.+||+|||+
T Consensus 92 e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 92 EYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp CCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 99999999999965 33588999999999999999999863 33899999999999999999999999999
Q ss_pred CccCCcccc------ccceeccCCcccccccccccC-------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcc-cchh
Q 008216 419 SKFVPWEVM------QERTVMAGGTYGYLAPEFVYR-------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV-CWQS 484 (573)
Q Consensus 419 ~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-~~~~ 484 (573)
+........ ........||+.|+|||++.+ ..++.++||||||+++|||++|..||...... ....
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 246 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence 987653321 111223349999999999976 45677999999999999999997776543321 1111
Q ss_pred hHHh----------hhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 485 IFEW----------ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 485 ~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
.... ........ ...+.... ........++.+.++|.+||+.||++|||+.|+++.|+++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 247 AFQTEVGNHPTFEDMQVLVSRE----KQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTS----CCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhhcccCCCchHHHHHhhhccc----ccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 1000 00000000 00011100 1112234677899999999999999999999999999988754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=345.88 Aligned_cols=263 Identities=17% Similarity=0.176 Sum_probs=203.2
Q ss_pred CCcCCeeecccCceEEEEEEeCC---------CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeE-----------
Q 008216 270 FSEGNRLLGDSKTGGTYSGILPD---------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVA----------- 329 (573)
Q Consensus 270 ~~~~~~~lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~----------- 329 (573)
-+...+.||+|+||.||+|.... ++.||||++... +.+.+|+.++++++||||++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 34455678999999999999753 789999999754 35789999999999999887
Q ss_pred ----EeeEEee-CCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCee
Q 008216 330 ----VKGCCYD-HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404 (573)
Q Consensus 330 ----l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIl 404 (573)
+++++.. .+..++||||+ +++|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl 191 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF 191 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence 6677766 67789999999 99999999752 235699999999999999999999999 9999999999999
Q ss_pred eCCCC--CeeEecccCCccCCcccccc-----ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 008216 405 LDEEF--GAHLMGVGLSKFVPWEVMQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAV 477 (573)
Q Consensus 405 l~~~~--~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 477 (573)
++.++ .+||+|||+++......... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99988 89999999998765432211 112234999999999999989999999999999999999999999875
Q ss_pred CcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 478 DSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
.... ..+......... ......+. .......++.+.+++.+||+.||++|||+++|++.|+++...
T Consensus 272 ~~~~-~~~~~~~~~~~~--~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 272 LPNT-EDIMKQKQKFVD--KPGPFVGP-------CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp TTCH-HHHHHHHHHHHH--SCCCEECT-------TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CcCH-HHHHHHHHhccC--Chhhhhhh-------ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 4221 111111111100 00111110 001122356799999999999999999999999999988643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=342.75 Aligned_cols=247 Identities=24% Similarity=0.274 Sum_probs=195.1
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
+..+.||+|+||.||++... +|+.||||+++.... ...+|++++.++ +||||+++++++.+.+..++||||+++
T Consensus 25 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g 100 (342)
T 2qr7_A 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100 (342)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence 33457899999999999964 588999999976532 234688888888 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-C---CeeEecccCCccCCcc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-F---GAHLMGVGLSKFVPWE 425 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-~---~~kl~Dfg~~~~~~~~ 425 (573)
|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+.++ + .+||+|||++......
T Consensus 101 g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 101 GELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 999999864 34699999999999999999999999 99999999999998543 2 4999999999865433
Q ss_pred ccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.. ......||+.|+|||++.+..++.++||||||+++|||++|..||..........+..... .....
T Consensus 174 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~~~~~------ 241 (342)
T 2qr7_A 174 NG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG----SGKFS------ 241 (342)
T ss_dssp TC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH----HCCCC------
T ss_pred CC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc----cCCcc------
Confidence 21 1223458999999999988889999999999999999999999998643322222221111 11100
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
. ........++.+.+||.+||+.||++|||+.++++
T Consensus 242 ~----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 L----SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp C----CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred c----CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 01111234567999999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=329.92 Aligned_cols=247 Identities=20% Similarity=0.279 Sum_probs=198.2
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccch------hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 344 (573)
...+.||+|+||.||++... +|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 87 (283)
T 3bhy_A 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLIL 87 (283)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEE
Confidence 34557899999999999975 689999999976422 13578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC----CeeEecccCCc
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVGLSK 420 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfg~~~ 420 (573)
||+++++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++ .+||+|||++.
T Consensus 88 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 88 ELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred eecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999999964 34689999999999999999999999 999999999999998877 79999999998
Q ss_pred cCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccc
Q 008216 421 FVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500 (573)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (573)
........ ....||+.|+|||.+.+..++.++||||||+++|+|++|..||........... . .....
T Consensus 161 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~-~~~~~-- 228 (283)
T 3bhy_A 161 KIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTN------I-SAVNY-- 228 (283)
T ss_dssp ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------H-HTTCC--
T ss_pred eccCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHH------h-Hhccc--
Confidence 76433221 122389999999999988999999999999999999999999987543211100 0 00000
Q ss_pred ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
..... .....++.+.+++.+||+.||++|||+.++++
T Consensus 229 ~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 DFDEE--------YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCCHH--------HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCcch--------hcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00000 01123467899999999999999999999997
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=334.50 Aligned_cols=253 Identities=21% Similarity=0.334 Sum_probs=198.6
Q ss_pred HhhcCCCcCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEE
Q 008216 265 SITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 343 (573)
....+.++..+.||+|+||.||+|... +|+.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 333344455667899999999999965 58999999997653 356789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCC
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 423 (573)
|||+++++|.+++.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 103 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 103 MEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred eecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 999999999999863 235689999999999999999999999 99999999999999999999999999997654
Q ss_pred ccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccc
Q 008216 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503 (573)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (573)
..... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||......... ..... .. .
T Consensus 177 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-~~-----~ 242 (314)
T 3com_A 177 DTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI------FMIPT-NP-----P 242 (314)
T ss_dssp TTBSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHH-SC-----C
T ss_pred hhccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhc-CC-----C
Confidence 33221 12234899999999999889999999999999999999999999765432110 00000 00 0
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+ ....+...+..+.+++.+||+.||++|||+.++++
T Consensus 243 ~------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 243 P------TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp C------CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 00112234567999999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=330.00 Aligned_cols=245 Identities=19% Similarity=0.299 Sum_probs=201.4
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
...+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 97 (294)
T 2rku_A 18 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC 97 (294)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecC
Confidence 44567899999999999975 5889999998754 2344577889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 98 RRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp TTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 99999998864 24689999999999999999999999 999999999999999999999999999987643322
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
. .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ .. .. ....
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~---~~-~~~~---------- 231 (294)
T 2rku_A 171 R--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET---YL---RI-KKNE---------- 231 (294)
T ss_dssp C--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH---HH-HTTC----------
T ss_pred c--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH---HH-hhcc----------
Confidence 1 1223489999999999988899999999999999999999999976543211 00 00 0000
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
...+...+..+.+++.+||+.||++|||++++++.
T Consensus 232 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 ----YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00112234678999999999999999999999973
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=339.61 Aligned_cols=265 Identities=20% Similarity=0.264 Sum_probs=196.0
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhh-----HHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQR-----KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
+..+.||+|+||.||+|... +|+.||||+++...... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 13 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 92 (346)
T 1ua2_A 13 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 92 (346)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred EEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEE
Confidence 34567899999999999964 58999999997542211 2467899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|+++ +|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 93 FMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred cCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 9975 89888863 335688899999999999999999999 9999999999999999999999999999876433
Q ss_pred ccccceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchh-hHHhhhhhhhcccccc---
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPLVQSHRYLE--- 500 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~--- 500 (573)
... .....||+.|+|||++.+. .++.++||||||+++|||++|.+||...+...... +...... .....+.+
T Consensus 166 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~ 242 (346)
T 1ua2_A 166 NRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT-PTEEQWPDMCS 242 (346)
T ss_dssp CCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC-CCTTTSSSTTS
T ss_pred ccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCC-CChhhhhhhcc
Confidence 221 1223489999999998764 58899999999999999999999998765421111 1110000 00000000
Q ss_pred ccccccccCCCCCc----chHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 501 LLDPLISSLSSDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 501 ~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
..+..........+ ....++.+.+||.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000000000001 02345689999999999999999999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=336.15 Aligned_cols=257 Identities=23% Similarity=0.297 Sum_probs=194.9
Q ss_pred cCCeeecccCceEEEEEEeC--CCC--EEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGILP--DGS--RVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~--~g~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 344 (573)
+..+.||+|+||.||+|.+. +++ .||||+++... ....+.+.+|+.++++++||||+++++++.+.+ .++||
T Consensus 21 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 99 (291)
T 1u46_A 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVT 99 (291)
T ss_dssp EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEE
T ss_pred eeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeE
Confidence 44567899999999999853 333 69999987542 234578899999999999999999999987754 89999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCc
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 424 (573)
||+++++|.+++... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 100 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 100 ELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp ECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred ecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999999742 24589999999999999999999999 999999999999999999999999999987654
Q ss_pred ccccc-ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccc
Q 008216 425 EVMQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502 (573)
Q Consensus 425 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (573)
..... ......+|..|+|||.+.+..++.++||||||+++|+|++ |+.||...+.... .. .......
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~---~~~~~~~----- 242 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---LH---KIDKEGE----- 242 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HH---HHHTSCC-----
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH---HH---HHHccCC-----
Confidence 32211 1222337889999999988889999999999999999999 9999987653211 11 1000000
Q ss_pred ccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
........++.+.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 243 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 243 --------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred --------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 01112234567999999999999999999999999999887653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=328.49 Aligned_cols=242 Identities=24% Similarity=0.305 Sum_probs=199.4
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 17 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 96 (284)
T 2vgo_A 17 DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFA 96 (284)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeC
Confidence 44567899999999999965 57899999996542 123467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 168 (284)
T 2vgo_A 97 PRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 168 (284)
T ss_dssp TTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence 99999999864 24589999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||.......... .... . +
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~-~------~---- 228 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR------RIVN-V------D---- 228 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHT-T------C----
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH------HHhc-c------c----
Confidence 122348999999999999899999999999999999999999997654321110 0000 0 0
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
...+...+..+.++|.+||+.||.+|||++++++
T Consensus 229 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 ----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0011224567899999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=339.11 Aligned_cols=254 Identities=20% Similarity=0.302 Sum_probs=186.7
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEeEEeeEEee--------CCce
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYD--------HGDR 340 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~--------~~~~ 340 (573)
+...+.||+|+||.||++.. .+|+.||||++........+.+.+|+.++.++. ||||+++++++.. ....
T Consensus 30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 109 (337)
T 3ll6_A 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109 (337)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence 34456789999999999996 468999999997776667788999999999995 9999999999842 3447
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCeeeCCCCCeeEecccC
Q 008216 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLDEEFGAHLMGVGL 418 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--iiH~Dlkp~NIll~~~~~~kl~Dfg~ 418 (573)
++||||+. |+|.+++.... ....+++..++.++.||+.||+|||++ + |+||||||+|||++.++.+||+|||+
T Consensus 110 ~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 110 LLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred EEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 99999995 79999886422 234699999999999999999999999 8 99999999999999999999999999
Q ss_pred CccCCcccccc----------ceeccCCcccccccccc---cCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhh
Q 008216 419 SKFVPWEVMQE----------RTVMAGGTYGYLAPEFV---YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI 485 (573)
Q Consensus 419 ~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~ 485 (573)
+.......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---- 260 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---- 260 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence 98765432211 11123489999999998 56678999999999999999999999997543211
Q ss_pred HHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 486 FEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
...... ........+..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 261 ---------------~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 261 ---------------IVNGKY----SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp --------------------C----CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------------hhcCcc----cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 000000 000111123358899999999999999999999999988864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=337.46 Aligned_cols=244 Identities=19% Similarity=0.296 Sum_probs=201.1
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
...+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 44 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 123 (335)
T 2owb_A 44 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC 123 (335)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecC
Confidence 44567899999999999965 4789999998754 2344677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++++|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 124 ~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 124 RRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp TTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 99999998864 24689999999999999999999999 999999999999999999999999999987643322
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||........ .. .... ..
T Consensus 197 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~---~~~~-~~---------- 257 (335)
T 2owb_A 197 R--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET---YL---RIKK-NE---------- 257 (335)
T ss_dssp C--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH---HHHH-TC----------
T ss_pred c--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH---HH---HHhc-CC----------
Confidence 1 1223489999999999988899999999999999999999999976543211 00 0000 00
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
...+...+..+.++|.+||+.||++|||++|+++
T Consensus 258 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 258 ----YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011123457899999999999999999999997
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=327.15 Aligned_cols=243 Identities=22% Similarity=0.318 Sum_probs=192.3
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (276)
T 2h6d_A 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV 93 (276)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEecc
Confidence 44567899999999999975 69999999997542 223567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++........
T Consensus 94 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 94 SGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp CSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred CCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 99999999964 24589999999999999999999999 999999999999999999999999999987654322
Q ss_pred ccceeccCCcccccccccccCCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
. ....+|+.|+|||.+.+..+ +.++||||||+++|+|++|+.||....... ..... ....
T Consensus 167 ~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~----~~~~--------- 227 (276)
T 2h6d_A 167 L---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LFKKI----RGGV--------- 227 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHCC---------
T ss_pred e---ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHh----hcCc---------
Confidence 1 12238999999999987765 689999999999999999999997654321 11110 0000
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
...+...+..+.+++.+||+.||++|||++++++
T Consensus 228 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 228 -----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0011223457899999999999999999999997
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=328.72 Aligned_cols=248 Identities=22% Similarity=0.316 Sum_probs=195.6
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccc----hhhHHHHHHHHHHHhhcCCCcEeEEeeEEe--eCCceEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARLHHPNLVAVKGCCY--DHGDRYIVY 344 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~lv~ 344 (573)
...+.||+|+||.||++.. .+++.||||+++... ....+.+.+|+.++++++||||+++++++. +.+..++||
T Consensus 8 ~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (305)
T 2wtk_C 8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVM 87 (305)
T ss_dssp CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEE
T ss_pred eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEe
Confidence 3455789999999999996 468899999997642 234577999999999999999999999984 456789999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCc
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 424 (573)
||++++ |.+++... ....+++..+..++.||+.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 88 e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 88 EYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp ECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred hhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 999776 77777653 245699999999999999999999999 999999999999999999999999999987654
Q ss_pred cccccceeccCCcccccccccccCCC--CCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccc
Q 008216 425 EVMQERTVMAGGTYGYLAPEFVYRNE--LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502 (573)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (573)
...........||+.|+|||++.+.. .+.++||||||+++|||++|+.||...+.... .. .. .....
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~---~i-~~~~~---- 230 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL---FE---NI-GKGSY---- 230 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH---HH-HHCCC----
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH---HH---HH-hcCCC----
Confidence 33333333344899999999987644 37899999999999999999999986543211 11 00 00000
Q ss_pred ccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
..+...++.+.+++.+||+.||++|||++|+++.
T Consensus 231 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111245678999999999999999999999963
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=347.45 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=188.6
Q ss_pred hcCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccch--------hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC
Q 008216 267 TKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337 (573)
Q Consensus 267 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 337 (573)
.++| ...+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.+|++++||||+++++++. .
T Consensus 134 ~~~y-~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 134 RDEY-IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HTTE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hccE-EEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 3344 4456789999999999986 4589999999975421 11234789999999999999999999975 4
Q ss_pred CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC---CeeEe
Q 008216 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLM 414 (573)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~ 414 (573)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 568999999999999998853 35699999999999999999999999 999999999999997544 59999
Q ss_pred cccCCccCCccccccceeccCCcccccccccccC---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhh
Q 008216 415 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP 491 (573)
Q Consensus 415 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~ 491 (573)
|||+++....... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||....... .+....
T Consensus 285 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i-- 357 (419)
T 3i6u_A 285 DFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI-- 357 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHH--
T ss_pred ecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHH--
Confidence 9999987653322 122349999999999863 567889999999999999999999997654321 011000
Q ss_pred hhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 492 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
..... ..... .....++.+.+++.+||+.||++|||++|+++
T Consensus 358 --~~~~~-~~~~~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 358 --TSGKY-NFIPE---------VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp --HTTCC-CCCHH---------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --hcCCC-CCCch---------hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000 00000 01124567999999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=336.41 Aligned_cols=268 Identities=19% Similarity=0.236 Sum_probs=197.0
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC--------Cce
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH--------GDR 340 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------~~~ 340 (573)
+..+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+.++++++||||+++++++.+. +..
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 99 (351)
T 3mi9_A 20 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 99 (351)
T ss_dssp EEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEE
T ss_pred eEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceE
Confidence 3345789999999999996 5789999999865432 2346788999999999999999999998874 467
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
++||||+++ +|.+.+.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 100 ~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 100 YLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp EEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 999999965 77777753 234699999999999999999999999 99999999999999999999999999998
Q ss_pred cCCcccc--ccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccc
Q 008216 421 FVPWEVM--QERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 497 (573)
Q Consensus 421 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 497 (573)
....... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......................
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 7643221 112223348999999999876 4579999999999999999999999987654322111111100000000
Q ss_pred cc-----cccccccccCCCCCcc-h-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 498 YL-----ELLDPLISSLSSDIPE-A-----GVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 498 ~~-----~~~~~~~~~~~~~~~~-~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
.. +..+............ . ..++.+.+||.+||+.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00 0000000000000000 0 114568899999999999999999999973
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=353.00 Aligned_cols=252 Identities=22% Similarity=0.311 Sum_probs=200.7
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
...+.||+|+||.||++... +|+.||||++.... ......+.+|+.++++++||||+++++++.+.+..++||||+.
T Consensus 25 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 104 (486)
T 3mwu_A 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT 104 (486)
T ss_dssp EEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCC
Confidence 34567899999999999964 68999999996532 2345788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC---CCCCeeEecccCCccCCcc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~ 425 (573)
+++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++......
T Consensus 105 ~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 105 GGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp SCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999998864 24699999999999999999999999 999999999999995 4567999999999866433
Q ss_pred ccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.. .....||+.|+|||++.+ .++.++||||||+++|+|++|.+||...+........ .......
T Consensus 178 ~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-------~~~~~~~----- 241 (486)
T 3mwu_A 178 TK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-------ETGKYAF----- 241 (486)
T ss_dssp -------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTCCCS-----
T ss_pred Cc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhCCCCC-----
Confidence 22 122349999999999865 5899999999999999999999999876542211110 0010000
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhccc
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQLA 551 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 551 (573)
........++.+.+||.+||+.||++|||+.++++. +++..
T Consensus 242 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 242 -----DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp -----CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred -----CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 001112356779999999999999999999999973 44443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=334.59 Aligned_cols=248 Identities=24% Similarity=0.368 Sum_probs=196.1
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+..+.||+|+||.||+|... +|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 22 ~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (302)
T 2j7t_A 22 EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGG 101 (302)
T ss_dssp EEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTE
T ss_pred eecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCC
Confidence 44557899999999999975 58999999998776666788999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++... ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....... ..
T Consensus 102 ~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 173 (302)
T 2j7t_A 102 AVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QK 173 (302)
T ss_dssp EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC
T ss_pred cHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc--cc
Confidence 999988642 34589999999999999999999999 99999999999999999999999999875432111 11
Q ss_pred eeccCCccccccccccc-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 431 TVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.....||+.|+|||++. +..++.++||||||+++|+|++|..||...+.... ........ .
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~-~------- 239 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSD-P------- 239 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSC-C-------
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHhccC-C-------
Confidence 12234899999999883 56789999999999999999999999987553211 00000000 0
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.....+...+..+.+++.+||+.||++|||+.++++
T Consensus 240 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 ----PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ----CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ----cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 011122344567999999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=332.99 Aligned_cols=250 Identities=24% Similarity=0.401 Sum_probs=184.5
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccc-hhh-HHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
+..+.||+|+||.||++.. .+|+.||||+++... ... .+.+.++...++.++||||+++++++.+.+..++||||++
T Consensus 10 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 89 (290)
T 3fme_A 10 EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD 89 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS
T ss_pred hhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc
Confidence 3456789999999999996 578999999997652 222 2334455556788899999999999999999999999996
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
|+|.+++......+..+++..+..++.|++.||+|||++. +++||||||+||+++.++.+||+|||++.........
T Consensus 90 -~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 166 (290)
T 3fme_A 90 -TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166 (290)
T ss_dssp -EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred -cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccccccc
Confidence 5888887653334567999999999999999999999842 8999999999999999999999999999876543222
Q ss_pred cceeccCCcccccccccc----cCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFV----YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
....||+.|+|||.+ .+..++.++||||||+++|+|++|+.||....... ... .......
T Consensus 167 ---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~----~~~~~~~-------- 230 (290)
T 3fme_A 167 ---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-QQL----KQVVEEP-------- 230 (290)
T ss_dssp ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-HHH----HHHHHSC--------
T ss_pred ---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-HHH----HHHhccC--------
Confidence 122389999999996 45678999999999999999999999997643221 111 0101100
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....+....++.+.+++.+||+.||++|||+.|+++
T Consensus 231 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 -----SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -----CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 011122334567999999999999999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=340.84 Aligned_cols=250 Identities=20% Similarity=0.244 Sum_probs=197.8
Q ss_pred cCCeeecccCceEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEE
Q 008216 272 EGNRLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI 342 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 342 (573)
+..+.||+|+||.||+++. .+|+.||||+++... ....+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 57 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 136 (355)
T 1vzo_A 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL 136 (355)
T ss_dssp EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEE
T ss_pred EEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEE
Confidence 3456789999999999996 478999999997542 22345677899999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
||||+++++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 137 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 137 ILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 9999999999999965 24589999999999999999999999 9999999999999999999999999999876
Q ss_pred CccccccceeccCCcccccccccccC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccc
Q 008216 423 PWEVMQERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500 (573)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (573)
........ ....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......... .........
T Consensus 210 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~----- 281 (355)
T 1vzo_A 210 VADETERA-YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILKS----- 281 (355)
T ss_dssp CGGGGGGG-CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHHC-----
T ss_pred ccCCCCcc-cCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--HHHHHHhcc-----
Confidence 54332222 22349999999999985 347899999999999999999999997654321111 101110000
Q ss_pred ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 008216 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVHQ 546 (573)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 546 (573)
....+...+..+.+||.+||+.||++|| +++|+++.
T Consensus 282 ----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 282 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 0111223456789999999999999999 99999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=337.71 Aligned_cols=262 Identities=25% Similarity=0.328 Sum_probs=195.8
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
+..+.||+|+||.||++... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 107 (331)
T 4aaa_A 28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD 107 (331)
T ss_dssp EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCC
Confidence 33457899999999999965 48999999986543 2335668899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.........
T Consensus 108 ~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 108 HTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp EEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred cchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 9999887653 34599999999999999999999999 9999999999999999999999999999865433221
Q ss_pred cceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchh-hHHhhh-------hhhh-cccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWAT-------PLVQ-SHRY 498 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~~-------~~~~-~~~~ 498 (573)
.....||+.|+|||++.+. .++.++||||||+++|+|++|+.||.......... ...... .... ....
T Consensus 181 --~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 181 --YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred --cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 1223489999999998775 68999999999999999999999998765432111 000000 0000 0000
Q ss_pred ccccccccccCCCCCc----chHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 499 LELLDPLISSLSSDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 499 ~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.....+.. ....+ ....++.+.+|+.+||+.||++|||+.|+++
T Consensus 259 ~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 259 AGVRLPEI---KEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TTCCCCCC---SSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccCccc---cccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 00011 1134578999999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=337.68 Aligned_cols=264 Identities=17% Similarity=0.233 Sum_probs=189.6
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccchh--hHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ--RKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
...+.||+|+||.||++.. .+|+.||||+++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 37 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 116 (329)
T 3gbz_A 37 RRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE 116 (329)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC
Confidence 4456789999999999985 46899999999765322 24567899999999999999999999999999999999996
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC-----CCCCeeEecccCCccCC
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-----EEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~-----~~~~~kl~Dfg~~~~~~ 423 (573)
++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++....
T Consensus 117 -~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 117 -NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp -EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred -CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 599999865 24589999999999999999999999 999999999999994 44559999999998654
Q ss_pred ccccccceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccc-
Q 008216 424 WEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL- 501 (573)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 501 (573)
..... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||...........................
T Consensus 189 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 189 IPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp -------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred Ccccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 32211 1222379999999999874 4899999999999999999999999876543211110000000000000000
Q ss_pred -c---ccccccCCCCC----cchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 502 -L---DPLISSLSSDI----PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 502 -~---~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
. ........... .....++++.+||.+||+.||++|||++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 00000000000 01124567899999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=348.99 Aligned_cols=238 Identities=17% Similarity=0.177 Sum_probs=184.9
Q ss_pred CCeeecccCceEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHH---HHHhhcCCCcEeEEe-------eEEeeCC
Q 008216 273 GNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS---SFQRKKEFYSEI---GRFARLHHPNLVAVK-------GCCYDHG 338 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~nIv~l~-------~~~~~~~ 338 (573)
..+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|+ .++++++||||++++ +++.+.+
T Consensus 77 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 156 (377)
T 3byv_A 77 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 156 (377)
T ss_dssp EEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTT
T ss_pred EcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccC
Confidence 346789999999999995 56999999999743 334567889999 455556899999998 6665553
Q ss_pred c-----------------eEEEEEecCCCCHHHHhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC
Q 008216 339 D-----------------RYIVYEFVVNGPLDRWLHHIP---RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDI 398 (573)
Q Consensus 339 ~-----------------~~lv~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dl 398 (573)
. .++||||+ +|+|.+++.... .....+++..++.++.||+.||+|||++ +|+||||
T Consensus 157 ~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDi 232 (377)
T 3byv_A 157 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL 232 (377)
T ss_dssp SCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred CccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 2 78999999 689999997421 1122344688889999999999999999 9999999
Q ss_pred CCCCeeeCCCCCeeEecccCCccCCccccccceeccCCcccccccccccCC-----------CCCcchhhHHHHHHHHHH
Q 008216 399 RASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-----------ELTTKSDVYSFGVLLLEI 467 (573)
Q Consensus 399 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvil~el 467 (573)
||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||+++|||
T Consensus 233 kp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 233 RPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 99999999999999999999986432 1223347 999999999887 899999999999999999
Q ss_pred HcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 468 VSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 468 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
++|+.||........ ....... ....++.+.+||.+||+.||++|||+.|+++
T Consensus 307 ltg~~Pf~~~~~~~~-------------------~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 307 WCADLPITKDAALGG-------------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHSSCCC------CC-------------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHCCCCCcccccccc-------------------hhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999976543211 0000000 0123467999999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=355.71 Aligned_cols=247 Identities=24% Similarity=0.342 Sum_probs=200.9
Q ss_pred CcCCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 271 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
++..+.||+|+||.||++... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 28 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 107 (484)
T 3nyv_A 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV 107 (484)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 344567899999999999965 68999999996542 33467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee---CCCCCeeEecccCCccCC
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~ 423 (573)
+.+++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++....
T Consensus 108 ~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 108 YTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp CCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999998864 35699999999999999999999999 99999999999999 567889999999998665
Q ss_pred ccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccc
Q 008216 424 WEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503 (573)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (573)
..... ....||+.|+|||++.+ .++.++||||||+++|+|++|.+||...+.......+ ...... .
T Consensus 181 ~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-------~~~~~~-~-- 246 (484)
T 3nyv_A 181 ASKKM---KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV-------EKGKYT-F-- 246 (484)
T ss_dssp CCCSH---HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCCCC-C--
T ss_pred ccccc---ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HcCCCC-C--
Confidence 43221 22349999999999865 6899999999999999999999999876543211110 011000 0
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
........++.+.+||.+||+.||++|||+.|+++
T Consensus 247 -------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 -------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00111245678999999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=342.54 Aligned_cols=259 Identities=20% Similarity=0.307 Sum_probs=191.2
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC------ceEE
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRYI 342 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~l 342 (573)
...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.++++++||||+++++++...+ ..++
T Consensus 28 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l 107 (367)
T 1cm8_A 28 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 107 (367)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEE
Confidence 4456789999999999996 46999999999653 3334567899999999999999999999987653 4599
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
||||+ +++|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 108 VMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp EEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 99999 8899999875 4589999999999999999999999 9999999999999999999999999999875
Q ss_pred CccccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchh-hHHhhhh----hhh--
Q 008216 423 PWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATP----LVQ-- 494 (573)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~~~----~~~-- 494 (573)
... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+...... +...... ...
T Consensus 179 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 179 DSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp CSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred ccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 432 122348999999999877 678999999999999999999999998765432111 1000000 000
Q ss_pred -ccccccccccccccCCCC---CcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 495 -SHRYLELLDPLISSLSSD---IPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 495 -~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.......+.. +...... ......++.+.+|+.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 254 QSDEAKNYMKG-LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp SCHHHHHHHHH-SCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHh-CCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000000000 0000000 001123567999999999999999999999997
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=341.25 Aligned_cols=259 Identities=19% Similarity=0.314 Sum_probs=199.8
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccchhh-----------------HHHHHHHHHHHhhcCCCcEeEEeeEE
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQR-----------------KKEFYSEIGRFARLHHPNLVAVKGCC 334 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~nIv~l~~~~ 334 (573)
...+.||+|+||.||+|.. +|+.||||++....... .+.+.+|+.++++++||||+++++++
T Consensus 34 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 112 (348)
T 2pml_X 34 RIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII 112 (348)
T ss_dssp EEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEE
T ss_pred EEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 4456789999999999999 99999999997542221 17899999999999999999999999
Q ss_pred eeCCceEEEEEecCCCCHHHH------hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCC
Q 008216 335 YDHGDRYIVYEFVVNGPLDRW------LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDE 407 (573)
Q Consensus 335 ~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~ 407 (573)
.+.+..++||||+++++|.++ +.. .....+++..+..++.|++.||+|||+ + +++||||||+||+++.
T Consensus 113 ~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 113 TNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDK 187 (348)
T ss_dssp ESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECT
T ss_pred eeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcC
Confidence 999999999999999999998 432 224679999999999999999999999 8 9999999999999999
Q ss_pred CCCeeEecccCCccCCccccccceeccCCcccccccccccCC-CCCc-chhhHHHHHHHHHHHcCCCCCCCCCcccchhh
Q 008216 408 EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTT-KSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI 485 (573)
Q Consensus 408 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~ 485 (573)
++.+||+|||++...... ......||+.|+|||.+.+. .++. ++||||||+++|||++|..||...... ...
T Consensus 188 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~ 261 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VEL 261 (348)
T ss_dssp TSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HHH
T ss_pred CCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHH
Confidence 999999999999875433 12223489999999999877 6666 999999999999999999999876541 111
Q ss_pred HHhhhhhhhcccccc----ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 486 FEWATPLVQSHRYLE----LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 486 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....... ...... ...+.. ...........+..+.+++.+||+.||.+|||++|+++
T Consensus 262 ~~~i~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 FNNIRTK--NIEYPLDRNHFLYPLT-NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHTSC--CCCCCCSSSSSTTTTC-C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHhcc--CcCCccchhhhhcccc-ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111000 000000 000000 00000011334568999999999999999999999987
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=349.27 Aligned_cols=190 Identities=22% Similarity=0.362 Sum_probs=150.2
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC-----CceEEE
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIV 343 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv 343 (573)
+..+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+|++++||||+++++++... ...|+|
T Consensus 56 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 135 (458)
T 3rp9_A 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVV 135 (458)
T ss_dssp EECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred EEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEE
Confidence 44557899999999999854 6899999999653 334557889999999999999999999998543 568999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCC
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 423 (573)
|||+ +++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 136 ~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 136 LEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp ECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred Eecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 9998 6799998864 35699999999999999999999999 99999999999999999999999999998764
Q ss_pred ccccc-------------------------cceeccCCcccccccccc-cCCCCCcchhhHHHHHHHHHHHc
Q 008216 424 WEVMQ-------------------------ERTVMAGGTYGYLAPEFV-YRNELTTKSDVYSFGVLLLEIVS 469 (573)
Q Consensus 424 ~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~ellt 469 (573)
..... .......||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 32211 111223489999999976 45679999999999999999999
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=340.94 Aligned_cols=275 Identities=19% Similarity=0.259 Sum_probs=197.9
Q ss_pred HHHHHHhhcCCCcCCeeecccCceEEEEEEeCCCCEEEEEEecccch-----------hhHHHHHHHHHHHhhcCCCcEe
Q 008216 260 TEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF-----------QRKKEFYSEIGRFARLHHPNLV 328 (573)
Q Consensus 260 ~~el~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~nIv 328 (573)
..++..+.++|.. .+.||+|+||.||+|...+|+.||||++..... ...+.+.+|+.++++++||||+
T Consensus 14 ~~~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 14 IAELHAMQSPYTV-QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHTTCSCEE-EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHhccceEE-eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4566777777655 557799999999999988899999999865321 1237789999999999999999
Q ss_pred EEeeEEeeC-----CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCe
Q 008216 329 AVKGCCYDH-----GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403 (573)
Q Consensus 329 ~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NI 403 (573)
++++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 999998543 35799999996 688888863 335699999999999999999999999 999999999999
Q ss_pred eeCCCCCeeEecccCCccCCccccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccc
Q 008216 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCW 482 (573)
Q Consensus 404 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~ 482 (573)
+++.++.+||+|||++......... ....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADANK---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEcCCCCEEEEecCccccccccccc---ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999754433222 22338999999999876 6789999999999999999999999987653221
Q ss_pred hh-hHHhhhhh-------hhccccccccccccccCCCCC---cchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 483 QS-IFEWATPL-------VQSHRYLELLDPLISSLSSDI---PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 483 ~~-~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.. +....... .......+.+........... .....++.+.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11 11000000 000000001111110000000 01123467999999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=346.10 Aligned_cols=196 Identities=21% Similarity=0.313 Sum_probs=162.1
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC-----CceEEE
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIV 343 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv 343 (573)
...+.||+|+||.||+|... +|+.||||+++.. .....+.+.+|+.+|++++||||+++++++... +..|+|
T Consensus 29 ~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv 108 (432)
T 3n9x_A 29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIV 108 (432)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred EEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEE
Confidence 44567899999999999964 5889999999754 334457889999999999999999999998776 568999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCC
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 423 (573)
|||+. ++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 109 ~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 109 LEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 99985 699999864 35699999999999999999999999 99999999999999999999999999998765
Q ss_pred ccccc--------------------cceeccCCcccccccccc-cCCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 008216 424 WEVMQ--------------------ERTVMAGGTYGYLAPEFV-YRNELTTKSDVYSFGVLLLEIVSGRRPAQ 475 (573)
Q Consensus 424 ~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltG~~Pf~ 475 (573)
..... .......||+.|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 43211 112334589999999986 45679999999999999999998655543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=335.78 Aligned_cols=254 Identities=20% Similarity=0.331 Sum_probs=200.7
Q ss_pred HHhhcCCCcCCeeecccCceEEEEEEeC-CCCEEEEEEecccch--------hhHHHHHHHHHHHhhc-CCCcEeEEeeE
Q 008216 264 RSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARL-HHPNLVAVKGC 333 (573)
Q Consensus 264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 333 (573)
..+..+|.. .+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+.+++++ +||||++++++
T Consensus 90 ~~~~~~y~~-~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 90 KEFYQKYDP-KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhccc-ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 344444443 457899999999999975 699999999875421 1245678999999999 89999999999
Q ss_pred EeeCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeE
Q 008216 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHL 413 (573)
Q Consensus 334 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 413 (573)
+...+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. |++||||||+|||++.++.+||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999964 24689999999999999999999999 9999999999999999999999
Q ss_pred ecccCCccCCccccccceeccCCcccccccccccC------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHH
Q 008216 414 MGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE 487 (573)
Q Consensus 414 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 487 (573)
+|||++......... ....||+.|+|||++.+ ..++.++||||||+++|||++|..||..........
T Consensus 242 ~DfG~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~--- 315 (365)
T 2y7j_A 242 SDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR--- 315 (365)
T ss_dssp CCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---
T ss_pred EecCcccccCCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHH---
Confidence 999999876543221 22349999999998863 357889999999999999999999997654321110
Q ss_pred hhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 488 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
... .... ....+. ....+..+.+++.+||+.||++|||+.++++
T Consensus 316 ---~i~-~~~~-~~~~~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 ---MIM-EGQY-QFSSPE---------WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---HHH-HTCC-CCCHHH---------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHH-hCCC-CCCCcc---------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 0000 000000 0123457999999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=351.48 Aligned_cols=246 Identities=22% Similarity=0.309 Sum_probs=194.1
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
...+.||+|+||.||+|... ++..||||+++... ......+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 40 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 119 (494)
T 3lij_A 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119 (494)
T ss_dssp EEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 34567899999999999964 68899999997653 2345778999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC---CCeeEecccCCccCCcc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~ 425 (573)
+|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||++......
T Consensus 120 ~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 120 GGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp SCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999998864 24589999999999999999999999 99999999999999764 45999999999876433
Q ss_pred ccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.. .....||+.|+|||++. ..++.++|||||||++|+|++|.+||............ ..... ....+
T Consensus 193 ~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-------~~~~~-~~~~~- 259 (494)
T 3lij_A 193 KK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV-------EKGKY-TFDSP- 259 (494)
T ss_dssp BC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTCC-CCCSG-
T ss_pred cc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhCCC-CCCch-
Confidence 22 12234999999999885 56899999999999999999999999876543211111 00000 00000
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.....++.+.+||.+||+.||++|||+.|+++
T Consensus 260 --------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 260 --------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp --------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --------hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 11234567999999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=364.36 Aligned_cols=244 Identities=23% Similarity=0.297 Sum_probs=200.3
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEe
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
+..++||+|+||.||+|... +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..|+||||
T Consensus 344 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~ 423 (674)
T 3pfq_A 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 423 (674)
T ss_dssp EEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEEC
T ss_pred EEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeC
Confidence 34567899999999999964 58899999997542 23456788899999988 799999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 424 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 424 VNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 999999999975 24599999999999999999999999 99999999999999999999999999998643322
Q ss_pred cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+.... ... .. ..
T Consensus 497 ~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~---~~~---i~---------~~-- 557 (674)
T 3pfq_A 497 V--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQS---IM---------EH-- 557 (674)
T ss_dssp C--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH---HH---------SS--
T ss_pred c--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH---HHH---HH---------hC--
Confidence 2 22334599999999999999999999999999999999999999987654211 111 00 00
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM-----SHVVH 545 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 545 (573)
....+...++++.+||.+||+.||++||++ +||++
T Consensus 558 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 558 ----NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ----CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 011122356789999999999999999998 67764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=332.24 Aligned_cols=257 Identities=19% Similarity=0.247 Sum_probs=196.6
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEeEEeeEEee--CCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYD--HGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~lv~e~~ 347 (573)
+..+.||+|+||.||+|.. .+++.||||+++.. ..+.+.+|+.++++++ ||||+++++++.+ ....++||||+
T Consensus 39 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~ 115 (330)
T 3nsz_A 39 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115 (330)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred EEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence 3456789999999999985 56899999999754 3467889999999996 9999999999987 56789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-CeeEecccCCccCCccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~ 426 (573)
++++|.+++. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++......
T Consensus 116 ~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 116 NNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp CCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred CchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 9999999884 388999999999999999999999 999999999999999776 79999999998665432
Q ss_pred cccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhh--------hhccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL--------VQSHR 497 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~--------~~~~~ 497 (573)
.. ....+|..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ..+....... .....
T Consensus 186 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 186 EY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp CC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHHHHHHHCHHHHHHHHHHTT
T ss_pred cc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHHHHHhcCCchhhhHHHHhc
Confidence 22 22348999999999877 678999999999999999999999996543321 1111100000 00000
Q ss_pred --c----cccc----ccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 498 --Y----LELL----DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 498 --~----~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
. .+.. ................++++.+||.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0000 0000011111222335678999999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=334.01 Aligned_cols=247 Identities=23% Similarity=0.373 Sum_probs=192.6
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEee------CCceEEE
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD------HGDRYIV 343 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~------~~~~~lv 343 (573)
+..+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.+++++ +||||+++++++.. .+..++|
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv 105 (326)
T 2x7f_A 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 105 (326)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEE
T ss_pred EEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEE
Confidence 3456789999999999996 468999999997653 3456789999999999 89999999999987 4578999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCC
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 423 (573)
|||+++++|.+++... ....+++..+..++.||+.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 106 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 106 MEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred EEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 9999999999999753 235689999999999999999999999 99999999999999999999999999998664
Q ss_pred ccccccceeccCCccccccccccc-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccc
Q 008216 424 WEVMQERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY 498 (573)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 498 (573)
..... .....||+.|+|||++. +..++.++||||||+++|+|++|..||......... ..... ...
T Consensus 181 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-~~~ 251 (326)
T 2x7f_A 181 RTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FLIPR-NPA 251 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHH-SCC
T ss_pred cCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH------HHhhc-Ccc
Confidence 32211 12234899999999987 466889999999999999999999999765432110 00000 000
Q ss_pred ccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
........+..+.++|.+||+.||++|||++++++
T Consensus 252 ------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 252 ------------PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ------------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ------------ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111223567999999999999999999999987
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.78 Aligned_cols=260 Identities=19% Similarity=0.262 Sum_probs=189.4
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC------ceEE
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRYI 342 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~l 342 (573)
...+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++.++||||+++++++...+ ..++
T Consensus 28 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~l 107 (371)
T 2xrw_A 28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 107 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEE
T ss_pred eEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEE
Confidence 34567899999999999854 6889999999754 3344567889999999999999999999987665 6799
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
||||++ ++|.+++. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 108 VMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred EEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 999996 57888875 3489999999999999999999999 9999999999999999999999999999865
Q ss_pred CccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchh-hHHhh------------
Q 008216 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWA------------ 489 (573)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~------------ 489 (573)
..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+...... +....
T Consensus 178 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 178 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred ccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 43221 122348999999999999999999999999999999999999998765421110 00000
Q ss_pred ---hhhhhc-c-----ccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 490 ---TPLVQS-H-----RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 490 ---~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
...... . .+...+...... .........+..+.+|+.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFP-ADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSC-CSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHHHhhCccccccchhhhcccccCc-ccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000000 0 000000000000 000011234678999999999999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=338.43 Aligned_cols=265 Identities=20% Similarity=0.254 Sum_probs=197.6
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC-----CceEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIVY 344 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~ 344 (573)
...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++... ...++||
T Consensus 30 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~ 109 (364)
T 3qyz_A 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 109 (364)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred EEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEE
Confidence 44567899999999999864 68899999997543 33457789999999999999999999998765 3679999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCc
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 424 (573)
||+. ++|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 110 e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 110 DLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp ECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred cccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 9996 599999864 3599999999999999999999999 999999999999999999999999999987654
Q ss_pred cccccc-eeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccc
Q 008216 425 EVMQER-TVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502 (573)
Q Consensus 425 ~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (573)
...... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+........................
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 432211 122349999999998754 458999999999999999999999998765432211111000000000000000
Q ss_pred c----cccccCC--CCCc----chHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 503 D----PLISSLS--SDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 503 ~----~~~~~~~--~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+ ....... ...+ ....+.++.+||.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 0000000 0000 0123567999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=341.48 Aligned_cols=249 Identities=12% Similarity=-0.027 Sum_probs=177.1
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHhhc--CCCcEeEEe-------eEEeeCC-
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYSEIGRFARL--HHPNLVAVK-------GCCYDHG- 338 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~nIv~l~-------~~~~~~~- 338 (573)
..+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+.+++.+ +||||++++ +++...+
T Consensus 66 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~ 145 (371)
T 3q60_A 66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQ 145 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTS
T ss_pred eeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCC
Confidence 4557899999999999964 689999999987532 3356677885544444 699988855 4444332
Q ss_pred ----------------ceEEEEEecCCCCHHHHhccCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCeEEc
Q 008216 339 ----------------DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR------MKVATTLAQGIAFLHDKVKPHVVHR 396 (573)
Q Consensus 339 ----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~qi~~~L~~LH~~~~~~iiH~ 396 (573)
..++||||++ |+|.+++... +..+++..+ ..++.||+.||+|||++ +|+||
T Consensus 146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHr 218 (371)
T 3q60_A 146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHG 218 (371)
T ss_dssp CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccC
Confidence 3799999998 8999999752 123444455 67789999999999999 99999
Q ss_pred CCCCCCeeeCCCCCeeEecccCCccCCccccccceeccCCcccccccccccC--CCCCcchhhHHHHHHHHHHHcCCCCC
Q 008216 397 DIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPA 474 (573)
Q Consensus 397 Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~Pf 474 (573)
||||+|||++.++.+||+|||+++....... ...+|+.|+|||++.+ ..++.++||||||+++|||+||+.||
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEEE-----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCcc-----CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999986643221 2237799999999987 67999999999999999999999999
Q ss_pred CCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 475 QAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 475 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.......... .............. ........++.+.+||.+||+.||++|||+.++++
T Consensus 294 ~~~~~~~~~~--------~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 294 GLVTPGIKGS--------WKRPSLRVPGTDSL----AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TBCCTTCTTC--------CCBCCTTSCCCCSC----CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCcCcccccc--------hhhhhhhhcccccc----chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 8764321100 00000000000000 01111245678999999999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=337.34 Aligned_cols=256 Identities=20% Similarity=0.350 Sum_probs=195.6
Q ss_pred CcCCeeecccCceEEEEEEeCCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 271 SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
++..+.||+|+||.||+|...+ .||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 112 (319)
T 2y4i_B 35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112 (319)
T ss_dssp EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence 3445678999999999998743 49999987542 2233567789999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc-
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM- 427 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 427 (573)
+++|.+++.. ....+++..+..++.||+.||+|||++ +++||||||+||+++ ++.+||+|||++........
T Consensus 113 ~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 113 GRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp SEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 9999999964 234689999999999999999999999 999999999999998 67999999999876532211
Q ss_pred --ccceeccCCcccccccccccC---------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcc
Q 008216 428 --QERTVMAGGTYGYLAPEFVYR---------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH 496 (573)
Q Consensus 428 --~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 496 (573)
........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......... . .. ...
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~---~~-~~~ 258 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII---W---QM-GTG 258 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH---H---HH-HTT
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H---Hh-ccC
Confidence 111223348999999999864 35788999999999999999999999865532111 0 00 000
Q ss_pred ccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
.. ........+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 259 -----~~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 259 -----MK-------PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp -----CC-------CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred -----CC-------CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 00 11111123346899999999999999999999999999987653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=325.62 Aligned_cols=247 Identities=21% Similarity=0.300 Sum_probs=198.6
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc---------hhhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeCCce
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---------FQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDR 340 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~ 340 (573)
+..+.||+|+||.||++... +|+.||||+++... ....+.+.+|+.+++++. ||||+++++++.+.+..
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 99 (298)
T 1phk_A 20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 99 (298)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeE
Confidence 34567899999999999964 68899999997542 122466889999999995 99999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 100 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 100 FLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchh
Confidence 999999999999999964 24689999999999999999999999 99999999999999999999999999998
Q ss_pred cCCccccccceeccCCccccccccccc------CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhh
Q 008216 421 FVPWEVMQERTVMAGGTYGYLAPEFVY------RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ 494 (573)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 494 (573)
........ ....||+.|+|||++. ...++.++||||||+++|+|++|..||.......... ....
T Consensus 173 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~ 243 (298)
T 1phk_A 173 QLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR------MIMS 243 (298)
T ss_dssp ECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHH
T ss_pred hcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHH------HHhc
Confidence 76533221 2234899999999885 4567899999999999999999999997654321111 0000
Q ss_pred ccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.... . ........+..+.+++.+||+.||++|||+.|+++
T Consensus 244 -~~~~-~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 244 -GNYQ-F---------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -TCCC-C---------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -CCcc-c---------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0000 0 01111245678999999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=332.21 Aligned_cols=263 Identities=21% Similarity=0.331 Sum_probs=184.8
Q ss_pred CCCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 269 NFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
+-++..+.||+|+||.||+|.. .+++.||||++.... ....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 3345567889999999999985 468999999987543 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 347 VVNGPLDRWLHHI----PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 347 ~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
+++++|.+++... ......+++..+..++.||+.||+|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 9999999998642 11235689999999999999999999999 9999999999999999999999999998765
Q ss_pred Cccccc---cceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccc
Q 008216 423 PWEVMQ---ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY 498 (573)
Q Consensus 423 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 498 (573)
...... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......... ..... ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~-~~ 244 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM------LTLQN-DP 244 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH------HHHTS-SC
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH------HHhcc-CC
Confidence 432211 11122348999999999875 568999999999999999999999998765432110 00000 00
Q ss_pred ccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....... .........+..+.+++.+||+.||.+|||+.++++
T Consensus 245 ~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 PSLETGV----QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCTTC---------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Ccccccc----ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0000000 000111224467999999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=350.63 Aligned_cols=246 Identities=24% Similarity=0.341 Sum_probs=195.6
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccch-------------hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-------------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDH 337 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 337 (573)
...+.||+|+||.||+|... +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 39 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 118 (504)
T 3q5i_A 39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK 118 (504)
T ss_dssp EEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred EEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 33567899999999999964 588999999975421 2346789999999999999999999999999
Q ss_pred CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC---CeeEe
Q 008216 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF---GAHLM 414 (573)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~ 414 (573)
+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 119 ~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 119 KYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred CEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999998864 24599999999999999999999999 999999999999998775 69999
Q ss_pred cccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhh
Q 008216 415 GVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ 494 (573)
Q Consensus 415 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 494 (573)
|||++......... ....||+.|+|||++. ..++.++||||+|+++|+|++|.+||...+........ .
T Consensus 192 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-------~ 260 (504)
T 3q5i_A 192 DFGLSSFFSKDYKL---RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV-------E 260 (504)
T ss_dssp CCTTCEECCTTSCB---CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------H
T ss_pred ECCCCEEcCCCCcc---ccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------H
Confidence 99999876543221 2234999999999886 56899999999999999999999999876543211111 0
Q ss_pred ccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
..... .+ .......++++.+||.+||+.||.+|||++|+++
T Consensus 261 ~~~~~--~~--------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 261 KGKYY--FD--------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HCCCC--CC--------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCCC--CC--------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 01000 00 0001224567999999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=340.69 Aligned_cols=263 Identities=21% Similarity=0.271 Sum_probs=192.1
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC------------
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------------ 338 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------------ 338 (573)
...+.||+|+||.||+|.. .+|+.||||++..... ...+|+.+++.++||||+++++++...+
T Consensus 10 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 85 (383)
T 3eb0_A 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD 85 (383)
T ss_dssp EEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred EEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence 4456789999999999985 5799999999975532 2347999999999999999999985432
Q ss_pred --------------------------ceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 008216 339 --------------------------DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392 (573)
Q Consensus 339 --------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ 392 (573)
..++||||++ ++|.+.+......+..+++..+..++.||+.||+|||++ +
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---g 161 (383)
T 3eb0_A 86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---G 161 (383)
T ss_dssp ------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---T
T ss_pred cccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---c
Confidence 3789999997 588877765434456799999999999999999999999 9
Q ss_pred eEEcCCCCCCeeeC-CCCCeeEecccCCccCCccccccceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcC
Q 008216 393 VVHRDIRASNVLLD-EEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSG 470 (573)
Q Consensus 393 iiH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG 470 (573)
|+||||||+|||++ .++.+||+|||+++......... ...+|+.|+|||.+.+. .++.++||||+|+++|||++|
T Consensus 162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 238 (383)
T 3eb0_A 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV---AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238 (383)
T ss_dssp EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCC---CCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCc---CcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC
Confidence 99999999999997 67889999999998764433222 22389999999998765 489999999999999999999
Q ss_pred CCCCCCCCcccch-hhHHhhhh-----hh-hccccccccccccccC-CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 008216 471 RRPAQAVDSVCWQ-SIFEWATP-----LV-QSHRYLELLDPLISSL-SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSH 542 (573)
Q Consensus 471 ~~Pf~~~~~~~~~-~~~~~~~~-----~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 542 (573)
+.||...+..... .+...... .. ......+..-+..... .....+...++.+.+|+.+||+.||++|||+.|
T Consensus 239 ~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 318 (383)
T 3eb0_A 239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE 318 (383)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 9999876543211 11100000 00 0000000000000000 000011224567999999999999999999999
Q ss_pred HHH
Q 008216 543 VVH 545 (573)
Q Consensus 543 vl~ 545 (573)
+++
T Consensus 319 ~l~ 321 (383)
T 3eb0_A 319 AMA 321 (383)
T ss_dssp HHT
T ss_pred Hhc
Confidence 985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=344.45 Aligned_cols=260 Identities=18% Similarity=0.228 Sum_probs=204.1
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCC-CcEeEEeeEEeeCCceEEEEEecC
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
+...+.||+|+||.||+|.. .+++.||||++..... ..++.+|+++++.++| ++|..+..+..+.+..++||||+
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~- 85 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence 34456789999999999995 5699999999875532 3457899999999976 66666777777888889999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee---CCCCCeeEecccCCccCCcc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL---DEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~ 425 (573)
+++|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 86 g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 86 GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999999742 34699999999999999999999999 99999999999999 58889999999999876543
Q ss_pred cccc-----ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccc
Q 008216 426 VMQE-----RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500 (573)
Q Consensus 426 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (573)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.................... ..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----~~ 235 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----AT 235 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH----HS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc----cc
Confidence 3211 11234499999999999999999999999999999999999999987655332222222111110 01
Q ss_pred ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
.+.... ..++.++.+++.+||+.||++||++.+|++.|+++..
T Consensus 236 ~~~~l~---------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 236 SIEALC---------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp CHHHHH---------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cHHHHh---------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 111100 1234679999999999999999999999999988743
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=329.56 Aligned_cols=264 Identities=21% Similarity=0.304 Sum_probs=195.7
Q ss_pred cCCeeecccCceEEEEEEe--CCCCEEEEEEecccch--hhHHHHHHHHHHHhhc---CCCcEeEEeeEEe-----eCCc
Q 008216 272 EGNRLLGDSKTGGTYSGIL--PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARL---HHPNLVAVKGCCY-----DHGD 339 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~-----~~~~ 339 (573)
...+.||+|+||.||+|.. .+|+.||||+++.... .....+.+|+.+++.+ +||||+++++++. ....
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 93 (326)
T 1blx_A 14 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93 (326)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred eeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCce
Confidence 3455789999999999997 4688999999875422 1223566777777666 8999999999987 4567
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCC
Q 008216 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (573)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 419 (573)
.++||||++ |+|.+++.... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++
T Consensus 94 ~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 94 LTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp EEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred EEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCccc
Confidence 899999997 69999997632 34589999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchh-hHHhhhhhhhcccc
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPLVQSHRY 498 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~ 498 (573)
........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......... +..... ......+
T Consensus 168 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~ 243 (326)
T 1blx_A 168 RIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG-LPGEEDW 243 (326)
T ss_dssp CCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCCGGGS
T ss_pred ccccCCCC---ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC-CCCcccC
Confidence 87653322 122348999999999998899999999999999999999999998765432111 110000 0000000
Q ss_pred cccc---ccccccCCC---CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 499 LELL---DPLISSLSS---DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 499 ~~~~---~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.... ......... .......+..+.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 000000000 0011234567899999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=342.67 Aligned_cols=197 Identities=18% Similarity=0.227 Sum_probs=168.7
Q ss_pred CcCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhc------CCCcEeEEeeEEeeCCceEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARL------HHPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~l~~~~~~~~~~~lv 343 (573)
++..+.||+|+||.||+|... +++.||||+++.. ......+.+|+.+++.+ +|+||+++++++...+..++|
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 177 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence 344567899999999999864 5889999999765 23446677888888877 577999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCC--eeEecccCCcc
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG--AHLMGVGLSKF 421 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~Dfg~~~~ 421 (573)
|||+. ++|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++..
T Consensus 178 ~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 178 FELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp ECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 99995 6999998763 234589999999999999999999999 9999999999999999887 99999999976
Q ss_pred CCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCc
Q 008216 422 VPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 479 (573)
Q Consensus 422 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 479 (573)
.... .....||+.|+|||++.+..++.++|||||||++|||+||.+||...+.
T Consensus 252 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 252 EHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp TTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 5322 1223489999999999999999999999999999999999999987654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=347.36 Aligned_cols=204 Identities=18% Similarity=0.321 Sum_probs=155.2
Q ss_pred CCCcCCeeecccCceEEEEEEeC---CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEee--CCceEEE
Q 008216 269 NFSEGNRLLGDSKTGGTYSGILP---DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIV 343 (573)
Q Consensus 269 ~~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv 343 (573)
.|....++||+|+||.||+|... +++.||||++.... ....+.+|+.+|++++||||+++++++.. ....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 34444557899999999999964 57899999997653 23568899999999999999999999954 5678999
Q ss_pred EEecCCCCHHHHhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee----CCCCCeeEe
Q 008216 344 YEFVVNGPLDRWLHHIP-----RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----DEEFGAHLM 414 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~ 414 (573)
|||+. ++|.+++.... .....+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99995 58887775311 1223589999999999999999999999 99999999999999 677899999
Q ss_pred cccCCccCCccccc-cceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 008216 415 GVGLSKFVPWEVMQ-ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVD 478 (573)
Q Consensus 415 Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 478 (573)
|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99999876533211 11223348999999999987 458999999999999999999999997654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.87 Aligned_cols=252 Identities=27% Similarity=0.360 Sum_probs=201.1
Q ss_pred CCeeecccCceEEEEEEeCC----CCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 273 GNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
..+.||+|+||.||+|.+.. +..||||+++.. .....+.+.+|+.++++++||||+++++++. ++..++||||+
T Consensus 394 i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~ 472 (656)
T 2j0j_A 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 472 (656)
T ss_dssp EEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcC
Confidence 34678999999999998642 457999998764 3344578999999999999999999999984 56789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 473 ~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~ 546 (656)
T 2j0j_A 473 TLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546 (656)
T ss_dssp TTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred CCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence 999999999742 34689999999999999999999999 999999999999999999999999999987654332
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
... ....+|+.|+|||++.+..++.++||||||+++|||++ |..||........ .... .. ..
T Consensus 547 ~~~-~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~~~i---~~-~~--------- 609 (656)
T 2j0j_A 547 YKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRI---EN-GE--------- 609 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHH---HH-TC---------
T ss_pred eec-cCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHH---Hc-CC---------
Confidence 221 22237789999999998899999999999999999997 9999987553211 1110 00 00
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
....+..+++.+.++|.+||+.||++|||+.+|++.|+++..
T Consensus 610 ----~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 610 ----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 001122345679999999999999999999999999998754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=329.01 Aligned_cols=260 Identities=21% Similarity=0.249 Sum_probs=200.1
Q ss_pred CcCCeeecccCceEEEEEEe--CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCC------cEeEEeeEEeeCCceEE
Q 008216 271 SEGNRLLGDSKTGGTYSGIL--PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP------NLVAVKGCCYDHGDRYI 342 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------nIv~l~~~~~~~~~~~l 342 (573)
++..+.||+|+||.||++.. .+|+.||||+++.. ....+.+.+|+.+++.++|+ +++++++++.+.+..++
T Consensus 16 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~l 94 (339)
T 1z57_A 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICI 94 (339)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEE
T ss_pred eEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEE
Confidence 34456789999999999986 36889999999764 34456788999999988655 49999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---------------
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE--------------- 407 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~--------------- 407 (573)
||||+ +++|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 95 v~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 95 VFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 99999 88999999752 234689999999999999999999999 9999999999999987
Q ss_pred ----CCCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccch
Q 008216 408 ----EFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ 483 (573)
Q Consensus 408 ----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~ 483 (573)
++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|..||...+.....
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred ccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 6689999999998654321 2234899999999999989999999999999999999999999876543222
Q ss_pred hhHHhhhh-----hhhcccccc---------------------ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCC
Q 008216 484 SIFEWATP-----LVQSHRYLE---------------------LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMR 537 (573)
Q Consensus 484 ~~~~~~~~-----~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 537 (573)
........ ......... ...+.. .........++.+.+|+.+||+.||++|
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK---EFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGG---GGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchh---hhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 11111100 000000000 000000 0011233567889999999999999999
Q ss_pred CCHHHHHH
Q 008216 538 PRMSHVVH 545 (573)
Q Consensus 538 Ps~~evl~ 545 (573)
||+.|+++
T Consensus 321 pt~~ell~ 328 (339)
T 1z57_A 321 ITLREALK 328 (339)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=347.33 Aligned_cols=258 Identities=22% Similarity=0.299 Sum_probs=191.3
Q ss_pred HhhcCCCcCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEE
Q 008216 265 SITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 343 (573)
...+++....++||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 11 ~~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp CSCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred hhhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 3445566667789999999998776668999999998754 235678899999887 899999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC------------
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRS---LDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE------------ 408 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~------------ 408 (573)
|||+. |+|.+++......... .++..++.++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCC
Confidence 99995 6999999753221111 13334678999999999999999 99999999999999754
Q ss_pred -CCeeEecccCCccCCcccccc--ceeccCCcccccccccccC-------CCCCcchhhHHHHHHHHHHHc-CCCCCCCC
Q 008216 409 -FGAHLMGVGLSKFVPWEVMQE--RTVMAGGTYGYLAPEFVYR-------NELTTKSDVYSFGVLLLEIVS-GRRPAQAV 477 (573)
Q Consensus 409 -~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-G~~Pf~~~ 477 (573)
+.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||...
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 479999999998765432211 1223349999999999875 568999999999999999999 99999764
Q ss_pred CcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 478 DSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.... ..+ .... . . . +.. ........++++.++|.+||+.||++|||+.+|++
T Consensus 244 ~~~~-~~i-------~~~~-~-~-~-~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 244 YSRE-SNI-------IRGI-F-S-L-DEM----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TTHH-HHH-------HHTC-C-C-C-CCC----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhH-HHH-------hcCC-C-C-c-ccc----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 3321 000 0000 0 0 0 000 12224467789999999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.32 Aligned_cols=254 Identities=17% Similarity=0.257 Sum_probs=174.3
Q ss_pred hhcCCCcCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEee----CCce
Q 008216 266 ITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDR 340 (573)
Q Consensus 266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~ 340 (573)
+.++|....++||+|+||.||+|... +|+.||||++.... . ...+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 45566665677899999999999975 69999999997542 1 11222334566799999999999876 3447
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---CCCeeEeccc
Q 008216 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVG 417 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg 417 (573)
++||||+++|+|.+++.. .....+++..++.++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 102 ~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 999999999999999975 2335699999999999999999999999 9999999999999976 4459999999
Q ss_pred CCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccc
Q 008216 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 497 (573)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 497 (573)
++........ ....+|+.|+|||++.+..++.++||||||+++|+|++|..||............ ..
T Consensus 177 ~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~------ 243 (336)
T 3fhr_A 177 FAKETTQNAL----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KR------ 243 (336)
T ss_dssp TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred cceecccccc----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HH------
Confidence 9986543221 2233899999999998888999999999999999999999999765432110000 00
Q ss_pred cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....... .. ........++.+.+|+.+||+.||++|||++|+++
T Consensus 244 --~~~~~~~-~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 244 --RIRLGQY-GF-PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ----------CC-CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --hhhcccc-cc-CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000000 00 11111235667999999999999999999999997
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=344.36 Aligned_cols=258 Identities=22% Similarity=0.292 Sum_probs=190.9
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC------ceEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRYIVY 344 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~lv~ 344 (573)
...+.||+|+||.||+|+.. +|+.||||++.... ....+|+++|++++||||+++++++...+ ..++||
T Consensus 57 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred EeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 34567899999999999974 59999999997542 22347999999999999999999886432 257899
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-CCeeEecccCCccCC
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVP 423 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~ 423 (573)
||+++ +|.+.+.........+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++...
T Consensus 133 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp ECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred hcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99965 67666654333456799999999999999999999999 99999999999999965 558999999998764
Q ss_pred ccccccceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhh---------
Q 008216 424 WEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV--------- 493 (573)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~--------- 493 (573)
..... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+... .+........
T Consensus 209 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 209 RGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp TTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHHH
T ss_pred cCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHh
Confidence 33222 123489999999998764 78999999999999999999999998765421 1111111000
Q ss_pred hccccccccccccccCCCCC----cchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 494 QSHRYLELLDPLISSLSSDI----PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....+.+...+.+ .... .....++++.+||.+||+.||++|||+.|+++
T Consensus 284 ~~~~~~~~~~p~~---~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 284 MNPNYTEFKFPQI---KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HCSCCCCCCCCCC---CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccCcc---CCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0000111100000 0000 11223568999999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=340.35 Aligned_cols=263 Identities=20% Similarity=0.281 Sum_probs=191.6
Q ss_pred CcCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCc------eEEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD------RYIVY 344 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------~~lv~ 344 (573)
+...++||+|+||.||+|+..++..||+|++..... ...+|+.+++.++||||+++++++...+. .++||
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 344567899999999999987777899998865422 12369999999999999999999876543 78999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC-CCCCeeEecccCCccCC
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~ 423 (573)
||++++ +.+.+.........+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++...
T Consensus 118 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 118 EYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp ECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 999765 4333332222345799999999999999999999999 999999999999998 78899999999998764
Q ss_pred ccccccceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhh--cccc--
Q 008216 424 WEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ--SHRY-- 498 (573)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~-- 498 (573)
...... ...+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.... +......... ...+
T Consensus 194 ~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 194 AGEPNV---SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp TTCCCC---SSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHH
T ss_pred CCCCCc---ccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHh
Confidence 332221 23389999999998764 589999999999999999999999987654321 1111100000 0000
Q ss_pred --ccccccccccCCCCC----cchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 499 --LELLDPLISSLSSDI----PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 499 --~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
............... .....++++.+|+.+||+.||++|||+.|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000000000000 011245689999999999999999999999873
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=329.28 Aligned_cols=247 Identities=24% Similarity=0.330 Sum_probs=190.7
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccch--------hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEE
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYI 342 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 342 (573)
...+.||+|+||.||+|... +++.||||++..... .....+.+|+.++++++||||+++++++... ..++
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~l 91 (322)
T 2ycf_A 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYI 91 (322)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred eEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-ceEE
Confidence 34567899999999999964 588999999975421 1234578999999999999999999998665 4899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCC---eeEecccCC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGVGLS 419 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~~ 419 (573)
||||+++++|.+++.. ...+++..+..++.||+.||+|||++ +++||||||+||+++.++. +||+|||++
T Consensus 92 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 92 VLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp EEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred EEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 9999999999998853 35699999999999999999999999 9999999999999987654 999999999
Q ss_pred ccCCccccccceeccCCccccccccccc---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcc
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH 496 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 496 (573)
......... ....||+.|+|||++. ...++.++||||||+++|+|++|..||........ +.... ...
T Consensus 165 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~----~~~ 235 (322)
T 2ycf_A 165 KILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI----TSG 235 (322)
T ss_dssp EECCCCHHH---HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHH----HHT
T ss_pred eeccccccc---ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHH----HhC
Confidence 876533221 1223899999999874 46788999999999999999999999976543210 11100 000
Q ss_pred ccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.. ... +. .....++.+.+++.+||+.||++|||+.++++
T Consensus 236 ~~-~~~-~~--------~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 236 KY-NFI-PE--------VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CC-CCC-HH--------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cc-ccC-ch--------hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00 000 00 01123567999999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=340.38 Aligned_cols=260 Identities=20% Similarity=0.302 Sum_probs=180.5
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC------CceEE
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------GDRYI 342 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~l 342 (573)
...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++... ...++
T Consensus 32 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~l 111 (367)
T 2fst_X 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 111 (367)
T ss_dssp EEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEE
Confidence 3456789999999999985 46899999999653 334557788999999999999999999998754 56799
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
|+|++ +++|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 112 v~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 112 VTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp EEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred Eeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 99999 7899988853 4599999999999999999999999 9999999999999999999999999999865
Q ss_pred CccccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccc
Q 008216 423 PWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL 501 (573)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (573)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+......................+
T Consensus 183 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 183 ADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred ccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 432 122348999999999877 67899999999999999999999999876543211111000000000000000
Q ss_pred cc----cccccCCC--CCc----chHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 502 LD----PLISSLSS--DIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 502 ~~----~~~~~~~~--~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.. ..+..... ... ....++.+.+|+.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00 00000000 000 0123467899999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=333.09 Aligned_cols=265 Identities=21% Similarity=0.294 Sum_probs=190.8
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEe--------------e
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCY--------------D 336 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--------------~ 336 (573)
...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||+++++++. +
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 93 (320)
T 2i6l_A 14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTE 93 (320)
T ss_dssp EEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCS
T ss_pred eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccc
Confidence 34567899999999999975 48999999998776667788999999999999999999999874 3
Q ss_pred CCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC-CCCCeeEec
Q 008216 337 HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLMG 415 (573)
Q Consensus 337 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~D 415 (573)
.+..++||||++ |+|.+++.. ..+++..+..++.|++.||+|||++ +++||||||+||+++ +++.+||+|
T Consensus 94 ~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 94 LNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp CSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred cCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEcc
Confidence 356799999997 699999853 4589999999999999999999999 999999999999997 567899999
Q ss_pred ccCCccCCccccc-cceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhh
Q 008216 416 VGLSKFVPWEVMQ-ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV 493 (573)
Q Consensus 416 fg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 493 (573)
||++......... .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...+............+..
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999876432211 11122237899999998865 678999999999999999999999998765432111110000000
Q ss_pred hcccccc---cccccccc-CC-CCCc----chHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 494 QSHRYLE---LLDPLISS-LS-SDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 494 ~~~~~~~---~~~~~~~~-~~-~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
......+ .+...... .. ...+ ....+..+.++|.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000000 00000000 00 0000 1124567999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=328.10 Aligned_cols=248 Identities=19% Similarity=0.276 Sum_probs=191.6
Q ss_pred CcCCeeecccCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcC--CCcEeEEeeEEeeCCceEEEEEe
Q 008216 271 SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLH--HPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
+...+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ ||||+++++++.+.+..++|||
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 108 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 108 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-
Confidence 3445678999999999999888999999999754 3345578899999999996 5999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+.+++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||++++ +.+||+|||++.......
T Consensus 109 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 109 CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence 558899999975 24689999999999999999999999 9999999999999965 789999999998765443
Q ss_pred cccceeccCCcccccccccccC-----------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYR-----------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS 495 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 495 (573)
.........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ......
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~~~--- 252 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHAI--- 252 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHH---
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----HHHHHH---
Confidence 3222223348999999999865 467889999999999999999999997643210 000000
Q ss_pred cccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.++.. ....+...+..+.+++.+||+.||++|||+.|+++
T Consensus 253 ------~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 253 ------IDPNH----EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp ------HCTTS----CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------Hhccc----ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 11100 00011112457899999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.29 Aligned_cols=280 Identities=24% Similarity=0.294 Sum_probs=191.6
Q ss_pred HHHHhhcCCCcCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCc-
Q 008216 262 ELRSITKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD- 339 (573)
Q Consensus 262 el~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~- 339 (573)
+.....++|.. .+.||+|+||.||+|... +|+.||||++.... .......+|+..+..++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 17 RSRKEMDRFQV-ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHTTEEE-C----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hchhhccceEE-EEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 34445556544 457799999999999964 68999999986543 233456778888999999999999999976543
Q ss_pred ------eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEEcCCCCCCeeeCC-CCC
Q 008216 340 ------RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH--DKVKPHVVHRDIRASNVLLDE-EFG 410 (573)
Q Consensus 340 ------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~~~~iiH~Dlkp~NIll~~-~~~ 410 (573)
.++||||+++ +|.+.+.........+++..+..++.|++.||.||| ++ +|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 7899999976 555544432234567899999999999999999999 88 9999999999999996 889
Q ss_pred eeEecccCCccCCccccccceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhH-Hh
Q 008216 411 AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF-EW 488 (573)
Q Consensus 411 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~-~~ 488 (573)
+||+|||++......... ....||+.|+|||++.+. .++.++||||||+++|||++|+.||...+........ ..
T Consensus 171 ~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp EEECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 999999999876543322 223489999999998665 4899999999999999999999999876543211111 00
Q ss_pred hh--------hhhhccccccccccc---cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhccc
Q 008216 489 AT--------PLVQSHRYLELLDPL---ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQLA 551 (573)
Q Consensus 489 ~~--------~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 551 (573)
.. ............+.. .... ........++++.+|+.+||+.||.+|||+.|+++. ++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNV-FSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHH-TTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccc-cchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 00 000000000000000 0000 000111246789999999999999999999999963 44443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=322.21 Aligned_cols=246 Identities=22% Similarity=0.310 Sum_probs=196.9
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
...+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 25 ~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (287)
T 2wei_A 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT 104 (287)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccC
Confidence 44567899999999999975 68999999996542 2346789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC---CCeeEecccCCccCCcc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE---FGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~ 425 (573)
+++|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.+ +.+||+|||++......
T Consensus 105 ~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 105 GGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp SCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 9999998864 24589999999999999999999999 99999999999999754 46999999999866433
Q ss_pred ccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.... ...+|+.|+|||.+.+ .++.++||||||+++|+|++|..||...+...... .. .......
T Consensus 178 ~~~~---~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~-~~~~~~~----- 241 (287)
T 2wei_A 178 TKMK---DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK------RV-ETGKYAF----- 241 (287)
T ss_dssp SSCS---CHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HH-HHCCCCC-----
T ss_pred Cccc---cccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHH------HH-HcCCCCC-----
Confidence 2211 1228899999998865 48999999999999999999999998755321111 11 1111000
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
........++++.+++.+||+.||++|||+.|+++
T Consensus 242 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 -----DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -----CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00001234567999999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=336.00 Aligned_cols=264 Identities=16% Similarity=0.208 Sum_probs=197.7
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC--------CCcEeEEeeEEe----eC
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH--------HPNLVAVKGCCY----DH 337 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~l~~~~~----~~ 337 (573)
+...+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+.++++++ ||||+++++++. +.
T Consensus 39 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~ 117 (397)
T 1wak_A 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNG 117 (397)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTE
T ss_pred EEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCC
Confidence 34456789999999999985 45889999999754 344577889999999985 788999999987 45
Q ss_pred CceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC--------
Q 008216 338 GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-------- 409 (573)
Q Consensus 338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-------- 409 (573)
...++||||+ +++|.+++.. .....+++..++.++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 118 ~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 118 THICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred ceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhh
Confidence 6789999999 6667666654 22356999999999999999999999853 899999999999998775
Q ss_pred -----------------------------------------CeeEecccCCccCCccccccceeccCCcccccccccccC
Q 008216 410 -----------------------------------------GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448 (573)
Q Consensus 410 -----------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 448 (573)
.+||+|||++....... ....||+.|+|||++.+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCCHHHHHT
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcccCChhhcC
Confidence 79999999998764321 22348999999999999
Q ss_pred CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhh---h--------cccc-cccccc--ccccCC----
Q 008216 449 NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV---Q--------SHRY-LELLDP--LISSLS---- 510 (573)
Q Consensus 449 ~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~---~--------~~~~-~~~~~~--~~~~~~---- 510 (573)
..++.++|||||||++|||+||+.||...+............... . .... .+.+.. ......
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 999999999999999999999999998765432211111110000 0 0000 000000 000000
Q ss_pred ---------CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 511 ---------SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 511 ---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
........+..+.+||.+||+.||++|||++|+++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 01123566788999999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=336.11 Aligned_cols=259 Identities=18% Similarity=0.260 Sum_probs=192.4
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCce------EE
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR------YI 342 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~------~l 342 (573)
...+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++...+.. ++
T Consensus 45 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 124 (371)
T 4exu_A 45 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 124 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEE
T ss_pred EEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEE
Confidence 34567899999999999854 6899999999764 233457788999999999999999999999877654 99
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
||||+. ++|.+++. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 125 v~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 125 VMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp EEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred EEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 999996 68888774 3489999999999999999999999 9999999999999999999999999999865
Q ss_pred CccccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcc---c-
Q 008216 423 PWEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH---R- 497 (573)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~- 497 (573)
... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+.................. .
T Consensus 195 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 195 DAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred ccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence 432 122348999999999887 678999999999999999999999998765321111100000000000 0
Q ss_pred ----cccccccccccCCCCC---cchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 498 ----YLELLDPLISSLSSDI---PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 498 ----~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
....... +....... .....++.+.+||.+||+.||++|||+.|+++.
T Consensus 270 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 270 NDKAAKSYIQS-LPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp SCHHHHHHHHH-SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhc-cCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000 00000000 001235689999999999999999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=331.16 Aligned_cols=262 Identities=21% Similarity=0.247 Sum_probs=195.3
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC-----CceEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIVY 344 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~ 344 (573)
...+.||+|+||.||+|... +|+.||||+++.. .......+.+|+.++++++||||+++++++... ...++||
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 93 (353)
T 2b9h_A 14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ 93 (353)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEE
T ss_pred EEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEE
Confidence 33567899999999999964 6899999999754 233456788999999999999999999987754 6789999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCc
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 424 (573)
||+. ++|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 94 ELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 9996 699999864 4589999999999999999999999 999999999999999999999999999987653
Q ss_pred ccccc--------ceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhc
Q 008216 425 EVMQE--------RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS 495 (573)
Q Consensus 425 ~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 495 (573)
..... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+........ ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~ 241 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI---FGIIGT 241 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCC
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HHHhCC
Confidence 32111 1112348999999998764 67899999999999999999999999876532111100 000000
Q ss_pred cc----cccccc----cccccCCC--CCc----chHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 496 HR----YLELLD----PLISSLSS--DIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 496 ~~----~~~~~~----~~~~~~~~--~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.. ...... ........ ... ....++.+.+|+.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00 000000 00000000 000 1134567899999999999999999999997
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=328.90 Aligned_cols=202 Identities=18% Similarity=0.250 Sum_probs=167.4
Q ss_pred hcCCCcCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CC-----cEeEEeeEEeeCCc
Q 008216 267 TKNFSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HP-----NLVAVKGCCYDHGD 339 (573)
Q Consensus 267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~l~~~~~~~~~ 339 (573)
.++| ...+.||+|+||.||+|... +++.||||+++.. .....++.+|+.+++.++ |+ +|+++++++...+.
T Consensus 53 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 53 MDRY-EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp TTTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeE-EEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3344 33457899999999999864 5889999999754 234566778888888884 55 49999999999999
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC--CCCCeeEeccc
Q 008216 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD--EEFGAHLMGVG 417 (573)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~Dfg 417 (573)
.++||||++ ++|.+++... ....+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+|||
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred eEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 999999995 5999999763 234589999999999999999999952 12899999999999995 47789999999
Q ss_pred CCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCc
Q 008216 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDS 479 (573)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 479 (573)
++....... ....||+.|+|||++.+..++.++|||||||++|||+||+.||...+.
T Consensus 207 ~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 207 SSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp TCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred Cceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 998764321 223489999999999999999999999999999999999999987654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=317.81 Aligned_cols=247 Identities=20% Similarity=0.311 Sum_probs=187.5
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEee-------------CCc
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-------------HGD 339 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-------------~~~ 339 (573)
.+.||+|+||.||+|.. .+|+.||||+++.. ....+.+.+|+.++++++||||+++++++.+ .+.
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (303)
T 1zy4_A 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89 (303)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEE
T ss_pred hheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCc
Confidence 45789999999999996 47999999999654 3455778999999999999999999998865 345
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCC
Q 008216 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (573)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 419 (573)
.++||||+++++|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 90 LFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp EEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcch
Confidence 7999999999999999974 235678899999999999999999999 9999999999999999999999999999
Q ss_pred ccCCcccc------------ccceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhH
Q 008216 420 KFVPWEVM------------QERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF 486 (573)
Q Consensus 420 ~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 486 (573)
........ ........||+.|+|||++.+. .++.++||||||+++|||++ ||...... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~--~~~~ 238 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER--VNIL 238 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--HHHH
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH--HHHH
Confidence 87643210 1111223489999999998764 68999999999999999998 55422110 0111
Q ss_pred HhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 487 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 487 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
.... .. .... +.......+..+.+++.+||+.||++|||+.++++.
T Consensus 239 ---~~~~-~~------~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 239 ---KKLR-SV------SIEF----PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ---HHHH-ST------TCCC----CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---Hhcc-cc------cccc----CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 0000 00 0000 111122345678999999999999999999999873
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.19 Aligned_cols=258 Identities=19% Similarity=0.262 Sum_probs=191.7
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCc------eEEE
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD------RYIV 343 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------~~lv 343 (573)
..+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++...+. .++|
T Consensus 28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 107 (353)
T 3coi_A 28 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107 (353)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred EeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEE
Confidence 3457899999999999964 6899999999754 23335678899999999999999999999987654 4999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCC
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 423 (573)
|||+. ++|.+++. ..+++..+..++.||+.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 108 ~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 108 MPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp EECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred ecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 99996 68887763 3489999999999999999999999 99999999999999999999999999998654
Q ss_pred ccccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcc---cc-
Q 008216 424 WEVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH---RY- 498 (573)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~- 498 (573)
.. .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+.................. ..
T Consensus 178 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 178 AE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred CC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 32 112348999999999876 678999999999999999999999998765321111000000000000 00
Q ss_pred ----ccccccccccCCC--CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 499 ----LELLDPLISSLSS--DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 499 ----~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
...+......... .......++.+.+++.+||+.||++|||++++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000000 0011234678999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=325.58 Aligned_cols=253 Identities=22% Similarity=0.375 Sum_probs=175.7
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHH-HHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS-FQRKKEFYSEIG-RFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
+..+.||+|+||.||+|... +|+.||||+++... .....++..|+. +++.++||||+++++++.+.+..++||||++
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (327)
T 3aln_A 25 KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS 104 (327)
T ss_dssp EC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred hehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC
Confidence 34557899999999999974 68999999997653 333455666666 6777899999999999999999999999997
Q ss_pred CCCHHHHhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 349 NGPLDRWLHHIP-RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 349 ~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
+ +|.+++.... .....+++..+..++.|++.||.|||++. +++||||||+||+++.++.+||+|||++........
T Consensus 105 ~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 181 (327)
T 3aln_A 105 T-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181 (327)
T ss_dssp E-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred C-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecccccc
Confidence 5 8887775311 12456899999999999999999999852 899999999999999999999999999987643322
Q ss_pred ccceeccCCcccccccccc----cCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFV----YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (573)
. ....||+.|+|||++ .+..++.++||||||+++|+|++|+.||....... +. ......
T Consensus 182 ~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~---------~~~~~~ 244 (327)
T 3aln_A 182 K---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQ---------LTQVVK 244 (327)
T ss_dssp ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------------CCCCC
T ss_pred c---ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HH---------HHHHhc
Confidence 1 122389999999998 45678999999999999999999999997643210 00 001111
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
...... ........++.+.+++.+||+.||++|||+.++++
T Consensus 245 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 245 GDPPQL-SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SCCCCC-CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCC-CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000000 01111234567999999999999999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=324.37 Aligned_cols=263 Identities=18% Similarity=0.219 Sum_probs=197.0
Q ss_pred CcCCeeecccCceEEEEEEeC-CC-CEEEEEEecccchhhHHHHHHHHHHHhhcCCCc------EeEEeeEEeeCCceEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILP-DG-SRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN------LVAVKGCCYDHGDRYI 342 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~~~l 342 (573)
++..+.||+|+||.||++... ++ +.||||+++.. ....+.+.+|+.++++++|++ ++.+++++...+..++
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~l 99 (355)
T 2eu9_A 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI 99 (355)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEE
T ss_pred EEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEE
Confidence 344567899999999999964 34 68999999754 344567888999999997655 9999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee-----------------
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL----------------- 405 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll----------------- 405 (573)
||||+ +++|.+++.. .....+++..+..++.||+.||+|||++ +|+||||||+|||+
T Consensus 100 v~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 100 AFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccc
Confidence 99999 6677777764 2234699999999999999999999999 99999999999999
Q ss_pred --CCCCCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccch
Q 008216 406 --DEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ 483 (573)
Q Consensus 406 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~ 483 (573)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|..||.........
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 567889999999998643221 2234899999999999999999999999999999999999999876543211
Q ss_pred hhHHhhhh-----hhhccccccccc-----------------ccccc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCH
Q 008216 484 SIFEWATP-----LVQSHRYLELLD-----------------PLISS-LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM 540 (573)
Q Consensus 484 ~~~~~~~~-----~~~~~~~~~~~~-----------------~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 540 (573)
........ ............ ..... ..........+..+.+||.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 11111000 000000000000 00000 00011223456789999999999999999999
Q ss_pred HHHHH
Q 008216 541 SHVVH 545 (573)
Q Consensus 541 ~evl~ 545 (573)
.|+++
T Consensus 329 ~e~l~ 333 (355)
T 2eu9_A 329 AEALL 333 (355)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99984
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=327.08 Aligned_cols=264 Identities=15% Similarity=0.239 Sum_probs=194.8
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-----------CCcEeEEeeEEeeCC
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-----------HPNLVAVKGCCYDHG 338 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~~~~ 338 (573)
+...+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+.++++++ ||||+++++++...+
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~ 99 (373)
T 1q8y_A 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 99 (373)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC
Confidence 34456789999999999996 56899999999754 334567889999999886 899999999988654
Q ss_pred ----ceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC------CC
Q 008216 339 ----DRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD------EE 408 (573)
Q Consensus 339 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~------~~ 408 (573)
..++|||++ +++|.+++.... ...+++..+..++.||+.||+|||+++ +|+||||||+|||++ ..
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 100 PNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp TTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTE
T ss_pred CCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCc
Confidence 679999999 899999997632 345899999999999999999999953 899999999999994 34
Q ss_pred CCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHh
Q 008216 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEW 488 (573)
Q Consensus 409 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 488 (573)
+.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||+||+.||..............
T Consensus 175 ~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 479999999998664321 122489999999999999999999999999999999999999986543221111000
Q ss_pred hhhhhh-----------ccccc-ccccc--ccccC-------------CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHH
Q 008216 489 ATPLVQ-----------SHRYL-ELLDP--LISSL-------------SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS 541 (573)
Q Consensus 489 ~~~~~~-----------~~~~~-~~~~~--~~~~~-------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 541 (573)
...... ..... ..++. ..... .....+...+..+.+||.+||+.||++|||++
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 000000 00000 00000 00000 01122356788999999999999999999999
Q ss_pred HHHH
Q 008216 542 HVVH 545 (573)
Q Consensus 542 evl~ 545 (573)
|+++
T Consensus 330 ell~ 333 (373)
T 1q8y_A 330 GLVN 333 (373)
T ss_dssp HHHT
T ss_pred HHhh
Confidence 9987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=333.00 Aligned_cols=246 Identities=23% Similarity=0.295 Sum_probs=183.6
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
...++||+|+||+|+.....+|+.||||++..... ..+.+|+.+|+++ +||||+++++++.+.+..++||||+. |
T Consensus 27 ~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g 102 (432)
T 3p23_A 27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A 102 (432)
T ss_dssp EEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred ecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence 33467899999996655556899999999975432 2356899999999 89999999999999999999999995 6
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-----CCCeeEecccCCccCCcc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-----EFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~Dfg~~~~~~~~ 425 (573)
+|.+++.... .......+..++.||+.||+|||++ +|+||||||+|||++. ...+||+|||+++.....
T Consensus 103 ~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 103 TLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp EHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred CHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 9999997532 2344455678999999999999999 9999999999999953 335789999999876543
Q ss_pred ccc-cceeccCCccccccccccc---CCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccc
Q 008216 426 VMQ-ERTVMAGGTYGYLAPEFVY---RNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500 (573)
Q Consensus 426 ~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (573)
... .......||+.|+|||++. ...++.++|||||||++|||+| |..||........ ........
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-------~~~~~~~~--- 246 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------NILLGACS--- 246 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-------HHHTTCCC---
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-------HHHhccCC---
Confidence 211 1222344999999999997 4567889999999999999999 9999865432110 00000000
Q ss_pred ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.....+....+..+.+||.+||+.||++|||+++|++
T Consensus 247 --------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 --------LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp --------CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0011123345667899999999999999999999984
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=325.99 Aligned_cols=237 Identities=20% Similarity=0.311 Sum_probs=193.7
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchh------hHHHHHHHHHHHhhcC--CCcEeEEeeEEeeCCceE
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ------RKKEFYSEIGRFARLH--HPNLVAVKGCCYDHGDRY 341 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~ 341 (573)
+...+.||+|+||.||+|.. .+|+.||||+++..... ..+.+.+|+.++++++ ||||+++++++.+.+..+
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~ 124 (320)
T 3a99_A 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 124 (320)
T ss_dssp EEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEE
Confidence 34556789999999999985 46889999999765321 2345678999999996 599999999999999999
Q ss_pred EEEEecCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC-CCCCeeEecccCC
Q 008216 342 IVYEFVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGAHLMGVGLS 419 (573)
Q Consensus 342 lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~~ 419 (573)
+|||++.+ ++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++ +++.+||+|||++
T Consensus 125 lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 125 LILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp EEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 99999976 899999864 34689999999999999999999999 999999999999999 7789999999999
Q ss_pred ccCCccccccceeccCCcccccccccccCCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccc
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY 498 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 498 (573)
........ ....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... ... .
T Consensus 198 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------------~~~-~- 259 (320)
T 3a99_A 198 ALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------------IRG-Q- 259 (320)
T ss_dssp EECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------------HHC-C-
T ss_pred cccccccc----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh------------hcc-c-
Confidence 87653322 12348999999999887665 68899999999999999999999653210 000 0
Q ss_pred ccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.......++++.++|.+||+.||++|||++||++
T Consensus 260 -------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 -------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001123457999999999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=322.82 Aligned_cols=242 Identities=23% Similarity=0.326 Sum_probs=188.6
Q ss_pred HhhcCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchh------hHHHHHHHHHHHhhc----CCCcEeEEeeE
Q 008216 265 SITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ------RKKEFYSEIGRFARL----HHPNLVAVKGC 333 (573)
Q Consensus 265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~nIv~l~~~ 333 (573)
...++| ...+.||+|+||.||+|.. .+|+.||||+++..... ....+.+|+.++.++ +||||++++++
T Consensus 28 ~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 28 AFEAEY-RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp -----C-EEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhce-EEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 334444 4456789999999999985 46899999999765321 223456799999998 89999999999
Q ss_pred EeeCCceEEEEEe-cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC-CCCCe
Q 008216 334 CYDHGDRYIVYEF-VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD-EEFGA 411 (573)
Q Consensus 334 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~ 411 (573)
+.+.+..++|||+ +.+++|.+++.. ...+++..++.++.||+.||+|||++ +++||||||+||+++ .++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 9999999999999 789999999965 24589999999999999999999999 999999999999999 78899
Q ss_pred eEecccCCccCCccccccceeccCCcccccccccccCCCCC-cchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhh
Q 008216 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT-TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT 490 (573)
Q Consensus 412 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 490 (573)
||+|||++........ ....||..|+|||++.+..+. .++||||||+++|||++|+.||..... .
T Consensus 180 kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~----- 245 (312)
T 2iwi_A 180 KLIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----I----- 245 (312)
T ss_dssp EECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-----
T ss_pred EEEEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----H-----
Confidence 9999999987654322 223389999999998776664 589999999999999999999965321 0
Q ss_pred hhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 491 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.. .. .......+..+.++|.+||+.||++|||++|+++
T Consensus 246 --~~-~~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 --LE-AE--------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp --HH-TC--------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --hh-hc--------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 00 0011224467899999999999999999999997
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=317.95 Aligned_cols=245 Identities=21% Similarity=0.354 Sum_probs=175.1
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccch-hh-HHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QR-KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|+||.||+|... +|+.||||++..... .. .+.+.++..+++.++||||+++++++.+.+..++||||+ ++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 108 (318)
T 2dyl_A 30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GT 108 (318)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SE
T ss_pred cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CC
Confidence 457899999999999974 689999999976532 22 233444556778889999999999999999999999999 55
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
.+..+... ....+++..+..++.|++.||+|||+ . +++||||||+||+++.++.+||+|||++.........
T Consensus 109 ~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~- 181 (318)
T 2dyl_A 109 CAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK- 181 (318)
T ss_dssp EHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred cHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccc-
Confidence 66665542 13568999999999999999999998 6 8999999999999999999999999999765433221
Q ss_pred ceeccCCccccccccccc-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
....||+.|+|||++. ...++.++||||||+++|||++|+.||....... .. ........ .+
T Consensus 182 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~---~~~~~~~~------~~ 248 (318)
T 2dyl_A 182 --DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EV---LTKVLQEE------PP 248 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HH---HHHHHHSC------CC
T ss_pred --cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HH---HHHHhccC------CC
Confidence 1223899999999984 4568899999999999999999999997643210 11 11111100 00
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.. ......+..+.+++.+||+.||.+|||++++++
T Consensus 249 ~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 LL------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CC------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CC------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00 001124567999999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=339.98 Aligned_cols=270 Identities=20% Similarity=0.307 Sum_probs=201.1
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEee------CCceEE
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD------HGDRYI 342 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~l 342 (573)
++..+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|+.++++++||||+++++++.. .+..++
T Consensus 16 Y~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~L 95 (676)
T 3qa8_A 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLL 95 (676)
T ss_dssp -CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEE
Confidence 34455789999999999986 46899999998764 34456779999999999999999999998765 567799
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCC---eeEecccCC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG---AHLMGVGLS 419 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~~ 419 (573)
||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++
T Consensus 96 VmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 96 AMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp EEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred EEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 999999999999997532 234588999999999999999999999 9999999999999997765 899999999
Q ss_pred ccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccc--
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR-- 497 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-- 497 (573)
......... ....||+.|+|||.+.+..++.++||||||+++|+|++|..||...... ..+.........
T Consensus 172 ~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 172 KELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNEH 243 (676)
T ss_dssp CBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC------
T ss_pred ccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccchh
Confidence 876543322 2234899999999999999999999999999999999999999764321 111111000000
Q ss_pred --cccccccccc--c--CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHH-----HHHHhcccC
Q 008216 498 --YLELLDPLIS--S--LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV-----VHQLQQLAQ 552 (573)
Q Consensus 498 --~~~~~~~~~~--~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev-----l~~L~~~~~ 552 (573)
..+....... . ..........++.+.+++.+||+.||++|||+.++ .+.++.+..
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0000000000 0 00112234577899999999999999999999873 344544443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=306.41 Aligned_cols=231 Identities=14% Similarity=0.072 Sum_probs=181.5
Q ss_pred CcCCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 271 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
++..+.||+|+||.||+|... +|+.||||+++... ....+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 112 (286)
T 3uqc_A 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEW 112 (286)
T ss_dssp EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEe
Confidence 444568899999999999975 48999999997653 23347789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++++|.+++.. .....++..++.|++.||+|||++ ||+||||||+|||++.++.+||++++
T Consensus 113 ~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 113 IRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp CCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred cCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999853 135567889999999999999999 99999999999999999999997443
Q ss_pred cccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
|++| ++.++||||||+++|||+||+.||...+....... . ........
T Consensus 175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~---------~~~~~~~~ 222 (286)
T 3uqc_A 175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---A---------ERDTAGQP 222 (286)
T ss_dssp -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---C---------CBCTTSCB
T ss_pred -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---H---------HHHhccCC
Confidence 3333 68899999999999999999999987654210000 0 00000000
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
. .........++.+.+++.+||+.||++| |+.|+++.|+++....
T Consensus 223 ~--~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 223 I--EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp C--CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred C--ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0 0000012345679999999999999999 9999999999887643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=305.98 Aligned_cols=230 Identities=17% Similarity=0.286 Sum_probs=179.8
Q ss_pred hhcCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHH-hhcCCCcEeEEeeEEee----CCc
Q 008216 266 ITKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRF-ARLHHPNLVAVKGCCYD----HGD 339 (573)
Q Consensus 266 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~----~~~ 339 (573)
+.++|....++||+|+||.||++.. .+++.||||+++.. ..+.+|+.++ +.++||||+++++++.. .+.
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 3445555557789999999999996 46899999999643 4567888888 55599999999999887 667
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---CCCeeEecc
Q 008216 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGV 416 (573)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Df 416 (573)
.++||||+++++|.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 8999999999999999976 3335699999999999999999999999 9999999999999998 788999999
Q ss_pred cCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcc
Q 008216 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH 496 (573)
Q Consensus 417 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 496 (573)
|++.... +..++.++||||||+++|||++|+.||..........
T Consensus 165 g~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~------------ 208 (299)
T 3m2w_A 165 GFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------------ 208 (299)
T ss_dssp TTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C------------
T ss_pred ccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH------------
Confidence 9886432 2346789999999999999999999997654321000
Q ss_pred ccccccccccccCCCCCcc---hHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 497 RYLELLDPLISSLSSDIPE---AGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....... ......+. ...++++.+++.+||+.||++|||+.|+++
T Consensus 209 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 209 GMKTRIR----MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CSCCSSC----TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHh----hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000000 00001111 234678999999999999999999999997
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=342.49 Aligned_cols=236 Identities=22% Similarity=0.254 Sum_probs=190.0
Q ss_pred CcCCeeecccCceEEEEEEeC--CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCc-----eEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILP--DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD-----RYI 342 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-----~~l 342 (573)
+...+.||+|+||.||++... +|+.||||++... .......+.+|+.++++++||||+++++++...+. .|+
T Consensus 82 y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l 161 (681)
T 2pzi_A 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI 161 (681)
T ss_dssp EEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence 344567899999999999975 5899999998654 33445678999999999999999999999988765 699
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
||||+++++|.+++. ..+++.+++.++.||+.||.|||++ +|+||||||+|||++.+ .+||+|||+++..
T Consensus 162 v~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 162 VMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred EEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 999999999988764 2599999999999999999999999 99999999999999986 8999999999876
Q ss_pred CccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccc
Q 008216 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502 (573)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (573)
... ....||+.|+|||++.+.. +.++||||||+++|+|++|.+||.......
T Consensus 232 ~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------------- 283 (681)
T 2pzi_A 232 NSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------------- 283 (681)
T ss_dssp TCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------------
T ss_pred ccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---------------------
Confidence 433 2234999999999987654 889999999999999999998876421110
Q ss_pred ccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHhcc
Q 008216 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-MSHVVHQLQQL 550 (573)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~~ 550 (573)
.....+....++.+.++|.+||+.||++||+ ++++.+.|..+
T Consensus 284 ------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 284 ------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0011122334567999999999999999995 66666666544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=322.38 Aligned_cols=237 Identities=18% Similarity=0.172 Sum_probs=177.2
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCC-CcE---------------eE----
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHH-PNL---------------VA---- 329 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~nI---------------v~---- 329 (573)
.++||+|+||.||+|.. .+|+.||||+++... ....+.+.+|+.+++.++| +|. +.
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 45789999999999994 569999999997432 2235779999999999977 221 11
Q ss_pred --EeeEEee-----CCceEEEEEecCCCCHHHHhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 008216 330 --VKGCCYD-----HGDRYIVYEFVVNGPLDRWLHHI---PRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIR 399 (573)
Q Consensus 330 --l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlk 399 (573)
+..+... ....+++|+++ +++|.+++... ...+..+++..++.++.||+.||+|||++ +|+|||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiK 238 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLR 238 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcc
Confidence 1111111 12457777766 78999988521 23345688889999999999999999999 99999999
Q ss_pred CCCeeeCCCCCeeEecccCCccCCccccccceeccCCcccccccccc----------cCCCCCcchhhHHHHHHHHHHHc
Q 008216 400 ASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFV----------YRNELTTKSDVYSFGVLLLEIVS 469 (573)
Q Consensus 400 p~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwSlGvil~ellt 469 (573)
|+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|||+|
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred cceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 99999999999999999998865433 223347 999999999 55568889999999999999999
Q ss_pred CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 470 GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 470 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
|+.||........ ........ . ..++.+.+||.+||+.||++|||+.++++
T Consensus 313 g~~Pf~~~~~~~~-------------------~~~~~~~~-~-----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 313 ADLPNTDDAALGG-------------------SEWIFRSC-K-----NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp SSCCCCTTGGGSC-------------------SGGGGSSC-C-----CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCcchhhh-------------------HHHHHhhc-c-----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999976543211 11111100 1 22467999999999999999999877754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=309.70 Aligned_cols=238 Identities=14% Similarity=0.146 Sum_probs=179.0
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccch--------hhHHHHHHHHHHHhhcC---------CCcEeEEeeEE
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLH---------HPNLVAVKGCC 334 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h~nIv~l~~~~ 334 (573)
+..+.||+|+||.||+|+. +|+.||||+++.... ...+.+.+|+.+++.++ ||||+++.+.+
T Consensus 23 ~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~ 101 (336)
T 2vuw_A 23 QRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH 101 (336)
T ss_dssp HTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEE
T ss_pred hheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhccee
Confidence 4456789999999999998 789999999976521 22377889999988885 77777776654
Q ss_pred e-----------------e-------------CCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 008216 335 Y-----------------D-------------HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAF 384 (573)
Q Consensus 335 ~-----------------~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~ 384 (573)
. + .+..++||||+++|++.+.+.. ..+++..++.++.||+.||+|
T Consensus 102 ~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHHHHHH
T ss_pred EecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHHHHHH
Confidence 2 2 6788999999999976666632 458999999999999999999
Q ss_pred HH-hCCCCCeEEcCCCCCCeeeCCCC--------------------CeeEecccCCccCCccccccceeccCCccccccc
Q 008216 385 LH-DKVKPHVVHRDIRASNVLLDEEF--------------------GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP 443 (573)
Q Consensus 385 LH-~~~~~~iiH~Dlkp~NIll~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 443 (573)
|| ++ +|+||||||+|||++.++ .+||+|||+++..... ...||+.|+||
T Consensus 177 lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aP 246 (336)
T 2vuw_A 177 AEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDE 246 (336)
T ss_dssp HHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCS
T ss_pred HHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccCh
Confidence 99 89 999999999999999886 8999999999865422 12399999999
Q ss_pred ccccCCCCCcchhhHHHHHH-HHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHH
Q 008216 444 EFVYRNELTTKSDVYSFGVL-LLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKV 522 (573)
Q Consensus 444 E~~~~~~~~~~~DvwSlGvi-l~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 522 (573)
|++.+.. +.++||||+|++ .+++++|..||...... ... ............ ..........++++
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~~~---~~~~~~~~~~~~--------~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--HYL---TDKMLKQMTFKT--------KCNTPAMKQIKRKI 312 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--HHH---HHHHHHTCCCSS--------CCCSHHHHHHHHHH
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh--hHH---HHhhhhhhccCc--------ccchhhhhhcCHHH
Confidence 9998766 899999998777 77888999997431000 000 000000000000 00111234678899
Q ss_pred HHHHHHhcCCCCCCCCCHHHHH
Q 008216 523 VDLVYACTQHVPSMRPRMSHVV 544 (573)
Q Consensus 523 ~~li~~cl~~dP~~RPs~~evl 544 (573)
.+||.+||+.| |++|++
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 99999999976 899887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-31 Score=284.71 Aligned_cols=183 Identities=17% Similarity=0.088 Sum_probs=128.7
Q ss_pred cccCceEEEEEE-eCCCCEEEEEEecccc----------hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEE
Q 008216 278 GDSKTGGTYSGI-LPDGSRVAVKRLKRSS----------FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 278 g~G~~g~Vy~~~-~~~g~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
+.|+.|.+..++ .-.|+.+|+|++.... ....++|.+|+++|+++ +|+||+++++++++++..|||||
T Consensus 243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVME 322 (569)
T 4azs_A 243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVME 322 (569)
T ss_dssp C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEE
T ss_pred ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEe
Confidence 455555555443 2358899999996541 23346799999999999 79999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|++|++|.++|.. +.+++.. .|+.||+.||+|+|++ |||||||||+|||++.++.+||+|||+++.....
T Consensus 323 yv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 323 KLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp CCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred cCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 9999999999964 3456654 4789999999999999 9999999999999999999999999999876543
Q ss_pred ccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCC
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRP 473 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~P 473 (573)
.... ....||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 393 ~~~~--~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSWP--TNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCS--HHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Cccc--cCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 3222 22349999999999865 466789999999998877665444
|
| >1ypq_A Oxidised low density lipoprotein (lectin-like) receptor 1; oxidized low density lipoprotein receptor, LOX-1, CTLD, C- type lectin like domain; 1.40A {Homo sapiens} SCOP: d.169.1.1 PDB: 1ypu_A 1yxk_A 3vlg_A 1ypo_A 1yxj_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=214.16 Aligned_cols=129 Identities=19% Similarity=0.446 Sum_probs=111.8
Q ss_pred CCCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCce
Q 008216 49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW 128 (573)
Q Consensus 49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w 128 (573)
.+..||.||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|.+|++||.+++......+||||+ +...++.|
T Consensus 5 ~~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~~~~~~w 80 (135)
T 1ypq_A 5 CSAPCPQDWI--WHGENCYLFSSGSFNWEKSQEKCLSLDAKLLKINSTADLDFIQQAISYSSFPFWMGLS--RRNPSYPW 80 (135)
T ss_dssp CCCSSCTTSE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHTTCCCCEEEEEE--ESSTTSCC
T ss_pred cCCcCCcccE--EcCCEEEEEECCccCHHHHHHHHHhCCCEEeEeCCHHHHHHHHHHHhccCCCEEEecc--ccCCCCCe
Confidence 3468999999 9999999999999999999999999999999999999999999999754567999999 55567999
Q ss_pred EEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccccc
Q 008216 129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 129 ~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
+|+||+++..+++|..++|++. .+.++|+.+.. +.|++..|....+|||+++.
T Consensus 81 ~W~dg~~~~~~~~w~~g~P~~~---------~~~~~Cv~~~~--~~w~~~~C~~~~~fICe~~~ 133 (135)
T 1ypq_A 81 LWEDGSPLMPHLFRVRGAVSQT---------YPSGTCAYIQR--GAVYAENCILAAFSICQKKA 133 (135)
T ss_dssp EETTSCBCCTTSCCEEESCSCC---------CTTCEEEEEET--TEEEEEETTSCBEEEEEEEC
T ss_pred EeCCcCccCcccccccCCCCCC---------CCCCCeeEEeC--CcEEccCCCCCeeeEeeecC
Confidence 9999988766788887777653 23567888764 57999999999999999865
|
| >3vpp_A C-type lectin domain family 9 member A; dendritic cell, C-type lectin-like domain, membrane, immune; 1.64A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=209.61 Aligned_cols=127 Identities=24% Similarity=0.489 Sum_probs=104.1
Q ss_pred CCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 008216 50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 50 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (573)
|.+||.||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 1 c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~ 76 (132)
T 3vpp_A 1 SSPCPNNWI--QNRESCYYVSEIWSIWHTSQENCLKEGSTLLQIESKEEMDFITGSLRKIKGSYDYWVGLS--QDGHSGR 76 (132)
T ss_dssp -CCSCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHTTSSSCCEEEEEEE--ECTTTCC
T ss_pred CCCCCccce--EeCCEEEEEECCccCHHHHHHHHHhcCCEEeEECCHHHHHHHHHHHhccCCCccEEEEec--ccCCCCc
Confidence 578999999 9999999999999999999999999999999999999999999988643 456999999 5556799
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccccCC
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHEN 194 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~~~ 194 (573)
|+|+||+++ .+++|..++|+ .+.++|+.+.. +.|++..|....+|||+++...
T Consensus 77 w~W~dg~~~-~~~~w~~~~p~-----------~~~~~C~~~~~--~~w~~~~C~~~~~fiCe~~~~~ 129 (132)
T 3vpp_A 77 WLWQDGSSP-SPGLLPAERSQ-----------SANQVCGYVKS--NSLLSSNCDTWKYFICEKYALR 129 (132)
T ss_dssp EEETTSCCC-CTTSCCCC-----------------CEEEEEET--TEEEEEESSSCBEEEEEEECC-
T ss_pred eEecCCCcC-ChhhcccCCCC-----------CCCCceEEEEC--CeEeccCCCCCceEECCccccc
Confidence 999999766 45667666543 23467888864 4699999999999999987644
|
| >2py2_A Antifreeze protein type II; type II antifreeze protein; 1.70A {Clupea harengus} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.8e-28 Score=211.10 Aligned_cols=129 Identities=23% Similarity=0.527 Sum_probs=107.9
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEE
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW 130 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W 130 (573)
..||+||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|++|++||.+++......+||||+ +...++.|.|
T Consensus 2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~~~~~~w~W 77 (136)
T 2py2_A 2 DECPTDWK--MFNGRCFLFNPLQLHWADAQESCMKEGANLASIHSLEESTFVKELTSADLIPSWIGGT--DCQVSTRWFW 77 (136)
T ss_dssp --CCTTCE--EETTEEEEEEEEEECHHHHHHHHHTTTCEECCCCSHHHHHHHHTTSTTTTCCEEEEEE--CCSSTTCCEE
T ss_pred CCCCcCce--ecCCEEEEEECCCcCHHHHHHHHhhCCCEEeeeCCHHHHHHHHHHHHcCCCCEeEeeE--cCCCCCceEe
Confidence 47999999 9999999999999999999999999999999999999999999998743468999999 6666799999
Q ss_pred cCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecC-CCceeccccCCCCCcccccccCC
Q 008216 131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMVEHEN 194 (573)
Q Consensus 131 ~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~-~~~W~d~~C~~~~~~iC~~~~~~ 194 (573)
+||+++ .++.|..++|++. .+ ++|+.+... .+.|+|..|+...+|||+++.+.
T Consensus 78 ~dG~~~-~y~~W~~geP~~~---------~~-~~Cv~~~~~~~~~W~d~~C~~~~~fIC~~~~~~ 131 (136)
T 2py2_A 78 MDSTSM-DYADWCAAQPDTT---------LT-ECCIQMNVGIGKCWNDTPCTHLHSSICAKPLKH 131 (136)
T ss_dssp TTCCCC-CCCCBCTTCCCCC---------GG-GCEEEEEETTTTEEEEECTTSCEEEEEEEECC-
T ss_pred CCCCCc-ccCCCCCCCCCCC---------CC-CCCeEEccCCCCeEcCCCCCCCccEEeeECccc
Confidence 999775 5566777766642 12 567777553 56799999999999999987655
|
| >3rs1_A C-type lectin domain family 2 member I; C-type lectin-like, ligand of NK receptor, natural killer CE receptors, surface of activated T lymphocytes; 1.94A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=203.39 Aligned_cols=120 Identities=23% Similarity=0.451 Sum_probs=102.3
Q ss_pred CCCCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCc
Q 008216 48 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 48 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~ 127 (573)
..+++||+||. .|+++||+++.+.++|.+|+.+|+++||+||+|+|++|++||.+++. ...+||||+ +...++.
T Consensus 3 ~~~~~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~~~~~~~ 76 (122)
T 3rs1_A 3 KTYAACSKNWT--GVGNKCFYFSGYPRNWTFAQAFCMAQEAQLARFDNEEELIFLKRFKG--DFDSWIGLH--RESSEHP 76 (122)
T ss_dssp BSSSSCCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCSSHHHHHHHHHHTT--TSCEEEEEE--CSSTTSC
T ss_pred cccCCCChhhe--ecCCEEEEEECCccCHHHHHHHHHhcCCEEeeeCCHHHHHHHHHhcC--CCCEEEEEE--ecCCCCc
Confidence 45679999999 99999999999999999999999999999999999999999999986 468999999 6666799
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccccc
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
|.|+||+++.+ ..|.. +.++|+.+... .|++..|....+|||++|+
T Consensus 77 w~W~dg~~~~~-~~w~~----------------~~~~C~~~~~~--~w~~~~C~~~~~fICekps 122 (122)
T 3rs1_A 77 WKWTNNTEYNN-MNPIL----------------GVGRYAYLSSD--RISSSRSYINRMWICSKLN 122 (122)
T ss_dssp CEETTCCBCCC-CSCCC----------------SSCSEEEEETT--EEEEECSCSCBCBEEEEEC
T ss_pred eECCCCCcCCc-cccCC----------------CCCceEEEeCC--cEeccccCCCCCeeeecCC
Confidence 99999976543 33421 23457777654 6999999999999999874
|
| >3kqg_A Langerin, C-type lectin domain family 4 member K; trimer, NECK and CRD, coiled coil, immune system; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-27 Score=218.17 Aligned_cols=128 Identities=20% Similarity=0.353 Sum_probs=109.9
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (573)
.||.||. .|+++||+|+.+.++|.+|+.+|++.||+||+|+|.+|++||.+++. ...+||||+ +...+|.|.|+
T Consensus 48 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~~~~~~~w~W~ 121 (182)
T 3kqg_A 48 VVSQGWK--YFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAG--GLIYWIGLT--KAGMEGDWSWV 121 (182)
T ss_dssp HHTTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHT--TCCEEEEEE--ECSTTCCEEET
T ss_pred cCCCCCE--EeCCEEEEEECCCCCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHhcC--CCcEEEEeE--ccCCCCceEeC
Confidence 6999999 99999999999999999999999999999999999999999999986 457999999 55567999999
Q ss_pred CCCCCCC---CCccccCCCCCCccCCCCcCCcccceeEEeecCC-CceeccccCCCCCcccccccCC
Q 008216 132 DNMSKWN---ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS-RSLVTERCNTSHPFICMVEHEN 194 (573)
Q Consensus 132 Dgt~~~~---~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~-~~W~d~~C~~~~~~iC~~~~~~ 194 (573)
||+++.+ |+.|.+++|++. .+.++|+.+...+ +.|+|..|....+|||+++..+
T Consensus 122 dG~~~~~~~~~~~W~~geP~~~---------~~~~~Cv~~~~~~~~~W~d~~C~~~~~fICe~~~~~ 179 (182)
T 3kqg_A 122 DDTPFNKVQSARFWIPGEPNNA---------GNNEHCGNIKAPSLQAWNDAPCDKTFLFICKRPYVP 179 (182)
T ss_dssp TCCCCCHHHHTTTBCTTCCCCT---------TSCCCEEEECSSSSSCEEEECTTSCBEEEEEEECCC
T ss_pred CCCccccccccCCCCCCCCCCC---------CCCCCeeEEecCCCCCEeCcCCCCCeeEEeccCCCC
Confidence 9987763 677887777653 2345677776543 5799999999999999998654
|
| >2b6b_D CD209 antigen; cryo EM dengue CRD DC-SIGN, icosahedral virus, virus-recepto; 25.00A {Homo sapiens} SCOP: d.169.1.1 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=212.86 Aligned_cols=134 Identities=23% Similarity=0.456 Sum_probs=112.8
Q ss_pred cCCCCCCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCC
Q 008216 45 MNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTV 124 (573)
Q Consensus 45 ~~~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~ 124 (573)
.....|..||.||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|++|++||..++......+||||+ +...
T Consensus 19 ~~~~~~~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~~~~~~~WIGl~--~~~~ 94 (175)
T 2b6b_D 19 SHMRLCHPCPWEWT--FFQGNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNRFTWMGLS--DLNQ 94 (175)
T ss_pred ccccccCCCCcCcE--EeCCEEEEEECCccCHHHHHHHHhhCCCEEeeeCCHHHHHHHHHHhccCCCcEEEeeE--ccCC
Confidence 34566789999999 9999999999999999999999999999999999999999999877544667999999 6666
Q ss_pred CCceEEcCCCCCCC--CCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccccCC
Q 008216 125 GLSWKWSDNMSKWN--ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHEN 194 (573)
Q Consensus 125 ~~~w~W~Dgt~~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~~~ 194 (573)
++.|.|+||+++.+ +..|..++|++. +.++|+.+... +|++..|....+|||+++...
T Consensus 95 ~~~w~W~dGs~~~~~~~~~W~~geP~~~----------~~~~Cv~~~~~--gW~d~~C~~~~~fICe~~~~~ 154 (175)
T 2b6b_D 95 EGTWQWVDGSPLLPSFKQYWNRGEPNNV----------GEEDCAEFSGN--GWNDDKCNLAKFWICKKSAAS 154 (175)
T ss_pred CCcEEeCCCCCcccccccCCCCCCCCCC----------CCCCeeEEcCC--ceEccCCCCCeeEEEEECCCC
Confidence 79999999988764 456777766542 34577777654 399999999999999998763
|
| >1dv8_A Asialoglycoprotein receptor 1; C-type lectin CRD, signaling protein; 2.30A {Homo sapiens} SCOP: d.169.1.1 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=201.82 Aligned_cols=126 Identities=21% Similarity=0.490 Sum_probs=106.5
Q ss_pred CCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcC
Q 008216 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD 132 (573)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~D 132 (573)
||+||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|++|++||.+++. ...+||||+ +. ++.|.|+|
T Consensus 1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~~--~~~~~W~d 72 (128)
T 1dv8_A 1 CPVNWV--EHERSCYWFSRSGKAWADADNYCRLEDAHLVVVTSWEEQKFVQHHIG--PVNTWMGLH--DQ--NGPWKWVD 72 (128)
T ss_dssp CCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC--SSCEEEEEE--CT--TSSCEETT
T ss_pred CCCcce--ecCCEEEEEECCCcCHHHHHHHHhhCCCEEcccCCHHHHHHHHHhhC--CCCEEeeEE--cC--CCcEEeCC
Confidence 999999 99999999999999999999999999999999999999999999987 468999999 54 68999999
Q ss_pred CCCCC-CCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 133 NMSKW-NESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 133 gt~~~-~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
|+++. .++.|.+++|++.... ...+.++|+.+.. .+.|++..|....+|||+++
T Consensus 73 g~~~~~~~~~W~~g~P~~~~~~----~~~~~~~C~~~~~-~g~W~~~~C~~~~~fICe~~ 127 (128)
T 1dv8_A 73 GTDYETGFKNWRPEQPDDWYGH----GLGGGEDCAHFTD-DGRWNDDVCQRPYRWVCETE 127 (128)
T ss_dssp CCCSTTSCCCBCTTCCCCCCTT----SSSSCCCEEEECT-TSCEEEECTTSCBEEEEEEE
T ss_pred CCcCCcccccCCCCCCCCcccc----cCCCCCcCceecC-CCcCCCccCCCCcceeeeeC
Confidence 98763 5667777777653211 0134567888764 36899999999999999875
|
| >1sl6_A C-type lectin DC-signr; sugar binding protein; HET: GAL NDG FUC; 2.25A {Homo sapiens} SCOP: d.169.1.1 PDB: 1xar_A | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-27 Score=217.33 Aligned_cols=129 Identities=22% Similarity=0.450 Sum_probs=109.9
Q ss_pred CCCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCce
Q 008216 49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW 128 (573)
Q Consensus 49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w 128 (573)
.|..||.||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|.+|++||..++......+||||+ +...++.|
T Consensus 49 ~~~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~~~~~~~WIGl~--~~~~~~~w 124 (184)
T 1sl6_A 49 LCRHCPKDWT--FFQGNCYFMSNSQRNWHDSVTACQEVRAQLVVIKTAEEQNFLQLQTSRSNRFSWMGLS--DLNQEGTW 124 (184)
T ss_dssp TCCBCCTTCE--EETTEEEEECSSCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHHHTTCCEEEEEE--CCSSTTCC
T ss_pred cCCCCCCCcE--EECCEEEEEECCCCCHHHHHHHHHhcCCEEEEeCCHHHHHHHHHHhccCCccEEEEEE--ccCCCCCe
Confidence 4678999999 8999999999999999999999999999999999999999999765433567999999 66667999
Q ss_pred EEcCCCCCCC--CCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccccC
Q 008216 129 KWSDNMSKWN--ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHE 193 (573)
Q Consensus 129 ~W~Dgt~~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~~ 193 (573)
.|+||+++.+ ++.|..++|++. +.++|+.+... +|++..|....+|||+++..
T Consensus 125 ~W~DGs~~~~~~~~~W~~geP~~~----------~~~~Cv~~~~~--gW~d~~C~~~~~fICe~~~~ 179 (184)
T 1sl6_A 125 QWVDGSPLSPSFQRYWNSGEPNNS----------GNEDCAEFSGS--GWNDNRCDVDNYWICKKPAA 179 (184)
T ss_dssp EETTSCBCCGGGGGGBCTTCCCCT----------TSCCEEEEETT--EEEEECTTSCBEEEEEEECB
T ss_pred EecCCCccCCcccCCCCCCCCCCC----------CCCCceEEeCC--cEEccCCCCCeeEEEeECCc
Confidence 9999987764 456777776642 34678888764 49999999999999999865
|
| >3c22_A C-type lectin domain family 4 member K; coiled coil, glycoprotein, membrane, signal-anchor, transmembrane, immune system, sugar binding protein; 1.50A {Homo sapiens} PDB: 3p5g_A* 3p5d_A* 3p5f_A* 3p5e_A* 3p5h_A* 3p5i_A* 3p7g_A* 3p7f_A* 3p7h_A* 3bc7_A* 3bbs_A* 3bc6_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.2e-27 Score=210.73 Aligned_cols=130 Identities=19% Similarity=0.342 Sum_probs=107.9
Q ss_pred CCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceE
Q 008216 50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWK 129 (573)
Q Consensus 50 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~ 129 (573)
+..||.||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|++|++||.+++. ...+||||+ +...++.|.
T Consensus 20 ~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~~~~~~~w~ 93 (156)
T 3c22_A 20 LQVVSQGWK--YFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAG--GLIYWIGLT--KAGMEGDWS 93 (156)
T ss_dssp ----CCCCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHT--TCCEEEEEE--EETTTTEEE
T ss_pred hccCCCCCE--EcCCEEEEEECCCCCHHHHHHHHHhCCCEEeecCCHHHHHHHHHhhc--CCcEEEeee--ccCCCCceE
Confidence 458999999 99999999999999999999999999999999999999999999987 568999999 555569999
Q ss_pred EcCCCCCCC---CCccccCCCCCCccCCCCcCCcccceeEEeecCC-CceeccccCCCCCcccccccCC
Q 008216 130 WSDNMSKWN---ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS-RSLVTERCNTSHPFICMVEHEN 194 (573)
Q Consensus 130 W~Dgt~~~~---~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~-~~W~d~~C~~~~~~iC~~~~~~ 194 (573)
|+||+++.+ +..|..++|++. .+.++|+.+.... +.|+|..|....+|||+++..+
T Consensus 94 W~dG~~~~~~~~~~~W~~geP~~~---------~~~~~Cv~~~~~~~~~W~d~~C~~~~~fICe~~~~~ 153 (156)
T 3c22_A 94 WVDDTPFNKVQSARFWIPGEPNNA---------GNNEHCGNIKAPSLQAWNDAPCDKTFLFICKRPYVP 153 (156)
T ss_dssp ETTCCCCCHHHHGGGBCTTCCCCG---------GGCCCEEEECSSSSSCEEEECTTSCBEEEEEEECCC
T ss_pred eCCCCccccccccCcCCCCCCCCC---------CCCCCceEECCCCCCcEECCCCCCCeeEEEeeCCcC
Confidence 999988765 467877776652 2345677776543 6799999999999999987644
|
| >2c6u_A CLEC1B protein; lectin, rhodocytin, aggretin, C-type lectin-like, platelets, thrombosis; 1.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-27 Score=203.63 Aligned_cols=120 Identities=18% Similarity=0.402 Sum_probs=104.4
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (573)
+||.||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|++|++||.+++. ..+||||+ +...++.|+|+
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~L~~i~s~~e~~~l~~~~~---~~~WiGl~--~~~~~~~~~W~ 74 (122)
T 2c6u_A 2 PCDTNWR--YYGDSCYGFFRHNLTWEESKQYCTDMNATLLKIDNRNIVEYIKARTH---LIRWVGLS--RQKSNEVWKWE 74 (122)
T ss_dssp CSCTTEE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHTTCC---SCEEEEEE--CSSTTSCCBCT
T ss_pred CCCccce--EeCCEEEEEECCcCCHHHHHHHHHhCCCeEeeECCHHHHHHHHHhhc---CCEEEEee--ecCCCCCeEeC
Confidence 7999999 99999999999999999999999999999999999999999999886 36899999 66667999999
Q ss_pred CCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccccc
Q 008216 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 132 Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
||+++.+ .|.+++|++. +.++|+.+. .+.|++..|....+|||+++.
T Consensus 75 dg~~~~~--~W~~~~P~~~----------~~~~C~~~~--~g~w~~~~C~~~~~~ICe~~~ 121 (122)
T 2c6u_A 75 DGSVISE--NMFEFLEDGK----------GNMNCAYFH--NGKMHPTFCENKHYLMCERKA 121 (122)
T ss_dssp TSCBCCG--GGGGGBCCCC----------TTCCEEEEE--TTEEEEECTTSCEEEEEEEEC
T ss_pred CCCccCc--CcccCCCCCC----------CCCCeeEEc--CCeEEeccCCCCceEeeeecC
Confidence 9977654 6777776642 345677774 358999999999999999864
|
| >2afp_A Protein (SEA raven type II antifreeze protein); recombinant SEA raven protein, solution backbone fold, C- type lectin; NMR {Hemitripterus americanus} SCOP: d.169.1.1 | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-27 Score=204.74 Aligned_cols=125 Identities=26% Similarity=0.511 Sum_probs=105.8
Q ss_pred CCCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCce
Q 008216 49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW 128 (573)
Q Consensus 49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w 128 (573)
.+..||.||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|++|++||.++ . ...+||||+ +...++.|
T Consensus 3 ~~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~-~--~~~~WIGl~--~~~~~~~~ 75 (129)
T 2afp_A 3 AGPNCPAGWQ--PLGDRCIYYETTAMTWALAETNCMKLGGHLASIHSQEEHSFIQTL-N--AGVVWIGGS--ACLQAGAW 75 (129)
T ss_dssp CCCSSCSSSC--CCSSSEECCCCSCCCHHHHHHHHHHHSCEECCCSSSHHHHHHHHH-C--SSCBCCSCB--CSSSSSCC
T ss_pred ccCCCCcCcE--EcCCEEEEEECCcCCHHHHHHHHHHcCCEECCcCCHHHHHHHHhc-C--CCCEEEccc--ccCCCCce
Confidence 4568999999 999999999999999999999999999999999999999999999 3 567999999 66667999
Q ss_pred EEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCC-ceeccccCCCCCcccccc
Q 008216 129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR-SLVTERCNTSHPFICMVE 191 (573)
Q Consensus 129 ~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~-~W~d~~C~~~~~~iC~~~ 191 (573)
+|+||+++ .++.|..++|++.. + ++|+.+...++ .|++..|....+|||+++
T Consensus 76 ~W~dg~~~-~~~~W~~~~P~~~~---------~-~~C~~~~~~~~~~w~~~~C~~~~~~iCe~~ 128 (129)
T 2afp_A 76 TWSDGTPM-NFRSWCSTKPDDVL---------A-ACCMQMTAAADQCWDDLPCPASHKSVCAMT 128 (129)
T ss_dssp BSSSSCCC-CCCCSSSCCSCCST---------T-CCBCCBCCSSSSCBCCBCSCCCCCCCEEEC
T ss_pred EeCCCCcc-ccCCcCCCccCCCC---------C-CCCeEEccCCCCEEeCCCCCCCcceEEeee
Confidence 99999776 55667777666421 1 56776655544 599999999999999875
|
| >1wmz_A Lectin CEL-I, N-acetyl-D-galactosamine-specific C-type; C-type lectin, N-acetylgalactosamine, invertebrate, sugar binding protein; HET: NGA A2G; 1.70A {Cucumaria echinata} SCOP: d.169.1.1 PDB: 1wmy_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-27 Score=207.11 Aligned_cols=128 Identities=14% Similarity=0.354 Sum_probs=108.4
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHh-------hcCCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeec
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCK-------EIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSI 120 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~-------~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~ 120 (573)
+.||+||. .|+++||+++.+.++|.+|+.+|+ +.||+||+|+|++|++||.+++... ...+||||+
T Consensus 1 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WiGl~-- 76 (140)
T 1wmz_A 1 NQCPTDWE--AEGDHCYRFFNTLTTWENAHHECVSYSCSTLNVRSDLVSVHSAAEQAYVFNYWRGIDSQAGQLWIGLY-- 76 (140)
T ss_dssp CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTTCBGGGTEEEEECCCCSHHHHHHHHHHHHHHCCSSCCEEEEEE--
T ss_pred CcCCCcce--ecCCEEEEEECCCcCHHHHHHhhhhhccCCCCCCcEEcccCCHHHHHHHHHHHhhccCCCCCEEEeee--
Confidence 37999999 999999999999999999999999 9999999999999999999888532 467999999
Q ss_pred CCCCCCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCC-ceeccccCCCCCccccccc
Q 008216 121 NTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR-SLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 121 ~~~~~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~-~W~d~~C~~~~~~iC~~~~ 192 (573)
+...++.|.|+||+++ .++.|..++|++. .+.++|+.+...++ .|++..|....+|||+++.
T Consensus 77 ~~~~~~~~~W~dg~~~-~~~~W~~~~P~~~---------~~~~~Cv~~~~~~~~~W~~~~C~~~~~fICe~~~ 139 (140)
T 1wmz_A 77 DKYNEGDFIWTDGSKV-GYTKWAGGQPDNW---------NNAEDYGQFRHTEGGAWNDNSAAAQAKYMCKLTF 139 (140)
T ss_dssp CSSSTTCCEETTCCCC-CCCCBCTTCCCCG---------GGCEEEEEECSSTTTCEEEEETTCCEEEEEEEEE
T ss_pred ecCCCCeeEECCcCcc-cccCcCcccCCCC---------CCcCCcEEEccCCCCCEeCCCCCCCceEEEEEec
Confidence 6666799999999776 5566777766642 23567888876554 7999999999999998763
|
| >2kv3_A Regenerating islet-derived protein 4; GISP, C-type lectin, REG IV, disulfide bond, glycoPro lectin, secreted, sugar binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=202.94 Aligned_cols=124 Identities=24% Similarity=0.598 Sum_probs=105.4
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhc--CCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (573)
.||+||. .|+++||+++.+.++|.+|+.+|++. ||+||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~ 77 (131)
T 2kv3_A 2 SCAPGWF--YHKSNCYGYFRKLRNWSDAELECQSYGNGAHLASILSLKEASTIAEYISGYQRSQSIWIGLH--DPQKRQQ 77 (131)
T ss_dssp CSCTTCC--EETTEEEEEEEEEECHHHHHHHHHTTSSSCEECCCSSHHHHHHHHHHHTCTTSCCCCBCSEE--CSSSSSC
T ss_pred cCCcccE--EcCCEeEEEECCCCCHHHHHHHHhccCCCceEeeeCCHHHHHHHHHHHHhcCCCCCEEEecc--CCCCCCC
Confidence 6999999 89999999999999999999999999 99999999999999999998754 467999999 6666799
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCC--ceeccccCCCCCccccccc
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR--SLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~--~W~d~~C~~~~~~iC~~~~ 192 (573)
|.|+||+++ .++.|..++| .+.++|+.+...++ .|++..|....+|||++++
T Consensus 78 ~~W~dg~~~-~~~~W~~~~P------------~~~~~C~~~~~~~~~~~W~~~~C~~~~~~iCe~~p 131 (131)
T 2kv3_A 78 WQWIDGAMY-LYRSWSGKSM------------GGNKHCAEMSSNNNFLTWSSNECNKRQHFLCKYRP 131 (131)
T ss_dssp CEETTCCCC-SSCCCSSCCC------------TTCTTEEEECTTCTTCCEEEECTTCCEEEEEEECC
T ss_pred eEeCCcCcc-cccccCCCCC------------CCCCCceEEECCCCcCceecCCCCCCceEEEeeCC
Confidence 999999776 5555665554 13456777766543 5999999999999999863
|
| >3bx4_B Aggretin beta chain; toxin; 1.70A {Agkistrodon rhodostoma} PDB: 2vrp_B | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=207.13 Aligned_cols=118 Identities=25% Similarity=0.535 Sum_probs=101.3
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (573)
.||+||. .|+++||+++.+.++|.+|+.+|++ .||+||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 24 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~ 99 (146)
T 3bx4_B 24 DCPSGWS--SYEGHCYKPFNEPKNWADAERFCKLQPKHSHLVSFQSAEEADFVVKLTRPRLKANLVWMGLS--NIWHGCN 99 (146)
T ss_dssp -CCTTCE--EETTEEEEEEEEEECHHHHHHHHHHSSSCCEECCCSSHHHHHHHHHHHTTTTTTSEEECSCC--CTTSSSC
T ss_pred CCCcCcE--eeCCEEEEEECCCcCHHHHHHHHhccCCCceEeccCCHHHHHHHHHHHhhcCCCCCEEEecc--cCCCCCc
Confidence 7999999 9999999999999999999999999 599999999999999999998754 457999999 6666799
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
|.|+||+++ .++.|. ++| +|+.+....+.|+|..|+...+|||+++
T Consensus 100 ~~W~dg~~~-~~~~W~-g~P----------------~C~~~~~~~g~w~~~~C~~~~~~ICe~~ 145 (146)
T 3bx4_B 100 WQWSDGARL-NYKDWQ-EQS----------------ECLAFRGVHTEWLNMDCSSTCSFVCKFK 145 (146)
T ss_dssp EEETTCCCC-CSCCBC-SCC----------------EEEEEETTCCCEEEEETTSCEEEEEEEE
T ss_pred eEeCCCCcc-cccCcC-CCC----------------CceEEECCCCeEecCCCCCCcceEEeec
Confidence 999999775 444455 543 5777766556899999999999999875
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=250.58 Aligned_cols=184 Identities=16% Similarity=0.165 Sum_probs=146.5
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccch--------hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEE
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
.++||+|+||.||++.. .++.+++|....... ...+.+.+|++++++++||||+++..++.+.+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 45789999999999965 688999998644311 123558999999999999999966666667788899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||++. .+||+|||+++.....
T Consensus 420 ~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 420 YINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp CCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred CCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 9999999999853 558999999999999999 9999999999999998 9999999999987654
Q ss_pred cccc-----ceeccCCcccccccccccC--CCCCcchhhHHHHHHHHHHHcCCCCCC
Q 008216 426 VMQE-----RTVMAGGTYGYLAPEFVYR--NELTTKSDVYSFGVLLLEIVSGRRPAQ 475 (573)
Q Consensus 426 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~Pf~ 475 (573)
.... ......||+.|||||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 3221 1123349999999999986 568888999999999988888777663
|
| >1tdq_B Aggrecan core protein; extracellular matrix, lecticans, tenascins, protein-protein interactions, C-type lectin domain; 2.60A {Rattus norvegicus} SCOP: d.169.1.1 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-26 Score=200.60 Aligned_cols=126 Identities=21% Similarity=0.418 Sum_probs=106.5
Q ss_pred CCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceE
Q 008216 50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWK 129 (573)
Q Consensus 50 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~ 129 (573)
...||+||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|.+|++||.+++. ..+||||+ +...++.|.
T Consensus 4 ~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--~~~~~~~~~ 76 (130)
T 1tdq_B 4 QEQCEEGWT--KFQGHCYRHFPDRETWVDAERRCREQQSHLSSIVTPEEQEFVNKNAQ---DYQWIGLN--DRTIEGDFR 76 (130)
T ss_dssp -CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC---SCEEEEEE--CSSSTTCCE
T ss_pred ccCCCcccE--EeCCEEEEEECCCCCHHHHHHHHHhcCCEEeeeCCHHHHHHHHhccC---CCEEEeee--cCCCCCEEE
Confidence 357999999 99999999999999999999999999999999999999999999885 57999999 666679999
Q ss_pred EcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeec-CCCceeccccCCCCCcccccc
Q 008216 130 WSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 130 W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~-~~~~W~d~~C~~~~~~iC~~~ 191 (573)
|+||+++. +..|..++|++. ..+.++|+.+.. ..+.|++..|....+|||+++
T Consensus 77 W~dg~~~~-~~~W~~~~P~~~--------~~~~~~C~~~~~~~~~~w~~~~C~~~~~fICe~~ 130 (130)
T 1tdq_B 77 WSDGHSLQ-FEKWRPNQPDNF--------FATGEDCVVMIWHERGEWNDVPCNYQLPFTCKKG 130 (130)
T ss_dssp ETTCCCCC-CCCBCTTCCCCC--------STTTEEEEEEETTTTTEEEEEETTSCEEEEEEEC
T ss_pred ecCCCcCC-ccccCCCCCCCc--------cCCCCCeEEEccCCCCcccCcCCCCCeeeeeecC
Confidence 99997764 566776766542 234567887763 456899999999999999863
|
| >1gz2_A Ovocleidin-17, OC-17 ovocleidin; structural protein, CTLD, eggshell structural protein, phosphoprotein, sugar-binding protein, glycoprotein; HET: SEP; 1.5A {Gallus gallus} SCOP: d.169.1.1 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=205.06 Aligned_cols=126 Identities=23% Similarity=0.536 Sum_probs=105.9
Q ss_pred CCCCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC----------CCCeEEee
Q 008216 50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN----------VNGCWVGG 117 (573)
Q Consensus 50 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~----------~~~~WiGl 117 (573)
+..||+||. .|+++||+++.+.++|.+|+.+|++ .||+||+|+|.+|++||.+++... ...+||||
T Consensus 2 ~~~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~~~~~~~WIGl 79 (142)
T 1gz2_A 2 PDGCGPGWV--PTPGGCLGFFSRELSWSRAESFCRRWGPGSHLAAVRSAAELRLLAELLNASRGGDGSGEGADGRVWIGL 79 (142)
T ss_dssp --CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTTCTTEEECCCCSHHHHHHHHHHHHCSSCCSSSCCCCSSCEEEEE
T ss_pred CCCCCcccE--EcCCEEEEEcCCCcCHHHHHHHHhccCCCceECccCCHHHHHHHHHHHHhcccccccccccCCCEEEEe
Confidence 468999999 8999999999999999999999999 999999999999999999988643 35699999
Q ss_pred eecCCCCCCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCC--ceeccccCCCCCcccccc
Q 008216 118 RSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR--SLVTERCNTSHPFICMVE 191 (573)
Q Consensus 118 ~~~~~~~~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~--~W~d~~C~~~~~~iC~~~ 191 (573)
+ +...++.|.|+||+++ .+..|..++|++. .++|+.+...++ .|++..|....+|||+++
T Consensus 80 ~--~~~~~~~w~W~dg~~~-~~~~W~~~~P~~~-----------~~~C~~~~~~~~~~~w~~~~C~~~~~fICe~~ 141 (142)
T 1gz2_A 80 H--RPAGSRSWRWSDGTAP-RFASWHRTAKARR-----------GGRCAALRDEEAFTSWAARPCTERNAFVCKAA 141 (142)
T ss_dssp E--CCTTCSSCEETTSCCC-CCCCBCSSSGGGC-----------SCSEEEECTTTTSSCEEEECTTCCEEEEEEEE
T ss_pred e--cCCCCCCcEeCCCCcc-CccCcCCCCCCCC-----------CCCCeEEecCCCCCeEecCCCCCCceeEEeec
Confidence 9 6666799999999775 4555666665542 456777766543 799999999999999875
|
| >3bdw_B NKG2-A/NKG2-B type II integral membrane protein; NK cells, receptor, glycoprotein, lectin, signal-A transmembrane, immune system receptor; 2.50A {Homo sapiens} PDB: 3cdg_K 3cii_H | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=197.93 Aligned_cols=118 Identities=19% Similarity=0.397 Sum_probs=99.1
Q ss_pred CCCCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCc
Q 008216 48 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 48 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~ 127 (573)
..|+.||+||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|++|++||.++. ..+||||+ +...++.
T Consensus 2 ~~c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~----~~~WIGl~--~~~~~~~ 73 (120)
T 3bdw_B 2 RHCGHCPEEWI--TYSNSCYYIGKERRTWEESLLACTSKNSSLLSIDNEEEMKFLSIIS----PSSWIGVF--RNSSHHP 73 (120)
T ss_dssp CCCTTSCTTCE--ESSSSEEEEEEEEECHHHHHHHHHHTTSEECCCCCHHHHHHHHHHC----SEEEEEEE--CSSTTSC
T ss_pred CcCCCCCCCce--EECCEEEEEECCccCHHHHHHHHHhCCCEEceeCCHHHHHHHHHcC----CCEeEEEE--ecCCCCc
Confidence 46789999999 9999999999999999999999999999999999999999999875 37999999 6666799
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccc
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~ 190 (573)
|+|+||+++.+ +.| +|++ +.++|+.+... .|++..|....+|||++
T Consensus 74 w~W~dg~~~~~-~~~---~p~~-----------~~~~C~~~~~~--~w~~~~C~~~~~fICe~ 119 (120)
T 3bdw_B 74 WVTMNGLAFKH-EIK---DSDN-----------AELNCAVLQVN--RLKSAQCGSSIIYHCKH 119 (120)
T ss_dssp CEETTSSBCCS-CCC------------------CCCCEEEEESS--SEEEECTTSCEEEEEEC
T ss_pred eEeCCCCccCc-cCc---CCCC-----------CCCCccEEeCC--ceECCCCCCCcceeeee
Confidence 99999977543 222 2221 24578887654 49999999999999986
|
| >2bpd_A Dectin-1; receptor, beta-glucan, fungal recognition, C-type lectin-like domain, CTLD, carbohydrate; 1.5A {Mus musculus} PDB: 2bph_A 2bpe_A 2cl8_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-26 Score=205.01 Aligned_cols=128 Identities=22% Similarity=0.494 Sum_probs=104.3
Q ss_pred CCCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCC-CCCeEEeeeecCCCCCCc
Q 008216 49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~ 127 (573)
....||.||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 13 ~~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~WIGl~--~~~~~~~ 88 (142)
T 2bpd_A 13 FSQSCLPNWI--MHGKSCYLFSFSGNSWYGSKRHCSQLGAHLLKIDNSKEFEFIESQTSSHRINAFWIGLS--RNQSEGP 88 (142)
T ss_dssp --CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHGGGTTSEEEEEEE--CSSTTSC
T ss_pred CCCCCCccce--ecCCEEEEEECCCCCHHHHHHHHHHcCCEEeeeCCHHHHHHHHHHHhccCCCCEEEEee--cCCCCCC
Confidence 3468999999 9999999999999999999999999999999999999999999998643 457999999 6666799
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
|.|+||+++.+.+|....++++ ..+.++|+.+.. +.|++..|....+|||+++
T Consensus 89 w~W~dg~~~~~~~w~~~~~~~~---------~~~~~~Cv~~~~--~~W~d~~C~~~~~fICe~~ 141 (142)
T 2bpd_A 89 WFWEDGSAFFPNSFQVRNAVPQ---------ESLLHNCVWIHG--SEVYNQICNTSSYSICEKE 141 (142)
T ss_dssp CEETTSCBCCSSSCCEECCCCS---------CCSCCCEEEEET--TEEEEECTTSCEEEEEEEC
T ss_pred eEeCCCCccccccccccCCCCC---------CCCCCCCcEEcC--CeEECcCCCCCceeeeeee
Confidence 9999997766544433222222 123567888764 4899999999999999875
|
| >3m9z_A Killer cell lectin-like receptor subfamily B MEMB; C-type lectin-like domain, domain swapping, disulfide bond, transmembrane protein; 1.70A {Mus musculus} SCOP: d.169.1.0 PDB: 3t3a_A | Back alignment and structure |
|---|
Probab=99.93 E-value=8.9e-27 Score=205.86 Aligned_cols=126 Identities=25% Similarity=0.553 Sum_probs=106.7
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEE
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW 130 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W 130 (573)
..||.||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|.+|++||.+++......+||||+ +...++.|+|
T Consensus 4 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~~~~~~w~W 79 (139)
T 3m9z_A 4 LECPQDWL--SHRDKCFHVSQVSNTWEEGLVDCDGKGATLMLIQDQEELRFLLDSIKEKYNSFWIGLR--YTLPDMNWKW 79 (139)
T ss_dssp CCCCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCCHHHHHHHHHHHTCSSSCEEEEEE--EECCCCCCBC
T ss_pred CCCCccce--ecCCEEEEEECCcCCHHHHHHHHHhcCCeEeeeCCHHHHHHHHHHhcccCccEEEEEe--ccCCCCCeEe
Confidence 58999999 9999999999999999999999999999999999999999999999855567999999 5445689999
Q ss_pred cCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccccCCc
Q 008216 131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHENK 195 (573)
Q Consensus 131 ~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~~~~ 195 (573)
+||+++.+.+||..+++ ++++|+.+.. +.|++..|....+|||+++....
T Consensus 80 ~dg~~~~~~~~~~~~~~-------------~~~~Cv~~~~--~~w~~~~C~~~~~fICe~~~~~~ 129 (139)
T 3m9z_A 80 INGSTLNSDVLKITGDT-------------ENDSCAAISG--DKVTFESCNSDNRWICQKELYHE 129 (139)
T ss_dssp TTSCBCCHHHHTTSSCT-------------TCEEEEEEET--TEEEEEETTSCBEEEEEEECC--
T ss_pred CCCCcCCcCccccCCCC-------------CCCCeeEEeC--CcEEeCCCCCCCceEeeecCccc
Confidence 99988766666644432 1357888764 47999999999999999876543
|
| >3bdw_A Natural killer cells antigen CD94; NK cells, receptor, glycoprotein, lectin, signal-A transmembrane, immune system receptor; 2.50A {Homo sapiens} SCOP: d.169.1.1 PDB: 3cdg_J 1b6e_A 3cii_G | Back alignment and structure |
|---|
Probab=99.93 E-value=7.2e-27 Score=201.82 Aligned_cols=122 Identities=16% Similarity=0.362 Sum_probs=102.2
Q ss_pred CCCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCce
Q 008216 49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW 128 (573)
Q Consensus 49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w 128 (573)
+|..||+||. .|+++||+++.+.++|.+|+.+|+++||+||+|+|++|++||.++ ...+||||+ +...++.|
T Consensus 1 ~c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~----~~~~WIGl~--~~~~~~~w 72 (123)
T 3bdw_A 1 DCCSCQEKWV--GYRCNCYFISSEQKTWNESRHLCASQKSSLLQLQNTDELDFMSSS----QQFYWIGLS--YSEEHTAW 72 (123)
T ss_dssp CCCCCTTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCSCGGGGGGGTTC----CCCEECSEE--EETTTTEE
T ss_pred CCCCCCCCce--EECCEEEEEeCCCCCHHHHHHHHHHCCCeeEEECCHHHHHHHHhC----cCCEEeeee--cCCCCCcE
Confidence 4789999999 999999999999999999999999999999999999999999876 457999999 55567999
Q ss_pred EEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccccc
Q 008216 129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 129 ~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
.|+||+++.+. .|..++|+ +.++|+.+... +.|++..|....+|||+++.
T Consensus 73 ~W~dg~~~~~~-~w~~~~~~------------~~~~C~~~~~~-~~w~d~~C~~~~~fICe~~~ 122 (123)
T 3bdw_A 73 LWENGSALSQY-LFPSFETF------------NTKNCIAYNPN-GNALDESCEDKNRYICKQQL 122 (123)
T ss_dssp EETTSCBCCTT-TSGGGGGC------------CTTSEEEEETT-TEEEEECTTSCBEEEEEECC
T ss_pred EeeCCCcCCcc-cccccCCC------------CCCCCcEEcCC-CcEEccCCCCCCeeeEeEec
Confidence 99999776544 45433321 34568877654 57999999999999999863
|
| >1egg_A Macrophage mannose receptor; C-type lectin, sugar binding protein; 2.30A {Homo sapiens} SCOP: d.169.1.1 PDB: 1egi_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=205.69 Aligned_cols=130 Identities=25% Similarity=0.533 Sum_probs=103.9
Q ss_pred CCCCccC--cccCCCCeeeEEec----ccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecC
Q 008216 51 APCPPDW--IINEEKSKCFGYIG----NFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSIN 121 (573)
Q Consensus 51 ~~Cp~~w--~~~~~~~~Cy~~~~----~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~ 121 (573)
..||.|| . .++++||+++. +.++|.+|+.+|++.||+||+|+|++|++||.+++... ...+||||+ +
T Consensus 3 ~~Cp~gw~~~--~~~~~CY~~~~~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~ 78 (147)
T 1egg_A 3 PKCPEDWGAS--SRTSLCFKLYAKGKHEKKTWFESRDFCRALGGDLASINNKEEQQTIWRLITASGSYHKLFWLGLT--Y 78 (147)
T ss_dssp --CCTTCEEC--SSSSCEEEEECSCGGGCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHHHHTCTTCEEEEEEE--C
T ss_pred CCCCCCCccc--cCCCEEEEEeccCCccccCHHHHHHHHHHcCCEECccCCHHHHHHHHHHHHhccCCCCcEEEeee--c
Confidence 4799999 8 99999999999 99999999999999999999999999999999887532 357999999 6
Q ss_pred CCCCCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecC-CCceeccccCCCCCcccccccCC
Q 008216 122 TTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMVEHEN 194 (573)
Q Consensus 122 ~~~~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~-~~~W~d~~C~~~~~~iC~~~~~~ 194 (573)
...++.|+|+||+++ .++.|..++|++. .+.++|+.+... ++.|++..|....+|||+++...
T Consensus 79 ~~~~~~w~W~dg~~~-~~~~W~~g~P~~~---------~~~~~Cv~~~~~~~~~W~d~~C~~~~~fICe~~~~~ 142 (147)
T 1egg_A 79 GSPSEGFTWSDGSPV-SYENWAYGEPNNY---------QNVEYCGELKGDPTMSWNDINCEHLNNWICQIQKGQ 142 (147)
T ss_dssp C----CCCCTTSCCC-CCCCCCTTCSCGG---------GSCCEEEEEECSTTCCEEEEETTSCBEEEEECCC--
T ss_pred CCCCCcEEecCCCCc-ccCccCCCCCCCC---------CCCCCCeEECCCCCCceeccCCCCCccEEeeCCCCC
Confidence 656799999999775 4556766666542 245678887654 47899999999999999987644
|
| >1jwi_B Platelet aggregation inducer; domain swapping, C-type lectin, toxin; 2.00A {Bitis arietans} SCOP: d.169.1.1 PDB: 1uex_B | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=200.40 Aligned_cols=119 Identities=24% Similarity=0.489 Sum_probs=100.5
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHh--hcCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCC
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCK--EIGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGL 126 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~--~~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~ 126 (573)
..||+||. .|+++||+++.+.++|.+|+.+|+ ..||+||+|+|++|++||.+++... ...+||||+ +...++
T Consensus 2 ~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~ 77 (125)
T 1jwi_B 2 EGCLPDWS--SYKGHCYKVFKVEKTWADAEKFCKELVNGGHLMSVNSREEGEFISKLALEKMRIVLVWIGLS--HFWRIC 77 (125)
T ss_dssp -CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHTTCCCEEEEEEE--ECGGGS
T ss_pred CCCCCCCE--ecCCEEEEEECCCcCHHHHHHHhhccCCCceECccCCHHHHHHHHHHHHhcCCCCCEEEeee--cCCCCC
Confidence 47999999 999999999999999999999999 8999999999999999999988642 457999999 555579
Q ss_pred ceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 127 ~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
.|.|+||+++ .++.|.+++ | |+.+....+.|++..|....+|||+++
T Consensus 78 ~~~W~dg~~~-~~~~W~~g~--------p---------C~~~~~~~~~W~~~~C~~~~~~iCe~~ 124 (125)
T 1jwi_B 78 PLRWTDGARL-DYRALSDEP--------I---------CFVAESFHNKWIQWTCNRKKSFVCKYR 124 (125)
T ss_dssp CEEETTCCCC-CSCCSCCSC--------E---------EEEEETTTCCEEEEETTSCEEEEEEEE
T ss_pred ceEeeCcCcC-ccCCcCCCC--------C---------eEEEECCCCeEecCCCCCCCcEEEeEe
Confidence 9999999775 444554443 3 666665557899999999999999875
|
| >2yhf_A C-type lectin domain family 5 member A; immune system; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=196.38 Aligned_cols=117 Identities=22% Similarity=0.407 Sum_probs=99.4
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (573)
+||+||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|++|++||.+++. ...+||||+ +...++.|.|+
T Consensus 1 ~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~~~~~~~w~W~ 74 (118)
T 2yhf_A 1 MCPKDWE--FYQARCFFLSTSESSWNESRDFCKGKGSTLAIVNTPEKLKFLQDITD--AEKYFIGLI--YHREEKRWRWI 74 (118)
T ss_dssp CCCTTCE--EETTEEEEECSSCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHC--SSCEEEEEE--EETTTTEEEET
T ss_pred CCCCCcE--EeCCEEEEEeCCCCCHHHHHHHHhhcCCEEEEeCCHHHHHHHHHhhC--CCcEEEecc--ccCCCCcEEEe
Confidence 5999999 99999999999999999999999999999999999999999999986 568999999 55567999999
Q ss_pred CCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 132 Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
||+++. .|..++| ++++|+.+... +.|++..|....+|||+++
T Consensus 75 dg~~~~---~~~~~~~-------------~~~~C~~~~~~-~~w~~~~C~~~~~fICe~~ 117 (118)
T 2yhf_A 75 NNSVFN---GNVTNQN-------------QNFNCATIGLT-KTFDAASCDISYRRICEKN 117 (118)
T ss_dssp TTEECC---SCEESCC-------------TTCCEEEESSS-SSEEEECTTSCBEEEEEEE
T ss_pred CCCcCC---CCccCCC-------------CCCCeeEEcCC-CcCccccCCCCceeeeccc
Confidence 997642 3433322 23567777543 5799999999999999875
|
| >2ox9_A Collectin placenta 1; C-type lectin, sugar binding protein; HET: GAL NAG FUC; 1.95A {Mus musculus} PDB: 2ox8_A | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-26 Score=201.05 Aligned_cols=132 Identities=21% Similarity=0.444 Sum_probs=109.9
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEE
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW 130 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W 130 (573)
..||.||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|++|++||.+++.. ...+||||+ +...++.|.|
T Consensus 3 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~-~~~~WIGl~--~~~~~~~~~W 77 (140)
T 2ox9_A 3 NGCPPHWK--NFTDKCYYFSLEKEIFEDAKLFCEDKSSHLVFINSREEQQWIKKHTVG-RESHWIGLT--DSEQESEWKW 77 (140)
T ss_dssp -CCCTTCE--EETTEEEEECSCCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHTCCS-SSCEEEEEE--CSSSTTCCEE
T ss_pred CCCCcCce--EcCCEEEEEECCCcCHHHHHHHHHhcCCEEeeeCCHHHHHHHHHHhcC-CCCEEeeeE--eCCCCCceEe
Confidence 47999999 899999999999999999999999999999999999999999998863 467999999 6666799999
Q ss_pred cCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccccCC
Q 008216 131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHEN 194 (573)
Q Consensus 131 ~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~~~ 194 (573)
+||+++ .+..|..++|++... ...+.++|+.+.. .+.|++..|....+|||+++...
T Consensus 78 ~dg~~~-~~~~W~~~~P~~~~~-----~~~~~~~Cv~~~~-~g~W~d~~C~~~~~fICe~~~~~ 134 (140)
T 2ox9_A 78 LDGSPV-DYKNWKAGQPDNWGS-----GHGPGEDCAGLIY-AGQWNDFQCDEINNFICEKEREA 134 (140)
T ss_dssp TTSCBC-CSCCBCTTCCCCTTT-----TTSSCCCEEEECG-GGCEEEECTTSCBEEEEEEECC-
T ss_pred CCcCcC-CccCcCCcCCCCccc-----CCCCCCCCceECC-CCeEeccCCCCCceeEEeecCCC
Confidence 999764 566777777776411 1234567887764 36799999999999999987654
|
| >1fvu_B Botrocetin beta chain; VON WILLBRAND factor modulator, C-type lectin, metal- binding, loop exchanged dimer, toxin; 1.80A {Bothrops jararaca} SCOP: d.169.1.1 PDB: 1ijk_C 1u0n_C 1u0o_B | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-26 Score=198.33 Aligned_cols=120 Identities=23% Similarity=0.530 Sum_probs=101.2
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (573)
+||+||. .|+++||+++.+.++|.+|+.+|++ .||+||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 1 ~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~ 76 (125)
T 1fvu_B 1 DCPPDWS--SYEGHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEMLKGDVVWIGLS--DVWNKCR 76 (125)
T ss_dssp CCSTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHTTCTTSCTTCCEECSCC--CCSTTSC
T ss_pred CcCCccE--EcCCEEEEEeCCCCCHHHHHHHHhccCCCcEECccCCHHHHHHHHHHHHhcCCCCCEEEeee--ecCCCCc
Confidence 5999999 9999999999999999999999999 899999999999999999988754 367999999 6666799
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
|.|+||+++ .++.|..++|+ +|+.+....+.|++..|....+|||+++
T Consensus 77 ~~W~dg~~~-~~~~w~~~~P~---------------~C~~~~~~~g~w~~~~C~~~~~~iCe~~ 124 (125)
T 1fvu_B 77 FEWTDGMEF-DYDDYYLIAEY---------------ECVASKPTNNKWWIIPCTRFKNFVCEFQ 124 (125)
T ss_dssp EEETTSCCC-CC----CCSCC---------------EEEEEETTTTEEEEEETTSCEEEEEEEC
T ss_pred eEecCCCcc-CccccCCCCCC---------------CceEEECCCCcEeCCcCCCCCcEEEeec
Confidence 999999775 45556655543 5777766556899999999999999875
|
| >2xr6_A CD209 antigen; sugar binding protein, carbohydrate binding, mannose; HET: MAN 07B; 1.35A {Homo sapiens} PDB: 1sl4_A* 2it6_A* 1k9i_A* 2xr5_A* 1sl5_A* 2it5_A* 1xph_A 1k9j_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=211.08 Aligned_cols=131 Identities=24% Similarity=0.478 Sum_probs=107.0
Q ss_pred CCCCCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCC
Q 008216 47 KDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGL 126 (573)
Q Consensus 47 ~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~ 126 (573)
...+..||.||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|++|++||..++......+||||+ +...++
T Consensus 16 ~~~~~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~~~~~~~WIGl~--~~~~~~ 91 (170)
T 2xr6_A 16 ERLSHPCPWEWT--FFQGNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNRFTWMGLS--DLNQEG 91 (170)
T ss_dssp -----CCCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHTCCEEEEEE--EEEETT
T ss_pred ccccCCCCcCcE--EeCCEEEEEECCcCCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHHhccCCCCEEeccc--cCCCCC
Confidence 445678999999 8999999999999999999999999999999999999999999765333567999999 444569
Q ss_pred ceEEcCCCCCCC--CCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccccC
Q 008216 127 SWKWSDNMSKWN--ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHE 193 (573)
Q Consensus 127 ~w~W~Dgt~~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~~ 193 (573)
.|.|+||+++.+ +..|..++|++. +.++|+.+... +|+|..|....+|||+++..
T Consensus 92 ~w~W~dG~~~~~~~~~~W~~geP~~~----------~~~~Cv~~~~~--gW~d~~C~~~~~fICe~~~~ 148 (170)
T 2xr6_A 92 TWQWVDGSPLLPSFKQYWNRGEPNNV----------GEEDCAEFSGN--GWNDDKCNLAKFWICKKSAA 148 (170)
T ss_dssp EEEETTSCBCCGGGGGGBCTTCCCCT----------TCCCEEEEETT--EEEEECTTSCBEEEEEEETT
T ss_pred eEEeCCCCCcccccccCCCCCCCCCC----------CCCCCeEEeCC--cEEccccCCCccEEEEECCC
Confidence 999999987764 466777776542 34678887764 49999999999999999876
|
| >1mpu_A NKG2-D type II integral membrane protein; C-type lectin-like domain, immune system; 2.50A {Homo sapiens} SCOP: d.169.1.1 PDB: 1hyr_B | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=204.70 Aligned_cols=128 Identities=22% Similarity=0.508 Sum_probs=105.9
Q ss_pred ccccCCCCCCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecC
Q 008216 42 AASMNKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSIN 121 (573)
Q Consensus 42 ~~~~~~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~ 121 (573)
..+.....|..||.||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|++|++||..+. ..+||||+ +
T Consensus 10 ~~~~~~~~~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~fl~~~~----~~~WIGl~--~ 81 (138)
T 1mpu_A 10 QIPLTESYCGPCPKNWI--CYKNNCYQFFDESKNWYESQASCMSQNASLLKVYSKEDQDLLKLVK----SYHWMGLV--H 81 (138)
T ss_dssp CCCCCCCCCCCCCTTCE--ECSSCEEEEEEEEECHHHHHHHHHHTSCEECCCCCTTTCGGGGGCC----SEEEEEEE--E
T ss_pred CcCCCCCccCCCChhhe--EeCCEEEEEECCCCCHHHHHHHHHhcCCEEeeeCCHHHHHHHHhcc----CCEeEeee--c
Confidence 33445667789999999 9999999999999999999999999999999999999999998643 47999999 5
Q ss_pred CCCCCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccccc
Q 008216 122 TTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 122 ~~~~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
...++.|.|+||+++. ++.|..++|+ +++|+.+... +.|++..|....+|||+++.
T Consensus 82 ~~~~~~w~W~dG~~~~-~~~w~~~~p~-------------~~~C~~~~~~-~~w~~~~C~~~~~fICe~~~ 137 (138)
T 1mpu_A 82 IPTNGSWQWEDGSILS-PNLLTIIEMQ-------------KGDCALYASS-FKGYIENCSTPNTYICMQRT 137 (138)
T ss_dssp CTTTCCEEETTSCBCC-TTSCEEECSS-------------CCSEEEEETT-TEEEEECTTSCEEEEEEECC
T ss_pred cCCCCceEeCCCCcCC-ccccccCCCC-------------CCCCeEEECC-CcEEccCCCCCCeEcccCcC
Confidence 5567999999997654 5556555432 2467777654 57999999999999999863
|
| >1fm5_A Early activation antigen CD69; C-type lectin-like domain, natural killer cell receptor, lectin, C-type lectin, immune system; 2.27A {Homo sapiens} SCOP: d.169.1.1 | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-26 Score=213.29 Aligned_cols=120 Identities=24% Similarity=0.523 Sum_probs=99.2
Q ss_pred CCCCCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCC
Q 008216 47 KDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGL 126 (573)
Q Consensus 47 ~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~ 126 (573)
...+..||.||. .|+++||+++.+.++|.+|+.+|+++||+||+|+|++|++||.+++. ...+||||+ +.. ++
T Consensus 79 ~~~~~~Cp~gW~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~--~~~~WIGl~--~~~-~~ 151 (199)
T 1fm5_A 79 DSHVSSCSEDWV--GYQRKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAG--REEHWVGLK--KEP-GH 151 (199)
T ss_dssp CC----CCTTSE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC--SSCEEEEEE--CCT-TS
T ss_pred CCCCCCCCCCcE--EECCEEEEEeCCccCHHHHHHHHhhcCCEEEecCCHHHHHHHHHhhC--CCCEEeeeE--ECC-CC
Confidence 455678999999 99999999999999999999999999999999999999999999997 468999999 554 79
Q ss_pred ceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccccc
Q 008216 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 127 ~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
.|.|+||+++ +.|.. ..+.++|+.+.. +.|+|..|+...+|||+++.
T Consensus 152 ~w~W~DGs~~---~~W~~--------------~~~~~~Cv~l~~--~~W~d~~C~~~~~fICe~~~ 198 (199)
T 1fm5_A 152 PWKWSNGKEF---NNWFN--------------VTGSDKCVFLKN--TEVSSMECEKNLYWICNKPY 198 (199)
T ss_dssp CCEETTSCBC---CCSSC--------------CCSSSSEEEECS--SCEEEECTTSCBEEEEEEEC
T ss_pred CeEECCCCcc---ccccC--------------CCCCCCceEEEC--CCEEEecCCCCEEEEccccC
Confidence 9999999752 34431 123456777765 57999999999999999863
|
| >2zib_A Type II antifreeze protein; thermal hysteresis, lectin; 1.34A {Brachyopsis rostratus} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=197.28 Aligned_cols=125 Identities=26% Similarity=0.526 Sum_probs=107.0
Q ss_pred CCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceE
Q 008216 50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWK 129 (573)
Q Consensus 50 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~ 129 (573)
..++|.+|. .|+++||+++.+.++|.+|+.+|++.||+||+|+|++|++||.+++. ..+||||+ +...++.|.
T Consensus 7 ~~~~~~~~~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--~~~~~~~w~ 79 (133)
T 2zib_A 7 ALVCPAGWT--LHGQRCFYSEATAMTWDLAEANCVNKGGHLASIHSLEEQLYIKDIVA---GIVWIGGS--ACKVAGAWS 79 (133)
T ss_dssp CCCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTSEECCCCSHHHHHHHHHHCS---SCEEEEEE--CCSSTTCCE
T ss_pred eeeCCCCEE--EeCCEEEEEECCccCHHHHHHHHHHCCCEECccCCHHHHHHHHHhhc---cCEEEccE--ecCCCCceE
Confidence 357899999 99999999999999999999999999999999999999999999986 68999999 666679999
Q ss_pred EcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCC-ceeccccCCCCCccccccc
Q 008216 130 WSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR-SLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 130 W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~-~W~d~~C~~~~~~iC~~~~ 192 (573)
|+||+++ .++.|..++|++. . + ++|+.+...++ .|++..|....+|||++++
T Consensus 80 W~dG~~~-~y~~W~~g~P~~~--------~-~-~~Cv~~~~~~~~~W~d~~C~~~~~fICe~~~ 132 (133)
T 2zib_A 80 WTDGTPV-DYRTWCPTKPNDI--------L-S-DCCMQMTAAVDKCWDDLPCPASHASICAKAA 132 (133)
T ss_dssp ETTCCCC-CCCCBCTTCCCCC--------T-T-SCEEEECSSTTCCEEEECTTCCEEEEEEEEC
T ss_pred ECCCCCc-ccCCcCCCCCCCC--------C-C-CCceEEecCCCCcEeCCCCCCCeeEEEeEcC
Confidence 9999776 5666776766642 1 2 57777766544 5999999999999999864
|
| >1jzn_A Galactose-specific lectin; C-type lectin, protein-disaccharide complex, sugar binding P; HET: BGC GAL; 2.20A {Crotalus atrox} SCOP: d.169.1.1 PDB: 1muq_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-26 Score=201.03 Aligned_cols=126 Identities=21% Similarity=0.602 Sum_probs=105.6
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCC
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGL 126 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~ 126 (573)
+||+||. .|+++||+++.+.++|.+|+.+|++ .||+||+|+|.+|++||.+++... ...+||||+ +...++
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~~~~~~ 77 (135)
T 1jzn_A 2 NCPLDWL--PMNGLCYKIFNQLKTWEDAEMFCRKYKPGCHLASFHRYGESLEIAEYISDYHKGQENVWIGLR--DKKKDF 77 (135)
T ss_dssp CSCTTSE--EETTEEEEEEEEEECHHHHHHHHHHHSSSEEECCCCSHHHHHHHHHHHHHHCCSSCCEEEEEE--CTTSSS
T ss_pred cCCCCce--eeCCEEEEEECCccCHHHHHHHHhccCCCCEECccCCHHHHHHHHHHHHhcccCCCCEEEeeE--cCCcCC
Confidence 6999999 9999999999999999999999999 699999999999999999887532 357999999 666679
Q ss_pred ceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCC--CceeccccCCCCCcccccc
Q 008216 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 127 ~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~--~~W~d~~C~~~~~~iC~~~ 191 (573)
.|.|+||+++ .++.|..++|++. .+.++|+.+.... +.|++..|....+|||+++
T Consensus 78 ~~~W~dg~~~-~~~~W~~~~P~~~---------~~~~~C~~~~~~~~~~~w~~~~C~~~~~~ICe~~ 134 (135)
T 1jzn_A 78 SWEWTDRSCT-DYLTWDKNQPDHY---------QNKEFCVELVSLTGYRLWNDQVCESKDAFLCQCK 134 (135)
T ss_dssp CCEETTCCCC-CCCCBCTTCCCCG---------GGCCCEEEECGGGTTCSEEEECTTSCEEEEEEEC
T ss_pred ceEECCCCcc-CcCcCCcCCCCCC---------CCCCCceEEECCCCCCcCCCcCCCCCCceeeeec
Confidence 9999999774 5566777776652 2345677776543 5799999999999999875
|
| >1hq8_A NKG2-D; homodimer, CIS-proline, apoptosis; 1.95A {Mus musculus} SCOP: d.169.1.1 PDB: 1jsk_A 1kcg_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-26 Score=199.70 Aligned_cols=121 Identities=22% Similarity=0.520 Sum_probs=102.1
Q ss_pred CCCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCce
Q 008216 49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW 128 (573)
Q Consensus 49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w 128 (573)
.|..||+||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|++|++||..+. ..+||||+ +...++.|
T Consensus 2 ~c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~fl~~~~----~~~WIGl~--~~~~~~~w 73 (123)
T 1hq8_A 2 YCGPCPNNWI--CHRNNCYQFFNEEKTWNQSQASCLSQNSSLLKIYSKEEQDFLKLVK----SYHWMGLV--QIPANGSW 73 (123)
T ss_dssp CCCCCSTTCE--EETTEEEEEEEEEECHHHHHHHHHTTTCEECCCSCTTTTGGGGGCC----SCEEEEEE--ECTTTCCE
T ss_pred cCCCCCcccE--EcCCEEEEEeCCccCHHHHHHHHHhcCCEecccCCHHHHHHHHhcc----CCEEEEee--ecCCCCCe
Confidence 5789999999 8999999999999999999999999999999999999999998653 47999999 55567999
Q ss_pred EEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccccc
Q 008216 129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 129 ~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
+|+||+++. ++.|..++|+ +++|+.+... +.|++..|....+|||+++.
T Consensus 74 ~W~dg~~~~-~~~w~~~~p~-------------~~~C~~~~~~-~~w~~~~C~~~~~fICe~~~ 122 (123)
T 1hq8_A 74 QWEDGSSLS-YNQLTLVEIP-------------KGSCAVYGSS-FKAYTEDCANLNTYICMKRA 122 (123)
T ss_dssp EETTSCBCC-TTTCEEECCT-------------TCCEEEECST-TEEEEECTTSCEEEEEEECC
T ss_pred EeCCCCCcc-ccccccCCCC-------------CCCcEEEecc-CCEeccCCCCCceeEeeeec
Confidence 999997654 5556555433 2467777554 57999999999999999863
|
| >1qdd_A Lithostathine; pancreatic stone inhibitor, metal binding protein; HET: SIA NDG GAL; 1.30A {Homo sapiens} SCOP: d.169.1.1 PDB: 1lit_A | Back alignment and structure |
|---|
Probab=99.93 E-value=5.1e-26 Score=202.25 Aligned_cols=126 Identities=17% Similarity=0.467 Sum_probs=106.1
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhhc-CCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCC
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGL 126 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~ 126 (573)
..||.||. .|+++||+++.+.++|.+|+.+|++. ||+||+|+|++|++||.+++... ...+||||+ +...++
T Consensus 12 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~gg~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~~~~~~ 87 (144)
T 1qdd_A 12 ISCPEGTN--AYRSYCYYFNEDRETWVDADLYCQNMNSGNLVSVLTQAEGAFVASLIKESGTDDFNVWIGLH--DPKKNR 87 (144)
T ss_dssp TSCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTSCEECCCCSHHHHHHHHHHHHHTTCCCSEEEEEEE--CTTSSS
T ss_pred CCCCCCce--ecCCEeEEEeCCCcCHHHHHHHhhccCCceECccCCHHHHHHHHHHHHhcCCCCCCEEEeeE--cCCCCC
Confidence 58999999 99999999999999999999999998 89999999999999999988642 457999999 666679
Q ss_pred ceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCC--CceeccccCCCCCcccccc
Q 008216 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 127 ~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~--~~W~d~~C~~~~~~iC~~~ 191 (573)
.|.|+||+++ .++.|.+++|++. +.++|+.+.... +.|++..|....+|||+++
T Consensus 88 ~~~W~dg~~~-~~~~W~~~~P~~~----------~~~~Cv~~~~~~~~~~W~d~~C~~~~~fICe~~ 143 (144)
T 1qdd_A 88 AWHWSSGSLV-SYKSWGIGAPSSV----------NPGYCVSLTSSTGFQKWKDVPCEDKFSFVCKFK 143 (144)
T ss_dssp CCEETTCCCC-CCCCBCTTCSCSS----------SCCSEEEEEGGGTTCSEEEECTTSCEEEEEEEE
T ss_pred eEEeCCCCCc-CcCccCCCCcCCC----------CCCCcEEEEecCCCCeEeCCCCCCCceeeeeec
Confidence 9999999765 4566776666541 345777776543 4799999999999999875
|
| >2h2t_B Low affinity immunoglobulin epsilon FC receptor ( IGE receptor) (FC-epsilon-RII)...; C-type lectin, calcium-bound, lectin domain; 1.30A {Homo sapiens} PDB: 2h2r_A 1t8c_A 1t8d_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-26 Score=209.64 Aligned_cols=130 Identities=22% Similarity=0.433 Sum_probs=106.0
Q ss_pred CCCCCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCC
Q 008216 47 KDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGL 126 (573)
Q Consensus 47 ~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~ 126 (573)
+..+..||.||. .|+++||+++.+.++|.+|+.+|+++||+||+|+|++|++||.+++. ...+||||+ +...++
T Consensus 11 ~~~~~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~--~~~~WIGl~--~~~~~~ 84 (175)
T 2h2t_B 11 GFVCNTCPEKWI--NFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKRAS--HTGSWIGLR--NLDLKG 84 (175)
T ss_dssp ---CCBCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHTTCC--TTCEEEEEE--EETTTT
T ss_pred CccCCCCCcccE--EeCCEEEEEeCCccCHHHHHHHHhhcCCEEeecCCHHHHHHHHHHhc--CCcEEecce--ecCCCC
Confidence 445678999999 99999999999999999999999999999999999999999999886 467999999 444569
Q ss_pred ceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCC-CcccccccC
Q 008216 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSH-PFICMVEHE 193 (573)
Q Consensus 127 ~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~-~~iC~~~~~ 193 (573)
.|.|+||+++ .++.|..++|++. .+.++|+.+.. .+.|+|..|.... +|||+++..
T Consensus 85 ~w~W~dG~~~-~y~~W~~geP~~~---------~~~~~Cv~~~~-~g~W~d~~C~~~~~~fICe~~~~ 141 (175)
T 2h2t_B 85 EFIWVDGSHV-DYSNWAPGEPTSR---------SQSEDCVMMRG-SGRWNDAFCDRKLGAWVCDRLAT 141 (175)
T ss_dssp EEEETTSCCC-SSCCBCTTCCCC--------------CEEEECT-TSCEEEECTTCCEEEEEEEEECB
T ss_pred CeEeCCCCcc-cCcCcCCCCCCCC---------CCCCCceEEcC-CCcEEECCCCCcCcceEEeECCc
Confidence 9999999765 5566777766642 23457777754 4689999999999 999998753
|
| >1oz7_B Echicetin B-chain; platelet aggregation, dimer, toxin; 2.40A {Echis carinatus} SCOP: d.169.1.1 | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-26 Score=196.65 Aligned_cols=118 Identities=20% Similarity=0.484 Sum_probs=101.5
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (573)
+||+||. .|+++||+++.+.++|.+|+.+|++ .||+||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~ 76 (123)
T 1oz7_B 1 NCLPDWS--VYEGYCYKVFKERMNWADAEKFCTKQHKDGHLVSFRNSKEVDFVISLAFPMLKNDLVWIGLT--DYWRDCN 76 (123)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCCSSHHHHHHHTSSTTTTCSEEEEEEE--CCCCGGG
T ss_pred CCCCCcE--EcCCEEEEEECCccCHHHHHHHHhccCCCcEECCcCCHHHHHHHHHHHHhcCCCCCEEEeee--eCCCCCC
Confidence 5999999 9999999999999999999999999 899999999999999999998753 357999999 6666799
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
|.|+||+++ .++.|. ++| +|+.+....+.|++..|....+|||+++
T Consensus 77 ~~W~dg~~~-~~~~W~-g~P----------------~C~~~~~~~g~w~~~~C~~~~~~ICe~~ 122 (123)
T 1oz7_B 77 WEWSDGAQL-DYKAWD-NER----------------HCFIYKNTDNQWTRRDCTWTFSFVCKCP 122 (123)
T ss_dssp EEETTCCCC-CSCCBC-SST----------------TEEEEEGGGTEEEEECTTSCEEEEEEEE
T ss_pred EEEcCCCcc-cccCCC-CCC----------------CeEEEECCCCcEeCCCCCCCeeEEEeEe
Confidence 999999775 444555 554 4666655456899999999999999875
|
| >1umr_C Convulxin beta, CVX beta; lectin, C-type lectin, platelet, sugar-binding protein, activator, snake venom; 2.40A {Crotalus durissus terrificus} SCOP: d.169.1.1 PDB: 1uos_B | Back alignment and structure |
|---|
Probab=99.93 E-value=6.9e-26 Score=196.24 Aligned_cols=119 Identities=23% Similarity=0.545 Sum_probs=102.1
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCC
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGL 126 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~ 126 (573)
..||+||. .|+++||+++.+.++|.+|+.+|++ .||+||+|+|.+|++||.+++... ...+||||+ +...++
T Consensus 2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~ 77 (125)
T 1umr_C 2 FCCPSHWS--SYDRYCYKVFKQEMTWADAEKFCTQQHTGSHLVSFHSTEEVDFVVKMTHQSLKSTFFWIGAN--NIWNKC 77 (125)
T ss_dssp CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHTTCSSSEEECSCC--CTTTSS
T ss_pred CCCCCCCE--EcCCEeEEEECCCcCHHHHHHHHhccCCcceECccCCHHHHHHHHHHHHhcCCCCCEEEeeE--eCCCCC
Confidence 37999999 9999999999999999999999999 899999999999999999988643 357999999 666679
Q ss_pred ceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 127 ~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
.|.|+||+++ .++.|. ++| +|+.+....+.|++..|....+|||+++
T Consensus 78 ~~~W~dg~~~-~~~~W~-g~P----------------~C~~~~~~~g~w~~~~C~~~~~fICe~~ 124 (125)
T 1umr_C 78 NWQWSDGTKP-EYKEWH-EEF----------------ECLISRTFDNQWLSAPCSDTYSFVCKFE 124 (125)
T ss_dssp CEEETTSCCC-SSCCBC-CCC----------------EEEEEESSCSCEEEEETTSCEEEEEEEE
T ss_pred eeEeCCcCcc-CcccCC-CCC----------------CcEEEECCCCcEeCCCCCCCcceEEeec
Confidence 9999999775 444455 543 5777766556899999999999999875
|
| >1j34_B Coagulation factor IX-binding protein B chain; magnesium ION, calcium ION, GLA domain, protein binding/blood clotting complex; HET: CGU; 1.55A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1bj3_B 1ixx_B* 1j35_B* 1x2t_B* 1x2w_B 1wt9_B 1iod_B 1y17_B | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-26 Score=196.89 Aligned_cols=118 Identities=24% Similarity=0.561 Sum_probs=101.3
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (573)
+||+||. .|+++||+++.+.++|.+|+.+|++ .||+||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~ 76 (123)
T 1j34_B 1 DCPSDWS--SYEGHCYKPFSEPKNWADAENFCTQQHAGGHLVSFQSSEEADFVVKLAFQTFGHSIFWMGLS--NVWNQCN 76 (123)
T ss_dssp CCCTTSE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHHHHCSCEEECSCC--SCSTTSC
T ss_pred CcCCccc--ccCCEEEEEECCCcCHHHHHHHHhccCCCcEEcccCCHHHHHHHHHHHHhcCCCCCEEEeeE--cCCCCCe
Confidence 5999999 9999999999999999999999999 899999999999999999887532 357999999 6666799
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
|.|+||+++ .++.|. ++| +|+.+....+.|++..|....+|||+++
T Consensus 77 ~~W~dg~~~-~~~~W~-g~P----------------~C~~~~~~~g~w~~~~C~~~~~~iCe~~ 122 (123)
T 1j34_B 77 WQWSNAAML-RYKAWA-EES----------------YCVYFKSTNNKWRSRACRMMAQFVCEFQ 122 (123)
T ss_dssp EEETTCCCC-CCCCBS-CSC----------------EEEEEETTSCCBEEEETTSCEEEEEEEE
T ss_pred eEeCCCCCc-CccCcC-CCC----------------CcEEEECCCCCCcCCCCCCCCcEEEeec
Confidence 999999775 444455 543 5777776556899999999999999875
|
| >3hup_A Early activation antigen CD69; C-type lectin-like domain, disulfide bond, glycoprotein, LEC membrane, phosphoprotein, signal-anchor, transmembrane; 1.37A {Homo sapiens} SCOP: d.169.1.1 PDB: 1e87_A 1e8i_A 3cck_A | Back alignment and structure |
|---|
Probab=99.92 E-value=7.9e-26 Score=197.28 Aligned_cols=119 Identities=24% Similarity=0.514 Sum_probs=100.6
Q ss_pred CCCCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCc
Q 008216 48 DWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 48 ~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~ 127 (573)
..+..||.||. .|+++||+++.+.++|.+|+.+|+++||+||+|+|++|++||.+++. ...+||||++ . .++.
T Consensus 11 ~~~~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~~--~-~~~~ 83 (130)
T 3hup_A 11 SHVSSCSEDWV--GYQRKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAG--REEHWVGLKK--E-PGHP 83 (130)
T ss_dssp CCCBCCCTTCE--EETTEEEEECSSCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHT--TSCEEEEEEE--C-TTSC
T ss_pred CCCCCCChhhe--ecCCEEEEEECCccCHHHHHHHHHhcCCEEeecCCHHHHHHHHHhhC--CCCEEEEEEe--C-CCCe
Confidence 44578999999 99999999999999999999999999999999999999999999987 4689999994 2 4689
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccccc
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
|.|+||++ ++.|.. ..+.++|+.+... .|++..|....+|||++++
T Consensus 84 w~W~dg~~---~~~w~~--------------~~~~~~Cv~~~~~--~w~~~~C~~~~~fICe~~~ 129 (130)
T 3hup_A 84 WKWSNGKE---FNNWFN--------------VTGSDKCVFLKNT--EVSSMECEKNLYWICNKPY 129 (130)
T ss_dssp EEETTSCB---CCCCSC--------------CCSSCSEEEEETT--EEEEECTTSCBEEEEEEEC
T ss_pred EEeCCCCc---ccCccC--------------CCCCCCceEEeCC--CcccCCCCCCccEEeccCc
Confidence 99999976 334431 1234568887653 6999999999999999874
|
| >2e3x_C Coagulation factor X-activating enzyme light CHAI; disintegrin, metalloproteinase, C-type lectin, hydrolase, BL clotting, toxin; HET: NAG MAN GM6; 2.91A {Daboia russellii siamensis} | Back alignment and structure |
|---|
Probab=99.92 E-value=9.5e-26 Score=194.45 Aligned_cols=117 Identities=26% Similarity=0.575 Sum_probs=100.0
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (573)
+||+||. .|+++||+++.+.++|.+|+.+|++ .||+||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~ 77 (122)
T 2e3x_C 2 DCPSGWL--SYEQHCYKGFNDLKNWTDAEKFCTEQKKGSHLVSLHSREEEKFVVNLISENLEYPATWIGLG--NMWKDCR 77 (122)
T ss_dssp CCCSSCE--EETTEEEEECCCCBCHHHHHHHHHHHSTTCCBCCCSSHHHHHHHHHHHHHHCSSSEEEEEEE--STTSSSC
T ss_pred CCCcchh--hhCCEeEEEECCCcCHHHHHHHHhccCCCCEECccCCHHHHHHHHHHHHhcCCCCCEEEeee--ecCCCCc
Confidence 6999999 9999999999999999999999999 899999999999999999887532 357999999 6666799
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccc
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~ 190 (573)
|.|+||+++ .++.|. ++| +|+.+....+.|++..|....+|||++
T Consensus 78 ~~W~dg~~~-~~~~W~-~~P----------------~C~~~~~~~g~w~~~~C~~~~~~ICe~ 122 (122)
T 2e3x_C 78 MEWSDRGNV-KYKALA-EES----------------YCLIMITHEKVWKSMTCNFIAPVVCKF 122 (122)
T ss_dssp EEETTSCCC-CCCCBC-SCC----------------EEEEEETTTCCEEEEETTSCBCCEEC-
T ss_pred eEeCCCCcc-cccccC-CCC----------------CCEEEECCCCcEeCCCCCCCCceeecC
Confidence 999999775 444455 543 577776655689999999999999974
|
| >1hup_A Mannose-binding protein; alpha-helical coiled-coil, C-type lectin; 2.50A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1 | Back alignment and structure |
|---|
Probab=99.92 E-value=5.8e-26 Score=201.04 Aligned_cols=122 Identities=15% Similarity=0.161 Sum_probs=105.6
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (573)
.||+||. .++++||+++.+.++|.+|+.+|++.||+||+|+|.+|++||.+++. ..+||||+ +...++.|.|+
T Consensus 19 ~~~~~w~--~~~~~Cy~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--~~~~~~~w~W~ 91 (141)
T 1hup_A 19 LTFSLGK--QVGNKFFLTNGEIMTFEKVKALCVKFQASVATPRNAAENGAIQNLIK---EEAFLGIT--DEKTEGQFVDL 91 (141)
T ss_dssp HHHHTSE--EETTEEEEEEEEEEEHHHHHHHHHHTTCEECCCCSHHHHHHHHHHCS---SCEEEEEE--CSSSTTCCEET
T ss_pred hhcCCeE--EECCEEEEEeCCCcCHHHHHHHHHhCCCEECccCCHHHHHHHHHHhc---CCEEEeee--ecCcCCcEEEC
Confidence 6899999 99999999999999999999999999999999999999999999886 68999999 66677999999
Q ss_pred CCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 132 Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
||+++ .++.|.+++|++. .+.++|+.+.. .+.|++..|....+|||+++
T Consensus 92 dG~~~-~~~~W~~g~P~~~---------~~~~~Cv~~~~-~g~W~~~~C~~~~~fICe~~ 140 (141)
T 1hup_A 92 TGNRL-TYTNWNEGEPNNA---------GSDEDCVLLLK-NGQWNDVPCSTSHLAVCEFP 140 (141)
T ss_dssp TSCBC-SCCCBCTTCCCCG---------GGCCCEEEECT-TSCEEEECTTSEEEEEEEEE
T ss_pred CcCCC-cCCCCCCCCCCCC---------CCCCCeEEECC-CCcEeccCCCCCccEEEEEE
Confidence 99766 5666777776642 23567887763 45899999999999999875
|
| >1c3a_A Flavocetin-A: alpha subunit; C-type lectin-like domains, membrane protein; 2.50A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1v4l_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6.5e-26 Score=199.21 Aligned_cols=124 Identities=23% Similarity=0.463 Sum_probs=103.5
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC---CC-CeEEeeeecCCCC
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VN-GCWVGGRSINTTV 124 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~---~~-~~WiGl~~~~~~~ 124 (573)
..||+||. .|+++||+++.+.++|.+|+.+|++ .||+||+|+|++|++||.+++... .. .+||||++.+...
T Consensus 2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~ 79 (135)
T 1c3a_A 2 FDCIPGWS--AYDRYCYQAFSKPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEKIKTSFQYVWIGLRIQNKEQ 79 (135)
T ss_dssp CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCCSCCSEEEEEEEECCCSS
T ss_pred cCCCCcCE--ecCCeeEEEeCCCcCHHHHHHHHhhcCCCCEECeeCCHHHHHHHHHHHhhccccCCCcEEecccccCCCC
Confidence 37999999 9999999999999999999999999 899999999999999999888642 24 7999998444445
Q ss_pred CCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCC--CceeccccCCCCCccccccc
Q 008216 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 125 ~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~--~~W~d~~C~~~~~~iC~~~~ 192 (573)
++.|.|+||+++ .++.|.+++|+ +|+.+.... +.|++..|....+|||++++
T Consensus 80 ~~~~~W~dg~~~-~~~~W~~~~P~---------------~C~~~~~~~~~~~W~d~~C~~~~~fICe~~~ 133 (135)
T 1c3a_A 80 QCRSEWSDASSV-NYENLVKQFSK---------------KCYALKKGTELRTWFNVYCGTENPEVCKYTP 133 (135)
T ss_dssp SCCCBCTTSCBC-CCCCBCGGGCC---------------CEEEEETTSCSCSBEEECTTSCEEEEEEECC
T ss_pred CCceEECCCCcc-cccccCCCCCC---------------cceEEeccCCCCeEccCCCCCCccEEcccCC
Confidence 699999999765 45556665544 466665544 57999999999999999875
|
| >1uv0_A Pancreatitis-associated protein 1; lectin, C-type, secreted, inflammatory response, acute phase; 1.78A {Homo sapiens} SCOP: d.169.1.1 PDB: 2go0_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=200.14 Aligned_cols=126 Identities=21% Similarity=0.421 Sum_probs=105.7
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhhc-CCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCC
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGL 126 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~ 126 (573)
..||.||. .|+++||+++.+.++|.+|+.+|++. ||+||+|+|++|++||.+++... ...+||||+ +...++
T Consensus 12 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WiGl~--~~~~~~ 87 (149)
T 1uv0_A 12 IRCPKGSK--AYGSHCYALFLSPKSWTDADLACQKRPSGNLVSVLSGAEGSFVSSLVKSIGNSYSYVWIGLH--DPTQGT 87 (149)
T ss_dssp CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHTTSTTCEECCCCSHHHHHHHHHHHTTSCTTCCEEEEEEE--CTTTTC
T ss_pred CCCCcccc--ccCCEEEEEECCCCCHHHHHHHhhcCCCccEeEeCCHHHHHHHHHHHHhhccCCCCEEEeeE--ccCCCC
Confidence 47999999 99999999999999999999999998 89999999999999999999753 456999999 555556
Q ss_pred c-----eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCC--CceeccccCCCCCcccccc
Q 008216 127 S-----WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 127 ~-----w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~--~~W~d~~C~~~~~~iC~~~ 191 (573)
. |.|+||+++ .++.|..++|++ .+.++|+.+.... +.|++..|....+|||+++
T Consensus 88 ~~~~~~w~W~dg~~~-~~~~W~~~~P~~----------~~~~~Cv~~~~~~~~~~W~d~~C~~~~~fICe~~ 148 (149)
T 1uv0_A 88 EPNGEGWEWSSSDVM-NYFAWERNPSTI----------SSPGHCASLSRSTAFLRWKDYNCNVRLPYVCKFT 148 (149)
T ss_dssp C--CCCCEETTCCCC-CCCCBSSCGGGS----------SSCCSEEEEEGGGTTCSEEEECTTSCEEEEEEEC
T ss_pred ccCCCccEECCCCcc-CccCcCCCCcCC----------CCCCCCEEEEcCCCCCeEeCcCCCCCCceEEeec
Confidence 5 999999765 556676666553 2345677776543 5799999999999999875
|
| >3alu_A Lectin CEL-IV, C-type; C-type lectin, raffinose, sugar binding protein; HET: RAF; 1.65A {Cucumaria echinata} PDB: 3als_A* 3alt_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-26 Score=205.36 Aligned_cols=128 Identities=22% Similarity=0.391 Sum_probs=107.7
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhh--c---------CCeEeeeCCHHHHHHHHHHhCCC-------C--
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--I---------GGHLAALTSYEEEHSAQKLCGKN-------V-- 110 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~---------~~~L~~i~~~~e~~f~~~~~~~~-------~-- 110 (573)
..||+||. .|+++||+++.+.++|.+|+.+|++ . ||+||+|+|.+|++||.+++... .
T Consensus 3 ~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~~~~~~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~~~ 80 (157)
T 3alu_A 3 TSCPPLWT--GFNGKCFRLFHNHLNFDNAENACRQFGLASCSGDELATGHLASIHSAESQAFLTELVKTSLPDLITGGWA 80 (157)
T ss_dssp CEECTTCE--EETTEEEEEEEEEECHHHHHHHHTTEEEEETTSCEEEECEECCCCSHHHHHHHHHHHHHHCGGGCCSSSC
T ss_pred CCCCCCcE--eeCCEEEEEECCccCHHHHHHHhhccccccccCCCCCCeEEcccCCHHHHHHHHHHHHhcccccccccCC
Confidence 47999999 9999999999999999999999999 8 99999999999999999887532 1
Q ss_pred CCeEEeeeecCCCCCCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCC-CceeccccCCCCCcccc
Q 008216 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS-RSLVTERCNTSHPFICM 189 (573)
Q Consensus 111 ~~~WiGl~~~~~~~~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~-~~W~d~~C~~~~~~iC~ 189 (573)
..+||||+ +...++.|.|+||+++ .++.|.+++|++. .+.++|+.+.... +.|++..|....+|||+
T Consensus 81 ~~~WIGl~--~~~~~~~w~W~dG~~~-~y~~W~~g~P~~~---------~~~~~Cv~~~~~~~~~W~d~~C~~~~~fICe 148 (157)
T 3alu_A 81 PQVYIGMK--VGSTNSDQTWTDGSSV-DYDGWVSGEPNNG---------PNSRGAIAAGDYSRGFWADVYSNNNFKYICQ 148 (157)
T ss_dssp SEEEEEEE--ECSSTTCEEETTCCCC-CCCCBCTTCCCSC---------SSEEEEEECSTTTTTCEEEECTTCCEEEEEE
T ss_pred CCEEEeee--eCCCCCCeEeCCCCCC-CccCcCCCCCCCC---------CCCCCeEEEecCCCCeEcCCCCCCccceEec
Confidence 57999999 5556799999999775 5566777776653 2356788776543 68999999999999999
Q ss_pred ccc
Q 008216 190 VEH 192 (573)
Q Consensus 190 ~~~ 192 (573)
++.
T Consensus 149 ~~~ 151 (157)
T 3alu_A 149 LPC 151 (157)
T ss_dssp CCC
T ss_pred ccc
Confidence 865
|
| >1c3a_B Flavocetin-A: beta subunit; C-type lectin-like domains, membrane protein; 2.50A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1v4l_B | Back alignment and structure |
|---|
Probab=99.92 E-value=7.5e-26 Score=196.01 Aligned_cols=119 Identities=19% Similarity=0.425 Sum_probs=101.6
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCC
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGL 126 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~ 126 (573)
..||+||. .|+++||+++.+.++|.+|+.+|++ .||+||+|+|++|++||.+++... ...+||||+ +...++
T Consensus 2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~ 77 (125)
T 1c3a_B 2 FCCPLGWS--SYDEHCYQVFQQKMNWEDAEKFCTQQHKGSHLVSFHSSEEVDFVTSKTFPILKYDFVWIGLS--NVWNEC 77 (125)
T ss_dssp CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHHHHCSCEEECSCC--CTTTSS
T ss_pred CCCCCcce--ecCCEEEEEECCCCCHHHHHHHhhccCCCcEECccCCHHHHHHHHHHHHhcCCCCCEEEeeE--cCCCCC
Confidence 37999999 9999999999999999999999999 899999999999999999887532 357999999 666679
Q ss_pred ceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 127 ~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
.|.|+||+++ .++.|. ++| +|+.+....+.|++..|....+|||+++
T Consensus 78 ~~~W~dg~~~-~~~~w~-~~P----------------~C~~~~~~~g~w~~~~C~~~~~fiCe~~ 124 (125)
T 1c3a_B 78 TKEWSDGTKL-DYKAWS-GGS----------------DCIVSKTTDNQWLSMDCSSKYYVVCKFQ 124 (125)
T ss_dssp CEEETTCCCC-CSCCBC-CCC----------------EEEEEESSSSCEEEEETTSCEEEEEEEE
T ss_pred ceEeCCCCcc-cccccC-CCC----------------CcEEEECCCCCEeCCCCCCCCeeEEeee
Confidence 9999999775 444455 543 5777765556899999999999999875
|
| >3bx4_A Aggretin alpha chain; toxin; 1.70A {Agkistrodon rhodostoma} PDB: 2vrp_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-25 Score=198.23 Aligned_cols=124 Identities=25% Similarity=0.481 Sum_probs=102.6
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC--C---CCeEEeeeecCCC
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--V---NGCWVGGRSINTT 123 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~---~~~WiGl~~~~~~ 123 (573)
..||+||. .|+++||+++.+.++|.+|+.+|++ .||+||+|+|++|++||.+++... . ..+||||++.+..
T Consensus 3 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~~WIGl~~~~~~ 80 (136)
T 3bx4_A 3 EDCDFGWS--PYDQHCYQAFNEQKTWDEAEKFCRAQENGAHLASIESNGEADFVSWLISQKDELADEDYVWIGLRAQNKE 80 (136)
T ss_dssp -CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTSTTTCEECCCCSHHHHHHHHHHHHTCGGGTTCCEEEEEEEECCCS
T ss_pred CCCCCCCE--ecCCEEEEEECCCcCHHHHHHHHhccCCCcEEcccCCHHHHHHHHHHHHhhcccCccCCEEEeeeccCCC
Confidence 47999999 9999999999999999999999999 899999999999999999988643 2 5699999844444
Q ss_pred CCCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCC--CceeccccCCCCCccccccc
Q 008216 124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 124 ~~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~--~~W~d~~C~~~~~~iC~~~~ 192 (573)
.++.|.|+||+++ .++.|..++|+ +|+.+.... +.|++..|....+|||+++.
T Consensus 81 ~~~~~~W~dg~~~-~~~~W~~~~P~---------------~C~~~~~~~~~~~W~~~~C~~~~~fICe~~~ 135 (136)
T 3bx4_A 81 QQCSSEWSDGSSV-SYENLIDLHTK---------------KCGALEKLTGFRKWVNYYCEQMHAFVCKLLP 135 (136)
T ss_dssp SSSCCBCTTSCBC-CCCCCTTCCCC---------------CEEEEEGGGTTTSEEEECTTSCEEEEEEECC
T ss_pred CCCceEeCCCCcc-CcccccCCCCC---------------ccEEEEecCCCCeEeCCCCCCCcceEEeecC
Confidence 5699999999765 45556666544 466665443 57999999999999999863
|
| >1rtm_1 Mannose-binding protein-A; lectin; 1.80A {Rattus norvegicus} SCOP: d.169.1.1 h.1.1.1 PDB: 1kwu_A* 1kwv_A* 1kwt_A* 1kwx_A* 1kwy_A* 1kx1_A* 1kww_A 1kwz_A* 1kx0_A* 3kmb_1* 1kmb_1* 2kmb_1* 4kmb_1* 1afb_1* 1afa_1* 1afd_1 1bch_1* 1bcj_1* 1fif_A 1fih_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-25 Score=201.45 Aligned_cols=122 Identities=14% Similarity=0.172 Sum_probs=105.4
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (573)
.||+||. .++++||+++.+.++|.+|+.+|++.||+||+|+|.+|++||.+++. ..+||||+ +...++.|.|+
T Consensus 27 ~~~~~w~--~~~~~Cy~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--~~~~~~~w~W~ 99 (149)
T 1rtm_1 27 HAFSMGK--KSGKKFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAK---TSAFLGIT--DEVTEGQFMYV 99 (149)
T ss_dssp HHHHTTC--CTTSCEEEEEEEEEEHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHS---SCEEEEEE--CSSSTTCCEET
T ss_pred hcCCCeE--EeCCEEEEEeCCCCCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHHhc---CCEEEEee--ccCcCCeEEEC
Confidence 5889999 99999999999999999999999999999999999999999999985 57999999 66677999999
Q ss_pred CCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 132 Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
||+++ .++.|.+++|++. .++++|+.+.. .+.|++..|....+|||+++
T Consensus 100 dg~~~-~~~~W~~g~P~~~---------~~~~~Cv~~~~-~g~W~d~~C~~~~~fICe~~ 148 (149)
T 1rtm_1 100 TGGRL-TYSNWKKDEPNDH---------GSGEDCVTIVD-NGLWNDISCQASHTAVCEFP 148 (149)
T ss_dssp TSSBC-CSCCBCTTCCCCC---------TTCCCEEEECG-GGCEEEECTTSEEEEEEEEC
T ss_pred CCCCc-cccCcCCCCCCCC---------CCCCCeEEECC-CCCEeCCCCCCCeeEEEEee
Confidence 99776 5566777776642 24567887763 45899999999999999875
|
| >3ff9_A Killer cell lectin-like receptor subfamily G member 1; natural killer cell receptor KLTG1, glycoprotein, membrane, phosphoprotein, signal-anchor; 1.80A {Mus musculus} SCOP: d.169.1.0 PDB: 3ff8_C | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=191.73 Aligned_cols=114 Identities=22% Similarity=0.506 Sum_probs=96.8
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (573)
.||+||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|++|++||.+++. ...+||||+ + ++.|+|+
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~---~~~w~W~ 71 (115)
T 3ff9_A 1 MCPILWT--RNGSHCYYFSMEKKDWNSSLKFCADKGSHLLTFPDNQGVKLFGEYLG--QDFYWIGLR--N---IDGWRWE 71 (115)
T ss_dssp CCCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCTTSCCHHHHHTTCC--SSCEEEEEE--E---SSSEEET
T ss_pred CCCccce--ecCCEEEEEEcCCcCHHHHHHHHHhcCCeeeeeCCHHHHHHHHHhhC--CCcEEEeee--e---CCceEeC
Confidence 4999999 99999999999999999999999999999999999999999999887 458999999 4 3789999
Q ss_pred CCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccccc
Q 008216 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 132 Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
||+++.+ ++ +|+ .+.++|+.+... .|++..|....+|||+++.
T Consensus 72 dg~~~~~-~~----~p~-----------~~~~~C~~~~~~--~w~~~~C~~~~~fICe~~~ 114 (115)
T 3ff9_A 72 GGPALSL-RI----LTN-----------SLIQRCGAIHRN--GLQASSCEVALQWICKKVL 114 (115)
T ss_dssp TSCBCCS-CC----BCS-----------STTCCEEEEETT--EEEEECTTSCBEEEEEEEC
T ss_pred CCCcccc-cc----cCC-----------CCCCCCeEEcCC--CcccccCCCCCceEEEEec
Confidence 9977644 21 111 134578887654 5999999999999999863
|
| >3gpr_D Rhodocetin subunit delta; disulfide bond, lectin, secreted, toxin, cell adhesion; 3.20A {Calloselasma rhodostoma} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-26 Score=198.28 Aligned_cols=118 Identities=23% Similarity=0.585 Sum_probs=99.8
Q ss_pred CCccCcccCCCCeeeEEecccCChHHHHHHHhhc--CCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCce
Q 008216 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLSW 128 (573)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~w 128 (573)
||+||. .|+++||+++.+.++|.+|+.+|++. ||+||+|+|++|++||.+++... ...+||||+ +...++.|
T Consensus 1 Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~~ 76 (124)
T 3gpr_D 1 CPLHWS--SYNGYCYRVFSELKTWEDAESFCYAQHKGSRLASIHSREEEAFVGKLASQTLKYTSMWLGLN--NAWAACKW 76 (124)
T ss_dssp CCSSCC--CSSSEEEEEEEEEEESHHHHHHHHHHSTTCBSCCCCSHHHHHHHHHHHHHSCSSCCBCCSEE--CCSSCSSC
T ss_pred CCCcce--ecCCEeEEEeCCCcCHHHHHHHHHhcCCCCEEcccCCHHHHHHHHHHHHhcCCCCCEEEEeE--cCCCCCce
Confidence 999999 99999999999999999999999999 99999999999999999988632 357999999 66667999
Q ss_pred EEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCC--CceeccccCCCCCccccccc
Q 008216 129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 129 ~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~--~~W~d~~C~~~~~~iC~~~~ 192 (573)
.|+||+++ .++.|.+ +| +|+.+...+ +.|++..|....+|||++|+
T Consensus 77 ~W~dg~~~-~~~~W~~-~p----------------~C~~~~~~~~~~~W~~~~C~~~~~fiCe~ps 124 (124)
T 3gpr_D 77 EWSDDAKL-DYKVWLR-RA----------------YCAVMVVKTDRIFWYNRGCEKTVSFLCKFYS 124 (124)
T ss_dssp SSSSCCCS-CCBCCCS-CC----------------CEECCBCCSSSCBBCEECTTSEEEEEEEEEC
T ss_pred EECCCCcc-cccccCC-CC----------------CcEEEEcCCCCCcEeCCCCCCCccEEeeecC
Confidence 99999776 4555654 21 355555444 57999999999999999864
|
| >3ubu_B Agglucetin subunit beta-2; platelet inhibiting, agkisacucetin, dimer, toxin, C-type LEC GPIB inhibitor, GPIB binding; 1.91A {Deinagkistrodon acutus} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=194.01 Aligned_cols=119 Identities=24% Similarity=0.502 Sum_probs=101.0
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCC
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGL 126 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~ 126 (573)
..||+||. .|+++||+++.+.++|.+|+.+|++ .||+||+|+|++|++||.+++... ...+||||+ +...++
T Consensus 2 ~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~ 77 (126)
T 3ubu_B 2 FCCPLRWS--AYEGHCYLVVKEKKTWDDAEKFCTEQRKGGHLVSVHSREEADFLVHLAYPILDLSLIWMGLS--NMWNDC 77 (126)
T ss_dssp CSCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHHCSCEEEEEEE--CTTTSS
T ss_pred CCCCCCCe--EcCCEeEEEeCCCCCHHHHHHHHhccCCCcEECccCCHHHHHHHHHHHhhccCCCcEEEeEE--cCCCCC
Confidence 37999999 9999999999999999999999999 999999999999999999987532 347999999 666679
Q ss_pred ceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCC-CceeccccCCCCCcccccc
Q 008216 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS-RSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 127 ~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~-~~W~d~~C~~~~~~iC~~~ 191 (573)
.|+|+||+++ .+..|.+ .++|+.+...+ +.|++..|....+|||+++
T Consensus 78 ~~~W~dg~~~-~~~~W~~-----------------~~~Cv~~~~~~~~~W~~~~C~~~~~fICe~~ 125 (126)
T 3ubu_B 78 KREWSDGTKL-DFKSWAK-----------------TSDCLIGKTDGDNQWLNMDCSKKHYFVCKFK 125 (126)
T ss_dssp EEEETTCCCC-CCCCBCC-----------------CCCEEEEESSTTCCEEEECTTSCEEEEEEEE
T ss_pred ceEecCCCee-eeeccCC-----------------CCCeEEEecCCCCcCcCCCCCCCceeEEeee
Confidence 9999999776 4454543 34577776554 5799999999999999875
|
| >1ukm_A EMS16 A chain, EMS16 subunit A; domain swapping, C-type lectin, toxin; HET: NAG; 1.90A {Echis multisquamatus} SCOP: d.169.1.1 PDB: 1v7p_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-25 Score=197.67 Aligned_cols=122 Identities=25% Similarity=0.510 Sum_probs=102.3
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC---CC-CeEEeeeecCC--
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VN-GCWVGGRSINT-- 122 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~---~~-~~WiGl~~~~~-- 122 (573)
..||+||. .|+++||+++.+.++|.+|+.+|++ .||+||+|+|++|++||.+++... .. .+||||+ +.
T Consensus 2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~--~~~~ 77 (134)
T 1ukm_A 2 FDCPSDWT--AYDQHCYLAIGEPQNWYEAERFCTEQAKDGHLVSIQSREEGNFVAQLVSGFMHRSEIYVWIGLR--DRRE 77 (134)
T ss_dssp -CCSTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHTGGGGGSSCCEEEEEEE--ECCS
T ss_pred cCCCCccE--ecCCEEEEEECCCcCHHHHHHHHhhcCCCcEECccCCHHHHHHHHHHHhhhccCCCCCEEEeee--cCCC
Confidence 37999999 9999999999999999999999999 899999999999999999988643 25 7999999 54
Q ss_pred CCCCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCC--CceeccccCCCCCccccccc
Q 008216 123 TVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 123 ~~~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~--~~W~d~~C~~~~~~iC~~~~ 192 (573)
..++.|.|+||+++ .++.|.+++|+ +|+.+.... +.|++..|+...+|||+++.
T Consensus 78 ~~~~~~~W~dg~~~-~~~~W~~g~P~---------------~C~~~~~~~~~~~W~~~~C~~~~~~ICe~~~ 133 (134)
T 1ukm_A 78 EQQCNPEWNDGSKI-IYVNWKEGESK---------------MCQGLTKWTNFHDWNNINCEDLYPFVCKFSA 133 (134)
T ss_dssp SSCSCCBCTTSCBC-CCCCBCTTCCC---------------CEEEEEGGGTSCSEEEECTTSCEEEEEEEEC
T ss_pred CCCCceEEcCcCcc-ccceECCCcCc---------------cceEEEecCCCCeeecCCCCCCceeEEeEcC
Confidence 55799999999765 45566666544 466665443 67999999999999999864
|
| >3gpr_C Rhodocetin subunit gamma; disulfide bond, lectin, secreted, toxin, cell adhesion; 3.20A {Calloselasma rhodostoma} | Back alignment and structure |
|---|
Probab=99.92 E-value=8e-26 Score=198.37 Aligned_cols=121 Identities=24% Similarity=0.500 Sum_probs=101.8
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhc--CCeEeeeCCHHHHHHHHHHhCCC----CCCeEEeeeecCCCCC
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTVG 125 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~~ 125 (573)
.||+||. .|+++||+++.+.++|.+|+.+|++. ||+||+|+|++|++||.+++... ...+||||+ +...+
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~G~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~--~~~~~ 77 (134)
T 3gpr_C 2 NCLPGWS--AYDQHCYQAFNEPKTWDEAERFCTEQAKRGHLVSIGSDGEADFVAQLVTNNIKRPELYVWIGLR--DRRKE 77 (134)
T ss_dssp CCCTTCE--ESSSCEEEECSCCBCSHHHHHHHTTSSSCCEECCCCCHHHHHHHHHHHHHHHCSSCCBCCCSCB--CCSST
T ss_pred cCCCcce--eeCCEEEEEeCCCcCHHHHHHHHHhhCCCceEeeeCCHHHHHHHHHHHHhhccCCCCcEEEeeE--ecCCC
Confidence 6999999 99999999999999999999999998 89999999999999999887632 167999999 66667
Q ss_pred Cc-e-EEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCC--ceeccccCCCCCccccccc
Q 008216 126 LS-W-KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR--SLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 126 ~~-w-~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~--~W~d~~C~~~~~~iC~~~~ 192 (573)
+. | .|+||+++ .++.|.+++| ++|+.+....+ .|++..|....+|||++++
T Consensus 78 ~~~w~~W~dG~~~-~~~~W~~~~~---------------~~Cv~~~~~~~~~~W~~~~C~~~~~fICe~~~ 132 (134)
T 3gpr_C 78 QQCSSEWSMSASI-IYVNWNTGES---------------QMCQGLARWTGFRKWDYSDCQAKNPFVCKFSS 132 (134)
T ss_dssp TSCSCEETTCCCS-CCBCBSSCEE---------------CCEECCBCSSSSCBBCEECTTCCBCCEEEECC
T ss_pred CCcCCEeCCcCcc-cccccCCCCC---------------CcceEEeccCCCCcCcCCCCCCCCcEEeCcCC
Confidence 99 9 99999766 4555655432 35666655433 7999999999999999875
|
| >3ubu_A Agglucetin subunit alpha-1; platelet inhibiting, agkisacucetin, dimer, toxin, C-type LEC GPIB inhibitor, GPIB binding; 1.91A {Deinagkistrodon acutus} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=196.72 Aligned_cols=124 Identities=22% Similarity=0.523 Sum_probs=101.8
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhhc--CCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCC
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGL 126 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~ 126 (573)
..||+||. .|+++||+++.+.++|.+|+.+|++. ||+||+|+|++|++||.+++... ...+||||++.....++
T Consensus 2 ~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~G~~La~i~s~~e~~~l~~~~~~~~~~~~~WIGl~~~~~~~~~ 79 (131)
T 3ubu_A 2 VDCLPGWS--AYDQSCYRVFKLLKTWDDAEKFCTERPKGGHLVSIESAGERDFVAQLVSENKQTDNVWLGLKIQSKGQQC 79 (131)
T ss_dssp CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTSTTCCEECCCCSHHHHHHHHHHHHHTTCCSCEEEEEEEECSSSSS
T ss_pred cCCCccCE--ecCCEeeEEcCCCcCHHHHHHHHhccCCCceEceeCCHHHHHHHHHHHHhcCCCCCEEEeEecCCCCCCC
Confidence 37999999 99999999999999999999999998 89999999999999999988643 34799999954322269
Q ss_pred ceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCC--ceeccccCCCCCccccccc
Q 008216 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR--SLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 127 ~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~--~W~d~~C~~~~~~iC~~~~ 192 (573)
.|.|+||+++ .++.|.+++| ++|+.+....+ .|++..|....+|||++++
T Consensus 80 ~~~W~dg~~~-~~~~w~~~~~---------------~~Cv~~~~~~~~~~W~~~~C~~~~~fiCe~~p 131 (131)
T 3ubu_A 80 STEWTDGSSV-SYENFSEYQS---------------KKCFVLEKNTGFRTWLNLNCGSEYSFVCKSPP 131 (131)
T ss_dssp CCBCTTSCBC-CCCCBCTTTC---------------CCEEEECGGGTSCSEEEECTTCCEEEEEEECC
T ss_pred ceEeCCCCcc-ceeccCCCCC---------------CCcEEEeCCCCCCeEcCCCCCCCceeEEecCC
Confidence 9999999765 4555655431 45777765433 7999999999999999864
|
| >2vuv_A Codakine; sugar-binding protein, C-type, lectin, mannose, invertebrate; HET: CIT; 1.3A {Codakia orbicularis} PDB: 2vuz_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=195.99 Aligned_cols=123 Identities=24% Similarity=0.493 Sum_probs=103.2
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCC--CCCe--EEeeeecCCCCCCc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN--VNGC--WVGGRSINTTVGLS 127 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~--~~~~--WiGl~~~~~~~~~~ 127 (573)
+||+||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|++|++||.+++... ...+ ||| . .. .++.
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WiG-~-~~--~~~~ 74 (129)
T 2vuv_A 1 GCPDGWT--QFLDLCYIYQSAKASWASAQSSCQALGGILAEPDTACENEVLIHMCKENGDAGSFGPWLG-G-QK--VGGA 74 (129)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTSEECCCCSHHHHHHHHHHHHHTTCCSSSCCEEE-E-EE--ETTE
T ss_pred CCCcchh--hhCCEEEEEECCCcCHHHHHHHHHhcCCEECccCCHHHHHHHHHHHHhccCCCCcccccC-C-CC--CCCe
Confidence 5999999 9999999999999999999999999999999999999999999988643 3467 999 3 13 4589
Q ss_pred eEEcC-CCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccccc
Q 008216 128 WKWSD-NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 128 w~W~D-gt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
|.|+| |+++ .++.|.+++|++. .+.++|+.+...+ |++..|....+|||++++
T Consensus 75 ~~W~d~g~~~-~~~~W~~~~P~~~---------~~~~~C~~~~~~~--w~~~~C~~~~~~ICe~~~ 128 (129)
T 2vuv_A 75 WQWSSSGAAF-DYLRWGPNEPNNS---------GGNEDCLHYNWLS--WNDLRCHYQASYLCQRAA 128 (129)
T ss_dssp EEETTTCCBC-SSCCBCTTCSCCT---------TSCCCEEEEETTE--EEEECTTSCEEEEEEEEC
T ss_pred EEEcCCCCcc-ccCCcCCCCCCCC---------CCCCCccEEcCCc--ccCCCCCCCcceEeeecC
Confidence 99999 9766 5666777776652 2356788887654 999999999999999865
|
| >1ukm_B EMS16 B chain, EMS16 subunit B; domain swapping, C-type lectin, toxin; HET: NAG; 1.90A {Echis multisquamatus} SCOP: d.169.1.1 PDB: 1v7p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=194.92 Aligned_cols=120 Identities=28% Similarity=0.554 Sum_probs=100.2
Q ss_pred CCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCce
Q 008216 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLSW 128 (573)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~w 128 (573)
||+||. .|+++||+++.+.++|.+|+.+|++ .||+||+|+|++|++||.+++... ...+||||+ +...++.|
T Consensus 1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~~ 76 (128)
T 1ukm_B 1 CPLGWS--SFDQHCYKVFEPVKNWTEAEEICMQQHKGSRLASIHSSEEEAFVSKLASKALKFTSMWIGLN--NPWKDCKW 76 (128)
T ss_dssp CCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCSSCEEEEEEE--CTTTTCCE
T ss_pred CCCcCE--ecCCEeEEEECCccCHHHHHHHHhccCCccEEcccCCHHHHHHHHHHHHhcCCcCcEEEecc--cCCCCCce
Confidence 999999 9999999999999999999999999 899999999999999999887532 357999999 66667999
Q ss_pred EEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecC--CCceeccccCCCCCcccccccCC
Q 008216 129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVEHEN 194 (573)
Q Consensus 129 ~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~--~~~W~d~~C~~~~~~iC~~~~~~ 194 (573)
.|+||+++ .++.|. ++| +|+.+... .+.|++..|....+|||+++..+
T Consensus 77 ~W~dg~~~-~~~~W~-g~P----------------~C~~~~~~~~~~~w~~~~C~~~~~fICe~~~~~ 126 (128)
T 1ukm_B 77 EWSDNARF-DYKAWK-RRP----------------YCTVMVVKPDRIFWFTRGCEKSVSFVCKFLTDP 126 (128)
T ss_dssp EETTCCCC-CCCCBC-CCC----------------EEEEEEECSSCEEEEEEETTSCEEEEEEEEC--
T ss_pred EeCCCCcc-ccCCCC-CCC----------------CcEEEeCCCCCCeEeCCCCCCCcCeEeeecCCC
Confidence 99999775 444455 554 46666543 25799999999999999987644
|
| >3ff7_C Killer cell lectin-like receptor subfamily G member 1; KLRG1-cadherin complex, calcium, cell adhesion, cell junction, cell membrane; 1.80A {Homo sapiens} SCOP: d.169.1.0 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=189.83 Aligned_cols=112 Identities=23% Similarity=0.534 Sum_probs=95.8
Q ss_pred CCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcC
Q 008216 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD 132 (573)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~D 132 (573)
||+||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|.+|++||.+++. ...+||||+ + ++.|+|+|
T Consensus 1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WiGl~--~---~~~~~W~d 71 (112)
T 3ff7_C 1 CPDRWM--KYGNHCYYFSVEEKDWNSSLEFCLARDSHLLVITDNQEMSLLQVFLS--EAFSWIGLR--N---NSGWRWED 71 (112)
T ss_dssp CCTTCE--EETTEEEEECSSCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHTTCC--SSCEEEEEE--E---SSSEEETT
T ss_pred CCccce--EeCCEEEEEeCCccCHHHHHHHHhhcCCeEeeECCHHHHHHHHHhcc--CCCEEEeee--c---CCceEeCC
Confidence 999999 99999999999999999999999999999999999999999999887 457999999 4 37899999
Q ss_pred CCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccc
Q 008216 133 NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (573)
Q Consensus 133 gt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~ 190 (573)
|+++. ++.|.++. ..++|+.+... .|++..|....+|||++
T Consensus 72 g~~~~-~~~w~~~~--------------~~~~C~~~~~~--~w~~~~C~~~~~fICek 112 (112)
T 3ff7_C 72 GSPLN-FSRISSNS--------------FVQTCGAINKN--GLQASSCEVPLHWVCKK 112 (112)
T ss_dssp SCBCC-SSCEECSS--------------TTCCEEEEETT--EEEEECTTSCBEEEEEC
T ss_pred CCccc-cceecCCC--------------CCCCCeEEeCC--CcccCCCCCCCceeecC
Confidence 97764 44554321 23567777653 59999999999999975
|
| >1tn3_A Tetranectin; plasminogen binding, kringle 4, C-type lectin, carbohydrate recognition domain; 2.00A {Homo sapiens} SCOP: d.169.1.1 PDB: 1rjh_A 3l9j_C | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-25 Score=198.45 Aligned_cols=125 Identities=16% Similarity=0.318 Sum_probs=103.5
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCCc
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~~ 127 (573)
..||+||. ++++||+++.+.++|.+|+.+|++.||+||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 4 ~~Cp~gw~---~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~~~~~~~ 78 (137)
T 1tn3_A 4 TVCLKGTK---VHMKCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSVGNEAEIWLGLN--DMAAEGT 78 (137)
T ss_dssp CEEEECSS---SSEEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHTCTTCEEEEEEE--EEEETTE
T ss_pred CCCCCCeE---ECCEEEEEeCCCCCHHHHHHHHHhcCCEEcccCCHHHHHHHHHHHHhhcCCCCCEEEeeE--ccCCCce
Confidence 47999997 689999999999999999999999999999999999999999887532 457999999 5445699
Q ss_pred eEEcCCCCCCCCCccc---cCCCCCCccCCCCcCCcccceeEEeec-CCCceeccccCCCCCcccccc
Q 008216 128 WKWSDNMSKWNESIHA---VGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~---~~~~~~~~~~~p~~~~~~~~~C~~~~~-~~~~W~d~~C~~~~~~iC~~~ 191 (573)
|.|+||+++ .++.|. +++|++ .+.++|+.+.. ..+.|++..|....+|||+++
T Consensus 79 w~W~dg~~~-~~~~W~~~~~g~P~~----------~~~~~Cv~~~~~~~~~W~d~~C~~~~~fiCe~~ 135 (137)
T 1tn3_A 79 WVDMTGARI-AYKNWETEITAQPDG----------GKTENCAVLSGAANGKWFDKRCRDQLPYICQFG 135 (137)
T ss_dssp EEETTSCBC-SCCCBCCTTTCSSCC----------GGGCCEEEEETTTTTEEEEECTTSCEEEEEEEE
T ss_pred EEeCCcCCC-cccccCcCCCCcCCC----------CCccCCcEEccCCCCeEeCcCCCCCccceEeEe
Confidence 999999765 455666 555543 23467777764 356799999999999999876
|
| >1buu_A Protein (mannose-binding protein A); lectin, HOST defense, metalloprotein, sugar binding protein; 1.90A {Rattus norvegicus} SCOP: d.169.1.1 h.1.1.1 | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=202.70 Aligned_cols=122 Identities=14% Similarity=0.172 Sum_probs=106.2
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (573)
.||++|. .++++||+++.+.++|.+|+.+|++.||+||+|+|.+|++||.+++. ..+||||+ +...++.|.|+
T Consensus 46 ~~~~~~~--~~~~~Cy~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--d~~~~g~w~W~ 118 (168)
T 1buu_A 46 HAFSMGK--KSGKKFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAK---TSAFLGIT--DEVTEGQFMYV 118 (168)
T ss_dssp HHHHTTC--CTTSCEEEEEEEEECHHHHHHHHHHTTSEECCCCSHHHHHHHHHHHC---SCEECSEE--CSSSTTCCEET
T ss_pred ccCCCeE--EECCEEEEEeCCccCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHHhc---CCEEeeee--cCCcCCCEEeC
Confidence 5899999 99999999999999999999999999999999999999999999985 57999999 76678999999
Q ss_pred CCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 132 Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
||+++ .|+.|..++|++. .+.++|+.+.. .+.|+|..|....+|||+++
T Consensus 119 dG~~~-~y~~W~~geP~~~---------~~~e~Cv~~~~-~g~W~d~~C~~~~~~ICe~~ 167 (168)
T 1buu_A 119 TGGRL-TYSNWKKDEPNDH---------GSGEDCVTIVD-NGLWNDISCQASHTAVCEFP 167 (168)
T ss_dssp TSSBC-SCCCBSSSSCCCT---------TSCCCEEEECT-TSCEEEECTTSCEEEEEEEC
T ss_pred CCCCc-CCCCCCCCCCCCC---------CCCCCeEEECC-CCCEEccCCCCCEEEEEEec
Confidence 99776 5666777776652 24567888763 45899999999999999875
|
| >1jwi_A Bitiscetin; domain swapping, C-type lectin, toxin; 2.00A {Bitis arietans} SCOP: d.169.1.1 PDB: 1uex_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=196.31 Aligned_cols=121 Identities=28% Similarity=0.546 Sum_probs=98.3
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCC---CC-CeEEeeeecCCCCCCc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VN-GCWVGGRSINTTVGLS 127 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~-~~WiGl~~~~~~~~~~ 127 (573)
.||+||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|++|++||.+++... .. .+||||++.+...++.
T Consensus 3 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~~~ 80 (131)
T 1jwi_A 3 GCLPDWS--SYKGHCYKVFKKVGTWEDAEKFCVENSGHLASIDSKEEADFVTKLASQTLTKFVYDAWIGLRDESKTQQCS 80 (131)
T ss_dssp -CCTTSE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHC--CCSCEEEEEEECCSSSSSC
T ss_pred CCCCCCE--EeCCEeEEEECCCcCHHHHHHHHHHcCCeECccCCHHHHHHHHHHHhhcccccCccEEEeeeecCCCCCCc
Confidence 6999999 9999999999999999999999999999999999999999999887532 24 8999998434445699
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCC--CceeccccCCCCCccccccc
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~--~~W~d~~C~~~~~~iC~~~~ 192 (573)
|.|+||+++ .++.|. +|+ +|+.+.... +.|++..|....+|||+++.
T Consensus 81 ~~W~dg~~~-~~~~W~--~P~---------------~C~~~~~~~~~~~w~~~~C~~~~~fICe~~~ 129 (131)
T 1jwi_A 81 PQWTDGSSV-VYENVD--EPT---------------KCFGLDVHTEYRTWTDLPCGEKNPFICKSRL 129 (131)
T ss_dssp SBCTTSCBC-CSCCBS--SCC---------------CEEEECGGGTTSSEEEECTTSCEEEEEEC--
T ss_pred eEEeCcCcc-cCcCCC--CCC---------------CceEEecCCCCCeEcCcCCCCCcceeeCcCC
Confidence 999999775 445554 333 466665443 67999999999999999864
|
| >2ls8_A C-type lectin domain family 4 member D; structural genomics, NEW YORK structural genomics research consortium, nysgrc, PSI-biology, immune system; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=8.5e-27 Score=210.16 Aligned_cols=128 Identities=20% Similarity=0.437 Sum_probs=108.0
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (573)
.||.||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|.+|++||.+++.. ...+||||+ +...++.|.|+
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~-~~~~WIGl~--~~~~~~~w~W~ 76 (156)
T 2ls8_A 2 VCPIDWR--AFQSNCYFPLTDNKTWAESERNCSGMGAHLMTISTEAEQNFIIQFLDR-RLSYFLGLR--DENAKGQWRWV 76 (156)
Confidence 6999999 999999999999999999999999999999999999999999998863 457999999 66667999999
Q ss_pred CCCCCC-CCCccccCCCCCCccCCCCcCCcccceeEEeecCC--CceeccccCCCCCcccccccCC
Q 008216 132 DNMSKW-NESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEHEN 194 (573)
Q Consensus 132 Dgt~~~-~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~--~~W~d~~C~~~~~~iC~~~~~~ 194 (573)
||+++. .+..|..++|++. +.++|+.+...+ +.|+|..|....+|||+++...
T Consensus 77 dG~~~~~~~~~W~~g~P~~~----------~~~~Cv~l~~~~~~~~W~d~~C~~~~~fICe~~~~~ 132 (156)
T 2ls8_A 77 DQTPFNPRRVFWHKNEPDNS----------QGENCVVLVYNQDKWAWNDVPCNFEASRICKIPGTT 132 (156)
Confidence 998764 4666777776642 245677765543 3799999999999999987644
|
| >1umr_A Convulxin alpha, CVX alpha; lectin, C-type lectin, platelet, sugar-binding protein, activator, snake venom; 2.40A {Crotalus durissus terrificus} SCOP: d.169.1.1 PDB: 1uos_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=197.27 Aligned_cols=124 Identities=24% Similarity=0.450 Sum_probs=102.6
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC---CC-CeEEeeeecCCCC
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VN-GCWVGGRSINTTV 124 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~---~~-~~WiGl~~~~~~~ 124 (573)
..||+||. .|+++||+++.+.++|.+|+.+|++ .||+||+|+|++|++||.+++... .. .+||||+..+...
T Consensus 2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~ 79 (135)
T 1umr_A 2 LHCPSDWY--YYDQHCYRIFNEEMNWEDAEWFCTKQAKGAHLVSIKSAKEADFVAWMVTQNIEESFSHVSIGLRVQNKEK 79 (135)
T ss_dssp CSSCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHSCTTCCEEECSEEECCSSS
T ss_pred CCCCCCCE--EcCCEeEEEECCCCCHHHHHHHHHccCCCceECccCCHHHHHHHHHHHHhhcccCCCCEEEeccccCCCC
Confidence 37999999 9999999999999999999999999 899999999999999999887542 24 7999998333345
Q ss_pred CCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCC--CceeccccCCCCCccccccc
Q 008216 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 125 ~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~--~~W~d~~C~~~~~~iC~~~~ 192 (573)
++.|.|+||+++ .++.|..++|+ +|+.+.... +.|++..|....+|||++++
T Consensus 80 ~~~w~W~dg~~~-~~~~W~~g~P~---------------~C~~~~~~~~~g~W~~~~C~~~~~~ICe~~~ 133 (135)
T 1umr_A 80 QCSTKWSDGSSV-SYDNLLDLYIT---------------KCSLLKKETGFRKWFVASCIGKIPFVCKFPP 133 (135)
T ss_dssp SSCCBCTTSCBC-CCCCBCGGGCC---------------CEEEEEGGGTTCSBEEECTTCCEEEEEEECC
T ss_pred CCccCcCCCCee-cccccCCCCCC---------------ccEEEecCCCCCeEecCCCCCCCcEEeCccC
Confidence 699999999765 45566666544 466665543 57999999999999999875
|
| >1sb2_A Rhodocetin alpha subunit; C-type lectin, domain swapping, toxin; 1.90A {Calloselasma rhodostoma} SCOP: d.169.1.1 PDB: 3gpr_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=193.91 Aligned_cols=123 Identities=24% Similarity=0.497 Sum_probs=101.4
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC----CCCeEEeeeecCCCCC
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTVG 125 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~~ 125 (573)
+||+||. .|+++||+++.+.++|.+|+.+|++ .||+||+|+|++|++||.+++... ...+||||+..+...+
T Consensus 1 ~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~ 78 (133)
T 1sb2_A 1 DCPDGWS--STKSYCYRPFKEKKTWEEAERFCTEQEKEAHLVSMENRLEAVFVDMVMENNFENKIYRSWIGLKIENKGQR 78 (133)
T ss_dssp CCCTTCE--ECSSEEEEEEEEEECHHHHHHHHHTSSSCCEECCCSSHHHHHHHHHHHHHHTTTCCEEEEEEEEEECSSTT
T ss_pred CcCCCcE--EcCCEeEEEECCcCCHHHHHHHHhhhCCCcEEeeECCHHHHHHHHHHHHhhccCccCCEEEeeeccCCCCC
Confidence 5999999 9999999999999999999999999 899999999999999999887532 3569999983233356
Q ss_pred CceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCC--CceeccccCCCCCccccccc
Q 008216 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 126 ~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~--~~W~d~~C~~~~~~iC~~~~ 192 (573)
+.|.|+||+++. ++.|.. +| .++|+.+.... +.|++..|....+|||+++.
T Consensus 79 ~~~~W~dg~~~~-~~~W~~-~P--------------~~~C~~~~~~~~~~~w~~~~C~~~~~fICe~~~ 131 (133)
T 1sb2_A 79 SNLEWSDGSSIS-YENLYE-PY--------------MEKCFLMDHQSGLPKWHTADCEEKNVFMCKFQL 131 (133)
T ss_dssp SSEEETTCCCCC-CCCBSS-CC--------------CEEEEEEEESSSSCEEEEECTTSCEEEEEEEEC
T ss_pred CceEECCCCccc-ccccCc-CC--------------CCCcEEEEecCCCCeEccCCCCCCceeEecccC
Confidence 999999997753 445554 43 34577766554 57999999999999999864
|
| >1fvu_A Botrocetin alpha chain; VON WILLBRAND factor modulator, C-type lectin, metal- binding, loop exchanged dimer, toxin; 1.80A {Bothrops jararaca} SCOP: d.169.1.1 PDB: 1ijk_B 1u0n_B 1u0o_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=195.47 Aligned_cols=123 Identities=25% Similarity=0.518 Sum_probs=101.5
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHH-HHHHHHHHhCCC----CCCeEEeeeecCCCC
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYE-EEHSAQKLCGKN----VNGCWVGGRSINTTV 124 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~-e~~f~~~~~~~~----~~~~WiGl~~~~~~~ 124 (573)
+||+||. .|+++||+++.+.++|.+|+.+|++ .||+||+|+|.+ |++||.+++... ...+||||+..+...
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~ 78 (133)
T 1fvu_A 1 DCPSGWS--SYEGNCYKFFQQKMNWADAERFCSEQAKGGHLVSIKIYSKEKDFVGDLVTKNIQSSDLYAWIGLRVENKEK 78 (133)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCTTSTHHHHHHHHHHHHCCSSCCEEEEEEEECCSSS
T ss_pred CcCCCcE--EcCCeeEEEECCCcCHHHHHHHHhccCCCcEEeeecChHHHHHHHHHHHhhccccCCCCEEEeeecccCCC
Confidence 5999999 8999999999999999999999999 799999999999 999999887532 357999998323345
Q ss_pred CCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCC--CceeccccCCCCCccccccc
Q 008216 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 125 ~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~--~~W~d~~C~~~~~~iC~~~~ 192 (573)
++.|.|+||+++ .++.|.. +|+ ++|+.+.... +.|++..|....+|||+++.
T Consensus 79 ~~~w~W~dg~~~-~~~~W~~-~P~--------------~~C~~~~~~~~~~~w~~~~C~~~~~fICe~~~ 132 (133)
T 1fvu_A 79 QCSSEWSDGSSV-SYENVVE-RTV--------------KKCFALEKDLGFVLWINLYCAQKNPFVCKSPP 132 (133)
T ss_dssp SSCCBCTTSCBC-CCCCBCG-GGC--------------CCEEEEETTTTSCSEEEECTTCCEEEEEEECC
T ss_pred CCccEeCCCCcc-cccCccc-CCC--------------CCcEEEEecCCCCeEecCCCCCCCCEEeeecC
Confidence 689999999775 4445555 444 4567766554 57999999999999999864
|
| >3c8j_A Natural killer cell receptor LY49C; MHC, virus, immune system; 2.60A {Mus musculus} SCOP: d.169.1.1 PDB: 3c8k_D 1p4l_D 1ja3_A 1p1z_D | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-25 Score=209.27 Aligned_cols=127 Identities=18% Similarity=0.317 Sum_probs=105.5
Q ss_pred CCCCCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCC
Q 008216 47 KDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGL 126 (573)
Q Consensus 47 ~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~ 126 (573)
...+++||+||. .|+++||+|+.+.++|.+|+.+|++.||+||+|+|.+|++||..++. ...+||||+ +...++
T Consensus 74 ~~~~~~Cp~gW~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~LasI~s~~E~~fl~~~~~--~~~~WIGl~--~~~~~~ 147 (203)
T 3c8j_A 74 SRDTGRGVKYWF--CYSTKCYYFIMNKTTWSGCKANCQHYGVPILKIEDEDELKFLQRHVI--PGNYWIGLS--YDKKKK 147 (203)
T ss_dssp ---CCCCCEEEE--EEETEEEEEEEEEECHHHHHHHHHHTTCCBCCCCSHHHHHHHHHHSC--SSCEEEEEE--EETTTT
T ss_pred ccCCCCCCCCcE--EeCCEEEEEECCCCCHHHHHHHHHhCCCEeeeeCCHHHHHHHHHhcC--CCCEEEeee--ecCCCC
Confidence 344678999999 99999999999999999999999999999999999999999999987 567999999 555679
Q ss_pred ceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccccCC
Q 008216 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHEN 194 (573)
Q Consensus 127 ~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~~~ 194 (573)
.|.|+||+++. + .|..++|+ .+.++|+.+.. +.|++..|....+|||+++...
T Consensus 148 ~w~W~DGs~~~-~-~w~~~~pn-----------~~~~~Cv~l~~--~~W~d~~C~~~~~fICe~~~~~ 200 (203)
T 3c8j_A 148 EWAWIDNGPSK-L-DMKIKKMN-----------FKSRGCVFLSK--ARIEDIDCNIPYYCICGKKLDK 200 (203)
T ss_dssp EEEETTSCCCT-T-HHHHHTTC-----------CCSSSEEEECS--SCEEEECTTSCEEEEEEEECSS
T ss_pred ceEECCCCCCC-C-CCCCCCCC-----------CCCCCcEEEEC--CcEECcCCCCCEEEEEeECCcc
Confidence 99999998765 3 35555543 13457887764 3799999999999999987643
|
| >2e3x_B Coagulation factor X-activating enzyme light CHAI; disintegrin, metalloproteinase, C-type lectin, hydrolase, BL clotting, toxin; HET: NAG MAN GM6; 2.91A {Daboia russellii siamensis} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-25 Score=196.14 Aligned_cols=123 Identities=26% Similarity=0.500 Sum_probs=101.9
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCCC---C-CeEEeeeecCCCCC
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV---N-GCWVGGRSINTTVG 125 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~~---~-~~WiGl~~~~~~~~ 125 (573)
+||+||. .|+++||+++.+.++|.+|+.+|++ .||+||+|+|++|++||.+++.... . .+||||+..+...+
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~ 79 (134)
T 2e3x_B 2 DCPPDSS--LYRYFCYRVFKEHKTWEAAERFCMEHPNNGHLVSIESMEEAEFVAKLLSNTTGKFITHFWIGLMIKDKEQE 79 (134)
T ss_dssp CCTTTSE--EETTEEEEEEEEEEEHHHHHHHHTSTTTTCCBCCCCSHHHHHHHHHHHHTCC----CEEECCEEECSSCTT
T ss_pred CCCCCCE--EeCCEeeEEeCCCcCHHHHHHHHhccCCCcEEcccCCHHHHHHHHHHHHhhccCCCCCEEEeeeecCCCCC
Confidence 6999999 9999999999999999999999999 8999999999999999999887542 4 89999983233356
Q ss_pred CceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCC--CceeccccCCCCCccccccc
Q 008216 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 126 ~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~--~~W~d~~C~~~~~~iC~~~~ 192 (573)
+.|.|+||+++ .++.|..++|+ +|+.+.... +.|++..|+...+|||+++.
T Consensus 80 ~~~~W~dg~~~-~~~~W~~~~P~---------------~C~~~~~~~~~~~w~~~~C~~~~~~ICe~~~ 132 (134)
T 2e3x_B 80 CSSEWSDGSSV-SYDKLGKQEFR---------------KCFVLEKESGYRMWFNRNCEERYLFVCKVPP 132 (134)
T ss_dssp TTCCCTTSCCC-CCCCBCGGGCC---------------CEEEEEGGGTTCCBEEECTTSEEEEEEEECC
T ss_pred CccEeCCCCcc-cccccCCCCCC---------------CeEEEEecCCCCcCCCCCCCCCcceEeCccC
Confidence 89999999775 45556666544 466665443 67999999999999999875
|
| >1j34_A Coagulation factor IX-binding protein A chain; magnesium ION, calcium ION, GLA domain, protein binding/blood clotting complex; HET: CGU; 1.55A {Trimeresurus flavoviridis} SCOP: d.169.1.1 PDB: 1bj3_A* 1j35_A* 1x2t_A* 1x2w_A 1ixx_A 1y17_A 1wt9_A 1iod_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-25 Score=193.77 Aligned_cols=121 Identities=26% Similarity=0.575 Sum_probs=99.5
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC---CC-CeEEeeeecCCCCC
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VN-GCWVGGRSINTTVG 125 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~---~~-~~WiGl~~~~~~~~ 125 (573)
+||+||. .|+++||+++.+.++|.+|+.+|++ .||+||+|+|++|++||.+++... .. .+||||+..+...+
T Consensus 1 ~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~ 78 (129)
T 1j34_A 1 DCPSGWS--SYEGHCYKPFKLYKTWDDAERFCTEQAKGGHLVSIESAGEADFVAQLVTENIQNTKSYVWIGLRVQGKEKQ 78 (129)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCCCTTCCEEEEEEECSSCSC
T ss_pred CCCCCcE--EeCCEEEEEECCCCCHHHHHHHHhccCCCCEECccCCHHHHHHHHHHHhhcccCCCCCEEEeeecCCCCCC
Confidence 5999999 9999999999999999999999999 899999999999999999887532 24 89999983233456
Q ss_pred CceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCC--CceeccccCCCCCccccc
Q 008216 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMV 190 (573)
Q Consensus 126 ~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~--~~W~d~~C~~~~~~iC~~ 190 (573)
+.|.|+||+++ .++.|..++|+ +|+.+.... +.|++..|....+|||++
T Consensus 79 ~~~~W~dg~~~-~~~~W~~~~P~---------------~C~~~~~~~~~~~w~~~~C~~~~~fiCe~ 129 (129)
T 1j34_A 79 CSSEWSDGSSV-SYENWIEAESK---------------TCLGLEKETGFRKWVNIYCGQQNPFVCEA 129 (129)
T ss_dssp SCCBCTTSCBC-CCCCBCGGGSC---------------CEEEECGGGTTCSBEEECTTSCEEEEEEC
T ss_pred CceEECCcCcc-ceeccCCCCCC---------------cceEEEccCCCCeEccCCCCCCCceEeeC
Confidence 99999999765 45556666544 456655433 579999999999999974
|
| >1oz7_A Echicetin A-chain; platelet aggregation, dimer, toxin; 2.40A {Echis carinatus} SCOP: d.169.1.1 | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-25 Score=194.61 Aligned_cols=120 Identities=27% Similarity=0.586 Sum_probs=100.6
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCC--C
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTT--V 124 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~--~ 124 (573)
+||+||. .|+++||+++.+.++|.+|+.+|++ .||+||+|+|++|++||.+++... ...+||||+ +.. .
T Consensus 1 ~Cp~gw~--~~~~~Cy~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~~~~~~ 76 (131)
T 1oz7_A 1 MCPPGWS--SNGVYCYMLFKEPKTWDEAEKFCNKQGKDGHLLSIESKKEEILVDIVVSENIGKMYKIWTGLS--ERSKEQ 76 (131)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHSCCCSEEEEEEE--ECCCGG
T ss_pred CcCCCcE--EeCCEEEEEECCCCCHHHHHHHHHhcCCCCEECccCCHHHHHHHHHHHHhhcCCCCCEEEeee--CCCCCC
Confidence 5999999 9999999999999999999999999 899999999999999999887532 357999999 544 5
Q ss_pred CCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCC--CceeccccCCCCCccccccc
Q 008216 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 125 ~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~--~~W~d~~C~~~~~~iC~~~~ 192 (573)
++.|.|+||+++. ++.|.. +|+ +|+.+.... +.|++..|....+|||+++.
T Consensus 77 ~~~~~W~dg~~~~-~~~W~~-~P~---------------~Cv~~~~~~~~~~w~~~~C~~~~~fICe~~~ 129 (131)
T 1oz7_A 77 HCSSRWSDGSFFR-SYEIAI-RYS---------------ECFVLEKQSVFRTWVATPCENTFPFMCKYPV 129 (131)
T ss_dssp GSCCBCSSSBCCS-CCCCCC-SCC---------------CEEEEEGGGTTCSEEEECTTSCEEEEEEECT
T ss_pred CCceEECCCCeec-cccccC-CCC---------------CeEEEEccCCCCeEeecCCCCCCcEEeeecC
Confidence 7999999997754 445555 443 466665543 57999999999999999865
|
| >3g8l_A Lectin-related NK cell receptor LY49L1; natural killer cell receptor, immune system; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-25 Score=205.47 Aligned_cols=126 Identities=17% Similarity=0.349 Sum_probs=105.5
Q ss_pred CCCCCCCCc-cCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCC
Q 008216 47 KDWKAPCPP-DWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVG 125 (573)
Q Consensus 47 ~~~~~~Cp~-~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~ 125 (573)
...++.||+ ||. .|+++||+|+.+.++|.+|+.+|++.||+||+|+|.+|++||..++. ...+||||+ +...+
T Consensus 60 ~~~~~~Cp~~gW~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~LasI~s~~e~~fl~~~~~--~~~~WIGl~--~~~~~ 133 (190)
T 3g8l_A 60 SQHTGRGFEKYWF--CYGIKCYYFVMDRKTWSGCKQTCQISSLSLLKIDNEDELKFLKLLVP--SDSYWIGLS--YDNKK 133 (190)
T ss_dssp SSSTTCEEEEEEE--EEETEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHSC--SSCEEEEEE--EETTT
T ss_pred CCCCCCCCCCCcE--EECCEEEEEEcccCCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHhhC--cCCEEEEEE--cCCCC
Confidence 455678999 999 99999999999999999999999999999999999999999999987 568999999 55567
Q ss_pred CceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccccC
Q 008216 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEHE 193 (573)
Q Consensus 126 ~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~~ 193 (573)
+.|.|+||+++ .+.+|..++ +.+.++|+.+.. +.|++..|....+|||+++..
T Consensus 134 ~~w~W~DGs~~-~~~~~~~~~------------~~~~~~Cv~l~~--~~W~d~~C~~~~~fICek~~~ 186 (190)
T 3g8l_A 134 KDWAWINNGPS-KLALNTMKY------------NIRDGGCMLLSK--TRLDNDNCDKSFICICGKRLD 186 (190)
T ss_dssp TEEEETTTBCC-CCCCCGGGC------------CGGGCSEEEECS--SCEEEECTTSCEEEEEEEECC
T ss_pred CceEeCCCCcc-cccccCCCC------------CCCCCCeEEEeC--CcEECCCCCCCeeEEEeeCCC
Confidence 99999999754 455565432 123456777753 479999999999999998764
|
| >1sb2_B Rhodocetin beta subunit; C-type lectin, domain swapping, toxin; 1.90A {Calloselasma rhodostoma} SCOP: d.169.1.1 PDB: 3gpr_B | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-25 Score=192.91 Aligned_cols=118 Identities=21% Similarity=0.426 Sum_probs=99.6
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC----CCCeEEeeeecCCCC
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTV 124 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~ 124 (573)
..||+||. .|+++||+++.+.++|.+|+.+|++ .||+||+|+|++|++||.+++... ...+||||+
T Consensus 2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WiGl~------ 73 (129)
T 1sb2_B 2 FRCPTTWS--ASKLYCYKPFKEKKTWIEAERFCAKQAENGHLVSIGSAAEADFLDLVIVVNFDKQRYRAWTGLT------ 73 (129)
T ss_dssp CCCCTTCE--ECSSEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHC---CCCEEEEEE------
T ss_pred CCCCCCCE--EeCCEeEEEECCCcCHHHHHHHHhhcCCCceECccCCHHHHHHHHHHHHhhcccCCCCEeEeec------
Confidence 37999999 9999999999999999999999999 899999999999999999887532 357999997
Q ss_pred CCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCC--ceeccccCCCCCccccccc
Q 008216 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSR--SLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 125 ~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~--~W~d~~C~~~~~~iC~~~~ 192 (573)
++.|.|+||+++ .++.|..++|+ +|+.+....+ .|++..|....+|||+++.
T Consensus 74 ~~~~~W~dg~~~-~~~~W~~~~P~---------------~C~~~~~~~~~~~W~~~~C~~~~~fICe~~~ 127 (129)
T 1sb2_B 74 ERNLKWTNGASV-SYENLYEPYIR---------------KCFVVQPWEGKSKWYKADCEEKNAFLCKFPK 127 (129)
T ss_dssp ECCCBCTTSCBC-CSCCBSSCCCC---------------CEEEEEEETTEEEEEEECTTSCEEEEEEEEC
T ss_pred CCccEECCCCcc-cccccCCCCCC---------------CeEEEEecCCCCeEeCcCCCCCcceEecccC
Confidence 489999999765 45566666544 4666655443 7999999999999999864
|
| >2msb_A Mannose-binding protein-A; lectin; HET: BMA MAN; 1.70A {Rattus rattus} SCOP: d.169.1.1 PDB: 1msb_A 1ytt_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=183.87 Aligned_cols=113 Identities=15% Similarity=0.220 Sum_probs=95.4
Q ss_pred CCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCCCCCcc
Q 008216 63 KSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIH 142 (573)
Q Consensus 63 ~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dgt~~~~~~~~ 142 (573)
+++||+++.+.++|.+|+.+|++.||+||+|+|++|++||.++++ ..+||||+ +...++.|.|+||+++ .++.|
T Consensus 2 g~~Cy~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WiGl~--~~~~~~~w~W~dg~~~-~~~~W 75 (115)
T 2msb_A 2 GKKFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAK---TSAFLGIT--DEVTEGQFMYVTGGRL-TYSNW 75 (115)
T ss_dssp --CEEEEEEEEECHHHHHHHHHHTTCEECCCSSHHHHHHHHHHHS---SCEEEEEE--CSSSTTCCEETTSSBC-CSCCB
T ss_pred CCEEEEEeCCCcCHHHHHHHHHhCCCEEeccCCHHHHHHHHHhhc---CCEEEeeE--cCCCCCcEEECCCCEe-eecCc
Confidence 688999999999999999999999999999999999999999985 57999999 6667799999999766 56667
Q ss_pred ccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 143 AVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 143 ~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
.+++|++. .+.++|+.+.. .+.|++..|....+|||+++
T Consensus 76 ~~~~P~~~---------~~~~~C~~~~~-~g~W~~~~C~~~~~fiCe~~ 114 (115)
T 2msb_A 76 KKDEPNDH---------GSGEDCVTIVD-NGLWNDISCQASHTAVCEFP 114 (115)
T ss_dssp CTTCCCCC---------TTCCCEEEECT-TSCEEEECTTSCEEEEEEEC
T ss_pred CCCCCCCC---------CCCCCeEEECC-CCCEECcCCCCCeEEEEeEc
Confidence 77776642 23567887763 45899999999999999875
|
| >1wk1_A Hypothetical protein YK1067A12; lectin C-type domain, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Caenorhabditis elegans} SCOP: d.169.1.1 | Back alignment and structure |
|---|
Probab=99.91 E-value=3.4e-24 Score=191.77 Aligned_cols=119 Identities=18% Similarity=0.322 Sum_probs=100.5
Q ss_pred CCCCeeeEEeccc---CChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCC
Q 008216 61 EEKSKCFGYIGNF---RSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKW 137 (573)
Q Consensus 61 ~~~~~Cy~~~~~~---~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dgt~~~ 137 (573)
.|+++||+|+.+. ++|.+|+.+|++.||+||+|+|++|++||.+++. ...+||||+ + ..++.|.|+||+++.
T Consensus 2 ~~~~~CY~~~~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~-~~~~~w~W~dg~~~~ 76 (150)
T 1wk1_A 2 SSGSSGVKFLTVNDDILSMPQARNFCASAGGYLADDLGDDKNNFYSSIAA--NTQFWIGLF--K-NSDGQFYWDRGQGIN 76 (150)
T ss_dssp CCSSCCCCSSSCCSSCBCHHHHHHHHHHHTCEECCCCSHHHHHHHHHHTT--TCEEEEEEE--E-CSSSCEEECCSSSSC
T ss_pred ccCCEEEEEEecCCCccCHHHHHHHHHhCCCEEeeeCCHHHHHHHHHhhc--cCCEEEEEE--e-CCCCcEEeCCCCccc
Confidence 6899999999999 9999999999999999999999999999999987 357999999 5 567999999998764
Q ss_pred ------CCCccccCCCCCCccCCCCcCCcccceeEEee----cCCCceeccccCCCCCcccccccCC
Q 008216 138 ------NESIHAVGSFNSSCTSLPCHVHATVDLCTLVS----NGSRSLVTERCNTSHPFICMVEHEN 194 (573)
Q Consensus 138 ------~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~----~~~~~W~d~~C~~~~~~iC~~~~~~ 194 (573)
.++.|..++|++ .+.++|+.+. ...+.|++..|....+|||+++...
T Consensus 77 ~~~~~~~y~~W~~geP~~----------~~~~~Cv~~~~~~~~~~~~W~d~~C~~~~~fICe~~~~~ 133 (150)
T 1wk1_A 77 PDLLNQPITYWANGEPSN----------DPTRQCVYFDGRSGDKSKVWTTDTCATPRPFICQKHRYD 133 (150)
T ss_dssp CEECCCSCCCBCTTCSCC----------CSSCCEEEEESSCSCGGGCEEEECTTSCBCCCEECCCCC
T ss_pred cccccCCcCCCCCCCCCC----------CCCCCcEEEeCccCCCCCEEeCcCcCCCeeEEEeecCCC
Confidence 566677666554 2345777776 3446799999999999999987543
|
| >1htn_A Tetranectin; plasminogen binding, kringle 4, alpha-helical coiled coil, C-type lectin, carbohydrate recognition domain; 2.80A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=8.3e-25 Score=202.26 Aligned_cols=125 Identities=16% Similarity=0.318 Sum_probs=104.3
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCCc
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~~ 127 (573)
..||.||. ++++||+++.+.++|.+|+.+|++.||+||+|+|.+|++||.+++... ...+||||+ +...++.
T Consensus 49 ~~Cp~gw~---~~~~CY~~~~~~~tw~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~~~~~~~~~~WIGl~--~~~~~g~ 123 (182)
T 1htn_A 49 TVCLKGTK---VHMKCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSVGNEAEIWLGLN--DMAAEGT 123 (182)
T ss_dssp HHHHHSEE---ETTEEEEEEEEEECHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHHHHTCSSCEEEEEEE--CSSSTTC
T ss_pred CCCCCCcE---ECCEEEEEECCCcCHHHHHHHHhhCCCEEeeeCCHHHHHHHHHHHHhccCCCCcEEEeeE--CCCCCCe
Confidence 37999998 679999999999999999999999999999999999999999887532 357999999 6667799
Q ss_pred eEEcCCCCCCCCCccc---cCCCCCCccCCCCcCCcccceeEEeec-CCCceeccccCCCCCcccccc
Q 008216 128 WKWSDNMSKWNESIHA---VGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~---~~~~~~~~~~~p~~~~~~~~~C~~~~~-~~~~W~d~~C~~~~~~iC~~~ 191 (573)
|.|+||+++ .|+.|. .++|++ .+.++|+.+.. ..+.|+|..|....+|||+.+
T Consensus 124 w~W~dG~~~-~y~nW~~~~~geP~~----------~~~~~Cv~l~~~~~g~W~d~~C~~~~~fICe~~ 180 (182)
T 1htn_A 124 WVDMTGARI-AYKNWETEITAQPDG----------GKTENCAVLSGAANGKWFDKRCRDQLPYICQFG 180 (182)
T ss_dssp CBCTTSCBC-CCCCBCCSSSCSCCC----------TTTCCEEEEETTTTTEEEEECTTSCEEEEEEEE
T ss_pred EEeCCCCCc-cCCCCCCCCCCcCCC----------CCCCCCEEEccCCCCCEECCCCCCCeeEEEEEe
Confidence 999999776 455666 565543 23467887764 456899999999999999875
|
| >1rdl_1 SUB-MBP-C, mannose-binding protein-C; C-type lectin, calcium-binding protein; HET: MMA; 1.70A {Rattus rattus} SCOP: d.169.1.1 PDB: 1rdj_1* 1rdk_1* 1rdi_1* 1rdm_1* 1rdn_1* 1rdo_1 1bv4_A 1kza_1* 1kzb_1* 1kzc_1* 1kzd_1* 1kze_1* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.8e-24 Score=179.42 Aligned_cols=112 Identities=14% Similarity=0.201 Sum_probs=94.8
Q ss_pred CeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCCCCCccc
Q 008216 64 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHA 143 (573)
Q Consensus 64 ~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dgt~~~~~~~~~ 143 (573)
.+||+++.+.++|.+|+.+|++.||+||+|+|++|++||.+++. ..+||||+ +...++.|.|+||+++ .++.|.
T Consensus 1 ~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WIGl~--~~~~~~~~~W~dg~~~-~y~~W~ 74 (113)
T 1rdl_1 1 KKYFMSSVRRMPLNRAKALCSELQGTVATPRNAEENRAIQNVAK---DVAFLGIT--DQRTENVFEDLTGNRV-RYTNWN 74 (113)
T ss_dssp -CEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHCS---SCEEEEEE--CSSSTTCCEETTSCBC-CCCCBC
T ss_pred CeEEEEeCCccCHHHHHHHHHhcCCEEcccCCHHHHHHHHHHhc---CCEEEEeE--CCCCCCcEEECCCCEe-ecCCCC
Confidence 37999999999999999999999999999999999999999873 58999999 6666799999999766 556677
Q ss_pred cCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 144 VGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 144 ~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
+++|++. .+.++|+.+.. .+.|++..|....+|||+++
T Consensus 75 ~~~P~~~---------~~~~~Cv~~~~-~g~w~~~~C~~~~~~ICe~~ 112 (113)
T 1rdl_1 75 EGEPNNV---------GSGENCVVLLT-NGKWNDVPCSDSFLVVCEFS 112 (113)
T ss_dssp TTCCCCC---------TTCCCEEEECT-TSCEEEECTTSCBEEEEEEC
T ss_pred CCcCCCC---------CCCCCeeEECC-CCcEeccCCCCCceEEEeeC
Confidence 7776642 24567777764 36899999999999999875
|
| >1pwb_A SP-D, PSP-D, pulmonary surfactant-associated protein D; collectin, C-type lectin, alpha-helical coiled coil, carbohydrate recognition domain; HET: GLC; 1.40A {Homo sapiens} SCOP: d.169.1.1 h.1.1.1 PDB: 1pw9_A* 3ikn_A* 3ikp_A* 3ikq_A* 3ikr_A* 2rie_A* 2ggx_A* 2ggu_A* 2ork_A* 2orj_A* 2ria_A* 2rib_A* 2ric_A* 2rid_A* 2os9_A* 3dbz_A 3g81_A* 3g83_A* 1b08_A 3g84_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-24 Score=198.85 Aligned_cols=124 Identities=18% Similarity=0.251 Sum_probs=105.0
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (573)
.|+++|. .++++||+++.+.++|.+|+.+|++.||+||+|+|.+|++||.+++......+||||+ +...++.|.|+
T Consensus 54 ~~~~~~~--~~~~~Cy~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~~~~~~w~W~ 129 (177)
T 1pwb_A 54 ELFPNGQ--SVGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFLSMT--DSKTEGKFTYP 129 (177)
T ss_dssp HHTTTEE--EETTEEEEEEEEEEEHHHHHHHHHHTTSEECCCCSHHHHHHHHHHHHHHTCCEECSCB--CSSSTTCCBCT
T ss_pred hcCCCeE--EECCEEEEEcCCccCHHHHHHHHHhcCCEEcccCCHHHHHHHHHHHhcCCCcEEEEEe--ccCcCCceEeC
Confidence 4789999 9999999999999999999999999999999999999999999988533468999999 66677999999
Q ss_pred CCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccc
Q 008216 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (573)
Q Consensus 132 Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~ 190 (573)
||+++ .|+.|..++|++. .+.++|+.+.. .+.|+|..|....+|||+.
T Consensus 130 dG~~~-~y~~W~~geP~~~---------~~~~~Cv~~~~-~g~W~d~~C~~~~~fICe~ 177 (177)
T 1pwb_A 130 TGESL-VYSNWAPGEPNDD---------GGSEDCVEIFT-NGKWNDRACGEKRLVVCEF 177 (177)
T ss_dssp TSCBC-SCCCBCTTCCCCG---------GGCCCEEEECT-TSCEEEECTTSEEEEEEEC
T ss_pred CcCCc-ccCCcCCCcCCCC---------CCCCCcEEECC-CCcEeCCCCCCCeeEEEeC
Confidence 99776 5666777776642 23567887754 4689999999999999973
|
| >1h8u_A MBP, eosinophil granule major basic protein 1; lectin, eosinophil granule protein, EMBP; 1.8A {Homo sapiens} SCOP: d.169.1.1 PDB: 2brs_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-23 Score=178.43 Aligned_cols=114 Identities=18% Similarity=0.347 Sum_probs=94.3
Q ss_pred ee-eEEecccCChHHHHHHHhh-cCCeEeeeCCHHHHHHHHHHhCCC-CCCeEEeeeecCCCCCCceEEcCCCCCCCCCc
Q 008216 65 KC-FGYIGNFRSWDESETYCKE-IGGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLSWKWSDNMSKWNESI 141 (573)
Q Consensus 65 ~C-y~~~~~~~~w~~a~~~C~~-~~~~L~~i~~~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~w~W~Dgt~~~~~~~ 141 (573)
+| |+++.+.++|.+|+.+|++ .||+||+|+|++|++||.+++... ...+||||++.+...++.|.|+||+++ .+..
T Consensus 1 ~C~Y~~~~~~~tw~~A~~~C~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~WIGl~~~~~~~~~~~~W~dg~~~-~y~~ 79 (117)
T 1h8u_A 1 TCRYLLVRSLQTFSQAWFTCRRCYRGNLVSIHNFNINYRIQCSVSALNQGQVWIGGRITGSGRCRRFQWVDGSRW-NFAY 79 (117)
T ss_dssp --CEEEEEEEECHHHHHHHHHHHHSSEECCCCSHHHHHHHHHHHTTCSSSEEEEEEEEECSSSCCEEEETTCCCC-CCCC
T ss_pred CeEEEEeCCccCHHHHHHHhccCCCCeEEeecCHHHHHHHHHHHhccCCCCEEEcccccCCCCCCccEeCCCCcC-CccC
Confidence 59 9999999999999999999 999999999999999999998743 356999999654556799999999765 5666
Q ss_pred cccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccc
Q 008216 142 HAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (573)
Q Consensus 142 ~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~ 190 (573)
|.+++|++ ..++|+.+....+.|++..|....+|||+.
T Consensus 80 W~~~~P~~-----------~~~~C~~~~~~~g~W~~~~C~~~~~fiCe~ 117 (117)
T 1h8u_A 80 WAAHQPWS-----------RGGHCVALCTRGGYWRRAHCLRRLPFICSY 117 (117)
T ss_dssp BCSSSCCT-----------TSCSEEEEETTTTCEEEECTTSCEEEEEEC
T ss_pred cCCCCCCC-----------CCCCCeEEECCCCcCCCCCCCCCcceeEeC
Confidence 76666554 235788887666689999999999999973
|
| >3pbf_A Pulmonary surfactant-associated protein A; collectin, carbohydrate binding, lectin, mannose, sugar BIND protein; 1.80A {Rattus norvegicus} PDB: 1r14_A* 1r13_A* 3paq_A* 3par_A 3pak_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=187.43 Aligned_cols=121 Identities=16% Similarity=0.219 Sum_probs=100.2
Q ss_pred CCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcC
Q 008216 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD 132 (573)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~D 132 (573)
+...+. .++++||+++.+.++|.+|+.+|++.||+||+|+|.+|++||..++......+||||+ +...++.|.|+|
T Consensus 27 ~~~~~~--~~~~~Cy~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~~~~~~w~W~d 102 (148)
T 3pbf_A 27 LQGSML--SVGDKVFSTNGQSVNFDTIKEMCTRAGGNIAVPRTPEENEAIASIAKKYNNYVYLGMI--EDQTPGDFHYLD 102 (148)
T ss_dssp HTTSCE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHTSCEEEEEE--ECSSTTCEEETT
T ss_pred HHhcce--eeCCEEEEEcCCccCHHHHHHHHhhcCCEEeeeCCHHHHHHHHHHHHhCCCCEEEEeE--ecCCCCceEeCC
Confidence 344445 8999999999999999999999999999999999999999999988643457999999 555569999999
Q ss_pred CCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccc
Q 008216 133 NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICM 189 (573)
Q Consensus 133 gt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~ 189 (573)
|+++ .++.|.+++|++. +.++|+.+.. .+.|++..|....+|||+
T Consensus 103 g~~~-~~~~W~~~~P~~~----------~~~~Cv~~~~-~g~W~~~~C~~~~~fICe 147 (148)
T 3pbf_A 103 GASV-SYTNWYPGEPRGQ----------GKEKCVEMYT-DGTWNDRGCLQYRLAVCE 147 (148)
T ss_dssp SCBC-CSCCBCTTCCCST----------TSCCEEEECT-TSCEEEECSCSCEEEEEE
T ss_pred CCCc-ccCCcCCCccCcC----------CCCCceEECC-CCcEecCCCCCCeeEeee
Confidence 9765 5666776766642 3456787765 358999999999999996
|
| >1byf_A TC14, protein (polyandrocarpa lectin); C-type lectin, galactose-specific, sugar binding protein; 2.00A {Polyandrocarpa misakiensis} SCOP: d.169.1.1 PDB: 1tlg_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=180.04 Aligned_cols=118 Identities=16% Similarity=0.262 Sum_probs=96.0
Q ss_pred CCeeeEEecccCChHHHHHHHhhcCCeEee--eCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCc--eEEcCCCCCCC
Q 008216 63 KSKCFGYIGNFRSWDESETYCKEIGGHLAA--LTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLS--WKWSDNMSKWN 138 (573)
Q Consensus 63 ~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~--i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~--w~W~Dgt~~~~ 138 (573)
+++||+++.+.++|.+|+.+|++.||+||+ |+|++|++||.++.......+|||| +.. .++. |.|+||+++..
T Consensus 1 g~~Cy~~~~~~~~w~~A~~~C~~~g~~La~~~i~s~~e~~~l~~~~~~~~~~~WIGl-~~~--~~~~~~w~W~dg~~~~~ 77 (125)
T 1byf_A 1 MDYEILFSDETMNYADAGTYCQSRGMALVSSAMRDSTMVKAILAFTEVKGHDYWVGA-DNL--QDGAYNFLWNDGVSLPT 77 (125)
T ss_dssp -CEEEEEEEEEECHHHHHHHHHTTTCEESCGGGGSHHHHHHHHHHHHHHTCCEEEEE-EST--TTCTTCCEETTSCBCCT
T ss_pred CCeEEEEeCCCCCHHHHHHHHHHcCCEeeecCCCCHHHHHHHHHhcCCCCCCEEEec-ccC--CCCceeEEECCCCCCcc
Confidence 478999999999999999999999999999 9999999999988211146799999 543 4588 99999987645
Q ss_pred CC-ccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccccc
Q 008216 139 ES-IHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 139 ~~-~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
++ .|.+++|++. .+.++|+.+....+.|++..|....+|||++++
T Consensus 78 ~~~~W~~~~P~~~---------~~~~~Cv~~~~~~~~W~d~~C~~~~~fICe~~~ 123 (125)
T 1byf_A 78 DSDLWSPNEPSNP---------QSWQLCVQIWSKYNLLDDVGCGGARRVICEKEL 123 (125)
T ss_dssp TCTTBCTTCSCSC---------TTSCCEEEEETTTTEEEEECSCSCEEEEEEEEC
T ss_pred cccCcCCCcCCCC---------CCCCCceEEECCCCcEECcCCCCceeEEEeeeC
Confidence 66 7777776653 234568887755568999999999999999875
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=9.5e-24 Score=209.26 Aligned_cols=144 Identities=17% Similarity=0.158 Sum_probs=115.8
Q ss_pred CCcCCeeecccCceEEEEEEeCCCCEEEEEEecccch------------------hhHHHHHHHHHHHhhcCCCcEeEEe
Q 008216 270 FSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF------------------QRKKEFYSEIGRFARLHHPNLVAVK 331 (573)
Q Consensus 270 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~l~ 331 (573)
++...+.||+|+||.||+|...+|+.||||+++.... .....+.+|+.++++++ | +++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 3334578899999999999997799999999965321 13467899999999998 4 5555
Q ss_pred eEEeeCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCe
Q 008216 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA 411 (573)
Q Consensus 332 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 411 (573)
+++. .+..++||||+++++|.+ +.. .....++.|++.||.|||++ +|+||||||+|||++ ++.+
T Consensus 168 ~~~~-~~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~v 231 (282)
T 1zar_A 168 KVYA-WEGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGI 231 (282)
T ss_dssp CEEE-EETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEE
T ss_pred eEEe-ccceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcE
Confidence 5443 356799999999999988 421 12346999999999999999 999999999999999 9999
Q ss_pred eEecccCCccCCccccccceeccCCccccccccccc
Q 008216 412 HLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447 (573)
Q Consensus 412 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 447 (573)
||+|||+++ .+..++|||++.
T Consensus 232 kl~DFG~a~---------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 232 WIIDFPQSV---------------EVGEEGWREILE 252 (282)
T ss_dssp EECCCTTCE---------------ETTSTTHHHHHH
T ss_pred EEEECCCCe---------------ECCCCCHHHHHH
Confidence 999999986 334578999874
|
| >1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A | Back alignment and structure |
|---|
Probab=99.85 E-value=1.7e-21 Score=176.55 Aligned_cols=114 Identities=18% Similarity=0.332 Sum_probs=95.5
Q ss_pred eeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCC--CCCccc
Q 008216 66 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKW--NESIHA 143 (573)
Q Consensus 66 Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dgt~~~--~~~~~~ 143 (573)
||+|+.+.++|.+|+.+|++.||+||+|+|++|++||.+++......+||||++ . ++.|+|+||+++. .++.|.
T Consensus 2 ~Y~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~~--~--~~~~~W~dg~~~~~~~~~~W~ 77 (162)
T 1g1s_A 2 TYHYSTKAYSWNISRKYCQNRYTDLVAIQNKNEIDYLNKVLPYYSSYYWIGIRK--N--NKTWTWVGTKKALTNEAENWA 77 (162)
T ss_dssp EEEEEEEEECHHHHHHHHHHHSSEECCCCCHHHHHHHHHHSCCCTTCEEEEEEE--E--TTEEEETTTCCBCCTTTCCBC
T ss_pred eEEEecCCcCHHHHHHHHHhcCCEEeeeCCHHHHHHHHHHhccCCCCEEEeEEC--C--CCCeEECCCCccCCcccCccC
Confidence 899999999999999999999999999999999999999997555679999994 3 5899999997544 367787
Q ss_pred cCCCCCCccCCCCcCCcccceeEEeec----CCCceeccccCCCCCccccccc
Q 008216 144 VGSFNSSCTSLPCHVHATVDLCTLVSN----GSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 144 ~~~~~~~~~~~p~~~~~~~~~C~~~~~----~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
+++|++. .+.++|+.+.. ..+.|++..|....+|||++..
T Consensus 78 ~geP~~~---------~~~~~Cv~~~~~~~~~~~~W~d~~C~~~~~fICe~~~ 121 (162)
T 1g1s_A 78 DNEPNNK---------RNNEDCVEIYIKSPSAPGKWNDEHCLKKKHALCYTAS 121 (162)
T ss_dssp TTCCCCT---------TSCCCEEEECTTCSSSTTCEEEECTTSCEEEEEEECC
T ss_pred CCCCCCC---------CCCcceEEEeccCCCCCCeEECCCCCCCCCEEEEeCC
Confidence 7776653 23567777764 3467999999999999999863
|
| >3cfw_A L-selectin; EGF, cell adhesion, EGF-like domain, glycoprotein, membrane, sushi, transmembrane; HET: NAG MAN BMA; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.5e-21 Score=177.33 Aligned_cols=115 Identities=16% Similarity=0.324 Sum_probs=95.9
Q ss_pred eeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCC--CCCcc
Q 008216 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKW--NESIH 142 (573)
Q Consensus 65 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dgt~~~--~~~~~ 142 (573)
.||+|+.+.++|.+|+.+|++.||+||+|+|++|++||.+++......+||||+ +. ++.|+|+||+.+. .++.|
T Consensus 1 wcY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fl~~~~~~~~~~~WIGl~--~~--~~~~~W~dg~~~~~~~y~~W 76 (164)
T 3cfw_A 1 WTYHYSEKPMNWQRARRFCRDNYTDLVAIQNKAEIEYLEKTLPFSRSYYWIGIR--KI--GGIWTWVGTNKSLTEEAENW 76 (164)
T ss_dssp CEEEEEEEEECHHHHHHHHHHHSSEECCCCSHHHHHHHHHHSCCCTTCEEESEE--EE--TTEEEETTTCCBCCTTTCCB
T ss_pred CeEEEecCCcCHHHHHHHHHHCCCEECccCCHHHHHHHHHHhccCCccEEEeEE--CC--CCEEEECCCCcccccccCCC
Confidence 399999999999999999999999999999999999999998754567999999 43 5899999997544 36677
Q ss_pred ccCCCCCCccCCCCcCCcccceeEEeec----CCCceeccccCCCCCccccccc
Q 008216 143 AVGSFNSSCTSLPCHVHATVDLCTLVSN----GSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 143 ~~~~~~~~~~~~p~~~~~~~~~C~~~~~----~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
.+++|++. .+.++|+.+.. ..+.|++..|....+|||++++
T Consensus 77 ~~geP~~~---------~~~~~Cv~~~~~~~~~~~~W~d~~C~~~~~fICe~~~ 121 (164)
T 3cfw_A 77 GDGEPNNK---------KNKEDCVEIYIKRNKDAGKWNDDACHKLKAALCYTAS 121 (164)
T ss_dssp CTTCCCCG---------GGCCCEEEECTTCSSSTTCEEEECTTSCEEEEEEECC
T ss_pred CCCCCCCC---------CCCccceeeeccCCCCCCceeCCCCCCCcEeEEccCC
Confidence 77776653 23567777753 3467999999999999999874
|
| >1g1t_A E-selectin; EGF, adhesion molecule, SLEX, immune system, membrane protein; HET: SIA GAL MAG FUC; 1.50A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1esl_A | Back alignment and structure |
|---|
Probab=99.85 E-value=2.4e-21 Score=174.62 Aligned_cols=114 Identities=19% Similarity=0.346 Sum_probs=95.1
Q ss_pred eeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCC--CCCccc
Q 008216 66 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKW--NESIHA 143 (573)
Q Consensus 66 Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dgt~~~--~~~~~~ 143 (573)
||+|+.+.++|.+|+.+|++.||+||+|+|++|++||.+++......+||||+ +. ++.|.|+||+.+. .++.|.
T Consensus 2 ~Y~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WIGl~--~~--~~~~~W~dg~~~~~~~y~~W~ 77 (157)
T 1g1t_A 2 SYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIR--KV--NNVWVWVGTQKPLTEEAKNWA 77 (157)
T ss_dssp EEEECSSCBCHHHHHHHHHHHSSEECCCCSHHHHHHHHHHSCCCTTCEEESEE--EE--TTEEEETTTCCBCCTTTCCBC
T ss_pred ceEeCCCccCHHHHHHHHHHCCCEEcccCCHHHHHHHHHHhccCCCCEEEEEE--CC--CCeeEEeCCCccCCcccCCCC
Confidence 89999999999999999999999999999999999999998755567999999 43 4899999997543 467777
Q ss_pred cCCCCCCccCCCCcCCcccceeEEeec----CCCceeccccCCCCCccccccc
Q 008216 144 VGSFNSSCTSLPCHVHATVDLCTLVSN----GSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 144 ~~~~~~~~~~~p~~~~~~~~~C~~~~~----~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
+++|++. .+.++|+.+.. ..+.|+|..|....+|||+++.
T Consensus 78 ~geP~~~---------~~~~~Cv~~~~~~~~~~~~W~d~~C~~~~~fICe~~~ 121 (157)
T 1g1t_A 78 PGEPNNR---------QKDEDCVEIYIKREKDVGMWNDERCSKKKLALCYTAA 121 (157)
T ss_dssp TTCCCCC---------STTCCEEEECTTCSSSTTCEEEECTTSCBEEEEEECC
T ss_pred CCcCCCC---------CCCCCceEEeCcCCCCCCccccCCCCCCcceEeCcCC
Confidence 7776653 23456777753 2467999999999999999864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.5e-19 Score=176.85 Aligned_cols=136 Identities=13% Similarity=0.118 Sum_probs=105.8
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCE--EEEEEecccchh------------------------hHHHHHHHHHHHhhcC
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSR--VAVKRLKRSSFQ------------------------RKKEFYSEIGRFARLH 323 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 323 (573)
++..+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.+|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 34456789999999999997 68989 999997543111 1236789999999998
Q ss_pred CCcE--eEEeeEEeeCCceEEEEEecCC-C----CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEE
Q 008216 324 HPNL--VAVKGCCYDHGDRYIVYEFVVN-G----PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH-DKVKPHVVH 395 (573)
Q Consensus 324 h~nI--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~iiH 395 (573)
|+++ +.+++. +..++||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 7754 344432 366899999942 3 67766532 234567789999999999999 88 9999
Q ss_pred cCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 396 RDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 396 ~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
|||||+|||++. .++|+|||++...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=3e-17 Score=167.04 Aligned_cols=137 Identities=14% Similarity=0.080 Sum_probs=100.3
Q ss_pred CCcCCeeecccCceEEEEEEeCCCCEEEEEEecccch--------------hhH--------HHHHHHHHHHhhcCCCcE
Q 008216 270 FSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--------------QRK--------KEFYSEIGRFARLHHPNL 327 (573)
Q Consensus 270 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------------~~~--------~~~~~E~~~l~~l~h~nI 327 (573)
.+.....||.|++|.||+|...+|+.||||+++.... ... ....+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4566678999999999999998999999998753210 000 112457777777755443
Q ss_pred e--EEeeEEeeCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee
Q 008216 328 V--AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405 (573)
Q Consensus 328 v--~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll 405 (573)
. ..++. ...+|||||++|++|..+.. . .....++.|++.+|.+||+. |||||||||.|||+
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl 238 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKH---GLIHGDFNEFNILI 238 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEE
Confidence 2 22222 23479999999988866432 1 12356789999999999999 99999999999999
Q ss_pred CCCCC----------eeEecccCCccCC
Q 008216 406 DEEFG----------AHLMGVGLSKFVP 423 (573)
Q Consensus 406 ~~~~~----------~kl~Dfg~~~~~~ 423 (573)
++++. +.|+||+-+....
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred eCCCCcccccccccceEEEEeCCcccCC
Confidence 87763 8899999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=4.6e-12 Score=123.63 Aligned_cols=136 Identities=12% Similarity=0.030 Sum_probs=106.4
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeCCceEEEEEecCCCCHH
Q 008216 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 353 (573)
..++.|+.+.||+... +|+.+++|+...........+.+|+.+++.+. +..+.+++++..+.+..|+|||+++|.+|.
T Consensus 20 ~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 98 (263)
T 3tm0_A 20 KDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp ECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred eeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence 3557788899999986 47899999987532223346889999999984 677889999998888999999999999998
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 008216 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-------------------------------------------- 389 (573)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------------------------------------------- 389 (573)
+.+.. ......++.+++.+|+.||+..
T Consensus 99 ~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T 3tm0_A 99 EEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp HHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred hccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence 76421 1223467889999999999810
Q ss_pred ------------CCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 390 ------------KPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 390 ------------~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
.+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1359999999999999876556799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.15 E-value=4.5e-11 Score=116.18 Aligned_cols=128 Identities=16% Similarity=0.141 Sum_probs=97.0
Q ss_pred cccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCc--EeEEeeEEeeCCceEEEEEecCCCCHHHH
Q 008216 278 GDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN--LVAVKGCCYDHGDRYIVYEFVVNGPLDRW 355 (573)
Q Consensus 278 g~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 355 (573)
+.|..+.||++...+|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++..+++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 355569999998877889999998654 2245778999999885434 566888888878889999999998884
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------------
Q 008216 356 LHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV---------------------------------------------- 389 (573)
Q Consensus 356 l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------------------------------- 389 (573)
... .+ ...++.+++..|..||+..
T Consensus 104 ~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 104 SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 211 12 1256778888888888742
Q ss_pred ---------CCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 390 ---------KPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 390 ---------~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999877656799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.08 E-value=3.6e-10 Score=115.52 Aligned_cols=141 Identities=18% Similarity=0.220 Sum_probs=106.3
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEec--ccc-hhhHHHHHHHHHHHhhcC--CCcEeEEeeEEeeC---CceEEEEEe
Q 008216 275 RLLGDSKTGGTYSGILPDGSRVAVKRLK--RSS-FQRKKEFYSEIGRFARLH--HPNLVAVKGCCYDH---GDRYIVYEF 346 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~---~~~~lv~e~ 346 (573)
+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 45799999999999874 5688999876 332 123456888999999996 45678888888776 457999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV------------------------------------- 389 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------------------- 389 (573)
++|.++.+.. -..++..+...++.+++..|+.||+..
T Consensus 123 v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 123 VSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred cCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9988774321 134678888899999999999999731
Q ss_pred ------------------CCCeEEcCCCCCCeeeCCCCC--eeEecccCCccC
Q 008216 390 ------------------KPHVVHRDIRASNVLLDEEFG--AHLMGVGLSKFV 422 (573)
Q Consensus 390 ------------------~~~iiH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~ 422 (573)
.+.++|+|++|.||+++.++. +.|+||+.+...
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 247999999999999997753 589999988754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.94 E-value=4.6e-10 Score=111.95 Aligned_cols=186 Identities=16% Similarity=0.172 Sum_probs=122.3
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCc--EeEEeeEEeeCC---ceEEEEEecC
Q 008216 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPN--LVAVKGCCYDHG---DRYIVYEFVV 348 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--Iv~l~~~~~~~~---~~~lv~e~~~ 348 (573)
+.++.|....||+.. ..+++|+.... .....+.+|+.+|+.+ .+.. +.+++......+ ..|+|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 357999999999853 56899986543 3456788999999888 3332 345555443333 3489999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK---------------------------------------- 388 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------------------------------------- 388 (573)
|.+|.+... ..++..+...++.+++..|+.||+.
T Consensus 100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 988865332 2367788888899999999999862
Q ss_pred ---------------CCCCeEEcCCCCCCeeeCC--CCCeeEecccCCccCCccccccceecc---CC---------ccc
Q 008216 389 ---------------VKPHVVHRDIRASNVLLDE--EFGAHLMGVGLSKFVPWEVMQERTVMA---GG---------TYG 439 (573)
Q Consensus 389 ---------------~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~---~g---------t~~ 439 (573)
..+.++|+|++|.||++++ +..+.|+||+.+............... .+ ..+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1135899999999999988 455789999988654321110000000 00 001
Q ss_pred ccc-cccccCCCCCcchhhHHHHHHHHHHHcCCCCC
Q 008216 440 YLA-PEFVYRNELTTKSDVYSFGVLLLEIVSGRRPA 474 (573)
Q Consensus 440 y~a-PE~~~~~~~~~~~DvwSlGvil~elltG~~Pf 474 (573)
... |+.... .....+.|++|.++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 221110 112368999999999999998775
|
| >3k7b_A Protein A33; C-type lectin-like domain, homodimer, poxvirus, EEV, EV, VIR protein; 2.10A {Vaccinia virus WR} | Back alignment and structure |
|---|
Probab=98.75 E-value=1.1e-09 Score=85.89 Aligned_cols=46 Identities=7% Similarity=0.161 Sum_probs=43.5
Q ss_pred CCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhC
Q 008216 61 EEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCG 107 (573)
Q Consensus 61 ~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~ 107 (573)
.|+++||+|+.+.++|.+|+..|.+.|++|++|++.++ .||..++.
T Consensus 15 ~f~~~CY~f~~~pkTW~eA~~~C~~~G~~Lpsi~s~~~-~wL~~YL~ 60 (96)
T 3k7b_A 15 YYQGSCYILHSDYQMFSDAAANCTAESSTLPNKSDVMI-TWLIDYVE 60 (96)
T ss_dssp EETTEEEEEEEEEECHHHHHHHHHHTTCBCCCHHHHTT-STTHHHHB
T ss_pred eeCCeeEEEeCCCCCHHHHHHHHHHcCCccCCcccchh-HHHHHHHh
Confidence 68999999999999999999999999999999999988 99988875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.1e-06 Score=87.28 Aligned_cols=136 Identities=17% Similarity=0.104 Sum_probs=96.7
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCC---cEeEEeeEEe-eCCceEEEEEecCCC
Q 008216 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHP---NLVAVKGCCY-DHGDRYIVYEFVVNG 350 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~-~~~~~~lv~e~~~~g 350 (573)
+.++.|....||+. |..+++|+... ......+.+|+.+|+.+.+. .+.+++.+.. ..+..++|||+++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 35688888899987 67788998532 23456788999999999642 3566666664 445678999999998
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK------------------------------------------ 388 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------------------------------------------ 388 (573)
+|.+... ..++..+...++.+++..|+.||+.
T Consensus 99 ~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 99 ILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp ECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 8876321 1245555666666666666666643
Q ss_pred ---------------CCCCeEEcCCCCCCeeeCC---CCCe-eEecccCCccC
Q 008216 389 ---------------VKPHVVHRDIRASNVLLDE---EFGA-HLMGVGLSKFV 422 (573)
Q Consensus 389 ---------------~~~~iiH~Dlkp~NIll~~---~~~~-kl~Dfg~~~~~ 422 (573)
..+.++|+|++|.||+++. ++.+ .|+||+.+...
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1235699999999999987 4554 89999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.4e-06 Score=84.82 Aligned_cols=133 Identities=18% Similarity=0.128 Sum_probs=96.4
Q ss_pred ecccCce-EEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeCCceEEEEEecCCCCHH
Q 008216 277 LGDSKTG-GTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (573)
Q Consensus 277 lg~G~~g-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 353 (573)
+..|..+ .||+.... ++..+++|+-... ....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 3555554 68987754 4678999987644 3456788999998883 334678888888889999999999998887
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 008216 354 RWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-------------------------------------------- 389 (573)
Q Consensus 354 ~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------------------------------------------- 389 (573)
+.... .......+..+++..|.-||+..
T Consensus 109 ~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 109 QVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 76532 11223345666777777777421
Q ss_pred -----------CCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 390 -----------KPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 390 -----------~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
.+.++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137999999999999987667799998775
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=1.5e-06 Score=88.44 Aligned_cols=79 Identities=5% Similarity=-0.051 Sum_probs=55.6
Q ss_pred eee-cccCceEEEEEEeC-------CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcC-C--CcEeEEeeEEeeC---
Q 008216 275 RLL-GDSKTGGTYSGILP-------DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLH-H--PNLVAVKGCCYDH--- 337 (573)
Q Consensus 275 ~~l-g~G~~g~Vy~~~~~-------~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~--- 337 (573)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + ..+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 356 78888999998764 26789999875432 111245778888888873 2 3567788776655
Q ss_pred CceEEEEEecCCCCHH
Q 008216 338 GDRYIVYEFVVNGPLD 353 (573)
Q Consensus 338 ~~~~lv~e~~~~gsL~ 353 (573)
+..++|||+++|.++.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999887764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.01 E-value=2.7e-05 Score=78.24 Aligned_cols=140 Identities=17% Similarity=0.212 Sum_probs=78.7
Q ss_pred eecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC--CCcEeEEee------EEeeCCceEEEEEec
Q 008216 276 LLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH--HPNLVAVKG------CCYDHGDRYIVYEFV 347 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~------~~~~~~~~~lv~e~~ 347 (573)
.|+.|..+.||+....+| .+++|+.... ...+..|..+++.|. .-.+++++. +....+..+++|||+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 456677899999987554 5999998753 133344555555542 112333332 123456779999999
Q ss_pred CCCCHH-----------H---HhccCCC----C-C-----CCCCHHH-------------------------------HH
Q 008216 348 VNGPLD-----------R---WLHHIPR----G-G-----RSLDWAM-------------------------------RM 372 (573)
Q Consensus 348 ~~gsL~-----------~---~l~~~~~----~-~-----~~l~~~~-------------------------------~~ 372 (573)
+|.++. . .++.... . . ....+.. ..
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 0 1111000 0 0 0011211 01
Q ss_pred HHHHHHHHHHHHHHh----------CCCCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 373 KVATTLAQGIAFLHD----------KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 373 ~i~~qi~~~L~~LH~----------~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
.+..++..++++|++ .....++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 112234446667763 023489999999999999888889999999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=3.6e-05 Score=79.28 Aligned_cols=74 Identities=14% Similarity=0.001 Sum_probs=49.1
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEecccch-------hhHHHHHHHHHHHhhcCC--C-cEeEEeeEEeeCCceEEE
Q 008216 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-------QRKKEFYSEIGRFARLHH--P-NLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-nIv~l~~~~~~~~~~~lv 343 (573)
+.+|.|..+.||++... +++.++||....... ...+.+..|.++|+.+.. | .+.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46799999999999754 478999998654211 123456778888887732 3 34455543 44567899
Q ss_pred EEecCCC
Q 008216 344 YEFVVNG 350 (573)
Q Consensus 344 ~e~~~~g 350 (573)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.95 E-value=3.4e-05 Score=75.71 Aligned_cols=75 Identities=25% Similarity=0.228 Sum_probs=55.1
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-C--CcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-H--PNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
...+|.|..+.||+....+|+.|++|+...........+..|+..|+.|. . --+++++++ +..++|||+++++
T Consensus 20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~ 95 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDER 95 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCC
T ss_pred EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeeccc
Confidence 34569999999999999999999999876554444456788999988883 2 234455543 2347899999876
Q ss_pred CH
Q 008216 351 PL 352 (573)
Q Consensus 351 sL 352 (573)
..
T Consensus 96 ~~ 97 (288)
T 3f7w_A 96 PP 97 (288)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.88 E-value=9.1e-05 Score=73.45 Aligned_cols=138 Identities=19% Similarity=0.228 Sum_probs=91.5
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC---CCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH---HPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
+.|+.|....+|+... ++..+++|+.... ....+..|+..|+.|. ...+++++++....+..++|||++++..
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 3579999999999886 5778999987643 3567888999888883 3668888888888888999999999876
Q ss_pred HH--------H---HhccCCC-CC-----------------CCCCHHHHH---HHH----------------HHHHHHH-
Q 008216 352 LD--------R---WLHHIPR-GG-----------------RSLDWAMRM---KVA----------------TTLAQGI- 382 (573)
Q Consensus 352 L~--------~---~l~~~~~-~~-----------------~~l~~~~~~---~i~----------------~qi~~~L- 382 (573)
+. + -|+.... .. ..-+|.... ++. ..++..+
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 42 1 1222111 00 011343221 111 1122122
Q ss_pred HHHHh-CCCCCeEEcCCCCCCeeeCCCCCeeEeccc
Q 008216 383 AFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVG 417 (573)
Q Consensus 383 ~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 417 (573)
..|.. ...+.++|+|+.+.|++++.++ +.|+|+.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23421 2356899999999999999887 8888874
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00022 Score=65.63 Aligned_cols=160 Identities=10% Similarity=0.043 Sum_probs=100.8
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
-+|.+.|.. .+.++++++++.++.|.+.+|.-+-.+. .-..+=+.|..|++..+|.+...+ ..+. .
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------~ 98 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD--------A 98 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc--------c
Confidence 378888874 3478999999999999999987762210 111233456899999999887653 1110 0
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
....+.|||... ...+.+.=|||||+++|..+-=..|-+.
T Consensus 99 ------~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e--------------------------------- 138 (229)
T 2yle_A 99 ------GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE--------------------------------- 138 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE---------------------------------
T ss_pred ------cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc---------------------------------
Confidence 223467888763 4556788999999999998873333110
Q ss_pred CCCCcchHHHHHHHHHHHHhcCC-------------------------CCCCCCCHHHHHHHHhcccCCCchhhhhhhhh
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQH-------------------------VPSMRPRMSHVVHQLQQLAQPPVTKLLFKGLD 564 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~-------------------------dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~ 564 (573)
+...+++|-+||..|... .+..|++.++|++.-..-.+.|.. .-.+++
T Consensus 139 -----E~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~~ps~--A~~HY~ 211 (229)
T 2yle_A 139 -----ERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLPTESD--APNHYQ 211 (229)
T ss_dssp -----EECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTTSSSGGG--HHHHHH
T ss_pred -----chhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhhccCccc--chHHHH
Confidence 112334566677766644 357899999999998887776642 335555
Q ss_pred cccccc
Q 008216 565 RLRHIF 570 (573)
Q Consensus 565 ~~~~~~ 570 (573)
.++.-+
T Consensus 212 aVCraL 217 (229)
T 2yle_A 212 AVCRAL 217 (229)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 555544
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00033 Score=72.64 Aligned_cols=78 Identities=9% Similarity=0.099 Sum_probs=48.6
Q ss_pred CCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccceeccCCcccccccccccCC---CCCcchhhHHHHHHHHHH
Q 008216 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN---ELTTKSDVYSFGVLLLEI 467 (573)
Q Consensus 391 ~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~el 467 (573)
+.++|+|++|.|||++.++ ++++||+.+........-.... ..-...|.+|+..... ......++.+....+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH-HHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 3899999999999998876 9999999887644221110000 0012346666654311 112245666888888887
Q ss_pred HcC
Q 008216 468 VSG 470 (573)
Q Consensus 468 ltG 470 (573)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.0017 Score=64.47 Aligned_cols=161 Identities=14% Similarity=0.161 Sum_probs=89.0
Q ss_pred ccCHHHHHHhhcCCCcC----CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCc--EeEE
Q 008216 257 VFTTEELRSITKNFSEG----NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN--LVAV 330 (573)
Q Consensus 257 ~~~~~el~~~~~~~~~~----~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l 330 (573)
.++.+++..+...|... -+.|+.|....+|+....+| .+++|+.... .....+..|+.++..|...+ +.++
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 35667777777665431 23457788899999987555 6889988753 12234556777777663212 3333
Q ss_pred eeE------EeeCCceEEEEEecCCCCHHH-----------H---hccC----CCCC-CCC---CHHHHHH---------
Q 008216 331 KGC------CYDHGDRYIVYEFVVNGPLDR-----------W---LHHI----PRGG-RSL---DWAMRMK--------- 373 (573)
Q Consensus 331 ~~~------~~~~~~~~lv~e~~~~gsL~~-----------~---l~~~----~~~~-~~l---~~~~~~~--------- 373 (573)
+.. ....+..++++++++|..+.. . ++.. .... ... .|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 122356789999998865321 0 1110 0000 001 1111000
Q ss_pred ---HHHHHHHHHHHHHhC----CCCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 374 ---VATTLAQGIAFLHDK----VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 374 ---i~~qi~~~L~~LH~~----~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
+...+...++.+++. ...+++|+|+.+.|||++++..+.++||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234455555532 23479999999999999887556899998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.43 E-value=0.0014 Score=65.33 Aligned_cols=162 Identities=15% Similarity=0.130 Sum_probs=90.8
Q ss_pred cccCHHHHHHhhcCCCc----CCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCC--CcEeE
Q 008216 256 KVFTTEELRSITKNFSE----GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH--PNLVA 329 (573)
Q Consensus 256 ~~~~~~el~~~~~~~~~----~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~ 329 (573)
...+.+++..+...+.. ....++ |....||+....+|+.+++|+..... .....+..|..++..+.. -.+++
T Consensus 9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~ 86 (328)
T 1zyl_A 9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAA 86 (328)
T ss_dssp CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecc
Confidence 34556666655544322 223466 88889999887778889999986432 234566778888877732 22444
Q ss_pred EeeE-----EeeCCceEEEEEecCCCCHH-----H------H---hcc----CCC-CCCCCCHHHH----HHH-------
Q 008216 330 VKGC-----CYDHGDRYIVYEFVVNGPLD-----R------W---LHH----IPR-GGRSLDWAMR----MKV------- 374 (573)
Q Consensus 330 l~~~-----~~~~~~~~lv~e~~~~gsL~-----~------~---l~~----~~~-~~~~l~~~~~----~~i------- 374 (573)
++.. ....+..+++|++++|.++. . . ++. ... .....+.... ..+
T Consensus 87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 166 (328)
T 1zyl_A 87 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI 166 (328)
T ss_dssp CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred eeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence 4443 12245568899999875432 1 0 111 000 0111222111 000
Q ss_pred --------HHHHHHHHHHHHhC----CCCCeEEcCCCCCCeeeCCCCCeeEecccCCcc
Q 008216 375 --------ATTLAQGIAFLHDK----VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 375 --------~~qi~~~L~~LH~~----~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 421 (573)
...+...++.+.+. ....++|+|+++.||+++ + .+.++||+.+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11111222333221 234689999999999999 4 899999987754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00068 Score=66.76 Aligned_cols=71 Identities=7% Similarity=-0.026 Sum_probs=43.6
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcE-eEEeeEEeeCCceEEEEEec-CCCC
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL-VAVKGCCYDHGDRYIVYEFV-VNGP 351 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~-~~gs 351 (573)
-+.|+.|....+|+. ..+++|+....... .....+|+.+++.+...++ .++++. +.+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 456789999999998 56889988654211 1123457777776632222 455543 344457899999 6654
Q ss_pred H
Q 008216 352 L 352 (573)
Q Consensus 352 L 352 (573)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0019 Score=64.47 Aligned_cols=141 Identities=12% Similarity=0.023 Sum_probs=72.5
Q ss_pred ecccCceE-EEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC--CCcEeEEeeEEeeCCceEEEEEecCCCCHH
Q 008216 277 LGDSKTGG-TYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH--HPNLVAVKGCCYDHGDRYIVYEFVVNGPLD 353 (573)
Q Consensus 277 lg~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~ 353 (573)
|+.|.... +|+....+|+.+++|....... ..+..|+.+++.+. .-.+.+++.+..+. -+++||++.+.++.
T Consensus 26 l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l~ 100 (333)
T 3csv_A 26 LAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALFT 100 (333)
T ss_dssp --------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBHH
T ss_pred CCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcchH
Confidence 45554444 6677654477888886644311 23445666666663 22355666653332 37899999776665
Q ss_pred HHhccC---------------------CCCC-CCCCHHHHH-------H-H------------HHHHHHHHHHHH---hC
Q 008216 354 RWLHHI---------------------PRGG-RSLDWAMRM-------K-V------------ATTLAQGIAFLH---DK 388 (573)
Q Consensus 354 ~~l~~~---------------------~~~~-~~l~~~~~~-------~-i------------~~qi~~~L~~LH---~~ 388 (573)
+++... .... ..++..... . + ...+...++.+. ..
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 443211 0000 112111100 0 0 011112222221 11
Q ss_pred CCCCeEEcCCCCCCeeeCCC----CCeeEecccCCccC
Q 008216 389 VKPHVVHRDIRASNVLLDEE----FGAHLMGVGLSKFV 422 (573)
Q Consensus 389 ~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfg~~~~~ 422 (573)
....++|||+.+.||+++.+ ..+.|+||+.+...
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 23479999999999999874 67899999988654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0011 Score=68.85 Aligned_cols=71 Identities=14% Similarity=0.161 Sum_probs=48.3
Q ss_pred eecccCceEEEEEEeCC--------CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcE-eEEeeEEeeCCceEEEEEe
Q 008216 276 LLGDSKTGGTYSGILPD--------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL-VAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~ 346 (573)
.|+.|....+|+....+ ++.+++|+..... ....+.+|+.+++.|...++ +++++.+.+ .+|+||
T Consensus 80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 46888889999998753 5789999984421 12455679988888843333 566665432 389999
Q ss_pred cCCCCH
Q 008216 347 VVNGPL 352 (573)
Q Consensus 347 ~~~gsL 352 (573)
++|.+|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0023 Score=65.01 Aligned_cols=140 Identities=16% Similarity=0.148 Sum_probs=81.5
Q ss_pred eecccCceEEEEEEeC--------CCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeCCceEEEEEe
Q 008216 276 LLGDSKTGGTYSGILP--------DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
.|..|....+|+.... +++.+++|+.... ......+.+|..+++.|. +.-..++++.+.+ .+||||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 4677888889998864 3578999986432 223456678999988883 3223566666543 289999
Q ss_pred cCCCCHHHH-----------------hccCCC-CCCCCC--HHHHHHHHHHHHH-------------------HHHHHH-
Q 008216 347 VVNGPLDRW-----------------LHHIPR-GGRSLD--WAMRMKVATTLAQ-------------------GIAFLH- 386 (573)
Q Consensus 347 ~~~gsL~~~-----------------l~~~~~-~~~~l~--~~~~~~i~~qi~~-------------------~L~~LH- 386 (573)
++|.+|..- |+.... .+.... +.++.++..++.. .+..|.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 988655311 111111 111222 3455555544322 223332
Q ss_pred ---hC-CCCCeEEcCCCCCCeeeCCC----CCeeEecccCCc
Q 008216 387 ---DK-VKPHVVHRDIRASNVLLDEE----FGAHLMGVGLSK 420 (573)
Q Consensus 387 ---~~-~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfg~~~ 420 (573)
.. ....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 21 13368999999999999876 688999998775
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0061 Score=63.64 Aligned_cols=72 Identities=10% Similarity=-0.090 Sum_probs=46.4
Q ss_pred eecccCceEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcE-eEEeeEEeeCCceEEEEEecCCCCH
Q 008216 276 LLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL-VAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
.|+.|-...+|+....+ +..+++|+....... .-...+|+.++..|...++ .++++.+. + .+||||++|.+|
T Consensus 115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 115 IINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 56888899999998755 478999987543211 1112578888888864444 46777652 2 359999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0069 Score=60.67 Aligned_cols=31 Identities=26% Similarity=0.290 Sum_probs=27.4
Q ss_pred CCeEEcCCCCCCeeeCCCCCeeEecccCCcc
Q 008216 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 391 ~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 421 (573)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3799999999999999888899999987764
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0018 Score=42.76 Aligned_cols=33 Identities=33% Similarity=0.352 Sum_probs=21.5
Q ss_pred ceEEEehhHHHHHHHHHHHHHHHHHHHhhhccc
Q 008216 203 REYLITLGVVSGLILLTTFAIVIWLLAYRRSKR 235 (573)
Q Consensus 203 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~r~~~ 235 (573)
.+..|++++++|++++++++++++++.+||+++
T Consensus 9 ~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 9 KIPSIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp CSSSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred CcceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 334477888888887777666666665555443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0058 Score=61.94 Aligned_cols=72 Identities=13% Similarity=0.080 Sum_probs=43.0
Q ss_pred eecccCceEEEEEEeCC---------CCEEEEEEecccchhhHHHHHHHHHHHhhcCCCc-EeEEeeEEeeCCceEEEEE
Q 008216 276 LLGDSKTGGTYSGILPD---------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN-LVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e 345 (573)
.++.|....+|+....+ ++.+++|+...... .......|..+++.+...+ +.++++.. . -++|||
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 46788888999988654 27899998765321 1112356888887774223 34566543 2 378999
Q ss_pred ecCCCCH
Q 008216 346 FVVNGPL 352 (573)
Q Consensus 346 ~~~~gsL 352 (573)
|++|.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >3fd4_A Glycoprotein GP42; C type lectin, virus entry, membrane fusion, HOST-virus interaction, lectin, membrane, transmembrane, viral protein; 2.40A {Human herpesvirus 4} PDB: 1kg0_C | Back alignment and structure |
|---|
Probab=96.07 E-value=0.024 Score=48.26 Aligned_cols=120 Identities=18% Similarity=0.288 Sum_probs=85.3
Q ss_pred CCCCCCCCCcc-CcccCCCCeeeEEecccCChHHHHHHHhhc--CCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCC
Q 008216 46 NKDWKAPCPPD-WIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINT 122 (573)
Q Consensus 46 ~~~~~~~Cp~~-w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~ 122 (573)
+.+.|.-|+.- .++ .+++.||+|....-+|+..=.+|++. --.|.-. .+...-++.+.+++ .+..|||..+.
T Consensus 63 ~k~~C~~C~~r~~tF-s~~~~CyYftp~kytf~~CF~aCa~ls~C~yfY~P-q~~~~PiV~~NLk~-~eslWVGifK~-- 137 (191)
T 3fd4_A 63 TKANCTYCNTREYTF-SYKGCCFYFTKKKHTWNGCFQACAELYPCTYFYGP-TPDILPVVTRNLNA-IESLWVGVYRV-- 137 (191)
T ss_dssp CCCCSCCCCTTTCSE-EETTEEEEECSSCBCTTHHHHHHHHHSTTEEECCC-CTTTHHHHHTTSCT-TCEEEECCEEC--
T ss_pred CCCCCeecCcceeEE-EecceEEEeCcccccHHHHHHHHHhhcCeeEEecC-CccCChhhhcccCC-cCcEEEEEEEc--
Confidence 67788889965 332 69999999999999999999999985 3334433 34457788888874 46899999842
Q ss_pred CCCCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCc-eeccccCCCCCccccc
Q 008216 123 TVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRS-LVTERCNTSHPFICMV 190 (573)
Q Consensus 123 ~~~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~-W~d~~C~~~~~~iC~~ 190 (573)
.++.|.=.||. ++.-|+.. ...|+.+...+.. |....|+...+=.|..
T Consensus 138 -~~~~W~sLDn~---n~~V~Di~----------------gSyCaYvt~~S~~P~s~~eC~~~K~CLC~s 186 (191)
T 3fd4_A 138 -GEGNWTSLDGG---TFKVYQIF----------------GSHCTYVSKFSTVPVSHHECSFLKPCLCVS 186 (191)
T ss_dssp -TTCCEEETTEE---EECCBCSS----------------SSSCEEEESSCSSCEECSCTTSCBCBEEEE
T ss_pred -CccceEEccCC---ceEEEEec----------------cCeeeEEecccccccceeeccccceeEEee
Confidence 23889888883 33334322 2357777666544 8888898888766653
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.82 E-value=0.0049 Score=40.58 Aligned_cols=32 Identities=28% Similarity=0.515 Sum_probs=20.1
Q ss_pred EEEehhHHHHHHHHHHHHHHHHHHHhhhcccc
Q 008216 205 YLITLGVVSGLILLTTFAIVIWLLAYRRSKRR 236 (573)
Q Consensus 205 ~~i~~~~~~~~~~~~~~~~~~~~~~~~r~~~~ 236 (573)
..|..++++|++++++++++++++.+||++++
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 34677777777777666666665555554443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=95.52 E-value=0.0077 Score=39.56 Aligned_cols=27 Identities=26% Similarity=0.586 Sum_probs=13.1
Q ss_pred hhHHHHHHHHHHHHHHHHHHHhhhccc
Q 008216 209 LGVVSGLILLTTFAIVIWLLAYRRSKR 235 (573)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~r~~~ 235 (573)
++.++|++++++++++++++.+||+.+
T Consensus 15 a~~vVGvll~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 15 ISAVVGILLVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred HHHHHHHHHHHHHHHHHHhheehhhhh
Confidence 344445554444444445555555444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.08 E-value=0.047 Score=56.22 Aligned_cols=72 Identities=13% Similarity=0.046 Sum_probs=46.7
Q ss_pred eecccCceEEEEEEeCC--------CCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeCCceEEEEEe
Q 008216 276 LLGDSKTGGTYSGILPD--------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
.+..|-...+|+....+ ++.+++|+...... ...+..+|..+++.+. +.-..++++.+ . -++||||
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef 151 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF 151 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence 46778889999998753 68899998754321 1122356888887773 22234555533 2 3789999
Q ss_pred cCCCCH
Q 008216 347 VVNGPL 352 (573)
Q Consensus 347 ~~~gsL 352 (573)
++|.+|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.99 E-value=0.42 Score=48.67 Aligned_cols=30 Identities=27% Similarity=0.414 Sum_probs=24.6
Q ss_pred CeEEcCCCCCCeee------CCCCCeeEecccCCcc
Q 008216 392 HVVHRDIRASNVLL------DEEFGAHLMGVGLSKF 421 (573)
Q Consensus 392 ~iiH~Dlkp~NIll------~~~~~~kl~Dfg~~~~ 421 (573)
.++|+|+.+.|||+ +++..+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4456789999988753
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.64 E-value=2.4 Score=38.85 Aligned_cols=114 Identities=12% Similarity=0.173 Sum_probs=74.5
Q ss_pred CCCcEeEEeeEEeeCCceEEEEEecCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEEcCCCC
Q 008216 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNG-PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA-FLHDKVKPHVVHRDIRA 400 (573)
Q Consensus 323 ~h~nIv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~-~LH~~~~~~iiH~Dlkp 400 (573)
.||+. -...-.+++...+.++.-+++ ++.. + ..++...+++++..|+.... +++ .-+|--|.|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i-------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I-------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H-------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H-------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeC
Confidence 67887 333445666666666654333 3433 3 23788899999999888766 555 457888999
Q ss_pred CCeeeCCCCCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 008216 401 SNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQ 475 (573)
Q Consensus 401 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~ 475 (573)
+|++++.++.+++.-.|+-. -++|.-+ +..-=.-.+=+++..++.++..|+
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~-------------------~lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKE-------------------SLPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GGEEECTTCCEEESCCEETT-------------------TBSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred ceEEEeCCCcEEEEEcCCcc-------------------cCCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999998766543 2334322 111112345667778888887764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.40 E-value=2 Score=39.19 Aligned_cols=116 Identities=10% Similarity=0.138 Sum_probs=77.6
Q ss_pred CCCcEeEEeeEEeeCCceEEEEEecC-CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 008216 323 HHPNLVAVKGCCYDHGDRYIVYEFVV-NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRAS 401 (573)
Q Consensus 323 ~h~nIv~l~~~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~ 401 (573)
.||+.++. .+-.+.+...+.++.-+ .-++.. + +.++...+++++..|+....++++. +|--|.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence 68888865 45555565555555433 223333 3 3478899999999999888666644 78889999
Q ss_pred CeeeCCCCCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 008216 402 NVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQA 476 (573)
Q Consensus 402 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 476 (573)
|++++.++.+++.-.|+... ++|.- .+...=.-.+=+++..+++++..|+.
T Consensus 109 NL~f~~~~~p~i~~RGik~~-------------------l~P~~-----~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNV-------------------VDPLP-----VSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp GEEECTTSCEEESCCEETTT-------------------BSCCC-----CCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred eEEEcCCCCEEEEEccCccC-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999987665432 22321 12222233566788889999988753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 573 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-50 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-48 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-44 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-43 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-38 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-35 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-33 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-32 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-32 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-30 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-29 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-29 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-26 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-20 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-13 | |
| d1ypqa1 | 131 | d.169.1.1 (A:140-270) Oxidised low density lipopro | 2e-12 | |
| d1egga_ | 136 | d.169.1.1 (A:) Macrophage mannose receptor, CRD4 { | 3e-11 | |
| d1g1sa1 | 118 | d.169.1.1 (A:1-118) P-selectin, C-lectin domain {H | 2e-10 | |
| d1e87a_ | 117 | d.169.1.1 (A:) CD69 {Human (Homo sapiens) [TaxId: | 2e-10 | |
| d1xpha1 | 130 | d.169.1.1 (A:265-394) DC-SIGNR (DC-SIGN related re | 9e-10 | |
| d1wk1a_ | 150 | d.169.1.1 (A:) Hypothetical protein F28B4.3 {Caeno | 1e-09 | |
| d1hq8a_ | 123 | d.169.1.1 (A:) NK cell-activating receptor nkg2d { | 1e-09 | |
| d1qo3c_ | 133 | d.169.1.1 (C:) NK cell receptor {Mouse (Mus muscul | 2e-09 | |
| d3c8ja1 | 122 | d.169.1.1 (A:138-259) NK cell receptor {Mouse (Mus | 2e-09 | |
| d1tdqb_ | 126 | d.169.1.1 (B:) Aggrecan core protein {Rat (Rattus | 8e-09 | |
| d1g1ta1 | 118 | d.169.1.1 (A:1-118) E-selectin, C-lectin domain {H | 1e-08 | |
| d1dv8a_ | 128 | d.169.1.1 (A:) H1 subunit of the asialoglycoprotei | 2e-08 | |
| d1h8ua_ | 115 | d.169.1.1 (A:) Eosinophil major basic protein {Hum | 5e-08 | |
| d1kg0c_ | 136 | d.169.1.1 (C:) EBV gp42 {Epstein-Barr virus [TaxId | 2e-07 | |
| d1r13a1 | 119 | d.169.1.1 (A:110-228) Surfactant protein, lectin d | 4e-07 | |
| d1t8da1 | 143 | d.169.1.1 (A:1-143) Low affinity immunoglobulin ep | 6e-07 | |
| d1oz7b_ | 123 | d.169.1.1 (B:) Snake coagglutinin beta chain {Saw- | 6e-07 | |
| d2msba_ | 112 | d.169.1.1 (A:) Mannose-binding protein A, C-lectin | 6e-07 | |
| d1tn3a_ | 137 | d.169.1.1 (A:) Tetranectin {Human (Homo sapiens) [ | 6e-07 | |
| d1pwba1 | 121 | d.169.1.1 (A:235-355) Surfactant protein, lectin d | 7e-07 | |
| d1v7pb_ | 127 | d.169.1.1 (B:) Snake coagglutinin beta chain {Snak | 7e-07 | |
| d1wmza_ | 140 | d.169.1.1 (A:) Lectin CEL-I {Cucumaria echinata [T | 1e-06 | |
| d1c3ab_ | 125 | d.169.1.1 (B:) Snake coagglutinin beta chain {Habu | 1e-06 | |
| d1hupa1 | 117 | d.169.1.1 (A:112-228) Mannose-binding protein A, C | 2e-06 | |
| d3bdwa1 | 121 | d.169.1.1 (A:59-179) CD94 {Human (Homo sapiens) [T | 2e-06 | |
| d1jwia_ | 124 | d.169.1.1 (A:) Snake coagglutinin alpha chain {Puf | 3e-06 | |
| d1gz2a_ | 139 | d.169.1.1 (A:) Ovocleidin-17 {Chicken (Gallus gall | 6e-06 | |
| d1oz7a_ | 131 | d.169.1.1 (A:) Snake coagglutinin alpha chain {Saw | 7e-06 | |
| d1uv0a_ | 140 | d.169.1.1 (A:) Pancreatitis-associated protein 1 { | 8e-06 | |
| d1rdl1_ | 111 | d.169.1.1 (1:) Mannose-binding protein A, C-lectin | 9e-06 | |
| d1jwib_ | 123 | d.169.1.1 (B:) Snake coagglutinin beta chain {Puff | 1e-05 | |
| d1jzna_ | 135 | d.169.1.1 (A:) Galactose-specific C-type lectin {W | 2e-05 | |
| d1qdda_ | 144 | d.169.1.1 (A:) Lithostathine, inhibitor of stone f | 3e-05 | |
| d2afpa_ | 129 | d.169.1.1 (A:) Type II antifreeze protein {Sea rav | 3e-05 | |
| d1umrc_ | 125 | d.169.1.1 (C:) Snake coagglutinin beta chain {Sout | 4e-05 | |
| d1v7pa_ | 134 | d.169.1.1 (A:) Snake coagglutinin alpha chain {Sna | 5e-05 | |
| d1c3aa_ | 135 | d.169.1.1 (A:) Snake coagglutinin alpha chain {Hab | 7e-05 | |
| d1byfa_ | 123 | d.169.1.1 (A:) Lectin TC14 {Tunicate (Polyandrocar | 8e-05 | |
| d1j34b_ | 123 | d.169.1.1 (B:) Snake coagglutinin beta chain {Habu | 1e-04 | |
| d1fvub_ | 125 | d.169.1.1 (B:) Snake coagglutinin beta chain {Jara | 2e-04 | |
| d1umra_ | 135 | d.169.1.1 (A:) Snake coagglutinin alpha chain {Sou | 2e-04 | |
| d1fvua_ | 133 | d.169.1.1 (A:) Snake coagglutinin alpha chain {Jar | 2e-04 | |
| d1sb2a1 | 132 | d.169.1.1 (A:1-132) Snake coagglutinin alpha chain | 2e-04 | |
| d1sb2b1 | 127 | d.169.1.1 (B:2-128) Snake coagglutinin beta chain | 5e-04 | |
| d1j34a_ | 129 | d.169.1.1 (A:) Snake coagglutinin alpha chain {Hab | 5e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 6e-57
Identities = 63/283 (22%), Positives = 122/283 (43%), Gaps = 29/283 (10%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKG 332
+ +G G Y G VAVK L ++ Q+ + F +E+G + H N++ G
Sbjct: 14 QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
IV ++ L LH + + +A AQG+ +LH K
Sbjct: 72 YS-TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAK---S 124
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY---RN 449
++HRD++++N+ L E+ + GL+ + G+ ++APE + +N
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 450 ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509
+ +SDVY+FG++L E+++G+ P +++ + L P +S +
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ----------IIFMVGRGYLSPDLSKV 234
Query: 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
S+ P+A + L+ C + RP ++ ++ LA+
Sbjct: 235 RSNCPKA-----MKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 5e-51
Identities = 68/274 (24%), Positives = 116/274 (42%), Gaps = 27/274 (9%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
LG + G + G ++VAVK LK+ S F +E +L H LV +
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
YI+ E++ NG L +L G L + +A +A+G+AF+ ++ + +
Sbjct: 78 TQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRD+RA+N+L+ + + GL++ + R A + APE + T K
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYGTFTIK 190
Query: 455 SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 514
SDV+SFG+LL EIV+ R + E++ L P
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMT------------------NPEVIQNLERGYRMVRP 232
Query: 515 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
+ +++ L+ C + P RP ++ L+
Sbjct: 233 D-NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-50
Identities = 59/278 (21%), Positives = 120/278 (43%), Gaps = 27/278 (9%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+ +G + G + G + +VA+K ++ + +++F E +L HP LV + G C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
+ +V+EF+ +G L +L + + + +G+A+L + V+
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVI 123
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRD+ A N L+ E + G+++FV + + + +PE + ++K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 455 SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 514
SDV+SFGVL+ E+ S + ++ E+++ + + P
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPY------------------ENRSNSEVVEDISTGFRLYKP 224
Query: 515 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
V ++ C + P RP S ++ QL ++A+
Sbjct: 225 R-LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 5e-50
Identities = 60/276 (21%), Positives = 113/276 (40%), Gaps = 27/276 (9%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+ LG + G G VA+K +K S + EF E L H LV + G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
+I+ E++ NG L +L +++ + + + +L K +
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 122
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRD+ A N L++++ + GLS++V + +V + + PE + ++ ++K
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 455 SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 514
SD+++FGVL+ EI S + +E T + + L L+S+
Sbjct: 182 SDIWAFGVLMWEIYSLGKM-----------PYERFTNSETAEHIAQGLRLYRPHLASE-- 228
Query: 515 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
KV ++Y+C RP ++ + +
Sbjct: 229 ------KVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 167 bits (424), Expect = 4e-48
Identities = 67/314 (21%), Positives = 133/314 (42%), Gaps = 43/314 (13%)
Query: 258 FTTEELRSITKNFSEGN--------RLLGDSKTGGTYSGILPDGSR----VAVKRLKRS- 304
FT E+ + F++ +++G + G SG L + VA+K LK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 305 SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGR 364
+ +++++F SE + HPN++ ++G I+ EF+ NG LD +L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDG 123
Query: 365 SLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424
+ + +A G+ +L D + VHRD+ A N+L++ + GLS+F+
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 425 EVMQE---RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSV 480
+ + + APE + + T+ SDV+S+G+++ E++S G RP + +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 481 CWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRM 540
++++ + P + L+ C Q + RP+
Sbjct: 241 -------------------DVINAIEQDYRLPPPM-DCPSALHQLMLDCWQKDRNHRPKF 280
Query: 541 SHVVHQLQQLAQPP 554
+V+ L ++ + P
Sbjct: 281 GQIVNTLDKMIRNP 294
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 5e-48
Identities = 57/296 (19%), Positives = 113/296 (38%), Gaps = 25/296 (8%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+G + G + G G VAVK +R +EI + L H N++
Sbjct: 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 335 YDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV- 389
++V ++ +G L +L+ ++ +K+A + A G+A LH ++
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 390 ----KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYLAP 443
KP + HRD+++ N+L+ + + +GL+ GT Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 444 EFVYRN------ELTTKSDVYSFGVLLLEIVSGRRP-AQAVDSVCWQSIFEWATPLVQSH 496
E + + E ++D+Y+ G++ EI D + P V+
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
R + L ++ + ++ + ++ C + R + L QL+Q
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 7e-48
Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 27/280 (9%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
LG G + G +RVA+K LK + + F E +L H LV +
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 81
Query: 335 YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVV 394
YIV E++ G L +L G+ L + +A +A G+A++ + V
Sbjct: 82 S-EEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 135
Query: 395 HRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTK 454
HRD+RA+N+L+ E + GL++ + R + APE T K
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 194
Query: 455 SDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIP 514
SDV+SFG+LL E+ + R + E+LD + P
Sbjct: 195 SDVWSFGILLTELTTKGRV-----------PYPGMVN-------REVLDQVERGYRMPCP 236
Query: 515 EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554
+ + DL+ C + P RP ++ L+
Sbjct: 237 P-ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (420), Expect = 1e-47
Identities = 74/279 (26%), Positives = 119/279 (42%), Gaps = 27/279 (9%)
Query: 275 RLLGDSKTGGTYSGILPDGSR-VAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
LG + G Y G+ S VAVK LK + + + EF E + HPNLV + G
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 81
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
C YI+ EF+ G L +L + + + + +AT ++ + +L K +
Sbjct: 82 CTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE---KKNF 136
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT 453
+HRD+ A N L+ E + GLS+ + + A + APE + N+ +
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYNKFSI 195
Query: 454 KSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 513
KSDV++FGVLL EI + ++ + L +
Sbjct: 196 KSDVWAFGVLLWEIATYGM------------------SPYPGIDLSQVYELLEKDYRMER 237
Query: 514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
PE G +KV +L+ AC Q PS RP + + + + Q
Sbjct: 238 PE-GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-47
Identities = 61/294 (20%), Positives = 112/294 (38%), Gaps = 35/294 (11%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKG 332
LG G + P G +A K + + + E+ + P +V G
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
Y G+ I E + G LD+ L R + + KV+ + +G+ +L +K K
Sbjct: 72 AFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKHK-- 125
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 452
++HRD++ SN+L++ L G+S + + GT Y++PE + +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYS 181
Query: 453 TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF-----------------------EWA 489
+SD++S G+ L+E+ GR P D+ + +F +
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 490 TPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
ELLD +++ +P + D V C P+ R + +
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 6e-47
Identities = 69/277 (24%), Positives = 115/277 (41%), Gaps = 33/277 (11%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCC 334
+ +G + G G G++VAVK +K + + F +E +L H NLV + G
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 335 YDHGDR-YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
+ YIV E++ G L +L RG L +K + + + + +L +
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 124
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTT 453
VHRD+ A NVL+ E+ A + GL+K + APE + + +T
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPEALREKKFST 179
Query: 454 KSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDI 513
KSDV+SFG+LL EI S R + +++ + D
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPL------------------KDVVPRVEKGYKMDA 221
Query: 514 PEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
P+ G V +++ C +MRP + QL+ +
Sbjct: 222 PD-GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-45
Identities = 73/297 (24%), Positives = 126/297 (42%), Gaps = 36/297 (12%)
Query: 265 SITKNFSEGNRLLGDSKTGGTYSGILPDGSR----VAVKRLKRSSFQRK-KEFYSEIGRF 319
S+ +F+E ++G G Y G L D AVK L R + + +F +E
Sbjct: 26 SLIVHFNE---VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82
Query: 320 ARLHHPNLVAVKGCCYDH-GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTL 378
HPN++++ G C G +V ++ +G L ++ + + + +
Sbjct: 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQV 139
Query: 379 AQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--G 436
A+G+ FL K VHRD+ A N +LDE+F + GL++ + + G
Sbjct: 140 AKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 437 TYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH 496
++A E + + TTKSDV+SFGVLL E+++ P + F+ L+Q
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP-----DVNTFDITVYLLQGR 251
Query: 497 RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553
R LL P P+ + +++ C MRP S +V ++ +
Sbjct: 252 R---LLQP------EYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 1e-45
Identities = 65/303 (21%), Positives = 122/303 (40%), Gaps = 36/303 (11%)
Query: 259 TTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR-----VAVKRLKRSSFQR-KKEF 312
TTE S + +++G + G Y G+L S VA+K LK ++ + +F
Sbjct: 1 TTEIHPS---CVTRQ-KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF 56
Query: 313 YSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRM 372
E G + H N++ ++G + I+ E++ NG LD + +
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALD---KFLREKDGEFSVLQLV 113
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
+ +A G+ +L + VHRD+ A N+L++ + GLS+ + + T
Sbjct: 114 GMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 170
Query: 433 MAG-GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATP 491
G + APE + + T+ SDV+SFG+++ E+++ W
Sbjct: 171 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER------------PYWELS 218
Query: 492 LVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551
E++ + P + L+ C Q + RP+ + +V L +L
Sbjct: 219 NH------EVMKAINDGFRLPTPM-DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
Query: 552 QPP 554
+ P
Sbjct: 272 RAP 274
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (404), Expect = 3e-45
Identities = 64/305 (20%), Positives = 117/305 (38%), Gaps = 49/305 (16%)
Query: 275 RLLGDSKTGGTYSGILP------DGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNL 327
R +G+ G + P + VAVK LK + + +F E A +PN+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLH--------------------HIPRGGRSLD 367
V + G C +++E++ G L+ +L G L
Sbjct: 79 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138
Query: 368 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427
A ++ +A +A G+A+L + VHRD+ N L+ E + GLS+ +
Sbjct: 139 CAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195
Query: 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFE 487
+ ++ PE ++ N TT+SDV+++GV+L EI S +
Sbjct: 196 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ-----------PYY 244
Query: 488 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQL 547
E++ + PE ++ +L+ C +P+ RP + L
Sbjct: 245 GMAH-------EEVIYYVRDGNILACPE-NCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
Query: 548 QQLAQ 552
Q++ +
Sbjct: 297 QRMCE 301
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-45
Identities = 61/277 (22%), Positives = 104/277 (37%), Gaps = 29/277 (10%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQR--KKEFYSEIGRFARLHHPNLVAVK 331
+G G DG + K L S K+ SE+ L HPN+V
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 332 GCCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK- 388
D + YIV E+ G L + + + LD ++V T L + H +
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 389 -VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVY 447
V+HRD++ +NV LD + L GL++ + + + + GT Y++PE +
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV--GTPYYMSPEQMN 187
Query: 448 RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507
R KSD++S G LL E+ + P F + + + E I
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPP------------FTAFSQKELAGKIREGKFRRIP 235
Query: 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
SD ++ +++ RP + ++
Sbjct: 236 YRYSD--------ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 5e-45
Identities = 63/301 (20%), Positives = 114/301 (37%), Gaps = 35/301 (11%)
Query: 261 EELRSITKNFSEGNR-----LLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYS 314
E+LRSI + +G +G Y+ + + G VA++++ +K+ +
Sbjct: 7 EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN 66
Query: 315 EIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKV 374
EI +PN+V + ++V E++ G L + +D V
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAV 121
Query: 375 ATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMA 434
Q + FLH V+HRDI++ N+LL + L G + E Q +
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTM 176
Query: 435 GGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ 494
GT ++APE V R K D++S G++ +E++ G P + PL
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP------------YLNENPLRA 224
Query: 495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQLQQLAQP 553
+ P + + + D + C R ++ HQ ++A+P
Sbjct: 225 LYLIATNGTPELQN-PEKLSAI-----FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278
Query: 554 P 554
Sbjct: 279 L 279
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 6e-45
Identities = 59/295 (20%), Positives = 114/295 (38%), Gaps = 31/295 (10%)
Query: 261 EELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR---VAVKRLKRSSFQR-KKEFYSEI 316
++L N + LG G G+ + VA+K LK+ + + +E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 317 GRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 376
+L +P +V + G C +V E GPL ++L + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLH 116
Query: 377 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV-PWEVMQERTVMAG 435
++ G+ +L +K + VHRD+ A NVLL A + GLSK + +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS 495
+ APE + + +++SDV+S+GV + E +S + ++
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP-----------YKKMKG---- 218
Query: 496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
E++ + + P ++ L+ C + RP V +++
Sbjct: 219 ---PEVMAFIEQGKRMECPP-ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-44
Identities = 62/300 (20%), Positives = 110/300 (36%), Gaps = 43/300 (14%)
Query: 275 RLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARL-HHPN 326
+ LG G VAVK LK S+ ++ SE+ + L +H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 327 LVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHH--------------IPRGGRSLDWAMRM 372
+V + G C G ++ E+ G L +L + +LD +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 373 KVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432
+ +A+G+AFL K + +HRD+ A N+LL + GL++ + +
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL 492
A ++APE ++ T +SDV+S+G+ L E+ S V +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--------- 256
Query: 493 VQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
+ PE ++ D++ C P RP +V +++
Sbjct: 257 --------FYKMIKEGFRMLSPE-HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-44
Identities = 61/299 (20%), Positives = 124/299 (41%), Gaps = 32/299 (10%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSR----VAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLV 328
++LG G Y G+ +P+G + VA+K L+ + S + KE E A + +P++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
+ G C ++ + + G L L ++ ++ + +A+G+ +L D+
Sbjct: 75 RLLGICLT-STVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
+VHRD+ A NVL+ + GL+K + E + ++A E +
Sbjct: 131 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 449 NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508
T +SDV+S+GV + E+++ D + I +++ L
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEISS----ILEKGERLP-------- 233
Query: 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKLLFKGLDRLR 567
P V ++ C RP+ ++ + ++A+ P L+ +G +R+
Sbjct: 234 ----QPP-ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMH 287
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 4e-44
Identities = 70/289 (24%), Positives = 120/289 (41%), Gaps = 35/289 (12%)
Query: 268 KNFSEGNRLLGDSKTGGTYSGILPD---GSRVAVKRLKRSSFQR--KKEFYSEIGRFARL 322
K + ++ LG G G VAVK LK + K E +E +L
Sbjct: 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 65
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGI 382
+P +V + G C + +V E GPL+++L R + +++ ++ G+
Sbjct: 66 DNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGM 120
Query: 383 AFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG-GTYGYL 441
+L + + VHRD+ A NVLL + A + GLSK + + + G +
Sbjct: 121 KYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500
APE + + ++KSDV+SFGVL+ E S G++P + + E
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------------------E 218
Query: 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQ 549
+ L P G +++ DL+ C + RP + V +L+
Sbjct: 219 VTAMLEKGERMGCPA-GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-44
Identities = 69/308 (22%), Positives = 123/308 (39%), Gaps = 43/308 (13%)
Query: 268 KNFSEGNRLLGDSKTGGTYSGILPDGSR---VAVKRLKR-SSFQRKKEFYSEIGRFARL- 322
+ + ++G+ G + A+KR+K +S ++F E+ +L
Sbjct: 10 NDIKFQD-VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68
Query: 323 HHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLH------------HIPRGGRSLDWAM 370
HHPN++ + G C G Y+ E+ +G L +L +L
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 371 RMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430
+ A +A+G+ +L + +HRD+ A N+L+ E + A + GLS+ V +
Sbjct: 129 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---K 182
Query: 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWAT 490
M ++A E + + TT SDV+S+GVLL EIVS +
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---------- 232
Query: 491 PLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
EL + L + P +V DL+ C + P RP + ++ L ++
Sbjct: 233 --------AELYEKLPQGYRLEKPL-NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
Query: 551 AQPPVTKL 558
+ T +
Sbjct: 284 LEERKTYV 291
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (396), Expect = 6e-44
Identities = 68/328 (20%), Positives = 125/328 (38%), Gaps = 46/328 (14%)
Query: 252 PPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK- 309
P ++F ++ K FS+ + G G Y + + VA+K++ S Q
Sbjct: 2 PDVAELFFKDD---PEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE 57
Query: 310 --KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLD 367
++ E+ +L HPN + +GC ++V E+ + D H + L
Sbjct: 58 KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQ 113
Query: 368 WAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427
V QG+A+LH +++HRD++A N+LL E L G + +
Sbjct: 114 EVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----- 165
Query: 428 QERTVMAGGTYGYLAPEFV---YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS 484
GT ++APE + + K DV+S G+ +E+ + P
Sbjct: 166 -APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP----------- 213
Query: 485 IFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
+ + + P + S E + V +C Q +P RP ++
Sbjct: 214 -LFNMNAMSALYHIAQNESPALQ--SGHWSEY-----FRNFVDSCLQKIPQDRPTSEVLL 265
Query: 545 -HQLQQLAQPP--VTKLLFKGLDRLRHI 569
H+ +PP + L+ + D +R +
Sbjct: 266 KHRFVLRERPPTVIMDLIQRTKDAVREL 293
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 6e-44
Identities = 65/338 (19%), Positives = 121/338 (35%), Gaps = 48/338 (14%)
Query: 238 KSRKLSNPAASALVPPSWKVFTTEELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSR-- 295
+ +++ + + ++ + + + E ++LG G + S+
Sbjct: 6 QMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTG 65
Query: 296 ----VAVKRLKRSSFQR-KKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVVN 349
VAVK LK + ++ SE+ +L H N+V + G C G Y+++E+
Sbjct: 66 VSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCY 125
Query: 350 GPLDRWLH-------------------HIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
G L +L L + + A +A+G+ FL K
Sbjct: 126 GDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-- 183
Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
VHRD+ A NVL+ + GL++ + + A ++APE ++
Sbjct: 184 -SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI 242
Query: 451 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
T KSDV+S+G+LL EI S P + +
Sbjct: 243 YTIKSDVWSYGILLWEIFSLGVN-----------------PYPGIPVDANFYKLIQNGFK 285
Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548
D P +++ ++ +C RP ++ L
Sbjct: 286 MDQPF-YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-43
Identities = 53/290 (18%), Positives = 105/290 (36%), Gaps = 36/290 (12%)
Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQR--KKEFYSEIGRFA 320
S F + + +G Y G+ + VA L+ + ++ F E
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63
Query: 321 RLHHPNLVAVKGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 376
L HPN+V +V E + +G L +L + + +
Sbjct: 64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCR 119
Query: 377 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFG-AHLMGVGLSKFVPWEVMQERTVMAG 435
+ +G+ FLH + P ++HRD++ N+ + G + +GL+ +
Sbjct: 120 QILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI---- 174
Query: 436 GTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS 495
GT ++APE +Y + DVY+FG+ +LE+ + P + I+ V S
Sbjct: 175 GTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYS--ECQNAAQIYRR----VTS 227
Query: 496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545
D + +V +++ C + R + +++
Sbjct: 228 GVKPASFDKVAI------------PEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-43
Identities = 66/274 (24%), Positives = 104/274 (37%), Gaps = 36/274 (13%)
Query: 275 RLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 330
R LG K G Y +A+K L ++ ++ + E+ + L HPN++ +
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
G +D Y++ E+ G + R L + + D T LA +++ H K
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSK-- 125
Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
V+HRDI+ N+LL + G S P R GT YL PE +
Sbjct: 126 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIEGRM 180
Query: 451 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
K D++S GVL E + G+ P FE T R + ++
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPP------------FEANTYQETYKRISRVEFTFPDFVT 228
Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV 544
DL+ +H PS RP + V+
Sbjct: 229 EG---------ARDLISRLLKHNPSQRPMLREVL 253
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 3e-42
Identities = 60/293 (20%), Positives = 108/293 (36%), Gaps = 34/293 (11%)
Query: 275 RLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
LGD G Y + A K + S + +++ EI A HPN+V +
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
Y + +I+ EF G +D + R L + V + +LHD +
Sbjct: 78 FYYENNLWILIEFCAGGAVD---AVMLELERPLTESQIQVVCKQTLDALNYLHDN---KI 131
Query: 394 VHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-- 451
+HRD++A N+L + L G+S + + + + GT ++APE V
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKD 189
Query: 452 ---TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508
K+DV+S G+ L+E+ P P+ + + P ++
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPP------------HHELNPMRVLLKIAKSEPPTLAQ 237
Query: 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQ-LQQLAQPPVTKLL 559
S D + C + R S ++ H + + P+ +L+
Sbjct: 238 PSRWSSNF------KDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELI 284
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-41
Identities = 60/299 (20%), Positives = 123/299 (41%), Gaps = 35/299 (11%)
Query: 275 RLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNL 327
R LG G Y G+ +RVA+K + ++ R + EF +E + ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRS------LDWAMRMKVATTLAQG 381
V + G ++ E + G L +L + + + +++A +A G
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
+A+L+ VHRD+ A N ++ E+F + G+++ + + ++
Sbjct: 146 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202
Query: 442 APEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL 501
+PE + TT SDV+SFGV+L EI + ++ + ++
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----------YQGLSN-------EQV 244
Query: 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKLLF 560
L ++ D P+ + +L+ C Q+ P MRP ++ +++ +P ++ F
Sbjct: 245 LRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 302
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-41
Identities = 66/283 (23%), Positives = 110/283 (38%), Gaps = 36/283 (12%)
Query: 284 GTYSGILPDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRY 341
G ++VAVK LK + ++ + SE+ + H N++ + G C G Y
Sbjct: 36 GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 95
Query: 342 IVYEFVVNGPLDRWLHHIPRGG------------RSLDWAMRMKVATTLAQGIAFLHDKV 389
++ E+ G L +L G L + A +A+G+ +L K
Sbjct: 96 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK- 154
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
+HRD+ A NVL+ E+ + GL++ + ++T ++APE ++
Sbjct: 155 --KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 212
Query: 450 ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509
T +SDV+SFGVLL EI + V EL L
Sbjct: 213 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------------------EELFKLLKEGH 254
Query: 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
D P ++ ++ C VPS RP +V L ++
Sbjct: 255 RMDKPS-NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-41
Identities = 65/283 (22%), Positives = 111/283 (39%), Gaps = 32/283 (11%)
Query: 275 RLLGDSKTGGTYSGILPDGSR----VAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVA 329
R +G+ + G + GI VA+K K + +E F E + HP++V
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
+ G ++ +I+ E G L + SLD A + A L+ +A+L K
Sbjct: 73 LIGVITEN-PVWIIMELCTLGEL---RSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 127
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
VHRDI A NVL+ L GLS+++ + ++APE +
Sbjct: 128 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFR 184
Query: 450 ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509
T+ SDV+ FGV + EI+ Q + +++ + +
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPF------------------QGVKNNDVIGRIENGE 226
Query: 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
+P + L+ C + PS RPR + + QL + +
Sbjct: 227 RLPMPP-NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 149 bits (376), Expect = 1e-40
Identities = 50/272 (18%), Positives = 91/272 (33%), Gaps = 29/272 (10%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
LG G + + G K + K +EI +LHHP L+ +
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
D + ++ EF+ G L I + A + +G+ +H+ +
Sbjct: 95 FEDKYEMVLILEFLSGGEL---FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SI 148
Query: 394 VHRDIRASNVLLDEEFGAH--LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
VH DI+ N++ + + + ++ GL+ + + E + T + APE V R +
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPV 205
Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511
+D+++ GVL ++SG P F L S
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSP------------FAGEDDLETLQNVKRCDWEFDEDAFS 253
Query: 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
+ D + Q P R +
Sbjct: 254 SVSPE-----AKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 147 bits (373), Expect = 2e-40
Identities = 50/272 (18%), Positives = 92/272 (33%), Gaps = 29/272 (10%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
LG G + G+ A K + K+ EI + L HP LV +
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
D + ++YEF+ G L + + ++ + +G+ +H+ +
Sbjct: 92 FEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NY 145
Query: 394 VHRDIRASNVLLDEEFGAHLMGV--GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
VH D++ N++ + L + GL+ + ++ + GT + APE +
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTTGTAEFAAPEVAEGKPV 202
Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511
+D++S GVL ++SG P F + S S
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSP------------FGGENDDETLRNVKSCDWNMDDSAFS 250
Query: 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
I E D + P+ R +
Sbjct: 251 GISED-----GKDFIRKLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 3e-40
Identities = 53/294 (18%), Positives = 99/294 (33%), Gaps = 37/294 (12%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 330
++LG+ L A+K L++ ++ E +RL HP V +
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
D Y + NG L +++ I D + + +LH
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLH---G 126
Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
++HRD++ N+LL+E+ + G +K + E Q R GT Y++PE +
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186
Query: 451 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
SD+++ G ++ ++V+G P F + + ++L
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPP------------FRAGNEYLIFQKIIKLEYDFPEKFF 234
Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKLLFKGLD 564
DLV + R + A P F+ +
Sbjct: 235 PK---------ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP-----FFESVT 274
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 7e-40
Identities = 58/291 (19%), Positives = 104/291 (35%), Gaps = 34/291 (11%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRL-KRSSFQRKKEFYSEIGRFARLHHPNLVAVKG 332
+ LG+ G + VAVK + + + + EI L+H N+V G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
+ +Y+ E+ G L + + + L G+ +LH
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---G 123
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL- 451
+ HRDI+ N+LLDE + GL+ + + GT Y+APE + R E
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511
DV+S G++L +++G P ++ + Q + + ++
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELP------------WDQPSDSCQEYSDWKEKKTYLN---- 227
Query: 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKLLFKG 562
P + + L++ PS R + + K L KG
Sbjct: 228 --PWKKIDSAPLALLHKILVENPSARITIPDI------KKDRWYNKPLKKG 270
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-38
Identities = 53/271 (19%), Positives = 92/271 (33%), Gaps = 29/271 (10%)
Query: 284 GTYSGILPDGSRVAVKRLKRSSF---QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDR 340
G + VAVK LK + +F E+ L H NL+ + G
Sbjct: 27 GEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85
Query: 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRA 400
+V E G L L + + + A +A+G+ +L K +HRD+ A
Sbjct: 86 KMVTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAA 139
Query: 401 SNVLLDEEFGAHLMGVGLSKFVPWEV-MQERTVMAGGTYGYLAPEFVYRNELTTKSDVYS 459
N+LL + GL + +P + + APE + + SD +
Sbjct: 140 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWM 199
Query: 460 FGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVV 519
FGV L E+ + + + H+ + + D P+
Sbjct: 200 FGVTLWEMFTYGQE-----------PWIGLNGSQILHKIDK--EGERLPRPEDCPQ---- 242
Query: 520 QKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550
+ +++ C H P RP + L +
Sbjct: 243 -DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-38
Identities = 69/299 (23%), Positives = 106/299 (35%), Gaps = 42/299 (14%)
Query: 275 RLLGDSKTGGTYSGI------LPDGSRVAVKRLKRSSFQ-RKKEFYSEIGRFAR-LHHPN 326
+ LG G VAVK LK + + SE+ HH N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 327 LVAVKGCCYDHGDR-YIVYEFVVNGPLDRWLHH------------IPRGGRSLDWAMRMK 373
+V + G C G ++ EF G L +L L +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 374 VATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVM 433
+ +A+G+ FL + +HRD+ A N+LL E+ + GL++ + + R
Sbjct: 139 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 434 AGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV 493
A ++APE ++ T +SDV+SFGVLL EI S I E +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRL 250
Query: 494 QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
+ + D ++ + C PS RP S +V L L Q
Sbjct: 251 KEGTRMRAPD-------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 139 bits (351), Expect = 5e-38
Identities = 58/286 (20%), Positives = 108/286 (37%), Gaps = 34/286 (11%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK---KEFYSEIGRFARLHHPNLVAV 330
+LG + L VAVK L+ + F E A L+HP +VAV
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 331 KGCCYDHGDR----YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLH 386
YIV E+V L +H + ++V Q + F H
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSH 128
Query: 387 DKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV-MQERTVMAGGTYGYLAPEF 445
++HRD++ +N+++ +M G+++ + +T GT YL+PE
Sbjct: 129 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 446 VYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505
+ + +SDVYS G +L E+++G P F +P+ +++++
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPP------------FTGDSPVSVAYQHVREDPIP 233
Query: 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-MSHVVHQLQQL 550
S+ + + +V P R + + + L ++
Sbjct: 234 PSARHEGLSAD-----LDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-36
Identities = 45/290 (15%), Positives = 95/290 (32%), Gaps = 32/290 (11%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
LG + G + + K +K + EI H N++ +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLHES 69
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
+ +++EF+ + ++ L+ + + + + FLH ++
Sbjct: 70 FESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NI 123
Query: 394 VHRDIRASNVLLDEEFGAH--LMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
H DIR N++ + ++ G ++ + + + Y APE + +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511
+T +D++S G L+ ++SG P F T +
Sbjct: 181 STATDMWSLGTLVYVLLSGINP------------FLAETNQQIIENIMNAEYTFDEEAFK 228
Query: 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQ-LQQLAQPPVTKLL 559
+I +D V R S + H L+Q + TK++
Sbjct: 229 EISIE-----AMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVI 273
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 4e-35
Identities = 53/303 (17%), Positives = 112/303 (36%), Gaps = 31/303 (10%)
Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL 322
+I ++ +++LG G + A+K L+ + E+ R
Sbjct: 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRA 61
Query: 323 -HHPNLVAVKGCCYD----HGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATT 377
P++V + + IV E + G L + RG ++ ++ +
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKS 119
Query: 378 LAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGT 437
+ + I +LH ++ HRD++ N+L + ++ + F T
Sbjct: 120 IGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 497
Y+APE + + D++S GV++ ++ G P + +I ++ +
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKTRIRMGQ 233
Query: 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQ-LQQLAQPPV 555
Y E +P S +S + V L+ + P+ R ++ + H + Q + P
Sbjct: 234 Y-EFPNPEWSEVSEE---------VKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 283
Query: 556 TKL 558
T L
Sbjct: 284 TPL 286
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (333), Expect = 9e-35
Identities = 58/304 (19%), Positives = 112/304 (36%), Gaps = 44/304 (14%)
Query: 269 NFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRK------KEFYSEIGRFAR 321
+FS R++G G Y D G A+K L + + K + +
Sbjct: 5 DFSVH-RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 322 LHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
P +V + + + + + G L L A A + G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILG 119
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYL 441
+ +H++ VV+RD++ +N+LLDE + +GL+ +++ + GT+GY+
Sbjct: 120 LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYM 172
Query: 442 APEFVYRNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500
APE + + + +D +S G +L +++ G P + + I L
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---------RMTLT 223
Query: 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKLLF 560
+ L S S + + L+ Q + R + Q++ + P F
Sbjct: 224 MAVELPDSFSPE---------LRSLLEGLLQRDVNRRL--GCLGRGAQEVKESP----FF 268
Query: 561 KGLD 564
+ LD
Sbjct: 269 RSLD 272
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 129 bits (326), Expect = 3e-34
Identities = 52/271 (19%), Positives = 90/271 (33%), Gaps = 26/271 (9%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE-FYSEIGRFARLHHPNLVAVKG 332
+LG VA+K + + + + K+ +EI ++ HPN+VA+
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
G Y++ + V G L + ++ + + +LHD H
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLGIVH 130
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELT 452
+ LDE+ + GLSK E A GT GY+APE + + +
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 453 TKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSSD 512
D +S GV+ ++ G P F + L+ S D
Sbjct: 188 KAVDCWSIGVIAYILLCGYPP------------FYDENDAKLFEQILKAEYEFDSPYWDD 235
Query: 513 IPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
I ++ D + + P R
Sbjct: 236 ISDS-----AKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 127 bits (320), Expect = 2e-33
Identities = 54/268 (20%), Positives = 95/268 (35%), Gaps = 37/268 (13%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAV 330
R LG G + +G A+K LK+ R K+ E + + HP ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
G D +++ +++ G L L A+ L
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-------RFPNPVAKFYAAEVCLALEYLHS 122
Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
+++RD++ N+LLD+ + G +K+VP + T GT Y+APE V
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVVSTKP 177
Query: 451 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
D +SFG+L+ E+++G P F + + + L +
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTP------------FYDSNTMKTYEKILNAELRFPPFFN 225
Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRP 538
D+ DL+ S R
Sbjct: 226 EDVK---------DLLSRLITRDLSQRL 244
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-33
Identities = 55/269 (20%), Positives = 90/269 (33%), Gaps = 35/269 (13%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFAR-LHHPNLVA 329
++LG G + A+K LK+ + E + HP L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 330 VKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV 389
+ + + V E++ G L + D + A + G+ FLH K
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK- 122
Query: 390 KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
+V+RD++ N+LLD++ + G+ K + T GT Y+APE +
Sbjct: 123 --GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPDYIAPEILLGQ 178
Query: 450 ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509
+ D +SFGVLL E++ G+ P F H L
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSP------------FHGQDEEELFHSIRMDNPFYPRWL 226
Query: 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
+ DL+ P R
Sbjct: 227 EKE---------AKDLLVKLFVREPEKRL 246
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 125 bits (315), Expect = 7e-33
Identities = 45/287 (15%), Positives = 90/287 (31%), Gaps = 30/287 (10%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
R +G G Y G + G VA+K + + + + E + + +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 334 CYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHV 393
C GD ++ ++ L+ + R + +A + I ++H K +
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NF 124
Query: 394 VHRDIRASNVL---LDEEFGAHLMGVGLSKFVPWE-----VMQERTVMAGGTYGYLAPEF 445
+HRD++ N L + +++ GL+K + GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 446 VYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505
E + + D+ S G +L+ G WQ + + +
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSL--------PWQGLKAATKRQKYERISEKKMSTP 236
Query: 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
I L P + C +P S++ + L
Sbjct: 237 IEVLCKGYPSE-----FATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 123 bits (310), Expect = 3e-32
Identities = 42/290 (14%), Positives = 90/290 (31%), Gaps = 34/290 (11%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKG 332
R +G+ G + G L + +VA+K R S + E + L + V
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
+ +V + + + GR A + + +H+K
Sbjct: 69 FGQEGLHNVLVIDLLGPS----LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---S 121
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKF----------VPWEVMQERTVMAGGTYGYLA 442
+V+RDI+ N L+ + + + F + GT Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 443 PEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL 502
E + + D+ + G + + + G P Q + + + +E QS
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS------- 234
Query: 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552
+ L + PE ++ P ++ ++ +
Sbjct: 235 -TPLRELCAGFPEE-----FYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 3e-32
Identities = 60/306 (19%), Positives = 113/306 (36%), Gaps = 23/306 (7%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQR-KKEFYSEIGRFARLHHPNLVAVKG 332
+G+ G S + RVA+K++ Q + EI R H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
+ ++V + L+ + + L + +G+ ++H +
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSA---N 129
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFV-PWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
V+HRD++ SN+LL+ + GL++ P T Y APE + ++
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 452 TTKS-DVYSFGVLLLEIVSGRRP----------AQAVDSVCWQSIFEWATPLVQSHRYLE 500
TKS D++S G +L E++S R + + S + + R
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQ-LQQLAQP---PV 555
L P + + + K +DL+ P R + + H L+Q P P+
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 309
Query: 556 TKLLFK 561
+ FK
Sbjct: 310 AEAPFK 315
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 4e-32
Identities = 51/298 (17%), Positives = 98/298 (32%), Gaps = 42/298 (14%)
Query: 257 VFTTEELRSITKNFSEGNRLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQR------K 309
VF E ++ + G LG + G + A K +K+ + +
Sbjct: 2 VFRQE---NVDDYYDTG-EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR 57
Query: 310 KEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWA 369
++ E+ + HPN++ + + D ++ E V G L +L SL
Sbjct: 58 EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEE 113
Query: 370 MRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGA----HLMGVGLSKFVPWE 425
+ + G+ +LH + H D++ N++L + ++ GL+ +
Sbjct: 114 EATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-- 168
Query: 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI 485
GT ++APE V L ++D++S GV+ ++SG P
Sbjct: 169 -FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP------------ 215
Query: 486 FEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
F T + S+ D + P R +
Sbjct: 216 FLGDTKQETLANVSAVNYEFEDEYFSNTSAL-----AKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 122 bits (306), Expect = 8e-32
Identities = 56/286 (19%), Positives = 102/286 (35%), Gaps = 44/286 (15%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSF---------QRKKEFYSEIGRFARLH- 323
+LG + I P AVK + + + ++ E+ ++
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 324 HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
HPN++ +K + ++V++ + G L +L +L K+ L + I
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVIC 124
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAP 443
LH ++VHRD++ N+LLD++ L G S + E+ GT YLAP
Sbjct: 125 ALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---PGEKLREVCGTPSYLAP 178
Query: 444 EFVYRNEL------TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 497
E + + + D++S GV++ +++G P F ++
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP------------FWHRKQMLMLRM 226
Query: 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
+ S D + V DLV P R
Sbjct: 227 IMSGNYQFGSPEWDDYSDT-----VKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-31
Identities = 53/292 (18%), Positives = 109/292 (37%), Gaps = 29/292 (9%)
Query: 264 RSITKNFSEGNRLLGDSKTGGTYSGILPD-GSRVAVKRLKRSSFQRKKEFYSEIGRFARL 322
R ++++ +++G+ G Y L D G VA+K++ Q K+ E+ +L
Sbjct: 16 RPQEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKL 70
Query: 323 HHPNLVAVKGCCYDHGDR------YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVAT 376
H N+V ++ Y G++ +V ++V H+ R ++L
Sbjct: 71 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQTLPVIYVKLYMY 129
Query: 377 TLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAH-LMGVGLSKFVPWEVMQERTVMAG 435
L + +A++H + HRDI+ N+LLD + L G +K + +
Sbjct: 130 QLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-- 184
Query: 436 GTYGYLAP-EFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV--------CWQSIF 486
+ Y AP + T+ DV+S G +L E++ G+ V +
Sbjct: 185 -SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 487 EWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
+ + + + + + + + L ++ P+ R
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 2e-30
Identities = 51/308 (16%), Positives = 102/308 (33%), Gaps = 32/308 (10%)
Query: 275 RLLGDSKTGGTYSG--ILPDGSRVAVKRLKRSSFQRKKEFY-----SEIGRFARLHHPNL 327
+G+ G + + G VA+KR++ + + + + HPN+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 328 VAVKGCCYDHGDRYIVYEFVVNGPLDRW--LHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
V + C +V +D+ + + + L +G+ FL
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 445
H VVHRD++ N+L+ L GL++ +++ V T Y APE
Sbjct: 133 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VTLWYRAPEV 186
Query: 446 VYRNELTTKSDVYSFGVLLLEIVSGRRP------AQAVDSVCWQSIFEWATPLVQSHRYL 499
+ ++ T D++S G + E+ + + + +
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKLL 559
S+ + + + DL+ C P+ R L+ P
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA------LSHP-----Y 295
Query: 560 FKGLDRLR 567
F+ L+R +
Sbjct: 296 FQDLERCK 303
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 9e-30
Identities = 55/278 (19%), Positives = 94/278 (33%), Gaps = 23/278 (8%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE-----FYSEIGRFARLHHPNLV 328
LG+ + Y VA+K++K K+ EI L HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 329 AVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDK 388
+ + +V++F+ I L + QG+ +LH
Sbjct: 64 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 389 VKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYR 448
++HRD++ +N+LLDE L GL+K + T Y APE ++
Sbjct: 120 ---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV--VTRWYRAPELLFG 174
Query: 449 NEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSV-CWQSIFE--WATPLVQSHRYLELLDP 504
+ D+++ G +L E++ + IFE Q L D
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 505 LISSLSSDIPEAGVVQKV----VDLVYACTQHVPSMRP 538
+ IP + +DL+ P R
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 272
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 1e-29
Identities = 59/294 (20%), Positives = 95/294 (32%), Gaps = 40/294 (13%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAV 330
+LLG G G A+K L++ K E +E HP L A+
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
K H V E+ G L L R + + +LH +
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR-- 124
Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
VV+RDI+ N++LD++ + GL K + GT YLAPE + N+
Sbjct: 125 -DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDND 181
Query: 451 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
D + GV++ E++ GR P F L +LS
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP------------FYNQDHERLFELILMEEIRFPRTLS 229
Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKLLFKGLD 564
+ L+ + P R +++ + F ++
Sbjct: 230 PE---------AKSLLAGLLKKDPKQRL--GGGPSDAKEVMEHR----FFLSIN 268
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 2e-29
Identities = 59/293 (20%), Positives = 105/293 (35%), Gaps = 22/293 (7%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK 331
+G+ G Y G VA+K+++ + EI L+HPN+V +
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
+ Y+V+EF+ G + + L QG+AF H
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFCHSH--- 121
Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE- 450
V+HRD++ N+L++ E L GL++ V + T Y APE + +
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--VTLWYRAPEILLGCKY 179
Query: 451 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSV--------CWQSIFEWATPLVQSHRYLELL 502
+T D++S G + E+V+ R + + E P V S +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 503 DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVV-HQ-LQQLAQP 553
P + + + L+ + P+ R + H Q + +P
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 5e-29
Identities = 54/280 (19%), Positives = 96/280 (34%), Gaps = 48/280 (17%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE------FYSEIGRFARLH--HP 325
LLG G YSGI + D VA+K +++ E E+ ++
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
++ + ++ E L +L + + + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPE 444
H+ V+HRDI+ N+L+D G L+ G + V + GT Y PE
Sbjct: 127 HNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPE 179
Query: 445 FVYRNELTTKS-DVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503
++ + +S V+S G+LL ++V G P FE +++ +
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP------------FEHDEEIIRGQVFFR--- 224
Query: 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
+SS+ L+ C PS RP +
Sbjct: 225 ---QRVSSE---------CQHLIRWCLALRPSDRPTFEEI 252
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 112 bits (280), Expect = 3e-28
Identities = 51/280 (18%), Positives = 98/280 (35%), Gaps = 20/280 (7%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVKG 332
+G+ G Y G A+K+++ EI L H N+V +
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 333 CCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH 392
+ +V+E + + L+ L GIA+ HD+
Sbjct: 68 VIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---R 120
Query: 393 VVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE-L 451
V+HRD++ N+L++ E + GL++ V + + T Y AP+ + ++
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI--VTLWYRAPDVLMGSKKY 178
Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSV--------CWQSIFEWATPLVQSHRYLELLD 503
+T D++S G + E+V+G V + P V +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
+ L + G+ + +DL+ + P+ R
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (281), Expect = 7e-28
Identities = 56/268 (20%), Positives = 99/268 (36%), Gaps = 37/268 (13%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKE---FYSEIGRFARLHHPNLVAV 330
+ LG G G+ A+K L + + K+ +E ++ P LV +
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 331 KGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
+ D+ + Y+V E+V G + L I R A + +LH
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSL-- 160
Query: 391 PHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNE 450
+++RD++ N+L+D++ + G +K ++ RT GT LAPE +
Sbjct: 161 -DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKG 214
Query: 451 LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510
D ++ GVL+ E+ +G P F P+ + + S S
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP------------FFADQPIQIYEKIVSGKVRFPSHFS 262
Query: 511 SDIPEAGVVQKVVDLVYACTQHVPSMRP 538
SD+ DL+ Q + R
Sbjct: 263 SDLK---------DLLRNLLQVDLTKRF 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 2e-27
Identities = 45/297 (15%), Positives = 95/297 (31%), Gaps = 23/297 (7%)
Query: 258 FTTEELRSITKNFSEGNRL---LGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KE 311
F +E+ R +G G S + G++VA+K+L R K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 312 FYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMR 371
Y E+ + H N++ + +F + P L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 372 MKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431
+ + +G+ ++H ++HRD++ N+ ++E+ ++ GL++ E T
Sbjct: 124 QFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMT 176
Query: 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSV--------CWQ 483
+ + T D++S G ++ E+++G+ + D +
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 484 SIFEWATPLVQSHRYLELLDPLISSLSSDIPE--AGVVQKVVDLVYACTQHVPSMRP 538
+ +QS + L D V+L+ R
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 8e-27
Identities = 45/289 (15%), Positives = 95/289 (32%), Gaps = 32/289 (11%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK 331
+G G + G +VA+K++ + + EI L H N+V +
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 332 GCCYDH--------GDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIA 383
C G Y+V++F + + + + +L R+ + +
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRV-----MQMLLN 128
Query: 384 FLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAG--GTYGYL 441
L+ + ++HRD++A+NVL+ + L GL++ + T Y
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 442 APEFV-YRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSH---- 496
PE + + D++ G ++ E+ + Q ++ +
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 497 -------RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP 538
LEL+ + + +DL+ P+ R
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 6e-26
Identities = 58/301 (19%), Positives = 103/301 (34%), Gaps = 42/301 (13%)
Query: 275 RLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSSFQRK----KEFYSEIGRFARL-HHP 325
++LG G + G A+K LK+++ +K + +E + P
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
LV + +++ +++ G L L R + + L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHL 145
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 445
H +++RDI+ N+LLD L GLSK ER GT Y+AP+
Sbjct: 146 HKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGTIEYMAPDI 201
Query: 446 VYRNE--LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503
V + D +S GVL+ E+++G P + E + S R L+
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASP--------FTVDGEKNSQAEISRRILKSEP 253
Query: 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKLLFKGL 563
P +S+ DL+ P R ++ + F+ +
Sbjct: 254 PYPQEMSAL---------AKDLIQRLLMKDPKKRL--GCGPRDADEIKEHL----FFQKI 298
Query: 564 D 564
+
Sbjct: 299 N 299
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 2e-25
Identities = 48/283 (16%), Positives = 95/283 (33%), Gaps = 24/283 (8%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK 331
+G+ G + VA+KR++ EI L H N+V +
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
+ +V+EF + LD + L +G+ F H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR--- 120
Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
+V+HRD++ N+L++ L GL++ ++ + +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ-----------SIFEWATPLVQSHRYLE 500
+T D++S G + E+ + RP + V Q + +W +
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHV 543
+ P +SL + +P+ + DL+ + P R
Sbjct: 240 PMYPATTSLVNVVPK--LNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 97.2 bits (241), Expect = 9e-23
Identities = 51/286 (17%), Positives = 100/286 (34%), Gaps = 37/286 (12%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKG 332
R LG K + I + + +V VK LK +KK+ EI L PN++ +
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLAD 97
Query: 333 CCYDHGDR--YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVK 390
D R +V+E V N + ++L + + + + H
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM-- 148
Query: 391 PHVVHRDIRASNVLLDEEFG-AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRN 449
++HRD++ NV++D E L+ GL++F QE V Y V
Sbjct: 149 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVDYQ 205
Query: 450 ELTTKSDVYSFGVLLLEIVSGRRP-----------AQAVDSVCWQSIFEWAT--PLVQSH 496
D++S G +L ++ + P + + + ++++ +
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265
Query: 497 RYLELLDPLISSLSSDIPEAGVVQKV----VDLVYACTQHVPSMRP 538
R+ ++L + V +D + ++ R
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 311
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.6 bits (234), Expect = 1e-21
Identities = 44/277 (15%), Positives = 89/277 (32%), Gaps = 20/277 (7%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVK 331
+G G + G RVAVK+L R S K Y E+ + H N++ +
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 332 GCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKP 391
+ + L + + L + + +G+ ++H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA--- 140
Query: 392 HVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL 451
++HRD++ SN+ ++E+ ++ GL++ E T + +
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHY 196
Query: 452 TTKSDVYSFGVLLLEIVSGRRPAQAVDSV--------CWQSIFEWATPLVQSHRYLELLD 503
D++S G ++ E+++GR D + + + S +
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 504 PLISSLSSDIPEA--GVVQKVVDLVYACTQHVPSMRP 538
L + G VDL+ R
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.5 bits (226), Expect = 1e-20
Identities = 39/208 (18%), Positives = 77/208 (37%), Gaps = 22/208 (10%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRK--KEFYSEIGRFARLHHPNLVAVK 331
+ +G G + VA+K+L R + K Y E+ ++H N++++
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 332 GCC------YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFL 385
+ D Y+V E + + + + GI L
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHL 135
Query: 386 HDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEF 445
H ++HRD++ SN+++ + ++ GL++ M V T Y APE
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPEV 189
Query: 446 VYRNELTTKSDVYSFGVLLLEIVSGRRP 473
+ D++S G ++ E+V +
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 90.1 bits (222), Expect = 4e-20
Identities = 41/322 (12%), Positives = 101/322 (31%), Gaps = 34/322 (10%)
Query: 275 RLLGDSKTGGTYSGI-LPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGC 333
R LG + + + + VA+K ++ + EI R++ +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTKEDSM 77
Query: 334 CYDHGDRYIVYE------------FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQG 381
+H + + + + R + +++ L G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 382 IAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGY 440
+ ++H + ++H DI+ NVL++ +L+ + ++ E + T Y
Sbjct: 138 LDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 441 LAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500
+PE + +D++S L+ E+++G + + + +E
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP------DEGHSYTKDDDHIAQIIE 249
Query: 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTKLLF 560
LL L S L + L+ ++ + ++ + ++ L
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309
Query: 561 KGLDR-----------LRHIFF 571
L + H +
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWL 331
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 65.2 bits (158), Expect = 7e-13
Identities = 40/209 (19%), Positives = 71/209 (33%), Gaps = 40/209 (19%)
Query: 275 RLLGDSKTGGTYSGILPDGSRVAVK--RLKRSSFQ--------RKKEFYSEIGRFARLHH 324
+L+G+ K ++ VK ++ +SF+ F R AR
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 325 PNLVAVKGCC----YDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQ 380
L ++G Y ++ E + L R P +V + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPD-----------EVLDMILE 114
Query: 381 GIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP---WEVMQERTVMAGGT 437
+A + + +VH D+ NVL+ E G ++ S V W + ER V T
Sbjct: 115 EVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIIT 170
Query: 438 YGYLAPEFVYRNELTTKSDVYSFGVLLLE 466
Y + T+ D+ S +L+
Sbjct: 171 Y--------FSRTYRTEKDINSAIDRILQ 191
|
| >d1ypqa1 d.169.1.1 (A:140-270) Oxidised low density lipoprotein {Human (Homo sapiens) [TaxId: 9606]} Length = 131 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Oxidised low density lipoprotein species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.2 bits (150), Expect = 2e-12
Identities = 28/138 (20%), Positives = 48/138 (34%), Gaps = 15/138 (10%)
Query: 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
APCP DWI + C+ + +W++S+ C + L + S + Q+ +
Sbjct: 3 APCPQDWIWHG--ENCYLFSSGSFNWEKSQEKCLSLDAKLLKINSTADLDFIQQAISYSS 60
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
W+G N W W D G+ + + S C +
Sbjct: 61 FPFWMGLSRRNP--SYPWLWEDGSPLMPHLFRVRGAVSQTYPS---------GTCAYIQR 109
Query: 171 GSRSLVTERCNTSHPFIC 188
G ++ E C + IC
Sbjct: 110 G--AVYAENCILAAFSIC 125
|
| >d1egga_ d.169.1.1 (A:) Macrophage mannose receptor, CRD4 {Human (Homo sapiens) [TaxId: 9606]} Length = 136 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Macrophage mannose receptor, CRD4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.1 bits (141), Expect = 3e-11
Identities = 28/143 (19%), Positives = 53/143 (37%), Gaps = 12/143 (8%)
Query: 53 CPPDWIINEEKSKCFGYIGNF----RSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGK 108
CP DW + S CF ++W ES +C+ +GG LA++ + EE+ + +L
Sbjct: 1 CPEDWGASSRTSLCFKLYAKGKHEKKTWFESRDFCRALGGDLASINNKEEQQTIWRLITA 60
Query: 109 NVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 168
+ + + + + S + A G N+ C L
Sbjct: 61 SGSYHKLFWLGLTYGSPSEGFTWSDGSPVSYENWAYGEPNNYQNVEYC--------GELK 112
Query: 169 SNGSRSLVTERCNTSHPFICMVE 191
+ + S C + +IC ++
Sbjct: 113 GDPTMSWNDINCEHLNNWICQIQ 135
|
| >d1g1sa1 d.169.1.1 (A:1-118) P-selectin, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]} Length = 118 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: P-selectin, C-lectin domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.6 bits (135), Expect = 2e-10
Identities = 23/123 (18%), Positives = 39/123 (31%), Gaps = 7/123 (5%)
Query: 66 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVG 125
+ Y SW+ S YC+ L A+ + E K+ + W+G R N T
Sbjct: 2 TYHYSTKAYSWNISRKYCQNRYTDLVAIQNKNEIDYLNKVLPYYSSYYWIGIRKNNKTW- 60
Query: 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHP 185
+W + A N+ + C V++ + E C
Sbjct: 61 -TWVGTKKALTNEAENWADNEPNNKRNNEDC-----VEIYIKSPSAPGKWNDEHCLKKKH 114
Query: 186 FIC 188
+C
Sbjct: 115 ALC 117
|
| >d1e87a_ d.169.1.1 (A:) CD69 {Human (Homo sapiens) [TaxId: 9606]} Length = 117 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: CD69 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.0 bits (134), Expect = 2e-10
Identities = 28/138 (20%), Positives = 52/138 (37%), Gaps = 26/138 (18%)
Query: 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
+ C DW+ + KC+ RSW ++ C E G LA + S ++ + ++ G+
Sbjct: 1 SSCSEDWV--GYQRKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAGREE 58
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
+ + G WKWS+ ++N + GS C + N
Sbjct: 59 HWVGL-----KKEPGHPWKWSNG-KEFNNWFNVTGSDK----------------CVFLKN 96
Query: 171 GSRSLVTERCNTSHPFIC 188
+ + C + +IC
Sbjct: 97 T--EVSSMECEKNLYWIC 112
|
| >d1xpha1 d.169.1.1 (A:265-394) DC-SIGNR (DC-SIGN related receptor) {Human (Homo sapiens) [TaxId: 9606]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: DC-SIGNR (DC-SIGN related receptor) species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.7 bits (130), Expect = 9e-10
Identities = 29/137 (21%), Positives = 51/137 (37%), Gaps = 14/137 (10%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
CP DW + C+ + R+W +S T C+E+ L + + EE++ Q ++
Sbjct: 3 HCPKDWTFFQ--GNCYFMSNSQRNWHDSVTACQEVRAQLVVIKTAEEQNFLQLQTSRSNR 60
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
W+G +N W +S + G N+S + C S
Sbjct: 61 FSWMGLSDLNQEGTWQWVDGSPLSPSFQRYWNSGEPNNSGN----------EDCAEFSGS 110
Query: 172 SRSLVTERCNTSHPFIC 188
RC+ + +IC
Sbjct: 111 --GWNDNRCDVDNYWIC 125
|
| >d1wk1a_ d.169.1.1 (A:) Hypothetical protein F28B4.3 {Caenorhabditis elegans [TaxId: 6239]} Length = 150 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Hypothetical protein F28B4.3 species: Caenorhabditis elegans [TaxId: 6239]
Score = 55.0 bits (131), Expect = 1e-09
Identities = 19/126 (15%), Positives = 39/126 (30%), Gaps = 7/126 (5%)
Query: 64 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 123
K + S ++ +C GG+LA ++ + + + S
Sbjct: 8 VKFLTVNDDILSMPQARNFCASAGGYLADDLGDDKNNFYSSIAANTQFWIGLFKNSDGQF 67
Query: 124 VGLSW-KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNT 182
+ ++ + A G ++ T + + S+ T+ C T
Sbjct: 68 YWDRGQGINPDLLNQPITYWANGEPSNDPTRQCVYFDGR------SGDKSKVWTTDTCAT 121
Query: 183 SHPFIC 188
PFIC
Sbjct: 122 PRPFIC 127
|
| >d1hq8a_ d.169.1.1 (A:) NK cell-activating receptor nkg2d {Mouse (Mus musculus) [TaxId: 10090]} Length = 123 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: NK cell-activating receptor nkg2d species: Mouse (Mus musculus) [TaxId: 10090]
Score = 53.8 bits (128), Expect = 1e-09
Identities = 27/137 (19%), Positives = 48/137 (35%), Gaps = 23/137 (16%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
PCP +WI + + C+ + ++W++S+ C L + S EE+ + +
Sbjct: 5 PCPNNWICHR--NNCYQFFNEEKTWNQSQASCLSQNSSLLKIYSKEEQDFLKLVK----- 57
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
+ + SW+W D S + V SC S+
Sbjct: 58 -SYHWMGLVQIPANGSWQWEDGSSLSYNQLTLVEIPKGSC-------------AVYGSSF 103
Query: 172 SRSLVTERCNTSHPFIC 188
TE C + +IC
Sbjct: 104 --KAYTEDCANLNTYIC 118
|
| >d1qo3c_ d.169.1.1 (C:) NK cell receptor {Mouse (Mus musculus), ly49-a [TaxId: 10090]} Length = 133 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: NK cell receptor species: Mouse (Mus musculus), ly49-a [TaxId: 10090]
Score = 54.1 bits (129), Expect = 2e-09
Identities = 20/137 (14%), Positives = 37/137 (27%), Gaps = 21/137 (15%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
W KC+ ++ + ++W + C+ L + +E Q + +
Sbjct: 13 GDKVYWF--CYGMKCYYFVMDRKTWSGCKQTCQSSSLSLLKIDDEDELKFLQLVVPSDSC 70
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
+ + W W DN S + C L+S
Sbjct: 71 WVGLSYDNKKK----DWAWIDNRP-------------SKLALNTRKYNIRDGGCMLLSKT 113
Query: 172 SRSLVTERCNTSHPFIC 188
L C+ IC
Sbjct: 114 --RLDNGNCDQVFICIC 128
|
| >d3c8ja1 d.169.1.1 (A:138-259) NK cell receptor {Mouse (Mus musculus), ly49-c [TaxId: 10090]} Length = 122 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: NK cell receptor species: Mouse (Mus musculus), ly49-c [TaxId: 10090]
Score = 53.3 bits (127), Expect = 2e-09
Identities = 22/136 (16%), Positives = 38/136 (27%), Gaps = 21/136 (15%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
W +KC+ +I N +W + C+ G + + +E Q+
Sbjct: 2 GVKYWFCYS--TKCYYFIMNKTTWSGCKANCQHYGVPILKIEDEDELKFLQRHVIPGNYW 59
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
+ W W DN + +F S C +S
Sbjct: 60 IGLSYDKKKKE----WAWIDNGPSKLDMKIKKMNFKSRG-------------CVFLSKA- 101
Query: 173 RSLVTERCNTSHPFIC 188
+ CN + IC
Sbjct: 102 -RIEDIDCNIPYYCIC 116
|
| >d1tdqb_ d.169.1.1 (B:) Aggrecan core protein {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 126 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Aggrecan core protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.0 bits (123), Expect = 8e-09
Identities = 26/137 (18%), Positives = 48/137 (35%), Gaps = 15/137 (10%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
C W + + C+ + + +W ++E C+E HL+++ + EE+ KN
Sbjct: 2 QCEEGWT--KFQGHCYRHFPDRETWVDAERRCREQQSHLSSIVTPEEQE----FVNKNAQ 55
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
G + T G ++WSD H++ D ++ +
Sbjct: 56 DYQWIGLNDRTIEG-DFRWSDG--------HSLQFEKWRPNQPDNFFATGEDCVVMIWHE 106
Query: 172 SRSLVTERCNTSHPFIC 188
CN PF C
Sbjct: 107 RGEWNDVPCNYQLPFTC 123
|
| >d1g1ta1 d.169.1.1 (A:1-118) E-selectin, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]} Length = 118 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: E-selectin, C-lectin domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 1e-08
Identities = 23/115 (20%), Positives = 41/115 (35%), Gaps = 7/115 (6%)
Query: 74 RSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN 133
++DE+ YC++ HL A+ + EE + + + W+G R +N W +
Sbjct: 10 MTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRKVNNVW--VWVGTQK 67
Query: 134 MSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
A G N+ C V++ ERC+ +C
Sbjct: 68 PLTEEAKNWAPGEPNNRQKDEDC-----VEIYIKREKDVGMWNDERCSKKKLALC 117
|
| >d1dv8a_ d.169.1.1 (A:) H1 subunit of the asialoglycoprotein receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 128 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: H1 subunit of the asialoglycoprotein receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.0 bits (120), Expect = 2e-08
Identities = 23/142 (16%), Positives = 45/142 (31%), Gaps = 18/142 (12%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP +W+ E + C+ + + ++W +++ YC+ HL +TS+EE+ Q G
Sbjct: 1 CPVNWV--EHERSCYWFSRSGKAWADADNYCRLEDAHLVVVTSWEEQKFVQHHIGPVNTW 58
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLP---CHVHATVDLCTLVS 169
+ KW + F + P
Sbjct: 59 MG-------------LHDQNGPWKWVDGTDYETGFKNWRPEQPDDWYGHGLGGGEDCAHF 105
Query: 170 NGSRSLVTERCNTSHPFICMVE 191
+ C + ++C E
Sbjct: 106 TDDGRWNDDVCQRPYRWVCETE 127
|
| >d1h8ua_ d.169.1.1 (A:) Eosinophil major basic protein {Human (Homo sapiens) [TaxId: 9606]} Length = 115 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Eosinophil major basic protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (116), Expect = 5e-08
Identities = 18/117 (15%), Positives = 37/117 (31%), Gaps = 14/117 (11%)
Query: 74 RSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGK-NVNGCWVGGRSINTTVGLSWKWS 131
+++ ++ C+ G+L ++ ++ + Q N W+GGR + ++W
Sbjct: 9 QTFSQAWFTCRRCYRGNLVSIHNFNINYRIQCSVSALNQGQVWIGGRITGSGRCRRFQWV 68
Query: 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFIC 188
D A ++ C + C PFIC
Sbjct: 69 DGSRWNFAYWAAHQPWSRG------------GHCVALCTRGGYWRRAHCLRRLPFIC 113
|
| >d1kg0c_ d.169.1.1 (C:) EBV gp42 {Epstein-Barr virus [TaxId: 10376]} Length = 136 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: EBV gp42 species: Epstein-Barr virus [TaxId: 10376]
Score = 48.3 bits (114), Expect = 2e-07
Identities = 14/138 (10%), Positives = 28/138 (20%), Gaps = 23/138 (16%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
K CF + +W+ C E + +
Sbjct: 18 NTREYTF--SYKGCCFYFTKKKHTWNGCFQACAEKYPCTYFYGPTPDILPVVTRNLNAIE 75
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
WVG + +W D + +
Sbjct: 76 SLWVG---VYRVGEGNWTSLDG-GTFKVYQIFGSHC-----------------TYVSKFS 114
Query: 172 SRSLVTERCNTSHPFICM 189
+ + C+ P +C+
Sbjct: 115 TVPVSHHECSFLKPCLCV 132
|
| >d1r13a1 d.169.1.1 (A:110-228) Surfactant protein, lectin domain {Rat (Rattus norvegicus), SP-A [TaxId: 10116]} Length = 119 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Surfactant protein, lectin domain species: Rat (Rattus norvegicus), SP-A [TaxId: 10116]
Score = 46.9 bits (110), Expect = 4e-07
Identities = 18/125 (14%), Positives = 37/125 (29%), Gaps = 14/125 (11%)
Query: 64 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 123
K F G ++D + C GG++A + EE + + K N ++
Sbjct: 7 DKVFSTNGQSVNFDTIKEMCTRAGGNIAVPRTPEENEAIASIAKKYNNYVYL-------- 58
Query: 124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS 183
++ A S+ + P + ++G + C
Sbjct: 59 ---GMIEDQTPGDFHYLDGASVSYTNWYPGEPRG-QGKEKCVEMYTDG--TWNDRGCLQY 112
Query: 184 HPFIC 188
+C
Sbjct: 113 RLAVC 117
|
| >d1t8da1 d.169.1.1 (A:1-143) Low affinity immunoglobulin epsilon Fc receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 143 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Low affinity immunoglobulin epsilon Fc receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (110), Expect = 6e-07
Identities = 26/138 (18%), Positives = 46/138 (33%), Gaps = 18/138 (13%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
CP WI + KC+ + + W + C ++ G L ++ S EE+ K +
Sbjct: 7 TCPEKWI--NFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHASHTGS 64
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
+ + + W D S + S A G S C ++ G
Sbjct: 65 WIGLRNLDLKGE----FIWVDG-SHVDYSNWAPGEPTSRSQGEDC----------VMMRG 109
Query: 172 SRSLVTERCNTS-HPFIC 188
S C+ ++C
Sbjct: 110 SGRWNDAFCDRKLGAWVC 127
|
| >d1oz7b_ d.169.1.1 (B:) Snake coagglutinin beta chain {Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]} Length = 123 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]
Score = 46.6 bits (109), Expect = 6e-07
Identities = 25/142 (17%), Positives = 43/142 (30%), Gaps = 30/142 (21%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
C PDW + C+ +W ++E +C + GHL + + +E L +
Sbjct: 2 CLPDWS--VYEGYCYKVFKERMNWADAEKFCTKQHKDGHLVSFRNSKEVDFVISLAFPML 59
Query: 111 NGCWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
V + +W+WSD W+ H C
Sbjct: 60 KNDLVWIGLTDYWRDCNWEWSDGAQLDYKAWDNERH----------------------CF 97
Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
+ N C + F+C
Sbjct: 98 IYKNTDNQWTRRDCTWTFSFVC 119
|
| >d2msba_ d.169.1.1 (A:) Mannose-binding protein A, C-lectin domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 112 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Mannose-binding protein A, C-lectin domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.1 bits (108), Expect = 6e-07
Identities = 17/125 (13%), Positives = 36/125 (28%), Gaps = 18/125 (14%)
Query: 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN-GCWVGGRSINTT 123
K F + + + C E+ G +A + EE + Q++ + G
Sbjct: 2 KFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAKTSAFLGITDEVTEGQFM 61
Query: 124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS 183
+ + + K +E + C ++ + C S
Sbjct: 62 YVTGGRLTYSNWKKDEPNDHGSGED--CVTI---------------VDNGLWNDISCQAS 104
Query: 184 HPFIC 188
H +C
Sbjct: 105 HTAVC 109
|
| >d1tn3a_ d.169.1.1 (A:) Tetranectin {Human (Homo sapiens) [TaxId: 9606]} Length = 137 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Tetranectin species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.7 bits (109), Expect = 6e-07
Identities = 18/137 (13%), Positives = 39/137 (28%), Gaps = 11/137 (8%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN- 111
C ++ KCF +++ E+ C GG L+ + E + + ++V
Sbjct: 6 CLKGTKVH---MKCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSVGN 62
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
+ + +W ++ + L
Sbjct: 63 EAEIWLGLNDMAAEGTWVDMTGARIAYKNWETEITAQPDGGKTENCAV-------LSGAA 115
Query: 172 SRSLVTERCNTSHPFIC 188
+ +RC P+IC
Sbjct: 116 NGKWFDKRCRDQLPYIC 132
|
| >d1pwba1 d.169.1.1 (A:235-355) Surfactant protein, lectin domain {Human (Homo sapiens), SP-D [TaxId: 9606]} Length = 121 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Surfactant protein, lectin domain species: Human (Homo sapiens), SP-D [TaxId: 9606]
Score = 46.2 bits (108), Expect = 7e-07
Identities = 22/125 (17%), Positives = 40/125 (32%), Gaps = 13/125 (10%)
Query: 64 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 123
K F G + + E++ C + GG LA+ S E + Q+L ++
Sbjct: 8 EKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFL-------- 59
Query: 124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS 183
S S K+ +++ P + D + +NG C
Sbjct: 60 ---SMTDSKTEGKFTYPTGESLVYSNWAPGEPNDDGGSEDCVEIFTNG--KWNDRACGEK 114
Query: 184 HPFIC 188
+C
Sbjct: 115 RLVVC 119
|
| >d1v7pb_ d.169.1.1 (B:) Snake coagglutinin beta chain {Snake (Echis multisquamatus), Ems16 [TaxId: 93050]} Length = 127 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Snake (Echis multisquamatus), Ems16 [TaxId: 93050]
Score = 46.2 bits (108), Expect = 7e-07
Identities = 33/142 (23%), Positives = 46/142 (32%), Gaps = 28/142 (19%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CP W C+ ++W E+E C + G LA++ S EEE KL K +
Sbjct: 1 CPLGWS--SFDQHCYKVFEPVKNWTEAEEICMQQHKGSRLASIHSSEEEAFVSKLASKAL 58
Query: 111 NGCWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
+ N W+WSDN W CT +
Sbjct: 59 KFTSMWIGLNNPWKDCKWEWSDNARFDYKAWKR--------RPYCTVM------------ 98
Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
+V T C S F+C
Sbjct: 99 VVKPDRIFWFTRGCEKSVSFVC 120
|
| >d1wmza_ d.169.1.1 (A:) Lectin CEL-I {Cucumaria echinata [TaxId: 40245]} Length = 140 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Lectin CEL-I species: Cucumaria echinata [TaxId: 40245]
Score = 45.6 bits (106), Expect = 1e-06
Identities = 17/148 (11%), Positives = 36/148 (24%), Gaps = 17/148 (11%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGG-------HLAALTSYEEEHSAQKL 105
CP DW E C+ + +W+ + C L ++ S E+
Sbjct: 3 CPTDWE--AEGDHCYRFFNTLTTWENAHHECVSYSCSTLNVRSDLVSVHSAAEQAYVFNY 60
Query: 106 CGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLC 165
+ + + SK + A G ++ +
Sbjct: 61 WRGIDSQAGQLWIGLYDKYNEGDFIWTDGSKVGYTKWAGGQPDNWNNAEDY--------G 112
Query: 166 TLVSNGSRSLVTERCNTSHPFICMVEHE 193
+ ++C + E
Sbjct: 113 QFRHTEGGAWNDNSAAAQAKYMCKLTFE 140
|
| >d1c3ab_ d.169.1.1 (B:) Snake coagglutinin beta chain {Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]} Length = 125 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]
Score = 45.5 bits (106), Expect = 1e-06
Identities = 22/142 (15%), Positives = 42/142 (29%), Gaps = 30/142 (21%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
CP W C+ +W+++E +C + G HL + S EE +
Sbjct: 4 CPLGWS--SYDEHCYQVFQQKMNWEDAEKFCTQQHKGSHLVSFHSSEEVDFVTSKTFPIL 61
Query: 111 NGCWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
+V N + +WSD W+ C
Sbjct: 62 KYDFVWIGLSNVWNECTKEWSDGTKLDYKAWSGGSD----------------------CI 99
Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
+ ++ C++ + +C
Sbjct: 100 VSKTTDNQWLSMDCSSKYYVVC 121
|
| >d1hupa1 d.169.1.1 (A:112-228) Mannose-binding protein A, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]} Length = 117 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Mannose-binding protein A, C-lectin domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (105), Expect = 2e-06
Identities = 18/125 (14%), Positives = 41/125 (32%), Gaps = 16/125 (12%)
Query: 64 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 123
+K F G ++++ + C + +A + E + Q L + ++G T
Sbjct: 5 NKFFLTNGEIMTFEKVKALCVKFQASVATPRNAAENGAIQNLIKEEA---FLGITDEKTE 61
Query: 124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS 183
++ + G N++ + C + + C+TS
Sbjct: 62 G---QFVDLTGNRLTYTNWNEGEPNNAGSDEDCVLL----------LKNGQWNDVPCSTS 108
Query: 184 HPFIC 188
H +C
Sbjct: 109 HLAVC 113
|
| >d3bdwa1 d.169.1.1 (A:59-179) CD94 {Human (Homo sapiens) [TaxId: 9606]} Length = 121 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: CD94 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (104), Expect = 2e-06
Identities = 20/137 (14%), Positives = 40/137 (29%), Gaps = 22/137 (16%)
Query: 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN 111
C W+ C+ ++W+ES C L L + +E
Sbjct: 2 SCQEKWVGYR--CNCYFISSEQKTWNESRHLCASQKSSLLQLQNTDELDFMSSSQQFYWI 59
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
G + +W W + S ++ + ++ + NG
Sbjct: 60 GLS------YSEEHTAWLWENG-SALSQYLFPSFETFNTK-----------NCIAYNPNG 101
Query: 172 SRSLVTERCNTSHPFIC 188
+ + E C + +IC
Sbjct: 102 --NALDESCEDKNRYIC 116
|
| >d1jwia_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]
Score = 44.7 bits (104), Expect = 3e-06
Identities = 36/144 (25%), Positives = 54/144 (37%), Gaps = 30/144 (20%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVN- 111
C PDW K C+ +W+++E +C E GHLA++ S EE KL + +
Sbjct: 1 CLPDWS--SYKGHCYKVFKKVGTWEDAEKFCVENSGHLASIDSKEEADFVTKLASQTLTK 58
Query: 112 ---GCWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVGSFNSSCTSLPCHVHATVDL 164
W+G R + T S +W+D +E + C L H
Sbjct: 59 FVYDAWIGLRDESKTQQCSPQWTDGSSVVYENVDE--------PTKCFGLDVH------- 103
Query: 165 CTLVSNGSRSLVTERCNTSHPFIC 188
R+ C +PFIC
Sbjct: 104 -----TEYRTWTDLPCGEKNPFIC 122
|
| >d1gz2a_ d.169.1.1 (A:) Ovocleidin-17 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 139 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Ovocleidin-17 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 44.0 bits (102), Expect = 6e-06
Identities = 24/137 (17%), Positives = 35/137 (25%), Gaps = 4/137 (2%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG-GHLAALTSYEEEHSAQKLCGKNVN 111
C P W+ C G+ SW +E++C+ G G A E
Sbjct: 2 CGPGWV--PTPGGCLGFFSRELSWSRAESFCRRWGPGSHLAAVRSAAELRLLAELLNASR 59
Query: 112 GCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG 171
G G + V + W S F S +
Sbjct: 60 GGDGSGEGADGRVWIGLHRPAGSRSWRWSDGTAPRFASWHRTAKAR-RGGRCAALRDEEA 118
Query: 172 SRSLVTERCNTSHPFIC 188
S C + F+C
Sbjct: 119 FTSWAARPCTERNAFVC 135
|
| >d1oz7a_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]} Length = 131 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]
Score = 43.5 bits (101), Expect = 7e-06
Identities = 26/136 (19%), Positives = 44/136 (32%), Gaps = 12/136 (8%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CPP W N C+ ++WDE+E +C + G L+ ++
Sbjct: 2 CPPGWSSNG--VYCYMLFKEPKTWDEAEKFCNKQGKDGHLLSIESKKEEILVDI----VV 55
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
G+ GLS + + S S S + + +
Sbjct: 56 SENIGKMYKIWTGLSERSKEQHCSSRW------SDGSFFRSYEIAIRYSECFVLEKQSVF 109
Query: 173 RSLVTERCNTSHPFIC 188
R+ V C + PF+C
Sbjct: 110 RTWVATPCENTFPFMC 125
|
| >d1uv0a_ d.169.1.1 (A:) Pancreatitis-associated protein 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 140 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Pancreatitis-associated protein 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 8e-06
Identities = 18/136 (13%), Positives = 38/136 (27%), Gaps = 4/136 (2%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP S C+ + +SW +++ C++ E S K++
Sbjct: 5 CPKGSK--AYGSHCYALFLSPKSWTDADLACQKRPSGNLVSVLSGAEGSFVSSLVKSIGN 62
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
+ + + +W S V ++ + + S
Sbjct: 63 SYSYVWIGLHDPTQGTEPNGEGWEW--SSSDVMNYFAWERNPSTISSPGHCASLSRSTAF 120
Query: 173 RSLVTERCNTSHPFIC 188
CN P++C
Sbjct: 121 LRWKDYNCNVRLPYVC 136
|
| >d1rdl1_ d.169.1.1 (1:) Mannose-binding protein A, C-lectin domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 111 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Mannose-binding protein A, C-lectin domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (99), Expect = 9e-06
Identities = 16/124 (12%), Positives = 34/124 (27%), Gaps = 16/124 (12%)
Query: 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTV 124
K F + ++ C E+ G +A +A++ V I
Sbjct: 1 KYFMSSVRRMPLNRAKALCSELQGTVATP------RNAEENRAIQNVAKDVAFLGITDQR 54
Query: 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSH 184
+ ++ + G N+ + C +V + C+ S
Sbjct: 55 TENVFEDLTGNRVRYTNWNEGEPNNVGSGENC----------VVLLTNGKWNDVPCSDSF 104
Query: 185 PFIC 188
+C
Sbjct: 105 LVVC 108
|
| >d1jwib_ d.169.1.1 (B:) Snake coagglutinin beta chain {Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]} Length = 123 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]
Score = 42.3 bits (98), Expect = 1e-05
Identities = 29/138 (21%), Positives = 49/138 (35%), Gaps = 22/138 (15%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
C PDW K C+ ++W ++E +CKE+ GGHL ++ S EE KL + +
Sbjct: 2 CLPDWS--SYKGHCYKVFKVEKTWADAEKFCKELVNGGHLMSVNSREEGEFISKLALEKM 59
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
V + +W+D L + +C + +
Sbjct: 60 RIVLVWIGLSHFWRICPLRWTDG------------------ARLDYRALSDEPICFVAES 101
Query: 171 GSRSLVTERCNTSHPFIC 188
+ CN F+C
Sbjct: 102 FHNKWIQWTCNRKKSFVC 119
|
| >d1jzna_ d.169.1.1 (A:) Galactose-specific C-type lectin {Western diamondback rattlesnake (Crotalus atrox) [TaxId: 8730]} Length = 135 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Galactose-specific C-type lectin species: Western diamondback rattlesnake (Crotalus atrox) [TaxId: 8730]
Score = 42.5 bits (98), Expect = 2e-05
Identities = 21/137 (15%), Positives = 44/137 (32%), Gaps = 9/137 (6%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
CP DW+ C+ ++W+++E +C++ + + S +
Sbjct: 3 CPLDWL--PMNGLCYKIFNQLKTWEDAEMFCRKYKPGCHLASFHRYGESLEIAE------ 54
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS-NG 171
V + + W + + + + + P H LVS G
Sbjct: 55 YISDYHKGQENVWIGLRDKKKDFSWEWTDRSCTDYLTWDKNQPDHYQNKEFCVELVSLTG 114
Query: 172 SRSLVTERCNTSHPFIC 188
R + C + F+C
Sbjct: 115 YRLWNDQVCESKDAFLC 131
|
| >d1qdda_ d.169.1.1 (A:) Lithostathine, inhibitor of stone formation {Human (Homo sapiens) [TaxId: 9606]} Length = 144 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Lithostathine, inhibitor of stone formation species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (97), Expect = 3e-05
Identities = 18/140 (12%), Positives = 41/140 (29%), Gaps = 11/140 (7%)
Query: 50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN 109
+ CP +S C+ + + +W +++ YC+ + + E + K
Sbjct: 11 RISCPEGTN--AYRSYCYYFNEDRETWVDADLYCQNMNSGNLVSVLTQAEGAFVASLIKE 68
Query: 110 VNGCWVGGRSINTTVGLSWKWSD-NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLV 168
+ W + S + +G+ +S + +
Sbjct: 69 SGTDDFNVWIGLHDPKKNRAWHWSSGSLVSYKSWGIGAPSSVNPGYCVSLTS-------- 120
Query: 169 SNGSRSLVTERCNTSHPFIC 188
S G + C F+C
Sbjct: 121 STGFQKWKDVPCEDKFSFVC 140
|
| >d2afpa_ d.169.1.1 (A:) Type II antifreeze protein {Sea raven (Hemitripterus americanus) [TaxId: 8094]} Length = 129 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Type II antifreeze protein species: Sea raven (Hemitripterus americanus) [TaxId: 8094]
Score = 42.0 bits (97), Expect = 3e-05
Identities = 25/138 (18%), Positives = 40/138 (28%), Gaps = 17/138 (12%)
Query: 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV 110
CP W +C Y +W +ET C ++GGHLA++ S EE Q L V
Sbjct: 5 PNCPAGWQ--PLGDRCIYYETTAMTWALAETNCMKLGGHLASIHSQEEHSFIQTLNAGVV 62
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
+ + N + + + +
Sbjct: 63 WIGGSACLQAG------AWTWSDGTPMNFRSWCSTKPDDVLAA---------CCMQMTAA 107
Query: 171 GSRSLVTERCNTSHPFIC 188
+ C SH +C
Sbjct: 108 ADQCWDDLPCPASHKSVC 125
|
| >d1umrc_ d.169.1.1 (C:) Snake coagglutinin beta chain {South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]} Length = 125 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]
Score = 41.3 bits (95), Expect = 4e-05
Identities = 25/142 (17%), Positives = 49/142 (34%), Gaps = 30/142 (21%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
CP W C+ +W ++E +C + G HL + S EE K+ +++
Sbjct: 4 CPSHWS--SYDRYCYKVFKQEMTWADAEKFCTQQHTGSHLVSFHSTEEVDFVVKMTHQSL 61
Query: 111 NGCWVGGRSINTTVGLSWKWSDNM----SKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
+ + N +W+WSD +W+E C
Sbjct: 62 KSTFFWIGANNIWNKCNWQWSDGTKPEYKEWHEEFE----------------------CL 99
Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
+ ++ C+ ++ F+C
Sbjct: 100 ISRTFDNQWLSAPCSDTYSFVC 121
|
| >d1v7pa_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Snake (Echis multisquamatus), Ems16 [TaxId: 93050]} Length = 134 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Snake (Echis multisquamatus), Ems16 [TaxId: 93050]
Score = 41.3 bits (95), Expect = 5e-05
Identities = 29/142 (20%), Positives = 47/142 (33%), Gaps = 22/142 (15%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGK-- 108
CP DW C+ IG ++W E+E +C E GHL ++ S EE + +L
Sbjct: 4 CPSDWT--AYDQHCYLAIGEPQNWYEAERFCTEQAKDGHLVSIQSREEGNFVAQLVSGFM 61
Query: 109 --NVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
+ W+G R + +W+D + S +
Sbjct: 62 HRSEIYVWIGLRDRREEQQCNPEWNDGSKIIYVNWKEGESKMCQGLT------------- 108
Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
C +PF+C
Sbjct: 109 -KWTNFHDWNNINCEDLYPFVC 129
|
| >d1c3aa_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]} Length = 135 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]
Score = 40.9 bits (94), Expect = 7e-05
Identities = 15/136 (11%), Positives = 37/136 (27%), Gaps = 10/136 (7%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNG 112
C P W C+ ++W+++E++C+E ++
Sbjct: 4 CIPGWS--AYDRYCYQAFSKPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEKI 61
Query: 113 CWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS 172
+ + + S + ++ + +A
Sbjct: 62 KTSFQYVWIGLR---IQNKEQQCRSEWSDASSVNYENLVKQFSKKCYALKK-----GTEL 113
Query: 173 RSLVTERCNTSHPFIC 188
R+ C T +P +C
Sbjct: 114 RTWFNVYCGTENPEVC 129
|
| >d1byfa_ d.169.1.1 (A:) Lectin TC14 {Tunicate (Polyandrocarpa misakiensis) [TaxId: 7723]} Length = 123 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Lectin TC14 species: Tunicate (Polyandrocarpa misakiensis) [TaxId: 7723]
Score = 40.2 bits (92), Expect = 8e-05
Identities = 19/124 (15%), Positives = 38/124 (30%), Gaps = 9/124 (7%)
Query: 66 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNV-NGCWVGGRSINTTV 124
+ ++ ++ TYC+ G L + + L V + G
Sbjct: 3 EILFSDETMNYADAGTYCQSRGMALVSSAMRDSTMVKAILAFTEVKGHDYWVGADNLQDG 62
Query: 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSH 184
++ W+D +S +S + S+ S V + + L C +
Sbjct: 63 AYNFLWNDGVSLPTDSDLWSPNEPSNPQSWQLCVQ--------IWSKYNLLDDVGCGGAR 114
Query: 185 PFIC 188
IC
Sbjct: 115 RVIC 118
|
| >d1j34b_ d.169.1.1 (B:) Snake coagglutinin beta chain {Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]} Length = 123 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]
Score = 40.1 bits (92), Expect = 1e-04
Identities = 27/142 (19%), Positives = 45/142 (31%), Gaps = 30/142 (21%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
CP DW + C+ ++W ++E +C + GGHL + S EE KL +
Sbjct: 2 CPSDWS--SYEGHCYKPFSEPKNWADAENFCTQQHAGGHLVSFQSSEEADFVVKLAFQTF 59
Query: 111 NGCWVGGRSINTTVGLSWKWSD----NMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCT 166
N +W+WS+ W E + C
Sbjct: 60 GHSIFWMGLSNVWNQCNWQWSNAAMLRYKAWAEESY----------------------CV 97
Query: 167 LVSNGSRSLVTERCNTSHPFIC 188
+ + + C F+C
Sbjct: 98 YFKSTNNKWRSRACRMMAQFVC 119
|
| >d1fvub_ d.169.1.1 (B:) Snake coagglutinin beta chain {Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]} Length = 125 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]
Score = 39.5 bits (90), Expect = 2e-04
Identities = 26/138 (18%), Positives = 44/138 (31%), Gaps = 20/138 (14%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKNV 110
CPPDW + C+ + + WD++E +C E G HL + S EE + L + +
Sbjct: 2 CPPDWS--SYEGHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEML 59
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
G V + ++W+D + T
Sbjct: 60 KGDVVWIGLSDVWNKCRFEWTDG------MEFDYDDYYLIAEYECVASKPT--------- 104
Query: 171 GSRSLVTERCNTSHPFIC 188
+ C F+C
Sbjct: 105 -NNKWWIIPCTRFKNFVC 121
|
| >d1umra_ d.169.1.1 (A:) Snake coagglutinin alpha chain {South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]} Length = 135 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]
Score = 39.7 bits (91), Expect = 2e-04
Identities = 26/140 (18%), Positives = 48/140 (34%), Gaps = 18/140 (12%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
CP DW C+ +W+++E +C + G HL ++ S +E + +N+
Sbjct: 4 CPSDWY--YYDQHCYRIFNEEMNWEDAEWFCTKQAKGAHLVSIKSAKEADFVAWMVTQNI 61
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS- 169
+ S + E + + S S + + C+L+
Sbjct: 62 EESF------------SHVSIGLRVQNKEKQCSTKWSDGSSVSYDNLLDLYITKCSLLKK 109
Query: 170 -NGSRSLVTERCNTSHPFIC 188
G R C PF+C
Sbjct: 110 ETGFRKWFVASCIGKIPFVC 129
|
| >d1fvua_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]} Length = 133 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]
Score = 39.3 bits (90), Expect = 2e-04
Identities = 24/138 (17%), Positives = 41/138 (29%), Gaps = 13/138 (9%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG--GHLAALTSYEEEHSAQKLCGKNV 110
CP W + C+ + +W ++E +C E GHL ++ Y +E
Sbjct: 2 CPSGWS--SYEGNCYKFFQQKMNWADAERFCSEQAKGGHLVSIKIYSKEKDFVGDLVTKN 59
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
I V K + S+ S+ + A
Sbjct: 60 IQSSDLYAWIGLRVENKEKQCSSEWSDGSSV----SYENVVERTVKKCFALEK-----DL 110
Query: 171 GSRSLVTERCNTSHPFIC 188
G + C +PF+C
Sbjct: 111 GFVLWINLYCAQKNPFVC 128
|
| >d1sb2a1 d.169.1.1 (A:1-132) Snake coagglutinin alpha chain {Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]} Length = 132 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]
Score = 39.3 bits (90), Expect = 2e-04
Identities = 25/138 (18%), Positives = 41/138 (29%), Gaps = 14/138 (10%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
CP W KS C+ ++W+E+E +C E HL ++ + E + N
Sbjct: 2 CPDGWS--STKSYCYRPFKEKKTWEEAERFCTEQEKEAHLVSMENRLEAVFVDMVMENNF 59
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
SW +K S +S + +
Sbjct: 60 ENKIYR----------SWIGLKIENKGQRSNLEWSDGSSISYENLYEPYMEKCFLMDHQS 109
Query: 171 GSRSLVTERCNTSHPFIC 188
G T C + F+C
Sbjct: 110 GLPKWHTADCEEKNVFMC 127
|
| >d1sb2b1 d.169.1.1 (B:2-128) Snake coagglutinin beta chain {Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]} Length = 127 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]
Score = 38.2 bits (87), Expect = 5e-04
Identities = 22/138 (15%), Positives = 39/138 (28%), Gaps = 20/138 (14%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKNV 110
CP W K C+ ++W E+E +C + GHL ++ S E + N
Sbjct: 3 CPTTWS--ASKLYCYKPFKEKKTWIEAERFCAKQAENGHLVSIGSAAEADFLDLVIVVNF 60
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
+ +W + + +V N +
Sbjct: 61 DKQR----------YRAWTGLTERNLKWTNGASVSYENLY------EPYIRKCFVVQPWE 104
Query: 171 GSRSLVTERCNTSHPFIC 188
G C + F+C
Sbjct: 105 GKSKWYKADCEEKNAFLC 122
|
| >d1j34a_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]} Length = 129 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]
Score = 38.2 bits (87), Expect = 5e-04
Identities = 29/140 (20%), Positives = 51/140 (36%), Gaps = 18/140 (12%)
Query: 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYC--KEIGGHLAALTSYEEEHSAQKLCGKNV 110
CP W + C+ +++WD++E +C + GGHL ++ S E +L +N+
Sbjct: 2 CPSGWS--SYEGHCYKPFKLYKTWDDAERFCTEQAKGGHLVSIESAGEADFVAQLVTENI 59
Query: 111 NGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN 170
+ W + E + + S S + A C +
Sbjct: 60 QNTKS------------YVWIGLRVQGKEKQCSSEWSDGSSVSYENWIEAESKTCLGLEK 107
Query: 171 --GSRSLVTERCNTSHPFIC 188
G R V C +PF+C
Sbjct: 108 ETGFRKWVNIYCGQQNPFVC 127
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 573 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ypqa1 | 131 | Oxidised low density lipoprotein {Human (Homo sapi | 99.94 | |
| d1xpha1 | 130 | DC-SIGNR (DC-SIGN related receptor) {Human (Homo s | 99.94 | |
| d1hq8a_ | 123 | NK cell-activating receptor nkg2d {Mouse (Mus musc | 99.93 | |
| d1t8da1 | 143 | Low affinity immunoglobulin epsilon Fc receptor {H | 99.93 | |
| d1dv8a_ | 128 | H1 subunit of the asialoglycoprotein receptor {Hum | 99.93 | |
| d1tdqb_ | 126 | Aggrecan core protein {Rat (Rattus norvegicus) [Ta | 99.93 | |
| d1oz7b_ | 123 | Snake coagglutinin beta chain {Saw-scaled viper (E | 99.92 | |
| d1fvub_ | 125 | Snake coagglutinin beta chain {Jararaca (Bothrops | 99.92 | |
| d2afpa_ | 129 | Type II antifreeze protein {Sea raven (Hemitripter | 99.92 | |
| d1wmza_ | 140 | Lectin CEL-I {Cucumaria echinata [TaxId: 40245]} | 99.92 | |
| d1e87a_ | 117 | CD69 {Human (Homo sapiens) [TaxId: 9606]} | 99.92 | |
| d1j34b_ | 123 | Snake coagglutinin beta chain {Habu snake (Trimere | 99.92 | |
| d1gz2a_ | 139 | Ovocleidin-17 {Chicken (Gallus gallus) [TaxId: 903 | 99.92 | |
| d1qdda_ | 144 | Lithostathine, inhibitor of stone formation {Human | 99.92 | |
| d1jwia_ | 124 | Snake coagglutinin alpha chain {Puff adder (Bitis | 99.92 | |
| d1tn3a_ | 137 | Tetranectin {Human (Homo sapiens) [TaxId: 9606]} | 99.92 | |
| d1umrc_ | 125 | Snake coagglutinin beta chain {South american ratt | 99.91 | |
| d1c3ab_ | 125 | Snake coagglutinin beta chain {Habu snake (Trimere | 99.91 | |
| d1jwib_ | 123 | Snake coagglutinin beta chain {Puff adder (Bitis a | 99.91 | |
| d1sb2a1 | 132 | Snake coagglutinin alpha chain {Malayan pit viper | 99.91 | |
| d1qo3c_ | 133 | NK cell receptor {Mouse (Mus musculus), ly49-a [Ta | 99.91 | |
| d1jzna_ | 135 | Galactose-specific C-type lectin {Western diamondb | 99.91 | |
| d1v7pb_ | 127 | Snake coagglutinin beta chain {Snake (Echis multis | 99.91 | |
| d3c8ja1 | 122 | NK cell receptor {Mouse (Mus musculus), ly49-c [Ta | 99.91 | |
| d1c3aa_ | 135 | Snake coagglutinin alpha chain {Habu snake (Trimer | 99.91 | |
| d3bdwa1 | 121 | CD94 {Human (Homo sapiens) [TaxId: 9606]} | 99.91 | |
| d1umra_ | 135 | Snake coagglutinin alpha chain {South american rat | 99.91 | |
| d1egga_ | 136 | Macrophage mannose receptor, CRD4 {Human (Homo sap | 99.91 | |
| d1v7pa_ | 134 | Snake coagglutinin alpha chain {Snake (Echis multi | 99.9 | |
| d1j34a_ | 129 | Snake coagglutinin alpha chain {Habu snake (Trimer | 99.9 | |
| d1sb2b1 | 127 | Snake coagglutinin beta chain {Malayan pit viper ( | 99.9 | |
| d1fvua_ | 133 | Snake coagglutinin alpha chain {Jararaca (Bothrops | 99.9 | |
| d1oz7a_ | 131 | Snake coagglutinin alpha chain {Saw-scaled viper ( | 99.9 | |
| d1uv0a_ | 140 | Pancreatitis-associated protein 1 {Human (Homo sap | 99.9 | |
| d1pwba1 | 121 | Surfactant protein, lectin domain {Human (Homo sap | 99.89 | |
| d2msba_ | 112 | Mannose-binding protein A, C-lectin domain {Rat (R | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1hupa1 | 117 | Mannose-binding protein A, C-lectin domain {Human | 99.88 | |
| d1r13a1 | 119 | Surfactant protein, lectin domain {Rat (Rattus nor | 99.88 | |
| d1rdl1_ | 111 | Mannose-binding protein A, C-lectin domain {Rat (R | 99.87 | |
| d1h8ua_ | 115 | Eosinophil major basic protein {Human (Homo sapien | 99.86 | |
| d1kg0c_ | 136 | EBV gp42 {Epstein-Barr virus [TaxId: 10376]} | 99.86 | |
| d1g1ta1 | 118 | E-selectin, C-lectin domain {Human (Homo sapiens) | 99.83 | |
| d1wk1a_ | 150 | Hypothetical protein F28B4.3 {Caenorhabditis elega | 99.82 | |
| d1g1sa1 | 118 | P-selectin, C-lectin domain {Human (Homo sapiens) | 99.81 | |
| d1byfa_ | 123 | Lectin TC14 {Tunicate (Polyandrocarpa misakiensis) | 99.75 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.51 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.0 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.41 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.02 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.6 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.37 | |
| d2pf5a1 | 95 | TSG-6, Link module {Human (Homo sapiens) [TaxId: 9 | 80.26 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.2e-53 Score=420.15 Aligned_cols=270 Identities=25% Similarity=0.433 Sum_probs=206.8
Q ss_pred CHHHHHHhhcCCCc--------CCeeecccCceEEEEEEeCC-C---CEEEEEEeccc-chhhHHHHHHHHHHHhhcCCC
Q 008216 259 TTEELRSITKNFSE--------GNRLLGDSKTGGTYSGILPD-G---SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHP 325 (573)
Q Consensus 259 ~~~el~~~~~~~~~--------~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~ 325 (573)
+++++.+++.+|.. ..++||+|+||+||+|.+.. | ..||||.+... .....++|.+|+.+|++++||
T Consensus 8 t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~Hp 87 (299)
T d1jpaa_ 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 87 (299)
T ss_dssp GSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCT
T ss_pred CHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCC
Confidence 44455555555543 23678999999999999643 3 26899998764 344567899999999999999
Q ss_pred cEeEEeeEEeeCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee
Q 008216 326 NLVAVKGCCYDHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLL 405 (573)
Q Consensus 326 nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll 405 (573)
|||+++|++.+++..++||||+++|+|.+++.. ....+++.+++.++.||++||+|||++ +|+||||||+|||+
T Consensus 88 nIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 88 NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV 161 (299)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CCccEEEEEeeCCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence 999999999999999999999999999998864 335699999999999999999999999 99999999999999
Q ss_pred CCCCCeeEecccCCccCCccccccc---eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCccc
Q 008216 406 DEEFGAHLMGVGLSKFVPWEVMQER---TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVC 481 (573)
Q Consensus 406 ~~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~ 481 (573)
+.++.+||+|||+++.......... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.......
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~ 241 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999987654332211 112237899999999999999999999999999999998 899998765432
Q ss_pred chhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 482 WQSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
. .... .... ....+..+++.+.+||.+||+.||++|||+.||++.|+++.+.|
T Consensus 242 ~---~~~i---~~~~--------------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 242 V---INAI---EQDY--------------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp H---HHHH---HTTC--------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred H---HHHH---HcCC--------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 1 1111 0100 11122345678999999999999999999999999999887654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-53 Score=415.28 Aligned_cols=259 Identities=24% Similarity=0.397 Sum_probs=201.8
Q ss_pred CcCCeeecccCceEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 271 SEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
++..+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|+.+|++++||||+++++++. .+..++||||++
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~ 86 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCE 86 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCC
T ss_pred EEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCC
Confidence 344567899999999999863 36999999754 3445678999999999999999999999875 457899999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+|+|.+++.. .+..+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+........
T Consensus 87 ~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 87 GSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 9999999964 235699999999999999999999999 9999999999999999999999999999877544333
Q ss_pred cceeccCCcccccccccccC---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.......||+.|||||++.+ ..++.++|||||||++|||+||+.||...+.... +.. ..... ...+.
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~~----~~~~~----~~~p~ 230 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIF----MVGRG----YLSPD 230 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHH----HHHHT----SCCCC
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HHH----HHhcC----CCCCc
Confidence 33334459999999999864 3578999999999999999999999987654211 111 11111 11111
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
... ....+++++.+||.+||+.||++|||++||++.|+.+.+.
T Consensus 231 ~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 231 LSK-----VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp GGG-----SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred chh-----ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 111 1123456799999999999999999999999999988653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=410.85 Aligned_cols=252 Identities=24% Similarity=0.399 Sum_probs=198.6
Q ss_pred CCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
..+.||+|+||.||+|.+.+++.||||+++... ...+++.+|++++++++||||++++|++.+++..++||||+++|+|
T Consensus 9 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L 87 (263)
T d1sm2a_ 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL 87 (263)
T ss_dssp EEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred EEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcH
Confidence 345789999999999999889999999998653 4457899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...........
T Consensus 88 ~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~- 160 (263)
T d1sm2a_ 88 SDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST- 160 (263)
T ss_dssp HHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred HHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeec-
Confidence 999864 335689999999999999999999999 9999999999999999999999999999876544332222
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcC-CCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG-RRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
...||+.|+|||++.+..++.++|||||||++|||+|+ .+||...+.. .+..... ... .
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~---~~~~~i~---~~~--------------~ 220 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDIS---TGF--------------R 220 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH---HHHHHHH---HTC--------------C
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH---HHHHHHH---hcC--------------C
Confidence 23489999999999999999999999999999999995 5555543321 1111111 100 0
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
...+..+++++.+||.+||+.||++|||++||++.|+++++
T Consensus 221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 11122345679999999999999999999999999998754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=408.50 Aligned_cols=249 Identities=22% Similarity=0.296 Sum_probs=201.2
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
+..+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.+|++++||||+++++++.+++..++||||+++
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 87 (271)
T d1nvra_ 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 87 (271)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCC
Confidence 3346789999999999996 4699999999976532 3346789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|.+++.. ...+++.++..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+.........
T Consensus 88 g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 88 GELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999853 35699999999999999999999999 99999999999999999999999999998775443333
Q ss_pred ceeccCCcccccccccccCCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
......||+.|||||++.+..+ +.++|||||||++|||+||++||........ .... .....
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~~----~~~~~------------ 223 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSD----WKEKK------------ 223 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHHH----HHTTC------------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HHHH----HhcCC------------
Confidence 3334559999999999988776 5789999999999999999999976543211 0000 00000
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....+....++++.+|+.+||+.||++|||++|+++
T Consensus 224 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 224 -TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011122345678899999999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=406.77 Aligned_cols=247 Identities=20% Similarity=0.327 Sum_probs=206.7
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
++..+.||+|+||.||+|.. .+|+.||||+++.......+.+.+|+.+|++++||||+++++++.+++..|+||||+++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence 34456789999999999995 56999999999876556678899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|.+++.. ..+++.++..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++........
T Consensus 102 g~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~- 172 (293)
T d1yhwa1 102 GSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (293)
T ss_dssp CBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred CcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc-
Confidence 999998864 4599999999999999999999999 9999999999999999999999999999876543322
Q ss_pred ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccC
Q 008216 430 RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSL 509 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (573)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...+.... + ........
T Consensus 173 -~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~----~~~~~~~~------------ 233 (293)
T d1yhwa1 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--L----YLIATNGT------------ 233 (293)
T ss_dssp -BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H----HHHHHHCS------------
T ss_pred -ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH--H----HHHHhCCC------------
Confidence 2233499999999999999999999999999999999999999976553211 1 01111100
Q ss_pred CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 510 SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 510 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.....+...++++.+||.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011112345678999999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-52 Score=411.12 Aligned_cols=257 Identities=28% Similarity=0.430 Sum_probs=210.2
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+..+.||+|+||+||+|.+. +|+.||||+++... ...+++.+|+.+|++++||||+++++++.+++..++||||+++|
T Consensus 20 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g 98 (287)
T d1opja_ 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 98 (287)
T ss_dssp EEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred EEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCc
Confidence 33457899999999999975 58899999997653 34678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|.+++.. .....+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 99 ~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~ 173 (287)
T d1opja_ 99 NLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 173 (287)
T ss_dssp BHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEE
T ss_pred chHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCceee
Confidence 99999975 3346799999999999999999999999 999999999999999999999999999997754433222
Q ss_pred eeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 431 TVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
. ...||+.|+|||++.+..++.++|||||||++|||++|..|+....+. ..+... .....
T Consensus 174 ~-~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~~~----i~~~~------------- 233 (287)
T d1opja_ 174 A-GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYEL----LEKDY------------- 233 (287)
T ss_dssp T-TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHH----HHTTC-------------
T ss_pred c-cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHHHH----HhcCC-------------
Confidence 2 223889999999999999999999999999999999977665443321 111111 11100
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
....+..+++++.+||.+||+.||++|||++||++.|+.+.++.
T Consensus 234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 01112235568999999999999999999999999999887654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-52 Score=408.45 Aligned_cols=252 Identities=26% Similarity=0.410 Sum_probs=202.8
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
+..+.||+|+||.||+|.+++++.||||+++... ...+.+.+|+.++++++|||||+++|++.+ +..++||||+++|+
T Consensus 16 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~ 93 (272)
T d1qpca_ 16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGS 93 (272)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCB
T ss_pred EEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCc
Confidence 3345689999999999999888999999997653 345789999999999999999999998754 56799999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|.+++.. .....+++..++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+..........
T Consensus 94 L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~- 167 (272)
T d1qpca_ 94 LVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR- 167 (272)
T ss_dssp HHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC-
T ss_pred HHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccccc-
Confidence 9998754 2234589999999999999999999999 999999999999999999999999999987754432222
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
....||+.|+|||++.+..++.++|||||||++|||+||..|+...... ....... .. . . .
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~~i---~~-~-----~--------~ 228 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNL---ER-G-----Y--------R 228 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHH---HT-T-----C--------C
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHHHH---Hh-c-----C--------C
Confidence 2234899999999999899999999999999999999965554433221 1111111 00 0 0 1
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
...+..+++++.+|+.+||+.||++|||++||++.|+.+
T Consensus 229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 111223556799999999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=401.57 Aligned_cols=242 Identities=26% Similarity=0.346 Sum_probs=202.4
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 9 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~ 88 (263)
T d2j4za1 9 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA 88 (263)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeec
Confidence 33567899999999999974 68999999997542 233567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++|+|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 89 ~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 161 (263)
T d2j4za1 89 PLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 161 (263)
T ss_dssp TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC
T ss_pred CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCcc
Confidence 99999999964 34699999999999999999999999 999999999999999999999999999987653322
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .... ...
T Consensus 162 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i----~~~----------- 219 (263)
T d2j4za1 162 ----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YKRI----SRV----------- 219 (263)
T ss_dssp ----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHH----HTT-----------
T ss_pred ----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH---HHHH----HcC-----------
Confidence 234499999999999999999999999999999999999999986553211 1110 000
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....+...++++.+|+.+||+.||++|||++|+++
T Consensus 220 ---~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 220 ---EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 00111234567999999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=398.63 Aligned_cols=250 Identities=23% Similarity=0.371 Sum_probs=209.2
Q ss_pred CCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 273 GNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
..+.||+|+||+||+|++++++.||||+++.... ..+++.+|+.++++++||||++++|++.+++..++||||+++|+|
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l 86 (258)
T d1k2pa_ 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86 (258)
T ss_dssp CCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred EeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence 3456899999999999998888999999987643 457899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++.. ....+++..+.+++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++......... ..
T Consensus 87 ~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~ 159 (258)
T d1k2pa_ 87 LNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SV 159 (258)
T ss_dssp HHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC-CC
T ss_pred HHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCcee-ec
Confidence 999763 235689999999999999999999999 99999999999999999999999999998765443322 22
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
...||+.|+|||.+.+..++.++||||||+++|||+| |+.||...+..+.... ... .. .
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~------i~~-~~-------------~ 219 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH------IAQ-GL-------------R 219 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH------HHT-TC-------------C
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH------HHh-CC-------------C
Confidence 2348999999999999999999999999999999998 8999987654321111 111 00 1
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
...+...++++.+||.+||+.||++|||+++|++.|.++
T Consensus 220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 111223456799999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=406.59 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=205.4
Q ss_pred CCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 270 FSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 270 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
+++..+.||+|+||.||+|+. .+|+.||||+++.......+.+.+|+++|++++||||+++++++.+++..++||||++
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 345456789999999999996 4689999999987766677889999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+|+|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 93 ~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~- 165 (288)
T d2jfla1 93 GGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 165 (288)
T ss_dssp TEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence 99999987642 35699999999999999999999999 999999999999999999999999999976543221
Q ss_pred cceeccCCccccccccccc-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVY-----RNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (573)
......||+.|+|||++. +..++.++|||||||++|||+||+.||...+..... . ...... .
T Consensus 166 -~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~---~---~i~~~~-~----- 232 (288)
T d2jfla1 166 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL---L---KIAKSE-P----- 232 (288)
T ss_dssp -HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---H---HHHHSC-C-----
T ss_pred -cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH---H---HHHcCC-C-----
Confidence 122334999999999984 456889999999999999999999999876543211 0 001100 0
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+ ....+...++++.+||.+||+.||++|||++|+++
T Consensus 233 ~------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 P------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp C------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 11112345678999999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=404.42 Aligned_cols=251 Identities=23% Similarity=0.293 Sum_probs=192.5
Q ss_pred CCeeecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEee--CCceEEEEEec
Q 008216 273 GNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--HGDRYIVYEFV 347 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~ 347 (573)
..+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+++|++++||||+++++++.+ ++..|+||||+
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~ 87 (269)
T d2java1 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 87 (269)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECC
T ss_pred EeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecC
Confidence 345789999999999986 468999999997653 3345678999999999999999999999865 45679999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV--KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
++|+|.+++......+..+++..++.++.||+.||+|||++. ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 167 (269)
T d2java1 88 EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 167 (269)
T ss_dssp TTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---
T ss_pred CCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC
Confidence 999999998654344567999999999999999999999861 113999999999999999999999999999876543
Q ss_pred ccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+... +.... .....
T Consensus 168 ~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~~i----~~~~~------- 231 (269)
T d2java1 168 TSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKI----REGKF------- 231 (269)
T ss_dssp ----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH----HHTCC-------
T ss_pred CCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HHHHH----HcCCC-------
Confidence 222 122349999999999999999999999999999999999999998755321 11110 11111
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
...+...++++.+||.+||+.||++|||++|+++
T Consensus 232 ------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 ------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0112235568999999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-51 Score=401.94 Aligned_cols=248 Identities=23% Similarity=0.340 Sum_probs=203.5
Q ss_pred ecccCceEEEEEEeC---CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCCH
Q 008216 277 LGDSKTGGTYSGILP---DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGPL 352 (573)
Q Consensus 277 lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 352 (573)
||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++|||||+++|++.+ +..++||||+++|+|
T Consensus 17 iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L 95 (285)
T d1u59a_ 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPL 95 (285)
T ss_dssp EECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEH
T ss_pred EecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcH
Confidence 799999999999853 35579999997653 3446789999999999999999999999865 568999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc-cce
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ-ERT 431 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~ 431 (573)
.+++.. .+..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 96 ~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 169 (285)
T d1u59a_ 96 HKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169 (285)
T ss_dssp HHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred HHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccccc
Confidence 999853 335699999999999999999999999 9999999999999999999999999999877544322 222
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLS 510 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 510 (573)
....||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+.... ...+.
T Consensus 170 ~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~-------i~~~~------------- 229 (285)
T d1u59a_ 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-------IEQGK------------- 229 (285)
T ss_dssp CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-------HHTTC-------------
T ss_pred cccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCC-------------
Confidence 23448999999999999999999999999999999998 9999987654321111 11110
Q ss_pred CCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 511 SDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 511 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
....+..+++++.+||.+||+.||++|||+.+|++.|+...
T Consensus 230 ~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 230 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 01112345678999999999999999999999999987653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-51 Score=400.68 Aligned_cols=248 Identities=27% Similarity=0.390 Sum_probs=200.2
Q ss_pred eeecccCceEEEEEEeCC---CCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 275 RLLGDSKTGGTYSGILPD---GSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
+.||+|+||.||+|.+.+ ++.||||+++... ....+++.+|+++|++++||||++++|++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 568999999999998543 5689999997542 2335789999999999999999999999865 567899999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc-
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ- 428 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~- 428 (573)
|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999964 35699999999999999999999999 9999999999999999999999999999876544322
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
.......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+....... ...+.
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~-------i~~~~---------- 227 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-------LEKGE---------- 227 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-------HHTTC----------
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHH-------HHcCC----------
Confidence 22223448999999999999999999999999999999998 8999987654321111 11110
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
....+..+++++.+||.+||+.||++|||+++|++.|+..
T Consensus 228 ---~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 228 ---RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 0111233567899999999999999999999999988764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-51 Score=398.69 Aligned_cols=246 Identities=19% Similarity=0.336 Sum_probs=196.1
Q ss_pred CCcCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEee----CCceEE
Q 008216 270 FSEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD----HGDRYI 342 (573)
Q Consensus 270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~l 342 (573)
|.+..+.||+|+||+||+|... +++.||+|++... .....+.+.+|+++|++++||||+++++++.+ .+..++
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 4444556899999999999964 5889999998754 33445779999999999999999999999875 345799
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCeeeC-CCCCeeEecccCC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPH--VVHRDIRASNVLLD-EEFGAHLMGVGLS 419 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--iiH~Dlkp~NIll~-~~~~~kl~Dfg~~ 419 (573)
||||+++|+|.+++.. ...+++..++.++.||++||+|||++ + |+||||||+|||++ .++.+||+|||++
T Consensus 90 vmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 9999999999999964 34699999999999999999999998 7 99999999999996 5789999999999
Q ss_pred ccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
+....... ....||+.|+|||++.+ .++.++|||||||++|||++|+.||....... .+.... .....
T Consensus 163 ~~~~~~~~----~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~~i----~~~~~- 230 (270)
T d1t4ha_ 163 TLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRV----TSGVK- 230 (270)
T ss_dssp GGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHH----TTTCC-
T ss_pred eeccCCcc----CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHHHHH----HcCCC-
Confidence 86543222 23349999999998865 69999999999999999999999997654321 111110 00000
Q ss_pred cccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 500 ELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
+...+...++++.+||.+||+.||++|||++|+++
T Consensus 231 -----------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 -----------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -----------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11112223457899999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=404.11 Aligned_cols=246 Identities=21% Similarity=0.302 Sum_probs=201.1
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
+..+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+++|++++||||+++++++.+++..|+||||+
T Consensus 11 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~ 90 (288)
T d1uu3a_ 11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA 90 (288)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEcc
Confidence 4456889999999999996 469999999997542 234567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 91 ~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 91 KNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp TTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999998864 35699999999999999999999999 999999999999999999999999999998765443
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
........||+.|+|||++.+..++.++|||||||++|||+||+.||...+.... ... .. ...
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~~---i~-~~~---------- 226 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI---FQK---II-KLE---------- 226 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH---HH-TTC----------
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH---HHH---HH-cCC----------
Confidence 3333344599999999999999999999999999999999999999987543211 110 00 000
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.. .+...++++.+||.+||+.||++|||++|+++
T Consensus 227 ---~~-~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 227 ---YD-FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ---CC-CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ---CC-CCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 00 11234567999999999999999999999754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=399.88 Aligned_cols=257 Identities=23% Similarity=0.385 Sum_probs=199.8
Q ss_pred CCeeecccCceEEEEEEeCCC-----CEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 273 GNRLLGDSKTGGTYSGILPDG-----SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~~g-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
..++||+|+||.||+|.+.++ ..||||+++.. ......+|.+|+.++++++|||||+++|++.+.+..++||||
T Consensus 11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~ 90 (283)
T d1mqba_ 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 90 (283)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence 356899999999999986532 37999999764 334456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+.+++|.+++.. ....+++.+++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 91 ~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 91 MENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp CTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred cccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence 999999998764 235699999999999999999999999 99999999999999999999999999998765432
Q ss_pred ccc-ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 427 MQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 427 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
... ......||+.|+|||++.+..++.++|||||||++|||+||..|+...... ..+.... ..+.
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i----~~~~-------- 230 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAI----NDGF-------- 230 (283)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH----HTTC--------
T ss_pred ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHHH----hccC--------
Confidence 221 222234899999999999999999999999999999999966655433221 1111111 1000
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
....+..++..+.+||.+||+.||++|||+.||++.|+++.+.|
T Consensus 231 -----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 231 -----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp -----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -----CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 11112235567999999999999999999999999999887764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-51 Score=410.23 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=203.0
Q ss_pred cCCeeecccCceEEEEEEeCC-C-----CEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEE
Q 008216 272 EGNRLLGDSKTGGTYSGILPD-G-----SRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~-g-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 343 (573)
+..+.||+|+||+||+|+... + ..||||.+... .......+.+|+.+|.++ +|||||++++++.+.+..++|
T Consensus 40 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 119 (325)
T d1rjba_ 40 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 119 (325)
T ss_dssp EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEE
Confidence 445688999999999998532 2 36999998654 334456789999999998 899999999999999999999
Q ss_pred EEecCCCCHHHHhccCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCee
Q 008216 344 YEFVVNGPLDRWLHHIPR-------------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVL 404 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIl 404 (573)
|||+++|+|.+++..... ....+++..++.++.||++||+|||++ +|+||||||+|||
T Consensus 120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Nil 196 (325)
T d1rjba_ 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVL 196 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEE
T ss_pred EEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhccc
Confidence 999999999999975321 123589999999999999999999999 9999999999999
Q ss_pred eCCCCCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccch
Q 008216 405 LDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQ 483 (573)
Q Consensus 405 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~ 483 (573)
++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+...
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~-- 274 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA-- 274 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--
T ss_pred cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999987654433333333348999999999999999999999999999999998 899998755421
Q ss_pred hhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q 008216 484 SIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQ 548 (573)
Q Consensus 484 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 548 (573)
.+.. ...... ....+..+++++.+||.+||+.||++|||++||++.|.
T Consensus 275 ~~~~----~~~~~~-------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 275 NFYK----LIQNGF-------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHH----HHHTTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH----HHhcCC-------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1111 111100 11112235578999999999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-51 Score=411.53 Aligned_cols=263 Identities=22% Similarity=0.363 Sum_probs=203.5
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
+..+.||+|+||+||+|.. .+|+.||+|+++.. .....+.+.+|+.+|++++|||||++++++.+.+..++||||+++
T Consensus 9 ~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~g 88 (322)
T d1s9ja_ 9 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 88 (322)
T ss_dssp EEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 3345789999999999996 46899999999765 333457889999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
|+|.+++.+ ...+++..+..++.|++.||+|||+ + +|+||||||+|||++.++.+||+|||+|+......
T Consensus 89 g~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 159 (322)
T d1s9ja_ 89 GSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 159 (322)
T ss_dssp EEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--
T ss_pred CcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCCc--
Confidence 999999964 2469999999999999999999996 6 89999999999999999999999999998653221
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhh-h--------------
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL-V-------------- 493 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~-~-------------- 493 (573)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+.............. .
T Consensus 160 --~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 160 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp --C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred --cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 12335999999999999999999999999999999999999999875543211110000000 0
Q ss_pred --------hccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 494 --------QSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 494 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
......+..+..........+....+.++.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000000111111111122223334578999999999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-50 Score=404.49 Aligned_cols=240 Identities=23% Similarity=0.386 Sum_probs=197.7
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
-+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+++..++||||+++
T Consensus 20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~ 99 (309)
T d1u5ra_ 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 99 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCC
Confidence 45679999999999985 468899999997653 23346789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQE 429 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 429 (573)
|+|..++.. ...+++.++..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 100 g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~--- 169 (309)
T d1u5ra_ 100 SASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN--- 169 (309)
T ss_dssp EHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC---
T ss_pred CchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCCC---
Confidence 999877643 35699999999999999999999999 99999999999999999999999999998754321
Q ss_pred ceeccCCcccccccccccC---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccc
Q 008216 430 RTVMAGGTYGYLAPEFVYR---NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLI 506 (573)
Q Consensus 430 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (573)
...||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ........
T Consensus 170 ---~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~------~~~i~~~~---------- 230 (309)
T d1u5ra_ 170 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNE---------- 230 (309)
T ss_dssp ---CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSC----------
T ss_pred ---ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhCC----------
Confidence 2349999999999864 4589999999999999999999999976543210 01111100
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 507 SSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 507 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.........++.+.+||.+||+.||++|||++|+++
T Consensus 231 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 231 ---SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ---CCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 011122334578999999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-50 Score=401.11 Aligned_cols=249 Identities=20% Similarity=0.302 Sum_probs=188.8
Q ss_pred CcCCeeecccCceEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 271 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF-QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
++..+.||+|+||+||+|+.. +|+.||||++..... .....+.+|+.+|++++||||+++++++.+++..|+||||++
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 455678899999999999964 689999999976532 334568899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC---CCCCeeEecccCCccCCcc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~ 425 (573)
||+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+++.....
T Consensus 91 gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 91 GGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp SCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred CCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999999964 35699999999999999999999999 999999999999995 5788999999999876433
Q ss_pred ccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....... .. ... ... ..
T Consensus 164 ~~~---~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~~---i~~-~~~-~~---- 228 (307)
T d1a06a_ 164 SVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF---EQ---ILK-AEY-EF---- 228 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HH---HHT-TCC-CC----
T ss_pred Cee---eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH---HH---Hhc-cCC-CC----
Confidence 222 2234999999999999999999999999999999999999999875532111 10 000 000 00
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
........++++.+||.+||+.||++|||++|+++.
T Consensus 229 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 229 -----DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -----CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 011122355789999999999999999999999973
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.9e-49 Score=403.51 Aligned_cols=249 Identities=19% Similarity=0.278 Sum_probs=206.6
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCC
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVN 349 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 349 (573)
++..+.||+|+||.||+|.. .+|+.||||+++.......+.+.+|+.+|++++||||+++++++.+++..|+||||+++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 45556889999999999996 46999999999877666677899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC--CCCCeeEecccCCccCCcccc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD--EEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
|+|.+++.. .+..+++.+++.++.||+.||+|||++ ||+||||||+|||++ .++.+||+|||+|........
T Consensus 111 g~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 111 GELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred ChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 999988753 345699999999999999999999999 999999999999997 578899999999988764432
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
. ....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+.... .... .. ... . .
T Consensus 185 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i---~~-~~~-~-----~- 247 (352)
T d1koba_ 185 V---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQNV---KR-CDW-E-----F- 247 (352)
T ss_dssp E---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHH---HH-CCC-C-----C-
T ss_pred e---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH---Hh-CCC-C-----C-
Confidence 2 223499999999999999999999999999999999999999987654321 1100 00 000 0 0
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
........++++.+||.+||+.||.+|||++|+++
T Consensus 248 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 ---DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ---CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ---CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111235568999999999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.1e-49 Score=402.79 Aligned_cols=249 Identities=19% Similarity=0.280 Sum_probs=206.0
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+..+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++||||+++++++.+++..++||||+++|
T Consensus 29 ~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg 108 (350)
T d1koaa2 29 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 108 (350)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 4456789999999999996 468999999998877677788999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC--CCCeeEecccCCccCCccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE--EFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++........
T Consensus 109 ~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 109 ELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp BHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred CHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 99999853 235699999999999999999999999 9999999999999964 578999999999876543322
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
....||+.|||||++.+..++.++|||||||++|||+||+.||.+.+.... .... .. ... ..
T Consensus 183 ---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i---~~-~~~-~~------- 244 (350)
T d1koaa2 183 ---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LRNV---KS-CDW-NM------- 244 (350)
T ss_dssp ---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH---HH-TCC-CS-------
T ss_pred ---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH---HHHH---Hh-CCC-CC-------
Confidence 223499999999999999999999999999999999999999986553211 1111 00 000 00
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
........++++.+||.+||+.||++|||++|+++.
T Consensus 245 --~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 --DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111112345679999999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-50 Score=395.38 Aligned_cols=256 Identities=25% Similarity=0.363 Sum_probs=201.4
Q ss_pred cCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
+..+.||+|+||.||+|.+++++.||||+++... ...+.|.+|+.++++++|||||+++|++. .+..++||||+++|+
T Consensus 20 ~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~ 97 (285)
T d1fmka3 20 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGS 97 (285)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred EEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCc
Confidence 4455689999999999999888899999997653 44578999999999999999999999985 456899999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
|..++.. .....+++.+++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++..........
T Consensus 98 l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~- 171 (285)
T d1fmka3 98 LLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR- 171 (285)
T ss_dssp HHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred hhhhhhh--cccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceee-
Confidence 9998865 2234699999999999999999999999 999999999999999999999999999987654332222
Q ss_pred eccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 432 VMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
....||+.|+|||++.+..++.++||||||+++|||+||..|+...... ........ ... .
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~----~~~-------------~ 232 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVE----RGY-------------R 232 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHH----TTC-------------C
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHH----hcC-------------C
Confidence 2234899999999999999999999999999999999976665443221 11111111 000 0
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
...+..+++++.++|.+||+.||++|||+++|++.|+......
T Consensus 233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 1112235568999999999999999999999999999876543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-49 Score=396.10 Aligned_cols=259 Identities=25% Similarity=0.392 Sum_probs=208.6
Q ss_pred CcCCeeecccCceEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIV 343 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 343 (573)
.+..+.||+|+||.||+|+.. +++.||||+++... ....+++.+|+.+|++++||||+++++++.+.+..+++
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 344567899999999999853 35789999997653 33457799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCe
Q 008216 344 YEFVVNGPLDRWLHHIP--------------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNV 403 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NI 403 (573)
|||+++|+|.+++.... .....+++..++.++.|++.||+|||++ +++||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccce
Confidence 99999999999996422 1223588999999999999999999999 999999999999
Q ss_pred eeCCCCCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCC-CCCCCCCcccc
Q 008216 404 LLDEEFGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR-RPAQAVDSVCW 482 (573)
Q Consensus 404 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~-~Pf~~~~~~~~ 482 (573)
|++.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++|. +||...+..+.
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~ 251 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHH
Confidence 99999999999999998765544444444455899999999999999999999999999999999985 67776554321
Q ss_pred hhhHHhhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 483 QSIFEWATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
... ...+.. . ..+..+++++.+||.+||+.||++||||.||++.|+++.+
T Consensus 252 ~~~-------v~~~~~------------~-~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 252 IYY-------VRDGNI------------L-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HHH-------HHTTCC------------C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHH-------HHcCCC------------C-CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111 111111 0 1122345679999999999999999999999999998753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=391.90 Aligned_cols=255 Identities=27% Similarity=0.358 Sum_probs=196.8
Q ss_pred CcCCeeecccCceEEEEEEeCC----CCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEE
Q 008216 271 SEGNRLLGDSKTGGTYSGILPD----GSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
++..+.||+|+||.||+|++.. +..||||.++.. .....+.+.+|+.+|++++||||+++++++. ++..++|||
T Consensus 9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E 87 (273)
T d1mp8a_ 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME 87 (273)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred eEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEE
Confidence 4455688999999999998643 357999998754 3344577999999999999999999999985 567899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
|+++|+|.+++.. ....+++..++.++.||++||+|||++ +++||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 88 LCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp CCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred eccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 9999999998764 235689999999999999999999999 9999999999999999999999999999876543
Q ss_pred ccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
.... .....||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..... ... .. ..
T Consensus 162 ~~~~-~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~---~~i---~~-~~------- 226 (273)
T d1mp8a_ 162 TYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRI---EN-GE------- 226 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHH---HT-TC-------
T ss_pred ccee-ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH---HHH---Hc-CC-------
Confidence 3222 223348999999999999999999999999999999998 89999876543211 111 01 10
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
....+..+++++.+||.+||+.||++|||++||++.|+++.++
T Consensus 227 ------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 227 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0111224567899999999999999999999999999887543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=391.19 Aligned_cols=250 Identities=19% Similarity=0.283 Sum_probs=203.2
Q ss_pred CCCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccch------hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceE
Q 008216 269 NFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF------QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRY 341 (573)
Q Consensus 269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 341 (573)
+.++..+.||+|+||.||+|+. .+|+.||||+++.... ...+.+.+|+.+|++++||||+++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3445567789999999999996 5699999999975421 23578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC----CeeEeccc
Q 008216 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF----GAHLMGVG 417 (573)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfg 417 (573)
+||||+++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||
T Consensus 90 iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999965 24699999999999999999999999 999999999999998776 49999999
Q ss_pred CCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccc
Q 008216 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 497 (573)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 497 (573)
++......... ....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+.... .... . ...
T Consensus 163 ~a~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~~i---~-~~~ 232 (293)
T d1jksa_ 163 LAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LANV---S-AVN 232 (293)
T ss_dssp TCEECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH---H-TTC
T ss_pred hhhhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH---HHHH---H-hcC
Confidence 99876543222 223489999999999999999999999999999999999999987654211 1100 0 000
Q ss_pred cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
. . . ........++.+.+||.+||+.||++|||++|+++
T Consensus 233 ~-~-~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 Y-E-F--------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C-C-C--------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C-C-C--------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0 0 00001234567899999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=397.64 Aligned_cols=256 Identities=22% Similarity=0.374 Sum_probs=202.8
Q ss_pred cCCeeecccCceEEEEEEeC-CCC----EEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGS----RVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 345 (573)
+..++||+|+||+||+|.+. +|+ +||||.++.. .....+++.+|+.++++++|||||+++|++.++ ..++++|
T Consensus 12 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e 90 (317)
T d1xkka_ 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQ 90 (317)
T ss_dssp EEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEE
T ss_pred EEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEE
Confidence 33468899999999999863 444 6899988654 334567899999999999999999999999764 5678899
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
++.+|+|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 91 LMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp CCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 9999999998864 345699999999999999999999999 9999999999999999999999999999977654
Q ss_pred ccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
..........||+.|+|||++.++.++.++|||||||++|||+| |.+||...+......... .+.
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-------~~~------- 230 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE------- 230 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-------HTC-------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCC-------
Confidence 44333333448999999999999999999999999999999999 899988765432221111 110
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
....+..+++++.+|+.+||+.||++|||+.||++.|+.+...+
T Consensus 231 ------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~ 274 (317)
T d1xkka_ 231 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274 (317)
T ss_dssp ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred ------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence 01112235567999999999999999999999999998876554
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=385.45 Aligned_cols=246 Identities=28% Similarity=0.433 Sum_probs=195.4
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEee-CCceEEEEEecCCCCH
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYEFVVNGPL 352 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~~~~gsL 352 (573)
.+.||+|+||.||+|.+ .|+.||||+++.+. ..+.+.+|++++++++||||++++|++.+ .+..++||||+++|+|
T Consensus 12 ~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L 88 (262)
T d1byga_ 12 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 88 (262)
T ss_dssp EEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred eEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence 45689999999999998 68899999997653 45779999999999999999999999865 4668999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccccccee
Q 008216 353 DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERTV 432 (573)
Q Consensus 353 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 432 (573)
.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 89 ~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----~ 158 (262)
T d1byga_ 89 VDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----D 158 (262)
T ss_dssp HHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred HHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC-----c
Confidence 9999642 223589999999999999999999999 99999999999999999999999999998654321 1
Q ss_pred ccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhccccccccccccccCCC
Q 008216 433 MAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISSLSS 511 (573)
Q Consensus 433 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (573)
...+|..|+|||++.+..+++++||||||+++|||+| |++||...+... +..... .+.. .
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~----~~~~------------~ 219 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVE----KGYK------------M 219 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHT----TTCC------------C
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH----cCCC------------C
Confidence 2238899999999999999999999999999999998 788877654332 111111 1100 1
Q ss_pred CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 512 DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 512 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
. .+...++++.+||.+||+.||++|||+.+|++.|+++..
T Consensus 220 ~-~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 220 D-APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp C-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 1 122345679999999999999999999999999988743
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=392.60 Aligned_cols=260 Identities=26% Similarity=0.342 Sum_probs=196.9
Q ss_pred CcCCeeecccCceEEEEEEeC------CCCEEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeC-CceE
Q 008216 271 SEGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDH-GDRY 341 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-~~~~ 341 (573)
++..+.||+|+||.||+|.+. +++.||||+++.. .....+.+.+|...+.++ +|+||+.+++++.+. +..+
T Consensus 15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~ 94 (299)
T d1ywna1 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 94 (299)
T ss_dssp EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred EEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEE
Confidence 445667899999999999853 3468999999764 334456788888888887 789999999988765 4679
Q ss_pred EEEEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC
Q 008216 342 IVYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF 409 (573)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~ 409 (573)
+||||+++|+|.+++..... ....+++.+++.++.||++||+|||++ +|+||||||+|||++.++
T Consensus 95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKN 171 (299)
T ss_dssp EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCC
Confidence 99999999999999975321 134589999999999999999999999 999999999999999999
Q ss_pred CeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcC-CCCCCCCCcccchhhHHh
Q 008216 410 GAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG-RRPAQAVDSVCWQSIFEW 488 (573)
Q Consensus 410 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~ 488 (573)
.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+|| .+||....... .+..
T Consensus 172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~--~~~~- 248 (299)
T d1ywna1 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR- 248 (299)
T ss_dssp CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HHHH-
T ss_pred cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH--HHHH-
Confidence 9999999999876544433333344599999999999999999999999999999999996 56776554321 1111
Q ss_pred hhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 489 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
....+. ....+...++++.++|.+||+.||++|||++||++.|+++.+
T Consensus 249 ---~~~~~~-------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 249 ---RLKEGT-------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp ---HHHHTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHhcCC-------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111110 001112345679999999999999999999999999998753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=391.22 Aligned_cols=244 Identities=23% Similarity=0.254 Sum_probs=203.0
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
+..+.||+|+||.||+|+. .+|+.||||++++.. ....+.+.+|+.+|++++||||+++++++.+.+..|+||||+
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~ 87 (337)
T d1o6la_ 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceecc
Confidence 3356789999999999996 579999999997642 234577899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 88 ~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 88 NGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp TTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred CCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 99999999865 35689999999999999999999999 999999999999999999999999999987643322
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
. ....+||+.|+|||++.+..++.++||||+||++|||++|++||...+.... .... ...
T Consensus 161 ~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---~~~i----~~~----------- 220 (337)
T d1o6la_ 161 T--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELI----LME----------- 220 (337)
T ss_dssp C--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHC-----------
T ss_pred c--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH---HHHH----hcC-----------
Confidence 1 2233499999999999999999999999999999999999999987654321 1110 000
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 545 (573)
....+...++++.+||.+||+.||++||+ ++|+++
T Consensus 221 ---~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 221 ---EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 00112235667999999999999999995 788876
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=387.40 Aligned_cols=258 Identities=25% Similarity=0.397 Sum_probs=205.8
Q ss_pred CcCCeeecccCceEEEEEEeCC--------CCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCce
Q 008216 271 SEGNRLLGDSKTGGTYSGILPD--------GSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDR 340 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 340 (573)
++..+.||+|+||.||+|+... +..||||+++... .....++.+|...+.++ +||||+++++++.+++..
T Consensus 15 ~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~ 94 (299)
T d1fgka_ 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 94 (299)
T ss_dssp EEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred eEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeE
Confidence 3445688999999999998522 3479999997754 34457889999999888 899999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC
Q 008216 341 YIVYEFVVNGPLDRWLHHIPR------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~ 408 (573)
++||||+++|+|.+++..... ....+++.+++.++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 95 ~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~ 171 (299)
T d1fgka_ 95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED 171 (299)
T ss_dssp EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCC
Confidence 999999999999999975432 235689999999999999999999999 99999999999999999
Q ss_pred CCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHH
Q 008216 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFE 487 (573)
Q Consensus 409 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 487 (573)
+.+||+|||+++...............+|+.|+|||.+.++.++.++||||||+++|||++ |.+||...+... +..
T Consensus 172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---~~~ 248 (299)
T d1fgka_ 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFK 248 (299)
T ss_dssp CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH
T ss_pred CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---HHH
Confidence 9999999999997765544444444558999999999999999999999999999999998 788887655321 111
Q ss_pred hhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 488 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
. ...+. ....+...++.+.+||.+||+.||++|||+.||++.|+++.
T Consensus 249 ~----i~~~~-------------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 249 L----LKEGH-------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp H----HHTTC-------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H----HHcCC-------------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 1 11110 01112234567999999999999999999999999998774
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=384.29 Aligned_cols=255 Identities=26% Similarity=0.418 Sum_probs=203.3
Q ss_pred CeeecccCceEEEEEEeCCC----CEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEee-CCceEEEEEec
Q 008216 274 NRLLGDSKTGGTYSGILPDG----SRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYD-HGDRYIVYEFV 347 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~~ 347 (573)
+++||+|+||+||+|.+.++ ..||||+++.. .....++|.+|+++|++++||||++++|++.+ ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 35789999999999996442 26899999753 44556789999999999999999999999876 45789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999874 345678889999999999999999999 999999999999999999999999999987654422
Q ss_pred cc--ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccc
Q 008216 428 QE--RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPL 505 (573)
Q Consensus 428 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 505 (573)
.. ......||+.|+|||.+.+..++.++||||||+++|||+||..||...... . +.........+
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~---~~~~~i~~g~~-------- 252 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--F---DITVYLLQGRR-------- 252 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTTCC--------
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--H---HHHHHHHcCCC--------
Confidence 21 112234899999999999999999999999999999999988887653321 1 11111111110
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCC
Q 008216 506 ISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQP 553 (573)
Q Consensus 506 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 553 (573)
. ..+..+++++.+||.+||+.||++|||+.||++.|+++.+.
T Consensus 253 -----~-~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 253 -----L-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp -----C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----C-CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 0 11123456799999999999999999999999999988654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=383.23 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=192.9
Q ss_pred CeeecccCceEEEEEEeC--CC--CEEEEEEeccc---chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEe
Q 008216 274 NRLLGDSKTGGTYSGILP--DG--SRVAVKRLKRS---SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEF 346 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~--~g--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 346 (573)
.+.||+|+||.||+|++. ++ ..||||+++.. .....++|.+|+.+|++++||||++++|++.+ +..++||||
T Consensus 13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~ 91 (273)
T d1u46a_ 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTEL 91 (273)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeee
Confidence 446799999999999853 23 37999998764 23345689999999999999999999999976 467899999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 426 (573)
+++|+|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 92 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 92 APLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp CTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred ecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 999999988764 234699999999999999999999999 99999999999999999999999999999775443
Q ss_pred ccc-ceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHHhhhhhhhcccccccccc
Q 008216 427 MQE-RTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDP 504 (573)
Q Consensus 427 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (573)
... ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||...+.... ... ......
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~---~~~---i~~~~~------- 232 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---LHK---IDKEGE------- 232 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH---HHTSCC-------
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH---HHH---HHhCCC-------
Confidence 222 2223347889999999999999999999999999999998 8999987654321 111 111100
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcc
Q 008216 505 LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQL 550 (573)
Q Consensus 505 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 550 (573)
....+...+..+.+||.+||+.||++|||+.||++.|++.
T Consensus 233 ------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 ------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 0111223456799999999999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=391.76 Aligned_cols=260 Identities=23% Similarity=0.365 Sum_probs=208.9
Q ss_pred CcCCeeecccCceEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEE
Q 008216 271 SEGNRLLGDSKTGGTYSGIL------PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYI 342 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 342 (573)
.+..+.||+|+||.||+|++ .+++.||||+++... ......+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 25 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~l 104 (311)
T d1t46a_ 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 104 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEE
Confidence 34466889999999999985 346789999997653 34556799999999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC
Q 008216 343 VYEFVVNGPLDRWLHHIPR--------------GGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE 408 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~ 408 (573)
||||+++|+|.+++..... ....+++..+..++.||+.||+|||++ +++||||||+||+++.+
T Consensus 105 vmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~ 181 (311)
T d1t46a_ 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG 181 (311)
T ss_dssp EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETT
T ss_pred EEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccccc
Confidence 9999999999999975321 234589999999999999999999999 99999999999999999
Q ss_pred CCeeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCcccchhhHH
Q 008216 409 FGAHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVS-GRRPAQAVDSVCWQSIFE 487 (573)
Q Consensus 409 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 487 (573)
+.+|++|||+++...............||+.|+|||.+.+..++.++||||||+++|||+| |.+||...+.... +..
T Consensus 182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~--~~~ 259 (311)
T d1t46a_ 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--FYK 259 (311)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--HHH
T ss_pred CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--HHH
Confidence 9999999999998765444333344458999999999999999999999999999999999 5555655443211 111
Q ss_pred hhhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 488 WATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
....+. ....+...++.+.+||.+||+.||++|||+++|+++|+++..
T Consensus 260 ----~i~~~~-------------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 260 ----MIKEGF-------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp ----HHHHTC-------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHhcCC-------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 111100 111112345679999999999999999999999999987644
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-47 Score=383.95 Aligned_cols=240 Identities=22% Similarity=0.295 Sum_probs=200.8
Q ss_pred CCeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 273 GNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+++..|+||||++
T Consensus 8 i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 87 (316)
T d1fota_ 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 87 (316)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecC
Confidence 345789999999999996 469999999997542 2345778999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
||+|..++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 88 gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-- 158 (316)
T d1fota_ 88 GGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 158 (316)
T ss_dssp SCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred Cccccccccc----cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecccc--
Confidence 9999998864 35688899999999999999999999 99999999999999999999999999998764322
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
....||+.|+|||++.+..++.++|||||||++|||+||+.||...+...... .... .
T Consensus 159 ---~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~i~~-~------------ 216 (316)
T d1fota_ 159 ---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE------KILN-A------------ 216 (316)
T ss_dssp ---CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHH-C------------
T ss_pred ---ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH------HHHc-C------------
Confidence 23459999999999999999999999999999999999999998755421111 1100 0
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH 545 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 545 (573)
....+...++++.+++.+||+.||++|| |++++++
T Consensus 217 --~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 217 --ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 0011123456799999999999999996 8999985
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=389.80 Aligned_cols=253 Identities=17% Similarity=0.232 Sum_probs=199.5
Q ss_pred hcCCCcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhc-CCCcEeEEeeEEee----CCce
Q 008216 267 TKNFSEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYD----HGDR 340 (573)
Q Consensus 267 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~~ 340 (573)
.++|....++||+|+||.||+|+. .+|+.||||+++.. ..+.+|+.++.++ +||||+++++++.+ .+..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 345655566789999999999996 56999999999653 4577899987665 89999999999876 3567
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---CCCeeEeccc
Q 008216 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE---EFGAHLMGVG 417 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg 417 (573)
|+||||++||+|.+++.. .....+++.++..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence 999999999999999975 3345799999999999999999999999 9999999999999985 4569999999
Q ss_pred CCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccc
Q 008216 418 LSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHR 497 (573)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 497 (573)
+++........ ....||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+........ ..
T Consensus 160 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~------~~--- 227 (335)
T d2ozaa1 160 FAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------KT--- 227 (335)
T ss_dssp TCEECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------
T ss_pred eeeeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH------HH---
Confidence 99876543322 2334999999999999999999999999999999999999999765432111000 00
Q ss_pred cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.+..... ..+.......++++.+||.+||+.||++|||+.|+++
T Consensus 228 --~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 228 --RIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp --CCCSCSS--SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --HHhcCCC--CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000000 0011112345678999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=387.25 Aligned_cols=263 Identities=22% Similarity=0.377 Sum_probs=212.2
Q ss_pred cCCeeecccCceEEEEEEeC------CCCEEEEEEeccc-chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGILP------DGSRVAVKRLKRS-SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 344 (573)
+..+.||+|+||+||+|.+. +++.||||+++.. .......+.+|+.++++++||||+++++++...+..++||
T Consensus 23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 102 (308)
T d1p4oa_ 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 102 (308)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence 44567899999999999863 3578999999764 3344567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccC
Q 008216 345 EFVVNGPLDRWLHHIP------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGL 418 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 418 (573)
||+++|+|.+++.... .....+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeeccc
Confidence 9999999999886421 1224578999999999999999999999 999999999999999999999999999
Q ss_pred CccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcC-CCCCCCCCcccchhhHHhhhhhhhccc
Q 008216 419 SKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSG-RRPAQAVDSVCWQSIFEWATPLVQSHR 497 (573)
Q Consensus 419 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 497 (573)
++...............||+.|+|||.+.+..++.++||||||+++|||+|| .+||...+.... ... .. ...
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~---~~~---i~-~~~ 252 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---LRF---VM-EGG 252 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH---HHH---HH-TTC
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH---HHH---HH-hCC
Confidence 9876554433333333489999999999999999999999999999999998 477766543211 111 11 111
Q ss_pred cccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCCchh
Q 008216 498 YLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPPVTK 557 (573)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 557 (573)
. .. .+..+++.+.++|.+||+.||++|||+++|++.|++..++...+
T Consensus 253 ~------------~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 253 L------------LD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp C------------CC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred C------------CC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 0 11 11234567999999999999999999999999999998876543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-47 Score=378.69 Aligned_cols=257 Identities=23% Similarity=0.306 Sum_probs=199.9
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCc----eEE
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGD----RYI 342 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----~~l 342 (573)
++..+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+.++++++||||+++++++...+. .|+
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence 34566889999999999995 579999999997643 2335678999999999999999999999887543 789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
||||++|++|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++..+++|||.+...
T Consensus 89 vmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhh
Confidence 9999999999998864 34699999999999999999999999 9999999999999999999999999998765
Q ss_pred Ccccc-ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccc
Q 008216 423 PWEVM-QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLEL 501 (573)
Q Consensus 423 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 501 (573)
..... ........||+.|+|||++.+..++.++|||||||++|||+||++||...+.... .........
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~~---- 231 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP---- 231 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCC----
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcCC----
Confidence 43322 2222334599999999999999999999999999999999999999987553211 111111100
Q ss_pred cccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhccc
Q 008216 502 LDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-RMSHVVHQLQQLA 551 (573)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~ 551 (573)
..+ .......++++.++|.+||+.||++|| |++++++.|.++.
T Consensus 232 ~~~-------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 232 IPP-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCG-------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCC-------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 000 001123456799999999999999999 8999999988764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=382.62 Aligned_cols=262 Identities=18% Similarity=0.216 Sum_probs=194.9
Q ss_pred eeecccCceEEEEEEe-CCCCEEEEEEecccchhh-----HHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 275 RLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQR-----KKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
++||+|+||+||+|+. .+|+.||||+++...... .+.+.+|+.+|++++||||+++++++.+++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 5789999999999996 469999999997543221 2468899999999999999999999999999999999998
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 428 (573)
++++..+.. .+..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 84 TDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp EEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred chHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 887766653 345689999999999999999999999 9999999999999999999999999999876543322
Q ss_pred cceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccc---cc
Q 008216 429 ERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL---DP 504 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 504 (573)
. ....||+.|+|||++.+ ..++.++|||||||++|||+||.+||...+..+..................... ..
T Consensus 157 ~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 157 Y--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp C--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred c--cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence 1 22348999999999865 467999999999999999999999998765432111110000000000000000 00
Q ss_pred ccccCCCCCcc----hHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 505 LISSLSSDIPE----AGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 505 ~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.........+. ...++++.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000001110 123567999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-48 Score=386.62 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=203.0
Q ss_pred CeeecccCceEEEEEEeCC-CC--EEEEEEeccc-chhhHHHHHHHHHHHhhc-CCCcEeEEeeEEeeCCceEEEEEecC
Q 008216 274 NRLLGDSKTGGTYSGILPD-GS--RVAVKRLKRS-SFQRKKEFYSEIGRFARL-HHPNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
.+.||+|+||.||+|.+.+ |. .||||+++.. .....+.+.+|+++|+++ +||||+++++++.+.+..++||||++
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 4678999999999999643 43 5788888654 333456799999999999 79999999999999999999999999
Q ss_pred CCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecc
Q 008216 349 NGPLDRWLHHIP------------RGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGV 416 (573)
Q Consensus 349 ~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 416 (573)
+|+|.++++... .....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~Df 171 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF 171 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCT
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEccc
Confidence 999999997531 2346799999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCC-CCCCCCCcccchhhHHhhhhhhhc
Q 008216 417 GLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGR-RPAQAVDSVCWQSIFEWATPLVQS 495 (573)
Q Consensus 417 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~ 495 (573)
|+++........ ....||..|+|||.+.+..++.++|||||||++|||++|. +||...+... +.... ...
T Consensus 172 G~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~~~i---~~~ 242 (309)
T d1fvra_ 172 GLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL---PQG 242 (309)
T ss_dssp TCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHG---GGT
T ss_pred cccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HHHHH---Hhc
Confidence 999865433222 2234899999999999999999999999999999999975 5676544321 11111 010
Q ss_pred cccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccCCC
Q 008216 496 HRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQPP 554 (573)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 554 (573)
. ....+..+++++.+||.+||+.||++|||++||++.|+++.+..
T Consensus 243 ~--------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 243 Y--------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp C--------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred C--------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 0 01112235578999999999999999999999999999887543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=383.22 Aligned_cols=265 Identities=21% Similarity=0.286 Sum_probs=196.7
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC----ceEEEEEecCC
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG----DRYIVYEFVVN 349 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~e~~~~ 349 (573)
.+.||+|+||.||+|++ +|+.||||+++.... .......|+..+.+++||||+++++++.+.+ ..++||||+++
T Consensus 8 ~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~ 85 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence 45689999999999997 789999999975432 2222344566667789999999999998754 47999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCc
Q 008216 350 GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV-----KPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (573)
Q Consensus 350 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 424 (573)
|+|.++++. ..+++..++.++.|++.||+|||+.. ..+|+||||||+||||+.++.+||+|||+++....
T Consensus 86 g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 86 GSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp CBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 999999975 35899999999999999999999631 23999999999999999999999999999987644
Q ss_pred cccc--cceeccCCcccccccccccCCC------CCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhh--------HHh
Q 008216 425 EVMQ--ERTVMAGGTYGYLAPEFVYRNE------LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI--------FEW 488 (573)
Q Consensus 425 ~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~--------~~~ 488 (573)
.... .......||+.|+|||++.+.. ++.++|||||||++|||+||..||........... ...
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHH
Confidence 3221 1222345999999999987542 57799999999999999999988765332211000 000
Q ss_pred hhhhhhccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 489 ATPLVQSHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
....... +.+++.+ ............+.+|+.+||+.||++|||+.||++.|+++.+
T Consensus 241 ~~~~~~~----~~~~p~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 241 MRKVVCE----QKLRPNI---PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHTT----SCCCCCC---CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhc----cccCCCC---CcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0000000 1111111 1111233466779999999999999999999999999998764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.6e-47 Score=375.09 Aligned_cols=247 Identities=22% Similarity=0.307 Sum_probs=200.9
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccch---------hhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeCCce
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF---------QRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDR 340 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~ 340 (573)
+..+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.++++++ ||||+++++++.+++..
T Consensus 6 ~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 85 (277)
T d1phka_ 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 85 (277)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcce
Confidence 4456789999999999996 5689999999975421 12346889999999996 99999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
|+||||+++|+|.+++.. ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 86 FLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhee
Confidence 999999999999999964 34699999999999999999999999 99999999999999999999999999998
Q ss_pred cCCccccccceeccCCcccccccccccC------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhh
Q 008216 421 FVPWEVMQERTVMAGGTYGYLAPEFVYR------NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQ 494 (573)
Q Consensus 421 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 494 (573)
........ ....||+.|+|||.+.+ ..++.++||||+||++|||+||+.||...+...... ...
T Consensus 159 ~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~------~i~- 228 (277)
T d1phka_ 159 QLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR------MIM- 228 (277)
T ss_dssp ECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHH-
T ss_pred EccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH------HHH-
Confidence 76543322 22349999999998863 356889999999999999999999998765422111 001
Q ss_pred ccccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 495 SHRYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
..... . ........++++.+|+.+||+.||++|||++||++
T Consensus 229 ~~~~~-~---------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 SGNYQ-F---------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HTCCC-C---------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hCCCC-C---------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11100 0 11122346678999999999999999999999865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=382.61 Aligned_cols=247 Identities=17% Similarity=0.198 Sum_probs=201.1
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
+..+.||+|+||+||+|... +|+.||||+++... .+...+.+|+++|++++||||+++++++.+++..|+||||++||
T Consensus 8 ~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg 86 (321)
T d1tkia_ 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence 34567899999999999964 68899999998764 34466889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC--CCeeEecccCCccCCccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE--FGAHLMGVGLSKFVPWEVMQ 428 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~--~~~kl~Dfg~~~~~~~~~~~ 428 (573)
+|.+++.. .+..+++.++..++.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+++........
T Consensus 87 ~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~ 160 (321)
T d1tkia_ 87 DIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp BHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred cHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence 99999964 234699999999999999999999999 99999999999999854 47999999999876543322
Q ss_pred cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccccccccc
Q 008216 429 ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLISS 508 (573)
Q Consensus 429 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 508 (573)
....+|+.|+|||.+.+..++.++||||+||++|+|++|+.||...+.... ... ... ... . ++
T Consensus 161 ---~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~---~~~---i~~-~~~-~-~~----- 223 (321)
T d1tkia_ 161 ---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI---IEN---IMN-AEY-T-FD----- 223 (321)
T ss_dssp ---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHH---HHH-TCC-C-CC-----
T ss_pred ---cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH---HHH---HHh-CCC-C-CC-----
Confidence 223389999999999999999999999999999999999999987654211 111 000 000 0 00
Q ss_pred CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 509 LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 509 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
.......++++.+||.+||+.||++|||++|+++
T Consensus 224 ---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 224 ---EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001124567899999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.9e-47 Score=388.41 Aligned_cols=245 Identities=20% Similarity=0.243 Sum_probs=195.9
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEecccch---hhHHHHHH---HHHHHhhcCCCcEeEEeeEEeeCCceEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSF---QRKKEFYS---EIGRFARLHHPNLVAVKGCCYDHGDRYIVY 344 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~---E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 344 (573)
+..++||+|+||.||+|+.. +|+.||||++..... .....+.+ |+.+++.++||||+++++++.+.+..|+||
T Consensus 7 ~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivm 86 (364)
T d1omwa3 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 86 (364)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEE
Confidence 34568899999999999964 699999999965321 12233444 467777889999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCc
Q 008216 345 EFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPW 424 (573)
Q Consensus 345 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 424 (573)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 87 E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 87 DLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp CCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999964 35689999999999999999999999 999999999999999999999999999987654
Q ss_pred cccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccc
Q 008216 425 EVMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLD 503 (573)
Q Consensus 425 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 503 (573)
... ....||+.|+|||++.. ..++.++|||||||++|||+||+.||..........+.... ..
T Consensus 160 ~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~------------~~ 223 (364)
T d1omwa3 160 KKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT------------LT 223 (364)
T ss_dssp SCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS------------SS
T ss_pred Ccc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------------cc
Confidence 322 23349999999999875 56899999999999999999999999875543221111100 00
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008216 504 PLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH 545 (573)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 545 (573)
. ....+...++++.+||.+||+.||++||| ++|+++
T Consensus 224 ~------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 224 M------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp C------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred C------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0 11112235667999999999999999999 688875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8e-47 Score=384.00 Aligned_cols=241 Identities=20% Similarity=0.257 Sum_probs=200.8
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS---FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
+..+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+.+..++||||+
T Consensus 44 ~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~ 123 (350)
T d1rdqe_ 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123 (350)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccc
Confidence 3345789999999999996 469999999997542 233567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
.+|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 124 ~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~- 195 (350)
T d1rdqe_ 124 AGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp TTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred cccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-
Confidence 99999999864 24699999999999999999999999 99999999999999999999999999998765322
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
....||+.|||||++.+..++.++|||||||++|||+||+.||.+.+.... ... ... .
T Consensus 196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~---i~~-~----------- 253 (350)
T d1rdqe_ 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---YEK---IVS-G----------- 253 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH---HHH-C-----------
T ss_pred ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH---HHH---Hhc-C-----------
Confidence 123499999999999999999999999999999999999999987543211 110 000 0
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRP-----RMSHVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 545 (573)
....+...++++.+||.+||+.||.+|+ |++++++
T Consensus 254 ---~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 254 ---KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0011223456799999999999999994 8999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=381.99 Aligned_cols=243 Identities=22% Similarity=0.301 Sum_probs=198.3
Q ss_pred CCeeecccCceEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHh-hcCCCcEeEEeeEEeeCCceEEEEEec
Q 008216 273 GNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSS---FQRKKEFYSEIGRFA-RLHHPNLVAVKGCCYDHGDRYIVYEFV 347 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~lv~e~~ 347 (573)
..+.||+|+||+||+|+.. +|+.||||++++.. ....+.+..|..++. .++||||+++++++.+++..|+||||+
T Consensus 6 i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~ 85 (320)
T d1xjda_ 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL 85 (320)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeec
Confidence 3467899999999999964 68999999997542 223456677777665 689999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVM 427 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 427 (573)
++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 86 ~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 86 NGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 99999999964 34689999999999999999999999 999999999999999999999999999986654322
Q ss_pred ccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccccccccccc
Q 008216 428 QERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELLDPLIS 507 (573)
Q Consensus 428 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 507 (573)
. .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+.... .... ...
T Consensus 159 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~~~i----~~~----------- 218 (320)
T d1xjda_ 159 K--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---FHSI----RMD----------- 218 (320)
T ss_dssp C--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHC-----------
T ss_pred c--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH---HHHH----HcC-----------
Confidence 2 2223499999999999999999999999999999999999999987654321 1111 000
Q ss_pred cCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 008216 508 SLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS-HVVH 545 (573)
Q Consensus 508 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 545 (573)
....+...++++.+||.+||+.||++|||+. ++++
T Consensus 219 ---~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 ---NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0011123456799999999999999999995 6753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=372.70 Aligned_cols=271 Identities=21% Similarity=0.291 Sum_probs=199.0
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|+||+||+|+. .+|+.||||+++.... ...+++.+|+.+|++++||||+++++++.+++..++||||+.+
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~- 85 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ- 85 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-
Confidence 35789999999999996 5699999999975532 2357889999999999999999999999999999999999965
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
++.+++.. .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.........
T Consensus 86 ~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~- 159 (298)
T d1gz8a_ 86 DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY- 159 (298)
T ss_dssp EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT-
T ss_pred chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcccc-
Confidence 44455543 3345699999999999999999999999 99999999999999999999999999998664332221
Q ss_pred eeccCCcccccccccccCCC-CCcchhhHHHHHHHHHHHcCCCCCCCCCcccchh-hHHhhhhhhhccccccc--cc---
Q 008216 431 TVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATPLVQSHRYLEL--LD--- 503 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~--~~--- 503 (573)
....||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+...... ....... ......... ..
T Consensus 160 -~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 160 -THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT-PDEVVWPGVTSMPDYK 237 (298)
T ss_dssp -TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTTTSTTGGGSTTCC
T ss_pred -eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCC-Cchhhccccccccccc
Confidence 2224999999999877655 5789999999999999999999998765421110 0000000 000000000 00
Q ss_pred cccccCCCCCc---chHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhcccCC
Q 008216 504 PLISSLSSDIP---EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQLAQP 553 (573)
Q Consensus 504 ~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~ 553 (573)
........... ....++++.+|+.+||+.||++|||++|+++. ++++.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 00000000000 11234678999999999999999999999984 6665443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.9e-46 Score=367.22 Aligned_cols=263 Identities=20% Similarity=0.245 Sum_probs=197.0
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccch--hhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCCC
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF--QRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNGP 351 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 351 (573)
-+.||+|+||+||+|+.++|+.||||+++.... ...+.+.+|+.+|++++||||+++++++.+++..+++||++.+++
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~ 86 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL 86 (286)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhh
Confidence 456799999999999998999999999976532 235789999999999999999999999999999999999998777
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccce
Q 008216 352 LDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQERT 431 (573)
Q Consensus 352 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 431 (573)
+..+.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+......... .
T Consensus 87 ~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~ 157 (286)
T d1ob3a_ 87 KKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--Y 157 (286)
T ss_dssp HHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred HHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccc--c
Confidence 766653 246699999999999999999999999 9999999999999999999999999999876433222 1
Q ss_pred eccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc---cc--cccc
Q 008216 432 VMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL---EL--LDPL 505 (573)
Q Consensus 432 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~--~~~~ 505 (573)
....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..................... .. ....
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 222389999999998764 56899999999999999999999998765432111100000000000000 00 0000
Q ss_pred cccCCC---CCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 506 ISSLSS---DIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 506 ~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
...... .......++.+.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 0111234567899999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=368.87 Aligned_cols=265 Identities=20% Similarity=0.239 Sum_probs=193.1
Q ss_pred cCCeeecccCceEEEEEEe-CC-CCEEEEEEecccch--hhHHHHHHHHHHHhhc---CCCcEeEEeeEEee-----CCc
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PD-GSRVAVKRLKRSSF--QRKKEFYSEIGRFARL---HHPNLVAVKGCCYD-----HGD 339 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~-g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~-----~~~ 339 (573)
+..+.||+|+||+||+|+. .+ ++.||||+++.... .....+.+|+.+|+.| +||||+++++++.. ...
T Consensus 10 ~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~ 89 (305)
T d1blxa_ 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 89 (305)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCce
Confidence 4445789999999999996 34 56799999975422 2234566777777666 89999999999863 245
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCC
Q 008216 340 RYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLS 419 (573)
Q Consensus 340 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 419 (573)
.+++|||+.++++..... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 90 LTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp EEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred EEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhh
Confidence 799999998877655443 3345689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhccccc
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYL 499 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 499 (573)
+....... .....||+.|+|||++.+..++.++||||+||++|||+||++||...+...................+.
T Consensus 164 ~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 164 RIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 87654332 223349999999999999999999999999999999999999998765432111110000000000000
Q ss_pred c---ccccccccC---CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 500 E---LLDPLISSL---SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 500 ~---~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
. ......... .........++.+.+|+.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 000000000 000011234567899999999999999999999976
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=369.95 Aligned_cols=237 Identities=21% Similarity=0.308 Sum_probs=192.4
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchh------hHHHHHHHHHHHhhcC--CCcEeEEeeEEeeCCceE
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQ------RKKEFYSEIGRFARLH--HPNLVAVKGCCYDHGDRY 341 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~ 341 (573)
++..++||+|+||.||+|+. .+|+.||||+++..... ...++.+|+.+|++++ ||||+++++++.+++..+
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~ 85 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 85 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence 34567889999999999996 46999999999754211 1234678999999996 899999999999999999
Q ss_pred EEEEecCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-CCeeEecccCC
Q 008216 342 IVYEFVVN-GPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEE-FGAHLMGVGLS 419 (573)
Q Consensus 342 lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~~ 419 (573)
+||||+.+ +++.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||++
T Consensus 86 lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccc
Confidence 99999976 678887754 35699999999999999999999999 99999999999999854 68999999999
Q ss_pred ccCCccccccceeccCCcccccccccccCCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccc
Q 008216 420 KFVPWEVMQERTVMAGGTYGYLAPEFVYRNEL-TTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY 498 (573)
Q Consensus 420 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 498 (573)
+....... ....||+.|+|||++.+..+ +.++|||||||++|||+||+.||...+. . ... .
T Consensus 159 ~~~~~~~~----~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i-------~~~-~- 220 (273)
T d1xwsa_ 159 ALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I-------IRG-Q- 220 (273)
T ss_dssp EECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-------HHC-C-
T ss_pred eecccccc----cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----H-------hhc-c-
Confidence 86543322 22349999999999987665 5779999999999999999999975321 0 000 0
Q ss_pred ccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
...+...++++.+||.+||+.||++|||++|+++
T Consensus 221 -------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 -------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0011124567999999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-44 Score=358.66 Aligned_cols=267 Identities=16% Similarity=0.209 Sum_probs=192.6
Q ss_pred CCeeecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEee--------CCceE
Q 008216 273 GNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYD--------HGDRY 341 (573)
Q Consensus 273 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------~~~~~ 341 (573)
..+.||+|+||+||+|+. .+|+.||||++.... .....++.+|+.+|++++||||+++++++.. .+..+
T Consensus 14 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~ 93 (318)
T d3blha1 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 93 (318)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEE
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEE
Confidence 345679999999999996 579999999986542 2335678999999999999999999998865 34579
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCcc
Q 008216 342 IVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 342 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 421 (573)
+||||+.++++..+.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 94 iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 94 LVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp EEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeee
Confidence 9999998776665543 345689999999999999999999999 999999999999999999999999999986
Q ss_pred CCccccc--cceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccc
Q 008216 422 VPWEVMQ--ERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY 498 (573)
Q Consensus 422 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 498 (573)
....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+....................
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 6543221 122223499999999998765 6899999999999999999999999876543222211111100000000
Q ss_pred ccccc----cccccCCCCCc-c------hHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 499 LELLD----PLISSLSSDIP-E------AGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 499 ~~~~~----~~~~~~~~~~~-~------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
..... ........... . ...++.+.+||.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00000 00000000000 0 1124567899999999999999999999863
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=364.39 Aligned_cols=267 Identities=21% Similarity=0.254 Sum_probs=192.4
Q ss_pred CeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC------CceEEEEEe
Q 008216 274 NRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------GDRYIVYEF 346 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~lv~e~ 346 (573)
.++||+|+||+||+|+.. +|+.||||+++.... ...+|+.+|++++||||+++++++... ...++||||
T Consensus 25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred eeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 467899999999999964 699999999976532 234799999999999999999998643 236899999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-CeeEecccCCccCCcc
Q 008216 347 VVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWE 425 (573)
Q Consensus 347 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~ 425 (573)
++++.+. .+.........+++.+++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++......
T Consensus 101 ~~~~~~~-~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 101 VPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp CSEEHHH-HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred cCCccHH-HHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 9765433 3332223346799999999999999999999999 999999999999999775 7999999999876543
Q ss_pred ccccceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchh-hHHhhhh----hhh--ccc
Q 008216 426 VMQERTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQS-IFEWATP----LVQ--SHR 497 (573)
Q Consensus 426 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~~~~----~~~--~~~ 497 (573)
.... ...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+...... +...... ... ...
T Consensus 177 ~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 177 EPNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp SCCC---SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred cccc---cccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 3222 2348999999998765 568999999999999999999999998765432111 1000000 000 000
Q ss_pred ccccccccccc-CCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhccc
Q 008216 498 YLELLDPLISS-LSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQLA 551 (573)
Q Consensus 498 ~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~ 551 (573)
..+..-+.... ..........++++.+|+.+||+.||++|||+.|+++ .++++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 00000000000 0000111234567999999999999999999999996 355543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-44 Score=362.97 Aligned_cols=267 Identities=18% Similarity=0.226 Sum_probs=193.6
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccc-hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC----ceEEEEE
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS-FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG----DRYIVYE 345 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~e 345 (573)
+..+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+.+|++++||||+++++++.... ..+++++
T Consensus 11 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~ 90 (345)
T d1pmea_ 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVT 90 (345)
T ss_dssp EEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred EEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEE
Confidence 3346789999999999985 579999999997543 344567899999999999999999999987653 2345556
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCcc
Q 008216 346 FVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 346 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 425 (573)
++.+|+|.+++.. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 91 HLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp ECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 6779999999964 3599999999999999999999999 9999999999999999999999999999876544
Q ss_pred cccc-ceeccCCcccccccccccC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccccc-
Q 008216 426 VMQE-RTVMAGGTYGYLAPEFVYR-NELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLELL- 502 (573)
Q Consensus 426 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 502 (573)
.... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||...+........................
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 3221 2233459999999999854 567899999999999999999999998765422111110000000000000000
Q ss_pred ---ccccccCC--CCCc----chHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 008216 503 ---DPLISSLS--SDIP----EAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ 546 (573)
Q Consensus 503 ---~~~~~~~~--~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 546 (573)
........ ...+ ....+.++.+|+.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 0000 01234578999999999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-44 Score=364.07 Aligned_cols=261 Identities=21% Similarity=0.289 Sum_probs=193.3
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCC------ceEE
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHG------DRYI 342 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~l 342 (573)
+..+.||+|+||+||+|.. .+|+.||||+++.. .....+.+.+|+.+|++++|||||++++++...+ ..++
T Consensus 21 ~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 100 (346)
T d1cm8a_ 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 100 (346)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEE
Confidence 3445789999999999996 46999999999754 2334567899999999999999999999997654 4699
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
||||+ +.+|..++.. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+++..
T Consensus 101 v~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 101 VMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp EEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceecc
Confidence 99999 6788887754 4599999999999999999999999 9999999999999999999999999999876
Q ss_pred CccccccceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhh-----hhcc
Q 008216 423 PWEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPL-----VQSH 496 (573)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~-----~~~~ 496 (573)
.... ....||+.|+|||.+.+. .++.++||||+||++|||++|++||...+.............. ....
T Consensus 172 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 172 DSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred CCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 4332 223499999999998764 5689999999999999999999999876543211111000000 0000
Q ss_pred ----------ccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--Hhccc
Q 008216 497 ----------RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQ--LQQLA 551 (573)
Q Consensus 497 ----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 551 (573)
...+........ .....++.+.+||.+||+.||++|||++|+++. ++.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFAS-----ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGG-----TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred cchhhhhhhccCCcccccchHH-----hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 000000000000 012235678999999999999999999999974 65554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.9e-43 Score=349.80 Aligned_cols=260 Identities=18% Similarity=0.222 Sum_probs=203.8
Q ss_pred CcCCeeecccCceEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHhhcCC-CcEeEEeeEEeeCCceEEEEEecC
Q 008216 271 SEGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~ 348 (573)
++..+.||+|+||.||+|+.. +|+.||||+++... ....+.+|++.++.++| +|++.+++++.+....++||||+
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 345667899999999999964 68999999986543 23457789999999965 89999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-----CCCeeEecccCCccCC
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDE-----EFGAHLMGVGLSKFVP 423 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~Dfg~~~~~~ 423 (573)
+++|.+++.. .+..++..++..++.|++.||+|||++ ||+||||||+|||++. ++.+||+|||+|+...
T Consensus 84 ~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 84 GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 7899998864 235699999999999999999999999 9999999999999974 5679999999998764
Q ss_pred ccccc-----cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccc
Q 008216 424 WEVMQ-----ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRY 498 (573)
Q Consensus 424 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 498 (573)
..... .......||+.|||||++.+..++.++||||||+++|||+||+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 33211 1122345999999999999999999999999999999999999999876544322222111111110000
Q ss_pred ccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcccC
Q 008216 499 LELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLAQ 552 (573)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 552 (573)
.+ + ...+++++.+++..|+..+|++||+++.+.+.|+++.+
T Consensus 238 ~~-----l--------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 238 RE-----L--------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HH-----H--------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HH-----h--------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 00 0 01234579999999999999999999999988877643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-43 Score=351.74 Aligned_cols=259 Identities=17% Similarity=0.234 Sum_probs=195.2
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCc-EeEEeeEEeeCCceEEEEEecC
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN-LVAVKGCCYDHGDRYIVYEFVV 348 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e~~~ 348 (573)
++..+.||+|+||.||+|.. .+|+.||||++.... ..+++..|++++++++|+| |+.+.++..+.+..++||||+
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence 44556789999999999996 468999999987653 2345788999999997666 555566667778889999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC---CCCCeeEecccCCccCCcc
Q 008216 349 NGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLD---EEFGAHLMGVGLSKFVPWE 425 (573)
Q Consensus 349 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~ 425 (573)
+++|.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+.....
T Consensus 86 ~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 86 GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 5677666653 235699999999999999999999999 999999999999985 3557999999999876543
Q ss_pred ccc-----cceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccc
Q 008216 426 VMQ-----ERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500 (573)
Q Consensus 426 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (573)
... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~--- 236 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 236 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC---
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC---
Confidence 221 122233599999999999999999999999999999999999999987654322111111110000000
Q ss_pred ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhccc
Q 008216 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVHQLQQLA 551 (573)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 551 (573)
.+.. ...+++++.+++.+||+.||++||+++++.+.|+.+.
T Consensus 237 --~~~~--------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 237 --IEVL--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp --HHHH--------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred --hhHh--------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 0000 1124467999999999999999999999988887663
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.3e-43 Score=355.64 Aligned_cols=258 Identities=19% Similarity=0.240 Sum_probs=194.8
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeC--CceEEEEEec
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDH--GDRYIVYEFV 347 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lv~e~~ 347 (573)
+..+.||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+.+|++++ ||||+++++++... ...++||||+
T Consensus 38 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 38 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 3446789999999999996 56899999999764 3467889999999995 99999999998754 5689999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-CeeEecccCCccCCccc
Q 008216 348 VNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEF-GAHLMGVGLSKFVPWEV 426 (573)
Q Consensus 348 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~ 426 (573)
.+++|..+. +.+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|.......
T Consensus 115 ~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 115 NNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp CSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred CCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999997654 3599999999999999999999999 999999999999998765 58999999998765433
Q ss_pred cccceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccch--hhHHhhh-----hhhhc---
Q 008216 427 MQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQ--SIFEWAT-----PLVQS--- 495 (573)
Q Consensus 427 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~-----~~~~~--- 495 (573)
.. ....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....+.... .+..... .....
T Consensus 185 ~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 185 EY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp CC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred cc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 22 233489999999998765 4799999999999999999999999765542111 0000000 00000
Q ss_pred ---ccccccc----ccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 496 ---HRYLELL----DPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 496 ---~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....... ................++++.+||.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 0001111122223345678999999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=349.62 Aligned_cols=261 Identities=19% Similarity=0.236 Sum_probs=199.1
Q ss_pred CeeecccCceEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeCCceEEEEEecCCC
Q 008216 274 NRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSS--FQRKKEFYSEIGRFARLHHPNLVAVKGCCYDHGDRYIVYEFVVNG 350 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 350 (573)
.+.||+|+||+||+|+. .+|+.||||+++... .....++.+|+.+|++++||||+++++++.+....++|+|++.++
T Consensus 7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~ 86 (292)
T d1unla_ 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD 86 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEE
T ss_pred eeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccc
Confidence 45789999999999996 568999999997543 234578899999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCCccccccc
Q 008216 351 PLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVPWEVMQER 430 (573)
Q Consensus 351 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 430 (573)
+|..++.. .+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.........
T Consensus 87 ~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~- 158 (292)
T d1unla_ 87 LKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY- 158 (292)
T ss_dssp HHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC-
T ss_pred cccccccc----ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCccc-
Confidence 98887753 45689999999999999999999999 99999999999999999999999999998765433222
Q ss_pred eeccCCcccccccccccCCC-CCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhc---ccc---ccccc
Q 008216 431 TVMAGGTYGYLAPEFVYRNE-LTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQS---HRY---LELLD 503 (573)
Q Consensus 431 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~---~~~~~ 503 (573)
....+++.|+|||.+.+.. ++.++|||||||++|||++|+.||....... ............ ... ....+
T Consensus 159 -~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 159 -SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp -CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred -eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhhhccc
Confidence 2223788899999987654 6899999999999999999999975543321 111111110000 000 00000
Q ss_pred c-----ccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 504 P-----LISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 504 ~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
. ..............++.+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00000011112334567899999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=354.95 Aligned_cols=249 Identities=20% Similarity=0.226 Sum_probs=197.6
Q ss_pred cCCeeecccCceEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHhhcCC-CcEeEEeeEEeeCCceEE
Q 008216 272 EGNRLLGDSKTGGTYSGIL----PDGSRVAVKRLKRSS----FQRKKEFYSEIGRFARLHH-PNLVAVKGCCYDHGDRYI 342 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~l 342 (573)
+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.+|++++| |||+++++++.+....++
T Consensus 27 ~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~ 106 (322)
T d1vzoa_ 27 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL 106 (322)
T ss_dssp EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEE
T ss_pred EEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceee
Confidence 3455789999999999984 248899999986542 2334668899999999966 899999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
+|||+.+|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 107 v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 107 ILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 9999999999999865 34578899999999999999999999 9999999999999999999999999999876
Q ss_pred CccccccceeccCCcccccccccccCC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhhhcccccc
Q 008216 423 PWEVMQERTVMAGGTYGYLAPEFVYRN--ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLVQSHRYLE 500 (573)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 500 (573)
......... ...|++.|+|||.+.+. .++.++|||||||+||||+||+.||................ .. .
T Consensus 180 ~~~~~~~~~-~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--~~-~---- 251 (322)
T d1vzoa_ 180 VADETERAY-DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LK-S---- 251 (322)
T ss_dssp CGGGGGGGC-GGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HH-C----
T ss_pred ccccccccc-ccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--cc-C----
Confidence 544333222 23499999999998764 46889999999999999999999998765432211111100 00 0
Q ss_pred ccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 008216 501 LLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPR-----MSHVVH 545 (573)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 545 (573)
....+...++++.+|+.+||+.||++||| ++|+++
T Consensus 252 ----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 00112235678999999999999999994 788875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=352.63 Aligned_cols=260 Identities=18% Similarity=0.239 Sum_probs=187.6
Q ss_pred cCCeeecccCceEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC------CceEE
Q 008216 272 EGNRLLGDSKTGGTYSGILP-DGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH------GDRYI 342 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~l 342 (573)
+..+.||+|+||+||+|... +|+.||||+++.. ......++.+|+.+|++++||||+++++++... +..|+
T Consensus 20 ~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~i 99 (355)
T d2b1pa1 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 99 (355)
T ss_dssp EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred EEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEE
Confidence 33457899999999999964 6999999999765 234456789999999999999999999998643 57799
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccC
Q 008216 343 VYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFV 422 (573)
Q Consensus 343 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 422 (573)
||||+.++.+. .+. ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|++|||+++..
T Consensus 100 v~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 100 VMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcc
Confidence 99999765554 442 3589999999999999999999999 9999999999999999999999999998866
Q ss_pred CccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhH-Hhh------------
Q 008216 423 PWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIF-EWA------------ 489 (573)
Q Consensus 423 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~-~~~------------ 489 (573)
...... ....+|+.|+|||++.+..+++++||||+||++|||++|+.||.+.+........ ...
T Consensus 170 ~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 170 GTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccccc---ccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 543222 2234899999999999999999999999999999999999999765532211100 000
Q ss_pred ---hhhhhcc------ccccccccccccCCCCCcchHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 008216 490 ---TPLVQSH------RYLELLDPLISSLSSDIPEAGVVQKVVDLVYACTQHVPSMRPRMSHVVH 545 (573)
Q Consensus 490 ---~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 545 (573)
....... ........... ..........++++.+|+.+||+.||++|||++||++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLF-PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGS-CCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhHHHHhhcCccccccccccccccccc-cccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000 00000000000 0011112346788999999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=353.57 Aligned_cols=266 Identities=18% Similarity=0.243 Sum_probs=193.6
Q ss_pred cCCeeecccCceEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHhhcCCCcEeEEeeEEeeC-----CceEEE
Q 008216 272 EGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRS--SFQRKKEFYSEIGRFARLHHPNLVAVKGCCYDH-----GDRYIV 343 (573)
Q Consensus 272 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv 343 (573)
+..+.||+|+||+||+|+. .+|+.||||+++.. +....+.+.+|+.+|++++||||+++++++... ...+++
T Consensus 21 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i 100 (348)
T d2gfsa1 21 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 100 (348)
T ss_dssp EEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEE
Confidence 4456789999999999995 57999999999754 234456789999999999999999999998643 334667
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEecccCCccCC
Q 008216 344 YEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSKFVP 423 (573)
Q Consensus 344 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 423 (573)
++++.+|+|.+++.. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++....
T Consensus 101 ~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 101 VTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp EEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred EEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC
Confidence 777889999999853 4599999999999999999999999 99999999999999999999999999997654
Q ss_pred ccccccceeccCCcccccccccccCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhhHHhhhhhh----hcccc
Q 008216 424 WEVMQERTVMAGGTYGYLAPEFVYRN-ELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSIFEWATPLV----QSHRY 498 (573)
Q Consensus 424 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~----~~~~~ 498 (573)
... ....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+............... .....
T Consensus 173 ~~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 173 DEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp GGG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred ccc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 322 223489999999987765 46889999999999999999999998765432211111000000 00000
Q ss_pred cccccc---ccccCCCCCc---chHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcc
Q 008216 499 LELLDP---LISSLSSDIP---EAGVVQKVVDLVYACTQHVPSMRPRMSHVVH--QLQQL 550 (573)
Q Consensus 499 ~~~~~~---~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~ 550 (573)
...... .......... ....++.+.+||.+||+.||++|||++|+++ .+.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 000000 0000000000 0124567899999999999999999999997 45544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-37 Score=315.12 Aligned_cols=265 Identities=16% Similarity=0.186 Sum_probs=186.4
Q ss_pred CcCCeeecccCceEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-----------CCcEeEEeeEEeeC-
Q 008216 271 SEGNRLLGDSKTGGTYSGIL-PDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-----------HPNLVAVKGCCYDH- 337 (573)
Q Consensus 271 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~~~- 337 (573)
++..+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++...
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 45567889999999999996 579999999998653 23467788999888875 57899999887653
Q ss_pred -CceEEEEEecCCCCH-HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCC----
Q 008216 338 -GDRYIVYEFVVNGPL-DRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFG---- 410 (573)
Q Consensus 338 -~~~~lv~e~~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~~~~---- 410 (573)
...+++++++..+.. ...... .....+++..+..++.||+.||+|||+ . ||+||||||+|||++.++.
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred ccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence 455667776655433 222222 334668999999999999999999998 6 9999999999999986543
Q ss_pred --eeEecccCCccCCccccccceeccCCcccccccccccCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCcccchhh---
Q 008216 411 --AHLMGVGLSKFVPWEVMQERTVMAGGTYGYLAPEFVYRNELTTKSDVYSFGVLLLEIVSGRRPAQAVDSVCWQSI--- 485 (573)
Q Consensus 411 --~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~--- 485 (573)
++++|||.+....... ....||+.|+|||++.+..++.++||||+||++++|++|+.||...........
T Consensus 169 ~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 8999999997654221 233499999999999999999999999999999999999999976543211110
Q ss_pred -HHhhhhh-------hhc-ccccccccc-----ccccC----------CCCCcchHHHHHHHHHHHHhcCCCCCCCCCHH
Q 008216 486 -FEWATPL-------VQS-HRYLELLDP-----LISSL----------SSDIPEAGVVQKVVDLVYACTQHVPSMRPRMS 541 (573)
Q Consensus 486 -~~~~~~~-------~~~-~~~~~~~~~-----~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 541 (573)
......+ ... .......+. ..... .........++++.+|+.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 0000000 000 000000000 00000 01122356778999999999999999999999
Q ss_pred HHHHH
Q 008216 542 HVVHQ 546 (573)
Q Consensus 542 evl~~ 546 (573)
|+++.
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99873
|
| >d1ypqa1 d.169.1.1 (A:140-270) Oxidised low density lipoprotein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Oxidised low density lipoprotein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=6.6e-27 Score=202.35 Aligned_cols=127 Identities=20% Similarity=0.451 Sum_probs=108.2
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEE
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW 130 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W 130 (573)
++||+||. .|+++||+|+.+.++|.+|+.+|++.||+||+|+|++|++||.+++......+||||+ +...++.|.|
T Consensus 3 ~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~~~~~~w~w 78 (131)
T d1ypqa1 3 APCPQDWI--WHGENCYLFSSGSFNWEKSQEKCLSLDAKLLKINSTADLDFIQQAISYSSFPFWMGLS--RRNPSYPWLW 78 (131)
T ss_dssp CSSCTTSE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHTTCCCCEEEEEE--ESSTTSCCEE
T ss_pred CCCCCCCE--EECCEEEEEECCccCHHHHHHHHHHcCCeeccchhhhhhhhhhhhhhccCCceEEEEE--ecCCCCceEe
Confidence 58999999 9999999999999999999999999999999999999999999998765667999999 5556799999
Q ss_pred cCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccccc
Q 008216 131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 131 ~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
+||+++.+..+|..+++++ ....+.|+.+.. +.|++..|....+|||+++.
T Consensus 79 ~dg~~~~~~~~~~~~~~~~---------~~~~~~C~~~~~--~~w~~~~C~~~~~~ICek~a 129 (131)
T d1ypqa1 79 EDGSPLMPHLFRVRGAVSQ---------TYPSGTCAYIQR--GAVYAENCILAAFSICQKKA 129 (131)
T ss_dssp TTSCBCCTTSCCEEESCSC---------CCTTCEEEEEET--TEEEEEETTSCBEEEEEEEC
T ss_pred CCCCCccccccccCCCCCC---------CCCCCCEEEEEC--CeEEEeCCCCCEeEEEeEEC
Confidence 9998877766665554443 223457887754 47999999999999999864
|
| >d1xpha1 d.169.1.1 (A:265-394) DC-SIGNR (DC-SIGN related receptor) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: DC-SIGNR (DC-SIGN related receptor) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=4.3e-27 Score=203.25 Aligned_cols=127 Identities=22% Similarity=0.454 Sum_probs=108.3
Q ss_pred CCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceE
Q 008216 50 KAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWK 129 (573)
Q Consensus 50 ~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~ 129 (573)
|.+||+||. .|+++||+|+.++++|.+|+..|+++||+||+|+|++|++|+..++......+|||++ +...++.|+
T Consensus 1 c~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~gg~La~i~s~~~~~~~~~~~~~~~~~~wig~~--~~~~~~~~~ 76 (130)
T d1xpha1 1 CRHCPKDWT--FFQGNCYFMSNSQRNWHDSVTACQEVRAQLVVIKTAEEQNFLQLQTSRSNRFSWMGLS--DLNQEGTWQ 76 (130)
T ss_dssp SCBCCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHTCCEEEEEE--CCSTTCCCE
T ss_pred CCCCCCCCE--EECCEEEEEECcccCHHHHHHHHhhcCCeEeeeCCHHHhhhhhhhhccccceeeeeee--ccCcccceE
Confidence 678999999 8999999999999999999999999999999999999999999888755667999999 666779999
Q ss_pred EcCCCCCCC--CCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccccc
Q 008216 130 WSDNMSKWN--ESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 130 W~Dgt~~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
|+||+++.. +..|..++|++ .+.++|+.+.. ++|++.+|....+|||++|.
T Consensus 77 W~dg~~~~~~~~~~W~~~~P~~----------~~~~~Cv~~~~--~~w~~~~C~~~~~fICe~pA 129 (130)
T d1xpha1 77 WVDGSPLSPSFQRYWNSGEPNN----------SGNEDCAEFSG--SGWNDNRCDVDNYWICKKPA 129 (130)
T ss_dssp ETTSCBCCGGGGGGBCTTCCCC----------CTTCCEEEEET--TEEEEECTTSCBEEEEEEEC
T ss_pred eccccccccccccccCCcCCCC----------CCCCcEEEEEC--CEEEECCCCCCEEEEEEEeC
Confidence 999976543 55677666553 23356888754 47999999999999999874
|
| >d1hq8a_ d.169.1.1 (A:) NK cell-activating receptor nkg2d {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: NK cell-activating receptor nkg2d species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.93 E-value=1.6e-27 Score=203.77 Aligned_cols=121 Identities=23% Similarity=0.535 Sum_probs=99.4
Q ss_pred CCCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCce
Q 008216 49 WKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSW 128 (573)
Q Consensus 49 ~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w 128 (573)
-|.+||+||. .|+++||+++.+.++|.+|+.+|+++||+||+|+|++|++||+.. ...+||||+ +...++.|
T Consensus 2 ~c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~fl~~~----~~~~WiGl~--~~~~~~~w 73 (123)
T d1hq8a_ 2 YCGPCPNNWI--CHRNNCYQFFNEEKTWNQSQASCLSQNSSLLKIYSKEEQDFLKLV----KSYHWMGLV--QIPANGSW 73 (123)
T ss_dssp CCCCCSTTCE--EETTEEEEEEEEEECHHHHHHHHHTTTCEECCCSCTTTTGGGGGC----CSCEEEEEE--ECTTTCCE
T ss_pred cCCCCCccCE--EECCEEEEEECcccCHHHHHHHHhhccCccceEehHHHHHHHhhh----hhceeeeee--ecCCCCce
Confidence 3689999999 999999999999999999999999999999999999999999654 347999999 55667999
Q ss_pred EEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccccc
Q 008216 129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 129 ~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
+|+||+++.+ +.|..++|++ .+|+.+. .++.|.+..|....+|||+++.
T Consensus 74 ~W~dgs~~~~-~~w~~~~~~~-------------~~c~~~~-~~~~w~~~~C~~~~~~ICek~a 122 (123)
T d1hq8a_ 74 QWEDGSSLSY-NQLTLVEIPK-------------GSCAVYG-SSFKAYTEDCANLNTYICMKRA 122 (123)
T ss_dssp EETTSCBCCT-TTCEEECCTT-------------CCEEEEC-STTEEEEECTTSCEEEEEEECC
T ss_pred EECCCCcccc-cccCCCCCCC-------------CCEEEEE-CCCeEEEeCCCCCEeEEEEEcc
Confidence 9999976644 4454444332 2344443 3467999999999999999864
|
| >d1t8da1 d.169.1.1 (A:1-143) Low affinity immunoglobulin epsilon Fc receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Low affinity immunoglobulin epsilon Fc receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.3e-26 Score=202.04 Aligned_cols=133 Identities=22% Similarity=0.405 Sum_probs=110.4
Q ss_pred CCCCCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCC
Q 008216 47 KDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGL 126 (573)
Q Consensus 47 ~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~ 126 (573)
+..|.+||+||. .|+++||+|+.+.++|.+|+.+|+++||+||+|+|.+|++||.++.. ...+||||+ +...++
T Consensus 2 g~~c~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~--~~~~wiGl~--~~~~~~ 75 (143)
T d1t8da1 2 GFVCNTCPEKWI--NFQRKCYYFGKGTKQWVHARYACDDMEGQLVSIHSPEEQDFLTKHAS--HTGSWIGLR--NLDLKG 75 (143)
T ss_dssp CCSSCCCCSSSE--ECSSEEEEEEECCSSHHHHHHHHHHHTSBCCCCCSHHHHHHHHHHCS--SSCEEEEEE--ESSSSS
T ss_pred CCcCCCCCcccE--EECCEEEEEECcccCHHHHHHHhhhcCCEEeeecCHHHhhhcccccc--cccccccce--ecCCCC
Confidence 456789999999 89999999999999999999999999999999999999999999877 557999999 555679
Q ss_pred ceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCC-CCcccccccCCcc
Q 008216 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTS-HPFICMVEHENKC 196 (573)
Q Consensus 127 ~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~-~~~iC~~~~~~~~ 196 (573)
.|.|+||++ ..++.|..++|++. .+.++|+.+.. .+.|++..|+.. .+|||+++....+
T Consensus 76 ~~~w~dg~~-~~~~~w~~~~P~~~---------~~~~~Cv~~~~-~g~W~~~~C~~~~~~fICek~~~~~~ 135 (143)
T d1t8da1 76 EFIWVDGSH-VDYSNWAPGEPTSR---------SQGEDCVMMRG-SGRWNDAFCDRKLGAWVCDRLATCTP 135 (143)
T ss_dssp CEEETTSCB-CSSCCBSSSCCCSC---------CSCCSEEEEET-TTEEEEECSCSCCCEEEEEEECSCCC
T ss_pred ccEeCCCCc-cccccccccCCCCC---------CCCCCEEEEcC-CCEEEeeCCCCCccCeEEEECCCCCC
Confidence 999999965 55666777776653 23446887765 467999999876 5799998765433
|
| >d1dv8a_ d.169.1.1 (A:) H1 subunit of the asialoglycoprotein receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: H1 subunit of the asialoglycoprotein receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=5e-26 Score=195.89 Aligned_cols=126 Identities=21% Similarity=0.487 Sum_probs=107.3
Q ss_pred CCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcC
Q 008216 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSD 132 (573)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~D 132 (573)
||+||. .|+++||+++.++++|.+|+.+|+++||+||+|+|.+|++||.+++. ...+||||+ +. ++.|+|+|
T Consensus 1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~~~~e~~~i~~~~~--~~~~WiG~~--~~--~~~~~W~d 72 (128)
T d1dv8a_ 1 CPVNWV--EHERSCYWFSRSGKAWADADNYCRLEDAHLVVVTSWEEQKFVQHHIG--PVNTWMGLH--DQ--NGPWKWVD 72 (128)
T ss_dssp CCTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC--SSCEEEEEE--CT--TSSCEETT
T ss_pred CCCCCE--EECCEEEEEECCccCHHHHHHHHhhcCCEEeeecccchhhhhhcccc--ceeeeeecc--cc--CCceEEee
Confidence 999999 99999999999999999999999999999999999999999999997 567999999 54 38999999
Q ss_pred CCCCC-CCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 133 NMSKW-NESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 133 gt~~~-~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
||... .+..|.+++|++.-... ..+.++|+.+.. .+.|++..|+...+|||+++
T Consensus 73 gs~~~~~~~~W~~~~P~~~~~~~----~~~~~~C~~~~~-~~~w~~~~C~~~~~fICe~~ 127 (128)
T d1dv8a_ 73 GTDYETGFKNWRPEQPDDWYGHG----LGGGEDCAHFTD-DGRWNDDVCQRPYRWVCETE 127 (128)
T ss_dssp CCCSTTSCCCBCTTCCCCCCTTS----SSSCCCEEEECT-TSCEEEECTTSCBEEEEEEE
T ss_pred ccccCCcceeeccCCCCcccccc----CCCCcceEEECC-CCEEEeEcCCCCEEEEEEEE
Confidence 97653 46778888887643222 334567887754 46799999999999999874
|
| >d1tdqb_ d.169.1.1 (B:) Aggrecan core protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Aggrecan core protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.93 E-value=3.4e-26 Score=196.38 Aligned_cols=123 Identities=22% Similarity=0.439 Sum_probs=103.5
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (573)
.||+||+ .|+++||+|+.++++|.+|+..|+++||+||+|+|.+|++||.++.. ..+||||+ +...++.|+|+
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~sw~~A~~~C~~~g~~La~i~~~~e~~~l~~~~~---~~~wigl~--~~~~~~~~~W~ 74 (126)
T d1tdqb_ 2 QCEEGWT--KFQGHCYRHFPDRETWVDAERRCREQQSHLSSIVTPEEQEFVNKNAQ---DYQWIGLN--DRTIEGDFRWS 74 (126)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC---SCEEEEEE--CSSSTTCCEET
T ss_pred CCCCCCe--eeCCEEEEEECcccCHHHHHHHHHhhCcEEeEECChhHhhhhhcccc---ceeeeecc--cccCCCccCcC
Confidence 6999999 89999999999999999999999999999999999999999999875 47999999 66677999999
Q ss_pred CCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEee-cCCCceeccccCCCCCccccc
Q 008216 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS-NGSRSLVTERCNTSHPFICMV 190 (573)
Q Consensus 132 Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~-~~~~~W~d~~C~~~~~~iC~~ 190 (573)
||+++. ++.|..++|++. ....++|+.+. ...+.|++..|+...+|||++
T Consensus 75 dg~~~~-~~~w~~~~p~~~--------~~~~~~C~~~~~~~~~~W~~~~C~~~~~fICek 125 (126)
T d1tdqb_ 75 DGHSLQ-FEKWRPNQPDNF--------FATGEDCVVMIWHERGEWNDVPCNYQLPFTCKK 125 (126)
T ss_dssp TCCCCC-CCCBCTTCCCCC--------STTTEEEEEEETTTTTEEEEEETTSCEEEEEEE
T ss_pred CCCCcc-cccccccCCCcc--------ccCCcceEEEEeCCCCeEEecCCCCCEEEEeee
Confidence 997654 555666665542 23345566664 344679999999999999986
|
| >d1oz7b_ d.169.1.1 (B:) Snake coagglutinin beta chain {Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]
Probab=99.92 E-value=3.4e-26 Score=195.44 Aligned_cols=118 Identities=20% Similarity=0.461 Sum_probs=99.3
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (573)
.||+||. .|+++||+|+.+.++|.+|+.+|+. .||+||+|+|++|++||.+++... ...+||||+ +...+|.
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~~~~~A~~~C~~~~~gg~L~~i~s~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~ 76 (123)
T d1oz7b_ 1 NCLPDWS--VYEGYCYKVFKERMNWADAEKFCTKQHKDGHLVSFRNSKEVDFVISLAFPMLKNDLVWIGLT--DYWRDCN 76 (123)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCCSSHHHHHHHTSSTTTTCSEEEEEEE--CCCCGGG
T ss_pred CCCccCE--eECCEEEEEeCcccCHHHHHHHHhhccCCCcccccCCHHHhhhceeeeeecccceeEEEEee--ccCcccc
Confidence 3999999 9999999999999999999999975 489999999999999999987653 346899999 7677799
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
|+|+|||++. ++.|..+ ++|+.+....+.|++..|+...+|||++|
T Consensus 77 ~~W~dg~~~~-y~nW~~~-----------------~~C~~~~~~~~~W~~~~C~~~~~fICe~P 122 (123)
T d1oz7b_ 77 WEWSDGAQLD-YKAWDNE-----------------RHCFIYKNTDNQWTRRDCTWTFSFVCKCP 122 (123)
T ss_dssp EEETTCCCCC-SCCBCSS-----------------TTEEEEEGGGTEEEEECTTSCEEEEEEEE
T ss_pred eeccCCCEee-ccccCCC-----------------CCEEEEECCCCEEEeeCCCCcEEEEEEEc
Confidence 9999997764 4445321 24666666667899999999999999986
|
| >d1fvub_ d.169.1.1 (B:) Snake coagglutinin beta chain {Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]
Probab=99.92 E-value=4.6e-26 Score=195.26 Aligned_cols=120 Identities=23% Similarity=0.527 Sum_probs=99.4
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (573)
.||+||. .|+++||+++.+.++|.+|+..|+. .||+||+|+|++|++||..++... ...+||||+ +...++.
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~t~~~A~~~C~~~~~gg~L~~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~ 76 (125)
T d1fvub_ 1 DCPPDWS--SYEGHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEMLKGDVVWIGLS--DVWNKCR 76 (125)
T ss_dssp CCSTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHTTCTTSCTTCCEECSCC--CCSTTSC
T ss_pred CCCCCCE--eeCCEEEEEeCccCCHHHHHHhhhhccCCceecccCCHHHcccccccccccccceeEEeeee--ccCcccc
Confidence 4999999 9999999999999999999999964 589999999999999999988654 346999999 7777899
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
|+|+|||++.+.+|+. + ++.+|+.+...++.|++.+|....+|||+.+
T Consensus 77 ~~W~dg~~~~~~~w~~-~---------------~~~~Cv~~~~~~~~W~~~~C~~~~~fICe~~ 124 (125)
T d1fvub_ 77 FEWTDGMEFDYDDYYL-I---------------AEYECVASKPTNNKWWIIPCTRFKNFVCEFQ 124 (125)
T ss_dssp EEETTSCCCCC----C-C---------------SCCEEEEEETTTTEEEEEETTSCEEEEEEEC
T ss_pred cEecCCCccccCCCCC-C---------------CCcceEEEEcCCCEEEeeCCCCCEEEEEEEc
Confidence 9999998775554432 1 1235777776777899999999999999875
|
| >d2afpa_ d.169.1.1 (A:) Type II antifreeze protein {Sea raven (Hemitripterus americanus) [TaxId: 8094]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Type II antifreeze protein species: Sea raven (Hemitripterus americanus) [TaxId: 8094]
Probab=99.92 E-value=6.8e-26 Score=195.27 Aligned_cols=123 Identities=26% Similarity=0.532 Sum_probs=103.3
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEE
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKW 130 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W 130 (573)
+.||+||. .++++||+++.++++|.+|+.+|++.||+||+|+|++|++||+++.. ..+||||+ +...++.|+|
T Consensus 5 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~fl~~~~~---~~~Wig~~--~~~~~~~w~W 77 (129)
T d2afpa_ 5 PNCPAGWQ--PLGDRCIYYETTAMTWALAETNCMKLGGHLASIHSQEEHSFIQTLNA---GVVWIGGS--ACLQAGAWTW 77 (129)
T ss_dssp CSSCSSSC--CCSSSEECCCCSCCCHHHHHHHHHHHSCEECCCSSSHHHHHHHHHCS---SCBCCSCB--CSSSSSCCBS
T ss_pred CCCCCCCE--EECCEEEEEECcccCHHHHHHHHHhcCCeEeeeeehhcchhhccccc---Cceeeeee--cccccceeec
Confidence 46999999 99999999999999999999999999999999999999999999865 46999999 6667799999
Q ss_pred cCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecC-CCceeccccCCCCCcccccc
Q 008216 131 SDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG-SRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 131 ~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~-~~~W~d~~C~~~~~~iC~~~ 191 (573)
+||+++ .++.|.+++|++ ...++|+.+... ...|++..|....+|||++.
T Consensus 78 ~dgs~~-~y~~W~~~~P~~----------~~~~~c~~~~~~~~~~W~~~~C~~~~~~ICe~t 128 (129)
T d2afpa_ 78 SDGTPM-NFRSWCSTKPDD----------VLAACCMQMTAAADQCWDDLPCPASHKSVCAMT 128 (129)
T ss_dssp SSSCCC-CCCCSSSCCSCC----------STTCCBCCBCCSSSSCBCCBCSCCCCCCCEEEC
T ss_pred cCCCee-ecccccCCCCCC----------CCCCcEEEEECCCCCcEEeeCCCCCEeEEEEEe
Confidence 999765 456677676653 223466666443 45699999999999999863
|
| >d1wmza_ d.169.1.1 (A:) Lectin CEL-I {Cucumaria echinata [TaxId: 40245]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Lectin CEL-I species: Cucumaria echinata [TaxId: 40245]
Probab=99.92 E-value=8.9e-26 Score=197.53 Aligned_cols=127 Identities=14% Similarity=0.358 Sum_probs=104.1
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhcC-------CeEeeeCCHHHHHHHHHHhCC---CCCCeEEeeeecC
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG-------GHLAALTSYEEEHSAQKLCGK---NVNGCWVGGRSIN 121 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~-------~~L~~i~~~~e~~f~~~~~~~---~~~~~WiGl~~~~ 121 (573)
.||+||. .|+++||+|+.++++|.+|+.+|++.| ||||+|++.+|++||.+++.. ....+||||+ +
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~~~~~A~~~C~~~g~~l~~~~~~L~~i~~~~e~~~~~~~~~~~~~~~~~~WiGl~--~ 77 (140)
T d1wmza_ 2 QCPTDWE--AEGDHCYRFFNTLTTWENAHHECVSYSCSTLNVRSDLVSVHSAAEQAYVFNYWRGIDSQAGQLWIGLY--D 77 (140)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTTCBGGGTEEEEECCCCSHHHHHHHHHHHHHHCCSSCCEEEEEE--C
T ss_pred CCCCCCE--eeCCEEEEEECccCCHHHHHHHHHHhhcccccccceeeeeCCHHHHHhhhhhhccccccccceeeeee--e
Confidence 6999999 899999999999999999999999987 679999999999999887642 2456999999 6
Q ss_pred CCCCCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEee-cCCCceeccccCCCCCccccccc
Q 008216 122 TTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS-NGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 122 ~~~~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~-~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
...++.|.|+||+++ .++.|.+++|++. .+.++|+.+. ...+.|++..|+...+|||+.+.
T Consensus 78 ~~~~~~w~W~dG~~~-~y~~W~~g~P~~~---------~~~~~c~~~~~~~~~~W~~~~C~~~~~fICe~~~ 139 (140)
T d1wmza_ 78 KYNEGDFIWTDGSKV-GYTKWAGGQPDNW---------NNAEDYGQFRHTEGGAWNDNSAAAQAKYMCKLTF 139 (140)
T ss_dssp SSSTTCCEETTCCCC-CCCCBCTTCCCCG---------GGCEEEEEECSSTTTCEEEEETTCCEEEEEEEEE
T ss_pred ccccceeeecCCccc-ccccccccccccC---------CCCccEEEEEeCCCCEEEeeCCCCCEeEEEEEee
Confidence 677799999999765 4556777766542 2334566654 34567999999999999998763
|
| >d1e87a_ d.169.1.1 (A:) CD69 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: CD69 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.3e-25 Score=189.87 Aligned_cols=115 Identities=25% Similarity=0.540 Sum_probs=96.6
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (573)
+||+||. .|+++||+|+.++++|.+|+.+|+++||+||+|+|++|++||..++. ...+||||+ +. .++.|+|+
T Consensus 2 sCp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~L~~i~s~~e~~~l~~~~~--~~~~WiGl~--~~-~~~~w~w~ 74 (117)
T d1e87a_ 2 SCSEDWV--GYQRKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAG--REEHWVGLK--KE-PGHPWKWS 74 (117)
T ss_dssp CSCTTSE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHC--SSCEEEEEE--CC-TTSCCEET
T ss_pred CCCCCCE--EECCEEEEEECcccCHHHHHHHHhhcCCEEeeecCHHHHHHHhhhhc--cceeecccc--cc-ccCccEeC
Confidence 6999999 99999999999999999999999999999999999999999999987 467999998 43 34789999
Q ss_pred CCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccccc
Q 008216 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 132 Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
||++. +.|.... ++++|+.+.. +.|++..|....+|||++|-
T Consensus 75 dg~~~---~~w~~~~--------------~~~~C~~l~~--~~w~~~~C~~~~~~ICekp~ 116 (117)
T d1e87a_ 75 NGKEF---NNWFNVT--------------GSDKCVFLKN--TEVSSMECEKNLYWICNKPY 116 (117)
T ss_dssp TSCBC---CCSSCCB--------------SSCSEEEEET--TEEEEECTTSCBEEEEEEEC
T ss_pred CCCcc---cCccCCC--------------CCCcEEEEEC--CEEEEecCCCCEEEEEEEee
Confidence 99753 3343222 1235777754 47999999999999999873
|
| >d1j34b_ d.169.1.1 (B:) Snake coagglutinin beta chain {Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]
Probab=99.92 E-value=7.5e-26 Score=193.24 Aligned_cols=118 Identities=24% Similarity=0.556 Sum_probs=99.5
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (573)
.||+||. .++++||+++.++++|.+|+.+|++ .||+||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~~~~~A~~~C~~~~~gg~L~~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~ 76 (123)
T d1j34b_ 1 DCPSDWS--SYEGHCYKPFSEPKNWADAENFCTQQHAGGHLVSFQSSEEADFVVKLAFQTFGHSIFWMGLS--NVWNQCN 76 (123)
T ss_dssp CCCTTSE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHHHHCSCEEECSCC--SCSTTSC
T ss_pred CCCCCCE--eECCEEEEEEccccCHHHHHHHHHhccCCCcccccCCHhHhhhhhhhhccccceeEEeecee--cccccce
Confidence 3999999 9999999999999999999999975 489999999999999999877532 456999999 7777899
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
|+|+|||++. ++.|.+ +++|+.+....+.|++..|....+|||+.+
T Consensus 77 w~W~dg~~~~-y~~W~~-----------------~~~Cv~~~~~~~~W~~~~C~~~~~fiCe~~ 122 (123)
T d1j34b_ 77 WQWSNAAMLR-YKAWAE-----------------ESYCVYFKSTNNKWRSRACRMMAQFVCEFQ 122 (123)
T ss_dssp EEETTCCCCC-CCCBSC-----------------SCEEEEEETTSCCBEEEETTSCEEEEEEEE
T ss_pred eecCCCCccc-ccCCCC-----------------CCCeEEEECCCCEEEeeCCCCCEeEEEEEc
Confidence 9999997653 444532 235777777777899999999999999875
|
| >d1gz2a_ d.169.1.1 (A:) Ovocleidin-17 {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Ovocleidin-17 species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.92 E-value=2.3e-25 Score=194.58 Aligned_cols=124 Identities=23% Similarity=0.538 Sum_probs=100.2
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhc--CCeEeeeCCHHHHHHHHHHhCCC----------CCCeEEeeee
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN----------VNGCWVGGRS 119 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~----------~~~~WiGl~~ 119 (573)
.||+||. .|+++||+|+.++++|.+|+.+|++. ||+||+|+|.+|++||.+++... ...+||||+
T Consensus 1 gCp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~L~~i~s~~e~~~i~~~l~~~~~~~~~~~~~~~~~WiGl~- 77 (139)
T d1gz2a_ 1 GCGPGWV--PTPGGCLGFFSRELSWSRAESFCRRWGPGSHLAAVRSAAELRLLAELLNASRGGDGSGEGADGRVWIGLH- 77 (139)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHTTCTTEEECCCCSHHHHHHHHHHHHCSSCCSSSCCCCSSCEEEEEE-
T ss_pred CCCCCCE--eECCEEEEEeCeecCHHHHHhhhhcccCCceecchhhHHHHHHHHHHHHhhccccccccccccceeeeee-
Confidence 4999999 99999999999999999999999865 99999999999999999987432 346999999
Q ss_pred cCCCCCCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecC--CCceeccccCCCCCcccccc
Q 008216 120 INTTVGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 120 ~~~~~~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~--~~~W~d~~C~~~~~~iC~~~ 191 (573)
+...++.|+|+|||++ .++.|..++|++ .++ .|+.+... ...|++..|....+|||++|
T Consensus 78 -~~~~~~~w~W~dgs~~-~y~~W~~~~p~~----------~~~-~C~~l~~~~~~~~W~~~~C~~~~~fiCe~~ 138 (139)
T d1gz2a_ 78 -RPAGSRSWRWSDGTAP-RFASWHRTAKAR----------RGG-RCAALRDEEAFTSWAARPCTERNAFVCKAA 138 (139)
T ss_dssp -CCTTCSSCEETTSCCC-CCCCBCSSSGGG----------CSC-SEEEECTTTTSSCEEEECTTCCEEEEEEEE
T ss_pred -ecccCCceEeccCCcc-eeecccCCCCCC----------CCC-cEEEEEecCCCCcEEecCCCCCEeEEEEEc
Confidence 6667799999999765 455576666543 122 34444332 24699999999999999986
|
| >d1qdda_ d.169.1.1 (A:) Lithostathine, inhibitor of stone formation {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Lithostathine, inhibitor of stone formation species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.8e-25 Score=196.60 Aligned_cols=126 Identities=17% Similarity=0.452 Sum_probs=101.6
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhhc-CCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCC
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGL 126 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~ 126 (573)
..||+||. .|+++||+|+.+.++|.+|+.+|++. ||+||+|+|++|++||..++... ...+||||+ +...++
T Consensus 12 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~gg~L~~i~s~~e~~~l~~~l~~~~~~~~~~WiGl~--~~~~~~ 87 (144)
T d1qdda_ 12 ISCPEGTN--AYRSYCYYFNEDRETWVDADLYCQNMNSGNLVSVLTQAEGAFVASLIKESGTDDFNVWIGLH--DPKKNR 87 (144)
T ss_dssp TSCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHTTSCEECCCCSHHHHHHHHHHHHHTTCCCSEEEEEEE--CTTSSS
T ss_pred CcCCCCCE--EECCEEEEEECCccCHHHHHHHHHhccccccceEEeeecchhhhhccccccccccceeeeee--cccccc
Confidence 37999999 99999999999999999999999986 78999999999999999887533 335899999 777779
Q ss_pred ceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeec-C-CCceeccccCCCCCcccccc
Q 008216 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN-G-SRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 127 ~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~-~-~~~W~d~~C~~~~~~iC~~~ 191 (573)
.|+|+||++. .++.|..++|++. +..+|+.+.. . .+.|++..|+...+|||+.+
T Consensus 88 ~w~W~dGs~~-~y~~W~~~~P~~~----------~~~~C~~~~~~~~~~~W~~~~C~~~~~fICe~k 143 (144)
T d1qdda_ 88 AWHWSSGSLV-SYKSWGIGAPSSV----------NPGYCVSLTSSTGFQKWKDVPCEDKFSFVCKFK 143 (144)
T ss_dssp CCEETTCCCC-CCCCBCTTCSCSS----------SCCSEEEEEGGGTTCSEEEECTTSCEEEEEEEE
T ss_pred eeEecCCCee-ecccccCCCCCCC----------CCccEEEEEccCCCCcEEecCCCCCeEEEEEEC
Confidence 9999999654 5556766665542 2234555433 2 34699999999999999864
|
| >d1jwia_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]
Probab=99.92 E-value=5.5e-26 Score=194.49 Aligned_cols=120 Identities=32% Similarity=0.606 Sum_probs=95.8
Q ss_pred CCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCC----CCCCeEEeeeecCCCCCCce
Q 008216 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGK----NVNGCWVGGRSINTTVGLSW 128 (573)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~~~~w 128 (573)
||+||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|++|++||.+++.. ....+||||++.....++.|
T Consensus 1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~e~~~i~~~~~~~~~~~~~~~WiGl~~~~~~~~~~~ 78 (124)
T d1jwia_ 1 CLPDWS--SYKGHCYKVFKKVGTWEDAEKFCVENSGHLASIDSKEEADFVTKLASQTLTKFVYDAWIGLRDESKTQQCSP 78 (124)
T ss_dssp CCTTSE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHC--CCSCEEEEEEECCSSSSSCS
T ss_pred CCCCCE--eeCCEEEEEECcccCHHHHHHHHHhcCCeeeeeehHHHHHHHHHHHhccccccccceeeEeeeccCCCccce
Confidence 999999 999999999999999999999999999999999999999999887642 24469999997666666889
Q ss_pred EEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccc
Q 008216 129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (573)
Q Consensus 129 ~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~ 190 (573)
+|+||+++.+.+ | ++|+ +|.+. ......+.|++..|+...+|||+.
T Consensus 79 ~W~dgs~~~y~n-~--~~p~-~c~~~------------~~~~~~~~W~~~~C~~~~~fICet 124 (124)
T d1jwia_ 79 QWTDGSSVVYEN-V--DEPT-KCFGL------------DVHTEYRTWTDLPCGEKNPFICKS 124 (124)
T ss_dssp BCTTSCBCCSCC-B--SSCC-CEEEE------------CGGGTTSSEEEECTTSCEEEEEEC
T ss_pred ecCCCCcccccC-C--CCCC-ccEEE------------EEecCCCCEEccCCCCCEeeEeCC
Confidence 999997764332 3 4433 23222 111234579999999999999973
|
| >d1tn3a_ d.169.1.1 (A:) Tetranectin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Tetranectin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=6.6e-26 Score=197.54 Aligned_cols=128 Identities=18% Similarity=0.320 Sum_probs=101.1
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCC---CCCCeEEeeeecCCCCCCc
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGK---NVNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~---~~~~~WiGl~~~~~~~~~~ 127 (573)
..||+||. ++++||+++.+.++|.+|+.+|++.||+||+|+|.+|++||..++.+ ....+||||+ +...++.
T Consensus 4 t~C~~G~~---~~~~CY~~~~~~~tw~~A~~~C~~~gg~La~i~s~~e~~~l~~~l~~~~~~~~~~WiGl~--~~~~~~~ 78 (137)
T d1tn3a_ 4 TVCLKGTK---VHMKCFLAFTQTKTFHEASEDCISRGGTLSTPQTGSENDALYEYLRQSVGNEAEIWLGLN--DMAAEGT 78 (137)
T ss_dssp CEEEECSS---SSEEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHHHHHTCTTCEEEEEEE--EEEETTE
T ss_pred CcCCCCeE---ECCEEEEEeCccCCHHHHHHHHHHcCCccccccchHhcccccccccccccccccEeeeec--cCCcccc
Confidence 36999996 78999999999999999999999999999999999999999987743 2456999999 5556699
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeec-CCCceeccccCCCCCcccccc
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~-~~~~W~d~~C~~~~~~iC~~~ 191 (573)
|.|+||+++.+ +.|.... .++|. +...++|+.+.. ..+.|++..|+...+|||+++
T Consensus 79 w~w~dg~~~~y-~~w~~~~-----p~~p~--~~~~~~C~~~~~~~~~~W~~~~C~~~~~fICe~~ 135 (137)
T d1tn3a_ 79 WVDMTGARIAY-KNWETEI-----TAQPD--GGKTENCAVLSGAANGKWFDKRCRDQLPYICQFG 135 (137)
T ss_dssp EEETTSCBCSC-CCBCCTT-----TCSSC--CGGGCCEEEEETTTTTEEEEECTTSCEEEEEEEE
T ss_pred cEeCCCCeeee-eeecccc-----ccCCC--CCCcceeEEEEeCCCCEEEeeCCCCCEEEEEEEe
Confidence 99999976544 4443322 22333 233456777654 446799999999999999975
|
| >d1umrc_ d.169.1.1 (C:) Snake coagglutinin beta chain {South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]
Probab=99.91 E-value=1.9e-25 Score=191.25 Aligned_cols=118 Identities=22% Similarity=0.514 Sum_probs=99.1
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhc--CCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (573)
.||+||. .|+++||+++.+.++|.+|+.+|+++ ||+||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 3 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~gg~La~i~~~~e~~~l~~~~~~~~~~~~~WIGl~--~~~~~~~ 78 (125)
T d1umrc_ 3 CCPSHWS--SYDRYCYKVFKQEMTWADAEKFCTQQHTGSHLVSFHSTEEVDFVVKMTHQSLKSTFFWIGAN--NIWNKCN 78 (125)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHTTCSSSEEECSCC--CTTTSSC
T ss_pred CCCccCE--EECCEEEEEECCccCHHHHHHhhcccCCCCcccccCCHHHhhhhhhhhcccccceeEEEeee--ccccccc
Confidence 5999999 89999999999999999999999764 89999999999999999987643 456999999 7777799
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
|+|+|||++ .++.|.++ ++|+.+....+.|++.+|+...+|||+.+
T Consensus 79 w~W~dgs~~-~y~~w~~~-----------------~~c~~~~~~~~~W~~~~C~~~~~fICe~~ 124 (125)
T d1umrc_ 79 WQWSDGTKP-EYKEWHEE-----------------FECLISRTFDNQWLSAPCSDTYSFVCKFE 124 (125)
T ss_dssp EEETTSCCC-SSCCBCCC-----------------CEEEEEESSCSCEEEEETTSCEEEEEEEE
T ss_pred eEecCCCcc-cccCcCCc-----------------CCeeEEECCCCeEEeeCCCCCEEEEEEEe
Confidence 999999765 34445322 24566666667899999999999999875
|
| >d1c3ab_ d.169.1.1 (B:) Snake coagglutinin beta chain {Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]
Probab=99.91 E-value=1.5e-25 Score=191.91 Aligned_cols=118 Identities=19% Similarity=0.409 Sum_probs=98.3
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (573)
.||+||. .++++||+++.+.++|.+|+.+|++ .||+||+|+|++|++||.+++... ...+||||+ +...++.
T Consensus 3 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~L~~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~ 78 (125)
T d1c3ab_ 3 CCPLGWS--SYDEHCYQVFQQKMNWEDAEKFCTQQHKGSHLVSFHSSEEVDFVTSKTFPILKYDFVWIGLS--NVWNECT 78 (125)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCSSHHHHHHHHHHHHHHHCSCEEECSCC--CTTTSSC
T ss_pred CCCCCCE--EECCEEEEEECcccCHHHHHHhhccccCCCeecccCCHHHhhhhhhhhhccCCceeEEEEec--ccCccee
Confidence 5999999 9999999999999999999999964 589999999999999998877532 456999999 7777899
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
|+|+|||++ .++.|.+ ++ .|+.+....+.|++.+|....+|||+.+
T Consensus 79 ~~W~dGs~~-~y~~W~~--------~e---------~Cv~~~~~~~~W~~~~C~~~~~fICe~~ 124 (125)
T d1c3ab_ 79 KEWSDGTKL-DYKAWSG--------GS---------DCIVSKTTDNQWLSMDCSSKYYVVCKFQ 124 (125)
T ss_dssp EEETTCCCC-CSCCBCC--------CC---------EEEEEESSSSCEEEEETTSCEEEEEEEE
T ss_pred eEeCCCCee-eccccCC--------CC---------ceEEEECCCCeEEeeCCCCCEEEEEEEe
Confidence 999999765 3444532 23 3566666667899999999999999874
|
| >d1jwib_ d.169.1.1 (B:) Snake coagglutinin beta chain {Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Puff adder (Bitis arietans), bitiscetin [TaxId: 8692]
Probab=99.91 E-value=1.6e-25 Score=191.27 Aligned_cols=118 Identities=25% Similarity=0.512 Sum_probs=97.9
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhc--CCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~ 127 (573)
.||+||. .++++||+++.++++|.+|+.+|++. ||+||+|+|.+|++||.+++... ...+||||+ +...++.
T Consensus 1 gCp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~gg~L~~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~ 76 (123)
T d1jwib_ 1 GCLPDWS--SYKGHCYKVFKVEKTWADAEKFCKELVNGGHLMSVNSREEGEFISKLALEKMRIVLVWIGLS--HFWRICP 76 (123)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHTTCCCEEEEEEE--ECGGGSC
T ss_pred CCCCCcE--eeCCEEEEEeCcccCHHHHHHHhhhccCCccccccCCHHHhhhhhhheeccccccceEeeee--ccCccce
Confidence 4999999 89999999999999999999999875 89999999999999999876533 345899999 6666799
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
|+|+|||++. +++|.. +.+|..+....+.|++..|+...+|||+.+
T Consensus 77 ~~W~dgs~~~-y~~w~~-----------------~~~c~~~~~~~~~W~~~~C~~~~~fiCe~k 122 (123)
T d1jwib_ 77 LRWTDGARLD-YRALSD-----------------EPICFVAESFHNKWIQWTCNRKKSFVCKYR 122 (123)
T ss_dssp EEETTCCCCC-SCCSCC-----------------SCEEEEEETTTCCEEEEETTSCEEEEEEEE
T ss_pred eEccCCCCcc-cccCCC-----------------CCCEEEEECCCCeEEecCCCCCEeEEEeEE
Confidence 9999997764 444421 124666666667899999999999999864
|
| >d1sb2a1 d.169.1.1 (A:1-132) Snake coagglutinin alpha chain {Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]
Probab=99.91 E-value=2.9e-25 Score=192.15 Aligned_cols=122 Identities=24% Similarity=0.508 Sum_probs=100.0
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCC----CCCCeEEeeeecCCCCC
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGK----NVNGCWVGGRSINTTVG 125 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~~ 125 (573)
.||+||. .|+++||+|+.++++|.+|+.+|++ .||+||+|+|++|++||.+++.. ....+||||++.+...+
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~~~~~A~~~C~~~~~g~~L~~i~s~~e~~~i~~~~~~~~~~~~~~~WiGl~~~~~~~~ 78 (132)
T d1sb2a1 1 DCPDGWS--STKSYCYRPFKEKKTWEEAERFCTEQEKEAHLVSMENRLEAVFVDMVMENNFENKIYRSWIGLKIENKGQR 78 (132)
T ss_dssp CCCTTCE--ECSSEEEEEEEEEECHHHHHHHHHTSSSCCEECCCSSHHHHHHHHHHHHHHTTTCCEEEEEEEEEECSSTT
T ss_pred CCCCcCE--EECCEEEEEECcccCHHHHHHHHhhccCCccccccCCHHHHHHHHHHHhcccccccchhhhhhhccccccc
Confidence 4999999 9999999999999999999999975 48999999999999999888752 23468999997777778
Q ss_pred CceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCC--CceeccccCCCCCcccccc
Q 008216 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 126 ~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~--~~W~d~~C~~~~~~iC~~~ 191 (573)
+.|+|+|||++.+.+|+.++ .++|+.+.... +.|++..|....+|||+.+
T Consensus 79 ~~~~W~dG~~~~y~n~~~~~----------------~~~C~~~~~~~~~~~W~~~~C~~~~~fICe~~ 130 (132)
T d1sb2a1 79 SNLEWSDGSSISYENLYEPY----------------MEKCFLMDHQSGLPKWHTADCEEKNVFMCKFQ 130 (132)
T ss_dssp SSEEETTCCCCCCCCBSSCC----------------CEEEEEEEESSSSCEEEEECTTSCEEEEEEEE
T ss_pred cceecccCCcccceecCCCC----------------CccEEEEEcCCCCCcEEecCCCCCEeEEEEEe
Confidence 89999999887666554211 23466654432 5699999999999999875
|
| >d1qo3c_ d.169.1.1 (C:) NK cell receptor {Mouse (Mus musculus), ly49-a [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: NK cell receptor species: Mouse (Mus musculus), ly49-a [TaxId: 10090]
Probab=99.91 E-value=2.6e-25 Score=192.59 Aligned_cols=125 Identities=18% Similarity=0.353 Sum_probs=98.5
Q ss_pred CCCCCCCCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCC
Q 008216 46 NKDWKAPCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVG 125 (573)
Q Consensus 46 ~~~~~~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~ 125 (573)
.+.....|+.+|. .|+++||+|+.+.++|.+|+..|++.||+||+|+|++|++||+.++. ...|||||+ +...+
T Consensus 7 ~~~~~~~c~~~W~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~--~~~~WIGl~--~~~~~ 80 (133)
T d1qo3c_ 7 LQHTGRGDKVYWF--CYGMKCYYFVMDRKTWSGCKQTCQSSSLSLLKIDDEDELKFLQLVVP--SDSCWVGLS--YDNKK 80 (133)
T ss_dssp SCC-----CEEEE--EETTEEEEEEEEEECHHHHHHHHHHTTCEECCCCSHHHHHHHHHHSC--SSCEEEEEE--EEGGG
T ss_pred cccCCCCCCCceE--EECCEEEEEECccCCHHHHHHHHHhcCCEEeEEeecceeeehhcccc--cceeEEEEE--EcCCC
Confidence 3455678999999 99999999999999999999999999999999999999999999987 567999999 44556
Q ss_pred CceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 126 ~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
+.|+|+||++. .+++|...+ +...+.|+.+.. +.|++..|....+|||++.
T Consensus 81 ~~w~W~dg~~~-~~~~~~~~~------------~~~~~~C~~l~~--~~w~~~~C~~~~~~ICek~ 131 (133)
T d1qo3c_ 81 KDWAWIDNRPS-KLALNTRKY------------NIRDGGCMLLSK--TRLDNGNCDQVFICICGKR 131 (133)
T ss_dssp TEEEETTSCCC-SSCCCTTSS------------CGGGCSEEEECS--SCEEEECTTSCEEEEEEEE
T ss_pred CCEEECCCCcc-ccccccCCC------------CCCCCCEEEEEC--CEEEEcCCCCCEEEEEeEE
Confidence 99999999654 444443222 112345777643 4799999999999999875
|
| >d1jzna_ d.169.1.1 (A:) Galactose-specific C-type lectin {Western diamondback rattlesnake (Crotalus atrox) [TaxId: 8730]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Galactose-specific C-type lectin species: Western diamondback rattlesnake (Crotalus atrox) [TaxId: 8730]
Probab=99.91 E-value=2.7e-25 Score=193.17 Aligned_cols=126 Identities=21% Similarity=0.603 Sum_probs=103.3
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhc--CCeEeeeCCHHHHHHHHHHhCC---CCCCeEEeeeecCCCCCC
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGK---NVNGCWVGGRSINTTVGL 126 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~---~~~~~WiGl~~~~~~~~~ 126 (573)
.||+||. .++++||+++.++++|.+|+.+|++. |++||+|+|.+|++||...+.. ....+||||+ +...++
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~L~~i~s~~e~~~i~~~l~~~~~~~~~~WiGl~--~~~~~~ 77 (135)
T d1jzna_ 2 NCPLDWL--PMNGLCYKIFNQLKTWEDAEMFCRKYKPGCHLASFHRYGESLEIAEYISDYHKGQENVWIGLR--DKKKDF 77 (135)
T ss_dssp CSCTTSE--EETTEEEEEEEEEECHHHHHHHHHHHSSSEEECCCCSHHHHHHHHHHHHHHCCSSCCEEEEEE--CTTSSS
T ss_pred CCCCCCE--eECCEEEEEECcccCHHHHHHHhhhccccccccccCCHHHHHHHHHhhhhccCCCccEEEEEe--ecCccc
Confidence 6999999 99999999999999999999999775 7999999999999999887642 2456999999 666779
Q ss_pred ceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecC--CCceeccccCCCCCcccccc
Q 008216 127 SWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 127 ~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~--~~~W~d~~C~~~~~~iC~~~ 191 (573)
.|+|+||+++ .++.|.+++|++. .+.+.|+.+... .+.|++..|+...+|||+++
T Consensus 78 ~~~W~dg~~~-~~~~W~~~~P~~~---------~~~~~Cv~~~~~~~~~~W~~~~C~~~~~fiCe~k 134 (135)
T d1jzna_ 78 SWEWTDRSCT-DYLTWDKNQPDHY---------QNKEFCVELVSLTGYRLWNDQVCESKDAFLCQCK 134 (135)
T ss_dssp CCEETTCCCC-CCCCBCTTCCCCG---------GGCCCEEEECGGGTTCSEEEECTTSCEEEEEEEC
T ss_pred ceeecCCcee-eccccCCCCCCCC---------CCCCCEEEEEecCCCCcEEeeCCCCCEEEEeeec
Confidence 9999999765 4556777776542 234467776432 34799999999999999874
|
| >d1v7pb_ d.169.1.1 (B:) Snake coagglutinin beta chain {Snake (Echis multisquamatus), Ems16 [TaxId: 93050]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Snake (Echis multisquamatus), Ems16 [TaxId: 93050]
Probab=99.91 E-value=3.2e-25 Score=190.47 Aligned_cols=120 Identities=28% Similarity=0.531 Sum_probs=96.7
Q ss_pred CCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCCCce
Q 008216 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVGLSW 128 (573)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~~~w 128 (573)
||+||. .|+++||+++.+.++|.+|+.+|+. .||+||+|+|++|++||.+++... ...+||||+ +...++.|
T Consensus 1 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~WiGl~--~~~~~~~w 76 (127)
T d1v7pb_ 1 CPLGWS--SFDQHCYKVFEPVKNWTEAEEICMQQHKGSRLASIHSSEEEAFVSKLASKALKFTSMWIGLN--NPWKDCKW 76 (127)
T ss_dssp CCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCSSCEEEEEEE--CTTTTCCC
T ss_pred CCCCCE--eeCCEEEEEECcccCHHHHHHhhcccCCCCcccchhhhhhhhhhceeecccccceeEEeeee--ccCcccee
Confidence 999999 8999999999999999999999965 479999999999999999886532 456999999 77778999
Q ss_pred EEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEee--cCCCceeccccCCCCCcccccccCC
Q 008216 129 KWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS--NGSRSLVTERCNTSHPFICMVEHEN 194 (573)
Q Consensus 129 ~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~--~~~~~W~d~~C~~~~~~iC~~~~~~ 194 (573)
+|+||+++. ++.|..+ +| |+.+. ...+.|++..|+...+|||+.+..+
T Consensus 77 ~W~dg~~~~-y~~W~~~--------~~---------c~~~~~~~~~~~W~~~~C~~~~~fiCe~~~~P 126 (127)
T d1v7pb_ 77 EWSDNARFD-YKAWKRR--------PY---------CTVMVVKPDRIFWFTRGCEKSVSFVCKFLTDP 126 (127)
T ss_dssp EETTCCCCC-CCCBCCC--------CE---------EEEEEECSSCEEEEEEETTSCEEEEEEEECCC
T ss_pred EecCCCccc-ccccCCC--------CC---------cEEEEEECCCCeEEecCCCCCEEEEEEEcCCC
Confidence 999997654 4445432 22 33332 2234699999999999999987543
|
| >d3c8ja1 d.169.1.1 (A:138-259) NK cell receptor {Mouse (Mus musculus), ly49-c [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: NK cell receptor species: Mouse (Mus musculus), ly49-c [TaxId: 10090]
Probab=99.91 E-value=2.3e-25 Score=189.88 Aligned_cols=120 Identities=18% Similarity=0.318 Sum_probs=99.4
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (573)
.|+.+|. .|+++||+|+.+.+||.+|+.+|+++||+||+|+|++|++||.+++. ...+||||+ +...++.|+|+
T Consensus 1 ~~~k~W~--~~~~~CY~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~fi~~~~~--~~~~WIGl~--~~~~~~~w~W~ 74 (122)
T d3c8ja1 1 RGVKYWF--CYSTKCYYFIMNKTTWSGCKANCQHYGVPILKIEDEDELKFLQRHVI--PGNYWIGLS--YDKKKKEWAWI 74 (122)
T ss_dssp CCCEEEE--EEETEEEEEEEEEECHHHHHHHHHHTTCCBCCCCSHHHHHHHHHHSC--SSCEEEEEE--EETTTTEEEET
T ss_pred CCCcccE--EECCEEEEEeCCcCCHHHHHHHHHhCCCcccceehHHHhhhhhhhhe--eeeeEEEEE--EcCCCCcEEEC
Confidence 4899999 99999999999999999999999999999999999999999999887 467999999 55566999999
Q ss_pred CCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccccc
Q 008216 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 132 Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
||++..+ ++|...++. +.++|+.+.. +.|++..|....+|||+++.
T Consensus 75 dg~~~~~-~~~~~~~~~------------~~~~Cv~~~~--~~w~~~~C~~~~~~ICek~l 120 (122)
T d3c8ja1 75 DNGPSKL-DMKIKKMNF------------KSRGCVFLSK--ARIEDIDCNIPYYCICGKKL 120 (122)
T ss_dssp TSCCCTT-HHHHHTTCC------------CSSSEEEECS--SCEEEECTTSCEEEEEEEEC
T ss_pred CCCcccc-cccCCCCCC------------CCCCEEEEEC--CEEEEcCCCCCEeEEEeEEC
Confidence 9976544 334333211 2345777743 47999999999999999864
|
| >d1c3aa_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Habu snake (Trimeresurus flavoviridis), flavocetin-A [TaxId: 88087]
Probab=99.91 E-value=3.7e-25 Score=192.25 Aligned_cols=123 Identities=24% Similarity=0.470 Sum_probs=98.6
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhc--CCeEeeeCCHHHHHHHHHHhCCC----CCCeEEeeeecCCCCC
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTVG 125 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~~ 125 (573)
.||+||. .|+++||+|+...++|.+|+.+|++. ||+||+|+|++|++||.+++.+. ...+||||++.+....
T Consensus 3 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~~l~~~~~~~~~~~~~~~WiGl~~~~~~~~ 80 (135)
T d1c3aa_ 3 DCIPGWS--AYDRYCYQAFSKPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEKIKTSFQYVWIGLRIQNKEQQ 80 (135)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCCSCCSEEEEEEEECCCSSS
T ss_pred CCCCCCE--eECCEEEEEECcccCHHHHHHHHhhccccccccccCCHHHHHHHHHhhhccccccccccceeeeecCCccc
Confidence 6999999 89999999999999999999999864 99999999999999998877422 3458999996555556
Q ss_pred CceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecC--CCceeccccCCCCCccccccc
Q 008216 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 126 ~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~--~~~W~d~~C~~~~~~iC~~~~ 192 (573)
+.|.|+|||++ .++.|..++|. .|+.+... .+.|++..|+...+|||+.++
T Consensus 81 ~~~~W~dgs~~-~y~nw~~~~p~---------------~C~~~~~~~~~~~W~~~~C~~~~~fICe~~P 133 (135)
T d1c3aa_ 81 CRSEWSDASSV-NYENLVKQFSK---------------KCYALKKGTELRTWFNVYCGTENPEVCKYTP 133 (135)
T ss_dssp CCCBCTTSCBC-CCCCBCGGGCC---------------CEEEEETTSCSCSBEEECTTSCEEEEEEECC
T ss_pred ccccccccCcc-cccccCCCCCC---------------CeEEEEecCCCCCEEccCCCCCEeEEEEECC
Confidence 78999999765 44445544322 35555433 346999999999999999875
|
| >d3bdwa1 d.169.1.1 (A:59-179) CD94 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: CD94 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=2.7e-25 Score=189.25 Aligned_cols=118 Identities=16% Similarity=0.429 Sum_probs=98.4
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEc
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWS 131 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~ 131 (573)
+||.||. .|+++||+++.+.++|.+|+.+|++.||+||+|+|++|++||.. ....+||||+ +...++.|+|+
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~La~i~s~~~~~fl~~----~~~~~WiGl~--~~~~~~~w~w~ 73 (121)
T d3bdwa1 2 SCQEKWV--GYRCNCYFISSEQKTWNESRHLCASQKSSLLQLQNTDELDFMSS----SQQFYWIGLS--YSEEHTAWLWE 73 (121)
T ss_dssp CCTTTCE--EETTEEEEECSSCBCHHHHHHHHHHTTCEECCCSCGGGGGGGTT----CCCCEECSEE--EETTTTEEEET
T ss_pred cCCCCcE--EECCEEEEEEccccCHHHHHHHHhhcCCcccceeeeeeeeEeee----cccceEEEEe--ecCccceeEeC
Confidence 7999999 99999999999999999999999999999999999999999854 2457999999 55566999999
Q ss_pred CCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 132 DNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 132 Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
|||++ .++.|..++|++ ..+|+.+.. .+.|.+..|....+|||+++
T Consensus 74 dg~~~-~~~~w~~~~~~~------------~~~C~~~~~-~g~w~~~~C~~~~~fICek~ 119 (121)
T d3bdwa1 74 NGSAL-SQYLFPSFETFN------------TKNCIAYNP-NGNALDESCEDKNRYICKQQ 119 (121)
T ss_dssp TSCBC-CTTTSGGGGGCC------------TTSEEEEET-TTEEEEECTTSCBEEEEEEC
T ss_pred CCCcc-cccccCCCCCCC------------CCCEEEEEC-CCEEEeeCCCCCEEEEEeEE
Confidence 99764 455566665443 234666654 35799999999999999986
|
| >d1umra_ d.169.1.1 (A:) Snake coagglutinin alpha chain {South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: South american rattlesnake (Crotalus durissus terrificus), convulxin [TaxId: 8732]
Probab=99.91 E-value=1.8e-25 Score=194.31 Aligned_cols=124 Identities=25% Similarity=0.472 Sum_probs=100.2
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhhc--CCeEeeeCCHHHHHHHHHHhCCC----CCCeEEeeeecCCCC
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTV 124 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~ 124 (573)
..||+||. .|+++||+++.+.++|.+|+.+|+++ ||+||+|+|.+|++||.+++.+. ...+||||++.+...
T Consensus 2 ~~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~g~~La~i~s~~e~~fl~~~~~~~~~~~~~~~WiGl~~~~~~~ 79 (135)
T d1umra_ 2 LHCPSDWY--YYDQHCYRIFNEEMNWEDAEWFCTKQAKGAHLVSIKSAKEADFVAWMVTQNIEESFSHVSIGLRVQNKEK 79 (135)
T ss_dssp CSSCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHSCTTCCEEECSEEECCSSS
T ss_pred CCCCCCCE--EECCEEEEEECcccCHHHHHHHhhccCCCcceeeehhhhhhHHHHHHhhcccCCCCcceeeeeeeecccc
Confidence 37999999 89999999999999999999999764 89999999999999998876432 346899999777777
Q ss_pred CCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeec--CCCceeccccCCCCCccccccc
Q 008216 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN--GSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 125 ~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~--~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
++.|+|+|||++ .|+.|..++|+ +|+.+.. ..+.|++..|....+|||++|+
T Consensus 80 ~~~~~W~dGs~~-~y~nw~~~~~~---------------~C~~~~~~~~~~~W~~~~C~~~~~fICe~pP 133 (135)
T d1umra_ 80 QCSTKWSDGSSV-SYDNLLDLYIT---------------KCSLLKKETGFRKWFVASCIGKIPFVCKFPP 133 (135)
T ss_dssp SSCCBCTTSCBC-CCCCBCGGGCC---------------CEEEEEGGGTTCSBEEECTTCCEEEEEEECC
T ss_pred cCccccccCCcc-cccccCCCCCC---------------CEEEEEeeCCCCcEEecCCCCCEeEEEeECC
Confidence 789999999775 44455544432 2444443 2356999999999999999875
|
| >d1egga_ d.169.1.1 (A:) Macrophage mannose receptor, CRD4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Macrophage mannose receptor, CRD4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=6.6e-25 Score=190.92 Aligned_cols=127 Identities=25% Similarity=0.529 Sum_probs=99.5
Q ss_pred CCccCcccCCCCeeeEEe----cccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCC
Q 008216 53 CPPDWIINEEKSKCFGYI----GNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVG 125 (573)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~----~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~ 125 (573)
||+||....++++||+++ .++++|.+|+.+|++.||+||+|+|++|++||.+++... ...+||||+ +...+
T Consensus 1 Cp~gW~~~~~~~~CY~~~~~~~~~~~~w~~A~~~C~~~gg~L~~i~s~~e~~~i~~~l~~~~~~~~~~wiG~~--~~~~~ 78 (136)
T d1egga_ 1 CPEDWGASSRTSLCFKLYAKGKHEKKTWFESRDFCRALGGDLASINNKEEQQTIWRLITASGSYHKLFWLGLT--YGSPS 78 (136)
T ss_dssp CCTTCEECSSSSCEEEEECSCGGGCBCHHHHHHHHHTTTCEECCCCSHHHHHHHHHHHHHHTCTTCEEEEEEE--CC---
T ss_pred CCCCCeeCCCCCEEEEEEecCCCcccCHHHHHHHHHHCCCEEeEEecchhhhhhhhhcccccccccccccccc--ccccc
Confidence 999997557789999984 567799999999999999999999999999999987532 446899999 66677
Q ss_pred CceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeec-CCCceeccccCCCCCcccccc
Q 008216 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 126 ~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~-~~~~W~d~~C~~~~~~iC~~~ 191 (573)
+.|.|+||+++ .++.|.+++|++. .+.++|+.+.. ....|++..|....+|||+.+
T Consensus 79 ~~~~W~dg~~~-~y~~W~~g~P~~~---------~~~~~C~~~~~~~~~~W~~~~C~~~~~fICe~~ 135 (136)
T d1egga_ 79 EGFTWSDGSPV-SYENWAYGEPNNY---------QNVEYCGELKGDPTMSWNDINCEHLNNWICQIQ 135 (136)
T ss_dssp -CCCCTTSCCC-CCCCCCTTCSCGG---------GSCCEEEEEECSTTCCEEEEETTSCBEEEEECC
T ss_pred eeeeeecCCcc-eeecccCCCCCCC---------CCCcceEEEEcCCCCeEEecCCCCcEeEEEEEe
Confidence 99999999765 5666777766542 23446776654 346799999999999999875
|
| >d1v7pa_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Snake (Echis multisquamatus), Ems16 [TaxId: 93050]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Snake (Echis multisquamatus), Ems16 [TaxId: 93050]
Probab=99.90 E-value=5.9e-25 Score=190.70 Aligned_cols=126 Identities=25% Similarity=0.458 Sum_probs=98.4
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhhc--CCeEeeeCCHHHHHHHHHHhCCC----CCCeEEeeeecCCCC
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI--GGHLAALTSYEEEHSAQKLCGKN----VNGCWVGGRSINTTV 124 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~--~~~L~~i~~~~e~~f~~~~~~~~----~~~~WiGl~~~~~~~ 124 (573)
..||+||. .|+++||+++.+.++|.+|+.+|+++ ||+||+|+|++|++||.+++... ...+||||++.....
T Consensus 2 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~~g~La~i~s~~e~~fi~~~~~~~~~~~~~~~WIGl~~~~~~~ 79 (134)
T d1v7pa_ 2 FDCPSDWT--AYDQHCYLAIGEPQNWYEAERFCTEQAKDGHLVSIQSREEGNFVAQLVSGFMHRSEIYVWIGLRDRREEQ 79 (134)
T ss_dssp TTSCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHTGGGGGSSCSEEEEEEECCCSSS
T ss_pred CCCCCCCE--EECCEEEEEECcccCHHHHHHhhcccCCCccccccCCHHHhHHHHhhcccccccccchhhhhccccCCcc
Confidence 36999999 99999999999999999999999764 89999999999999999988643 335999999433333
Q ss_pred CCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccccc
Q 008216 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 125 ~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
...|+|+|||++ .++.|.+++|++ |.+. ......+.|++..|+...+|||+++.
T Consensus 80 ~~~~~W~dgs~~-~y~~W~~~~p~~-~~~~------------~~~~~~~~W~~~~C~~~~~fICe~~A 133 (134)
T d1v7pa_ 80 QCNPEWNDGSKI-IYVNWKEGESKM-CQGL------------TKWTNFHDWNNINCEDLYPFVCKFSA 133 (134)
T ss_dssp CSCCBCTTSCBC-CCCCBCTTCCCC-EEEE------------EGGGTTCSEEEECTTSCEEEEEEEEC
T ss_pred eeeeeecCCCcc-cccccCCCCCCc-eeEE------------EEecCCCcEEeeCCCCCEEEEEEEee
Confidence 346789999765 556677776543 3211 12234467999999999999998863
|
| >d1j34a_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Habu snake (Trimeresurus flavoviridis) [TaxId: 88087]
Probab=99.90 E-value=3.6e-25 Score=190.73 Aligned_cols=120 Identities=27% Similarity=0.583 Sum_probs=96.4
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCC----CCCCeEEeeeecCCCCC
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGK----NVNGCWVGGRSINTTVG 125 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~~ 125 (573)
.||+||. .|+++||+|+.++++|.+|+.+|++ .||+||+|+|++|++||.+++.. ....+||||++.+....
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~~~~~A~~~C~~~~~g~~L~~i~s~~e~~~l~~~~~~~~~~~~~~~WIGl~~~~~~~~ 78 (129)
T d1j34a_ 1 DCPSGWS--SYEGHCYKPFKLYKTWDDAERFCTEQAKGGHLVSIESAGEADFVAQLVTENIQNTKSYVWIGLRVQGKEKQ 78 (129)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHCCCTTCCEEEEEEECSSCSC
T ss_pred CCCCcCE--eeCCEEEEEECcccCHHHHHHhhhhccCCccccccCCHHHHHHHHhhhccccccccceEEeeeeccccccc
Confidence 4999999 9999999999999999999999975 59999999999999999887642 24569999996655555
Q ss_pred CceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeec--CCCceeccccCCCCCcccc
Q 008216 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN--GSRSLVTERCNTSHPFICM 189 (573)
Q Consensus 126 ~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~--~~~~W~d~~C~~~~~~iC~ 189 (573)
+.|+|+|||++ .++.|.+++|++ |+.+.. ..+.|++..|....+|||+
T Consensus 79 ~~~~W~dgs~~-~y~~W~~~ep~~---------------c~~~~~~~~~~~W~~~~C~~~~~fICe 128 (129)
T d1j34a_ 79 CSSEWSDGSSV-SYENWIEAESKT---------------CLGLEKETGFRKWVNIYCGQQNPFVCE 128 (129)
T ss_dssp SCCBCTTSCBC-CCCCBCGGGSCC---------------EEEECGGGTTCSBEEECTTSCEEEEEE
T ss_pred cceecCCCCcc-cccccCCCCCCc---------------EEEEEccCCCCCEEecCCCCCcceEec
Confidence 67999999765 455576666542 333322 2346999999999999997
|
| >d1sb2b1 d.169.1.1 (B:2-128) Snake coagglutinin beta chain {Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin beta chain species: Malayan pit viper (Calloselasma rhodostoma), rhodocetin [TaxId: 8717]
Probab=99.90 E-value=3.9e-25 Score=189.92 Aligned_cols=117 Identities=22% Similarity=0.482 Sum_probs=92.4
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCCHHHHHHHHHHhCC----CCCCeEEeeeecCCCCC
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTSYEEEHSAQKLCGK----NVNGCWVGGRSINTTVG 125 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~~ 125 (573)
.||+||. .|+++||+++.+.++|.+|+..|++ .||+||+|+|.+|++||..++.. ....+||||+ +
T Consensus 2 ~Cp~gw~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~gg~La~i~s~~e~~fl~~~~~~~~~~~~~~~WiGl~--~---- 73 (127)
T d1sb2b1 2 RCPTTWS--ASKLYCYKPFKEKKTWIEAERFCAKQAENGHLVSIGSAAEADFLDLVIVVNFDKQRYRAWTGLT--E---- 73 (127)
T ss_dssp CCCTTCE--ECSSEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHC---CCCEEEEEE--E----
T ss_pred cCCCCCe--ecCCEEEEEECeecCHHHHHHHHHhhcCCcccccccCHHHHHHHHHHHhhhccccccceeeeec--c----
Confidence 5999999 9999999999999999999999976 49999999999999999887642 1446999998 4
Q ss_pred CceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEee--cCCCceeccccCCCCCccccccc
Q 008216 126 LSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVS--NGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 126 ~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~--~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
+.|+|+|||++.+.+|+ .+. + +.|+.+. ...+.|++..|+...+|||+.|.
T Consensus 74 ~~~~W~dGs~~~y~nw~-~~~-~--------------~~c~~~~~~~~~~~W~~~~C~~~~~fICe~Pk 126 (127)
T d1sb2b1 74 RNLKWTNGASVSYENLY-EPY-I--------------RKCFVVQPWEGKSKWYKADCEEKNAFLCKFPK 126 (127)
T ss_dssp CCCBCTTSCBCCSCCBS-SCC-C--------------CCEEEEEEETTEEEEEEECTTSCEEEEEEEEC
T ss_pred cceeecccCCccccccC-CCC-C--------------cceeEEEEeCCCCCEEecCCCCCEEEEEEEcC
Confidence 56999999876554443 221 1 1233332 23356999999999999999863
|
| >d1fvua_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Jararaca (Bothrops jararaca), botrocetin [TaxId: 8724]
Probab=99.90 E-value=8.4e-25 Score=189.45 Aligned_cols=123 Identities=24% Similarity=0.502 Sum_probs=97.2
Q ss_pred CCCccCcccCCCCeeeEEecccCChHHHHHHHhh--cCCeEeeeCC-HHHHHHHHHHhCC----CCCCeEEeeeecCCCC
Q 008216 52 PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKE--IGGHLAALTS-YEEEHSAQKLCGK----NVNGCWVGGRSINTTV 124 (573)
Q Consensus 52 ~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~--~~~~L~~i~~-~~e~~f~~~~~~~----~~~~~WiGl~~~~~~~ 124 (573)
.||+||. .|+++||+|+.+.++|.+|+.+|++ .||+||+|++ ++|+.||..++.. ....+||||++.+...
T Consensus 1 ~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~~g~~La~i~~~~e~~~~~~~~~~~~~~~~~~~~WIGl~~~~~~~ 78 (133)
T d1fvua_ 1 DCPSGWS--SYEGNCYKFFQQKMNWADAERFCSEQAKGGHLVSIKIYSKEKDFVGDLVTKNIQSSDLYAWIGLRVENKEK 78 (133)
T ss_dssp CCCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCTTSTHHHHHHHHHHHHCCSSCCEEEEEEEECCSSS
T ss_pred CCCCCCE--EECCEEEEEECcccCHHHHHHHHhhccccccccccCCHHHHHHHHHhhhhccccCccccceEEEeeccccc
Confidence 4999999 8999999999999999999999975 5899999975 6788888876542 2446899999766666
Q ss_pred CCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCC--CceeccccCCCCCccccccc
Q 008216 125 GLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGS--RSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 125 ~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~--~~W~d~~C~~~~~~iC~~~~ 192 (573)
.+.|+|+|||++ .++.|..++|+ .|+.+.... +.|++..|....+|||++++
T Consensus 79 ~~~w~W~dGs~~-~y~~w~~~~p~---------------~C~~~~~~~~~~~W~~~~C~~~~~fICe~~P 132 (133)
T d1fvua_ 79 QCSSEWSDGSSV-SYENVVERTVK---------------KCFALEKDLGFVLWINLYCAQKNPFVCKSPP 132 (133)
T ss_dssp SSCCBCTTSCBC-CCCCBCGGGCC---------------CEEEEETTTTSCSEEEECTTCCEEEEEEECC
T ss_pred ccccccccCCcc-cccccCCCCCC---------------CeEEEEecCCCCeEEccCCCCCEEEEEEECc
Confidence 688999999765 44456555543 244554432 46999999999999999875
|
| >d1oz7a_ d.169.1.1 (A:) Snake coagglutinin alpha chain {Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Snake coagglutinin alpha chain species: Saw-scaled viper (Echis carinatus), echicetin [TaxId: 40353]
Probab=99.90 E-value=1e-24 Score=188.34 Aligned_cols=121 Identities=26% Similarity=0.570 Sum_probs=94.5
Q ss_pred CCccCcccCCCCeeeEEecccCChHHHHHHHhhcC--CeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCCCCCc
Q 008216 53 CPPDWIINEEKSKCFGYIGNFRSWDESETYCKEIG--GHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTTVGLS 127 (573)
Q Consensus 53 Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~--~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~~~~~ 127 (573)
||+||. .++++||+++.+.++|.+|+.+|+++| |+||+|+|.+|++||..++... ...+||||++........
T Consensus 2 Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~g~~g~L~~i~s~~e~~fi~~~~~~~~~~~~~~WIGl~~~~~~~~~~ 79 (131)
T d1oz7a_ 2 CPPGWS--SNGVYCYMLFKEPKTWDEAEKFCNKQGKDGHLLSIESKKEEILVDIVVSENIGKMYKIWTGLSERSKEQHCS 79 (131)
T ss_dssp CCTTCE--EETTEEEEEEEEEECHHHHHHHHHHHSTTCEECCCCSHHHHHHHHHHHHHHSCCCSEEEEEEEECCCGGGSC
T ss_pred CCCCCE--EECCEEEEEECcccCHHHHHhhhhccCCCccccccCCHHHhhhhhhheecccCCCccEEEEEEecCcccccc
Confidence 999999 999999999999999999999999876 9999999999999998877422 456999999544333346
Q ss_pred eEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecC--CCceeccccCCCCCccccccc
Q 008216 128 WKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 128 w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~--~~~W~d~~C~~~~~~iC~~~~ 192 (573)
|+|+|||...+.+++. .+++|+.+... ...|++..|+...+|||+++.
T Consensus 80 ~~W~dgs~~~~~~~~~-----------------~~~~C~~~~~~~~~~~W~~~~C~~~~~fICe~~~ 129 (131)
T d1oz7a_ 80 SRWSDGSFFRSYEIAI-----------------RYSECFVLEKQSVFRTWVATPCENTFPFMCKYPV 129 (131)
T ss_dssp CBCSSSBCCSCCCCCC-----------------SCCCEEEEEGGGTTCSEEEECTTSCEEEEEEECT
T ss_pred cccCCCCcccCCccCC-----------------CCCCEEEEEecCCCCcEEecCCCCCEeEEEeEeC
Confidence 9999997644333221 12245555432 346999999999999999874
|
| >d1uv0a_ d.169.1.1 (A:) Pancreatitis-associated protein 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Pancreatitis-associated protein 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=6.4e-24 Score=185.52 Aligned_cols=127 Identities=19% Similarity=0.362 Sum_probs=99.2
Q ss_pred CCCCccCcccCCCCeeeEEecccCChHHHHHHHhhc-CCeEeeeCCHHHHHHHHHHhCCC---CCCeEEeeeecCCC---
Q 008216 51 APCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKN---VNGCWVGGRSINTT--- 123 (573)
Q Consensus 51 ~~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~~~~e~~f~~~~~~~~---~~~~WiGl~~~~~~--- 123 (573)
..||+||. .|+++||+|+.+.++|.+|+.+|++. ||+||+|+|.+|++||..+++.. ...+||||++....
T Consensus 3 ~~Cp~gw~--~~~~~CY~~~~~~~~w~~A~~~C~~~~gg~La~i~s~~e~~~l~~~l~~~~~~~~~~WiGl~~~~~~~~~ 80 (140)
T d1uv0a_ 3 IRCPKGSK--AYGSHCYALFLSPKSWTDADLACQKRPSGNLVSVLSGAEGSFVSSLVKSIGNSYSYVWIGLHDPTQGTEP 80 (140)
T ss_dssp CCCCTTCE--EETTEEEEEEEEEECHHHHHHHHTTSTTCEECCCCSHHHHHHHHHHHTTSCTTCCEEEEEEECTTTTCC-
T ss_pred CccCcCcE--eeCCEEEEEECCccCHHHHHHhhhccccceecccCCHHHHHHHHHhhhccccccceeEEeeecccccccC
Confidence 47999999 99999999999999999999999874 99999999999999999998753 34599999943222
Q ss_pred CCCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecC--CCceeccccCCCCCccccc
Q 008216 124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNG--SRSLVTERCNTSHPFICMV 190 (573)
Q Consensus 124 ~~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~--~~~W~d~~C~~~~~~iC~~ 190 (573)
....|.|+||+++. ++.|..++|+. .+.++|+.+... .+.|++.+|+...+|||+.
T Consensus 81 ~~~~w~w~dg~~~~-~~~w~~~~~~~----------~~~~~C~~~~~~~~~~~W~~~~C~~~~~fICe~ 138 (140)
T d1uv0a_ 81 NGEGWEWSSSDVMN-YFAWERNPSTI----------SSPGHCASLSRSTAFLRWKDYNCNVRLPYVCKF 138 (140)
T ss_dssp -CCCCEETTCCCCC-CCCBSSCGGGS----------SSCCSEEEEEGGGTTCSEEEECTTSCEEEEEEE
T ss_pred CCCceEccCCCccc-ccccCCCCCCC----------CCCCCEEEEEccCCCCeEEecCCCCCEeEEEEE
Confidence 12469999997654 45565554332 233457666543 2469999999999999985
|
| >d1pwba1 d.169.1.1 (A:235-355) Surfactant protein, lectin domain {Human (Homo sapiens), SP-D [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Surfactant protein, lectin domain species: Human (Homo sapiens), SP-D [TaxId: 9606]
Probab=99.89 E-value=1.7e-24 Score=184.08 Aligned_cols=120 Identities=18% Similarity=0.276 Sum_probs=99.6
Q ss_pred CccCcccCCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCC
Q 008216 54 PPDWIINEEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDN 133 (573)
Q Consensus 54 p~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dg 133 (573)
|.|+ .++++||+++.+.++|.+|+..|++.||+||+|+|++|++||.+++......+||||+ +...++.|.|.||
T Consensus 1 P~g~---~~g~~cy~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~~~~~~~~w~dg 75 (121)
T d1pwba1 1 PNGQ---SVGEKIFKTAGFVKPFTEAQLLCTQAGGQLASPRSAAENAALQQLVVAKNEAAFLSMT--DSKTEGKFTYPTG 75 (121)
T ss_dssp TTEE---EETTEEEEEEEEEEEHHHHHHHHHHTTSEECCCCSHHHHHHHHHHHHHHTCCEECSCB--CSSSTTCCBCTTS
T ss_pred CCcE---EECCEEEEEeCeeECHHHHHHHHHHcCCEecceeechhhhhhhhccccceeeeeeeee--ccCccceeeeccc
Confidence 4554 4899999999999999999999999999999999999999999987654667999999 6667799999999
Q ss_pred CCCCCCCccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccc
Q 008216 134 MSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICM 189 (573)
Q Consensus 134 t~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~ 189 (573)
+++ .++.|.+++|++. .+.++|+.+.. ++.|++..|....+|||+
T Consensus 76 ~~~-~~~~W~~~eP~~~---------~~~~~C~~~~~-~~~W~~~~C~~~~~fICe 120 (121)
T d1pwba1 76 ESL-VYSNWAPGEPNDD---------GGSEDCVEIFT-NGKWNDRACGEKRLVVCE 120 (121)
T ss_dssp CBC-SCCCBCTTCCCCG---------GGCCCEEEECT-TSCEEEECTTSEEEEEEE
T ss_pred ccc-ccceecCCCCCCC---------CCceeEEEECC-CCEEEeeCCCCCEEEEEe
Confidence 765 5566777776642 23456777754 467999999999999996
|
| >d2msba_ d.169.1.1 (A:) Mannose-binding protein A, C-lectin domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Mannose-binding protein A, C-lectin domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.89 E-value=1.5e-23 Score=175.25 Aligned_cols=111 Identities=15% Similarity=0.220 Sum_probs=94.1
Q ss_pred eeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCCCCCcccc
Q 008216 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAV 144 (573)
Q Consensus 65 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dgt~~~~~~~~~~ 144 (573)
+||+++.++++|.+|+.+|++.||+||+|+|++|++||.++.. ..+||||+ +...+|.|.|+||+++ .++.|.+
T Consensus 2 k~y~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~---~~~WiGl~--~~~~~g~~~w~dg~~~-~y~~W~~ 75 (112)
T d2msba_ 2 KFFVTNHERMPFSKVKALCSELRGTVAIPRNAEENKAIQEVAK---TSAFLGIT--DEVTEGQFMYVTGGRL-TYSNWKK 75 (112)
T ss_dssp CEEEEEEEEECHHHHHHHHHHTTCEECCCSSHHHHHHHHHHHS---SCEEEEEE--CSSSTTCCEETTSSBC-CSCCBCT
T ss_pred cEEEECCcEeCHHHHHHHHHhCCCEEeeEcCHHHhhhhhhccc---ceEEEEEe--ecCccccccccccccc-ccccccc
Confidence 6999999999999999999999999999999999999999886 47999999 7677799999999765 5566766
Q ss_pred CCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 145 GSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 145 ~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
++|++.. +.++|+.+.. .+.|++..|....+|||+.|
T Consensus 76 ~eP~~~~---------~~~~Cv~~~~-~~~W~~~~C~~~~~fICe~P 112 (112)
T d2msba_ 76 DEPNDHG---------SGEDCVTIVD-NGLWNDISCQASHTAVCEFP 112 (112)
T ss_dssp TCCCCCT---------TCCCEEEECT-TSCEEEECTTSCEEEEEEEC
T ss_pred CCCCCCC---------CCCCEEEEeC-CCEEEEeCCCCcEEEEEecC
Confidence 7766532 3456777753 46799999999999999875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1e-23 Score=194.55 Aligned_cols=161 Identities=19% Similarity=0.188 Sum_probs=119.3
Q ss_pred CeeecccCceEEEEEEeCCCCEEEEEEecccch------------------hhHHHHHHHHHHHhhcCCCcEeEEeeEEe
Q 008216 274 NRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSF------------------QRKKEFYSEIGRFARLHHPNLVAVKGCCY 335 (573)
Q Consensus 274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 335 (573)
++.||+|+||.||+|...+|+.||||+++.... .......+|+..+.++.|++++..+++.
T Consensus 5 g~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~- 83 (191)
T d1zara2 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE- 83 (191)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE-
T ss_pred CCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec-
Confidence 467899999999999988999999998753210 1123456788999999999999887653
Q ss_pred eCCceEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCCeeEec
Q 008216 336 DHGDRYIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKVKPHVVHRDIRASNVLLDEEFGAHLMG 415 (573)
Q Consensus 336 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 415 (573)
..+++|||+++..+.+ ++......++.|++.+|+|||++ +|+||||||+|||++++ .++|+|
T Consensus 84 ---~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 84 ---GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ---TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred ---CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 2379999998765533 33344567899999999999999 99999999999999965 589999
Q ss_pred ccCCccCCccccccceeccCCcccccc------cccccCCCCCcchhhHHHHHHH
Q 008216 416 VGLSKFVPWEVMQERTVMAGGTYGYLA------PEFVYRNELTTKSDVYSFGVLL 464 (573)
Q Consensus 416 fg~~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~DvwSlGvil 464 (573)
||.|.....+... .|.. .+. ....|+.++|+||..--+
T Consensus 146 FG~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 9999765432211 1111 111 135678889999976443
|
| >d1hupa1 d.169.1.1 (A:112-228) Mannose-binding protein A, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Mannose-binding protein A, C-lectin domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=3.5e-23 Score=174.64 Aligned_cols=115 Identities=16% Similarity=0.206 Sum_probs=96.1
Q ss_pred CCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCCCCC
Q 008216 61 EEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNES 140 (573)
Q Consensus 61 ~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dgt~~~~~~ 140 (573)
.++++||+++.+.++|.+|+.+|++.||+||+|+|++|++||.+++. ..+||||+ +...+|.|.|.||+++. ++
T Consensus 2 ~vG~~~y~~~~~~~tw~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~---~~~WiGl~--~~~~~~~w~w~dg~~~~-~~ 75 (117)
T d1hupa1 2 QVGNKFFLTNGEIMTFEKVKALCVKFQASVATPRNAAENGAIQNLIK---EEAFLGIT--DEKTEGQFVDLTGNRLT-YT 75 (117)
T ss_dssp EETTEEEEEEEEEEEHHHHHHHHHHTTCEECCCCSHHHHHHHHHHCS---SCEEEEEE--CSSSTTCCEETTSCBCS-CC
T ss_pred cccCEEEEEcCEEECHHHHHHHHHHCCCEEcccCCHHHHHHHhhccc---ceEEEEee--ccCcccceeeccccccc-cc
Confidence 46889999999999999999999999999999999999999999985 47999999 66677999999997654 45
Q ss_pred ccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccccc
Q 008216 141 IHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 141 ~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~ 191 (573)
.|..++|++. .++++|+.+.. ++.|++.+|....+|||+.|
T Consensus 76 ~w~~~~p~~~---------~~~~~Cv~~~~-~~~W~~~~C~~~~~fICe~P 116 (117)
T d1hupa1 76 NWNEGEPNNA---------GSDEDCVLLLK-NGQWNDVPCSTSHLAVCEFP 116 (117)
T ss_dssp CBCTTCCCCG---------GGCCCEEEECT-TSCEEEECTTSEEEEEEEEE
T ss_pred ccCCCCCCCC---------CCcCCeEEECC-CCeEEeeCCCCCEEEEEEEe
Confidence 5666665542 23456777654 46899999999999999886
|
| >d1r13a1 d.169.1.1 (A:110-228) Surfactant protein, lectin domain {Rat (Rattus norvegicus), SP-A [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Surfactant protein, lectin domain species: Rat (Rattus norvegicus), SP-A [TaxId: 10116]
Probab=99.88 E-value=4.1e-23 Score=174.61 Aligned_cols=115 Identities=17% Similarity=0.232 Sum_probs=97.4
Q ss_pred CCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCCCCC
Q 008216 61 EEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNES 140 (573)
Q Consensus 61 ~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dgt~~~~~~ 140 (573)
..+++||+++.++++|.+|+..|++.||+||+|+|.+|++||.+++......+||||+ +...++.|.|.||+++ .++
T Consensus 4 ~vG~~cy~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~~~~~~w~w~dg~~~-~y~ 80 (119)
T d1r13a1 4 SVGDKVFSTNGQSVNFDTIKEMCTRAGGNIAVPRTPEENEAIASIAKKYNNYVYLGMI--EDQTPGDFHYLDGASV-SYT 80 (119)
T ss_dssp EETTEEEEEEEEEECHHHHHHHHHHTTSEECCCCSHHHHHHHHHHHHHTTSCEEEEEE--ECSSTTCEEETTSCBC-CSC
T ss_pred cCccEEEEECCEEECHHHHHHHhhhCCCEEeEEeehHHhhhhhhcccccceEEEEEee--cCCcceeeeeeccccc-ccc
Confidence 5789999999999999999999999999999999999999999988755667999999 5667799999999764 566
Q ss_pred ccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccc
Q 008216 141 IHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICM 189 (573)
Q Consensus 141 ~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~ 189 (573)
.|.+++|++ .++++|+.+.. .+.|++.+|+...+|||+
T Consensus 81 ~W~~~~P~~----------~~~~~Cv~~~~-~~~W~~~~C~~~~~~ICe 118 (119)
T d1r13a1 81 NWYPGEPRG----------QGKEKCVEMYT-DGTWNDRGCLQYRLAVCE 118 (119)
T ss_dssp CBCTTCCCC----------SSCCCEEEECT-TSCEEEECSCSCEEEEEE
T ss_pred eEEeeccCC----------CCCCCEEEEcC-CCEEEecCCCCCEeEEEe
Confidence 677676653 23456777764 367999999999999996
|
| >d1rdl1_ d.169.1.1 (1:) Mannose-binding protein A, C-lectin domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Mannose-binding protein A, C-lectin domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.87 E-value=3.4e-22 Score=166.69 Aligned_cols=110 Identities=15% Similarity=0.204 Sum_probs=92.0
Q ss_pred eeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCCCCCcccc
Q 008216 65 KCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAV 144 (573)
Q Consensus 65 ~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dgt~~~~~~~~~~ 144 (573)
+||+++.++++|.+|+.+|++.||+||+|+|++|++||.+++. ..+||||+ +...+|.|.|+||+++ .++.|.+
T Consensus 1 kyy~~~~~~~~~~~A~~~C~~~gg~La~i~s~~e~~~l~~~~~---~~~WiGl~--~~~~~~~~~w~dG~~~-~y~~W~~ 74 (111)
T d1rdl1_ 1 KYFMSSVRRMPLNRAKALCSELQGTVATPRNAEENRAIQNVAK---DVAFLGIT--DQRTENVFEDLTGNRV-RYTNWNE 74 (111)
T ss_dssp CEEEECSSCBCHHHHHHHHHHTTCEECCCCSHHHHHHHHHHCS---SCEEEEEE--CSSSTTCCEETTSCBC-CCCCBCT
T ss_pred CEEEECCcEeCHHHHHHHHHHcCCEEEEECCHHHhHHHhhccc---ceeeEEee--ecCccceeeecccccc-eeeeccc
Confidence 5899999999999999999999999999999999999999875 46999999 6667799999999765 4566777
Q ss_pred CCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccc
Q 008216 145 GSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMV 190 (573)
Q Consensus 145 ~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~ 190 (573)
++|++. .+.++|+.+.. ++.|++..|....+|||+.
T Consensus 75 geP~~~---------~~~~~Cv~~~~-~g~W~d~~C~~~~~fICe~ 110 (111)
T d1rdl1_ 75 GEPNNV---------GSGENCVVLLT-NGKWNDVPCSDSFLVVCEF 110 (111)
T ss_dssp TCCCCC---------TTCCCEEEECT-TSCEEEECTTSCBEEEEEE
T ss_pred cCCCCC---------CCcceEEEECC-CCEEEeeCCCCCEEEEEEE
Confidence 766653 23456777754 4579999999999999974
|
| >d1h8ua_ d.169.1.1 (A:) Eosinophil major basic protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Eosinophil major basic protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=3e-22 Score=168.13 Aligned_cols=111 Identities=17% Similarity=0.325 Sum_probs=92.6
Q ss_pred eEEecccCChHHHHHHHhh-cCCeEeeeCCHHHHHHHHHHhCCC-CCCeEEeeeecCCCCCCceEEcCCCCCCCCCcccc
Q 008216 67 FGYIGNFRSWDESETYCKE-IGGHLAALTSYEEEHSAQKLCGKN-VNGCWVGGRSINTTVGLSWKWSDNMSKWNESIHAV 144 (573)
Q Consensus 67 y~~~~~~~~w~~a~~~C~~-~~~~L~~i~~~~e~~f~~~~~~~~-~~~~WiGl~~~~~~~~~~w~W~Dgt~~~~~~~~~~ 144 (573)
|+++.+.+||.+|+.+|++ .|||||+|+|.+|++||..++... ...+||||...+...++.|.|+|||++ .|+.|..
T Consensus 2 Y~~~~~~~tw~~A~~~C~~~~gg~L~sI~s~~e~~~i~~~~~~~~~~~~WIGl~~~~~~~~~~~~W~dGs~~-~y~~W~~ 80 (115)
T d1h8ua_ 2 YLLVRSLQTFSQAWFTCRRCYRGNLVSIHNFNINYRIQCSVSALNQGQVWIGGRITGSGRCRRFQWVDGSRW-NFAYWAA 80 (115)
T ss_dssp EEEEEEEECHHHHHHHHHHHHSSEECCCCSHHHHHHHHHHHTTCSSSEEEEEEEEECSSSCCEEEETTCCCC-CCCCBCS
T ss_pred eEEECCccCHHHHHHHhhcccCCcCcccCHHHHHHHHHHHHhhcCCCcEEEEEEecCCCCcceEEEecCcee-ecccccC
Confidence 8899999999999999987 699999999999999999998764 456999987657667789999999765 5666776
Q ss_pred CCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCcccc
Q 008216 145 GSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICM 189 (573)
Q Consensus 145 ~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~ 189 (573)
++|++. .++|+.+...++.|++..|....+|||+
T Consensus 81 ~~P~~~-----------~~~Cv~~~~~~g~W~~~~C~~~~~fICe 114 (115)
T d1h8ua_ 81 HQPWSR-----------GGHCVALCTRGGYWRRAHCLRRLPFICS 114 (115)
T ss_dssp SSCCTT-----------SCSEEEEETTTTCEEEECTTSCEEEEEE
T ss_pred CCCCCC-----------CCCEEEEECCCCEEEeeCCCCCEeeEEe
Confidence 665531 2357777766678999999999999996
|
| >d1kg0c_ d.169.1.1 (C:) EBV gp42 {Epstein-Barr virus [TaxId: 10376]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: EBV gp42 species: Epstein-Barr virus [TaxId: 10376]
Probab=99.86 E-value=2.6e-22 Score=172.94 Aligned_cols=120 Identities=17% Similarity=0.196 Sum_probs=94.6
Q ss_pred CCCCC--CCCccCcccCCCCeeeEEecccCChHHHHHHHhhc-CCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCC
Q 008216 47 KDWKA--PCPPDWIINEEKSKCFGYIGNFRSWDESETYCKEI-GGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTT 123 (573)
Q Consensus 47 ~~~~~--~Cp~~w~~~~~~~~Cy~~~~~~~~w~~a~~~C~~~-~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~ 123 (573)
.+.|. .||.+|. .|+++||+|+.+.++|.+|+.+|++. +++|++|++++|+.||..++.. ...|||||++ +
T Consensus 11 ~~~c~~c~~~~~~~--~~~~~CY~~~~~~~tw~~A~~~C~~~~~~~L~~i~~~~e~~fl~~~~~~-~~~~WIGL~~-~-- 84 (136)
T d1kg0c_ 11 KANCTYCNTREYTF--SYKGCCFYFTKKKHTWNGCFQACAEKYPCTYFYGPTPDILPVVTRNLNA-IESLWVGVYR-V-- 84 (136)
T ss_dssp CCCSBCCCTTTCSE--EETTEEEEECSSCBCTTHHHHHHHHHSTTCEECCCCTTTHHHHHHTSCS-SCCEECSEEE-S--
T ss_pred CCCCCcCCCCCCeE--eECCEEEEEEcccCcHHHHHHHHhcCCCCcEeccCCHHHHHHHHHhcCC-CCcEEEEEEe-c--
Confidence 34443 5689999 99999999999999999999999886 5699999999999999998763 4579999984 2
Q ss_pred CCCceEEcCCCCCCCCCccccCCCCCCccCCCCcCCcccceeEEeec-CCCceeccccCCCCCcccccc
Q 008216 124 VGLSWKWSDNMSKWNESIHAVGSFNSSCTSLPCHVHATVDLCTLVSN-GSRSLVTERCNTSHPFICMVE 191 (573)
Q Consensus 124 ~~~~w~W~Dgt~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~-~~~~W~d~~C~~~~~~iC~~~ 191 (573)
.+|.|+|+||++..+++. .++.|+.+.. ....|++..|+...+|||+.+
T Consensus 85 ~~~~W~W~Dgs~~~~~~~-------------------~~~~C~~l~~~~~~~w~~~~C~~~~~~IC~~~ 134 (136)
T d1kg0c_ 85 GEGNWTSLDGGTFKVYQI-------------------FGSHCTYVSKFSTVPVSHHECSFLKPCLCVSQ 134 (136)
T ss_dssp SSSSEEETTCSCCCCBCS-------------------SCTTCEEECTTCSSCEECSCTTSCBCBEEEEE
T ss_pred CCCceEECCCCccccccc-------------------cccceEEEEecCCCcEeecCCCCCcceEEEEe
Confidence 358999999976422211 1124555543 345799999999999999874
|
| >d1g1ta1 d.169.1.1 (A:1-118) E-selectin, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: E-selectin, C-lectin domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=8.7e-21 Score=160.13 Aligned_cols=110 Identities=20% Similarity=0.366 Sum_probs=89.4
Q ss_pred eeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCC--CCCCccc
Q 008216 66 CFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSK--WNESIHA 143 (573)
Q Consensus 66 Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dgt~~--~~~~~~~ 143 (573)
||+|+.++++|.+|+.+|++.||+||+|+|++|++||.+++......+||||+ +. ++.|.|+||+.. ..+..|.
T Consensus 2 ~Y~~~~~~~tw~~A~~~C~~~g~~La~i~s~~e~~~l~~~~~~~~~~~WiGl~--~~--~~~~~w~~~~~~~~~~~~~W~ 77 (118)
T d1g1ta1 2 SYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIR--KV--NNVWVWVGTQKPLTEEAKNWA 77 (118)
T ss_dssp EEEECSSCBCHHHHHHHHHHHSSEECCCCSHHHHHHHHHHSCCCTTCEEESEE--EE--TTEEEETTTCCBCCTTTCCBC
T ss_pred EEEEeCCccCHHHHHHHHHHCCCEEeEEccHHHhHHHHhccccccceeeeccc--cc--ceeeeeecCCCCccccccccC
Confidence 79999999999999999999999999999999999999998766677999999 43 378999998654 2456677
Q ss_pred cCCCCCCccCCCCcCCcccceeEEee----cCCCceeccccCCCCCccc
Q 008216 144 VGSFNSSCTSLPCHVHATVDLCTLVS----NGSRSLVTERCNTSHPFIC 188 (573)
Q Consensus 144 ~~~~~~~~~~~p~~~~~~~~~C~~~~----~~~~~W~d~~C~~~~~~iC 188 (573)
+++|++. . +.++|+.+. ...+.|+|..|+...+|||
T Consensus 78 ~~eP~~~--------~-~~~~Cv~l~~~~~~~~~~W~d~~C~~~~~fIC 117 (118)
T d1g1ta1 78 PGEPNNR--------Q-KDEDCVEIYIKREKDVGMWNDERCSKKKLALC 117 (118)
T ss_dssp TTCCCCC--------S-TTCCEEEECTTCSSSTTCEEEECTTSCBEEEE
T ss_pred CCCccCC--------C-CCCCeEEEEecCCCCCCeEeccCCCCCeeEEc
Confidence 6666542 2 234577663 2335699999999999999
|
| >d1wk1a_ d.169.1.1 (A:) Hypothetical protein F28B4.3 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Hypothetical protein F28B4.3 species: Caenorhabditis elegans [TaxId: 6239]
Probab=99.82 E-value=1.6e-20 Score=165.38 Aligned_cols=125 Identities=15% Similarity=0.316 Sum_probs=91.0
Q ss_pred CCCCeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCCCCCC
Q 008216 61 EEKSKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSKWNES 140 (573)
Q Consensus 61 ~~~~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dgt~~~~~~ 140 (573)
..+.+||.+..+.++|.+|+.+|+++||+||+|++++|++||.++.. ...|||||++ . .+|.|+|+||+++....
T Consensus 5 ~~g~~~~~~~~~~~s~~~A~~~C~~~gg~La~i~~~~e~~fi~~~~~--~~~~WiGl~~--~-~~g~w~W~dg~~~~~~~ 79 (150)
T d1wk1a_ 5 SSGVKFLTVNDDILSMPQARNFCASAGGYLADDLGDDKNNFYSSIAA--NTQFWIGLFK--N-SDGQFYWDRGQGINPDL 79 (150)
T ss_dssp SCCCCSSSCCSSCBCHHHHHHHHHHHTCEECCCCSHHHHHHHHHHTT--TCEEEEEEEE--C-SSSCEEECCSSSSCCEE
T ss_pred CCCcEEEEEeCCccCHHHHHHHHHhCCCEEeeeCCHHHHHHhhhccc--ccceeEeeee--c-ccccccccccccccccc
Confidence 34455666788899999999999999999999999999999999987 5689999984 2 45899999997754221
Q ss_pred ccccCCCCCCccCCCCcCCcccceeEEeec-CC---CceeccccCCCCCcccccccCC
Q 008216 141 IHAVGSFNSSCTSLPCHVHATVDLCTLVSN-GS---RSLVTERCNTSHPFICMVEHEN 194 (573)
Q Consensus 141 ~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~-~~---~~W~d~~C~~~~~~iC~~~~~~ 194 (573)
+. ..+.+|-.++|.+ ...+.|+.+.. .+ ..|++..|....+|||+++...
T Consensus 80 ~~--~~~~~W~~~eP~~--~~~~~C~~~~~~~~~~~~~W~~~~C~~~~~fICe~~~~~ 133 (150)
T d1wk1a_ 80 LN--QPITYWANGEPSN--DPTRQCVYFDGRSGDKSKVWTTDTCATPRPFICQKHRYD 133 (150)
T ss_dssp CC--CSCCCBCTTCSCC--CSSCCEEEEESSCSCGGGCEEEECTTSCBCCCEECCCCC
T ss_pred cc--cccccccCCCCCC--CCCcceEEEeccCCCCCCceEccCCCCCEeEEEEECCCC
Confidence 11 1233444445532 22234555433 22 3599999999999999986543
|
| >d1g1sa1 d.169.1.1 (A:1-118) P-selectin, C-lectin domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: P-selectin, C-lectin domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=9.4e-21 Score=159.91 Aligned_cols=109 Identities=19% Similarity=0.344 Sum_probs=87.7
Q ss_pred eEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCCCCCeEEeeeecCCCCCCceEEcCCCCC--CCCCcccc
Q 008216 67 FGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKNVNGCWVGGRSINTTVGLSWKWSDNMSK--WNESIHAV 144 (573)
Q Consensus 67 y~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~~~~~WiGl~~~~~~~~~~w~W~Dgt~~--~~~~~~~~ 144 (573)
|+|+.++++|.+|+.+|++.||+||+|+|++|++||.+++......+||||+ +.. +.|+|+||+.. ..++.|.+
T Consensus 3 Y~~~~~~~~w~~A~~~C~~~gg~La~i~s~~e~~fl~~~~~~~~~~~WiGl~--~~~--~~~~W~~~~~~~~~~~~~W~~ 78 (118)
T d1g1sa1 3 YHYSTKAYSWNISRKYCQNRYTDLVAIQNKNEIDYLNKVLPYYSSYYWIGIR--KNN--KTWTWVGTKKALTNEAENWAD 78 (118)
T ss_dssp EEEEEEEECHHHHHHHHHHHSSEECCCCCHHHHHHHHHHSCCCTTCEEEEEE--EET--TEEEETTTCCBCCTTTCCBCT
T ss_pred EEEECCccCHHHHHHHHHHcCCEEeEEeCHHHHHHHHhhhccccccchhhcc--ccc--cccceecCCCCccceecccCC
Confidence 8999999999999999999999999999999999999998766667999999 433 78999988653 34556766
Q ss_pred CCCCCCccCCCCcCCcccceeEEeec----CCCceeccccCCCCCccc
Q 008216 145 GSFNSSCTSLPCHVHATVDLCTLVSN----GSRSLVTERCNTSHPFIC 188 (573)
Q Consensus 145 ~~~~~~~~~~p~~~~~~~~~C~~~~~----~~~~W~d~~C~~~~~~iC 188 (573)
++|++. .+.++|+.+.. ..+.|++..|....+|||
T Consensus 79 ~eP~~~---------~~~~~Cv~~~~~~~~~~~~W~d~~C~~~~~fIC 117 (118)
T d1g1sa1 79 NEPNNK---------RNNEDCVEIYIKSPSAPGKWNDEHCLKKKHALC 117 (118)
T ss_dssp TCCCCT---------TSCCCEEEECTTCSSSTTCEEEECTTSCEEEEE
T ss_pred CCCCCC---------CCCCCeEEEEccCCCCCCeEEeeCCCCCEeEEc
Confidence 666542 23446776632 235699999999999999
|
| >d1byfa_ d.169.1.1 (A:) Lectin TC14 {Tunicate (Polyandrocarpa misakiensis) [TaxId: 7723]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: C-type lectin domain domain: Lectin TC14 species: Tunicate (Polyandrocarpa misakiensis) [TaxId: 7723]
Probab=99.75 E-value=8.9e-19 Score=148.64 Aligned_cols=118 Identities=18% Similarity=0.300 Sum_probs=93.2
Q ss_pred CeeeEEecccCChHHHHHHHhhcCCeEeeeCCHHHHHHHHHHhCCC--CCCeEEeeeecCCCCC-CceEEcCCCCCC-CC
Q 008216 64 SKCFGYIGNFRSWDESETYCKEIGGHLAALTSYEEEHSAQKLCGKN--VNGCWVGGRSINTTVG-LSWKWSDNMSKW-NE 139 (573)
Q Consensus 64 ~~Cy~~~~~~~~w~~a~~~C~~~~~~L~~i~~~~e~~f~~~~~~~~--~~~~WiGl~~~~~~~~-~~w~W~Dgt~~~-~~ 139 (573)
++.|.|+.+.++|.+|+.+|++.||+||+|.+++|+.|+..+.... ...+|||++ +...+ ..|.|.||+++. .+
T Consensus 1 ~y~~~f~~~~~tw~~A~~~C~~~g~~La~i~~~~~~~~~~~~~~~~~~~~~~WiG~~--~~~~~~~~w~~~~~~~~~~~~ 78 (123)
T d1byfa_ 1 DYEILFSDETMNYADAGTYCQSRGMALVSSAMRDSTMVKAILAFTEVKGHDYWVGAD--NLQDGAYNFLWNDGVSLPTDS 78 (123)
T ss_dssp CEEEEEEEEEECHHHHHHHHHTTTCEESCGGGGSHHHHHHHHHHHHHHTCCEEEEEE--STTTCTTCCEETTSCBCCTTC
T ss_pred CeEEEEECcEeCHHHHHHHHHHCCCCCCccCCHHHHHHHHHHHhccCCCccEEEeec--cccccccccccccCCcccccc
Confidence 3578999999999999999999999999999999999987655322 557999999 44333 369999998654 35
Q ss_pred CccccCCCCCCccCCCCcCCcccceeEEeecCCCceeccccCCCCCccccccc
Q 008216 140 SIHAVGSFNSSCTSLPCHVHATVDLCTLVSNGSRSLVTERCNTSHPFICMVEH 192 (573)
Q Consensus 140 ~~~~~~~~~~~~~~~p~~~~~~~~~C~~~~~~~~~W~d~~C~~~~~~iC~~~~ 192 (573)
++|..++|++. .+.++|+.+....+.|++.+|....+|||+++.
T Consensus 79 ~~~~~~~p~~~---------~~~~~Cv~l~~~~~~W~~~~C~~~~~fICe~~~ 122 (123)
T d1byfa_ 79 DLWSPNEPSNP---------QSWQLCVQIWSKYNLLDDVGCGGARRVICEKEL 122 (123)
T ss_dssp TTBCTTCSCSC---------TTSCCEEEEETTTTEEEEECSCSCEEEEEEEEC
T ss_pred ccccccccccc---------cCcceeEEEecCCCeEeeeCCCCCEeEEEEEcc
Confidence 66666665542 234568888777778999999999999998864
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.51 E-value=2.2e-07 Score=87.69 Aligned_cols=148 Identities=12% Similarity=0.060 Sum_probs=99.0
Q ss_pred HHHHhhcCCCcCCeeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeCCce
Q 008216 262 ELRSITKNFSEGNRLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDR 340 (573)
Q Consensus 262 el~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~ 340 (573)
|+......+.. .+..+.++.+.||+... +++.++||+...........+.+|...+..+. +--+.+++.+..+++..
T Consensus 8 ~l~~~~~~~~~-~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRC-VKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEE-EECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhhhceEE-EEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 55555544432 22222334468998875 67778899887654444556778888887773 43466778888888889
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 008216 341 YIVYEFVVNGPLDRWLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHDKV------------------------------- 389 (573)
Q Consensus 341 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------------- 389 (573)
++||++++|.++.+.... ......++.+++..++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEecccccccccccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 999999999888665421 0112234555666666666421
Q ss_pred -------------------------CCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 390 -------------------------KPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 390 -------------------------~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
.+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1137999999999999987666799998775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.00 E-value=6.7e-06 Score=76.73 Aligned_cols=128 Identities=16% Similarity=0.128 Sum_probs=84.9
Q ss_pred cccCc-eEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcC--CCcEeEEeeEEeeCCceEEEEEecCCCCHHH
Q 008216 278 GDSKT-GGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLH--HPNLVAVKGCCYDHGDRYIVYEFVVNGPLDR 354 (573)
Q Consensus 278 g~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 354 (573)
..|.. +.||+...+++..+++|...... ...+..|...++.+. .-.+.+++.+..+++..++||++++|.++.+
T Consensus 19 ~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 19 TIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp SCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred CCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence 44443 67999998788889999876553 234667888777763 3346678888888888999999998866533
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 008216 355 WLHHIPRGGRSLDWAMRMKVATTLAQGIAFLHD----------------------------------------------- 387 (573)
Q Consensus 355 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~----------------------------------------------- 387 (573)
.. .... ..+.+++..|+-||+
T Consensus 96 ~~---------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 96 SH---------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp SC---------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cc---------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 11 1111 112223333333332
Q ss_pred ----CC----CCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 388 ----KV----KPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 388 ----~~----~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
.. .+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 11 1248999999999999987667899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.41 E-value=0.00024 Score=70.50 Aligned_cols=74 Identities=15% Similarity=-0.002 Sum_probs=47.9
Q ss_pred eecccCceEEEEEEeCC-CCEEEEEEeccc------c-hhhHHHHHHHHHHHhhc-CC--CcEeEEeeEEeeCCceEEEE
Q 008216 276 LLGDSKTGGTYSGILPD-GSRVAVKRLKRS------S-FQRKKEFYSEIGRFARL-HH--PNLVAVKGCCYDHGDRYIVY 344 (573)
Q Consensus 276 ~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l-~h--~nIv~l~~~~~~~~~~~lv~ 344 (573)
-||.|....||+....+ ++.|+||.-... . .....+...|...|+.+ .+ ..+++++.+ ++...++||
T Consensus 33 eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvm 110 (392)
T d2pula1 33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVM 110 (392)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEE
T ss_pred EeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEE
Confidence 46999999999998654 678999975431 0 11223455688777766 22 345566654 555678999
Q ss_pred EecCCCC
Q 008216 345 EFVVNGP 351 (573)
Q Consensus 345 e~~~~gs 351 (573)
|++++..
T Consensus 111 E~L~~~~ 117 (392)
T d2pula1 111 EDLSHLK 117 (392)
T ss_dssp CCCTTSE
T ss_pred eccCCcc
Confidence 9997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.02 E-value=0.00064 Score=65.44 Aligned_cols=136 Identities=14% Similarity=0.128 Sum_probs=78.1
Q ss_pred eEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCcE--eEEee-----EEeeCCceEEEEEecCCCCHH--
Q 008216 283 GGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPNL--VAVKG-----CCYDHGDRYIVYEFVVNGPLD-- 353 (573)
Q Consensus 283 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~l~~-----~~~~~~~~~lv~e~~~~gsL~-- 353 (573)
-.||++..++|+.+++|+.+... ...+++..|+..+..|...++ +..+. .....+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 58999999999999999987652 345678889888888742222 11111 123345678899998764321
Q ss_pred ---HH------h-------ccCC-CCCCCCCH-------------------H---HHHHHHHHHHHHHHHH-HhCCCCCe
Q 008216 354 ---RW------L-------HHIP-RGGRSLDW-------------------A---MRMKVATTLAQGIAFL-HDKVKPHV 393 (573)
Q Consensus 354 ---~~------l-------~~~~-~~~~~l~~-------------------~---~~~~i~~qi~~~L~~L-H~~~~~~i 393 (573)
.+ + .... ......+. . .....+.++...+.-. .+....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 10 0 0000 00111111 1 1122233333333222 12224479
Q ss_pred EEcCCCCCCeeeCCCCCeeEecccCCcc
Q 008216 394 VHRDIRASNVLLDEEFGAHLMGVGLSKF 421 (573)
Q Consensus 394 iH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 421 (573)
||+|+.|.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 56899998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.60 E-value=0.0019 Score=61.62 Aligned_cols=160 Identities=13% Similarity=0.067 Sum_probs=83.3
Q ss_pred cCHHHHHHhhcCCCcCC----eeecccCceEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHhhcCCCc--EeEEe
Q 008216 258 FTTEELRSITKNFSEGN----RLLGDSKTGGTYSGILPDGSRVAVKRLKRSSFQRKKEFYSEIGRFARLHHPN--LVAVK 331 (573)
Q Consensus 258 ~~~~el~~~~~~~~~~~----~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~ 331 (573)
.+.+|+..+...|..+. +.|..|---+.|+.+.++| .+++|+..... ..+++..|+.++..|...+ +...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 56788888888875532 1234566678899988665 48999986542 2344556677777763222 21111
Q ss_pred eE------EeeCCceEEEEEecCCCCHHH-----------H---hcc----C--CCCCCCC-----------------CH
Q 008216 332 GC------CYDHGDRYIVYEFVVNGPLDR-----------W---LHH----I--PRGGRSL-----------------DW 368 (573)
Q Consensus 332 ~~------~~~~~~~~lv~e~~~~gsL~~-----------~---l~~----~--~~~~~~l-----------------~~ 368 (573)
.. ..-.+....++.+..+..... . ++. . ....... ..
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 11 112234456666665532211 0 000 0 0000000 00
Q ss_pred HHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCCeeEecccCCc
Q 008216 369 AMRMKVATTLAQGIAFLHD-KVKPHVVHRDIRASNVLLDEEFGAHLMGVGLSK 420 (573)
Q Consensus 369 ~~~~~i~~qi~~~L~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 420 (573)
......+..+...+.-.+. ..+.++||+|+.++||+++.+...-++||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111222223333333322 223489999999999999988777899999774
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.37 E-value=0.0047 Score=60.84 Aligned_cols=72 Identities=13% Similarity=0.106 Sum_probs=48.4
Q ss_pred eeecccCceEEEEEEeCC--------CCEEEEEEecccchhhHHHHHHHHHHHhhcC-CCcEeEEeeEEeeCCceEEEEE
Q 008216 275 RLLGDSKTGGTYSGILPD--------GSRVAVKRLKRSSFQRKKEFYSEIGRFARLH-HPNLVAVKGCCYDHGDRYIVYE 345 (573)
Q Consensus 275 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e 345 (573)
+.|+.|-.-.+|+...++ ++.|.+++.... .......+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 356889999999998654 356777776532 22344567888888884 4334467776642 68999
Q ss_pred ecCCCCH
Q 008216 346 FVVNGPL 352 (573)
Q Consensus 346 ~~~~gsL 352 (573)
|++|.+|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2pf5a1 d.169.1.4 (A:1-95) TSG-6, Link module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: C-type lectin-like superfamily: C-type lectin-like family: Link domain domain: TSG-6, Link module species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.26 E-value=0.46 Score=35.42 Aligned_cols=24 Identities=29% Similarity=0.526 Sum_probs=20.9
Q ss_pred cCChHHHHHHHhhcCCeEeeeCCH
Q 008216 73 FRSWDESETYCKEIGGHLAALTSY 96 (573)
Q Consensus 73 ~~~w~~a~~~C~~~~~~L~~i~~~ 96 (573)
..|+.||+..|++.|+.||+.+.-
T Consensus 13 ~l~f~eA~~~C~~~ga~LAt~~QL 36 (95)
T d2pf5a1 13 KLTYAEAKAVCEFEGGHLATYKQL 36 (95)
T ss_dssp CBCHHHHHHHHHHTTCEECCHHHH
T ss_pred cCCHHHHHHHHHHcCCccCCHHHH
Confidence 479999999999999999987433
|